data_2kcz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kcz _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.686 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 4.4 p . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 121.929 0.871 . . . . 73.430000000000007 109.828 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.3 t -92.05 134.35 30.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.336 -0.847 . . . . 43.399999999999999 110.544 -176.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.64 ' HD2' ' O ' ' A' ' 7' ' ' ARG . 7.4 ppt_? -115.65 112.1 21.61 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.277 0.56 . . . . 74.310000000000002 110.261 175.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.436 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 31.3 t0 -157.48 172.52 18.42 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.002 -0.74 . . . . 65.25 109.002 177.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.615 ' HB3' HG13 ' A' ' 105' ' ' VAL . . . -138.39 132.27 31.18 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.733 0.301 . . . . 75.129999999999995 111.359 -176.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.459 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 23.8 m -110.76 145.95 16.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.194 -0.457 . . . . 70.140000000000001 110.581 178.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 97.4 m -109.71 118.78 37.45 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.053 -0.521 . . . . 72.230000000000004 111.031 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.744 HG23 ' HG3' ' A' ' 144' ' ' GLN . 5.0 mp -127.04 150.16 32.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.829 -0.623 . . . . 74.409999999999997 109.37 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.33 54.2 3.57 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.775 -0.726 . . . . 72.430000000000007 113.106 -178.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.546 ' HD3' ' HB2' ' A' ' 18' ' ' GLN . 50.9 mttp -131.67 144.4 53.15 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 108.849 -0.797 . . . . 71.109999999999999 108.849 174.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.59 -56.9 2.08 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.759 2.306 . . . . 62.520000000000003 113.803 -171.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.445 ' HA ' HD11 ' A' ' 19' ' ' LEU . . . 174.01 -47.48 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.649 0.738 . . . . 75.299999999999997 109.175 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -48.76 -47.15 41.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.081 -1.418 . . . . 72.140000000000001 111.952 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.546 ' HB2' ' HD3' ' A' ' 14' ' ' LYS . 67.5 mt-30 -83.39 -10.93 58.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.874 0.369 . . . . 73.299999999999997 111.119 -174.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.445 HD11 ' HA ' ' A' ' 16' ' ' ALA . 95.4 mt -77.57 -48.49 16.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.52 -0.309 . . . . 71.349999999999994 110.543 -178.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.666 ' HB3' ' HZ ' ' A' ' 93' ' ' PHE . 16.8 p90 -73.67 -23.85 59.89 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.107 -0.637 . . . . 71.450000000000003 109.483 175.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.483 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . . . -73.18 -1.79 19.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.212 -0.904 . . . . 72.120000000000005 111.791 177.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.605 HG11 ' HZ ' ' A' ' 140' ' ' PHE . 12.1 p -54.06 -22.89 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 122.666 0.386 . . . . 73.019999999999996 111.681 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -75.17 -8.22 55.99 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.092 0.472 . . . . 74.129999999999995 110.955 178.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.493 ' HA ' ' HE ' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -115.83 -174.5 2.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.676 -0.693 . . . . 71.120000000000005 110.032 178.568 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.13 33.9 1.31 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.698 -0.683 . . . . 62.409999999999997 109.225 177.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.433 HD21 ' HB3' ' A' ' 18' ' ' GLN . 75.7 mt 55.26 85.25 0.19 Allowed Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 115.208 -0.905 . . . . 63.32 110.375 -173.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo . . . . . 0 C--N 1.345 0.394 0 C-N-CA 123.11 2.54 . . . . 70.450000000000003 113.508 -173.898 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.346 0 CA-C-O 121.446 0.641 . . . . 73.239999999999995 112.493 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.476 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 19.6 tt0 -129.37 160.51 32.83 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.74 -1.118 . . . . 72.099999999999994 109.162 176.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.574 ' CD1' ' HA ' ' A' ' 77' ' ' TRP . 4.1 mm? -108.92 116.49 32.1 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.832 -0.803 . . . . 72.019999999999996 108.832 170.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.6 t -78.04 -16.65 57.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.06 -0.518 . . . . 75.209999999999994 112.174 -168.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.6 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -143.32 130.05 20.34 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 121.012 -0.275 . . . . 74.200000000000003 110.464 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.543 ' HA ' HG13 ' A' ' 75' ' ' ILE . 18.7 t70 -145.03 113.36 6.59 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.117 -0.492 . . . . 74.140000000000001 110.127 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -130.33 144.92 55.22 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.625 -0.509 . . . . 71.219999999999999 109.625 176.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -52.67 -34.14 62.53 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.175 2.584 . . . . 73.319999999999993 113.009 -177.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -168.74 55.67 0.21 Allowed Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.868 -0.682 . . . . 45.140000000000001 111.994 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -127.87 -77.39 0.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.201 -0.296 . . . . 74.109999999999999 110.201 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 18.1 ptp180 -157.43 138.91 13.84 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.14 -0.482 . . . . 75.049999999999997 110.123 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.716 HD12 ' HE2' ' A' ' 93' ' ' PHE . 3.1 mp -129.57 122.06 54.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.196 -0.456 . . . . 73.420000000000002 109.966 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.6 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -111.34 130.41 55.69 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.939 -0.393 . . . . 65.299999999999997 109.939 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.574 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 4.6 p90 -85.31 153.65 22.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.568 0.699 . . . . 74.340000000000003 111.759 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.828 ' HG3' ' H ' ' A' ' 80' ' ' LEU . 4.1 tpp180 -144.32 172.82 12.4 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.707 -1.133 . . . . 65.120000000000005 108.686 -174.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.656 ' N ' ' HG3' ' A' ' 78' ' ' ARG . 59.0 m -145.64 24.84 1.36 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.755 -0.461 . . . . 51.409999999999997 109.755 174.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.828 ' H ' ' HG3' ' A' ' 78' ' ' ARG . 73.3 mt 63.96 149.64 0.11 Allowed Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 115.268 -0.878 . . . . 71.140000000000001 112.738 174.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -64.5 -8.22 16.54 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 122.345 2.03 . . . . 73.209999999999994 112.492 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -76.38 -57.22 4.0 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.854 -0.688 . . . . 73.120000000000005 111.865 175.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.75 -26.59 29.55 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.595 0.22 . . . . 71.129999999999995 111.595 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 63.31 103.92 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.361 0.664 . . . . 74.329999999999998 111.149 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.52 ' HB ' ' HB2' ' A' ' 79' ' ' SER . 17.1 tt -70.08 129.23 34.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.402 0.62 . . . . 72.129999999999995 111.184 -178.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -82.09 -29.17 31.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.476 -0.784 . . . . 73.230000000000004 110.015 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -88.73 168.27 12.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.593 -0.73 . . . . 74.150000000000006 110.562 -175.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.6 m -155.24 135.35 13.03 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.299 -0.26 . . . . 73.230000000000004 110.299 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.34 127.81 0.97 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.605 -0.807 . . . . 71.430000000000007 112.599 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -115.37 118.52 33.46 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.612 -0.514 . . . . 71.340000000000003 109.612 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.634 HG11 HG13 ' A' ' 106' ' ' VAL . 3.8 m -87.15 130.38 37.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.873 0.368 . . . . 72.140000000000001 110.522 -177.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.638 ' HB2' HG22 ' A' ' 105' ' ' VAL . 9.5 mp -110.52 147.38 34.27 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.008 -0.367 . . . . 73.120000000000005 110.008 176.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.716 ' HE2' HD12 ' A' ' 75' ' ' ILE . 79.8 m-85 -117.61 132.01 56.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.831 0.348 . . . . 70.239999999999995 111.268 -177.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -141.86 145.15 35.38 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.94 -0.573 . . . . 74.530000000000001 109.902 173.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -58.01 127.62 25.73 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.474 2.116 . . . . 72.510000000000005 111.559 176.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.47 144.14 86.13 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.283 -0.417 . . . . 63.149999999999999 111.7 -174.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -58.45 138.39 85.54 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.911 2.408 . . . . 60.109999999999999 111.999 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.08 12.71 84.39 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.899 -0.667 . . . . 72.5 111.769 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 58.62 37.01 25.37 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 121.059 0.457 . . . . 73.530000000000001 111.051 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -78.95 1.14 24.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 62.43 111.411 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 129.7 -138.48 10.26 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.281 -0.728 . . . . 70.230000000000004 111.281 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 47.4 m -121.92 132.81 54.75 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.951 0.405 . . . . 74.400000000000006 110.23 176.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.484 ' HG2' ' HB1' ' A' ' 9' ' ' ALA . 42.5 tt0 -100.85 117.54 35.12 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.827 -0.624 . . . . 75.319999999999993 110.023 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.561 HG22 HG12 ' A' ' 106' ' ' VAL . 2.7 p -93.88 106.91 18.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.315 0.578 . . . . 73.150000000000006 110.757 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.638 HG22 ' HB2' ' A' ' 92' ' ' LEU . 10.8 m -88.23 114.24 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.759 -0.655 . . . . 72.299999999999997 110.343 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.634 HG13 HG11 ' A' ' 91' ' ' VAL . 27.2 m -124.15 134.97 65.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.404 0.621 . . . . 72.109999999999999 111.884 -175.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.487 ' HG3' ' HB3' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -118.32 97.89 6.0 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.821 -1.177 . . . . 72.450000000000003 107.821 170.089 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.436 ' H ' HD21 ' A' ' 108' ' ' LEU . 2.7 pt? -132.41 144.91 50.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.033 0.444 . . . . 64.25 110.792 -173.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.686 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 8.3 t -97.99 138.54 35.16 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.84 -0.618 . . . . 75.129999999999995 109.336 174.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 44.5 p90 . . . . . 0 C--N 1.318 -0.788 0 CA-C-N 116.491 -0.322 . . . . 74.129999999999995 110.434 -177.857 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.611 -0.196 . . . . 64.230000000000004 112.611 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.5 m -73.41 -22.31 60.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.923 0.392 . . . . 65.329999999999998 111.185 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.452 ' HA ' HG22 ' A' ' 120' ' ' VAL . . . -61.76 -22.79 65.71 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.219 -0.446 . . . . 75.120000000000005 111.571 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.87 -21.52 65.54 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.106 -0.569 . . . . 61.350000000000001 112.513 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -86.49 -44.68 11.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.928 0.394 . . . . 75.0 111.483 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.452 HG22 ' HA ' ' A' ' 117' ' ' ALA . 27.6 m -67.7 -17.61 22.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.297 0.48 . . . . 74.150000000000006 112.297 -172.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.513 ' O ' HD13 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -61.9 -28.61 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 120.978 0.418 . . . . 74.319999999999993 110.35 178.257 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.74 -18.59 63.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.329 -0.396 . . . . 73.239999999999995 111.678 -177.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 57.7 ttp85 -65.88 -16.0 63.44 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.624 0.249 . . . . 73.340000000000003 111.311 -176.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.8 ttm . . . . . 0 C--O 1.234 0.279 0 CA-C-O 120.961 0.41 . . . . 75.109999999999999 109.988 176.714 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.538 ' HG3' ' HE3' ' A' ' 138' ' ' MET . 2.4 ptm180 . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 112.516 0.562 . . . . 75.439999999999998 112.516 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -49.12 -52.08 28.22 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.258 0.623 . . . . 74.319999999999993 111.954 -173.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' A' ' 139' ' ' ARG . 33.8 t70 -61.99 -39.01 90.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.569 -0.741 . . . . 74.25 112.192 -174.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.459 ' HG ' ' CG1' ' A' ' 10' ' ' VAL . 14.3 tp -80.34 -20.28 44.56 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.857 0.36 . . . . 70.530000000000001 110.899 -176.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.855 ' HA ' ' HE1' ' A' ' 138' ' ' MET . 22.4 mmt -65.78 -41.73 91.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.775 0.287 . . . . 61.119999999999997 111.775 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.452 ' HG2' ' O ' ' A' ' 136' ' ' ASP . 15.9 ptt180 -62.67 -31.21 72.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.832 0.349 . . . . 63.450000000000003 110.359 178.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.605 ' HZ ' HG11 ' A' ' 22' ' ' VAL . 92.2 t80 -64.58 -45.87 85.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.897 -0.592 . . . . 71.549999999999997 110.311 178.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.439 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 23.3 ttpp -57.1 -47.65 80.54 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.15 -0.477 . . . . 63.299999999999997 110.036 176.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 28.4 ttp180 -53.82 -45.77 70.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.052 -0.976 . . . . 71.219999999999999 111.816 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -77.79 -28.45 50.45 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.233 -0.439 . . . . 75.049999999999997 111.514 -175.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.744 ' HG3' HG23 ' A' ' 12' ' ' ILE . 4.9 tp-100 -71.31 -44.66 64.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.621 0.248 . . . . 73.319999999999993 110.502 175.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 11.1 pt-20 -71.64 -23.3 61.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.848 0.356 . . . . 72.409999999999997 110.764 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.8 -47.79 20.52 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.557 -0.534 . . . . 73.510000000000005 109.557 178.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.484 0 CA-C-N 115.776 -0.647 . . . . 52.130000000000003 112.606 -179.673 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.599 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 11.1 p . . . . . 0 N--CA 1.449 -0.506 0 CA-C-O 120.906 0.384 . . . . 74.200000000000003 110.378 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.0 t -95.75 116.44 37.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.294 -0.632 . . . . 75.140000000000001 109.294 174.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 59.9 ttt180 -125.77 108.38 11.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.08 0.467 . . . . 72.340000000000003 110.078 174.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -143.73 159.14 43.03 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.13 -1.063 . . . . 75.409999999999997 108.13 176.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.454 ' HB2' ' HG2' ' A' ' 103' ' ' GLU . . . -141.18 121.13 13.62 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.931 0.396 . . . . 75.030000000000001 110.642 -174.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.649 ' HB ' ' HB2' ' A' ' 141' ' ' LYS . 10.5 m -108.32 136.58 43.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.442 0.639 . . . . 72.030000000000001 111.714 -176.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.14 109.92 22.19 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.227 -0.897 . . . . 65.349999999999994 111.239 -177.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.867 HG21 ' HG3' ' A' ' 145' ' ' GLU . 4.8 mp -125.26 149.4 29.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.789 -0.819 . . . . 72.140000000000001 108.789 176.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.88 57.51 2.65 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 121.114 -0.565 . . . . 55.32 113.226 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.625 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 10.9 mmpt? -118.15 154.52 51.75 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 108.803 -0.814 . . . . 72.120000000000005 108.803 176.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -58.98 -57.66 0.9 Allowed 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.327 2.018 . . . . 72.439999999999998 113.026 -177.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 19' ' ' LEU . . . -178.26 -72.91 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.224 0.453 . . . . 61.439999999999998 112.224 178.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -66.36 -31.12 71.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.711 0.291 . . . . 74.230000000000004 111.174 -173.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -56.67 -32.28 65.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.424 -0.353 . . . . 74.019999999999996 110.552 175.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.561 ' HB2' ' O ' ' A' ' 16' ' ' ALA . 65.4 mt -62.89 -41.63 99.49 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.88 -0.6 . . . . 74.129999999999995 110.444 176.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.735 ' HB2' ' HZ ' ' A' ' 93' ' ' PHE . 77.9 t80 -73.07 -36.36 66.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.734 -0.666 . . . . 71.239999999999995 110.766 178.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.23 -3.61 30.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.683 -0.69 . . . . 75.209999999999994 112.188 -175.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.768 HG13 ' HZ ' ' A' ' 140' ' ' PHE . 9.0 p -53.69 -21.46 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 123.213 0.605 . . . . 74.329999999999998 112.242 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.8 t-105 -52.94 -37.25 60.74 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.445 0.64 . . . . 74.439999999999998 109.764 176.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.584 ' HD3' ' N ' ' A' ' 25' ' ' ASP . 4.0 tmt_? -109.59 159.76 16.83 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.866 -1.161 . . . . 72.239999999999995 107.866 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.584 ' N ' ' HD3' ' A' ' 24' ' ' ARG . 26.1 t70 -66.83 67.17 0.06 Allowed 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.497 0.554 . . . . 74.0 112.497 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 41.86 79.3 0.33 Allowed Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 124.168 0.987 . . . . 72.540000000000006 112.78 169.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.569 ' HA ' ' NH1' ' A' ' 24' ' ' ARG . 31.6 Cg_exo . . . . . 0 C--N 1.344 0.336 0 C-N-CA 122.445 2.097 . . . . 74.349999999999994 113.787 -172.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.97 0 N-CA-C 109.381 -0.6 . . . . 70.010000000000005 109.381 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.483 ' HB2' HD21 ' A' ' 80' ' ' LEU . 1.2 mm-40 -107.92 134.23 51.13 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 109.587 -0.523 . . . . 65.019999999999996 109.587 176.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.73 HD12 ' HA ' ' A' ' 77' ' ' TRP . 3.6 mm? -88.21 137.91 31.91 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.581 -0.526 . . . . 63.439999999999998 109.581 -178.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.9 t -73.93 -9.18 58.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.497 0.665 . . . . 50.340000000000003 110.048 -177.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.91 123.35 10.36 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.973 -1.012 . . . . 74.209999999999994 108.725 166.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -139.09 83.64 1.96 Allowed 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.738 -0.838 . . . . 75.439999999999998 108.738 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 73' ' ' LYS . 48.5 mt-10 -115.86 143.86 31.58 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 114.879 -1.055 . . . . 71.239999999999995 109.581 -176.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.81 94.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.031 2.487 . . . . 50.32 113.029 -174.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 61.82 26.36 66.94 Favored Glycine 0 CA--C 1.518 0.277 0 CA-C-N 115.657 -0.701 . . . . 61.229999999999997 113.446 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.718 ' HE2' ' HA ' ' A' ' 73' ' ' LYS . 9.7 mmpt? -104.66 -72.56 0.7 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.18 0.514 . . . . 70.140000000000001 110.193 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -149.91 137.66 20.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.758 -0.655 . . . . 73.019999999999996 109.642 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 67.1 mt -122.18 110.3 26.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.768 -0.651 . . . . 74.349999999999994 109.394 177.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.66 ' HB3' ' HG3' ' A' ' 90' ' ' GLU . . . -104.23 127.44 51.86 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.847 -0.615 . . . . 72.439999999999998 109.574 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.73 ' HA ' HD12 ' A' ' 66' ' ' LEU . 59.2 t90 -79.93 143.71 33.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.702 0.763 . . . . 73.319999999999993 111.509 -169.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.555 ' HG3' ' H ' ' A' ' 79' ' ' SER . 0.0 OUTLIER -166.61 175.35 8.03 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.834 -1.076 . . . . 65.400000000000006 108.99 -175.296 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.555 ' H ' ' HG3' ' A' ' 78' ' ' ARG . 46.9 m -141.57 165.63 26.95 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.348 -0.982 . . . . 64.030000000000001 108.348 174.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.483 HD21 ' HB2' ' A' ' 65' ' ' GLU . 53.0 mt -60.57 150.76 73.53 Favored Pre-proline 0 C--N 1.326 -0.445 0 O-C-N 123.11 0.256 . . . . 63.43 110.729 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.31 -22.71 66.62 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 123.069 2.512 . . . . 73.129999999999995 112.82 -178.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.28 2.7 88.02 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.06 -0.591 . . . . 71.200000000000003 112.251 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -109.62 -168.89 1.38 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.715 0.293 . . . . 71.439999999999998 110.372 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -111.45 118.3 35.42 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.764 0.316 . . . . 65.109999999999999 110.553 -174.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.4 pt -110.19 129.73 64.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.032 0.444 . . . . 72.319999999999993 110.931 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -105.99 -85.48 0.49 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.138 -0.483 . . . . 64.019999999999996 111.906 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -96.03 166.48 11.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.935 0.397 . . . . 54.25 111.46 -171.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.7 t -103.81 139.02 39.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.031 -0.531 . . . . 73.140000000000001 109.875 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.59 ' HA3' ' HG ' ' A' ' 108' ' ' LEU . . . -158.69 129.12 2.19 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 121.038 -0.601 . . . . 72.109999999999999 112.113 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.66 ' HG3' ' HB3' ' A' ' 76' ' ' ALA . 45.5 tt0 -128.84 134.75 48.43 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.913 -0.403 . . . . 72.219999999999999 109.913 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 69.7 t -115.67 128.67 72.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.152 0.501 . . . . 71.200000000000003 111.144 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.593 ' HB2' ' HB ' ' A' ' 105' ' ' VAL . 6.8 mp -102.95 138.16 40.19 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.366 -0.834 . . . . 74.549999999999997 110.517 178.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.735 ' HZ ' ' HB2' ' A' ' 20' ' ' TYR . 89.2 m-85 -115.54 106.29 13.77 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.226 0.536 . . . . 72.209999999999994 109.695 175.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -124.26 144.5 45.8 Favored Pre-proline 0 C--N 1.317 -0.841 0 CA-C-N 116.138 -0.483 . . . . 52.310000000000002 110.61 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.26 125.98 19.58 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.639 2.226 . . . . 54.340000000000003 111.101 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.1 143.39 56.87 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.552 -0.295 . . . . 71.109999999999999 111.219 -175.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.514 ' O ' ' HG2' ' A' ' 100' ' ' ARG . 31.0 Cg_endo -65.37 156.5 63.0 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.775 2.316 . . . . 61.240000000000002 111.35 175.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 63.94 20.71 64.82 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.926 -0.654 . . . . 72.439999999999998 112.939 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 58.21 32.91 22.62 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.661 0.384 . . . . 64.040000000000006 112.006 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 97' ' ' PRO . 24.9 mmt180 -68.74 -18.98 64.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.862 0.363 . . . . 73.319999999999993 111.244 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 127.72 -133.12 7.72 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.305 -0.718 . . . . 73.310000000000002 111.305 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.2 m -118.65 132.85 56.18 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.518 -0.549 . . . . 74.120000000000005 109.518 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.454 ' HG2' ' HB2' ' A' ' 9' ' ' ALA . 40.1 tt0 -96.21 117.02 29.92 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.847 0.356 . . . . 61.109999999999999 110.535 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.462 HG23 ' CG1' ' A' ' 91' ' ' VAL . 1.7 p -88.33 103.97 14.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.818 0.818 . . . . 71.430000000000007 109.521 174.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.593 ' HB ' ' HB2' ' A' ' 92' ' ' LEU . 16.4 t -91.36 110.24 22.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.631 -1.168 . . . . 71.530000000000001 109.919 -175.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 47.7 t -100.74 117.77 46.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.232 -0.44 . . . . 74.519999999999996 111.217 -175.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -121.09 98.72 6.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.928 -0.578 . . . . 75.109999999999999 109.52 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.59 ' HG ' ' HA3' ' A' ' 89' ' ' GLY . 1.9 tt -138.83 137.3 36.48 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.84 -0.43 . . . . 73.209999999999994 109.84 -175.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.599 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 8.9 t -84.53 139.71 31.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.28 0.562 . . . . 65.129999999999995 111.254 -177.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 . . . . . 0 C--N 1.324 -0.528 0 CA-C-N 115.798 -0.637 . . . . 75.209999999999994 110.374 -178.684 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.658 0 CA-C-O 120.818 0.121 . . . . 60.219999999999999 112.856 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.3 m -62.04 -23.86 66.72 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.066 0.546 . . . . 65.310000000000002 111.925 -174.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.91 -43.02 76.93 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.304 -0.407 . . . . 73.120000000000005 111.801 -176.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -78.59 -19.83 72.78 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.575 -0.822 . . . . 52.439999999999998 112.34 -178.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.49 -38.73 23.46 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.736 -0.273 . . . . 71.310000000000002 111.712 -175.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.5 m -64.5 -25.56 38.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.615 0.598 . . . . 75.230000000000004 112.615 -174.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 14.4 tt -75.13 -21.84 16.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.922 0.392 . . . . 70.540000000000006 111.085 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.97 -18.81 64.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.366 -0.379 . . . . 53.109999999999999 111.876 -175.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 23.7 ttt85 -79.17 -14.5 59.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.059 0.457 . . . . 74.439999999999998 110.919 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 49.1 ttm . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 116.238 -0.437 . . . . 72.239999999999995 110.322 179.176 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 23.5 mtp-105 . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 121.815 0.816 . . . . 73.129999999999995 113.049 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -69.7 -33.18 72.16 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.494 -1.23 . . . . 73.340000000000003 112.639 -173.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -56.51 -55.65 31.1 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.048 0.388 . . . . 74.439999999999998 112.048 -175.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 15.5 tp -81.08 -20.7 40.96 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.851 -0.34 . . . . 70.430000000000007 110.975 -175.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.454 ' HB3' ' HE3' ' A' ' 138' ' ' MET . 1.8 ttp -54.34 -38.65 66.27 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.49 -0.323 . . . . 74.120000000000005 110.896 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 139' ' ' ARG . 0.8 OUTLIER -70.86 -32.71 69.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.793 0.33 . . . . 74.540000000000006 110.738 179.438 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.768 ' HZ ' HG13 ' A' ' 22' ' ' VAL . 90.3 t80 -60.34 -35.17 75.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 64.400000000000006 110.439 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.649 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 38.8 tttp -55.02 -49.5 71.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.771 -0.649 . . . . 71.530000000000001 110.194 173.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.629 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 34.4 mmt180 -71.67 -25.69 62.22 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.805 -0.634 . . . . 73.140000000000001 111.772 -175.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -63.48 -44.32 94.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.861 0.362 . . . . 64.299999999999997 111.054 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.707 ' HG2' HG23 ' A' ' 12' ' ' ILE . 8.3 tt0 -82.36 -44.36 16.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.068 -0.514 . . . . 73.209999999999994 111.038 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.867 ' HG3' HG21 ' A' ' 12' ' ' ILE . 2.5 tt0 -66.52 -20.21 65.97 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 116.203 -0.453 . . . . 74.25 111.994 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.629 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 21.3 tp -64.71 -40.95 96.23 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.538 -0.542 . . . . 75.230000000000004 109.538 175.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.517 0 CA-C-N 115.303 -0.862 . . . . 73.310000000000002 111.361 178.941 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.751 HG12 ' HA ' ' A' ' 109' ' ' THR . 51.0 t . . . . . 0 N--CA 1.447 -0.612 0 N-CA-C 109.083 -0.71 . . . . 65.049999999999997 109.083 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.7 t -80.79 115.54 23.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.977 0.418 . . . . 73.409999999999997 111.397 -171.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.472 ' HG3' ' CB ' ' A' ' 107' ' ' ARG . 9.0 mpt_? -107.14 108.09 19.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.537 -0.912 . . . . 73.5 108.537 168.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.497 ' HB3' HD22 ' A' ' 137' ' ' LEU . 2.5 t70 -147.99 173.31 13.02 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.516 -0.55 . . . . 74.200000000000003 109.516 178.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.803 ' HB2' HG13 ' A' ' 105' ' ' VAL . . . -138.56 154.35 48.73 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.045 0.45 . . . . 52.399999999999999 111.488 -171.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.48 ' HB ' ' HB2' ' A' ' 141' ' ' LYS . 12.8 m -132.55 141.07 46.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.838 -0.619 . . . . 72.010000000000005 109.987 174.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.438 HG21 ' HG3' ' A' ' 100' ' ' ARG . 25.2 m -106.38 118.32 36.34 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.156 -0.475 . . . . 74.430000000000007 111.259 -174.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.952 HG21 ' HB3' ' A' ' 145' ' ' GLU . 3.9 mp -123.19 141.94 41.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.845 -0.616 . . . . 64.25 109.716 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.26 52.02 4.24 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.843 -0.694 . . . . 74.019999999999996 112.455 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.449 ' HB2' HD22 ' A' ' 19' ' ' LEU . 94.8 mttt -131.22 144.24 52.68 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.066 -0.716 . . . . 75.109999999999999 109.066 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.403 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 51.0 Cg_exo -54.75 -58.87 1.01 Allowed 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 122.688 2.259 . . . . 73.109999999999999 113.783 -169.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.408 ' HA ' HD12 ' A' ' 19' ' ' LEU . . . 173.56 -52.87 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.311 0.577 . . . . 63.140000000000001 110.462 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -57.09 -46.0 82.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.266 -0.879 . . . . 52.119999999999997 111.66 -175.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -68.57 -8.85 45.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.401 -0.363 . . . . 72.420000000000002 111.945 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.449 HD22 ' HB2' ' A' ' 14' ' ' LYS . 96.5 mt -80.55 -20.56 43.16 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 122.378 -0.201 . . . . 73.219999999999999 110.928 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -70.94 -29.4 65.42 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.458 0.647 . . . . 72.140000000000001 109.704 174.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.702 ' HB3' ' HD2' ' A' ' 27' ' ' PRO . . . -71.51 -4.72 28.3 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.54 -0.754 . . . . 43.350000000000001 112.073 -174.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.2 p -60.4 -24.2 30.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 71.010000000000005 111.245 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -55.72 -43.46 76.57 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 112.375 0.509 . . . . 74.420000000000002 112.375 -177.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 28.4 ttt180 -105.53 -76.09 0.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.235 -0.586 . . . . 73.349999999999994 112.057 -174.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -147.78 2.96 0.72 Allowed 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 120.474 -0.49 . . . . 74.200000000000003 112.207 -168.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.723 HD13 ' HA ' ' A' ' 144' ' ' GLN . 51.6 mt 58.67 63.97 3.69 Favored Pre-proline 0 N--CA 1.47 0.539 0 CA-C-N 116.196 -0.456 . . . . 75.329999999999998 111.75 -175.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.702 ' HD2' ' HB3' ' A' ' 21' ' ' ALA . 83.5 Cg_endo . . . . . 0 N--CA 1.454 -0.826 0 C-N-CA 122.774 2.316 . . . . 64.329999999999998 112.76 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.511 0 CA-C-O 121.057 0.456 . . . . 54.149999999999999 111.088 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -117.8 136.73 53.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.928 -0.578 . . . . 75.25 109.78 174.031 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.65 ' HG ' ' HA ' ' A' ' 77' ' ' TRP . 6.8 mp -91.37 128.38 37.17 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.73 0.3 . . . . 74.329999999999998 110.548 -178.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.756 ' HB ' ' HG3' ' A' ' 78' ' ' ARG . 12.9 t -70.55 -28.57 65.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 74.519999999999996 110.84 -173.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.11 131.46 17.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.895 -0.593 . . . . 73.150000000000006 109.793 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -141.5 91.88 2.42 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.037 0.446 . . . . 72.439999999999998 109.849 -178.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.555 ' HB2' ' H ' ' A' ' 74' ' ' ARG . 10.3 mm-40 -95.72 142.37 24.49 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 109.185 -0.672 . . . . 64.340000000000003 109.185 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.77 94.48 0.39 Allowed 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.417 2.078 . . . . 72.040000000000006 112.713 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.71 35.04 89.19 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.994 -0.622 . . . . 71.420000000000002 112.258 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.489 ' HB2' ' CB ' ' A' ' 70' ' ' GLU . 75.2 mmtt -127.05 -70.41 0.72 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.679 0.276 . . . . 70.109999999999999 110.332 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.555 ' H ' ' HB2' ' A' ' 70' ' ' GLU . 30.8 ptt-85 -150.58 132.35 15.0 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.737 -0.468 . . . . 75.239999999999995 109.737 176.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.536 ' HB ' HG13 ' A' ' 91' ' ' VAL . 3.9 mp -126.9 116.23 44.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.077 -0.511 . . . . 71.439999999999998 109.792 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -106.98 118.61 37.17 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.063 -0.517 . . . . 73.010000000000005 110.53 -178.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.65 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 36.2 m95 -87.07 145.58 26.41 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.841 -0.618 . . . . 62.530000000000001 111.238 -174.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.756 ' HG3' ' HB ' ' A' ' 67' ' ' THR . 19.0 mmm-85 -148.97 175.13 11.56 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.814 -0.63 . . . . 71.409999999999997 109.777 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.517 ' HB2' ' HB2' ' A' ' 86' ' ' GLU . 63.2 m -134.92 142.43 46.54 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.449 -0.945 . . . . 71.150000000000006 108.449 175.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 94.5 mt -67.0 153.12 95.15 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.579 -0.282 . . . . 55.530000000000001 110.931 -176.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -52.2 -16.78 5.13 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.953 3.102 . . . . 73.030000000000001 114.297 -173.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.85 -35.38 89.51 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.66 -0.781 . . . . 64.420000000000002 111.921 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.66 147.85 26.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.993 0.425 . . . . 72.140000000000001 111.093 -176.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.458 ' HD2' ' C ' ' A' ' 84' ' ' ARG . 6.0 ppt_? -115.44 -1.59 12.79 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.086 -0.507 . . . . 74.519999999999996 110.742 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.443 ' O ' HG13 ' A' ' 85' ' ' ILE . 10.1 tp -107.86 33.59 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.995 0.902 . . . . 60.329999999999998 110.247 -178.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 79' ' ' SER . 42.1 tt0 -64.24 122.01 15.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.664 -0.698 . . . . 73.5 110.555 177.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -103.59 140.56 37.37 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.355 -0.98 . . . . 71.430000000000007 108.355 174.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.1 m -94.77 126.19 39.93 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.19 0.519 . . . . 64.219999999999999 110.145 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 107' ' ' ARG . . . -159.0 146.39 12.95 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.304 -0.862 . . . . 62.340000000000003 111.443 -178.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -147.02 126.4 13.13 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 110.357 -0.238 . . . . 60.049999999999997 110.357 -176.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.616 HG22 HG21 ' A' ' 104' ' ' VAL . 2.5 p -108.6 121.68 62.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.055 0.455 . . . . 75.319999999999993 110.942 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.431 ' HB2' ' CG2' ' A' ' 105' ' ' VAL . 8.9 mp -108.96 139.82 43.3 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.736 -0.468 . . . . 73.239999999999995 109.736 174.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.505 ' HE2' HD12 ' A' ' 75' ' ' ILE . 93.9 m-85 -104.45 108.97 20.65 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.251 0.548 . . . . 72.540000000000006 110.073 178.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -126.73 144.88 51.46 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 115.461 -0.791 . . . . 72.540000000000006 110.046 -177.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.75 136.85 47.32 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.187 1.924 . . . . 42.210000000000001 111.551 176.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.519 ' CB ' ' HB3' ' A' ' 100' ' ' ARG . . . -77.63 146.99 74.13 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.185 -0.461 . . . . 75.120000000000005 110.011 178.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -37.78 108.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 124.111 3.208 . . . . 64.400000000000006 114.463 -172.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 90.04 -67.99 2.57 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 114.671 -1.149 . . . . 62.509999999999998 112.067 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -178.28 32.07 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.203 -0.498 . . . . 74.340000000000003 110.877 -174.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.519 ' HB3' ' CB ' ' A' ' 96' ' ' ALA . 21.8 tpp180 -74.2 -13.61 60.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.962 0.411 . . . . 75.150000000000006 110.802 -177.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 129.38 -157.53 21.76 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.962 -0.855 . . . . 37.020000000000003 110.962 -177.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 32.7 m -101.91 127.72 48.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.063 0.459 . . . . 73.010000000000005 109.815 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.401 ' CG ' ' HB3' ' A' ' 9' ' ' ALA . 44.2 tt0 -100.49 110.38 22.56 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.634 -0.712 . . . . 70.209999999999994 110.105 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.616 HG21 HG22 ' A' ' 91' ' ' VAL . 1.7 p -87.88 97.92 7.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.698 0.761 . . . . 71.140000000000001 109.364 175.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.803 HG13 ' HB2' ' A' ' 9' ' ' ALA . 22.7 m -84.43 110.79 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 115.059 -0.973 . . . . 71.109999999999999 109.802 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.7 p -112.67 123.89 68.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.797 -0.638 . . . . 74.310000000000002 110.878 -176.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.534 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 22.5 ptt180 -115.22 99.06 7.14 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.714 -0.676 . . . . 74.409999999999997 109.661 174.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 52.3 tp -120.46 141.98 49.67 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.021 -0.733 . . . . 71.329999999999998 109.021 -177.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.751 ' HA ' HG12 ' A' ' 5' ' ' VAL . 51.8 m -83.1 119.58 24.67 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.715 0.769 . . . . 61.100000000000001 111.922 -172.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 . . . . . 0 C--N 1.323 -0.554 0 CA-C-N 114.686 -1.143 . . . . 74.319999999999993 109.08 174.931 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.824 -0.111 . . . . 65.219999999999999 112.824 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.9 m -62.41 -29.08 70.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.891 0.377 . . . . 75.340000000000003 110.912 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.83 -30.58 65.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.072 -0.513 . . . . 64.420000000000002 110.866 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -73.88 -20.23 79.74 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.81 -0.632 . . . . 51.409999999999997 112.916 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.51 -19.82 27.24 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 112.262 0.468 . . . . 37.020000000000003 112.262 -177.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.42 ' O ' ' HG3' ' A' ' 124' ' ' MET . 13.8 p -60.13 -29.79 44.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 62.200000000000003 111.832 -177.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.7 pp -65.46 -32.69 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 C-N-CA 120.85 -0.34 . . . . 75.310000000000002 111.022 -177.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.94 -39.36 56.3 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.689 -0.486 . . . . 63.210000000000001 109.689 176.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -59.01 -28.33 66.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.378 -0.828 . . . . 74.349999999999994 111.6 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.42 ' HG3' ' O ' ' A' ' 120' ' ' VAL . 66.1 mtt . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 116.208 -0.451 . . . . 75.310000000000002 111.362 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 . . . . . 0 CA--C 1.532 0.26 0 CA-C-O 120.874 0.369 . . . . 73.129999999999995 111.103 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.429 ' O ' ' HG3' ' A' ' 138' ' ' MET . 18.1 t70 -65.55 -43.92 88.42 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.002 0.43 . . . . 74.400000000000006 110.601 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -74.54 -36.46 63.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.239 0.542 . . . . 75.010000000000005 110.319 174.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.497 HD22 ' HB3' ' A' ' 8' ' ' ASP . 1.3 mp -70.63 -29.76 66.21 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.618 0.599 . . . . 75.120000000000005 112.618 -174.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.429 ' HG3' ' O ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -64.2 -26.2 68.41 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.412 -0.515 . . . . 75.299999999999997 110.076 175.442 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 55.8 mtt180 -69.61 -48.93 58.36 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.496 -0.557 . . . . 75.549999999999997 109.496 174.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -56.29 -48.95 75.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.841 -1.072 . . . . 74.219999999999999 110.985 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.576 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 0.6 OUTLIER -63.49 -44.13 95.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.016 -0.538 . . . . 74.310000000000002 110.141 179.748 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 48.0 ttt180 -57.46 -50.61 72.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.063 -0.517 . . . . 74.219999999999999 111.076 -175.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -66.17 -27.47 68.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.073 0.463 . . . . 74.400000000000006 110.594 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.723 ' HA ' HD13 ' A' ' 26' ' ' LEU . 54.5 tt0 -77.49 -29.21 52.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.795 -0.639 . . . . 72.439999999999998 112.035 -174.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.952 ' HB3' HG21 ' A' ' 12' ' ' ILE . 2.2 pp20? -108.49 -13.4 14.85 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.265 0.468 . . . . 73.209999999999994 112.265 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 57.5 tp -62.08 -40.33 95.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.265 0.555 . . . . 74.310000000000002 109.612 175.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.71 0 C-N-CA 120.83 -0.7 . . . . 74.409999999999997 111.408 175.729 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.559 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 70.0 t . . . . . 0 N--CA 1.446 -0.675 0 N-CA-C 108.456 -0.942 . . . . 53.350000000000001 108.456 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.4 p -77.82 124.38 36.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.466 0.65 . . . . 73.030000000000001 110.44 -174.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.692 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -141.52 110.56 6.23 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.344 -0.844 . . . . 72.530000000000001 110.621 -179.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.491 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 14.3 t70 -146.21 171.38 15.03 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.036 -0.727 . . . . 74.25 109.036 175.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.6 ' HB3' HG12 ' A' ' 105' ' ' VAL . . . -139.72 120.69 14.57 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.939 0.4 . . . . 73.129999999999995 111.02 -174.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.1 m -115.09 143.44 24.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.985 -0.552 . . . . 74.439999999999998 110.163 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.523 HG23 ' HB2' ' A' ' 100' ' ' ARG . 42.6 m -103.79 111.87 24.57 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.967 -0.56 . . . . 71.400000000000006 110.322 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.62 HD13 ' HG2' ' A' ' 141' ' ' LYS . 9.4 mm -100.63 146.0 10.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.287 -0.415 . . . . 74.230000000000004 109.945 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.16 60.11 4.5 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.689 -0.767 . . . . 75.519999999999996 111.817 174.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.48 ' HB2' HD21 ' A' ' 19' ' ' LEU . 24.2 mmtm -141.19 145.25 37.85 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 109.764 -0.458 . . . . 62.100000000000001 109.764 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.411 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 72.9 Cg_exo -52.24 -57.68 1.98 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.157 2.572 . . . . 64.409999999999997 113.58 -175.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . 174.54 -46.66 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.932 0.396 . . . . 63.399999999999999 111.156 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -59.19 -45.43 91.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.075 -0.511 . . . . 74.540000000000006 110.866 -176.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.563 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . 21.4 mp0 -66.64 -16.67 64.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.886 -0.597 . . . . 72.099999999999994 110.906 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.752 ' HA ' ' NE2' ' A' ' 144' ' ' GLN . 74.5 mt -73.76 -45.5 51.45 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.36 -0.382 . . . . 74.140000000000001 110.256 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -74.28 -29.9 61.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.383 0.611 . . . . 73.340000000000003 109.896 174.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.563 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . . . -70.34 -3.03 15.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.276 -0.874 . . . . 60.299999999999997 111.927 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.701 HG22 ' HD2' ' A' ' 140' ' ' PHE . 10.9 p -53.2 -21.21 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.096 0.558 . . . . 62.109999999999999 111.991 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 4.2 m95 -59.19 -26.15 64.57 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.796 0.332 . . . . 74.420000000000002 110.92 176.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -136.95 -164.67 1.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 74.209999999999994 110.168 -177.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.437 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 5.3 t70 -88.03 46.67 1.41 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.282 -0.417 . . . . 70.209999999999994 110.209 -176.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 25' ' ' ASP . 0.4 OUTLIER 43.14 84.87 0.18 Allowed Pre-proline 0 N--CA 1.476 0.86 0 C-N-CA 123.513 0.725 . . . . 71.109999999999999 111.965 -177.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 C--N 1.344 0.298 0 C-N-CA 122.983 2.455 . . . . 54.439999999999998 113.867 -173.276 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.655 0 N-CA-C 109.312 -0.625 . . . . 61.310000000000002 109.312 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 7.6 tt0 -108.83 134.61 51.29 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.964 -0.294 . . . . 63.109999999999999 110.533 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.998 HD13 ' HA ' ' A' ' 77' ' ' TRP . 2.2 mm? -83.95 137.32 33.69 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.356 -0.609 . . . . 70.450000000000003 109.356 174.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.547 HG21 ' HB2' ' A' ' 78' ' ' ARG . 20.8 p -67.67 -34.37 76.79 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.502 0.668 . . . . 72.329999999999998 110.546 -176.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -135.72 124.85 24.43 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.979 -1.009 . . . . 72.099999999999994 110.725 177.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -117.36 90.77 3.41 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.432 -0.804 . . . . 75.129999999999995 109.581 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.966 ' HB3' ' HB2' ' A' ' 73' ' ' LYS . 48.9 mt-10 -120.02 86.52 37.09 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.483 -0.781 . . . . 73.120000000000005 110.452 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -60.6 107.03 0.39 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.599 2.199 . . . . 72.310000000000002 111.82 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.09 6.16 55.94 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.896 -0.669 . . . . 53.350000000000001 111.827 -177.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.966 ' HB2' ' HB3' ' A' ' 70' ' ' GLU . 2.8 mmmp? -128.62 -66.38 0.84 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.586 0.231 . . . . 70.239999999999995 110.488 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 22.4 ptt180 -168.3 150.09 5.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.323 -0.399 . . . . 75.310000000000002 110.643 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.6 mp -124.98 114.29 39.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 116.195 -0.457 . . . . 74.040000000000006 109.793 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.564 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . . . -101.68 121.02 41.25 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.076 -0.511 . . . . 74.209999999999994 110.448 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.998 ' HA ' HD13 ' A' ' 66' ' ' LEU . 26.3 m0 -80.49 155.43 27.03 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.989 0.737 . . . . 72.219999999999999 112.989 -172.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.64 ' HG3' ' H ' ' A' ' 79' ' ' SER . 24.7 tpp180 -176.62 174.63 1.83 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 114.394 -1.275 . . . . 60.43 108.238 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.64 ' H ' ' HG3' ' A' ' 78' ' ' ARG . 24.6 m -148.75 145.81 27.78 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.001 -1.111 . . . . 70.420000000000002 108.001 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.2 mt -71.7 152.08 93.48 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.911 -0.404 . . . . 75.439999999999998 109.911 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -52.35 -23.3 18.11 Favored 'Trans proline' 0 N--CA 1.476 0.445 0 C-N-CA 123.315 2.677 . . . . 72.439999999999998 113.93 -175.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -78.53 -4.14 87.16 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.821 -0.704 . . . . 74.519999999999996 112.997 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.33 -170.74 2.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.919 0.39 . . . . 60.229999999999997 110.935 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.438 ' HB2' HD13 ' A' ' 85' ' ' ILE . 86.8 mtt180 -118.06 -38.42 3.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.052 -0.522 . . . . 70.010000000000005 112.095 -172.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.438 HD13 ' HB2' ' A' ' 84' ' ' ARG . 4.8 mp -121.5 122.84 68.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.928 -0.309 . . . . 75.219999999999999 110.722 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.458 ' HB3' ' HB2' ' A' ' 79' ' ' SER . 11.3 pt-20 -125.79 123.19 38.22 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.53 -0.544 . . . . 74.230000000000004 109.53 172.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -111.64 138.67 47.88 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.032 -0.729 . . . . 74.140000000000001 109.032 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.2 m -96.04 128.15 42.69 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.685 -0.487 . . . . 41.210000000000001 109.685 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.24 123.73 0.69 Allowed Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.74 -0.743 . . . . 61.509999999999998 111.896 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 0.5 OUTLIER -108.95 126.19 52.83 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.904 0.383 . . . . 75.120000000000005 110.297 178.419 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 4.4 m -97.81 126.68 50.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.463 -0.569 . . . . 71.5 109.463 176.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.477 ' HB2' ' CG2' ' A' ' 105' ' ' VAL . 9.5 mp -105.32 139.06 40.53 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.422 -0.354 . . . . 65.239999999999995 110.886 -177.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -99.57 105.64 17.54 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.456 -0.942 . . . . 62.539999999999999 108.456 172.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.4 mtp85 -112.68 150.25 42.43 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 115.288 -0.869 . . . . 64.420000000000002 111.1 -171.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -49.71 127.3 18.41 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.427 2.084 . . . . 71.219999999999999 111.204 172.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.37 150.85 85.23 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.881 -0.599 . . . . 72.030000000000001 111.762 -172.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.78 109.43 0.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.824 2.349 . . . . 72.549999999999997 112.089 175.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.8 -73.9 1.34 Allowed Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.175 -0.92 . . . . 63.240000000000002 111.483 177.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 174.31 24.57 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.273 0.631 . . . . 72.219999999999999 111.264 -175.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.523 ' HB2' HG23 ' A' ' 11' ' ' THR . 19.6 mtp180 -82.62 7.04 15.8 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.544 0.572 . . . . 74.120000000000005 112.544 -171.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 126.68 -113.14 1.71 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.49 -0.862 . . . . 44.32 111.78 177.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.734 ' HB ' HD11 ' A' ' 19' ' ' LEU . 15.7 m -141.17 140.6 34.07 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.841 0.353 . . . . 72.099999999999994 110.265 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -96.59 119.02 34.3 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.176 -0.466 . . . . 65.109999999999999 110.755 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 p -100.67 107.49 21.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.495 0.664 . . . . 62.119999999999997 110.258 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.6 HG12 ' HB3' ' A' ' 9' ' ' ALA . 18.8 m -95.45 118.69 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 115.37 -0.832 . . . . 74.219999999999999 110.046 178.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.692 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 18.6 m -112.2 127.92 69.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.837 -0.62 . . . . 72.019999999999996 110.584 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.467 ' HG3' ' HB3' ' A' ' 7' ' ' ARG . 10.1 ttp180 -137.67 100.38 4.19 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.054 -0.521 . . . . 74.239999999999995 109.857 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 pp -145.46 155.23 42.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.974 -0.557 . . . . 74.239999999999995 109.508 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 11.4 t -80.82 137.69 36.21 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.154 -0.618 . . . . 64.040000000000006 109.876 -176.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 30.8 t80 . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 108.069 -1.085 . . . . 74.200000000000003 108.069 -171.946 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.418 0 N-CA-C 112.417 -0.273 . . . . 52.32 112.417 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.6 m -85.26 -48.8 8.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.078 0.466 . . . . 73.129999999999995 110.585 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.49 ' O ' HG22 ' A' ' 120' ' ' VAL . . . -72.69 -39.61 66.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.926 -0.579 . . . . 72.140000000000001 111.431 -177.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.483 ' O ' HG23 ' A' ' 121' ' ' ILE . . . -67.01 -20.02 70.43 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 121.037 -0.601 . . . . 62.539999999999999 113.273 -177.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.17 -21.31 60.72 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.228 0.455 . . . . 73.519999999999996 112.228 -175.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 117' ' ' ALA . 10.7 m -77.12 -18.84 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.509 0.559 . . . . 54.109999999999999 112.509 -173.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.483 HG23 ' O ' ' A' ' 118' ' ' GLY . 16.1 tt -68.86 -28.98 41.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.893 -0.323 . . . . 70.439999999999998 111.061 -176.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.33 -27.49 68.53 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.779 -0.646 . . . . 72.420000000000002 111.953 -175.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 16.7 mtm180 -66.79 -42.59 85.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.091 0.472 . . . . 75.120000000000005 110.009 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 40.5 ttp . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 115.758 -0.656 . . . . 70.109999999999999 109.789 177.616 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 33.9 mtt-85 . . . . . 0 N--CA 1.463 0.177 0 N-CA-C 110.369 -0.234 . . . . 74.439999999999998 110.369 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -56.96 -56.5 20.85 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.77 0.285 . . . . 72.150000000000006 111.77 -173.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -76.56 -39.52 52.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.886 0.374 . . . . 75.329999999999998 110.156 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.565 ' CD1' ' HE1' ' A' ' 140' ' ' PHE . 0.3 OUTLIER -53.75 -51.0 64.78 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.667 -0.697 . . . . 55.020000000000003 111.589 -178.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.824 ' HE3' ' HA ' ' A' ' 138' ' ' MET . 0.6 OUTLIER -65.17 -38.18 89.71 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.429 -0.35 . . . . 72.209999999999994 111.001 -175.927 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.414 ' O ' ' HB3' ' A' ' 142' ' ' ARG . 34.2 mtm105 -65.68 -51.66 57.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.509 -0.314 . . . . 72.140000000000001 111.676 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.701 ' HD2' HG22 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -73.57 -30.21 62.89 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 120.06 -0.656 . . . . 75.409999999999997 109.779 -175.123 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.62 ' HG2' HD13 ' A' ' 12' ' ' ILE . 13.5 tmtt? -55.44 -50.44 69.83 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.235 -0.654 . . . . 63.030000000000001 109.235 173.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.561 ' HE ' ' HG3' ' A' ' 143' ' ' GLU . 43.7 ttp180 -52.53 -54.93 26.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.514 -1.221 . . . . 73.420000000000002 111.674 177.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.561 ' HG3' ' HE ' ' A' ' 142' ' ' ARG . 30.6 mt-10 -72.97 -34.02 66.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.958 -0.565 . . . . 73.099999999999994 111.812 -174.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.752 ' NE2' ' HA ' ' A' ' 19' ' ' LEU . 46.0 tt0 -61.65 -44.46 96.92 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.299 0.481 . . . . 75.430000000000007 112.299 -174.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -85.73 -8.74 57.98 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.272 -0.571 . . . . 75.420000000000002 111.12 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 57.5 tp -84.21 -53.18 5.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.082 0.468 . . . . 64.150000000000006 109.869 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.688 0 N-CA-C 110.933 -0.867 . . . . 54.439999999999998 110.933 -178.647 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 82.4 t . . . . . 0 N--CA 1.45 -0.467 0 N-CA-C 109.801 -0.444 . . . . 73.310000000000002 109.801 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.5 t -93.72 116.52 35.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.826 -0.625 . . . . 73.040000000000006 110.314 -176.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.44 109.79 13.15 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.965 -0.754 . . . . 73.010000000000005 108.965 172.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.571 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 7.0 t70 -157.72 172.03 19.24 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.039 -1.097 . . . . 62.130000000000003 108.039 175.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.463 ' CB ' HG21 ' A' ' 105' ' ' VAL . . . -136.84 121.05 17.91 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.949 0.404 . . . . 74.219999999999999 111.486 -173.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.9 m -109.27 141.67 23.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.256 -0.646 . . . . 63.219999999999999 109.256 175.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 t -116.47 124.68 50.55 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.937 0.875 . . . . 74.099999999999994 110.99 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.757 HG23 ' HB3' ' A' ' 145' ' ' GLU . 4.7 mp -121.85 150.18 25.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.692 -1.14 . . . . 51.310000000000002 109.685 -176.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.9 37.99 0.76 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.509 -0.377 . . . . 71.409999999999997 113.582 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.514 ' HG2' HG21 ' A' ' 12' ' ' ILE . 74.3 mmtt -105.66 152.0 39.98 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 108.264 -1.013 . . . . 52.109999999999999 108.264 175.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.405 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 52.9 Cg_exo -55.73 -57.85 1.37 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.151 1.9 . . . . 51.25 112.593 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . 173.33 -54.1 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.404 0.621 . . . . 74.439999999999998 110.164 178.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.735 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 7.8 mt-10 -55.56 -39.32 70.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.82 -1.082 . . . . 63.119999999999997 111.814 -175.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.6 ' NE2' ' HB2' ' A' ' 17' ' ' GLU . 2.5 mp0 -73.43 -14.11 61.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.864 -0.607 . . . . 74.340000000000003 111.135 -175.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.3 mt -76.04 -44.07 40.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.592 -0.276 . . . . 71.420000000000002 111.064 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.735 ' CE2' ' HA ' ' A' ' 17' ' ' GLU . 21.1 p90 -73.75 -23.47 59.74 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 119.999 -0.68 . . . . 74.109999999999999 110.22 175.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.588 ' HB1' ' HD2' ' A' ' 27' ' ' PRO . . . -75.58 -2.64 30.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.5 -0.773 . . . . 71.319999999999993 111.74 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.447 HG13 ' HZ ' ' A' ' 140' ' ' PHE . 15.0 p -52.14 -31.55 14.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 112.144 0.424 . . . . 74.450000000000003 112.144 -177.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -67.7 -13.0 61.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.706 0.289 . . . . 75.549999999999997 111.449 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.745 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . 39.3 mmt180 -117.14 15.28 14.99 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.193 -0.458 . . . . 72.299999999999997 110.715 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.417 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 11.6 t70 61.5 37.57 16.4 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.864 0.84 . . . . 71.340000000000003 109.117 -175.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER 43.84 85.33 0.17 Allowed Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 114.967 -1.015 . . . . 73.430000000000007 111.726 -177.492 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.745 ' HD3' ' HB2' ' A' ' 24' ' ' ARG . 63.3 Cg_endo . . . . . 0 N--CA 1.461 -0.402 0 C-N-CA 122.617 2.211 . . . . 74.409999999999997 112.579 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.589 0 N-CA-C 109.5 -0.556 . . . . 62.240000000000002 109.5 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.781 ' HB2' HD21 ' A' ' 80' ' ' LEU . 5.5 tm-20 -108.05 135.21 49.8 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.356 -1.35 . . . . 62.100000000000001 107.356 177.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.732 HD21 ' HB2' ' A' ' 69' ' ' ASP . 29.3 tp -137.96 149.38 46.09 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.486 -0.486 . . . . 74.540000000000006 110.462 -171.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.9 t -119.11 -18.34 8.74 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.251 -0.58 . . . . 73.5 111.773 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -152.61 129.07 10.65 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 120.776 -0.37 . . . . 74.329999999999998 111.605 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.732 ' HB2' HD21 ' A' ' 66' ' ' LEU . 19.3 t70 -136.17 90.66 2.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.4 -0.818 . . . . 74.230000000000004 110.273 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.54 ' HB2' ' HB2' ' A' ' 73' ' ' LYS . 31.4 mt-10 -139.38 142.82 33.6 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 110.067 -0.346 . . . . 65.209999999999994 110.067 177.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 16.5 Cg_exo -69.1 -55.06 0.21 Allowed 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.747 2.298 . . . . 63.119999999999997 113.061 -178.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.56 49.88 0.83 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.572 -0.823 . . . . 75.349999999999994 112.42 -176.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.54 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 7.7 mmmm -139.0 -74.48 0.38 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.026 0.441 . . . . 74.230000000000004 110.428 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.499 ' HB3' HD13 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -166.51 137.78 3.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.957 -0.565 . . . . 71.010000000000005 110.1 179.127 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.666 HD12 ' HE2' ' A' ' 93' ' ' PHE . 3.2 mp -109.44 110.11 30.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.901 -0.778 . . . . 72.209999999999994 108.901 173.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -119.2 115.19 23.69 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.438 -0.949 . . . . 36.539999999999999 108.438 176.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.662 ' HA ' HD12 ' A' ' 66' ' ' LEU . 63.0 p-90 -121.48 157.65 30.15 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.511 0.672 . . . . 74.430000000000007 111.544 -169.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.67 ' HD2' ' OE1' ' A' ' 65' ' ' GLU . 69.8 mtt180 -136.39 175.8 9.28 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 107.92 -1.141 . . . . 62.119999999999997 107.92 176.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.681 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 19.6 m -137.19 51.54 1.95 Allowed 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.678 -0.49 . . . . 61.310000000000002 109.678 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.781 HD21 ' HB2' ' A' ' 65' ' ' GLU . 13.0 mt 65.3 142.21 0.07 OUTLIER Pre-proline 0 N--CA 1.471 0.624 0 O-C-N 124.264 0.977 . . . . 64.109999999999999 111.014 -175.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 80' ' ' LEU . 22.4 Cg_exo -66.38 -35.33 31.57 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.461 2.107 . . . . 71.439999999999998 112.097 177.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.87 18.46 57.17 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.596 -0.811 . . . . 55.219999999999999 112.87 -177.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.681 ' HB1' ' O ' ' A' ' 79' ' ' SER . . . -118.14 -158.13 0.7 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 122.582 -0.363 . . . . 64.540000000000006 111.167 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.403 ' HA ' ' HD2' ' A' ' 84' ' ' ARG . 24.5 tpt180 -66.5 -66.07 0.6 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.642 0.608 . . . . 54.109999999999999 112.642 -168.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 50.2 mt 59.61 87.96 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.264 0.555 . . . . 74.239999999999995 110.547 -172.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -80.19 -46.25 16.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.98 -0.554 . . . . 63.049999999999997 110.952 -175.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.606 HD22 ' HB2' ' A' ' 108' ' ' LEU . 54.2 t30 -125.89 162.15 25.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.1 -0.5 . . . . 65.310000000000002 109.771 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.8 m -138.35 128.65 25.95 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.082 -0.34 . . . . 74.439999999999998 110.082 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.18 148.89 4.91 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.751 -0.737 . . . . 53.409999999999997 111.807 178.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.72 159.31 16.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.151 0.5 . . . . 72.219999999999999 111.369 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.9 p -110.89 128.05 67.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.667 -0.697 . . . . 75.109999999999999 110.492 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.499 HD13 ' HB3' ' A' ' 74' ' ' ARG . 3.9 mm? -100.25 126.88 46.6 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.499 -0.773 . . . . 74.510000000000005 110.357 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.666 ' HE2' HD12 ' A' ' 75' ' ' ILE . 85.7 m-85 -107.63 106.69 17.15 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.23 -0.656 . . . . 74.140000000000001 109.23 175.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.467 ' HD3' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -129.93 144.9 54.92 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 116.152 -0.476 . . . . 74.150000000000006 110.763 -175.147 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -61.57 123.39 12.62 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.603 2.202 . . . . 62.409999999999997 111.377 175.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.7 144.03 93.23 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.287 -0.415 . . . . 71.150000000000006 110.247 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -43.25 115.31 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.584 2.856 . . . . 72.430000000000007 114.056 -176.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.15 -75.38 0.33 Allowed Glycine 0 N--CA 1.437 -1.268 0 CA-C-N 115.125 -0.943 . . . . 71.230000000000004 111.169 174.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 175.04 24.2 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.159 -0.521 . . . . 61.299999999999997 111.556 -175.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -67.87 -33.63 75.11 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.887 0.375 . . . . 64.140000000000001 111.505 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.02 -154.58 25.63 Favored Glycine 0 CA--C 1.506 -0.478 0 N-CA-C 111.33 -0.708 . . . . 62.549999999999997 111.33 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 91.6 m -106.79 117.83 35.08 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.252 0.549 . . . . 75.340000000000003 110.378 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.42 ' CG ' ' HB2' ' A' ' 9' ' ' ALA . 43.3 tt0 -78.86 115.85 18.81 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.125 -0.943 . . . . 72.209999999999994 110.408 178.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.4 p -94.01 103.95 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.708 0.766 . . . . 65.129999999999995 110.033 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.467 HG22 ' HD3' ' A' ' 94' ' ' ARG . 18.9 t -100.46 111.02 28.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 114.939 -1.028 . . . . 72.019999999999996 110.084 -177.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.437 HG12 HD21 ' A' ' 108' ' ' LEU . 10.9 t -120.14 132.33 70.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.031 0.443 . . . . 73.109999999999999 110.707 -178.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 107' ' ' ARG . 0.6 OUTLIER -118.13 103.31 9.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.833 -0.621 . . . . 75.549999999999997 109.843 175.214 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.606 ' HB2' HD22 ' A' ' 87' ' ' ASN . 2.3 pt? -150.68 155.25 38.96 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.449 -0.341 . . . . 62.009999999999998 111.058 -172.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 13.8 t -81.43 133.98 35.48 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.04 -1.096 . . . . 73.340000000000003 108.04 172.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 14.2 t80 . . . . . 0 N--CA 1.442 -0.857 0 N-CA-C 108.968 -0.753 . . . . 74.010000000000005 108.968 -167.374 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.804 0 N-CA-C 111.841 -0.504 . . . . 53.210000000000001 111.841 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 16.5 m -61.91 -22.19 65.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.857 0.36 . . . . 55.240000000000002 110.744 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.23 -22.14 66.67 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.077 -0.511 . . . . 54.219999999999999 110.813 175.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -60.36 -20.54 55.35 Favored Glycine 0 CA--C 1.519 0.307 0 CA-C-N 116.108 -0.496 . . . . 74.5 112.424 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.93 -20.33 66.18 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 122.68 -0.306 . . . . 63.039999999999999 111.041 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.469 ' O ' ' HG2' ' A' ' 123' ' ' ARG . 66.5 t -69.23 -47.63 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.791 0.329 . . . . 73.349999999999994 110.41 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.415 ' O ' ' HB3' ' A' ' 124' ' ' MET . 14.2 tt -75.32 -27.05 19.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.043 0.449 . . . . 71.120000000000005 110.182 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.87 -42.93 84.79 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.373 -0.376 . . . . 72.209999999999994 111.052 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 120' ' ' VAL . 13.3 ptp180 -74.51 -14.8 60.86 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.142 0.496 . . . . 71.049999999999997 110.393 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.415 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 26.2 ttt . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 115.609 -0.723 . . . . 60.43 110.002 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.937 0 CA-C-O 121.873 0.844 . . . . 62.130000000000003 109.447 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -48.06 -43.68 30.7 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 113.823 -1.535 . . . . 73.019999999999996 112.949 -173.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -73.34 -36.91 66.23 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.915 0.388 . . . . 71.340000000000003 111.048 -175.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.571 ' CD2' ' HB3' ' A' ' 8' ' ' ASP . 24.3 tp -77.05 -21.85 53.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.224 0.535 . . . . 72.409999999999997 109.729 -178.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.712 ' HA ' ' HE1' ' A' ' 138' ' ' MET . 0.1 OUTLIER -63.89 -35.2 79.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.914 -0.584 . . . . 75.530000000000001 109.442 175.386 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.661 ' O ' ' HG3' ' A' ' 142' ' ' ARG . 52.6 mtt180 -73.14 -32.56 64.97 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.664 -0.698 . . . . 52.350000000000001 110.023 177.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.447 ' HZ ' HG13 ' A' ' 22' ' ' VAL . 83.4 t80 -62.05 -34.29 75.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.707 -0.679 . . . . 63.329999999999998 110.046 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.453 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 21.0 ttpp -60.81 -53.02 62.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.41 . . . . 73.019999999999996 110.957 176.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.661 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 3.5 ptm180 -64.68 -29.31 70.3 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.585 0.587 . . . . 61.310000000000002 112.585 -174.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -79.57 -33.62 41.62 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.143 -0.623 . . . . 73.340000000000003 110.42 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.504 ' CB ' HG12 ' A' ' 12' ' ' ILE . 13.4 mm-40 -59.31 -43.92 92.59 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.29 0.566 . . . . 71.129999999999995 111.263 176.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.757 ' HB3' HG23 ' A' ' 12' ' ' ILE . 9.0 pt-20 -81.97 -3.44 54.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.718 -0.674 . . . . 74.519999999999996 111.48 -177.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 54.2 tp -112.76 -61.56 1.71 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.063 0.459 . . . . 54.200000000000003 111.306 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.72 0 N-CA-C 111.101 -0.8 . . . . 44.130000000000003 111.101 -173.721 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.762 HG11 ' HG1' ' A' ' 109' ' ' THR . 74.6 t . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 110.034 -0.358 . . . . 72.409999999999997 110.034 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.6 t -78.77 117.28 24.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.095 0.474 . . . . 72.319999999999993 111.159 -173.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -140.06 109.81 6.36 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.541 -0.754 . . . . 75.219999999999999 109.971 173.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.528 ' HB3' HD22 ' A' ' 137' ' ' LEU . 4.1 t70 -151.46 172.57 15.77 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.759 -1.2 . . . . 64.140000000000001 107.759 174.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.416 ' HB3' ' CG ' ' A' ' 103' ' ' GLU . . . -139.8 120.81 14.61 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.05 0.453 . . . . 64.349999999999994 111.205 -172.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.552 HG22 HD13 ' A' ' 12' ' ' ILE . 19.4 m -111.24 148.9 14.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.73 -0.668 . . . . 65.340000000000003 110.313 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.6 t -114.44 103.75 11.36 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.796 0.808 . . . . 74.540000000000006 110.781 175.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.792 HG23 ' HB3' ' A' ' 144' ' ' GLN . 1.1 mp -96.16 151.81 3.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.238 -0.892 . . . . 73.439999999999998 108.711 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.39 51.12 1.39 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.322 -0.466 . . . . 74.099999999999994 113.483 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.672 ' HB3' ' HB2' ' A' ' 18' ' ' GLN . 79.7 mttt -128.13 144.82 53.07 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 108.049 -1.093 . . . . 75.239999999999995 108.049 172.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -55.21 -57.74 1.51 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.32 2.013 . . . . 74.120000000000005 113.332 -174.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 173.32 -51.37 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.45 -0.945 . . . . 63.299999999999997 108.45 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.674 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 2.5 tt0 -48.76 -37.86 20.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 113.943 -1.48 . . . . 63.43 111.421 174.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.672 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 31.0 mm-40 -85.84 -13.29 48.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.577 -0.738 . . . . 75.219999999999999 111.15 -176.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.671 HD23 HD11 ' A' ' 12' ' ' ILE . 91.7 mt -83.89 -53.21 5.75 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 112.079 0.4 . . . . 73.450000000000003 112.079 -177.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.674 ' CE2' ' HA ' ' A' ' 17' ' ' GLU . 32.7 p90 -66.96 -23.29 65.94 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.193 0.521 . . . . 65.340000000000003 111.06 -175.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.1 -3.01 30.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.771 -0.65 . . . . 71.340000000000003 111.661 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 25' ' ' ASP . 13.5 p -52.64 -22.28 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 113.162 0.801 . . . . 71.409999999999997 113.162 -175.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -56.51 -32.32 64.93 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.138 0.494 . . . . 73.129999999999995 110.35 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -116.71 6.05 13.24 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.099 -0.704 . . . . 75.25 109.099 175.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.557 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 31.3 t70 48.63 95.69 0.01 OUTLIER 'General case' 0 C--O 1.235 0.305 0 CA-C-N 114.312 -1.313 . . . . 73.530000000000001 111.644 -168.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.531 HD21 ' HZ1' ' A' ' 14' ' ' LYS . 16.5 mt 67.32 153.85 0.13 Allowed Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 114.686 -1.143 . . . . 74.510000000000005 111.232 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 26' ' ' LEU . 3.3 Cg_exo . . . . . 0 N--CA 1.46 -0.445 0 C-N-CA 122.684 2.256 . . . . 72.319999999999993 112.45 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.289 0 N-CA-C 109.562 -0.533 . . . . 72.420000000000002 109.562 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -106.1 134.97 48.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.823 0.344 . . . . 74.299999999999997 110.105 -178.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.827 HD12 ' HA ' ' A' ' 77' ' ' TRP . 3.1 mm? -97.7 151.98 19.57 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.837 -0.801 . . . . 55.130000000000003 108.837 176.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.1 p -75.32 -36.91 61.02 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.006 -0.739 . . . . 74.319999999999993 109.006 175.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -173.28 127.91 0.44 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.602 -1.181 . . . . 74.420000000000002 111.418 177.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -124.48 94.16 4.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.53 -0.759 . . . . 74.239999999999995 109.211 174.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 48.9 mt-10 -104.09 142.45 24.62 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 63.439999999999998 111.296 -174.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 31.5 Cg_exo -59.18 99.25 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.362 2.708 . . . . 74.329999999999998 113.694 -172.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.51 40.76 96.67 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.367 -0.833 . . . . 71.310000000000002 113.072 177.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -128.58 -79.67 0.57 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.021 0.438 . . . . 74.25 110.341 178.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -136.59 132.74 35.54 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.013 -0.54 . . . . 73.430000000000007 109.551 176.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 30.7 mm -120.36 110.34 28.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.809 -0.632 . . . . 75.150000000000006 109.354 -177.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -119.41 116.99 27.28 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.309 0.576 . . . . 75.140000000000001 110.47 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.827 ' HA ' HD12 ' A' ' 66' ' ' LEU . 44.9 m95 -89.9 159.56 16.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.374 -0.83 . . . . 72.209999999999994 111.072 -174.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -164.92 175.75 9.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.72 -0.673 . . . . 74.530000000000001 109.688 -178.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.568 ' HB3' ' O ' ' A' ' 84' ' ' ARG . 9.2 t -138.04 173.11 11.98 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.203 -1.406 . . . . 65.140000000000001 107.203 175.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 97.5 mt -79.01 144.28 63.15 Favored Pre-proline 0 C--N 1.314 -0.957 0 C-N-CA 121.054 -0.258 . . . . 73.540000000000006 110.689 -177.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.437 ' HA ' HG23 ' A' ' 85' ' ' ILE . 52.5 Cg_exo -56.14 -37.54 96.32 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.123 2.548 . . . . 74.519999999999996 112.676 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.69 -16.65 74.34 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.684 -0.769 . . . . 73.319999999999993 112.26 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.2 -62.58 1.26 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.705 0.288 . . . . 61.149999999999999 111.033 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.568 ' O ' ' HB3' ' A' ' 79' ' ' SER . 29.4 ttm180 -177.23 117.56 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.752 -0.658 . . . . 75.040000000000006 110.808 -173.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.44 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 2.1 pp -113.97 -166.58 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.543 -0.299 . . . . 74.299999999999997 110.732 175.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 49.4 mm-40 71.61 8.09 6.11 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.15 0.58 . . . . 73.109999999999999 111.707 -177.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -74.03 131.79 41.72 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.301 -0.629 . . . . 75.310000000000002 109.301 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.413 ' HB3' ' H ' ' A' ' 109' ' ' THR . 22.7 t -112.36 127.1 55.91 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.934 -0.395 . . . . 71.129999999999995 109.934 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -179.25 72.26 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.645 -0.788 . . . . 62.439999999999998 112.033 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -102.82 116.42 32.52 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.758 -0.46 . . . . 71.219999999999999 109.758 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.653 HG22 HG22 ' A' ' 106' ' ' VAL . 89.6 t -102.61 126.55 56.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.458 0.647 . . . . 73.349999999999994 111.267 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.521 ' HB2' ' HB ' ' A' ' 105' ' ' VAL . 3.2 mm? -110.4 120.81 43.62 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.965 -1.016 . . . . 71.109999999999999 109.833 176.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -97.62 118.04 33.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.929 0.395 . . . . 73.329999999999998 110.345 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.0 mtp180 -123.78 145.39 47.41 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.008 -0.542 . . . . 73.099999999999994 110.552 -176.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.34 119.01 6.0 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.591 2.194 . . . . 75.340000000000003 111.187 175.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.95 143.99 47.01 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.045 0.45 . . . . 74.519999999999996 111.935 -173.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -60.54 131.01 35.87 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.312 2.675 . . . . 63.240000000000002 112.231 177.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.41 0.38 90.02 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 121.099 -0.572 . . . . 72.329999999999998 111.851 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 58.76 34.01 23.45 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 122.921 0.488 . . . . 75.120000000000005 111.306 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -60.37 -31.99 70.87 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.263 0.554 . . . . 72.329999999999998 110.504 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 170.49 -137.85 4.66 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.194 -1.162 . . . . 74.430000000000007 110.194 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 72.0 m -121.43 130.64 53.71 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 117.06 0.43 . . . . 62.399999999999999 110.19 175.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.416 ' CG ' ' HB3' ' A' ' 9' ' ' ALA . 42.5 tt0 -76.97 119.3 20.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.056 -0.52 . . . . 75.120000000000005 110.904 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.639 HG21 HG13 ' A' ' 91' ' ' VAL . 2.4 p -99.1 106.62 19.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.627 -0.715 . . . . 64.099999999999994 110.041 175.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 92' ' ' LEU . 26.1 t -91.8 109.91 21.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.765 -0.652 . . . . 74.349999999999994 109.413 177.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.653 HG22 HG22 ' A' ' 91' ' ' VAL . 48.8 t -112.11 121.43 64.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.953 0.406 . . . . 64.439999999999998 110.71 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -113.97 104.82 12.54 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.72 -0.844 . . . . 72.140000000000001 108.72 172.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.575 ' H ' HD21 ' A' ' 108' ' ' LEU . 2.4 pt? -119.0 120.47 37.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.181 0.515 . . . . 73.540000000000006 109.824 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.762 ' HG1' HG11 ' A' ' 5' ' ' VAL . 86.6 m -103.45 125.26 49.93 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.2 -0.455 . . . . 64.239999999999995 110.787 -177.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 52.0 p90 . . . . . 0 N--CA 1.445 -0.707 0 N-CA-C 108.612 -0.884 . . . . 74.310000000000002 108.612 -179.359 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.462 0 N-CA-C 111.977 -0.449 . . . . 74.129999999999995 111.977 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.1 m -60.63 -27.99 68.2 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.648 0.24 . . . . 61.119999999999997 111.648 -176.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.88 -23.38 67.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.935 0.398 . . . . 74.120000000000005 111.194 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.73 -21.07 70.82 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.986 -0.626 . . . . 72.019999999999996 112.774 -177.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.99 -41.95 67.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.64 0.257 . . . . 72.340000000000003 111.451 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.402 ' O ' ' HG3' ' A' ' 124' ' ' MET . 30.4 m -76.67 -35.34 25.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.792 -0.363 . . . . 63.25 110.805 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 79.2 mt -59.58 -30.9 45.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 116.358 -0.383 . . . . 72.530000000000001 110.709 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -52.64 -58.41 6.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.901 -0.591 . . . . 62.340000000000003 111.179 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -79.52 -17.02 54.96 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.15 -0.477 . . . . 72.340000000000003 111.26 -177.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.402 ' HG3' ' O ' ' A' ' 120' ' ' VAL . 76.2 mtp . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.483 -0.326 . . . . 73.319999999999993 111.343 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 52.2 mtt85 . . . . . 0 N--CA 1.47 0.54 0 N-CA-C 112.587 0.588 . . . . 73.439999999999998 112.587 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -69.92 -28.53 65.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.655 0.264 . . . . 74.530000000000001 110.346 -177.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -63.8 -30.48 71.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.927 0.394 . . . . 51.439999999999998 110.585 173.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.528 HD22 ' HB3' ' A' ' 8' ' ' ASP . 39.0 tp -67.9 -26.12 65.83 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.728 -0.471 . . . . 74.230000000000004 109.728 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.748 ' HA ' ' HE2' ' A' ' 138' ' ' MET . 2.8 mmt -66.74 -30.07 70.2 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.822 -0.626 . . . . 70.310000000000002 109.911 174.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 -78.52 -35.77 45.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.522 -0.763 . . . . 74.5 109.36 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -57.62 -49.15 77.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.204 -0.907 . . . . 72.25 111.729 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.71 ' HB2' HG13 ' A' ' 12' ' ' ILE . 13.4 ptmm? -60.21 -38.48 83.48 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.897 0.379 . . . . 72.239999999999995 110.238 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.661 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 35.6 ttp180 -64.02 -44.0 93.9 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.719 -0.673 . . . . 73.219999999999999 110.81 -176.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.477 ' HA ' HD11 ' A' ' 146' ' ' LEU . 41.7 mt-10 -65.42 -30.4 71.2 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.949 0.404 . . . . 71.400000000000006 110.66 177.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.792 ' HB3' HG23 ' A' ' 12' ' ' ILE . 0.9 OUTLIER -65.49 -47.0 77.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 73.230000000000004 111.054 178.436 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.409 ' HB3' HG22 ' A' ' 12' ' ' ILE . 6.2 pt-20 -80.41 -9.29 59.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.886 0.374 . . . . 73.019999999999996 111.066 -178.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' A' ' 142' ' ' ARG . 55.4 mt -73.29 -41.13 63.96 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.721 -0.474 . . . . 71.540000000000006 109.721 170.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.399 0 C-N-CA 121.048 -0.596 . . . . 64.219999999999999 112.703 177.082 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.5 t . . . . . 0 N--CA 1.45 -0.434 0 N-CA-C 109.181 -0.674 . . . . 74.5 109.181 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.5 t -78.82 119.55 28.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 116.016 -0.538 . . . . 75.299999999999997 110.288 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 15.0 ptt180 -141.65 125.01 16.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.429 0.633 . . . . 74.510000000000005 111.225 176.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.411 ' HB3' HD23 ' A' ' 137' ' ' LEU . 3.8 t70 -157.42 174.1 15.91 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.946 -1.131 . . . . 63.32 107.946 174.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.58 ' HB3' ' HG2' ' A' ' 103' ' ' GLU . . . -134.45 122.37 22.39 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.798 0.332 . . . . 62.229999999999997 111.279 -170.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.547 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 17.1 m -108.04 130.14 61.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.271 0.557 . . . . 61.350000000000001 110.998 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.664 HG21 ' HB1' ' A' ' 96' ' ' ALA . 21.2 m -86.83 100.16 12.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.715 -0.675 . . . . 73.25 110.497 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.674 HG21 ' HG3' ' A' ' 144' ' ' GLN . 66.9 mt -111.89 145.6 17.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.697 0.285 . . . . 71.519999999999996 111.105 -174.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.68 66.04 3.91 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 121.136 -0.554 . . . . 55.409999999999997 112.955 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.442 ' HD3' ' HB3' ' A' ' 18' ' ' GLN . 43.3 mttp -143.32 147.43 40.23 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.755 -0.461 . . . . 75.219999999999999 109.755 174.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.413 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 50.1 Cg_exo -55.14 -55.65 2.99 Favored 'Trans proline' 0 N--CA 1.479 0.65 0 C-N-CA 123.406 2.737 . . . . 52.310000000000002 114.079 -172.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.413 ' HB1' ' O ' ' A' ' 15' ' ' PRO . . . 174.65 -64.02 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.146 0.498 . . . . 70.319999999999993 110.015 178.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.433 ' OE1' ' HG2' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -56.54 -42.5 78.59 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.198 -0.91 . . . . 73.329999999999998 111.507 179.353 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.442 ' HB3' ' HD3' ' A' ' 14' ' ' LYS . 31.4 mm-40 -62.0 -21.32 64.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 74.340000000000003 111.997 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.532 ' O ' HG11 ' A' ' 22' ' ' VAL . 59.3 mt -73.96 -32.35 63.43 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.305 -0.247 . . . . 74.549999999999997 111.629 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -69.69 -24.22 63.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.182 0.515 . . . . 73.439999999999998 110.181 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.05 -23.85 67.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.752 -0.658 . . . . 75.140000000000001 111.616 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.532 HG11 ' O ' ' A' ' 19' ' ' LEU . 4.3 p -67.38 -21.97 28.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 121.174 0.512 . . . . 63.140000000000001 110.742 -178.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 54.8 t90 -64.49 -26.25 68.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.783 -0.644 . . . . 74.439999999999998 110.69 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.51 -82.65 0.64 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.767 -0.651 . . . . 75.239999999999995 109.647 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.533 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 28.5 t70 -165.92 149.66 7.85 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.466 -0.788 . . . . 74.409999999999997 109.031 178.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.37 86.14 7.81 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 121.086 0.47 . . . . 74.099999999999994 110.941 177.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 25' ' ' ASP . 2.1 Cg_endo . . . . . 0 N--CA 1.454 -0.84 0 C-N-CA 123.433 2.755 . . . . 72.209999999999994 111.371 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 108.854 -0.795 . . . . 74.430000000000007 108.854 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.463 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 7.2 pt-20 -103.7 135.71 44.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.325 0.583 . . . . 75.530000000000001 111.748 -176.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.568 HD13 HG23 ' A' ' 75' ' ' ILE . 41.4 tp -105.12 126.38 52.01 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.817 -0.438 . . . . 71.099999999999994 109.817 177.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 64.2 p -84.11 -36.63 22.81 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.103 0.478 . . . . 71.25 111.224 -176.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.703 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -118.93 137.94 53.13 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.828 -0.624 . . . . 64.340000000000003 111.312 -170.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -139.61 33.3 2.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.781 -0.645 . . . . 72.420000000000002 109.856 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.979 ' HG3' ' HG2' ' A' ' 74' ' ' ARG . 5.4 mm-40 -57.33 142.83 75.29 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.427 -0.806 . . . . 72.450000000000003 110.307 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 9.2 Cg_exo -71.89 76.08 2.09 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.85 2.367 . . . . 74.129999999999995 112.173 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.47 43.82 43.69 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.947 -0.645 . . . . 72.400000000000006 112.076 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.591 ' HB2' ' HB3' ' A' ' 70' ' ' GLU . 70.9 mmtt -127.73 -69.3 0.74 Allowed 'General case' 0 C--N 1.328 -0.328 0 O-C-N 122.897 -0.178 . . . . 74.420000000000002 111.106 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.979 ' HG2' ' HG3' ' A' ' 70' ' ' GLU . 9.2 ptt180 -145.69 130.84 18.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.115 0.483 . . . . 72.329999999999998 110.397 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.672 HD12 ' HE2' ' A' ' 93' ' ' PHE . 2.3 mp -126.31 113.02 31.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.956 -0.565 . . . . 73.420000000000002 109.907 176.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.703 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -107.73 116.82 32.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.66 -0.7 . . . . 74.230000000000004 109.835 176.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.698 ' HZ3' HG13 ' A' ' 91' ' ' VAL . 31.5 p90 -98.72 143.54 28.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.471 0.653 . . . . 74.5 111.325 -174.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -141.21 179.18 6.91 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.959 -1.019 . . . . 74.329999999999998 109.44 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.5 m -132.84 147.79 52.3 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.203 -1.036 . . . . 53.020000000000003 108.203 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.463 ' CD1' ' HB3' ' A' ' 65' ' ' GLU . 5.4 mp -57.65 144.93 71.75 Favored Pre-proline 0 C--N 1.323 -0.549 0 O-C-N 123.497 0.498 . . . . 74.450000000000003 111.594 -176.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.35 -22.04 39.65 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.643 2.895 . . . . 71.340000000000003 113.766 -174.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -79.67 -14.83 80.59 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.015 -0.612 . . . . 44.439999999999998 112.311 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -111.17 172.32 6.95 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.683 0.277 . . . . 72.420000000000002 110.316 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -75.89 138.72 41.24 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.163 -0.68 . . . . 73.530000000000001 109.163 173.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.4 pt -75.92 88.87 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.32 0.581 . . . . 73.439999999999998 109.449 173.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -54.15 -34.67 60.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.192 -0.913 . . . . 75.099999999999994 112.047 -173.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.547 HD21 ' N ' ' A' ' 88' ' ' SER . 0.2 OUTLIER -166.73 132.82 2.31 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.897 -0.779 . . . . 65.450000000000003 108.897 178.629 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.547 ' N ' HD21 ' A' ' 87' ' ' ASN . 30.0 m -115.6 128.57 56.04 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.053 -0.351 . . . . 70.109999999999999 110.053 177.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -174.77 -178.56 44.74 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.635 -0.793 . . . . 54.299999999999997 111.981 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -147.03 132.71 18.86 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.916 -0.401 . . . . 61.32 109.916 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.698 HG13 ' HZ3' ' A' ' 77' ' ' TRP . 25.2 m -107.68 138.01 36.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.016 0.436 . . . . 75.120000000000005 110.711 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.409 ' HB2' ' HB ' ' A' ' 105' ' ' VAL . 3.4 mm? -112.32 120.82 43.01 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.708 -0.678 . . . . 73.420000000000002 109.631 177.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.672 ' HE2' HD12 ' A' ' 75' ' ' ILE . 76.2 m-85 -98.11 112.42 24.39 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.924 0.393 . . . . 72.430000000000007 110.499 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 94' ' ' ARG . 5.0 ptt180 -126.2 145.23 51.71 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.03 -0.532 . . . . 75.140000000000001 110.442 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -51.46 131.18 35.76 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.209 2.606 . . . . 74.439999999999998 112.296 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.664 ' HB1' HG21 ' A' ' 11' ' ' THR . . . -82.6 144.94 49.91 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.0 -0.545 . . . . 61.140000000000001 111.751 -175.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.79 133.19 52.32 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.913 2.409 . . . . 61.409999999999997 112.111 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.09 5.71 81.26 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 121.228 -0.511 . . . . 75.5 112.762 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 62.66 34.69 14.68 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.855 0.462 . . . . 72.120000000000005 111.34 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.16 -35.72 71.97 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 108.653 -0.869 . . . . 73.420000000000002 108.653 172.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.71 -107.16 0.29 Allowed Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 114.942 -1.026 . . . . 64.340000000000003 110.764 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.457 ' HB ' HD11 ' A' ' 19' ' ' LEU . 28.8 m -142.69 136.61 29.19 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 110.027 -0.36 . . . . 72.420000000000002 110.027 176.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.58 ' HG2' ' HB3' ' A' ' 9' ' ' ALA . 38.4 tt0 -96.57 108.38 20.96 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 109.326 -0.62 . . . . 74.329999999999998 109.326 177.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.4 p -87.79 108.66 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.679 0.752 . . . . 74.409999999999997 110.015 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.486 HG13 ' HB2' ' A' ' 9' ' ' ALA . 3.4 t -92.44 109.22 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 114.721 -1.127 . . . . 70.040000000000006 108.781 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.654 HG23 HD12 ' A' ' 108' ' ' LEU . 7.4 p -112.87 130.89 65.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 121.017 0.437 . . . . 75.310000000000002 111.303 -173.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.586 ' HD3' ' O ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -123.6 125.83 45.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.778 -0.646 . . . . 75.109999999999999 110.097 174.361 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.654 HD12 HG23 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -150.52 152.54 34.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.936 -0.575 . . . . 74.099999999999994 110.141 -179.21 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.8 t -88.32 143.23 27.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.801 0.334 . . . . 64.340000000000003 111.022 -177.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.419 ' HD1' ' HA ' ' A' ' 110' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--N 1.326 -0.415 0 N-CA-C 109.103 -0.703 . . . . 73.040000000000006 109.103 177.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.513 0 N-CA-C 112.871 -0.092 . . . . 73.310000000000002 112.871 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.4 p -81.19 -25.06 37.06 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.224 0.453 . . . . 63.420000000000002 112.224 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.451 ' O ' HG21 ' A' ' 120' ' ' VAL . . . -64.83 -41.01 96.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.079 0.466 . . . . 64.540000000000006 110.717 178.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.55 -20.67 75.76 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.932 -0.652 . . . . 64.25 112.837 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.6 -40.72 95.81 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 111.728 0.27 . . . . 71.140000000000001 111.728 -176.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.451 HG21 ' O ' ' A' ' 117' ' ' ALA . 25.0 m -70.68 -27.84 32.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.767 0.318 . . . . 75.340000000000003 110.7 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 57.9 mt -75.04 -36.64 38.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.053 0.454 . . . . 75.510000000000005 110.231 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.27 -35.13 78.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.767 -0.651 . . . . 73.140000000000001 111.409 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 27.4 ptt85 -90.22 -14.37 33.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.975 0.417 . . . . 73.340000000000003 110.93 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 23.4 ttt . . . . . 0 C--N 1.326 -0.449 0 CA-C-N 116.029 -0.532 . . . . 74.140000000000001 110.641 178.6 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.646 ' HB2' ' HB3' ' A' ' 137' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.223 0 N-CA-C 112.07 0.396 . . . . 74.099999999999994 112.07 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -59.56 -35.84 75.03 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.025 0.441 . . . . 71.030000000000001 110.573 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -71.57 -37.68 71.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.279 0.561 . . . . 73.400000000000006 109.933 176.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.646 ' HB3' ' HB2' ' A' ' 134' ' ' ARG . 47.2 tp -66.27 -28.08 68.43 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.588 -0.733 . . . . 74.140000000000001 110.202 178.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.781 ' HA ' ' HE2' ' A' ' 138' ' ' MET . 11.8 mmt -63.27 -39.76 95.5 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.101 0.477 . . . . 65.510000000000005 110.173 174.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -67.36 -39.7 85.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.61 -0.723 . . . . 75.420000000000002 109.796 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -59.47 -48.68 80.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.099 -0.955 . . . . 75.150000000000006 110.347 172.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.647 ' HE2' ' O ' ' A' ' 11' ' ' THR . 37.0 tttm -52.06 -49.93 62.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.432 -0.804 . . . . 60.549999999999997 111.657 177.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -56.08 -44.08 78.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.615 -0.721 . . . . 72.129999999999995 111.89 -174.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -68.51 -34.42 75.86 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 121.027 -0.269 . . . . 64.530000000000001 111.662 -176.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.674 ' HG3' HG21 ' A' ' 12' ' ' ILE . 5.4 tp60 -72.53 -34.9 67.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.807 0.336 . . . . 72.099999999999994 110.973 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.607 ' HB3' HG22 ' A' ' 12' ' ' ILE . 15.5 pt-20 -83.06 -38.79 22.05 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 121.022 -0.271 . . . . 74.310000000000002 110.606 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 22.4 tp -72.58 -23.62 60.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.941 0.401 . . . . 73.409999999999997 110.551 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.392 0 CA-C-N 115.749 -0.66 . . . . 74.510000000000005 112.976 -179.723 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.447 -0.612 0 CA-C-O 121.697 0.76 . . . . 75.010000000000005 109.261 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.5 m -84.65 134.23 27.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.288 -0.869 . . . . 61.329999999999998 111.258 -173.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -141.39 132.17 25.79 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.539 -0.755 . . . . 75.439999999999998 109.772 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -143.93 155.69 44.16 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.057 -0.72 . . . . 74.409999999999997 109.057 175.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -130.44 142.86 50.49 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.133 0.492 . . . . 75.430000000000007 111.231 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.58 ' HB ' ' HB2' ' A' ' 141' ' ' LYS . 12.4 m -123.42 137.28 57.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.469 -0.787 . . . . 75.120000000000005 110.206 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -95.58 118.47 32.33 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.243 -0.435 . . . . 72.049999999999997 110.969 -175.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 1.029 HG21 ' HG2' ' A' ' 145' ' ' GLU . 4.0 mp -122.46 139.24 49.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.017 -0.538 . . . . 72.200000000000003 109.565 176.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.07 53.19 3.76 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.804 -0.712 . . . . 71.329999999999998 112.847 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.538 ' HG2' ' HB3' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -123.37 144.81 44.87 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 108.78 -0.822 . . . . 72.140000000000001 108.78 176.207 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.58 -58.37 1.29 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.429 2.086 . . . . 71.120000000000005 113.0 -175.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.549 ' HA ' HD11 ' A' ' 19' ' ' LEU . . . 173.4 -52.98 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.62 0.575 . . . . 62.450000000000003 110.157 178.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -49.44 -49.34 45.57 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.779 -1.101 . . . . 74.439999999999998 112.377 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.657 HE21 HD23 ' A' ' 26' ' ' LEU . 47.0 tt0 -68.71 -20.66 64.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.008 -0.542 . . . . 64.420000000000002 112.113 -175.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.549 HD11 ' HA ' ' A' ' 16' ' ' ALA . 66.6 mt -67.6 -33.15 74.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.66 -0.245 . . . . 64.439999999999998 111.274 -176.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.405 ' O ' ' HD1' ' A' ' 23' ' ' TRP . 27.9 t80 -73.03 -23.95 60.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.991 0.424 . . . . 75.319999999999993 110.743 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.408 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . . . -75.55 -3.53 34.69 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.924 0.392 . . . . 62.32 112.02 -177.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.6 p -56.16 -21.29 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 115.689 -0.687 . . . . 70.340000000000003 112.305 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.405 ' HD1' ' O ' ' A' ' 20' ' ' TYR . 51.1 m95 -48.21 -31.13 5.39 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.287 0.847 . . . . 72.430000000000007 113.287 -176.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -118.27 -85.37 0.65 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.502 -0.479 . . . . 71.109999999999999 111.318 176.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -150.74 35.92 0.62 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.118 0.485 . . . . 75.109999999999999 110.027 -175.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.657 HD23 HE21 ' A' ' 18' ' ' GLN . 9.6 mp 65.55 165.4 0.12 Allowed Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 115.465 -0.789 . . . . 73.409999999999997 110.914 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.467 ' CD ' ' HG3' ' A' ' 18' ' ' GLN . 31.6 Cg_exo . . . . . 0 C--N 1.346 0.433 0 C-N-CA 122.398 2.065 . . . . 64.109999999999999 111.824 176.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.651 0 CA-C-O 120.892 0.377 . . . . 72.530000000000001 110.88 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.468 ' HG2' ' H ' ' A' ' 66' ' ' LEU . 33.0 tt0 -105.53 172.28 6.88 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.863 -1.162 . . . . 71.109999999999999 107.863 172.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.488 ' CD1' ' HA ' ' A' ' 77' ' ' TRP . 11.6 tp -130.43 145.13 51.77 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 122.013 -0.429 . . . . 63.039999999999999 111.061 -174.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.693 HG23 ' HB2' ' A' ' 78' ' ' ARG . 61.5 p -96.68 -34.75 11.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.084 0.469 . . . . 62.219999999999999 110.983 178.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.518 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -140.44 136.02 32.61 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.731 -0.668 . . . . 63.119999999999997 110.857 -177.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -137.38 75.05 1.51 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.576 0.703 . . . . 63.240000000000002 111.051 -177.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.432 ' HB2' ' H ' ' A' ' 74' ' ' ARG . 16.3 mm-40 -96.37 143.42 26.08 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.926 -0.579 . . . . 74.540000000000006 110.22 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -67.81 -38.11 14.3 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.832 2.355 . . . . 73.310000000000002 112.776 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -151.56 42.01 0.73 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.364 -0.922 . . . . 37.0 112.659 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.43 ' HD2' ' OE1' ' A' ' 70' ' ' GLU . 76.0 mttt -130.11 -74.34 0.55 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.169 -0.308 . . . . 72.310000000000002 110.169 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.432 ' H ' ' HB2' ' A' ' 70' ' ' GLU . 5.9 ptp180 -151.71 150.44 30.22 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.872 -0.418 . . . . 75.219999999999999 109.872 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.54 HD13 ' HE2' ' A' ' 93' ' ' PHE . 70.7 mt -134.97 109.49 11.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.365 -0.606 . . . . 70.239999999999995 109.365 171.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.518 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -96.65 116.04 28.44 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.213 -0.662 . . . . 63.119999999999997 109.213 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.488 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 12.8 t90 -81.81 154.07 26.11 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.38 -0.827 . . . . 74.510000000000005 110.394 -172.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.693 ' HB2' HG23 ' A' ' 67' ' ' THR . 64.5 ttt180 -140.42 173.3 11.64 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.89 -0.781 . . . . 62.100000000000001 108.89 -178.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.517 ' HB2' ' HA ' ' A' ' 85' ' ' ILE . 45.8 m -135.9 152.68 51.26 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.944 -0.391 . . . . 54.130000000000003 109.944 175.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 66.5 mt -78.32 145.78 69.1 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 116.205 -0.452 . . . . 71.019999999999996 110.973 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.47 -31.93 92.72 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.352 2.702 . . . . 72.439999999999998 112.343 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.51 -5.41 89.96 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.107 -0.568 . . . . 62.539999999999999 112.255 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.57 -65.21 1.01 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.274 -0.269 . . . . 72.540000000000006 110.274 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.671 ' HG2' ' HB2' ' A' ' 86' ' ' GLU . 20.5 ttt180 -177.53 -53.57 0.01 OUTLIER 'General case' 0 C--N 1.335 -0.063 0 CA-C-N 116.074 -0.512 . . . . 63.119999999999997 111.005 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.517 ' HA ' ' HB2' ' A' ' 79' ' ' SER . 13.0 tt 44.85 40.88 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-O 122.213 1.006 . . . . 74.200000000000003 112.02 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.671 ' HB2' ' HG2' ' A' ' 84' ' ' ARG . 0.8 OUTLIER -97.55 -4.37 37.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.453 -0.794 . . . . 54.439999999999998 110.492 -179.716 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -135.03 172.51 12.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.574 -0.739 . . . . 71.329999999999998 110.311 -177.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.0 m -148.06 145.21 28.36 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.769 0.319 . . . . 74.040000000000006 110.625 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -142.68 122.83 2.02 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.319 -0.713 . . . . 75.329999999999998 111.319 177.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -117.56 120.79 39.14 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.171 -0.307 . . . . 74.219999999999999 110.171 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.51 HG21 HG21 ' A' ' 106' ' ' VAL . 78.3 t -112.83 119.75 61.21 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.625 0.726 . . . . 74.420000000000002 111.425 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.8 mp -104.51 125.05 50.32 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.151 -0.931 . . . . 74.230000000000004 110.15 176.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.54 ' HE2' HD13 ' A' ' 75' ' ' ILE . 73.6 m-85 -89.48 106.43 18.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.115 0.484 . . . . 74.400000000000006 109.818 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 33.3 ptt180 -127.18 143.98 48.99 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.859 -0.61 . . . . 71.430000000000007 110.816 -176.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 94' ' ' ARG . 30.3 Cg_exo -62.55 127.29 20.37 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.662 2.241 . . . . 74.439999999999998 111.5 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.52 146.83 96.5 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 116.081 -0.508 . . . . 71.230000000000004 110.23 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -48.19 127.53 15.41 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.64 2.893 . . . . 61.039999999999999 113.111 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.87 20.33 68.31 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.801 -0.636 . . . . 74.319999999999993 112.447 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 56.66 34.25 24.19 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.129 0.49 . . . . 65.129999999999995 111.347 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 100' ' ' ARG . 4.4 mmp_? -82.11 0.47 40.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.053 -0.521 . . . . 74.040000000000006 111.439 -177.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 144.33 -157.53 27.2 Favored Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 111.063 -0.815 . . . . 64.340000000000003 111.063 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 71.7 m -121.52 128.04 51.63 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.609 -0.515 . . . . 72.200000000000003 109.609 176.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -103.91 130.78 51.55 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.26 0.552 . . . . 71.299999999999997 109.899 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.695 HG23 ' HE2' ' A' ' 140' ' ' PHE . 4.7 m -89.36 132.45 34.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 108.623 -0.88 . . . . 62.43 108.623 175.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 7.3 p -118.0 115.45 48.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 121.375 0.607 . . . . 74.409999999999997 109.896 -177.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.51 HG21 HG21 ' A' ' 91' ' ' VAL . 39.6 t -105.1 115.13 46.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.574 -0.739 . . . . 72.409999999999997 110.849 -174.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -90.52 106.42 18.49 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.422 -0.584 . . . . 61.140000000000001 109.422 173.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.406 ' HA ' HD22 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -99.3 135.67 40.38 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.794 -0.447 . . . . 64.030000000000001 109.794 -177.043 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.4 p -83.81 119.91 25.41 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.214 0.53 . . . . 73.340000000000003 111.236 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 81.2 t80 . . . . . 0 C--N 1.32 -0.708 0 CA-C-N 115.594 -0.73 . . . . 71.109999999999999 109.257 -179.884 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.907 0 N-CA-C 111.952 -0.459 . . . . 44.32 111.952 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.0 t -61.05 -45.41 94.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.776 0.322 . . . . 54.219999999999999 110.554 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.24 -32.65 74.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.221 -0.445 . . . . 53.329999999999998 110.774 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -71.47 -37.0 62.62 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.772 -0.728 . . . . 41.420000000000002 111.993 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.79 -45.52 71.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.652 0.263 . . . . 71.409999999999997 111.544 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 28.1 m -66.09 -36.54 77.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.042 0.386 . . . . 64.209999999999994 112.042 -175.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 35.6 pt -75.66 -32.36 24.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 120.761 -0.376 . . . . 73.019999999999996 110.781 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.57 -34.57 74.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.971 0.415 . . . . 64.329999999999998 110.171 176.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -59.23 -34.81 72.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.118 -0.492 . . . . 72.219999999999999 110.227 175.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 14.7 tpt . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 115.862 -0.608 . . . . 74.120000000000005 110.646 176.95 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.513 ' HG2' ' HG2' ' A' ' 138' ' ' MET . 54.4 ttt85 . . . . . 0 N--CA 1.453 -0.297 0 CA-C-O 120.787 0.327 . . . . 74.340000000000003 110.123 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -54.09 -48.12 71.02 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.254 -0.43 . . . . 71.450000000000003 111.066 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -69.12 -35.8 76.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.146 -0.479 . . . . 74.310000000000002 111.07 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 16.3 tp -76.97 -21.84 54.13 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.33 -0.395 . . . . 64.230000000000004 110.442 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.949 ' HE3' ' HA ' ' A' ' 138' ' ' MET . 4.8 mmt -65.99 -37.7 86.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.404 -0.362 . . . . 73.019999999999996 110.572 175.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.36 -35.22 75.64 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.711 -0.478 . . . . 71.510000000000005 109.711 177.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.695 ' HE2' HG23 ' A' ' 104' ' ' VAL . 72.5 t80 -57.44 -46.36 83.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.791 -0.641 . . . . 73.239999999999995 109.862 175.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.58 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 40.5 tttp -63.61 -40.25 96.44 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.366 -0.379 . . . . 72.549999999999997 110.876 176.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -57.51 -58.34 8.74 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.194 -0.457 . . . . 70.120000000000005 110.421 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -66.1 -28.21 68.65 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 121.114 -0.235 . . . . 71.109999999999999 111.352 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.715 ' HB3' HG12 ' A' ' 12' ' ' ILE . 25.4 mm-40 -56.91 -49.71 74.77 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.312 0.577 . . . . 75.209999999999994 111.263 176.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 1.029 ' HG2' HG21 ' A' ' 12' ' ' ILE . 26.8 mt-10 -87.35 -32.3 19.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.779 -0.646 . . . . 64.329999999999998 111.1 -175.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 24.2 tp -90.47 -58.09 2.61 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.479 0.657 . . . . 73.400000000000006 111.625 -174.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.436 ' HA2' HD13 ' A' ' 26' ' ' LEU . . . . . . . . 0 N--CA 1.441 -0.967 0 N-CA-C 109.405 -1.478 . . . . 74.319999999999993 109.405 -167.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.8 t . . . . . 0 N--CA 1.446 -0.674 0 N-CA-C 109.477 -0.564 . . . . 73.010000000000005 109.477 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 52.4 t -99.07 122.6 51.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.835 -0.62 . . . . 74.129999999999995 110.851 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 57.1 ttt-85 -126.12 109.59 12.55 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.363 -0.606 . . . . 73.109999999999999 109.363 171.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.587 ' HB3' HD22 ' A' ' 137' ' ' LEU . 18.1 t0 -130.83 151.14 51.58 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.954 -1.128 . . . . 72.120000000000005 107.954 177.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.594 ' HB3' HG13 ' A' ' 105' ' ' VAL . . . -135.99 129.48 32.14 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.948 0.404 . . . . 51.049999999999997 111.948 -170.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.828 ' HB ' ' HG3' ' A' ' 141' ' ' LYS . 16.1 m -120.56 143.25 33.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.896 -0.593 . . . . 73.099999999999994 110.188 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.428 HG23 ' HD3' ' A' ' 100' ' ' ARG . 26.6 m -107.25 114.1 27.93 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.582 -0.281 . . . . 70.230000000000004 110.669 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.951 HG21 ' HB3' ' A' ' 145' ' ' GLU . 4.9 mp -110.73 139.64 33.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.311 -0.404 . . . . 65.519999999999996 110.79 -176.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.46 60.31 4.55 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 121.249 -0.5 . . . . 73.340000000000003 113.039 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.64 ' HD3' ' HG2' ' A' ' 18' ' ' GLN . 43.0 mttp -140.69 150.38 59.94 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 110.2 -0.296 . . . . 71.510000000000005 110.2 176.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.44 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 51.4 Cg_exo -56.01 -59.28 0.75 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.817 2.345 . . . . 60.509999999999998 114.123 -173.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . 170.73 -48.04 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.453 0.644 . . . . 65.310000000000002 110.007 175.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -48.17 -56.36 8.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.257 -1.338 . . . . 71.219999999999999 112.954 -173.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.64 ' HG2' ' HD3' ' A' ' 14' ' ' LYS . 0.6 OUTLIER -80.9 -7.65 59.54 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.257 -0.429 . . . . 75.549999999999997 111.65 -173.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.549 ' CB ' ' HE2' ' A' ' 93' ' ' PHE . 64.0 mt -75.87 -26.8 57.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.796 -0.183 . . . . 70.510000000000005 111.163 177.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -65.18 -29.81 70.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.241 0.543 . . . . 74.230000000000004 110.447 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.45 -8.45 56.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.577 -0.738 . . . . 71.109999999999999 111.689 -175.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.495 HG12 ' HE2' ' A' ' 140' ' ' PHE . 6.2 p -60.16 -22.2 24.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.808 0.337 . . . . 74.140000000000001 111.735 -175.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -70.41 -23.48 62.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.919 0.39 . . . . 74.549999999999997 110.774 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -128.58 19.47 6.21 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.885 -0.413 . . . . 72.430000000000007 109.885 -178.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.538 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 18.6 t70 64.84 162.43 0.13 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.62 -0.718 . . . . 64.129999999999995 110.968 -174.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.496 ' H ' HD21 ' A' ' 26' ' ' LEU . 1.3 pt? -113.95 85.7 10.25 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 121.364 0.602 . . . . 55.240000000000002 112.019 -175.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.538 ' HD3' ' O ' ' A' ' 25' ' ' ASP . 1.9 Cg_endo . . . . . 0 N--CA 1.459 -0.54 0 C-N-CA 123.059 2.506 . . . . 72.310000000000002 111.623 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.779 0 CA-C-O 121.221 0.534 . . . . 71.439999999999998 110.507 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.67 ' HB3' ' HD2' ' A' ' 78' ' ' ARG . 1.8 tm-20 -107.24 175.57 5.45 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.291 -1.003 . . . . 75.140000000000001 108.291 176.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.602 HD12 ' HA ' ' A' ' 77' ' ' TRP . 22.8 tp -124.08 119.64 30.05 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.132 -0.692 . . . . 75.409999999999997 109.132 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.3 t -81.53 -23.71 37.09 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.627 0.251 . . . . 64.120000000000005 111.389 -174.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.519 ' HB1' ' HB3' ' A' ' 76' ' ' ALA . . . -144.12 127.31 16.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.932 0.396 . . . . 55.240000000000002 111.043 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.576 ' HB2' HD23 ' A' ' 66' ' ' LEU . 11.0 t70 -138.79 104.03 4.98 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.266 -0.879 . . . . 54.530000000000001 109.788 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.438 ' HB2' ' H ' ' A' ' 74' ' ' ARG . 8.0 mm-40 -106.71 144.2 28.58 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.718 -0.673 . . . . 74.129999999999995 109.855 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 35.3 Cg_exo -62.04 -24.61 76.82 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.92 2.414 . . . . 50.109999999999999 112.536 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.98 56.93 0.12 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.917 -0.659 . . . . 75.040000000000006 111.592 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -141.41 -68.76 0.38 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.345 -0.142 . . . . 74.450000000000003 111.019 -176.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.438 ' H ' ' HB2' ' A' ' 70' ' ' GLU . 18.5 ptt180 -153.32 155.38 36.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.857 0.36 . . . . 75.340000000000003 111.51 -176.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.868 ' HB ' HG12 ' A' ' 91' ' ' VAL . 49.0 mm -125.14 110.82 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.765 -0.652 . . . . 72.019999999999996 109.723 174.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.519 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . . . -108.81 120.41 42.4 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.981 -0.748 . . . . 73.430000000000007 108.981 174.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.602 ' HA ' HD12 ' A' ' 66' ' ' LEU . 13.7 p-90 -106.85 138.95 42.05 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.612 0.72 . . . . 64.409999999999997 112.195 -170.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.67 ' HD2' ' HB3' ' A' ' 65' ' ' GLU . 7.8 ptp85 -113.07 173.35 6.43 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 107.676 -1.231 . . . . 65.150000000000006 107.676 171.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.433 ' HB2' ' HD3' ' A' ' 84' ' ' ARG . 6.1 m -138.6 30.3 2.34 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.343 -0.543 . . . . 73.230000000000004 109.873 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.457 HD23 ' HB2' ' A' ' 65' ' ' GLU . 22.1 mt 66.52 147.02 0.11 Allowed Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 115.086 -0.961 . . . . 72.109999999999999 111.093 -175.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.64 -23.16 55.83 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 123.104 2.536 . . . . 64.510000000000005 113.529 -174.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.21 -3.32 88.92 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.717 -0.754 . . . . 64.010000000000005 113.263 -176.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -136.44 25.98 3.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.201 0.5 . . . . 75.310000000000002 111.851 -177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.433 ' HD3' ' HB2' ' A' ' 79' ' ' SER . 9.4 mmm180 -126.83 107.79 10.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.827 0.346 . . . . 73.010000000000005 111.457 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.741 HG13 ' H ' ' A' ' 86' ' ' GLU . 13.8 pt -91.11 -63.3 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.053 -0.521 . . . . 63.310000000000002 110.298 173.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.741 ' H ' HG13 ' A' ' 85' ' ' ILE . 34.2 tt0 -163.74 109.42 1.07 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.885 0.374 . . . . 74.340000000000003 110.366 176.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -162.15 141.01 9.3 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.682 -0.859 . . . . 75.409999999999997 108.682 175.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.4 m -151.37 129.38 11.79 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.142 -0.318 . . . . 75.109999999999999 110.142 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.09 110.26 0.25 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.55 -0.833 . . . . 39.219999999999999 112.247 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.13 149.98 23.73 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.242 -0.281 . . . . 73.310000000000002 110.242 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.868 HG12 ' HB ' ' A' ' 75' ' ' ILE . 7.6 p -88.97 140.98 14.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.213 -0.662 . . . . 74.129999999999995 109.213 174.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.681 ' HB2' ' CG2' ' A' ' 105' ' ' VAL . 3.2 mm? -108.99 119.81 40.66 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.154 -0.684 . . . . 70.409999999999997 109.154 172.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.549 ' HE2' ' CB ' ' A' ' 19' ' ' LEU . 15.7 m-85 -96.91 106.03 18.28 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.824 -0.806 . . . . 64.420000000000002 108.824 174.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 32.7 mtp180 -125.95 142.9 43.69 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 116.112 -0.495 . . . . 74.219999999999999 110.046 -174.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -57.85 115.57 2.61 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.436 2.091 . . . . 74.25 110.634 175.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . . . -65.36 143.63 98.78 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.019 -0.537 . . . . 63.520000000000003 111.413 -173.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 96' ' ' ALA . 51.5 Cg_exo -55.79 137.39 78.39 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.885 2.39 . . . . 70.219999999999999 111.925 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.63 16.51 79.13 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.947 -0.644 . . . . 61.450000000000003 112.101 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 57.16 33.69 23.7 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.341 0.591 . . . . 64.219999999999999 110.794 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.428 ' HD3' HG23 ' A' ' 11' ' ' THR . 34.6 ttt180 -77.27 1.04 19.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.41 -0.814 . . . . 71.409999999999997 111.04 -175.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 123.23 -125.13 5.84 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 111.508 -0.637 . . . . 70.519999999999996 111.508 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 88.0 m -135.01 130.53 35.84 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.952 0.406 . . . . 73.150000000000006 110.564 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -100.9 113.91 27.3 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.902 -0.59 . . . . 74.150000000000006 109.534 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.2 m -88.74 127.29 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-O 121.703 0.763 . . . . 72.150000000000006 108.991 175.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.681 ' CG2' ' HB2' ' A' ' 92' ' ' LEU . 14.0 m -123.18 119.39 57.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.204 -0.907 . . . . 60.229999999999997 109.815 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.64 HG13 HG21 ' A' ' 91' ' ' VAL . 1.8 m -119.84 121.52 66.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.908 -0.587 . . . . 73.540000000000006 111.074 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.85 109.85 19.19 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.537 -0.912 . . . . 75.430000000000007 108.537 174.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.428 HD22 ' HE2' ' A' ' 110' ' ' TYR . 0.4 OUTLIER -141.12 151.39 43.9 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.058 0.456 . . . . 75.109999999999999 111.544 -174.435 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.9 t -98.77 133.09 43.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.378 0.609 . . . . 60.43 110.911 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.428 ' HE2' HD22 ' A' ' 108' ' ' LEU . 57.8 m-85 . . . . . 0 C--N 1.324 -0.524 0 CA-C-N 115.039 -0.982 . . . . 75.140000000000001 109.233 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.197 0 CA-C-O 120.989 0.216 . . . . 63.119999999999997 113.124 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.7 m -86.54 -30.61 21.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.93 0.395 . . . . 71.030000000000001 111.153 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.93 -36.15 83.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.939 -0.573 . . . . 61.020000000000003 112.194 -173.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -60.14 -25.69 62.56 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 121.078 -0.582 . . . . 74.439999999999998 113.292 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.03 -46.76 86.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.727 0.299 . . . . 64.140000000000001 111.311 -177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.9 m -75.1 -23.73 17.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.495 -0.321 . . . . 64.25 111.177 -177.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 65.1 mt -72.7 -33.44 44.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.389 -0.369 . . . . 75.209999999999994 110.418 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.08 -22.64 65.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.169 -0.469 . . . . 72.510000000000005 111.279 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -63.87 -26.75 68.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.064 -0.517 . . . . 73.239999999999995 111.171 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 16.7 tpt . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 120.949 0.404 . . . . 72.530000000000001 110.959 -179.044 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.538 ' HG2' ' H ' ' A' ' 137' ' ' LEU . 35.7 ttt85 . . . . . 0 N--CA 1.449 -0.486 0 CA-C-O 121.141 0.496 . . . . 74.200000000000003 110.369 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -61.51 -39.45 91.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.361 -0.836 . . . . 72.310000000000002 110.655 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -61.01 -34.99 75.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.836 -0.62 . . . . 74.310000000000002 111.206 177.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.587 HD22 ' HB3' ' A' ' 8' ' ' ASP . 11.5 tp -79.14 -35.8 41.51 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.503 0.668 . . . . 75.340000000000003 109.844 -175.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.488 ' HE2' ' HB3' ' A' ' 138' ' ' MET . 2.3 ttp -66.28 -36.89 84.12 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.532 -0.758 . . . . 71.219999999999999 110.367 174.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -69.81 -51.05 37.06 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.128 -0.487 . . . . 75.540000000000006 112.182 -177.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.495 ' HE2' HG12 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -66.32 -29.54 69.76 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.261 -0.576 . . . . 71.200000000000003 109.685 -175.346 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.828 ' HG3' ' HB ' ' A' ' 10' ' ' VAL . 14.9 tmtt? -57.1 -42.37 80.66 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 115.788 -0.642 . . . . 62.119999999999997 110.46 173.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -55.11 -52.2 64.02 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.284 0.564 . . . . 73.420000000000002 110.269 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -66.58 -40.81 89.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.022 -0.99 . . . . 61.43 111.928 -172.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.514 ' CD ' HG12 ' A' ' 12' ' ' ILE . 4.6 pt20 -74.17 -17.3 60.93 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.571 0.582 . . . . 74.450000000000003 112.571 -173.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.951 ' HB3' HG21 ' A' ' 12' ' ' ILE . 19.7 pt-20 -110.73 -4.46 15.33 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.618 -0.433 . . . . 75.099999999999994 111.102 175.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 24.4 tp -61.8 -52.83 62.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.068 0.461 . . . . 72.409999999999997 110.453 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.878 0 C-N-CA 121.022 -0.609 . . . . 73.109999999999999 111.77 175.631 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.798 HG22 HG23 ' A' ' 109' ' ' THR . 66.5 t . . . . . 0 N--CA 1.445 -0.678 0 CA-C-O 120.771 0.32 . . . . 74.310000000000002 110.248 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.6 m -83.77 126.28 40.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.387 0.613 . . . . 64.310000000000002 111.022 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.28 118.03 10.46 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.569 -0.741 . . . . 61.030000000000001 110.553 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -128.18 170.14 13.32 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.081 -0.711 . . . . 73.420000000000002 109.081 176.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.573 ' HB1' HG11 ' A' ' 105' ' ' VAL . . . -145.43 123.19 11.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.676 0.274 . . . . 71.109999999999999 111.325 -173.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.6 m -112.32 148.15 15.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.292 -0.413 . . . . 64.129999999999995 111.014 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.431 ' CG2' ' HB3' ' A' ' 96' ' ' ALA . 0.6 OUTLIER -105.21 110.43 22.8 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.952 -0.567 . . . . 70.329999999999998 112.0 -171.177 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.835 HG22 ' HB2' ' A' ' 144' ' ' GLN . 0.1 OUTLIER -124.4 151.23 29.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.109 0.48 . . . . 74.230000000000004 112.139 177.111 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.563 ' HA2' ' HA3' ' A' ' 101' ' ' GLY . . . -82.8 20.43 9.47 Favored Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.756 -0.656 . . . . 63.32 112.396 177.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.548 ' HB2' HD21 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -79.53 143.93 60.26 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.354 -0.61 . . . . 65.439999999999998 109.354 176.284 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.429 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 23.0 Cg_endo -62.28 -60.01 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.023 1.815 . . . . 74.120000000000005 113.359 -171.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.483 ' HA ' HD11 ' A' ' 19' ' ' LEU . . . 172.17 -50.76 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.492 0.717 . . . . 60.109999999999999 109.967 171.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.479 ' HA ' ' HD2' ' A' ' 20' ' ' TYR . 1.9 mp0 -56.29 -47.45 78.64 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.976 -0.556 . . . . 71.510000000000005 110.621 -177.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -66.71 -13.27 61.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.282 -0.872 . . . . 72.329999999999998 111.205 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.673 HD21 HG13 ' A' ' 12' ' ' ILE . 98.1 mt -83.88 -43.08 15.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.229 -0.441 . . . . 73.319999999999993 110.387 175.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.622 ' CE1' HD13 ' A' ' 75' ' ' ILE . 73.6 m-85 -62.68 -32.34 73.4 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.424 0.631 . . . . 74.420000000000002 109.8 176.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.52 -7.76 49.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.085 -0.961 . . . . 73.129999999999995 111.996 -176.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.545 HG23 ' CE2' ' A' ' 140' ' ' PHE . 7.8 p -53.74 -30.38 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 120.889 0.376 . . . . 72.239999999999995 111.65 -176.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 28.8 t90 -68.4 -23.73 64.68 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.044 0.449 . . . . 74.420000000000002 111.144 -177.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -124.21 13.54 8.97 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.583 -0.525 . . . . 72.430000000000007 109.583 -178.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.707 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 28.9 t70 62.38 168.73 0.12 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.427 -0.806 . . . . 74.530000000000001 110.532 -169.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.626 HD23 ' H ' ' A' ' 26' ' ' LEU . 1.3 pt? -104.83 87.2 1.73 Allowed Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 121.11 0.481 . . . . 74.400000000000006 110.767 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.707 ' HD3' ' O ' ' A' ' 25' ' ' ASP . 9.9 Cg_endo . . . . . 0 N--CA 1.45 -1.034 0 C-N-CA 123.208 2.605 . . . . 74.109999999999999 111.79 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 79' ' ' SER . . . . . . . . 0 N--CA 1.452 -0.373 0 N-CA-C 110.17 -0.307 . . . . 74.530000000000001 110.17 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.55 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -106.77 135.74 47.79 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.745 -0.465 . . . . 74.230000000000004 109.745 178.328 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 77' ' ' TRP . 3.0 mm? -86.57 147.05 26.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.139 -0.482 . . . . 75.310000000000002 111.305 -169.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.6 t -98.67 -16.5 19.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.082 0.467 . . . . 72.329999999999998 110.53 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.551 ' HB2' ' H ' ' A' ' 76' ' ' ALA . . . -138.72 124.96 20.26 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.173 -0.677 . . . . 61.149999999999999 109.173 173.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -125.2 99.62 6.17 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.267 -0.424 . . . . 72.209999999999994 111.754 -171.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.453 ' O ' HD12 ' A' ' 75' ' ' ILE . 22.8 mt-10 -121.48 142.69 36.09 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.769 -0.826 . . . . 63.409999999999997 108.769 166.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 31.1 Cg_exo -61.16 -42.96 32.03 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.588 2.192 . . . . 74.140000000000001 112.328 -177.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -150.48 56.02 0.47 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.636 -0.792 . . . . 72.030000000000001 112.198 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -147.09 -82.43 0.13 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.816 -0.354 . . . . 73.329999999999998 110.914 174.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.583 ' HD2' ' OE2' ' A' ' 90' ' ' GLU . 16.7 ttp180 -124.38 123.14 39.53 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.444 -0.502 . . . . 74.239999999999995 111.168 -170.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.622 HD13 ' CE1' ' A' ' 20' ' ' TYR . 2.6 mp -125.82 110.87 25.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.748 -0.66 . . . . 71.129999999999995 110.506 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.551 ' H ' ' HB2' ' A' ' 68' ' ' ALA . . . -96.6 116.11 28.56 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.259 -1.015 . . . . 61.32 108.259 170.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.606 ' CZ2' ' HB3' ' A' ' 87' ' ' ASN . 3.9 p-90 -85.69 151.72 23.64 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.409 0.623 . . . . 60.409999999999997 111.269 -171.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.55 ' HB3' ' O ' ' A' ' 65' ' ' GLU . 5.5 tpm_? -155.37 170.88 20.87 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.183 -1.414 . . . . 73.299999999999997 107.183 -175.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 64' ' ' ALA . 20.0 p -145.24 170.38 16.38 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.075 0.464 . . . . 52.450000000000003 110.888 -177.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.508 HD11 ' HB2' ' A' ' 65' ' ' GLU . 5.7 mp -87.45 154.33 53.85 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.761 -0.654 . . . . 72.310000000000002 110.576 178.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.57 -1.4 3.93 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 123.089 2.526 . . . . 64.230000000000004 112.981 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.21 -8.18 66.84 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.994 -0.622 . . . . 61.530000000000001 112.136 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.17 -177.62 5.75 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.744 0.307 . . . . 75.200000000000003 110.56 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.473 ' HD2' ' HA ' ' A' ' 84' ' ' ARG . 14.3 tpt180 -122.12 -28.34 4.4 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.592 -0.443 . . . . 74.400000000000006 111.302 -178.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.85 132.56 70.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.117 0.484 . . . . 54.219999999999999 110.154 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -147.24 142.83 27.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.839 -0.618 . . . . 72.0 110.089 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.606 ' HB3' ' CZ2' ' A' ' 77' ' ' TRP . 28.1 t-20 -137.13 150.27 47.86 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.722 -0.844 . . . . 73.319999999999993 108.722 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 60.9 m -100.7 127.5 47.09 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.397 0.618 . . . . 70.329999999999998 110.216 -176.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -171.54 169.25 42.34 Favored Glycine 0 N--CA 1.438 -1.223 0 CA-C-N 115.227 -0.897 . . . . 43.32 111.559 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.583 ' OE2' ' HD2' ' A' ' 74' ' ' ARG . 33.1 tt0 -144.64 129.42 18.26 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.993 -0.373 . . . . 74.340000000000003 109.993 -175.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.612 HG11 HG13 ' A' ' 106' ' ' VAL . 9.3 m -111.05 137.89 41.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 110.095 -0.335 . . . . 73.219999999999999 110.095 178.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.637 ' CD2' ' HB ' ' A' ' 105' ' ' VAL . 0.0 OUTLIER -128.19 119.7 25.76 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.75 0.786 . . . . 73.209999999999994 110.046 173.078 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.614 ' HE2' ' HB3' ' A' ' 19' ' ' LEU . 2.5 m-85 -97.73 106.43 18.74 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.485 -1.234 . . . . 72.409999999999997 109.215 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -119.66 144.93 38.02 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 115.418 -0.81 . . . . 71.030000000000001 110.35 -172.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -46.86 117.78 2.33 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.246 2.631 . . . . 75.120000000000005 112.102 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.431 ' HB3' ' CG2' ' A' ' 11' ' ' THR . . . -58.93 144.54 81.67 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.741 -0.663 . . . . 75.230000000000004 111.094 -176.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -46.31 115.98 1.36 Allowed 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 123.303 2.669 . . . . 75.540000000000006 113.022 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 96.15 3.57 60.25 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.665 -0.698 . . . . 52.539999999999999 112.162 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 64.79 32.49 10.98 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 123.08 0.552 . . . . 71.120000000000005 111.164 -178.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 37.7 ttt-85 -75.46 -19.43 59.44 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.957 -0.565 . . . . 72.030000000000001 110.992 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.563 ' HA3' ' HA2' ' A' ' 13' ' ' GLY . . . 165.82 -130.74 2.21 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.885 -0.886 . . . . 41.109999999999999 110.885 -175.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.2 m -138.73 133.95 32.9 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 110.152 -0.314 . . . . 62.109999999999999 110.152 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -96.55 133.06 41.49 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.928 -0.767 . . . . 62.229999999999997 108.928 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.592 HG12 HD13 ' A' ' 12' ' ' ILE . 1.5 p -95.15 100.32 10.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.794 0.807 . . . . 65.049999999999997 110.35 179.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.637 ' HB ' ' CD2' ' A' ' 92' ' ' LEU . 4.1 t -97.4 111.47 27.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.688 -1.142 . . . . 73.310000000000002 108.941 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.612 HG13 HG11 ' A' ' 91' ' ' VAL . 26.1 m -112.47 123.46 68.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.318 0.58 . . . . 75.349999999999994 111.517 -176.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 31.1 ttt85 -105.17 100.89 10.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.524 -0.762 . . . . 73.420000000000002 109.678 174.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.4 mt -116.94 126.8 53.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.257 -0.429 . . . . 71.420000000000002 110.146 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.798 HG23 HG22 ' A' ' 5' ' ' VAL . 25.9 m -90.22 116.26 28.08 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 120.214 -0.594 . . . . 73.549999999999997 110.726 -176.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 51.2 p90 . . . . . 0 C--N 1.326 -0.455 0 CA-C-N 115.485 -0.78 . . . . 73.019999999999996 108.917 174.376 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 CA-C-O 120.558 -0.023 . . . . 37.409999999999997 113.114 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.0 m -86.08 -24.17 26.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.694 0.283 . . . . 73.150000000000006 111.152 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.63 -41.64 99.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.435 -0.348 . . . . 74.430000000000007 110.933 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.01 -31.25 77.97 Favored Glycine 0 N--CA 1.452 -0.256 0 CA-C-N 116.05 -0.523 . . . . 65.230000000000004 112.48 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.34 -29.3 64.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.163 0.506 . . . . 72.329999999999998 110.572 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 59.6 t -73.67 -51.36 25.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.881 -0.6 . . . . 71.049999999999997 110.51 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.9 pp -68.92 -22.64 26.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.24 -0.437 . . . . 73.409999999999997 111.981 -175.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -81.2 -30.96 34.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.742 0.306 . . . . 64.329999999999998 111.16 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -88.77 -39.16 14.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.4 -0.364 . . . . 71.519999999999996 111.219 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 47.9 ttm . . . . . 0 N--CA 1.464 0.253 0 O-C-N 123.33 0.394 . . . . 75.219999999999999 110.707 -177.201 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 . . . . . 0 N--CA 1.451 -0.394 0 CA-C-O 121.056 0.455 . . . . 73.549999999999997 110.098 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -58.53 -44.6 89.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.636 -0.711 . . . . 73.319999999999993 111.695 -175.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -60.54 -52.72 64.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.425 . . . . 74.140000000000001 111.087 -177.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.476 HD11 ' HA ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -68.35 -36.13 78.77 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.545 -0.298 . . . . 72.120000000000005 111.27 -179.52 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 27.9 tpp -67.89 -41.64 82.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.884 0.373 . . . . 74.420000000000002 110.9 -177.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -63.63 -36.11 82.73 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.441 -0.577 . . . . 74.319999999999993 109.441 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.59 ' HE1' HG13 ' A' ' 104' ' ' VAL . 55.5 t80 -63.65 -49.85 71.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.427 -0.806 . . . . 72.310000000000002 110.25 174.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -55.81 -50.1 71.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.496 -0.775 . . . . 62.43 111.42 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -62.04 -45.34 94.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.335 -0.393 . . . . 75.040000000000006 110.924 -176.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -65.49 -28.85 69.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.313 -0.403 . . . . 74.209999999999994 111.716 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.835 ' HB2' HG22 ' A' ' 12' ' ' ILE . 9.9 mm-40 -68.62 -35.99 78.03 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.617 -0.433 . . . . 75.219999999999999 111.102 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.554 ' HG3' HG21 ' A' ' 12' ' ' ILE . 35.4 mt-10 -78.39 -37.15 44.73 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.713 -0.395 . . . . 75.230000000000004 110.143 178.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 67.2 mt -65.35 -40.55 93.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.972 -0.558 . . . . 73.310000000000002 110.678 176.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.405 0 C-N-CA 121.095 -0.574 . . . . 75.400000000000006 112.054 176.606 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 N--CA 1.452 -0.356 0 CA-C-O 120.811 0.339 . . . . 70.439999999999998 110.45 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.3 t -119.93 126.38 75.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.692 -0.485 . . . . 72.329999999999998 109.692 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -127.78 132.84 49.46 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.054 0.454 . . . . 74.230000000000004 110.508 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.439 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 11.3 t70 -158.09 171.74 19.69 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.799 -1.186 . . . . 72.549999999999997 107.799 173.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.622 ' HB2' HG12 ' A' ' 105' ' ' VAL . . . -134.06 120.42 20.18 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.068 0.461 . . . . 73.409999999999997 112.12 -174.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.534 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 21.4 m -101.27 130.04 51.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.67 -0.696 . . . . 65.109999999999999 109.749 174.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.664 ' HA ' ' HA ' ' A' ' 103' ' ' GLU . 5.1 t -102.83 113.48 26.94 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.78 0.8 . . . . 75.030000000000001 110.436 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.614 HG21 ' HB3' ' A' ' 145' ' ' GLU . 4.5 mp -112.36 151.47 14.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.954 -1.021 . . . . 73.230000000000004 108.871 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.86 42.3 1.1 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.862 -0.685 . . . . 74.109999999999999 112.907 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.63 ' HB3' ' HB2' ' A' ' 18' ' ' GLN . 6.7 mmpt? -112.24 144.25 30.45 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 108.394 -0.965 . . . . 72.099999999999994 108.394 178.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -52.99 -57.96 1.75 Allowed 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.335 2.023 . . . . 54.100000000000001 113.738 -172.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 174.4 -53.46 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.251 0.548 . . . . 74.329999999999998 109.66 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.79 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 0.1 OUTLIER -54.43 -39.22 67.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.069 -0.969 . . . . 72.109999999999999 110.891 177.631 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.63 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 21.4 mm-40 -63.06 -27.79 69.64 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.061 -0.972 . . . . 71.540000000000006 111.37 -177.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.516 ' HA ' ' NE2' ' A' ' 144' ' ' GLN . 95.5 mt -74.94 -48.35 24.93 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.9 -0.591 . . . . 62.32 111.162 -174.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.79 ' CE2' ' HA ' ' A' ' 17' ' ' GLU . 36.2 p90 -74.77 -23.42 58.52 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 119.704 -0.798 . . . . 74.239999999999995 110.643 177.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.56 -2.08 21.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.043 -0.526 . . . . 73.340000000000003 111.627 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.469 ' HB ' ' NE2' ' A' ' 144' ' ' GLN . 12.0 p -53.38 -22.59 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 115.806 -0.633 . . . . 45.539999999999999 112.525 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -66.75 -27.31 67.5 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.275 0.559 . . . . 75.239999999999995 110.709 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.836 ' HG3' ' H ' ' A' ' 25' ' ' ASP . 15.0 tpp180 -105.54 -164.21 1.01 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.924 -1.139 . . . . 74.329999999999998 107.924 176.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.836 ' H ' ' HG3' ' A' ' 24' ' ' ARG . 28.6 t0 -83.93 36.47 0.56 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.45 0.643 . . . . 74.439999999999998 109.363 176.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.536 HD12 ' HA3' ' A' ' 147' ' ' GLY . 0.3 OUTLIER 41.89 63.1 6.9 Favored Pre-proline 0 N--CA 1.47 0.543 0 CA-C-N 114.897 -1.047 . . . . 72.120000000000005 112.279 -177.606 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.46 ' HD3' ' N ' ' A' ' 26' ' ' LEU . 89.9 Cg_endo . . . . . 0 N--CA 1.452 -0.93 0 C-N-CA 123.225 2.617 . . . . 64.439999999999998 113.094 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.234 0 N-CA-C 108.123 -1.066 . . . . 63.25 108.123 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.774 ' HB2' HD21 ' A' ' 80' ' ' LEU . 0.7 OUTLIER -112.57 134.15 54.24 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 107.708 -1.219 . . . . 74.420000000000002 107.708 -176.78 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -107.83 141.34 39.56 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 119.616 -0.834 . . . . 70.049999999999997 111.221 -171.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.9 t -108.1 -24.38 11.59 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.854 -0.338 . . . . 72.129999999999995 111.008 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.446 ' HB2' ' HB3' ' A' ' 76' ' ' ALA . . . -135.98 153.78 51.29 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.542 -0.54 . . . . 61.350000000000001 109.542 175.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -150.61 16.68 0.8 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.876 0.325 . . . . 53.219999999999999 111.876 -172.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.576 ' HG2' ' HD3' ' A' ' 73' ' ' LYS . 1.6 mp0 -61.29 142.03 93.82 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 110.416 -0.216 . . . . 74.409999999999997 110.416 -176.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -79.51 -20.17 9.65 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.661 2.241 . . . . 74.230000000000004 113.017 -173.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -162.67 38.29 0.35 Allowed Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.303 -0.719 . . . . 72.329999999999998 111.303 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.576 ' HD3' ' HG2' ' A' ' 70' ' ' GLU . 54.3 tttp -129.74 -51.57 1.15 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.008 -0.367 . . . . 70.409999999999997 110.008 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 29.3 ttp180 -166.09 129.47 2.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.25 -0.432 . . . . 73.340000000000003 110.902 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.609 ' HB ' HG23 ' A' ' 91' ' ' VAL . 6.3 mm -108.38 109.99 30.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.399 -0.963 . . . . 71.299999999999997 108.399 175.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.517 ' HB1' ' HG3' ' A' ' 90' ' ' GLU . . . -129.94 116.3 18.42 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.05 0.452 . . . . 61.109999999999999 110.486 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.515 ' NE1' ' HA3' ' A' ' 89' ' ' GLY . 69.0 p-90 -113.18 155.54 24.82 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.629 -0.714 . . . . 70.239999999999995 109.928 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -142.87 176.45 9.06 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.935 -1.135 . . . . 75.530000000000001 107.935 175.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 51.3 p -96.05 177.68 5.66 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.924 -0.71 . . . . 74.049999999999997 110.153 174.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.774 HD21 ' HB2' ' A' ' 65' ' ' GLU . 7.3 mt -71.64 156.89 90.77 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 116.038 -0.528 . . . . 71.099999999999994 110.019 -177.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -52.93 -36.57 75.6 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.864 2.376 . . . . 74.140000000000001 112.755 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.92 21.44 44.93 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.764 -0.731 . . . . 73.420000000000002 112.696 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -120.5 176.64 5.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.608 0.242 . . . . 74.129999999999995 110.552 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.414 ' HD2' ' N ' ' A' ' 84' ' ' ARG . 8.5 mpt_? -115.05 144.85 42.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.534 -0.303 . . . . 73.319999999999993 110.351 -179.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.6 pp -88.91 166.74 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.984 0.421 . . . . 74.510000000000005 111.639 -178.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -126.07 -64.34 1.05 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.665 -0.698 . . . . 64.019999999999996 110.399 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -130.11 173.15 11.02 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.937 -1.135 . . . . 62.219999999999999 107.937 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.8 m -95.75 126.98 41.39 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.497 -0.557 . . . . 72.540000000000006 109.497 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.515 ' HA3' ' NE1' ' A' ' 77' ' ' TRP . . . -115.92 74.87 0.26 Allowed Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.663 -0.779 . . . . 73.109999999999999 111.85 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.517 ' HG3' ' HB1' ' A' ' 76' ' ' ALA . 35.2 tt0 -131.0 113.9 14.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.01 0.433 . . . . 71.150000000000006 110.241 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.609 HG23 ' HB ' ' A' ' 75' ' ' ILE . 18.6 m -120.47 131.91 71.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.533 -0.758 . . . . 71.239999999999995 109.401 177.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.773 ' HB2' HG22 ' A' ' 105' ' ' VAL . 4.5 mp -113.36 141.08 47.47 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.428 -0.509 . . . . 71.129999999999995 109.875 175.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.457 ' HZ ' ' HB3' ' A' ' 20' ' ' TYR . 58.2 m-85 -120.8 131.59 54.55 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.206 -0.452 . . . . 71.200000000000003 110.461 -177.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -141.18 142.8 28.44 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 109.53 -0.545 . . . . 74.420000000000002 109.53 173.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -62.67 112.89 1.75 Allowed 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 122.251 1.967 . . . . 72.450000000000003 110.757 174.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.504 ' HB1' ' HB2' ' A' ' 100' ' ' ARG . . . -63.37 144.11 97.64 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.748 -0.66 . . . . 74.310000000000002 110.674 -174.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -23.5 109.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.691 1 C-N-CA 126.046 4.497 . . . . 65.439999999999998 115.356 -171.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.5 -67.79 3.65 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 114.77 -1.104 . . . . 45.200000000000003 111.849 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -177.81 38.41 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.731 -0.735 . . . . 72.230000000000004 110.453 -172.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.519 ' HA ' ' NE ' ' A' ' 100' ' ' ARG . 4.6 mmp_? -78.44 -6.98 56.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.259 0.552 . . . . 71.129999999999995 110.11 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 119.74 -143.66 17.06 Favored Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 110.145 -1.182 . . . . 71.439999999999998 110.145 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.6 m -127.22 116.5 20.68 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.791 -0.448 . . . . 74.349999999999994 109.791 174.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.664 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 11.0 pt-20 -88.38 138.42 31.45 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.253 -0.647 . . . . 71.439999999999998 109.253 177.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 1.5 p -108.49 108.83 26.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 115.336 -0.847 . . . . 65.420000000000002 111.135 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.773 HG22 ' HB2' ' A' ' 92' ' ' LEU . 2.6 m -87.27 110.35 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.446 -0.797 . . . . 63.140000000000001 109.319 174.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.83 138.48 50.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.678 -0.692 . . . . 73.530000000000001 110.676 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -122.84 102.35 7.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.658 -0.701 . . . . 70.329999999999998 110.702 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.48 HD21 ' CZ ' ' A' ' 110' ' ' TYR . 0.0 OUTLIER -123.19 152.82 40.85 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.133 -0.485 . . . . 74.049999999999997 109.772 178.782 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.7 t -100.58 149.34 23.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.381 0.61 . . . . 70.400000000000006 111.709 -172.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.48 ' CZ ' HD21 ' A' ' 108' ' ' LEU . 97.5 m-85 . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 115.166 -0.925 . . . . 75.319999999999993 109.019 174.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.545 0 N-CA-C 112.116 -0.394 . . . . 60.240000000000002 112.116 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.6 m -78.95 -12.47 60.03 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.654 0.242 . . . . 51.229999999999997 111.654 -177.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.43 -36.46 73.65 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.941 0.4 . . . . 74.299999999999997 111.395 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -73.28 -23.71 76.85 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.771 -0.728 . . . . 72.099999999999994 112.767 -177.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.09 -45.75 83.11 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.06 0.393 . . . . 63.32 112.06 -174.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 16.7 m -74.34 -41.77 50.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 111.977 0.362 . . . . 70.420000000000002 111.977 -176.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.8 pp -75.99 -22.73 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.729 0.299 . . . . 74.400000000000006 111.715 -176.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.4 -20.36 64.67 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.951 0.352 . . . . 53.229999999999997 111.951 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -64.44 -14.55 57.47 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.924 -0.58 . . . . 73.400000000000006 111.796 -175.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.581 -0.282 . . . . 71.150000000000006 111.213 179.743 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.553 ' O ' ' HG2' ' A' ' 138' ' ' MET . 32.7 mtp-105 . . . . . 0 N--CA 1.451 -0.405 0 N-CA-C 111.356 0.132 . . . . 73.430000000000007 111.356 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.29 -39.33 94.28 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 111.935 0.346 . . . . 64.120000000000005 111.935 -171.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.484 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 32.5 t70 -70.33 -30.68 67.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.228 0.537 . . . . 73.329999999999998 110.155 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.534 ' HG ' ' CG1' ' A' ' 10' ' ' VAL . 22.2 tp -78.08 -27.96 48.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.069 -0.514 . . . . 70.120000000000005 109.817 178.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.598 ' HA ' ' HE2' ' A' ' 138' ' ' MET . 29.5 mmt -66.49 -42.15 87.88 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.16 -0.473 . . . . 74.439999999999998 110.409 176.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' A' ' 136' ' ' ASP . 5.9 ppt_? -75.05 -27.61 60.08 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.009 -0.367 . . . . 75.129999999999995 110.009 178.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.452 ' HZ ' HG13 ' A' ' 22' ' ' VAL . 83.7 t80 -61.54 -39.83 92.48 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.094 0.473 . . . . 72.530000000000001 109.819 173.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 138' ' ' MET . 35.0 ttmt -56.44 -42.18 77.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.443 -0.799 . . . . 73.530000000000001 109.72 174.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.427 HH21 ' CD ' ' A' ' 145' ' ' GLU . 0.0 OUTLIER -58.43 -48.66 79.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.876 -1.056 . . . . 74.409999999999997 111.083 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.37 -31.43 72.09 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.436 -0.347 . . . . 61.439999999999998 111.635 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.536 ' HG3' HG23 ' A' ' 12' ' ' ILE . 6.6 tp-100 -76.51 -43.38 39.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.726 0.298 . . . . 74.230000000000004 110.798 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.614 ' HB3' HG21 ' A' ' 12' ' ' ILE . 16.3 pt-20 -80.07 -4.32 52.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.867 0.365 . . . . 73.109999999999999 110.714 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 60.6 tp -65.84 -36.41 83.4 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.185 -0.672 . . . . 65.25 109.185 171.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.536 ' HA3' HD12 ' A' ' 26' ' ' LEU . . . . . . . . 0 N--CA 1.449 -0.491 0 CA-C-N 115.398 -0.819 . . . . 73.430000000000007 112.3 176.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 108.923 -0.769 . . . . 75.310000000000002 108.923 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.1 m -88.62 143.37 11.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.297 0.57 . . . . 75.030000000000001 111.22 -173.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.775 ' HD2' ' O ' ' A' ' 7' ' ' ARG . 0.5 OUTLIER -137.91 109.63 7.09 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.481 -0.782 . . . . 71.530000000000001 109.949 178.568 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.581 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 2.1 t70 -132.92 172.3 12.79 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.452 -0.573 . . . . 61.240000000000002 109.452 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.61 ' HB1' ' HG2' ' A' ' 103' ' ' GLU . . . -144.7 122.94 12.23 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.026 0.441 . . . . 55.549999999999997 111.007 -173.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.512 HG21 HD11 ' A' ' 12' ' ' ILE . 4.4 m -113.02 149.35 15.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.886 -0.597 . . . . 73.209999999999994 111.133 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.8 m -100.98 109.87 21.83 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.855 -0.611 . . . . 74.120000000000005 111.017 -175.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.792 HG13 ' HG2' ' A' ' 141' ' ' LYS . 4.5 mp -118.49 145.93 23.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 110.091 -0.337 . . . . 74.239999999999995 110.091 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.37 56.97 4.9 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 121.12 -0.562 . . . . 64.209999999999994 112.552 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.573 ' HG2' HG22 ' A' ' 12' ' ' ILE . 75.6 mmtt -121.77 156.56 58.85 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 108.584 -0.895 . . . . 73.439999999999998 108.584 175.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.424 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 47.1 Cg_exo -56.51 -59.1 0.73 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 121.762 1.641 . . . . 75.120000000000005 112.4 -178.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 15' ' ' PRO . . . 171.09 -58.72 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.768 0.667 . . . . 71.239999999999995 110.046 174.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -49.31 -55.01 14.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.525 -1.216 . . . . 54.450000000000003 112.215 -173.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.522 ' O ' HD12 ' A' ' 26' ' ' LEU . 16.9 mm-40 -69.39 -10.69 59.09 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.177 0.806 . . . . 73.319999999999993 113.177 -173.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.453 ' HA ' HD22 ' A' ' 19' ' ' LEU . 16.2 mt -63.47 -24.79 67.97 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.007 -0.433 . . . . 72.209999999999994 111.624 176.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -72.86 -25.0 60.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.943 0.402 . . . . 75.099999999999994 110.387 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.84 -9.0 58.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.222 -0.444 . . . . 74.099999999999994 111.726 -176.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.832 HG22 ' HG2' ' A' ' 144' ' ' GLN . 14.0 p -52.36 -21.92 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 112.247 0.462 . . . . 65.340000000000003 112.247 -175.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -51.76 -38.21 54.51 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.471 -0.331 . . . . 73.030000000000001 110.523 175.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -145.23 61.23 1.3 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.633 -0.258 . . . . 72.019999999999996 110.703 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.46 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 21.4 t70 63.07 171.35 0.15 Allowed 'General case' 0 CA--C 1.538 0.507 0 O-C-N 123.83 0.706 . . . . 74.530000000000001 111.525 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.522 HD12 ' O ' ' A' ' 18' ' ' GLN . 0.6 OUTLIER -104.05 85.83 1.14 Allowed Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 110.012 -0.366 . . . . 71.140000000000001 110.012 -178.119 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 25' ' ' ASP . 61.4 Cg_endo . . . . . 0 C--N 1.344 0.292 0 C-N-CA 122.282 1.988 . . . . 72.409999999999997 112.77 -175.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.444 0 CA-C-O 120.676 0.274 . . . . 72.439999999999998 111.203 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.64 158.28 17.07 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.498 -0.556 . . . . 61.409999999999997 109.498 173.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.663 HD22 ' HB3' ' A' ' 69' ' ' ASP . 26.3 tp -109.64 141.45 42.17 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.359 -0.238 . . . . 63.310000000000002 110.359 -176.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.0 t -107.81 -6.98 16.45 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 120.861 -0.336 . . . . 70.140000000000001 111.708 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.617 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -153.98 124.82 7.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.654 0.264 . . . . 72.109999999999999 110.831 177.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.663 ' HB3' HD22 ' A' ' 66' ' ' LEU . 2.4 p30 -136.32 43.46 2.48 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.796 -0.638 . . . . 74.209999999999994 110.878 -176.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.417 ' HB2' ' H ' ' A' ' 74' ' ' ARG . 26.1 mm-40 -57.81 143.22 77.21 Favored Pre-proline 0 C--O 1.234 0.252 0 CA-C-N 116.173 -0.467 . . . . 74.099999999999994 110.412 -178.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.96 92.97 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.219 2.613 . . . . 75.319999999999993 113.208 -172.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 58.75 34.24 76.45 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.477 -0.783 . . . . 71.540000000000006 112.979 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 92' ' ' LEU . 92.0 mttt -129.1 -85.71 0.55 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.953 0.353 . . . . 74.019999999999996 111.953 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.804 ' HB2' ' HG ' ' A' ' 92' ' ' LEU . 31.8 ttt180 -118.23 113.78 22.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.412 0.625 . . . . 74.420000000000002 111.197 -173.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.458 HD13 ' HE2' ' A' ' 93' ' ' PHE . 3.8 mp -117.05 121.87 68.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.089 -0.959 . . . . 71.319999999999993 109.515 178.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.617 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -109.71 116.28 31.42 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.473 -0.566 . . . . 74.209999999999994 109.473 176.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.524 ' CZ2' ' HA3' ' A' ' 89' ' ' GLY . 31.4 p90 -87.85 141.33 28.67 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.626 0.727 . . . . 62.520000000000003 111.306 -173.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.469 ' NE ' ' HA ' ' A' ' 78' ' ' ARG . 0.5 OUTLIER -137.57 175.36 9.66 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.03 -0.986 . . . . 65.099999999999994 110.148 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.2 p -144.7 164.93 29.5 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.81 -0.811 . . . . 63.340000000000003 108.81 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.3 mt -77.86 149.27 77.0 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.913 -0.403 . . . . 65.420000000000002 109.913 -177.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.12 -27.23 54.61 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.945 2.43 . . . . 74.340000000000003 112.791 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.75 0.72 82.91 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.902 -0.666 . . . . 65.219999999999999 113.189 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.63 159.4 20.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.047 0.423 . . . . 75.340000000000003 110.927 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -98.35 13.06 32.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.019 0.438 . . . . 65.409999999999997 110.769 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.427 HD11 ' N ' ' A' ' 85' ' ' ILE . 4.2 mp -99.44 80.14 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.573 -0.529 . . . . 64.239999999999995 109.573 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -81.36 91.93 6.33 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.588 -0.523 . . . . 73.049999999999997 109.588 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -148.71 139.88 23.17 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.495 -0.775 . . . . 62.520000000000003 109.883 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.8 m -124.69 128.65 49.14 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.842 -0.799 . . . . 74.099999999999994 108.842 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.524 ' HA3' ' CZ2' ' A' ' 77' ' ' TRP . . . -155.69 174.0 33.73 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.014 -1.088 . . . . 71.430000000000007 112.89 -175.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -163.15 128.96 3.21 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.462 -0.57 . . . . 71.230000000000004 109.462 -175.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.777 ' HB ' HG12 ' A' ' 106' ' ' VAL . 2.5 p -122.58 120.9 62.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.159 0.504 . . . . 74.420000000000002 111.688 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.804 ' HG ' ' HB2' ' A' ' 74' ' ' ARG . 8.0 mp -110.97 122.63 48.36 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.83 -0.623 . . . . 75.200000000000003 110.087 173.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.458 ' HE2' HD13 ' A' ' 75' ' ' ILE . 79.1 m-85 -87.28 126.71 35.0 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.847 0.355 . . . . 74.329999999999998 110.556 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.69 144.06 49.79 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.351 -0.386 . . . . 75.219999999999999 110.375 177.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.46 131.12 30.56 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.56 2.173 . . . . 73.510000000000005 111.196 176.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.08 143.53 57.2 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.582 -0.281 . . . . 70.129999999999995 110.73 -177.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.88 141.97 96.18 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 123.131 2.554 . . . . 72.140000000000001 112.572 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.79 20.38 79.51 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.878 -0.601 . . . . 72.439999999999998 112.109 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 52.84 36.71 22.2 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 121.021 0.439 . . . . 72.349999999999994 110.893 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 -72.57 -18.88 61.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.789 -0.642 . . . . 73.109999999999999 110.94 -176.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 146.2 -143.05 11.1 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.978 -0.849 . . . . 74.420000000000002 110.978 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.6 m -123.83 131.35 53.57 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.123 0.487 . . . . 74.340000000000003 110.1 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.61 ' HG2' ' HB1' ' A' ' 9' ' ' ALA . 31.8 tt0 -99.64 121.41 41.18 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.832 -0.622 . . . . 44.200000000000003 110.105 -178.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.504 HG22 ' CG2' ' A' ' 91' ' ' VAL . 2.3 p -98.04 112.13 29.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.432 -0.804 . . . . 73.109999999999999 110.932 -178.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 92' ' ' LEU . 11.1 p -101.81 120.66 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-O 121.33 0.586 . . . . 74.129999999999995 109.786 177.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.777 HG12 ' HB ' ' A' ' 91' ' ' VAL . 30.3 m -123.77 147.1 28.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.945 -0.57 . . . . 70.409999999999997 111.596 -175.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -100.55 116.88 33.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.318 -0.855 . . . . 73.510000000000005 109.898 170.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.3 tt -113.06 120.59 41.86 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.018 -0.734 . . . . 74.430000000000007 109.018 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 25.1 m -109.71 133.12 53.49 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.252 -0.431 . . . . 63.299999999999997 111.099 -176.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 . . . . . 0 N--CA 1.443 -0.792 0 N-CA-C 108.845 -0.798 . . . . 75.439999999999998 108.845 176.189 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.581 0 N-CA-C 111.246 -0.741 . . . . 64.299999999999997 111.246 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.3 t -85.89 -40.44 15.93 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 117.233 0.516 . . . . 64.340000000000003 110.174 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.401 ' O ' HG13 ' A' ' 120' ' ' VAL . . . -73.0 -30.54 63.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.341 0.591 . . . . 74.510000000000005 110.126 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.504 ' O ' HG23 ' A' ' 121' ' ' ILE . . . -81.57 -19.92 65.09 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.337 -0.847 . . . . 64.310000000000002 113.043 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -79.44 -22.38 44.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 117.089 0.444 . . . . 75.510000000000005 112.094 -176.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 117' ' ' ALA . 7.0 p -64.96 -27.08 41.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.693 -0.23 . . . . 60.25 111.514 -174.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.504 HG23 ' O ' ' A' ' 118' ' ' GLY . 10.6 tp -65.45 -29.79 48.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.638 0.256 . . . . 74.329999999999998 110.727 -177.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.98 -23.15 59.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 71.430000000000007 110.922 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.4 -29.27 19.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.304 0.573 . . . . 73.530000000000001 109.608 176.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.815 -0.63 . . . . 60.149999999999999 109.669 177.281 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 . . . . . 0 N--CA 1.461 0.081 0 N-CA-C 112.717 0.636 . . . . 73.150000000000006 112.717 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -71.83 -37.64 70.28 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.48 -0.488 . . . . 72.439999999999998 111.037 -177.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -74.84 -38.29 62.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.243 0.544 . . . . 74.530000000000001 110.168 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.581 ' CD2' ' HB3' ' A' ' 8' ' ' ASP . 24.4 tp -66.59 -24.38 66.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.567 -0.742 . . . . 73.400000000000006 109.523 178.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.465 ' O ' ' HB3' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -62.64 -29.71 70.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.749 -0.66 . . . . 63.200000000000003 110.307 176.679 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -69.01 -43.42 74.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.889 -0.596 . . . . 75.439999999999998 110.149 176.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.505 ' O ' ' HG3' ' A' ' 144' ' ' GLN . 18.2 t80 -60.74 -37.96 83.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.876 -0.602 . . . . 73.430000000000007 109.9 174.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.792 ' HG2' HG13 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -53.64 -41.93 67.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.778 -0.647 . . . . 73.310000000000002 110.52 176.074 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -63.52 -31.36 72.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.879 -0.6 . . . . 75.540000000000006 110.436 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -79.17 -27.89 42.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.662 -0.699 . . . . 74.329999999999998 110.949 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.832 ' HG2' HG22 ' A' ' 22' ' ' VAL . 10.7 mt-30 -69.69 -40.61 76.24 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.069 0.461 . . . . 72.209999999999994 110.676 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.655 ' HB3' HG21 ' A' ' 12' ' ' ILE . 16.5 pt-20 -78.0 -13.63 59.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.926 -0.579 . . . . 63.310000000000002 110.4 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 58.4 tp -91.0 -61.58 1.64 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.818 -0.628 . . . . 75.519999999999996 110.88 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 110.97 -0.852 . . . . 71.230000000000004 110.97 -172.943 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.666 HG13 ' CB ' ' A' ' 108' ' ' LEU . 77.4 t . . . . . 0 N--CA 1.445 -0.679 0 CA-C-O 120.885 0.374 . . . . 74.349999999999994 110.05 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.8 m -146.68 151.3 14.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.926 -0.579 . . . . 73.409999999999997 110.15 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.46 109.79 22.28 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.204 -0.665 . . . . 73.530000000000001 109.204 173.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.439 ' HB3' HD23 ' A' ' 137' ' ' LEU . 2.6 t70 -157.36 174.27 15.68 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.105 -0.331 . . . . 74.329999999999998 110.105 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.445 ' CB ' HG23 ' A' ' 105' ' ' VAL . . . -131.43 131.5 43.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.242 -0.436 . . . . 73.540000000000006 110.848 -174.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.539 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 16.4 m -116.66 137.37 50.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.035 0.445 . . . . 73.439999999999998 110.663 177.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.1 m -83.65 105.14 14.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.935 -0.575 . . . . 64.219999999999999 110.222 -178.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.524 HG23 ' HB3' ' A' ' 144' ' ' GLN . 24.6 mm -114.3 149.93 16.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.727 0.299 . . . . 54.450000000000003 111.078 -177.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.76 25.68 8.26 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 121.159 -0.543 . . . . 75.340000000000003 112.67 177.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -98.4 145.65 30.23 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 108.764 -0.828 . . . . 70.230000000000004 108.764 176.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -59.0 -58.58 0.63 Allowed 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 121.946 1.764 . . . . 53.109999999999999 112.914 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 173.48 -43.55 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.097 0.559 . . . . 72.400000000000006 109.824 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.602 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 25.3 tt0 -48.3 -51.24 26.81 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 114.876 -1.057 . . . . 75.519999999999996 111.756 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -78.56 -11.09 59.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.611 -0.722 . . . . 63.210000000000001 111.504 -174.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.2 mt -83.66 -47.88 10.76 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.611 -0.268 . . . . 75.25 111.544 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.602 ' CE2' ' HA ' ' A' ' 17' ' ' GLU . 18.7 p90 -71.65 -24.37 61.84 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.383 -0.527 . . . . 74.010000000000005 110.811 -177.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.36 -13.36 61.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.974 -0.557 . . . . 61.329999999999998 111.495 -177.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.546 HG23 ' CZ ' ' A' ' 140' ' ' PHE . 6.1 p -57.01 -21.81 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 111.892 0.331 . . . . 72.519999999999996 111.892 -174.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -54.26 -31.81 54.57 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.139 -0.482 . . . . 74.310000000000002 110.696 177.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.605 ' HA ' ' NE ' ' A' ' 24' ' ' ARG . 4.7 tpm_? -135.42 32.33 3.09 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.425 -0.583 . . . . 64.209999999999994 109.425 176.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.682 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 29.2 t70 65.26 169.21 0.2 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.027 -0.988 . . . . 61.0 111.441 -177.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.57 86.84 2.39 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 121.034 0.445 . . . . 74.25 112.037 -176.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.682 ' HD3' ' O ' ' A' ' 25' ' ' ASP . 3.5 Cg_endo . . . . . 0 N--CA 1.457 -0.655 0 C-N-CA 123.339 2.693 . . . . 74.109999999999999 112.233 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.251 0 N-CA-C 108.819 -0.808 . . . . 64.109999999999999 108.819 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.485 ' HB2' HD21 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -121.31 134.83 55.16 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.197 -1.038 . . . . 74.209999999999994 108.197 179.076 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 30.9 tp -113.58 127.51 56.09 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.921 -0.312 . . . . 62.299999999999997 110.342 -170.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.0 p -92.4 -25.01 18.68 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.198 0.523 . . . . 61.450000000000003 111.119 -176.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.637 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -140.39 128.69 22.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.953 -0.567 . . . . 75.450000000000003 111.637 -177.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -130.19 26.47 5.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.352 -0.84 . . . . 74.0 110.189 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.787 ' HB3' ' HB3' ' A' ' 73' ' ' LYS . 6.0 mm-40 -62.63 141.79 96.87 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.805 -0.634 . . . . 64.439999999999998 110.673 -177.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.45 95.89 1.06 Allowed 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 123.04 2.493 . . . . 55.350000000000001 112.026 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.74 21.04 62.58 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-N 116.064 -0.516 . . . . 41.399999999999999 112.742 178.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.787 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 1.3 tmtp? -109.76 -57.93 2.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.893 0.378 . . . . 75.129999999999995 109.985 -176.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.849 ' HG3' ' HG ' ' A' ' 92' ' ' LEU . 40.5 ttp180 -155.97 111.63 3.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.12 -0.491 . . . . 73.400000000000006 109.832 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.431 HD13 ' N ' ' A' ' 75' ' ' ILE . 3.8 mp -109.27 110.52 32.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.504 -0.554 . . . . 73.510000000000005 109.504 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.637 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -119.21 115.4 24.13 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.104 -0.498 . . . . 37.030000000000001 109.861 177.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.45 ' HZ3' HG11 ' A' ' 91' ' ' VAL . 39.9 p90 -105.3 135.98 45.67 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.697 -0.683 . . . . 73.239999999999995 109.914 -177.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.5 mmt85 -142.42 174.02 11.0 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.308 -0.86 . . . . 70.400000000000006 108.861 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.403 ' OG ' ' HA ' ' A' ' 85' ' ' ILE . 30.1 p -98.8 -163.44 1.04 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.82 -0.807 . . . . 74.430000000000007 108.82 171.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.485 HD21 ' HB2' ' A' ' 65' ' ' GLU . 14.6 mt -71.98 142.93 85.86 Favored Pre-proline 0 C--N 1.321 -0.662 0 C-N-CA 120.277 -0.569 . . . . 74.310000000000002 109.784 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -63.11 -20.31 70.86 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 123.158 2.572 . . . . 70.409999999999997 113.047 -174.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.56 16.35 34.41 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.895 -0.669 . . . . 74.129999999999995 112.55 178.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -123.25 176.79 5.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.914 0.387 . . . . 73.439999999999998 111.133 -177.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -63.15 137.32 58.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.718 -0.674 . . . . 64.450000000000003 109.912 175.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.403 ' HA ' ' OG ' ' A' ' 79' ' ' SER . 19.6 tt -115.82 -27.18 2.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.962 -0.295 . . . . 63.439999999999998 111.493 -176.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 66.41 -81.73 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 122.962 0.505 . . . . 74.329999999999998 111.81 178.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -133.24 132.42 41.43 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.747 -0.464 . . . . 72.140000000000001 109.747 -177.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.8 m -96.82 128.03 43.38 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.716 0.293 . . . . 73.120000000000005 110.45 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -125.63 144.48 15.15 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.997 -0.62 . . . . 71.120000000000005 111.712 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -156.64 133.17 10.06 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.133 -0.321 . . . . 74.530000000000001 110.133 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.464 ' CG2' HG21 ' A' ' 104' ' ' VAL . 2.4 p -124.41 118.47 53.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.329 0.585 . . . . 75.420000000000002 111.497 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.849 ' HG ' ' HG3' ' A' ' 74' ' ' ARG . 2.9 mp -108.14 126.91 53.32 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.973 -0.751 . . . . 72.129999999999995 108.973 174.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.505 ' HZ ' ' HB3' ' A' ' 20' ' ' TYR . 85.2 m-85 -91.46 120.95 32.74 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.046 0.45 . . . . 75.319999999999993 110.426 -178.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -110.5 143.94 29.16 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.821 -0.627 . . . . 72.209999999999994 109.912 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.64 116.69 3.46 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.298 1.998 . . . . 74.530000000000001 111.258 177.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.44 144.21 97.68 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.409 . . . . 65.239999999999995 111.715 -174.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.65 130.68 41.59 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.978 2.452 . . . . 74.439999999999998 111.73 176.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.53 7.05 88.95 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.801 -0.714 . . . . 51.219999999999999 112.186 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 60.67 28.14 17.86 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.682 0.393 . . . . 72.150000000000006 111.591 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 66.2 mtt180 -89.29 14.53 10.84 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.173 0.435 . . . . 73.340000000000003 112.173 -176.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.97 -137.44 6.51 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.723 -0.751 . . . . 53.009999999999998 112.125 176.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 40.6 m -136.75 130.36 31.87 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.912 0.387 . . . . 74.310000000000002 110.098 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -91.32 115.68 28.22 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.315 0.579 . . . . 74.150000000000006 109.625 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.464 HG21 ' CG2' ' A' ' 91' ' ' VAL . 2.1 p -88.29 112.0 23.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.439 -0.8 . . . . 73.129999999999995 110.916 -176.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.445 HG23 ' CB ' ' A' ' 9' ' ' ALA . 23.9 t -100.27 110.44 27.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.277 -0.874 . . . . 53.149999999999999 109.748 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.2 t -118.62 127.85 75.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.067 0.46 . . . . 62.32 111.111 -177.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 107' ' ' ARG . 51.3 ttt-85 -106.73 122.39 46.27 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.012 -0.54 . . . . 74.420000000000002 110.178 176.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.666 ' CB ' HG13 ' A' ' 5' ' ' VAL . 4.6 mp -122.3 154.39 37.66 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.57 -0.53 . . . . 70.319999999999993 109.57 177.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.573 ' O ' HG12 ' A' ' 5' ' ' VAL . 6.2 m -84.75 119.33 25.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.789 0.328 . . . . 71.329999999999998 111.602 -177.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 14.2 p90 . . . . . 0 C--N 1.325 -0.484 0 CA-C-O 121.453 0.644 . . . . 71.219999999999999 111.386 -179.338 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.282 -0.327 . . . . 75.109999999999999 112.282 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.3 m -72.23 -15.54 61.93 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.047 0.451 . . . . 65.319999999999993 111.42 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -72.87 -19.9 61.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 61.200000000000003 110.973 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.561 ' HA2' HG22 ' A' ' 121' ' ' ILE . . . -55.92 -39.03 77.17 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 121.385 -0.436 . . . . 74.010000000000005 112.91 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.56 -29.34 70.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.127 0.489 . . . . 74.540000000000006 111.009 176.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 57.9 t -80.14 -46.81 21.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.829 -0.623 . . . . 73.030000000000001 110.614 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.561 HG22 ' HA2' ' A' ' 118' ' ' GLY . 15.5 tt -65.26 -21.69 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 116.271 -0.422 . . . . 72.219999999999999 110.925 -177.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.05 -25.25 63.57 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.503 -0.317 . . . . 75.129999999999995 111.131 176.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.446 ' HD3' ' C ' ' A' ' 123' ' ' ARG . 0.0 OUTLIER -74.95 -39.24 61.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.159 0.504 . . . . 71.450000000000003 110.094 175.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 17.1 tpt . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 116.054 -0.521 . . . . 74.519999999999996 111.063 179.293 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? . . . . . 0 N--CA 1.463 0.18 0 N-CA-C 111.391 0.145 . . . . 64.010000000000005 111.391 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -57.41 -56.07 26.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.803 0.335 . . . . 74.510000000000005 111.82 -174.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -74.93 -32.53 61.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.399 -0.364 . . . . 64.409999999999997 110.994 -176.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.539 ' HG ' ' CG1' ' A' ' 10' ' ' VAL . 20.6 tp -70.58 -24.74 62.82 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.243 -0.435 . . . . 73.450000000000003 109.972 -177.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.42 ' HA ' ' HE1' ' A' ' 138' ' ' MET . 0.0 OUTLIER -68.76 -45.78 70.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.152 -0.476 . . . . 75.439999999999998 110.199 177.636 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 71.0 mtm-85 -67.13 -37.89 84.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 71.230000000000004 110.171 177.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.546 ' CZ ' HG23 ' A' ' 22' ' ' VAL . 84.0 t80 -57.03 -42.45 80.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.457 -0.792 . . . . 75.420000000000002 110.586 174.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.482 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 26.0 ttpp -57.19 -46.85 82.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 71.420000000000002 110.726 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -60.66 -41.7 95.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.53 -0.759 . . . . 73.340000000000003 112.341 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -79.31 -24.68 42.67 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.554 -0.459 . . . . 73.329999999999998 110.937 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.524 ' HB3' HG23 ' A' ' 12' ' ' ILE . 8.1 mm-40 -71.83 -49.74 35.72 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.794 0.331 . . . . 74.129999999999995 110.958 175.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 13.4 pt-20 -67.9 -30.77 70.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.217 -0.447 . . . . 73.239999999999995 110.331 -177.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 48.7 tp -71.17 -41.32 70.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.773 -0.649 . . . . 74.409999999999997 109.658 174.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.551 0 CA-C-N 115.567 -0.742 . . . . 71.450000000000003 111.344 -177.927 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.839 HG22 HG22 ' A' ' 109' ' ' THR . 69.0 t . . . . . 0 N--CA 1.449 -0.507 0 N-CA-C 109.298 -0.63 . . . . 64.420000000000002 109.298 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.4 m -95.73 145.52 8.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.783 -0.644 . . . . 74.430000000000007 111.103 -174.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.496 ' HD2' ' O ' ' A' ' 7' ' ' ARG . 4.5 ppt_? -141.64 108.98 5.54 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.434 -0.803 . . . . 72.219999999999999 109.069 175.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -142.09 161.84 36.97 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.039 -0.726 . . . . 75.040000000000006 109.039 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.597 ' HB2' HG21 ' A' ' 105' ' ' VAL . . . -140.39 130.17 24.45 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.128 0.49 . . . . 71.510000000000005 111.969 -170.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.477 HG21 HD11 ' A' ' 12' ' ' ILE . 15.8 m -113.28 145.75 18.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.486 -0.779 . . . . 64.400000000000006 110.255 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 102' ' ' THR . 20.4 m -107.15 109.6 21.47 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.782 0.325 . . . . 72.129999999999995 111.067 -178.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.811 HG13 ' HG2' ' A' ' 141' ' ' LYS . 4.1 mp -98.82 147.97 6.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.26 -0.427 . . . . 73.409999999999997 109.883 -177.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.38 58.27 4.41 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.994 -0.622 . . . . 54.340000000000003 112.709 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.598 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 8.2 mmpt? -129.8 167.01 22.04 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 108.555 -0.905 . . . . 61.219999999999999 108.555 177.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.537 ' HD2' ' HB3' ' A' ' 14' ' ' LYS . 27.5 Cg_endo -65.22 -58.35 0.21 Allowed 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 121.309 1.339 . . . . 75.25 112.306 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.418 ' HB1' ' O ' ' A' ' 15' ' ' PRO . . . 171.69 -55.73 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.622 0.725 . . . . 60.020000000000003 110.266 174.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -55.09 -51.82 65.17 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.46 -1.245 . . . . 74.400000000000006 112.848 -173.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -54.07 -27.11 30.51 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.154 0.427 . . . . 75.150000000000006 112.154 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.485 ' CD1' ' HB ' ' A' ' 102' ' ' THR . 56.2 mt -69.32 -20.41 63.87 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.167 0.432 . . . . 73.409999999999997 112.167 -175.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.44 ' CE1' HG22 ' A' ' 75' ' ' ILE . 46.3 t80 -72.0 -25.27 61.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.099 0.475 . . . . 73.430000000000007 110.65 175.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.6 -12.98 60.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.364 -0.38 . . . . 73.340000000000003 111.411 -176.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.4 p -53.95 -24.04 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 112.626 0.602 . . . . 64.329999999999998 112.626 -174.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.417 ' HD1' ' O ' ' A' ' 20' ' ' TYR . 98.1 m95 -57.69 -24.34 56.25 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.18 0.437 . . . . 75.530000000000001 112.18 -176.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.429 ' HA ' ' HD2' ' A' ' 24' ' ' ARG . 7.5 tpt180 -156.33 59.28 0.57 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.792 0.33 . . . . 71.329999999999998 110.582 175.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.709 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 18.3 t70 65.24 168.82 0.19 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.571 -0.74 . . . . 73.329999999999998 111.227 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.5 mt -102.29 87.8 1.2 Allowed Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.714 -0.476 . . . . 73.329999999999998 109.714 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.709 ' HD3' ' O ' ' A' ' 25' ' ' ASP . 2.3 Cg_endo . . . . . 0 N--CA 1.458 -0.597 0 C-N-CA 123.186 2.59 . . . . 73.109999999999999 112.697 -174.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.504 0 CA-C-O 120.719 0.295 . . . . 73.310000000000002 111.076 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 1.043 ' HB2' HD23 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -105.61 133.66 49.99 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.859 -0.793 . . . . 73.019999999999996 108.859 175.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.467 HD11 ' HA ' ' A' ' 77' ' ' TRP . 1.6 mm? -88.91 145.5 25.5 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 121.085 -0.246 . . . . 74.329999999999998 110.791 -173.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.5 t -92.53 -21.48 20.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.957 0.408 . . . . 71.200000000000003 110.209 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.764 ' HB2' ' H ' ' A' ' 76' ' ' ALA . . . -121.87 130.48 53.4 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.338 -0.616 . . . . 71.129999999999995 109.338 174.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -128.58 23.98 5.82 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.473 0.654 . . . . 71.409999999999997 110.249 -172.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.551 ' HB3' ' HD3' ' A' ' 73' ' ' LYS . 29.2 mt-10 -73.17 141.52 81.12 Favored Pre-proline 0 C--N 1.326 -0.429 0 C-N-CA 120.582 -0.447 . . . . 74.120000000000005 110.551 -174.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.62 88.33 1.04 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.8 2.333 . . . . 72.5 113.326 -173.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.78 12.07 78.19 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 121.045 -0.597 . . . . 63.450000000000003 112.281 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.551 ' HD3' ' HB3' ' A' ' 70' ' ' GLU . 42.9 mtpt -95.36 -69.19 0.76 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.909 0.385 . . . . 74.230000000000004 110.325 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.457 ' HD2' ' OE2' ' A' ' 90' ' ' GLU . 10.2 ttp180 -147.72 127.15 13.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.908 -0.587 . . . . 71.140000000000001 110.095 -175.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.616 HD11 ' HE2' ' A' ' 93' ' ' PHE . 4.6 mp -131.01 111.4 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.398 0.618 . . . . 72.329999999999998 111.216 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.764 ' H ' ' HB2' ' A' ' 68' ' ' ALA . . . -104.87 125.93 51.42 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.211 -0.904 . . . . 73.239999999999995 108.707 170.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.467 ' HA ' HD11 ' A' ' 66' ' ' LEU . 64.8 p-90 -80.4 159.07 25.8 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.369 0.604 . . . . 75.400000000000006 111.349 -175.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.498 ' HB3' ' O ' ' A' ' 65' ' ' GLU . 44.7 ttp180 -158.64 164.38 36.04 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.05 -0.977 . . . . 74.400000000000006 108.64 -177.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.529 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 19.9 m -123.65 60.34 1.09 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.621 0.248 . . . . 61.020000000000003 110.343 -178.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 1.043 HD23 ' HB2' ' A' ' 65' ' ' GLU . 22.4 mt 68.09 153.95 0.14 Allowed Pre-proline 0 N--CA 1.471 0.621 0 CA-C-N 115.701 -0.682 . . . . 71.150000000000006 111.632 -178.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.26 -19.49 38.45 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.598 2.199 . . . . 74.030000000000001 111.784 173.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.76 -24.27 77.13 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.906 -0.664 . . . . 60.520000000000003 112.059 178.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.529 ' HB1' ' O ' ' A' ' 79' ' ' SER . . . -108.52 178.87 4.36 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.245 -0.65 . . . . 63.509999999999998 109.245 175.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.515 ' HD2' ' N ' ' A' ' 84' ' ' ARG . 5.1 mpt_? -118.28 164.86 14.58 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.89 0.376 . . . . 63.530000000000001 110.3 -177.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.574 HD11 ' HA ' ' A' ' 88' ' ' SER . 6.2 tt -131.62 108.52 14.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.657 -0.701 . . . . 74.549999999999997 109.484 176.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -77.15 -37.42 53.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.777 -0.647 . . . . 73.340000000000003 110.942 -175.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -126.28 132.17 51.73 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.69 -0.485 . . . . 74.549999999999997 109.69 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.574 ' HA ' HD11 ' A' ' 85' ' ' ILE . 25.8 m -95.87 128.17 42.52 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.963 0.411 . . . . 61.350000000000001 111.282 -173.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -109.63 90.35 0.59 Allowed Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.133 -0.787 . . . . 38.020000000000003 111.133 174.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.457 ' OE2' ' HD2' ' A' ' 74' ' ' ARG . 40.9 tt0 -102.63 118.63 37.27 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.922 0.392 . . . . 75.319999999999993 110.478 -177.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.7 m -112.43 142.82 23.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.407 -0.59 . . . . 62.229999999999997 109.407 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.632 HD21 ' HD3' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -134.56 137.74 44.03 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.367 0.603 . . . . 74.319999999999993 110.178 171.209 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.616 ' HE2' HD11 ' A' ' 75' ' ' ILE . 85.5 m-85 -97.22 119.0 34.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.315 -0.857 . . . . 74.310000000000002 110.15 -174.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.632 ' HD3' HD21 ' A' ' 92' ' ' LEU . 18.5 mmm180 -104.01 143.01 25.79 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.643 -0.503 . . . . 74.310000000000002 109.643 179.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.5 109.91 2.87 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.129 1.886 . . . . 72.140000000000001 111.439 176.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.568 ' HB3' ' HB3' ' A' ' 100' ' ' ARG . . . -73.68 144.03 82.65 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.362 -0.607 . . . . 70.239999999999995 109.362 177.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -48.6 113.33 0.82 Allowed 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 123.445 2.763 . . . . 62.140000000000001 114.479 -169.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.23 -66.54 3.78 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 114.875 -1.057 . . . . 38.020000000000003 112.501 170.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -170.13 24.04 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.085 -0.558 . . . . 63.32 110.821 -173.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.568 ' HB3' ' HB3' ' A' ' 96' ' ' ALA . 5.6 tpm_? -64.47 -22.86 67.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.057 -0.52 . . . . 74.349999999999994 110.499 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 127.92 -154.77 19.92 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.29 -0.724 . . . . 73.219999999999999 111.29 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 11' ' ' THR . 2.5 m -105.68 125.29 50.82 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.96 -0.385 . . . . 64.299999999999997 109.96 175.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -89.89 100.65 13.42 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.031 -0.729 . . . . 71.099999999999994 109.031 173.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.501 HG13 ' HD1' ' A' ' 93' ' ' PHE . 3.4 m -87.46 129.47 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 109.13 -0.693 . . . . 64.120000000000005 109.13 178.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.626 ' HB ' ' CD2' ' A' ' 92' ' ' LEU . 18.7 t -117.19 115.92 50.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 109.082 -0.71 . . . . 74.109999999999999 109.082 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.604 HG11 HD22 ' A' ' 108' ' ' LEU . 24.0 t -103.5 116.67 47.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.304 -0.407 . . . . 73.409999999999997 110.371 -177.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -107.54 107.72 18.69 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.566 -0.531 . . . . 74.0 109.566 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.604 HD22 HG11 ' A' ' 106' ' ' VAL . 2.6 pt? -145.7 152.04 38.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.133 -0.485 . . . . 65.329999999999998 110.232 -177.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.839 HG22 HG22 ' A' ' 5' ' ' VAL . 51.2 p -107.4 132.91 52.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.327 -0.397 . . . . 64.099999999999994 111.011 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 49.2 p90 . . . . . 0 C--N 1.32 -0.685 0 CA-C-N 116.285 -0.416 . . . . 71.239999999999995 109.883 176.161 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.404 0 N-CA-C 112.151 -0.38 . . . . 71.299999999999997 112.151 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.5 m -64.78 -30.24 71.24 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 122.288 0.235 . . . . 64.140000000000001 111.501 -177.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.32 -28.34 69.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.516 -0.311 . . . . 62.109999999999999 111.364 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -60.82 -39.26 96.57 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.085 -0.578 . . . . 62.140000000000001 112.396 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.25 -34.43 78.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.144 0.497 . . . . 73.340000000000003 110.634 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.9 t -68.59 -43.32 83.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.792 -0.64 . . . . 71.439999999999998 110.17 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.7 mm -65.91 -36.62 77.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.969 -0.559 . . . . 71.209999999999994 110.487 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.39 -19.3 65.89 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.866 -0.607 . . . . 70.519999999999996 111.577 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -73.38 -32.31 64.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.777 0.322 . . . . 75.340000000000003 110.688 178.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 121.11 0.481 . . . . 74.209999999999994 110.516 179.517 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.435 ' O ' ' HG2' ' A' ' 134' ' ' ARG . 42.0 ttm180 . . . . . 0 C--O 1.219 -0.541 0 N-CA-C 111.601 0.223 . . . . 74.0 111.601 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -54.61 -43.63 72.36 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.956 -0.465 . . . . 75.0 111.018 -175.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -68.64 -47.39 66.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 72.120000000000005 111.273 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 23.7 tp -69.49 -25.47 64.08 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.101 0.477 . . . . 72.019999999999996 110.219 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.605 ' HA ' ' HE1' ' A' ' 138' ' ' MET . 0.1 OUTLIER -69.9 -33.27 71.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.042 -0.526 . . . . 71.409999999999997 110.015 176.018 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -39.73 89.4 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.236 -0.438 . . . . 70.140000000000001 110.153 176.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -56.97 -52.21 66.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.987 -0.551 . . . . 54.450000000000003 109.916 174.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.811 ' HG2' HG13 ' A' ' 12' ' ' ILE . 14.5 tmtt? -59.06 -35.34 73.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.717 -0.674 . . . . 63.130000000000003 110.73 176.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.403 ' HD2' ' HA ' ' A' ' 142' ' ' ARG . 14.4 tpt180 -62.48 -58.78 6.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.02 -0.536 . . . . 73.200000000000003 109.997 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -63.15 -32.98 74.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.025 -0.534 . . . . 74.239999999999995 110.906 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -58.32 -37.04 74.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.675 -0.693 . . . . 75.340000000000003 112.369 -175.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.488 ' HB3' HG22 ' A' ' 12' ' ' ILE . 8.2 pt-20 -109.96 -18.09 13.46 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.827 -0.349 . . . . 75.230000000000004 111.894 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.0 tt -87.23 -38.53 16.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.168 0.508 . . . . 63.200000000000003 110.283 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.724 0 N-CA-C 111.343 -0.703 . . . . 72.209999999999994 111.343 -175.591 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 3.1 p . . . . . 0 N--CA 1.448 -0.55 0 CA-C-O 121.28 0.562 . . . . 70.230000000000004 109.769 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.3 t -97.92 116.72 41.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 116.213 -0.449 . . . . 75.430000000000007 109.81 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -93.23 123.44 36.5 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.372 0.606 . . . . 61.32 110.84 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.758 ' HB3' HD22 ' A' ' 137' ' ' LEU . 20.4 t0 -142.08 156.1 45.39 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.84 -1.17 . . . . 73.219999999999999 107.84 176.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.42 128.47 25.55 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.756 -0.378 . . . . 72.349999999999994 110.826 -176.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.506 HG11 HD21 ' A' ' 137' ' ' LEU . 27.9 m -110.07 134.91 50.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.664 -0.495 . . . . 74.129999999999995 109.664 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.739 HG21 ' HG3' ' A' ' 100' ' ' ARG . 1.3 m -108.07 110.99 22.81 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.768 -0.456 . . . . 70.519999999999996 109.768 -178.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.595 ' HB ' HD22 ' A' ' 19' ' ' LEU . 12.9 mm -108.24 150.86 10.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.925 -0.58 . . . . 63.109999999999999 110.117 -174.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.83 44.54 2.32 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.14 -0.553 . . . . 73.040000000000006 112.523 176.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.426 ' HB2' HD22 ' A' ' 19' ' ' LEU . 67.0 mmtt -119.24 145.42 38.39 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 107.889 -1.152 . . . . 73.219999999999999 107.889 176.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.444 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 83.1 Cg_exo -48.49 -58.01 2.01 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.568 2.179 . . . . 73.299999999999997 113.57 -173.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 15' ' ' PRO . . . 173.34 -53.28 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.378 0.609 . . . . 72.430000000000007 110.389 177.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -52.93 -32.43 45.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.677 -1.147 . . . . 75.109999999999999 111.98 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -85.49 -8.52 58.31 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.943 -0.571 . . . . 74.25 111.37 -175.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.833 ' HB2' ' HE2' ' A' ' 93' ' ' PHE . 96.1 mt -79.31 -44.42 21.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.711 -0.222 . . . . 75.349999999999994 111.437 -176.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.525 ' HB2' ' HZ ' ' A' ' 93' ' ' PHE . 64.1 t80 -71.46 -30.31 65.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.511 0.672 . . . . 74.420000000000002 109.787 177.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.859 ' HB3' ' HA ' ' A' ' 26' ' ' LEU . . . -66.11 -3.96 6.52 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.245 -0.889 . . . . 73.340000000000003 112.357 -175.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.538 HG22 ' CD1' ' A' ' 140' ' ' PHE . 13.4 p -61.37 -22.18 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.348 -0.387 . . . . 75.420000000000002 111.333 176.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.418 ' HD1' ' O ' ' A' ' 20' ' ' TYR . 76.2 m95 -66.6 -10.83 49.7 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.82 0.343 . . . . 72.439999999999998 111.286 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.458 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 6.5 mmm180 -132.56 -84.47 0.48 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.643 -0.253 . . . . 75.129999999999995 111.298 173.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.577 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 3.9 t70 -166.8 33.51 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.885 -0.326 . . . . 72.230000000000004 110.73 -176.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.859 ' HA ' ' HB3' ' A' ' 21' ' ' ALA . 0.7 OUTLIER 44.19 71.87 1.36 Allowed Pre-proline 0 N--CA 1.472 0.666 0 O-C-N 123.758 0.661 . . . . 72.530000000000001 112.46 -177.692 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 21' ' ' ALA . 94.0 Cg_endo . . . . . 0 N--CA 1.457 -0.638 0 C-N-CA 122.644 2.229 . . . . 71.099999999999994 112.359 -178.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.302 0 CA-C-O 120.732 0.301 . . . . 63.399999999999999 110.415 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.405 ' HG3' ' CB ' ' A' ' 78' ' ' ARG . 15.3 pt-20 -108.27 154.99 20.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.211 -0.45 . . . . 72.230000000000004 111.113 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.1 tp -117.58 123.02 45.2 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.059 -0.719 . . . . 75.129999999999995 109.059 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.425 ' HB ' ' CG ' ' A' ' 78' ' ' ARG . 12.2 t -83.52 -22.53 32.42 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.621 -0.432 . . . . 70.299999999999997 112.073 -171.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.935 ' HB2' ' H ' ' A' ' 76' ' ' ALA . . . -132.63 132.36 42.39 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.67 -0.412 . . . . 75.329999999999998 110.713 -178.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -139.42 40.87 2.06 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.793 -0.639 . . . . 62.32 110.797 -176.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.544 ' CB ' ' HB3' ' A' ' 73' ' ' LYS . 5.4 mm-40 -80.38 143.43 55.79 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 75.349999999999994 109.842 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.82 -55.67 0.49 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.59 2.194 . . . . 45.32 112.528 -178.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -134.12 64.15 0.6 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.852 -0.689 . . . . 72.400000000000006 111.856 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.544 ' HB3' ' CB ' ' A' ' 70' ' ' GLU . 69.2 tttt -143.78 -78.83 0.21 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.898 -0.408 . . . . 65.409999999999997 109.898 -176.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -168.03 147.5 4.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.785 0.326 . . . . 73.219999999999999 110.682 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.723 HD12 ' HE1' ' A' ' 93' ' ' PHE . 2.4 mp -122.8 116.68 49.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.76 -0.655 . . . . 73.519999999999996 109.913 175.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.935 ' H ' ' HB2' ' A' ' 68' ' ' ALA . . . -103.72 149.1 25.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.187 -0.46 . . . . 51.420000000000002 109.835 176.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 29.1 p-90 -94.0 152.6 18.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.098 0.475 . . . . 73.209999999999994 111.836 -172.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.425 ' CG ' ' HB ' ' A' ' 67' ' ' THR . 75.7 mmt-85 -144.27 173.53 11.68 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.071 -1.085 . . . . 74.109999999999999 108.071 169.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.617 ' OG ' HG13 ' A' ' 85' ' ' ILE . 11.5 m -150.13 22.75 0.85 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.799 -0.361 . . . . 74.109999999999999 110.598 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.417 ' HB2' ' O ' ' A' ' 79' ' ' SER . 91.2 mt 65.97 158.39 0.13 Allowed Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 115.834 -0.621 . . . . 64.5 110.233 -173.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -67.7 5.39 1.03 Allowed 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.76 2.307 . . . . 72.340000000000003 113.264 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.11 -21.01 10.43 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.8 -0.714 . . . . 75.299999999999997 113.095 -177.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 79' ' ' SER . . . -150.45 167.98 25.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.154 0.477 . . . . 74.129999999999995 111.282 -175.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -138.29 141.35 39.82 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.468 -0.567 . . . . 73.310000000000002 109.468 174.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.617 HG13 ' OG ' ' A' ' 79' ' ' SER . 71.1 mt -70.65 -16.45 19.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-O 120.917 0.389 . . . . 73.150000000000006 110.365 176.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 75.39 -38.37 0.36 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.685 0.794 . . . . 65.450000000000003 110.773 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -64.82 132.7 50.2 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.173 -0.677 . . . . 74.209999999999994 109.173 170.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.1 t -126.35 127.89 46.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.941 0.4 . . . . 71.409999999999997 110.899 -175.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.485 ' HA3' ' HB3' ' A' ' 107' ' ' ARG . . . 158.94 133.0 1.45 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 121.042 -0.599 . . . . 73.150000000000006 112.115 176.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -101.27 138.46 38.26 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.899 0.381 . . . . 62.229999999999997 109.977 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.469 HG21 HG13 ' A' ' 106' ' ' VAL . 63.1 t -89.04 125.02 42.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.79 -0.641 . . . . 62.43 111.484 -175.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.3 mp -107.37 132.04 53.59 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.053 -0.976 . . . . 73.430000000000007 110.241 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.833 ' HE2' ' HB2' ' A' ' 19' ' ' LEU . 91.9 m-85 -99.36 109.42 22.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.188 0.518 . . . . 64.200000000000003 109.872 177.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.46 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 21.0 mtp180 -109.67 144.65 30.33 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.554 -0.748 . . . . 74.329999999999998 110.176 -173.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 94' ' ' ARG . 11.9 Cg_exo -70.5 123.93 10.32 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.764 2.31 . . . . 71.400000000000006 112.636 -176.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.909 ' HB1' ' HB3' ' A' ' 100' ' ' ARG . . . -98.06 160.04 29.33 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 108.828 -0.804 . . . . 55.25 108.828 171.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.05 159.69 11.82 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 121.789 1.66 . . . . 75.219999999999999 110.604 169.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -52.38 -26.64 22.85 Favored Glycine 0 CA--C 1.519 0.3 0 N-CA-C 114.35 0.5 . . . . 71.129999999999995 114.35 -172.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -105.61 7.8 32.92 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 112.996 0.739 . . . . 61.450000000000003 112.996 -176.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.909 ' HB3' ' HB1' ' A' ' 96' ' ' ALA . 9.5 tpp180 -101.53 -35.99 8.95 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.343 -0.614 . . . . 71.299999999999997 109.343 175.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.607 ' O ' ' HB2' ' A' ' 96' ' ' ALA . . . 111.51 -130.05 9.5 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 121.15 -0.548 . . . . 72.299999999999997 112.012 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 54.7 m -129.89 132.91 46.57 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.73 -0.471 . . . . 65.230000000000004 109.73 173.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -88.24 107.02 18.59 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.126 0.489 . . . . 74.230000000000004 110.9 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.484 HG11 ' O ' ' A' ' 10' ' ' VAL . 6.4 p -88.33 101.59 11.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.466 -0.788 . . . . 73.319999999999993 109.812 174.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 59.5 t -86.25 108.5 17.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.901 -0.59 . . . . 73.129999999999995 110.187 -178.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.469 HG13 HG21 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -111.55 129.16 67.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.597 -0.728 . . . . 72.420000000000002 110.574 -178.275 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.485 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 39.9 ttm180 -107.79 110.68 22.55 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.61 -0.723 . . . . 72.5 109.452 177.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.463 ' H ' HD22 ' A' ' 108' ' ' LEU . 1.5 pt? -123.33 121.12 35.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.472 0.653 . . . . 74.219999999999999 111.7 -176.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 6.6 m -95.79 120.48 36.13 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.22 -0.9 . . . . 70.530000000000001 108.875 175.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 31.1 p90 . . . . . 0 N--CA 1.447 -0.621 0 CA-C-O 121.482 0.658 . . . . 71.140000000000001 111.458 -173.805 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.395 0 N-CA-C 112.754 -0.138 . . . . 73.329999999999998 112.754 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.8 t -63.73 -49.0 74.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.758 0.313 . . . . 74.030000000000001 110.49 -178.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.53 -32.56 73.52 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.281 -0.418 . . . . 75.319999999999993 110.742 178.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.64 -29.1 71.51 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.754 -0.657 . . . . 64.329999999999998 112.204 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.01 -31.41 62.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.931 0.396 . . . . 65.25 110.677 178.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.24 -50.01 56.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.015 -0.539 . . . . 73.540000000000006 110.585 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.55 ' HA ' ' HB3' ' A' ' 124' ' ' MET . 29.0 pt -69.1 -21.56 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.489 . . . . 63.229999999999997 111.261 -178.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.25 -39.68 83.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.541 -0.3 . . . . 63.100000000000001 111.367 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -89.92 -23.03 21.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.239 0.542 . . . . 74.340000000000003 110.192 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.55 ' HB3' ' HA ' ' A' ' 121' ' ' ILE . 16.3 tpt . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.735 -0.666 . . . . 72.299999999999997 110.993 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.627 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.453 -0.275 0 CA-C-O 120.709 0.29 . . . . 70.040000000000006 110.695 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.486 ' HB2' HD11 ' A' ' 121' ' ' ILE . 9.1 m-20 -61.58 -30.68 70.83 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.238 -0.653 . . . . 71.319999999999993 109.238 178.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.13 -53.23 53.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.784 -1.098 . . . . 72.430000000000007 110.422 176.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.758 HD22 ' HB3' ' A' ' 8' ' ' ASP . 1.2 tp -79.74 -31.42 41.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.599 -0.728 . . . . 73.019999999999996 110.929 -178.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.685 ' SD ' ' HD3' ' A' ' 141' ' ' LYS . 28.3 tpp -63.67 -26.6 68.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.936 -0.574 . . . . 71.109999999999999 111.395 -177.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -62.91 -54.35 39.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.981 -0.554 . . . . 64.010000000000005 111.151 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.703 ' HE2' ' HG ' ' A' ' 137' ' ' LEU . 3.1 p90 -77.31 -29.71 53.75 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.93 -0.308 . . . . 72.219999999999999 110.493 -177.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.685 ' HD3' ' SD ' ' A' ' 138' ' ' MET . 51.3 tttm -49.41 -51.99 31.59 Favored 'General case' 0 C--O 1.232 0.153 0 O-C-N 123.28 0.363 . . . . 55.140000000000001 111.297 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.423 ' HA ' ' HG2' ' A' ' 145' ' ' GLU . 0.5 OUTLIER -67.44 -30.68 70.48 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.903 -0.589 . . . . 64.409999999999997 110.668 -174.775 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -71.67 -36.58 70.7 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.813 0.34 . . . . 74.109999999999999 110.15 177.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.452 ' HB3' HG23 ' A' ' 12' ' ' ILE . 14.1 mm100 -64.12 -38.33 90.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 75.430000000000007 111.438 177.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.465 ' HB3' HG21 ' A' ' 12' ' ' ILE . 11.6 pt-20 -87.91 -4.96 58.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.249 -0.432 . . . . 74.420000000000002 111.368 -176.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.6 tp -111.02 -38.3 5.12 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.767 0.318 . . . . 73.230000000000004 111.113 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.39 0 C-N-CA 121.145 -0.55 . . . . 70.549999999999997 113.802 -173.2 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.741 HG23 ' HB ' ' A' ' 109' ' ' THR . 99.0 t . . . . . 0 N--CA 1.447 -0.592 0 N-CA-C 108.711 -0.848 . . . . 74.120000000000005 108.711 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.9 p -78.94 139.37 18.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.998 -0.546 . . . . 71.099999999999994 110.753 -174.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.466 ' HB3' ' HG3' ' A' ' 107' ' ' ARG . 17.3 ptt180 -132.55 134.79 45.41 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.992 -0.549 . . . . 62.210000000000001 110.379 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.743 ' HB3' HD22 ' A' ' 137' ' ' LEU . 4.2 t70 -158.14 171.81 19.54 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.443 -0.947 . . . . 74.439999999999998 108.443 172.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.412 ' CB ' HG21 ' A' ' 105' ' ' VAL . . . -146.33 120.42 9.45 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.874 0.368 . . . . 65.5 111.286 -174.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.2 m -112.73 133.55 58.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.9 -0.591 . . . . 74.129999999999995 110.756 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.0 m -97.96 112.31 24.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.922 0.392 . . . . 75.109999999999999 111.069 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.891 HG22 ' HG3' ' A' ' 144' ' ' GLN . 4.4 mp -117.28 146.38 21.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.386 -0.598 . . . . 75.510000000000005 109.386 176.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.52 53.51 3.2 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.086 -0.578 . . . . 75.219999999999999 112.972 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.504 ' HD2' ' OE1' ' A' ' 144' ' ' GLN . 0.2 OUTLIER -105.83 153.99 39.68 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 107.868 -1.16 . . . . 64.010000000000005 107.868 173.121 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.413 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 51.9 Cg_exo -55.43 -57.44 1.62 Allowed 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 121.795 1.664 . . . . 72.109999999999999 111.438 178.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.413 ' HB1' ' O ' ' A' ' 15' ' ' PRO . . . 171.46 -49.63 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.27 0.981 . . . . 52.520000000000003 108.762 172.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -48.92 -44.22 40.2 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.17 -1.377 . . . . 64.120000000000005 112.124 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -64.61 -23.18 67.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.914 -0.584 . . . . 62.049999999999997 112.033 -176.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.463 ' O ' HG12 ' A' ' 22' ' ' VAL . 92.4 mt -76.98 -24.9 52.23 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.893 0.378 . . . . 71.200000000000003 110.577 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.564 ' HE1' HG12 ' A' ' 75' ' ' ILE . 55.9 t80 -72.12 -41.53 67.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.536 0.684 . . . . 74.200000000000003 109.795 175.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.841 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . . . -76.43 -8.9 58.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.319 -0.855 . . . . 55.329999999999998 112.943 -175.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 19' ' ' LEU . 9.6 p -61.8 -22.3 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 111.765 0.283 . . . . 73.120000000000005 111.765 -174.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 33.6 t-105 -64.04 -14.79 56.94 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.401 -0.363 . . . . 73.299999999999997 111.147 -176.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -142.3 46.24 1.62 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.027 0.441 . . . . 75.430000000000007 110.784 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 36.3 t70 62.88 28.46 16.38 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.579 -0.737 . . . . 72.310000000000002 112.456 172.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 22' ' ' VAL . 5.5 mp 53.46 80.27 0.3 Allowed Pre-proline 0 N--CA 1.47 0.557 0 CA-C-N 115.935 -0.575 . . . . 70.450000000000003 111.45 177.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.841 ' HD2' ' HB2' ' A' ' 21' ' ' ALA . 58.8 Cg_endo . . . . . 0 C--O 1.233 0.245 0 C-N-CA 122.693 2.262 . . . . 72.239999999999995 113.179 -177.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 110.038 -0.356 . . . . 62.340000000000003 110.038 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 79' ' ' SER . 7.3 tp10 -123.99 154.92 39.13 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.387 -0.598 . . . . 74.129999999999995 109.387 177.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.943 ' HG ' ' HA ' ' A' ' 77' ' ' TRP . 3.3 mp -115.76 135.26 54.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.118 0.485 . . . . 74.019999999999996 111.6 -174.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.6 t -75.02 -32.41 61.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.313 -0.858 . . . . 74.439999999999998 111.474 -174.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.8 130.36 18.93 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.394 -0.522 . . . . 71.129999999999995 111.47 -176.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.459 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 8.0 p-10 -149.18 110.89 4.52 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.295 -0.866 . . . . 65.349999999999994 109.268 173.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.621 ' HB2' ' HB3' ' A' ' 73' ' ' LYS . 5.1 mm-40 -108.26 142.31 25.07 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 115.591 -0.731 . . . . 64.030000000000001 109.371 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -61.98 -27.37 79.55 Favored 'Trans proline' 0 N--CA 1.466 -0.097 0 C-N-CA 122.806 2.337 . . . . 74.409999999999997 112.238 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -146.36 49.54 0.64 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.575 -0.822 . . . . 73.129999999999995 112.625 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.621 ' HB3' ' HB2' ' A' ' 70' ' ' GLU . 39.4 ttmt -148.37 -79.92 0.14 Allowed 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.77 -0.253 . . . . 70.109999999999999 110.587 177.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.642 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 10.3 ptp180 -154.47 150.91 28.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.996 0.426 . . . . 75.540000000000006 111.135 175.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.564 HG12 ' HE1' ' A' ' 20' ' ' TYR . 4.5 mp -123.33 110.47 26.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 108.771 -0.826 . . . . 62.530000000000001 108.771 173.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -126.14 141.82 51.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.301 0.572 . . . . 71.109999999999999 112.396 -172.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.943 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 0.5 OUTLIER -90.31 124.83 35.23 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.137 -0.938 . . . . 75.530000000000001 112.34 -173.374 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.663 ' HG3' ' O ' ' A' ' 77' ' ' TRP . 32.6 mtm180 175.54 118.73 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 O-C-N 124.382 1.052 . . . . 73.230000000000004 111.827 173.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.575 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 23.6 m -163.25 -54.32 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.657 0.265 . . . . 72.530000000000001 111.34 166.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.8 mp -102.72 146.41 32.34 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.697 0.284 . . . . 75.230000000000004 111.218 -176.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.46 -16.96 11.67 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 123.088 2.525 . . . . 61.439999999999998 112.508 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.67 13.05 54.65 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.904 -0.665 . . . . 74.209999999999994 112.293 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 84' ' ' ARG . . . -129.55 -165.72 1.56 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.157 -0.312 . . . . 75.439999999999998 110.157 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.517 ' O ' HG12 ' A' ' 85' ' ' ILE . 58.4 mtm180 73.47 -170.12 0.12 Allowed 'General case' 0 N--CA 1.465 0.325 0 O-C-N 123.864 0.727 . . . . 74.219999999999999 110.972 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.517 HG12 ' O ' ' A' ' 84' ' ' ARG . 14.2 pt 60.93 -46.26 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 125.896 1.678 . . . . 64.230000000000004 113.891 179.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -79.08 -31.33 44.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.151 0.501 . . . . 74.430000000000007 109.792 177.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -130.73 134.63 47.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.609 -0.723 . . . . 74.439999999999998 109.695 176.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.8 m -145.51 131.35 19.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.937 -0.574 . . . . 73.129999999999995 109.454 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.535 ' HA2' ' O ' ' A' ' 107' ' ' ARG . . . 173.0 127.15 0.95 Allowed Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 119.877 -1.154 . . . . 74.200000000000003 113.604 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 0.3 OUTLIER -118.87 142.03 48.11 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.269 -0.641 . . . . 72.510000000000005 109.269 171.432 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 95.6 t -100.84 136.86 30.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.58 -0.282 . . . . 73.420000000000002 110.478 177.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.781 ' HB2' ' HB ' ' A' ' 105' ' ' VAL . 3.4 mm? -113.66 120.41 40.79 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.924 -0.58 . . . . 73.450000000000003 109.85 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -98.82 105.85 18.05 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.982 -0.748 . . . . 74.329999999999998 108.982 172.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.436 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 0.7 OUTLIER -103.99 143.45 26.69 Favored Pre-proline 0 C--N 1.317 -0.841 0 CA-C-N 115.771 -0.649 . . . . 71.230000000000004 110.132 -175.519 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 94' ' ' ARG . 5.8 Cg_exo -74.32 103.16 1.64 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.24 1.96 . . . . 64.109999999999999 110.23 172.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.99 142.99 95.07 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.117 -0.492 . . . . 62.020000000000003 110.689 -174.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -40.04 120.21 0.77 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 124.311 3.341 . . . . 74.450000000000003 114.925 -171.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.25 -69.6 2.56 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.025 -0.989 . . . . 62.409999999999997 111.583 174.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 175.78 26.83 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.437 -0.882 . . . . 74.400000000000006 109.559 -176.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -66.19 -22.48 66.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.948 -0.569 . . . . 71.310000000000002 111.17 -174.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 138.64 -151.16 21.48 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.35 -0.7 . . . . 61.030000000000001 111.35 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.9 m -114.2 127.15 55.76 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.953 0.406 . . . . 63.119999999999997 110.268 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -95.73 111.21 23.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.773 -0.649 . . . . 60.229999999999997 110.121 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.6 p -88.29 99.31 8.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.839 0.828 . . . . 73.120000000000005 109.943 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.781 ' HB ' ' HB2' ' A' ' 92' ' ' LEU . 21.6 t -89.2 110.08 21.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 114.995 -1.002 . . . . 73.129999999999995 108.757 177.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.67 HG23 HD21 ' A' ' 108' ' ' LEU . 7.7 p -114.35 120.3 63.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 121.48 0.657 . . . . 74.019999999999996 110.869 -176.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.535 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 19.7 ttp180 -114.43 98.4 6.89 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.545 -0.752 . . . . 73.409999999999997 108.99 176.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.67 HD21 HG23 ' A' ' 106' ' ' VAL . 2.3 pt? -131.91 151.31 51.79 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.767 0.317 . . . . 71.129999999999995 111.027 -171.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.741 ' HB ' HG23 ' A' ' 5' ' ' VAL . 12.2 t -97.81 127.75 43.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.147 0.499 . . . . 74.420000000000002 110.756 179.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 115.303 -0.862 . . . . 75.239999999999995 109.38 -176.41 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.706 0 CA-C-O 120.73 0.072 . . . . 62.409999999999997 113.033 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.7 m -61.59 -11.11 9.88 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.603 0.964 . . . . 62.520000000000003 113.603 -172.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.16 -35.11 61.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.738 0.304 . . . . 75.230000000000004 111.545 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.42 -28.74 42.73 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.593 -0.813 . . . . 70.209999999999994 112.704 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.09 -40.65 98.28 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.706 0.261 . . . . 54.409999999999997 111.706 -176.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.3 p -67.67 -30.4 48.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.967 0.413 . . . . 72.230000000000004 110.73 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 48.0 mm -73.44 -33.88 41.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.06 0.457 . . . . 73.329999999999998 110.411 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.27 -19.88 65.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.959 -0.564 . . . . 65.530000000000001 111.373 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.567 ' HA ' ' NE ' ' A' ' 123' ' ' ARG . 5.6 mmp_? -77.7 -13.65 59.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.559 -0.291 . . . . 72.200000000000003 111.339 178.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 35.4 ttp . . . . . 0 C--N 1.331 -0.205 0 N-CA-C 109.955 -0.387 . . . . 74.219999999999999 109.955 176.394 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 . . . . . 0 C--O 1.234 0.284 0 CA-C-O 120.82 0.343 . . . . 73.019999999999996 110.24 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.402 ' O ' ' HE3' ' A' ' 138' ' ' MET . 9.9 t70 -49.5 -56.5 9.6 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.652 -0.704 . . . . 75.140000000000001 112.854 -174.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -66.36 -33.78 76.49 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.835 -0.346 . . . . 64.430000000000007 111.216 -172.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.743 HD22 ' HB3' ' A' ' 8' ' ' ASP . 4.3 mp -71.01 -43.84 67.11 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.522 -0.308 . . . . 74.129999999999995 111.054 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.501 ' HB3' ' HE3' ' A' ' 138' ' ' MET . 1.5 ttp -60.07 -37.92 81.32 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.141 0.496 . . . . 74.109999999999999 110.006 174.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -65.74 -54.78 22.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.441 -0.799 . . . . 71.230000000000004 111.269 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.543 ' CE2' ' HA ' ' A' ' 137' ' ' LEU . 4.2 p90 -73.52 -29.8 62.7 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 120.078 -0.649 . . . . 74.310000000000002 110.911 -176.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 145' ' ' GLU . 60.5 tttm -55.43 -47.11 76.5 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.677 -0.49 . . . . 71.239999999999995 109.677 174.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 11.4 mmm180 -51.18 -52.18 46.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.903 -1.044 . . . . 74.230000000000004 111.609 176.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -70.55 -45.12 66.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.102 -0.499 . . . . 71.25 111.241 -176.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.891 ' HG3' HG22 ' A' ' 12' ' ' ILE . 5.0 tp-100 -63.12 -43.9 97.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.82 -0.627 . . . . 62.100000000000001 111.301 -177.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.633 ' HG3' HG23 ' A' ' 12' ' ' ILE . 3.0 tt0 -77.03 -23.0 52.13 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 112.212 0.449 . . . . 74.010000000000005 112.212 -177.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 0.7 OUTLIER -63.07 -57.45 10.6 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.809 -0.441 . . . . 72.319999999999993 109.809 -179.258 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.637 0 N-CA-C 111.449 -0.66 . . . . 53.140000000000001 111.449 -179.961 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.891 HG22 HG23 ' A' ' 109' ' ' THR . 86.0 t . . . . . 0 N--CA 1.445 -0.677 0 N-CA-C 110.029 -0.36 . . . . 73.099999999999994 110.029 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.2 m -114.23 142.56 26.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.198 0.523 . . . . 65.519999999999996 110.752 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -136.05 109.66 8.01 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.062 -0.718 . . . . 75.329999999999998 109.062 175.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.514 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 1.5 t70 -140.23 171.65 13.86 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.18 -0.674 . . . . 71.099999999999994 109.18 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.18 120.56 12.37 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.841 0.353 . . . . 75.450000000000003 110.575 -175.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.433 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 12.4 m -102.4 133.52 45.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.121 -0.49 . . . . 61.219999999999999 110.183 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.82 HG23 ' HB1' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -84.58 102.34 12.82 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.089 0.471 . . . . 72.340000000000003 110.275 -179.171 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.578 HG23 ' HG2' ' A' ' 144' ' ' GLN . 35.7 mm -107.47 138.91 31.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.752 -0.658 . . . . 72.230000000000004 111.272 -172.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.57 ' O ' ' HE3' ' A' ' 14' ' ' LYS . . . -85.58 39.9 3.02 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 121.358 -0.449 . . . . 74.340000000000003 113.541 -176.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.57 ' HE3' ' O ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -111.49 148.71 39.4 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.301 -0.629 . . . . 74.540000000000006 109.301 174.964 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.432 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 82.3 Cg_exo -50.52 -57.75 2.09 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.021 2.481 . . . . 72.450000000000003 114.0 -174.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 19' ' ' LEU . . . 172.87 -63.48 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.582 0.551 . . . . 73.329999999999998 110.817 174.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -64.82 -34.73 79.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.962 -0.563 . . . . 73.239999999999995 110.648 -175.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.709 ' HB3' ' HG3' ' A' ' 27' ' ' PRO . 2.4 mp0 -63.41 -15.75 58.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.959 -0.564 . . . . 60.340000000000003 111.217 178.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 16' ' ' ALA . 66.9 mt -75.1 -23.93 58.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.507 -0.315 . . . . 70.510000000000005 111.354 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.534 ' CE1' HG22 ' A' ' 75' ' ' ILE . 48.8 t80 -71.77 -27.25 62.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.183 0.516 . . . . 70.310000000000002 110.352 177.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.42 -7.11 34.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.847 -0.615 . . . . 62.200000000000003 111.52 -178.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.2 p -63.59 -22.3 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 116.412 -0.358 . . . . 64.540000000000006 110.365 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 47.3 t90 -60.27 -31.07 69.87 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.874 -0.603 . . . . 75.030000000000001 111.171 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 24' ' ' ARG . 22.2 mtm180 -94.91 -76.46 0.49 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.336 -0.393 . . . . 62.25 110.365 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -168.89 48.67 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.915 -0.772 . . . . 72.439999999999998 108.915 175.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.706 HD13 ' HA2' ' A' ' 147' ' ' GLY . 24.5 mt 67.56 161.1 0.14 Allowed Pre-proline 0 N--CA 1.468 0.458 0 CA-C-N 114.777 -1.101 . . . . 72.400000000000006 111.667 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.709 ' HG3' ' HB3' ' A' ' 18' ' ' GLN . 55.1 Cg_endo . . . . . 0 C--N 1.344 0.341 0 C-N-CA 122.483 2.122 . . . . 74.439999999999998 111.773 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.985 ' HA ' HD12 ' A' ' 80' ' ' LEU . . . . . . . . 0 CA--C 1.512 -0.488 0 CA-C-O 121.344 0.592 . . . . 72.010000000000005 110.151 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 1.067 ' HB3' ' HB2' ' A' ' 79' ' ' SER . 0.2 OUTLIER -161.71 145.11 12.35 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 107.167 -1.419 . . . . 73.129999999999995 107.167 -177.253 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.535 HD11 ' HA ' ' A' ' 77' ' ' TRP . 1.4 mm? -114.39 131.88 56.42 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.428 0.529 . . . . 72.530000000000001 112.428 -168.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.4 t -92.61 -31.56 15.12 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.834 -0.621 . . . . 71.230000000000004 110.601 177.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.471 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -116.32 126.77 53.99 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.864 -0.421 . . . . 73.010000000000005 109.864 177.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.504 ' O ' ' HD3' ' A' ' 71' ' ' PRO . 10.0 p-10 -130.66 38.61 3.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.835 -0.62 . . . . 73.510000000000005 110.548 -174.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.562 ' HB3' ' HB3' ' A' ' 73' ' ' LYS . 4.5 mm-40 -97.78 88.25 0.6 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.038 -0.528 . . . . 53.219999999999999 110.6 -176.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 69' ' ' ASP . 33.9 Cg_endo -61.93 -28.61 81.14 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.828 2.352 . . . . 71.219999999999999 113.114 -170.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -114.63 27.44 8.81 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.658 -0.782 . . . . 54.130000000000003 112.293 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.562 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 49.6 tptt -142.55 -61.46 0.44 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.627 0.251 . . . . 74.150000000000006 110.943 -178.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.457 ' H ' ' HB2' ' A' ' 70' ' ' GLU . 23.0 ptt180 -165.13 140.04 5.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.109 0.481 . . . . 71.519999999999996 110.472 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.717 HD12 ' HE2' ' A' ' 93' ' ' PHE . 3.5 mp -121.72 125.5 73.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.147 -0.479 . . . . 64.409999999999997 109.9 175.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.471 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -139.11 117.46 11.98 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.79 -0.818 . . . . 70.420000000000002 108.79 176.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.535 ' HA ' HD11 ' A' ' 66' ' ' LEU . 10.2 p90 -96.41 120.47 36.79 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.443 -0.503 . . . . 73.519999999999996 111.263 -174.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.521 ' HG3' ' O ' ' A' ' 77' ' ' TRP . 17.2 mtt85 174.31 127.68 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 O-C-N 124.339 1.024 . . . . 72.430000000000007 112.833 173.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 1.067 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 50.2 m -150.63 -32.35 0.18 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.757 -0.656 . . . . 72.239999999999995 109.954 167.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.985 HD12 ' HA ' ' A' ' 64' ' ' ALA . 3.9 mp -46.78 144.0 3.92 Favored Pre-proline 0 C--O 1.234 0.265 0 N-CA-C 113.125 0.787 . . . . 74.310000000000002 113.125 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -77.59 -17.48 14.29 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 123.438 2.759 . . . . 62.329999999999998 113.661 -175.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.41 -14.71 12.44 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.479 -0.867 . . . . 71.409999999999997 112.31 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.673 ' HB1' ' HB2' ' A' ' 80' ' ' LEU . . . -90.32 17.38 7.27 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.826 0.346 . . . . 65.230000000000004 111.826 -173.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -92.27 6.64 46.03 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.41 0.522 . . . . 74.549999999999997 112.41 -173.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.3 tt -67.59 116.39 7.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 107.806 -1.183 . . . . 75.329999999999998 107.806 168.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 13.0 pt-20 -77.69 81.01 4.14 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 114.779 1.4 . . . . 64.430000000000007 114.779 -160.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -84.77 129.23 34.85 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 104.601 -2.37 . . . . 71.430000000000007 104.601 151.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.0 t -94.66 135.56 35.98 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 118.913 -1.115 . . . . 74.209999999999994 112.145 -161.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -139.05 41.41 1.35 Allowed Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 114.895 -1.048 . . . . 53.140000000000001 111.074 177.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -102.43 113.67 27.2 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.525 -0.546 . . . . 75.349999999999994 109.525 177.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.4 m -115.33 132.42 64.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.993 -0.549 . . . . 74.140000000000001 110.77 -177.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.6 mp -108.5 130.49 55.26 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.049 -0.523 . . . . 63.329999999999998 110.605 178.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.717 ' HE2' HD12 ' A' ' 75' ' ' ILE . 63.3 m-85 -108.9 123.69 49.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.05 0.453 . . . . 75.540000000000006 110.332 178.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.564 ' NH1' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -141.27 152.07 63.25 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.94 -0.573 . . . . 74.030000000000001 110.176 177.866 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -52.38 126.86 21.9 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.852 2.368 . . . . 71.549999999999997 111.639 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.82 ' HB1' HG23 ' A' ' 11' ' ' THR . . . -92.44 143.17 26.88 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.101 -0.499 . . . . 72.400000000000006 111.444 -176.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -71.44 166.04 30.6 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.828 2.352 . . . . 61.039999999999999 112.39 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 68.31 17.87 70.79 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.085 -0.579 . . . . 64.030000000000001 112.344 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 55.56 27.89 11.05 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 122.733 0.413 . . . . 54.109999999999999 111.2 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 58.6 mtt-85 -78.86 -9.76 59.58 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.381 -0.372 . . . . 61.329999999999998 111.899 -175.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 119.32 -109.55 1.71 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.205 -0.998 . . . . 43.450000000000003 112.445 176.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.429 ' HB ' HD11 ' A' ' 19' ' ' LEU . 23.8 m -125.71 133.95 51.96 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.08 0.467 . . . . 75.109999999999999 111.18 -178.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.445 ' HB3' ' HG2' ' A' ' 94' ' ' ARG . 37.1 tt0 -87.28 105.05 16.97 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.62 -0.718 . . . . 75.340000000000003 109.347 175.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.0 p -89.2 103.3 13.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.864 0.84 . . . . 74.349999999999994 109.705 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.564 HG22 ' NH1' ' A' ' 94' ' ' ARG . 27.3 t -89.01 112.89 24.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.694 -1.139 . . . . 74.299999999999997 109.855 -177.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 46.8 t -116.12 116.52 52.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.626 -0.716 . . . . 73.239999999999995 111.345 -174.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -97.19 113.8 25.44 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.796 -1.187 . . . . 75.209999999999994 107.796 169.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.432 HD11 ' CD1' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -123.0 125.36 45.1 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.687 0.279 . . . . 74.310000000000002 110.364 -173.502 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.891 HG23 HG22 ' A' ' 5' ' ' VAL . 17.1 p -105.18 116.94 32.8 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.94 -0.393 . . . . 54.020000000000003 109.94 173.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.432 ' CD1' HD11 ' A' ' 108' ' ' LEU . 6.7 p90 . . . . . 0 C--N 1.322 -0.591 0 CA-C-N 115.76 -0.655 . . . . 75.310000000000002 109.802 -176.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.631 0 CA-C-O 120.454 -0.081 . . . . 72.040000000000006 113.049 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.6 t -62.96 -49.08 76.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.803 0.335 . . . . 73.319999999999993 111.176 -172.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.432 ' HA ' HG21 ' A' ' 120' ' ' VAL . . . -61.78 -30.72 70.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 64.209999999999994 111.042 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.72 -22.35 73.54 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.975 -0.631 . . . . 74.450000000000003 112.356 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.07 -40.28 17.0 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.766 0.317 . . . . 62.119999999999997 111.058 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.432 HG21 ' HA ' ' A' ' 117' ' ' ALA . 33.3 m -74.71 -32.92 29.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 111.939 0.348 . . . . 74.219999999999999 111.939 -175.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.469 ' HA ' ' HG2' ' A' ' 124' ' ' MET . 37.3 pt -69.71 -23.97 26.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.895 0.378 . . . . 74.340000000000003 110.882 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.0 -21.04 60.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.957 -0.565 . . . . 73.430000000000007 110.912 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 123' ' ' ARG . 33.5 ttt180 -86.27 -43.36 13.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.055 0.455 . . . . 75.409999999999997 110.555 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.469 ' HG2' ' HA ' ' A' ' 121' ' ' ILE . 23.6 ptp . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 74.540000000000006 111.238 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.542 ' O ' ' HG2' ' A' ' 138' ' ' MET . 8.4 mpt_? . . . . . 0 N--CA 1.463 0.178 0 N-CA-C 109.656 -0.498 . . . . 75.239999999999995 109.656 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.407 ' CG ' HH12 ' A' ' 139' ' ' ARG . 36.8 t70 -48.82 -49.79 37.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.958 -1.019 . . . . 74.049999999999997 112.393 -172.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -67.77 -39.71 84.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.899 0.38 . . . . 72.420000000000002 111.548 -176.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.514 ' CD2' ' HB3' ' A' ' 8' ' ' ASP . 12.6 tp -79.67 -20.92 45.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.469 -0.332 . . . . 73.349999999999994 110.858 -175.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.765 ' HA ' ' HE2' ' A' ' 138' ' ' MET . 24.2 mmt -69.18 -44.01 73.07 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.652 0.263 . . . . 72.319999999999993 111.096 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.407 HH12 ' CG ' ' A' ' 135' ' ' ASP . 89.8 mtm-85 -64.55 -42.64 95.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.956 0.408 . . . . 73.299999999999997 110.322 178.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -59.84 -45.47 92.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.278 -0.874 . . . . 71.420000000000002 110.152 176.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 39.5 tttp -58.05 -51.47 69.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.884 -0.598 . . . . 73.209999999999994 111.632 177.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 -56.61 -40.87 76.09 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.067 -0.515 . . . . 71.299999999999997 111.805 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -79.22 -36.06 40.69 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.668 -0.413 . . . . 74.129999999999995 110.764 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.634 ' HA ' HD22 ' A' ' 26' ' ' LEU . 61.4 tt0 -63.41 -43.57 97.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 74.310000000000002 111.42 -176.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.507 ' HB3' HG21 ' A' ' 12' ' ' ILE . 12.1 pt-20 -77.21 -24.06 51.34 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 120.83 -0.348 . . . . 74.219999999999999 111.023 -179.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 62.2 tp -66.27 -61.39 2.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.294 -0.412 . . . . 73.219999999999999 110.088 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.706 ' HA2' HD13 ' A' ' 26' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.41 0 C-N-CA 120.828 -0.701 . . . . 71.219999999999999 111.618 -177.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.449 -0.507 0 N-CA-C 109.37 -0.604 . . . . 72.319999999999993 109.37 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.72 ' HB ' ' CE1' ' A' ' 110' ' ' TYR . 12.2 p -118.35 140.18 42.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.139 0.495 . . . . 61.219999999999999 110.515 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.577 ' HD2' ' O ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -136.32 109.73 7.91 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.542 -0.911 . . . . 64.400000000000006 108.542 172.152 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.536 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 4.2 t70 -132.17 171.38 13.73 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.653 -0.869 . . . . 72.040000000000006 108.653 -178.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.686 ' HB2' HG13 ' A' ' 105' ' ' VAL . . . -141.17 121.96 14.39 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.114 0.483 . . . . 73.150000000000006 111.366 -173.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.472 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 14.3 m -111.9 136.62 47.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.727 -0.67 . . . . 75.010000000000005 109.915 176.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.8 m -88.75 107.41 18.94 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.291 -0.413 . . . . 75.340000000000003 110.06 -178.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.556 HG21 ' HB3' ' A' ' 145' ' ' GLU . 14.2 mm -105.84 132.68 52.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.233 -0.44 . . . . 73.049999999999997 110.52 -176.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.94 58.03 4.94 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.912 -0.661 . . . . 73.439999999999998 112.584 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.63 ' HB2' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -132.28 153.12 81.15 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 108.361 -0.977 . . . . 63.030000000000001 108.361 175.827 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.433 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 10.5 Cg_endo -54.6 -58.74 1.1 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.714 2.276 . . . . 73.519999999999996 113.692 -172.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.433 ' HB1' ' O ' ' A' ' 15' ' ' PRO . . . 172.16 -54.1 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.283 0.564 . . . . 65.450000000000003 110.808 175.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -55.5 -43.89 76.05 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.111 -0.95 . . . . 74.510000000000005 112.256 -174.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.561 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 2.7 mp0 -79.18 -8.32 58.91 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.043 -0.526 . . . . 72.209999999999994 111.172 -174.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.63 HD23 ' HB2' ' A' ' 14' ' ' LYS . 77.8 mt -73.95 -50.73 18.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.028 -0.533 . . . . 72.219999999999999 111.057 178.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.712 ' HB3' ' HZ ' ' A' ' 93' ' ' PHE . 17.1 p90 -74.37 -24.06 59.09 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.784 -0.766 . . . . 74.420000000000002 109.487 176.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.561 ' HB1' ' HA ' ' A' ' 18' ' ' GLN . . . -71.39 -2.98 18.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.278 -0.874 . . . . 74.030000000000001 111.107 176.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.672 HG12 ' HZ ' ' A' ' 140' ' ' PHE . 9.9 p -54.49 -21.57 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.049 -0.523 . . . . 74.019999999999996 111.029 176.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 15.5 t90 -60.14 -22.71 63.19 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.993 -0.549 . . . . 63.130000000000003 110.693 177.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -109.3 2.12 20.58 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.097 -0.501 . . . . 65.310000000000002 110.035 177.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.0 t70 55.54 80.35 0.14 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.899 -0.591 . . . . 73.549999999999997 110.87 -176.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.427 ' HA ' ' HD2' ' A' ' 27' ' ' PRO . 68.5 mt 45.18 85.6 0.16 Allowed Pre-proline 0 N--CA 1.47 0.547 0 CA-C-N 115.544 -0.753 . . . . 74.129999999999995 111.998 -178.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 26' ' ' LEU . 10.9 Cg_endo . . . . . 0 C--N 1.344 0.313 0 C-N-CA 123.63 2.887 . . . . 64.319999999999993 113.336 -173.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.397 0 N-CA-C 108.918 -0.771 . . . . 62.399999999999999 108.918 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.603 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -108.56 134.64 51.04 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.429 -0.952 . . . . 74.010000000000005 108.429 -175.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.405 ' N ' HD23 ' A' ' 66' ' ' LEU . 1.2 mm? -113.83 116.63 29.63 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 121.846 -0.534 . . . . 74.329999999999998 110.294 -176.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.501 HG23 ' HB3' ' A' ' 76' ' ' ALA . 7.1 t -78.26 -26.03 47.04 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.627 -0.429 . . . . 74.319999999999993 111.568 -174.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.413 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . . . -147.42 129.61 15.59 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.767 0.318 . . . . 75.430000000000007 110.368 176.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -132.23 7.93 4.3 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.098 -0.501 . . . . 72.239999999999995 111.424 -175.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -59.18 93.41 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 123.94 0.896 . . . . 72.150000000000006 112.486 -173.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -59.74 114.16 1.94 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.314 2.676 . . . . 74.409999999999997 112.642 -169.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.53 6.37 70.66 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.84 -0.695 . . . . 72.430000000000007 112.519 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -123.91 -67.94 0.9 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.002 -0.37 . . . . 73.329999999999998 110.002 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.418 ' C ' HD11 ' A' ' 75' ' ' ILE . 15.4 ptt180 -150.6 134.9 17.05 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.983 -0.377 . . . . 74.430000000000007 109.983 175.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.606 HD13 ' HE2' ' A' ' 93' ' ' PHE . 3.5 mp -126.73 126.52 68.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 109.183 -0.673 . . . . 72.319999999999993 109.183 177.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.583 ' HB1' ' HG3' ' A' ' 90' ' ' GLU . . . -139.59 120.57 14.57 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.969 -0.559 . . . . 71.209999999999994 110.559 -176.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 13.3 m-90 -98.04 152.17 19.57 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.78 -0.646 . . . . 74.019999999999996 110.483 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.603 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 1.0 OUTLIER -156.16 175.68 13.66 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.682 -0.858 . . . . 75.010000000000005 108.682 175.625 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 1.054 ' HB2' ' HA ' ' A' ' 85' ' ' ILE . 20.3 m -105.91 -171.07 1.83 Allowed 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 109.672 -0.492 . . . . 74.540000000000006 109.672 176.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.6 mt -82.79 144.88 49.11 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.631 -0.259 . . . . 72.420000000000002 111.075 -175.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.94 -32.36 95.0 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.601 2.2 . . . . 64.230000000000004 111.436 173.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.97 35.83 3.86 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.482 -0.647 . . . . 43.240000000000002 111.482 175.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -155.01 -173.94 4.78 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.654 -0.498 . . . . 60.299999999999997 109.654 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -80.38 101.62 9.11 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.591 -0.522 . . . . 73.540000000000006 109.591 172.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 1.054 ' HA ' ' HB2' ' A' ' 79' ' ' SER . 0.0 OUTLIER -70.04 -51.37 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 116.175 -0.466 . . . . 75.299999999999997 109.777 -179.071 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 47.78 -83.25 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.371 1.068 . . . . 55.43 113.608 175.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -64.69 132.51 49.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.588 0.709 . . . . 54.530000000000001 111.52 -175.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.1 m -139.5 128.73 23.95 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.537 -0.756 . . . . 72.409999999999997 109.548 176.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.25 145.15 9.16 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.716 -0.754 . . . . 62.310000000000002 112.064 -178.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.583 ' HG3' ' HB1' ' A' ' 76' ' ' ALA . 43.4 tt0 -138.57 125.61 21.31 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.077 -0.342 . . . . 65.140000000000001 110.077 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.1 m -106.75 128.07 61.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.121 0.486 . . . . 64.209999999999994 110.223 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.661 ' HB2' HG21 ' A' ' 105' ' ' VAL . 9.1 mp -110.53 145.7 37.3 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.463 -0.569 . . . . 65.420000000000002 109.463 173.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.712 ' HZ ' ' HB3' ' A' ' 20' ' ' TYR . 73.9 m-85 -110.07 106.72 16.32 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.094 0.473 . . . . 73.400000000000006 111.104 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -112.3 142.87 27.74 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.304 -0.628 . . . . 74.5 109.304 175.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -72.16 125.19 10.63 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.421 2.08 . . . . 75.120000000000005 111.327 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.89 144.51 98.86 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.239 -0.652 . . . . 62.140000000000001 109.239 176.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -39.32 119.64 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.623 2.882 . . . . 75.450000000000003 113.622 -174.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 90.82 8.97 64.69 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.011 -0.614 . . . . 54.509999999999998 112.642 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 59.01 36.04 24.24 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.201 0.524 . . . . 74.329999999999998 110.427 -178.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -73.79 -65.42 0.83 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.672 -0.695 . . . . 62.450000000000003 110.458 -178.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -131.78 -167.85 11.97 Favored Glycine 0 N--CA 1.439 -1.127 0 N-CA-C 110.512 -1.035 . . . . 72.140000000000001 110.512 176.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.477 ' HB ' HD12 ' A' ' 19' ' ' LEU . 10.7 m -110.45 122.71 48.38 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.023 0.439 . . . . 73.099999999999994 110.182 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.489 ' HG2' ' HB3' ' A' ' 9' ' ' ALA . 41.3 tt0 -92.4 106.5 18.48 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.455 -0.943 . . . . 75.409999999999997 108.455 178.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 5.2 m -86.72 128.88 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 CA-C-O 121.393 0.615 . . . . 70.0 109.506 -177.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.686 HG13 ' HB2' ' A' ' 9' ' ' ALA . 3.5 m -108.95 114.98 48.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.521 -0.763 . . . . 71.349999999999994 109.797 178.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 40.1 t -110.02 119.12 58.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.828 -0.623 . . . . 64.310000000000002 111.377 -173.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -107.06 116.48 32.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.633 -0.712 . . . . 71.030000000000001 109.739 175.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.5 pp -147.0 151.69 37.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.934 0.397 . . . . 75.530000000000001 111.085 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.1 t -90.09 144.85 25.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.93 -0.577 . . . . 74.540000000000006 110.18 178.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.72 ' CE1' ' HB ' ' A' ' 6' ' ' VAL . 5.7 p90 . . . . . 0 C--N 1.326 -0.449 0 N-CA-C 109.921 -0.4 . . . . 75.219999999999999 109.921 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.567 0 N-CA-C 112.342 -0.303 . . . . 55.32 112.342 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 38.0 t -86.29 -23.73 26.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.988 0.423 . . . . 63.130000000000003 110.572 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -68.41 -29.09 67.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.146 -0.479 . . . . 72.299999999999997 111.641 -174.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.452 ' O ' HG22 ' A' ' 121' ' ' ILE . . . -69.73 -19.68 75.18 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.098 -0.572 . . . . 52.100000000000001 113.041 -178.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.26 -20.34 65.99 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.307 0.484 . . . . 62.200000000000003 112.307 -174.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.57 -19.48 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.785 0.326 . . . . 73.219999999999999 111.723 -176.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.452 HG22 ' O ' ' A' ' 118' ' ' GLY . 13.8 tt -67.62 -22.64 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 121.032 0.444 . . . . 70.510000000000005 110.967 -177.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.54 -20.85 63.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.269 -0.423 . . . . 61.420000000000002 111.191 -178.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -71.03 -28.93 64.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.057 -0.52 . . . . 73.430000000000007 110.776 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.5 ttm . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 74.439999999999998 111.153 -175.358 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.538 ' O ' ' HG2' ' A' ' 138' ' ' MET . 51.0 mtp180 . . . . . 0 C--O 1.232 0.161 0 N-CA-C 109.061 -0.718 . . . . 74.209999999999994 109.061 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -57.22 -38.6 73.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.882 -1.054 . . . . 72.010000000000005 112.996 -171.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.48 -42.57 98.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.889 0.376 . . . . 75.409999999999997 110.889 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.536 ' CD2' ' HB3' ' A' ' 8' ' ' ASP . 13.9 tp -79.4 -20.95 46.37 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.254 -0.43 . . . . 71.430000000000007 110.112 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.538 ' HG2' ' O ' ' A' ' 134' ' ' ARG . 30.4 mmt -69.48 -47.51 63.68 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.307 -0.406 . . . . 60.420000000000002 110.268 175.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.07 -43.28 99.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.094 -0.503 . . . . 71.319999999999993 110.092 174.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.672 ' HZ ' HG12 ' A' ' 22' ' ' VAL . 67.8 t80 -57.22 -48.9 77.64 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.228 -0.897 . . . . 75.120000000000005 111.004 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.8 tttp -54.81 -56.23 21.63 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.185 -0.462 . . . . 75.109999999999999 111.727 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -55.49 -42.82 74.94 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.821 0.343 . . . . 62.350000000000001 111.737 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -75.49 -27.44 58.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.486 -0.325 . . . . 60.130000000000003 111.4 -178.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -80.94 -39.13 26.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.056 -0.52 . . . . 74.439999999999998 111.216 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.556 ' HB3' HG21 ' A' ' 12' ' ' ILE . 16.9 pt-20 -80.57 -36.85 32.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.55 -0.296 . . . . 73.349999999999994 111.495 -176.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.1 tt -71.79 -63.01 1.21 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.781 -0.452 . . . . 75.109999999999999 109.781 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.419 ' HA3' HD13 ' A' ' 26' ' ' LEU . . . . . . . . 0 N--CA 1.449 -0.466 0 CA-C-N 115.652 -0.704 . . . . 72.329999999999998 113.486 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.448 -0.558 0 N-CA-C 109.145 -0.687 . . . . 64.510000000000005 109.145 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 71.4 t -101.16 116.76 45.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 121.303 0.573 . . . . 74.019999999999996 110.881 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -132.21 109.84 10.22 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.981 -1.008 . . . . 75.420000000000002 108.638 176.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.481 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 1.3 t70 -141.47 146.15 36.11 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.836 -1.172 . . . . 52.439999999999998 107.836 175.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -122.8 140.25 53.13 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.135 0.493 . . . . 62.340000000000003 110.982 -173.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.604 ' CG2' ' HG2' ' A' ' 141' ' ' LYS . 2.5 m -133.85 142.28 41.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.47 -0.786 . . . . 74.519999999999996 110.469 -176.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 29.7 m -94.0 133.7 37.17 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.975 -0.557 . . . . 72.409999999999997 111.125 -175.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.795 HD13 ' HG3' ' A' ' 141' ' ' LYS . 35.3 mt -121.38 140.15 46.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.654 -0.703 . . . . 72.120000000000005 109.917 172.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.498 ' H ' ' HB3' ' A' ' 145' ' ' GLU . . . -83.31 62.35 4.64 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.991 -0.624 . . . . 74.430000000000007 112.555 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.517 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 7.4 mmpt? -144.59 144.8 26.13 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 109.183 -0.673 . . . . 73.329999999999998 109.183 175.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 72.8 Cg_exo -51.81 -56.3 3.09 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.25 2.633 . . . . 72.519999999999996 113.945 -176.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 15' ' ' PRO . . . 174.51 -63.11 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.686 0.279 . . . . 74.310000000000002 110.836 177.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -50.23 -42.57 51.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.553 -0.749 . . . . 73.040000000000006 111.428 -176.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.567 ' HG3' ' HD2' ' A' ' 27' ' ' PRO . 2.6 mp0 -61.61 -23.55 66.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.727 -0.67 . . . . 74.319999999999993 111.863 -177.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 19' ' ' LEU . 53.6 mt -77.8 -34.32 52.21 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.95 0.352 . . . . 71.439999999999998 111.95 -176.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -71.73 -28.07 63.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.644 0.735 . . . . 71.030000000000001 109.421 177.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.22 -2.69 32.52 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 114.901 -1.045 . . . . 73.430000000000007 112.385 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.831 HG23 ' HZ ' ' A' ' 140' ' ' PHE . 10.9 p -53.01 -22.56 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 113.042 0.756 . . . . 63.219999999999999 113.042 -174.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 23.2 m0 -63.18 -14.1 44.99 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.703 0.631 . . . . 74.340000000000003 112.703 -176.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.447 ' HD3' ' HA ' ' A' ' 24' ' ' ARG . 25.8 mmt180 -121.84 -80.15 0.62 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.407 -0.183 . . . . 75.219999999999999 110.624 175.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' A' ' 26' ' ' LEU . 8.3 t70 -172.19 53.63 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.549 -0.537 . . . . 74.129999999999995 109.549 176.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 9.1 mp 66.37 165.89 0.12 Allowed Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 115.409 -0.814 . . . . 72.239999999999995 110.771 -178.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.567 ' HD2' ' HG3' ' A' ' 18' ' ' GLN . 35.4 Cg_exo . . . . . 0 C--N 1.347 0.45 0 C-N-CA 122.38 2.053 . . . . 73.329999999999998 111.781 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 78' ' ' ARG . . . . . . . . 0 N--CA 1.446 -0.636 0 N-CA-C 108.582 -0.895 . . . . 63.520000000000003 108.582 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.574 ' HB2' ' HA ' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -108.05 133.97 51.6 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.986 -1.116 . . . . 73.530000000000001 107.986 177.01 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.528 ' CD2' ' HB3' ' A' ' 69' ' ' ASP . 40.1 tp -105.49 117.81 34.96 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.651 -0.82 . . . . 74.329999999999998 110.713 -169.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.8 t -93.32 -13.86 27.63 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.003 -0.544 . . . . 43.130000000000003 111.126 -175.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.401 ' HB1' ' H ' ' A' ' 76' ' ' ALA . . . -147.25 125.16 11.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.952 0.406 . . . . 73.239999999999995 110.806 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.528 ' HB3' ' CD2' ' A' ' 66' ' ' LEU . 4.1 p-10 -140.19 40.5 1.94 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.498 -0.774 . . . . 72.439999999999998 109.835 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -60.03 144.96 85.9 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.078 -0.964 . . . . 75.549999999999997 109.919 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -47.25 -41.34 27.84 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.826 3.017 . . . . 73.109999999999999 113.451 -173.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -166.57 33.26 0.22 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.352 -0.928 . . . . 60.130000000000003 112.215 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -97.21 -63.46 1.13 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.164 0.507 . . . . 71.420000000000002 110.523 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 74' ' ' ARG . 3.5 ptp85 -161.51 140.84 10.1 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.758 -0.83 . . . . 71.439999999999998 108.758 177.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 68.5 mt -121.99 109.81 25.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 109.412 -0.588 . . . . 64.319999999999993 109.412 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.609 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . . . -111.34 115.32 29.1 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.975 -0.557 . . . . 75.510000000000005 110.499 -177.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 23.5 p-90 -96.1 124.09 39.97 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.921 0.867 . . . . 74.340000000000003 110.086 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 30.9 mmt180 -113.67 176.15 5.15 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.353 -1.351 . . . . 73.040000000000006 107.353 178.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.866 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 16.5 m -99.12 163.98 12.35 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 118.839 -1.144 . . . . 73.349999999999994 110.187 174.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.58 HD13 ' H ' ' A' ' 80' ' ' LEU . 4.4 mp -69.55 161.5 73.62 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.885 -0.598 . . . . 64.200000000000003 110.784 -176.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.14 -40.82 75.81 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.769 2.313 . . . . 65.099999999999994 112.252 177.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.0 -20.86 58.56 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.786 -0.721 . . . . 74.230000000000004 112.327 178.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.417 ' HA ' ' NH1' ' A' ' 84' ' ' ARG . . . -82.38 167.31 18.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.749 0.309 . . . . 74.319999999999993 110.728 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.417 ' NH1' ' HA ' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -82.16 104.71 12.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.003 0.43 . . . . 62.310000000000002 110.507 -176.639 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.866 ' HB ' ' HB2' ' A' ' 79' ' ' SER . 6.8 tt -117.44 116.81 53.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.867 -0.606 . . . . 51.409999999999997 110.517 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -153.55 -42.15 0.09 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.052 -0.522 . . . . 71.25 109.961 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -77.18 154.17 33.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.123 -0.489 . . . . 73.230000000000004 110.166 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.4 m -96.13 127.64 42.32 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.363 -0.381 . . . . 63.119999999999997 110.65 -178.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -122.49 61.53 0.55 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.942 -0.647 . . . . 72.439999999999998 111.524 177.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.609 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 39.3 tt0 -102.69 121.97 43.51 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 122.627 -0.337 . . . . 72.239999999999995 110.661 -176.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.663 HG21 HG23 ' A' ' 106' ' ' VAL . 83.0 t -112.79 122.03 66.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.273 0.558 . . . . 74.420000000000002 110.684 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.882 ' HB2' ' HB ' ' A' ' 105' ' ' VAL . 10.1 mp -96.19 142.34 28.48 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.597 -0.729 . . . . 62.109999999999999 110.104 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -121.55 115.9 23.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.152 -0.476 . . . . 74.329999999999998 110.164 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -141.08 144.65 35.75 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.318 -0.401 . . . . 75.540000000000006 110.567 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.67 134.72 66.21 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.679 2.253 . . . . 70.549999999999997 111.932 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -94.61 145.04 28.93 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.996 -0.547 . . . . 75.150000000000006 111.706 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -54.12 151.33 28.46 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.088 2.525 . . . . 73.140000000000001 112.361 175.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.49 -0.89 79.42 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.72 -0.753 . . . . 53.43 111.251 -178.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 59.57 33.93 22.24 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 122.8 0.44 . . . . 53.009999999999998 111.031 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -64.09 -42.89 96.76 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.19 0.519 . . . . 71.510000000000005 110.419 176.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 162.24 -122.37 1.1 Allowed Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 115.46 -0.791 . . . . 73.329999999999998 111.421 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 39.3 m -128.72 135.09 48.76 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.564 0.697 . . . . 73.219999999999999 111.003 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -90.88 131.27 36.62 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.867 -1.061 . . . . 72.019999999999996 110.181 -178.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.435 HG22 HG21 ' A' ' 10' ' ' VAL . 17.9 m -87.41 131.58 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 108.164 -1.05 . . . . 71.450000000000003 108.164 173.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.882 ' HB ' ' HB2' ' A' ' 92' ' ' LEU . 44.3 t -123.1 111.49 29.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 116.022 -0.536 . . . . 74.010000000000005 110.391 -174.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.663 HG23 HG21 ' A' ' 91' ' ' VAL . 37.9 t -128.29 121.2 55.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.405 -0.361 . . . . 64.109999999999999 111.12 -177.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.571 ' O ' ' HD2' ' A' ' 107' ' ' ARG . 0.4 OUTLIER -107.05 108.83 20.51 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.278 0.561 . . . . 71.200000000000003 109.816 170.6 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 50.1 tp -114.19 142.82 45.76 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.032 -0.531 . . . . 62.420000000000002 110.847 -175.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.8 t -93.95 142.33 27.51 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.006 -0.543 . . . . 74.209999999999994 110.498 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 . . . . . 0 C--N 1.322 -0.592 0 CA-C-N 115.934 -0.575 . . . . 75.120000000000005 110.234 177.874 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.846 0 N-CA-C 112.472 -0.251 . . . . 75.530000000000001 112.472 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.3 t -78.96 -26.97 43.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.51 0.195 . . . . 63.350000000000001 111.36 -175.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.65 -34.6 71.39 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.563 0.22 . . . . 61.329999999999998 111.448 -176.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.69 -31.82 76.89 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.922 -0.656 . . . . 73.230000000000004 112.397 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.96 -38.21 37.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.843 0.354 . . . . 63.329999999999998 110.588 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 93.4 t -61.32 -50.0 82.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.916 -0.584 . . . . 74.209999999999994 110.954 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.6 tp -65.8 -34.13 68.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 74.299999999999997 110.808 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.31 -37.11 84.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.443 -0.344 . . . . 61.310000000000002 111.192 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 70.2 ttp85 -68.33 -48.12 65.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.32 -0.4 . . . . 72.200000000000003 110.935 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 27.2 ptm . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.437 -0.347 . . . . 71.049999999999997 111.154 -177.282 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 109.771 -0.455 . . . . 73.239999999999995 109.771 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -60.7 -55.33 34.56 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.615 -0.72 . . . . 70.120000000000005 110.455 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -66.48 -30.84 71.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.16 0.505 . . . . 60.32 110.347 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.661 ' O ' ' HD3' ' A' ' 141' ' ' LYS . 43.5 tp -65.12 -48.24 74.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.616 -0.72 . . . . 72.450000000000003 110.167 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.795 ' HA ' ' HE1' ' A' ' 138' ' ' MET . 3.1 tpt -75.03 -35.12 61.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.494 -0.321 . . . . 74.540000000000006 110.692 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.9 ttm-85 -52.67 -54.8 28.39 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.969 -0.56 . . . . 73.510000000000005 111.124 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.831 ' HZ ' HG23 ' A' ' 22' ' ' VAL . 54.1 t80 -67.8 -46.05 73.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.799 -0.637 . . . . 73.530000000000001 111.625 -177.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.795 ' HG3' HD13 ' A' ' 12' ' ' ILE . 14.0 mptt -64.75 -35.04 79.8 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 111.94 0.348 . . . . 73.129999999999995 111.94 -173.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.734 ' HG2' ' HE2' ' A' ' 138' ' ' MET . 16.7 mmt180 -66.32 -31.64 72.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.606 0.241 . . . . 73.340000000000003 111.308 177.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -79.67 -35.76 38.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.942 0.401 . . . . 75.150000000000006 110.443 176.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -59.06 -44.06 91.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.851 -0.613 . . . . 73.519999999999996 111.529 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.498 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 7.9 pt-20 -72.82 -14.71 61.57 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.556 -0.458 . . . . 72.519999999999996 111.266 -178.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.88 -25.65 59.11 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.333 -0.618 . . . . 63.520000000000003 109.333 177.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.569 0 CA-C-N 115.668 -0.696 . . . . 52.43 112.439 176.704 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.598 HG22 ' HA ' ' A' ' 109' ' ' THR . 41.0 t . . . . . 0 N--CA 1.446 -0.674 0 N-CA-C 108.556 -0.905 . . . . 53.439999999999998 108.556 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 107' ' ' ARG . 10.6 p -80.11 141.63 15.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.516 -0.766 . . . . 72.299999999999997 111.82 -168.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.575 ' HG2' ' HB2' ' A' ' 107' ' ' ARG . 2.8 tmm_? -134.74 116.61 15.07 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.368 -0.605 . . . . 74.140000000000001 109.368 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.506 ' HB3' HD23 ' A' ' 137' ' ' LEU . 4.8 t70 -144.71 173.05 12.17 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.709 -0.848 . . . . 72.349999999999994 108.709 173.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.766 ' HB2' HG13 ' A' ' 105' ' ' VAL . . . -134.47 126.59 29.75 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.133 0.492 . . . . 73.450000000000003 112.012 -171.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.481 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 36.0 m -121.66 134.23 65.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.793 -0.639 . . . . 64.540000000000006 109.956 176.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 t -110.08 123.38 49.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.688 0.756 . . . . 73.209999999999994 111.011 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.591 ' HB ' HD23 ' A' ' 19' ' ' LEU . 4.7 mp -118.71 151.04 20.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.768 -1.105 . . . . 70.230000000000004 109.712 -178.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.85 20.63 1.05 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 114.005 0.362 . . . . 52.409999999999997 114.005 -177.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.758 ' HE3' HD21 ' A' ' 19' ' ' LEU . 49.3 mtmt -89.95 144.07 30.93 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.197 -0.668 . . . . 72.120000000000005 109.197 173.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.45 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 95.0 Cg_exo -45.69 -57.96 1.89 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.977 2.451 . . . . 63.219999999999999 113.822 -174.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 15' ' ' PRO . . . 173.21 -58.24 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.578 0.704 . . . . 53.210000000000001 110.911 177.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -55.83 -36.75 67.82 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.456 -1.247 . . . . 70.319999999999993 112.247 -171.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.542 ' CG ' ' HD2' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -87.65 -5.33 58.76 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.132 -0.485 . . . . 60.549999999999997 111.853 -175.06 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.758 HD21 ' HE3' ' A' ' 14' ' ' LYS . 59.9 mt -68.56 -48.13 65.05 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.963 -0.295 . . . . 70.140000000000001 111.081 176.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.816 ' HB3' ' HZ ' ' A' ' 93' ' ' PHE . 1.1 p90 -73.15 -24.55 60.59 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.469 -0.493 . . . . 72.409999999999997 110.372 -177.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.56 -2.99 31.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.575 -0.738 . . . . 70.329999999999998 111.862 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.779 HG12 ' HZ ' ' A' ' 140' ' ' PHE . 14.8 p -54.2 -22.05 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 112.843 0.683 . . . . 64.219999999999999 112.843 -175.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 -68.48 -9.82 51.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.881 0.372 . . . . 75.209999999999994 111.11 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.821 ' HD3' ' HG3' ' A' ' 27' ' ' PRO . 47.1 ttt180 -137.04 179.27 6.48 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.61 -0.515 . . . . 73.129999999999995 109.61 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.801 ' H ' ' HG2' ' A' ' 24' ' ' ARG . 0.8 OUTLIER -63.39 12.58 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.072 1.349 . . . . 74.200000000000003 112.873 177.511 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.488 ' H ' ' C ' ' A' ' 24' ' ' ARG . 41.2 mt 65.43 86.09 0.14 Allowed Pre-proline 0 N--CA 1.467 0.38 0 CA-C-O 121.184 0.516 . . . . 60.299999999999997 109.628 -176.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.821 ' HG3' ' HD3' ' A' ' 24' ' ' ARG . 33.2 Cg_exo . . . . . 0 C--N 1.342 0.234 0 C-N-CA 123.71 2.94 . . . . 75.439999999999998 114.031 -169.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 109.881 -0.415 . . . . 73.099999999999994 109.881 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.22 135.73 51.32 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.736 0.303 . . . . 74.329999999999998 110.571 179.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.452 ' HG ' ' HA ' ' A' ' 77' ' ' TRP . 10.5 mp -104.63 127.28 52.33 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 120.253 -0.579 . . . . 72.030000000000001 109.597 174.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.3 t -95.46 -13.84 24.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.114 -0.494 . . . . 74.510000000000005 111.801 -172.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.557 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -123.32 128.04 49.36 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.944 -0.302 . . . . 75.319999999999993 110.782 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -137.91 84.83 2.06 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.895 -0.593 . . . . 73.540000000000006 110.443 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.506 ' HG3' ' HG2' ' A' ' 74' ' ' ARG . 6.6 mm-40 -107.18 141.68 23.44 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.361 -0.977 . . . . 75.010000000000005 108.361 173.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.46 93.82 0.59 Allowed 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.548 2.166 . . . . 72.120000000000005 112.376 -175.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 56.77 38.92 85.9 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.802 -0.635 . . . . 45.109999999999999 112.799 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -127.87 -46.37 1.41 Allowed 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.884 -0.326 . . . . 63.329999999999998 110.917 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.506 ' HG2' ' HG3' ' A' ' 70' ' ' GLU . 16.4 ptt-85 -159.91 147.64 16.8 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.48 -0.563 . . . . 75.430000000000007 109.48 173.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.658 HD13 ' HE2' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -147.34 120.54 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.411 0.624 . . . . 75.510000000000005 111.594 -179.498 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.693 ' HB1' ' HG3' ' A' ' 90' ' ' GLU . . . -120.21 120.13 35.26 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.918 -1.037 . . . . 62.009999999999998 109.942 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.452 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 49.5 p90 -99.35 144.33 28.59 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.027 -0.533 . . . . 75.25 110.282 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -136.25 175.85 9.23 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.641 -0.874 . . . . 71.409999999999997 108.641 176.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.0 m -133.02 152.1 52.0 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.603 -0.517 . . . . 52.100000000000001 109.603 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.9 mt -67.94 156.82 88.62 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.239 -0.437 . . . . 74.349999999999994 110.251 -178.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -56.82 -21.7 41.58 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.862 2.375 . . . . 61.229999999999997 113.337 -177.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.53 10.98 66.96 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.809 -0.71 . . . . 64.540000000000006 112.679 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.431 ' HB3' HG12 ' A' ' 85' ' ' ILE . . . -137.19 142.3 42.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.904 0.383 . . . . 37.609999999999999 111.105 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -118.96 41.81 2.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.584 0.707 . . . . 74.150000000000006 109.719 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.431 HG12 ' HB3' ' A' ' 83' ' ' ALA . 46.2 mm -77.75 118.26 24.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.131 -0.94 . . . . 74.530000000000001 111.525 -175.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 69.91 154.5 0.12 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.975 0.797 . . . . 75.409999999999997 112.34 171.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -72.35 135.91 46.01 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.88 -0.785 . . . . 70.310000000000002 108.88 174.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 26.2 m -94.95 145.02 25.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.291 0.567 . . . . 54.530000000000001 111.233 -174.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -174.62 -166.26 32.3 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.107 -0.952 . . . . 74.239999999999995 111.671 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.693 ' HG3' ' HB1' ' A' ' 76' ' ' ALA . 43.0 tt0 -145.44 136.81 25.04 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.292 -0.262 . . . . 73.310000000000002 110.292 -178.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.542 ' CG2' HG13 ' A' ' 75' ' ' ILE . 3.0 m -120.23 134.17 64.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 120.901 0.381 . . . . 73.409999999999997 110.714 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.469 ' HB2' ' CG2' ' A' ' 105' ' ' VAL . 9.7 mp -113.76 137.42 51.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.293 -0.412 . . . . 75.219999999999999 110.231 175.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.816 ' HZ ' ' HB3' ' A' ' 20' ' ' TYR . 76.7 m-85 -105.05 106.9 17.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.986 -0.552 . . . . 70.120000000000005 110.1 177.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -117.15 145.36 35.63 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.137 -0.483 . . . . 73.409999999999997 111.041 -176.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.69 135.98 59.7 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.585 2.19 . . . . 75.109999999999999 111.749 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.449 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . . . -105.03 143.38 26.6 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.627 -0.261 . . . . 61.439999999999998 111.011 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 96' ' ' ALA . 26.7 Cg_exo -64.06 150.24 88.76 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 123.306 2.671 . . . . 75.219999999999999 112.477 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.84 10.74 86.02 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.081 -0.581 . . . . 70.530000000000001 112.117 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 57.4 35.27 25.77 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 122.889 0.475 . . . . 70.049999999999997 111.449 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -58.66 -38.4 78.06 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.092 0.472 . . . . 64.510000000000005 110.736 176.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 149.38 -119.9 1.1 Allowed Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.812 -0.915 . . . . 61.539999999999999 110.812 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 92.4 m -129.0 127.93 42.64 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.989 0.423 . . . . 74.439999999999998 110.386 175.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -84.12 114.48 21.8 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.602 -0.726 . . . . 74.019999999999996 110.235 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.1 p -99.05 115.73 40.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.164 0.507 . . . . 70.319999999999993 110.661 177.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.766 HG13 ' HB2' ' A' ' 9' ' ' ALA . 21.7 m -86.81 110.68 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-O 121.444 0.64 . . . . 74.349999999999994 109.382 174.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 46.5 t -100.61 125.18 54.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.626 -0.715 . . . . 73.340000000000003 110.343 -176.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.575 ' HB2' ' HG2' ' A' ' 7' ' ' ARG . 26.9 ttt180 -137.03 113.08 9.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.235 -0.438 . . . . 74.109999999999999 111.201 174.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.0 mp -116.01 140.93 48.77 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.706 -0.679 . . . . 73.329999999999998 109.885 175.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.598 ' HA ' HG22 ' A' ' 5' ' ' VAL . 86.7 m -84.25 120.09 25.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.163 -0.471 . . . . 73.030000000000001 110.237 178.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.009 -0.541 . . . . 75.329999999999998 109.662 -178.099 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.45 0 N-CA-C 111.777 -0.529 . . . . 61.530000000000001 111.777 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.1 m -59.64 -40.06 86.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.846 0.355 . . . . 65.329999999999998 111.327 -176.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.514 ' O ' HG12 ' A' ' 121' ' ' ILE . . . -72.92 -24.82 60.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.316 -0.402 . . . . 74.209999999999994 111.506 -178.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.14 -28.72 73.82 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.921 -0.657 . . . . 71.150000000000006 112.637 -177.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.41 -43.27 81.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.357 . . . . 63.119999999999997 111.478 -178.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.431 HG12 ' O ' ' A' ' 117' ' ' ALA . 9.1 p -73.47 -20.49 18.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.834 0.35 . . . . 71.239999999999995 111.032 -176.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.514 HG12 ' O ' ' A' ' 117' ' ' ALA . 49.6 mm -63.39 -56.87 14.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.647 -0.251 . . . . 75.150000000000006 110.652 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.48 -31.07 72.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.153 0.502 . . . . 74.549999999999997 110.605 178.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -66.96 -31.04 71.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.415 -0.812 . . . . 73.230000000000004 110.689 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 17.9 tpt . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 115.816 -0.629 . . . . 75.549999999999997 110.921 -179.851 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 134' ' ' ARG . 8.6 mtp180 . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.728 0.299 . . . . 63.030000000000001 110.742 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 17.3 t70 -57.22 -38.8 74.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.92 -0.582 . . . . 74.409999999999997 110.082 177.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -62.48 -43.54 98.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.483 -0.781 . . . . 53.310000000000002 111.049 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.506 HD23 ' HB3' ' A' ' 8' ' ' ASP . 22.2 tp -75.3 -27.02 59.15 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.661 -0.496 . . . . 73.420000000000002 109.661 -178.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.656 ' HA ' ' HE2' ' A' ' 138' ' ' MET . 0.0 OUTLIER -64.41 -47.08 80.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.862 -0.608 . . . . 74.230000000000004 109.829 175.916 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 135' ' ' ASP . 81.6 mtp180 -61.91 -40.82 96.79 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.611 -0.722 . . . . 75.239999999999995 109.683 175.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.779 ' HZ ' HG12 ' A' ' 22' ' ' VAL . 89.8 t80 -56.55 -40.86 75.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.204 -0.907 . . . . 74.109999999999999 111.232 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.568 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 24.2 ttpp -65.23 -52.22 55.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.345 -0.389 . . . . 74.450000000000003 110.06 176.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -53.62 -44.94 69.91 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.458 -0.792 . . . . 75.209999999999994 111.321 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -62.81 -39.4 94.15 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.641 -0.254 . . . . 74.209999999999994 111.571 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.559 ' HB2' HG12 ' A' ' 12' ' ' ILE . 30.6 mt-30 -70.19 -47.27 62.25 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.958 -0.297 . . . . 74.409999999999997 111.504 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.568 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 11.0 pt-20 -76.45 -13.81 60.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.033 0.444 . . . . 61.439999999999998 111.231 -176.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -83.25 -43.51 15.99 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.791 -0.818 . . . . 53.109999999999999 108.791 172.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.488 0 CA-C-N 115.604 -0.726 . . . . 71.239999999999995 112.898 -179.065 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.434 ' H1 ' ' CD ' ' A' ' 3' ' ' GLU . 90.5 mmm . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 120.677 0.275 . . . . 74.239999999999995 111.232 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -140.05 36.29 1.83 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.838 -0.696 . . . . 72.400000000000006 111.767 -176.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.434 ' CD ' ' H1 ' ' A' ' 1' ' ' MET . 7.4 mp0 -67.61 111.84 4.41 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.46 -0.57 . . . . 73.310000000000002 109.46 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.9 m -113.34 134.48 54.6 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.986 -0.552 . . . . 75.109999999999999 110.728 -173.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.686 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 4.4 p -93.48 98.82 8.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.929 0.871 . . . . 73.430000000000007 109.828 175.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.3 t -92.05 134.35 30.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.336 -0.847 . . . . 43.399999999999999 110.544 -176.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.64 ' HD2' ' O ' ' A' ' 7' ' ' ARG . 7.4 ppt_? -115.65 112.1 21.61 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.277 0.56 . . . . 74.310000000000002 110.261 175.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.436 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 31.3 t0 -157.48 172.52 18.42 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.002 -0.74 . . . . 65.25 109.002 177.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.615 ' HB3' HG13 ' A' ' 105' ' ' VAL . . . -138.39 132.27 31.18 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.733 0.301 . . . . 75.129999999999995 111.359 -176.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.459 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 23.8 m -110.76 145.95 16.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.194 -0.457 . . . . 70.140000000000001 110.581 178.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 97.4 m -109.71 118.78 37.45 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.053 -0.521 . . . . 72.230000000000004 111.031 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.744 HG23 ' HG3' ' A' ' 144' ' ' GLN . 5.0 mp -127.04 150.16 32.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.829 -0.623 . . . . 74.409999999999997 109.37 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.33 54.2 3.57 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.775 -0.726 . . . . 72.430000000000007 113.106 -178.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.546 ' HD3' ' HB2' ' A' ' 18' ' ' GLN . 50.9 mttp -131.67 144.4 53.15 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 108.849 -0.797 . . . . 71.109999999999999 108.849 174.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.59 -56.9 2.08 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.759 2.306 . . . . 62.520000000000003 113.803 -171.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.445 ' HA ' HD11 ' A' ' 19' ' ' LEU . . . 174.01 -47.48 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.649 0.738 . . . . 75.299999999999997 109.175 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -48.76 -47.15 41.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.081 -1.418 . . . . 72.140000000000001 111.952 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.546 ' HB2' ' HD3' ' A' ' 14' ' ' LYS . 67.5 mt-30 -83.39 -10.93 58.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.874 0.369 . . . . 73.299999999999997 111.119 -174.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.445 HD11 ' HA ' ' A' ' 16' ' ' ALA . 95.4 mt -77.57 -48.49 16.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.52 -0.309 . . . . 71.349999999999994 110.543 -178.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.666 ' HB3' ' HZ ' ' A' ' 93' ' ' PHE . 16.8 p90 -73.67 -23.85 59.89 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.107 -0.637 . . . . 71.450000000000003 109.483 175.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.483 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . . . -73.18 -1.79 19.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.212 -0.904 . . . . 72.120000000000005 111.791 177.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.605 HG11 ' HZ ' ' A' ' 140' ' ' PHE . 12.1 p -54.06 -22.89 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 122.666 0.386 . . . . 73.019999999999996 111.681 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -75.17 -8.22 55.99 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.092 0.472 . . . . 74.129999999999995 110.955 178.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.493 ' HA ' ' HE ' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -115.83 -174.5 2.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.676 -0.693 . . . . 71.120000000000005 110.032 178.568 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.13 33.9 1.31 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.698 -0.683 . . . . 62.409999999999997 109.225 177.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.433 HD21 ' HB3' ' A' ' 18' ' ' GLN . 75.7 mt 55.26 85.25 0.19 Allowed Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 115.208 -0.905 . . . . 63.32 110.375 -173.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -82.52 167.51 15.11 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.11 2.54 . . . . 70.450000000000003 113.508 -173.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -143.71 69.96 0.41 Allowed Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.777 -0.647 . . . . 70.340000000000003 112.346 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.55 77.69 55.1 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 121.237 0.542 . . . . 71.319999999999993 111.391 177.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.431 ' HD2' HD12 ' A' ' 31' ' ' LEU . 5.7 Cg_exo -74.86 3.54 5.45 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.934 2.422 . . . . 74.010000000000005 111.919 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.431 HD12 ' HD2' ' A' ' 30' ' ' PRO . 4.8 mp -80.06 -31.36 39.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.534 -0.757 . . . . 75.329999999999998 110.034 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.554 HD12 ' HB ' ' A' ' 39' ' ' VAL . 3.3 mm? -99.02 73.02 1.92 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.282 0.563 . . . . 70.109999999999999 110.302 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 26.8 ptm -146.18 160.07 42.46 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.459 -0.941 . . . . 65.430000000000007 108.459 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.835 HG21 ' H ' ' A' ' 35' ' ' HIS . 4.3 m 64.53 -163.45 0.26 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.384 -0.969 . . . . 72.129999999999995 108.384 -176.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.835 ' H ' HG21 ' A' ' 34' ' ' THR . 50.6 m170 -86.12 -179.11 6.68 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 121.932 -0.48 . . . . 75.109999999999999 110.217 175.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.528 ' O ' ' HG ' ' A' ' 36' ' ' LEU . 54.7 tp 74.35 28.24 1.37 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.686 0.755 . . . . 71.310000000000002 110.509 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.6 mtm-85 -95.91 120.31 35.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.008 -0.542 . . . . 72.430000000000007 109.841 176.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.541 ' O ' HG13 ' A' ' 51' ' ' VAL . 50.0 m -92.95 -39.62 11.03 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.48 -0.563 . . . . 55.329999999999998 109.48 173.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.554 ' HB ' HD12 ' A' ' 32' ' ' LEU . 23.4 t -83.42 84.56 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.894 -0.594 . . . . 75.200000000000003 111.299 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -82.12 48.27 1.23 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.247 0.546 . . . . 74.140000000000001 110.036 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 98.8 t -116.19 121.06 66.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.204 0.526 . . . . 74.439999999999998 110.586 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.703 HD12 ' HB3' ' A' ' 44' ' ' ASP . 0.9 OUTLIER -126.3 -38.37 2.14 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.463 -0.79 . . . . 72.450000000000003 110.821 -178.494 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.5 t70 75.19 -11.86 1.03 Allowed 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.606 -0.725 . . . . 74.219999999999999 111.255 174.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.703 ' HB3' HD12 ' A' ' 42' ' ' LEU . 6.1 t70 -44.24 -64.53 0.66 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.713 -1.13 . . . . 74.400000000000006 112.478 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.534 ' O ' ' HB2' ' A' ' 46' ' ' ARG . 1.1 tppm? -109.25 29.3 7.66 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.534 -0.543 . . . . 72.510000000000005 109.534 -177.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.534 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 0.7 OUTLIER 75.81 170.87 0.26 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 113.821 -1.536 . . . . 74.519999999999996 109.33 -162.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.3 m -165.12 -39.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.447 0.166 . . . . 74.340000000000003 111.447 -173.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.412 ' HG3' HG22 ' A' ' 60' ' ' VAL . 30.8 mmt180 64.26 99.83 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.823 -0.806 . . . . 64.319999999999993 108.823 -168.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 29.3 p90 -78.29 72.72 4.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.877 0.846 . . . . 75.310000000000002 111.737 -172.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.442 HG21 ' H ' ' A' ' 51' ' ' VAL . 1.7 t -92.06 -55.4 3.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.433 -0.803 . . . . 75.310000000000002 110.889 176.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 38' ' ' SER . 93.0 t 72.69 -42.71 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 123.152 0.581 . . . . 64.219999999999999 112.014 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.408 ' H ' ' C ' ' A' ' 50' ' ' THR . 28.4 mt-10 -82.62 -35.05 27.35 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.275 0.472 . . . . 64.310000000000002 112.275 -173.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.88 143.78 86.97 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 111.986 0.365 . . . . 72.349999999999994 111.986 -173.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.22 129.72 16.48 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.682 2.255 . . . . 54.32 111.572 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 69.19 144.55 0.1 Allowed Pre-proline 0 N--CA 1.462 0.174 0 O-C-N 123.848 0.717 . . . . 75.010000000000005 110.729 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.478 ' HG2' HD13 ' A' ' 57' ' ' LEU . 36.0 Cg_endo -65.2 -18.54 61.39 Favored 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.232 1.955 . . . . 72.140000000000001 112.902 -177.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.68 HD13 HD21 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -132.51 4.34 3.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.197 0.522 . . . . 65.030000000000001 112.298 -175.409 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -87.37 43.81 3.23 Favored Glycine 0 C--N 1.316 -0.553 0 C-N-CA 120.487 -0.863 . . . . 62.119999999999997 113.193 -176.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -166.74 -52.91 0.03 OUTLIER 'General case' 0 C--O 1.233 0.209 0 N-CA-C 113.086 0.773 . . . . 73.120000000000005 113.086 -177.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.464 HG23 ' OE1' ' A' ' 63' ' ' GLU . 5.3 m -89.9 -0.51 8.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 113.519 0.933 . . . . 74.150000000000006 113.519 -167.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.1 m 75.21 -47.28 0.6 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.47 0.708 . . . . 72.150000000000006 112.706 172.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 26.1 m95 -129.65 121.69 27.51 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.09 -0.708 . . . . 64.349999999999994 109.09 173.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.602 ' HG3' ' HA ' ' A' ' 57' ' ' LEU . 0.8 OUTLIER -152.57 166.14 32.98 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.457 -0.792 . . . . 72.230000000000004 109.732 -175.185 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -130.67 139.2 50.32 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.883 -0.727 . . . . 73.239999999999995 112.493 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.476 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 19.6 tt0 -129.37 160.51 32.83 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.74 -1.118 . . . . 72.099999999999994 109.162 176.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.574 ' CD1' ' HA ' ' A' ' 77' ' ' TRP . 4.1 mm? -108.92 116.49 32.1 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.832 -0.803 . . . . 72.019999999999996 108.832 170.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.6 t -78.04 -16.65 57.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.06 -0.518 . . . . 75.209999999999994 112.174 -168.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.6 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -143.32 130.05 20.34 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 121.012 -0.275 . . . . 74.200000000000003 110.464 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.543 ' HA ' HG13 ' A' ' 75' ' ' ILE . 18.7 t70 -145.03 113.36 6.59 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.117 -0.492 . . . . 74.140000000000001 110.127 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -130.33 144.92 55.22 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.625 -0.509 . . . . 71.219999999999999 109.625 176.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -52.67 -34.14 62.53 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.175 2.584 . . . . 73.319999999999993 113.009 -177.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -168.74 55.67 0.21 Allowed Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.868 -0.682 . . . . 45.140000000000001 111.994 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -127.87 -77.39 0.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.201 -0.296 . . . . 74.109999999999999 110.201 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 18.1 ptp180 -157.43 138.91 13.84 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.14 -0.482 . . . . 75.049999999999997 110.123 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.716 HD12 ' HE2' ' A' ' 93' ' ' PHE . 3.1 mp -129.57 122.06 54.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.196 -0.456 . . . . 73.420000000000002 109.966 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.6 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -111.34 130.41 55.69 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.939 -0.393 . . . . 65.299999999999997 109.939 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.574 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 4.6 p90 -85.31 153.65 22.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.568 0.699 . . . . 74.340000000000003 111.759 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.828 ' HG3' ' H ' ' A' ' 80' ' ' LEU . 4.1 tpp180 -144.32 172.82 12.4 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.707 -1.133 . . . . 65.120000000000005 108.686 -174.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.656 ' N ' ' HG3' ' A' ' 78' ' ' ARG . 59.0 m -145.64 24.84 1.36 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.755 -0.461 . . . . 51.409999999999997 109.755 174.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.828 ' H ' ' HG3' ' A' ' 78' ' ' ARG . 73.3 mt 63.96 149.64 0.11 Allowed Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 115.268 -0.878 . . . . 71.140000000000001 112.738 174.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -64.5 -8.22 16.54 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 122.345 2.03 . . . . 73.209999999999994 112.492 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -76.38 -57.22 4.0 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.854 -0.688 . . . . 73.120000000000005 111.865 175.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.75 -26.59 29.55 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.595 0.22 . . . . 71.129999999999995 111.595 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 63.31 103.92 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.361 0.664 . . . . 74.329999999999998 111.149 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.52 ' HB ' ' HB2' ' A' ' 79' ' ' SER . 17.1 tt -70.08 129.23 34.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.402 0.62 . . . . 72.129999999999995 111.184 -178.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -82.09 -29.17 31.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.476 -0.784 . . . . 73.230000000000004 110.015 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -88.73 168.27 12.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.593 -0.73 . . . . 74.150000000000006 110.562 -175.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.6 m -155.24 135.35 13.03 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.299 -0.26 . . . . 73.230000000000004 110.299 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.34 127.81 0.97 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.605 -0.807 . . . . 71.430000000000007 112.599 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -115.37 118.52 33.46 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.612 -0.514 . . . . 71.340000000000003 109.612 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.634 HG11 HG13 ' A' ' 106' ' ' VAL . 3.8 m -87.15 130.38 37.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.873 0.368 . . . . 72.140000000000001 110.522 -177.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.638 ' HB2' HG22 ' A' ' 105' ' ' VAL . 9.5 mp -110.52 147.38 34.27 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.008 -0.367 . . . . 73.120000000000005 110.008 176.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.716 ' HE2' HD12 ' A' ' 75' ' ' ILE . 79.8 m-85 -117.61 132.01 56.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.831 0.348 . . . . 70.239999999999995 111.268 -177.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -141.86 145.15 35.38 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.94 -0.573 . . . . 74.530000000000001 109.902 173.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -58.01 127.62 25.73 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.474 2.116 . . . . 72.510000000000005 111.559 176.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.47 144.14 86.13 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.283 -0.417 . . . . 63.149999999999999 111.7 -174.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -58.45 138.39 85.54 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.911 2.408 . . . . 60.109999999999999 111.999 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.08 12.71 84.39 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.899 -0.667 . . . . 72.5 111.769 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 58.62 37.01 25.37 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 121.059 0.457 . . . . 73.530000000000001 111.051 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -78.95 1.14 24.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 62.43 111.411 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 129.7 -138.48 10.26 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.281 -0.728 . . . . 70.230000000000004 111.281 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 47.4 m -121.92 132.81 54.75 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.951 0.405 . . . . 74.400000000000006 110.23 176.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.484 ' HG2' ' HB1' ' A' ' 9' ' ' ALA . 42.5 tt0 -100.85 117.54 35.12 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.827 -0.624 . . . . 75.319999999999993 110.023 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.561 HG22 HG12 ' A' ' 106' ' ' VAL . 2.7 p -93.88 106.91 18.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.315 0.578 . . . . 73.150000000000006 110.757 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.638 HG22 ' HB2' ' A' ' 92' ' ' LEU . 10.8 m -88.23 114.24 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.759 -0.655 . . . . 72.299999999999997 110.343 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.634 HG13 HG11 ' A' ' 91' ' ' VAL . 27.2 m -124.15 134.97 65.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.404 0.621 . . . . 72.109999999999999 111.884 -175.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.487 ' HG3' ' HB3' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -118.32 97.89 6.0 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.821 -1.177 . . . . 72.450000000000003 107.821 170.089 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.436 ' H ' HD21 ' A' ' 108' ' ' LEU . 2.7 pt? -132.41 144.91 50.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.033 0.444 . . . . 64.25 110.792 -173.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.686 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 8.3 t -97.99 138.54 35.16 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.84 -0.618 . . . . 75.129999999999995 109.336 174.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -160.52 176.12 11.96 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.491 -0.322 . . . . 74.129999999999995 110.434 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -95.56 141.57 23.37 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 109.334 -0.617 . . . . 74.439999999999998 109.334 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 90.6 Cg_endo -88.41 153.94 6.58 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.492 2.128 . . . . 72.040000000000006 113.155 -174.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 15.6 Cg_exo -69.06 134.83 30.47 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.781 2.32 . . . . 75.319999999999993 111.447 175.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.25 -35.25 63.89 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.11 -0.567 . . . . 64.450000000000003 112.774 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -101.14 100.02 2.04 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.575 -0.821 . . . . 64.230000000000004 112.611 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.5 m -73.41 -22.31 60.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.923 0.392 . . . . 65.329999999999998 111.185 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.452 ' HA ' HG22 ' A' ' 120' ' ' VAL . . . -61.76 -22.79 65.71 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.219 -0.446 . . . . 75.120000000000005 111.571 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.87 -21.52 65.54 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.106 -0.569 . . . . 61.350000000000001 112.513 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -86.49 -44.68 11.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.928 0.394 . . . . 75.0 111.483 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.452 HG22 ' HA ' ' A' ' 117' ' ' ALA . 27.6 m -67.7 -17.61 22.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.297 0.48 . . . . 74.150000000000006 112.297 -172.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.513 ' O ' HD13 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -61.9 -28.61 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 120.978 0.418 . . . . 74.319999999999993 110.35 178.257 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 126' ' ' ASN . . . -69.74 -18.59 63.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.329 -0.396 . . . . 73.239999999999995 111.678 -177.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 57.7 ttp85 -65.88 -16.0 63.44 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.624 0.249 . . . . 73.340000000000003 111.311 -176.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.8 ttm -55.32 -43.19 74.69 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.961 0.41 . . . . 75.109999999999999 109.988 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -166.96 90.05 0.37 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.643 -0.873 . . . . 72.439999999999998 108.643 175.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 122' ' ' ALA . 28.9 p-10 -104.61 -30.79 9.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.997 -0.547 . . . . 64.049999999999997 111.138 -175.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 61.67 21.93 12.54 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.579 0.704 . . . . 65.450000000000003 110.226 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -124.1 86.88 53.82 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.66 -0.7 . . . . 74.409999999999997 110.727 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -76.62 74.98 4.59 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.284 1.99 . . . . 71.0 111.66 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.2 t -120.18 34.65 5.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.937 0.398 . . . . 72.129999999999995 110.853 -174.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 71.08 171.8 0.32 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.496 -0.775 . . . . 72.549999999999997 112.34 175.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -95.51 24.4 5.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.363 -0.835 . . . . 72.129999999999995 111.093 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.692 ' O ' ' HG2' ' A' ' 134' ' ' ARG . 3.1 mm? -116.09 177.21 4.77 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.966 -0.561 . . . . 74.439999999999998 109.664 178.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.692 ' HG2' ' O ' ' A' ' 133' ' ' LEU . 2.4 ptm180 48.58 32.6 3.54 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 124.074 0.859 . . . . 75.439999999999998 112.516 172.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -49.12 -52.08 28.22 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.258 0.623 . . . . 74.319999999999993 111.954 -173.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' A' ' 139' ' ' ARG . 33.8 t70 -61.99 -39.01 90.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.569 -0.741 . . . . 74.25 112.192 -174.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.459 ' HG ' ' CG1' ' A' ' 10' ' ' VAL . 14.3 tp -80.34 -20.28 44.56 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.857 0.36 . . . . 70.530000000000001 110.899 -176.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.855 ' HA ' ' HE1' ' A' ' 138' ' ' MET . 22.4 mmt -65.78 -41.73 91.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.775 0.287 . . . . 61.119999999999997 111.775 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.452 ' HG2' ' O ' ' A' ' 136' ' ' ASP . 15.9 ptt180 -62.67 -31.21 72.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.832 0.349 . . . . 63.450000000000003 110.359 178.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.605 ' HZ ' HG11 ' A' ' 22' ' ' VAL . 92.2 t80 -64.58 -45.87 85.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.897 -0.592 . . . . 71.549999999999997 110.311 178.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.439 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 23.3 ttpp -57.1 -47.65 80.54 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.15 -0.477 . . . . 63.299999999999997 110.036 176.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 28.4 ttp180 -53.82 -45.77 70.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.052 -0.976 . . . . 71.219999999999999 111.816 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -77.79 -28.45 50.45 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.233 -0.439 . . . . 75.049999999999997 111.514 -175.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.744 ' HG3' HG23 ' A' ' 12' ' ' ILE . 4.9 tp-100 -71.31 -44.66 64.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.621 0.248 . . . . 73.319999999999993 110.502 175.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 11.1 pt-20 -71.64 -23.3 61.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.848 0.356 . . . . 72.409999999999997 110.764 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.8 -47.79 20.52 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.557 -0.534 . . . . 73.510000000000005 109.557 178.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -66.18 123.5 23.65 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.776 -0.647 . . . . 52.130000000000003 112.606 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.406 HD21 ' N ' ' A' ' 149' ' ' GLU . 1.6 tt -152.67 132.73 13.42 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.325 -0.62 . . . . 75.319999999999993 109.325 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.494 ' CD ' ' H ' ' A' ' 150' ' ' HIS . 0.3 OUTLIER -138.99 171.76 13.85 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.814 -0.809 . . . . 73.120000000000005 108.814 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.494 ' H ' ' CD ' ' A' ' 149' ' ' GLU . 78.5 m80 -58.58 142.02 50.48 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.548 -0.538 . . . . 74.040000000000006 109.548 174.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -66.5 -23.01 66.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.789 0.328 . . . . 71.230000000000004 111.286 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -81.2 -18.16 47.12 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.447 -0.342 . . . . 65.109999999999999 110.171 175.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 65.6 t60 65.87 109.01 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.723 -0.671 . . . . 74.150000000000006 110.794 -175.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -116.72 116.37 27.4 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.171 -0.468 . . . . 73.420000000000002 109.997 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 51.9 t60 . . . . . 0 C--O 1.247 0.924 0 CA-C-O 118.429 -0.796 . . . . 71.230000000000004 110.036 -178.281 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.796 0.331 . . . . 73.430000000000007 110.949 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.52 -88.23 0.92 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.678 -0.772 . . . . 73.310000000000002 112.353 177.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 42.51 41.48 2.33 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.726 0.81 . . . . 75.450000000000003 111.574 -178.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.0 m -95.64 136.17 36.38 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.72 -0.673 . . . . 72.129999999999995 110.171 -177.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.599 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 11.1 p -126.19 137.21 58.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.307 -0.406 . . . . 74.200000000000003 110.378 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.0 t -95.75 116.44 37.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.294 -0.632 . . . . 75.140000000000001 109.294 174.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 59.9 ttt180 -125.77 108.38 11.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.08 0.467 . . . . 72.340000000000003 110.078 174.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.46 ' HA ' HD22 ' A' ' 133' ' ' LEU . 11.6 m-20 -143.73 159.14 43.03 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.13 -1.063 . . . . 75.409999999999997 108.13 176.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.768 ' H ' HD13 ' A' ' 133' ' ' LEU . . . -141.18 121.13 13.62 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.931 0.396 . . . . 75.030000000000001 110.642 -174.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.649 ' HB ' ' HB2' ' A' ' 141' ' ' LYS . 10.5 m -108.32 136.58 43.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.442 0.639 . . . . 72.030000000000001 111.714 -176.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.14 109.92 22.19 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.227 -0.897 . . . . 65.349999999999994 111.239 -177.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.867 HG21 ' HG3' ' A' ' 145' ' ' GLU . 4.8 mp -125.26 149.4 29.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.789 -0.819 . . . . 72.140000000000001 108.789 176.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.88 57.51 2.65 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 121.114 -0.565 . . . . 55.32 113.226 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.625 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 10.9 mmpt? -118.15 154.52 51.75 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 108.803 -0.814 . . . . 72.120000000000005 108.803 176.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -58.98 -57.66 0.9 Allowed 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.327 2.018 . . . . 72.439999999999998 113.026 -177.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 19' ' ' LEU . . . -178.26 -72.91 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.224 0.453 . . . . 61.439999999999998 112.224 178.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -66.36 -31.12 71.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.711 0.291 . . . . 74.230000000000004 111.174 -173.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -56.67 -32.28 65.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.424 -0.353 . . . . 74.019999999999996 110.552 175.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.561 ' HB2' ' O ' ' A' ' 16' ' ' ALA . 65.4 mt -62.89 -41.63 99.49 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.88 -0.6 . . . . 74.129999999999995 110.444 176.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.735 ' HB2' ' HZ ' ' A' ' 93' ' ' PHE . 77.9 t80 -73.07 -36.36 66.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.734 -0.666 . . . . 71.239999999999995 110.766 178.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.23 -3.61 30.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.683 -0.69 . . . . 75.209999999999994 112.188 -175.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.768 HG13 ' HZ ' ' A' ' 140' ' ' PHE . 9.0 p -53.69 -21.46 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 123.213 0.605 . . . . 74.329999999999998 112.242 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.8 t-105 -52.94 -37.25 60.74 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.445 0.64 . . . . 74.439999999999998 109.764 176.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.584 ' HD3' ' N ' ' A' ' 25' ' ' ASP . 4.0 tmt_? -109.59 159.76 16.83 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.866 -1.161 . . . . 72.239999999999995 107.866 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.584 ' N ' ' HD3' ' A' ' 24' ' ' ARG . 26.1 t70 -66.83 67.17 0.06 Allowed 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.497 0.554 . . . . 74.0 112.497 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.467 ' O ' ' HE1' ' A' ' 152' ' ' HIS . 3.6 mm? 41.86 79.3 0.33 Allowed Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 124.168 0.987 . . . . 72.540000000000006 112.78 169.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.569 ' HA ' ' NH1' ' A' ' 24' ' ' ARG . 31.6 Cg_exo -58.31 -57.8 0.97 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.445 2.097 . . . . 74.349999999999994 113.787 -172.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.16 -145.56 30.32 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.563 -0.827 . . . . 74.230000000000004 111.405 -172.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.508 ' N ' ' HD3' ' A' ' 30' ' ' PRO . 57.8 mt 44.32 53.7 11.18 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 113.424 0.898 . . . . 75.150000000000006 113.424 176.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.508 ' HD3' ' N ' ' A' ' 29' ' ' LEU . 2.9 Cg_endo -81.25 60.77 7.91 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 121.736 1.624 . . . . 64.430000000000007 111.125 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mp -150.72 -68.23 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.426 -0.806 . . . . 54.009999999999998 109.143 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 81.9 mt 64.51 -80.13 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 114.843 -1.072 . . . . 73.409999999999997 111.178 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.549 ' HG3' ' H ' ' A' ' 34' ' ' THR . 19.1 ptp -175.44 -60.84 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.044 -0.526 . . . . 74.420000000000002 110.217 -178.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.549 ' H ' ' HG3' ' A' ' 33' ' ' MET . 2.2 p -157.16 -68.94 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.501 0.667 . . . . 74.200000000000003 109.694 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -146.13 109.01 4.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.184 -0.917 . . . . 62.32 109.3 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 59.2 tp -154.8 105.41 2.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.437 -0.347 . . . . 72.530000000000001 110.705 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.609 ' HG3' HG22 ' A' ' 41' ' ' VAL . 23.8 ttp180 -116.69 87.78 2.76 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.029 0.442 . . . . 75.400000000000006 109.971 177.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.2 m -139.55 -2.77 1.55 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.13 -0.486 . . . . 73.420000000000002 111.442 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.557 HG13 ' H ' ' A' ' 40' ' ' GLU . 6.1 p -152.48 -61.49 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 121.029 -0.268 . . . . 74.219999999999999 111.375 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.557 ' H ' HG13 ' A' ' 39' ' ' VAL . 17.7 mm-40 -88.34 121.85 31.2 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.885 -0.413 . . . . 75.409999999999997 109.885 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.609 HG22 ' HG3' ' A' ' 37' ' ' ARG . 47.6 t -138.42 141.24 38.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 110.204 -0.295 . . . . 74.019999999999996 110.204 -178.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -75.07 -58.52 3.23 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.411 -0.588 . . . . 71.349999999999994 109.411 175.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.7 t70 73.7 -69.35 0.19 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.01 -0.995 . . . . 71.109999999999999 112.604 169.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -76.47 -33.43 58.69 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.247 0.546 . . . . 72.200000000000003 110.498 -176.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.439 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 14.5 mmmm -90.98 39.74 1.0 Allowed 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.913 -0.773 . . . . 63.240000000000002 108.913 172.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.472 HH11 ' HG3' ' A' ' 56' ' ' PRO . 2.8 ptp180 74.46 140.25 0.06 Allowed 'General case' 0 C--N 1.327 -0.375 0 O-C-N 125.352 1.657 . . . . 64.530000000000001 110.186 -172.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.8 m -64.91 -54.47 30.28 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.585 -0.734 . . . . 65.049999999999997 111.907 -172.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.484 ' HD3' ' OE2' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -149.33 144.73 26.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.773 0.32 . . . . 72.439999999999998 110.878 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.433 ' CG ' ' HD2' ' A' ' 46' ' ' ARG . 2.8 p-90 -152.71 143.98 23.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.159 -0.473 . . . . 71.430000000000007 111.084 -177.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 24.1 m 72.95 -63.04 0.45 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.579 -0.737 . . . . 73.120000000000005 112.776 173.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.0 m -66.28 89.85 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 121.298 0.571 . . . . 64.099999999999994 111.821 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 54.19 30.9 13.03 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.291 -0.868 . . . . 75.319999999999993 111.0 -174.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.449 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . . . -133.69 143.87 49.53 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.575 -0.739 . . . . 62.109999999999999 109.692 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 53' ' ' ALA . 6.9 Cg_exo -73.99 -164.64 0.22 Allowed 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 123.102 2.535 . . . . 40.229999999999997 112.435 -178.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.47 144.58 86.66 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.658 -0.701 . . . . 70.120000000000005 109.912 176.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.509 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 20.0 Cg_endo -59.7 -18.92 50.87 Favored 'Trans proline' 0 N--CA 1.474 0.37 0 C-N-CA 123.109 2.539 . . . . 75.239999999999995 113.265 -175.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.9 19.07 2.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.611 0.72 . . . . 74.540000000000006 110.565 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -136.15 115.09 1.26 Allowed Glycine 0 C--N 1.314 -0.64 0 CA-C-N 114.656 -1.157 . . . . 74.129999999999995 111.904 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 72.31 24.87 2.94 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.449 0.642 . . . . 71.230000000000004 110.302 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.9 p -136.81 162.5 34.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.305 -0.862 . . . . 71.430000000000007 109.18 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.7 m -67.96 -77.78 0.07 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.355 -0.239 . . . . 74.310000000000002 110.355 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 7.0 m-90 -146.34 143.19 28.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.813 0.34 . . . . 73.200000000000003 110.432 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.644 ' O ' ' HG ' ' A' ' 80' ' ' LEU . 6.5 mm-40 -132.85 166.0 23.31 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.782 -0.822 . . . . 75.340000000000003 108.782 168.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.44 114.07 24.69 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 120.002 -0.679 . . . . 70.010000000000005 109.381 172.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.483 ' HB2' HD21 ' A' ' 80' ' ' LEU . 1.2 mm-40 -107.92 134.23 51.13 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 109.587 -0.523 . . . . 65.019999999999996 109.587 176.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.73 HD12 ' HA ' ' A' ' 77' ' ' TRP . 3.6 mm? -88.21 137.91 31.91 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.581 -0.526 . . . . 63.439999999999998 109.581 -178.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.9 t -73.93 -9.18 58.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.497 0.665 . . . . 50.340000000000003 110.048 -177.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.91 123.35 10.36 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.973 -1.012 . . . . 74.209999999999994 108.725 166.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -139.09 83.64 1.96 Allowed 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.738 -0.838 . . . . 75.439999999999998 108.738 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 73' ' ' LYS . 48.5 mt-10 -115.86 143.86 31.58 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 114.879 -1.055 . . . . 71.239999999999995 109.581 -176.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.81 94.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.031 2.487 . . . . 50.32 113.029 -174.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 61.82 26.36 66.94 Favored Glycine 0 CA--C 1.518 0.277 0 CA-C-N 115.657 -0.701 . . . . 61.229999999999997 113.446 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.718 ' HE2' ' HA ' ' A' ' 73' ' ' LYS . 9.7 mmpt? -104.66 -72.56 0.7 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.18 0.514 . . . . 70.140000000000001 110.193 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -149.91 137.66 20.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.758 -0.655 . . . . 73.019999999999996 109.642 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 67.1 mt -122.18 110.3 26.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.768 -0.651 . . . . 74.349999999999994 109.394 177.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.66 ' HB3' ' HG3' ' A' ' 90' ' ' GLU . . . -104.23 127.44 51.86 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.847 -0.615 . . . . 72.439999999999998 109.574 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.73 ' HA ' HD12 ' A' ' 66' ' ' LEU . 59.2 t90 -79.93 143.71 33.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.702 0.763 . . . . 73.319999999999993 111.509 -169.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.555 ' HG3' ' H ' ' A' ' 79' ' ' SER . 0.0 OUTLIER -166.61 175.35 8.03 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.834 -1.076 . . . . 65.400000000000006 108.99 -175.296 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.555 ' H ' ' HG3' ' A' ' 78' ' ' ARG . 46.9 m -141.57 165.63 26.95 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.348 -0.982 . . . . 64.030000000000001 108.348 174.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 63' ' ' GLU . 53.0 mt -60.57 150.76 73.53 Favored Pre-proline 0 C--N 1.326 -0.445 0 O-C-N 123.11 0.256 . . . . 63.43 110.729 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.31 -22.71 66.62 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 123.069 2.512 . . . . 73.129999999999995 112.82 -178.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.28 2.7 88.02 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.06 -0.591 . . . . 71.200000000000003 112.251 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -109.62 -168.89 1.38 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.715 0.293 . . . . 71.439999999999998 110.372 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -111.45 118.3 35.42 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.764 0.316 . . . . 65.109999999999999 110.553 -174.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.4 pt -110.19 129.73 64.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.032 0.444 . . . . 72.319999999999993 110.931 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -105.99 -85.48 0.49 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.138 -0.483 . . . . 64.019999999999996 111.906 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -96.03 166.48 11.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.935 0.397 . . . . 54.25 111.46 -171.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.7 t -103.81 139.02 39.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.031 -0.531 . . . . 73.140000000000001 109.875 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.59 ' HA3' ' HG ' ' A' ' 108' ' ' LEU . . . -158.69 129.12 2.19 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 121.038 -0.601 . . . . 72.109999999999999 112.113 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.66 ' HG3' ' HB3' ' A' ' 76' ' ' ALA . 45.5 tt0 -128.84 134.75 48.43 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.913 -0.403 . . . . 72.219999999999999 109.913 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 69.7 t -115.67 128.67 72.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.152 0.501 . . . . 71.200000000000003 111.144 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.593 ' HB2' ' HB ' ' A' ' 105' ' ' VAL . 6.8 mp -102.95 138.16 40.19 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.366 -0.834 . . . . 74.549999999999997 110.517 178.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.735 ' HZ ' ' HB2' ' A' ' 20' ' ' TYR . 89.2 m-85 -115.54 106.29 13.77 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.226 0.536 . . . . 72.209999999999994 109.695 175.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -124.26 144.5 45.8 Favored Pre-proline 0 C--N 1.317 -0.841 0 CA-C-N 116.138 -0.483 . . . . 52.310000000000002 110.61 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.26 125.98 19.58 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.639 2.226 . . . . 54.340000000000003 111.101 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.1 143.39 56.87 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.552 -0.295 . . . . 71.109999999999999 111.219 -175.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.514 ' O ' ' HG2' ' A' ' 100' ' ' ARG . 31.0 Cg_endo -65.37 156.5 63.0 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.775 2.316 . . . . 61.240000000000002 111.35 175.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 63.94 20.71 64.82 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.926 -0.654 . . . . 72.439999999999998 112.939 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 58.21 32.91 22.62 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.661 0.384 . . . . 64.040000000000006 112.006 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 97' ' ' PRO . 24.9 mmt180 -68.74 -18.98 64.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.862 0.363 . . . . 73.319999999999993 111.244 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 127.72 -133.12 7.72 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.305 -0.718 . . . . 73.310000000000002 111.305 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.2 m -118.65 132.85 56.18 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.518 -0.549 . . . . 74.120000000000005 109.518 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.454 ' HG2' ' HB2' ' A' ' 9' ' ' ALA . 40.1 tt0 -96.21 117.02 29.92 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.847 0.356 . . . . 61.109999999999999 110.535 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.462 HG23 ' CG1' ' A' ' 91' ' ' VAL . 1.7 p -88.33 103.97 14.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.818 0.818 . . . . 71.430000000000007 109.521 174.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.593 ' HB ' ' HB2' ' A' ' 92' ' ' LEU . 16.4 t -91.36 110.24 22.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.631 -1.168 . . . . 71.530000000000001 109.919 -175.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 47.7 t -100.74 117.77 46.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.232 -0.44 . . . . 74.519999999999996 111.217 -175.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -121.09 98.72 6.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.928 -0.578 . . . . 75.109999999999999 109.52 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.59 ' HG ' ' HA3' ' A' ' 89' ' ' GLY . 1.9 tt -138.83 137.3 36.48 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.84 -0.43 . . . . 73.209999999999994 109.84 -175.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.599 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 8.9 t -84.53 139.71 31.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.28 0.562 . . . . 65.129999999999995 111.254 -177.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -140.67 179.6 6.59 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.798 -0.637 . . . . 75.209999999999994 110.374 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -120.66 144.55 38.94 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.835 -0.62 . . . . 72.099999999999994 109.836 174.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -69.79 156.9 62.06 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 121.947 1.765 . . . . 72.340000000000003 110.946 171.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.02 -36.01 52.52 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.925 2.417 . . . . 71.519999999999996 112.566 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.86 97.7 0.38 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.754 -0.736 . . . . 42.149999999999999 112.271 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 142.02 -151.48 22.88 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.51 -0.853 . . . . 60.219999999999999 112.856 176.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.3 m -62.04 -23.86 66.72 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.066 0.546 . . . . 65.310000000000002 111.925 -174.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.91 -43.02 76.93 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.304 -0.407 . . . . 73.120000000000005 111.801 -176.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -78.59 -19.83 72.78 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.575 -0.822 . . . . 52.439999999999998 112.34 -178.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.49 -38.73 23.46 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.736 -0.273 . . . . 71.310000000000002 111.712 -175.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.5 m -64.5 -25.56 38.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.615 0.598 . . . . 75.230000000000004 112.615 -174.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 14.4 tt -75.13 -21.84 16.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.922 0.392 . . . . 70.540000000000006 111.085 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.97 -18.81 64.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.366 -0.379 . . . . 53.109999999999999 111.876 -175.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 23.7 ttt85 -79.17 -14.5 59.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.059 0.457 . . . . 74.439999999999998 110.919 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 49.1 ttm -70.49 -25.86 63.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.238 -0.437 . . . . 72.239999999999995 110.322 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 68.09 177.62 0.25 Allowed 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.816 -0.629 . . . . 71.219999999999999 111.09 -176.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.6 t30 65.6 -177.39 0.18 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.825 -0.625 . . . . 62.439999999999998 109.767 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -129.64 174.06 10.03 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 122.244 -0.285 . . . . 75.439999999999998 110.431 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -86.41 155.45 56.97 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 109.054 -0.721 . . . . 73.439999999999998 109.054 175.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.0 -55.5 3.82 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.454 2.103 . . . . 72.140000000000001 112.197 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.2 m 69.8 -41.92 0.5 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.59 0.756 . . . . 70.409999999999997 111.961 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 23.6 tm0? -67.0 -46.24 75.15 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.473 -1.306 . . . . 73.340000000000003 107.473 169.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -85.82 137.62 32.65 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.76 -1.2 . . . . 64.540000000000006 107.76 164.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.768 HD13 ' H ' ' A' ' 9' ' ' ALA . 63.2 mt -71.3 168.44 17.34 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.007 0.432 . . . . 73.109999999999999 112.06 -170.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 23.5 mtp-105 -82.45 164.01 21.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.815 0.816 . . . . 73.129999999999995 113.049 -168.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -69.7 -33.18 72.16 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.494 -1.23 . . . . 73.340000000000003 112.639 -173.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -56.51 -55.65 31.1 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.048 0.388 . . . . 74.439999999999998 112.048 -175.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 15.5 tp -81.08 -20.7 40.96 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.851 -0.34 . . . . 70.430000000000007 110.975 -175.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.454 ' HB3' ' HE3' ' A' ' 138' ' ' MET . 1.8 ttp -54.34 -38.65 66.27 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.49 -0.323 . . . . 74.120000000000005 110.896 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 139' ' ' ARG . 0.8 OUTLIER -70.86 -32.71 69.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.793 0.33 . . . . 74.540000000000006 110.738 179.438 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.768 ' HZ ' HG13 ' A' ' 22' ' ' VAL . 90.3 t80 -60.34 -35.17 75.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 64.400000000000006 110.439 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.649 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 38.8 tttp -55.02 -49.5 71.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.771 -0.649 . . . . 71.530000000000001 110.194 173.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.629 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 34.4 mmt180 -71.67 -25.69 62.22 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.805 -0.634 . . . . 73.140000000000001 111.772 -175.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -63.48 -44.32 94.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.861 0.362 . . . . 64.299999999999997 111.054 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.707 ' HG2' HG23 ' A' ' 12' ' ' ILE . 8.3 tt0 -82.36 -44.36 16.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.068 -0.514 . . . . 73.209999999999994 111.038 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.867 ' HG3' HG21 ' A' ' 12' ' ' ILE . 2.5 tt0 -66.52 -20.21 65.97 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 116.203 -0.453 . . . . 74.25 111.994 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.629 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 21.3 tp -64.71 -40.95 96.23 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.538 -0.542 . . . . 75.230000000000004 109.538 175.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 105.77 96.19 2.43 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.303 -0.862 . . . . 73.310000000000002 111.361 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.582 ' H ' HD22 ' A' ' 148' ' ' LEU . 2.5 pt? -122.62 127.37 49.29 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.11 0.481 . . . . 70.530000000000001 111.192 -176.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -154.94 95.42 1.75 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.31 -0.859 . . . . 72.219999999999999 109.213 171.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -127.54 137.41 52.61 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.6 -0.727 . . . . 72.349999999999994 110.478 -174.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 71.7 t60 73.9 8.91 4.8 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.889 0.743 . . . . 74.430000000000007 110.054 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.467 ' HE1' ' O ' ' A' ' 26' ' ' LEU . 1.9 t60 -68.56 128.96 38.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.104 -0.498 . . . . 75.310000000000002 110.026 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -130.33 136.3 48.97 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.782 -0.645 . . . . 75.510000000000005 109.704 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -111.75 151.17 29.27 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.423 -0.584 . . . . 74.040000000000006 109.423 175.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 66.8 t60 . . . . . 0 C--N 1.315 -0.918 0 N-CA-C 108.594 -0.891 . . . . 74.219999999999999 108.594 174.802 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.481 1.119 0 CA-C-O 120.887 0.375 . . . . 53.539999999999999 110.296 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -161.69 60.86 0.29 Allowed Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.326 -0.71 . . . . 52.130000000000003 111.326 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -90.5 107.03 18.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.023 0.44 . . . . 54.520000000000003 110.928 -177.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 50.5 m -124.54 120.73 32.82 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.144 -0.688 . . . . 63.219999999999999 109.144 176.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.751 HG12 ' HA ' ' A' ' 109' ' ' THR . 51.0 t -93.96 132.34 38.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.605 -0.725 . . . . 65.049999999999997 109.083 178.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.7 t -80.79 115.54 23.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.977 0.418 . . . . 73.409999999999997 111.397 -171.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.472 ' HG3' ' CB ' ' A' ' 107' ' ' ARG . 9.0 mpt_? -107.14 108.09 19.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.537 -0.912 . . . . 73.5 108.537 168.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.497 ' HB3' HD22 ' A' ' 137' ' ' LEU . 2.5 t70 -147.99 173.31 13.02 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.516 -0.55 . . . . 74.200000000000003 109.516 178.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.803 ' HB2' HG13 ' A' ' 105' ' ' VAL . . . -138.56 154.35 48.73 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.045 0.45 . . . . 52.399999999999999 111.488 -171.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.48 ' HB ' ' HB2' ' A' ' 141' ' ' LYS . 12.8 m -132.55 141.07 46.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.838 -0.619 . . . . 72.010000000000005 109.987 174.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.438 HG21 ' HG3' ' A' ' 100' ' ' ARG . 25.2 m -106.38 118.32 36.34 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.156 -0.475 . . . . 74.430000000000007 111.259 -174.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.952 HG21 ' HB3' ' A' ' 145' ' ' GLU . 3.9 mp -123.19 141.94 41.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.845 -0.616 . . . . 64.25 109.716 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.26 52.02 4.24 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.843 -0.694 . . . . 74.019999999999996 112.455 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.449 ' HB2' HD22 ' A' ' 19' ' ' LEU . 94.8 mttt -131.22 144.24 52.68 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.066 -0.716 . . . . 75.109999999999999 109.066 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.403 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 51.0 Cg_exo -54.75 -58.87 1.01 Allowed 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 122.688 2.259 . . . . 73.109999999999999 113.783 -169.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.408 ' HA ' HD12 ' A' ' 19' ' ' LEU . . . 173.56 -52.87 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.311 0.577 . . . . 63.140000000000001 110.462 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -57.09 -46.0 82.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.266 -0.879 . . . . 52.119999999999997 111.66 -175.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -68.57 -8.85 45.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.401 -0.363 . . . . 72.420000000000002 111.945 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.449 HD22 ' HB2' ' A' ' 14' ' ' LYS . 96.5 mt -80.55 -20.56 43.16 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 122.378 -0.201 . . . . 73.219999999999999 110.928 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -70.94 -29.4 65.42 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.458 0.647 . . . . 72.140000000000001 109.704 174.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.702 ' HB3' ' HD2' ' A' ' 27' ' ' PRO . . . -71.51 -4.72 28.3 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.54 -0.754 . . . . 43.350000000000001 112.073 -174.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.2 p -60.4 -24.2 30.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 71.010000000000005 111.245 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -55.72 -43.46 76.57 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 112.375 0.509 . . . . 74.420000000000002 112.375 -177.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 28.4 ttt180 -105.53 -76.09 0.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.235 -0.586 . . . . 73.349999999999994 112.057 -174.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -147.78 2.96 0.72 Allowed 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 120.474 -0.49 . . . . 74.200000000000003 112.207 -168.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.723 HD13 ' HA ' ' A' ' 144' ' ' GLN . 51.6 mt 58.67 63.97 3.69 Favored Pre-proline 0 N--CA 1.47 0.539 0 CA-C-N 116.196 -0.456 . . . . 75.329999999999998 111.75 -175.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.702 ' HD2' ' HB3' ' A' ' 21' ' ' ALA . 83.5 Cg_endo -96.19 158.84 1.34 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.774 2.316 . . . . 64.329999999999998 112.76 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.81 53.76 4.55 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.817 -0.706 . . . . 62.240000000000002 112.281 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.596 HD21 ' HB2' ' A' ' 27' ' ' PRO . 3.8 mm? -117.01 81.13 12.07 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-O 120.416 0.15 . . . . 70.230000000000004 111.326 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.776 ' HD2' HD11 ' A' ' 31' ' ' LEU . 3.4 Cg_exo -79.14 -13.91 13.69 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.332 2.021 . . . . 64.540000000000006 111.535 172.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.776 HD11 ' HD2' ' A' ' 30' ' ' PRO . 4.7 mp -96.1 11.28 34.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.725 -0.67 . . . . 71.099999999999994 111.681 -173.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.809 ' HA ' HD11 ' A' ' 36' ' ' LEU . 1.5 pp -73.46 -12.11 60.68 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.794 -0.362 . . . . 75.010000000000005 111.821 -177.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 53.4 ttp -106.61 -4.82 19.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.688 0.28 . . . . 73.319999999999993 111.5 -177.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.2 p -80.32 -71.53 0.45 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.625 -0.43 . . . . 75.129999999999995 110.38 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -170.49 96.18 0.24 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.955 0.407 . . . . 75.400000000000006 110.957 175.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.809 HD11 ' HA ' ' A' ' 32' ' ' LEU . 2.7 pp -168.02 -29.46 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.54 -0.754 . . . . 75.430000000000007 109.398 173.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.578 ' HD2' ' OE1' ' A' ' 52' ' ' GLU . 28.2 mtp180 68.45 9.01 7.02 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.226 -0.897 . . . . 72.230000000000004 113.088 168.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.485 ' H ' HD13 ' A' ' 36' ' ' LEU . 50.1 m -83.95 90.82 7.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.815 0.34 . . . . 72.239999999999995 110.142 174.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.1 p -159.97 149.56 6.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.912 -0.585 . . . . 41.450000000000003 109.879 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.576 ' HG2' ' H ' ' A' ' 41' ' ' VAL . 15.1 tt0 -98.68 -162.8 0.98 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.662 -0.496 . . . . 75.120000000000005 109.662 -177.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.576 ' H ' ' HG2' ' A' ' 40' ' ' GLU . 65.6 t -44.8 130.95 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 122.413 0.285 . . . . 75.010000000000005 110.85 177.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.437 ' CD1' ' H ' ' A' ' 45' ' ' LYS . 2.0 tm? -130.22 -61.52 0.97 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.106 -0.497 . . . . 72.040000000000006 110.924 -168.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 73.28 -41.51 0.5 Allowed 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 113.018 0.748 . . . . 72.310000000000002 113.018 175.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.45 ' OD2' ' HG2' ' A' ' 45' ' ' LYS . 8.8 t70 -47.9 -43.12 28.49 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.974 0.51 . . . . 71.329999999999998 111.921 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.599 ' HZ1' HD22 ' A' ' 66' ' ' LEU . 27.3 mmtm -125.04 59.07 1.24 Allowed 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.007 0.432 . . . . 72.409999999999997 110.282 176.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.429 ' HD2' ' HG2' ' A' ' 65' ' ' GLU . 0.2 OUTLIER 74.01 157.73 0.19 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-N 114.775 -1.102 . . . . 74.430000000000007 112.108 177.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.457 ' H ' ' CD ' ' A' ' 63' ' ' GLU . 7.3 m -109.92 28.37 8.66 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.949 -1.023 . . . . 75.239999999999995 109.87 176.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.59 42.77 0.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 72.120000000000005 110.927 -174.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 20.6 t90 63.66 86.18 0.12 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.469 -0.787 . . . . 74.310000000000002 111.587 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.455 HG23 ' HB3' ' A' ' 37' ' ' ARG . 24.5 m 74.37 145.37 0.08 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.204 -0.907 . . . . 63.109999999999999 112.457 175.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.1 m -84.43 88.62 2.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.607 0.718 . . . . 72.530000000000001 111.582 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.578 ' OE1' ' HD2' ' A' ' 37' ' ' ARG . 41.8 tt0 -171.32 -34.07 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.303 -0.862 . . . . 73.239999999999995 109.213 177.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.75 149.43 84.98 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 114.82 -1.082 . . . . 64.430000000000007 111.757 -178.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -86.82 -177.86 2.4 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.004 2.469 . . . . 74.430000000000007 112.547 178.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 72.09 144.03 0.1 Allowed Pre-proline 0 N--CA 1.466 0.33 0 O-C-N 123.969 0.793 . . . . 74.040000000000006 111.311 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -66.95 -51.99 0.74 Allowed 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.239 1.959 . . . . 74.439999999999998 112.628 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.682 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 1.7 pt? -130.42 8.6 5.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.542 0.687 . . . . 75.109999999999999 110.74 -177.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.99 -75.79 1.68 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.086 -0.961 . . . . 64.310000000000002 112.505 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -116.24 -85.44 0.63 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.816 0.341 . . . . 60.020000000000003 110.69 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.7 p -154.05 15.68 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.939 0.876 . . . . 64.120000000000005 109.517 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.5 m -70.15 160.13 32.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.026 -0.988 . . . . 74.510000000000005 109.777 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 2.2 m95 -71.47 124.3 24.33 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.825 -0.806 . . . . 75.209999999999994 108.825 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.607 ' HB3' HD13 ' A' ' 80' ' ' LEU . 8.6 tp10 -140.46 153.21 46.17 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.145 -0.48 . . . . 72.209999999999994 110.846 -174.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -104.71 114.62 28.96 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.576 -0.738 . . . . 54.149999999999999 111.088 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -117.8 136.73 53.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.928 -0.578 . . . . 75.25 109.78 174.031 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.65 ' HG ' ' HA ' ' A' ' 77' ' ' TRP . 6.8 mp -91.37 128.38 37.17 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.73 0.3 . . . . 74.329999999999998 110.548 -178.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.756 ' HB ' ' HG3' ' A' ' 78' ' ' ARG . 12.9 t -70.55 -28.57 65.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 74.519999999999996 110.84 -173.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.11 131.46 17.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.895 -0.593 . . . . 73.150000000000006 109.793 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -141.5 91.88 2.42 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.037 0.446 . . . . 72.439999999999998 109.849 -178.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.555 ' HB2' ' H ' ' A' ' 74' ' ' ARG . 10.3 mm-40 -95.72 142.37 24.49 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 109.185 -0.672 . . . . 64.340000000000003 109.185 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.77 94.48 0.39 Allowed 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.417 2.078 . . . . 72.040000000000006 112.713 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.71 35.04 89.19 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.994 -0.622 . . . . 71.420000000000002 112.258 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.489 ' HB2' ' CB ' ' A' ' 70' ' ' GLU . 75.2 mmtt -127.05 -70.41 0.72 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.679 0.276 . . . . 70.109999999999999 110.332 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.555 ' H ' ' HB2' ' A' ' 70' ' ' GLU . 30.8 ptt-85 -150.58 132.35 15.0 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.737 -0.468 . . . . 75.239999999999995 109.737 176.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.536 ' HB ' HG13 ' A' ' 91' ' ' VAL . 3.9 mp -126.9 116.23 44.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.077 -0.511 . . . . 71.439999999999998 109.792 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -106.98 118.61 37.17 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.063 -0.517 . . . . 73.010000000000005 110.53 -178.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.65 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 36.2 m95 -87.07 145.58 26.41 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.841 -0.618 . . . . 62.530000000000001 111.238 -174.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.756 ' HG3' ' HB ' ' A' ' 67' ' ' THR . 19.0 mmm-85 -148.97 175.13 11.56 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.814 -0.63 . . . . 71.409999999999997 109.777 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.517 ' HB2' ' HB2' ' A' ' 86' ' ' GLU . 63.2 m -134.92 142.43 46.54 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.449 -0.945 . . . . 71.150000000000006 108.449 175.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.682 ' CD1' ' HB3' ' A' ' 57' ' ' LEU . 94.5 mt -67.0 153.12 95.15 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.579 -0.282 . . . . 55.530000000000001 110.931 -176.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -52.2 -16.78 5.13 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.953 3.102 . . . . 73.030000000000001 114.297 -173.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.85 -35.38 89.51 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.66 -0.781 . . . . 64.420000000000002 111.921 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.66 147.85 26.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.993 0.425 . . . . 72.140000000000001 111.093 -176.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.458 ' HD2' ' C ' ' A' ' 84' ' ' ARG . 6.0 ppt_? -115.44 -1.59 12.79 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.086 -0.507 . . . . 74.519999999999996 110.742 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.443 ' O ' HG13 ' A' ' 85' ' ' ILE . 10.1 tp -107.86 33.59 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.995 0.902 . . . . 60.329999999999998 110.247 -178.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 79' ' ' SER . 42.1 tt0 -64.24 122.01 15.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.664 -0.698 . . . . 73.5 110.555 177.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -103.59 140.56 37.37 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.355 -0.98 . . . . 71.430000000000007 108.355 174.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.1 m -94.77 126.19 39.93 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.19 0.519 . . . . 64.219999999999999 110.145 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 107' ' ' ARG . . . -159.0 146.39 12.95 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.304 -0.862 . . . . 62.340000000000003 111.443 -178.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -147.02 126.4 13.13 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 110.357 -0.238 . . . . 60.049999999999997 110.357 -176.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.616 HG22 HG21 ' A' ' 104' ' ' VAL . 2.5 p -108.6 121.68 62.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.055 0.455 . . . . 75.319999999999993 110.942 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.431 ' HB2' ' CG2' ' A' ' 105' ' ' VAL . 8.9 mp -108.96 139.82 43.3 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.736 -0.468 . . . . 73.239999999999995 109.736 174.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.505 ' HE2' HD12 ' A' ' 75' ' ' ILE . 93.9 m-85 -104.45 108.97 20.65 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.251 0.548 . . . . 72.540000000000006 110.073 178.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -126.73 144.88 51.46 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 115.461 -0.791 . . . . 72.540000000000006 110.046 -177.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.75 136.85 47.32 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.187 1.924 . . . . 42.210000000000001 111.551 176.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.519 ' CB ' ' HB3' ' A' ' 100' ' ' ARG . . . -77.63 146.99 74.13 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.185 -0.461 . . . . 75.120000000000005 110.011 178.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -37.78 108.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 124.111 3.208 . . . . 64.400000000000006 114.463 -172.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 90.04 -67.99 2.57 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 114.671 -1.149 . . . . 62.509999999999998 112.067 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -178.28 32.07 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.203 -0.498 . . . . 74.340000000000003 110.877 -174.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.519 ' HB3' ' CB ' ' A' ' 96' ' ' ALA . 21.8 tpp180 -74.2 -13.61 60.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.962 0.411 . . . . 75.150000000000006 110.802 -177.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 129.38 -157.53 21.76 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.962 -0.855 . . . . 37.020000000000003 110.962 -177.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 32.7 m -101.91 127.72 48.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.063 0.459 . . . . 73.010000000000005 109.815 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.401 ' CG ' ' HB3' ' A' ' 9' ' ' ALA . 44.2 tt0 -100.49 110.38 22.56 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.634 -0.712 . . . . 70.209999999999994 110.105 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.616 HG21 HG22 ' A' ' 91' ' ' VAL . 1.7 p -87.88 97.92 7.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.698 0.761 . . . . 71.140000000000001 109.364 175.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.803 HG13 ' HB2' ' A' ' 9' ' ' ALA . 22.7 m -84.43 110.79 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 115.059 -0.973 . . . . 71.109999999999999 109.802 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.7 p -112.67 123.89 68.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.797 -0.638 . . . . 74.310000000000002 110.878 -176.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.534 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 22.5 ptt180 -115.22 99.06 7.14 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.714 -0.676 . . . . 74.409999999999997 109.661 174.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 52.3 tp -120.46 141.98 49.67 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.021 -0.733 . . . . 71.329999999999998 109.021 -177.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.751 ' HA ' HG12 ' A' ' 5' ' ' VAL . 51.8 m -83.1 119.58 24.67 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.715 0.769 . . . . 61.100000000000001 111.922 -172.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -124.23 120.18 31.5 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.686 -1.143 . . . . 74.319999999999993 109.08 174.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -120.0 145.76 40.57 Favored Pre-proline 0 C--N 1.316 -0.849 0 N-CA-C 109.537 -0.542 . . . . 75.120000000000005 109.537 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.37 153.6 76.41 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.227 1.952 . . . . 73.030000000000001 111.343 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -80.18 5.12 6.24 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.565 2.176 . . . . 53.329999999999998 111.839 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 115.35 -147.86 18.92 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.005 -0.838 . . . . 50.049999999999997 111.005 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 61.38 45.46 96.37 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.924 -0.655 . . . . 65.219999999999999 112.824 176.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.9 m -62.41 -29.08 70.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.891 0.377 . . . . 75.340000000000003 110.912 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.83 -30.58 65.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.072 -0.513 . . . . 64.420000000000002 110.866 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -73.88 -20.23 79.74 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.81 -0.632 . . . . 51.409999999999997 112.916 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.51 -19.82 27.24 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 112.262 0.468 . . . . 37.020000000000003 112.262 -177.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.42 ' O ' ' HG3' ' A' ' 124' ' ' MET . 13.8 p -60.13 -29.79 44.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 62.200000000000003 111.832 -177.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.7 pp -65.46 -32.69 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 C-N-CA 120.85 -0.34 . . . . 75.310000000000002 111.022 -177.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.94 -39.36 56.3 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.689 -0.486 . . . . 63.210000000000001 109.689 176.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -59.01 -28.33 66.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.378 -0.828 . . . . 74.349999999999994 111.6 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.42 ' HG3' ' O ' ' A' ' 120' ' ' VAL . 66.1 mtt -60.07 -45.81 91.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.208 -0.451 . . . . 75.310000000000002 111.362 -178.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -106.86 -26.04 11.41 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.816 0.302 . . . . 72.140000000000001 111.816 -176.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -103.19 125.49 49.9 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.412 -0.588 . . . . 74.219999999999999 109.412 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -78.41 -0.87 30.88 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.271 -0.422 . . . . 72.099999999999994 111.509 -177.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 54.65 67.94 2.97 Favored Pre-proline 0 C--O 1.234 0.249 0 N-CA-C 109.289 -0.634 . . . . 74.329999999999998 109.289 -170.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -56.41 -41.41 76.51 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.08 2.52 . . . . 70.239999999999995 112.73 -172.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.6 t -147.26 168.22 22.28 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.64 -0.504 . . . . 74.25 109.64 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -92.87 -10.98 34.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.458 -0.337 . . . . 74.230000000000004 111.019 -175.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.02 116.71 12.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.573 0.701 . . . . 54.329999999999998 110.744 174.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 95.8 mt -127.95 135.02 49.37 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.695 -0.684 . . . . 74.329999999999998 110.121 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -88.96 40.44 0.98 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.874 0.369 . . . . 73.129999999999995 111.103 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.429 ' O ' ' HG3' ' A' ' 138' ' ' MET . 18.1 t70 -65.55 -43.92 88.42 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.002 0.43 . . . . 74.400000000000006 110.601 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -74.54 -36.46 63.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.239 0.542 . . . . 75.010000000000005 110.319 174.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.497 HD22 ' HB3' ' A' ' 8' ' ' ASP . 1.3 mp -70.63 -29.76 66.21 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.618 0.599 . . . . 75.120000000000005 112.618 -174.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.429 ' HG3' ' O ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -64.2 -26.2 68.41 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.412 -0.515 . . . . 75.299999999999997 110.076 175.442 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 55.8 mtt180 -69.61 -48.93 58.36 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.496 -0.557 . . . . 75.549999999999997 109.496 174.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -56.29 -48.95 75.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.841 -1.072 . . . . 74.219999999999999 110.985 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.576 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 0.6 OUTLIER -63.49 -44.13 95.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.016 -0.538 . . . . 74.310000000000002 110.141 179.748 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 48.0 ttt180 -57.46 -50.61 72.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.063 -0.517 . . . . 74.219999999999999 111.076 -175.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -66.17 -27.47 68.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.073 0.463 . . . . 74.400000000000006 110.594 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.723 ' HA ' HD13 ' A' ' 26' ' ' LEU . 54.5 tt0 -77.49 -29.21 52.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.795 -0.639 . . . . 72.439999999999998 112.035 -174.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.952 ' HB3' HG21 ' A' ' 12' ' ' ILE . 2.2 pp20? -108.49 -13.4 14.85 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.265 0.468 . . . . 73.209999999999994 112.265 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 57.5 tp -62.08 -40.33 95.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.265 0.555 . . . . 74.310000000000002 109.612 175.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -105.18 113.47 4.32 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.83 -0.7 . . . . 74.409999999999997 111.408 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 89.5 mt -80.78 -61.13 2.06 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.921 -0.4 . . . . 64.409999999999997 109.921 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -124.09 112.86 17.62 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.409 -0.96 . . . . 75.120000000000005 108.409 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.411 ' O ' ' HA ' ' A' ' 27' ' ' PRO . 13.5 t-80 -136.94 140.43 42.24 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.884 0.373 . . . . 73.420000000000002 110.864 -173.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -128.83 55.75 1.7 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.39 0.614 . . . . 62.43 109.987 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.469 ' HB3' ' H ' ' A' ' 153' ' ' HIS . 6.5 t60 51.37 -114.94 0.84 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.702 -1.135 . . . . 75.010000000000005 111.064 -176.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.469 ' H ' ' HB3' ' A' ' 152' ' ' HIS . 8.3 p-80 -173.04 157.69 3.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.721 0.296 . . . . 72.140000000000001 111.001 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -163.68 -107.87 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.283 -1.006 . . . . 75.109999999999999 108.283 171.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 . . . . . 0 C--O 1.246 0.892 0 CA-C-O 118.229 -0.891 . . . . 74.450000000000003 108.837 177.139 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtm . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 121.337 0.589 . . . . 72.409999999999997 110.135 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 123.06 -76.9 0.36 Allowed Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.508 -0.769 . . . . 37.060000000000002 111.222 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 47.29 55.32 8.34 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.361 0.6 . . . . 75.239999999999995 110.475 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.3 m -119.44 123.41 44.0 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.653 0.739 . . . . 75.120000000000005 111.617 -169.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.559 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 70.0 t -118.39 110.71 31.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 114.876 -1.056 . . . . 53.350000000000001 108.456 172.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.4 p -77.82 124.38 36.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.466 0.65 . . . . 73.030000000000001 110.44 -174.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.692 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -141.52 110.56 6.23 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.344 -0.844 . . . . 72.530000000000001 110.621 -179.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.491 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 14.3 t70 -146.21 171.38 15.03 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.036 -0.727 . . . . 74.25 109.036 175.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.6 ' HB3' HG12 ' A' ' 105' ' ' VAL . . . -139.72 120.69 14.57 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.939 0.4 . . . . 73.129999999999995 111.02 -174.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.1 m -115.09 143.44 24.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.985 -0.552 . . . . 74.439999999999998 110.163 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.523 HG23 ' HB2' ' A' ' 100' ' ' ARG . 42.6 m -103.79 111.87 24.57 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.967 -0.56 . . . . 71.400000000000006 110.322 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.62 HD13 ' HG2' ' A' ' 141' ' ' LYS . 9.4 mm -100.63 146.0 10.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.287 -0.415 . . . . 74.230000000000004 109.945 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.16 60.11 4.5 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.689 -0.767 . . . . 75.519999999999996 111.817 174.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.48 ' HB2' HD21 ' A' ' 19' ' ' LEU . 24.2 mmtm -141.19 145.25 37.85 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 109.764 -0.458 . . . . 62.100000000000001 109.764 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.411 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 72.9 Cg_exo -52.24 -57.68 1.98 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.157 2.572 . . . . 64.409999999999997 113.58 -175.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . 174.54 -46.66 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.932 0.396 . . . . 63.399999999999999 111.156 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -59.19 -45.43 91.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.075 -0.511 . . . . 74.540000000000006 110.866 -176.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.563 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . 21.4 mp0 -66.64 -16.67 64.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.886 -0.597 . . . . 72.099999999999994 110.906 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.752 ' HA ' ' NE2' ' A' ' 144' ' ' GLN . 74.5 mt -73.76 -45.5 51.45 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.36 -0.382 . . . . 74.140000000000001 110.256 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -74.28 -29.9 61.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.383 0.611 . . . . 73.340000000000003 109.896 174.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.563 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . . . -70.34 -3.03 15.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.276 -0.874 . . . . 60.299999999999997 111.927 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.701 HG22 ' HD2' ' A' ' 140' ' ' PHE . 10.9 p -53.2 -21.21 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.096 0.558 . . . . 62.109999999999999 111.991 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 4.2 m95 -59.19 -26.15 64.57 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.796 0.332 . . . . 74.420000000000002 110.92 176.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -136.95 -164.67 1.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 74.209999999999994 110.168 -177.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.437 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 5.3 t70 -88.03 46.67 1.41 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.282 -0.417 . . . . 70.209999999999994 110.209 -176.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 25' ' ' ASP . 0.4 OUTLIER 43.14 84.87 0.18 Allowed Pre-proline 0 N--CA 1.476 0.86 0 C-N-CA 123.513 0.725 . . . . 71.109999999999999 111.965 -177.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.617 ' HB3' ' HB2' ' A' ' 38' ' ' SER . 32.1 Cg_exo -59.41 -55.61 1.73 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.983 2.455 . . . . 54.439999999999998 113.867 -173.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.71 71.34 1.03 Allowed Glycine 0 C--N 1.32 -0.309 0 C-N-CA 120.858 -0.687 . . . . 42.149999999999999 112.013 -176.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.602 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 0.8 OUTLIER -127.95 70.44 77.89 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.74 0.781 . . . . 72.409999999999997 112.007 -179.446 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -75.08 0.85 8.44 Favored 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.267 1.978 . . . . 74.519999999999996 112.027 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.402 ' N ' HD13 ' A' ' 31' ' ' LEU . 6.0 mp -82.36 -52.19 7.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.812 -0.631 . . . . 74.409999999999997 110.492 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.1 mt 59.74 31.09 20.64 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.717 -0.674 . . . . 74.540000000000006 111.519 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 50.0 ttm -132.61 135.02 45.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.614 -0.266 . . . . 63.130000000000003 110.761 -177.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.4 m 66.95 8.82 6.38 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 123.697 0.623 . . . . 71.109999999999999 111.925 175.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 57.61 143.68 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.995 1.318 . . . . 71.430000000000007 112.881 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.7 mp -112.95 -171.55 1.89 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.005 -0.739 . . . . 73.019999999999996 109.005 175.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -64.29 -23.28 67.24 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.391 0.615 . . . . 71.120000000000005 110.246 175.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.617 ' HB2' ' HB3' ' A' ' 27' ' ' PRO . 17.2 m -138.08 131.08 30.02 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.533 -0.758 . . . . 72.099999999999994 109.369 177.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.551 ' HA ' ' CD1' ' A' ' 29' ' ' LEU . 8.3 m -119.96 162.97 17.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.616 -0.265 . . . . 71.129999999999995 111.126 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.601 ' HG2' ' HD3' ' A' ' 45' ' ' LYS . 18.8 tt0 -88.64 13.61 11.86 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.914 0.864 . . . . 75.400000000000006 110.47 -176.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.506 HG13 ' HD1' ' A' ' 49' ' ' TRP . 14.6 p -141.85 128.55 19.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.326 -0.852 . . . . 70.209999999999994 109.708 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.1 tp -171.87 -53.74 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.694 0.283 . . . . 75.439999999999998 110.77 -172.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.547 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 32.0 t70 -161.09 -38.73 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.046 -0.524 . . . . 74.400000000000006 110.755 -177.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -68.69 -69.84 0.3 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.292 -0.867 . . . . 72.230000000000004 111.804 -175.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.629 ' HA ' ' CD2' ' A' ' 66' ' ' LEU . 39.2 mtpt -72.45 -43.86 63.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.16 0.505 . . . . 75.0 111.067 -178.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 46' ' ' ARG . 21.2 mtt180 -148.12 143.26 27.0 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.238 -0.892 . . . . 55.409999999999997 109.296 171.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.589 ' H ' ' HG3' ' A' ' 63' ' ' GLU . 15.2 m -79.77 115.25 19.26 Favored 'General case' 0 C--N 1.318 -0.765 0 O-C-N 123.583 0.552 . . . . 74.319999999999993 110.714 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 68.43 165.17 0.24 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.317 -0.856 . . . . 74.439999999999998 110.653 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.506 ' HD1' HG13 ' A' ' 41' ' ' VAL . 39.4 t90 -76.48 80.77 3.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.202 0.525 . . . . 73.319999999999993 110.425 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.4 p -86.3 -80.76 0.23 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.989 -0.55 . . . . 73.140000000000001 110.377 177.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.46 HG12 ' HG3' ' A' ' 52' ' ' GLU . 47.7 t 67.56 -70.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 O-C-N 123.579 0.55 . . . . 64.200000000000003 111.533 178.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.46 ' HG3' HG12 ' A' ' 51' ' ' VAL . 48.3 mt-10 -120.27 94.26 4.32 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.031 0.443 . . . . 73.120000000000005 110.016 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.15 151.46 44.66 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.71 -0.677 . . . . 73.530000000000001 110.115 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.83 113.8 2.14 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.221 1.947 . . . . 72.340000000000003 110.913 174.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.496 ' HB1' ' HA3' ' A' ' 58' ' ' GLY . . . 66.38 143.3 0.08 OUTLIER Pre-proline 0 N--CA 1.466 0.344 0 O-C-N 123.971 0.794 . . . . 74.150000000000006 110.523 -171.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.452 ' HB2' HD11 ' A' ' 80' ' ' LEU . 11.0 Cg_endo -54.95 -54.6 4.2 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.515 2.143 . . . . 63.310000000000002 112.161 -177.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.593 ' H ' HD21 ' A' ' 57' ' ' LEU . 2.6 pt? -103.73 12.83 34.2 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.744 -0.662 . . . . 74.230000000000004 110.418 -176.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.496 ' HA3' ' HB1' ' A' ' 55' ' ' ALA . . . -78.01 5.67 52.8 Favored Glycine 0 C--N 1.318 -0.434 0 CA-C-N 115.263 -0.88 . . . . 64.329999999999998 113.526 -174.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -126.65 0.46 6.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.089 0.471 . . . . 73.519999999999996 111.172 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.9 m -128.01 179.6 3.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.245 -0.434 . . . . 74.420000000000002 110.972 -175.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.7 m -75.16 -42.69 55.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.554 0.692 . . . . 64.129999999999995 109.415 175.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -161.93 159.65 26.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.925 -1.034 . . . . 75.200000000000003 108.398 170.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.777 ' HB3' HD13 ' A' ' 80' ' ' LEU . 44.0 tt0 -136.72 137.93 40.47 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.955 -0.387 . . . . 75.140000000000001 109.955 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.9 114.67 26.31 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.312 -0.625 . . . . 61.310000000000002 109.312 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 7.6 tt0 -108.83 134.61 51.29 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.964 -0.294 . . . . 63.109999999999999 110.533 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.998 HD13 ' HA ' ' A' ' 77' ' ' TRP . 2.2 mm? -83.95 137.32 33.69 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.356 -0.609 . . . . 70.450000000000003 109.356 174.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.547 HG21 ' HB2' ' A' ' 78' ' ' ARG . 20.8 p -67.67 -34.37 76.79 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.502 0.668 . . . . 72.329999999999998 110.546 -176.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -135.72 124.85 24.43 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.979 -1.009 . . . . 72.099999999999994 110.725 177.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -117.36 90.77 3.41 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.432 -0.804 . . . . 75.129999999999995 109.581 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.966 ' HB3' ' HB2' ' A' ' 73' ' ' LYS . 48.9 mt-10 -120.02 86.52 37.09 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.483 -0.781 . . . . 73.120000000000005 110.452 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -60.6 107.03 0.39 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.599 2.199 . . . . 72.310000000000002 111.82 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.09 6.16 55.94 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.896 -0.669 . . . . 53.350000000000001 111.827 -177.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.966 ' HB2' ' HB3' ' A' ' 70' ' ' GLU . 2.8 mmmp? -128.62 -66.38 0.84 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.586 0.231 . . . . 70.239999999999995 110.488 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 22.4 ptt180 -168.3 150.09 5.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.323 -0.399 . . . . 75.310000000000002 110.643 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.6 mp -124.98 114.29 39.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 116.195 -0.457 . . . . 74.040000000000006 109.793 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.564 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . . . -101.68 121.02 41.25 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.076 -0.511 . . . . 74.209999999999994 110.448 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.998 ' HA ' HD13 ' A' ' 66' ' ' LEU . 26.3 m0 -80.49 155.43 27.03 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.989 0.737 . . . . 72.219999999999999 112.989 -172.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.64 ' HG3' ' H ' ' A' ' 79' ' ' SER . 24.7 tpp180 -176.62 174.63 1.83 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 114.394 -1.275 . . . . 60.43 108.238 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.64 ' H ' ' HG3' ' A' ' 78' ' ' ARG . 24.6 m -148.75 145.81 27.78 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.001 -1.111 . . . . 70.420000000000002 108.001 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.777 HD13 ' HB3' ' A' ' 63' ' ' GLU . 90.2 mt -71.7 152.08 93.48 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.911 -0.404 . . . . 75.439999999999998 109.911 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -52.35 -23.3 18.11 Favored 'Trans proline' 0 N--CA 1.476 0.445 0 C-N-CA 123.315 2.677 . . . . 72.439999999999998 113.93 -175.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -78.53 -4.14 87.16 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.821 -0.704 . . . . 74.519999999999996 112.997 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.33 -170.74 2.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.919 0.39 . . . . 60.229999999999997 110.935 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.438 ' HB2' HD13 ' A' ' 85' ' ' ILE . 86.8 mtt180 -118.06 -38.42 3.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.052 -0.522 . . . . 70.010000000000005 112.095 -172.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.438 HD13 ' HB2' ' A' ' 84' ' ' ARG . 4.8 mp -121.5 122.84 68.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.928 -0.309 . . . . 75.219999999999999 110.722 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.458 ' HB3' ' HB2' ' A' ' 79' ' ' SER . 11.3 pt-20 -125.79 123.19 38.22 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.53 -0.544 . . . . 74.230000000000004 109.53 172.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -111.64 138.67 47.88 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.032 -0.729 . . . . 74.140000000000001 109.032 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.2 m -96.04 128.15 42.69 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.685 -0.487 . . . . 41.210000000000001 109.685 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.24 123.73 0.69 Allowed Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.74 -0.743 . . . . 61.509999999999998 111.896 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 0.5 OUTLIER -108.95 126.19 52.83 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.904 0.383 . . . . 75.120000000000005 110.297 178.419 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 4.4 m -97.81 126.68 50.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.463 -0.569 . . . . 71.5 109.463 176.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.477 ' HB2' ' CG2' ' A' ' 105' ' ' VAL . 9.5 mp -105.32 139.06 40.53 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.422 -0.354 . . . . 65.239999999999995 110.886 -177.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -99.57 105.64 17.54 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.456 -0.942 . . . . 62.539999999999999 108.456 172.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.4 mtp85 -112.68 150.25 42.43 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 115.288 -0.869 . . . . 64.420000000000002 111.1 -171.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -49.71 127.3 18.41 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.427 2.084 . . . . 71.219999999999999 111.204 172.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.37 150.85 85.23 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.881 -0.599 . . . . 72.030000000000001 111.762 -172.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.78 109.43 0.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.824 2.349 . . . . 72.549999999999997 112.089 175.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.8 -73.9 1.34 Allowed Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.175 -0.92 . . . . 63.240000000000002 111.483 177.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 174.31 24.57 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.273 0.631 . . . . 72.219999999999999 111.264 -175.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.523 ' HB2' HG23 ' A' ' 11' ' ' THR . 19.6 mtp180 -82.62 7.04 15.8 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.544 0.572 . . . . 74.120000000000005 112.544 -171.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 126.68 -113.14 1.71 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.49 -0.862 . . . . 44.32 111.78 177.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.734 ' HB ' HD11 ' A' ' 19' ' ' LEU . 15.7 m -141.17 140.6 34.07 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.841 0.353 . . . . 72.099999999999994 110.265 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -96.59 119.02 34.3 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.176 -0.466 . . . . 65.109999999999999 110.755 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 p -100.67 107.49 21.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.495 0.664 . . . . 62.119999999999997 110.258 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.6 HG12 ' HB3' ' A' ' 9' ' ' ALA . 18.8 m -95.45 118.69 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 115.37 -0.832 . . . . 74.219999999999999 110.046 178.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.692 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 18.6 m -112.2 127.92 69.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.837 -0.62 . . . . 72.019999999999996 110.584 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.467 ' HG3' ' HB3' ' A' ' 7' ' ' ARG . 10.1 ttp180 -137.67 100.38 4.19 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.054 -0.521 . . . . 74.239999999999995 109.857 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 pp -145.46 155.23 42.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.974 -0.557 . . . . 74.239999999999995 109.508 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 11.4 t -80.82 137.69 36.21 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.154 -0.618 . . . . 64.040000000000006 109.876 -176.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -160.17 111.41 1.93 Allowed 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.069 -1.085 . . . . 74.200000000000003 108.069 -171.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.449 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 1.2 ppt_? -95.36 144.53 27.96 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-O 121.041 0.448 . . . . 74.310000000000002 111.692 -170.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 111' ' ' ARG . 24.1 Cg_endo -91.21 160.59 3.79 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 123.154 2.569 . . . . 64.019999999999996 111.673 175.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -65.64 -22.92 57.3 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.473 2.115 . . . . 65.310000000000002 112.359 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -160.62 -133.13 1.43 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 121.001 -0.618 . . . . 71.430000000000007 111.998 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 121.48 -15.21 9.23 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.705 -0.759 . . . . 52.32 112.417 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.6 m -85.26 -48.8 8.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.078 0.466 . . . . 73.129999999999995 110.585 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.49 ' O ' HG22 ' A' ' 120' ' ' VAL . . . -72.69 -39.61 66.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.926 -0.579 . . . . 72.140000000000001 111.431 -177.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.483 ' O ' HG23 ' A' ' 121' ' ' ILE . . . -67.01 -20.02 70.43 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 121.037 -0.601 . . . . 62.539999999999999 113.273 -177.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.17 -21.31 60.72 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.228 0.455 . . . . 73.519999999999996 112.228 -175.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 117' ' ' ALA . 10.7 m -77.12 -18.84 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.509 0.559 . . . . 54.109999999999999 112.509 -173.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.483 HG23 ' O ' ' A' ' 118' ' ' GLY . 16.1 tt -68.86 -28.98 41.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.893 -0.323 . . . . 70.439999999999998 111.061 -176.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.446 ' HB1' ' HG2' ' A' ' 129' ' ' PRO . . . -61.33 -27.49 68.53 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.779 -0.646 . . . . 72.420000000000002 111.953 -175.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 16.7 mtm180 -66.79 -42.59 85.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.091 0.472 . . . . 75.120000000000005 110.009 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 40.5 ttp -71.18 -54.14 12.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.758 -0.656 . . . . 70.109999999999999 109.789 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.406 ' CD2' ' HG3' ' A' ' 127' ' ' GLN . 16.6 t80 -159.26 136.92 10.09 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.505 -0.924 . . . . 74.439999999999998 108.505 178.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -58.31 -74.0 0.07 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.046 0.387 . . . . 62.409999999999997 112.046 -170.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.406 ' HG3' ' CD2' ' A' ' 125' ' ' PHE . 92.5 mt-30 60.39 12.74 3.62 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.388 0.514 . . . . 64.420000000000002 112.388 178.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 56.42 82.08 0.25 Allowed Pre-proline 0 CA--C 1.534 0.35 0 O-C-N 123.541 0.525 . . . . 72.109999999999999 111.035 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.446 ' HG2' ' HB1' ' A' ' 122' ' ' ALA . 6.2 Cg_exo -79.03 -56.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.79 2.327 . . . . 42.130000000000003 112.818 -176.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 29.9 p -129.88 105.88 8.29 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.235 -0.439 . . . . 75.319999999999993 110.548 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -135.16 -66.29 0.58 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.114 -0.494 . . . . 75.409999999999997 110.553 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 67.56 -58.99 0.42 Allowed 'General case' 0 N--CA 1.466 0.342 0 O-C-N 124.013 0.821 . . . . 71.409999999999997 110.529 -172.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 42.4 tp 53.48 76.35 0.22 Allowed 'General case' 0 C--O 1.233 0.215 0 O-C-N 123.689 0.618 . . . . 74.420000000000002 111.58 174.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 33.9 mtt-85 57.08 42.9 25.14 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.532 -0.758 . . . . 74.439999999999998 110.369 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -56.96 -56.5 20.85 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.77 0.285 . . . . 72.150000000000006 111.77 -173.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -76.56 -39.52 52.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.886 0.374 . . . . 75.329999999999998 110.156 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.565 ' CD1' ' HE1' ' A' ' 140' ' ' PHE . 0.3 OUTLIER -53.75 -51.0 64.78 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.667 -0.697 . . . . 55.020000000000003 111.589 -178.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.824 ' HE3' ' HA ' ' A' ' 138' ' ' MET . 0.6 OUTLIER -65.17 -38.18 89.71 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.429 -0.35 . . . . 72.209999999999994 111.001 -175.927 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.414 ' O ' ' HB3' ' A' ' 142' ' ' ARG . 34.2 mtm105 -65.68 -51.66 57.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.509 -0.314 . . . . 72.140000000000001 111.676 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.701 ' HD2' HG22 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -73.57 -30.21 62.89 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 120.06 -0.656 . . . . 75.409999999999997 109.779 -175.123 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.62 ' HG2' HD13 ' A' ' 12' ' ' ILE . 13.5 tmtt? -55.44 -50.44 69.83 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.235 -0.654 . . . . 63.030000000000001 109.235 173.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.561 ' HE ' ' HG3' ' A' ' 143' ' ' GLU . 43.7 ttp180 -52.53 -54.93 26.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.514 -1.221 . . . . 73.420000000000002 111.674 177.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.561 ' HG3' ' HE ' ' A' ' 142' ' ' ARG . 30.6 mt-10 -72.97 -34.02 66.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.958 -0.565 . . . . 73.099999999999994 111.812 -174.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.752 ' NE2' ' HA ' ' A' ' 19' ' ' LEU . 46.0 tt0 -61.65 -44.46 96.92 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.299 0.481 . . . . 75.430000000000007 112.299 -174.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -85.73 -8.74 57.98 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.272 -0.571 . . . . 75.420000000000002 111.12 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 57.5 tp -84.21 -53.18 5.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.082 0.468 . . . . 64.150000000000006 109.869 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 138.98 -176.48 20.89 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.933 -0.867 . . . . 54.439999999999998 110.933 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.512 ' HG ' ' H ' ' A' ' 149' ' ' GLU . 12.2 tp 71.67 175.91 0.28 Allowed 'General case' 0 CA--C 1.534 0.364 0 O-C-N 123.872 0.395 . . . . 72.140000000000001 110.418 177.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.512 ' H ' ' HG ' ' A' ' 148' ' ' LEU . 31.5 tt0 -77.45 -70.11 0.49 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.965 0.412 . . . . 73.329999999999998 110.597 177.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.578 ' HE1' ' HB2' ' A' ' 140' ' ' PHE . 0.1 OUTLIER -177.17 145.08 0.45 Allowed 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.531 -0.759 . . . . 75.310000000000002 109.329 -176.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -75.84 -29.0 58.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.719 0.295 . . . . 64.519999999999996 110.333 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 24.5 m170 63.08 -170.57 0.18 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.838 -0.619 . . . . 71.510000000000005 112.55 174.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.452 ' HB3' ' H ' ' A' ' 154' ' ' HIS . 0.9 OUTLIER 68.44 -89.32 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 114.752 -1.113 . . . . 70.019999999999996 111.14 174.557 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.452 ' H ' ' HB3' ' A' ' 153' ' ' HIS . 56.4 t-80 55.63 73.61 0.42 Allowed 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.494 0.496 . . . . 75.319999999999993 110.633 -176.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 24.2 t60 . . . . . 0 C--O 1.244 0.766 0 CA-C-O 118.361 -0.828 . . . . 70.109999999999999 109.314 179.313 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.461 ' O ' ' HG3' ' A' ' 3' ' ' GLU . 52.3 mtt . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 109.68 -0.489 . . . . 73.099999999999994 109.68 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.34 -97.27 0.76 Allowed Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 110.789 -0.924 . . . . 74.129999999999995 110.789 -172.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 1' ' ' MET . 35.9 mt-10 45.11 81.05 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.54 0.736 . . . . 64.200000000000003 112.551 169.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.438 ' HB ' ' O ' ' A' ' 110' ' ' TYR . 26.8 m -128.8 122.67 31.01 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.607 -0.516 . . . . 71.409999999999997 109.607 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 82.4 t -111.54 109.14 27.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.801 -0.444 . . . . 73.310000000000002 109.801 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.5 t -93.72 116.52 35.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.826 -0.625 . . . . 73.040000000000006 110.314 -176.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.44 109.79 13.15 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.965 -0.754 . . . . 73.010000000000005 108.965 172.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.571 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 7.0 t70 -157.72 172.03 19.24 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.039 -1.097 . . . . 62.130000000000003 108.039 175.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.463 ' CB ' HG21 ' A' ' 105' ' ' VAL . . . -136.84 121.05 17.91 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.949 0.404 . . . . 74.219999999999999 111.486 -173.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.9 m -109.27 141.67 23.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.256 -0.646 . . . . 63.219999999999999 109.256 175.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 t -116.47 124.68 50.55 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.937 0.875 . . . . 74.099999999999994 110.99 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.757 HG23 ' HB3' ' A' ' 145' ' ' GLU . 4.7 mp -121.85 150.18 25.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.692 -1.14 . . . . 51.310000000000002 109.685 -176.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.9 37.99 0.76 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.509 -0.377 . . . . 71.409999999999997 113.582 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.514 ' HG2' HG21 ' A' ' 12' ' ' ILE . 74.3 mmtt -105.66 152.0 39.98 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 108.264 -1.013 . . . . 52.109999999999999 108.264 175.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.405 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 52.9 Cg_exo -55.73 -57.85 1.37 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.151 1.9 . . . . 51.25 112.593 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . 173.33 -54.1 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.404 0.621 . . . . 74.439999999999998 110.164 178.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.735 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 7.8 mt-10 -55.56 -39.32 70.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.82 -1.082 . . . . 63.119999999999997 111.814 -175.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.6 ' NE2' ' HB2' ' A' ' 17' ' ' GLU . 2.5 mp0 -73.43 -14.11 61.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.864 -0.607 . . . . 74.340000000000003 111.135 -175.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.3 mt -76.04 -44.07 40.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.592 -0.276 . . . . 71.420000000000002 111.064 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.735 ' CE2' ' HA ' ' A' ' 17' ' ' GLU . 21.1 p90 -73.75 -23.47 59.74 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 119.999 -0.68 . . . . 74.109999999999999 110.22 175.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.588 ' HB1' ' HD2' ' A' ' 27' ' ' PRO . . . -75.58 -2.64 30.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.5 -0.773 . . . . 71.319999999999993 111.74 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.447 HG13 ' HZ ' ' A' ' 140' ' ' PHE . 15.0 p -52.14 -31.55 14.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 112.144 0.424 . . . . 74.450000000000003 112.144 -177.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -67.7 -13.0 61.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.706 0.289 . . . . 75.549999999999997 111.449 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.745 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . 39.3 mmt180 -117.14 15.28 14.99 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.193 -0.458 . . . . 72.299999999999997 110.715 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.417 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 11.6 t70 61.5 37.57 16.4 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.864 0.84 . . . . 71.340000000000003 109.117 -175.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER 43.84 85.33 0.17 Allowed Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 114.967 -1.015 . . . . 73.430000000000007 111.726 -177.492 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.745 ' HD3' ' HB2' ' A' ' 24' ' ' ARG . 63.3 Cg_endo -73.59 111.63 3.34 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.617 2.211 . . . . 74.409999999999997 112.579 -175.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.439 ' C ' ' HD3' ' A' ' 30' ' ' PRO . . . -79.14 97.61 1.55 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.584 -0.817 . . . . 60.0 111.482 176.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.44 74.06 11.22 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 121.057 0.456 . . . . 64.340000000000003 111.839 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.439 ' HD3' ' C ' ' A' ' 28' ' ' GLY . 8.0 Cg_exo -72.58 -4.1 14.68 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.888 2.392 . . . . 73.540000000000006 111.778 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.633 ' H ' HD12 ' A' ' 31' ' ' LEU . 4.4 mp -64.7 -35.11 79.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.803 -0.635 . . . . 72.140000000000001 110.07 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -76.97 -14.72 59.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.823 -0.626 . . . . 71.019999999999996 110.176 177.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 46.6 ttm 71.24 -57.09 0.61 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.248 -0.887 . . . . 73.430000000000007 111.604 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 45.3 p -69.53 141.13 53.92 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.209 -0.45 . . . . 73.5 110.965 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -72.72 -66.14 0.7 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.84 -0.43 . . . . 71.400000000000006 109.84 176.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 50.2 tp -139.86 87.74 2.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.24 -0.436 . . . . 61.229999999999997 110.018 175.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -173.32 128.87 0.45 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.799 -0.637 . . . . 71.510000000000005 109.605 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 43.0 m 67.14 9.0 6.6 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.406 0.521 . . . . 72.420000000000002 112.406 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.435 HG11 HG13 ' A' ' 51' ' ' VAL . 43.8 t -98.18 -53.92 7.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.811 -0.811 . . . . 72.019999999999996 108.811 174.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.419 ' OE2' HG12 ' A' ' 51' ' ' VAL . 23.7 mm-40 -85.45 -160.16 0.5 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.064 -0.971 . . . . 72.329999999999998 110.665 173.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.753 ' HB ' ' HB3' ' A' ' 47' ' ' SER . 5.8 p -42.6 127.27 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 121.872 0.844 . . . . 72.099999999999994 112.279 -177.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 73.0 mt -91.39 -30.74 16.35 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.964 -1.017 . . . . 71.099999999999994 110.298 -176.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 45' ' ' LYS . 2.9 m-20 -80.35 -3.99 51.71 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.337 -0.847 . . . . 53.240000000000002 111.583 -178.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.403 ' H ' HG22 ' A' ' 41' ' ' VAL . 16.3 t70 68.72 -39.67 0.42 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.943 0.897 . . . . 72.329999999999998 112.249 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.968 ' HG3' ' HG3' ' A' ' 46' ' ' ARG . 17.3 tppt? -88.77 -62.62 1.45 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.545 0.212 . . . . 73.030000000000001 111.468 178.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.968 ' HG3' ' HG3' ' A' ' 45' ' ' LYS . 70.4 mtp85 -117.98 129.93 55.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.792 0.33 . . . . 72.430000000000007 110.761 -175.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.753 ' HB3' ' HB ' ' A' ' 41' ' ' VAL . 46.7 p -96.62 150.1 21.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.232 -0.44 . . . . 61.240000000000002 110.9 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -85.85 -37.64 18.97 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.306 -0.628 . . . . 73.439999999999998 109.306 175.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 33.3 t90 -161.21 133.95 6.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.375 -0.829 . . . . 74.400000000000006 109.838 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.3 m -94.28 140.57 29.61 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.23 -0.441 . . . . 71.450000000000003 110.343 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.435 HG13 HG11 ' A' ' 39' ' ' VAL . 11.2 p -94.69 -26.13 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.678 0.275 . . . . 74.25 110.77 -175.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -56.91 -57.27 13.22 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.03 -0.729 . . . . 62.439999999999998 109.03 176.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.26 143.78 49.34 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.086 -0.961 . . . . 73.209999999999994 109.049 175.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.79 124.83 16.61 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.376 2.051 . . . . 61.409999999999997 112.257 -178.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.546 ' HB1' ' O ' ' A' ' 58' ' ' GLY . . . 70.36 142.41 0.09 OUTLIER Pre-proline 0 N--CA 1.467 0.402 0 O-C-N 123.957 0.786 . . . . 65.409999999999997 111.817 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.563 ' CB ' ' HB3' ' A' ' 64' ' ' ALA . 9.9 Cg_endo -53.86 -56.17 2.85 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 123.23 2.62 . . . . 73.109999999999999 113.052 -176.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.628 HD21 ' O ' ' A' ' 63' ' ' GLU . 0.1 OUTLIER -97.94 7.92 45.57 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.567 -0.453 . . . . 73.010000000000005 111.749 -177.457 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.546 ' O ' ' HB1' ' A' ' 55' ' ' ALA . . . 116.83 -82.8 0.33 Allowed Glycine 0 C--O 1.225 -0.465 0 C-N-CA 120.137 -1.03 . . . . 52.329999999999998 113.606 176.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -139.85 16.35 2.49 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 122.034 -0.686 . . . . 74.409999999999997 111.874 -176.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.455 HG22 ' HB2' ' A' ' 57' ' ' LEU . 34.5 m -101.22 11.19 7.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 120.978 -0.289 . . . . 74.420000000000002 111.216 -178.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.434 ' HB3' ' HE3' ' A' ' 62' ' ' TRP . 22.3 t 60.31 -152.68 0.39 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.094 -0.706 . . . . 71.200000000000003 109.094 -175.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.434 ' HE3' ' HB3' ' A' ' 61' ' ' SER . 1.2 m-90 74.98 -162.92 0.07 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.288 0.566 . . . . 72.329999999999998 112.51 173.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.628 ' O ' HD21 ' A' ' 57' ' ' LEU . 11.3 mt-10 -107.4 166.28 10.77 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.835 -1.075 . . . . 73.040000000000006 110.249 -175.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.563 ' HB3' ' CB ' ' A' ' 56' ' ' PRO . . . -105.09 146.87 28.54 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.5 -0.556 . . . . 62.240000000000002 109.5 169.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.781 ' HB2' HD21 ' A' ' 80' ' ' LEU . 5.5 tm-20 -108.05 135.21 49.8 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.356 -1.35 . . . . 62.100000000000001 107.356 177.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.732 HD21 ' HB2' ' A' ' 69' ' ' ASP . 29.3 tp -137.96 149.38 46.09 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.486 -0.486 . . . . 74.540000000000006 110.462 -171.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.9 t -119.11 -18.34 8.74 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.251 -0.58 . . . . 73.5 111.773 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -152.61 129.07 10.65 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 120.776 -0.37 . . . . 74.329999999999998 111.605 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.732 ' HB2' HD21 ' A' ' 66' ' ' LEU . 19.3 t70 -136.17 90.66 2.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.4 -0.818 . . . . 74.230000000000004 110.273 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.54 ' HB2' ' HB2' ' A' ' 73' ' ' LYS . 31.4 mt-10 -139.38 142.82 33.6 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 110.067 -0.346 . . . . 65.209999999999994 110.067 177.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 16.5 Cg_exo -69.1 -55.06 0.21 Allowed 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.747 2.298 . . . . 63.119999999999997 113.061 -178.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.56 49.88 0.83 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.572 -0.823 . . . . 75.349999999999994 112.42 -176.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.54 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 7.7 mmmm -139.0 -74.48 0.38 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.026 0.441 . . . . 74.230000000000004 110.428 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.499 ' HB3' HD13 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -166.51 137.78 3.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.957 -0.565 . . . . 71.010000000000005 110.1 179.127 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.666 HD12 ' HE2' ' A' ' 93' ' ' PHE . 3.2 mp -109.44 110.11 30.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.901 -0.778 . . . . 72.209999999999994 108.901 173.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -119.2 115.19 23.69 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.438 -0.949 . . . . 36.539999999999999 108.438 176.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.662 ' HA ' HD12 ' A' ' 66' ' ' LEU . 63.0 p-90 -121.48 157.65 30.15 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.511 0.672 . . . . 74.430000000000007 111.544 -169.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.67 ' HD2' ' OE1' ' A' ' 65' ' ' GLU . 69.8 mtt180 -136.39 175.8 9.28 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 107.92 -1.141 . . . . 62.119999999999997 107.92 176.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.681 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 19.6 m -137.19 51.54 1.95 Allowed 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.678 -0.49 . . . . 61.310000000000002 109.678 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.781 HD21 ' HB2' ' A' ' 65' ' ' GLU . 13.0 mt 65.3 142.21 0.07 OUTLIER Pre-proline 0 N--CA 1.471 0.624 0 O-C-N 124.264 0.977 . . . . 64.109999999999999 111.014 -175.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 80' ' ' LEU . 22.4 Cg_exo -66.38 -35.33 31.57 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.461 2.107 . . . . 71.439999999999998 112.097 177.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.87 18.46 57.17 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.596 -0.811 . . . . 55.219999999999999 112.87 -177.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.681 ' HB1' ' O ' ' A' ' 79' ' ' SER . . . -118.14 -158.13 0.7 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 122.582 -0.363 . . . . 64.540000000000006 111.167 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.403 ' HA ' ' HD2' ' A' ' 84' ' ' ARG . 24.5 tpt180 -66.5 -66.07 0.6 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.642 0.608 . . . . 54.109999999999999 112.642 -168.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 50.2 mt 59.61 87.96 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.264 0.555 . . . . 74.239999999999995 110.547 -172.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -80.19 -46.25 16.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.98 -0.554 . . . . 63.049999999999997 110.952 -175.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.606 HD22 ' HB2' ' A' ' 108' ' ' LEU . 54.2 t30 -125.89 162.15 25.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.1 -0.5 . . . . 65.310000000000002 109.771 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.8 m -138.35 128.65 25.95 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.082 -0.34 . . . . 74.439999999999998 110.082 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.18 148.89 4.91 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.751 -0.737 . . . . 53.409999999999997 111.807 178.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.72 159.31 16.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.151 0.5 . . . . 72.219999999999999 111.369 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.9 p -110.89 128.05 67.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.667 -0.697 . . . . 75.109999999999999 110.492 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.499 HD13 ' HB3' ' A' ' 74' ' ' ARG . 3.9 mm? -100.25 126.88 46.6 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.499 -0.773 . . . . 74.510000000000005 110.357 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.666 ' HE2' HD12 ' A' ' 75' ' ' ILE . 85.7 m-85 -107.63 106.69 17.15 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.23 -0.656 . . . . 74.140000000000001 109.23 175.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.467 ' HD3' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -129.93 144.9 54.92 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 116.152 -0.476 . . . . 74.150000000000006 110.763 -175.147 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -61.57 123.39 12.62 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.603 2.202 . . . . 62.409999999999997 111.377 175.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.7 144.03 93.23 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.287 -0.415 . . . . 71.150000000000006 110.247 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -43.25 115.31 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.584 2.856 . . . . 72.430000000000007 114.056 -176.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.15 -75.38 0.33 Allowed Glycine 0 N--CA 1.437 -1.268 0 CA-C-N 115.125 -0.943 . . . . 71.230000000000004 111.169 174.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 175.04 24.2 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.159 -0.521 . . . . 61.299999999999997 111.556 -175.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -67.87 -33.63 75.11 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.887 0.375 . . . . 64.140000000000001 111.505 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.02 -154.58 25.63 Favored Glycine 0 CA--C 1.506 -0.478 0 N-CA-C 111.33 -0.708 . . . . 62.549999999999997 111.33 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 91.6 m -106.79 117.83 35.08 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.252 0.549 . . . . 75.340000000000003 110.378 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.42 ' CG ' ' HB2' ' A' ' 9' ' ' ALA . 43.3 tt0 -78.86 115.85 18.81 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.125 -0.943 . . . . 72.209999999999994 110.408 178.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.4 p -94.01 103.95 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.708 0.766 . . . . 65.129999999999995 110.033 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.467 HG22 ' HD3' ' A' ' 94' ' ' ARG . 18.9 t -100.46 111.02 28.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 114.939 -1.028 . . . . 72.019999999999996 110.084 -177.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.437 HG12 HD21 ' A' ' 108' ' ' LEU . 10.9 t -120.14 132.33 70.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.031 0.443 . . . . 73.109999999999999 110.707 -178.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 107' ' ' ARG . 0.6 OUTLIER -118.13 103.31 9.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.833 -0.621 . . . . 75.549999999999997 109.843 175.214 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.606 ' HB2' HD22 ' A' ' 87' ' ' ASN . 2.3 pt? -150.68 155.25 38.96 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.449 -0.341 . . . . 62.009999999999998 111.058 -172.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 13.8 t -81.43 133.98 35.48 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.04 -1.096 . . . . 73.340000000000003 108.04 172.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.438 ' O ' ' HB ' ' A' ' 4' ' ' THR . 14.2 t80 -155.76 179.33 9.3 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.968 -0.753 . . . . 74.010000000000005 108.968 -167.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 4.8 ptt180 -143.83 144.4 26.73 Favored Pre-proline 0 C--N 1.313 -0.989 0 N-CA-C 109.669 -0.493 . . . . 65.420000000000002 109.669 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.429 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 72.3 Cg_endo -78.6 152.98 26.39 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.917 1.745 . . . . 62.420000000000002 112.247 178.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 11.3 Cg_exo -72.93 135.47 23.38 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.883 2.389 . . . . 72.329999999999998 111.571 176.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.28 150.39 47.06 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.839 -0.696 . . . . 70.439999999999998 111.762 178.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 88.74 52.25 2.85 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.323 -0.942 . . . . 53.210000000000001 111.841 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 16.5 m -61.91 -22.19 65.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.857 0.36 . . . . 55.240000000000002 110.744 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.23 -22.14 66.67 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.077 -0.511 . . . . 54.219999999999999 110.813 175.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -60.36 -20.54 55.35 Favored Glycine 0 CA--C 1.519 0.307 0 CA-C-N 116.108 -0.496 . . . . 74.5 112.424 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.93 -20.33 66.18 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 122.68 -0.306 . . . . 63.039999999999999 111.041 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.469 ' O ' ' HG2' ' A' ' 123' ' ' ARG . 66.5 t -69.23 -47.63 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.791 0.329 . . . . 73.349999999999994 110.41 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.415 ' O ' ' HB3' ' A' ' 124' ' ' MET . 14.2 tt -75.32 -27.05 19.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.043 0.449 . . . . 71.120000000000005 110.182 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.87 -42.93 84.79 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.373 -0.376 . . . . 72.209999999999994 111.052 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 120' ' ' VAL . 13.3 ptp180 -74.51 -14.8 60.86 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.142 0.496 . . . . 71.049999999999997 110.393 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.415 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 26.2 ttt -70.49 -33.04 70.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.609 -0.723 . . . . 60.43 110.002 176.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -83.95 -53.96 5.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.807 -0.633 . . . . 64.430000000000007 110.054 178.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -104.24 113.81 27.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.757 -0.656 . . . . 62.399999999999999 110.133 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.469 HE21 ' HB2' ' A' ' 127' ' ' GLN . 1.2 pt20 -77.93 79.2 4.41 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.254 0.549 . . . . 73.310000000000002 111.045 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.498 ' HA ' ' HD3' ' A' ' 129' ' ' PRO . 41.0 mt-10 -103.1 140.72 21.31 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.282 -0.417 . . . . 74.150000000000006 109.944 176.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 128' ' ' GLU . 10.2 Cg_endo -91.72 -46.74 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.223 2.615 . . . . 44.030000000000001 113.92 -175.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 49.2 m -105.55 102.77 12.21 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.227 0.454 . . . . 74.219999999999999 112.227 -171.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.557 ' HA ' ' HG2' ' A' ' 138' ' ' MET . 27.4 mp0 -100.96 -40.19 7.38 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.41 -0.959 . . . . 72.540000000000006 108.41 168.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 59.26 -163.49 0.22 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.323 -0.853 . . . . 74.319999999999993 111.072 173.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.539 ' HG ' ' H ' ' A' ' 134' ' ' ARG . 22.9 tp -69.01 175.63 3.62 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.402 -1.333 . . . . 64.430000000000007 107.402 164.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.539 ' H ' ' HG ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER 49.35 33.4 5.35 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.873 0.844 . . . . 62.130000000000003 109.447 -169.429 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -48.06 -43.68 30.7 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 113.823 -1.535 . . . . 73.019999999999996 112.949 -173.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -73.34 -36.91 66.23 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.915 0.388 . . . . 71.340000000000003 111.048 -175.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.571 ' CD2' ' HB3' ' A' ' 8' ' ' ASP . 24.3 tp -77.05 -21.85 53.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.224 0.535 . . . . 72.409999999999997 109.729 -178.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.712 ' HA ' ' HE1' ' A' ' 138' ' ' MET . 0.1 OUTLIER -63.89 -35.2 79.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.914 -0.584 . . . . 75.530000000000001 109.442 175.386 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.661 ' O ' ' HG3' ' A' ' 142' ' ' ARG . 52.6 mtt180 -73.14 -32.56 64.97 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.664 -0.698 . . . . 52.350000000000001 110.023 177.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.447 ' HZ ' HG13 ' A' ' 22' ' ' VAL . 83.4 t80 -62.05 -34.29 75.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.707 -0.679 . . . . 63.329999999999998 110.046 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.453 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 21.0 ttpp -60.81 -53.02 62.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.41 . . . . 73.019999999999996 110.957 176.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.661 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 3.5 ptm180 -64.68 -29.31 70.3 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.585 0.587 . . . . 61.310000000000002 112.585 -174.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -79.57 -33.62 41.62 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.143 -0.623 . . . . 73.340000000000003 110.42 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.504 ' CB ' HG12 ' A' ' 12' ' ' ILE . 13.4 mm-40 -59.31 -43.92 92.59 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.29 0.566 . . . . 71.129999999999995 111.263 176.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.757 ' HB3' HG23 ' A' ' 12' ' ' ILE . 9.0 pt-20 -81.97 -3.44 54.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.718 -0.674 . . . . 74.519999999999996 111.48 -177.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 54.2 tp -112.76 -61.56 1.71 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.063 0.459 . . . . 54.200000000000003 111.306 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 139.47 -92.85 0.19 Allowed Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 111.101 -0.8 . . . . 44.130000000000003 111.101 -173.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 60.7 tp -134.83 127.11 30.16 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.88 0.372 . . . . 65.219999999999999 110.764 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 150' ' ' HIS . 2.2 tm-20 -158.97 129.81 6.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.776 -1.194 . . . . 36.539999999999999 107.776 175.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.422 ' HB2' ' O ' ' A' ' 149' ' ' GLU . 10.1 m80 69.97 84.11 0.15 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.49 0.662 . . . . 75.010000000000005 111.04 -174.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -114.28 -20.17 10.98 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.481 -0.781 . . . . 64.319999999999993 109.829 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.5 t-80 -110.79 126.04 54.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.102 0.477 . . . . 65.519999999999996 110.64 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -98.53 149.77 22.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.914 -0.585 . . . . 72.420000000000002 109.997 175.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 26.2 m170 -79.41 91.39 5.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.89 0.376 . . . . 75.120000000000005 110.479 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 . . . . . 0 C--O 1.245 0.847 0 CA-C-O 118.43 -0.795 . . . . 75.420000000000002 109.259 179.815 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 109.954 -0.387 . . . . 64.430000000000007 109.954 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 146.43 146.49 4.4 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.858 -0.687 . . . . 72.510000000000005 112.212 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -79.72 176.79 9.4 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.031 0.443 . . . . 50.450000000000003 110.544 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.7 m -133.38 121.91 23.0 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.187 -0.461 . . . . 71.340000000000003 110.15 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.762 HG11 ' HG1' ' A' ' 109' ' ' THR . 74.6 t -108.44 136.39 44.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.126 -0.488 . . . . 72.409999999999997 110.034 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.6 t -78.77 117.28 24.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.095 0.474 . . . . 72.319999999999993 111.159 -173.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -140.06 109.81 6.36 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.541 -0.754 . . . . 75.219999999999999 109.971 173.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.528 ' HB3' HD22 ' A' ' 137' ' ' LEU . 4.1 t70 -151.46 172.57 15.77 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.759 -1.2 . . . . 64.140000000000001 107.759 174.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.416 ' HB3' ' CG ' ' A' ' 103' ' ' GLU . . . -139.8 120.81 14.61 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.05 0.453 . . . . 64.349999999999994 111.205 -172.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.552 HG22 HD13 ' A' ' 12' ' ' ILE . 19.4 m -111.24 148.9 14.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.73 -0.668 . . . . 65.340000000000003 110.313 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.6 t -114.44 103.75 11.36 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.796 0.808 . . . . 74.540000000000006 110.781 175.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.792 HG23 ' HB3' ' A' ' 144' ' ' GLN . 1.1 mp -96.16 151.81 3.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.238 -0.892 . . . . 73.439999999999998 108.711 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.39 51.12 1.39 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.322 -0.466 . . . . 74.099999999999994 113.483 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.672 ' HB3' ' HB2' ' A' ' 18' ' ' GLN . 79.7 mttt -128.13 144.82 53.07 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 108.049 -1.093 . . . . 75.239999999999995 108.049 172.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -55.21 -57.74 1.51 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.32 2.013 . . . . 74.120000000000005 113.332 -174.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 173.32 -51.37 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.45 -0.945 . . . . 63.299999999999997 108.45 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.674 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 2.5 tt0 -48.76 -37.86 20.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 113.943 -1.48 . . . . 63.43 111.421 174.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.672 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 31.0 mm-40 -85.84 -13.29 48.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.577 -0.738 . . . . 75.219999999999999 111.15 -176.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.671 HD23 HD11 ' A' ' 12' ' ' ILE . 91.7 mt -83.89 -53.21 5.75 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 112.079 0.4 . . . . 73.450000000000003 112.079 -177.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.674 ' CE2' ' HA ' ' A' ' 17' ' ' GLU . 32.7 p90 -66.96 -23.29 65.94 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.193 0.521 . . . . 65.340000000000003 111.06 -175.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.1 -3.01 30.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.771 -0.65 . . . . 71.340000000000003 111.661 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 25' ' ' ASP . 13.5 p -52.64 -22.28 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 113.162 0.801 . . . . 71.409999999999997 113.162 -175.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -56.51 -32.32 64.93 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.138 0.494 . . . . 73.129999999999995 110.35 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -116.71 6.05 13.24 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.099 -0.704 . . . . 75.25 109.099 175.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.557 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 31.3 t70 48.63 95.69 0.01 OUTLIER 'General case' 0 C--O 1.235 0.305 0 CA-C-N 114.312 -1.313 . . . . 73.530000000000001 111.644 -168.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.531 HD21 ' HZ1' ' A' ' 14' ' ' LYS . 16.5 mt 67.32 153.85 0.13 Allowed Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 114.686 -1.143 . . . . 74.510000000000005 111.232 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 26' ' ' LEU . 3.3 Cg_exo -76.63 108.88 2.75 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.684 2.256 . . . . 72.319999999999993 112.45 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.06 96.25 0.78 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 121.021 -0.609 . . . . 38.789999999999999 112.172 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 51.2 mt -75.58 150.37 84.39 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.502 0.191 . . . . 74.430000000000007 110.832 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.76 7.45 1.61 Allowed 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 123.294 2.663 . . . . 71.409999999999997 112.731 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.648 ' HG ' ' HB2' ' A' ' 36' ' ' LEU . 7.7 mp 65.81 8.19 5.11 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.111 -0.495 . . . . 73.310000000000002 110.804 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 59.46 20.15 8.53 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.623 -0.717 . . . . 64.120000000000005 110.584 -177.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 65.9 mtt 62.31 19.56 11.13 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.627 -0.715 . . . . 74.140000000000001 111.407 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.4 m -123.43 -63.38 1.24 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.302 -0.408 . . . . 74.019999999999996 109.965 177.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -179.86 142.82 0.17 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.411 -0.813 . . . . 71.439999999999998 109.347 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.648 ' HB2' ' HG ' ' A' ' 31' ' ' LEU . 1.0 OUTLIER -69.43 103.18 1.95 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.917 -0.772 . . . . 73.239999999999995 108.917 176.863 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -90.95 -35.76 14.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.332 -0.395 . . . . 71.450000000000003 110.579 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.8 p -175.73 156.11 1.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.955 -0.566 . . . . 73.129999999999995 110.307 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.4 t -105.41 97.75 5.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.14 -0.689 . . . . 72.510000000000005 109.14 173.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -128.08 140.13 52.12 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.973 -0.558 . . . . 74.439999999999998 110.841 -174.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.9 p -93.28 141.6 14.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.205 -0.452 . . . . 74.340000000000003 110.142 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 53' ' ' ALA . 94.6 mt -65.87 -45.44 82.09 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.323 0.49 . . . . 74.439999999999998 112.323 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -166.11 -85.43 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.962 0.411 . . . . 73.230000000000004 112.086 -173.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.2 t70 175.42 -47.87 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.072 -1.084 . . . . 71.540000000000006 108.072 -172.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.551 ' HB3' ' HB3' ' A' ' 56' ' ' PRO . 2.9 mptt -81.53 11.61 4.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.89 -1.05 . . . . 72.25 111.494 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -170.99 139.47 1.41 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.285 -0.635 . . . . 73.109999999999999 109.285 177.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.517 ' O ' ' HD2' ' A' ' 48' ' ' ARG . 12.1 p -139.11 105.44 5.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.933 0.397 . . . . 73.010000000000005 111.087 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.517 ' HD2' ' O ' ' A' ' 47' ' ' SER . 2.2 mpt_? -127.09 -85.66 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.804 0.335 . . . . 72.019999999999996 111.308 -176.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -135.46 -164.0 1.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.984 -0.553 . . . . 74.049999999999997 109.518 -175.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.5 p -90.13 19.08 5.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.442 0.639 . . . . 74.239999999999995 110.185 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.6 p -156.04 155.15 5.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.432 -0.804 . . . . 63.329999999999998 109.496 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.58 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 36.9 mt-10 64.78 98.91 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.794 0.684 . . . . 54.340000000000003 112.029 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.401 ' HA ' HD13 ' A' ' 42' ' ' LEU . . . -107.28 87.68 3.39 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.543 -0.753 . . . . 64.0 110.095 176.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.58 ' HD3' ' O ' ' A' ' 52' ' ' GLU . 4.9 Cg_exo -74.33 -171.57 0.95 Allowed 'Trans proline' 0 C--O 1.239 0.532 0 C-N-CA 123.235 2.623 . . . . 75.030000000000001 112.77 -173.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.61 146.45 98.56 Favored Pre-proline 0 N--CA 1.451 -0.412 0 CA-C-N 115.734 -0.667 . . . . 73.450000000000003 109.649 174.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.551 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 19.6 Cg_endo -57.44 -20.14 39.18 Favored 'Trans proline' 0 N--CA 1.476 0.463 0 C-N-CA 123.26 2.64 . . . . 61.140000000000001 113.445 -175.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.761 ' HA ' HD11 ' A' ' 80' ' ' LEU . 2.5 pt? -121.84 -6.91 9.04 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.523 -0.308 . . . . 74.329999999999998 111.36 -178.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.84 -111.71 2.66 Favored Glycine 0 N--CA 1.453 -0.209 0 CA-C-N 115.764 -0.653 . . . . 63.240000000000002 111.948 -175.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.35 -53.48 8.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.979 0.418 . . . . 61.149999999999999 110.218 175.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.0 p -177.84 -38.39 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.736 -0.665 . . . . 75.310000000000002 110.281 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.3 m -132.47 25.69 4.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.348 0.594 . . . . 38.789999999999999 109.696 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 42.4 t-105 -89.75 -33.51 16.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.587 -0.733 . . . . 73.0 111.009 -171.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.403 ' CD ' ' HE ' ' A' ' 48' ' ' ARG . 11.2 mm-40 -106.98 168.09 9.44 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.236 -0.893 . . . . 64.0 110.74 -175.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -116.98 124.75 50.14 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.562 -0.533 . . . . 72.420000000000002 109.562 175.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -106.1 134.97 48.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.823 0.344 . . . . 74.299999999999997 110.105 -178.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.827 HD12 ' HA ' ' A' ' 77' ' ' TRP . 3.1 mm? -97.7 151.98 19.57 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.837 -0.801 . . . . 55.130000000000003 108.837 176.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.1 p -75.32 -36.91 61.02 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.006 -0.739 . . . . 74.319999999999993 109.006 175.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -173.28 127.91 0.44 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.602 -1.181 . . . . 74.420000000000002 111.418 177.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -124.48 94.16 4.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.53 -0.759 . . . . 74.239999999999995 109.211 174.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 48.9 mt-10 -104.09 142.45 24.62 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 63.439999999999998 111.296 -174.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 31.5 Cg_exo -59.18 99.25 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.362 2.708 . . . . 74.329999999999998 113.694 -172.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.51 40.76 96.67 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.367 -0.833 . . . . 71.310000000000002 113.072 177.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -128.58 -79.67 0.57 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.021 0.438 . . . . 74.25 110.341 178.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -136.59 132.74 35.54 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.013 -0.54 . . . . 73.430000000000007 109.551 176.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 30.7 mm -120.36 110.34 28.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.809 -0.632 . . . . 75.150000000000006 109.354 -177.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -119.41 116.99 27.28 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.309 0.576 . . . . 75.140000000000001 110.47 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.827 ' HA ' HD12 ' A' ' 66' ' ' LEU . 44.9 m95 -89.9 159.56 16.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.374 -0.83 . . . . 72.209999999999994 111.072 -174.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -164.92 175.75 9.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.72 -0.673 . . . . 74.530000000000001 109.688 -178.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.568 ' HB3' ' O ' ' A' ' 84' ' ' ARG . 9.2 t -138.04 173.11 11.98 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.203 -1.406 . . . . 65.140000000000001 107.203 175.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.761 HD11 ' HA ' ' A' ' 57' ' ' LEU . 97.5 mt -79.01 144.28 63.15 Favored Pre-proline 0 C--N 1.314 -0.957 0 C-N-CA 121.054 -0.258 . . . . 73.540000000000006 110.689 -177.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.437 ' HA ' HG23 ' A' ' 85' ' ' ILE . 52.5 Cg_exo -56.14 -37.54 96.32 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.123 2.548 . . . . 74.519999999999996 112.676 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.69 -16.65 74.34 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.684 -0.769 . . . . 73.319999999999993 112.26 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.2 -62.58 1.26 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.705 0.288 . . . . 61.149999999999999 111.033 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.568 ' O ' ' HB3' ' A' ' 79' ' ' SER . 29.4 ttm180 -177.23 117.56 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.752 -0.658 . . . . 75.040000000000006 110.808 -173.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.44 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 2.1 pp -113.97 -166.58 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.543 -0.299 . . . . 74.299999999999997 110.732 175.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 49.4 mm-40 71.61 8.09 6.11 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.15 0.58 . . . . 73.109999999999999 111.707 -177.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -74.03 131.79 41.72 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.301 -0.629 . . . . 75.310000000000002 109.301 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.413 ' HB3' ' H ' ' A' ' 109' ' ' THR . 22.7 t -112.36 127.1 55.91 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.934 -0.395 . . . . 71.129999999999995 109.934 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -179.25 72.26 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.645 -0.788 . . . . 62.439999999999998 112.033 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -102.82 116.42 32.52 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.758 -0.46 . . . . 71.219999999999999 109.758 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.653 HG22 HG22 ' A' ' 106' ' ' VAL . 89.6 t -102.61 126.55 56.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.458 0.647 . . . . 73.349999999999994 111.267 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.521 ' HB2' ' HB ' ' A' ' 105' ' ' VAL . 3.2 mm? -110.4 120.81 43.62 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.965 -1.016 . . . . 71.109999999999999 109.833 176.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -97.62 118.04 33.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.929 0.395 . . . . 73.329999999999998 110.345 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.0 mtp180 -123.78 145.39 47.41 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.008 -0.542 . . . . 73.099999999999994 110.552 -176.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.34 119.01 6.0 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.591 2.194 . . . . 75.340000000000003 111.187 175.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.95 143.99 47.01 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.045 0.45 . . . . 74.519999999999996 111.935 -173.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -60.54 131.01 35.87 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.312 2.675 . . . . 63.240000000000002 112.231 177.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.41 0.38 90.02 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 121.099 -0.572 . . . . 72.329999999999998 111.851 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 58.76 34.01 23.45 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 122.921 0.488 . . . . 75.120000000000005 111.306 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -60.37 -31.99 70.87 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.263 0.554 . . . . 72.329999999999998 110.504 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 170.49 -137.85 4.66 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.194 -1.162 . . . . 74.430000000000007 110.194 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 72.0 m -121.43 130.64 53.71 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 117.06 0.43 . . . . 62.399999999999999 110.19 175.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.416 ' CG ' ' HB3' ' A' ' 9' ' ' ALA . 42.5 tt0 -76.97 119.3 20.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.056 -0.52 . . . . 75.120000000000005 110.904 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.639 HG21 HG13 ' A' ' 91' ' ' VAL . 2.4 p -99.1 106.62 19.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.627 -0.715 . . . . 64.099999999999994 110.041 175.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 92' ' ' LEU . 26.1 t -91.8 109.91 21.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.765 -0.652 . . . . 74.349999999999994 109.413 177.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.653 HG22 HG22 ' A' ' 91' ' ' VAL . 48.8 t -112.11 121.43 64.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.953 0.406 . . . . 64.439999999999998 110.71 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -113.97 104.82 12.54 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.72 -0.844 . . . . 72.140000000000001 108.72 172.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.575 ' H ' HD21 ' A' ' 108' ' ' LEU . 2.4 pt? -119.0 120.47 37.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.181 0.515 . . . . 73.540000000000006 109.824 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.762 ' HG1' HG11 ' A' ' 5' ' ' VAL . 86.6 m -103.45 125.26 49.93 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.2 -0.455 . . . . 64.239999999999995 110.787 -177.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -145.97 177.72 8.74 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.612 -0.884 . . . . 74.310000000000002 108.612 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 4.3 ptt180 -146.67 155.49 48.69 Favored Pre-proline 0 C--N 1.317 -0.807 0 CA-C-N 116.657 -0.247 . . . . 74.549999999999997 110.603 -175.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -63.23 155.91 58.77 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.398 2.065 . . . . 61.140000000000001 111.328 173.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -69.45 5.17 1.68 Allowed 'Trans proline' 0 N--CA 1.478 0.612 0 C-N-CA 123.294 2.663 . . . . 71.310000000000002 113.333 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -176.42 -47.46 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.969 -0.634 . . . . 65.109999999999999 111.581 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 160.37 -117.2 0.76 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.003 -0.617 . . . . 74.129999999999995 111.977 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.1 m -60.63 -27.99 68.2 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.648 0.24 . . . . 61.119999999999997 111.648 -176.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.88 -23.38 67.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.935 0.398 . . . . 74.120000000000005 111.194 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.73 -21.07 70.82 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.986 -0.626 . . . . 72.019999999999996 112.774 -177.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.99 -41.95 67.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.64 0.257 . . . . 72.340000000000003 111.451 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.402 ' O ' ' HG3' ' A' ' 124' ' ' MET . 30.4 m -76.67 -35.34 25.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.792 -0.363 . . . . 63.25 110.805 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 79.2 mt -59.58 -30.9 45.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 116.358 -0.383 . . . . 72.530000000000001 110.709 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.926 ' HA ' ' HB3' ' A' ' 126' ' ' ASN . . . -52.64 -58.41 6.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.901 -0.591 . . . . 62.340000000000003 111.179 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -79.52 -17.02 54.96 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.15 -0.477 . . . . 72.340000000000003 111.26 -177.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.402 ' HG3' ' O ' ' A' ' 120' ' ' VAL . 76.2 mtp -71.19 -53.66 13.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.483 -0.326 . . . . 73.319999999999993 111.343 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -156.05 -4.22 0.12 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.554 -0.458 . . . . 75.120000000000005 112.072 -176.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.926 ' HB3' ' HA ' ' A' ' 122' ' ' ALA . 63.4 t30 -82.47 -179.21 7.34 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.591 -0.522 . . . . 75.530000000000001 109.591 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -52.02 -57.86 8.26 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 111.816 0.302 . . . . 73.319999999999993 111.816 -177.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 58.46 86.85 0.15 Allowed Pre-proline 0 N--CA 1.466 0.325 0 O-C-N 123.655 0.597 . . . . 72.340000000000003 111.15 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -71.4 67.74 2.76 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 123.124 2.549 . . . . 71.319999999999993 112.427 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.554 ' HB2' ' HG2' ' A' ' 132' ' ' GLN . 9.8 m 59.35 22.09 10.44 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.942 -0.572 . . . . 64.239999999999995 111.914 175.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 60.96 22.99 13.15 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.83 0.452 . . . . 65.530000000000001 111.316 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.717 ' HG3' ' HB2' ' A' ' 136' ' ' ASP . 2.7 pt20 -134.79 170.53 15.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.571 -0.286 . . . . 74.400000000000006 110.564 -177.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.407 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 95.1 mt -136.5 146.26 46.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.672 -0.24 . . . . 73.239999999999995 110.477 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 133' ' ' LEU . 52.2 mtt85 72.72 -57.13 0.64 Allowed 'General case' 0 N--CA 1.47 0.54 0 O-C-N 123.879 0.737 . . . . 73.439999999999998 112.587 177.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -69.92 -28.53 65.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.655 0.264 . . . . 74.530000000000001 110.346 -177.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.717 ' HB2' ' HG3' ' A' ' 132' ' ' GLN . 25.3 t70 -63.8 -30.48 71.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.927 0.394 . . . . 51.439999999999998 110.585 173.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.528 HD22 ' HB3' ' A' ' 8' ' ' ASP . 39.0 tp -67.9 -26.12 65.83 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.728 -0.471 . . . . 74.230000000000004 109.728 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.748 ' HA ' ' HE2' ' A' ' 138' ' ' MET . 2.8 mmt -66.74 -30.07 70.2 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.822 -0.626 . . . . 70.310000000000002 109.911 174.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 -78.52 -35.77 45.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.522 -0.763 . . . . 74.5 109.36 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -57.62 -49.15 77.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.204 -0.907 . . . . 72.25 111.729 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.71 ' HB2' HG13 ' A' ' 12' ' ' ILE . 13.4 ptmm? -60.21 -38.48 83.48 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.897 0.379 . . . . 72.239999999999995 110.238 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.661 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 35.6 ttp180 -64.02 -44.0 93.9 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.719 -0.673 . . . . 73.219999999999999 110.81 -176.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.477 ' HA ' HD11 ' A' ' 146' ' ' LEU . 41.7 mt-10 -65.42 -30.4 71.2 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.949 0.404 . . . . 71.400000000000006 110.66 177.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.792 ' HB3' HG23 ' A' ' 12' ' ' ILE . 0.9 OUTLIER -65.49 -47.0 77.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 73.230000000000004 111.054 178.436 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.409 ' HB3' HG22 ' A' ' 12' ' ' ILE . 6.2 pt-20 -80.41 -9.29 59.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.886 0.374 . . . . 73.019999999999996 111.066 -178.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' A' ' 142' ' ' ARG . 55.4 mt -73.29 -41.13 63.96 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.721 -0.474 . . . . 71.540000000000006 109.721 170.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 91.41 149.62 23.95 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.048 -0.596 . . . . 64.219999999999999 112.703 177.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 5.9 tt -109.11 -69.06 0.88 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.5 -0.556 . . . . 55.219999999999999 109.5 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -104.25 -36.58 7.59 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.977 0.418 . . . . 72.549999999999997 110.686 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 21.9 m170 -114.2 102.62 10.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.437 -0.347 . . . . 74.340000000000003 110.371 -176.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -119.36 83.17 1.99 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.098 0.475 . . . . 74.340000000000003 110.289 177.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -168.25 134.5 1.94 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.504 -0.771 . . . . 73.450000000000003 109.874 176.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 30.5 t60 -77.91 102.54 7.35 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.49 -0.777 . . . . 74.299999999999997 111.057 -173.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -96.57 -7.3 34.8 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.947 -0.301 . . . . 73.420000000000002 111.39 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.693 -0.67 . . . . 74.439999999999998 109.465 179.901 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 110.394 -0.224 . . . . 70.219999999999999 110.394 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 144.13 -149.11 21.14 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.211 -0.995 . . . . 52.420000000000002 112.517 178.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 53.11 72.95 0.39 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.389 0.614 . . . . 71.230000000000004 110.565 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.8 m -146.06 121.03 10.02 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.952 -0.567 . . . . 55.340000000000003 110.995 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.5 t -124.41 109.88 23.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.681 -0.691 . . . . 74.5 109.181 173.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.5 t -78.82 119.55 28.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 116.016 -0.538 . . . . 75.299999999999997 110.288 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 15.0 ptt180 -141.65 125.01 16.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.429 0.633 . . . . 74.510000000000005 111.225 176.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.411 ' HB3' HD23 ' A' ' 137' ' ' LEU . 3.8 t70 -157.42 174.1 15.91 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.946 -1.131 . . . . 63.32 107.946 174.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.58 ' HB3' ' HG2' ' A' ' 103' ' ' GLU . . . -134.45 122.37 22.39 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.798 0.332 . . . . 62.229999999999997 111.279 -170.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.547 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 17.1 m -108.04 130.14 61.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.271 0.557 . . . . 61.350000000000001 110.998 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.664 HG21 ' HB1' ' A' ' 96' ' ' ALA . 21.2 m -86.83 100.16 12.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.715 -0.675 . . . . 73.25 110.497 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.674 HG21 ' HG3' ' A' ' 144' ' ' GLN . 66.9 mt -111.89 145.6 17.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.697 0.285 . . . . 71.519999999999996 111.105 -174.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.68 66.04 3.91 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 121.136 -0.554 . . . . 55.409999999999997 112.955 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.442 ' HD3' ' HB3' ' A' ' 18' ' ' GLN . 43.3 mttp -143.32 147.43 40.23 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.755 -0.461 . . . . 75.219999999999999 109.755 174.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.413 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 50.1 Cg_exo -55.14 -55.65 2.99 Favored 'Trans proline' 0 N--CA 1.479 0.65 0 C-N-CA 123.406 2.737 . . . . 52.310000000000002 114.079 -172.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.413 ' HB1' ' O ' ' A' ' 15' ' ' PRO . . . 174.65 -64.02 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.146 0.498 . . . . 70.319999999999993 110.015 178.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.433 ' OE1' ' HG2' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -56.54 -42.5 78.59 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.198 -0.91 . . . . 73.329999999999998 111.507 179.353 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.662 ' HG3' ' HB2' ' A' ' 150' ' ' HIS . 31.4 mm-40 -62.0 -21.32 64.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 74.340000000000003 111.997 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.532 ' O ' HG11 ' A' ' 22' ' ' VAL . 59.3 mt -73.96 -32.35 63.43 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.305 -0.247 . . . . 74.549999999999997 111.629 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -69.69 -24.22 63.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.182 0.515 . . . . 73.439999999999998 110.181 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.05 -23.85 67.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.752 -0.658 . . . . 75.140000000000001 111.616 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.532 HG11 ' O ' ' A' ' 19' ' ' LEU . 4.3 p -67.38 -21.97 28.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 121.174 0.512 . . . . 63.140000000000001 110.742 -178.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 54.8 t90 -64.49 -26.25 68.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.783 -0.644 . . . . 74.439999999999998 110.69 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.51 -82.65 0.64 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.767 -0.651 . . . . 75.239999999999995 109.647 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.533 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 28.5 t70 -165.92 149.66 7.85 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.466 -0.788 . . . . 74.409999999999997 109.031 178.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.37 86.14 7.81 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 121.086 0.47 . . . . 74.099999999999994 110.941 177.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.949 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 2.1 Cg_endo -87.2 146.27 7.49 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.433 2.755 . . . . 72.209999999999994 111.371 176.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.537 ' C ' ' HD3' ' A' ' 30' ' ' PRO . . . -79.47 56.76 4.45 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.861 -0.685 . . . . 62.299999999999997 112.733 -177.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.713 HD11 ' H ' ' A' ' 33' ' ' MET . 3.8 mm? -123.33 56.99 10.4 Favored Pre-proline 0 CA--C 1.534 0.33 0 O-C-N 122.741 -0.27 . . . . 75.439999999999998 111.707 176.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.537 ' HD3' ' C ' ' A' ' 28' ' ' GLY . 12.1 Cg_exo -70.49 -28.02 22.24 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.041 1.827 . . . . 63.310000000000002 111.331 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.6 ' H ' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -97.03 -6.46 35.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.364 -0.835 . . . . 74.140000000000001 110.787 177.52 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 71.2 mt 61.47 109.79 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.773 0.797 . . . . 70.349999999999994 113.123 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.713 ' H ' HD11 ' A' ' 29' ' ' LEU . 89.7 mtp -129.81 132.47 46.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.335 -0.848 . . . . 65.310000000000002 109.02 173.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.3 m -66.33 99.16 0.52 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.22 0.533 . . . . 72.340000000000003 111.446 -178.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.465 ' HB3' HD21 ' A' ' 36' ' ' LEU . 62.8 m170 -111.67 -75.98 0.6 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.727 -0.669 . . . . 71.420000000000002 109.32 174.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.465 HD21 ' HB3' ' A' ' 35' ' ' HIS . 2.9 mm? -124.8 17.35 8.67 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.74 -0.664 . . . . 40.420000000000002 109.532 177.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.417 ' HA ' ' OE2' ' A' ' 40' ' ' GLU . 77.5 mtm180 62.77 56.28 1.95 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.729 0.776 . . . . 75.439999999999998 109.537 -173.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.0 m -69.32 -77.99 0.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.747 -1.115 . . . . 71.150000000000006 112.433 -171.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.949 ' HB ' ' HG2' ' A' ' 27' ' ' PRO . 7.6 p -118.68 33.68 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.92 0.866 . . . . 65.230000000000004 110.69 -173.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.417 ' OE2' ' HA ' ' A' ' 37' ' ' ARG . 89.2 mt-10 -64.59 100.62 0.39 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.476 -0.784 . . . . 73.030000000000001 110.096 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.7 p -114.54 152.88 16.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.746 -0.661 . . . . 75.040000000000006 110.37 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.572 ' HG ' HG22 ' A' ' 51' ' ' VAL . 4.5 mp -77.22 -63.2 1.42 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.323 0.582 . . . . 73.430000000000007 110.303 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.84 ' HB3' ' HD3' ' A' ' 46' ' ' ARG . 15.2 t70 -150.07 168.96 22.38 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.269 -0.878 . . . . 72.549999999999997 109.213 -176.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -73.59 -22.35 60.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.352 . . . . 72.329999999999998 111.559 -173.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 45' ' ' LYS . 31.9 mmmt -79.18 6.67 9.14 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.179 0.437 . . . . 71.200000000000003 112.179 -177.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.84 ' HD3' ' HB3' ' A' ' 43' ' ' ASP . 0.0 OUTLIER -142.97 -167.07 2.44 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.084 -0.507 . . . . 71.310000000000002 109.75 179.343 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.7 m -112.27 173.47 6.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.771 0.796 . . . . 71.340000000000003 112.363 -174.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.576 ' HG3' ' HA ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -73.51 111.12 8.34 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.263 -0.88 . . . . 75.530000000000001 108.812 170.2 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 9.9 t-105 -136.74 -163.07 1.36 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.565 -0.531 . . . . 75.129999999999995 109.565 -175.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.51 ' O ' HG12 ' A' ' 51' ' ' VAL . 2.4 m -53.14 -27.67 22.19 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 122.766 0.426 . . . . 73.409999999999997 111.846 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.572 HG22 ' HG ' ' A' ' 42' ' ' LEU . 2.8 p 54.86 16.94 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.36 1.064 . . . . 62.119999999999997 112.392 176.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -93.69 -42.8 8.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.29 -0.414 . . . . 64.319999999999993 110.915 -176.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -99.94 143.94 27.43 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.512 -0.313 . . . . 75.120000000000005 110.775 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -89.18 159.86 5.71 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.939 2.426 . . . . 72.120000000000005 112.912 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.409 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . . . 64.1 78.5 0.27 Allowed Pre-proline 0 N--CA 1.464 0.237 0 CA-C-N 115.545 -0.752 . . . . 64.409999999999997 111.687 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.535 ' CB ' ' HB2' ' A' ' 63' ' ' GLU . 10.3 Cg_endo -54.43 -32.71 74.21 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 123.765 2.976 . . . . 65.109999999999999 113.051 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.805 ' HB3' HD22 ' A' ' 80' ' ' LEU . 0.7 OUTLIER -112.61 10.78 19.51 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.442 -0.799 . . . . 75.299999999999997 111.382 -173.784 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -80.19 -56.79 3.14 Favored Glycine 0 C--N 1.318 -0.453 0 CA-C-N 115.13 -0.941 . . . . 63.450000000000003 112.292 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.68 34.12 0.71 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.128 0.49 . . . . 75.200000000000003 111.144 -178.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.2 t 64.64 81.28 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.134 -0.939 . . . . 75.099999999999994 112.38 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.796 ' HA ' HD21 ' A' ' 80' ' ' LEU . 20.6 m 63.35 96.72 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.73 1.382 . . . . 65.010000000000005 114.73 167.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 20.2 m0 -114.42 -28.13 7.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.368 -0.833 . . . . 72.200000000000003 109.37 163.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.706 ' O ' HD12 ' A' ' 80' ' ' LEU . 7.2 mt-10 -117.44 174.59 6.06 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.402 -1.272 . . . . 74.340000000000003 112.954 -169.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.56 140.85 29.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.047 -0.979 . . . . 74.430000000000007 108.854 164.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.463 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 7.2 pt-20 -103.7 135.71 44.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.325 0.583 . . . . 75.530000000000001 111.748 -176.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.568 HD13 HG23 ' A' ' 75' ' ' ILE . 41.4 tp -105.12 126.38 52.01 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.817 -0.438 . . . . 71.099999999999994 109.817 177.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 64.2 p -84.11 -36.63 22.81 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.103 0.478 . . . . 71.25 111.224 -176.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.703 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -118.93 137.94 53.13 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.828 -0.624 . . . . 64.340000000000003 111.312 -170.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -139.61 33.3 2.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.781 -0.645 . . . . 72.420000000000002 109.856 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.979 ' HG3' ' HG2' ' A' ' 74' ' ' ARG . 5.4 mm-40 -57.33 142.83 75.29 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.427 -0.806 . . . . 72.450000000000003 110.307 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 9.2 Cg_exo -71.89 76.08 2.09 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.85 2.367 . . . . 74.129999999999995 112.173 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.47 43.82 43.69 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.947 -0.645 . . . . 72.400000000000006 112.076 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.591 ' HB2' ' HB3' ' A' ' 70' ' ' GLU . 70.9 mmtt -127.73 -69.3 0.74 Allowed 'General case' 0 C--N 1.328 -0.328 0 O-C-N 122.897 -0.178 . . . . 74.420000000000002 111.106 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.979 ' HG2' ' HG3' ' A' ' 70' ' ' GLU . 9.2 ptt180 -145.69 130.84 18.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.115 0.483 . . . . 72.329999999999998 110.397 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.672 HD12 ' HE2' ' A' ' 93' ' ' PHE . 2.3 mp -126.31 113.02 31.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.956 -0.565 . . . . 73.420000000000002 109.907 176.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.703 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -107.73 116.82 32.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.66 -0.7 . . . . 74.230000000000004 109.835 176.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.698 ' HZ3' HG13 ' A' ' 91' ' ' VAL . 31.5 p90 -98.72 143.54 28.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.471 0.653 . . . . 74.5 111.325 -174.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -141.21 179.18 6.91 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.959 -1.019 . . . . 74.329999999999998 109.44 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.5 m -132.84 147.79 52.3 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.203 -1.036 . . . . 53.020000000000003 108.203 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.805 HD22 ' HB3' ' A' ' 57' ' ' LEU . 5.4 mp -57.65 144.93 71.75 Favored Pre-proline 0 C--N 1.323 -0.549 0 O-C-N 123.497 0.498 . . . . 74.450000000000003 111.594 -176.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.35 -22.04 39.65 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.643 2.895 . . . . 71.340000000000003 113.766 -174.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -79.67 -14.83 80.59 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.015 -0.612 . . . . 44.439999999999998 112.311 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -111.17 172.32 6.95 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.683 0.277 . . . . 72.420000000000002 110.316 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -75.89 138.72 41.24 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.163 -0.68 . . . . 73.530000000000001 109.163 173.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.4 pt -75.92 88.87 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.32 0.581 . . . . 73.439999999999998 109.449 173.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -54.15 -34.67 60.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.192 -0.913 . . . . 75.099999999999994 112.047 -173.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.547 HD21 ' N ' ' A' ' 88' ' ' SER . 0.2 OUTLIER -166.73 132.82 2.31 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.897 -0.779 . . . . 65.450000000000003 108.897 178.629 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.547 ' N ' HD21 ' A' ' 87' ' ' ASN . 30.0 m -115.6 128.57 56.04 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.053 -0.351 . . . . 70.109999999999999 110.053 177.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -174.77 -178.56 44.74 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.635 -0.793 . . . . 54.299999999999997 111.981 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -147.03 132.71 18.86 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.916 -0.401 . . . . 61.32 109.916 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.698 HG13 ' HZ3' ' A' ' 77' ' ' TRP . 25.2 m -107.68 138.01 36.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.016 0.436 . . . . 75.120000000000005 110.711 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.409 ' HB2' ' HB ' ' A' ' 105' ' ' VAL . 3.4 mm? -112.32 120.82 43.01 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.708 -0.678 . . . . 73.420000000000002 109.631 177.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.672 ' HE2' HD12 ' A' ' 75' ' ' ILE . 76.2 m-85 -98.11 112.42 24.39 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.924 0.393 . . . . 72.430000000000007 110.499 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 94' ' ' ARG . 5.0 ptt180 -126.2 145.23 51.71 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.03 -0.532 . . . . 75.140000000000001 110.442 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -51.46 131.18 35.76 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.209 2.606 . . . . 74.439999999999998 112.296 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.664 ' HB1' HG21 ' A' ' 11' ' ' THR . . . -82.6 144.94 49.91 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.0 -0.545 . . . . 61.140000000000001 111.751 -175.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.79 133.19 52.32 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.913 2.409 . . . . 61.409999999999997 112.111 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.09 5.71 81.26 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 121.228 -0.511 . . . . 75.5 112.762 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 62.66 34.69 14.68 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.855 0.462 . . . . 72.120000000000005 111.34 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.16 -35.72 71.97 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 108.653 -0.869 . . . . 73.420000000000002 108.653 172.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.71 -107.16 0.29 Allowed Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 114.942 -1.026 . . . . 64.340000000000003 110.764 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.457 ' HB ' HD11 ' A' ' 19' ' ' LEU . 28.8 m -142.69 136.61 29.19 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 110.027 -0.36 . . . . 72.420000000000002 110.027 176.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.58 ' HG2' ' HB3' ' A' ' 9' ' ' ALA . 38.4 tt0 -96.57 108.38 20.96 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 109.326 -0.62 . . . . 74.329999999999998 109.326 177.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.4 p -87.79 108.66 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.679 0.752 . . . . 74.409999999999997 110.015 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.486 HG13 ' HB2' ' A' ' 9' ' ' ALA . 3.4 t -92.44 109.22 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 114.721 -1.127 . . . . 70.040000000000006 108.781 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.654 HG23 HD12 ' A' ' 108' ' ' LEU . 7.4 p -112.87 130.89 65.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 121.017 0.437 . . . . 75.310000000000002 111.303 -173.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.586 ' HD3' ' O ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -123.6 125.83 45.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.778 -0.646 . . . . 75.109999999999999 110.097 174.361 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.654 HD12 HG23 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -150.52 152.54 34.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.936 -0.575 . . . . 74.099999999999994 110.141 -179.21 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.8 t -88.32 143.23 27.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.801 0.334 . . . . 64.340000000000003 111.022 -177.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.419 ' HD1' ' HA ' ' A' ' 110' ' ' TYR . 0.4 OUTLIER -152.47 126.22 8.95 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.103 -0.703 . . . . 73.040000000000006 109.103 177.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.5 ptt180 -121.75 144.41 40.67 Favored Pre-proline 0 C--N 1.315 -0.908 0 N-CA-C 109.328 -0.619 . . . . 71.510000000000005 109.328 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -61.63 152.18 75.49 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.259 1.973 . . . . 75.299999999999997 112.035 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -82.08 146.94 14.58 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.712 2.274 . . . . 72.209999999999994 112.653 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -100.61 128.69 9.65 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.833 -0.699 . . . . 65.409999999999997 111.748 177.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 137.24 -154.28 22.29 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.439 -0.886 . . . . 73.310000000000002 112.871 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.4 p -81.19 -25.06 37.06 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.224 0.453 . . . . 63.420000000000002 112.224 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.451 ' O ' HG21 ' A' ' 120' ' ' VAL . . . -64.83 -41.01 96.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.079 0.466 . . . . 64.540000000000006 110.717 178.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.55 -20.67 75.76 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.932 -0.652 . . . . 64.25 112.837 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.6 -40.72 95.81 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 111.728 0.27 . . . . 71.140000000000001 111.728 -176.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.451 HG21 ' O ' ' A' ' 117' ' ' ALA . 25.0 m -70.68 -27.84 32.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.767 0.318 . . . . 75.340000000000003 110.7 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 57.9 mt -75.04 -36.64 38.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.053 0.454 . . . . 75.510000000000005 110.231 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.27 -35.13 78.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.767 -0.651 . . . . 73.140000000000001 111.409 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 27.4 ptt85 -90.22 -14.37 33.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.975 0.417 . . . . 73.340000000000003 110.93 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 23.4 ttt -71.63 -52.1 19.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.029 -0.532 . . . . 74.140000000000001 110.641 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 60.2 -164.7 0.22 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.856 -0.611 . . . . 74.329999999999998 110.576 -176.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -81.44 89.64 6.15 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.677 -0.86 . . . . 64.329999999999998 108.677 175.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -63.78 -29.84 71.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.971 -0.558 . . . . 70.439999999999998 111.051 -174.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -123.05 86.37 51.05 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.343 -0.844 . . . . 72.040000000000006 109.855 -177.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -50.44 96.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.437 2.758 . . . . 75.450000000000003 112.939 -173.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.5 p -88.12 131.58 34.64 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.201 -0.909 . . . . 72.219999999999999 110.576 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -81.1 -10.91 59.6 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.379 0.609 . . . . 75.219999999999999 109.959 178.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -120.62 134.33 55.29 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.552 -0.907 . . . . 72.230000000000004 108.552 172.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.5 tt -70.66 -37.71 73.74 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.024 0.44 . . . . 75.019999999999996 110.199 -175.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.646 ' HB2' ' HB3' ' A' ' 137' ' ' LEU . 0.0 OUTLIER -82.33 28.16 0.47 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.191 -0.459 . . . . 74.099999999999994 112.07 -177.711 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -59.56 -35.84 75.03 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.025 0.441 . . . . 71.030000000000001 110.573 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -71.57 -37.68 71.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.279 0.561 . . . . 73.400000000000006 109.933 176.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.646 ' HB3' ' HB2' ' A' ' 134' ' ' ARG . 47.2 tp -66.27 -28.08 68.43 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.588 -0.733 . . . . 74.140000000000001 110.202 178.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.781 ' HA ' ' HE2' ' A' ' 138' ' ' MET . 11.8 mmt -63.27 -39.76 95.5 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.101 0.477 . . . . 65.510000000000005 110.173 174.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -67.36 -39.7 85.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.61 -0.723 . . . . 75.420000000000002 109.796 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -59.47 -48.68 80.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.099 -0.955 . . . . 75.150000000000006 110.347 172.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.647 ' HE2' ' O ' ' A' ' 11' ' ' THR . 37.0 tttm -52.06 -49.93 62.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.432 -0.804 . . . . 60.549999999999997 111.657 177.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -56.08 -44.08 78.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.615 -0.721 . . . . 72.129999999999995 111.89 -174.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -68.51 -34.42 75.86 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 121.027 -0.269 . . . . 64.530000000000001 111.662 -176.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.674 ' HG3' HG21 ' A' ' 12' ' ' ILE . 5.4 tp60 -72.53 -34.9 67.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.807 0.336 . . . . 72.099999999999994 110.973 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.607 ' HB3' HG22 ' A' ' 12' ' ' ILE . 15.5 pt-20 -83.06 -38.79 22.05 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 121.022 -0.271 . . . . 74.310000000000002 110.606 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 22.4 tp -72.58 -23.62 60.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.941 0.401 . . . . 73.409999999999997 110.551 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -64.36 -22.5 67.51 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.749 -0.66 . . . . 74.510000000000005 112.976 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.889 ' HG ' ' H ' ' A' ' 149' ' ' GLU . 16.5 tp 60.59 -161.25 0.29 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.406 0.282 . . . . 61.210000000000001 110.509 177.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.889 ' H ' ' HG ' ' A' ' 148' ' ' LEU . 5.5 mm-40 70.26 123.63 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.761 0.824 . . . . 70.049999999999997 113.055 174.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.662 ' HB2' ' HG3' ' A' ' 18' ' ' GLN . 26.8 p80 173.4 7.48 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 114.849 -1.068 . . . . 74.310000000000002 110.721 175.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.408 ' HE1' ' HG2' ' A' ' 30' ' ' PRO . 36.3 m80 68.74 123.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.411 0.684 . . . . 73.329999999999998 110.492 -172.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 24.3 t60 -82.0 82.01 7.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.013 0.435 . . . . 73.019999999999996 109.972 -176.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 64.8 t60 -64.15 116.0 5.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.594 -0.73 . . . . 65.129999999999995 110.664 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -82.18 123.6 29.14 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.178 -0.464 . . . . 65.420000000000002 109.756 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.754 -0.641 . . . . 74.230000000000004 109.748 176.879 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 120.769 0.319 . . . . 74.430000000000007 110.62 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.91 -97.38 2.31 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.577 -0.821 . . . . 43.399999999999999 111.813 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -83.5 120.05 25.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.013 0.435 . . . . 75.099999999999994 110.063 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.656 ' O ' ' HB3' ' A' ' 110' ' ' TYR . 87.4 m -145.61 121.33 10.52 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.865 -0.607 . . . . 71.530000000000001 109.729 177.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.7 p -89.71 98.84 8.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.697 0.76 . . . . 75.010000000000005 109.261 178.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.5 m -84.65 134.23 27.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.288 -0.869 . . . . 61.329999999999998 111.258 -173.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -141.39 132.17 25.79 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.539 -0.755 . . . . 75.439999999999998 109.772 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -143.93 155.69 44.16 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.057 -0.72 . . . . 74.409999999999997 109.057 175.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -130.44 142.86 50.49 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.133 0.492 . . . . 75.430000000000007 111.231 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.58 ' HB ' ' HB2' ' A' ' 141' ' ' LYS . 12.4 m -123.42 137.28 57.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.469 -0.787 . . . . 75.120000000000005 110.206 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -95.58 118.47 32.33 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.243 -0.435 . . . . 72.049999999999997 110.969 -175.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 1.029 HG21 ' HG2' ' A' ' 145' ' ' GLU . 4.0 mp -122.46 139.24 49.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.017 -0.538 . . . . 72.200000000000003 109.565 176.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.07 53.19 3.76 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.804 -0.712 . . . . 71.329999999999998 112.847 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.538 ' HG2' ' HB3' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -123.37 144.81 44.87 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 108.78 -0.822 . . . . 72.140000000000001 108.78 176.207 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.58 -58.37 1.29 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.429 2.086 . . . . 71.120000000000005 113.0 -175.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.549 ' HA ' HD11 ' A' ' 19' ' ' LEU . . . 173.4 -52.98 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.62 0.575 . . . . 62.450000000000003 110.157 178.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -49.44 -49.34 45.57 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.779 -1.101 . . . . 74.439999999999998 112.377 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.657 HE21 HD23 ' A' ' 26' ' ' LEU . 47.0 tt0 -68.71 -20.66 64.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.008 -0.542 . . . . 64.420000000000002 112.113 -175.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.549 HD11 ' HA ' ' A' ' 16' ' ' ALA . 66.6 mt -67.6 -33.15 74.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.66 -0.245 . . . . 64.439999999999998 111.274 -176.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.405 ' O ' ' HD1' ' A' ' 23' ' ' TRP . 27.9 t80 -73.03 -23.95 60.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.991 0.424 . . . . 75.319999999999993 110.743 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.408 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . . . -75.55 -3.53 34.69 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.924 0.392 . . . . 62.32 112.02 -177.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.6 p -56.16 -21.29 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 115.689 -0.687 . . . . 70.340000000000003 112.305 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.405 ' HD1' ' O ' ' A' ' 20' ' ' TYR . 51.1 m95 -48.21 -31.13 5.39 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.287 0.847 . . . . 72.430000000000007 113.287 -176.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -118.27 -85.37 0.65 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.502 -0.479 . . . . 71.109999999999999 111.318 176.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -150.74 35.92 0.62 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.118 0.485 . . . . 75.109999999999999 110.027 -175.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.657 HD23 HE21 ' A' ' 18' ' ' GLN . 9.6 mp 65.55 165.4 0.12 Allowed Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 115.465 -0.789 . . . . 73.409999999999997 110.914 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 31.6 Cg_exo -59.73 104.06 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.398 2.065 . . . . 64.109999999999999 111.824 176.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 153.79 -50.44 0.49 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.84 -0.695 . . . . 63.100000000000001 111.714 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.54 ' C ' ' H ' ' A' ' 31' ' ' LEU . 3.8 mm? 61.54 168.06 0.09 OUTLIER Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 120.94 0.4 . . . . 74.519999999999996 111.94 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -58.54 9.3 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.62 2.88 . . . . 71.120000000000005 114.072 173.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.54 ' H ' ' C ' ' A' ' 29' ' ' LEU . 7.5 mp 68.54 33.83 3.82 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.312 0.645 . . . . 71.329999999999998 110.666 -177.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.49 87.23 0.64 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.445 -0.798 . . . . 75.319999999999993 111.285 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 48.34 26.73 1.17 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.638 1.175 . . . . 65.299999999999997 113.309 174.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.9 t -117.74 122.42 43.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.489 0.661 . . . . 73.409999999999997 111.248 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 20.7 m80 -141.13 19.73 2.27 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.444 -0.798 . . . . 73.239999999999995 109.184 174.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.5 tp -87.83 7.56 30.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.948 -1.024 . . . . 74.310000000000002 110.412 -177.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 75.43 -18.06 0.47 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.404 -0.816 . . . . 74.540000000000006 111.715 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.9 m -71.18 95.89 1.31 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.642 -0.503 . . . . 61.030000000000001 109.642 173.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 27' ' ' PRO . 16.9 m -134.42 28.71 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.222 0.534 . . . . 73.140000000000001 110.81 -175.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.43 -164.75 1.39 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.654 -0.703 . . . . 72.439999999999998 110.598 -177.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.5 t -58.11 146.36 8.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.935 -0.575 . . . . 74.209999999999994 110.683 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 49' ' ' TRP . 60.0 tp -54.29 -45.31 72.49 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.065 -0.516 . . . . 70.140000000000001 111.873 -175.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.602 ' HB3' ' CG ' ' A' ' 46' ' ' ARG . 15.1 t70 -151.89 163.03 40.09 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.695 -0.483 . . . . 75.430000000000007 109.695 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -92.2 -12.27 33.19 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 123.156 0.285 . . . . 65.430000000000007 111.684 -174.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.992 ' HE2' ' HA ' ' A' ' 45' ' ' LYS . 9.9 mmpt? -93.01 4.05 54.69 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.788 0.804 . . . . 72.150000000000006 110.552 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.602 ' CG ' ' HB3' ' A' ' 43' ' ' ASP . 0.5 OUTLIER -152.64 -177.03 5.99 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.137 -1.392 . . . . 74.510000000000005 111.041 -176.198 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.548 ' O ' ' HD3' ' A' ' 46' ' ' ARG . 21.1 m -113.34 -154.48 0.54 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.3 -1.0 . . . . 54.520000000000003 108.3 174.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 71.47 167.27 0.31 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.139 0.495 . . . . 65.329999999999998 111.067 170.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.4 ' HA ' ' HB2' ' A' ' 42' ' ' LEU . 76.4 t90 -150.92 110.25 3.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.405 -0.361 . . . . 74.040000000000006 110.181 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.1 m -157.11 125.56 5.67 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.009 -0.737 . . . . 63.25 109.009 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.2 m -72.12 -13.32 16.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.351 0.5 . . . . 71.420000000000002 112.351 -173.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -134.28 100.3 4.65 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.991 0.424 . . . . 75.109999999999999 110.523 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -137.42 86.08 20.09 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.669 -0.696 . . . . 73.340000000000003 111.06 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -65.89 114.16 2.86 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.555 2.17 . . . . 74.430000000000007 110.943 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 67.39 144.1 0.09 OUTLIER Pre-proline 0 N--CA 1.466 0.367 0 O-C-N 123.967 0.792 . . . . 70.510000000000005 110.263 -170.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -65.64 -57.13 0.27 Allowed 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 120.888 1.059 . . . . 75.129999999999995 111.384 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.991 ' HB3' HD11 ' A' ' 80' ' ' LEU . 1.5 pt? -112.47 -0.64 15.21 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.659 -0.7 . . . . 71.319999999999993 111.178 -170.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.72 95.82 0.04 OUTLIER Glycine 0 C--O 1.23 -0.136 0 O-C-N 124.095 0.872 . . . . 74.25 113.735 -172.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 71.63 7.69 6.01 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.513 0.725 . . . . 55.409999999999997 111.637 173.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.495 HG22 ' H ' ' A' ' 62' ' ' TRP . 26.6 m -95.67 -31.47 4.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.409 -0.517 . . . . 73.299999999999997 110.671 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.7 t 58.06 18.02 4.88 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.832 -0.622 . . . . 60.340000000000003 112.33 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.495 ' H ' HG22 ' A' ' 60' ' ' VAL . 23.5 m95 -130.67 -0.32 4.35 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.088 0.773 . . . . 73.129999999999995 113.088 -175.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.539 ' HB3' HD12 ' A' ' 80' ' ' LEU . 9.7 tp10 -86.81 152.16 22.73 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.086 0.47 . . . . 64.109999999999999 110.589 -174.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -122.33 145.34 48.34 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.741 -0.663 . . . . 72.530000000000001 110.88 -178.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.468 ' HG2' ' H ' ' A' ' 66' ' ' LEU . 33.0 tt0 -105.53 172.28 6.88 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.863 -1.162 . . . . 71.109999999999999 107.863 172.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.488 ' CD1' ' HA ' ' A' ' 77' ' ' TRP . 11.6 tp -130.43 145.13 51.77 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 122.013 -0.429 . . . . 63.039999999999999 111.061 -174.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.693 HG23 ' HB2' ' A' ' 78' ' ' ARG . 61.5 p -96.68 -34.75 11.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.084 0.469 . . . . 62.219999999999999 110.983 178.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.518 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -140.44 136.02 32.61 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.731 -0.668 . . . . 63.119999999999997 110.857 -177.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -137.38 75.05 1.51 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.576 0.703 . . . . 63.240000000000002 111.051 -177.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.432 ' HB2' ' H ' ' A' ' 74' ' ' ARG . 16.3 mm-40 -96.37 143.42 26.08 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.926 -0.579 . . . . 74.540000000000006 110.22 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -67.81 -38.11 14.3 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.832 2.355 . . . . 73.310000000000002 112.776 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -151.56 42.01 0.73 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.364 -0.922 . . . . 37.0 112.659 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.43 ' HD2' ' OE1' ' A' ' 70' ' ' GLU . 76.0 mttt -130.11 -74.34 0.55 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.169 -0.308 . . . . 72.310000000000002 110.169 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.432 ' H ' ' HB2' ' A' ' 70' ' ' GLU . 5.9 ptp180 -151.71 150.44 30.22 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.872 -0.418 . . . . 75.219999999999999 109.872 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.54 HD13 ' HE2' ' A' ' 93' ' ' PHE . 70.7 mt -134.97 109.49 11.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.365 -0.606 . . . . 70.239999999999995 109.365 171.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.518 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -96.65 116.04 28.44 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.213 -0.662 . . . . 63.119999999999997 109.213 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.488 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 12.8 t90 -81.81 154.07 26.11 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.38 -0.827 . . . . 74.510000000000005 110.394 -172.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.693 ' HB2' HG23 ' A' ' 67' ' ' THR . 64.5 ttt180 -140.42 173.3 11.64 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.89 -0.781 . . . . 62.100000000000001 108.89 -178.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.517 ' HB2' ' HA ' ' A' ' 85' ' ' ILE . 45.8 m -135.9 152.68 51.26 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.944 -0.391 . . . . 54.130000000000003 109.944 175.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.991 HD11 ' HB3' ' A' ' 57' ' ' LEU . 66.5 mt -78.32 145.78 69.1 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 116.205 -0.452 . . . . 71.019999999999996 110.973 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.47 -31.93 92.72 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.352 2.702 . . . . 72.439999999999998 112.343 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.51 -5.41 89.96 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.107 -0.568 . . . . 62.539999999999999 112.255 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.57 -65.21 1.01 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.274 -0.269 . . . . 72.540000000000006 110.274 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.671 ' HG2' ' HB2' ' A' ' 86' ' ' GLU . 20.5 ttt180 -177.53 -53.57 0.01 OUTLIER 'General case' 0 C--N 1.335 -0.063 0 CA-C-N 116.074 -0.512 . . . . 63.119999999999997 111.005 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.517 ' HA ' ' HB2' ' A' ' 79' ' ' SER . 13.0 tt 44.85 40.88 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-O 122.213 1.006 . . . . 74.200000000000003 112.02 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.671 ' HB2' ' HG2' ' A' ' 84' ' ' ARG . 0.8 OUTLIER -97.55 -4.37 37.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.453 -0.794 . . . . 54.439999999999998 110.492 -179.716 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -135.03 172.51 12.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.574 -0.739 . . . . 71.329999999999998 110.311 -177.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.0 m -148.06 145.21 28.36 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.769 0.319 . . . . 74.040000000000006 110.625 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -142.68 122.83 2.02 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.319 -0.713 . . . . 75.329999999999998 111.319 177.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -117.56 120.79 39.14 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.171 -0.307 . . . . 74.219999999999999 110.171 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.51 HG21 HG21 ' A' ' 106' ' ' VAL . 78.3 t -112.83 119.75 61.21 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.625 0.726 . . . . 74.420000000000002 111.425 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.8 mp -104.51 125.05 50.32 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.151 -0.931 . . . . 74.230000000000004 110.15 176.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.54 ' HE2' HD13 ' A' ' 75' ' ' ILE . 73.6 m-85 -89.48 106.43 18.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.115 0.484 . . . . 74.400000000000006 109.818 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 33.3 ptt180 -127.18 143.98 48.99 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.859 -0.61 . . . . 71.430000000000007 110.816 -176.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 94' ' ' ARG . 30.3 Cg_exo -62.55 127.29 20.37 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.662 2.241 . . . . 74.439999999999998 111.5 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.52 146.83 96.5 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 116.081 -0.508 . . . . 71.230000000000004 110.23 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -48.19 127.53 15.41 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.64 2.893 . . . . 61.039999999999999 113.111 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.87 20.33 68.31 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.801 -0.636 . . . . 74.319999999999993 112.447 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 56.66 34.25 24.19 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.129 0.49 . . . . 65.129999999999995 111.347 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 100' ' ' ARG . 4.4 mmp_? -82.11 0.47 40.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.053 -0.521 . . . . 74.040000000000006 111.439 -177.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 144.33 -157.53 27.2 Favored Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 111.063 -0.815 . . . . 64.340000000000003 111.063 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 71.7 m -121.52 128.04 51.63 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.609 -0.515 . . . . 72.200000000000003 109.609 176.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -103.91 130.78 51.55 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.26 0.552 . . . . 71.299999999999997 109.899 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.695 HG23 ' HE2' ' A' ' 140' ' ' PHE . 4.7 m -89.36 132.45 34.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 108.623 -0.88 . . . . 62.43 108.623 175.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 7.3 p -118.0 115.45 48.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 121.375 0.607 . . . . 74.409999999999997 109.896 -177.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.51 HG21 HG21 ' A' ' 91' ' ' VAL . 39.6 t -105.1 115.13 46.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.574 -0.739 . . . . 72.409999999999997 110.849 -174.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -90.52 106.42 18.49 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.422 -0.584 . . . . 61.140000000000001 109.422 173.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.406 ' HA ' HD22 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -99.3 135.67 40.38 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.794 -0.447 . . . . 64.030000000000001 109.794 -177.043 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.4 p -83.81 119.91 25.41 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.214 0.53 . . . . 73.340000000000003 111.236 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.656 ' HB3' ' O ' ' A' ' 4' ' ' THR . 81.2 t80 -132.73 112.24 11.82 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.594 -0.73 . . . . 71.109999999999999 109.257 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 25.6 ptt85 -138.04 154.73 74.47 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 115.705 -0.68 . . . . 74.420000000000002 110.119 -174.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.82 156.87 52.52 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.409 2.073 . . . . 63.229999999999997 111.98 -177.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.37 116.71 3.51 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.641 2.227 . . . . 75.230000000000004 111.829 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -77.95 66.3 3.13 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 116.084 -0.507 . . . . 41.439999999999998 112.069 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 169.92 143.94 4.1 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 121.183 -0.532 . . . . 44.32 111.952 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.0 t -61.05 -45.41 94.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.776 0.322 . . . . 54.219999999999999 110.554 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.24 -32.65 74.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.221 -0.445 . . . . 53.329999999999998 110.774 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -71.47 -37.0 62.62 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.772 -0.728 . . . . 41.420000000000002 111.993 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.79 -45.52 71.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.652 0.263 . . . . 71.409999999999997 111.544 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 28.1 m -66.09 -36.54 77.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.042 0.386 . . . . 64.209999999999994 112.042 -175.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 35.6 pt -75.66 -32.36 24.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 120.761 -0.376 . . . . 73.019999999999996 110.781 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 126' ' ' ASN . . . -69.57 -34.57 74.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.971 0.415 . . . . 64.329999999999998 110.171 176.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -59.23 -34.81 72.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.118 -0.492 . . . . 72.219999999999999 110.227 175.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 14.7 tpt -71.77 -51.87 20.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.862 -0.608 . . . . 74.120000000000005 110.646 176.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -126.6 88.24 2.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.078 0.466 . . . . 74.209999999999994 111.151 -178.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 122' ' ' ALA . 6.4 t30 -117.25 -49.61 2.58 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 107.78 -1.192 . . . . 71.430000000000007 107.78 173.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 58.22 51.35 8.61 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.742 -1.117 . . . . 63.509999999999998 112.01 171.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.442 ' HB3' ' HG2' ' A' ' 131' ' ' GLN . 51.5 mt-10 -127.82 82.66 67.95 Favored Pre-proline 0 C--N 1.327 -0.406 0 C-N-CA 120.82 -0.352 . . . . 71.409999999999997 111.045 176.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -72.24 -54.6 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.32 2.013 . . . . 71.310000000000002 110.539 172.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 56.5 p -115.66 3.93 14.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.421 -0.808 . . . . 74.5 109.865 173.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.442 ' HG2' ' HB3' ' A' ' 128' ' ' GLU . 75.8 mt-30 65.37 -169.19 0.2 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.424 -0.807 . . . . 71.540000000000006 110.325 -176.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -66.61 -25.99 66.87 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.269 -0.641 . . . . 64.019999999999996 109.269 171.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.831 ' HG ' ' H ' ' A' ' 134' ' ' ARG . 14.7 tp 54.13 -154.64 0.25 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 114.929 -1.032 . . . . 45.119999999999997 110.722 174.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.831 ' H ' ' HG ' ' A' ' 133' ' ' LEU . 54.4 ttt85 -79.83 -9.38 59.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.787 0.327 . . . . 74.340000000000003 110.123 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -54.09 -48.12 71.02 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.254 -0.43 . . . . 71.450000000000003 111.066 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -69.12 -35.8 76.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.146 -0.479 . . . . 74.310000000000002 111.07 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 16.3 tp -76.97 -21.84 54.13 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.33 -0.395 . . . . 64.230000000000004 110.442 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.949 ' HE3' ' HA ' ' A' ' 138' ' ' MET . 4.8 mmt -65.99 -37.7 86.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.404 -0.362 . . . . 73.019999999999996 110.572 175.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.36 -35.22 75.64 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.711 -0.478 . . . . 71.510000000000005 109.711 177.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.695 ' HE2' HG23 ' A' ' 104' ' ' VAL . 72.5 t80 -57.44 -46.36 83.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.791 -0.641 . . . . 73.239999999999995 109.862 175.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.58 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 40.5 tttp -63.61 -40.25 96.44 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.366 -0.379 . . . . 72.549999999999997 110.876 176.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -57.51 -58.34 8.74 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.194 -0.457 . . . . 70.120000000000005 110.421 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.415 ' HG2' HD13 ' A' ' 148' ' ' LEU . 1.7 mp0 -66.1 -28.21 68.65 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 121.114 -0.235 . . . . 71.109999999999999 111.352 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.715 ' HB3' HG12 ' A' ' 12' ' ' ILE . 25.4 mm-40 -56.91 -49.71 74.77 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.312 0.577 . . . . 75.209999999999994 111.263 176.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 1.029 ' HG2' HG21 ' A' ' 12' ' ' ILE . 26.8 mt-10 -87.35 -32.3 19.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.779 -0.646 . . . . 64.329999999999998 111.1 -175.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 24.2 tp -90.47 -58.09 2.61 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.479 0.657 . . . . 73.400000000000006 111.625 -174.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.436 ' HA2' HD13 ' A' ' 26' ' ' LEU . . . 128.01 172.16 13.16 Favored Glycine 0 N--CA 1.441 -0.967 0 N-CA-C 109.405 -1.478 . . . . 74.319999999999993 109.405 -167.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.415 HD13 ' HG2' ' A' ' 143' ' ' GLU . 27.7 tp -85.78 -0.57 55.62 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 117.812 0.806 . . . . 65.129999999999995 110.567 -175.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -94.22 120.66 34.78 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.898 -0.592 . . . . 55.43 111.382 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 9.7 t60 73.87 73.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.948 -1.024 . . . . 64.209999999999994 112.507 172.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -126.02 92.17 3.53 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.726 -0.842 . . . . 75.310000000000002 108.726 167.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.479 ' O ' ' HB2' ' A' ' 153' ' ' HIS . 83.0 t60 -74.69 127.07 32.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.962 -1.017 . . . . 74.450000000000003 112.008 -168.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.479 ' HB2' ' O ' ' A' ' 152' ' ' HIS . 7.4 t60 168.93 -62.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.618 -1.253 . . . . 74.230000000000004 107.618 176.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.429 ' HB2' ' O ' ' A' ' 153' ' ' HIS . 66.2 t60 168.34 -46.86 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 106.398 -1.704 . . . . 74.510000000000005 106.398 177.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 . . . . . 0 C--O 1.245 0.863 0 CA-C-N 114.054 -1.43 . . . . 44.420000000000002 107.704 168.402 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 110.378 -0.23 . . . . 71.439999999999998 110.378 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 117.97 -30.09 6.25 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.091 -0.803 . . . . 73.439999999999998 111.091 -178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -86.39 170.59 11.86 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.109 -0.7 . . . . 73.140000000000001 109.109 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.622 ' HB ' ' O ' ' A' ' 110' ' ' TYR . 30.5 m -98.75 121.72 41.06 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 109.196 -0.668 . . . . 73.400000000000006 109.196 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.8 t -120.61 113.0 38.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.477 -0.564 . . . . 73.010000000000005 109.477 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 52.4 t -99.07 122.6 51.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.835 -0.62 . . . . 74.129999999999995 110.851 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 57.1 ttt-85 -126.12 109.59 12.55 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.363 -0.606 . . . . 73.109999999999999 109.363 171.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.587 ' HB3' HD22 ' A' ' 137' ' ' LEU . 18.1 t0 -130.83 151.14 51.58 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.954 -1.128 . . . . 72.120000000000005 107.954 177.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.594 ' HB3' HG13 ' A' ' 105' ' ' VAL . . . -135.99 129.48 32.14 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.948 0.404 . . . . 51.049999999999997 111.948 -170.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.828 ' HB ' ' HG3' ' A' ' 141' ' ' LYS . 16.1 m -120.56 143.25 33.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.896 -0.593 . . . . 73.099999999999994 110.188 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.428 HG23 ' HD3' ' A' ' 100' ' ' ARG . 26.6 m -107.25 114.1 27.93 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.582 -0.281 . . . . 70.230000000000004 110.669 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.951 HG21 ' HB3' ' A' ' 145' ' ' GLU . 4.9 mp -110.73 139.64 33.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.311 -0.404 . . . . 65.519999999999996 110.79 -176.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.46 60.31 4.55 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 121.249 -0.5 . . . . 73.340000000000003 113.039 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.64 ' HD3' ' HG2' ' A' ' 18' ' ' GLN . 43.0 mttp -140.69 150.38 59.94 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 110.2 -0.296 . . . . 71.510000000000005 110.2 176.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.44 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 51.4 Cg_exo -56.01 -59.28 0.75 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.817 2.345 . . . . 60.509999999999998 114.123 -173.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . 170.73 -48.04 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.453 0.644 . . . . 65.310000000000002 110.007 175.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -48.17 -56.36 8.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.257 -1.338 . . . . 71.219999999999999 112.954 -173.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.64 ' HG2' ' HD3' ' A' ' 14' ' ' LYS . 0.6 OUTLIER -80.9 -7.65 59.54 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.257 -0.429 . . . . 75.549999999999997 111.65 -173.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.549 ' CB ' ' HE2' ' A' ' 93' ' ' PHE . 64.0 mt -75.87 -26.8 57.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.796 -0.183 . . . . 70.510000000000005 111.163 177.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -65.18 -29.81 70.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.241 0.543 . . . . 74.230000000000004 110.447 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.45 -8.45 56.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.577 -0.738 . . . . 71.109999999999999 111.689 -175.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.495 HG12 ' HE2' ' A' ' 140' ' ' PHE . 6.2 p -60.16 -22.2 24.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.808 0.337 . . . . 74.140000000000001 111.735 -175.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -70.41 -23.48 62.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.919 0.39 . . . . 74.549999999999997 110.774 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -128.58 19.47 6.21 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.885 -0.413 . . . . 72.430000000000007 109.885 -178.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.538 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 18.6 t70 64.84 162.43 0.13 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.62 -0.718 . . . . 64.129999999999995 110.968 -174.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.496 ' H ' HD21 ' A' ' 26' ' ' LEU . 1.3 pt? -113.95 85.7 10.25 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 121.364 0.602 . . . . 55.240000000000002 112.019 -175.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.538 ' HD3' ' O ' ' A' ' 25' ' ' ASP . 1.9 Cg_endo -84.75 -11.9 7.69 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.059 2.506 . . . . 72.310000000000002 111.623 173.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.38 57.94 6.36 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.819 -0.628 . . . . 74.450000000000003 112.698 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.509 ' N ' ' HD3' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -146.37 60.69 6.38 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 112.455 0.539 . . . . 74.209999999999994 112.455 178.403 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.509 ' HD3' ' N ' ' A' ' 29' ' ' LEU . 1.3 Cg_endo -84.49 -0.57 9.43 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.636 2.224 . . . . 63.149999999999999 111.67 175.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.497 HD11 ' HD2' ' A' ' 30' ' ' PRO . 6.6 mp -100.91 34.71 2.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.876 -0.602 . . . . 73.230000000000004 110.501 -177.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.595 ' H ' HD23 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -69.77 -15.22 63.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.235 -0.439 . . . . 61.409999999999997 111.981 -177.389 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.852 ' HG2' ' H ' ' A' ' 34' ' ' THR . 17.4 ttt 61.87 -164.73 0.24 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 110.175 -0.306 . . . . 65.540000000000006 110.175 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.852 ' H ' ' HG2' ' A' ' 33' ' ' MET . 0.9 OUTLIER -80.12 87.4 5.48 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.875 0.369 . . . . 74.319999999999993 111.062 176.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 65.18 74.4 0.39 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.369 -0.832 . . . . 74.540000000000006 112.656 177.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.52 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 61.1 tp -126.78 110.66 13.34 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.36 -0.978 . . . . 74.239999999999995 108.36 170.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.52 ' HB3' ' O ' ' A' ' 36' ' ' LEU . 26.5 ttt180 74.9 149.28 0.1 Allowed 'General case' 0 CA--C 1.535 0.375 0 O-C-N 124.065 0.853 . . . . 73.530000000000001 110.515 -174.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.8 m -71.98 102.11 2.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.361 -0.381 . . . . 53.520000000000003 110.494 178.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.424 HG12 HD12 ' A' ' 32' ' ' LEU . 13.0 p -156.49 158.85 3.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.391 -0.368 . . . . 74.349999999999994 110.147 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -61.91 156.49 20.76 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.625 -0.261 . . . . 75.010000000000005 110.589 177.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.706 HG21 HD22 ' A' ' 42' ' ' LEU . 8.3 p -74.56 -55.39 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 112.352 0.501 . . . . 75.530000000000001 112.352 -170.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.706 HD22 HG21 ' A' ' 41' ' ' VAL . 1.1 mm? -145.6 -68.46 0.29 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.949 0.404 . . . . 64.010000000000005 110.279 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 72.89 -13.59 0.66 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.135 -0.938 . . . . 73.129999999999995 112.563 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -93.41 -15.35 25.74 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.356 -0.609 . . . . 75.420000000000002 109.356 172.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -166.07 85.46 0.33 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.483 -0.932 . . . . 72.329999999999998 108.483 -175.747 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.409 ' HB3' ' O ' ' A' ' 45' ' ' LYS . 37.5 ttp180 75.55 132.59 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.102 -0.954 . . . . 73.219999999999999 112.347 176.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 25.8 m -152.4 115.87 4.75 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.041 -0.982 . . . . 64.349999999999994 111.064 177.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.481 ' HG3' ' OG1' ' A' ' 50' ' ' THR . 1.1 ptm180 -135.6 8.87 3.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.005 -0.543 . . . . 72.030000000000001 109.755 170.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 29.4 m-90 54.19 72.85 0.43 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.201 -0.908 . . . . 75.340000000000003 112.293 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.536 ' O ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -166.27 -73.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.463 -0.789 . . . . 71.340000000000003 110.185 174.163 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 50' ' ' THR . 1.4 p 57.12 15.55 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.623 1.169 . . . . 70.129999999999995 111.971 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 50' ' ' THR . 38.1 mt-10 -99.86 -18.32 17.2 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.939 -0.573 . . . . 73.209999999999994 110.548 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -103.24 150.55 38.04 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.861 -0.609 . . . . 64.049999999999997 110.567 -177.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.0 173.96 9.54 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 123.186 2.591 . . . . 64.319999999999993 112.101 177.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 72.51 153.78 0.15 Allowed Pre-proline 0 N--CA 1.466 0.37 0 C-N-CA 123.401 0.68 . . . . 75.420000000000002 111.394 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.805 ' HB2' HD13 ' A' ' 57' ' ' LEU . 75.7 Cg_exo -49.29 -46.89 24.23 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.582 2.188 . . . . 63.43 111.762 176.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.805 HD13 ' HB2' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -137.51 -20.37 1.19 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.941 -0.572 . . . . 74.420000000000002 111.982 178.862 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.484 ' N ' HD23 ' A' ' 57' ' ' LEU . . . 74.06 -60.04 2.23 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.493 -0.861 . . . . 72.540000000000006 111.705 -174.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -134.75 151.01 50.64 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.797 -0.445 . . . . 74.239999999999995 109.797 177.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.671 HG13 HD12 ' A' ' 80' ' ' LEU . 30.7 m -105.85 134.48 47.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.655 0.264 . . . . 70.25 110.922 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.8 t -154.11 -56.75 0.11 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.509 -0.314 . . . . 74.140000000000001 110.807 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -139.1 -11.91 1.24 Allowed 'General case' 0 C--O 1.234 0.278 0 N-CA-C 112.487 0.551 . . . . 74.200000000000003 112.487 -174.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.569 ' HG2' ' CD1' ' A' ' 80' ' ' LEU . 1.8 pm0 -84.27 166.3 17.6 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.623 0.725 . . . . 74.340000000000003 112.58 -172.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -134.36 143.35 47.6 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.64 -1.164 . . . . 71.439999999999998 110.507 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.67 ' HB3' ' HD2' ' A' ' 78' ' ' ARG . 1.8 tm-20 -107.24 175.57 5.45 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.291 -1.003 . . . . 75.140000000000001 108.291 176.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.602 HD12 ' HA ' ' A' ' 77' ' ' TRP . 22.8 tp -124.08 119.64 30.05 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.132 -0.692 . . . . 75.409999999999997 109.132 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.3 t -81.53 -23.71 37.09 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.627 0.251 . . . . 64.120000000000005 111.389 -174.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.519 ' HB1' ' HB3' ' A' ' 76' ' ' ALA . . . -144.12 127.31 16.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.932 0.396 . . . . 55.240000000000002 111.043 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.576 ' HB2' HD23 ' A' ' 66' ' ' LEU . 11.0 t70 -138.79 104.03 4.98 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.266 -0.879 . . . . 54.530000000000001 109.788 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.438 ' HB2' ' H ' ' A' ' 74' ' ' ARG . 8.0 mm-40 -106.71 144.2 28.58 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.718 -0.673 . . . . 74.129999999999995 109.855 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 35.3 Cg_exo -62.04 -24.61 76.82 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.92 2.414 . . . . 50.109999999999999 112.536 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.98 56.93 0.12 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.917 -0.659 . . . . 75.040000000000006 111.592 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -141.41 -68.76 0.38 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.345 -0.142 . . . . 74.450000000000003 111.019 -176.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.438 ' H ' ' HB2' ' A' ' 70' ' ' GLU . 18.5 ptt180 -153.32 155.38 36.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.857 0.36 . . . . 75.340000000000003 111.51 -176.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.868 ' HB ' HG12 ' A' ' 91' ' ' VAL . 49.0 mm -125.14 110.82 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.765 -0.652 . . . . 72.019999999999996 109.723 174.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.519 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . . . -108.81 120.41 42.4 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.981 -0.748 . . . . 73.430000000000007 108.981 174.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.602 ' HA ' HD12 ' A' ' 66' ' ' LEU . 13.7 p-90 -106.85 138.95 42.05 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.612 0.72 . . . . 64.409999999999997 112.195 -170.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.67 ' HD2' ' HB3' ' A' ' 65' ' ' GLU . 7.8 ptp85 -113.07 173.35 6.43 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 107.676 -1.231 . . . . 65.150000000000006 107.676 171.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.433 ' HB2' ' HD3' ' A' ' 84' ' ' ARG . 6.1 m -138.6 30.3 2.34 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.343 -0.543 . . . . 73.230000000000004 109.873 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.671 HD12 HG13 ' A' ' 60' ' ' VAL . 22.1 mt 66.52 147.02 0.11 Allowed Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 115.086 -0.961 . . . . 72.109999999999999 111.093 -175.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.64 -23.16 55.83 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 123.104 2.536 . . . . 64.510000000000005 113.529 -174.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.21 -3.32 88.92 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.717 -0.754 . . . . 64.010000000000005 113.263 -176.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -136.44 25.98 3.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.201 0.5 . . . . 75.310000000000002 111.851 -177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.433 ' HD3' ' HB2' ' A' ' 79' ' ' SER . 9.4 mmm180 -126.83 107.79 10.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.827 0.346 . . . . 73.010000000000005 111.457 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.741 HG13 ' H ' ' A' ' 86' ' ' GLU . 13.8 pt -91.11 -63.3 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.053 -0.521 . . . . 63.310000000000002 110.298 173.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.741 ' H ' HG13 ' A' ' 85' ' ' ILE . 34.2 tt0 -163.74 109.42 1.07 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.885 0.374 . . . . 74.340000000000003 110.366 176.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -162.15 141.01 9.3 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.682 -0.859 . . . . 75.409999999999997 108.682 175.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.4 m -151.37 129.38 11.79 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.142 -0.318 . . . . 75.109999999999999 110.142 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.09 110.26 0.25 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.55 -0.833 . . . . 39.219999999999999 112.247 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.13 149.98 23.73 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.242 -0.281 . . . . 73.310000000000002 110.242 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.868 HG12 ' HB ' ' A' ' 75' ' ' ILE . 7.6 p -88.97 140.98 14.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.213 -0.662 . . . . 74.129999999999995 109.213 174.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.681 ' HB2' ' CG2' ' A' ' 105' ' ' VAL . 3.2 mm? -108.99 119.81 40.66 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.154 -0.684 . . . . 70.409999999999997 109.154 172.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.549 ' HE2' ' CB ' ' A' ' 19' ' ' LEU . 15.7 m-85 -96.91 106.03 18.28 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.824 -0.806 . . . . 64.420000000000002 108.824 174.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 32.7 mtp180 -125.95 142.9 43.69 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 116.112 -0.495 . . . . 74.219999999999999 110.046 -174.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -57.85 115.57 2.61 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.436 2.091 . . . . 74.25 110.634 175.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . . . -65.36 143.63 98.78 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.019 -0.537 . . . . 63.520000000000003 111.413 -173.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 96' ' ' ALA . 51.5 Cg_exo -55.79 137.39 78.39 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.885 2.39 . . . . 70.219999999999999 111.925 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.63 16.51 79.13 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.947 -0.644 . . . . 61.450000000000003 112.101 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 57.16 33.69 23.7 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.341 0.591 . . . . 64.219999999999999 110.794 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.428 ' HD3' HG23 ' A' ' 11' ' ' THR . 34.6 ttt180 -77.27 1.04 19.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.41 -0.814 . . . . 71.409999999999997 111.04 -175.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 123.23 -125.13 5.84 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 111.508 -0.637 . . . . 70.519999999999996 111.508 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 88.0 m -135.01 130.53 35.84 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.952 0.406 . . . . 73.150000000000006 110.564 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -100.9 113.91 27.3 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.902 -0.59 . . . . 74.150000000000006 109.534 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.2 m -88.74 127.29 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-O 121.703 0.763 . . . . 72.150000000000006 108.991 175.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.681 ' CG2' ' HB2' ' A' ' 92' ' ' LEU . 14.0 m -123.18 119.39 57.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.204 -0.907 . . . . 60.229999999999997 109.815 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.64 HG13 HG21 ' A' ' 91' ' ' VAL . 1.8 m -119.84 121.52 66.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.908 -0.587 . . . . 73.540000000000006 111.074 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.85 109.85 19.19 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.537 -0.912 . . . . 75.430000000000007 108.537 174.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.428 HD22 ' HE2' ' A' ' 110' ' ' TYR . 0.4 OUTLIER -141.12 151.39 43.9 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.058 0.456 . . . . 75.109999999999999 111.544 -174.435 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.9 t -98.77 133.09 43.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.378 0.609 . . . . 60.43 110.911 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.622 ' O ' ' HB ' ' A' ' 4' ' ' THR . 57.8 m-85 -151.68 -179.4 7.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.039 -0.982 . . . . 75.140000000000001 109.233 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -122.01 149.42 53.95 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 109.222 -0.659 . . . . 72.329999999999998 109.222 174.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -61.42 152.43 72.96 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.448 2.099 . . . . 74.549999999999997 112.622 -177.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -63.44 -52.4 1.98 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.953 2.436 . . . . 74.349999999999994 112.139 -178.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.29 -28.94 7.53 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.765 -0.731 . . . . 65.049999999999997 112.436 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -55.03 112.56 2.96 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.576 -0.345 . . . . 63.119999999999997 113.124 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.7 m -86.54 -30.61 21.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.93 0.395 . . . . 71.030000000000001 111.153 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.93 -36.15 83.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.939 -0.573 . . . . 61.020000000000003 112.194 -173.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -60.14 -25.69 62.56 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 121.078 -0.582 . . . . 74.439999999999998 113.292 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.03 -46.76 86.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.727 0.299 . . . . 64.140000000000001 111.311 -177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.9 m -75.1 -23.73 17.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.495 -0.321 . . . . 64.25 111.177 -177.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 65.1 mt -72.7 -33.44 44.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.389 -0.369 . . . . 75.209999999999994 110.418 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.08 -22.64 65.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.169 -0.469 . . . . 72.510000000000005 111.279 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -63.87 -26.75 68.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.064 -0.517 . . . . 73.239999999999995 111.171 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 16.7 tpt -71.45 -26.86 62.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.949 0.404 . . . . 72.530000000000001 110.959 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -98.35 -174.22 2.77 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.254 -0.43 . . . . 70.439999999999998 111.256 -173.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -74.59 151.72 39.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.077 -0.511 . . . . 71.129999999999995 109.915 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -107.56 117.51 34.28 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.918 0.389 . . . . 65.120000000000005 111.488 -177.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -110.22 88.26 7.01 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.693 -0.685 . . . . 75.030000000000001 109.223 171.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -44.81 125.74 6.76 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.376 2.717 . . . . 62.439999999999998 113.134 -174.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.9 m -61.75 101.1 0.17 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.487 -0.778 . . . . 73.0 111.205 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -82.87 -10.53 58.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.291 0.567 . . . . 73.340000000000003 109.875 175.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -133.42 177.77 7.44 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.497 -0.927 . . . . 74.010000000000005 108.497 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.3 tt -71.3 -61.82 1.63 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.841 -0.344 . . . . 71.109999999999999 110.208 -177.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.538 ' HG2' ' H ' ' A' ' 137' ' ' LEU . 35.7 ttt85 -85.85 110.55 19.47 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.141 0.496 . . . . 74.200000000000003 110.369 178.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -61.51 -39.45 91.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.361 -0.836 . . . . 72.310000000000002 110.655 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -61.01 -34.99 75.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.836 -0.62 . . . . 74.310000000000002 111.206 177.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.587 HD22 ' HB3' ' A' ' 8' ' ' ASP . 11.5 tp -79.14 -35.8 41.51 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.503 0.668 . . . . 75.340000000000003 109.844 -175.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.488 ' HE2' ' HB3' ' A' ' 138' ' ' MET . 2.3 ttp -66.28 -36.89 84.12 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.532 -0.758 . . . . 71.219999999999999 110.367 174.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -69.81 -51.05 37.06 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.128 -0.487 . . . . 75.540000000000006 112.182 -177.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.495 ' HE2' HG12 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -66.32 -29.54 69.76 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.261 -0.576 . . . . 71.200000000000003 109.685 -175.346 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.828 ' HG3' ' HB ' ' A' ' 10' ' ' VAL . 14.9 tmtt? -57.1 -42.37 80.66 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 115.788 -0.642 . . . . 62.119999999999997 110.46 173.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -55.11 -52.2 64.02 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.284 0.564 . . . . 73.420000000000002 110.269 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -66.58 -40.81 89.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.022 -0.99 . . . . 61.43 111.928 -172.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.514 ' CD ' HG12 ' A' ' 12' ' ' ILE . 4.6 pt20 -74.17 -17.3 60.93 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.571 0.582 . . . . 74.450000000000003 112.571 -173.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.951 ' HB3' HG21 ' A' ' 12' ' ' ILE . 19.7 pt-20 -110.73 -4.46 15.33 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.618 -0.433 . . . . 75.099999999999994 111.102 175.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 24.4 tp -61.8 -52.83 62.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.068 0.461 . . . . 72.409999999999997 110.453 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -109.32 119.23 5.45 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 121.022 -0.609 . . . . 73.109999999999999 111.77 175.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.553 HD23 ' HZ3' ' A' ' 14' ' ' LYS . 87.4 mt -85.7 -42.66 14.07 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.077 -0.342 . . . . 65.239999999999995 110.077 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 59.78 -86.94 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 O-C-N 124.106 0.879 . . . . 71.129999999999995 113.217 175.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -138.37 140.47 39.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.468 0.651 . . . . 75.239999999999995 112.148 -172.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -103.7 121.38 42.86 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.154 -0.93 . . . . 72.329999999999998 108.769 172.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -76.51 71.61 3.15 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.074 -0.713 . . . . 74.510000000000005 109.074 175.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 29.3 m170 57.01 -143.61 0.69 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.673 -0.694 . . . . 75.140000000000001 109.542 -174.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 76.3 m80 66.01 -86.33 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 122.569 0.348 . . . . 74.450000000000003 110.969 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 117.936 -1.031 . . . . 74.150000000000006 108.899 177.602 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.9 ttm . . . . . 0 N--CA 1.482 1.159 0 CA-C-O 121.101 0.477 . . . . 55.329999999999998 110.361 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -157.86 27.67 0.46 Allowed Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.589 -1.004 . . . . 62.299999999999997 110.589 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.448 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 2.5 pm0 -60.26 153.27 22.79 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.922 -0.639 . . . . 74.319999999999993 111.693 -176.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 47.5 m -132.42 126.95 34.3 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.598 -0.89 . . . . 75.540000000000006 108.598 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.798 HG22 HG23 ' A' ' 109' ' ' THR . 66.5 t -99.46 127.71 51.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 116.045 -0.525 . . . . 74.310000000000002 110.248 -173.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.6 m -83.77 126.28 40.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.387 0.613 . . . . 64.310000000000002 111.022 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.28 118.03 10.46 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.569 -0.741 . . . . 61.030000000000001 110.553 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -128.18 170.14 13.32 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.081 -0.711 . . . . 73.420000000000002 109.081 176.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.573 ' HB1' HG11 ' A' ' 105' ' ' VAL . . . -145.43 123.19 11.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.676 0.274 . . . . 71.109999999999999 111.325 -173.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.6 m -112.32 148.15 15.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.292 -0.413 . . . . 64.129999999999995 111.014 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.431 ' CG2' ' HB3' ' A' ' 96' ' ' ALA . 0.6 OUTLIER -105.21 110.43 22.8 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.952 -0.567 . . . . 70.329999999999998 112.0 -171.177 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.835 HG22 ' HB2' ' A' ' 144' ' ' GLN . 0.1 OUTLIER -124.4 151.23 29.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.109 0.48 . . . . 74.230000000000004 112.139 177.111 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.563 ' HA2' ' HA3' ' A' ' 101' ' ' GLY . . . -82.8 20.43 9.47 Favored Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.756 -0.656 . . . . 63.32 112.396 177.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.548 ' HB2' HD21 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -79.53 143.93 60.26 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.354 -0.61 . . . . 65.439999999999998 109.354 176.284 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.429 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 23.0 Cg_endo -62.28 -60.01 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.023 1.815 . . . . 74.120000000000005 113.359 -171.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.483 ' HA ' HD11 ' A' ' 19' ' ' LEU . . . 172.17 -50.76 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.492 0.717 . . . . 60.109999999999999 109.967 171.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.479 ' HA ' ' HD2' ' A' ' 20' ' ' TYR . 1.9 mp0 -56.29 -47.45 78.64 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.976 -0.556 . . . . 71.510000000000005 110.621 -177.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -66.71 -13.27 61.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.282 -0.872 . . . . 72.329999999999998 111.205 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.673 HD21 HG13 ' A' ' 12' ' ' ILE . 98.1 mt -83.88 -43.08 15.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.229 -0.441 . . . . 73.319999999999993 110.387 175.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.622 ' CE1' HD13 ' A' ' 75' ' ' ILE . 73.6 m-85 -62.68 -32.34 73.4 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.424 0.631 . . . . 74.420000000000002 109.8 176.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.52 -7.76 49.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.085 -0.961 . . . . 73.129999999999995 111.996 -176.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.545 HG23 ' CE2' ' A' ' 140' ' ' PHE . 7.8 p -53.74 -30.38 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 120.889 0.376 . . . . 72.239999999999995 111.65 -176.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 28.8 t90 -68.4 -23.73 64.68 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.044 0.449 . . . . 74.420000000000002 111.144 -177.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -124.21 13.54 8.97 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.583 -0.525 . . . . 72.430000000000007 109.583 -178.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.707 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 28.9 t70 62.38 168.73 0.12 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.427 -0.806 . . . . 74.530000000000001 110.532 -169.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.626 HD23 ' H ' ' A' ' 26' ' ' LEU . 1.3 pt? -104.83 87.2 1.73 Allowed Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 121.11 0.481 . . . . 74.400000000000006 110.767 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.707 ' HD3' ' O ' ' A' ' 25' ' ' ASP . 9.9 Cg_endo -89.39 -175.33 1.08 Allowed 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 123.208 2.605 . . . . 74.109999999999999 111.79 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.443 ' HA2' ' HB2' ' A' ' 38' ' ' SER . . . -144.37 -38.88 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.48 -0.867 . . . . 63.310000000000002 112.619 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.556 HD22 HD23 ' A' ' 32' ' ' LEU . 8.4 mp 65.22 160.87 0.12 Allowed Pre-proline 0 C--O 1.234 0.239 0 C-N-CA 122.967 0.507 . . . . 65.25 110.521 -174.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.09 61.6 3.23 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 121.6 1.534 . . . . 72.219999999999999 111.723 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.7 mp 44.53 72.54 0.19 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 114.753 -1.112 . . . . 74.430000000000007 112.587 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.556 HD23 HD22 ' A' ' 29' ' ' LEU . 1.8 pt? -81.86 -13.35 57.73 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.596 -0.52 . . . . 73.340000000000003 109.596 174.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 14.6 tpt 64.57 105.38 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.211 -0.904 . . . . 74.439999999999998 111.543 177.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.6 m -133.36 -51.37 0.87 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.053 -0.521 . . . . 75.0 111.464 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 24.6 t-80 -161.07 -179.48 7.54 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.17 -0.678 . . . . 74.109999999999999 109.17 -173.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.615 ' O ' ' HB2' ' A' ' 37' ' ' ARG . 3.2 mm? -57.97 137.69 56.56 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 108.067 -1.086 . . . . 72.200000000000003 108.067 167.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.615 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER 75.37 129.88 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 108.239 -1.023 . . . . 74.140000000000001 108.239 -164.05 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.443 ' HB2' ' HA2' ' A' ' 28' ' ' GLY . 17.5 m -44.86 -37.54 3.95 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.053 0.76 . . . . 71.329999999999998 113.053 -170.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.444 HG13 ' N ' ' A' ' 40' ' ' GLU . 6.4 p -144.01 -58.3 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 120.961 -0.296 . . . . 62.240000000000002 110.849 173.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.489 ' HG2' ' H ' ' A' ' 41' ' ' VAL . 1.9 tt0 50.27 -159.98 0.07 Allowed 'General case' 0 C--O 1.237 0.401 0 O-C-N 123.444 0.465 . . . . 62.240000000000002 110.066 -176.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.489 ' H ' ' HG2' ' A' ' 40' ' ' GLU . 38.3 t -59.85 132.84 25.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.732 -0.47 . . . . 71.230000000000004 109.732 173.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.65 HD12 ' HA ' ' A' ' 48' ' ' ARG . 84.5 mt -61.54 -71.1 0.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.234 0.827 . . . . 72.329999999999998 113.234 -167.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.767 ' HB2' HG23 ' A' ' 50' ' ' THR . 12.5 t70 -64.74 -53.42 47.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.557 0.694 . . . . 70.129999999999995 111.132 -174.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -169.44 -82.75 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.717 -1.129 . . . . 65.430000000000007 108.545 -176.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.476 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 50.8 mmtt -123.45 14.89 9.61 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.385 -0.968 . . . . 72.349999999999994 108.385 167.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.603 ' HG2' ' O ' ' A' ' 64' ' ' ALA . 31.5 mtm-85 -109.04 175.22 5.54 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 114.477 -1.238 . . . . 72.040000000000006 111.645 -171.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 50.8 m -75.05 -161.0 0.12 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.997 1.11 . . . . 51.439999999999998 113.997 -166.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.65 ' HA ' HD12 ' A' ' 42' ' ' LEU . 47.9 mtt85 -84.04 178.29 7.91 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 114.84 -1.073 . . . . 75.510000000000005 111.678 -176.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 94.7 m95 71.8 -35.31 0.32 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.737 0.815 . . . . 72.209999999999994 113.05 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.767 HG23 ' HB2' ' A' ' 43' ' ' ASP . 3.2 t -75.4 69.73 2.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 122.197 0.998 . . . . 72.329999999999998 111.247 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.1 m -128.31 -34.18 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.12 -0.945 . . . . 71.120000000000005 109.363 171.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -122.1 27.5 7.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.308 -0.86 . . . . 50.439999999999998 109.873 175.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.65 157.27 63.03 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.447 -0.797 . . . . 72.530000000000001 109.825 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.41 -178.05 1.06 Allowed 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.466 2.111 . . . . 70.409999999999997 112.068 177.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.75 143.51 39.33 Favored Pre-proline 0 C--O 1.236 0.354 0 CA-C-N 116.312 -0.403 . . . . 53.310000000000002 111.265 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.468 ' HB3' ' HG3' ' A' ' 63' ' ' GLU . 34.8 Cg_endo -60.38 -54.95 1.74 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.041 2.494 . . . . 71.430000000000007 111.449 -177.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.641 HD11 ' HG3' ' A' ' 65' ' ' GLU . 13.4 mt -78.79 8.62 5.15 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.642 -1.163 . . . . 62.530000000000001 110.493 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -94.93 -64.49 0.99 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.747 -0.661 . . . . 72.430000000000007 111.548 175.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -151.48 60.68 0.88 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.918 0.39 . . . . 63.340000000000003 111.726 -178.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 80.4 t -132.5 140.71 46.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.722 -0.473 . . . . 64.450000000000003 109.722 176.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.7 m -55.58 -70.37 0.11 Allowed 'General case' 0 N--CA 1.462 0.172 0 O-C-N 123.194 0.309 . . . . 64.439999999999998 111.316 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 70.4 p-90 -129.34 136.71 50.37 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.489 0.662 . . . . 74.540000000000006 111.155 176.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.574 ' OE2' ' HB3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -154.8 169.31 24.27 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.537 -1.21 . . . . 74.099999999999994 108.299 177.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.603 ' O ' ' HG2' ' A' ' 46' ' ' ARG . . . -118.83 113.9 21.81 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.492 -0.483 . . . . 74.530000000000001 110.17 175.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.641 ' HG3' HD11 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -106.77 135.74 47.79 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.745 -0.465 . . . . 74.230000000000004 109.745 178.328 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 77' ' ' TRP . 3.0 mm? -86.57 147.05 26.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.139 -0.482 . . . . 75.310000000000002 111.305 -169.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.6 t -98.67 -16.5 19.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.082 0.467 . . . . 72.329999999999998 110.53 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.551 ' HB2' ' H ' ' A' ' 76' ' ' ALA . . . -138.72 124.96 20.26 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.173 -0.677 . . . . 61.149999999999999 109.173 173.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -125.2 99.62 6.17 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.267 -0.424 . . . . 72.209999999999994 111.754 -171.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.453 ' O ' HD12 ' A' ' 75' ' ' ILE . 22.8 mt-10 -121.48 142.69 36.09 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.769 -0.826 . . . . 63.409999999999997 108.769 166.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 31.1 Cg_exo -61.16 -42.96 32.03 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.588 2.192 . . . . 74.140000000000001 112.328 -177.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -150.48 56.02 0.47 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.636 -0.792 . . . . 72.030000000000001 112.198 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -147.09 -82.43 0.13 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.816 -0.354 . . . . 73.329999999999998 110.914 174.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.583 ' HD2' ' OE2' ' A' ' 90' ' ' GLU . 16.7 ttp180 -124.38 123.14 39.53 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.444 -0.502 . . . . 74.239999999999995 111.168 -170.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.622 HD13 ' CE1' ' A' ' 20' ' ' TYR . 2.6 mp -125.82 110.87 25.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.748 -0.66 . . . . 71.129999999999995 110.506 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.551 ' H ' ' HB2' ' A' ' 68' ' ' ALA . . . -96.6 116.11 28.56 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.259 -1.015 . . . . 61.32 108.259 170.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.606 ' CZ2' ' HB3' ' A' ' 87' ' ' ASN . 3.9 p-90 -85.69 151.72 23.64 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.409 0.623 . . . . 60.409999999999997 111.269 -171.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.55 ' HB3' ' O ' ' A' ' 65' ' ' GLU . 5.5 tpm_? -155.37 170.88 20.87 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.183 -1.414 . . . . 73.299999999999997 107.183 -175.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 64' ' ' ALA . 20.0 p -145.24 170.38 16.38 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.075 0.464 . . . . 52.450000000000003 110.888 -177.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.508 HD11 ' HB2' ' A' ' 65' ' ' GLU . 5.7 mp -87.45 154.33 53.85 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.761 -0.654 . . . . 72.310000000000002 110.576 178.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.57 -1.4 3.93 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 123.089 2.526 . . . . 64.230000000000004 112.981 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.21 -8.18 66.84 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.994 -0.622 . . . . 61.530000000000001 112.136 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.17 -177.62 5.75 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.744 0.307 . . . . 75.200000000000003 110.56 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.473 ' HD2' ' HA ' ' A' ' 84' ' ' ARG . 14.3 tpt180 -122.12 -28.34 4.4 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.592 -0.443 . . . . 74.400000000000006 111.302 -178.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.85 132.56 70.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.117 0.484 . . . . 54.219999999999999 110.154 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -147.24 142.83 27.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.839 -0.618 . . . . 72.0 110.089 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.606 ' HB3' ' CZ2' ' A' ' 77' ' ' TRP . 28.1 t-20 -137.13 150.27 47.86 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.722 -0.844 . . . . 73.319999999999993 108.722 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 60.9 m -100.7 127.5 47.09 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.397 0.618 . . . . 70.329999999999998 110.216 -176.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -171.54 169.25 42.34 Favored Glycine 0 N--CA 1.438 -1.223 0 CA-C-N 115.227 -0.897 . . . . 43.32 111.559 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.583 ' OE2' ' HD2' ' A' ' 74' ' ' ARG . 33.1 tt0 -144.64 129.42 18.26 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.993 -0.373 . . . . 74.340000000000003 109.993 -175.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.612 HG11 HG13 ' A' ' 106' ' ' VAL . 9.3 m -111.05 137.89 41.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 110.095 -0.335 . . . . 73.219999999999999 110.095 178.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.637 ' CD2' ' HB ' ' A' ' 105' ' ' VAL . 0.0 OUTLIER -128.19 119.7 25.76 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.75 0.786 . . . . 73.209999999999994 110.046 173.078 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.614 ' HE2' ' HB3' ' A' ' 19' ' ' LEU . 2.5 m-85 -97.73 106.43 18.74 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.485 -1.234 . . . . 72.409999999999997 109.215 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -119.66 144.93 38.02 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 115.418 -0.81 . . . . 71.030000000000001 110.35 -172.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -46.86 117.78 2.33 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.246 2.631 . . . . 75.120000000000005 112.102 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.431 ' HB3' ' CG2' ' A' ' 11' ' ' THR . . . -58.93 144.54 81.67 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.741 -0.663 . . . . 75.230000000000004 111.094 -176.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -46.31 115.98 1.36 Allowed 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 123.303 2.669 . . . . 75.540000000000006 113.022 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 96.15 3.57 60.25 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.665 -0.698 . . . . 52.539999999999999 112.162 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 64.79 32.49 10.98 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 123.08 0.552 . . . . 71.120000000000005 111.164 -178.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 37.7 ttt-85 -75.46 -19.43 59.44 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.957 -0.565 . . . . 72.030000000000001 110.992 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.563 ' HA3' ' HA2' ' A' ' 13' ' ' GLY . . . 165.82 -130.74 2.21 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.885 -0.886 . . . . 41.109999999999999 110.885 -175.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.2 m -138.73 133.95 32.9 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 110.152 -0.314 . . . . 62.109999999999999 110.152 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -96.55 133.06 41.49 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.928 -0.767 . . . . 62.229999999999997 108.928 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.592 HG12 HD13 ' A' ' 12' ' ' ILE . 1.5 p -95.15 100.32 10.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.794 0.807 . . . . 65.049999999999997 110.35 179.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.637 ' HB ' ' CD2' ' A' ' 92' ' ' LEU . 4.1 t -97.4 111.47 27.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.688 -1.142 . . . . 73.310000000000002 108.941 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.612 HG13 HG11 ' A' ' 91' ' ' VAL . 26.1 m -112.47 123.46 68.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.318 0.58 . . . . 75.349999999999994 111.517 -176.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 31.1 ttt85 -105.17 100.89 10.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.524 -0.762 . . . . 73.420000000000002 109.678 174.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.4 mt -116.94 126.8 53.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.257 -0.429 . . . . 71.420000000000002 110.146 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.798 HG23 HG22 ' A' ' 5' ' ' VAL . 25.9 m -90.22 116.26 28.08 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 120.214 -0.594 . . . . 73.549999999999997 110.726 -176.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -172.93 168.71 4.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.485 -0.78 . . . . 73.019999999999996 108.917 174.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -105.56 144.76 29.49 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 110.428 -0.212 . . . . 73.329999999999998 110.428 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.45 168.92 19.77 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 122.659 2.239 . . . . 55.340000000000003 111.586 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.647 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 7.3 Cg_endo -50.0 129.54 25.08 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.943 2.429 . . . . 71.510000000000005 112.029 177.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -49.22 -64.44 3.34 Favored Glycine 0 C--N 1.332 0.361 0 CA-C-N 115.36 -0.836 . . . . 72.319999999999993 114.554 -171.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -105.71 1.87 39.1 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.491 -0.862 . . . . 37.409999999999997 113.114 -175.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.647 ' HB2' ' HB2' ' A' ' 113' ' ' PRO . 13.0 m -86.08 -24.17 26.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.694 0.283 . . . . 73.150000000000006 111.152 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.63 -41.64 99.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.435 -0.348 . . . . 74.430000000000007 110.933 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.01 -31.25 77.97 Favored Glycine 0 N--CA 1.452 -0.256 0 CA-C-N 116.05 -0.523 . . . . 65.230000000000004 112.48 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.34 -29.3 64.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.163 0.506 . . . . 72.329999999999998 110.572 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 59.6 t -73.67 -51.36 25.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.881 -0.6 . . . . 71.049999999999997 110.51 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.9 pp -68.92 -22.64 26.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.24 -0.437 . . . . 73.409999999999997 111.981 -175.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -81.2 -30.96 34.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.742 0.306 . . . . 64.329999999999998 111.16 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -88.77 -39.16 14.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.4 -0.364 . . . . 71.519999999999996 111.219 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.569 ' HE1' HD21 ' A' ' 133' ' ' LEU . 47.9 ttm -52.55 -51.58 58.98 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 123.33 0.394 . . . . 75.219999999999999 110.707 -177.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.41 ' HD1' ' HA ' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -167.29 111.57 0.71 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.067 -0.716 . . . . 54.420000000000002 109.067 176.09 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -57.23 -45.63 83.72 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.029 -0.532 . . . . 74.319999999999993 111.483 -174.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.405 ' O ' ' HB2' ' A' ' 128' ' ' GLU . 9.3 pt20 -118.44 169.75 9.51 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.16 -0.473 . . . . 71.099999999999994 109.924 178.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 127' ' ' GLN . 0.5 OUTLIER 69.82 153.27 0.14 Allowed Pre-proline 0 N--CA 1.471 0.577 0 O-C-N 123.801 0.688 . . . . 63.5 111.449 -175.252 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.85 128.73 26.45 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.624 2.216 . . . . 73.530000000000001 111.881 175.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.55 ' HB3' ' SD ' ' A' ' 124' ' ' MET . 14.4 m -68.2 136.65 53.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.985 -0.552 . . . . 63.200000000000003 110.447 -178.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -83.32 -172.68 4.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.007 0.432 . . . . 74.239999999999995 111.579 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -81.13 56.49 2.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.863 -0.608 . . . . 60.299999999999997 111.627 -172.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.569 HD21 ' HE1' ' A' ' 124' ' ' MET . 54.1 tp -77.91 100.42 6.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.426 0.631 . . . . 71.409999999999997 109.486 175.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -124.58 77.39 1.58 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.202 -0.908 . . . . 73.549999999999997 110.098 -174.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -58.53 -44.6 89.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.636 -0.711 . . . . 73.319999999999993 111.695 -175.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -60.54 -52.72 64.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.425 . . . . 74.140000000000001 111.087 -177.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.476 HD11 ' HA ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -68.35 -36.13 78.77 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.545 -0.298 . . . . 72.120000000000005 111.27 -179.52 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 27.9 tpp -67.89 -41.64 82.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.884 0.373 . . . . 74.420000000000002 110.9 -177.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -63.63 -36.11 82.73 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.441 -0.577 . . . . 74.319999999999993 109.441 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.59 ' HE1' HG13 ' A' ' 104' ' ' VAL . 55.5 t80 -63.65 -49.85 71.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.427 -0.806 . . . . 72.310000000000002 110.25 174.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -55.81 -50.1 71.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.496 -0.775 . . . . 62.43 111.42 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -62.04 -45.34 94.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.335 -0.393 . . . . 75.040000000000006 110.924 -176.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -65.49 -28.85 69.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.313 -0.403 . . . . 74.209999999999994 111.716 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.835 ' HB2' HG22 ' A' ' 12' ' ' ILE . 9.9 mm-40 -68.62 -35.99 78.03 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.617 -0.433 . . . . 75.219999999999999 111.102 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.554 ' HG3' HG21 ' A' ' 12' ' ' ILE . 35.4 mt-10 -78.39 -37.15 44.73 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.713 -0.395 . . . . 75.230000000000004 110.143 178.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 67.2 mt -65.35 -40.55 93.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.972 -0.558 . . . . 73.310000000000002 110.678 176.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -80.02 55.23 4.54 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.095 -0.574 . . . . 75.400000000000006 112.054 176.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.493 HD22 ' HD3' ' A' ' 14' ' ' LYS . 57.1 tp 177.45 -48.17 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.945 -0.761 . . . . 73.340000000000003 108.945 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 71.11 -60.28 0.52 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.863 -1.062 . . . . 75.25 111.691 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 37.5 m170 -84.53 115.77 22.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.068 0.461 . . . . 74.140000000000001 110.728 -173.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -90.24 140.84 29.3 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.71 -0.677 . . . . 74.109999999999999 110.404 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -121.37 128.86 52.67 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.756 -0.461 . . . . 65.219999999999999 109.756 173.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 35.2 t60 -77.1 111.07 12.3 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.025 -0.534 . . . . 73.310000000000002 109.917 -177.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 59.11 -116.53 0.83 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.153 -0.684 . . . . 74.519999999999996 109.153 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.215 -0.898 . . . . 74.219999999999999 109.255 177.601 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 109.421 -0.585 . . . . 73.430000000000007 109.421 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.36 -51.48 1.61 Allowed Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 110.345 -1.102 . . . . 61.109999999999999 110.345 -171.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -95.93 140.32 30.85 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.742 -0.836 . . . . 72.140000000000001 108.742 170.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.0 m -75.12 121.29 21.84 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.166 -0.309 . . . . 63.140000000000001 110.166 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.6 p -125.42 135.76 62.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.811 0.339 . . . . 70.439999999999998 110.45 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.3 t -119.93 126.38 75.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.692 -0.485 . . . . 72.329999999999998 109.692 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -127.78 132.84 49.46 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.054 0.454 . . . . 74.230000000000004 110.508 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.439 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 11.3 t70 -158.09 171.74 19.69 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.799 -1.186 . . . . 72.549999999999997 107.799 173.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.622 ' HB2' HG12 ' A' ' 105' ' ' VAL . . . -134.06 120.42 20.18 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.068 0.461 . . . . 73.409999999999997 112.12 -174.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.534 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 21.4 m -101.27 130.04 51.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.67 -0.696 . . . . 65.109999999999999 109.749 174.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.664 ' HA ' ' HA ' ' A' ' 103' ' ' GLU . 5.1 t -102.83 113.48 26.94 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.78 0.8 . . . . 75.030000000000001 110.436 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.614 HG21 ' HB3' ' A' ' 145' ' ' GLU . 4.5 mp -112.36 151.47 14.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.954 -1.021 . . . . 73.230000000000004 108.871 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.86 42.3 1.1 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.862 -0.685 . . . . 74.109999999999999 112.907 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.63 ' HB3' ' HB2' ' A' ' 18' ' ' GLN . 6.7 mmpt? -112.24 144.25 30.45 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 108.394 -0.965 . . . . 72.099999999999994 108.394 178.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -52.99 -57.96 1.75 Allowed 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.335 2.023 . . . . 54.100000000000001 113.738 -172.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 174.4 -53.46 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.251 0.548 . . . . 74.329999999999998 109.66 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.79 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 0.1 OUTLIER -54.43 -39.22 67.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.069 -0.969 . . . . 72.109999999999999 110.891 177.631 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.63 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 21.4 mm-40 -63.06 -27.79 69.64 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.061 -0.972 . . . . 71.540000000000006 111.37 -177.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.516 ' HA ' ' NE2' ' A' ' 144' ' ' GLN . 95.5 mt -74.94 -48.35 24.93 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.9 -0.591 . . . . 62.32 111.162 -174.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.79 ' CE2' ' HA ' ' A' ' 17' ' ' GLU . 36.2 p90 -74.77 -23.42 58.52 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 119.704 -0.798 . . . . 74.239999999999995 110.643 177.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.56 -2.08 21.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.043 -0.526 . . . . 73.340000000000003 111.627 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.469 ' HB ' ' NE2' ' A' ' 144' ' ' GLN . 12.0 p -53.38 -22.59 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 115.806 -0.633 . . . . 45.539999999999999 112.525 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -66.75 -27.31 67.5 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.275 0.559 . . . . 75.239999999999995 110.709 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.836 ' HG3' ' H ' ' A' ' 25' ' ' ASP . 15.0 tpp180 -105.54 -164.21 1.01 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.924 -1.139 . . . . 74.329999999999998 107.924 176.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.836 ' H ' ' HG3' ' A' ' 24' ' ' ARG . 28.6 t0 -83.93 36.47 0.56 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.45 0.643 . . . . 74.439999999999998 109.363 176.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.536 HD12 ' HA3' ' A' ' 147' ' ' GLY . 0.3 OUTLIER 41.89 63.1 6.9 Favored Pre-proline 0 N--CA 1.47 0.543 0 CA-C-N 114.897 -1.047 . . . . 72.120000000000005 112.279 -177.606 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.46 ' HD3' ' N ' ' A' ' 26' ' ' LEU . 89.9 Cg_endo -103.93 -4.86 0.21 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.225 2.617 . . . . 64.439999999999998 113.094 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.99 -113.66 4.44 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.484 -1.047 . . . . 75.129999999999995 110.484 -170.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.544 HD11 HD13 ' A' ' 31' ' ' LEU . 0.9 OUTLIER -159.08 151.7 17.95 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 109.344 -0.613 . . . . 74.209999999999994 109.344 174.393 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.462 ' HD2' HD22 ' A' ' 32' ' ' LEU . 31.5 Cg_exo -62.14 7.28 0.14 Allowed 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 123.524 2.816 . . . . 73.430000000000007 113.112 176.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.544 HD13 HD11 ' A' ' 29' ' ' LEU . 11.0 mp 67.79 63.15 0.4 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.567 0.699 . . . . 64.420000000000002 110.608 -177.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.471 ' HG ' ' HB ' ' A' ' 39' ' ' VAL . 2.7 mm? -73.95 81.91 1.69 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.152 -0.931 . . . . 64.040000000000006 110.265 177.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -134.76 7.99 3.53 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.626 -0.716 . . . . 72.319999999999993 110.159 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.6 p -88.1 172.87 9.2 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.875 -0.602 . . . . 64.299999999999997 110.115 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -104.51 18.82 21.46 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.595 -0.442 . . . . 73.549999999999997 111.449 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 tt -76.54 108.31 9.44 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 105.825 -1.917 . . . . 72.200000000000003 105.825 164.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -81.7 59.83 4.37 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.193 0.52 . . . . 65.120000000000005 112.285 -160.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.7 m -98.88 -59.99 1.62 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.459 -0.941 . . . . 71.049999999999997 108.459 170.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.471 ' HB ' ' HG ' ' A' ' 32' ' ' LEU . 21.8 t -124.48 84.95 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.272 -1.01 . . . . 64.340000000000003 108.272 170.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -103.96 135.3 45.74 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.678 -0.692 . . . . 72.140000000000001 110.765 -174.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 73.5 t -88.05 104.69 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-O 121.513 0.673 . . . . 61.43 109.993 174.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.5 tp -70.35 -52.33 23.41 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.802 -1.09 . . . . 73.049999999999997 109.477 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -164.19 156.06 16.49 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.905 -1.146 . . . . 74.549999999999997 107.905 175.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -85.67 66.22 9.54 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 122.313 1.054 . . . . 74.099999999999994 109.568 -177.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.913 ' HE2' ' HA ' ' A' ' 45' ' ' LYS . 2.1 mmpt? -139.06 -60.22 0.58 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 113.629 -1.623 . . . . 71.109999999999999 110.258 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.486 ' HD3' ' HG3' ' A' ' 63' ' ' GLU . 83.7 mtt180 -114.69 121.35 43.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.65 -0.705 . . . . 72.439999999999998 110.52 178.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.0 p -110.37 96.16 6.03 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.491 -0.559 . . . . 73.409999999999997 109.491 172.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.719 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 38.8 ptt180 -89.76 156.56 18.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.113 -0.494 . . . . 62.240000000000002 111.075 -176.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 71.94 -64.65 0.38 Allowed 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.96 0.788 . . . . 72.420000000000002 111.946 -177.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.9 m 72.56 134.11 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.316 0.579 . . . . 71.319999999999993 111.823 178.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.4 t -100.13 -27.14 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.232 -0.44 . . . . 50.310000000000002 111.409 -177.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.662 ' HA ' ' NH2' ' A' ' 24' ' ' ARG . 15.8 mm-40 -70.86 -32.23 69.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.957 0.408 . . . . 52.030000000000001 111.433 -177.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -144.68 149.96 45.27 Favored Pre-proline 0 C--N 1.321 -0.674 0 N-CA-C 109.433 -0.581 . . . . 72.129999999999995 109.433 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -65.32 112.05 1.99 Allowed 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 121.831 1.687 . . . . 74.099999999999994 111.097 177.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.413 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . . . 65.64 142.25 0.07 OUTLIER Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 115.233 -0.894 . . . . 62.240000000000002 111.671 -174.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.671 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 38.4 Cg_exo -65.26 -56.72 0.33 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 123.059 2.506 . . . . 62.43 112.284 -178.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.673 HD22 ' HG ' ' A' ' 80' ' ' LEU . 0.4 OUTLIER -119.63 22.44 11.63 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.249 -0.887 . . . . 75.439999999999998 111.402 -178.001 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.49 19.3 35.58 Favored Glycine 0 C--N 1.31 -0.875 0 CA-C-N 114.964 -1.016 . . . . 42.409999999999997 112.735 178.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 71.28 28.36 3.01 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 122.998 0.519 . . . . 75.430000000000007 111.495 173.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.514 ' HB ' HD13 ' A' ' 57' ' ' LEU . 61.3 t -60.08 -50.2 81.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.905 -0.588 . . . . 73.400000000000006 109.485 174.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.3 m -115.45 -88.37 0.58 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.285 -0.635 . . . . 73.129999999999995 109.285 170.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -158.18 -35.96 0.07 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.828 0.347 . . . . 72.319999999999993 110.875 174.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.719 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 1.4 pm0 -108.49 167.1 10.28 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.077 0.769 . . . . 74.420000000000002 113.077 -170.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.671 ' HB3' ' HB3' ' A' ' 56' ' ' PRO . . . -110.47 147.81 33.33 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.123 -1.066 . . . . 63.25 108.123 163.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.774 ' HB2' HD21 ' A' ' 80' ' ' LEU . 0.7 OUTLIER -112.57 134.15 54.24 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 107.708 -1.219 . . . . 74.420000000000002 107.708 -176.78 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -107.83 141.34 39.56 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 119.616 -0.834 . . . . 70.049999999999997 111.221 -171.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.9 t -108.1 -24.38 11.59 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.854 -0.338 . . . . 72.129999999999995 111.008 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.446 ' HB2' ' HB3' ' A' ' 76' ' ' ALA . . . -135.98 153.78 51.29 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.542 -0.54 . . . . 61.350000000000001 109.542 175.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -150.61 16.68 0.8 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.876 0.325 . . . . 53.219999999999999 111.876 -172.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.576 ' HG2' ' HD3' ' A' ' 73' ' ' LYS . 1.6 mp0 -61.29 142.03 93.82 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 110.416 -0.216 . . . . 74.409999999999997 110.416 -176.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -79.51 -20.17 9.65 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.661 2.241 . . . . 74.230000000000004 113.017 -173.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -162.67 38.29 0.35 Allowed Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.303 -0.719 . . . . 72.329999999999998 111.303 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.576 ' HD3' ' HG2' ' A' ' 70' ' ' GLU . 54.3 tttp -129.74 -51.57 1.15 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.008 -0.367 . . . . 70.409999999999997 110.008 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 29.3 ttp180 -166.09 129.47 2.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.25 -0.432 . . . . 73.340000000000003 110.902 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.609 ' HB ' HG23 ' A' ' 91' ' ' VAL . 6.3 mm -108.38 109.99 30.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.399 -0.963 . . . . 71.299999999999997 108.399 175.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.517 ' HB1' ' HG3' ' A' ' 90' ' ' GLU . . . -129.94 116.3 18.42 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.05 0.452 . . . . 61.109999999999999 110.486 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.515 ' NE1' ' HA3' ' A' ' 89' ' ' GLY . 69.0 p-90 -113.18 155.54 24.82 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.629 -0.714 . . . . 70.239999999999995 109.928 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -142.87 176.45 9.06 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.935 -1.135 . . . . 75.530000000000001 107.935 175.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 51.3 p -96.05 177.68 5.66 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.924 -0.71 . . . . 74.049999999999997 110.153 174.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.774 HD21 ' HB2' ' A' ' 65' ' ' GLU . 7.3 mt -71.64 156.89 90.77 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 116.038 -0.528 . . . . 71.099999999999994 110.019 -177.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -52.93 -36.57 75.6 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.864 2.376 . . . . 74.140000000000001 112.755 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.92 21.44 44.93 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.764 -0.731 . . . . 73.420000000000002 112.696 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -120.5 176.64 5.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.608 0.242 . . . . 74.129999999999995 110.552 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.414 ' HD2' ' N ' ' A' ' 84' ' ' ARG . 8.5 mpt_? -115.05 144.85 42.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.534 -0.303 . . . . 73.319999999999993 110.351 -179.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.6 pp -88.91 166.74 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.984 0.421 . . . . 74.510000000000005 111.639 -178.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -126.07 -64.34 1.05 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.665 -0.698 . . . . 64.019999999999996 110.399 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -130.11 173.15 11.02 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.937 -1.135 . . . . 62.219999999999999 107.937 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.8 m -95.75 126.98 41.39 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.497 -0.557 . . . . 72.540000000000006 109.497 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.515 ' HA3' ' NE1' ' A' ' 77' ' ' TRP . . . -115.92 74.87 0.26 Allowed Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.663 -0.779 . . . . 73.109999999999999 111.85 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.517 ' HG3' ' HB1' ' A' ' 76' ' ' ALA . 35.2 tt0 -131.0 113.9 14.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.01 0.433 . . . . 71.150000000000006 110.241 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.609 HG23 ' HB ' ' A' ' 75' ' ' ILE . 18.6 m -120.47 131.91 71.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.533 -0.758 . . . . 71.239999999999995 109.401 177.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.773 ' HB2' HG22 ' A' ' 105' ' ' VAL . 4.5 mp -113.36 141.08 47.47 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.428 -0.509 . . . . 71.129999999999995 109.875 175.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.457 ' HZ ' ' HB3' ' A' ' 20' ' ' TYR . 58.2 m-85 -120.8 131.59 54.55 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.206 -0.452 . . . . 71.200000000000003 110.461 -177.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -141.18 142.8 28.44 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 109.53 -0.545 . . . . 74.420000000000002 109.53 173.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -62.67 112.89 1.75 Allowed 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 122.251 1.967 . . . . 72.450000000000003 110.757 174.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.504 ' HB1' ' HB2' ' A' ' 100' ' ' ARG . . . -63.37 144.11 97.64 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.748 -0.66 . . . . 74.310000000000002 110.674 -174.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -23.5 109.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.691 1 C-N-CA 126.046 4.497 . . . . 65.439999999999998 115.356 -171.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.5 -67.79 3.65 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 114.77 -1.104 . . . . 45.200000000000003 111.849 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -177.81 38.41 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.731 -0.735 . . . . 72.230000000000004 110.453 -172.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.519 ' HA ' ' NE ' ' A' ' 100' ' ' ARG . 4.6 mmp_? -78.44 -6.98 56.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.259 0.552 . . . . 71.129999999999995 110.11 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 119.74 -143.66 17.06 Favored Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 110.145 -1.182 . . . . 71.439999999999998 110.145 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.6 m -127.22 116.5 20.68 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.791 -0.448 . . . . 74.349999999999994 109.791 174.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.664 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 11.0 pt-20 -88.38 138.42 31.45 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.253 -0.647 . . . . 71.439999999999998 109.253 177.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 1.5 p -108.49 108.83 26.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 115.336 -0.847 . . . . 65.420000000000002 111.135 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.773 HG22 ' HB2' ' A' ' 92' ' ' LEU . 2.6 m -87.27 110.35 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.446 -0.797 . . . . 63.140000000000001 109.319 174.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.83 138.48 50.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.678 -0.692 . . . . 73.530000000000001 110.676 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -122.84 102.35 7.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.658 -0.701 . . . . 70.329999999999998 110.702 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.48 HD21 ' CZ ' ' A' ' 110' ' ' TYR . 0.0 OUTLIER -123.19 152.82 40.85 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.133 -0.485 . . . . 74.049999999999997 109.772 178.782 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.7 t -100.58 149.34 23.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.381 0.61 . . . . 70.400000000000006 111.709 -172.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.48 ' CZ ' HD21 ' A' ' 108' ' ' LEU . 97.5 m-85 -123.85 159.15 30.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.166 -0.925 . . . . 75.319999999999993 109.019 174.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 42.9 mtt180 -89.93 143.84 30.61 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 108.984 -0.747 . . . . 72.319999999999993 108.984 172.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.81 151.26 82.01 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 122.092 1.861 . . . . 53.200000000000003 112.008 -177.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -97.45 5.27 1.47 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.264 2.643 . . . . 64.540000000000006 113.312 -178.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.84 89.48 0.66 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.855 -0.688 . . . . 72.430000000000007 112.413 -177.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -170.96 174.7 44.76 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 121.02 -0.61 . . . . 60.240000000000002 112.116 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.6 m -78.95 -12.47 60.03 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.654 0.242 . . . . 51.229999999999997 111.654 -177.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.43 -36.46 73.65 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.941 0.4 . . . . 74.299999999999997 111.395 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -73.28 -23.71 76.85 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.771 -0.728 . . . . 72.099999999999994 112.767 -177.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.09 -45.75 83.11 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.06 0.393 . . . . 63.32 112.06 -174.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 16.7 m -74.34 -41.77 50.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 111.977 0.362 . . . . 70.420000000000002 111.977 -176.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.8 pp -75.99 -22.73 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.729 0.299 . . . . 74.400000000000006 111.715 -176.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.897 ' HB2' ' HA ' ' A' ' 127' ' ' GLN . . . -68.4 -20.36 64.67 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.951 0.352 . . . . 53.229999999999997 111.951 -178.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -64.44 -14.55 57.47 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.924 -0.58 . . . . 73.400000000000006 111.796 -175.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -63.08 -41.93 99.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.581 -0.282 . . . . 71.150000000000006 111.213 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -153.59 -75.37 0.12 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.161 0.505 . . . . 73.019999999999996 110.63 -176.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -132.41 145.55 51.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.481 -0.781 . . . . 52.229999999999997 109.238 -176.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.897 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . 10.0 pt20 -67.07 -26.62 66.82 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 123.354 0.409 . . . . 73.349999999999994 111.222 177.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -123.26 82.74 52.05 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.274 -0.421 . . . . 72.150000000000006 110.639 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -87.41 60.62 3.68 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.008 1.806 . . . . 71.409999999999997 111.656 178.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.3 t 55.81 112.02 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.236 -0.893 . . . . 37.600000000000001 112.165 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.442 ' H ' ' CD ' ' A' ' 131' ' ' GLN . 4.9 pm0 -75.55 67.15 2.02 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.275 0.56 . . . . 70.340000000000003 110.309 175.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 67.1 -67.31 0.17 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.08 -0.964 . . . . 72.319999999999993 111.086 -174.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.869 ' HG ' ' H ' ' A' ' 134' ' ' ARG . 16.6 tp 54.95 -153.9 0.3 Allowed 'General case' 0 CA--C 1.534 0.355 0 O-C-N 123.393 0.433 . . . . 71.25 110.372 178.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.869 ' H ' ' HG ' ' A' ' 133' ' ' LEU . 32.7 mtp-105 -84.3 -28.91 26.8 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 122.36 -0.213 . . . . 73.430000000000007 111.356 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.29 -39.33 94.28 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 111.935 0.346 . . . . 64.120000000000005 111.935 -171.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.484 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 32.5 t70 -70.33 -30.68 67.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.228 0.537 . . . . 73.329999999999998 110.155 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.534 ' HG ' ' CG1' ' A' ' 10' ' ' VAL . 22.2 tp -78.08 -27.96 48.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.069 -0.514 . . . . 70.120000000000005 109.817 178.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.598 ' HA ' ' HE2' ' A' ' 138' ' ' MET . 29.5 mmt -66.49 -42.15 87.88 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.16 -0.473 . . . . 74.439999999999998 110.409 176.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' A' ' 136' ' ' ASP . 5.9 ppt_? -75.05 -27.61 60.08 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.009 -0.367 . . . . 75.129999999999995 110.009 178.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.452 ' HZ ' HG13 ' A' ' 22' ' ' VAL . 83.7 t80 -61.54 -39.83 92.48 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.094 0.473 . . . . 72.530000000000001 109.819 173.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 138' ' ' MET . 35.0 ttmt -56.44 -42.18 77.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.443 -0.799 . . . . 73.530000000000001 109.72 174.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.427 HH21 ' CD ' ' A' ' 145' ' ' GLU . 0.0 OUTLIER -58.43 -48.66 79.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.876 -1.056 . . . . 74.409999999999997 111.083 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.37 -31.43 72.09 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.436 -0.347 . . . . 61.439999999999998 111.635 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.536 ' HG3' HG23 ' A' ' 12' ' ' ILE . 6.6 tp-100 -76.51 -43.38 39.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.726 0.298 . . . . 74.230000000000004 110.798 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.614 ' HB3' HG21 ' A' ' 12' ' ' ILE . 16.3 pt-20 -80.07 -4.32 52.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.867 0.365 . . . . 73.109999999999999 110.714 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 60.6 tp -65.84 -36.41 83.4 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.185 -0.672 . . . . 65.25 109.185 171.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.536 ' HA3' HD12 ' A' ' 26' ' ' LEU . . . -76.89 89.83 0.97 Allowed Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.398 -0.819 . . . . 73.430000000000007 112.3 176.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.402 ' HB3' ' O ' ' A' ' 147' ' ' GLY . 62.9 tp 73.96 114.29 0.06 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.57 0.748 . . . . 73.129999999999995 111.265 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -76.03 81.87 2.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.54 -0.754 . . . . 71.439999999999998 111.142 -178.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -108.13 13.27 26.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.902 0.858 . . . . 74.109999999999999 109.236 174.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -131.52 107.42 8.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.083 -0.962 . . . . 74.549999999999997 109.587 178.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -131.0 112.92 13.36 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.487 0.661 . . . . 73.409999999999997 111.057 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -155.2 80.77 1.06 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.282 -1.007 . . . . 75.209999999999994 108.282 177.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -77.38 100.85 6.1 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.704 -0.68 . . . . 74.510000000000005 111.471 -170.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 62.8 t60 . . . . . 0 C--O 1.244 0.786 0 CA-C-O 118.458 -0.782 . . . . 74.5 109.915 177.635 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.758 0.313 . . . . 70.540000000000006 110.555 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.16 -143.12 7.05 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.939 -0.648 . . . . 74.019999999999996 112.123 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -87.99 154.98 20.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.524 0.202 . . . . 70.209999999999994 110.58 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 97.7 m -135.44 122.24 21.06 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.213 0.53 . . . . 73.010000000000005 111.505 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.1 p -125.4 101.52 8.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.354 -0.839 . . . . 75.310000000000002 108.923 170.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.1 m -88.62 143.37 11.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.297 0.57 . . . . 75.030000000000001 111.22 -173.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.775 ' HD2' ' O ' ' A' ' 7' ' ' ARG . 0.5 OUTLIER -137.91 109.63 7.09 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.481 -0.782 . . . . 71.530000000000001 109.949 178.568 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.581 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 2.1 t70 -132.92 172.3 12.79 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.452 -0.573 . . . . 61.240000000000002 109.452 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.61 ' HB1' ' HG2' ' A' ' 103' ' ' GLU . . . -144.7 122.94 12.23 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.026 0.441 . . . . 55.549999999999997 111.007 -173.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.512 HG21 HD11 ' A' ' 12' ' ' ILE . 4.4 m -113.02 149.35 15.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.886 -0.597 . . . . 73.209999999999994 111.133 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.8 m -100.98 109.87 21.83 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.855 -0.611 . . . . 74.120000000000005 111.017 -175.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.792 HG13 ' HG2' ' A' ' 141' ' ' LYS . 4.5 mp -118.49 145.93 23.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 110.091 -0.337 . . . . 74.239999999999995 110.091 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.37 56.97 4.9 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 121.12 -0.562 . . . . 64.209999999999994 112.552 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.573 ' HG2' HG22 ' A' ' 12' ' ' ILE . 75.6 mmtt -121.77 156.56 58.85 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 108.584 -0.895 . . . . 73.439999999999998 108.584 175.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.424 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 47.1 Cg_exo -56.51 -59.1 0.73 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 121.762 1.641 . . . . 75.120000000000005 112.4 -178.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 15' ' ' PRO . . . 171.09 -58.72 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.768 0.667 . . . . 71.239999999999995 110.046 174.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -49.31 -55.01 14.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.525 -1.216 . . . . 54.450000000000003 112.215 -173.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.522 ' O ' HD12 ' A' ' 26' ' ' LEU . 16.9 mm-40 -69.39 -10.69 59.09 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.177 0.806 . . . . 73.319999999999993 113.177 -173.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.453 ' HA ' HD22 ' A' ' 19' ' ' LEU . 16.2 mt -63.47 -24.79 67.97 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.007 -0.433 . . . . 72.209999999999994 111.624 176.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -72.86 -25.0 60.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.943 0.402 . . . . 75.099999999999994 110.387 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.84 -9.0 58.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.222 -0.444 . . . . 74.099999999999994 111.726 -176.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.832 HG22 ' HG2' ' A' ' 144' ' ' GLN . 14.0 p -52.36 -21.92 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 112.247 0.462 . . . . 65.340000000000003 112.247 -175.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -51.76 -38.21 54.51 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.471 -0.331 . . . . 73.030000000000001 110.523 175.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -145.23 61.23 1.3 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.633 -0.258 . . . . 72.019999999999996 110.703 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.46 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 21.4 t70 63.07 171.35 0.15 Allowed 'General case' 0 CA--C 1.538 0.507 0 O-C-N 123.83 0.706 . . . . 74.530000000000001 111.525 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.522 HD12 ' O ' ' A' ' 18' ' ' GLN . 0.6 OUTLIER -104.05 85.83 1.14 Allowed Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 110.012 -0.366 . . . . 71.140000000000001 110.012 -178.119 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.55 ' HB2' HD12 ' A' ' 29' ' ' LEU . 61.4 Cg_endo -73.37 -29.79 10.89 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.282 1.988 . . . . 72.409999999999997 112.77 -175.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.88 28.77 64.16 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.909 -0.587 . . . . 71.329999999999998 113.032 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.55 HD12 ' HB2' ' A' ' 27' ' ' PRO . 1.6 mp -127.37 79.34 73.41 Favored Pre-proline 0 C--N 1.331 -0.206 0 O-C-N 122.358 -0.496 . . . . 70.349999999999994 111.785 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.416 ' HD2' HD12 ' A' ' 31' ' ' LEU . 91.2 Cg_endo -87.13 5.98 5.48 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.394 2.063 . . . . 64.5 111.541 171.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.416 HD12 ' HD2' ' A' ' 30' ' ' PRO . 7.5 mp -85.1 -0.17 53.64 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.609 -0.723 . . . . 64.540000000000006 111.85 -176.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.434 HD13 HD12 ' A' ' 36' ' ' LEU . 3.7 mm? -76.72 8.94 3.14 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.951 0.352 . . . . 61.0 111.951 -175.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 15.0 tmm? -61.52 -33.79 74.42 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.161 -0.472 . . . . 74.400000000000006 110.761 177.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.7 p -76.65 158.2 31.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.126 -0.488 . . . . 53.039999999999999 110.771 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -67.5 97.08 0.56 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.922 0.391 . . . . 72.400000000000006 111.228 -174.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.434 HD12 HD13 ' A' ' 32' ' ' LEU . 96.4 mt -131.41 -154.59 0.64 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.858 -0.61 . . . . 74.439999999999998 109.908 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -95.9 166.12 11.94 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.858 0.361 . . . . 73.340000000000003 110.22 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.7 m -74.85 95.47 2.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.929 -0.578 . . . . 61.549999999999997 111.773 -174.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 m -143.61 116.89 3.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.524 -0.307 . . . . 75.010000000000005 110.658 175.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.401 ' HB3' ' H ' ' A' ' 41' ' ' VAL . 1.3 mp0 64.65 -163.91 0.25 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.991 -0.55 . . . . 61.119999999999997 111.848 176.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.401 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 46.9 t -62.6 137.95 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 115.936 -0.575 . . . . 72.239999999999995 110.715 -179.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.0 tp -85.33 -81.11 0.2 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.842 -0.617 . . . . 61.109999999999999 112.248 -172.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.409 ' H ' ' HB2' ' A' ' 47' ' ' SER . 6.0 m-20 -66.75 -52.57 42.78 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.92 0.711 . . . . 64.439999999999998 112.92 -168.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -177.02 -77.3 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.807 0.337 . . . . 73.439999999999998 110.633 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.904 ' HB2' HD23 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -101.0 -28.31 12.81 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 120.91 0.386 . . . . 70.510000000000005 111.037 176.308 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.829 ' HG2' ' HB2' ' A' ' 66' ' ' LEU . 18.6 mmm180 -117.01 -169.95 1.74 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.873 -0.417 . . . . 73.230000000000004 109.873 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.409 ' HB2' ' H ' ' A' ' 43' ' ' ASP . 21.6 m 66.49 101.95 0.04 OUTLIER 'General case' 0 C--O 1.233 0.192 0 O-C-N 124.021 0.826 . . . . 75.439999999999998 110.696 -175.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.493 ' C ' ' H ' ' A' ' 50' ' ' THR . 46.5 mtm180 -71.23 -171.86 0.64 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.632 -0.713 . . . . 73.319999999999993 110.664 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 45.0 p90 -76.38 25.1 0.13 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.9 -0.591 . . . . 73.5 110.856 178.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.493 ' H ' ' C ' ' A' ' 48' ' ' ARG . 3.9 m -60.51 -72.32 0.11 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.745 -0.661 . . . . 71.010000000000005 110.598 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.7 t 52.84 26.76 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.935 0.874 . . . . 72.099999999999994 110.676 178.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.86 23.29 14.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.472 -0.786 . . . . 73.239999999999995 109.167 -177.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.502 ' HB3' ' HB1' ' A' ' 59' ' ' ALA . . . -167.78 144.3 3.46 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.114 -0.948 . . . . 74.219999999999999 109.486 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.512 ' O ' ' HA3' ' A' ' 58' ' ' GLY . 33.6 Cg_endo -68.83 114.33 3.51 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.03 1.82 . . . . 75.340000000000003 111.398 174.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 67.01 144.21 0.09 OUTLIER Pre-proline 0 N--CA 1.468 0.451 0 O-C-N 124.116 0.885 . . . . 72.549999999999997 111.392 -175.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.596 ' HG2' HD13 ' A' ' 57' ' ' LEU . 6.2 Cg_endo -52.91 -48.59 21.3 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.026 2.484 . . . . 75.140000000000001 112.536 179.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.708 ' H ' HD13 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -90.14 0.84 56.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.075 0.464 . . . . 65.400000000000006 110.138 -176.355 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 54' ' ' PRO . . . -72.84 -18.75 79.07 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.853 -0.612 . . . . 53.009999999999998 113.688 -172.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.502 ' HB1' ' HB3' ' A' ' 53' ' ' ALA . . . -154.89 -45.8 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.309 0.555 . . . . 42.140000000000001 112.105 -178.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.495 HG21 ' H ' ' A' ' 62' ' ' TRP . 5.7 p -93.68 117.53 37.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.388 0.613 . . . . 63.009999999999998 111.282 -176.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.1 m -79.1 -4.3 49.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.934 -0.576 . . . . 74.219999999999999 111.02 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.495 ' H ' HG21 ' A' ' 60' ' ' VAL . 19.0 m95 -90.93 -5.43 55.48 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.014 -0.539 . . . . 72.040000000000006 111.672 -177.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.741 ' O ' ' HG ' ' A' ' 80' ' ' LEU . 9.9 tp10 -85.27 167.0 16.03 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.879 -0.786 . . . . 73.239999999999995 108.879 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -120.62 139.48 52.93 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.823 -0.351 . . . . 72.439999999999998 111.203 -177.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.545 ' CG ' HD11 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -106.64 158.28 17.07 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.498 -0.556 . . . . 61.409999999999997 109.498 173.554 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.904 HD23 ' HB2' ' A' ' 45' ' ' LYS . 26.3 tp -109.64 141.45 42.17 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.359 -0.238 . . . . 63.310000000000002 110.359 -176.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.0 t -107.81 -6.98 16.45 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 120.861 -0.336 . . . . 70.140000000000001 111.708 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.617 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -153.98 124.82 7.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.654 0.264 . . . . 72.109999999999999 110.831 177.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.663 ' HB3' HD22 ' A' ' 66' ' ' LEU . 2.4 p30 -136.32 43.46 2.48 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.796 -0.638 . . . . 74.209999999999994 110.878 -176.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.417 ' HB2' ' H ' ' A' ' 74' ' ' ARG . 26.1 mm-40 -57.81 143.22 77.21 Favored Pre-proline 0 C--O 1.234 0.252 0 CA-C-N 116.173 -0.467 . . . . 74.099999999999994 110.412 -178.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.96 92.97 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.219 2.613 . . . . 75.319999999999993 113.208 -172.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 58.75 34.24 76.45 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.477 -0.783 . . . . 71.540000000000006 112.979 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 92' ' ' LEU . 92.0 mttt -129.1 -85.71 0.55 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.953 0.353 . . . . 74.019999999999996 111.953 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.804 ' HB2' ' HG ' ' A' ' 92' ' ' LEU . 31.8 ttt180 -118.23 113.78 22.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.412 0.625 . . . . 74.420000000000002 111.197 -173.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.458 HD13 ' HE2' ' A' ' 93' ' ' PHE . 3.8 mp -117.05 121.87 68.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.089 -0.959 . . . . 71.319999999999993 109.515 178.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.617 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -109.71 116.28 31.42 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.473 -0.566 . . . . 74.209999999999994 109.473 176.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.524 ' CZ2' ' HA3' ' A' ' 89' ' ' GLY . 31.4 p90 -87.85 141.33 28.67 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.626 0.727 . . . . 62.520000000000003 111.306 -173.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.469 ' NE ' ' HA ' ' A' ' 78' ' ' ARG . 0.5 OUTLIER -137.57 175.36 9.66 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.03 -0.986 . . . . 65.099999999999994 110.148 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.2 p -144.7 164.93 29.5 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.81 -0.811 . . . . 63.340000000000003 108.81 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 63' ' ' GLU . 14.3 mt -77.86 149.27 77.0 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.913 -0.403 . . . . 65.420000000000002 109.913 -177.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.12 -27.23 54.61 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.945 2.43 . . . . 74.340000000000003 112.791 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.75 0.72 82.91 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.902 -0.666 . . . . 65.219999999999999 113.189 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.63 159.4 20.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.047 0.423 . . . . 75.340000000000003 110.927 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -98.35 13.06 32.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.019 0.438 . . . . 65.409999999999997 110.769 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.427 HD11 ' N ' ' A' ' 85' ' ' ILE . 4.2 mp -99.44 80.14 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.573 -0.529 . . . . 64.239999999999995 109.573 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.662 ' HB3' ' HD2' ' A' ' 111' ' ' ARG . 35.8 tt0 -81.36 91.93 6.33 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.588 -0.523 . . . . 73.049999999999997 109.588 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -148.71 139.88 23.17 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.495 -0.775 . . . . 62.520000000000003 109.883 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.8 m -124.69 128.65 49.14 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.842 -0.799 . . . . 74.099999999999994 108.842 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.524 ' HA3' ' CZ2' ' A' ' 77' ' ' TRP . . . -155.69 174.0 33.73 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.014 -1.088 . . . . 71.430000000000007 112.89 -175.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -163.15 128.96 3.21 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.462 -0.57 . . . . 71.230000000000004 109.462 -175.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.777 ' HB ' HG12 ' A' ' 106' ' ' VAL . 2.5 p -122.58 120.9 62.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.159 0.504 . . . . 74.420000000000002 111.688 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.804 ' HG ' ' HB2' ' A' ' 74' ' ' ARG . 8.0 mp -110.97 122.63 48.36 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.83 -0.623 . . . . 75.200000000000003 110.087 173.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.458 ' HE2' HD13 ' A' ' 75' ' ' ILE . 79.1 m-85 -87.28 126.71 35.0 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.847 0.355 . . . . 74.329999999999998 110.556 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.69 144.06 49.79 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.351 -0.386 . . . . 75.219999999999999 110.375 177.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.46 131.12 30.56 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.56 2.173 . . . . 73.510000000000005 111.196 176.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.08 143.53 57.2 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.582 -0.281 . . . . 70.129999999999995 110.73 -177.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.88 141.97 96.18 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 123.131 2.554 . . . . 72.140000000000001 112.572 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.79 20.38 79.51 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.878 -0.601 . . . . 72.439999999999998 112.109 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 52.84 36.71 22.2 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 121.021 0.439 . . . . 72.349999999999994 110.893 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 -72.57 -18.88 61.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.789 -0.642 . . . . 73.109999999999999 110.94 -176.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 146.2 -143.05 11.1 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.978 -0.849 . . . . 74.420000000000002 110.978 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.6 m -123.83 131.35 53.57 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.123 0.487 . . . . 74.340000000000003 110.1 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.61 ' HG2' ' HB1' ' A' ' 9' ' ' ALA . 31.8 tt0 -99.64 121.41 41.18 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.832 -0.622 . . . . 44.200000000000003 110.105 -178.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.504 HG22 ' CG2' ' A' ' 91' ' ' VAL . 2.3 p -98.04 112.13 29.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.432 -0.804 . . . . 73.109999999999999 110.932 -178.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 92' ' ' LEU . 11.1 p -101.81 120.66 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-O 121.33 0.586 . . . . 74.129999999999995 109.786 177.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.777 HG12 ' HB ' ' A' ' 91' ' ' VAL . 30.3 m -123.77 147.1 28.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.945 -0.57 . . . . 70.409999999999997 111.596 -175.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -100.55 116.88 33.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.318 -0.855 . . . . 73.510000000000005 109.898 170.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.3 tt -113.06 120.59 41.86 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.018 -0.734 . . . . 74.430000000000007 109.018 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 25.1 m -109.71 133.12 53.49 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.252 -0.431 . . . . 63.299999999999997 111.099 -176.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -97.77 161.65 13.65 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.845 -0.798 . . . . 75.439999999999998 108.845 176.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.662 ' HD2' ' HB3' ' A' ' 86' ' ' GLU . 1.9 ptm180 -133.88 154.79 80.57 Favored Pre-proline 0 C--N 1.31 -1.115 0 CA-C-N 116.215 -0.448 . . . . 72.340000000000003 110.161 -174.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.52 152.9 80.46 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.344 2.029 . . . . 72.25 112.165 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' ' 118' ' ' GLY . 41.8 Cg_endo -71.31 108.06 2.27 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.495 2.13 . . . . 72.0 112.134 177.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -127.51 104.89 0.71 Allowed Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 111.094 -0.802 . . . . 62.439999999999998 111.094 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.18 -168.5 28.54 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.246 -0.741 . . . . 64.299999999999997 111.246 -176.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.3 t -85.89 -40.44 15.93 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 117.233 0.516 . . . . 64.340000000000003 110.174 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.401 ' O ' HG13 ' A' ' 120' ' ' VAL . . . -73.0 -30.54 63.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.341 0.591 . . . . 74.510000000000005 110.126 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.504 ' O ' HG23 ' A' ' 121' ' ' ILE . . . -81.57 -19.92 65.09 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.337 -0.847 . . . . 64.310000000000002 113.043 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -79.44 -22.38 44.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 117.089 0.444 . . . . 75.510000000000005 112.094 -176.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 117' ' ' ALA . 7.0 p -64.96 -27.08 41.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.693 -0.23 . . . . 60.25 111.514 -174.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.504 HG23 ' O ' ' A' ' 118' ' ' GLY . 10.6 tp -65.45 -29.79 48.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.638 0.256 . . . . 74.329999999999998 110.727 -177.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.98 -23.15 59.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 71.430000000000007 110.922 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.4 -29.27 19.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.304 0.573 . . . . 73.530000000000001 109.608 176.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 28.0 ttt -71.37 -53.6 13.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.815 -0.63 . . . . 60.149999999999999 109.669 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -135.59 105.41 6.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.756 -0.656 . . . . 74.400000000000006 109.586 175.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -83.34 72.79 10.19 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.347 -0.612 . . . . 74.109999999999999 109.347 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 70.73 -50.51 0.67 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 114.888 -1.051 . . . . 71.219999999999999 110.561 -174.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 60.09 71.62 0.86 Allowed Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 123.977 0.911 . . . . 65.340000000000003 111.821 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -91.54 62.73 1.09 Allowed 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 122.708 2.272 . . . . 74.140000000000001 111.086 175.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 49.2 m -112.0 32.19 5.68 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.512 -0.767 . . . . 54.409999999999997 110.219 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 66.1 -165.06 0.23 Allowed 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.491 -0.777 . . . . 74.349999999999994 111.13 -177.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -61.3 134.39 56.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.679 -0.691 . . . . 75.530000000000001 110.718 178.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.6 mp -91.89 29.04 1.65 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.9 -0.591 . . . . 73.120000000000005 110.694 -175.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -54.89 -38.74 67.95 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.717 0.636 . . . . 73.150000000000006 112.717 -174.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -71.83 -37.64 70.28 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.48 -0.488 . . . . 72.439999999999998 111.037 -177.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -74.84 -38.29 62.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.243 0.544 . . . . 74.530000000000001 110.168 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.581 ' CD2' ' HB3' ' A' ' 8' ' ' ASP . 24.4 tp -66.59 -24.38 66.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.567 -0.742 . . . . 73.400000000000006 109.523 178.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.465 ' O ' ' HB3' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -62.64 -29.71 70.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.749 -0.66 . . . . 63.200000000000003 110.307 176.679 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -69.01 -43.42 74.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.889 -0.596 . . . . 75.439999999999998 110.149 176.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.505 ' O ' ' HG3' ' A' ' 144' ' ' GLN . 18.2 t80 -60.74 -37.96 83.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.876 -0.602 . . . . 73.430000000000007 109.9 174.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.792 ' HG2' HG13 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -53.64 -41.93 67.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.778 -0.647 . . . . 73.310000000000002 110.52 176.074 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -63.52 -31.36 72.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.879 -0.6 . . . . 75.540000000000006 110.436 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -79.17 -27.89 42.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.662 -0.699 . . . . 74.329999999999998 110.949 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.832 ' HG2' HG22 ' A' ' 22' ' ' VAL . 10.7 mt-30 -69.69 -40.61 76.24 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.069 0.461 . . . . 72.209999999999994 110.676 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.655 ' HB3' HG21 ' A' ' 12' ' ' ILE . 16.5 pt-20 -78.0 -13.63 59.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.926 -0.579 . . . . 63.310000000000002 110.4 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 58.4 tp -91.0 -61.58 1.64 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.818 -0.628 . . . . 75.519999999999996 110.88 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 74.4 110.72 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 110.97 -0.852 . . . . 71.230000000000004 110.97 -172.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.2 tt -145.43 134.32 22.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.114 0.483 . . . . 64.340000000000003 111.989 -171.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -122.52 177.06 5.58 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.368 -0.975 . . . . 74.409999999999997 108.368 168.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -114.2 -42.34 3.36 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 119.642 -0.823 . . . . 75.329999999999998 111.79 -174.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -169.59 150.08 4.03 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.961 -0.385 . . . . 75.0 109.961 176.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -153.98 135.17 14.02 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.166 -0.47 . . . . 74.420000000000002 110.382 -177.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -87.77 166.26 14.75 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.187 -0.46 . . . . 75.439999999999998 110.513 -177.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -97.37 -175.25 3.16 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.261 -0.644 . . . . 74.340000000000003 109.261 175.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 59.8 m80 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.198 -0.906 . . . . 70.030000000000001 109.877 177.525 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 110.151 -0.314 . . . . 72.430000000000007 110.151 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -80.13 -59.2 2.62 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.698 -0.763 . . . . 73.239999999999995 111.555 177.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -84.66 -172.72 4.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.92 0.391 . . . . 71.230000000000004 110.044 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.458 HG21 ' HA ' ' A' ' 131' ' ' GLN . 11.3 m -118.36 121.45 40.4 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.69 -0.485 . . . . 63.100000000000001 109.69 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.666 HG13 ' CB ' ' A' ' 108' ' ' LEU . 77.4 t -107.87 110.39 31.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 116.345 -0.389 . . . . 74.349999999999994 110.05 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.8 m -146.68 151.3 14.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.926 -0.579 . . . . 73.409999999999997 110.15 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.46 109.79 22.28 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.204 -0.665 . . . . 73.530000000000001 109.204 173.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.439 ' HB3' HD23 ' A' ' 137' ' ' LEU . 2.6 t70 -157.36 174.27 15.68 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.105 -0.331 . . . . 74.329999999999998 110.105 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.445 ' CB ' HG23 ' A' ' 105' ' ' VAL . . . -131.43 131.5 43.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.242 -0.436 . . . . 73.540000000000006 110.848 -174.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.539 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 16.4 m -116.66 137.37 50.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.035 0.445 . . . . 73.439999999999998 110.663 177.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.1 m -83.65 105.14 14.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.935 -0.575 . . . . 64.219999999999999 110.222 -178.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.524 HG23 ' HB3' ' A' ' 144' ' ' GLN . 24.6 mm -114.3 149.93 16.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.727 0.299 . . . . 54.450000000000003 111.078 -177.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.76 25.68 8.26 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 121.159 -0.543 . . . . 75.340000000000003 112.67 177.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -98.4 145.65 30.23 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 108.764 -0.828 . . . . 70.230000000000004 108.764 176.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -59.0 -58.58 0.63 Allowed 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 121.946 1.764 . . . . 53.109999999999999 112.914 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 173.48 -43.55 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.097 0.559 . . . . 72.400000000000006 109.824 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.602 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 25.3 tt0 -48.3 -51.24 26.81 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 114.876 -1.057 . . . . 75.519999999999996 111.756 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -78.56 -11.09 59.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.611 -0.722 . . . . 63.210000000000001 111.504 -174.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.2 mt -83.66 -47.88 10.76 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.611 -0.268 . . . . 75.25 111.544 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.602 ' CE2' ' HA ' ' A' ' 17' ' ' GLU . 18.7 p90 -71.65 -24.37 61.84 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.383 -0.527 . . . . 74.010000000000005 110.811 -177.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.36 -13.36 61.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.974 -0.557 . . . . 61.329999999999998 111.495 -177.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.546 HG23 ' CZ ' ' A' ' 140' ' ' PHE . 6.1 p -57.01 -21.81 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 111.892 0.331 . . . . 72.519999999999996 111.892 -174.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -54.26 -31.81 54.57 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.139 -0.482 . . . . 74.310000000000002 110.696 177.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.605 ' HA ' ' NE ' ' A' ' 24' ' ' ARG . 4.7 tpm_? -135.42 32.33 3.09 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.425 -0.583 . . . . 64.209999999999994 109.425 176.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.682 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 29.2 t70 65.26 169.21 0.2 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.027 -0.988 . . . . 61.0 111.441 -177.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.57 86.84 2.39 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 121.034 0.445 . . . . 74.25 112.037 -176.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.682 ' HD3' ' O ' ' A' ' 25' ' ' ASP . 3.5 Cg_endo -86.32 -170.74 0.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.339 2.693 . . . . 74.109999999999999 112.233 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.55 92.8 0.61 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.983 -0.627 . . . . 74.430000000000007 112.573 -178.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.639 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -139.3 57.02 9.61 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 112.092 0.404 . . . . 62.119999999999997 112.092 175.978 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.525 ' HD3' ' N ' ' A' ' 29' ' ' LEU . 2.9 Cg_exo -75.76 -10.98 20.16 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.416 2.077 . . . . 61.420000000000002 110.95 177.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.457 ' N ' HD13 ' A' ' 31' ' ' LEU . 4.0 mp -113.91 -65.69 1.16 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.291 -0.868 . . . . 75.209999999999994 108.825 176.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.639 ' HB2' ' HB2' ' A' ' 29' ' ' LEU . 30.6 tp 57.78 87.89 0.06 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.409 -0.814 . . . . 71.25 112.256 173.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 55.3 mtt -140.3 110.64 6.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.883 -0.599 . . . . 73.5 110.412 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.6 t -156.45 144.87 19.86 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.025 -0.361 . . . . 72.5 110.025 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 63.52 96.16 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.888 0.743 . . . . 63.509999999999998 110.426 -177.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.6 mp -65.06 102.05 0.58 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.886 -0.597 . . . . 74.439999999999998 112.449 -171.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 176.79 -41.54 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.676 -1.147 . . . . 75.349999999999994 108.229 175.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.5 m -172.03 -174.25 1.26 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 107.74 -1.207 . . . . 71.019999999999996 107.74 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 90.5 t -72.44 -16.15 18.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.878 -0.786 . . . . 72.329999999999998 108.878 167.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 75.44 13.22 3.08 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.295 -1.32 . . . . 75.120000000000005 109.881 -177.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.1 t -142.98 106.65 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 113.58 -1.645 . . . . 64.140000000000001 107.409 170.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.465 ' H ' HD21 ' A' ' 42' ' ' LEU . 2.9 mm? -63.16 -72.21 0.14 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.52 -0.764 . . . . 75.0 110.089 -175.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.523 ' HA ' ' HB2' ' A' ' 47' ' ' SER . 39.0 t70 60.65 129.02 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 122.7 1.238 . . . . 72.230000000000004 113.554 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 35.0 t70 173.38 -74.29 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 112.827 -1.988 . . . . 74.319999999999993 108.193 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -103.4 -43.35 5.44 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.233 -0.894 . . . . 73.340000000000003 108.628 170.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.897 ' HA ' ' HB1' ' A' ' 64' ' ' ALA . 20.4 ptt180 -100.09 -172.78 2.28 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.303 -0.862 . . . . 72.150000000000006 110.728 177.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.523 ' HB2' ' HA ' ' A' ' 43' ' ' ASP . 17.9 m 69.35 -81.58 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.873 0.733 . . . . 72.25 110.593 -176.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.645 ' HD2' HD13 ' A' ' 66' ' ' LEU . 3.3 mmp_? 57.81 78.87 0.22 Allowed 'General case' 0 C--O 1.234 0.27 0 O-C-N 123.583 0.552 . . . . 61.140000000000001 112.095 177.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 6.3 m0 62.44 -165.24 0.24 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.168 -0.923 . . . . 73.019999999999996 111.761 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 21.9 m 60.61 89.95 0.07 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.62 -0.718 . . . . 54.530000000000001 111.45 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.5 t -81.22 -20.32 11.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.762 -0.654 . . . . 72.329999999999998 109.925 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -81.7 75.19 8.66 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.459 -0.791 . . . . 74.310000000000002 109.653 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 71.04 142.92 0.09 OUTLIER Pre-proline 0 N--CA 1.465 0.317 0 O-C-N 124.356 1.035 . . . . 54.509999999999998 110.391 -173.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.63 123.26 5.82 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.992 1.795 . . . . 61.329999999999998 112.75 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -120.79 84.0 37.19 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.968 -0.56 . . . . 62.43 110.922 176.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.574 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 6.5 Cg_exo -76.66 -50.08 0.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.843 2.362 . . . . 73.209999999999994 111.167 176.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 79' ' ' SER . 0.2 OUTLIER -122.58 41.15 3.5 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.496 -1.229 . . . . 72.430000000000007 110.153 177.925 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.58 -79.85 1.88 Allowed Glycine 0 C--N 1.31 -0.889 0 CA-C-N 114.446 -1.252 . . . . 71.019999999999996 111.786 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -163.96 99.29 0.86 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.809 0.338 . . . . 72.129999999999995 111.041 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.463 HG21 HD13 ' A' ' 57' ' ' LEU . 58.9 t -139.25 -87.89 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.266 -0.642 . . . . 52.140000000000001 109.266 173.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.7 m 174.5 21.37 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.202 1.001 . . . . 73.120000000000005 109.5 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.437 ' O ' ' HG2' ' A' ' 56' ' ' PRO . 1.0 OUTLIER -122.95 -166.02 1.39 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.458 0.647 . . . . 71.209999999999994 112.523 -170.498 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.462 ' HG2' ' HD3' ' A' ' 46' ' ' ARG . 52.3 mt-10 -94.52 169.27 10.31 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.589 -1.187 . . . . 74.409999999999997 111.414 -175.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.897 ' HB1' ' HA ' ' A' ' 46' ' ' ARG . . . -103.97 155.28 18.78 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.819 -0.808 . . . . 64.109999999999999 108.819 169.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.485 ' HB2' HD21 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -121.31 134.83 55.16 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.197 -1.038 . . . . 74.209999999999994 108.197 179.076 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.645 HD13 ' HD2' ' A' ' 48' ' ' ARG . 30.9 tp -113.58 127.51 56.09 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.921 -0.312 . . . . 62.299999999999997 110.342 -170.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.0 p -92.4 -25.01 18.68 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.198 0.523 . . . . 61.450000000000003 111.119 -176.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.637 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -140.39 128.69 22.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.953 -0.567 . . . . 75.450000000000003 111.637 -177.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -130.19 26.47 5.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.352 -0.84 . . . . 74.0 110.189 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.787 ' HB3' ' HB3' ' A' ' 73' ' ' LYS . 6.0 mm-40 -62.63 141.79 96.87 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.805 -0.634 . . . . 64.439999999999998 110.673 -177.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.45 95.89 1.06 Allowed 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 123.04 2.493 . . . . 55.350000000000001 112.026 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.74 21.04 62.58 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-N 116.064 -0.516 . . . . 41.399999999999999 112.742 178.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.787 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 1.3 tmtp? -109.76 -57.93 2.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.893 0.378 . . . . 75.129999999999995 109.985 -176.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.849 ' HG3' ' HG ' ' A' ' 92' ' ' LEU . 40.5 ttp180 -155.97 111.63 3.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.12 -0.491 . . . . 73.400000000000006 109.832 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.431 HD13 ' N ' ' A' ' 75' ' ' ILE . 3.8 mp -109.27 110.52 32.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.504 -0.554 . . . . 73.510000000000005 109.504 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.637 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -119.21 115.4 24.13 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.104 -0.498 . . . . 37.030000000000001 109.861 177.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.45 ' HZ3' HG11 ' A' ' 91' ' ' VAL . 39.9 p90 -105.3 135.98 45.67 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.697 -0.683 . . . . 73.239999999999995 109.914 -177.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.5 mmt85 -142.42 174.02 11.0 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.308 -0.86 . . . . 70.400000000000006 108.861 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.47 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 30.1 p -98.8 -163.44 1.04 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.82 -0.807 . . . . 74.430000000000007 108.82 171.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.485 HD21 ' HB2' ' A' ' 65' ' ' GLU . 14.6 mt -71.98 142.93 85.86 Favored Pre-proline 0 C--N 1.321 -0.662 0 C-N-CA 120.277 -0.569 . . . . 74.310000000000002 109.784 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -63.11 -20.31 70.86 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 123.158 2.572 . . . . 70.409999999999997 113.047 -174.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.56 16.35 34.41 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.895 -0.669 . . . . 74.129999999999995 112.55 178.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -123.25 176.79 5.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.914 0.387 . . . . 73.439999999999998 111.133 -177.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -63.15 137.32 58.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.718 -0.674 . . . . 64.450000000000003 109.912 175.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.403 ' HA ' ' OG ' ' A' ' 79' ' ' SER . 19.6 tt -115.82 -27.18 2.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.962 -0.295 . . . . 63.439999999999998 111.493 -176.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 66.41 -81.73 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 122.962 0.505 . . . . 74.329999999999998 111.81 178.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -133.24 132.42 41.43 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.747 -0.464 . . . . 72.140000000000001 109.747 -177.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.8 m -96.82 128.03 43.38 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.716 0.293 . . . . 73.120000000000005 110.45 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -125.63 144.48 15.15 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.997 -0.62 . . . . 71.120000000000005 111.712 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -156.64 133.17 10.06 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.133 -0.321 . . . . 74.530000000000001 110.133 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.464 ' CG2' HG21 ' A' ' 104' ' ' VAL . 2.4 p -124.41 118.47 53.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.329 0.585 . . . . 75.420000000000002 111.497 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.849 ' HG ' ' HG3' ' A' ' 74' ' ' ARG . 2.9 mp -108.14 126.91 53.32 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.973 -0.751 . . . . 72.129999999999995 108.973 174.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.505 ' HZ ' ' HB3' ' A' ' 20' ' ' TYR . 85.2 m-85 -91.46 120.95 32.74 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.046 0.45 . . . . 75.319999999999993 110.426 -178.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -110.5 143.94 29.16 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.821 -0.627 . . . . 72.209999999999994 109.912 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.64 116.69 3.46 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.298 1.998 . . . . 74.530000000000001 111.258 177.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.44 144.21 97.68 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.409 . . . . 65.239999999999995 111.715 -174.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.65 130.68 41.59 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.978 2.452 . . . . 74.439999999999998 111.73 176.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.53 7.05 88.95 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.801 -0.714 . . . . 51.219999999999999 112.186 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 60.67 28.14 17.86 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.682 0.393 . . . . 72.150000000000006 111.591 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 66.2 mtt180 -89.29 14.53 10.84 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.173 0.435 . . . . 73.340000000000003 112.173 -176.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.97 -137.44 6.51 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.723 -0.751 . . . . 53.009999999999998 112.125 176.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 40.6 m -136.75 130.36 31.87 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.912 0.387 . . . . 74.310000000000002 110.098 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -91.32 115.68 28.22 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.315 0.579 . . . . 74.150000000000006 109.625 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.464 HG21 ' CG2' ' A' ' 91' ' ' VAL . 2.1 p -88.29 112.0 23.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.439 -0.8 . . . . 73.129999999999995 110.916 -176.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.445 HG23 ' CB ' ' A' ' 9' ' ' ALA . 23.9 t -100.27 110.44 27.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.277 -0.874 . . . . 53.149999999999999 109.748 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.2 t -118.62 127.85 75.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.067 0.46 . . . . 62.32 111.111 -177.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 107' ' ' ARG . 51.3 ttt-85 -106.73 122.39 46.27 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.012 -0.54 . . . . 74.420000000000002 110.178 176.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.666 ' CB ' HG13 ' A' ' 5' ' ' VAL . 4.6 mp -122.3 154.39 37.66 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.57 -0.53 . . . . 70.319999999999993 109.57 177.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.573 ' O ' HG12 ' A' ' 5' ' ' VAL . 6.2 m -84.75 119.33 25.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.789 0.328 . . . . 71.329999999999998 111.602 -177.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -125.82 120.99 32.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.453 0.644 . . . . 71.219999999999999 111.386 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -139.82 161.52 55.76 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.168 -0.924 . . . . 75.530000000000001 109.115 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -57.16 153.93 36.68 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.219 1.946 . . . . 71.430000000000007 111.184 171.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.582 ' O ' ' HB1' ' A' ' 117' ' ' ALA . 43.0 Cg_endo -69.41 85.93 0.55 Allowed 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.512 2.141 . . . . 62.240000000000002 113.844 -174.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 70.17 -5.54 6.53 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 114.875 0.71 . . . . 74.129999999999995 114.875 168.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.41 -76.01 1.73 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.968 -0.634 . . . . 75.109999999999999 112.282 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.3 m -72.23 -15.54 61.93 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.047 0.451 . . . . 65.319999999999993 111.42 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.582 ' HB1' ' O ' ' A' ' 113' ' ' PRO . . . -72.87 -19.9 61.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 61.200000000000003 110.973 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.561 ' HA2' HG22 ' A' ' 121' ' ' ILE . . . -55.92 -39.03 77.17 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 121.385 -0.436 . . . . 74.010000000000005 112.91 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.56 -29.34 70.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.127 0.489 . . . . 74.540000000000006 111.009 176.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 57.9 t -80.14 -46.81 21.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.829 -0.623 . . . . 73.030000000000001 110.614 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.561 HG22 ' HA2' ' A' ' 118' ' ' GLY . 15.5 tt -65.26 -21.69 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 116.271 -0.422 . . . . 72.219999999999999 110.925 -177.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.05 -25.25 63.57 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.503 -0.317 . . . . 75.129999999999995 111.131 176.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.446 ' HD3' ' C ' ' A' ' 123' ' ' ARG . 0.0 OUTLIER -74.95 -39.24 61.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.159 0.504 . . . . 71.450000000000003 110.094 175.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.415 ' O ' ' HB2' ' A' ' 125' ' ' PHE . 17.1 tpt -73.05 -31.18 64.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.054 -0.521 . . . . 74.519999999999996 111.063 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.415 ' HB2' ' O ' ' A' ' 124' ' ' MET . 90.7 m-85 71.79 -71.62 0.13 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.521 -0.763 . . . . 64.430000000000007 111.035 -177.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.4 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 62.2 t30 59.69 -164.99 0.21 Allowed 'General case' 0 CA--C 1.535 0.366 0 O-C-N 123.454 0.471 . . . . 72.0 109.972 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.4 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 28.3 mm-40 -98.78 -67.33 0.85 Allowed 'General case' 0 C--N 1.324 -0.533 0 O-C-N 122.005 -0.434 . . . . 73.409999999999997 110.864 175.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 51.71 64.41 7.85 Favored Pre-proline 0 CA--C 1.531 0.24 0 O-C-N 123.802 0.689 . . . . 73.439999999999998 109.858 -172.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -66.23 -37.35 24.98 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.697 2.265 . . . . 62.43 112.172 -174.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 48.0 t -178.62 -61.68 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.86 -0.792 . . . . 73.120000000000005 108.86 -178.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.458 ' HA ' HG21 ' A' ' 4' ' ' THR . 83.0 mt-30 60.1 17.21 6.59 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.301 -0.863 . . . . 74.310000000000002 111.555 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -130.39 58.51 1.67 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.339 -0.985 . . . . 63.219999999999999 108.339 172.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.491 ' HG ' ' H ' ' A' ' 135' ' ' ASP . 2.0 pt? -156.0 -176.42 5.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.338 -0.846 . . . . 73.129999999999995 109.938 -174.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -112.92 14.89 19.82 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.391 0.145 . . . . 64.010000000000005 111.391 -175.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.491 ' H ' ' HG ' ' A' ' 133' ' ' LEU . 34.9 t70 -57.41 -56.07 26.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.803 0.335 . . . . 74.510000000000005 111.82 -174.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -74.93 -32.53 61.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.399 -0.364 . . . . 64.409999999999997 110.994 -176.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.539 ' HG ' ' CG1' ' A' ' 10' ' ' VAL . 20.6 tp -70.58 -24.74 62.82 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.243 -0.435 . . . . 73.450000000000003 109.972 -177.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.42 ' HA ' ' HE1' ' A' ' 138' ' ' MET . 0.0 OUTLIER -68.76 -45.78 70.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.152 -0.476 . . . . 75.439999999999998 110.199 177.636 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 71.0 mtm-85 -67.13 -37.89 84.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 71.230000000000004 110.171 177.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.546 ' CZ ' HG23 ' A' ' 22' ' ' VAL . 84.0 t80 -57.03 -42.45 80.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.457 -0.792 . . . . 75.420000000000002 110.586 174.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.482 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 26.0 ttpp -57.19 -46.85 82.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 71.420000000000002 110.726 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -60.66 -41.7 95.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.53 -0.759 . . . . 73.340000000000003 112.341 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -79.31 -24.68 42.67 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.554 -0.459 . . . . 73.329999999999998 110.937 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.524 ' HB3' HG23 ' A' ' 12' ' ' ILE . 8.1 mm-40 -71.83 -49.74 35.72 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.794 0.331 . . . . 74.129999999999995 110.958 175.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 13.4 pt-20 -67.9 -30.77 70.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.217 -0.447 . . . . 73.239999999999995 110.331 -177.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 48.7 tp -71.17 -41.32 70.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.773 -0.649 . . . . 74.409999999999997 109.658 174.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.99 46.32 67.05 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.567 -0.742 . . . . 71.450000000000003 111.344 -177.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 46.1 tp 71.04 156.93 0.16 Allowed 'General case' 0 N--CA 1.463 0.202 0 O-C-N 124.206 0.592 . . . . 74.519999999999996 109.449 -171.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -74.78 75.52 2.1 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.363 0.602 . . . . 75.099999999999994 110.556 -177.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -121.64 1.18 10.0 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.642 -0.708 . . . . 73.209999999999994 109.954 178.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -154.48 137.84 15.81 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.699 -0.852 . . . . 75.230000000000004 108.699 -177.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 47.4 p-80 -104.6 139.9 38.8 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.581 -0.448 . . . . 74.030000000000001 110.638 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -71.06 -44.89 64.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.766 -0.652 . . . . 71.099999999999994 109.865 -177.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 179.12 -67.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.759 -1.11 . . . . 75.219999999999999 108.619 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.349 -0.834 . . . . 73.0 109.344 176.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.5 ttm . . . . . 0 N--CA 1.477 0.904 0 CA-C-O 120.795 0.331 . . . . 72.120000000000005 111.115 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.65 1.83 79.93 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.557 -0.83 . . . . 74.549999999999997 113.688 172.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.519 ' HA ' ' HG2' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -104.06 178.59 4.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 117.386 0.593 . . . . 71.439999999999998 110.309 179.459 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.4 m -146.05 120.48 9.67 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.119 -0.696 . . . . 74.329999999999998 109.119 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.839 HG22 HG22 ' A' ' 109' ' ' THR . 69.0 t -92.32 98.66 8.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.298 -0.63 . . . . 64.420000000000002 109.298 176.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.4 m -95.73 145.52 8.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.783 -0.644 . . . . 74.430000000000007 111.103 -174.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.496 ' HD2' ' O ' ' A' ' 7' ' ' ARG . 4.5 ppt_? -141.64 108.98 5.54 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.434 -0.803 . . . . 72.219999999999999 109.069 175.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -142.09 161.84 36.97 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.039 -0.726 . . . . 75.040000000000006 109.039 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.597 ' HB2' HG21 ' A' ' 105' ' ' VAL . . . -140.39 130.17 24.45 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.128 0.49 . . . . 71.510000000000005 111.969 -170.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.477 HG21 HD11 ' A' ' 12' ' ' ILE . 15.8 m -113.28 145.75 18.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.486 -0.779 . . . . 64.400000000000006 110.255 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 102' ' ' THR . 20.4 m -107.15 109.6 21.47 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.782 0.325 . . . . 72.129999999999995 111.067 -178.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.811 HG13 ' HG2' ' A' ' 141' ' ' LYS . 4.1 mp -98.82 147.97 6.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.26 -0.427 . . . . 73.409999999999997 109.883 -177.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.38 58.27 4.41 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.994 -0.622 . . . . 54.340000000000003 112.709 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.598 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 8.2 mmpt? -129.8 167.01 22.04 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 108.555 -0.905 . . . . 61.219999999999999 108.555 177.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.537 ' HD2' ' HB3' ' A' ' 14' ' ' LYS . 27.5 Cg_endo -65.22 -58.35 0.21 Allowed 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 121.309 1.339 . . . . 75.25 112.306 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.418 ' HB1' ' O ' ' A' ' 15' ' ' PRO . . . 171.69 -55.73 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.622 0.725 . . . . 60.020000000000003 110.266 174.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -55.09 -51.82 65.17 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.46 -1.245 . . . . 74.400000000000006 112.848 -173.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -54.07 -27.11 30.51 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.154 0.427 . . . . 75.150000000000006 112.154 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.485 ' CD1' ' HB ' ' A' ' 102' ' ' THR . 56.2 mt -69.32 -20.41 63.87 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.167 0.432 . . . . 73.409999999999997 112.167 -175.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.44 ' CE1' HG22 ' A' ' 75' ' ' ILE . 46.3 t80 -72.0 -25.27 61.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.099 0.475 . . . . 73.430000000000007 110.65 175.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.6 -12.98 60.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.364 -0.38 . . . . 73.340000000000003 111.411 -176.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.4 p -53.95 -24.04 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 112.626 0.602 . . . . 64.329999999999998 112.626 -174.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.417 ' HD1' ' O ' ' A' ' 20' ' ' TYR . 98.1 m95 -57.69 -24.34 56.25 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.18 0.437 . . . . 75.530000000000001 112.18 -176.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.429 ' HA ' ' HD2' ' A' ' 24' ' ' ARG . 7.5 tpt180 -156.33 59.28 0.57 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.792 0.33 . . . . 71.329999999999998 110.582 175.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.709 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 18.3 t70 65.24 168.82 0.19 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.571 -0.74 . . . . 73.329999999999998 111.227 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.5 mt -102.29 87.8 1.2 Allowed Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.714 -0.476 . . . . 73.329999999999998 109.714 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.709 ' HD3' ' O ' ' A' ' 25' ' ' ASP . 2.3 Cg_endo -83.75 120.63 2.76 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.186 2.59 . . . . 73.109999999999999 112.697 -174.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.418 ' C ' ' HD3' ' A' ' 30' ' ' PRO . . . -78.88 79.33 1.59 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.811 -0.709 . . . . 41.210000000000001 111.752 177.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.731 HD13 HD11 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -134.5 52.12 7.25 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 112.189 0.44 . . . . 74.129999999999995 112.189 175.871 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.594 ' HD3' ' N ' ' A' ' 29' ' ' LEU . 4.5 Cg_endo -86.15 -3.9 8.71 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.311 2.007 . . . . 63.520000000000003 111.219 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.65 HD22 ' H ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -69.54 -30.8 68.7 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.653 -0.869 . . . . 73.540000000000006 108.653 178.886 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.8 mt 57.76 61.2 2.49 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 114.283 -1.326 . . . . 61.420000000000002 111.725 176.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.411 ' O ' ' HB ' ' A' ' 34' ' ' THR . 48.4 ttm -93.3 -65.09 1.02 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.23 -1.026 . . . . 64.140000000000001 108.23 172.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.474 HG22 ' N ' ' A' ' 35' ' ' HIS . 8.1 t 174.92 -60.07 0.01 OUTLIER 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.38 -0.827 . . . . 71.120000000000005 110.578 168.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.474 ' N ' HG22 ' A' ' 34' ' ' THR . 6.9 t-160 65.77 -60.1 0.29 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.556 0.742 . . . . 73.420000000000002 109.941 -172.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.5 tp 68.36 154.62 0.11 Allowed 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 124.093 0.957 . . . . 64.530000000000001 112.879 170.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.455 ' HB3' ' H ' ' A' ' 38' ' ' SER . 0.9 OUTLIER 173.75 -83.31 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 114.884 -1.053 . . . . 74.420000000000002 108.504 173.095 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.455 ' H ' ' HB3' ' A' ' 37' ' ' ARG . 9.5 t -160.34 27.44 0.16 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.78 -1.193 . . . . 75.319999999999993 107.78 173.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.451 HG11 ' H ' ' A' ' 41' ' ' VAL . 8.8 t -75.02 130.33 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 114.62 -1.173 . . . . 61.210000000000001 110.73 -174.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -93.88 18.22 10.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.086 -0.506 . . . . 64.519999999999996 111.516 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.451 ' H ' HG11 ' A' ' 39' ' ' VAL . 7.0 p -146.55 147.97 17.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.13 -0.486 . . . . 74.430000000000007 110.529 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.731 HD11 HD13 ' A' ' 29' ' ' LEU . 56.7 tp -177.74 -55.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.618 -0.882 . . . . 65.120000000000005 108.618 178.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.658 ' HB2' ' HA ' ' A' ' 49' ' ' TRP . 27.1 t70 -86.1 174.76 8.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.283 -0.872 . . . . 72.230000000000004 109.448 173.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.03 -24.6 63.3 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.385 -0.598 . . . . 75.510000000000005 109.385 -177.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.459 ' HD3' ' HA ' ' A' ' 45' ' ' LYS . 1.8 tppp? -100.2 23.59 9.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.647 -0.706 . . . . 75.030000000000001 110.491 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 67.7 mtt180 59.87 -164.82 0.21 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.879 -1.055 . . . . 73.120000000000005 111.882 175.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.855 ' HG ' ' HA ' ' A' ' 63' ' ' GLU . 74.8 m 43.55 69.7 0.38 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.588 0.958 . . . . 65.540000000000006 113.588 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 56.62 -162.3 0.18 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.559 -0.292 . . . . 73.200000000000003 110.498 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.658 ' HA ' ' HB2' ' A' ' 43' ' ' ASP . 12.4 p-90 -83.15 81.45 8.68 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.488 0.661 . . . . 70.329999999999998 110.428 177.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.2 t -86.33 77.78 9.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 122.039 0.923 . . . . 63.140000000000001 110.71 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.7 m -121.55 31.09 2.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.402 -0.817 . . . . 75.200000000000003 110.801 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -141.53 116.88 10.12 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.209 -0.451 . . . . 74.030000000000001 111.116 -177.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.4 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . . . 75.17 145.44 0.11 Allowed Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.656 1.222 . . . . 74.129999999999995 113.163 168.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 53' ' ' ALA . 3.2 Cg_exo -76.04 -172.9 1.48 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 123.408 2.739 . . . . 74.230000000000004 111.248 172.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 56.51 68.62 2.12 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.03 -0.532 . . . . 74.109999999999999 110.61 -176.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -68.9 -5.08 14.74 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.602 2.201 . . . . 71.310000000000002 113.885 -171.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.954 ' HB3' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -145.24 13.66 1.43 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.461 0.648 . . . . 72.299999999999997 111.384 178.098 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.04 -28.22 60.78 Favored Glycine 0 C--N 1.318 -0.426 0 CA-C-N 114.928 -1.033 . . . . 63.329999999999998 113.048 -178.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.72 23.27 1.94 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.863 0.363 . . . . 74.439999999999998 110.629 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.1 p -155.17 154.76 6.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.294 -0.412 . . . . 74.430000000000007 110.337 -174.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.565 ' O ' ' HB2' ' A' ' 62' ' ' TRP . 44.9 m -125.9 -163.71 1.24 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.979 -0.749 . . . . 73.230000000000004 108.979 175.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.565 ' HB2' ' O ' ' A' ' 61' ' ' SER . 10.4 m95 75.5 -12.02 1.03 Allowed 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.324 0.491 . . . . 75.530000000000001 112.324 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.855 ' HA ' ' HG ' ' A' ' 47' ' ' SER . 0.1 OUTLIER -85.77 151.17 24.04 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.979 0.418 . . . . 72.340000000000003 111.388 -171.112 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.93 115.85 25.76 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.651 -0.42 . . . . 73.310000000000002 111.076 176.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 1.043 ' HB2' HD23 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -105.61 133.66 49.99 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.859 -0.793 . . . . 73.019999999999996 108.859 175.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.467 HD11 ' HA ' ' A' ' 77' ' ' TRP . 1.6 mm? -88.91 145.5 25.5 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 121.085 -0.246 . . . . 74.329999999999998 110.791 -173.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.5 t -92.53 -21.48 20.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.957 0.408 . . . . 71.200000000000003 110.209 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.764 ' HB2' ' H ' ' A' ' 76' ' ' ALA . . . -121.87 130.48 53.4 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.338 -0.616 . . . . 71.129999999999995 109.338 174.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -128.58 23.98 5.82 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.473 0.654 . . . . 71.409999999999997 110.249 -172.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.551 ' HB3' ' HD3' ' A' ' 73' ' ' LYS . 29.2 mt-10 -73.17 141.52 81.12 Favored Pre-proline 0 C--N 1.326 -0.429 0 C-N-CA 120.582 -0.447 . . . . 74.120000000000005 110.551 -174.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.62 88.33 1.04 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.8 2.333 . . . . 72.5 113.326 -173.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.78 12.07 78.19 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 121.045 -0.597 . . . . 63.450000000000003 112.281 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.551 ' HD3' ' HB3' ' A' ' 70' ' ' GLU . 42.9 mtpt -95.36 -69.19 0.76 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.909 0.385 . . . . 74.230000000000004 110.325 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.457 ' HD2' ' OE2' ' A' ' 90' ' ' GLU . 10.2 ttp180 -147.72 127.15 13.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.908 -0.587 . . . . 71.140000000000001 110.095 -175.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.616 HD11 ' HE2' ' A' ' 93' ' ' PHE . 4.6 mp -131.01 111.4 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.398 0.618 . . . . 72.329999999999998 111.216 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.764 ' H ' ' HB2' ' A' ' 68' ' ' ALA . . . -104.87 125.93 51.42 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.211 -0.904 . . . . 73.239999999999995 108.707 170.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.467 ' HA ' HD11 ' A' ' 66' ' ' LEU . 64.8 p-90 -80.4 159.07 25.8 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.369 0.604 . . . . 75.400000000000006 111.349 -175.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.498 ' HB3' ' O ' ' A' ' 65' ' ' GLU . 44.7 ttp180 -158.64 164.38 36.04 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.05 -0.977 . . . . 74.400000000000006 108.64 -177.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.529 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 19.9 m -123.65 60.34 1.09 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.621 0.248 . . . . 61.020000000000003 110.343 -178.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 1.043 HD23 ' HB2' ' A' ' 65' ' ' GLU . 22.4 mt 68.09 153.95 0.14 Allowed Pre-proline 0 N--CA 1.471 0.621 0 CA-C-N 115.701 -0.682 . . . . 71.150000000000006 111.632 -178.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.26 -19.49 38.45 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.598 2.199 . . . . 74.030000000000001 111.784 173.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.76 -24.27 77.13 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.906 -0.664 . . . . 60.520000000000003 112.059 178.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.529 ' HB1' ' O ' ' A' ' 79' ' ' SER . . . -108.52 178.87 4.36 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.245 -0.65 . . . . 63.509999999999998 109.245 175.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.515 ' HD2' ' N ' ' A' ' 84' ' ' ARG . 5.1 mpt_? -118.28 164.86 14.58 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.89 0.376 . . . . 63.530000000000001 110.3 -177.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.574 HD11 ' HA ' ' A' ' 88' ' ' SER . 6.2 tt -131.62 108.52 14.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.657 -0.701 . . . . 74.549999999999997 109.484 176.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -77.15 -37.42 53.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.777 -0.647 . . . . 73.340000000000003 110.942 -175.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -126.28 132.17 51.73 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.69 -0.485 . . . . 74.549999999999997 109.69 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.574 ' HA ' HD11 ' A' ' 85' ' ' ILE . 25.8 m -95.87 128.17 42.52 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.963 0.411 . . . . 61.350000000000001 111.282 -173.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -109.63 90.35 0.59 Allowed Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.133 -0.787 . . . . 38.020000000000003 111.133 174.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.457 ' OE2' ' HD2' ' A' ' 74' ' ' ARG . 40.9 tt0 -102.63 118.63 37.27 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.922 0.392 . . . . 75.319999999999993 110.478 -177.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.7 m -112.43 142.82 23.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.407 -0.59 . . . . 62.229999999999997 109.407 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.632 HD21 ' HD3' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -134.56 137.74 44.03 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.367 0.603 . . . . 74.319999999999993 110.178 171.209 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.616 ' HE2' HD11 ' A' ' 75' ' ' ILE . 85.5 m-85 -97.22 119.0 34.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.315 -0.857 . . . . 74.310000000000002 110.15 -174.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.632 ' HD3' HD21 ' A' ' 92' ' ' LEU . 18.5 mmm180 -104.01 143.01 25.79 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.643 -0.503 . . . . 74.310000000000002 109.643 179.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.5 109.91 2.87 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.129 1.886 . . . . 72.140000000000001 111.439 176.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.568 ' HB3' ' HB3' ' A' ' 100' ' ' ARG . . . -73.68 144.03 82.65 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.362 -0.607 . . . . 70.239999999999995 109.362 177.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -48.6 113.33 0.82 Allowed 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 123.445 2.763 . . . . 62.140000000000001 114.479 -169.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.23 -66.54 3.78 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 114.875 -1.057 . . . . 38.020000000000003 112.501 170.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -170.13 24.04 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.085 -0.558 . . . . 63.32 110.821 -173.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.568 ' HB3' ' HB3' ' A' ' 96' ' ' ALA . 5.6 tpm_? -64.47 -22.86 67.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.057 -0.52 . . . . 74.349999999999994 110.499 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 127.92 -154.77 19.92 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.29 -0.724 . . . . 73.219999999999999 111.29 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 11' ' ' THR . 2.5 m -105.68 125.29 50.82 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.96 -0.385 . . . . 64.299999999999997 109.96 175.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -89.89 100.65 13.42 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.031 -0.729 . . . . 71.099999999999994 109.031 173.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.501 HG13 ' HD1' ' A' ' 93' ' ' PHE . 3.4 m -87.46 129.47 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 109.13 -0.693 . . . . 64.120000000000005 109.13 178.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.626 ' HB ' ' CD2' ' A' ' 92' ' ' LEU . 18.7 t -117.19 115.92 50.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 109.082 -0.71 . . . . 74.109999999999999 109.082 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.604 HG11 HD22 ' A' ' 108' ' ' LEU . 24.0 t -103.5 116.67 47.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.304 -0.407 . . . . 73.409999999999997 110.371 -177.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -107.54 107.72 18.69 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.566 -0.531 . . . . 74.0 109.566 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.604 HD22 HG11 ' A' ' 106' ' ' VAL . 2.6 pt? -145.7 152.04 38.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.133 -0.485 . . . . 65.329999999999998 110.232 -177.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.839 HG22 HG22 ' A' ' 5' ' ' VAL . 51.2 p -107.4 132.91 52.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.327 -0.397 . . . . 64.099999999999994 111.011 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -157.69 177.96 10.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.285 -0.416 . . . . 71.239999999999995 109.883 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.519 ' HG2' ' HA ' ' A' ' 3' ' ' GLU . 97.0 mtt180 -108.31 142.97 26.48 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-O 120.764 0.316 . . . . 75.310000000000002 110.409 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -86.7 162.16 9.24 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.94 2.426 . . . . 71.030000000000001 113.242 -173.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.8 162.66 40.56 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.548 2.165 . . . . 73.209999999999994 111.563 174.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -84.42 46.66 3.71 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.804 -0.713 . . . . 72.109999999999999 112.898 -176.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -110.77 33.41 5.93 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.78 -0.724 . . . . 71.299999999999997 112.151 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.5 m -64.78 -30.24 71.24 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 122.288 0.235 . . . . 64.140000000000001 111.501 -177.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.32 -28.34 69.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.516 -0.311 . . . . 62.109999999999999 111.364 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -60.82 -39.26 96.57 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.085 -0.578 . . . . 62.140000000000001 112.396 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.25 -34.43 78.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.144 0.497 . . . . 73.340000000000003 110.634 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.9 t -68.59 -43.32 83.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.792 -0.64 . . . . 71.439999999999998 110.17 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.7 mm -65.91 -36.62 77.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.969 -0.559 . . . . 71.209999999999994 110.487 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.39 -19.3 65.89 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.866 -0.607 . . . . 70.519999999999996 111.577 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -73.38 -32.31 64.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.777 0.322 . . . . 75.340000000000003 110.688 178.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 26.5 ttt -70.86 -26.0 63.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.11 0.481 . . . . 74.209999999999994 110.516 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -69.04 170.21 10.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.655 -0.702 . . . . 63.210000000000001 110.514 -177.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -56.18 153.63 9.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.912 -0.586 . . . . 71.150000000000006 111.468 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -47.93 -61.66 1.85 Allowed 'General case' 0 C--O 1.233 0.207 0 O-C-N 123.823 0.702 . . . . 73.219999999999999 111.278 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 49.29 84.1 0.21 Allowed Pre-proline 0 N--CA 1.463 0.204 0 O-C-N 124.009 0.818 . . . . 73.510000000000005 112.016 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -65.26 101.94 0.44 Allowed 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.635 2.223 . . . . 75.340000000000003 111.951 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.7 t -160.74 -166.23 1.57 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.301 -0.629 . . . . 64.450000000000003 109.301 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -88.76 -47.64 8.08 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.692 -0.231 . . . . 75.420000000000002 110.395 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 43.23 48.07 5.58 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.993 0.902 . . . . 62.140000000000001 110.833 -176.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.434 ' O ' ' HB3' ' A' ' 134' ' ' ARG . 55.8 tp -161.23 161.87 30.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.343 -1.299 . . . . 71.420000000000002 108.523 -174.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.435 ' O ' ' HG2' ' A' ' 134' ' ' ARG . 42.0 ttm180 73.21 6.55 5.23 Favored 'General case' 0 C--O 1.219 -0.541 0 O-C-N 123.399 0.437 . . . . 74.0 111.601 173.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -54.61 -43.63 72.36 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.956 -0.465 . . . . 75.0 111.018 -175.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -68.64 -47.39 66.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 72.120000000000005 111.273 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 23.7 tp -69.49 -25.47 64.08 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.101 0.477 . . . . 72.019999999999996 110.219 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.605 ' HA ' ' HE1' ' A' ' 138' ' ' MET . 0.1 OUTLIER -69.9 -33.27 71.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.042 -0.526 . . . . 71.409999999999997 110.015 176.018 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -39.73 89.4 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.236 -0.438 . . . . 70.140000000000001 110.153 176.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -56.97 -52.21 66.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.987 -0.551 . . . . 54.450000000000003 109.916 174.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.811 ' HG2' HG13 ' A' ' 12' ' ' ILE . 14.5 tmtt? -59.06 -35.34 73.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.717 -0.674 . . . . 63.130000000000003 110.73 176.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.403 ' HD2' ' HA ' ' A' ' 142' ' ' ARG . 14.4 tpt180 -62.48 -58.78 6.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.02 -0.536 . . . . 73.200000000000003 109.997 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.619 ' HG2' ' H ' ' A' ' 149' ' ' GLU . 31.0 mt-10 -63.15 -32.98 74.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.025 -0.534 . . . . 74.239999999999995 110.906 -178.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -58.32 -37.04 74.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.675 -0.693 . . . . 75.340000000000003 112.369 -175.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.488 ' HB3' HG22 ' A' ' 12' ' ' ILE . 8.2 pt-20 -109.96 -18.09 13.46 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.827 -0.349 . . . . 75.230000000000004 111.894 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.0 tt -87.23 -38.53 16.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.168 0.508 . . . . 63.200000000000003 110.283 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 125.84 -54.63 0.75 Allowed Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.343 -0.703 . . . . 72.209999999999994 111.343 -175.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -174.81 130.39 0.32 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.953 -0.388 . . . . 53.329999999999998 109.953 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.619 ' H ' ' HG2' ' A' ' 143' ' ' GLU . 40.2 tt0 -129.89 105.34 7.93 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.636 -0.505 . . . . 74.030000000000001 109.636 175.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -133.14 19.86 4.06 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.015 0.436 . . . . 74.319999999999993 110.404 -177.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -74.9 145.74 42.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.204 -0.453 . . . . 73.420000000000002 109.872 172.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -71.77 80.29 0.86 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.934 -0.576 . . . . 73.329999999999998 110.369 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -76.29 122.38 24.33 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.652 -0.703 . . . . 72.540000000000006 111.466 -178.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -89.97 -34.72 15.9 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.027 -1.101 . . . . 73.340000000000003 108.027 170.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 . . . . . 0 C--O 1.247 0.97 0 CA-C-N 114.765 -1.107 . . . . 75.010000000000005 108.734 172.612 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.481 1.081 0 N-CA-C 110.426 -0.213 . . . . 74.430000000000007 110.426 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 162.38 -58.06 0.29 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.278 -0.963 . . . . 54.229999999999997 112.346 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 58.51 92.78 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.204 0.526 . . . . 63.340000000000003 110.668 -177.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.4 m -80.33 123.74 28.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.349 0.595 . . . . 73.219999999999999 111.227 -176.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 3.1 p -109.69 113.82 45.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.61 -0.723 . . . . 70.230000000000004 109.769 175.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.3 t -97.92 116.72 41.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 116.213 -0.449 . . . . 75.430000000000007 109.81 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -93.23 123.44 36.5 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.372 0.606 . . . . 61.32 110.84 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.758 ' HB3' HD22 ' A' ' 137' ' ' LEU . 20.4 t0 -142.08 156.1 45.39 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.84 -1.17 . . . . 73.219999999999999 107.84 176.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.42 128.47 25.55 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.756 -0.378 . . . . 72.349999999999994 110.826 -176.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.506 HG11 HD21 ' A' ' 137' ' ' LEU . 27.9 m -110.07 134.91 50.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.664 -0.495 . . . . 74.129999999999995 109.664 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.739 HG21 ' HG3' ' A' ' 100' ' ' ARG . 1.3 m -108.07 110.99 22.81 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.768 -0.456 . . . . 70.519999999999996 109.768 -178.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.595 ' HB ' HD22 ' A' ' 19' ' ' LEU . 12.9 mm -108.24 150.86 10.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.925 -0.58 . . . . 63.109999999999999 110.117 -174.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.83 44.54 2.32 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.14 -0.553 . . . . 73.040000000000006 112.523 176.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.426 ' HB2' HD22 ' A' ' 19' ' ' LEU . 67.0 mmtt -119.24 145.42 38.39 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 107.889 -1.152 . . . . 73.219999999999999 107.889 176.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.444 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 83.1 Cg_exo -48.49 -58.01 2.01 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.568 2.179 . . . . 73.299999999999997 113.57 -173.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 15' ' ' PRO . . . 173.34 -53.28 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.378 0.609 . . . . 72.430000000000007 110.389 177.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -52.93 -32.43 45.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.677 -1.147 . . . . 75.109999999999999 111.98 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -85.49 -8.52 58.31 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.943 -0.571 . . . . 74.25 111.37 -175.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.833 ' HB2' ' HE2' ' A' ' 93' ' ' PHE . 96.1 mt -79.31 -44.42 21.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.711 -0.222 . . . . 75.349999999999994 111.437 -176.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.525 ' HB2' ' HZ ' ' A' ' 93' ' ' PHE . 64.1 t80 -71.46 -30.31 65.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.511 0.672 . . . . 74.420000000000002 109.787 177.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.859 ' HB3' ' HA ' ' A' ' 26' ' ' LEU . . . -66.11 -3.96 6.52 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.245 -0.889 . . . . 73.340000000000003 112.357 -175.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.538 HG22 ' CD1' ' A' ' 140' ' ' PHE . 13.4 p -61.37 -22.18 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.348 -0.387 . . . . 75.420000000000002 111.333 176.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.418 ' HD1' ' O ' ' A' ' 20' ' ' TYR . 76.2 m95 -66.6 -10.83 49.7 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.82 0.343 . . . . 72.439999999999998 111.286 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.458 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 6.5 mmm180 -132.56 -84.47 0.48 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.643 -0.253 . . . . 75.129999999999995 111.298 173.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.577 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 3.9 t70 -166.8 33.51 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.885 -0.326 . . . . 72.230000000000004 110.73 -176.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.859 ' HA ' ' HB3' ' A' ' 21' ' ' ALA . 0.7 OUTLIER 44.19 71.87 1.36 Allowed Pre-proline 0 N--CA 1.472 0.666 0 O-C-N 123.758 0.661 . . . . 72.530000000000001 112.46 -177.692 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 21' ' ' ALA . 94.0 Cg_endo -86.9 -170.56 0.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.644 2.229 . . . . 71.099999999999994 112.359 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -146.75 162.52 28.53 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 121.039 -0.601 . . . . 52.329999999999998 111.763 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.687 HD12 HD22 ' A' ' 32' ' ' LEU . 1.5 pt? -73.22 155.49 89.95 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 120.591 0.234 . . . . 70.439999999999998 111.141 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.468 ' HD2' HD23 ' A' ' 32' ' ' LEU . 19.1 Cg_exo -68.43 8.06 0.59 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.547 2.831 . . . . 73.099999999999994 113.354 177.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.5 ' H ' ' HG ' ' A' ' 29' ' ' LEU . 9.7 mp 66.78 49.11 1.27 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 122.806 0.442 . . . . 75.319999999999993 110.884 -177.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.707 ' H ' HD22 ' A' ' 32' ' ' LEU . 2.4 pt? -89.87 -0.68 57.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 73.540000000000006 110.717 177.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 70.8 mtm 65.06 2.18 1.73 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.586 0.958 . . . . 74.230000000000004 113.586 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.6 m -79.24 -76.14 0.22 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.638 -0.504 . . . . 75.299999999999997 109.638 173.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.414 ' O ' HD11 ' A' ' 29' ' ' LEU . 5.3 t60 -161.3 -67.78 0.06 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.571 -0.9 . . . . 73.219999999999999 108.571 174.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.528 ' O ' HD12 ' A' ' 36' ' ' LEU . 3.7 pp -170.71 120.05 0.55 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.718 -0.674 . . . . 63.210000000000001 109.611 172.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.492 ' CG ' ' H ' ' A' ' 38' ' ' SER . 17.7 ttp180 -178.36 -178.09 0.6 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.986 -1.116 . . . . 75.099999999999994 107.986 -176.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.492 ' H ' ' CG ' ' A' ' 37' ' ' ARG . 23.7 m 75.23 7.03 4.15 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.434 0.635 . . . . 62.32 110.474 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.679 HG23 ' H ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -123.16 -70.56 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.38 -0.827 . . . . 63.130000000000003 109.664 173.245 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.679 ' H ' HG23 ' A' ' 39' ' ' VAL . 51.6 mt-10 50.29 55.7 9.07 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.472 0.482 . . . . 72.239999999999995 111.678 171.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.6 p -78.67 -26.75 13.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.03 -0.532 . . . . 75.099999999999994 112.221 -174.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.823 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 1.9 tm? 178.81 -57.17 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.245 0.545 . . . . 71.340000000000003 111.567 -174.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -124.93 -33.43 2.92 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.341 -0.845 . . . . 61.030000000000001 111.236 -165.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -44.25 -65.12 0.55 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.297 -0.865 . . . . 71.430000000000007 111.945 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.837 ' HE2' ' HA ' ' A' ' 45' ' ' LYS . 0.6 OUTLIER -113.95 -39.69 3.9 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.639 -0.875 . . . . 74.420000000000002 108.639 171.342 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.546 ' HG3' ' HB2' ' A' ' 48' ' ' ARG . 23.3 ptt180 174.92 -174.26 0.08 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.172 -1.377 . . . . 75.310000000000002 108.753 177.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.823 ' HB3' ' HA ' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -108.4 90.01 3.17 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.493 -0.558 . . . . 72.409999999999997 109.493 172.287 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.546 ' HB2' ' HG3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -145.86 -51.93 0.25 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.08 0.4 . . . . 64.450000000000003 112.08 -173.644 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.414 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 54.1 t-105 75.57 -33.2 0.22 Allowed 'General case' 0 N--CA 1.473 0.689 0 O-C-N 123.62 0.575 . . . . 73.510000000000005 111.158 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.416 ' H ' ' C ' ' A' ' 48' ' ' ARG . 0.8 OUTLIER -92.04 130.33 37.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.827 0.346 . . . . 75.209999999999994 110.797 177.396 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.5 t -87.33 -47.38 15.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.046 -0.525 . . . . 72.209999999999994 111.221 -175.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -109.63 89.47 3.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.94 0.4 . . . . 74.409999999999997 111.035 -177.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.47 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . . . -133.28 144.03 50.75 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.891 -0.595 . . . . 72.239999999999995 110.29 176.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 53' ' ' ALA . 5.6 Cg_exo -78.56 142.77 18.61 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.815 2.343 . . . . 64.430000000000007 111.083 175.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 71.3 143.88 0.1 Allowed Pre-proline 0 N--CA 1.465 0.292 0 C-N-CA 123.473 0.709 . . . . 74.140000000000001 111.145 -175.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.507 ' HB2' HD23 ' A' ' 80' ' ' LEU . 20.5 Cg_endo -63.49 -47.66 7.15 Favored 'Trans proline' 0 CA--C 1.527 0.169 0 C-N-CA 122.501 2.134 . . . . 72.209999999999994 112.505 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.947 ' HB3' HD12 ' A' ' 80' ' ' LEU . 2.2 pt? -143.97 8.05 1.44 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.207 0.527 . . . . 73.439999999999998 110.898 -177.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.48 -70.19 2.2 Favored Glycine 0 C--N 1.319 -0.38 0 CA-C-N 115.627 -0.715 . . . . 70.099999999999994 111.695 -176.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.37 -73.67 0.19 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.842 -0.429 . . . . 44.020000000000003 109.842 176.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.9 p -143.27 113.96 2.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.442 0.639 . . . . 71.329999999999998 109.862 174.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.58 ' H ' HD12 ' A' ' 57' ' ' LEU . 26.5 m -132.07 -172.1 2.8 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.664 -0.698 . . . . 75.129999999999995 110.511 -174.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 44.6 m95 -97.25 4.04 51.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.384 0.612 . . . . 71.230000000000004 111.808 -176.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.521 ' HG3' ' CD1' ' A' ' 80' ' ' LEU . 2.1 pt-20 -86.15 164.99 16.92 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.381 -0.827 . . . . 64.340000000000003 111.086 -178.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -146.29 145.86 30.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.112 -0.494 . . . . 63.399999999999999 110.415 178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.405 ' HG3' ' CB ' ' A' ' 78' ' ' ARG . 15.3 pt-20 -108.27 154.99 20.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.211 -0.45 . . . . 72.230000000000004 111.113 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.1 tp -117.58 123.02 45.2 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.059 -0.719 . . . . 75.129999999999995 109.059 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.425 ' HB ' ' CG ' ' A' ' 78' ' ' ARG . 12.2 t -83.52 -22.53 32.42 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.621 -0.432 . . . . 70.299999999999997 112.073 -171.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.935 ' HB2' ' H ' ' A' ' 76' ' ' ALA . . . -132.63 132.36 42.39 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.67 -0.412 . . . . 75.329999999999998 110.713 -178.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -139.42 40.87 2.06 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.793 -0.639 . . . . 62.32 110.797 -176.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.544 ' CB ' ' HB3' ' A' ' 73' ' ' LYS . 5.4 mm-40 -80.38 143.43 55.79 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 75.349999999999994 109.842 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.82 -55.67 0.49 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.59 2.194 . . . . 45.32 112.528 -178.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -134.12 64.15 0.6 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.852 -0.689 . . . . 72.400000000000006 111.856 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.544 ' HB3' ' CB ' ' A' ' 70' ' ' GLU . 69.2 tttt -143.78 -78.83 0.21 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.898 -0.408 . . . . 65.409999999999997 109.898 -176.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -168.03 147.5 4.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.785 0.326 . . . . 73.219999999999999 110.682 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.723 HD12 ' HE1' ' A' ' 93' ' ' PHE . 2.4 mp -122.8 116.68 49.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.76 -0.655 . . . . 73.519999999999996 109.913 175.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.935 ' H ' ' HB2' ' A' ' 68' ' ' ALA . . . -103.72 149.1 25.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.187 -0.46 . . . . 51.420000000000002 109.835 176.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 29.1 p-90 -94.0 152.6 18.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.098 0.475 . . . . 73.209999999999994 111.836 -172.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.425 ' CG ' ' HB ' ' A' ' 67' ' ' THR . 75.7 mmt-85 -144.27 173.53 11.68 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.071 -1.085 . . . . 74.109999999999999 108.071 169.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.617 ' OG ' HG13 ' A' ' 85' ' ' ILE . 11.5 m -150.13 22.75 0.85 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.799 -0.361 . . . . 74.109999999999999 110.598 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.947 HD12 ' HB3' ' A' ' 57' ' ' LEU . 91.2 mt 65.97 158.39 0.13 Allowed Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 115.834 -0.621 . . . . 64.5 110.233 -173.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.54 ' HD2' HD23 ' A' ' 57' ' ' LEU . 22.6 Cg_exo -67.7 5.39 1.03 Allowed 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.76 2.307 . . . . 72.340000000000003 113.264 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.535 ' HA3' HD13 ' A' ' 57' ' ' LEU . . . -103.11 -21.01 10.43 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.8 -0.714 . . . . 75.299999999999997 113.095 -177.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 79' ' ' SER . . . -150.45 167.98 25.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.154 0.477 . . . . 74.129999999999995 111.282 -175.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -138.29 141.35 39.82 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.468 -0.567 . . . . 73.310000000000002 109.468 174.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.617 HG13 ' OG ' ' A' ' 79' ' ' SER . 71.1 mt -70.65 -16.45 19.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-O 120.917 0.389 . . . . 73.150000000000006 110.365 176.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 75.39 -38.37 0.36 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.685 0.794 . . . . 65.450000000000003 110.773 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -64.82 132.7 50.2 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.173 -0.677 . . . . 74.209999999999994 109.173 170.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.1 t -126.35 127.89 46.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.941 0.4 . . . . 71.409999999999997 110.899 -175.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.485 ' HA3' ' HB3' ' A' ' 107' ' ' ARG . . . 158.94 133.0 1.45 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 121.042 -0.599 . . . . 73.150000000000006 112.115 176.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -101.27 138.46 38.26 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.899 0.381 . . . . 62.229999999999997 109.977 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.469 HG21 HG13 ' A' ' 106' ' ' VAL . 63.1 t -89.04 125.02 42.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.79 -0.641 . . . . 62.43 111.484 -175.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.3 mp -107.37 132.04 53.59 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.053 -0.976 . . . . 73.430000000000007 110.241 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.833 ' HE2' ' HB2' ' A' ' 19' ' ' LEU . 91.9 m-85 -99.36 109.42 22.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.188 0.518 . . . . 64.200000000000003 109.872 177.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.46 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 21.0 mtp180 -109.67 144.65 30.33 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.554 -0.748 . . . . 74.329999999999998 110.176 -173.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 94' ' ' ARG . 11.9 Cg_exo -70.5 123.93 10.32 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.764 2.31 . . . . 71.400000000000006 112.636 -176.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.909 ' HB1' ' HB3' ' A' ' 100' ' ' ARG . . . -98.06 160.04 29.33 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 108.828 -0.804 . . . . 55.25 108.828 171.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.05 159.69 11.82 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 121.789 1.66 . . . . 75.219999999999999 110.604 169.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -52.38 -26.64 22.85 Favored Glycine 0 CA--C 1.519 0.3 0 N-CA-C 114.35 0.5 . . . . 71.129999999999995 114.35 -172.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -105.61 7.8 32.92 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 112.996 0.739 . . . . 61.450000000000003 112.996 -176.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.909 ' HB3' ' HB1' ' A' ' 96' ' ' ALA . 9.5 tpp180 -101.53 -35.99 8.95 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.343 -0.614 . . . . 71.299999999999997 109.343 175.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.607 ' O ' ' HB2' ' A' ' 96' ' ' ALA . . . 111.51 -130.05 9.5 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 121.15 -0.548 . . . . 72.299999999999997 112.012 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 54.7 m -129.89 132.91 46.57 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.73 -0.471 . . . . 65.230000000000004 109.73 173.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -88.24 107.02 18.59 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.126 0.489 . . . . 74.230000000000004 110.9 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.484 HG11 ' O ' ' A' ' 10' ' ' VAL . 6.4 p -88.33 101.59 11.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.466 -0.788 . . . . 73.319999999999993 109.812 174.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 59.5 t -86.25 108.5 17.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.901 -0.59 . . . . 73.129999999999995 110.187 -178.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.469 HG13 HG21 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -111.55 129.16 67.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.597 -0.728 . . . . 72.420000000000002 110.574 -178.275 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.485 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 39.9 ttm180 -107.79 110.68 22.55 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.61 -0.723 . . . . 72.5 109.452 177.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.463 ' H ' HD22 ' A' ' 108' ' ' LEU . 1.5 pt? -123.33 121.12 35.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.472 0.653 . . . . 74.219999999999999 111.7 -176.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 6.6 m -95.79 120.48 36.13 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.22 -0.9 . . . . 70.530000000000001 108.875 175.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -155.86 166.31 33.87 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.482 0.658 . . . . 71.140000000000001 111.458 -173.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.29 144.73 35.61 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 114.995 -1.002 . . . . 74.120000000000005 109.037 175.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.48 151.95 71.36 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.09 1.86 . . . . 74.420000000000002 112.389 -176.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -92.52 5.2 3.41 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.082 2.521 . . . . 71.349999999999994 112.532 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 116.7 -122.31 5.45 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.855 -0.688 . . . . 71.150000000000006 111.389 -178.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -139.43 -12.79 0.68 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.836 -0.697 . . . . 73.329999999999998 112.754 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.8 t -63.73 -49.0 74.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.758 0.313 . . . . 74.030000000000001 110.49 -178.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.53 -32.56 73.52 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.281 -0.418 . . . . 75.319999999999993 110.742 178.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.64 -29.1 71.51 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.754 -0.657 . . . . 64.329999999999998 112.204 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.01 -31.41 62.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.931 0.396 . . . . 65.25 110.677 178.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.24 -50.01 56.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.015 -0.539 . . . . 73.540000000000006 110.585 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.55 ' HA ' ' HB3' ' A' ' 124' ' ' MET . 29.0 pt -69.1 -21.56 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.489 . . . . 63.229999999999997 111.261 -178.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.25 -39.68 83.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.541 -0.3 . . . . 63.100000000000001 111.367 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -89.92 -23.03 21.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.239 0.542 . . . . 74.340000000000003 110.192 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.55 ' HB3' ' HA ' ' A' ' 121' ' ' ILE . 16.3 tpt -71.85 -32.34 67.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.735 -0.666 . . . . 72.299999999999997 110.993 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.445 ' HE1' ' HG2' ' A' ' 138' ' ' MET . 15.5 t80 -63.48 120.28 11.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.892 -0.594 . . . . 64.409999999999997 110.694 -177.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -61.47 -82.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.575 -0.739 . . . . 74.319999999999993 111.603 -175.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -134.99 -75.09 0.46 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.781 -0.452 . . . . 74.0 109.781 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -176.76 85.83 0.26 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.752 -0.658 . . . . 70.140000000000001 109.698 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.487 ' HG2' ' SD ' ' A' ' 138' ' ' MET . 7.8 Cg_exo -73.57 105.28 1.96 Allowed 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.694 2.263 . . . . 73.540000000000006 111.792 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 43.1 m 67.13 -167.85 0.2 Allowed 'General case' 0 C--O 1.235 0.303 0 O-C-N 123.731 0.644 . . . . 61.310000000000002 110.718 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -120.76 140.61 51.44 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.96 -0.296 . . . . 74.530000000000001 110.526 -177.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 66.95 94.24 0.07 Allowed 'General case' 0 N--CA 1.463 0.208 0 O-C-N 123.837 0.711 . . . . 74.25 111.025 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.61 ' HG ' ' HE3' ' A' ' 138' ' ' MET . 0.0 OUTLIER -157.96 164.8 36.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.834 -0.621 . . . . 75.209999999999994 110.627 -178.525 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.627 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . 0.6 OUTLIER -105.22 134.07 48.94 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.308 -0.405 . . . . 70.040000000000006 110.695 174.491 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.486 ' HB2' HD11 ' A' ' 121' ' ' ILE . 9.1 m-20 -61.58 -30.68 70.83 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.238 -0.653 . . . . 71.319999999999993 109.238 178.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.13 -53.23 53.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.784 -1.098 . . . . 72.430000000000007 110.422 176.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.758 HD22 ' HB3' ' A' ' 8' ' ' ASP . 1.2 tp -79.74 -31.42 41.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.599 -0.728 . . . . 73.019999999999996 110.929 -178.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.685 ' SD ' ' HD3' ' A' ' 141' ' ' LYS . 28.3 tpp -63.67 -26.6 68.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.936 -0.574 . . . . 71.109999999999999 111.395 -177.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -62.91 -54.35 39.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.981 -0.554 . . . . 64.010000000000005 111.151 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.703 ' HE2' ' HG ' ' A' ' 137' ' ' LEU . 3.1 p90 -77.31 -29.71 53.75 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.93 -0.308 . . . . 72.219999999999999 110.493 -177.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.685 ' HD3' ' SD ' ' A' ' 138' ' ' MET . 51.3 tttm -49.41 -51.99 31.59 Favored 'General case' 0 C--O 1.232 0.153 0 O-C-N 123.28 0.363 . . . . 55.140000000000001 111.297 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.423 ' HA ' ' HG2' ' A' ' 145' ' ' GLU . 0.5 OUTLIER -67.44 -30.68 70.48 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.903 -0.589 . . . . 64.409999999999997 110.668 -174.775 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -71.67 -36.58 70.7 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.813 0.34 . . . . 74.109999999999999 110.15 177.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.452 ' HB3' HG23 ' A' ' 12' ' ' ILE . 14.1 mm100 -64.12 -38.33 90.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 75.430000000000007 111.438 177.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.465 ' HB3' HG21 ' A' ' 12' ' ' ILE . 11.6 pt-20 -87.91 -4.96 58.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.249 -0.432 . . . . 74.420000000000002 111.368 -176.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.6 tp -111.02 -38.3 5.12 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.767 0.318 . . . . 73.230000000000004 111.113 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -77.39 133.74 13.67 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.145 -0.55 . . . . 70.549999999999997 113.802 -173.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 81.3 mt -80.68 -168.94 1.94 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.572 -0.529 . . . . 73.150000000000006 109.572 172.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -70.47 -50.32 39.3 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.352 -0.24 . . . . 73.530000000000001 110.352 -178.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 32.6 m170 56.72 39.72 29.55 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.073 -0.512 . . . . 64.319999999999993 112.183 174.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.449 ' HE1' ' O ' ' A' ' 26' ' ' LEU . 56.3 m170 -102.37 136.72 41.69 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.203 0.525 . . . . 71.219999999999999 111.246 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -116.54 -30.97 5.69 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.461 -0.79 . . . . 75.150000000000006 110.268 177.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 58.64 87.76 0.07 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.841 -0.618 . . . . 75.120000000000005 110.954 177.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -124.66 157.9 34.45 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.052 -0.522 . . . . 72.5 110.457 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 . . . . . 0 C--O 1.245 0.817 0 CA-C-O 118.665 -0.683 . . . . 73.0 109.408 179.461 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 110.179 -0.304 . . . . 74.439999999999998 110.179 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -122.25 79.54 0.34 Allowed Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.735 -0.745 . . . . 72.349999999999994 112.217 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.04 99.74 0.38 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.062 0.458 . . . . 74.310000000000002 109.797 177.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.5 m -111.31 120.61 42.8 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.261 0.553 . . . . 73.109999999999999 110.879 -174.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.741 HG23 ' HB ' ' A' ' 109' ' ' THR . 99.0 t -126.04 105.96 15.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 108.711 -0.848 . . . . 74.120000000000005 108.711 175.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.9 p -78.94 139.37 18.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.998 -0.546 . . . . 71.099999999999994 110.753 -174.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.466 ' HB3' ' HG3' ' A' ' 107' ' ' ARG . 17.3 ptt180 -132.55 134.79 45.41 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.992 -0.549 . . . . 62.210000000000001 110.379 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.743 ' HB3' HD22 ' A' ' 137' ' ' LEU . 4.2 t70 -158.14 171.81 19.54 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.443 -0.947 . . . . 74.439999999999998 108.443 172.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.412 ' CB ' HG21 ' A' ' 105' ' ' VAL . . . -146.33 120.42 9.45 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.874 0.368 . . . . 65.5 111.286 -174.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.2 m -112.73 133.55 58.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.9 -0.591 . . . . 74.129999999999995 110.756 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.0 m -97.96 112.31 24.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.922 0.392 . . . . 75.109999999999999 111.069 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.891 HG22 ' HG3' ' A' ' 144' ' ' GLN . 4.4 mp -117.28 146.38 21.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.386 -0.598 . . . . 75.510000000000005 109.386 176.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.52 53.51 3.2 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.086 -0.578 . . . . 75.219999999999999 112.972 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.504 ' HD2' ' OE1' ' A' ' 144' ' ' GLN . 0.2 OUTLIER -105.83 153.99 39.68 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 107.868 -1.16 . . . . 64.010000000000005 107.868 173.121 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.696 ' HG3' ' HA ' ' A' ' 153' ' ' HIS . 51.9 Cg_exo -55.43 -57.44 1.62 Allowed 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 121.795 1.664 . . . . 72.109999999999999 111.438 178.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.413 ' HB1' ' O ' ' A' ' 15' ' ' PRO . . . 171.46 -49.63 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.27 0.981 . . . . 52.520000000000003 108.762 172.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -48.92 -44.22 40.2 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.17 -1.377 . . . . 64.120000000000005 112.124 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -64.61 -23.18 67.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.914 -0.584 . . . . 62.049999999999997 112.033 -176.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.463 ' O ' HG12 ' A' ' 22' ' ' VAL . 92.4 mt -76.98 -24.9 52.23 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.893 0.378 . . . . 71.200000000000003 110.577 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.564 ' HE1' HG12 ' A' ' 75' ' ' ILE . 55.9 t80 -72.12 -41.53 67.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.536 0.684 . . . . 74.200000000000003 109.795 175.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.841 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . . . -76.43 -8.9 58.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.319 -0.855 . . . . 55.329999999999998 112.943 -175.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 19' ' ' LEU . 9.6 p -61.8 -22.3 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 111.765 0.283 . . . . 73.120000000000005 111.765 -174.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 33.6 t-105 -64.04 -14.79 56.94 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.401 -0.363 . . . . 73.299999999999997 111.147 -176.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -142.3 46.24 1.62 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.027 0.441 . . . . 75.430000000000007 110.784 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 36.3 t70 62.88 28.46 16.38 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.579 -0.737 . . . . 72.310000000000002 112.456 172.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 22' ' ' VAL . 5.5 mp 53.46 80.27 0.3 Allowed Pre-proline 0 N--CA 1.47 0.557 0 CA-C-N 115.935 -0.575 . . . . 70.450000000000003 111.45 177.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.841 ' HD2' ' HB2' ' A' ' 21' ' ' ALA . 58.8 Cg_endo -72.79 169.4 22.12 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.693 2.262 . . . . 72.239999999999995 113.179 -177.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -113.92 -1.83 23.91 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.106 -0.798 . . . . 75.329999999999998 111.106 175.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 63.97 143.35 0.07 OUTLIER Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 124.09 0.956 . . . . 75.010000000000005 112.71 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -89.47 6.07 4.55 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 123.245 2.63 . . . . 72.549999999999997 112.464 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.1 mp 62.23 57.24 2.03 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.794 -0.639 . . . . 73.120000000000005 110.409 -176.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.766 ' HB2' ' HA ' ' A' ' 37' ' ' ARG . 1.2 pt? -74.23 78.22 1.8 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.583 -0.735 . . . . 75.040000000000006 111.014 -178.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 23.1 ptt? -146.77 -39.16 0.21 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.439 -0.801 . . . . 73.409999999999997 109.939 177.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.1 m -99.29 18.21 18.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.872 0.844 . . . . 74.349999999999994 109.786 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -153.48 -171.77 4.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.162 -0.927 . . . . 70.25 108.784 -175.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 99.4 mt -64.74 105.95 1.1 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.979 0.419 . . . . 71.040000000000006 110.249 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.766 ' HA ' ' HB2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -90.5 104.39 16.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.165 -0.47 . . . . 63.210000000000001 111.22 -177.198 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 43.4 m -151.76 -82.29 0.09 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.923 -0.581 . . . . 74.010000000000005 109.796 175.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.8 t 60.31 43.03 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 121.558 0.694 . . . . 72.239999999999995 110.102 178.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 60.16 -163.59 0.24 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.166 -0.924 . . . . 74.299999999999997 110.418 -177.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 99.0 t -66.09 119.21 10.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.264 -0.643 . . . . 75.329999999999998 109.264 172.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.433 ' H ' HD22 ' A' ' 42' ' ' LEU . 3.1 mm? -54.61 -63.75 1.05 Allowed 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.795 0.684 . . . . 61.039999999999999 110.793 -175.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -150.51 -166.87 2.66 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.661 -0.866 . . . . 72.209999999999994 108.661 176.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.25 6.95 3.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.487 0.66 . . . . 72.430000000000007 110.65 -175.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.811 ' HD2' HD21 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -62.7 -56.7 15.22 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.262 -0.881 . . . . 64.510000000000005 111.011 178.299 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.643 ' HG2' ' HB3' ' A' ' 45' ' ' LYS . 4.8 ptt180 -160.7 150.84 17.82 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.384 -0.826 . . . . 74.420000000000002 110.779 -168.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.7 t -75.44 -36.89 60.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.151 0.5 . . . . 72.540000000000006 109.994 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.3 mtt180 -134.17 165.23 25.57 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.691 -0.686 . . . . 65.450000000000003 110.072 175.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 31.1 t90 -120.39 -85.85 0.65 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.384 -0.371 . . . . 75.200000000000003 110.112 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 23.9 m -160.2 83.3 0.71 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.374 -0.602 . . . . 72.340000000000003 109.374 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.414 ' HB ' ' H ' ' A' ' 52' ' ' GLU . 14.5 t -127.86 -82.33 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.199 -0.667 . . . . 74.299999999999997 109.199 -179.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.414 ' H ' ' HB ' ' A' ' 51' ' ' VAL . 42.9 tt0 -116.84 67.86 0.73 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.624 -0.88 . . . . 74.430000000000007 108.624 172.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -170.04 164.82 6.01 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 114.93 -1.032 . . . . 55.240000000000002 109.433 -175.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.76 -172.4 0.47 Allowed 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.566 2.177 . . . . 74.430000000000007 111.975 175.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.95 144.61 98.87 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.216 -0.447 . . . . 74.120000000000005 110.212 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.428 ' HB2' HD11 ' A' ' 57' ' ' LEU . 8.8 Cg_endo -50.57 -36.33 49.4 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.166 2.578 . . . . 74.219999999999999 113.411 -175.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.765 HD12 ' HG2' ' A' ' 65' ' ' GLU . 3.0 mp -119.83 10.28 11.56 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.863 0.363 . . . . 72.319999999999993 110.324 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.453 ' C ' ' H ' ' A' ' 60' ' ' VAL . . . -122.16 125.88 6.23 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.935 -0.65 . . . . 38.07 111.971 -176.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 75.21 -23.01 0.24 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.744 0.818 . . . . 72.530000000000001 111.224 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.453 ' H ' ' C ' ' A' ' 58' ' ' GLY . 3.1 p -127.42 110.41 22.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.373 0.606 . . . . 73.430000000000007 110.042 173.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.492 ' HA ' HD21 ' A' ' 80' ' ' LEU . 3.8 t -99.78 6.99 45.38 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.44 0.638 . . . . 70.230000000000004 109.992 -178.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.46 1.25 57.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.47 -0.786 . . . . 75.450000000000003 110.795 -178.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -86.45 165.09 16.58 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.74 -0.664 . . . . 74.519999999999996 110.089 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -116.15 116.41 27.79 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.038 -0.356 . . . . 62.340000000000003 110.038 177.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.765 ' HG2' HD12 ' A' ' 57' ' ' LEU . 7.3 tp10 -123.99 154.92 39.13 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.387 -0.598 . . . . 74.129999999999995 109.387 177.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.943 ' HG ' ' HA ' ' A' ' 77' ' ' TRP . 3.3 mp -115.76 135.26 54.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.118 0.485 . . . . 74.019999999999996 111.6 -174.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.6 t -75.02 -32.41 61.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.313 -0.858 . . . . 74.439999999999998 111.474 -174.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.8 130.36 18.93 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.394 -0.522 . . . . 71.129999999999995 111.47 -176.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.459 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 8.0 p-10 -149.18 110.89 4.52 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.295 -0.866 . . . . 65.349999999999994 109.268 173.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.621 ' HB2' ' HB3' ' A' ' 73' ' ' LYS . 5.1 mm-40 -108.26 142.31 25.07 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 115.591 -0.731 . . . . 64.030000000000001 109.371 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -61.98 -27.37 79.55 Favored 'Trans proline' 0 N--CA 1.466 -0.097 0 C-N-CA 122.806 2.337 . . . . 74.409999999999997 112.238 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -146.36 49.54 0.64 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.575 -0.822 . . . . 73.129999999999995 112.625 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.621 ' HB3' ' HB2' ' A' ' 70' ' ' GLU . 39.4 ttmt -148.37 -79.92 0.14 Allowed 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.77 -0.253 . . . . 70.109999999999999 110.587 177.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.642 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 10.3 ptp180 -154.47 150.91 28.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.996 0.426 . . . . 75.540000000000006 111.135 175.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.564 HG12 ' HE1' ' A' ' 20' ' ' TYR . 4.5 mp -123.33 110.47 26.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 108.771 -0.826 . . . . 62.530000000000001 108.771 173.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -126.14 141.82 51.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.301 0.572 . . . . 71.109999999999999 112.396 -172.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.943 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 0.5 OUTLIER -90.31 124.83 35.23 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.137 -0.938 . . . . 75.530000000000001 112.34 -173.374 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.663 ' HG3' ' O ' ' A' ' 77' ' ' TRP . 32.6 mtm180 175.54 118.73 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 O-C-N 124.382 1.052 . . . . 73.230000000000004 111.827 173.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.738 ' HB3' HD22 ' A' ' 57' ' ' LEU . 23.6 m -163.25 -54.32 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.657 0.265 . . . . 72.530000000000001 111.34 166.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.721 HD23 ' HA ' ' A' ' 57' ' ' LEU . 4.8 mp -102.72 146.41 32.34 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.697 0.284 . . . . 75.230000000000004 111.218 -176.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.46 -16.96 11.67 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 123.088 2.525 . . . . 61.439999999999998 112.508 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.67 13.05 54.65 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.904 -0.665 . . . . 74.209999999999994 112.293 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 84' ' ' ARG . . . -129.55 -165.72 1.56 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.157 -0.312 . . . . 75.439999999999998 110.157 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.517 ' O ' HG12 ' A' ' 85' ' ' ILE . 58.4 mtm180 73.47 -170.12 0.12 Allowed 'General case' 0 N--CA 1.465 0.325 0 O-C-N 123.864 0.727 . . . . 74.219999999999999 110.972 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.517 HG12 ' O ' ' A' ' 84' ' ' ARG . 14.2 pt 60.93 -46.26 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 125.896 1.678 . . . . 64.230000000000004 113.891 179.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -79.08 -31.33 44.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.151 0.501 . . . . 74.430000000000007 109.792 177.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -130.73 134.63 47.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.609 -0.723 . . . . 74.439999999999998 109.695 176.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.8 m -145.51 131.35 19.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.937 -0.574 . . . . 73.129999999999995 109.454 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.535 ' HA2' ' O ' ' A' ' 107' ' ' ARG . . . 173.0 127.15 0.95 Allowed Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 119.877 -1.154 . . . . 74.200000000000003 113.604 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 0.3 OUTLIER -118.87 142.03 48.11 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.269 -0.641 . . . . 72.510000000000005 109.269 171.432 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 95.6 t -100.84 136.86 30.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.58 -0.282 . . . . 73.420000000000002 110.478 177.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.781 ' HB2' ' HB ' ' A' ' 105' ' ' VAL . 3.4 mm? -113.66 120.41 40.79 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.924 -0.58 . . . . 73.450000000000003 109.85 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -98.82 105.85 18.05 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.982 -0.748 . . . . 74.329999999999998 108.982 172.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.436 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 0.7 OUTLIER -103.99 143.45 26.69 Favored Pre-proline 0 C--N 1.317 -0.841 0 CA-C-N 115.771 -0.649 . . . . 71.230000000000004 110.132 -175.519 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 94' ' ' ARG . 5.8 Cg_exo -74.32 103.16 1.64 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.24 1.96 . . . . 64.109999999999999 110.23 172.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.99 142.99 95.07 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.117 -0.492 . . . . 62.020000000000003 110.689 -174.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -40.04 120.21 0.77 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 124.311 3.341 . . . . 74.450000000000003 114.925 -171.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.25 -69.6 2.56 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.025 -0.989 . . . . 62.409999999999997 111.583 174.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 175.78 26.83 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.437 -0.882 . . . . 74.400000000000006 109.559 -176.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -66.19 -22.48 66.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.948 -0.569 . . . . 71.310000000000002 111.17 -174.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 138.64 -151.16 21.48 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.35 -0.7 . . . . 61.030000000000001 111.35 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.9 m -114.2 127.15 55.76 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.953 0.406 . . . . 63.119999999999997 110.268 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -95.73 111.21 23.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.773 -0.649 . . . . 60.229999999999997 110.121 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.6 p -88.29 99.31 8.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.839 0.828 . . . . 73.120000000000005 109.943 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.781 ' HB ' ' HB2' ' A' ' 92' ' ' LEU . 21.6 t -89.2 110.08 21.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 114.995 -1.002 . . . . 73.129999999999995 108.757 177.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.67 HG23 HD21 ' A' ' 108' ' ' LEU . 7.7 p -114.35 120.3 63.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 121.48 0.657 . . . . 74.019999999999996 110.869 -176.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.535 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 19.7 ttp180 -114.43 98.4 6.89 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.545 -0.752 . . . . 73.409999999999997 108.99 176.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.67 HD21 HG23 ' A' ' 106' ' ' VAL . 2.3 pt? -131.91 151.31 51.79 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.767 0.317 . . . . 71.129999999999995 111.027 -171.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.741 ' HB ' HG23 ' A' ' 5' ' ' VAL . 12.2 t -97.81 127.75 43.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.147 0.499 . . . . 74.420000000000002 110.756 179.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -168.77 166.84 11.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.303 -0.862 . . . . 75.239999999999995 109.38 -176.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -86.9 143.07 34.71 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.716 -0.476 . . . . 75.409999999999997 109.716 172.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.443 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 92.8 Cg_endo -83.93 153.29 12.97 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.329 2.019 . . . . 75.25 112.69 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 2.7 Cg_endo -85.4 77.26 2.81 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.08 2.52 . . . . 71.439999999999998 111.78 176.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -86.71 132.26 11.04 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.667 -0.777 . . . . 74.450000000000003 111.93 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 155.53 -123.57 1.36 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.745 -0.741 . . . . 62.409999999999997 113.033 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.7 m -61.59 -11.11 9.88 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.603 0.964 . . . . 62.520000000000003 113.603 -172.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.16 -35.11 61.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.738 0.304 . . . . 75.230000000000004 111.545 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.42 -28.74 42.73 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.593 -0.813 . . . . 70.209999999999994 112.704 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.09 -40.65 98.28 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.706 0.261 . . . . 54.409999999999997 111.706 -176.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.3 p -67.67 -30.4 48.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.967 0.413 . . . . 72.230000000000004 110.73 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 48.0 mm -73.44 -33.88 41.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.06 0.457 . . . . 73.329999999999998 110.411 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.832 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . . . -67.27 -19.88 65.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.959 -0.564 . . . . 65.530000000000001 111.373 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.567 ' HA ' ' NE ' ' A' ' 123' ' ' ARG . 5.6 mmp_? -77.7 -13.65 59.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.559 -0.291 . . . . 72.200000000000003 111.339 178.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.517 ' HG2' ' HD1' ' A' ' 125' ' ' PHE . 35.4 ttp -58.47 -39.43 79.91 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.955 -0.387 . . . . 74.219999999999999 109.955 176.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.517 ' HD1' ' HG2' ' A' ' 124' ' ' MET . 31.9 p90 -175.71 -42.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.571 -0.74 . . . . 74.120000000000005 109.441 172.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.404 ' O ' ' HB3' ' A' ' 127' ' ' GLN . 9.2 t30 178.43 172.19 0.72 Allowed 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.555 -1.276 . . . . 72.099999999999994 107.555 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.404 ' HB3' ' O ' ' A' ' 126' ' ' ASN . 62.9 tt0 75.25 110.41 0.07 Allowed 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.732 0.645 . . . . 73.219999999999999 111.133 177.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.832 ' HB3' ' HB2' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -113.86 87.86 13.23 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.509 -0.769 . . . . 75.340000000000003 110.814 -179.192 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.53 110.16 0.43 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.891 2.394 . . . . 71.010000000000005 112.5 -177.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.7 m -104.83 13.5 31.13 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.665 0.745 . . . . 70.400000000000006 109.851 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -82.96 162.02 21.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.171 -0.922 . . . . 73.310000000000002 109.525 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -63.95 111.15 2.37 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.818 0.342 . . . . 74.329999999999998 110.865 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 92.1 mt -114.2 174.74 5.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.079 0.466 . . . . 73.5 111.323 -177.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -106.96 48.63 0.83 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.857 -0.61 . . . . 73.019999999999996 110.24 -177.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.402 ' O ' ' HE3' ' A' ' 138' ' ' MET . 9.9 t70 -49.5 -56.5 9.6 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.652 -0.704 . . . . 75.140000000000001 112.854 -174.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -66.36 -33.78 76.49 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.835 -0.346 . . . . 64.430000000000007 111.216 -172.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.743 HD22 ' HB3' ' A' ' 8' ' ' ASP . 4.3 mp -71.01 -43.84 67.11 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.522 -0.308 . . . . 74.129999999999995 111.054 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.501 ' HB3' ' HE3' ' A' ' 138' ' ' MET . 1.5 ttp -60.07 -37.92 81.32 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.141 0.496 . . . . 74.109999999999999 110.006 174.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -65.74 -54.78 22.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.441 -0.799 . . . . 71.230000000000004 111.269 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.543 ' CE2' ' HA ' ' A' ' 137' ' ' LEU . 4.2 p90 -73.52 -29.8 62.7 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 120.078 -0.649 . . . . 74.310000000000002 110.911 -176.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 145' ' ' GLU . 60.5 tttm -55.43 -47.11 76.5 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.677 -0.49 . . . . 71.239999999999995 109.677 174.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 11.4 mmm180 -51.18 -52.18 46.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.903 -1.044 . . . . 74.230000000000004 111.609 176.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -70.55 -45.12 66.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.102 -0.499 . . . . 71.25 111.241 -176.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.891 ' HG3' HG22 ' A' ' 12' ' ' ILE . 5.0 tp-100 -63.12 -43.9 97.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.82 -0.627 . . . . 62.100000000000001 111.301 -177.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.633 ' HG3' HG23 ' A' ' 12' ' ' ILE . 3.0 tt0 -77.03 -23.0 52.13 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 112.212 0.449 . . . . 74.010000000000005 112.212 -177.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 0.7 OUTLIER -63.07 -57.45 10.6 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.809 -0.441 . . . . 72.319999999999993 109.809 -179.258 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 159.77 134.58 1.7 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.449 -0.66 . . . . 53.140000000000001 111.449 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.426 HD22 ' HA ' ' A' ' 148' ' ' LEU . 1.4 tm? -138.63 113.26 8.99 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.152 0.501 . . . . 74.140000000000001 110.297 -178.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 63.59 -103.01 0.11 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.811 -1.086 . . . . 62.409999999999997 110.48 177.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -144.85 16.72 1.6 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.989 -0.375 . . . . 65.430000000000007 109.989 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -63.58 118.99 8.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 64.019999999999996 110.696 -175.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 -116.63 134.2 55.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.441 -0.799 . . . . 73.140000000000001 108.968 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.696 ' HA ' ' HG3' ' A' ' 15' ' ' PRO . 2.1 p80 -86.7 132.46 33.86 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.193 -0.603 . . . . 72.409999999999997 110.18 -175.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -124.76 103.5 8.12 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.111 -0.7 . . . . 73.409999999999997 109.111 176.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 6.6 t60 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.576 -0.726 . . . . 75.099999999999994 109.61 -175.155 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.1 ttm . . . . . 0 N--CA 1.479 0.995 0 CA-C-O 120.742 0.306 . . . . 75.530000000000001 110.402 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -117.9 -36.9 0.93 Allowed Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 110.994 -0.842 . . . . 63.340000000000003 110.994 174.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -76.71 135.45 39.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.977 -0.611 . . . . 74.530000000000001 109.801 177.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.702 ' HB ' ' O ' ' A' ' 110' ' ' TYR . 28.2 m -101.83 121.59 42.38 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.591 -0.892 . . . . 71.329999999999998 108.591 175.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.891 HG22 HG23 ' A' ' 109' ' ' THR . 86.0 t -118.17 106.9 20.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.702 -0.681 . . . . 73.099999999999994 110.029 -174.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.2 m -114.23 142.56 26.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.198 0.523 . . . . 65.519999999999996 110.752 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -136.05 109.66 8.01 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.062 -0.718 . . . . 75.329999999999998 109.062 175.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.514 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 1.5 t70 -140.23 171.65 13.86 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.18 -0.674 . . . . 71.099999999999994 109.18 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.18 120.56 12.37 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.841 0.353 . . . . 75.450000000000003 110.575 -175.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.433 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 12.4 m -102.4 133.52 45.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.121 -0.49 . . . . 61.219999999999999 110.183 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.82 HG23 ' HB1' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -84.58 102.34 12.82 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.089 0.471 . . . . 72.340000000000003 110.275 -179.171 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.578 HG23 ' HG2' ' A' ' 144' ' ' GLN . 35.7 mm -107.47 138.91 31.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.752 -0.658 . . . . 72.230000000000004 111.272 -172.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.57 ' O ' ' HE3' ' A' ' 14' ' ' LYS . . . -85.58 39.9 3.02 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 121.358 -0.449 . . . . 74.340000000000003 113.541 -176.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.57 ' HE3' ' O ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -111.49 148.71 39.4 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.301 -0.629 . . . . 74.540000000000006 109.301 174.964 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.432 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 82.3 Cg_exo -50.52 -57.75 2.09 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.021 2.481 . . . . 72.450000000000003 114.0 -174.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 19' ' ' LEU . . . 172.87 -63.48 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.582 0.551 . . . . 73.329999999999998 110.817 174.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -64.82 -34.73 79.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.962 -0.563 . . . . 73.239999999999995 110.648 -175.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.709 ' HB3' ' HG3' ' A' ' 27' ' ' PRO . 2.4 mp0 -63.41 -15.75 58.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.959 -0.564 . . . . 60.340000000000003 111.217 178.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 16' ' ' ALA . 66.9 mt -75.1 -23.93 58.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.507 -0.315 . . . . 70.510000000000005 111.354 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.534 ' CE1' HG22 ' A' ' 75' ' ' ILE . 48.8 t80 -71.77 -27.25 62.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.183 0.516 . . . . 70.310000000000002 110.352 177.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.42 -7.11 34.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.847 -0.615 . . . . 62.200000000000003 111.52 -178.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.2 p -63.59 -22.3 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 116.412 -0.358 . . . . 64.540000000000006 110.365 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 47.3 t90 -60.27 -31.07 69.87 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.874 -0.603 . . . . 75.030000000000001 111.171 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 24' ' ' ARG . 22.2 mtm180 -94.91 -76.46 0.49 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.336 -0.393 . . . . 62.25 110.365 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.421 ' HB3' HD21 ' A' ' 29' ' ' LEU . 19.9 t70 -168.89 48.67 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.915 -0.772 . . . . 72.439999999999998 108.915 175.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.706 HD13 ' HA2' ' A' ' 147' ' ' GLY . 24.5 mt 67.56 161.1 0.14 Allowed Pre-proline 0 N--CA 1.468 0.458 0 CA-C-N 114.777 -1.101 . . . . 72.400000000000006 111.667 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.709 ' HG3' ' HB3' ' A' ' 18' ' ' GLN . 55.1 Cg_endo -70.62 122.34 8.79 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.483 2.122 . . . . 74.439999999999998 111.773 177.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.44 75.15 1.28 Allowed Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.851 -0.899 . . . . 50.229999999999997 110.851 -173.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.526 ' C ' ' H ' ' A' ' 31' ' ' LEU . 80.7 mt -68.87 153.48 95.96 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.364 -0.418 . . . . 72.409999999999997 111.591 -175.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -69.55 7.2 0.99 Allowed 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 123.322 2.681 . . . . 74.200000000000003 111.139 170.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.526 ' H ' ' C ' ' A' ' 29' ' ' LEU . 1.1 mm? 57.56 15.35 2.75 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.515 1.126 . . . . 63.530000000000001 112.218 -177.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 53.39 32.96 14.8 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.533 0.521 . . . . 64.010000000000005 111.366 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 25.0 ttt 70.83 146.45 0.07 Allowed 'General case' 0 CA--C 1.533 0.317 0 O-C-N 123.824 0.703 . . . . 73.349999999999994 111.548 178.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.8 p -73.78 56.94 0.57 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.624 -0.716 . . . . 73.019999999999996 111.496 177.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -165.59 -72.24 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.724 0.297 . . . . 65.329999999999998 111.74 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 pp -95.45 21.17 8.47 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.508 0.558 . . . . 50.109999999999999 112.508 -169.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -76.61 105.79 7.88 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.36 0.6 . . . . 74.540000000000006 111.585 -178.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.7 t -102.18 84.05 2.43 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.34 -0.615 . . . . 74.519999999999996 109.34 174.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.0 t -93.21 72.05 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.859 -0.61 . . . . 74.409999999999997 110.19 -177.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.608 ' HB3' ' HB2' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -84.83 81.54 8.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.981 -0.554 . . . . 61.409999999999997 109.934 179.155 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.5 p -129.11 135.58 61.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.313 -0.858 . . . . 64.209999999999994 109.18 175.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.9 tp -127.25 -49.94 1.43 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.982 0.42 . . . . 74.400000000000006 110.723 -174.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.54 ' OD2' ' HB2' ' A' ' 45' ' ' LYS . 20.9 t70 -128.33 156.42 43.1 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.972 -0.558 . . . . 72.319999999999993 110.024 -178.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -89.9 -19.2 24.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.97 0.414 . . . . 75.25 110.407 -177.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.54 ' HB2' ' OD2' ' A' ' 43' ' ' ASP . 31.7 mmtp -84.04 -60.2 2.17 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.42 -0.585 . . . . 73.530000000000001 109.42 174.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -91.0 109.4 20.64 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 115.979 -0.555 . . . . 65.010000000000005 109.926 177.305 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.8 t -78.99 133.55 36.84 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.283 -0.871 . . . . 74.430000000000007 109.809 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.419 ' HA ' ' NE ' ' A' ' 48' ' ' ARG . 2.4 mmp_? -86.62 -82.23 0.21 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.891 -0.595 . . . . 71.329999999999998 110.959 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.608 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 75.8 m95 -133.82 -66.08 0.65 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.493 -0.321 . . . . 72.540000000000006 110.823 177.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.613 ' O ' HG13 ' A' ' 51' ' ' VAL . 20.9 m 59.28 77.55 0.3 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.871 -0.788 . . . . 71.530000000000001 108.871 -168.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.613 HG13 ' O ' ' A' ' 50' ' ' THR . 1.0 OUTLIER 55.71 -174.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.054 0.941 . . . . 74.120000000000005 110.023 -170.732 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.557 ' H ' HG22 ' A' ' 51' ' ' VAL . 8.4 mp0 -82.27 66.06 7.68 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 121.276 -0.89 . . . . 74.5 110.813 178.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -159.66 69.17 3.13 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.83 -0.623 . . . . 60.130000000000003 110.616 175.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -86.25 116.06 1.43 Allowed 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.365 2.043 . . . . 55.219999999999999 112.573 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.14 86.09 4.9 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 115.76 -0.654 . . . . 63.240000000000002 111.34 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.16 -54.85 1.53 Allowed 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.456 2.104 . . . . 62.009999999999998 111.294 175.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.653 HD11 ' HB3' ' A' ' 83' ' ' ALA . 3.2 pp -145.73 3.66 0.97 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.742 -0.663 . . . . 74.120000000000005 110.636 175.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.423 ' O ' HD13 ' A' ' 57' ' ' LEU . . . 92.74 170.28 40.27 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.301 -0.863 . . . . 71.239999999999995 112.128 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 73.23 -61.33 0.51 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.38 0.672 . . . . 62.219999999999999 111.181 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.557 HG21 ' HD1' ' A' ' 62' ' ' TRP . 3.2 p -127.4 103.33 10.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.694 0.759 . . . . 50.039999999999999 110.967 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.0 m -97.33 73.67 2.46 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.811 -0.631 . . . . 72.109999999999999 111.334 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.557 ' HD1' HG21 ' A' ' 60' ' ' VAL . 98.4 m95 -133.74 -36.37 0.95 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.168 0.508 . . . . 74.409999999999997 110.883 177.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.724 ' HB2' ' CD2' ' A' ' 80' ' ' LEU . 9.9 mm-40 -138.23 166.2 24.77 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.486 -0.779 . . . . 73.439999999999998 109.325 -175.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.985 ' HA ' HD12 ' A' ' 80' ' ' LEU . . . -157.99 158.73 35.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.344 0.592 . . . . 72.010000000000005 110.151 166.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 1.067 ' HB3' ' HB2' ' A' ' 79' ' ' SER . 0.2 OUTLIER -161.71 145.11 12.35 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 107.167 -1.419 . . . . 73.129999999999995 107.167 -177.253 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.535 HD11 ' HA ' ' A' ' 77' ' ' TRP . 1.4 mm? -114.39 131.88 56.42 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.428 0.529 . . . . 72.530000000000001 112.428 -168.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.4 t -92.61 -31.56 15.12 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.834 -0.621 . . . . 71.230000000000004 110.601 177.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.471 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -116.32 126.77 53.99 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.864 -0.421 . . . . 73.010000000000005 109.864 177.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.504 ' O ' ' HD3' ' A' ' 71' ' ' PRO . 10.0 p-10 -130.66 38.61 3.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.835 -0.62 . . . . 73.510000000000005 110.548 -174.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.562 ' HB3' ' HB3' ' A' ' 73' ' ' LYS . 4.5 mm-40 -97.78 88.25 0.6 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.038 -0.528 . . . . 53.219999999999999 110.6 -176.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 69' ' ' ASP . 33.9 Cg_endo -61.93 -28.61 81.14 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.828 2.352 . . . . 71.219999999999999 113.114 -170.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -114.63 27.44 8.81 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.658 -0.782 . . . . 54.130000000000003 112.293 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.562 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 49.6 tptt -142.55 -61.46 0.44 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.627 0.251 . . . . 74.150000000000006 110.943 -178.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.457 ' H ' ' HB2' ' A' ' 70' ' ' GLU . 23.0 ptt180 -165.13 140.04 5.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.109 0.481 . . . . 71.519999999999996 110.472 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.717 HD12 ' HE2' ' A' ' 93' ' ' PHE . 3.5 mp -121.72 125.5 73.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.147 -0.479 . . . . 64.409999999999997 109.9 175.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.471 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -139.11 117.46 11.98 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.79 -0.818 . . . . 70.420000000000002 108.79 176.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.535 ' HA ' HD11 ' A' ' 66' ' ' LEU . 10.2 p90 -96.41 120.47 36.79 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.443 -0.503 . . . . 73.519999999999996 111.263 -174.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.521 ' HG3' ' O ' ' A' ' 77' ' ' TRP . 17.2 mtt85 174.31 127.68 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 O-C-N 124.339 1.024 . . . . 72.430000000000007 112.833 173.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 1.067 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 50.2 m -150.63 -32.35 0.18 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.757 -0.656 . . . . 72.239999999999995 109.954 167.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.985 HD12 ' HA ' ' A' ' 64' ' ' ALA . 3.9 mp -46.78 144.0 3.92 Favored Pre-proline 0 C--O 1.234 0.265 0 N-CA-C 113.125 0.787 . . . . 74.310000000000002 113.125 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -77.59 -17.48 14.29 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 123.438 2.759 . . . . 62.329999999999998 113.661 -175.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.41 -14.71 12.44 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.479 -0.867 . . . . 71.409999999999997 112.31 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.673 ' HB1' ' HB2' ' A' ' 80' ' ' LEU . . . -90.32 17.38 7.27 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.826 0.346 . . . . 65.230000000000004 111.826 -173.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -92.27 6.64 46.03 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.41 0.522 . . . . 74.549999999999997 112.41 -173.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.3 tt -67.59 116.39 7.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 107.806 -1.183 . . . . 75.329999999999998 107.806 168.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 13.0 pt-20 -77.69 81.01 4.14 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 114.779 1.4 . . . . 64.430000000000007 114.779 -160.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -84.77 129.23 34.85 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 104.601 -2.37 . . . . 71.430000000000007 104.601 151.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.0 t -94.66 135.56 35.98 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 118.913 -1.115 . . . . 74.209999999999994 112.145 -161.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -139.05 41.41 1.35 Allowed Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 114.895 -1.048 . . . . 53.140000000000001 111.074 177.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -102.43 113.67 27.2 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.525 -0.546 . . . . 75.349999999999994 109.525 177.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.4 m -115.33 132.42 64.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.993 -0.549 . . . . 74.140000000000001 110.77 -177.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.6 mp -108.5 130.49 55.26 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.049 -0.523 . . . . 63.329999999999998 110.605 178.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.717 ' HE2' HD12 ' A' ' 75' ' ' ILE . 63.3 m-85 -108.9 123.69 49.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.05 0.453 . . . . 75.540000000000006 110.332 178.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.564 ' NH1' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -141.27 152.07 63.25 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.94 -0.573 . . . . 74.030000000000001 110.176 177.866 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -52.38 126.86 21.9 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.852 2.368 . . . . 71.549999999999997 111.639 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.82 ' HB1' HG23 ' A' ' 11' ' ' THR . . . -92.44 143.17 26.88 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.101 -0.499 . . . . 72.400000000000006 111.444 -176.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -71.44 166.04 30.6 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.828 2.352 . . . . 61.039999999999999 112.39 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 68.31 17.87 70.79 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.085 -0.579 . . . . 64.030000000000001 112.344 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 55.56 27.89 11.05 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 122.733 0.413 . . . . 54.109999999999999 111.2 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 58.6 mtt-85 -78.86 -9.76 59.58 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.381 -0.372 . . . . 61.329999999999998 111.899 -175.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 119.32 -109.55 1.71 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.205 -0.998 . . . . 43.450000000000003 112.445 176.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.429 ' HB ' HD11 ' A' ' 19' ' ' LEU . 23.8 m -125.71 133.95 51.96 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.08 0.467 . . . . 75.109999999999999 111.18 -178.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.445 ' HB3' ' HG2' ' A' ' 94' ' ' ARG . 37.1 tt0 -87.28 105.05 16.97 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.62 -0.718 . . . . 75.340000000000003 109.347 175.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.0 p -89.2 103.3 13.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.864 0.84 . . . . 74.349999999999994 109.705 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.564 HG22 ' NH1' ' A' ' 94' ' ' ARG . 27.3 t -89.01 112.89 24.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.694 -1.139 . . . . 74.299999999999997 109.855 -177.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 46.8 t -116.12 116.52 52.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.626 -0.716 . . . . 73.239999999999995 111.345 -174.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -97.19 113.8 25.44 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.796 -1.187 . . . . 75.209999999999994 107.796 169.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.432 HD11 ' CD1' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -123.0 125.36 45.1 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.687 0.279 . . . . 74.310000000000002 110.364 -173.502 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.891 HG23 HG22 ' A' ' 5' ' ' VAL . 17.1 p -105.18 116.94 32.8 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.94 -0.393 . . . . 54.020000000000003 109.94 173.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.702 ' O ' ' HB ' ' A' ' 4' ' ' THR . 6.7 p90 -173.04 150.85 2.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.76 -0.655 . . . . 75.310000000000002 109.802 -176.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 61.8 mtt-85 -78.0 144.44 67.84 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 109.307 -0.627 . . . . 73.010000000000005 109.307 173.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -60.78 152.7 67.95 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.374 2.05 . . . . 71.109999999999999 112.154 -176.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.04 139.5 67.57 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.718 2.279 . . . . 70.340000000000003 112.048 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.27 117.37 1.04 Allowed Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.775 -0.726 . . . . 71.299999999999997 112.374 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 109.11 -94.32 0.83 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.646 -0.788 . . . . 72.040000000000006 113.049 177.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.6 t -62.96 -49.08 76.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.803 0.335 . . . . 73.319999999999993 111.176 -172.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.432 ' HA ' HG21 ' A' ' 120' ' ' VAL . . . -61.78 -30.72 70.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 64.209999999999994 111.042 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.72 -22.35 73.54 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.975 -0.631 . . . . 74.450000000000003 112.356 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.07 -40.28 17.0 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.766 0.317 . . . . 62.119999999999997 111.058 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.432 HG21 ' HA ' ' A' ' 117' ' ' ALA . 33.3 m -74.71 -32.92 29.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 111.939 0.348 . . . . 74.219999999999999 111.939 -175.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.469 ' HA ' ' HG2' ' A' ' 124' ' ' MET . 37.3 pt -69.71 -23.97 26.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.895 0.378 . . . . 74.340000000000003 110.882 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.0 -21.04 60.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.957 -0.565 . . . . 73.430000000000007 110.912 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 123' ' ' ARG . 33.5 ttt180 -86.27 -43.36 13.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.055 0.455 . . . . 75.409999999999997 110.555 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.469 ' HG2' ' HA ' ' A' ' 121' ' ' ILE . 23.6 ptp -72.4 -26.85 62.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 74.540000000000006 111.238 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 63.62 -85.74 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.235 0.614 . . . . 73.340000000000003 112.302 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 69.23 -55.05 0.57 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.426 0.69 . . . . 62.229999999999997 109.764 -168.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.624 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 0.0 OUTLIER -155.52 -164.21 1.69 Allowed 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 106.982 -1.488 . . . . 73.239999999999995 106.982 177.538 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -97.44 89.6 0.73 Allowed Pre-proline 0 C--N 1.318 -0.773 0 N-CA-C 109.654 -0.499 . . . . 64.310000000000002 109.654 169.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.624 ' HD3' ' O ' ' A' ' 127' ' ' GLN . 72.9 Cg_exo -46.14 129.75 13.05 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.58 2.853 . . . . 71.010000000000005 112.942 -170.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 43.9 t -90.41 148.18 22.97 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.553 -0.749 . . . . 73.200000000000003 110.465 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -70.12 -10.09 57.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.843 -0.617 . . . . 73.200000000000003 111.547 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -149.42 108.32 3.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.777 0.322 . . . . 75.030000000000001 110.14 175.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.739 ' HG ' ' H ' ' A' ' 134' ' ' ARG . 3.3 tp -175.61 -172.59 0.56 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.632 -0.877 . . . . 63.119999999999997 108.632 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.739 ' H ' ' HG ' ' A' ' 133' ' ' LEU . 8.4 mpt_? -85.46 30.16 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.656 -0.498 . . . . 75.239999999999995 109.656 171.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.407 ' CG ' HH12 ' A' ' 139' ' ' ARG . 36.8 t70 -48.82 -49.79 37.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.958 -1.019 . . . . 74.049999999999997 112.393 -172.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -67.77 -39.71 84.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.899 0.38 . . . . 72.420000000000002 111.548 -176.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.514 ' CD2' ' HB3' ' A' ' 8' ' ' ASP . 12.6 tp -79.67 -20.92 45.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.469 -0.332 . . . . 73.349999999999994 110.858 -175.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.765 ' HA ' ' HE2' ' A' ' 138' ' ' MET . 24.2 mmt -69.18 -44.01 73.07 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.652 0.263 . . . . 72.319999999999993 111.096 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.407 HH12 ' CG ' ' A' ' 135' ' ' ASP . 89.8 mtm-85 -64.55 -42.64 95.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.956 0.408 . . . . 73.299999999999997 110.322 178.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -59.84 -45.47 92.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.278 -0.874 . . . . 71.420000000000002 110.152 176.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 39.5 tttp -58.05 -51.47 69.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.884 -0.598 . . . . 73.209999999999994 111.632 177.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 -56.61 -40.87 76.09 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.067 -0.515 . . . . 71.299999999999997 111.805 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -79.22 -36.06 40.69 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.668 -0.413 . . . . 74.129999999999995 110.764 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.634 ' HA ' HD22 ' A' ' 26' ' ' LEU . 61.4 tt0 -63.41 -43.57 97.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 74.310000000000002 111.42 -176.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.507 ' HB3' HG21 ' A' ' 12' ' ' ILE . 12.1 pt-20 -77.21 -24.06 51.34 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 120.83 -0.348 . . . . 74.219999999999999 111.023 -179.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 62.2 tp -66.27 -61.39 2.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.294 -0.412 . . . . 73.219999999999999 110.088 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.706 ' HA2' HD13 ' A' ' 26' ' ' LEU . . . 61.19 39.42 97.14 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.828 -0.701 . . . . 71.219999999999999 111.618 -177.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 60.2 tp 68.67 -73.5 0.09 Allowed 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.304 0.642 . . . . 72.109999999999999 111.07 -175.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.443 ' OE1' ' HB3' ' A' ' 152' ' ' HIS . 3.2 mm-40 63.79 164.43 0.13 Allowed 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.055 0.542 . . . . 64.239999999999995 111.693 -175.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -176.51 89.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.964 -0.562 . . . . 74.099999999999994 110.899 -175.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 21.9 t60 43.98 65.07 1.09 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.651 -0.704 . . . . 73.129999999999995 110.535 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.443 ' HB3' ' OE1' ' A' ' 149' ' ' GLU . 38.7 t-80 -155.36 -44.69 0.08 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.48 -0.782 . . . . 72.040000000000006 109.939 -172.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.418 ' O ' ' HB3' ' A' ' 154' ' ' HIS . 5.1 p80 43.06 51.18 5.48 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.8 1.24 . . . . 74.120000000000005 112.262 175.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.418 ' HB3' ' O ' ' A' ' 153' ' ' HIS . 78.0 t60 69.71 -74.01 0.09 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.772 -0.649 . . . . 74.319999999999993 109.616 -177.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 . . . . . 0 C--O 1.247 0.95 0 CA-C-O 118.218 -0.896 . . . . 74.510000000000005 109.515 169.11 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.982 0.42 . . . . 63.310000000000002 110.385 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 133.77 -57.39 0.71 Allowed Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.373 -1.091 . . . . 64.239999999999995 110.373 -177.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -112.96 151.11 30.95 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.29 -1.004 . . . . 74.200000000000003 108.29 171.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.694 ' HB ' ' O ' ' A' ' 110' ' ' TYR . 11.5 m -76.13 120.33 21.27 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.417 0.627 . . . . 74.209999999999994 110.686 -176.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.98 141.46 45.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.525 -0.761 . . . . 72.319999999999993 109.37 177.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.72 ' HB ' ' CE1' ' A' ' 110' ' ' TYR . 12.2 p -118.35 140.18 42.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.139 0.495 . . . . 61.219999999999999 110.515 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.577 ' HD2' ' O ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -136.32 109.73 7.91 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.542 -0.911 . . . . 64.400000000000006 108.542 172.152 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.536 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 4.2 t70 -132.17 171.38 13.73 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.653 -0.869 . . . . 72.040000000000006 108.653 -178.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.686 ' HB2' HG13 ' A' ' 105' ' ' VAL . . . -141.17 121.96 14.39 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.114 0.483 . . . . 73.150000000000006 111.366 -173.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.472 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 14.3 m -111.9 136.62 47.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.727 -0.67 . . . . 75.010000000000005 109.915 176.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.8 m -88.75 107.41 18.94 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.291 -0.413 . . . . 75.340000000000003 110.06 -178.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.556 HG21 ' HB3' ' A' ' 145' ' ' GLU . 14.2 mm -105.84 132.68 52.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.233 -0.44 . . . . 73.049999999999997 110.52 -176.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.94 58.03 4.94 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.912 -0.661 . . . . 73.439999999999998 112.584 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.63 ' HB2' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -132.28 153.12 81.15 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 108.361 -0.977 . . . . 63.030000000000001 108.361 175.827 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.433 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 10.5 Cg_endo -54.6 -58.74 1.1 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.714 2.276 . . . . 73.519999999999996 113.692 -172.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.433 ' HB1' ' O ' ' A' ' 15' ' ' PRO . . . 172.16 -54.1 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.283 0.564 . . . . 65.450000000000003 110.808 175.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -55.5 -43.89 76.05 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.111 -0.95 . . . . 74.510000000000005 112.256 -174.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.561 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 2.7 mp0 -79.18 -8.32 58.91 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.043 -0.526 . . . . 72.209999999999994 111.172 -174.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.63 HD23 ' HB2' ' A' ' 14' ' ' LYS . 77.8 mt -73.95 -50.73 18.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.028 -0.533 . . . . 72.219999999999999 111.057 178.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.712 ' HB3' ' HZ ' ' A' ' 93' ' ' PHE . 17.1 p90 -74.37 -24.06 59.09 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.784 -0.766 . . . . 74.420000000000002 109.487 176.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.561 ' HB1' ' HA ' ' A' ' 18' ' ' GLN . . . -71.39 -2.98 18.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.278 -0.874 . . . . 74.030000000000001 111.107 176.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.672 HG12 ' HZ ' ' A' ' 140' ' ' PHE . 9.9 p -54.49 -21.57 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.049 -0.523 . . . . 74.019999999999996 111.029 176.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 15.5 t90 -60.14 -22.71 63.19 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.993 -0.549 . . . . 63.130000000000003 110.693 177.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -109.3 2.12 20.58 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.097 -0.501 . . . . 65.310000000000002 110.035 177.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.0 t70 55.54 80.35 0.14 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.899 -0.591 . . . . 73.549999999999997 110.87 -176.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.53 HD12 ' H ' ' A' ' 148' ' ' LEU . 68.5 mt 45.18 85.6 0.16 Allowed Pre-proline 0 N--CA 1.47 0.547 0 CA-C-N 115.544 -0.753 . . . . 74.129999999999995 111.998 -178.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 26' ' ' LEU . 10.9 Cg_endo -52.57 116.02 2.59 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.63 2.887 . . . . 64.319999999999993 113.336 -173.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -132.27 73.96 0.45 Allowed Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 110.618 -0.993 . . . . 45.32 110.618 176.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.633 HD21 HD22 ' A' ' 32' ' ' LEU . 0.4 OUTLIER -137.51 58.48 17.05 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 112.781 0.66 . . . . 54.329999999999998 112.781 -173.595 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.46 ' HD3' ' N ' ' A' ' 29' ' ' LEU . 13.9 Cg_exo -70.07 -13.57 34.04 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.206 1.937 . . . . 63.420000000000002 111.503 177.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.859 HD13 ' H ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -89.8 -8.58 51.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.617 -0.719 . . . . 72.420000000000002 110.675 177.05 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.633 HD22 HD21 ' A' ' 29' ' ' LEU . 21.9 tp -98.52 29.53 3.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.659 0.742 . . . . 72.530000000000001 109.629 -178.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 89.2 mtp -93.67 168.45 11.01 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.311 -0.859 . . . . 75.230000000000004 109.269 174.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.799 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 5.7 t -70.97 102.32 2.39 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.489 0.661 . . . . 73.010000000000005 111.436 -176.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -164.07 -59.81 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.63 -0.713 . . . . 74.439999999999998 110.204 176.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.4 tp -71.54 -58.25 3.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.715 0.293 . . . . 55.200000000000003 110.99 -177.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -111.44 15.11 21.41 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.927 0.394 . . . . 55.210000000000001 110.109 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.6 m 55.45 35.53 25.25 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.535 -0.757 . . . . 61.149999999999999 111.22 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.4 p -74.18 103.54 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.471 0.653 . . . . 72.329999999999998 110.83 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.799 ' HB3' ' HB ' ' A' ' 34' ' ' THR . 13.9 pt-20 -146.52 140.24 26.03 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.612 -0.722 . . . . 74.409999999999997 109.505 176.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.0 t -84.28 137.36 21.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.048 0.452 . . . . 43.240000000000002 110.424 -178.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.401 ' N ' HD21 ' A' ' 42' ' ' LEU . 3.2 mm? -71.67 -63.94 1.03 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.466 -0.788 . . . . 50.140000000000001 110.507 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.505 ' HB3' ' HG2' ' A' ' 46' ' ' ARG . 29.0 t70 -81.54 -86.14 0.1 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.14 -0.482 . . . . 72.219999999999999 111.116 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -161.89 -63.66 0.05 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.862 0.363 . . . . 63.43 111.156 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.473 ' HD3' ' HA ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -126.43 32.86 5.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.417 0.627 . . . . 73.219999999999999 111.03 -172.66 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.505 ' HG2' ' HB3' ' A' ' 43' ' ' ASP . 8.5 ptp180 -130.28 -175.88 3.77 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.402 -0.817 . . . . 74.340000000000003 109.958 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.0 m -143.53 178.41 7.79 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.381 -0.372 . . . . 64.409999999999997 110.002 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 48' ' ' ARG . 24.2 ttt180 -161.62 -56.99 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.07 -0.715 . . . . 65.230000000000004 109.07 174.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -89.61 -15.89 31.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.492 -0.776 . . . . 74.530000000000001 110.199 176.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 45.1 p 53.18 -171.5 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.501 -0.772 . . . . 74.409999999999997 111.786 -174.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.742 HG21 ' H ' ' A' ' 52' ' ' GLU . 1.9 m -126.75 -85.17 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.166 0.432 . . . . 64.209999999999994 112.166 -177.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.742 ' H ' HG21 ' A' ' 51' ' ' VAL . 29.7 mt-10 -102.99 -81.92 0.5 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.903 0.382 . . . . 71.219999999999999 110.387 -177.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.63 84.97 4.95 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.854 -0.612 . . . . 71.120000000000005 110.093 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -95.05 -168.51 0.15 Allowed 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 123.14 2.56 . . . . 63.539999999999999 111.886 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -161.66 85.73 1.65 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.325 -0.398 . . . . 73.430000000000007 110.497 174.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.834 ' HB3' ' HB1' ' A' ' 64' ' ' ALA . 14.4 Cg_exo -69.27 -54.24 0.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.591 2.194 . . . . 64.230000000000004 111.892 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.756 HD11 ' HB3' ' A' ' 79' ' ' SER . 0.2 OUTLIER -98.15 38.02 1.37 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.107 0.479 . . . . 62.310000000000002 110.312 -177.42 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.86 -58.89 4.59 Favored Glycine 0 C--N 1.318 -0.425 0 CA-C-N 116.033 -0.531 . . . . 64.129999999999995 112.626 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -121.75 -67.24 0.98 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.641 0.257 . . . . 71.310000000000002 110.826 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.75 HG21 HD22 ' A' ' 57' ' ' LEU . 15.6 m -55.99 140.01 14.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.254 -0.43 . . . . 64.209999999999994 110.584 178.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.523 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . 25.1 m -134.52 102.08 5.19 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.306 0.484 . . . . 74.430000000000007 112.306 -171.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 21.6 p-90 -157.48 -36.69 0.07 Allowed 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 120.991 -0.284 . . . . 65.450000000000003 111.507 173.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.637 ' HB3' HD11 ' A' ' 80' ' ' LEU . 34.7 tt0 -153.58 154.45 34.27 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.249 -0.432 . . . . 64.129999999999995 110.613 177.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.834 ' HB1' ' HB3' ' A' ' 56' ' ' PRO . . . -135.17 143.16 46.31 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.918 -0.771 . . . . 62.399999999999999 108.918 174.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.603 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -108.56 134.64 51.04 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.429 -0.952 . . . . 74.010000000000005 108.429 -175.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.444 ' HG ' ' HB3' ' A' ' 45' ' ' LYS . 1.2 mm? -113.83 116.63 29.63 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 121.846 -0.534 . . . . 74.329999999999998 110.294 -176.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.501 HG23 ' HB3' ' A' ' 76' ' ' ALA . 7.1 t -78.26 -26.03 47.04 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.627 -0.429 . . . . 74.319999999999993 111.568 -174.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.413 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . . . -147.42 129.61 15.59 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.767 0.318 . . . . 75.430000000000007 110.368 176.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -132.23 7.93 4.3 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.098 -0.501 . . . . 72.239999999999995 111.424 -175.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -59.18 93.41 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 123.94 0.896 . . . . 72.150000000000006 112.486 -173.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -59.74 114.16 1.94 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.314 2.676 . . . . 74.409999999999997 112.642 -169.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.53 6.37 70.66 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.84 -0.695 . . . . 72.430000000000007 112.519 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -123.91 -67.94 0.9 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.002 -0.37 . . . . 73.329999999999998 110.002 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.418 ' C ' HD11 ' A' ' 75' ' ' ILE . 15.4 ptt180 -150.6 134.9 17.05 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.983 -0.377 . . . . 74.430000000000007 109.983 175.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.606 HD13 ' HE2' ' A' ' 93' ' ' PHE . 3.5 mp -126.73 126.52 68.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 109.183 -0.673 . . . . 72.319999999999993 109.183 177.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.583 ' HB1' ' HG3' ' A' ' 90' ' ' GLU . . . -139.59 120.57 14.57 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.969 -0.559 . . . . 71.209999999999994 110.559 -176.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 13.3 m-90 -98.04 152.17 19.57 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.78 -0.646 . . . . 74.019999999999996 110.483 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.603 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 1.0 OUTLIER -156.16 175.68 13.66 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.682 -0.858 . . . . 75.010000000000005 108.682 175.625 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 1.054 ' HB2' ' HA ' ' A' ' 85' ' ' ILE . 20.3 m -105.91 -171.07 1.83 Allowed 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 109.672 -0.492 . . . . 74.540000000000006 109.672 176.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.637 HD11 ' HB3' ' A' ' 63' ' ' GLU . 12.6 mt -82.79 144.88 49.11 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.631 -0.259 . . . . 72.420000000000002 111.075 -175.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.94 -32.36 95.0 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.601 2.2 . . . . 64.230000000000004 111.436 173.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.97 35.83 3.86 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.482 -0.647 . . . . 43.240000000000002 111.482 175.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -155.01 -173.94 4.78 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.654 -0.498 . . . . 60.299999999999997 109.654 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -80.38 101.62 9.11 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.591 -0.522 . . . . 73.540000000000006 109.591 172.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 1.054 ' HA ' ' HB2' ' A' ' 79' ' ' SER . 0.0 OUTLIER -70.04 -51.37 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 116.175 -0.466 . . . . 75.299999999999997 109.777 -179.071 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 47.78 -83.25 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.371 1.068 . . . . 55.43 113.608 175.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -64.69 132.51 49.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.588 0.709 . . . . 54.530000000000001 111.52 -175.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.1 m -139.5 128.73 23.95 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.537 -0.756 . . . . 72.409999999999997 109.548 176.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.25 145.15 9.16 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.716 -0.754 . . . . 62.310000000000002 112.064 -178.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.583 ' HG3' ' HB1' ' A' ' 76' ' ' ALA . 43.4 tt0 -138.57 125.61 21.31 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.077 -0.342 . . . . 65.140000000000001 110.077 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.1 m -106.75 128.07 61.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.121 0.486 . . . . 64.209999999999994 110.223 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.661 ' HB2' HG21 ' A' ' 105' ' ' VAL . 9.1 mp -110.53 145.7 37.3 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.463 -0.569 . . . . 65.420000000000002 109.463 173.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.712 ' HZ ' ' HB3' ' A' ' 20' ' ' TYR . 73.9 m-85 -110.07 106.72 16.32 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.094 0.473 . . . . 73.400000000000006 111.104 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -112.3 142.87 27.74 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.304 -0.628 . . . . 74.5 109.304 175.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -72.16 125.19 10.63 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.421 2.08 . . . . 75.120000000000005 111.327 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.89 144.51 98.86 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.239 -0.652 . . . . 62.140000000000001 109.239 176.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -39.32 119.64 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.623 2.882 . . . . 75.450000000000003 113.622 -174.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 90.82 8.97 64.69 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.011 -0.614 . . . . 54.509999999999998 112.642 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 59.01 36.04 24.24 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.201 0.524 . . . . 74.329999999999998 110.427 -178.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -73.79 -65.42 0.83 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.672 -0.695 . . . . 62.450000000000003 110.458 -178.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -131.78 -167.85 11.97 Favored Glycine 0 N--CA 1.439 -1.127 0 N-CA-C 110.512 -1.035 . . . . 72.140000000000001 110.512 176.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.477 ' HB ' HD12 ' A' ' 19' ' ' LEU . 10.7 m -110.45 122.71 48.38 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.023 0.439 . . . . 73.099999999999994 110.182 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.489 ' HG2' ' HB3' ' A' ' 9' ' ' ALA . 41.3 tt0 -92.4 106.5 18.48 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.455 -0.943 . . . . 75.409999999999997 108.455 178.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 5.2 m -86.72 128.88 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 CA-C-O 121.393 0.615 . . . . 70.0 109.506 -177.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.686 HG13 ' HB2' ' A' ' 9' ' ' ALA . 3.5 m -108.95 114.98 48.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.521 -0.763 . . . . 71.349999999999994 109.797 178.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 40.1 t -110.02 119.12 58.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.828 -0.623 . . . . 64.310000000000002 111.377 -173.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -107.06 116.48 32.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.633 -0.712 . . . . 71.030000000000001 109.739 175.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.5 pp -147.0 151.69 37.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.934 0.397 . . . . 75.530000000000001 111.085 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.1 t -90.09 144.85 25.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.93 -0.577 . . . . 74.540000000000006 110.18 178.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.72 ' CE1' ' HB ' ' A' ' 6' ' ' VAL . 5.7 p90 -164.33 156.92 17.03 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.921 -0.4 . . . . 75.219999999999999 109.921 -178.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -134.71 144.68 51.7 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 116.619 -0.264 . . . . 73.340000000000003 110.383 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.13 153.88 76.17 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.511 2.141 . . . . 74.519999999999996 111.691 -178.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.64 108.69 1.91 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.738 2.292 . . . . 73.439999999999998 112.442 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -114.99 97.33 0.81 Allowed Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.638 -0.71 . . . . 54.43 111.352 175.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -165.95 144.13 8.95 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.637 -0.792 . . . . 55.32 112.342 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 38.0 t -86.29 -23.73 26.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.988 0.423 . . . . 63.130000000000003 110.572 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -68.41 -29.09 67.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.146 -0.479 . . . . 72.299999999999997 111.641 -174.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.452 ' O ' HG22 ' A' ' 121' ' ' ILE . . . -69.73 -19.68 75.18 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.098 -0.572 . . . . 52.100000000000001 113.041 -178.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.26 -20.34 65.99 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.307 0.484 . . . . 62.200000000000003 112.307 -174.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.57 -19.48 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.785 0.326 . . . . 73.219999999999999 111.723 -176.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.452 HG22 ' O ' ' A' ' 118' ' ' GLY . 13.8 tt -67.62 -22.64 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 121.032 0.444 . . . . 70.510000000000005 110.967 -177.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.54 -20.85 63.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.269 -0.423 . . . . 61.420000000000002 111.191 -178.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -71.03 -28.93 64.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.057 -0.52 . . . . 73.430000000000007 110.776 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.5 ttm -71.04 -53.62 14.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 74.439999999999998 111.153 -175.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -107.73 -79.63 0.58 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.121 0.486 . . . . 71.150000000000006 110.347 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -164.61 -55.89 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.258 -1.016 . . . . 64.120000000000005 108.258 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -177.65 147.75 0.52 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.884 -1.053 . . . . 75.430000000000007 109.9 171.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.476 ' HA ' ' HD2' ' A' ' 129' ' ' PRO . 28.5 tt0 -120.41 87.56 40.9 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 108.405 -0.961 . . . . 74.109999999999999 108.405 171.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.476 ' HD2' ' HA ' ' A' ' 128' ' ' GLU . 1.7 Cg_endo -40.11 129.81 2.22 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 124.482 3.455 . . . . 71.349999999999994 113.635 -171.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.8 m -71.13 97.9 1.58 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.746 -0.661 . . . . 73.25 109.859 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -71.35 106.12 3.77 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.69 -0.686 . . . . 74.530000000000001 111.12 -176.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -111.6 72.2 0.77 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.323 -0.992 . . . . 75.340000000000003 108.323 174.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.33 -154.58 0.54 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.036 -0.984 . . . . 72.439999999999998 109.265 -178.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.538 ' O ' ' HG2' ' A' ' 138' ' ' MET . 51.0 mtp180 -93.16 14.2 18.76 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.061 -0.718 . . . . 74.209999999999994 109.061 173.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -57.22 -38.6 73.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.882 -1.054 . . . . 72.010000000000005 112.996 -171.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.48 -42.57 98.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.889 0.376 . . . . 75.409999999999997 110.889 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.536 ' CD2' ' HB3' ' A' ' 8' ' ' ASP . 13.9 tp -79.4 -20.95 46.37 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.254 -0.43 . . . . 71.430000000000007 110.112 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.538 ' HG2' ' O ' ' A' ' 134' ' ' ARG . 30.4 mmt -69.48 -47.51 63.68 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.307 -0.406 . . . . 60.420000000000002 110.268 175.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.07 -43.28 99.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.094 -0.503 . . . . 71.319999999999993 110.092 174.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.672 ' HZ ' HG12 ' A' ' 22' ' ' VAL . 67.8 t80 -57.22 -48.9 77.64 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.228 -0.897 . . . . 75.120000000000005 111.004 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.8 tttp -54.81 -56.23 21.63 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.185 -0.462 . . . . 75.109999999999999 111.727 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -55.49 -42.82 74.94 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.821 0.343 . . . . 62.350000000000001 111.737 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -75.49 -27.44 58.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.486 -0.325 . . . . 60.130000000000003 111.4 -178.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -80.94 -39.13 26.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.056 -0.52 . . . . 74.439999999999998 111.216 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.556 ' HB3' HG21 ' A' ' 12' ' ' ILE . 16.9 pt-20 -80.57 -36.85 32.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.55 -0.296 . . . . 73.349999999999994 111.495 -176.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.1 tt -71.79 -63.01 1.21 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.781 -0.452 . . . . 75.109999999999999 109.781 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.419 ' HA3' HD13 ' A' ' 26' ' ' LEU . . . 64.13 -172.73 16.01 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.652 -0.704 . . . . 72.329999999999998 113.486 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.53 ' H ' HD12 ' A' ' 26' ' ' LEU . 5.8 mp -116.63 164.53 14.48 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.681 -0.488 . . . . 70.140000000000001 109.681 178.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -59.86 118.19 5.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.117 0.484 . . . . 71.319999999999993 111.732 -175.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -148.23 168.74 21.7 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.75 -0.833 . . . . 75.310000000000002 108.75 177.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -80.53 148.2 30.49 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.228 -0.286 . . . . 75.409999999999997 110.228 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 40.5 m-70 -79.52 115.09 18.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.6 -0.273 . . . . 72.549999999999997 111.009 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -104.55 125.55 50.8 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.745 -0.465 . . . . 74.439999999999998 109.745 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -107.25 158.57 17.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.948 -0.569 . . . . 75.129999999999995 109.743 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 3.4 p80 . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.661 -0.685 . . . . 71.530000000000001 109.546 176.737 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 109.83 -0.433 . . . . 75.299999999999997 109.83 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -112.93 -114.8 3.29 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.538 -1.025 . . . . 73.099999999999994 110.538 175.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -71.75 120.84 17.92 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.691 -0.855 . . . . 73.030000000000001 108.691 173.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.6 m -83.6 133.83 34.83 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.014 0.435 . . . . 62.43 111.418 -173.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -120.21 119.15 59.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.145 -0.687 . . . . 64.510000000000005 109.145 173.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 71.4 t -101.16 116.76 45.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 121.303 0.573 . . . . 74.019999999999996 110.881 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -132.21 109.84 10.22 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.981 -1.008 . . . . 75.420000000000002 108.638 176.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.481 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 1.3 t70 -141.47 146.15 36.11 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.836 -1.172 . . . . 52.439999999999998 107.836 175.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -122.8 140.25 53.13 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.135 0.493 . . . . 62.340000000000003 110.982 -173.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.604 ' CG2' ' HG2' ' A' ' 141' ' ' LYS . 2.5 m -133.85 142.28 41.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.47 -0.786 . . . . 74.519999999999996 110.469 -176.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 29.7 m -94.0 133.7 37.17 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.975 -0.557 . . . . 72.409999999999997 111.125 -175.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.795 HD13 ' HG3' ' A' ' 141' ' ' LYS . 35.3 mt -121.38 140.15 46.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.654 -0.703 . . . . 72.120000000000005 109.917 172.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.498 ' H ' ' HB3' ' A' ' 145' ' ' GLU . . . -83.31 62.35 4.64 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.991 -0.624 . . . . 74.430000000000007 112.555 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.517 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 7.4 mmpt? -144.59 144.8 26.13 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 109.183 -0.673 . . . . 73.329999999999998 109.183 175.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 72.8 Cg_exo -51.81 -56.3 3.09 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.25 2.633 . . . . 72.519999999999996 113.945 -176.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 15' ' ' PRO . . . 174.51 -63.11 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.686 0.279 . . . . 74.310000000000002 110.836 177.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -50.23 -42.57 51.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.553 -0.749 . . . . 73.040000000000006 111.428 -176.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.567 ' HG3' ' HD2' ' A' ' 27' ' ' PRO . 2.6 mp0 -61.61 -23.55 66.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.727 -0.67 . . . . 74.319999999999993 111.863 -177.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 19' ' ' LEU . 53.6 mt -77.8 -34.32 52.21 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.95 0.352 . . . . 71.439999999999998 111.95 -176.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -71.73 -28.07 63.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.644 0.735 . . . . 71.030000000000001 109.421 177.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.22 -2.69 32.52 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 114.901 -1.045 . . . . 73.430000000000007 112.385 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.831 HG23 ' HZ ' ' A' ' 140' ' ' PHE . 10.9 p -53.01 -22.56 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 113.042 0.756 . . . . 63.219999999999999 113.042 -174.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 23.2 m0 -63.18 -14.1 44.99 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.703 0.631 . . . . 74.340000000000003 112.703 -176.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.447 ' HD3' ' HA ' ' A' ' 24' ' ' ARG . 25.8 mmt180 -121.84 -80.15 0.62 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.407 -0.183 . . . . 75.219999999999999 110.624 175.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' A' ' 26' ' ' LEU . 8.3 t70 -172.19 53.63 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.549 -0.537 . . . . 74.129999999999995 109.549 176.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 9.1 mp 66.37 165.89 0.12 Allowed Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 115.409 -0.814 . . . . 72.239999999999995 110.771 -178.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.567 ' HD2' ' HG3' ' A' ' 18' ' ' GLN . 35.4 Cg_exo -58.75 122.11 11.09 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.38 2.053 . . . . 73.329999999999998 111.781 177.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 160.17 103.26 0.19 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.685 -0.769 . . . . 72.420000000000002 112.093 -178.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 62.1 mt -128.21 62.72 59.76 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 120.624 0.25 . . . . 73.140000000000001 110.626 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -87.79 60.54 3.38 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.218 1.945 . . . . 65.439999999999998 112.572 -175.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -145.63 7.73 1.12 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.409 -0.814 . . . . 74.349999999999994 109.079 173.359 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.465 ' O ' HD13 ' A' ' 32' ' ' LEU . 3.3 pp -154.41 144.98 22.28 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.523 -1.217 . . . . 71.329999999999998 107.725 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 56.6 mtt -78.31 -78.87 0.13 Allowed 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 121.0 -0.28 . . . . 61.439999999999998 110.31 176.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.815 HG23 ' H ' ' A' ' 35' ' ' HIS . 2.4 m 54.48 -163.54 0.12 Allowed 'General case' 0 CA--C 1.546 0.814 0 O-C-N 123.265 0.353 . . . . 74.209999999999994 111.06 176.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.815 ' H ' HG23 ' A' ' 34' ' ' THR . 2.3 t-80 -74.47 -161.56 0.13 Allowed 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 109.848 -0.427 . . . . 71.510000000000005 109.848 173.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.41 ' H ' ' CG ' ' A' ' 35' ' ' HIS . 37.4 tp -55.35 -20.14 10.88 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.785 0.661 . . . . 72.019999999999996 112.785 -176.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' A' ' 35' ' ' HIS . 52.5 mtt180 74.0 -71.32 0.13 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.487 0.715 . . . . 63.310000000000002 111.133 175.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.4 m 65.35 -84.88 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.085 -0.961 . . . . 53.520000000000003 110.315 -170.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.583 HG12 ' H ' ' A' ' 40' ' ' GLU . 2.1 t -144.33 172.8 5.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.427 -0.583 . . . . 72.310000000000002 109.427 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.583 ' H ' HG12 ' A' ' 39' ' ' VAL . 19.4 tt0 -77.08 77.54 3.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.145 0.498 . . . . 75.450000000000003 110.582 179.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.0 t -133.67 131.82 56.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.568 -0.901 . . . . 72.349999999999994 108.568 175.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.617 HD11 ' N ' ' A' ' 43' ' ' ASP . 3.3 pp -65.25 -37.2 86.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.934 0.397 . . . . 74.329999999999998 111.884 -171.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.617 ' N ' HD11 ' A' ' 42' ' ' LEU . 28.0 t70 -124.85 -161.76 1.04 Allowed 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.754 -0.832 . . . . 74.049999999999997 108.754 176.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.521 ' H ' ' CG ' ' A' ' 43' ' ' ASP . 10.7 m-20 -102.54 9.57 39.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.479 0.657 . . . . 63.509999999999998 109.6 178.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.688 ' HG3' ' HB3' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -103.84 -80.19 0.53 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.136 -0.938 . . . . 75.030000000000001 111.451 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.645 ' HG3' ' HB3' ' A' ' 64' ' ' ALA . 0.1 OUTLIER -145.03 -167.05 2.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.566 -0.288 . . . . 73.239999999999995 111.466 -172.482 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.0 m 64.98 -179.66 0.18 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.55 -0.75 . . . . 63.329999999999998 111.573 -177.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -143.69 -164.29 1.84 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 122.399 -0.188 . . . . 71.129999999999995 110.708 -173.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 77.5 t-105 75.41 -65.4 0.33 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.814 0.846 . . . . 74.450000000000003 113.146 170.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' A' ' 42' ' ' LEU . 2.4 m -81.64 169.83 16.54 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.637 -0.134 . . . . 73.340000000000003 110.637 -176.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.409 ' H ' HG22 ' A' ' 50' ' ' THR . 7.5 p -151.89 23.26 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 122.248 1.023 . . . . 71.140000000000001 109.555 176.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.45 ' H ' HG22 ' A' ' 50' ' ' THR . 9.0 tm-20 -103.08 3.89 36.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.121 -0.945 . . . . 74.310000000000002 110.388 -173.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 61.07 68.72 1.19 Allowed Pre-proline 0 N--CA 1.465 0.311 0 CA-C-N 115.701 -0.681 . . . . 74.040000000000006 111.773 -175.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.517 ' CD ' ' HB2' ' A' ' 42' ' ' LEU . 87.8 Cg_endo -96.05 -162.4 0.08 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 124.04 3.16 . . . . 71.400000000000006 111.434 174.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.04 142.77 45.3 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.281 -0.418 . . . . 72.310000000000002 110.613 176.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.87 -28.2 86.66 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.95 2.433 . . . . 72.129999999999995 113.009 -174.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.789 ' HB2' ' HG2' ' A' ' 63' ' ' GLU . 1.3 pt? -104.27 -10.19 18.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.256 -0.429 . . . . 72.030000000000001 111.736 -175.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 58.51 -109.43 1.97 Allowed Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.74 -0.743 . . . . 37.909999999999997 112.875 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -93.64 16.04 14.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.716 0.293 . . . . 70.219999999999999 111.59 -176.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.1 t 64.04 33.14 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 121.789 0.804 . . . . 74.530000000000001 110.68 176.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.434 ' O ' ' HB2' ' A' ' 62' ' ' TRP . 30.8 m -141.87 131.67 24.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.792 -0.64 . . . . 72.209999999999994 110.035 175.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.434 ' HB2' ' O ' ' A' ' 61' ' ' SER . 2.5 m-90 71.53 6.13 5.62 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 123.636 0.585 . . . . 74.409999999999997 111.631 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.789 ' HG2' ' HB2' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -84.34 165.6 18.11 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.469 -0.787 . . . . 75.25 112.351 -176.828 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.645 ' HB3' ' HG3' ' A' ' 46' ' ' ARG . . . -162.14 160.61 27.42 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.429 -1.26 . . . . 63.520000000000003 108.582 176.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.574 ' HB2' ' HA ' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -108.05 133.97 51.6 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.986 -1.116 . . . . 73.530000000000001 107.986 177.01 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.688 ' HB3' ' HG3' ' A' ' 45' ' ' LYS . 40.1 tp -105.49 117.81 34.96 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.651 -0.82 . . . . 74.329999999999998 110.713 -169.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.8 t -93.32 -13.86 27.63 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.003 -0.544 . . . . 43.130000000000003 111.126 -175.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.401 ' HB1' ' H ' ' A' ' 76' ' ' ALA . . . -147.25 125.16 11.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.952 0.406 . . . . 73.239999999999995 110.806 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.528 ' HB3' ' CD2' ' A' ' 66' ' ' LEU . 4.1 p-10 -140.19 40.5 1.94 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.498 -0.774 . . . . 72.439999999999998 109.835 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -60.03 144.96 85.9 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.078 -0.964 . . . . 75.549999999999997 109.919 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -47.25 -41.34 27.84 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.826 3.017 . . . . 73.109999999999999 113.451 -173.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -166.57 33.26 0.22 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.352 -0.928 . . . . 60.130000000000003 112.215 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -97.21 -63.46 1.13 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.164 0.507 . . . . 71.420000000000002 110.523 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 74' ' ' ARG . 3.5 ptp85 -161.51 140.84 10.1 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.758 -0.83 . . . . 71.439999999999998 108.758 177.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 68.5 mt -121.99 109.81 25.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 109.412 -0.588 . . . . 64.319999999999993 109.412 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.609 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . . . -111.34 115.32 29.1 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.975 -0.557 . . . . 75.510000000000005 110.499 -177.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 23.5 p-90 -96.1 124.09 39.97 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.921 0.867 . . . . 74.340000000000003 110.086 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 30.9 mmt180 -113.67 176.15 5.15 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.353 -1.351 . . . . 73.040000000000006 107.353 178.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.866 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 16.5 m -99.12 163.98 12.35 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 118.839 -1.144 . . . . 73.349999999999994 110.187 174.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.639 ' CD2' ' HB3' ' A' ' 57' ' ' LEU . 4.4 mp -69.55 161.5 73.62 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.885 -0.598 . . . . 64.200000000000003 110.784 -176.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.14 -40.82 75.81 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.769 2.313 . . . . 65.099999999999994 112.252 177.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.0 -20.86 58.56 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.786 -0.721 . . . . 74.230000000000004 112.327 178.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.417 ' HA ' ' NH1' ' A' ' 84' ' ' ARG . . . -82.38 167.31 18.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.749 0.309 . . . . 74.319999999999993 110.728 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.417 ' NH1' ' HA ' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -82.16 104.71 12.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.003 0.43 . . . . 62.310000000000002 110.507 -176.639 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.866 ' HB ' ' HB2' ' A' ' 79' ' ' SER . 6.8 tt -117.44 116.81 53.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.867 -0.606 . . . . 51.409999999999997 110.517 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -153.55 -42.15 0.09 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.052 -0.522 . . . . 71.25 109.961 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -77.18 154.17 33.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.123 -0.489 . . . . 73.230000000000004 110.166 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.4 m -96.13 127.64 42.32 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.363 -0.381 . . . . 63.119999999999997 110.65 -178.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -122.49 61.53 0.55 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.942 -0.647 . . . . 72.439999999999998 111.524 177.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.609 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 39.3 tt0 -102.69 121.97 43.51 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 122.627 -0.337 . . . . 72.239999999999995 110.661 -176.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.663 HG21 HG23 ' A' ' 106' ' ' VAL . 83.0 t -112.79 122.03 66.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.273 0.558 . . . . 74.420000000000002 110.684 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.882 ' HB2' ' HB ' ' A' ' 105' ' ' VAL . 10.1 mp -96.19 142.34 28.48 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.597 -0.729 . . . . 62.109999999999999 110.104 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -121.55 115.9 23.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.152 -0.476 . . . . 74.329999999999998 110.164 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -141.08 144.65 35.75 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.318 -0.401 . . . . 75.540000000000006 110.567 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.67 134.72 66.21 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.679 2.253 . . . . 70.549999999999997 111.932 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -94.61 145.04 28.93 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.996 -0.547 . . . . 75.150000000000006 111.706 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -54.12 151.33 28.46 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.088 2.525 . . . . 73.140000000000001 112.361 175.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.49 -0.89 79.42 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.72 -0.753 . . . . 53.43 111.251 -178.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 59.57 33.93 22.24 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 122.8 0.44 . . . . 53.009999999999998 111.031 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -64.09 -42.89 96.76 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.19 0.519 . . . . 71.510000000000005 110.419 176.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 162.24 -122.37 1.1 Allowed Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 115.46 -0.791 . . . . 73.329999999999998 111.421 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 39.3 m -128.72 135.09 48.76 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.564 0.697 . . . . 73.219999999999999 111.003 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -90.88 131.27 36.62 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.867 -1.061 . . . . 72.019999999999996 110.181 -178.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.435 HG22 HG21 ' A' ' 10' ' ' VAL . 17.9 m -87.41 131.58 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 108.164 -1.05 . . . . 71.450000000000003 108.164 173.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.882 ' HB ' ' HB2' ' A' ' 92' ' ' LEU . 44.3 t -123.1 111.49 29.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 116.022 -0.536 . . . . 74.010000000000005 110.391 -174.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.663 HG23 HG21 ' A' ' 91' ' ' VAL . 37.9 t -128.29 121.2 55.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.405 -0.361 . . . . 64.109999999999999 111.12 -177.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.571 ' O ' ' HD2' ' A' ' 107' ' ' ARG . 0.4 OUTLIER -107.05 108.83 20.51 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.278 0.561 . . . . 71.200000000000003 109.816 170.6 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 50.1 tp -114.19 142.82 45.76 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.032 -0.531 . . . . 62.420000000000002 110.847 -175.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.8 t -93.95 142.33 27.51 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.006 -0.543 . . . . 74.209999999999994 110.498 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -129.36 112.49 13.89 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.934 -0.575 . . . . 75.120000000000005 110.234 177.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 111' ' ' ARG . 14.3 mtm180 -107.85 158.19 34.1 Favored Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 109.227 -0.657 . . . . 74.140000000000001 109.227 178.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.441 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 37.1 Cg_exo -58.52 151.78 59.68 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.113 1.875 . . . . 65.150000000000006 111.935 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 16.0 Cg_exo -70.03 -54.15 0.22 Allowed 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.915 2.41 . . . . 72.340000000000003 111.972 -178.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -163.83 -79.49 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.906 -0.664 . . . . 62.100000000000001 111.842 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -124.73 -165.77 12.24 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.66 -0.781 . . . . 75.530000000000001 112.472 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.3 t -78.96 -26.97 43.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.51 0.195 . . . . 63.350000000000001 111.36 -175.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.65 -34.6 71.39 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.563 0.22 . . . . 61.329999999999998 111.448 -176.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.69 -31.82 76.89 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.922 -0.656 . . . . 73.230000000000004 112.397 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.96 -38.21 37.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.843 0.354 . . . . 63.329999999999998 110.588 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 93.4 t -61.32 -50.0 82.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.916 -0.584 . . . . 74.209999999999994 110.954 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.6 tp -65.8 -34.13 68.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 74.299999999999997 110.808 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.31 -37.11 84.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.443 -0.344 . . . . 61.310000000000002 111.192 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 70.2 ttp85 -68.33 -48.12 65.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.32 -0.4 . . . . 72.200000000000003 110.935 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 27.2 ptm -71.16 -28.49 64.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.437 -0.347 . . . . 71.049999999999997 111.154 -177.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -72.32 -41.65 66.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.385 -0.37 . . . . 73.219999999999999 110.456 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 49.3 t30 69.59 110.93 0.05 Allowed 'General case' 0 N--CA 1.469 0.488 0 O-C-N 124.129 0.893 . . . . 65.340000000000003 111.117 -177.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -104.14 139.5 39.11 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.748 -0.66 . . . . 73.25 110.678 -177.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -70.89 154.89 94.03 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.292 -0.413 . . . . 72.209999999999994 110.474 175.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.74 64.03 3.11 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.149 2.566 . . . . 72.219999999999999 112.7 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.432 ' O ' ' HB2' ' A' ' 131' ' ' GLN . 8.3 t -111.33 124.42 52.2 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.422 -0.955 . . . . 72.519999999999996 108.422 175.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.432 ' HB2' ' O ' ' A' ' 130' ' ' SER . 55.0 mt-30 70.31 153.55 0.12 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.839 0.712 . . . . 72.209999999999994 110.548 -171.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 64.06 -171.51 0.18 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.971 -0.559 . . . . 74.049999999999997 110.778 -177.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.4 mt 61.99 -168.92 0.18 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.115 -0.493 . . . . 74.319999999999993 110.692 -178.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -108.34 -13.84 14.8 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.771 -0.455 . . . . 73.239999999999995 109.771 176.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -60.7 -55.33 34.56 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.615 -0.72 . . . . 70.120000000000005 110.455 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -66.48 -30.84 71.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.16 0.505 . . . . 60.32 110.347 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.661 ' O ' ' HD3' ' A' ' 141' ' ' LYS . 43.5 tp -65.12 -48.24 74.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.616 -0.72 . . . . 72.450000000000003 110.167 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.795 ' HA ' ' HE1' ' A' ' 138' ' ' MET . 3.1 tpt -75.03 -35.12 61.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.494 -0.321 . . . . 74.540000000000006 110.692 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.9 ttm-85 -52.67 -54.8 28.39 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.969 -0.56 . . . . 73.510000000000005 111.124 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.831 ' HZ ' HG23 ' A' ' 22' ' ' VAL . 54.1 t80 -67.8 -46.05 73.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.799 -0.637 . . . . 73.530000000000001 111.625 -177.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.795 ' HG3' HD13 ' A' ' 12' ' ' ILE . 14.0 mptt -64.75 -35.04 79.8 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 111.94 0.348 . . . . 73.129999999999995 111.94 -173.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.734 ' HG2' ' HE2' ' A' ' 138' ' ' MET . 16.7 mmt180 -66.32 -31.64 72.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.606 0.241 . . . . 73.340000000000003 111.308 177.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -79.67 -35.76 38.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.942 0.401 . . . . 75.150000000000006 110.443 176.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -59.06 -44.06 91.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.851 -0.613 . . . . 73.519999999999996 111.529 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.498 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 7.9 pt-20 -72.82 -14.71 61.57 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.556 -0.458 . . . . 72.519999999999996 111.266 -178.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.88 -25.65 59.11 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.333 -0.618 . . . . 63.520000000000003 109.333 177.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.41 ' C ' HD12 ' A' ' 148' ' ' LEU . . . 137.03 -46.92 0.99 Allowed Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.668 -0.696 . . . . 52.43 112.439 176.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.41 HD12 ' C ' ' A' ' 147' ' ' GLY . 5.9 mp -132.94 152.56 51.9 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.12 -0.326 . . . . 73.230000000000004 110.12 -178.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.93 16.79 2.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.436 -0.347 . . . . 63.009999999999998 110.253 175.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 66.3 m80 68.75 97.92 0.06 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.328 -0.851 . . . . 73.400000000000006 110.454 -177.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -65.74 115.92 6.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.824 -0.625 . . . . 73.239999999999995 111.488 -174.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -125.7 -68.83 0.81 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.27 -1.011 . . . . 73.209999999999994 108.27 173.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -178.89 -37.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.325 -1.307 . . . . 75.209999999999994 108.38 178.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 69.15 123.04 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.099 0 CA-C-N 114.503 -1.226 . . . . 74.109999999999999 111.357 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 26.6 m170 . . . . . 0 C--O 1.245 0.859 0 N-CA-C 108.689 -0.856 . . . . 74.140000000000001 108.689 174.133 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.8 mtt . . . . . 0 N--CA 1.481 1.078 0 CA-C-O 121.17 0.509 . . . . 74.530000000000001 110.853 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 94.38 -0.63 66.06 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.438 -1.065 . . . . 53.399999999999999 110.438 -172.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.649 ' HG2' ' HD2' ' A' ' 112' ' ' PRO . 36.0 mt-10 -118.7 136.23 54.05 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.666 -0.865 . . . . 65.120000000000005 108.666 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.1 m -147.52 122.19 9.86 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.911 0.386 . . . . 71.049999999999997 110.783 -176.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.598 HG22 ' HA ' ' A' ' 109' ' ' THR . 41.0 t -101.88 97.25 5.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.556 -0.905 . . . . 53.439999999999998 108.556 174.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 107' ' ' ARG . 10.6 p -80.11 141.63 15.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.516 -0.766 . . . . 72.299999999999997 111.82 -168.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.575 ' HG2' ' HB2' ' A' ' 107' ' ' ARG . 2.8 tmm_? -134.74 116.61 15.07 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.368 -0.605 . . . . 74.140000000000001 109.368 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.506 ' HB3' HD23 ' A' ' 137' ' ' LEU . 4.8 t70 -144.71 173.05 12.17 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.709 -0.848 . . . . 72.349999999999994 108.709 173.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.766 ' HB2' HG13 ' A' ' 105' ' ' VAL . . . -134.47 126.59 29.75 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.133 0.492 . . . . 73.450000000000003 112.012 -171.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.481 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 36.0 m -121.66 134.23 65.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.793 -0.639 . . . . 64.540000000000006 109.956 176.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 t -110.08 123.38 49.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.688 0.756 . . . . 73.209999999999994 111.011 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.591 ' HB ' HD23 ' A' ' 19' ' ' LEU . 4.7 mp -118.71 151.04 20.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.768 -1.105 . . . . 70.230000000000004 109.712 -178.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.85 20.63 1.05 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 114.005 0.362 . . . . 52.409999999999997 114.005 -177.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.794 ' HG2' HD23 ' A' ' 148' ' ' LEU . 49.3 mtmt -89.95 144.07 30.93 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.197 -0.668 . . . . 72.120000000000005 109.197 173.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.45 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 95.0 Cg_exo -45.69 -57.96 1.89 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.977 2.451 . . . . 63.219999999999999 113.822 -174.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 15' ' ' PRO . . . 173.21 -58.24 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.578 0.704 . . . . 53.210000000000001 110.911 177.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -55.83 -36.75 67.82 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.456 -1.247 . . . . 70.319999999999993 112.247 -171.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.542 ' CG ' ' HD2' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -87.65 -5.33 58.76 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.132 -0.485 . . . . 60.549999999999997 111.853 -175.06 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.758 HD21 ' HE3' ' A' ' 14' ' ' LYS . 59.9 mt -68.56 -48.13 65.05 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.963 -0.295 . . . . 70.140000000000001 111.081 176.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.816 ' HB3' ' HZ ' ' A' ' 93' ' ' PHE . 1.1 p90 -73.15 -24.55 60.59 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.469 -0.493 . . . . 72.409999999999997 110.372 -177.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.56 -2.99 31.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.575 -0.738 . . . . 70.329999999999998 111.862 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.779 HG12 ' HZ ' ' A' ' 140' ' ' PHE . 14.8 p -54.2 -22.05 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 112.843 0.683 . . . . 64.219999999999999 112.843 -175.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 -68.48 -9.82 51.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.881 0.372 . . . . 75.209999999999994 111.11 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.821 ' HD3' ' HG3' ' A' ' 27' ' ' PRO . 47.1 ttt180 -137.04 179.27 6.48 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.61 -0.515 . . . . 73.129999999999995 109.61 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.801 ' H ' ' HG2' ' A' ' 24' ' ' ARG . 0.8 OUTLIER -63.39 12.58 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.072 1.349 . . . . 74.200000000000003 112.873 177.511 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.488 ' H ' ' C ' ' A' ' 24' ' ' ARG . 41.2 mt 65.43 86.09 0.14 Allowed Pre-proline 0 N--CA 1.467 0.38 0 CA-C-O 121.184 0.516 . . . . 60.299999999999997 109.628 -176.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.821 ' HG3' ' HD3' ' A' ' 24' ' ' ARG . 33.2 Cg_exo -58.87 115.5 2.6 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 123.71 2.94 . . . . 75.439999999999998 114.031 -169.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.617 ' C ' ' HD3' ' A' ' 30' ' ' PRO . . . -92.05 71.0 1.73 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.061 -0.815 . . . . 75.510000000000005 111.061 172.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.5 ' N ' ' HD3' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -120.83 60.83 8.81 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 112.252 0.464 . . . . 63.520000000000003 112.252 179.089 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.617 ' HD3' ' C ' ' A' ' 28' ' ' GLY . 9.9 Cg_endo -90.04 -163.79 0.14 Allowed 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.849 2.366 . . . . 71.540000000000006 109.991 173.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.0 mp 65.22 -79.0 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.279 0.362 . . . . 63.539999999999999 110.087 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.705 HD11 HD11 ' A' ' 42' ' ' LEU . 83.6 mt 58.07 80.56 0.17 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.434 0.902 . . . . 73.219999999999999 113.434 175.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 21.6 ttt -113.82 112.06 22.76 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 107.758 -1.201 . . . . 73.239999999999995 107.758 167.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 t -46.13 -48.0 17.36 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.77 0.669 . . . . 64.200000000000003 111.689 -174.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 66.06 2.45 2.28 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.253 0.464 . . . . 64.25 112.253 166.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.2 mp 65.4 11.9 7.71 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.226 0.611 . . . . 73.299999999999997 111.312 -177.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -169.34 161.15 9.85 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.341 -0.391 . . . . 63.229999999999997 110.285 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.7 m 61.8 -154.55 0.35 Allowed 'General case' 0 CA--C 1.531 0.228 0 O-C-N 123.644 0.59 . . . . 61.219999999999999 110.507 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 40' ' ' GLU . 57.5 t 75.32 137.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 121.578 0.704 . . . . 75.329999999999998 111.972 175.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.645 ' HG2' ' H ' ' A' ' 41' ' ' VAL . 17.8 tt0 -97.8 -164.31 1.13 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.23 -0.895 . . . . 54.229999999999997 108.868 177.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.645 ' H ' ' HG2' ' A' ' 40' ' ' GLU . 27.0 t -64.7 148.94 11.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 110.245 -0.28 . . . . 75.439999999999998 110.245 178.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.705 HD11 HD11 ' A' ' 32' ' ' LEU . 4.3 mm? -56.25 -59.26 5.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.495 0.664 . . . . 74.439999999999998 111.682 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.531 ' OD1' ' HB2' ' A' ' 45' ' ' LYS . 2.1 p30 -160.71 177.51 10.39 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.84 -1.073 . . . . 74.420000000000002 110.346 -174.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -77.44 15.18 0.81 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.953 -0.567 . . . . 75.040000000000006 110.797 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.661 ' HG2' HD21 ' A' ' 66' ' ' LEU . 28.6 mttt -85.91 -45.27 11.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.002 -0.545 . . . . 75.310000000000002 111.15 -177.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.05 167.78 21.87 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.268 -0.878 . . . . 61.32 110.2 -175.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.9 m -92.54 156.19 17.3 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.176 -0.465 . . . . 74.109999999999999 110.969 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 70.41 151.72 0.1 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.985 -0.552 . . . . 75.209999999999994 111.769 176.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.575 ' HA ' HD22 ' A' ' 42' ' ' LEU . 41.3 p90 -88.36 103.93 16.29 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.456 0.646 . . . . 74.239999999999995 109.876 171.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.489 ' HB ' ' HB3' ' A' ' 54' ' ' PRO . 2.8 p -108.15 -72.18 0.73 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.81 -0.632 . . . . 72.420000000000002 112.14 -176.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.5 m 47.77 -178.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.067 1.347 . . . . 71.040000000000006 113.804 -176.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 55.41 59.43 3.92 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.222 -0.899 . . . . 73.120000000000005 110.747 -177.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 49.66 74.72 0.76 Allowed Pre-proline 0 N--CA 1.467 0.38 0 CA-C-N 115.277 -0.874 . . . . 53.509999999999998 112.564 178.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.489 ' HB3' ' HB ' ' A' ' 50' ' ' THR . 86.0 Cg_endo -85.87 -178.29 2.85 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.5 2.133 . . . . 74.349999999999994 112.008 176.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.58 85.52 48.75 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.06 0.457 . . . . 70.150000000000006 110.978 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.542 ' HB3' ' HG2' ' A' ' 63' ' ' GLU . 4.3 Cg_exo -77.74 -45.64 0.14 Allowed 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.816 2.344 . . . . 64.040000000000006 112.245 178.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.501 HD12 ' N ' ' A' ' 58' ' ' GLY . 0.7 OUTLIER -112.48 -28.74 7.75 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.741 -0.663 . . . . 63.310000000000002 112.042 -173.614 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.501 ' N ' HD12 ' A' ' 57' ' ' LEU . . . -73.31 108.62 2.55 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.972 -0.632 . . . . 37.609999999999999 112.195 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 70.78 12.84 7.2 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 122.973 0.509 . . . . 64.299999999999997 110.778 177.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.7 t -131.62 -67.15 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.932 -0.576 . . . . 71.450000000000003 110.44 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.642 ' HA ' HD11 ' A' ' 80' ' ' LEU . 49.9 m 62.93 28.92 16.49 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.827 -0.624 . . . . 72.430000000000007 111.663 176.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -106.53 -15.66 14.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.393 0.616 . . . . 73.420000000000002 110.336 -177.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.542 ' HG2' ' HB3' ' A' ' 56' ' ' PRO . 10.4 tp10 -86.16 165.62 16.41 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.434 -0.803 . . . . 73.239999999999995 111.32 -172.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.05 129.73 38.89 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.181 -0.463 . . . . 73.099999999999994 109.881 173.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.22 135.73 51.32 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.736 0.303 . . . . 74.329999999999998 110.571 179.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.661 HD21 ' HG2' ' A' ' 45' ' ' LYS . 10.5 mp -104.63 127.28 52.33 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 120.253 -0.579 . . . . 72.030000000000001 109.597 174.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.3 t -95.46 -13.84 24.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.114 -0.494 . . . . 74.510000000000005 111.801 -172.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.557 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -123.32 128.04 49.36 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.944 -0.302 . . . . 75.319999999999993 110.782 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -137.91 84.83 2.06 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.895 -0.593 . . . . 73.540000000000006 110.443 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.506 ' HG3' ' HG2' ' A' ' 74' ' ' ARG . 6.6 mm-40 -107.18 141.68 23.44 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.361 -0.977 . . . . 75.010000000000005 108.361 173.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.46 93.82 0.59 Allowed 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.548 2.166 . . . . 72.120000000000005 112.376 -175.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 56.77 38.92 85.9 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.802 -0.635 . . . . 45.109999999999999 112.799 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -127.87 -46.37 1.41 Allowed 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.884 -0.326 . . . . 63.329999999999998 110.917 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.506 ' HG2' ' HG3' ' A' ' 70' ' ' GLU . 16.4 ptt-85 -159.91 147.64 16.8 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.48 -0.563 . . . . 75.430000000000007 109.48 173.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.658 HD13 ' HE2' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -147.34 120.54 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.411 0.624 . . . . 75.510000000000005 111.594 -179.498 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.693 ' HB1' ' HG3' ' A' ' 90' ' ' GLU . . . -120.21 120.13 35.26 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.918 -1.037 . . . . 62.009999999999998 109.942 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.452 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 49.5 p90 -99.35 144.33 28.59 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.027 -0.533 . . . . 75.25 110.282 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -136.25 175.85 9.23 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.641 -0.874 . . . . 71.409999999999997 108.641 176.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.0 m -133.02 152.1 52.0 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.603 -0.517 . . . . 52.100000000000001 109.603 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.642 HD11 ' HA ' ' A' ' 61' ' ' SER . 62.9 mt -67.94 156.82 88.62 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.239 -0.437 . . . . 74.349999999999994 110.251 -178.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -56.82 -21.7 41.58 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.862 2.375 . . . . 61.229999999999997 113.337 -177.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.53 10.98 66.96 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.809 -0.71 . . . . 64.540000000000006 112.679 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.431 ' HB3' HG12 ' A' ' 85' ' ' ILE . . . -137.19 142.3 42.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.904 0.383 . . . . 37.609999999999999 111.105 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -118.96 41.81 2.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.584 0.707 . . . . 74.150000000000006 109.719 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.431 HG12 ' HB3' ' A' ' 83' ' ' ALA . 46.2 mm -77.75 118.26 24.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.131 -0.94 . . . . 74.530000000000001 111.525 -175.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 69.91 154.5 0.12 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.975 0.797 . . . . 75.409999999999997 112.34 171.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -72.35 135.91 46.01 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.88 -0.785 . . . . 70.310000000000002 108.88 174.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 26.2 m -94.95 145.02 25.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.291 0.567 . . . . 54.530000000000001 111.233 -174.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -174.62 -166.26 32.3 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.107 -0.952 . . . . 74.239999999999995 111.671 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.693 ' HG3' ' HB1' ' A' ' 76' ' ' ALA . 43.0 tt0 -145.44 136.81 25.04 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.292 -0.262 . . . . 73.310000000000002 110.292 -178.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.542 ' CG2' HG13 ' A' ' 75' ' ' ILE . 3.0 m -120.23 134.17 64.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 120.901 0.381 . . . . 73.409999999999997 110.714 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.469 ' HB2' ' CG2' ' A' ' 105' ' ' VAL . 9.7 mp -113.76 137.42 51.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.293 -0.412 . . . . 75.219999999999999 110.231 175.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.816 ' HZ ' ' HB3' ' A' ' 20' ' ' TYR . 76.7 m-85 -105.05 106.9 17.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.986 -0.552 . . . . 70.120000000000005 110.1 177.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -117.15 145.36 35.63 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.137 -0.483 . . . . 73.409999999999997 111.041 -176.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.69 135.98 59.7 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.585 2.19 . . . . 75.109999999999999 111.749 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.449 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . . . -105.03 143.38 26.6 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.627 -0.261 . . . . 61.439999999999998 111.011 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 96' ' ' ALA . 26.7 Cg_exo -64.06 150.24 88.76 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 123.306 2.671 . . . . 75.219999999999999 112.477 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.84 10.74 86.02 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.081 -0.581 . . . . 70.530000000000001 112.117 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 57.4 35.27 25.77 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 122.889 0.475 . . . . 70.049999999999997 111.449 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -58.66 -38.4 78.06 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.092 0.472 . . . . 64.510000000000005 110.736 176.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 149.38 -119.9 1.1 Allowed Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.812 -0.915 . . . . 61.539999999999999 110.812 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 92.4 m -129.0 127.93 42.64 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.989 0.423 . . . . 74.439999999999998 110.386 175.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -84.12 114.48 21.8 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.602 -0.726 . . . . 74.019999999999996 110.235 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.1 p -99.05 115.73 40.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.164 0.507 . . . . 70.319999999999993 110.661 177.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.766 HG13 ' HB2' ' A' ' 9' ' ' ALA . 21.7 m -86.81 110.68 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-O 121.444 0.64 . . . . 74.349999999999994 109.382 174.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 46.5 t -100.61 125.18 54.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.626 -0.715 . . . . 73.340000000000003 110.343 -176.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.575 ' HB2' ' HG2' ' A' ' 7' ' ' ARG . 26.9 ttt180 -137.03 113.08 9.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.235 -0.438 . . . . 74.109999999999999 111.201 174.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.0 mp -116.01 140.93 48.77 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.706 -0.679 . . . . 73.329999999999998 109.885 175.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.598 ' HA ' HG22 ' A' ' 5' ' ' VAL . 86.7 m -84.25 120.09 25.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.163 -0.471 . . . . 73.030000000000001 110.237 178.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -120.77 133.67 55.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.009 -0.541 . . . . 75.329999999999998 109.662 -178.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.2 ptt180 -162.64 145.48 8.55 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 116.004 -0.543 . . . . 75.430000000000007 109.866 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.649 ' HD2' ' HG2' ' A' ' 3' ' ' GLU . 57.1 Cg_endo -72.42 154.42 55.71 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.465 2.11 . . . . 63.329999999999998 112.108 179.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -82.09 -166.15 0.38 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.776 2.317 . . . . 63.310000000000002 112.128 177.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.07 73.9 2.56 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.012 -0.613 . . . . 54.229999999999997 112.023 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -134.96 81.77 0.3 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.097 -0.573 . . . . 61.530000000000001 111.777 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.1 m -59.64 -40.06 86.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.846 0.355 . . . . 65.329999999999998 111.327 -176.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.514 ' O ' HG12 ' A' ' 121' ' ' ILE . . . -72.92 -24.82 60.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.316 -0.402 . . . . 74.209999999999994 111.506 -178.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.14 -28.72 73.82 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.921 -0.657 . . . . 71.150000000000006 112.637 -177.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.41 -43.27 81.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.357 . . . . 63.119999999999997 111.478 -178.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.431 HG12 ' O ' ' A' ' 117' ' ' ALA . 9.1 p -73.47 -20.49 18.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.834 0.35 . . . . 71.239999999999995 111.032 -176.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.514 HG12 ' O ' ' A' ' 117' ' ' ALA . 49.6 mm -63.39 -56.87 14.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.647 -0.251 . . . . 75.150000000000006 110.652 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.48 -31.07 72.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.153 0.502 . . . . 74.549999999999997 110.605 178.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -66.96 -31.04 71.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.415 -0.812 . . . . 73.230000000000004 110.689 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 17.9 tpt -66.36 -40.7 89.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.816 -0.629 . . . . 75.549999999999997 110.921 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -67.47 -60.97 2.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.411 -0.359 . . . . 73.530000000000001 110.635 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.0 t30 68.72 -2.01 1.82 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.927 -0.579 . . . . 74.439999999999998 111.968 175.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -56.49 -55.43 33.8 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.571 -0.529 . . . . 74.349999999999994 109.571 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -130.9 143.27 48.71 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.599 -0.728 . . . . 74.209999999999994 109.156 170.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.42 -4.56 13.73 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.88 2.387 . . . . 74.329999999999998 112.101 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.8 t 63.32 86.62 0.12 Allowed 'General case' 0 C--O 1.232 0.133 0 O-C-N 123.885 0.741 . . . . 65.349999999999994 109.497 -174.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -126.77 110.43 13.1 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.871 -0.604 . . . . 74.150000000000006 111.776 -172.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -97.15 138.5 34.56 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.766 -0.827 . . . . 74.340000000000003 108.766 169.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.1 mp -130.67 -173.04 2.96 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.376 0.608 . . . . 64.099999999999994 111.576 -172.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 134' ' ' ARG . 8.6 mtp180 -62.68 -22.53 66.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.314 -0.857 . . . . 63.030000000000001 110.742 175.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 17.3 t70 -57.22 -38.8 74.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.92 -0.582 . . . . 74.409999999999997 110.082 177.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -62.48 -43.54 98.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.483 -0.781 . . . . 53.310000000000002 111.049 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.506 HD23 ' HB3' ' A' ' 8' ' ' ASP . 22.2 tp -75.3 -27.02 59.15 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.661 -0.496 . . . . 73.420000000000002 109.661 -178.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.656 ' HA ' ' HE2' ' A' ' 138' ' ' MET . 0.0 OUTLIER -64.41 -47.08 80.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.862 -0.608 . . . . 74.230000000000004 109.829 175.916 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 135' ' ' ASP . 81.6 mtp180 -61.91 -40.82 96.79 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.611 -0.722 . . . . 75.239999999999995 109.683 175.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.779 ' HZ ' HG12 ' A' ' 22' ' ' VAL . 89.8 t80 -56.55 -40.86 75.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.204 -0.907 . . . . 74.109999999999999 111.232 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.568 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 24.2 ttpp -65.23 -52.22 55.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.345 -0.389 . . . . 74.450000000000003 110.06 176.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -53.62 -44.94 69.91 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.458 -0.792 . . . . 75.209999999999994 111.321 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -62.81 -39.4 94.15 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.641 -0.254 . . . . 74.209999999999994 111.571 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.559 ' HB2' HG12 ' A' ' 12' ' ' ILE . 30.6 mt-30 -70.19 -47.27 62.25 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.958 -0.297 . . . . 74.409999999999997 111.504 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.568 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 11.0 pt-20 -76.45 -13.81 60.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.033 0.444 . . . . 61.439999999999998 111.231 -176.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -83.25 -43.51 15.99 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.791 -0.818 . . . . 53.109999999999999 108.791 172.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -69.94 -42.43 69.13 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.604 -0.726 . . . . 71.239999999999995 112.898 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.794 HD23 ' HG2' ' A' ' 14' ' ' LYS . 4.8 tt -147.92 109.08 4.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.593 0.711 . . . . 74.040000000000006 110.46 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -120.86 10.59 10.92 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.77 -1.104 . . . . 73.25 109.275 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.573 ' H ' HD22 ' A' ' 148' ' ' LEU . 71.9 t60 70.73 -82.5 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 114.59 -1.186 . . . . 63.039999999999999 109.194 -172.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -145.4 164.24 32.12 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.898 -0.778 . . . . 73.140000000000001 108.898 172.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -64.02 123.84 20.04 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.443 0.64 . . . . 73.430000000000007 111.197 -173.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -88.33 -53.99 4.41 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.146 -0.934 . . . . 74.319999999999993 108.763 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 172.34 -19.68 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.377 -1.283 . . . . 73.310000000000002 108.446 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 . . . . . 0 C--O 1.246 0.875 0 CA-C-N 114.587 -1.188 . . . . 73.530000000000001 108.541 173.065 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.708 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 4.4 p . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 121.929 0.871 . . . . 72.32 109.828 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.3 t -92.05 134.35 30.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.336 -0.847 . . . . 43.4 110.544 -176.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.645 ' HD2' ' O ' ' A' ' 7' ' ' ARG . 7.4 ppt_? -115.65 112.1 21.61 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.277 0.56 . . . . 73.31 110.261 175.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.435 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 31.3 t0 -157.48 172.52 18.42 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.002 -0.74 . . . . 65.25 109.002 177.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.649 ' HB2' HG12 ' A' ' 105' ' ' VAL . . . -138.39 132.27 31.18 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.733 0.301 . . . . 75.13 111.359 -176.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.467 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 23.8 m -110.76 145.95 16.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.194 -0.457 . . . . 70.14 110.581 178.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 97.4 m -109.71 118.78 37.45 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.053 -0.521 . . . . 52.11 111.031 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.762 HG21 ' HG3' ' A' ' 144' ' ' GLN . 5.0 mp -127.04 150.16 32.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.829 -0.623 . . . . 61.43 109.37 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.33 54.2 3.57 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.775 -0.726 . . . . 61.12 113.106 -178.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.587 ' HD3' ' HB2' ' A' ' 18' ' ' GLN . 50.9 mttp -131.67 144.4 53.15 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 108.849 -0.797 . . . . 71.11 108.849 174.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.59 -56.9 2.08 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.759 2.306 . . . . 62.52 113.803 -171.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.471 ' HA ' HD12 ' A' ' 19' ' ' LEU . . . 174.01 -47.48 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.649 0.738 . . . . 75.3 109.175 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -48.76 -47.15 41.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.081 -1.418 . . . . 72.14 111.952 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.587 ' HB2' ' HD3' ' A' ' 14' ' ' LYS . 67.5 mt-30 -83.39 -10.93 58.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.874 0.369 . . . . 65.03 111.119 -174.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' A' ' 16' ' ' ALA . 95.4 mt -77.57 -48.49 16.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.52 -0.309 . . . . 71.35 110.543 -178.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.675 ' HB3' ' HZ ' ' A' ' 93' ' ' PHE . 16.8 p90 -73.67 -23.85 59.89 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.107 -0.637 . . . . 71.45 109.483 175.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.522 ' HB3' ' HA ' ' A' ' 18' ' ' GLN . . . -73.18 -1.79 19.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.212 -0.904 . . . . 63.25 111.791 177.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.615 HG11 ' HZ ' ' A' ' 140' ' ' PHE . 12.1 p -54.06 -22.89 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 122.666 0.386 . . . . 73.02 111.681 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -75.17 -8.22 55.99 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.092 0.472 . . . . 73.15 110.955 178.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.516 ' HE ' ' HA ' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -115.83 -174.5 2.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.676 -0.693 . . . . 54.15 110.032 178.568 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.13 33.9 1.31 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.698 -0.683 . . . . 62.41 109.225 177.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.452 HD22 ' HB3' ' A' ' 18' ' ' GLN . 75.7 mt 55.26 85.25 0.19 Allowed Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 115.208 -0.905 . . . . 63.32 110.375 -173.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo . . . . . 0 C--N 1.345 0.394 0 C-N-CA 123.11 2.54 . . . . 70.45 113.508 -173.898 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.346 0 CA-C-O 121.446 0.641 . . . . 73.24 112.493 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 19.6 tt0 -129.37 160.51 32.83 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.74 -1.118 . . . . 72.1 109.162 176.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.587 ' CD1' ' HA ' ' A' ' 77' ' ' TRP . 4.1 mm? -108.92 116.49 32.1 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.832 -0.803 . . . . 72.02 108.832 170.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.6 t -78.04 -16.65 57.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.06 -0.518 . . . . 75.21 112.174 -168.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.654 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -143.32 130.05 20.34 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 121.012 -0.275 . . . . 65.14 110.464 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.564 ' HA ' HG13 ' A' ' 75' ' ' ILE . 18.7 t70 -145.03 113.36 6.59 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.117 -0.492 . . . . 74.14 110.127 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.41 ' O ' HD11 ' A' ' 75' ' ' ILE . 78.8 mm-40 -130.33 144.92 55.22 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.625 -0.509 . . . . 71.22 109.625 176.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -52.67 -34.14 62.53 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.175 2.584 . . . . 73.32 113.009 -177.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -168.74 55.67 0.21 Allowed Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.868 -0.682 . . . . 45.14 111.994 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -127.87 -77.39 0.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.201 -0.296 . . . . 74.11 110.201 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 18.1 ptp180 -157.43 138.91 13.84 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.14 -0.482 . . . . 75.05 110.123 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.721 HD13 ' HE2' ' A' ' 93' ' ' PHE . 3.1 mp -129.57 122.06 54.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.196 -0.456 . . . . 73.42 109.966 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.654 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -111.34 130.41 55.69 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.939 -0.393 . . . . 65.3 109.939 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.587 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 4.6 p90 -85.31 153.65 22.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.568 0.699 . . . . 74.34 111.759 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.877 ' HG3' ' H ' ' A' ' 80' ' ' LEU . 4.1 tpp180 -144.32 172.82 12.4 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.707 -1.133 . . . . 63.24 108.686 -174.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.651 ' N ' ' HG3' ' A' ' 78' ' ' ARG . 59.0 m -145.64 24.84 1.36 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.755 -0.461 . . . . 51.41 109.755 174.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.877 ' H ' ' HG3' ' A' ' 78' ' ' ARG . 73.3 mt 63.96 149.64 0.11 Allowed Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 115.268 -0.878 . . . . 71.14 112.738 174.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -64.5 -8.22 16.54 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 122.345 2.03 . . . . 73.21 112.492 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -76.38 -57.22 4.0 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.854 -0.688 . . . . 73.12 111.865 175.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.75 -26.59 29.55 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.595 0.22 . . . . 71.13 111.595 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 63.31 103.92 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.361 0.664 . . . . 74.33 111.149 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.506 ' HB ' ' HB2' ' A' ' 79' ' ' SER . 17.1 tt -70.08 129.23 34.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.402 0.62 . . . . 52.5 111.184 -178.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -82.09 -29.17 31.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.476 -0.784 . . . . 73.23 110.015 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -88.73 168.27 12.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.593 -0.73 . . . . 74.15 110.562 -175.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.6 m -155.24 135.35 13.03 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.299 -0.26 . . . . 73.23 110.299 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.34 127.81 0.97 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.605 -0.807 . . . . 71.43 112.599 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 44.7 tt0 -115.37 118.52 33.46 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.612 -0.514 . . . . 71.34 109.612 176.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.623 HG12 HG12 ' A' ' 106' ' ' VAL . 3.8 m -87.15 130.38 37.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.873 0.368 . . . . 71.43 110.522 -177.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.657 ' HB2' HG23 ' A' ' 105' ' ' VAL . 9.5 mp -110.52 147.38 34.27 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.008 -0.367 . . . . 73.12 110.008 176.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.721 ' HE2' HD13 ' A' ' 75' ' ' ILE . 79.8 m-85 -117.61 132.01 56.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.831 0.348 . . . . 70.24 111.268 -177.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -141.86 145.15 35.38 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.94 -0.573 . . . . 74.53 109.902 173.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -58.01 127.62 25.73 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.474 2.116 . . . . 72.51 111.559 176.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.47 144.14 86.13 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.283 -0.417 . . . . 63.15 111.7 -174.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -58.45 138.39 85.54 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.911 2.408 . . . . 60.11 111.999 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.08 12.71 84.39 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.899 -0.667 . . . . 72.5 111.769 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 58.62 37.01 25.37 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 121.059 0.457 . . . . 63.35 111.051 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -78.95 1.14 24.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 55.14 111.411 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 129.7 -138.48 10.26 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.281 -0.728 . . . . 70.23 111.281 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 47.4 m -121.92 132.81 54.75 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.951 0.405 . . . . 74.4 110.23 176.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.52 ' HG2' ' HB1' ' A' ' 9' ' ' ALA . 42.5 tt0 -100.85 117.54 35.12 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.827 -0.624 . . . . 65.42 110.023 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.582 HG22 HG13 ' A' ' 106' ' ' VAL . 2.7 p -93.88 106.91 18.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.315 0.578 . . . . 73.15 110.757 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.657 HG23 ' HB2' ' A' ' 92' ' ' LEU . 10.8 m -88.23 114.24 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.759 -0.655 . . . . 72.3 110.343 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.623 HG12 HG12 ' A' ' 91' ' ' VAL . 27.2 m -124.15 134.97 65.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.404 0.621 . . . . 72.11 111.884 -175.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.523 ' HG3' ' HB3' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -118.32 97.89 6.0 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.821 -1.177 . . . . 72.45 107.821 170.089 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.526 ' H ' HD23 ' A' ' 108' ' ' LEU . 2.7 pt? -132.41 144.91 50.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.033 0.444 . . . . 64.25 110.792 -173.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.708 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 8.3 t -97.99 138.54 35.16 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.84 -0.618 . . . . 74.2 109.336 174.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 44.5 p90 . . . . . 0 C--N 1.318 -0.788 0 CA-C-N 116.491 -0.322 . . . . 73.52 110.434 -177.857 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.611 -0.196 . . . . 64.23 112.611 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.5 m -73.41 -22.31 60.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.923 0.392 . . . . 54.33 111.185 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.468 ' HA ' HG22 ' A' ' 120' ' ' VAL . . . -61.76 -22.79 65.71 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.219 -0.446 . . . . 74.53 111.571 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.87 -21.52 65.54 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.106 -0.569 . . . . 44.43 112.513 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -86.49 -44.68 11.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.928 0.394 . . . . 75.0 111.483 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 117' ' ' ALA . 27.6 m -67.7 -17.61 22.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.297 0.48 . . . . 74.15 112.297 -172.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.519 HD13 ' O ' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -61.9 -28.61 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 120.978 0.418 . . . . 74.32 110.35 178.257 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.74 -18.59 63.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.329 -0.396 . . . . 73.24 111.678 -177.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 57.7 ttp85 -65.88 -16.0 63.44 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.624 0.249 . . . . 73.34 111.311 -176.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.8 ttm . . . . . 0 C--O 1.234 0.279 0 CA-C-O 120.961 0.41 . . . . 75.11 109.988 176.714 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.406 ' O ' ' HG2' ' A' ' 138' ' ' MET . 2.4 ptm180 . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 112.516 0.562 . . . . 74.42 112.516 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -49.12 -52.08 28.22 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.258 0.623 . . . . 74.32 111.954 -173.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.475 ' O ' ' HG2' ' A' ' 139' ' ' ARG . 33.8 t70 -61.99 -39.01 90.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.569 -0.741 . . . . 74.25 112.192 -174.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.467 ' HG ' ' CG1' ' A' ' 10' ' ' VAL . 14.3 tp -80.34 -20.28 44.56 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.857 0.36 . . . . 70.53 110.899 -176.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.521 ' HA ' ' CE ' ' A' ' 138' ' ' MET . 22.4 mmt -65.78 -41.73 91.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.775 0.287 . . . . 61.12 111.775 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.475 ' HG2' ' O ' ' A' ' 136' ' ' ASP . 15.9 ptt180 -62.67 -31.21 72.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.832 0.349 . . . . 63.45 110.359 178.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.615 ' HZ ' HG11 ' A' ' 22' ' ' VAL . 92.2 t80 -64.58 -45.87 85.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.897 -0.592 . . . . 71.55 110.311 178.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.44 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 23.3 ttpp -57.1 -47.65 80.54 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.15 -0.477 . . . . 63.3 110.036 176.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 28.4 ttp180 -53.82 -45.77 70.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.052 -0.976 . . . . 71.22 111.816 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -77.79 -28.45 50.45 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.233 -0.439 . . . . 75.05 111.514 -175.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.762 ' HG3' HG21 ' A' ' 12' ' ' ILE . 4.9 tp-100 -71.31 -44.66 64.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.621 0.248 . . . . 73.32 110.502 175.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 11.1 pt-20 -71.64 -23.3 61.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.848 0.356 . . . . 72.41 110.764 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 1.0 OUTLIER -76.8 -47.79 20.52 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.557 -0.534 . . . . 73.51 109.557 178.189 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.484 0 CA-C-N 115.776 -0.647 . . . . 52.13 112.606 -179.673 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.617 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 11.1 p . . . . . 0 N--CA 1.449 -0.506 0 CA-C-O 120.906 0.384 . . . . 72.34 110.378 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.0 t -95.75 116.44 37.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.294 -0.632 . . . . 75.14 109.294 174.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 59.9 ttt180 -125.77 108.38 11.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.08 0.467 . . . . 72.34 110.078 174.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -143.73 159.14 43.03 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.13 -1.063 . . . . 74.3 108.13 176.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.487 ' HB1' ' HG2' ' A' ' 103' ' ' GLU . . . -141.18 121.13 13.62 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.931 0.396 . . . . 73.54 110.642 -174.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.632 ' HB ' ' HB2' ' A' ' 141' ' ' LYS . 10.5 m -108.32 136.58 43.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.442 0.639 . . . . 54.04 111.714 -176.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.14 109.92 22.19 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.227 -0.897 . . . . 65.3 111.239 -177.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.875 HG23 ' HG3' ' A' ' 145' ' ' GLU . 4.8 mp -125.26 149.4 29.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.789 -0.819 . . . . 72.14 108.789 176.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.88 57.51 2.65 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 121.114 -0.565 . . . . 55.32 113.226 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.657 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 10.9 mmpt? -118.15 154.52 51.75 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 108.803 -0.814 . . . . 72.12 108.803 176.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -58.98 -57.66 0.9 Allowed 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.327 2.018 . . . . 72.44 113.026 -177.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.557 ' O ' ' HB2' ' A' ' 19' ' ' LEU . . . -178.26 -72.91 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.224 0.453 . . . . 61.44 112.224 178.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -66.36 -31.12 71.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.711 0.291 . . . . 74.23 111.174 -173.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -56.67 -32.28 65.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.424 -0.353 . . . . 74.02 110.552 175.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.557 ' HB2' ' O ' ' A' ' 16' ' ' ALA . 65.4 mt -62.89 -41.63 99.49 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.88 -0.6 . . . . 74.13 110.444 176.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.742 ' HB2' ' HZ ' ' A' ' 93' ' ' PHE . 77.9 t80 -73.07 -36.36 66.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.734 -0.666 . . . . 71.21 110.766 178.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.23 -3.61 30.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.683 -0.69 . . . . 75.21 112.188 -175.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.765 HG11 ' HZ ' ' A' ' 140' ' ' PHE . 9.0 p -53.69 -21.46 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 123.213 0.605 . . . . 72.32 112.242 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.8 t-105 -52.94 -37.25 60.74 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.445 0.64 . . . . 74.44 109.764 176.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.579 ' HD3' ' N ' ' A' ' 25' ' ' ASP . 4.0 tmt_? -109.59 159.76 16.83 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.866 -1.161 . . . . 72.24 107.866 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.579 ' N ' ' HD3' ' A' ' 24' ' ' ARG . 26.1 t70 -66.83 67.17 0.06 Allowed 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.497 0.554 . . . . 74.0 112.497 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 41.86 79.3 0.33 Allowed Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 124.168 0.987 . . . . 65.13 112.78 169.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.522 ' HA ' ' NH1' ' A' ' 24' ' ' ARG . 31.6 Cg_exo . . . . . 0 C--N 1.344 0.336 0 C-N-CA 122.445 2.097 . . . . 44.22 113.787 -172.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.97 0 N-CA-C 109.381 -0.6 . . . . 53.41 109.381 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.465 ' HB2' HD23 ' A' ' 80' ' ' LEU . 1.2 mm-40 -107.92 134.23 51.13 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 109.587 -0.523 . . . . 65.02 109.587 176.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.746 HD12 ' HA ' ' A' ' 77' ' ' TRP . 3.6 mm? -88.21 137.91 31.91 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.581 -0.526 . . . . 24.11 109.581 -178.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.9 t -73.93 -9.18 58.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.497 0.665 . . . . 45.04 110.048 -177.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.91 123.35 10.36 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.973 -1.012 . . . . 74.21 108.725 166.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -139.09 83.64 1.96 Allowed 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.738 -0.838 . . . . 75.44 108.738 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 73' ' ' LYS . 48.5 mt-10 -115.86 143.86 31.58 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 114.879 -1.055 . . . . 71.24 109.581 -176.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.81 94.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.031 2.487 . . . . 50.32 113.029 -174.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 61.82 26.36 66.94 Favored Glycine 0 CA--C 1.518 0.277 0 CA-C-N 115.657 -0.701 . . . . 61.23 113.446 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.747 ' HE2' ' HA ' ' A' ' 73' ' ' LYS . 9.7 mmpt? -104.66 -72.56 0.7 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.18 0.514 . . . . 70.14 110.193 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.414 HH21 ' CD ' ' A' ' 90' ' ' GLU . 7.0 ptm180 -149.91 137.66 20.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.758 -0.655 . . . . 71.41 109.642 176.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 67.1 mt -122.18 110.3 26.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.768 -0.651 . . . . 74.35 109.394 177.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.667 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . . . -104.23 127.44 51.86 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.847 -0.615 . . . . 72.44 109.574 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.746 ' HA ' HD12 ' A' ' 66' ' ' LEU . 59.2 t90 -79.93 143.71 33.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.702 0.763 . . . . 73.32 111.509 -169.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.532 ' HG3' ' H ' ' A' ' 79' ' ' SER . 0.0 OUTLIER -166.61 175.35 8.03 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.834 -1.076 . . . . 65.4 108.99 -175.296 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.532 ' H ' ' HG3' ' A' ' 78' ' ' ARG . 46.9 m -141.57 165.63 26.95 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.348 -0.982 . . . . 64.03 108.348 174.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.465 HD23 ' HB2' ' A' ' 65' ' ' GLU . 53.0 mt -60.57 150.76 73.53 Favored Pre-proline 0 C--N 1.326 -0.445 0 O-C-N 123.11 0.256 . . . . 63.43 110.729 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.31 -22.71 66.62 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 123.069 2.512 . . . . 71.14 112.82 -178.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.28 2.7 88.02 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.06 -0.591 . . . . 34.43 112.251 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -109.62 -168.89 1.38 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.715 0.293 . . . . 71.44 110.372 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -111.45 118.3 35.42 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.764 0.316 . . . . 65.11 110.553 -174.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.4 pt -110.19 129.73 64.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.032 0.444 . . . . 72.32 110.931 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -105.99 -85.48 0.49 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.138 -0.483 . . . . 64.02 111.906 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -96.03 166.48 11.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.935 0.397 . . . . 54.25 111.46 -171.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.7 t -103.81 139.02 39.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.031 -0.531 . . . . 73.14 109.875 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.612 ' HA3' ' HG ' ' A' ' 108' ' ' LEU . . . -158.69 129.12 2.19 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 121.038 -0.601 . . . . 32.41 112.113 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.667 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 45.5 tt0 -128.84 134.75 48.43 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.913 -0.403 . . . . 72.22 109.913 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 69.7 t -115.67 128.67 72.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.152 0.501 . . . . 62.32 111.144 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.612 ' HB2' ' HB ' ' A' ' 105' ' ' VAL . 6.8 mp -102.95 138.16 40.19 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.366 -0.834 . . . . 74.55 110.517 178.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.742 ' HZ ' ' HB2' ' A' ' 20' ' ' TYR . 89.2 m-85 -115.54 106.29 13.77 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.226 0.536 . . . . 72.21 109.695 175.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -124.26 144.5 45.8 Favored Pre-proline 0 C--N 1.317 -0.841 0 CA-C-N 116.138 -0.483 . . . . 52.31 110.61 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.26 125.98 19.58 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.639 2.226 . . . . 54.34 111.101 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.1 143.39 56.87 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.552 -0.295 . . . . 71.11 111.219 -175.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.527 ' O ' ' HG2' ' A' ' 100' ' ' ARG . 31.0 Cg_endo -65.37 156.5 63.0 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.775 2.316 . . . . 61.24 111.35 175.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 63.94 20.71 64.82 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.926 -0.654 . . . . 72.44 112.939 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 58.21 32.91 22.62 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.661 0.384 . . . . 63.21 112.006 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 97' ' ' PRO . 24.9 mmt180 -68.74 -18.98 64.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.862 0.363 . . . . 64.45 111.244 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 127.72 -133.12 7.72 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.305 -0.718 . . . . 73.31 111.305 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.2 m -118.65 132.85 56.18 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.518 -0.549 . . . . 60.43 109.518 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.487 ' HG2' ' HB1' ' A' ' 9' ' ' ALA . 40.1 tt0 -96.21 117.02 29.92 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.847 0.356 . . . . 54.3 110.535 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.48 HG23 ' CG1' ' A' ' 91' ' ' VAL . 1.7 p -88.33 103.97 14.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.818 0.818 . . . . 71.43 109.521 174.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.612 ' HB ' ' HB2' ' A' ' 92' ' ' LEU . 16.4 t -91.36 110.24 22.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.631 -1.168 . . . . 71.53 109.919 -175.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 47.7 t -100.74 117.77 46.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.232 -0.44 . . . . 40.15 111.217 -175.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -121.09 98.72 6.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.928 -0.578 . . . . 75.11 109.52 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.612 ' HG ' ' HA3' ' A' ' 89' ' ' GLY . 1.9 tt -138.83 137.3 36.48 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.84 -0.43 . . . . 73.21 109.84 -175.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 8.9 t -84.53 139.71 31.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.28 0.562 . . . . 65.13 111.254 -177.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 . . . . . 0 C--N 1.324 -0.528 0 CA-C-N 115.798 -0.637 . . . . 75.21 110.374 -178.684 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.658 0 CA-C-O 120.818 0.121 . . . . 60.22 112.856 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.3 m -62.04 -23.86 66.72 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.066 0.546 . . . . 62.11 111.925 -174.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.91 -43.02 76.93 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.304 -0.407 . . . . 73.12 111.801 -176.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -78.59 -19.83 72.78 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.575 -0.822 . . . . 52.44 112.34 -178.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.49 -38.73 23.46 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.736 -0.273 . . . . 71.31 111.712 -175.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.5 m -64.5 -25.56 38.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.615 0.598 . . . . 52.22 112.615 -174.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 14.4 tt -75.13 -21.84 16.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.922 0.392 . . . . 70.54 111.085 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.97 -18.81 64.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.366 -0.379 . . . . 53.11 111.876 -175.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 123' ' ' ARG . 23.7 ttt85 -79.17 -14.5 59.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.059 0.457 . . . . 74.44 110.919 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 49.1 ttm . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 116.238 -0.437 . . . . 72.24 110.322 179.176 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 23.5 mtp-105 . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 121.815 0.816 . . . . 73.13 113.049 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -69.7 -33.18 72.16 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.494 -1.23 . . . . 73.34 112.639 -173.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -56.51 -55.65 31.1 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.048 0.388 . . . . 72.32 112.048 -175.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 15.5 tp -81.08 -20.7 40.96 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.851 -0.34 . . . . 62.43 110.975 -175.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.8 ttp -54.34 -38.65 66.27 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.49 -0.323 . . . . 74.12 110.896 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 139' ' ' ARG . 0.8 OUTLIER -70.86 -32.71 69.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.793 0.33 . . . . 74.14 110.738 179.438 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.765 ' HZ ' HG11 ' A' ' 22' ' ' VAL . 90.3 t80 -60.34 -35.17 75.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 64.4 110.439 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.632 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 38.8 tttp -55.02 -49.5 71.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.771 -0.649 . . . . 71.53 110.194 173.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.639 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 34.4 mmt180 -71.67 -25.69 62.22 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.805 -0.634 . . . . 73.14 111.772 -175.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -63.48 -44.32 94.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.861 0.362 . . . . 64.3 111.054 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.714 ' HG2' HG21 ' A' ' 12' ' ' ILE . 8.3 tt0 -82.36 -44.36 16.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.068 -0.514 . . . . 73.21 111.038 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.875 ' HG3' HG23 ' A' ' 12' ' ' ILE . 2.5 tt0 -66.52 -20.21 65.97 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 116.203 -0.453 . . . . 74.25 111.994 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.639 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 21.3 tp -64.71 -40.95 96.23 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.538 -0.542 . . . . 73.34 109.538 175.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.517 0 CA-C-N 115.303 -0.862 . . . . 73.31 111.361 178.941 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.782 HG13 ' HA ' ' A' ' 109' ' ' THR . 51.0 t . . . . . 0 N--CA 1.447 -0.612 0 N-CA-C 109.083 -0.71 . . . . 65.05 109.083 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.7 t -80.79 115.54 23.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.977 0.418 . . . . 71.4 111.397 -171.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.487 ' HG3' ' CB ' ' A' ' 107' ' ' ARG . 9.0 mpt_? -107.14 108.09 19.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.537 -0.912 . . . . 73.5 108.537 168.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.509 ' HB3' HD22 ' A' ' 137' ' ' LEU . 2.5 t70 -147.99 173.31 13.02 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.516 -0.55 . . . . 74.2 109.516 178.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.844 ' HB2' HG12 ' A' ' 105' ' ' VAL . . . -138.56 154.35 48.73 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.045 0.45 . . . . 52.4 111.488 -171.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.459 ' HB ' ' HB2' ' A' ' 141' ' ' LYS . 12.8 m -132.55 141.07 46.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.838 -0.619 . . . . 72.01 109.987 174.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.442 HG21 ' HG3' ' A' ' 100' ' ' ARG . 25.2 m -106.38 118.32 36.34 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.156 -0.475 . . . . 74.12 111.259 -174.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.953 HG23 ' HB3' ' A' ' 145' ' ' GLU . 3.9 mp -123.19 141.94 41.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.845 -0.616 . . . . 64.25 109.716 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.26 52.02 4.24 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.843 -0.694 . . . . 74.02 112.455 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.471 ' HB2' HD21 ' A' ' 19' ' ' LEU . 94.8 mttt -131.22 144.24 52.68 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.066 -0.716 . . . . 75.11 109.066 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.75 -58.87 1.01 Allowed 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 122.688 2.259 . . . . 73.11 113.783 -169.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.406 ' HA ' HD12 ' A' ' 19' ' ' LEU . . . 173.56 -52.87 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.311 0.577 . . . . 63.14 110.462 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -57.09 -46.0 82.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.266 -0.879 . . . . 52.12 111.66 -175.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -68.57 -8.85 45.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.401 -0.363 . . . . 72.42 111.945 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.471 HD21 ' HB2' ' A' ' 14' ' ' LYS . 96.5 mt -80.55 -20.56 43.16 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 122.378 -0.201 . . . . 73.22 110.928 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -70.94 -29.4 65.42 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.458 0.647 . . . . 72.14 109.704 174.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.726 ' HB1' ' HD2' ' A' ' 27' ' ' PRO . . . -71.51 -4.72 28.3 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.54 -0.754 . . . . 43.35 112.073 -174.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.2 p -60.4 -24.2 30.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 71.01 111.245 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -55.72 -43.46 76.57 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 112.375 0.509 . . . . 73.35 112.375 -177.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 24' ' ' ARG . 28.4 ttt180 -105.53 -76.09 0.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.235 -0.586 . . . . 73.35 112.057 -174.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -147.78 2.96 0.72 Allowed 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 120.474 -0.49 . . . . 74.2 112.207 -168.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.76 HD11 ' HA ' ' A' ' 144' ' ' GLN . 51.6 mt 58.67 63.97 3.69 Favored Pre-proline 0 N--CA 1.47 0.539 0 CA-C-N 116.196 -0.456 . . . . 75.33 111.75 -175.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.726 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 83.5 Cg_endo . . . . . 0 N--CA 1.454 -0.826 0 C-N-CA 122.774 2.316 . . . . 64.33 112.76 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.511 0 CA-C-O 121.057 0.456 . . . . 54.15 111.088 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -117.8 136.73 53.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.928 -0.578 . . . . 75.25 109.78 174.031 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.673 ' HG ' ' HA ' ' A' ' 77' ' ' TRP . 6.8 mp -91.37 128.38 37.17 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.73 0.3 . . . . 74.33 110.548 -178.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.782 ' HB ' ' HG3' ' A' ' 78' ' ' ARG . 12.9 t -70.55 -28.57 65.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 74.52 110.84 -173.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.11 131.46 17.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.895 -0.593 . . . . 50.21 109.793 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -141.5 91.88 2.42 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.037 0.446 . . . . 72.44 109.849 -178.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.608 ' HB2' ' H ' ' A' ' 74' ' ' ARG . 10.3 mm-40 -95.72 142.37 24.49 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 109.185 -0.672 . . . . 64.34 109.185 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.77 94.48 0.39 Allowed 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.417 2.078 . . . . 72.04 112.713 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.71 35.04 89.19 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.994 -0.622 . . . . 71.42 112.258 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.516 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 75.2 mmtt -127.05 -70.41 0.72 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.679 0.276 . . . . 70.11 110.332 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.608 ' H ' ' HB2' ' A' ' 70' ' ' GLU . 30.8 ptt-85 -150.58 132.35 15.0 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.737 -0.468 . . . . 75.24 109.737 176.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.579 ' HB ' HG13 ' A' ' 91' ' ' VAL . 3.9 mp -126.9 116.23 44.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.077 -0.511 . . . . 71.44 109.792 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -106.98 118.61 37.17 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.063 -0.517 . . . . 73.01 110.53 -178.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.673 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 36.2 m95 -87.07 145.58 26.41 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.841 -0.618 . . . . 62.3 111.238 -174.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.782 ' HG3' ' HB ' ' A' ' 67' ' ' THR . 19.0 mmm-85 -148.97 175.13 11.56 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.814 -0.63 . . . . 71.41 109.777 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.519 ' HB2' ' HB2' ' A' ' 86' ' ' GLU . 63.2 m -134.92 142.43 46.54 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.449 -0.945 . . . . 70.24 108.449 175.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 94.5 mt -67.0 153.12 95.15 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.579 -0.282 . . . . 55.53 110.931 -176.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -52.2 -16.78 5.13 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.953 3.102 . . . . 73.03 114.297 -173.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.85 -35.38 89.51 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.66 -0.781 . . . . 64.42 111.921 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.66 147.85 26.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.993 0.425 . . . . 72.14 111.093 -176.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.467 ' HD2' ' C ' ' A' ' 84' ' ' ARG . 6.0 ppt_? -115.44 -1.59 12.79 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.086 -0.507 . . . . 74.52 110.742 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.445 ' O ' HG13 ' A' ' 85' ' ' ILE . 10.1 tp -107.86 33.59 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.995 0.902 . . . . 60.33 110.247 -178.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 79' ' ' SER . 42.1 tt0 -64.24 122.01 15.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.664 -0.698 . . . . 73.5 110.555 177.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -103.59 140.56 37.37 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.355 -0.98 . . . . 71.43 108.355 174.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.1 m -94.77 126.19 39.93 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.19 0.519 . . . . 64.22 110.145 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 107' ' ' ARG . . . -159.0 146.39 12.95 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.304 -0.862 . . . . 62.34 111.443 -178.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -147.02 126.4 13.13 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 110.357 -0.238 . . . . 60.05 110.357 -176.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.656 HG23 HG23 ' A' ' 104' ' ' VAL . 2.5 p -108.6 121.68 62.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.055 0.455 . . . . 75.32 110.942 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.445 ' HB2' ' CG2' ' A' ' 105' ' ' VAL . 8.9 mp -108.96 139.82 43.3 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.736 -0.468 . . . . 73.24 109.736 174.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.513 ' HE2' HD13 ' A' ' 75' ' ' ILE . 93.9 m-85 -104.45 108.97 20.65 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.251 0.548 . . . . 72.54 110.073 178.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -126.73 144.88 51.46 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 115.461 -0.791 . . . . 72.54 110.046 -177.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.75 136.85 47.32 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.187 1.924 . . . . 42.21 111.551 176.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.524 ' CB ' ' HB3' ' A' ' 100' ' ' ARG . . . -77.63 146.99 74.13 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.185 -0.461 . . . . 75.12 110.011 178.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -37.78 108.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 124.111 3.208 . . . . 62.42 114.463 -172.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 90.04 -67.99 2.57 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 114.671 -1.149 . . . . 62.51 112.067 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -178.28 32.07 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.203 -0.498 . . . . 74.34 110.877 -174.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.524 ' HB3' ' CB ' ' A' ' 96' ' ' ALA . 21.8 tpp180 -74.2 -13.61 60.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.962 0.411 . . . . 74.22 110.802 -177.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 129.38 -157.53 21.76 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.962 -0.855 . . . . 32.32 110.962 -177.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 32.7 m -101.91 127.72 48.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.063 0.459 . . . . 73.01 109.815 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.422 ' CG ' ' HB1' ' A' ' 9' ' ' ALA . 44.2 tt0 -100.49 110.38 22.56 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.634 -0.712 . . . . 70.21 110.105 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.656 HG23 HG23 ' A' ' 91' ' ' VAL . 1.7 p -87.88 97.92 7.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.698 0.761 . . . . 71.14 109.364 175.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.844 HG12 ' HB2' ' A' ' 9' ' ' ALA . 22.7 m -84.43 110.79 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 115.059 -0.973 . . . . 71.11 109.802 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.7 p -112.67 123.89 68.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.797 -0.638 . . . . 64.14 110.878 -176.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.545 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 22.5 ptt180 -115.22 99.06 7.14 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.714 -0.676 . . . . 72.14 109.661 174.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 52.3 tp -120.46 141.98 49.67 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.021 -0.733 . . . . 71.33 109.021 -177.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.782 ' HA ' HG13 ' A' ' 5' ' ' VAL . 51.8 m -83.1 119.58 24.67 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.715 0.769 . . . . 53.25 111.922 -172.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 . . . . . 0 C--N 1.323 -0.554 0 CA-C-N 114.686 -1.143 . . . . 74.32 109.08 174.931 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.824 -0.111 . . . . 65.22 112.824 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.9 m -62.41 -29.08 70.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.891 0.377 . . . . 75.34 110.912 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.83 -30.58 65.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.072 -0.513 . . . . 45.21 110.866 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -73.88 -20.23 79.74 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.81 -0.632 . . . . 51.41 112.916 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.51 -19.82 27.24 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 112.262 0.468 . . . . 32.51 112.262 -177.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.426 ' O ' ' HG3' ' A' ' 124' ' ' MET . 13.8 p -60.13 -29.79 44.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 62.2 111.832 -177.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.7 pp -65.46 -32.69 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 C-N-CA 120.85 -0.34 . . . . 75.31 111.022 -177.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.94 -39.36 56.3 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.689 -0.486 . . . . 63.21 109.689 176.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -59.01 -28.33 66.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.378 -0.828 . . . . 74.35 111.6 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.426 ' HG3' ' O ' ' A' ' 120' ' ' VAL . 66.1 mtt . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 116.208 -0.451 . . . . 75.31 111.362 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 . . . . . 0 CA--C 1.532 0.26 0 CA-C-O 120.874 0.369 . . . . 73.12 111.103 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.449 ' O ' ' HG3' ' A' ' 138' ' ' MET . 18.1 t70 -65.55 -43.92 88.42 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.002 0.43 . . . . 74.4 110.601 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -74.54 -36.46 63.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.239 0.542 . . . . 75.01 110.319 174.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.509 HD22 ' HB3' ' A' ' 8' ' ' ASP . 1.3 mp -70.63 -29.76 66.21 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.618 0.599 . . . . 75.12 112.618 -174.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.449 ' HG3' ' O ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -64.2 -26.2 68.41 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.412 -0.515 . . . . 63.41 110.076 175.442 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 55.8 mtt180 -69.61 -48.93 58.36 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.496 -0.557 . . . . 75.55 109.496 174.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -56.29 -48.95 75.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.841 -1.072 . . . . 62.31 110.985 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.592 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 0.6 OUTLIER -63.49 -44.13 95.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.016 -0.538 . . . . 73.21 110.141 179.748 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 48.0 ttt180 -57.46 -50.61 72.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.063 -0.517 . . . . 74.22 111.076 -175.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -66.17 -27.47 68.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.073 0.463 . . . . 65.34 110.594 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.76 ' HA ' HD11 ' A' ' 26' ' ' LEU . 54.5 tt0 -77.49 -29.21 52.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.795 -0.639 . . . . 72.44 112.035 -174.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.953 ' HB3' HG23 ' A' ' 12' ' ' ILE . 2.2 pp20? -108.49 -13.4 14.85 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.265 0.468 . . . . 73.21 112.265 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 57.5 tp -62.08 -40.33 95.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.265 0.555 . . . . 74.31 109.612 175.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.71 0 C-N-CA 120.83 -0.7 . . . . 74.41 111.408 175.729 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.585 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 70.0 t . . . . . 0 N--CA 1.446 -0.675 0 N-CA-C 108.456 -0.942 . . . . 45.23 108.456 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.4 p -77.82 124.38 36.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.466 0.65 . . . . 73.03 110.44 -174.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.711 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -141.52 110.56 6.23 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.344 -0.844 . . . . 71.4 110.621 -179.889 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.506 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 14.3 t70 -146.21 171.38 15.03 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.036 -0.727 . . . . 64.11 109.036 175.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.68 ' HB2' HG12 ' A' ' 105' ' ' VAL . . . -139.72 120.69 14.57 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.939 0.4 . . . . 73.13 111.02 -174.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.1 m -115.09 143.44 24.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.985 -0.552 . . . . 74.44 110.163 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.544 HG21 ' HB2' ' A' ' 100' ' ' ARG . 42.6 m -103.79 111.87 24.57 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.967 -0.56 . . . . 71.4 110.322 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.642 HD13 ' HG2' ' A' ' 141' ' ' LYS . 9.4 mm -100.63 146.0 10.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.287 -0.415 . . . . 74.23 109.945 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.16 60.11 4.5 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.689 -0.767 . . . . 52.54 111.817 174.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.527 ' HB2' HD21 ' A' ' 19' ' ' LEU . 24.2 mmtm -141.19 145.25 37.85 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 109.764 -0.458 . . . . 62.1 109.764 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.41 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 72.9 Cg_exo -52.24 -57.68 1.98 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.157 2.572 . . . . 64.41 113.58 -175.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . 174.54 -46.66 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.932 0.396 . . . . 63.4 111.156 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -59.19 -45.43 91.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.075 -0.511 . . . . 74.54 110.866 -176.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.615 ' HA ' ' HB3' ' A' ' 21' ' ' ALA . 21.4 mp0 -66.64 -16.67 64.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.886 -0.597 . . . . 72.1 110.906 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.745 HD11 ' HB ' ' A' ' 102' ' ' THR . 74.5 mt -73.76 -45.5 51.45 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.36 -0.382 . . . . 74.14 110.256 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -74.28 -29.9 61.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.383 0.611 . . . . 73.34 109.896 174.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.615 ' HB3' ' HA ' ' A' ' 18' ' ' GLN . . . -70.34 -3.03 15.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.276 -0.874 . . . . 60.3 111.927 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.715 HG21 ' HD2' ' A' ' 140' ' ' PHE . 10.9 p -53.2 -21.21 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.096 0.558 . . . . 62.11 111.991 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 4.2 m95 -59.19 -26.15 64.57 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.796 0.332 . . . . 74.21 110.92 176.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -136.95 -164.67 1.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 74.21 110.168 -177.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.453 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 5.3 t70 -88.03 46.67 1.41 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.282 -0.417 . . . . 70.21 110.209 -176.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 25' ' ' ASP . 0.4 OUTLIER 43.14 84.87 0.18 Allowed Pre-proline 0 N--CA 1.476 0.86 0 C-N-CA 123.513 0.725 . . . . 71.11 111.965 -177.808 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 C--N 1.344 0.298 0 C-N-CA 122.983 2.455 . . . . 54.44 113.867 -173.276 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.655 0 N-CA-C 109.312 -0.625 . . . . 61.31 109.312 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.422 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 7.6 tt0 -108.83 134.61 51.29 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.964 -0.294 . . . . 52.35 110.533 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.015 HD12 ' HA ' ' A' ' 77' ' ' TRP . 2.2 mm? -83.95 137.32 33.69 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.356 -0.609 . . . . 70.35 109.356 174.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.564 HG23 ' HB2' ' A' ' 78' ' ' ARG . 20.8 p -67.67 -34.37 76.79 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.502 0.668 . . . . 72.33 110.546 -176.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -135.72 124.85 24.43 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.979 -1.009 . . . . 72.1 110.725 177.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -117.36 90.77 3.41 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.432 -0.804 . . . . 71.4 109.581 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.99 ' HB3' ' HB2' ' A' ' 73' ' ' LYS . 48.9 mt-10 -120.02 86.52 37.09 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.483 -0.781 . . . . 73.12 110.452 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -60.6 107.03 0.39 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.599 2.199 . . . . 72.31 111.82 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.409 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 99.09 6.16 55.94 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.896 -0.669 . . . . 53.35 111.827 -177.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.99 ' HB2' ' HB3' ' A' ' 70' ' ' GLU . 2.8 mmmp? -128.62 -66.38 0.84 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.586 0.231 . . . . 70.24 110.488 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 22.4 ptt180 -168.3 150.09 5.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.323 -0.399 . . . . 75.31 110.643 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.6 mp -124.98 114.29 39.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 116.195 -0.457 . . . . 74.04 109.793 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.579 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . . . -101.68 121.02 41.25 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.076 -0.511 . . . . 74.21 110.448 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 1.015 ' HA ' HD12 ' A' ' 66' ' ' LEU . 26.3 m0 -80.49 155.43 27.03 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.989 0.737 . . . . 72.22 112.989 -172.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.573 ' HG3' ' H ' ' A' ' 79' ' ' SER . 24.7 tpp180 -176.62 174.63 1.83 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 114.394 -1.275 . . . . 54.45 108.238 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.573 ' H ' ' HG3' ' A' ' 78' ' ' ARG . 24.6 m -148.75 145.81 27.78 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.001 -1.111 . . . . 70.42 108.001 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.2 mt -71.7 152.08 93.48 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.911 -0.404 . . . . 75.44 109.911 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -52.35 -23.3 18.11 Favored 'Trans proline' 0 N--CA 1.476 0.445 0 C-N-CA 123.315 2.677 . . . . 72.44 113.93 -175.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -78.53 -4.14 87.16 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.821 -0.704 . . . . 62.33 112.997 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.33 -170.74 2.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.919 0.39 . . . . 60.23 110.935 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.466 ' HB2' HD12 ' A' ' 85' ' ' ILE . 86.8 mtt180 -118.06 -38.42 3.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.052 -0.522 . . . . 70.01 112.095 -172.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.466 HD12 ' HB2' ' A' ' 84' ' ' ARG . 4.8 mp -121.5 122.84 68.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.928 -0.309 . . . . 63.53 110.722 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.468 ' HB3' ' HB2' ' A' ' 79' ' ' SER . 11.3 pt-20 -125.79 123.19 38.22 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.53 -0.544 . . . . 74.23 109.53 172.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -111.64 138.67 47.88 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.032 -0.729 . . . . 74.14 109.032 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.2 m -96.04 128.15 42.69 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.685 -0.487 . . . . 34.5 109.685 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.24 123.73 0.69 Allowed Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.74 -0.743 . . . . 60.01 111.896 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 0.5 OUTLIER -108.95 126.19 52.83 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.904 0.383 . . . . 75.12 110.297 178.419 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 4.4 m -97.81 126.68 50.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.463 -0.569 . . . . 52.32 109.463 176.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.485 ' HB2' ' CG2' ' A' ' 105' ' ' VAL . 9.5 mp -105.32 139.06 40.53 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.422 -0.354 . . . . 65.24 110.886 -177.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -99.57 105.64 17.54 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.456 -0.942 . . . . 62.54 108.456 172.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.4 mtp85 -112.68 150.25 42.43 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 115.288 -0.869 . . . . 64.42 111.1 -171.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -49.71 127.3 18.41 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.427 2.084 . . . . 71.22 111.204 172.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.37 150.85 85.23 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.881 -0.599 . . . . 51.23 111.762 -172.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.78 109.43 0.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.824 2.349 . . . . 71.44 112.089 175.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.8 -73.9 1.34 Allowed Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.175 -0.92 . . . . 63.24 111.483 177.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 174.31 24.57 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.273 0.631 . . . . 72.22 111.264 -175.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.544 ' HB2' HG21 ' A' ' 11' ' ' THR . 19.6 mtp180 -82.62 7.04 15.8 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.544 0.572 . . . . 53.3 112.544 -171.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 126.68 -113.14 1.71 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.49 -0.862 . . . . 44.32 111.78 177.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.745 ' HB ' HD11 ' A' ' 19' ' ' LEU . 15.7 m -141.17 140.6 34.07 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.841 0.353 . . . . 72.1 110.265 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -96.59 119.02 34.3 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.176 -0.466 . . . . 63.12 110.755 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 p -100.67 107.49 21.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.495 0.664 . . . . 62.12 110.258 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.68 HG12 ' HB2' ' A' ' 9' ' ' ALA . 18.8 m -95.45 118.69 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 115.37 -0.832 . . . . 74.22 110.046 178.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.711 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 18.6 m -112.2 127.92 69.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.837 -0.62 . . . . 72.02 110.584 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.479 ' HG3' ' HB3' ' A' ' 7' ' ' ARG . 10.1 ttp180 -137.67 100.38 4.19 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.054 -0.521 . . . . 74.24 109.857 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 pp -145.46 155.23 42.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.974 -0.557 . . . . 74.24 109.508 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 11.4 t -80.82 137.69 36.21 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.154 -0.618 . . . . 64.04 109.876 -176.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 30.8 t80 . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 108.069 -1.085 . . . . 73.4 108.069 -171.946 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.418 0 N-CA-C 112.417 -0.273 . . . . 52.32 112.417 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.6 m -85.26 -48.8 8.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.078 0.466 . . . . 71.31 110.585 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.495 ' O ' HG22 ' A' ' 120' ' ' VAL . . . -72.69 -39.61 66.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.926 -0.579 . . . . 63.11 111.431 -177.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.5 ' O ' HG22 ' A' ' 121' ' ' ILE . . . -67.01 -20.02 70.43 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 121.037 -0.601 . . . . 62.54 113.273 -177.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.17 -21.31 60.72 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.228 0.455 . . . . 61.33 112.228 -175.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 117' ' ' ALA . 10.7 m -77.12 -18.84 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.509 0.559 . . . . 54.11 112.509 -173.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.5 HG22 ' O ' ' A' ' 118' ' ' GLY . 16.1 tt -68.86 -28.98 41.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.893 -0.323 . . . . 70.44 111.061 -176.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.33 -27.49 68.53 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.779 -0.646 . . . . 72.42 111.953 -175.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 16.7 mtm180 -66.79 -42.59 85.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.091 0.472 . . . . 71.13 110.009 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 40.5 ttp . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 115.758 -0.656 . . . . 70.11 109.789 177.616 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 33.9 mtt-85 . . . . . 0 N--CA 1.463 0.177 0 N-CA-C 110.369 -0.234 . . . . 74.44 110.369 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -56.96 -56.5 20.85 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.77 0.285 . . . . 72.15 111.77 -173.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -76.56 -39.52 52.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.886 0.374 . . . . 75.33 110.156 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.564 ' CD1' ' HE1' ' A' ' 140' ' ' PHE . 0.3 OUTLIER -53.75 -51.0 64.78 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.667 -0.697 . . . . 55.02 111.589 -178.938 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.53 ' HA ' ' CE ' ' A' ' 138' ' ' MET . 0.6 OUTLIER -65.17 -38.18 89.71 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.429 -0.35 . . . . 72.21 111.001 -175.927 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.422 ' O ' ' HB3' ' A' ' 142' ' ' ARG . 34.2 mtm105 -65.68 -51.66 57.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.509 -0.314 . . . . 72.14 111.676 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.715 ' HD2' HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -73.57 -30.21 62.89 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 120.06 -0.656 . . . . 63.5 109.779 -175.123 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.642 ' HG2' HD13 ' A' ' 12' ' ' ILE . 13.5 tmtt? -55.44 -50.44 69.83 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.235 -0.654 . . . . 62.53 109.235 173.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.602 ' HE ' ' HG3' ' A' ' 143' ' ' GLU . 43.7 ttp180 -52.53 -54.93 26.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.514 -1.221 . . . . 73.42 111.674 177.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.602 ' HG3' ' HE ' ' A' ' 142' ' ' ARG . 30.6 mt-10 -72.97 -34.02 66.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.958 -0.565 . . . . 73.1 111.812 -174.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.619 ' OE1' ' HA ' ' A' ' 19' ' ' LEU . 9.0 tt0 -61.65 -44.46 96.92 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.299 0.481 . . . . 75.43 112.299 -174.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -85.73 -8.74 57.98 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.272 -0.571 . . . . 75.42 111.12 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 57.5 tp -84.21 -53.18 5.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.082 0.468 . . . . 43.52 109.869 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.688 0 N-CA-C 110.933 -0.867 . . . . 43.4 110.933 -178.647 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 82.4 t . . . . . 0 N--CA 1.45 -0.467 0 N-CA-C 109.801 -0.444 . . . . 73.31 109.801 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.5 t -93.72 116.52 35.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.826 -0.625 . . . . 72.21 110.314 -176.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.44 109.79 13.15 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.965 -0.754 . . . . 73.01 108.965 172.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.577 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 7.0 t70 -157.72 172.03 19.24 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.039 -1.097 . . . . 62.13 108.039 175.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.473 ' CB ' HG22 ' A' ' 105' ' ' VAL . . . -136.84 121.05 17.91 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.949 0.404 . . . . 74.22 111.486 -173.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.9 m -109.27 141.67 23.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.256 -0.646 . . . . 63.22 109.256 175.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 t -116.47 124.68 50.55 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.937 0.875 . . . . 74.1 110.99 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.76 HG23 ' HB3' ' A' ' 145' ' ' GLU . 4.7 mp -121.85 150.18 25.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.692 -1.14 . . . . 51.31 109.685 -176.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.9 37.99 0.76 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.509 -0.377 . . . . 71.41 113.582 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.557 ' HG2' HG22 ' A' ' 12' ' ' ILE . 74.3 mmtt -105.66 152.0 39.98 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 108.264 -1.013 . . . . 52.11 108.264 175.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.73 -57.85 1.37 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.151 1.9 . . . . 51.25 112.593 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 173.33 -54.1 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.404 0.621 . . . . 53.34 110.164 178.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.756 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 7.8 mt-10 -55.56 -39.32 70.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.82 -1.082 . . . . 63.12 111.814 -175.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.612 ' NE2' ' HB2' ' A' ' 17' ' ' GLU . 2.5 mp0 -73.43 -14.11 61.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.864 -0.607 . . . . 74.34 111.135 -175.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.3 mt -76.04 -44.07 40.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.592 -0.276 . . . . 64.11 111.064 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.756 ' CE2' ' HA ' ' A' ' 17' ' ' GLU . 21.1 p90 -73.75 -23.47 59.74 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 119.999 -0.68 . . . . 74.11 110.22 175.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.631 ' HB1' ' HD2' ' A' ' 27' ' ' PRO . . . -75.58 -2.64 30.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.5 -0.773 . . . . 71.21 111.74 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.45 HG11 ' HZ ' ' A' ' 140' ' ' PHE . 15.0 p -52.14 -31.55 14.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 112.144 0.424 . . . . 74.45 112.144 -177.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -67.7 -13.0 61.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.706 0.289 . . . . 75.55 111.449 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.767 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . 39.3 mmt180 -117.14 15.28 14.99 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.193 -0.458 . . . . 72.3 110.715 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.436 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 11.6 t70 61.5 37.57 16.4 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.864 0.84 . . . . 71.34 109.117 -175.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER 43.84 85.33 0.17 Allowed Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 114.967 -1.015 . . . . 73.43 111.726 -177.492 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.767 ' HD3' ' HB2' ' A' ' 24' ' ' ARG . 63.3 Cg_endo . . . . . 0 N--CA 1.461 -0.402 0 C-N-CA 122.617 2.211 . . . . 74.41 112.579 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.589 0 N-CA-C 109.5 -0.556 . . . . 61.12 109.5 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.827 ' HB2' HD23 ' A' ' 80' ' ' LEU . 5.5 tm-20 -108.05 135.21 49.8 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.356 -1.35 . . . . 51.21 107.356 177.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.719 HD21 ' HB2' ' A' ' 69' ' ' ASP . 29.3 tp -137.96 149.38 46.09 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.486 -0.486 . . . . 74.54 110.462 -171.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.9 t -119.11 -18.34 8.74 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.251 -0.58 . . . . 73.5 111.773 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -152.61 129.07 10.65 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 120.776 -0.37 . . . . 63.4 111.605 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.719 ' HB2' HD21 ' A' ' 66' ' ' LEU . 19.3 t70 -136.17 90.66 2.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.4 -0.818 . . . . 74.23 110.273 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 73' ' ' LYS . 31.4 mt-10 -139.38 142.82 33.6 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 110.067 -0.346 . . . . 65.21 110.067 177.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 16.5 Cg_exo -69.1 -55.06 0.21 Allowed 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.747 2.298 . . . . 63.12 113.061 -178.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.56 49.88 0.83 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.572 -0.823 . . . . 75.35 112.42 -176.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.568 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 7.7 mmmm -139.0 -74.48 0.38 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.026 0.441 . . . . 63.42 110.428 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.529 ' HB3' HD13 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -166.51 137.78 3.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.957 -0.565 . . . . 71.01 110.1 179.127 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.679 HD13 ' HE2' ' A' ' 93' ' ' PHE . 3.2 mp -109.44 110.11 30.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.901 -0.778 . . . . 72.21 108.901 173.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -119.2 115.19 23.69 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.438 -0.949 . . . . 23.34 108.438 176.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.695 ' HA ' HD12 ' A' ' 66' ' ' LEU . 63.0 p-90 -121.48 157.65 30.15 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.511 0.672 . . . . 65.35 111.544 -169.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.683 ' HD2' ' OE1' ' A' ' 65' ' ' GLU . 69.8 mtt180 -136.39 175.8 9.28 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 107.92 -1.141 . . . . 62.12 107.92 176.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.661 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 19.6 m -137.19 51.54 1.95 Allowed 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.678 -0.49 . . . . 61.31 109.678 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.827 HD23 ' HB2' ' A' ' 65' ' ' GLU . 13.0 mt 65.3 142.21 0.07 OUTLIER Pre-proline 0 N--CA 1.471 0.624 0 O-C-N 124.264 0.977 . . . . 64.11 111.014 -175.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 80' ' ' LEU . 22.4 Cg_exo -66.38 -35.33 31.57 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.461 2.107 . . . . 71.44 112.097 177.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.87 18.46 57.17 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.596 -0.811 . . . . 52.32 112.87 -177.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 79' ' ' SER . . . -118.14 -158.13 0.7 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 122.582 -0.363 . . . . 64.54 111.167 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -66.5 -66.07 0.6 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.642 0.608 . . . . 51.41 112.642 -168.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 50.2 mt 59.61 87.96 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.264 0.555 . . . . 74.24 110.547 -172.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -80.19 -46.25 16.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.98 -0.554 . . . . 63.05 110.952 -175.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.64 HD21 ' HB2' ' A' ' 108' ' ' LEU . 54.2 t30 -125.89 162.15 25.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.1 -0.5 . . . . 61.32 109.771 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.8 m -138.35 128.65 25.95 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.082 -0.34 . . . . 74.44 110.082 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.18 148.89 4.91 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.751 -0.737 . . . . 53.41 111.807 178.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.72 159.31 16.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.151 0.5 . . . . 72.22 111.369 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.9 p -110.89 128.05 67.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.667 -0.697 . . . . 64.33 110.492 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.529 HD13 ' HB3' ' A' ' 74' ' ' ARG . 3.9 mm? -100.25 126.88 46.6 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.499 -0.773 . . . . 74.51 110.357 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.679 ' HE2' HD13 ' A' ' 75' ' ' ILE . 85.7 m-85 -107.63 106.69 17.15 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.23 -0.656 . . . . 73.15 109.23 175.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.488 ' HD3' ' CG2' ' A' ' 105' ' ' VAL . 0.0 OUTLIER -129.93 144.9 54.92 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 116.152 -0.476 . . . . 74.15 110.763 -175.147 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -61.57 123.39 12.62 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.603 2.202 . . . . 62.41 111.377 175.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.7 144.03 93.23 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.287 -0.415 . . . . 71.15 110.247 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -43.25 115.31 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.584 2.856 . . . . 72.43 114.056 -176.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.15 -75.38 0.33 Allowed Glycine 0 N--CA 1.437 -1.268 0 CA-C-N 115.125 -0.943 . . . . 71.23 111.169 174.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 175.04 24.2 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.159 -0.521 . . . . 61.3 111.556 -175.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -67.87 -33.63 75.11 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.887 0.375 . . . . 64.14 111.505 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.02 -154.58 25.63 Favored Glycine 0 CA--C 1.506 -0.478 0 N-CA-C 111.33 -0.708 . . . . 62.55 111.33 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 91.6 m -106.79 117.83 35.08 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.252 0.549 . . . . 75.34 110.378 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.447 ' CG ' ' HB1' ' A' ' 9' ' ' ALA . 43.3 tt0 -78.86 115.85 18.81 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.125 -0.943 . . . . 72.21 110.408 178.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.4 p -94.01 103.95 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.708 0.766 . . . . 65.13 110.033 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.488 ' CG2' ' HD3' ' A' ' 94' ' ' ARG . 18.9 t -100.46 111.02 28.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 114.939 -1.028 . . . . 62.1 110.084 -177.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.472 HG12 HD22 ' A' ' 108' ' ' LEU . 10.9 t -120.14 132.33 70.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.031 0.443 . . . . 73.11 110.707 -178.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 107' ' ' ARG . 0.6 OUTLIER -118.13 103.31 9.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.833 -0.621 . . . . 75.55 109.843 175.214 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.64 ' HB2' HD21 ' A' ' 87' ' ' ASN . 2.3 pt? -150.68 155.25 38.96 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.449 -0.341 . . . . 53.33 111.058 -172.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 13.8 t -81.43 133.98 35.48 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.04 -1.096 . . . . 64.14 108.04 172.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 14.2 t80 . . . . . 0 N--CA 1.442 -0.857 0 N-CA-C 108.968 -0.753 . . . . 74.01 108.968 -167.374 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.804 0 N-CA-C 111.841 -0.504 . . . . 53.21 111.841 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 16.5 m -61.91 -22.19 65.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.857 0.36 . . . . 50.35 110.744 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.23 -22.14 66.67 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.077 -0.511 . . . . 53.45 110.813 175.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -60.36 -20.54 55.35 Favored Glycine 0 CA--C 1.519 0.307 0 CA-C-N 116.108 -0.496 . . . . 74.5 112.424 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.93 -20.33 66.18 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 122.68 -0.306 . . . . 63.04 111.041 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.49 ' O ' ' HG2' ' A' ' 123' ' ' ARG . 66.5 t -69.23 -47.63 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.791 0.329 . . . . 73.35 110.41 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.427 ' O ' ' HB3' ' A' ' 124' ' ' MET . 14.2 tt -75.32 -27.05 19.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.043 0.449 . . . . 71.12 110.182 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.87 -42.93 84.79 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.373 -0.376 . . . . 72.21 111.052 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 120' ' ' VAL . 13.3 ptp180 -74.51 -14.8 60.86 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.142 0.496 . . . . 71.05 110.393 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.427 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 26.2 ttt . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 115.609 -0.723 . . . . 60.43 110.002 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.937 0 CA-C-O 121.873 0.844 . . . . 52.43 109.447 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -48.06 -43.68 30.7 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 113.823 -1.535 . . . . 73.02 112.949 -173.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -73.34 -36.91 66.23 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.915 0.388 . . . . 71.34 111.048 -175.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.577 ' CD2' ' HB3' ' A' ' 8' ' ' ASP . 24.3 tp -77.05 -21.85 53.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.224 0.535 . . . . 72.41 109.729 -178.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.529 ' HA ' ' CE ' ' A' ' 138' ' ' MET . 0.1 OUTLIER -63.89 -35.2 79.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.914 -0.584 . . . . 75.53 109.442 175.386 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.675 ' O ' ' HG3' ' A' ' 142' ' ' ARG . 52.6 mtt180 -73.14 -32.56 64.97 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.664 -0.698 . . . . 52.35 110.023 177.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.45 ' HZ ' HG11 ' A' ' 22' ' ' VAL . 83.4 t80 -62.05 -34.29 75.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.707 -0.679 . . . . 63.33 110.046 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.456 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 21.0 ttpp -60.81 -53.02 62.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.41 . . . . 73.02 110.957 176.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.675 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 3.5 ptm180 -64.68 -29.31 70.3 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.585 0.587 . . . . 61.31 112.585 -174.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -79.57 -33.62 41.62 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.143 -0.623 . . . . 73.34 110.42 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.516 ' HB2' HG12 ' A' ' 12' ' ' ILE . 13.4 mm-40 -59.31 -43.92 92.59 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.29 0.566 . . . . 71.13 111.263 176.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.76 ' HB3' HG23 ' A' ' 12' ' ' ILE . 9.0 pt-20 -81.97 -3.44 54.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.718 -0.674 . . . . 53.12 111.48 -177.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 54.2 tp -112.76 -61.56 1.71 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.063 0.459 . . . . 54.2 111.306 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.72 0 N-CA-C 111.101 -0.8 . . . . 43.31 111.101 -173.721 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.534 HG13 ' HA ' ' A' ' 109' ' ' THR . 74.6 t . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 110.034 -0.358 . . . . 72.41 110.034 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.6 t -78.77 117.28 24.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.095 0.474 . . . . 72.32 111.159 -173.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -140.06 109.81 6.36 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.541 -0.754 . . . . 75.22 109.971 173.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.544 ' HB3' HD23 ' A' ' 137' ' ' LEU . 4.1 t70 -151.46 172.57 15.77 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.759 -1.2 . . . . 64.14 107.759 174.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.436 ' HB1' ' CG ' ' A' ' 103' ' ' GLU . . . -139.8 120.81 14.61 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.05 0.453 . . . . 64.35 111.205 -172.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.589 HG23 HD11 ' A' ' 12' ' ' ILE . 19.4 m -111.24 148.9 14.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.73 -0.668 . . . . 65.34 110.313 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.6 t -114.44 103.75 11.36 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.796 0.808 . . . . 55.43 110.781 175.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.82 HG21 ' HB3' ' A' ' 144' ' ' GLN . 1.1 mp -96.16 151.81 3.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.238 -0.892 . . . . 73.44 108.711 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.39 51.12 1.39 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.322 -0.466 . . . . 74.1 113.483 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.696 ' HB3' ' HB2' ' A' ' 18' ' ' GLN . 79.7 mttt -128.13 144.82 53.07 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 108.049 -1.093 . . . . 64.13 108.049 172.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -55.21 -57.74 1.51 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.32 2.013 . . . . 74.12 113.332 -174.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 173.32 -51.37 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.45 -0.945 . . . . 63.3 108.45 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.69 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 2.5 tt0 -48.76 -37.86 20.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 113.943 -1.48 . . . . 63.43 111.421 174.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.696 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 15.8 mm100 -85.84 -13.29 48.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.577 -0.738 . . . . 75.22 111.15 -176.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.698 HD22 HD13 ' A' ' 12' ' ' ILE . 91.7 mt -83.89 -53.21 5.75 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 112.079 0.4 . . . . 73.45 112.079 -177.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.69 ' CE2' ' HA ' ' A' ' 17' ' ' GLU . 32.7 p90 -66.96 -23.29 65.94 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.193 0.521 . . . . 44.14 111.06 -175.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.1 -3.01 30.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.771 -0.65 . . . . 71.34 111.661 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.573 ' HA ' ' HA ' ' A' ' 25' ' ' ASP . 13.5 p -52.64 -22.28 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 113.162 0.801 . . . . 71.41 113.162 -175.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -56.51 -32.32 64.93 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.138 0.494 . . . . 73.13 110.35 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -116.71 6.05 13.24 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.099 -0.704 . . . . 75.25 109.099 175.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.573 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 31.3 t70 48.63 95.69 0.01 OUTLIER 'General case' 0 C--O 1.235 0.305 0 CA-C-N 114.312 -1.313 . . . . 73.53 111.644 -168.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.526 HD22 ' NE2' ' A' ' 18' ' ' GLN . 16.5 mt 67.32 153.85 0.13 Allowed Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 114.686 -1.143 . . . . 63.34 111.232 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 26' ' ' LEU . 3.3 Cg_exo . . . . . 0 N--CA 1.46 -0.445 0 C-N-CA 122.684 2.256 . . . . 72.32 112.45 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.289 0 N-CA-C 109.562 -0.533 . . . . 72.42 109.562 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -106.1 134.97 48.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.823 0.344 . . . . 74.3 110.105 -178.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.841 HD12 ' HA ' ' A' ' 77' ' ' TRP . 3.1 mm? -97.7 151.98 19.57 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.837 -0.801 . . . . 55.13 108.837 176.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.1 p -75.32 -36.91 61.02 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.006 -0.739 . . . . 74.32 109.006 175.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -173.28 127.91 0.44 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.602 -1.181 . . . . 72.41 111.418 177.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -124.48 94.16 4.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.53 -0.759 . . . . 74.24 109.211 174.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 48.9 mt-10 -104.09 142.45 24.62 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 63.44 111.296 -174.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 31.5 Cg_exo -59.18 99.25 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.362 2.708 . . . . 74.33 113.694 -172.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.51 40.76 96.67 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.367 -0.833 . . . . 71.31 113.072 177.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -128.58 -79.67 0.57 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.021 0.438 . . . . 62.13 110.341 178.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -136.59 132.74 35.54 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.013 -0.54 . . . . 70.3 109.551 176.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 30.7 mm -120.36 110.34 28.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.809 -0.632 . . . . 75.15 109.354 -177.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -119.41 116.99 27.28 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.309 0.576 . . . . 71.41 110.47 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.841 ' HA ' HD12 ' A' ' 66' ' ' LEU . 44.9 m95 -89.9 159.56 16.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.374 -0.83 . . . . 72.21 111.072 -174.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -164.92 175.75 9.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.72 -0.673 . . . . 74.53 109.688 -178.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.575 ' HB3' ' O ' ' A' ' 84' ' ' ARG . 9.2 t -138.04 173.11 11.98 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.203 -1.406 . . . . 65.14 107.203 175.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 97.5 mt -79.01 144.28 63.15 Favored Pre-proline 0 C--N 1.314 -0.957 0 C-N-CA 121.054 -0.258 . . . . 73.54 110.689 -177.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.469 ' HA ' HG23 ' A' ' 85' ' ' ILE . 52.5 Cg_exo -56.14 -37.54 96.32 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.123 2.548 . . . . 74.52 112.676 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.69 -16.65 74.34 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.684 -0.769 . . . . 73.32 112.26 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.2 -62.58 1.26 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.705 0.288 . . . . 61.15 111.033 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.575 ' O ' ' HB3' ' A' ' 79' ' ' SER . 29.4 ttm180 -177.23 117.56 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.752 -0.658 . . . . 75.04 110.808 -173.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.469 HG23 ' HA ' ' A' ' 81' ' ' PRO . 2.1 pp -113.97 -166.58 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.543 -0.299 . . . . 65.14 110.732 175.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 49.4 mm-40 71.61 8.09 6.11 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.15 0.58 . . . . 73.11 111.707 -177.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -74.03 131.79 41.72 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.301 -0.629 . . . . 75.31 109.301 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.436 ' HB3' ' H ' ' A' ' 109' ' ' THR . 22.7 t -112.36 127.1 55.91 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.934 -0.395 . . . . 71.13 109.934 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -179.25 72.26 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.645 -0.788 . . . . 62.44 112.033 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -102.82 116.42 32.52 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.758 -0.46 . . . . 71.22 109.758 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.681 HG22 HG22 ' A' ' 106' ' ' VAL . 89.6 t -102.61 126.55 56.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.458 0.647 . . . . 73.35 111.267 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.538 ' HB2' ' HB ' ' A' ' 105' ' ' VAL . 3.2 mm? -110.4 120.81 43.62 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.965 -1.016 . . . . 71.11 109.833 176.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -97.62 118.04 33.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.929 0.395 . . . . 73.33 110.345 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.0 mtp180 -123.78 145.39 47.41 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.008 -0.542 . . . . 73.1 110.552 -176.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.34 119.01 6.0 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.591 2.194 . . . . 75.34 111.187 175.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . . . -82.95 143.99 47.01 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.045 0.45 . . . . 74.52 111.935 -173.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 96' ' ' ALA . 34.1 Cg_exo -60.54 131.01 35.87 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.312 2.675 . . . . 63.24 112.231 177.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.41 0.38 90.02 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 121.099 -0.572 . . . . 72.33 111.851 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 58.76 34.01 23.45 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 122.921 0.488 . . . . 75.12 111.306 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -60.37 -31.99 70.87 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.263 0.554 . . . . 72.33 110.504 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 170.49 -137.85 4.66 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.194 -1.162 . . . . 74.43 110.194 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 72.0 m -121.43 130.64 53.71 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 117.06 0.43 . . . . 62.4 110.19 175.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.436 ' CG ' ' HB1' ' A' ' 9' ' ' ALA . 42.5 tt0 -76.97 119.3 20.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.056 -0.52 . . . . 75.12 110.904 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.649 HG23 HG13 ' A' ' 91' ' ' VAL . 2.4 p -99.1 106.62 19.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.627 -0.715 . . . . 62.45 110.041 175.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.538 ' HB ' ' HB2' ' A' ' 92' ' ' LEU . 26.1 t -91.8 109.91 21.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.765 -0.652 . . . . 74.35 109.413 177.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.681 HG22 HG22 ' A' ' 91' ' ' VAL . 48.8 t -112.11 121.43 64.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.953 0.406 . . . . 64.44 110.71 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -113.97 104.82 12.54 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.72 -0.844 . . . . 72.14 108.72 172.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.662 ' H ' HD23 ' A' ' 108' ' ' LEU . 2.4 pt? -119.0 120.47 37.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.181 0.515 . . . . 71.11 109.824 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.534 ' HA ' HG13 ' A' ' 5' ' ' VAL . 86.6 m -103.45 125.26 49.93 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.2 -0.455 . . . . 62.14 110.787 -177.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 52.0 p90 . . . . . 0 N--CA 1.445 -0.707 0 N-CA-C 108.612 -0.884 . . . . 70.54 108.612 -179.359 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.462 0 N-CA-C 111.977 -0.449 . . . . 73.45 111.977 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.1 m -60.63 -27.99 68.2 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.648 0.24 . . . . 61.12 111.648 -176.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.88 -23.38 67.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.935 0.398 . . . . 74.12 111.194 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.73 -21.07 70.82 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.986 -0.626 . . . . 72.02 112.774 -177.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.99 -41.95 67.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.64 0.257 . . . . 72.34 111.451 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.4 m -76.67 -35.34 25.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.792 -0.363 . . . . 63.25 110.805 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.403 ' HA ' ' HB2' ' A' ' 124' ' ' MET . 79.2 mt -59.58 -30.9 45.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 116.358 -0.383 . . . . 72.53 110.709 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -52.64 -58.41 6.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.901 -0.591 . . . . 61.2 111.179 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -79.52 -17.02 54.96 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.15 -0.477 . . . . 72.34 111.26 -177.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.403 ' HB2' ' HA ' ' A' ' 121' ' ' ILE . 76.2 mtp . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.483 -0.326 . . . . 73.32 111.343 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 52.2 mtt85 . . . . . 0 N--CA 1.47 0.54 0 N-CA-C 112.587 0.588 . . . . 54.21 112.587 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -69.92 -28.53 65.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.655 0.264 . . . . 74.53 110.346 -177.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -63.8 -30.48 71.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.927 0.394 . . . . 51.44 110.585 173.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.544 HD23 ' HB3' ' A' ' 8' ' ' ASP . 39.0 tp -67.9 -26.12 65.83 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.728 -0.471 . . . . 74.23 109.728 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.513 ' O ' ' HG2' ' A' ' 141' ' ' LYS . 2.8 mmt -66.74 -30.07 70.2 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.822 -0.626 . . . . 70.31 109.911 174.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 -78.52 -35.77 45.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.522 -0.763 . . . . 74.5 109.36 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -57.62 -49.15 77.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.204 -0.907 . . . . 72.25 111.729 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.739 ' HB2' HG13 ' A' ' 12' ' ' ILE . 13.4 ptmm? -60.21 -38.48 83.48 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.897 0.379 . . . . 72.24 110.238 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.671 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 35.6 ttp180 -64.02 -44.0 93.9 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.719 -0.673 . . . . 73.22 110.81 -176.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.491 ' HA ' HD12 ' A' ' 146' ' ' LEU . 41.7 mt-10 -65.42 -30.4 71.2 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.949 0.404 . . . . 71.4 110.66 177.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.82 ' HB3' HG21 ' A' ' 12' ' ' ILE . 0.9 OUTLIER -65.49 -47.0 77.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 73.23 111.054 178.436 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.404 ' HB3' HG22 ' A' ' 12' ' ' ILE . 6.2 pt-20 -80.41 -9.29 59.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.886 0.374 . . . . 73.02 111.066 -178.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.671 ' HG ' ' O ' ' A' ' 142' ' ' ARG . 55.4 mt -73.29 -41.13 63.96 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.721 -0.474 . . . . 70.1 109.721 170.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.399 0 C-N-CA 121.048 -0.596 . . . . 64.22 112.703 177.082 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.5 t . . . . . 0 N--CA 1.45 -0.434 0 N-CA-C 109.181 -0.674 . . . . 62.1 109.181 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.5 t -78.82 119.55 28.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 116.016 -0.538 . . . . 75.3 110.288 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.592 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 15.0 ptt180 -141.65 125.01 16.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.429 0.633 . . . . 74.51 111.225 176.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.431 ' HB3' HD23 ' A' ' 137' ' ' LEU . 3.8 t70 -157.42 174.1 15.91 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.946 -1.131 . . . . 62.43 107.946 174.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.623 ' HB1' ' HG2' ' A' ' 103' ' ' GLU . . . -134.45 122.37 22.39 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.798 0.332 . . . . 62.23 111.279 -170.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.549 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 17.1 m -108.04 130.14 61.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.271 0.557 . . . . 61.35 110.998 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.661 ' O ' ' HE2' ' A' ' 141' ' ' LYS . 21.2 m -86.83 100.16 12.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.715 -0.675 . . . . 73.25 110.497 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.701 HG21 ' HG3' ' A' ' 144' ' ' GLN . 66.9 mt -111.89 145.6 17.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.697 0.285 . . . . 71.52 111.105 -174.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.407 ' HA2' ' HA3' ' A' ' 101' ' ' GLY . . . -81.68 66.04 3.91 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 121.136 -0.554 . . . . 54.34 112.955 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.452 ' HD3' ' HB3' ' A' ' 18' ' ' GLN . 43.3 mttp -143.32 147.43 40.23 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.755 -0.461 . . . . 75.22 109.755 174.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.14 -55.65 2.99 Favored 'Trans proline' 0 N--CA 1.479 0.65 0 C-N-CA 123.406 2.737 . . . . 52.31 114.079 -172.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 174.65 -64.02 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.146 0.498 . . . . 70.32 110.015 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.43 ' OE1' ' HG2' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -56.54 -42.5 78.59 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.198 -0.91 . . . . 73.33 111.507 179.353 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.452 ' HB3' ' HD3' ' A' ' 14' ' ' LYS . 17.0 mm100 -62.0 -21.32 64.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 74.34 111.997 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.581 ' HA ' HE21 ' A' ' 144' ' ' GLN . 59.3 mt -73.96 -32.35 63.43 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.305 -0.247 . . . . 74.55 111.629 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -69.69 -24.22 63.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.182 0.515 . . . . 73.44 110.181 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.05 -23.85 67.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.752 -0.658 . . . . 75.14 111.616 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 19' ' ' LEU . 4.3 p -67.38 -21.97 28.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 121.174 0.512 . . . . 63.14 110.742 -178.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 54.8 t90 -64.49 -26.25 68.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.783 -0.644 . . . . 74.44 110.69 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.51 -82.65 0.64 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.767 -0.651 . . . . 75.24 109.647 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.546 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 28.5 t70 -165.92 149.66 7.85 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.466 -0.788 . . . . 74.41 109.031 178.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.4 ' H ' HD23 ' A' ' 26' ' ' LEU . 0.8 OUTLIER -112.37 86.14 7.81 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 121.086 0.47 . . . . 74.1 110.941 177.243 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.546 ' HD3' ' O ' ' A' ' 25' ' ' ASP . 2.1 Cg_endo . . . . . 0 N--CA 1.454 -0.84 0 C-N-CA 123.433 2.755 . . . . 72.21 111.371 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 108.854 -0.795 . . . . 74.43 108.854 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.458 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 7.2 pt-20 -103.7 135.71 44.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.325 0.583 . . . . 75.53 111.748 -176.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.581 HD11 HG23 ' A' ' 75' ' ' ILE . 41.4 tp -105.12 126.38 52.01 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.817 -0.438 . . . . 71.1 109.817 177.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 64.2 p -84.11 -36.63 22.81 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.103 0.478 . . . . 63.3 111.224 -176.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.748 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -118.93 137.94 53.13 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.828 -0.624 . . . . 64.34 111.312 -170.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -139.61 33.3 2.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.781 -0.645 . . . . 72.42 109.856 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 1.01 ' HG3' ' HG2' ' A' ' 74' ' ' ARG . 5.4 mm-40 -57.33 142.83 75.29 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.427 -0.806 . . . . 72.45 110.307 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 9.2 Cg_exo -71.89 76.08 2.09 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.85 2.367 . . . . 74.13 112.173 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.47 43.82 43.69 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.947 -0.645 . . . . 70.21 112.076 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.611 ' HB2' ' HB3' ' A' ' 70' ' ' GLU . 70.9 mmtt -127.73 -69.3 0.74 Allowed 'General case' 0 C--N 1.328 -0.328 0 O-C-N 122.897 -0.178 . . . . 74.42 111.106 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 1.01 ' HG2' ' HG3' ' A' ' 70' ' ' GLU . 9.2 ptt180 -145.69 130.84 18.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.115 0.483 . . . . 72.33 110.397 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.683 HD13 ' HE2' ' A' ' 93' ' ' PHE . 2.3 mp -126.31 113.02 31.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.956 -0.565 . . . . 73.42 109.907 176.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.748 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -107.73 116.82 32.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.66 -0.7 . . . . 25.41 109.835 176.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.719 ' HZ3' HG13 ' A' ' 91' ' ' VAL . 31.5 p90 -98.72 143.54 28.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.471 0.653 . . . . 74.5 111.325 -174.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -141.21 179.18 6.91 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.959 -1.019 . . . . 74.33 109.44 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.5 m -132.84 147.79 52.3 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.203 -1.036 . . . . 53.02 108.203 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.458 ' CD1' ' HB3' ' A' ' 65' ' ' GLU . 5.4 mp -57.65 144.93 71.75 Favored Pre-proline 0 C--N 1.323 -0.549 0 O-C-N 123.497 0.498 . . . . 74.45 111.594 -176.024 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 80' ' ' LEU . 51.3 Cg_exo -56.35 -22.04 39.65 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.643 2.895 . . . . 71.34 113.766 -174.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -79.67 -14.83 80.59 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.015 -0.612 . . . . 44.44 112.311 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -111.17 172.32 6.95 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.683 0.277 . . . . 72.42 110.316 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -75.89 138.72 41.24 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.163 -0.68 . . . . 73.53 109.163 173.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.4 pt -75.92 88.87 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.32 0.581 . . . . 63.35 109.449 173.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -54.15 -34.67 60.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.192 -0.913 . . . . 75.1 112.047 -173.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.539 ' HB3' ' HE1' ' A' ' 77' ' ' TRP . 20.8 t-20 -166.73 132.82 2.31 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.897 -0.779 . . . . 65.45 108.897 178.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.0 m -115.6 128.57 56.04 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.053 -0.351 . . . . 63.51 110.053 177.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -174.77 -178.56 44.74 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.635 -0.793 . . . . 54.3 111.981 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -147.03 132.71 18.86 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.916 -0.401 . . . . 61.32 109.916 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.719 HG13 ' HZ3' ' A' ' 77' ' ' TRP . 25.2 m -107.68 138.01 36.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.016 0.436 . . . . 75.12 110.711 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.43 ' HB2' ' HB ' ' A' ' 105' ' ' VAL . 3.4 mm? -112.32 120.82 43.01 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.708 -0.678 . . . . 73.42 109.631 177.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.683 ' HE2' HD13 ' A' ' 75' ' ' ILE . 76.2 m-85 -98.11 112.42 24.39 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.924 0.393 . . . . 72.43 110.499 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.444 HH11 ' HD2' ' A' ' 94' ' ' ARG . 5.0 ptt180 -126.2 145.23 51.71 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.03 -0.532 . . . . 75.14 110.442 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -51.46 131.18 35.76 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.209 2.606 . . . . 74.44 112.296 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.641 ' HB1' HG23 ' A' ' 11' ' ' THR . . . -82.6 144.94 49.91 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.0 -0.545 . . . . 61.14 111.751 -175.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 96' ' ' ALA . 31.5 Cg_exo -58.79 133.19 52.32 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.913 2.409 . . . . 61.41 112.111 177.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.09 5.71 81.26 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 121.228 -0.511 . . . . 74.12 112.762 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 62.66 34.69 14.68 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.855 0.462 . . . . 72.12 111.34 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.16 -35.72 71.97 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 108.653 -0.869 . . . . 73.42 108.653 172.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.407 ' HA3' ' HA2' ' A' ' 13' ' ' GLY . . . 163.71 -107.16 0.29 Allowed Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 114.942 -1.026 . . . . 64.34 110.764 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.474 ' HB ' HD11 ' A' ' 19' ' ' LEU . 28.8 m -142.69 136.61 29.19 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 110.027 -0.36 . . . . 41.32 110.027 176.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.623 ' HG2' ' HB1' ' A' ' 9' ' ' ALA . 38.4 tt0 -96.57 108.38 20.96 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 109.326 -0.62 . . . . 74.33 109.326 177.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.4 p -87.79 108.66 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.679 0.752 . . . . 74.41 110.015 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.509 HG13 ' HB2' ' A' ' 9' ' ' ALA . 3.4 t -92.44 109.22 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 114.721 -1.127 . . . . 70.04 108.781 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.67 HG22 HD12 ' A' ' 108' ' ' LEU . 7.4 p -112.87 130.89 65.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 121.017 0.437 . . . . 75.31 111.303 -173.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.584 ' O ' ' HD3' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -123.6 125.83 45.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.778 -0.646 . . . . 75.11 110.097 174.361 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.67 HD12 HG22 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -150.52 152.54 34.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.936 -0.575 . . . . 74.1 110.141 -179.21 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.8 t -88.32 143.23 27.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.801 0.334 . . . . 64.32 111.022 -177.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.443 ' HD1' ' HA ' ' A' ' 110' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--N 1.326 -0.415 0 N-CA-C 109.103 -0.703 . . . . 73.04 109.103 177.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.513 0 N-CA-C 112.871 -0.092 . . . . 73.31 112.871 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.4 p -81.19 -25.06 37.06 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.224 0.453 . . . . 63.42 112.224 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.459 ' O ' HG22 ' A' ' 120' ' ' VAL . . . -64.83 -41.01 96.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.079 0.466 . . . . 64.54 110.717 178.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.55 -20.67 75.76 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.932 -0.652 . . . . 64.25 112.837 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.6 -40.72 95.81 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 111.728 0.27 . . . . 64.24 111.728 -176.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 117' ' ' ALA . 25.0 m -70.68 -27.84 32.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.767 0.318 . . . . 75.34 110.7 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 57.9 mt -75.04 -36.64 38.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.053 0.454 . . . . 71.13 110.231 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.27 -35.13 78.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.767 -0.651 . . . . 73.14 111.409 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 27.4 ptt85 -90.22 -14.37 33.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.975 0.417 . . . . 64.41 110.93 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 23.4 ttt . . . . . 0 C--N 1.326 -0.449 0 CA-C-N 116.029 -0.532 . . . . 74.14 110.641 178.6 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.665 ' HB2' ' HB3' ' A' ' 137' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.223 0 N-CA-C 112.07 0.396 . . . . 74.1 112.07 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -59.56 -35.84 75.03 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.025 0.441 . . . . 71.03 110.573 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -71.57 -37.68 71.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.279 0.561 . . . . 73.4 109.933 176.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.665 ' HB3' ' HB2' ' A' ' 134' ' ' ARG . 47.2 tp -66.27 -28.08 68.43 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.588 -0.733 . . . . 74.14 110.202 178.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.514 ' CE ' HG12 ' A' ' 10' ' ' VAL . 11.8 mmt -63.27 -39.76 95.5 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.101 0.477 . . . . 51.32 110.173 174.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -67.36 -39.7 85.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.61 -0.723 . . . . 75.42 109.796 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -59.47 -48.68 80.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.099 -0.955 . . . . 65.15 110.347 172.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.661 ' HE2' ' O ' ' A' ' 11' ' ' THR . 37.0 tttm -52.06 -49.93 62.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.432 -0.804 . . . . 60.55 111.657 177.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -56.08 -44.08 78.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.615 -0.721 . . . . 72.13 111.89 -174.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -68.51 -34.42 75.86 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 121.027 -0.269 . . . . 64.53 111.662 -176.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.701 ' HG3' HG21 ' A' ' 12' ' ' ILE . 5.4 tp60 -72.53 -34.9 67.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.807 0.336 . . . . 72.1 110.973 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.638 ' HB3' HG23 ' A' ' 12' ' ' ILE . 15.5 pt-20 -83.06 -38.79 22.05 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 121.022 -0.271 . . . . 74.31 110.606 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 22.4 tp -72.58 -23.62 60.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.941 0.401 . . . . 73.41 110.551 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.392 0 CA-C-N 115.749 -0.66 . . . . 74.51 112.976 -179.723 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.447 -0.612 0 CA-C-O 121.697 0.76 . . . . 44.42 109.261 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.403 HG23 ' HB3' ' A' ' 108' ' ' LEU . 17.5 m -84.65 134.23 27.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.288 -0.869 . . . . 61.33 111.258 -173.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 7' ' ' ARG . 15.0 ptt180 -141.39 132.17 25.79 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.539 -0.755 . . . . 75.44 109.772 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -143.93 155.69 44.16 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.057 -0.72 . . . . 74.41 109.057 175.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -130.44 142.86 50.49 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.133 0.492 . . . . 61.22 111.231 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.57 ' HB ' ' HB2' ' A' ' 141' ' ' LYS . 12.4 m -123.42 137.28 57.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.469 -0.787 . . . . 63.11 110.206 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -95.58 118.47 32.33 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.243 -0.435 . . . . 72.05 110.969 -175.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.979 HG23 ' HG2' ' A' ' 145' ' ' GLU . 4.0 mp -122.46 139.24 49.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.017 -0.538 . . . . 72.2 109.565 176.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.07 53.19 3.76 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.804 -0.712 . . . . 71.33 112.847 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.56 ' HG2' ' HB3' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -123.37 144.81 44.87 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 108.78 -0.822 . . . . 71.14 108.78 176.207 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.58 -58.37 1.29 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.429 2.086 . . . . 71.12 113.0 -175.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.61 ' HA ' HD12 ' A' ' 19' ' ' LEU . . . 173.4 -52.98 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.62 0.575 . . . . 62.45 110.157 178.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -49.44 -49.34 45.57 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.779 -1.101 . . . . 74.44 112.377 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.56 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 7.0 tt0 -68.71 -20.66 64.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.008 -0.542 . . . . 64.42 112.113 -175.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.61 HD12 ' HA ' ' A' ' 16' ' ' ALA . 66.6 mt -67.6 -33.15 74.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.66 -0.245 . . . . 64.44 111.274 -176.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.404 ' O ' ' HD1' ' A' ' 23' ' ' TRP . 27.9 t80 -73.03 -23.95 60.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.991 0.424 . . . . 75.32 110.743 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.55 -3.53 34.69 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.924 0.392 . . . . 53.33 112.02 -177.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.6 p -56.16 -21.29 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 115.689 -0.687 . . . . 70.34 112.305 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.404 ' HD1' ' O ' ' A' ' 20' ' ' TYR . 51.1 m95 -48.21 -31.13 5.39 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.287 0.847 . . . . 71.33 113.287 -176.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -118.27 -85.37 0.65 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.502 -0.479 . . . . 71.11 111.318 176.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -150.74 35.92 0.62 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.118 0.485 . . . . 75.11 110.027 -175.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.459 HD13 ' HA2' ' A' ' 147' ' ' GLY . 9.6 mp 65.55 165.4 0.12 Allowed Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 115.465 -0.789 . . . . 73.41 110.914 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.475 ' CD ' ' HG3' ' A' ' 18' ' ' GLN . 31.6 Cg_exo . . . . . 0 C--N 1.346 0.433 0 C-N-CA 122.398 2.065 . . . . 64.11 111.824 176.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.651 0 CA-C-O 120.892 0.377 . . . . 71.05 110.88 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.475 ' HG2' ' H ' ' A' ' 66' ' ' LEU . 33.0 tt0 -105.53 172.28 6.88 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.863 -1.162 . . . . 71.11 107.863 172.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.497 ' CD1' ' HA ' ' A' ' 77' ' ' TRP . 11.6 tp -130.43 145.13 51.77 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 122.013 -0.429 . . . . 44.22 111.061 -174.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.707 HG23 ' HB2' ' A' ' 78' ' ' ARG . 61.5 p -96.68 -34.75 11.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.084 0.469 . . . . 62.22 110.983 178.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.574 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -140.44 136.02 32.61 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.731 -0.668 . . . . 43.42 110.857 -177.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.41 ' HB3' HD23 ' A' ' 66' ' ' LEU . 6.9 p-10 -137.38 75.05 1.51 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.576 0.703 . . . . 63.24 111.051 -177.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.496 ' HB2' ' H ' ' A' ' 74' ' ' ARG . 16.3 mm-40 -96.37 143.42 26.08 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.926 -0.579 . . . . 74.54 110.22 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -67.81 -38.11 14.3 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.832 2.355 . . . . 73.31 112.776 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -151.56 42.01 0.73 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.364 -0.922 . . . . 33.01 112.659 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.437 ' HD2' ' OE1' ' A' ' 70' ' ' GLU . 76.0 mttt -130.11 -74.34 0.55 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.169 -0.308 . . . . 71.2 110.169 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.496 ' H ' ' HB2' ' A' ' 70' ' ' GLU . 5.9 ptp180 -151.71 150.44 30.22 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.872 -0.418 . . . . 75.22 109.872 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.528 HD12 ' HE2' ' A' ' 93' ' ' PHE . 70.7 mt -134.97 109.49 11.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.365 -0.606 . . . . 70.24 109.365 171.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.574 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -96.65 116.04 28.44 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.213 -0.662 . . . . 63.12 109.213 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.497 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 12.8 t90 -81.81 154.07 26.11 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.38 -0.827 . . . . 74.51 110.394 -172.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.707 ' HB2' HG23 ' A' ' 67' ' ' THR . 64.5 ttt180 -140.42 173.3 11.64 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.89 -0.781 . . . . 62.1 108.89 -178.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.533 ' HB2' ' HA ' ' A' ' 85' ' ' ILE . 45.8 m -135.9 152.68 51.26 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.944 -0.391 . . . . 44.45 109.944 175.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 66.5 mt -78.32 145.78 69.1 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 116.205 -0.452 . . . . 71.02 110.973 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 80' ' ' LEU . 51.4 Cg_exo -57.47 -31.93 92.72 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.352 2.702 . . . . 72.44 112.343 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.51 -5.41 89.96 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.107 -0.568 . . . . 62.54 112.255 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.57 -65.21 1.01 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.274 -0.269 . . . . 72.54 110.274 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.69 ' HG2' ' HB2' ' A' ' 86' ' ' GLU . 20.5 ttt180 -177.53 -53.57 0.01 OUTLIER 'General case' 0 C--N 1.335 -0.063 0 CA-C-N 116.074 -0.512 . . . . 63.12 111.005 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.533 ' HA ' ' HB2' ' A' ' 79' ' ' SER . 13.0 tt 44.85 40.88 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-O 122.213 1.006 . . . . 74.2 112.02 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.69 ' HB2' ' HG2' ' A' ' 84' ' ' ARG . 0.8 OUTLIER -97.55 -4.37 37.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.453 -0.794 . . . . 54.34 110.492 -179.716 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -135.03 172.51 12.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.574 -0.739 . . . . 71.33 110.311 -177.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.0 m -148.06 145.21 28.36 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.769 0.319 . . . . 74.04 110.625 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -142.68 122.83 2.02 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.319 -0.713 . . . . 75.33 111.319 177.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -117.56 120.79 39.14 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.171 -0.307 . . . . 74.22 110.171 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.539 HG22 HG22 ' A' ' 106' ' ' VAL . 78.3 t -112.83 119.75 61.21 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.625 0.726 . . . . 74.42 111.425 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.8 mp -104.51 125.05 50.32 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.151 -0.931 . . . . 74.23 110.15 176.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.528 ' HE2' HD12 ' A' ' 75' ' ' ILE . 73.6 m-85 -89.48 106.43 18.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.115 0.484 . . . . 74.4 109.818 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.425 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 33.3 ptt180 -127.18 143.98 48.99 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.859 -0.61 . . . . 71.43 110.816 -176.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 94' ' ' ARG . 30.3 Cg_exo -62.55 127.29 20.37 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.662 2.241 . . . . 74.44 111.5 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.52 146.83 96.5 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 116.081 -0.508 . . . . 71.23 110.23 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -48.19 127.53 15.41 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.64 2.893 . . . . 61.04 113.111 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.87 20.33 68.31 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.801 -0.636 . . . . 54.44 112.447 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 56.66 34.25 24.19 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.129 0.49 . . . . 65.13 111.347 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.436 HH11 ' HD3' ' A' ' 100' ' ' ARG . 4.4 mmp_? -82.11 0.47 40.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.053 -0.521 . . . . 74.04 111.439 -177.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 144.33 -157.53 27.2 Favored Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 111.063 -0.815 . . . . 64.34 111.063 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 71.7 m -121.52 128.04 51.63 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.609 -0.515 . . . . 72.2 109.609 176.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -103.91 130.78 51.55 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.26 0.552 . . . . 71.3 109.899 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.697 HG21 ' HE2' ' A' ' 140' ' ' PHE . 4.7 m -89.36 132.45 34.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 108.623 -0.88 . . . . 62.43 108.623 175.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 7.3 p -118.0 115.45 48.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 121.375 0.607 . . . . 74.41 109.896 -177.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.539 HG22 HG22 ' A' ' 91' ' ' VAL . 39.6 t -105.1 115.13 46.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.574 -0.739 . . . . 72.41 110.849 -174.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -90.52 106.42 18.49 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.422 -0.584 . . . . 61.14 109.422 173.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.425 ' HA ' HD22 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -99.3 135.67 40.38 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.794 -0.447 . . . . 64.03 109.794 -177.043 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.4 p -83.81 119.91 25.41 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.214 0.53 . . . . 73.34 111.236 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 81.2 t80 . . . . . 0 C--N 1.32 -0.708 0 CA-C-N 115.594 -0.73 . . . . 62.42 109.257 -179.884 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.907 0 N-CA-C 111.952 -0.459 . . . . 44.32 111.952 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.0 t -61.05 -45.41 94.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.776 0.322 . . . . 54.22 110.554 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.24 -32.65 74.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.221 -0.445 . . . . 53.33 110.774 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -71.47 -37.0 62.62 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.772 -0.728 . . . . 41.42 111.993 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.79 -45.52 71.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.652 0.263 . . . . 71.41 111.544 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 28.1 m -66.09 -36.54 77.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.042 0.386 . . . . 64.21 112.042 -175.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 35.6 pt -75.66 -32.36 24.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 120.761 -0.376 . . . . 73.02 110.781 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.57 -34.57 74.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.971 0.415 . . . . 64.33 110.171 176.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -59.23 -34.81 72.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.118 -0.492 . . . . 72.22 110.227 175.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 14.7 tpt . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 115.862 -0.608 . . . . 74.12 110.646 176.95 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.546 ' HG2' ' HG2' ' A' ' 138' ' ' MET . 54.4 ttt85 . . . . . 0 N--CA 1.453 -0.297 0 CA-C-O 120.787 0.327 . . . . 74.34 110.123 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -54.09 -48.12 71.02 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.254 -0.43 . . . . 71.45 111.066 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -69.12 -35.8 76.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.146 -0.479 . . . . 63.22 111.07 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 16.3 tp -76.97 -21.84 54.13 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.33 -0.395 . . . . 55.34 110.442 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.642 ' HA ' ' CE ' ' A' ' 138' ' ' MET . 4.8 mmt -65.99 -37.7 86.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.404 -0.362 . . . . 73.02 110.572 175.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.36 -35.22 75.64 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.711 -0.478 . . . . 71.51 109.711 177.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.697 ' HE2' HG21 ' A' ' 104' ' ' VAL . 72.5 t80 -57.44 -46.36 83.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.791 -0.641 . . . . 73.24 109.862 175.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.57 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 40.5 tttp -63.61 -40.25 96.44 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.366 -0.379 . . . . 72.55 110.876 176.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.4 ' HD2' HD22 ' A' ' 146' ' ' LEU . 21.3 tpp180 -57.51 -58.34 8.74 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.194 -0.457 . . . . 70.12 110.421 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -66.1 -28.21 68.65 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 121.114 -0.235 . . . . 71.11 111.352 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.734 ' HB3' HG12 ' A' ' 12' ' ' ILE . 25.4 mm-40 -56.91 -49.71 74.77 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.312 0.577 . . . . 75.21 111.263 176.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.979 ' HG2' HG23 ' A' ' 12' ' ' ILE . 26.8 mt-10 -87.35 -32.3 19.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.779 -0.646 . . . . 64.33 111.1 -175.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.4 HD22 ' HD2' ' A' ' 142' ' ' ARG . 24.2 tp -90.47 -58.09 2.61 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.479 0.657 . . . . 73.4 111.625 -174.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.459 ' HA2' HD13 ' A' ' 26' ' ' LEU . . . . . . . . 0 N--CA 1.441 -0.967 0 N-CA-C 109.405 -1.478 . . . . 74.32 109.405 -167.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.8 t . . . . . 0 N--CA 1.446 -0.674 0 N-CA-C 109.477 -0.564 . . . . 73.01 109.477 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 52.4 t -99.07 122.6 51.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.835 -0.62 . . . . 61.23 110.851 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.524 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 57.1 ttt-85 -126.12 109.59 12.55 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.363 -0.606 . . . . 73.11 109.363 171.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.597 ' HB3' HD22 ' A' ' 137' ' ' LEU . 18.1 t0 -130.83 151.14 51.58 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.954 -1.128 . . . . 72.12 107.954 177.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.658 ' HB2' HG12 ' A' ' 105' ' ' VAL . . . -135.99 129.48 32.14 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.948 0.404 . . . . 31.12 111.948 -170.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.846 ' HB ' ' HG3' ' A' ' 141' ' ' LYS . 16.1 m -120.56 143.25 33.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.896 -0.593 . . . . 73.1 110.188 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.426 HG21 ' HD3' ' A' ' 100' ' ' ARG . 26.6 m -107.25 114.1 27.93 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.582 -0.281 . . . . 63.41 110.669 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.972 HG23 ' HB3' ' A' ' 145' ' ' GLU . 4.9 mp -110.73 139.64 33.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.311 -0.404 . . . . 65.52 110.79 -176.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.46 60.31 4.55 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 121.249 -0.5 . . . . 73.34 113.039 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.676 ' HD3' ' HG2' ' A' ' 18' ' ' GLN . 43.0 mttp -140.69 150.38 59.94 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 110.2 -0.296 . . . . 71.31 110.2 176.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.441 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 51.4 Cg_exo -56.01 -59.28 0.75 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.817 2.345 . . . . 60.51 114.123 -173.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . 170.73 -48.04 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.453 0.644 . . . . 65.31 110.007 175.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -48.17 -56.36 8.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.257 -1.338 . . . . 71.22 112.954 -173.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.676 ' HG2' ' HD3' ' A' ' 14' ' ' LYS . 0.6 OUTLIER -80.9 -7.65 59.54 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.257 -0.429 . . . . 75.55 111.65 -173.95 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.55 ' CB ' ' HE2' ' A' ' 93' ' ' PHE . 64.0 mt -75.87 -26.8 57.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.796 -0.183 . . . . 64.31 111.163 177.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -65.18 -29.81 70.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.241 0.543 . . . . 71.43 110.447 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.45 -8.45 56.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.577 -0.738 . . . . 71.11 111.689 -175.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.474 HG11 ' HE2' ' A' ' 140' ' ' PHE . 6.2 p -60.16 -22.2 24.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.808 0.337 . . . . 74.14 111.735 -175.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -70.41 -23.48 62.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.919 0.39 . . . . 65.03 110.774 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.405 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 17.8 tpt180 -128.58 19.47 6.21 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.885 -0.413 . . . . 72.43 109.885 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.561 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 18.6 t70 64.84 162.43 0.13 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.62 -0.718 . . . . 61.42 110.968 -174.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.575 ' H ' HD23 ' A' ' 26' ' ' LEU . 1.3 pt? -113.95 85.7 10.25 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 121.364 0.602 . . . . 55.24 112.019 -175.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.561 ' HD3' ' O ' ' A' ' 25' ' ' ASP . 1.9 Cg_endo . . . . . 0 N--CA 1.459 -0.54 0 C-N-CA 123.059 2.506 . . . . 72.31 111.623 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.779 0 CA-C-O 121.221 0.534 . . . . 71.44 110.507 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.685 ' HB3' ' HD2' ' A' ' 78' ' ' ARG . 1.8 tm-20 -107.24 175.57 5.45 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.291 -1.003 . . . . 74.24 108.291 176.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.617 HD12 ' HA ' ' A' ' 77' ' ' TRP . 22.8 tp -124.08 119.64 30.05 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.132 -0.692 . . . . 75.41 109.132 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.3 t -81.53 -23.71 37.09 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.627 0.251 . . . . 64.12 111.389 -174.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.586 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . . . -144.12 127.31 16.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.932 0.396 . . . . 55.24 111.043 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.598 ' HB2' HD23 ' A' ' 66' ' ' LEU . 11.0 t70 -138.79 104.03 4.98 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.266 -0.879 . . . . 54.53 109.788 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.454 ' HB2' ' H ' ' A' ' 74' ' ' ARG . 8.0 mm-40 -106.71 144.2 28.58 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.718 -0.673 . . . . 73.22 109.855 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 35.3 Cg_exo -62.04 -24.61 76.82 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.92 2.414 . . . . 50.11 112.536 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.98 56.93 0.12 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.917 -0.659 . . . . 75.04 111.592 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -141.41 -68.76 0.38 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.345 -0.142 . . . . 74.45 111.019 -176.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.454 ' H ' ' HB2' ' A' ' 70' ' ' GLU . 18.5 ptt180 -153.32 155.38 36.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.857 0.36 . . . . 75.34 111.51 -176.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.896 ' HB ' HG12 ' A' ' 91' ' ' VAL . 49.0 mm -125.14 110.82 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.765 -0.652 . . . . 72.02 109.723 174.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.586 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . . . -108.81 120.41 42.4 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.981 -0.748 . . . . 71.25 108.981 174.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.617 ' HA ' HD12 ' A' ' 66' ' ' LEU . 13.7 p-90 -106.85 138.95 42.05 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.612 0.72 . . . . 64.41 112.195 -170.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.685 ' HD2' ' HB3' ' A' ' 65' ' ' GLU . 7.8 ptp85 -113.07 173.35 6.43 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 107.676 -1.231 . . . . 65.15 107.676 171.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.437 ' CB ' ' HD3' ' A' ' 84' ' ' ARG . 6.1 m -138.6 30.3 2.34 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.343 -0.543 . . . . 53.32 109.873 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.466 ' CD2' ' HB2' ' A' ' 65' ' ' GLU . 22.1 mt 66.52 147.02 0.11 Allowed Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 115.086 -0.961 . . . . 72.11 111.093 -175.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.64 -23.16 55.83 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 123.104 2.536 . . . . 64.51 113.529 -174.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.21 -3.32 88.92 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.717 -0.754 . . . . 64.01 113.263 -176.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -136.44 25.98 3.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.201 0.5 . . . . 75.31 111.851 -177.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.437 ' HD3' ' CB ' ' A' ' 79' ' ' SER . 9.4 mmm180 -126.83 107.79 10.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.827 0.346 . . . . 73.01 111.457 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.735 HG13 ' H ' ' A' ' 86' ' ' GLU . 13.8 pt -91.11 -63.3 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.053 -0.521 . . . . 63.31 110.298 173.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.735 ' H ' HG13 ' A' ' 85' ' ' ILE . 34.2 tt0 -163.74 109.42 1.07 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.885 0.374 . . . . 74.34 110.366 176.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -162.15 141.01 9.3 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.682 -0.859 . . . . 75.41 108.682 175.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.4 m -151.37 129.38 11.79 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.142 -0.318 . . . . 75.11 110.142 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.09 110.26 0.25 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.55 -0.833 . . . . 34.24 112.247 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.13 149.98 23.73 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.242 -0.281 . . . . 73.31 110.242 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.896 HG12 ' HB ' ' A' ' 75' ' ' ILE . 7.6 p -88.97 140.98 14.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.213 -0.662 . . . . 74.13 109.213 174.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.692 ' HB2' ' CG2' ' A' ' 105' ' ' VAL . 3.2 mm? -108.99 119.81 40.66 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.154 -0.684 . . . . 65.44 109.154 172.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.55 ' HE2' ' CB ' ' A' ' 19' ' ' LEU . 15.7 m-85 -96.91 106.03 18.28 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.824 -0.806 . . . . 61.55 108.824 174.024 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 32.7 mtp180 -125.95 142.9 43.69 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 116.112 -0.495 . . . . 72.13 110.046 -174.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -57.85 115.57 2.61 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.436 2.091 . . . . 74.25 110.634 175.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . . . -65.36 143.63 98.78 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.019 -0.537 . . . . 63.52 111.413 -173.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 96' ' ' ALA . 51.5 Cg_exo -55.79 137.39 78.39 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.885 2.39 . . . . 65.1 111.925 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.63 16.51 79.13 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.947 -0.644 . . . . 61.45 112.101 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 57.16 33.69 23.7 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.341 0.591 . . . . 64.22 110.794 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.426 ' HD3' HG21 ' A' ' 11' ' ' THR . 34.6 ttt180 -77.27 1.04 19.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.41 -0.814 . . . . 71.41 111.04 -175.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 123.23 -125.13 5.84 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 111.508 -0.637 . . . . 70.52 111.508 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 88.0 m -135.01 130.53 35.84 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.952 0.406 . . . . 73.15 110.564 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -100.9 113.91 27.3 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.902 -0.59 . . . . 74.15 109.534 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.2 m -88.74 127.29 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-O 121.703 0.763 . . . . 71.22 108.991 175.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.692 ' CG2' ' HB2' ' A' ' 92' ' ' LEU . 14.0 m -123.18 119.39 57.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.204 -0.907 . . . . 45.23 109.815 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.639 HG13 HG23 ' A' ' 91' ' ' VAL . 1.8 m -119.84 121.52 66.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.908 -0.587 . . . . 73.54 111.074 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.85 109.85 19.19 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.537 -0.912 . . . . 75.3 108.537 174.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.432 HD22 ' HE2' ' A' ' 110' ' ' TYR . 0.4 OUTLIER -141.12 151.39 43.9 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.058 0.456 . . . . 75.11 111.544 -174.435 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.9 t -98.77 133.09 43.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.378 0.609 . . . . 52.42 110.911 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.432 ' HE2' HD22 ' A' ' 108' ' ' LEU . 57.8 m-85 . . . . . 0 C--N 1.324 -0.524 0 CA-C-N 115.039 -0.982 . . . . 71.43 109.233 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.197 0 CA-C-O 120.989 0.216 . . . . 32.52 113.124 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.7 m -86.54 -30.61 21.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.93 0.395 . . . . 71.03 111.153 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.406 ' O ' HG22 ' A' ' 120' ' ' VAL . . . -64.93 -36.15 83.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.939 -0.573 . . . . 61.02 112.194 -173.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -60.14 -25.69 62.56 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 121.078 -0.582 . . . . 74.44 113.292 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.03 -46.76 86.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.727 0.299 . . . . 64.14 111.311 -177.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 117' ' ' ALA . 26.9 m -75.1 -23.73 17.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.495 -0.321 . . . . 53.4 111.177 -177.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 65.1 mt -72.7 -33.44 44.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.389 -0.369 . . . . 75.21 110.418 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.08 -22.64 65.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.169 -0.469 . . . . 72.51 111.279 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -63.87 -26.75 68.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.064 -0.517 . . . . 73.24 111.171 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 16.7 tpt . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 120.949 0.404 . . . . 72.53 110.959 -179.044 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.571 ' HG2' ' H ' ' A' ' 137' ' ' LEU . 35.7 ttt85 . . . . . 0 N--CA 1.449 -0.486 0 CA-C-O 121.141 0.496 . . . . 74.2 110.369 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -61.51 -39.45 91.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.361 -0.836 . . . . 71.11 110.655 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -61.01 -34.99 75.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.836 -0.62 . . . . 74.31 111.206 177.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.597 HD22 ' HB3' ' A' ' 8' ' ' ASP . 11.5 tp -79.14 -35.8 41.51 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.503 0.668 . . . . 75.34 109.844 -175.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.3 ttp -66.28 -36.89 84.12 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.532 -0.758 . . . . 71.22 110.367 174.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -69.81 -51.05 37.06 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.128 -0.487 . . . . 75.54 112.182 -177.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.474 ' HE2' HG11 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -66.32 -29.54 69.76 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.261 -0.576 . . . . 71.2 109.685 -175.346 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.846 ' HG3' ' HB ' ' A' ' 10' ' ' VAL . 14.9 tmtt? -57.1 -42.37 80.66 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 115.788 -0.642 . . . . 62.12 110.46 173.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -55.11 -52.2 64.02 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.284 0.564 . . . . 73.42 110.269 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -66.58 -40.81 89.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.022 -0.99 . . . . 61.43 111.928 -172.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.518 ' CD ' HG12 ' A' ' 12' ' ' ILE . 4.6 pt20 -74.17 -17.3 60.93 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.571 0.582 . . . . 74.45 112.571 -173.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.972 ' HB3' HG23 ' A' ' 12' ' ' ILE . 19.7 pt-20 -110.73 -4.46 15.33 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.618 -0.433 . . . . 75.1 111.102 175.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 24.4 tp -61.8 -52.83 62.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.068 0.461 . . . . 72.41 110.453 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.878 0 C-N-CA 121.022 -0.609 . . . . 73.11 111.77 175.631 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.817 HG22 HG23 ' A' ' 109' ' ' THR . 66.5 t . . . . . 0 N--CA 1.445 -0.678 0 CA-C-O 120.771 0.32 . . . . 72.22 110.248 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.6 m -83.77 126.28 40.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.387 0.613 . . . . 64.24 111.022 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.1 OUTLIER -142.28 118.03 10.46 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.569 -0.741 . . . . 61.03 110.553 -178.871 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.401 ' OD2' ' HD2' ' A' ' 134' ' ' ARG . 13.7 t70 -128.18 170.14 13.32 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.081 -0.711 . . . . 73.42 109.081 176.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.59 ' HB2' HG13 ' A' ' 105' ' ' VAL . . . -145.43 123.19 11.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.676 0.274 . . . . 71.11 111.325 -173.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.6 m -112.32 148.15 15.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.292 -0.413 . . . . 64.13 111.014 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.408 ' CG2' ' HB1' ' A' ' 96' ' ' ALA . 0.6 OUTLIER -105.21 110.43 22.8 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.952 -0.567 . . . . 70.33 112.0 -171.177 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.872 HG21 ' HB2' ' A' ' 144' ' ' GLN . 0.1 OUTLIER -124.4 151.23 29.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.109 0.48 . . . . 71.43 112.139 177.111 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.59 ' HA2' ' HA3' ' A' ' 101' ' ' GLY . . . -82.8 20.43 9.47 Favored Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.756 -0.656 . . . . 55.42 112.396 177.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.572 ' HB2' HD21 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -79.53 143.93 60.26 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.354 -0.61 . . . . 65.44 109.354 176.284 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.411 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 23.0 Cg_endo -62.28 -60.01 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.023 1.815 . . . . 74.12 113.359 -171.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.495 ' HA ' HD12 ' A' ' 19' ' ' LEU . . . 172.17 -50.76 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.492 0.717 . . . . 60.11 109.967 171.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.494 ' HA ' ' HD2' ' A' ' 20' ' ' TYR . 1.9 mp0 -56.29 -47.45 78.64 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.976 -0.556 . . . . 71.51 110.621 -177.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -66.71 -13.27 61.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.282 -0.872 . . . . 72.33 111.205 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.692 HD21 HG13 ' A' ' 12' ' ' ILE . 98.1 mt -83.88 -43.08 15.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.229 -0.441 . . . . 73.32 110.387 175.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.628 ' CE1' HD13 ' A' ' 75' ' ' ILE . 73.6 m-85 -62.68 -32.34 73.4 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.424 0.631 . . . . 64.13 109.8 176.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.52 -7.76 49.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.085 -0.961 . . . . 73.13 111.996 -176.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.557 HG21 ' CE2' ' A' ' 140' ' ' PHE . 7.8 p -53.74 -30.38 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 120.889 0.376 . . . . 72.24 111.65 -176.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 28.8 t90 -68.4 -23.73 64.68 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.044 0.449 . . . . 74.42 111.144 -177.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -124.21 13.54 8.97 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.583 -0.525 . . . . 71.42 109.583 -178.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.718 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 28.9 t70 62.38 168.73 0.12 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.427 -0.806 . . . . 55.23 110.532 -169.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.694 ' H ' HD23 ' A' ' 26' ' ' LEU . 1.3 pt? -104.83 87.2 1.73 Allowed Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 121.11 0.481 . . . . 74.4 110.767 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.718 ' HD3' ' O ' ' A' ' 25' ' ' ASP . 9.9 Cg_endo . . . . . 0 N--CA 1.45 -1.034 0 C-N-CA 123.208 2.605 . . . . 74.11 111.79 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 79' ' ' SER . . . . . . . . 0 N--CA 1.452 -0.373 0 N-CA-C 110.17 -0.307 . . . . 62.42 110.17 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.557 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -106.77 135.74 47.79 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.745 -0.465 . . . . 74.23 109.745 178.328 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.521 HD12 ' HA ' ' A' ' 77' ' ' TRP . 3.0 mm? -86.57 147.05 26.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.139 -0.482 . . . . 75.31 111.305 -169.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.6 t -98.67 -16.5 19.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.082 0.467 . . . . 65.45 110.53 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.619 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -138.72 124.96 20.26 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.173 -0.677 . . . . 51.54 109.173 173.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -125.2 99.62 6.17 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.267 -0.424 . . . . 72.21 111.754 -171.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.45 ' O ' HD11 ' A' ' 75' ' ' ILE . 22.8 mt-10 -121.48 142.69 36.09 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.769 -0.826 . . . . 63.41 108.769 166.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 31.1 Cg_exo -61.16 -42.96 32.03 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.588 2.192 . . . . 73.14 112.328 -177.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -150.48 56.02 0.47 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.636 -0.792 . . . . 72.03 112.198 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -147.09 -82.43 0.13 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.816 -0.354 . . . . 53.31 110.914 174.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.596 ' HD2' ' OE2' ' A' ' 90' ' ' GLU . 16.7 ttp180 -124.38 123.14 39.53 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.444 -0.502 . . . . 74.24 111.168 -170.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.628 HD13 ' CE1' ' A' ' 20' ' ' TYR . 2.6 mp -125.82 110.87 25.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.748 -0.66 . . . . 63.33 110.506 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.619 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -96.6 116.11 28.56 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.259 -1.015 . . . . 42.5 108.259 170.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.611 ' CZ2' ' HB3' ' A' ' 87' ' ' ASN . 3.9 p-90 -85.69 151.72 23.64 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.409 0.623 . . . . 60.41 111.269 -171.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.557 ' HB3' ' O ' ' A' ' 65' ' ' GLU . 5.5 tpm_? -155.37 170.88 20.87 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.183 -1.414 . . . . 53.54 107.183 -175.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.547 ' HA ' ' HA ' ' A' ' 64' ' ' ALA . 20.0 p -145.24 170.38 16.38 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.075 0.464 . . . . 51.41 110.888 -177.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.506 HD11 ' HB2' ' A' ' 65' ' ' GLU . 5.7 mp -87.45 154.33 53.85 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.761 -0.654 . . . . 65.05 110.576 178.162 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.57 -1.4 3.93 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 123.089 2.526 . . . . 64.23 112.981 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.21 -8.18 66.84 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.994 -0.622 . . . . 61.53 112.136 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.17 -177.62 5.75 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.744 0.307 . . . . 75.2 110.56 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.48 ' HD2' ' HA ' ' A' ' 84' ' ' ARG . 14.3 tpt180 -122.12 -28.34 4.4 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.592 -0.443 . . . . 62.51 111.302 -178.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.85 132.56 70.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.117 0.484 . . . . 53.05 110.154 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -147.24 142.83 27.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.839 -0.618 . . . . 72.0 110.089 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.611 ' HB3' ' CZ2' ' A' ' 77' ' ' TRP . 28.1 t-20 -137.13 150.27 47.86 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.722 -0.844 . . . . 52.24 108.722 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 60.9 m -100.7 127.5 47.09 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.397 0.618 . . . . 70.33 110.216 -176.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.406 ' HA3' HD23 ' A' ' 108' ' ' LEU . . . -171.54 169.25 42.34 Favored Glycine 0 N--CA 1.438 -1.223 0 CA-C-N 115.227 -0.897 . . . . 33.02 111.559 -176.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.596 ' OE2' ' HD2' ' A' ' 74' ' ' ARG . 33.1 tt0 -144.64 129.42 18.26 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.993 -0.373 . . . . 74.34 109.993 -175.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.611 HG12 HG12 ' A' ' 106' ' ' VAL . 9.3 m -111.05 137.89 41.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 110.095 -0.335 . . . . 73.22 110.095 178.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.646 ' CD2' ' HB ' ' A' ' 105' ' ' VAL . 0.0 OUTLIER -128.19 119.7 25.76 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.75 0.786 . . . . 73.21 110.046 173.078 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.63 ' HE2' ' HB3' ' A' ' 19' ' ' LEU . 2.5 m-85 -97.73 106.43 18.74 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.485 -1.234 . . . . 72.41 109.215 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -119.66 144.93 38.02 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 115.418 -0.81 . . . . 71.03 110.35 -172.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -46.86 117.78 2.33 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.246 2.631 . . . . 75.12 112.102 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.408 ' HB1' ' CG2' ' A' ' 11' ' ' THR . . . -58.93 144.54 81.67 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.741 -0.663 . . . . 75.23 111.094 -176.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -46.31 115.98 1.36 Allowed 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 123.303 2.669 . . . . 75.54 113.022 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 96.15 3.57 60.25 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.665 -0.698 . . . . 50.41 112.162 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 64.79 32.49 10.98 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 123.08 0.552 . . . . 71.12 111.164 -178.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 37.7 ttt-85 -75.46 -19.43 59.44 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.957 -0.565 . . . . 72.03 110.992 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.59 ' HA3' ' HA2' ' A' ' 13' ' ' GLY . . . 165.82 -130.74 2.21 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.885 -0.886 . . . . 41.11 110.885 -175.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.2 m -138.73 133.95 32.9 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 110.152 -0.314 . . . . 62.11 110.152 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -96.55 133.06 41.49 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.928 -0.767 . . . . 62.23 108.928 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.635 HG12 HD11 ' A' ' 12' ' ' ILE . 1.5 p -95.15 100.32 10.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.794 0.807 . . . . 53.15 110.35 179.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.646 ' HB ' ' CD2' ' A' ' 92' ' ' LEU . 4.1 t -97.4 111.47 27.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.688 -1.142 . . . . 73.31 108.941 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.611 HG12 HG12 ' A' ' 91' ' ' VAL . 26.1 m -112.47 123.46 68.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.318 0.58 . . . . 75.35 111.517 -176.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 31.1 ttt85 -105.17 100.89 10.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.524 -0.762 . . . . 73.42 109.678 174.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.406 HD23 ' HA3' ' A' ' 89' ' ' GLY . 95.4 mt -116.94 126.8 53.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.257 -0.429 . . . . 45.31 110.146 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.817 HG23 HG22 ' A' ' 5' ' ' VAL . 25.9 m -90.22 116.26 28.08 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 120.214 -0.594 . . . . 73.55 110.726 -176.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 51.2 p90 . . . . . 0 C--N 1.326 -0.455 0 CA-C-N 115.485 -0.78 . . . . 73.02 108.917 174.376 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 CA-C-O 120.558 -0.023 . . . . 24.11 113.114 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.0 m -86.08 -24.17 26.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.694 0.283 . . . . 73.15 111.152 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.63 -41.64 99.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.435 -0.348 . . . . 44.04 110.933 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.01 -31.25 77.97 Favored Glycine 0 N--CA 1.452 -0.256 0 CA-C-N 116.05 -0.523 . . . . 65.23 112.48 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.34 -29.3 64.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.163 0.506 . . . . 72.33 110.572 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 59.6 t -73.67 -51.36 25.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.881 -0.6 . . . . 71.05 110.51 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.9 pp -68.92 -22.64 26.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.24 -0.437 . . . . 73.41 111.981 -175.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -81.2 -30.96 34.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.742 0.306 . . . . 64.33 111.16 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -88.77 -39.16 14.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.4 -0.364 . . . . 71.52 111.219 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 47.9 ttm . . . . . 0 N--CA 1.464 0.253 0 O-C-N 123.33 0.394 . . . . 75.22 110.707 -177.201 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.401 ' HD2' ' OD2' ' A' ' 8' ' ' ASP . 8.7 ptt180 . . . . . 0 N--CA 1.451 -0.394 0 CA-C-O 121.056 0.455 . . . . 73.55 110.098 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -58.53 -44.6 89.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.636 -0.711 . . . . 73.32 111.695 -175.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -60.54 -52.72 64.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.425 . . . . 72.34 111.087 -177.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -68.35 -36.13 78.77 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.545 -0.298 . . . . 72.12 111.27 -179.52 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 27.9 tpp -67.89 -41.64 82.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.884 0.373 . . . . 74.42 110.9 -177.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -63.63 -36.11 82.73 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.441 -0.577 . . . . 74.32 109.441 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.612 ' HE1' HG11 ' A' ' 104' ' ' VAL . 55.5 t80 -63.65 -49.85 71.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.427 -0.806 . . . . 72.31 110.25 174.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -55.81 -50.1 71.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.496 -0.775 . . . . 62.43 111.42 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -62.04 -45.34 94.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.335 -0.393 . . . . 71.14 110.924 -176.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -65.49 -28.85 69.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.313 -0.403 . . . . 74.21 111.716 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.872 ' HB2' HG21 ' A' ' 12' ' ' ILE . 9.9 mm-40 -68.62 -35.99 78.03 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.617 -0.433 . . . . 72.23 111.102 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.583 ' HG3' HG22 ' A' ' 12' ' ' ILE . 35.4 mt-10 -78.39 -37.15 44.73 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.713 -0.395 . . . . 75.23 110.143 178.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 67.2 mt -65.35 -40.55 93.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.972 -0.558 . . . . 72.14 110.678 176.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.405 0 C-N-CA 121.095 -0.574 . . . . 75.4 112.054 176.606 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 N--CA 1.452 -0.356 0 CA-C-O 120.811 0.339 . . . . 70.44 110.45 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.3 t -119.93 126.38 75.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.692 -0.485 . . . . 72.33 109.692 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -127.78 132.84 49.46 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.054 0.454 . . . . 60.31 110.508 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.443 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 11.3 t70 -158.09 171.74 19.69 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.799 -1.186 . . . . 72.55 107.799 173.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.589 ' HB2' HG12 ' A' ' 105' ' ' VAL . . . -134.06 120.42 20.18 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.068 0.461 . . . . 73.41 112.12 -174.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.541 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 21.4 m -101.27 130.04 51.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.67 -0.696 . . . . 65.11 109.749 174.267 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.692 ' HA ' ' HA ' ' A' ' 103' ' ' GLU . 5.1 t -102.83 113.48 26.94 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.78 0.8 . . . . 71.32 110.436 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.631 HG23 ' HB3' ' A' ' 145' ' ' GLU . 4.5 mp -112.36 151.47 14.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.954 -1.021 . . . . 73.23 108.871 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.86 42.3 1.1 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.862 -0.685 . . . . 74.11 112.907 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.662 ' HB3' ' HB2' ' A' ' 18' ' ' GLN . 6.7 mmpt? -112.24 144.25 30.45 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 108.394 -0.965 . . . . 72.1 108.394 178.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -52.99 -57.96 1.75 Allowed 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.335 2.023 . . . . 54.1 113.738 -172.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 174.4 -53.46 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.251 0.548 . . . . 62.43 109.66 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.8 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 0.1 OUTLIER -54.43 -39.22 67.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.069 -0.969 . . . . 72.11 110.891 177.631 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.662 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 21.4 mm-40 -63.06 -27.79 69.64 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.061 -0.972 . . . . 71.54 111.37 -177.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.425 HD11 ' HB ' ' A' ' 102' ' ' THR . 95.5 mt -74.94 -48.35 24.93 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.9 -0.591 . . . . 31.14 111.162 -174.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.8 ' CE2' ' HA ' ' A' ' 17' ' ' GLU . 36.2 p90 -74.77 -23.42 58.52 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 119.704 -0.798 . . . . 61.1 110.643 177.259 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.56 -2.08 21.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.043 -0.526 . . . . 73.34 111.627 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.464 HG11 ' HZ ' ' A' ' 140' ' ' PHE . 12.0 p -53.38 -22.59 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 115.806 -0.633 . . . . 45.54 112.525 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -66.75 -27.31 67.5 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.275 0.559 . . . . 71.12 110.709 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.814 ' HG3' ' H ' ' A' ' 25' ' ' ASP . 15.0 tpp180 -105.54 -164.21 1.01 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.924 -1.139 . . . . 74.33 107.924 176.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.814 ' H ' ' HG3' ' A' ' 24' ' ' ARG . 28.6 t0 -83.93 36.47 0.56 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.45 0.643 . . . . 74.44 109.363 176.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.566 HD11 ' HA3' ' A' ' 147' ' ' GLY . 0.3 OUTLIER 41.89 63.1 6.9 Favored Pre-proline 0 N--CA 1.47 0.543 0 CA-C-N 114.897 -1.047 . . . . 72.12 112.279 -177.606 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.456 ' HD3' ' N ' ' A' ' 26' ' ' LEU . 89.9 Cg_endo . . . . . 0 N--CA 1.452 -0.93 0 C-N-CA 123.225 2.617 . . . . 55.42 113.094 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.234 0 N-CA-C 108.123 -1.066 . . . . 45.23 108.123 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.788 ' HB2' HD23 ' A' ' 80' ' ' LEU . 0.7 OUTLIER -112.57 134.15 54.24 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 107.708 -1.219 . . . . 74.42 107.708 -176.78 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -107.83 141.34 39.56 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 119.616 -0.834 . . . . 70.05 111.221 -171.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.9 t -108.1 -24.38 11.59 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.854 -0.338 . . . . 72.13 111.008 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.543 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . . . -135.98 153.78 51.29 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.542 -0.54 . . . . 60.21 109.542 175.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -150.61 16.68 0.8 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.876 0.325 . . . . 53.22 111.876 -172.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.601 ' HG2' ' HD3' ' A' ' 73' ' ' LYS . 1.6 mp0 -61.29 142.03 93.82 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 110.416 -0.216 . . . . 71.11 110.416 -176.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -79.51 -20.17 9.65 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.661 2.241 . . . . 74.23 113.017 -173.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -162.67 38.29 0.35 Allowed Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.303 -0.719 . . . . 72.33 111.303 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.601 ' HD3' ' HG2' ' A' ' 70' ' ' GLU . 54.3 tttp -129.74 -51.57 1.15 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.008 -0.367 . . . . 64.34 110.008 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.514 ' H ' ' HB2' ' A' ' 70' ' ' GLU . 29.3 ttp180 -166.09 129.47 2.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.25 -0.432 . . . . 73.34 110.902 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.646 ' HB ' HG22 ' A' ' 91' ' ' VAL . 6.3 mm -108.38 109.99 30.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.399 -0.963 . . . . 71.3 108.399 175.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.561 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . . . -129.94 116.3 18.42 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.05 0.452 . . . . 61.11 110.486 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.532 ' NE1' ' HA3' ' A' ' 89' ' ' GLY . 69.0 p-90 -113.18 155.54 24.82 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.629 -0.714 . . . . 70.24 109.928 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -142.87 176.45 9.06 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.935 -1.135 . . . . 75.53 107.935 175.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 51.3 p -96.05 177.68 5.66 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.924 -0.71 . . . . 74.05 110.153 174.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.788 HD23 ' HB2' ' A' ' 65' ' ' GLU . 7.3 mt -71.64 156.89 90.77 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 116.038 -0.528 . . . . 71.1 110.019 -177.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -52.93 -36.57 75.6 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.864 2.376 . . . . 74.14 112.755 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.92 21.44 44.93 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.764 -0.731 . . . . 73.42 112.696 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -120.5 176.64 5.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.608 0.242 . . . . 74.13 110.552 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.425 ' HD2' ' N ' ' A' ' 84' ' ' ARG . 8.5 mpt_? -115.05 144.85 42.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.534 -0.303 . . . . 73.32 110.351 -179.153 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.6 pp -88.91 166.74 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.984 0.421 . . . . 74.51 111.639 -178.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -126.07 -64.34 1.05 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.665 -0.698 . . . . 63.4 110.399 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -130.11 173.15 11.02 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.937 -1.135 . . . . 62.22 107.937 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.8 m -95.75 126.98 41.39 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.497 -0.557 . . . . 72.54 109.497 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.532 ' HA3' ' NE1' ' A' ' 77' ' ' TRP . . . -115.92 74.87 0.26 Allowed Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.663 -0.779 . . . . 73.11 111.85 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.561 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 35.2 tt0 -131.0 113.9 14.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.01 0.433 . . . . 71.15 110.241 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.646 HG22 ' HB ' ' A' ' 75' ' ' ILE . 18.6 m -120.47 131.91 71.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.533 -0.758 . . . . 71.24 109.401 177.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.79 ' HB2' HG23 ' A' ' 105' ' ' VAL . 4.5 mp -113.36 141.08 47.47 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.428 -0.509 . . . . 71.13 109.875 175.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.465 ' HZ ' ' HB3' ' A' ' 20' ' ' TYR . 58.2 m-85 -120.8 131.59 54.55 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.206 -0.452 . . . . 71.2 110.461 -177.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 34.2 ptt180 -141.18 142.8 28.44 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 109.53 -0.545 . . . . 74.42 109.53 173.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 94' ' ' ARG . 38.4 Cg_exo -62.67 112.89 1.75 Allowed 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 122.251 1.967 . . . . 72.45 110.757 174.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.45 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . . . -63.37 144.11 97.64 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.748 -0.66 . . . . 74.31 110.674 -174.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -23.5 109.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.691 1 C-N-CA 126.046 4.497 . . . . 65.44 115.356 -171.045 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.5 -67.79 3.65 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 114.77 -1.104 . . . . 41.32 111.849 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -177.81 38.41 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.731 -0.735 . . . . 72.23 110.453 -172.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.533 ' NE ' ' HA ' ' A' ' 100' ' ' ARG . 4.6 mmp_? -78.44 -6.98 56.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.259 0.552 . . . . 71.13 110.11 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 119.74 -143.66 17.06 Favored Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 110.145 -1.182 . . . . 63.32 110.145 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.425 ' HB ' HD11 ' A' ' 19' ' ' LEU . 30.6 m -127.22 116.5 20.68 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.791 -0.448 . . . . 74.35 109.791 174.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.692 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 11.0 pt-20 -88.38 138.42 31.45 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.253 -0.647 . . . . 71.44 109.253 177.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 1.5 p -108.49 108.83 26.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 115.336 -0.847 . . . . 65.42 111.135 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.79 HG23 ' HB2' ' A' ' 92' ' ' LEU . 2.6 m -87.27 110.35 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.446 -0.797 . . . . 63.14 109.319 174.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.83 138.48 50.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.678 -0.692 . . . . 71.21 110.676 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -122.84 102.35 7.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.658 -0.701 . . . . 65.14 110.702 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.481 HD21 ' CZ ' ' A' ' 110' ' ' TYR . 0.0 OUTLIER -123.19 152.82 40.85 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.133 -0.485 . . . . 72.1 109.772 178.782 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.7 t -100.58 149.34 23.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.381 0.61 . . . . 70.4 111.709 -172.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.481 ' CZ ' HD21 ' A' ' 108' ' ' LEU . 97.5 m-85 . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 115.166 -0.925 . . . . 75.32 109.019 174.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.545 0 N-CA-C 112.116 -0.394 . . . . 13.11 112.116 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.6 m -78.95 -12.47 60.03 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.654 0.242 . . . . 43.21 111.654 -177.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.43 -36.46 73.65 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.941 0.4 . . . . 74.3 111.395 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -73.28 -23.71 76.85 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.771 -0.728 . . . . 72.1 112.767 -177.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.09 -45.75 83.11 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.06 0.393 . . . . 63.32 112.06 -174.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 16.7 m -74.34 -41.77 50.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 111.977 0.362 . . . . 70.42 111.977 -176.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.8 pp -75.99 -22.73 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.729 0.299 . . . . 74.4 111.715 -176.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.4 -20.36 64.67 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.951 0.352 . . . . 41.34 111.951 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -64.44 -14.55 57.47 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.924 -0.58 . . . . 73.4 111.796 -175.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.581 -0.282 . . . . 54.45 111.213 179.743 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.559 ' O ' ' HG2' ' A' ' 138' ' ' MET . 32.7 mtp-105 . . . . . 0 N--CA 1.451 -0.405 0 N-CA-C 111.356 0.132 . . . . 73.43 111.356 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.29 -39.33 94.28 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 111.935 0.346 . . . . 64.12 111.935 -171.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.491 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 32.5 t70 -70.33 -30.68 67.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.228 0.537 . . . . 73.33 110.155 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.541 ' HG ' ' CG1' ' A' ' 10' ' ' VAL . 22.2 tp -78.08 -27.96 48.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.069 -0.514 . . . . 70.12 109.817 178.077 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.559 ' HG2' ' O ' ' A' ' 134' ' ' ARG . 29.5 mmt -66.49 -42.15 87.88 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.16 -0.473 . . . . 74.44 110.409 176.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 136' ' ' ASP . 5.9 ppt_? -75.05 -27.61 60.08 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.009 -0.367 . . . . 75.13 110.009 178.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.464 ' HZ ' HG11 ' A' ' 22' ' ' VAL . 83.7 t80 -61.54 -39.83 92.48 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.094 0.473 . . . . 71.31 109.819 173.038 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 138' ' ' MET . 35.0 ttmt -56.44 -42.18 77.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.443 -0.799 . . . . 73.53 109.72 174.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.435 HH21 ' CD ' ' A' ' 145' ' ' GLU . 0.0 OUTLIER -58.43 -48.66 79.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.876 -1.056 . . . . 74.41 111.083 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.37 -31.43 72.09 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.436 -0.347 . . . . 61.44 111.635 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.551 ' HG3' HG21 ' A' ' 12' ' ' ILE . 24.3 tp60 -76.51 -43.38 39.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.726 0.298 . . . . 74.23 110.798 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.631 ' HB3' HG23 ' A' ' 12' ' ' ILE . 16.3 pt-20 -80.07 -4.32 52.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.867 0.365 . . . . 65.24 110.714 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 60.6 tp -65.84 -36.41 83.4 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.185 -0.672 . . . . 34.41 109.185 171.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.566 ' HA3' HD11 ' A' ' 26' ' ' LEU . . . . . . . . 0 N--CA 1.449 -0.491 0 CA-C-N 115.398 -0.819 . . . . 73.43 112.3 176.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 108.923 -0.769 . . . . 75.31 108.923 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.1 m -88.62 143.37 11.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.297 0.57 . . . . 75.03 111.22 -173.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.781 ' HD2' ' O ' ' A' ' 7' ' ' ARG . 0.5 OUTLIER -137.91 109.63 7.09 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.481 -0.782 . . . . 71.22 109.949 178.568 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.589 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 2.1 t70 -132.92 172.3 12.79 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.452 -0.573 . . . . 61.24 109.452 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.643 ' HB1' ' HG2' ' A' ' 103' ' ' GLU . . . -144.7 122.94 12.23 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.026 0.441 . . . . 55.55 111.007 -173.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.476 HG23 HD11 ' A' ' 12' ' ' ILE . 4.4 m -113.02 149.35 15.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.886 -0.597 . . . . 73.21 111.133 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.8 m -100.98 109.87 21.83 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.855 -0.611 . . . . 73.14 111.017 -175.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.801 HG13 ' HG2' ' A' ' 141' ' ' LYS . 4.5 mp -118.49 145.93 23.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 110.091 -0.337 . . . . 74.24 110.091 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.37 56.97 4.9 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 121.12 -0.562 . . . . 64.21 112.552 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.627 ' HG2' HG22 ' A' ' 12' ' ' ILE . 75.6 mmtt -121.77 156.56 58.85 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 108.584 -0.895 . . . . 73.44 108.584 175.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.422 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 47.1 Cg_exo -56.51 -59.1 0.73 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 121.762 1.641 . . . . 75.12 112.4 -178.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . 171.09 -58.72 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.768 0.667 . . . . 65.4 110.046 174.204 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -49.31 -55.01 14.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.525 -1.216 . . . . 54.45 112.215 -173.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.534 ' O ' HD12 ' A' ' 26' ' ' LEU . 16.9 mm-40 -69.39 -10.69 59.09 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.177 0.806 . . . . 64.14 113.177 -173.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.45 ' HA ' HD23 ' A' ' 19' ' ' LEU . 16.2 mt -63.47 -24.79 67.97 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.007 -0.433 . . . . 72.21 111.624 176.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -72.86 -25.0 60.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.943 0.402 . . . . 55.42 110.387 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.84 -9.0 58.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.222 -0.444 . . . . 74.1 111.726 -176.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.837 HG21 ' HG2' ' A' ' 144' ' ' GLN . 14.0 p -52.36 -21.92 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 112.247 0.462 . . . . 65.34 112.247 -175.163 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -51.76 -38.21 54.51 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.471 -0.331 . . . . 73.03 110.523 175.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -145.23 61.23 1.3 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.633 -0.258 . . . . 72.02 110.703 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.491 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 21.4 t70 63.07 171.35 0.15 Allowed 'General case' 0 CA--C 1.538 0.507 0 O-C-N 123.83 0.706 . . . . 74.53 111.525 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.534 HD12 ' O ' ' A' ' 18' ' ' GLN . 0.6 OUTLIER -104.05 85.83 1.14 Allowed Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 110.012 -0.366 . . . . 71.14 110.012 -178.119 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 25' ' ' ASP . 61.4 Cg_endo . . . . . 0 C--N 1.344 0.292 0 C-N-CA 122.282 1.988 . . . . 72.41 112.77 -175.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.444 0 CA-C-O 120.676 0.274 . . . . 61.14 111.203 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.64 158.28 17.07 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.498 -0.556 . . . . 61.41 109.498 173.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.673 HD23 ' HB3' ' A' ' 69' ' ' ASP . 26.3 tp -109.64 141.45 42.17 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.359 -0.238 . . . . 62.03 110.359 -176.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.0 t -107.81 -6.98 16.45 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 120.861 -0.336 . . . . 64.44 111.708 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.673 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -153.98 124.82 7.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.654 0.264 . . . . 72.11 110.831 177.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.673 ' HB3' HD23 ' A' ' 66' ' ' LEU . 2.4 p30 -136.32 43.46 2.48 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.796 -0.638 . . . . 74.21 110.878 -176.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.476 ' HB2' ' H ' ' A' ' 74' ' ' ARG . 26.1 mm-40 -57.81 143.22 77.21 Favored Pre-proline 0 C--O 1.234 0.252 0 CA-C-N 116.173 -0.467 . . . . 74.1 110.412 -178.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.96 92.97 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.219 2.613 . . . . 75.32 113.208 -172.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 58.75 34.24 76.45 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.477 -0.783 . . . . 61.32 112.979 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 92' ' ' LEU . 92.0 mttt -129.1 -85.71 0.55 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.953 0.353 . . . . 74.02 111.953 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.79 ' HB2' ' HG ' ' A' ' 92' ' ' LEU . 31.8 ttt180 -118.23 113.78 22.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.412 0.625 . . . . 74.12 111.197 -173.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.48 HD13 ' HE2' ' A' ' 93' ' ' PHE . 3.8 mp -117.05 121.87 68.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.089 -0.959 . . . . 71.32 109.515 178.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.673 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -109.71 116.28 31.42 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.473 -0.566 . . . . 60.12 109.473 176.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.534 ' CZ2' ' HA3' ' A' ' 89' ' ' GLY . 31.4 p90 -87.85 141.33 28.67 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.626 0.727 . . . . 62.52 111.306 -173.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.49 ' HA ' ' NE ' ' A' ' 78' ' ' ARG . 0.5 OUTLIER -137.57 175.36 9.66 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.03 -0.986 . . . . 65.1 110.148 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.2 p -144.7 164.93 29.5 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.81 -0.811 . . . . 63.34 108.81 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.3 mt -77.86 149.27 77.0 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.913 -0.403 . . . . 65.42 109.913 -177.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.12 -27.23 54.61 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.945 2.43 . . . . 74.34 112.791 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.75 0.72 82.91 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.902 -0.666 . . . . 65.22 113.189 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.63 159.4 20.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.047 0.423 . . . . 64.31 110.927 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -98.35 13.06 32.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.019 0.438 . . . . 65.13 110.769 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.432 HD12 ' N ' ' A' ' 85' ' ' ILE . 4.2 mp -99.44 80.14 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.573 -0.529 . . . . 64.24 109.573 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -81.36 91.93 6.33 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.588 -0.523 . . . . 73.05 109.588 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -148.71 139.88 23.17 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.495 -0.775 . . . . 62.52 109.883 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.8 m -124.69 128.65 49.14 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.842 -0.799 . . . . 44.22 108.842 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.534 ' HA3' ' CZ2' ' A' ' 77' ' ' TRP . . . -155.69 174.0 33.73 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.014 -1.088 . . . . 71.43 112.89 -175.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -163.15 128.96 3.21 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.462 -0.57 . . . . 71.23 109.462 -175.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.788 ' HB ' HG12 ' A' ' 106' ' ' VAL . 2.5 p -122.58 120.9 62.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.159 0.504 . . . . 74.42 111.688 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.79 ' HG ' ' HB2' ' A' ' 74' ' ' ARG . 8.0 mp -110.97 122.63 48.36 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.83 -0.623 . . . . 75.2 110.087 173.279 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.48 ' HE2' HD13 ' A' ' 75' ' ' ILE . 79.1 m-85 -87.28 126.71 35.0 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.847 0.355 . . . . 74.33 110.556 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.69 144.06 49.79 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.351 -0.386 . . . . 75.22 110.375 177.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.46 131.12 30.56 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.56 2.173 . . . . 73.51 111.196 176.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.08 143.53 57.2 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.582 -0.281 . . . . 50.54 110.73 -177.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.88 141.97 96.18 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 123.131 2.554 . . . . 72.14 112.572 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.79 20.38 79.51 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.878 -0.601 . . . . 72.44 112.109 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 52.84 36.71 22.2 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 121.021 0.439 . . . . 72.35 110.893 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 -72.57 -18.88 61.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.789 -0.642 . . . . 73.11 110.94 -176.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 146.2 -143.05 11.1 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.978 -0.849 . . . . 61.42 110.978 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.6 m -123.83 131.35 53.57 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.123 0.487 . . . . 42.41 110.1 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.643 ' HG2' ' HB1' ' A' ' 9' ' ' ALA . 31.8 tt0 -99.64 121.41 41.18 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.832 -0.622 . . . . 44.2 110.105 -178.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.513 HG23 ' CG2' ' A' ' 91' ' ' VAL . 2.3 p -98.04 112.13 29.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.432 -0.804 . . . . 53.12 110.932 -178.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 92' ' ' LEU . 11.1 p -101.81 120.66 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-O 121.33 0.586 . . . . 73.41 109.786 177.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.788 HG12 ' HB ' ' A' ' 91' ' ' VAL . 30.3 m -123.77 147.1 28.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.945 -0.57 . . . . 70.41 111.596 -175.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -100.55 116.88 33.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.318 -0.855 . . . . 73.51 109.898 170.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.3 tt -113.06 120.59 41.86 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.018 -0.734 . . . . 74.43 109.018 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 25.1 m -109.71 133.12 53.49 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.252 -0.431 . . . . 63.3 111.099 -176.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 . . . . . 0 N--CA 1.443 -0.792 0 N-CA-C 108.845 -0.798 . . . . 75.44 108.845 176.189 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.581 0 N-CA-C 111.246 -0.741 . . . . 62.2 111.246 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.3 t -85.89 -40.44 15.93 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 117.233 0.516 . . . . 62.53 110.174 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.405 ' O ' HG12 ' A' ' 120' ' ' VAL . . . -73.0 -30.54 63.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.341 0.591 . . . . 74.51 110.126 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.496 ' O ' HG22 ' A' ' 121' ' ' ILE . . . -81.57 -19.92 65.09 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.337 -0.847 . . . . 64.31 113.043 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -79.44 -22.38 44.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 117.089 0.444 . . . . 75.51 112.094 -176.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 117' ' ' ALA . 7.0 p -64.96 -27.08 41.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.693 -0.23 . . . . 55.42 111.514 -174.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.496 HG22 ' O ' ' A' ' 118' ' ' GLY . 10.6 tp -65.45 -29.79 48.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.638 0.256 . . . . 74.33 110.727 -177.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.98 -23.15 59.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 65.05 110.922 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.4 -29.27 19.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.304 0.573 . . . . 73.53 109.608 176.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.815 -0.63 . . . . 60.15 109.669 177.281 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 . . . . . 0 N--CA 1.461 0.081 0 N-CA-C 112.717 0.636 . . . . 73.15 112.717 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -71.83 -37.64 70.28 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.48 -0.488 . . . . 72.44 111.037 -177.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -74.84 -38.29 62.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.243 0.544 . . . . 74.53 110.168 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.589 ' CD2' ' HB3' ' A' ' 8' ' ' ASP . 24.4 tp -66.59 -24.38 66.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.567 -0.742 . . . . 73.4 109.523 178.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.479 ' O ' ' HB3' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -62.64 -29.71 70.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.749 -0.66 . . . . 62.43 110.307 176.679 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -69.01 -43.42 74.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.889 -0.596 . . . . 75.44 110.149 176.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.525 ' O ' ' HG3' ' A' ' 144' ' ' GLN . 18.2 t80 -60.74 -37.96 83.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.876 -0.602 . . . . 65.35 109.9 174.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.801 ' HG2' HG13 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -53.64 -41.93 67.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.778 -0.647 . . . . 73.31 110.52 176.074 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -63.52 -31.36 72.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.879 -0.6 . . . . 64.43 110.436 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -79.17 -27.89 42.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.662 -0.699 . . . . 70.13 110.949 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.837 ' HG2' HG21 ' A' ' 22' ' ' VAL . 46.8 mt-30 -69.69 -40.61 76.24 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.069 0.461 . . . . 72.21 110.676 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.667 ' HB3' HG23 ' A' ' 12' ' ' ILE . 16.5 pt-20 -78.0 -13.63 59.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.926 -0.579 . . . . 63.31 110.4 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 58.4 tp -91.0 -61.58 1.64 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.818 -0.628 . . . . 75.52 110.88 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 110.97 -0.852 . . . . 71.23 110.97 -172.943 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.678 HG13 ' CB ' ' A' ' 108' ' ' LEU . 77.4 t . . . . . 0 N--CA 1.445 -0.679 0 CA-C-O 120.885 0.374 . . . . 74.35 110.05 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.8 m -146.68 151.3 14.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.926 -0.579 . . . . 73.41 110.15 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.46 109.79 22.28 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.204 -0.665 . . . . 64.25 109.204 173.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.443 ' HB3' HD23 ' A' ' 137' ' ' LEU . 2.6 t70 -157.36 174.27 15.68 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.105 -0.331 . . . . 74.33 110.105 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.481 ' HB2' HG22 ' A' ' 105' ' ' VAL . . . -131.43 131.5 43.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.242 -0.436 . . . . 73.54 110.848 -174.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.542 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 16.4 m -116.66 137.37 50.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.035 0.445 . . . . 62.4 110.663 177.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.1 m -83.65 105.14 14.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.935 -0.575 . . . . 54.24 110.222 -178.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.535 HD12 ' HB2' ' A' ' 144' ' ' GLN . 24.6 mm -114.3 149.93 16.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.727 0.299 . . . . 54.45 111.078 -177.039 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.76 25.68 8.26 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 121.159 -0.543 . . . . 75.34 112.67 177.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -98.4 145.65 30.23 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 108.764 -0.828 . . . . 70.23 108.764 176.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -59.0 -58.58 0.63 Allowed 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 121.946 1.764 . . . . 53.11 112.914 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 173.48 -43.55 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.097 0.559 . . . . 72.4 109.824 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.627 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 25.3 tt0 -48.3 -51.24 26.81 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 114.876 -1.057 . . . . 75.52 111.756 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -78.56 -11.09 59.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.611 -0.722 . . . . 63.21 111.504 -174.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.2 mt -83.66 -47.88 10.76 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.611 -0.268 . . . . 75.25 111.544 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.627 ' CE2' ' HA ' ' A' ' 17' ' ' GLU . 18.7 p90 -71.65 -24.37 61.84 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.383 -0.527 . . . . 74.01 110.811 -177.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.36 -13.36 61.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.974 -0.557 . . . . 51.45 111.495 -177.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.558 HG21 ' CZ ' ' A' ' 140' ' ' PHE . 6.1 p -57.01 -21.81 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 111.892 0.331 . . . . 72.52 111.892 -174.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -54.26 -31.81 54.57 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.139 -0.482 . . . . 71.22 110.696 177.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.64 ' NE ' ' HA ' ' A' ' 24' ' ' ARG . 4.7 tpm_? -135.42 32.33 3.09 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.425 -0.583 . . . . 64.21 109.425 176.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.691 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 29.2 t70 65.26 169.21 0.2 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.027 -0.988 . . . . 50.2 111.441 -177.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.57 86.84 2.39 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 121.034 0.445 . . . . 74.25 112.037 -176.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.691 ' HD3' ' O ' ' A' ' 25' ' ' ASP . 3.5 Cg_endo . . . . . 0 N--CA 1.457 -0.655 0 C-N-CA 123.339 2.693 . . . . 74.11 112.233 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.251 0 N-CA-C 108.819 -0.808 . . . . 64.11 108.819 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.485 ' HB2' HD23 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -121.31 134.83 55.16 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.197 -1.038 . . . . 74.21 108.197 179.076 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 30.9 tp -113.58 127.51 56.09 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.921 -0.312 . . . . 52.55 110.342 -170.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.0 p -92.4 -25.01 18.68 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.198 0.523 . . . . 61.45 111.119 -176.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.694 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -140.39 128.69 22.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.953 -0.567 . . . . 72.12 111.637 -177.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -130.19 26.47 5.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.352 -0.84 . . . . 74.0 110.189 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.818 ' HB3' ' HB3' ' A' ' 73' ' ' LYS . 6.0 mm-40 -62.63 141.79 96.87 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.805 -0.634 . . . . 64.44 110.673 -177.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 3.0 Cg_exo -76.45 95.89 1.06 Allowed 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 123.04 2.493 . . . . 55.35 112.026 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.74 21.04 62.58 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-N 116.064 -0.516 . . . . 41.4 112.742 178.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.818 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 1.3 tmtp? -109.76 -57.93 2.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.893 0.378 . . . . 75.12 109.985 -176.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.846 ' HG3' ' HG ' ' A' ' 92' ' ' LEU . 40.5 ttp180 -155.97 111.63 3.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.12 -0.491 . . . . 73.4 109.832 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.424 ' N ' HD12 ' A' ' 75' ' ' ILE . 3.8 mp -109.27 110.52 32.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.504 -0.554 . . . . 73.51 109.504 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.694 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -119.21 115.4 24.13 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.104 -0.498 . . . . 34.24 109.861 177.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.456 ' HZ3' HG12 ' A' ' 91' ' ' VAL . 39.9 p90 -105.3 135.98 45.67 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.697 -0.683 . . . . 64.35 109.914 -177.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.5 mmt85 -142.42 174.02 11.0 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.308 -0.86 . . . . 70.4 108.861 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.406 ' OG ' ' HA ' ' A' ' 85' ' ' ILE . 30.1 p -98.8 -163.44 1.04 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.82 -0.807 . . . . 74.43 108.82 171.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.485 HD23 ' HB2' ' A' ' 65' ' ' GLU . 14.6 mt -71.98 142.93 85.86 Favored Pre-proline 0 C--N 1.321 -0.662 0 C-N-CA 120.277 -0.569 . . . . 74.31 109.784 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -63.11 -20.31 70.86 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 123.158 2.572 . . . . 54.14 113.047 -174.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.56 16.35 34.41 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.895 -0.669 . . . . 74.13 112.55 178.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -123.25 176.79 5.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.914 0.387 . . . . 73.44 111.133 -177.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -63.15 137.32 58.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.718 -0.674 . . . . 64.45 109.912 175.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.406 ' HA ' ' OG ' ' A' ' 79' ' ' SER . 19.6 tt -115.82 -27.18 2.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.962 -0.295 . . . . 52.0 111.493 -176.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 66.41 -81.73 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 122.962 0.505 . . . . 74.33 111.81 178.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -133.24 132.42 41.43 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.747 -0.464 . . . . 72.14 109.747 -177.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.8 m -96.82 128.03 43.38 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.716 0.293 . . . . 73.12 110.45 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -125.63 144.48 15.15 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.997 -0.62 . . . . 71.12 111.712 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.411 ' HG2' ' HB3' ' A' ' 107' ' ' ARG . 9.2 pt-20 -156.64 133.17 10.06 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.133 -0.321 . . . . 74.53 110.133 177.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.474 ' CG2' HG23 ' A' ' 104' ' ' VAL . 2.4 p -124.41 118.47 53.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.329 0.585 . . . . 75.42 111.497 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.846 ' HG ' ' HG3' ' A' ' 74' ' ' ARG . 2.9 mp -108.14 126.91 53.32 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.973 -0.751 . . . . 72.13 108.973 174.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.514 ' HZ ' ' HB3' ' A' ' 20' ' ' TYR . 85.2 m-85 -91.46 120.95 32.74 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.046 0.45 . . . . 64.25 110.426 -178.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.409 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 2.0 mmp_? -110.5 143.94 29.16 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.821 -0.627 . . . . 72.21 109.912 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 94' ' ' ARG . 32.3 Cg_exo -59.64 116.69 3.46 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.298 1.998 . . . . 74.53 111.258 177.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . . . -63.44 144.21 97.68 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.409 . . . . 65.24 111.715 -174.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 96' ' ' ALA . 50.6 Cg_exo -54.65 130.68 41.59 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.978 2.452 . . . . 74.44 111.73 176.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.53 7.05 88.95 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.801 -0.714 . . . . 51.22 112.186 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 60.67 28.14 17.86 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.682 0.393 . . . . 72.15 111.591 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 66.2 mtt180 -89.29 14.53 10.84 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.173 0.435 . . . . 73.34 112.173 -176.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.97 -137.44 6.51 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.723 -0.751 . . . . 53.01 112.125 176.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 40.6 m -136.75 130.36 31.87 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.912 0.387 . . . . 74.31 110.098 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -91.32 115.68 28.22 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.315 0.579 . . . . 74.15 109.625 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.474 HG23 ' CG2' ' A' ' 91' ' ' VAL . 2.1 p -88.29 112.0 23.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.439 -0.8 . . . . 73.13 110.916 -176.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.481 HG22 ' HB2' ' A' ' 9' ' ' ALA . 23.9 t -100.27 110.44 27.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.277 -0.874 . . . . 53.15 109.748 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.406 HG23 HG22 ' A' ' 104' ' ' VAL . 12.2 t -118.62 127.85 75.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.067 0.46 . . . . 62.32 111.111 -177.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 107' ' ' ARG . 51.3 ttt-85 -106.73 122.39 46.27 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.012 -0.54 . . . . 74.42 110.178 176.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.678 ' CB ' HG13 ' A' ' 5' ' ' VAL . 4.6 mp -122.3 154.39 37.66 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.57 -0.53 . . . . 70.32 109.57 177.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.577 ' O ' HG11 ' A' ' 5' ' ' VAL . 6.2 m -84.75 119.33 25.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.789 0.328 . . . . 62.41 111.602 -177.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 14.2 p90 . . . . . 0 C--N 1.325 -0.484 0 CA-C-O 121.453 0.644 . . . . 71.22 111.386 -179.338 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.282 -0.327 . . . . 75.11 112.282 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.3 m -72.23 -15.54 61.93 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.047 0.451 . . . . 65.32 111.42 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -72.87 -19.9 61.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 61.2 110.973 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.557 ' HA2' HG22 ' A' ' 121' ' ' ILE . . . -55.92 -39.03 77.17 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 121.385 -0.436 . . . . 73.04 112.91 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.56 -29.34 70.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.127 0.489 . . . . 74.54 111.009 176.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 57.9 t -80.14 -46.81 21.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.829 -0.623 . . . . 53.35 110.614 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.557 HG22 ' HA2' ' A' ' 118' ' ' GLY . 15.5 tt -65.26 -21.69 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 116.271 -0.422 . . . . 72.22 110.925 -177.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.05 -25.25 63.57 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.503 -0.317 . . . . 61.53 111.131 176.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.442 ' C ' ' HD3' ' A' ' 123' ' ' ARG . 0.0 OUTLIER -74.95 -39.24 61.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.159 0.504 . . . . 71.13 110.094 175.967 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 17.1 tpt . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 116.054 -0.521 . . . . 74.52 111.063 179.293 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? . . . . . 0 N--CA 1.463 0.18 0 N-CA-C 111.391 0.145 . . . . 64.01 111.391 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -57.41 -56.07 26.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.803 0.335 . . . . 63.2 111.82 -174.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -74.93 -32.53 61.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.399 -0.364 . . . . 64.41 110.994 -176.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.542 ' HG ' ' CG1' ' A' ' 10' ' ' VAL . 20.6 tp -70.58 -24.74 62.82 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.243 -0.435 . . . . 73.45 109.972 -177.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.43 ' HA ' ' CE ' ' A' ' 138' ' ' MET . 0.0 OUTLIER -68.76 -45.78 70.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.152 -0.476 . . . . 72.51 110.199 177.636 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 71.0 mtm-85 -67.13 -37.89 84.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 71.23 110.171 177.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.558 ' CZ ' HG21 ' A' ' 22' ' ' VAL . 84.0 t80 -57.03 -42.45 80.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.457 -0.792 . . . . 75.42 110.586 174.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.505 ' HG3' HD13 ' A' ' 12' ' ' ILE . 26.0 ttpp -57.19 -46.85 82.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 62.54 110.726 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -60.66 -41.7 95.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.53 -0.759 . . . . 65.25 112.341 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -79.31 -24.68 42.67 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.554 -0.459 . . . . 73.33 110.937 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.535 ' HB2' HD12 ' A' ' 12' ' ' ILE . 8.1 mm-40 -71.83 -49.74 35.72 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.794 0.331 . . . . 74.13 110.958 175.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 13.4 pt-20 -67.9 -30.77 70.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.217 -0.447 . . . . 73.24 110.331 -177.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 48.7 tp -71.17 -41.32 70.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.773 -0.649 . . . . 74.41 109.658 174.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.551 0 CA-C-N 115.567 -0.742 . . . . 71.45 111.344 -177.927 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.846 HG22 HG22 ' A' ' 109' ' ' THR . 69.0 t . . . . . 0 N--CA 1.449 -0.507 0 N-CA-C 109.298 -0.63 . . . . 55.41 109.298 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.4 m -95.73 145.52 8.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.783 -0.644 . . . . 74.43 111.103 -174.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.489 ' HD2' ' O ' ' A' ' 7' ' ' ARG . 4.5 ppt_? -141.64 108.98 5.54 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.434 -0.803 . . . . 61.11 109.069 175.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -142.09 161.84 36.97 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.039 -0.726 . . . . 73.12 109.039 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.658 ' HB2' HG22 ' A' ' 105' ' ' VAL . . . -140.39 130.17 24.45 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.128 0.49 . . . . 71.51 111.969 -170.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.484 HG23 HD11 ' A' ' 12' ' ' ILE . 15.8 m -113.28 145.75 18.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.486 -0.779 . . . . 61.22 110.255 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 102' ' ' THR . 20.4 m -107.15 109.6 21.47 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.782 0.325 . . . . 64.32 111.067 -178.089 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.844 HG13 ' HG2' ' A' ' 141' ' ' LYS . 4.1 mp -98.82 147.97 6.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.26 -0.427 . . . . 73.41 109.883 -177.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.38 58.27 4.41 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.994 -0.622 . . . . 54.34 112.709 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.643 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 8.2 mmpt? -129.8 167.01 22.04 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 108.555 -0.905 . . . . 61.22 108.555 177.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 14' ' ' LYS . 27.5 Cg_endo -65.22 -58.35 0.21 Allowed 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 121.309 1.339 . . . . 75.25 112.306 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . 171.69 -55.73 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.622 0.725 . . . . 60.02 110.266 174.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -55.09 -51.82 65.17 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.46 -1.245 . . . . 74.4 112.848 -173.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -54.07 -27.11 30.51 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.154 0.427 . . . . 75.15 112.154 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.487 ' CD1' ' HB ' ' A' ' 102' ' ' THR . 56.2 mt -69.32 -20.41 63.87 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.167 0.432 . . . . 64.22 112.167 -175.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.454 ' CE1' HG21 ' A' ' 75' ' ' ILE . 46.3 t80 -72.0 -25.27 61.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.099 0.475 . . . . 73.43 110.65 175.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.6 -12.98 60.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.364 -0.38 . . . . 73.34 111.411 -176.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.4 p -53.95 -24.04 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 112.626 0.602 . . . . 64.33 112.626 -174.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.418 ' HD1' ' O ' ' A' ' 20' ' ' TYR . 98.1 m95 -57.69 -24.34 56.25 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.18 0.437 . . . . 74.35 112.18 -176.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.448 ' HA ' ' HD2' ' A' ' 24' ' ' ARG . 7.5 tpt180 -156.33 59.28 0.57 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.792 0.33 . . . . 71.33 110.582 175.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.709 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 18.3 t70 65.24 168.82 0.19 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.571 -0.74 . . . . 73.33 111.227 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.5 mt -102.29 87.8 1.2 Allowed Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.714 -0.476 . . . . 55.51 109.714 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.709 ' HD3' ' O ' ' A' ' 25' ' ' ASP . 2.3 Cg_endo . . . . . 0 N--CA 1.458 -0.597 0 C-N-CA 123.186 2.59 . . . . 72.0 112.697 -174.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.504 0 CA-C-O 120.719 0.295 . . . . 63.1 111.076 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 1.052 ' HB2' HD23 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -105.61 133.66 49.99 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.859 -0.793 . . . . 73.02 108.859 175.842 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.488 HD12 ' HA ' ' A' ' 77' ' ' TRP . 1.6 mm? -88.91 145.5 25.5 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 121.085 -0.246 . . . . 74.33 110.791 -173.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.5 t -92.53 -21.48 20.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.957 0.408 . . . . 71.2 110.209 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.783 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -121.87 130.48 53.4 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.338 -0.616 . . . . 54.31 109.338 174.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -128.58 23.98 5.82 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.473 0.654 . . . . 71.41 110.249 -172.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.556 ' HB3' ' HD3' ' A' ' 73' ' ' LYS . 29.2 mt-10 -73.17 141.52 81.12 Favored Pre-proline 0 C--N 1.326 -0.429 0 C-N-CA 120.582 -0.447 . . . . 64.34 110.551 -174.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.62 88.33 1.04 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.8 2.333 . . . . 72.5 113.326 -173.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.78 12.07 78.19 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 121.045 -0.597 . . . . 63.45 112.281 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.556 ' HD3' ' HB3' ' A' ' 70' ' ' GLU . 42.9 mtpt -95.36 -69.19 0.76 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.909 0.385 . . . . 74.23 110.325 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.465 ' HD2' ' OE2' ' A' ' 90' ' ' GLU . 10.2 ttp180 -147.72 127.15 13.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.908 -0.587 . . . . 71.14 110.095 -175.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.625 HD13 ' HE2' ' A' ' 93' ' ' PHE . 4.6 mp -131.01 111.4 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.398 0.618 . . . . 72.33 111.216 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.783 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -104.87 125.93 51.42 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.211 -0.904 . . . . 73.24 108.707 170.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.488 ' HA ' HD12 ' A' ' 66' ' ' LEU . 64.8 p-90 -80.4 159.07 25.8 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.369 0.604 . . . . 75.4 111.349 -175.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.494 ' HB3' ' O ' ' A' ' 65' ' ' GLU . 44.7 ttp180 -158.64 164.38 36.04 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.05 -0.977 . . . . 74.4 108.64 -177.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.561 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 19.9 m -123.65 60.34 1.09 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.621 0.248 . . . . 61.02 110.343 -178.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.052 HD23 ' HB2' ' A' ' 65' ' ' GLU . 22.4 mt 68.09 153.95 0.14 Allowed Pre-proline 0 N--CA 1.471 0.621 0 CA-C-N 115.701 -0.682 . . . . 71.13 111.632 -178.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.26 -19.49 38.45 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.598 2.199 . . . . 74.03 111.784 173.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.76 -24.27 77.13 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.906 -0.664 . . . . 60.52 112.059 178.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 79' ' ' SER . . . -108.52 178.87 4.36 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.245 -0.65 . . . . 63.51 109.245 175.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.518 ' HD2' ' N ' ' A' ' 84' ' ' ARG . 5.1 mpt_? -118.28 164.86 14.58 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.89 0.376 . . . . 63.53 110.3 -177.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.586 HD11 ' HA ' ' A' ' 88' ' ' SER . 6.2 tt -131.62 108.52 14.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.657 -0.701 . . . . 74.55 109.484 176.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -77.15 -37.42 53.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.777 -0.647 . . . . 73.34 110.942 -175.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -126.28 132.17 51.73 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.69 -0.485 . . . . 74.55 109.69 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.586 ' HA ' HD11 ' A' ' 85' ' ' ILE . 25.8 m -95.87 128.17 42.52 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.963 0.411 . . . . 61.35 111.282 -173.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -109.63 90.35 0.59 Allowed Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.133 -0.787 . . . . 35.31 111.133 174.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.465 ' OE2' ' HD2' ' A' ' 74' ' ' ARG . 40.9 tt0 -102.63 118.63 37.27 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.922 0.392 . . . . 75.13 110.478 -177.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.7 m -112.43 142.82 23.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.407 -0.59 . . . . 62.23 109.407 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.657 HD23 ' HD3' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -134.56 137.74 44.03 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.367 0.603 . . . . 74.32 110.178 171.209 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.625 ' HE2' HD13 ' A' ' 75' ' ' ILE . 85.5 m-85 -97.22 119.0 34.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.315 -0.857 . . . . 74.21 110.15 -174.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.657 ' HD3' HD23 ' A' ' 92' ' ' LEU . 18.5 mmm180 -104.01 143.01 25.79 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.643 -0.503 . . . . 74.31 109.643 179.009 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.5 109.91 2.87 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.129 1.886 . . . . 72.14 111.439 176.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.633 ' HB1' ' HB3' ' A' ' 100' ' ' ARG . . . -73.68 144.03 82.65 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.362 -0.607 . . . . 70.24 109.362 177.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -48.6 113.33 0.82 Allowed 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 123.445 2.763 . . . . 62.14 114.479 -169.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.23 -66.54 3.78 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 114.875 -1.057 . . . . 32.22 112.501 170.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -170.13 24.04 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.085 -0.558 . . . . 63.32 110.821 -173.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.633 ' HB3' ' HB1' ' A' ' 96' ' ' ALA . 5.6 tpm_? -64.47 -22.86 67.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.057 -0.52 . . . . 74.35 110.499 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 127.92 -154.77 19.92 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.29 -0.724 . . . . 73.22 111.29 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 11' ' ' THR . 2.5 m -105.68 125.29 50.82 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.96 -0.385 . . . . 51.14 109.96 175.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -89.89 100.65 13.42 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.031 -0.729 . . . . 71.1 109.031 173.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.511 HG12 ' HD1' ' A' ' 93' ' ' PHE . 3.4 m -87.46 129.47 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 109.13 -0.693 . . . . 63.53 109.13 178.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.658 HG22 ' HB2' ' A' ' 9' ' ' ALA . 18.7 t -117.19 115.92 50.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 109.082 -0.71 . . . . 74.11 109.082 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.601 HG12 HD22 ' A' ' 108' ' ' LEU . 24.0 t -103.5 116.67 47.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.304 -0.407 . . . . 60.13 110.371 -177.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -107.54 107.72 18.69 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.566 -0.531 . . . . 72.15 109.566 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.601 HD22 HG12 ' A' ' 106' ' ' VAL . 2.6 pt? -145.7 152.04 38.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.133 -0.485 . . . . 65.33 110.232 -177.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.846 HG22 HG22 ' A' ' 5' ' ' VAL . 51.2 p -107.4 132.91 52.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.327 -0.397 . . . . 60.13 111.011 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 49.2 p90 . . . . . 0 C--N 1.32 -0.685 0 CA-C-N 116.285 -0.416 . . . . 65.55 109.883 176.161 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.404 0 N-CA-C 112.151 -0.38 . . . . 71.3 112.151 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.5 m -64.78 -30.24 71.24 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 122.288 0.235 . . . . 45.54 111.501 -177.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.32 -28.34 69.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.516 -0.311 . . . . 52.44 111.364 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -60.82 -39.26 96.57 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.085 -0.578 . . . . 62.14 112.396 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.25 -34.43 78.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.144 0.497 . . . . 73.34 110.634 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.9 t -68.59 -43.32 83.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.792 -0.64 . . . . 71.44 110.17 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.7 mm -65.91 -36.62 77.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.969 -0.559 . . . . 71.21 110.487 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.39 -19.3 65.89 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.866 -0.607 . . . . 54.23 111.577 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -73.38 -32.31 64.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.777 0.322 . . . . 75.34 110.688 178.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 121.11 0.481 . . . . 70.12 110.516 179.517 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 134' ' ' ARG . 42.0 ttm180 . . . . . 0 C--O 1.219 -0.541 0 N-CA-C 111.601 0.223 . . . . 74.0 111.601 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -54.61 -43.63 72.36 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.956 -0.465 . . . . 75.0 111.018 -175.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -68.64 -47.39 66.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 72.12 111.273 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 23.7 tp -69.49 -25.47 64.08 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.101 0.477 . . . . 72.02 110.219 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.465 ' HA ' ' CE ' ' A' ' 138' ' ' MET . 0.1 OUTLIER -69.9 -33.27 71.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.042 -0.526 . . . . 71.41 110.015 176.018 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -39.73 89.4 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.236 -0.438 . . . . 63.04 110.153 176.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -56.97 -52.21 66.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.987 -0.551 . . . . 53.31 109.916 174.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.844 ' HG2' HG13 ' A' ' 12' ' ' ILE . 14.5 tmtt? -59.06 -35.34 73.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.717 -0.674 . . . . 61.0 110.73 176.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.426 ' HD2' ' HA ' ' A' ' 142' ' ' ARG . 14.4 tpt180 -62.48 -58.78 6.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.02 -0.536 . . . . 71.53 109.997 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -63.15 -32.98 74.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.025 -0.534 . . . . 64.54 110.906 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -58.32 -37.04 74.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.675 -0.693 . . . . 75.34 112.369 -175.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.489 ' HB3' HG23 ' A' ' 12' ' ' ILE . 8.2 pt-20 -109.96 -18.09 13.46 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.827 -0.349 . . . . 70.32 111.894 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.414 ' O ' HD23 ' A' ' 146' ' ' LEU . 5.0 tt -87.23 -38.53 16.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.168 0.508 . . . . 63.2 110.283 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.724 0 N-CA-C 111.343 -0.703 . . . . 72.21 111.343 -175.591 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 3.1 p . . . . . 0 N--CA 1.448 -0.55 0 CA-C-O 121.28 0.562 . . . . 61.33 109.769 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.3 t -97.92 116.72 41.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 116.213 -0.449 . . . . 75.43 109.81 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -93.23 123.44 36.5 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.372 0.606 . . . . 61.32 110.84 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.78 ' HB3' HD22 ' A' ' 137' ' ' LEU . 20.4 t0 -142.08 156.1 45.39 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.84 -1.17 . . . . 71.43 107.84 176.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.42 128.47 25.55 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.756 -0.378 . . . . 72.35 110.826 -176.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.525 HG13 HD23 ' A' ' 137' ' ' LEU . 27.9 m -110.07 134.91 50.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.664 -0.495 . . . . 74.13 109.664 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.782 HG21 ' HG3' ' A' ' 100' ' ' ARG . 1.3 m -108.07 110.99 22.81 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.768 -0.456 . . . . 63.35 109.768 -178.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.618 ' HB ' HD21 ' A' ' 19' ' ' LEU . 12.9 mm -108.24 150.86 10.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.925 -0.58 . . . . 63.11 110.117 -174.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.83 44.54 2.32 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.14 -0.553 . . . . 72.1 112.523 176.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.419 ' HB2' HD21 ' A' ' 19' ' ' LEU . 67.0 mmtt -119.24 145.42 38.39 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 107.889 -1.152 . . . . 73.22 107.889 176.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.411 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 83.1 Cg_exo -48.49 -58.01 2.01 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.568 2.179 . . . . 73.3 113.57 -173.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . 173.34 -53.28 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.378 0.609 . . . . 72.43 110.389 177.049 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -52.93 -32.43 45.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.677 -1.147 . . . . 75.11 111.98 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -85.49 -8.52 58.31 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.943 -0.571 . . . . 74.25 111.37 -175.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.849 ' HB2' ' HE2' ' A' ' 93' ' ' PHE . 96.1 mt -79.31 -44.42 21.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.711 -0.222 . . . . 54.42 111.437 -176.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.549 ' HB2' ' HZ ' ' A' ' 93' ' ' PHE . 64.1 t80 -71.46 -30.31 65.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.511 0.672 . . . . 74.42 109.787 177.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.935 ' HB1' ' HA ' ' A' ' 26' ' ' LEU . . . -66.11 -3.96 6.52 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.245 -0.889 . . . . 73.34 112.357 -175.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.549 HG21 ' CD1' ' A' ' 140' ' ' PHE . 13.4 p -61.37 -22.18 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.348 -0.387 . . . . 75.42 111.333 176.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.417 ' HD1' ' O ' ' A' ' 20' ' ' TYR . 76.2 m95 -66.6 -10.83 49.7 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.82 0.343 . . . . 72.44 111.286 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.451 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 6.5 mmm180 -132.56 -84.47 0.48 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.643 -0.253 . . . . 75.13 111.298 173.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.593 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 3.9 t70 -166.8 33.51 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.885 -0.326 . . . . 72.23 110.73 -176.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.935 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 0.7 OUTLIER 44.19 71.87 1.36 Allowed Pre-proline 0 N--CA 1.472 0.666 0 O-C-N 123.758 0.661 . . . . 72.53 112.46 -177.692 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo . . . . . 0 N--CA 1.457 -0.638 0 C-N-CA 122.644 2.229 . . . . 71.1 112.359 -178.431 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.302 0 CA-C-O 120.732 0.301 . . . . 63.4 110.415 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.443 ' HG2' ' H ' ' A' ' 80' ' ' LEU . 15.3 pt-20 -108.27 154.99 20.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.211 -0.45 . . . . 72.23 111.113 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.1 tp -117.58 123.02 45.2 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.059 -0.719 . . . . 75.13 109.059 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.434 ' HB ' ' CG ' ' A' ' 78' ' ' ARG . 12.2 t -83.52 -22.53 32.42 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.621 -0.432 . . . . 70.3 112.073 -171.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.948 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -132.63 132.36 42.39 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.67 -0.412 . . . . 72.0 110.713 -178.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -139.42 40.87 2.06 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.793 -0.639 . . . . 62.32 110.797 -176.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.555 ' CB ' ' HB3' ' A' ' 73' ' ' LYS . 5.4 mm-40 -80.38 143.43 55.79 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 75.35 109.842 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 23.9 Cg_exo -64.82 -55.67 0.49 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.59 2.194 . . . . 45.32 112.528 -178.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -134.12 64.15 0.6 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.852 -0.689 . . . . 72.4 111.856 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.555 ' HB3' ' CB ' ' A' ' 70' ' ' GLU . 69.2 tttt -143.78 -78.83 0.21 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.898 -0.408 . . . . 65.41 109.898 -176.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -168.03 147.5 4.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.785 0.326 . . . . 73.22 110.682 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.714 HD13 ' HE1' ' A' ' 93' ' ' PHE . 2.4 mp -122.8 116.68 49.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.76 -0.655 . . . . 72.34 109.913 175.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.948 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -103.72 149.1 25.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.187 -0.46 . . . . 51.42 109.835 176.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 29.1 p-90 -94.0 152.6 18.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.098 0.475 . . . . 73.21 111.836 -172.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.434 ' CG ' ' HB ' ' A' ' 67' ' ' THR . 75.7 mmt-85 -144.27 173.53 11.68 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.071 -1.085 . . . . 74.11 108.071 169.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.622 ' OG ' HG13 ' A' ' 85' ' ' ILE . 11.5 m -150.13 22.75 0.85 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.799 -0.361 . . . . 74.11 110.598 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.443 ' H ' ' HG2' ' A' ' 65' ' ' GLU . 91.2 mt 65.97 158.39 0.13 Allowed Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 115.834 -0.621 . . . . 62.45 110.233 -173.129 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -67.7 5.39 1.03 Allowed 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.76 2.307 . . . . 72.34 113.264 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.11 -21.01 10.43 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.8 -0.714 . . . . 75.3 113.095 -177.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.502 ' O ' ' HB2' ' A' ' 79' ' ' SER . . . -150.45 167.98 25.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.154 0.477 . . . . 74.13 111.282 -175.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 84' ' ' ARG . 3.7 mpt_? -138.29 141.35 39.82 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.468 -0.567 . . . . 73.31 109.468 174.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.622 HG13 ' OG ' ' A' ' 79' ' ' SER . 71.1 mt -70.65 -16.45 19.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-O 120.917 0.389 . . . . 73.15 110.365 176.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 75.39 -38.37 0.36 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.685 0.794 . . . . 65.45 110.773 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -64.82 132.7 50.2 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.173 -0.677 . . . . 74.21 109.173 170.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.1 t -126.35 127.89 46.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.941 0.4 . . . . 71.41 110.899 -175.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.493 ' HA3' ' HB3' ' A' ' 107' ' ' ARG . . . 158.94 133.0 1.45 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 121.042 -0.599 . . . . 73.15 112.115 176.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -101.27 138.46 38.26 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.899 0.381 . . . . 51.15 109.977 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.507 HG22 HG12 ' A' ' 106' ' ' VAL . 63.1 t -89.04 125.02 42.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.79 -0.641 . . . . 62.43 111.484 -175.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.3 mp -107.37 132.04 53.59 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.053 -0.976 . . . . 73.43 110.241 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.849 ' HE2' ' HB2' ' A' ' 19' ' ' LEU . 91.9 m-85 -99.36 109.42 22.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.188 0.518 . . . . 64.2 109.872 177.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.477 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 21.0 mtp180 -109.67 144.65 30.33 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.554 -0.748 . . . . 74.33 110.176 -173.301 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 94' ' ' ARG . 11.9 Cg_exo -70.5 123.93 10.32 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.764 2.31 . . . . 71.4 112.636 -176.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.917 ' HB1' ' HB3' ' A' ' 100' ' ' ARG . . . -98.06 160.04 29.33 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 108.828 -0.804 . . . . 55.25 108.828 171.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.05 159.69 11.82 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 121.789 1.66 . . . . 75.22 110.604 169.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -52.38 -26.64 22.85 Favored Glycine 0 CA--C 1.519 0.3 0 N-CA-C 114.35 0.5 . . . . 71.13 114.35 -172.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -105.61 7.8 32.92 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 112.996 0.739 . . . . 44.43 112.996 -176.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.917 ' HB3' ' HB1' ' A' ' 96' ' ' ALA . 9.5 tpp180 -101.53 -35.99 8.95 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.343 -0.614 . . . . 71.3 109.343 175.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.615 ' O ' ' HB3' ' A' ' 96' ' ' ALA . . . 111.51 -130.05 9.5 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 121.15 -0.548 . . . . 72.3 112.012 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 54.7 m -129.89 132.91 46.57 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.73 -0.471 . . . . 65.23 109.73 173.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -88.24 107.02 18.59 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.126 0.489 . . . . 74.23 110.9 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 10' ' ' VAL . 6.4 p -88.33 101.59 11.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.466 -0.788 . . . . 73.32 109.812 174.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 59.5 t -86.25 108.5 17.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.901 -0.59 . . . . 73.13 110.187 -178.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.507 HG12 HG22 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -111.55 129.16 67.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.597 -0.728 . . . . 65.53 110.574 -178.275 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.493 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 39.9 ttm180 -107.79 110.68 22.55 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.61 -0.723 . . . . 72.5 109.452 177.157 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.503 ' H ' HD23 ' A' ' 108' ' ' LEU . 1.5 pt? -123.33 121.12 35.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.472 0.653 . . . . 60.2 111.7 -176.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 6.6 m -95.79 120.48 36.13 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.22 -0.9 . . . . 54.1 108.875 175.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 31.1 p90 . . . . . 0 N--CA 1.447 -0.621 0 CA-C-O 121.482 0.658 . . . . 63.43 111.458 -173.805 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.395 0 N-CA-C 112.754 -0.138 . . . . 42.25 112.754 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.8 t -63.73 -49.0 74.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.758 0.313 . . . . 74.03 110.49 -178.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.53 -32.56 73.52 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.281 -0.418 . . . . 75.32 110.742 178.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.64 -29.1 71.51 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.754 -0.657 . . . . 64.33 112.204 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.01 -31.41 62.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.931 0.396 . . . . 65.25 110.677 178.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.24 -50.01 56.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.015 -0.539 . . . . 64.33 110.585 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.561 ' HA ' ' HB3' ' A' ' 124' ' ' MET . 29.0 pt -69.1 -21.56 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.489 . . . . 63.23 111.261 -178.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.25 -39.68 83.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.541 -0.3 . . . . 63.1 111.367 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -89.92 -23.03 21.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.239 0.542 . . . . 74.34 110.192 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.561 ' HB3' ' HA ' ' A' ' 121' ' ' ILE . 16.3 tpt . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.735 -0.666 . . . . 72.3 110.993 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.639 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.453 -0.275 0 CA-C-O 120.709 0.29 . . . . 70.04 110.695 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.517 ' HB2' HD12 ' A' ' 121' ' ' ILE . 9.1 m-20 -61.58 -30.68 70.83 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.238 -0.653 . . . . 53.23 109.238 178.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.13 -53.23 53.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.784 -1.098 . . . . 71.21 110.422 176.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.78 HD22 ' HB3' ' A' ' 8' ' ' ASP . 1.2 tp -79.74 -31.42 41.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.599 -0.728 . . . . 63.05 110.929 -178.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.698 ' SD ' ' HD3' ' A' ' 141' ' ' LYS . 28.3 tpp -63.67 -26.6 68.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.936 -0.574 . . . . 71.11 111.395 -177.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -62.91 -54.35 39.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.981 -0.554 . . . . 64.01 111.151 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.711 ' HE2' ' HG ' ' A' ' 137' ' ' LEU . 3.1 p90 -77.31 -29.71 53.75 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.93 -0.308 . . . . 72.22 110.493 -177.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.698 ' HD3' ' SD ' ' A' ' 138' ' ' MET . 51.3 tttm -49.41 -51.99 31.59 Favored 'General case' 0 C--O 1.232 0.153 0 O-C-N 123.28 0.363 . . . . 55.14 111.297 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.434 ' HA ' ' HG2' ' A' ' 145' ' ' GLU . 0.5 OUTLIER -67.44 -30.68 70.48 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.903 -0.589 . . . . 64.41 110.668 -174.775 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -71.67 -36.58 70.7 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.813 0.34 . . . . 74.11 110.15 177.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.459 ' HB3' HG21 ' A' ' 12' ' ' ILE . 14.1 mm100 -64.12 -38.33 90.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 74.04 111.438 177.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.469 ' HB3' HG23 ' A' ' 12' ' ' ILE . 11.6 pt-20 -87.91 -4.96 58.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.249 -0.432 . . . . 74.42 111.368 -176.191 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.6 tp -111.02 -38.3 5.12 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.767 0.318 . . . . 73.23 111.113 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.39 0 C-N-CA 121.145 -0.55 . . . . 70.55 113.802 -173.2 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.757 HG22 ' HB ' ' A' ' 109' ' ' THR . 99.0 t . . . . . 0 N--CA 1.447 -0.592 0 N-CA-C 108.711 -0.848 . . . . 74.12 108.711 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.9 p -78.94 139.37 18.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.998 -0.546 . . . . 71.1 110.753 -174.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.471 ' HB3' ' HG3' ' A' ' 107' ' ' ARG . 17.3 ptt180 -132.55 134.79 45.41 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.992 -0.549 . . . . 62.21 110.379 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.755 ' HB3' HD22 ' A' ' 137' ' ' LEU . 4.2 t70 -158.14 171.81 19.54 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.443 -0.947 . . . . 74.44 108.443 172.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.426 ' CB ' HG22 ' A' ' 105' ' ' VAL . . . -146.33 120.42 9.45 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.874 0.368 . . . . 65.5 111.286 -174.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.2 m -112.73 133.55 58.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.9 -0.591 . . . . 73.12 110.756 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.0 m -97.96 112.31 24.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.922 0.392 . . . . 75.11 111.069 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.904 HG21 ' HG3' ' A' ' 144' ' ' GLN . 4.4 mp -117.28 146.38 21.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.386 -0.598 . . . . 74.31 109.386 176.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.52 53.51 3.2 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.086 -0.578 . . . . 75.22 112.972 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.517 ' HG2' HG22 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -105.83 153.99 39.68 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 107.868 -1.16 . . . . 54.22 107.868 173.121 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.43 -57.44 1.62 Allowed 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 121.795 1.664 . . . . 72.11 111.438 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 171.46 -49.63 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.27 0.981 . . . . 52.52 108.762 172.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -48.92 -44.22 40.2 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.17 -1.377 . . . . 61.42 112.124 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -64.61 -23.18 67.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.914 -0.584 . . . . 62.05 112.033 -176.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.469 ' O ' HG12 ' A' ' 22' ' ' VAL . 92.4 mt -76.98 -24.9 52.23 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.893 0.378 . . . . 71.2 110.577 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.569 ' HE1' HG12 ' A' ' 75' ' ' ILE . 55.9 t80 -72.12 -41.53 67.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.536 0.684 . . . . 74.2 109.795 175.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.836 ' HB1' ' HD2' ' A' ' 27' ' ' PRO . . . -76.43 -8.9 58.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.319 -0.855 . . . . 55.33 112.943 -175.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 19' ' ' LEU . 9.6 p -61.8 -22.3 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 111.765 0.283 . . . . 71.11 111.765 -174.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 33.6 t-105 -64.04 -14.79 56.94 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.401 -0.363 . . . . 73.3 111.147 -176.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -142.3 46.24 1.62 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.027 0.441 . . . . 63.31 110.784 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 36.3 t70 62.88 28.46 16.38 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.579 -0.737 . . . . 72.24 112.456 172.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.445 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 5.5 mp 53.46 80.27 0.3 Allowed Pre-proline 0 N--CA 1.47 0.557 0 CA-C-N 115.935 -0.575 . . . . 53.11 111.45 177.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.836 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 58.8 Cg_endo . . . . . 0 C--O 1.233 0.245 0 C-N-CA 122.693 2.262 . . . . 72.24 113.179 -177.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 110.038 -0.356 . . . . 62.34 110.038 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.588 ' HB3' ' HB2' ' A' ' 79' ' ' SER . 7.3 tp10 -123.99 154.92 39.13 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.387 -0.598 . . . . 74.13 109.387 177.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.949 ' HG ' ' HA ' ' A' ' 77' ' ' TRP . 3.3 mp -115.76 135.26 54.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.118 0.485 . . . . 74.02 111.6 -174.218 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.6 t -75.02 -32.41 61.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.313 -0.858 . . . . 74.44 111.474 -174.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.8 130.36 18.93 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.394 -0.522 . . . . 71.13 111.47 -176.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 8.0 p-10 -149.18 110.89 4.52 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.295 -0.866 . . . . 62.3 109.268 173.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.645 ' HB2' ' HB3' ' A' ' 73' ' ' LYS . 5.1 mm-40 -108.26 142.31 25.07 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 115.591 -0.731 . . . . 64.03 109.371 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 38.5 Cg_exo -61.98 -27.37 79.55 Favored 'Trans proline' 0 N--CA 1.466 -0.097 0 C-N-CA 122.806 2.337 . . . . 74.41 112.238 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -146.36 49.54 0.64 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.575 -0.822 . . . . 73.13 112.625 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.645 ' HB3' ' HB2' ' A' ' 70' ' ' GLU . 39.4 ttmt -148.37 -79.92 0.14 Allowed 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.77 -0.253 . . . . 70.11 110.587 177.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.638 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 10.3 ptp180 -154.47 150.91 28.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.996 0.426 . . . . 75.54 111.135 175.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.569 HG12 ' HE1' ' A' ' 20' ' ' TYR . 4.5 mp -123.33 110.47 26.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 108.771 -0.826 . . . . 62.33 108.771 173.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -126.14 141.82 51.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.301 0.572 . . . . 71.11 112.396 -172.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.949 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 0.5 OUTLIER -90.31 124.83 35.23 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.137 -0.938 . . . . 73.52 112.34 -173.374 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.669 ' HG3' ' O ' ' A' ' 77' ' ' TRP . 32.6 mtm180 175.54 118.73 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 O-C-N 124.382 1.052 . . . . 73.23 111.827 173.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.588 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 23.6 m -163.25 -54.32 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.657 0.265 . . . . 63.32 111.34 166.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.8 mp -102.72 146.41 32.34 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.697 0.284 . . . . 75.23 111.218 -176.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.46 -16.96 11.67 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 123.088 2.525 . . . . 61.44 112.508 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.67 13.05 54.65 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.904 -0.665 . . . . 74.21 112.293 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 84' ' ' ARG . . . -129.55 -165.72 1.56 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.157 -0.312 . . . . 75.44 110.157 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.542 ' O ' HG12 ' A' ' 85' ' ' ILE . 58.4 mtm180 73.47 -170.12 0.12 Allowed 'General case' 0 N--CA 1.465 0.325 0 O-C-N 123.864 0.727 . . . . 74.22 110.972 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 84' ' ' ARG . 14.2 pt 60.93 -46.26 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 125.896 1.678 . . . . 64.23 113.891 179.222 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -79.08 -31.33 44.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.151 0.501 . . . . 74.43 109.792 177.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -130.73 134.63 47.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.609 -0.723 . . . . 74.44 109.695 176.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.8 m -145.51 131.35 19.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.937 -0.574 . . . . 40.44 109.454 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 107' ' ' ARG . . . 173.0 127.15 0.95 Allowed Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 119.877 -1.154 . . . . 74.2 113.604 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 0.3 OUTLIER -118.87 142.03 48.11 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.269 -0.641 . . . . 72.51 109.269 171.432 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 95.6 t -100.84 136.86 30.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.58 -0.282 . . . . 65.13 110.478 177.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.798 ' HB2' ' HB ' ' A' ' 105' ' ' VAL . 3.4 mm? -113.66 120.41 40.79 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.924 -0.58 . . . . 65.41 109.85 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -98.82 105.85 18.05 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.982 -0.748 . . . . 55.41 108.982 172.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.462 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 0.7 OUTLIER -103.99 143.45 26.69 Favored Pre-proline 0 C--N 1.317 -0.841 0 CA-C-N 115.771 -0.649 . . . . 71.23 110.132 -175.519 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 94' ' ' ARG . 5.8 Cg_exo -74.32 103.16 1.64 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.24 1.96 . . . . 64.11 110.23 172.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.99 142.99 95.07 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.117 -0.492 . . . . 62.02 110.689 -174.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -40.04 120.21 0.77 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 124.311 3.341 . . . . 74.45 114.925 -171.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.25 -69.6 2.56 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.025 -0.989 . . . . 62.41 111.583 174.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 175.78 26.83 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.437 -0.882 . . . . 74.4 109.559 -176.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -66.19 -22.48 66.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.948 -0.569 . . . . 71.23 111.17 -174.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 138.64 -151.16 21.48 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.35 -0.7 . . . . 61.03 111.35 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.9 m -114.2 127.15 55.76 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.953 0.406 . . . . 61.22 110.268 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -95.73 111.21 23.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.773 -0.649 . . . . 60.23 110.121 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.6 p -88.29 99.31 8.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.839 0.828 . . . . 71.53 109.943 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.798 ' HB ' ' HB2' ' A' ' 92' ' ' LEU . 21.6 t -89.2 110.08 21.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 114.995 -1.002 . . . . 73.13 108.757 177.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.708 HG22 HD22 ' A' ' 108' ' ' LEU . 7.7 p -114.35 120.3 63.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 121.48 0.657 . . . . 73.14 110.869 -176.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.552 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 19.7 ttp180 -114.43 98.4 6.89 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.545 -0.752 . . . . 73.41 108.99 176.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.708 HD22 HG22 ' A' ' 106' ' ' VAL . 2.3 pt? -131.91 151.31 51.79 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.767 0.317 . . . . 71.13 111.027 -171.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.757 ' HB ' HG22 ' A' ' 5' ' ' VAL . 12.2 t -97.81 127.75 43.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.147 0.499 . . . . 74.21 110.756 179.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 115.303 -0.862 . . . . 75.04 109.38 -176.41 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.706 0 CA-C-O 120.73 0.072 . . . . 62.41 113.033 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.7 m -61.59 -11.11 9.88 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.603 0.964 . . . . 62.52 113.603 -172.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.16 -35.11 61.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.738 0.304 . . . . 75.23 111.545 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.42 -28.74 42.73 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.593 -0.813 . . . . 70.21 112.704 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.09 -40.65 98.28 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.706 0.261 . . . . 54.41 111.706 -176.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.3 p -67.67 -30.4 48.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.967 0.413 . . . . 72.23 110.73 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 48.0 mm -73.44 -33.88 41.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.06 0.457 . . . . 73.33 110.411 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.27 -19.88 65.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.959 -0.564 . . . . 65.53 111.373 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.58 ' NE ' ' HA ' ' A' ' 123' ' ' ARG . 5.6 mmp_? -77.7 -13.65 59.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.559 -0.291 . . . . 72.2 111.339 178.189 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 35.4 ttp . . . . . 0 C--N 1.331 -0.205 0 N-CA-C 109.955 -0.387 . . . . 72.14 109.955 176.394 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 . . . . . 0 C--O 1.234 0.284 0 CA-C-O 120.82 0.343 . . . . 73.02 110.24 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -49.5 -56.5 9.6 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.652 -0.704 . . . . 75.14 112.854 -174.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -66.36 -33.78 76.49 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.835 -0.346 . . . . 64.43 111.216 -172.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.755 HD22 ' HB3' ' A' ' 8' ' ' ASP . 4.3 mp -71.01 -43.84 67.11 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.522 -0.308 . . . . 72.34 111.054 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.5 ttp -60.07 -37.92 81.32 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.141 0.496 . . . . 74.11 110.006 174.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -65.74 -54.78 22.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.441 -0.799 . . . . 71.23 111.269 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.563 ' CE2' ' HA ' ' A' ' 137' ' ' LEU . 4.2 p90 -73.52 -29.8 62.7 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 120.078 -0.649 . . . . 74.31 110.911 -176.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 145' ' ' GLU . 60.5 tttm -55.43 -47.11 76.5 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.677 -0.49 . . . . 71.24 109.677 174.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.466 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 11.4 mmm180 -51.18 -52.18 46.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.903 -1.044 . . . . 74.23 111.609 176.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -70.55 -45.12 66.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.102 -0.499 . . . . 62.43 111.241 -176.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.904 ' HG3' HG21 ' A' ' 12' ' ' ILE . 5.0 tp-100 -63.12 -43.9 97.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.82 -0.627 . . . . 62.1 111.301 -177.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.65 ' HG3' HG23 ' A' ' 12' ' ' ILE . 3.0 tt0 -77.03 -23.0 52.13 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 112.212 0.449 . . . . 74.01 112.212 -177.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 0.7 OUTLIER -63.07 -57.45 10.6 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.809 -0.441 . . . . 72.32 109.809 -179.258 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.637 0 N-CA-C 111.449 -0.66 . . . . 53.14 111.449 -179.961 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.891 HG22 HG22 ' A' ' 109' ' ' THR . 86.0 t . . . . . 0 N--CA 1.445 -0.677 0 N-CA-C 110.029 -0.36 . . . . 73.1 110.029 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.2 m -114.23 142.56 26.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.198 0.523 . . . . 65.52 110.752 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -136.05 109.66 8.01 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.062 -0.718 . . . . 75.33 109.062 175.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.528 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 1.5 t70 -140.23 171.65 13.86 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.18 -0.674 . . . . 71.1 109.18 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.18 120.56 12.37 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.841 0.353 . . . . 65.34 110.575 -175.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.436 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 12.4 m -102.4 133.52 45.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.121 -0.49 . . . . 54.23 110.183 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.836 HG22 ' HB1' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -84.58 102.34 12.82 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.089 0.471 . . . . 72.34 110.275 -179.171 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.585 HG21 ' HG2' ' A' ' 144' ' ' GLN . 35.7 mm -107.47 138.91 31.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.752 -0.658 . . . . 72.23 111.272 -172.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.583 ' O ' ' HE3' ' A' ' 14' ' ' LYS . . . -85.58 39.9 3.02 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 121.358 -0.449 . . . . 74.34 113.541 -176.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.583 ' HE3' ' O ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -111.49 148.71 39.4 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.301 -0.629 . . . . 74.54 109.301 174.964 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.416 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 82.3 Cg_exo -50.52 -57.75 2.09 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.021 2.481 . . . . 72.45 114.0 -174.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' A' ' 19' ' ' LEU . . . 172.87 -63.48 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.582 0.551 . . . . 73.33 110.817 174.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.425 ' HG3' ' HB2' ' A' ' 71' ' ' PRO . 1.7 tm-20 -64.82 -34.73 79.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.962 -0.563 . . . . 73.24 110.648 -175.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.718 ' HB3' ' HG3' ' A' ' 27' ' ' PRO . 2.4 mp0 -63.41 -15.75 58.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.959 -0.564 . . . . 60.34 111.217 178.299 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' A' ' 16' ' ' ALA . 66.9 mt -75.1 -23.93 58.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.507 -0.315 . . . . 70.14 111.354 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.54 ' CE1' HG21 ' A' ' 75' ' ' ILE . 48.8 t80 -71.77 -27.25 62.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.183 0.516 . . . . 70.31 110.352 177.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.42 -7.11 34.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.847 -0.615 . . . . 53.3 111.52 -178.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.2 p -63.59 -22.3 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 116.412 -0.358 . . . . 64.54 110.365 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 47.3 t90 -60.27 -31.07 69.87 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.874 -0.603 . . . . 75.03 111.171 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 24' ' ' ARG . 22.2 mtm180 -94.91 -76.46 0.49 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.336 -0.393 . . . . 62.25 110.365 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -168.89 48.67 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.915 -0.772 . . . . 72.44 108.915 175.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.713 HD13 ' HA2' ' A' ' 147' ' ' GLY . 24.5 mt 67.56 161.1 0.14 Allowed Pre-proline 0 N--CA 1.468 0.458 0 CA-C-N 114.777 -1.101 . . . . 72.4 111.667 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.718 ' HG3' ' HB3' ' A' ' 18' ' ' GLN . 55.1 Cg_endo . . . . . 0 C--N 1.344 0.341 0 C-N-CA 122.483 2.122 . . . . 74.44 111.773 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.952 ' HA ' HD11 ' A' ' 80' ' ' LEU . . . . . . . . 0 CA--C 1.512 -0.488 0 CA-C-O 121.344 0.592 . . . . 72.01 110.151 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 1.04 ' HB3' ' HB2' ' A' ' 79' ' ' SER . 0.2 OUTLIER -161.71 145.11 12.35 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 107.167 -1.419 . . . . 73.13 107.167 -177.253 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.532 HD12 ' HA ' ' A' ' 77' ' ' TRP . 1.4 mm? -114.39 131.88 56.42 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.428 0.529 . . . . 72.53 112.428 -168.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.4 t -92.61 -31.56 15.12 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.834 -0.621 . . . . 64.34 110.601 177.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.517 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -116.32 126.77 53.99 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.864 -0.421 . . . . 72.54 109.864 177.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.529 ' O ' ' HD3' ' A' ' 71' ' ' PRO . 10.0 p-10 -130.66 38.61 3.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.835 -0.62 . . . . 73.51 110.548 -174.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.597 ' HB3' ' HB3' ' A' ' 73' ' ' LYS . 4.5 mm-40 -97.78 88.25 0.6 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.038 -0.528 . . . . 53.22 110.6 -176.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.529 ' HD3' ' O ' ' A' ' 69' ' ' ASP . 33.9 Cg_endo -61.93 -28.61 81.14 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.828 2.352 . . . . 71.22 113.114 -170.089 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -114.63 27.44 8.81 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.658 -0.782 . . . . 54.13 112.293 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.597 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 49.6 tptt -142.55 -61.46 0.44 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.627 0.251 . . . . 74.15 110.943 -178.086 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.546 ' H ' ' HB2' ' A' ' 70' ' ' GLU . 23.0 ptt180 -165.13 140.04 5.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.109 0.481 . . . . 54.25 110.472 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.737 HD13 ' HE2' ' A' ' 93' ' ' PHE . 3.5 mp -121.72 125.5 73.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.147 -0.479 . . . . 64.41 109.9 175.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.517 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -139.11 117.46 11.98 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.79 -0.818 . . . . 51.02 108.79 176.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.532 ' HA ' HD12 ' A' ' 66' ' ' LEU . 10.2 p90 -96.41 120.47 36.79 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.443 -0.503 . . . . 72.41 111.263 -174.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.513 ' HG3' ' O ' ' A' ' 77' ' ' TRP . 17.2 mtt85 174.31 127.68 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 O-C-N 124.339 1.024 . . . . 72.43 112.833 173.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' SER . . . . . 1.04 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 50.2 m -150.63 -32.35 0.18 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.757 -0.656 . . . . 72.24 109.954 167.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.952 HD11 ' HA ' ' A' ' 64' ' ' ALA . 3.9 mp -46.78 144.0 3.92 Favored Pre-proline 0 C--O 1.234 0.265 0 N-CA-C 113.125 0.787 . . . . 74.31 113.125 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -77.59 -17.48 14.29 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 123.438 2.759 . . . . 61.43 113.661 -175.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.41 -14.71 12.44 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.479 -0.867 . . . . 71.41 112.31 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.682 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . . . -90.32 17.38 7.27 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.826 0.346 . . . . 65.23 111.826 -173.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -92.27 6.64 46.03 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.41 0.522 . . . . 74.55 112.41 -173.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.3 tt -67.59 116.39 7.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 107.806 -1.183 . . . . 75.33 107.806 168.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 13.0 pt-20 -77.69 81.01 4.14 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 114.779 1.4 . . . . 64.43 114.779 -160.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -84.77 129.23 34.85 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 104.601 -2.37 . . . . 71.43 104.601 151.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.0 t -94.66 135.56 35.98 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 118.913 -1.115 . . . . 74.21 112.145 -161.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -139.05 41.41 1.35 Allowed Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 114.895 -1.048 . . . . 53.14 111.074 177.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -102.43 113.67 27.2 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.525 -0.546 . . . . 75.35 109.525 177.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.4 m -115.33 132.42 64.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.993 -0.549 . . . . 74.14 110.77 -177.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.6 mp -108.5 130.49 55.26 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.049 -0.523 . . . . 52.43 110.605 178.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.737 ' HE2' HD13 ' A' ' 75' ' ' ILE . 63.3 m-85 -108.9 123.69 49.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.05 0.453 . . . . 73.14 110.332 178.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.568 ' NH1' HG21 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -141.27 152.07 63.25 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.94 -0.573 . . . . 74.03 110.176 177.866 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -52.38 126.86 21.9 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.852 2.368 . . . . 41.13 111.639 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.836 ' HB1' HG22 ' A' ' 11' ' ' THR . . . -92.44 143.17 26.88 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.101 -0.499 . . . . 72.4 111.444 -176.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -71.44 166.04 30.6 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.828 2.352 . . . . 61.04 112.39 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 68.31 17.87 70.79 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.085 -0.579 . . . . 64.03 112.344 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 55.56 27.89 11.05 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 122.733 0.413 . . . . 54.11 111.2 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 58.6 mtt-85 -78.86 -9.76 59.58 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.381 -0.372 . . . . 61.33 111.899 -175.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 119.32 -109.55 1.71 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.205 -0.998 . . . . 43.45 112.445 176.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.44 ' HB ' HD11 ' A' ' 19' ' ' LEU . 23.8 m -125.71 133.95 51.96 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.08 0.467 . . . . 75.11 111.18 -178.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.464 ' HB3' ' HG2' ' A' ' 94' ' ' ARG . 37.1 tt0 -87.28 105.05 16.97 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.62 -0.718 . . . . 75.34 109.347 175.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.0 p -89.2 103.3 13.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.864 0.84 . . . . 74.35 109.705 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.568 HG21 ' NH1' ' A' ' 94' ' ' ARG . 27.3 t -89.01 112.89 24.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.694 -1.139 . . . . 74.3 109.855 -177.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.407 ' CG1' HD23 ' A' ' 108' ' ' LEU . 46.8 t -116.12 116.52 52.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.626 -0.716 . . . . 73.24 111.345 -174.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -97.19 113.8 25.44 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.796 -1.187 . . . . 75.21 107.796 169.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.44 HD12 ' CD1' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -123.0 125.36 45.1 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.687 0.279 . . . . 74.31 110.364 -173.502 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.891 HG22 HG22 ' A' ' 5' ' ' VAL . 17.1 p -105.18 116.94 32.8 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.94 -0.393 . . . . 54.02 109.94 173.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.44 ' CD1' HD12 ' A' ' 108' ' ' LEU . 6.7 p90 . . . . . 0 C--N 1.322 -0.591 0 CA-C-N 115.76 -0.655 . . . . 70.04 109.802 -176.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.631 0 CA-C-O 120.454 -0.081 . . . . 44.33 113.049 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.6 t -62.96 -49.08 76.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.803 0.335 . . . . 73.32 111.176 -172.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.462 ' HA ' HG22 ' A' ' 120' ' ' VAL . . . -61.78 -30.72 70.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 43.35 111.042 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.72 -22.35 73.54 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.975 -0.631 . . . . 74.45 112.356 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.07 -40.28 17.0 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.766 0.317 . . . . 62.12 111.058 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 117' ' ' ALA . 33.3 m -74.71 -32.92 29.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 111.939 0.348 . . . . 74.1 111.939 -175.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.464 ' HA ' ' HG2' ' A' ' 124' ' ' MET . 37.3 pt -69.71 -23.97 26.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.895 0.378 . . . . 74.31 110.882 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.0 -21.04 60.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.957 -0.565 . . . . 30.21 110.912 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -86.27 -43.36 13.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.055 0.455 . . . . 75.41 110.555 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.464 ' HG2' ' HA ' ' A' ' 121' ' ' ILE . 23.6 ptp . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 73.52 111.238 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.553 ' O ' ' HG2' ' A' ' 138' ' ' MET . 8.4 mpt_? . . . . . 0 N--CA 1.463 0.178 0 N-CA-C 109.656 -0.498 . . . . 75.24 109.656 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -48.82 -49.79 37.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.958 -1.019 . . . . 74.05 112.393 -172.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -67.77 -39.71 84.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.899 0.38 . . . . 72.42 111.548 -176.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.528 ' CD2' ' HB3' ' A' ' 8' ' ' ASP . 12.6 tp -79.67 -20.92 45.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.469 -0.332 . . . . 73.35 110.858 -175.092 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.553 ' HG2' ' O ' ' A' ' 134' ' ' ARG . 24.2 mmt -69.18 -44.01 73.07 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.652 0.263 . . . . 72.32 111.096 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.406 ' HD2' ' SD ' ' A' ' 124' ' ' MET . 89.8 mtm-85 -64.55 -42.64 95.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.956 0.408 . . . . 71.42 110.322 178.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -59.84 -45.47 92.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.278 -0.874 . . . . 71.42 110.152 176.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 39.5 tttp -58.05 -51.47 69.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.884 -0.598 . . . . 73.21 111.632 177.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 -56.61 -40.87 76.09 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.067 -0.515 . . . . 71.3 111.805 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -79.22 -36.06 40.69 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.668 -0.413 . . . . 74.13 110.764 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.653 ' HA ' HD21 ' A' ' 26' ' ' LEU . 61.4 tt0 -63.41 -43.57 97.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 74.31 111.42 -176.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.514 ' HB3' HG23 ' A' ' 12' ' ' ILE . 12.1 pt-20 -77.21 -24.06 51.34 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 120.83 -0.348 . . . . 74.22 111.023 -179.082 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 62.2 tp -66.27 -61.39 2.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.294 -0.412 . . . . 73.22 110.088 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.713 ' HA2' HD13 ' A' ' 26' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.41 0 C-N-CA 120.828 -0.701 . . . . 71.22 111.618 -177.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.449 -0.507 0 N-CA-C 109.37 -0.604 . . . . 72.32 109.37 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.729 ' HB ' ' CE1' ' A' ' 110' ' ' TYR . 12.2 p -118.35 140.18 42.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.139 0.495 . . . . 61.22 110.515 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.567 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -136.32 109.73 7.91 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.542 -0.911 . . . . 64.32 108.542 172.152 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.544 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 4.2 t70 -132.17 171.38 13.73 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.653 -0.869 . . . . 72.04 108.653 -178.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.709 ' HB2' HG12 ' A' ' 105' ' ' VAL . . . -141.17 121.96 14.39 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.114 0.483 . . . . 73.15 111.366 -173.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.477 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 14.3 m -111.9 136.62 47.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.727 -0.67 . . . . 44.14 109.915 176.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.8 m -88.75 107.41 18.94 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.291 -0.413 . . . . 75.34 110.06 -178.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.563 HG23 ' HB3' ' A' ' 145' ' ' GLU . 14.2 mm -105.84 132.68 52.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.233 -0.44 . . . . 73.05 110.52 -176.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.94 58.03 4.94 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.912 -0.661 . . . . 73.44 112.584 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.638 ' HB2' HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -132.28 153.12 81.15 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 108.361 -0.977 . . . . 63.03 108.361 175.827 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.432 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 10.5 Cg_endo -54.6 -58.74 1.1 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.714 2.276 . . . . 73.52 113.692 -172.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . 172.16 -54.1 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.283 0.564 . . . . 65.45 110.808 175.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -55.5 -43.89 76.05 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.111 -0.95 . . . . 74.51 112.256 -174.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.591 ' HA ' ' HB3' ' A' ' 21' ' ' ALA . 2.7 mp0 -79.18 -8.32 58.91 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.043 -0.526 . . . . 72.21 111.172 -174.114 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.638 HD21 ' HB2' ' A' ' 14' ' ' LYS . 77.8 mt -73.95 -50.73 18.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.028 -0.533 . . . . 70.54 111.057 178.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.71 ' HB3' ' HZ ' ' A' ' 93' ' ' PHE . 17.1 p90 -74.37 -24.06 59.09 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.784 -0.766 . . . . 73.14 109.487 176.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.591 ' HB3' ' HA ' ' A' ' 18' ' ' GLN . . . -71.39 -2.98 18.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.278 -0.874 . . . . 74.03 111.107 176.037 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.679 HG11 ' HZ ' ' A' ' 140' ' ' PHE . 9.9 p -54.49 -21.57 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.049 -0.523 . . . . 74.02 111.029 176.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 15.5 t90 -60.14 -22.71 63.19 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.993 -0.549 . . . . 54.44 110.693 177.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -109.3 2.12 20.58 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.097 -0.501 . . . . 65.31 110.035 177.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.0 t70 55.54 80.35 0.14 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.899 -0.591 . . . . 73.55 110.87 -176.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.455 ' HA ' ' HD2' ' A' ' 27' ' ' PRO . 68.5 mt 45.18 85.6 0.16 Allowed Pre-proline 0 N--CA 1.47 0.547 0 CA-C-N 115.544 -0.753 . . . . 74.13 111.998 -178.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 26' ' ' LEU . 10.9 Cg_endo . . . . . 0 C--N 1.344 0.313 0 C-N-CA 123.63 2.887 . . . . 64.32 113.336 -173.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.397 0 N-CA-C 108.918 -0.771 . . . . 42.33 108.918 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.621 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -108.56 134.64 51.04 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.429 -0.952 . . . . 74.01 108.429 -175.959 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -113.83 116.63 29.63 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 121.846 -0.534 . . . . 74.33 110.294 -176.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.449 HG23 ' HB3' ' A' ' 76' ' ' ALA . 7.1 t -78.26 -26.03 47.04 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.627 -0.429 . . . . 71.14 111.568 -174.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . . . -147.42 129.61 15.59 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.767 0.318 . . . . 75.43 110.368 176.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -132.23 7.93 4.3 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.098 -0.501 . . . . 72.24 111.424 -175.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -59.18 93.41 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 123.94 0.896 . . . . 72.15 112.486 -173.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -59.74 114.16 1.94 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.314 2.676 . . . . 74.41 112.642 -169.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.53 6.37 70.66 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.84 -0.695 . . . . 72.43 112.519 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -123.91 -67.94 0.9 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.002 -0.37 . . . . 73.33 110.002 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.427 ' C ' HD12 ' A' ' 75' ' ' ILE . 15.4 ptt180 -150.6 134.9 17.05 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.983 -0.377 . . . . 74.43 109.983 175.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.621 HD13 ' HE2' ' A' ' 93' ' ' PHE . 3.5 mp -126.73 126.52 68.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 109.183 -0.673 . . . . 72.32 109.183 177.128 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.597 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . . . -139.59 120.57 14.57 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.969 -0.559 . . . . 71.21 110.559 -176.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 13.3 m-90 -98.04 152.17 19.57 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.78 -0.646 . . . . 73.33 110.483 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.621 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 1.0 OUTLIER -156.16 175.68 13.66 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.682 -0.858 . . . . 75.01 108.682 175.625 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' SER . . . . . 1.053 ' HB2' ' HA ' ' A' ' 85' ' ' ILE . 20.3 m -105.91 -171.07 1.83 Allowed 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 109.672 -0.492 . . . . 71.21 109.672 176.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.6 mt -82.79 144.88 49.11 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.631 -0.259 . . . . 72.42 111.075 -175.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.94 -32.36 95.0 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.601 2.2 . . . . 64.23 111.436 173.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.97 35.83 3.86 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.482 -0.647 . . . . 43.24 111.482 175.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -155.01 -173.94 4.78 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.654 -0.498 . . . . 34.43 109.654 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -80.38 101.62 9.11 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.591 -0.522 . . . . 73.54 109.591 172.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 1.053 ' HA ' ' HB2' ' A' ' 79' ' ' SER . 0.0 OUTLIER -70.04 -51.37 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 116.175 -0.466 . . . . 75.3 109.777 -179.071 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 47.78 -83.25 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.371 1.068 . . . . 55.43 113.608 175.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -64.69 132.51 49.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.588 0.709 . . . . 54.53 111.52 -175.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.1 m -139.5 128.73 23.95 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.537 -0.756 . . . . 62.11 109.548 176.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.25 145.15 9.16 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.716 -0.754 . . . . 62.31 112.064 -178.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.597 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 43.4 tt0 -138.57 125.61 21.31 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.077 -0.342 . . . . 65.14 110.077 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.1 m -106.75 128.07 61.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.121 0.486 . . . . 64.21 110.223 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.671 ' HB2' HG23 ' A' ' 105' ' ' VAL . 9.1 mp -110.53 145.7 37.3 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.463 -0.569 . . . . 65.42 109.463 173.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.71 ' HZ ' ' HB3' ' A' ' 20' ' ' TYR . 73.9 m-85 -110.07 106.72 16.32 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.094 0.473 . . . . 65.14 111.104 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.411 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 99.8 mtt180 -112.3 142.87 27.74 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.304 -0.628 . . . . 74.5 109.304 175.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 94' ' ' ARG . 9.2 Cg_exo -72.16 125.19 10.63 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.421 2.08 . . . . 75.12 111.327 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.89 144.51 98.86 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.239 -0.652 . . . . 62.14 109.239 176.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -39.32 119.64 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.623 2.882 . . . . 75.45 113.622 -174.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 90.82 8.97 64.69 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.011 -0.614 . . . . 54.51 112.642 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 59.01 36.04 24.24 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.201 0.524 . . . . 74.33 110.427 -178.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -73.79 -65.42 0.83 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.672 -0.695 . . . . 61.34 110.458 -178.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -131.78 -167.85 11.97 Favored Glycine 0 N--CA 1.439 -1.127 0 N-CA-C 110.512 -1.035 . . . . 72.14 110.512 176.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.482 ' HB ' HD11 ' A' ' 19' ' ' LEU . 10.7 m -110.45 122.71 48.38 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.023 0.439 . . . . 73.1 110.182 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.511 ' HG2' ' HB1' ' A' ' 9' ' ' ALA . 41.3 tt0 -92.4 106.5 18.48 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.455 -0.943 . . . . 75.41 108.455 178.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 5.2 m -86.72 128.88 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 CA-C-O 121.393 0.615 . . . . 70.0 109.506 -177.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.709 HG12 ' HB2' ' A' ' 9' ' ' ALA . 3.5 m -108.95 114.98 48.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.521 -0.763 . . . . 65.21 109.797 178.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 40.1 t -110.02 119.12 58.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.828 -0.623 . . . . 64.31 111.377 -173.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -107.06 116.48 32.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.633 -0.712 . . . . 71.03 109.739 175.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.5 pp -147.0 151.69 37.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.934 0.397 . . . . 75.53 111.085 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.1 t -90.09 144.85 25.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.93 -0.577 . . . . 74.54 110.18 178.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.729 ' CE1' ' HB ' ' A' ' 6' ' ' VAL . 5.7 p90 . . . . . 0 C--N 1.326 -0.449 0 N-CA-C 109.921 -0.4 . . . . 54.3 109.921 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.567 0 N-CA-C 112.342 -0.303 . . . . 55.32 112.342 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 38.0 t -86.29 -23.73 26.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.988 0.423 . . . . 55.11 110.572 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -68.41 -29.09 67.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.146 -0.479 . . . . 72.3 111.641 -174.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.456 ' O ' HG22 ' A' ' 121' ' ' ILE . . . -69.73 -19.68 75.18 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.098 -0.572 . . . . 44.34 113.041 -178.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.26 -20.34 65.99 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.307 0.484 . . . . 62.2 112.307 -174.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.57 -19.48 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.785 0.326 . . . . 73.22 111.723 -176.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.456 HG22 ' O ' ' A' ' 118' ' ' GLY . 13.8 tt -67.62 -22.64 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 121.032 0.444 . . . . 70.51 110.967 -177.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.54 -20.85 63.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.269 -0.423 . . . . 61.42 111.191 -178.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -71.03 -28.93 64.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.057 -0.52 . . . . 72.23 110.776 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.5 ttm . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 74.44 111.153 -175.358 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.549 ' O ' ' HG2' ' A' ' 138' ' ' MET . 51.0 mtp180 . . . . . 0 C--O 1.232 0.161 0 N-CA-C 109.061 -0.718 . . . . 74.21 109.061 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -57.22 -38.6 73.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.882 -1.054 . . . . 72.01 112.996 -171.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.48 -42.57 98.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.889 0.376 . . . . 60.23 110.889 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.544 ' CD2' ' HB3' ' A' ' 8' ' ' ASP . 13.9 tp -79.4 -20.95 46.37 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.254 -0.43 . . . . 71.43 110.112 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.549 ' HG2' ' O ' ' A' ' 134' ' ' ARG . 30.4 mmt -69.48 -47.51 63.68 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.307 -0.406 . . . . 60.42 110.268 175.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.07 -43.28 99.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.094 -0.503 . . . . 71.32 110.092 174.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.679 ' HZ ' HG11 ' A' ' 22' ' ' VAL . 67.8 t80 -57.22 -48.9 77.64 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.228 -0.897 . . . . 75.12 111.004 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.8 tttp -54.81 -56.23 21.63 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.185 -0.462 . . . . 75.11 111.727 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -55.49 -42.82 74.94 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.821 0.343 . . . . 62.35 111.737 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -75.49 -27.44 58.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.486 -0.325 . . . . 60.13 111.4 -178.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -80.94 -39.13 26.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.056 -0.52 . . . . 74.44 111.216 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.563 ' HB3' HG23 ' A' ' 12' ' ' ILE . 16.9 pt-20 -80.57 -36.85 32.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.55 -0.296 . . . . 73.35 111.495 -176.086 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.1 tt -71.79 -63.01 1.21 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.781 -0.452 . . . . 75.11 109.781 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.442 ' HA3' HD11 ' A' ' 26' ' ' LEU . . . . . . . . 0 N--CA 1.449 -0.466 0 CA-C-N 115.652 -0.704 . . . . 72.33 113.486 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.448 -0.558 0 N-CA-C 109.145 -0.687 . . . . 64.51 109.145 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 71.4 t -101.16 116.76 45.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 121.303 0.573 . . . . 71.21 110.881 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -132.21 109.84 10.22 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.981 -1.008 . . . . 75.41 108.638 176.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.485 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 1.3 t70 -141.47 146.15 36.11 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.836 -1.172 . . . . 52.44 107.836 175.04 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -122.8 140.25 53.13 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.135 0.493 . . . . 62.34 110.982 -173.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.605 ' CG2' ' HG2' ' A' ' 141' ' ' LYS . 2.5 m -133.85 142.28 41.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.47 -0.786 . . . . 74.52 110.469 -176.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 29.7 m -94.0 133.7 37.17 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.975 -0.557 . . . . 72.13 111.125 -175.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.808 HD11 ' HG3' ' A' ' 141' ' ' LYS . 35.3 mt -121.38 140.15 46.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.654 -0.703 . . . . 72.12 109.917 172.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.538 ' H ' ' HB3' ' A' ' 145' ' ' GLU . . . -83.31 62.35 4.64 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.991 -0.624 . . . . 74.43 112.555 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.566 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 7.4 mmpt? -144.59 144.8 26.13 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 109.183 -0.673 . . . . 73.33 109.183 175.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.408 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 72.8 Cg_exo -51.81 -56.3 3.09 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.25 2.633 . . . . 72.52 113.945 -176.349 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . 174.51 -63.11 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.686 0.279 . . . . 74.31 110.836 177.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -50.23 -42.57 51.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.553 -0.749 . . . . 73.04 111.428 -176.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.598 ' HG3' ' HD2' ' A' ' 27' ' ' PRO . 2.6 mp0 -61.61 -23.55 66.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.727 -0.67 . . . . 62.41 111.863 -177.104 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.6 mt -77.8 -34.32 52.21 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.95 0.352 . . . . 61.41 111.95 -176.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -71.73 -28.07 63.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.644 0.735 . . . . 63.45 109.421 177.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.22 -2.69 32.52 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 114.901 -1.045 . . . . 73.43 112.385 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.829 HG21 ' HZ ' ' A' ' 140' ' ' PHE . 10.9 p -53.01 -22.56 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 113.042 0.756 . . . . 63.22 113.042 -174.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 23.2 m0 -63.18 -14.1 44.99 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.703 0.631 . . . . 74.34 112.703 -176.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.463 ' HA ' ' HD3' ' A' ' 24' ' ' ARG . 25.8 mmt180 -121.84 -80.15 0.62 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.407 -0.183 . . . . 75.22 110.624 175.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 26' ' ' LEU . 8.3 t70 -172.19 53.63 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.549 -0.537 . . . . 74.13 109.549 176.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 9.1 mp 66.37 165.89 0.12 Allowed Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 115.409 -0.814 . . . . 50.22 110.771 -178.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.598 ' HD2' ' HG3' ' A' ' 18' ' ' GLN . 35.4 Cg_exo . . . . . 0 C--N 1.347 0.45 0 C-N-CA 122.38 2.053 . . . . 73.33 111.781 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.468 ' HB1' ' O ' ' A' ' 78' ' ' ARG . . . . . . . . 0 N--CA 1.446 -0.636 0 N-CA-C 108.582 -0.895 . . . . 63.52 108.582 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.574 ' HB2' ' HA ' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -108.05 133.97 51.6 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.986 -1.116 . . . . 65.14 107.986 177.01 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.542 ' CD2' ' HB3' ' A' ' 69' ' ' ASP . 40.1 tp -105.49 117.81 34.96 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.651 -0.82 . . . . 74.33 110.713 -169.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.8 t -93.32 -13.86 27.63 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.003 -0.544 . . . . 43.13 111.126 -175.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.464 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -147.25 125.16 11.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.952 0.406 . . . . 73.02 110.806 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.542 ' HB3' ' CD2' ' A' ' 66' ' ' LEU . 4.1 p-10 -140.19 40.5 1.94 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.498 -0.774 . . . . 72.44 109.835 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -60.03 144.96 85.9 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.078 -0.964 . . . . 75.55 109.919 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -47.25 -41.34 27.84 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.826 3.017 . . . . 73.11 113.451 -173.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -166.57 33.26 0.22 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.352 -0.928 . . . . 60.13 112.215 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -97.21 -63.46 1.13 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.164 0.507 . . . . 71.42 110.523 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 74' ' ' ARG . 3.5 ptp85 -161.51 140.84 10.1 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.758 -0.83 . . . . 71.44 108.758 177.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 68.5 mt -121.99 109.81 25.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 109.412 -0.588 . . . . 64.32 109.412 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.637 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . . . -111.34 115.32 29.1 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.975 -0.557 . . . . 75.51 110.499 -177.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 23.5 p-90 -96.1 124.09 39.97 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.921 0.867 . . . . 73.31 110.086 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.468 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 30.9 mmt180 -113.67 176.15 5.15 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.353 -1.351 . . . . 63.41 107.353 178.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.866 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 16.5 m -99.12 163.98 12.35 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 118.839 -1.144 . . . . 73.35 110.187 174.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.647 ' H ' HD12 ' A' ' 80' ' ' LEU . 4.4 mp -69.55 161.5 73.62 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.885 -0.598 . . . . 64.2 110.784 -176.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.14 -40.82 75.81 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.769 2.313 . . . . 62.53 112.252 177.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.0 -20.86 58.56 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.786 -0.721 . . . . 73.5 112.327 178.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.428 ' HA ' ' NH1' ' A' ' 84' ' ' ARG . . . -82.38 167.31 18.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.749 0.309 . . . . 74.32 110.728 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.428 ' NH1' ' HA ' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -82.16 104.71 12.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.003 0.43 . . . . 62.31 110.507 -176.639 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.866 ' HB ' ' HB2' ' A' ' 79' ' ' SER . 6.8 tt -117.44 116.81 53.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.867 -0.606 . . . . 51.41 110.517 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -153.55 -42.15 0.09 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.052 -0.522 . . . . 52.34 109.961 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -77.18 154.17 33.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.123 -0.489 . . . . 73.23 110.166 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.4 m -96.13 127.64 42.32 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.363 -0.381 . . . . 63.12 110.65 -178.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -122.49 61.53 0.55 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.942 -0.647 . . . . 54.34 111.524 177.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.637 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 39.3 tt0 -102.69 121.97 43.51 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 122.627 -0.337 . . . . 71.23 110.661 -176.152 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.675 HG22 HG22 ' A' ' 106' ' ' VAL . 83.0 t -112.79 122.03 66.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.273 0.558 . . . . 74.42 110.684 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.906 ' HB2' ' HB ' ' A' ' 105' ' ' VAL . 10.1 mp -96.19 142.34 28.48 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.597 -0.729 . . . . 62.11 110.104 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -121.55 115.9 23.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.152 -0.476 . . . . 74.33 110.164 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.413 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 34.9 ptt180 -141.08 144.65 35.75 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.318 -0.401 . . . . 75.54 110.567 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 94' ' ' ARG . 45.0 Cg_exo -56.67 134.72 66.21 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.679 2.253 . . . . 70.55 111.932 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -94.61 145.04 28.93 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.996 -0.547 . . . . 75.15 111.706 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -54.12 151.33 28.46 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.088 2.525 . . . . 73.14 112.361 175.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.49 -0.89 79.42 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.72 -0.753 . . . . 51.32 111.251 -178.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 59.57 33.93 22.24 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 122.8 0.44 . . . . 53.01 111.031 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -64.09 -42.89 96.76 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.19 0.519 . . . . 71.51 110.419 176.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 162.24 -122.37 1.1 Allowed Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 115.46 -0.791 . . . . 73.33 111.421 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 39.3 m -128.72 135.09 48.76 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.564 0.697 . . . . 73.22 111.003 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -90.88 131.27 36.62 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.867 -1.061 . . . . 72.02 110.181 -178.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.454 HG22 HG23 ' A' ' 10' ' ' VAL . 17.9 m -87.41 131.58 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 108.164 -1.05 . . . . 62.13 108.164 173.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.906 ' HB ' ' HB2' ' A' ' 92' ' ' LEU . 44.3 t -123.1 111.49 29.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 116.022 -0.536 . . . . 74.01 110.391 -174.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.675 HG22 HG22 ' A' ' 91' ' ' VAL . 37.9 t -128.29 121.2 55.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.405 -0.361 . . . . 64.11 111.12 -177.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.578 ' O ' ' HD2' ' A' ' 107' ' ' ARG . 0.4 OUTLIER -107.05 108.83 20.51 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.278 0.561 . . . . 71.2 109.816 170.6 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 50.1 tp -114.19 142.82 45.76 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.032 -0.531 . . . . 55.32 110.847 -175.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.8 t -93.95 142.33 27.51 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.006 -0.543 . . . . 74.21 110.498 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 . . . . . 0 C--N 1.322 -0.592 0 CA-C-N 115.934 -0.575 . . . . 71.14 110.234 177.874 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.846 0 N-CA-C 112.472 -0.251 . . . . 75.53 112.472 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.3 t -78.96 -26.97 43.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.51 0.195 . . . . 63.35 111.36 -175.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.65 -34.6 71.39 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.563 0.22 . . . . 61.31 111.448 -176.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.69 -31.82 76.89 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.922 -0.656 . . . . 73.23 112.397 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.96 -38.21 37.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.843 0.354 . . . . 63.33 110.588 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 93.4 t -61.32 -50.0 82.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.916 -0.584 . . . . 74.21 110.954 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.6 tp -65.8 -34.13 68.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 70.11 110.808 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.31 -37.11 84.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.443 -0.344 . . . . 50.42 111.192 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 70.2 ttp85 -68.33 -48.12 65.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.32 -0.4 . . . . 64.13 110.935 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 27.2 ptm . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.437 -0.347 . . . . 71.05 111.154 -177.282 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 109.771 -0.455 . . . . 73.24 109.771 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -60.7 -55.33 34.56 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.615 -0.72 . . . . 54.41 110.455 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -66.48 -30.84 71.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.16 0.505 . . . . 60.32 110.347 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.666 ' O ' ' HD3' ' A' ' 141' ' ' LYS . 43.5 tp -65.12 -48.24 74.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.616 -0.72 . . . . 72.45 110.167 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.415 ' HA ' ' CE ' ' A' ' 138' ' ' MET . 3.1 tpt -75.03 -35.12 61.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.494 -0.321 . . . . 74.54 110.692 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.9 ttm-85 -52.67 -54.8 28.39 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.969 -0.56 . . . . 73.51 111.124 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.829 ' HZ ' HG21 ' A' ' 22' ' ' VAL . 54.1 t80 -67.8 -46.05 73.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.799 -0.637 . . . . 65.31 111.625 -177.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.808 ' HG3' HD11 ' A' ' 12' ' ' ILE . 14.0 mptt -64.75 -35.04 79.8 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 111.94 0.348 . . . . 73.13 111.94 -173.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.432 ' HD3' ' HA ' ' A' ' 142' ' ' ARG . 16.7 mmt180 -66.32 -31.64 72.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.606 0.241 . . . . 64.45 111.308 177.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -79.67 -35.76 38.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.942 0.401 . . . . 75.15 110.443 176.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.406 ' HG2' HD13 ' A' ' 12' ' ' ILE . 6.0 tp60 -59.06 -44.06 91.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.851 -0.613 . . . . 72.13 111.529 178.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.538 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 7.9 pt-20 -72.82 -14.71 61.57 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.556 -0.458 . . . . 72.52 111.266 -178.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.88 -25.65 59.11 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.333 -0.618 . . . . 63.52 109.333 177.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.569 0 CA-C-N 115.668 -0.696 . . . . 41.11 112.439 176.704 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.628 HG22 ' HA ' ' A' ' 109' ' ' THR . 41.0 t . . . . . 0 N--CA 1.446 -0.674 0 N-CA-C 108.556 -0.905 . . . . 53.44 108.556 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 107' ' ' ARG . 10.6 p -80.11 141.63 15.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.516 -0.766 . . . . 72.3 111.82 -168.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.598 ' HG2' ' HB2' ' A' ' 107' ' ' ARG . 2.8 tmm_? -134.74 116.61 15.07 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.368 -0.605 . . . . 74.14 109.368 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' HB3' HD23 ' A' ' 137' ' ' LEU . 4.8 t70 -144.71 173.05 12.17 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.709 -0.848 . . . . 72.35 108.709 173.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.824 ' HB2' HG12 ' A' ' 105' ' ' VAL . . . -134.47 126.59 29.75 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.133 0.492 . . . . 71.04 112.012 -171.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.486 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 36.0 m -121.66 134.23 65.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.793 -0.639 . . . . 64.44 109.956 176.384 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 t -110.08 123.38 49.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.688 0.756 . . . . 44.25 111.011 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.634 ' HB ' HD21 ' A' ' 19' ' ' LEU . 4.7 mp -118.71 151.04 20.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.768 -1.105 . . . . 70.23 109.712 -178.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.85 20.63 1.05 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 114.005 0.362 . . . . 42.05 114.005 -177.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.82 ' HE3' HD23 ' A' ' 19' ' ' LEU . 49.3 mtmt -89.95 144.07 30.93 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.197 -0.668 . . . . 62.3 109.197 173.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 95.0 Cg_exo -45.69 -57.96 1.89 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.977 2.451 . . . . 63.22 113.822 -174.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . 173.21 -58.24 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.578 0.704 . . . . 53.21 110.911 177.089 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -55.83 -36.75 67.82 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.456 -1.247 . . . . 63.22 112.247 -171.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.545 ' CG ' ' HD2' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -87.65 -5.33 58.76 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.132 -0.485 . . . . 60.55 111.853 -175.06 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.82 HD23 ' HE3' ' A' ' 14' ' ' LYS . 59.9 mt -68.56 -48.13 65.05 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.963 -0.295 . . . . 70.14 111.081 176.127 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.831 ' HB3' ' HZ ' ' A' ' 93' ' ' PHE . 1.1 p90 -73.15 -24.55 60.59 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.469 -0.493 . . . . 71.42 110.372 -177.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.56 -2.99 31.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.575 -0.738 . . . . 70.33 111.862 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.781 HG11 ' HZ ' ' A' ' 140' ' ' PHE . 14.8 p -54.2 -22.05 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 112.843 0.683 . . . . 54.1 112.843 -175.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 -68.48 -9.82 51.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.881 0.372 . . . . 75.21 111.11 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.844 ' HG2' ' H ' ' A' ' 25' ' ' ASP . 47.1 ttt180 -137.04 179.27 6.48 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.61 -0.515 . . . . 70.32 109.61 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.844 ' H ' ' HG2' ' A' ' 24' ' ' ARG . 0.8 OUTLIER -63.39 12.58 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.072 1.349 . . . . 74.2 112.873 177.511 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.475 ' H ' ' C ' ' A' ' 24' ' ' ARG . 41.2 mt 65.43 86.09 0.14 Allowed Pre-proline 0 N--CA 1.467 0.38 0 CA-C-O 121.184 0.516 . . . . 60.3 109.628 -176.327 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.842 ' HG3' ' HD3' ' A' ' 24' ' ' ARG . 33.2 Cg_exo . . . . . 0 C--N 1.342 0.234 0 C-N-CA 123.71 2.94 . . . . 74.14 114.031 -169.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 109.881 -0.415 . . . . 73.1 109.881 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.22 135.73 51.32 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.736 0.303 . . . . 74.33 110.571 179.235 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.479 ' HG ' ' HA ' ' A' ' 77' ' ' TRP . 10.5 mp -104.63 127.28 52.33 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 120.253 -0.579 . . . . 72.03 109.597 174.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.3 t -95.46 -13.84 24.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.114 -0.494 . . . . 74.51 111.801 -172.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.616 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -123.32 128.04 49.36 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.944 -0.302 . . . . 75.32 110.782 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -137.91 84.83 2.06 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.895 -0.593 . . . . 73.54 110.443 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.532 ' HG3' ' HG2' ' A' ' 74' ' ' ARG . 6.6 mm-40 -107.18 141.68 23.44 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.361 -0.977 . . . . 75.01 108.361 173.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.46 93.82 0.59 Allowed 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.548 2.166 . . . . 72.12 112.376 -175.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 56.77 38.92 85.9 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.802 -0.635 . . . . 45.11 112.799 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -127.87 -46.37 1.41 Allowed 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.884 -0.326 . . . . 63.33 110.917 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.532 ' HG2' ' HG3' ' A' ' 70' ' ' GLU . 16.4 ptt-85 -159.91 147.64 16.8 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.48 -0.563 . . . . 75.43 109.48 173.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.643 HD11 ' HE2' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -147.34 120.54 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.411 0.624 . . . . 73.21 111.594 -179.498 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.689 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . . . -120.21 120.13 35.26 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.918 -1.037 . . . . 51.1 109.942 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.479 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 49.5 p90 -99.35 144.33 28.59 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.027 -0.533 . . . . 73.05 110.282 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -136.25 175.85 9.23 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.641 -0.874 . . . . 71.41 108.641 176.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.0 m -133.02 152.1 52.0 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.603 -0.517 . . . . 42.13 109.603 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.9 mt -67.94 156.82 88.62 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.239 -0.437 . . . . 74.35 110.251 -178.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -56.82 -21.7 41.58 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.862 2.375 . . . . 61.23 113.337 -177.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.53 10.98 66.96 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.809 -0.71 . . . . 64.54 112.679 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.472 ' HB1' HG12 ' A' ' 85' ' ' ILE . . . -137.19 142.3 42.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.904 0.383 . . . . 33.52 111.105 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -118.96 41.81 2.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.584 0.707 . . . . 74.15 109.719 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.472 HG12 ' HB1' ' A' ' 83' ' ' ALA . 46.2 mm -77.75 118.26 24.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.131 -0.94 . . . . 74.53 111.525 -175.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 69.91 154.5 0.12 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.975 0.797 . . . . 75.41 112.34 171.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -72.35 135.91 46.01 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.88 -0.785 . . . . 70.31 108.88 174.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 26.2 m -94.95 145.02 25.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.291 0.567 . . . . 54.53 111.233 -174.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -174.62 -166.26 32.3 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.107 -0.952 . . . . 74.24 111.671 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.689 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 43.0 tt0 -145.44 136.81 25.04 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.292 -0.262 . . . . 73.31 110.292 -178.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.559 ' CG2' HG13 ' A' ' 75' ' ' ILE . 3.0 m -120.23 134.17 64.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 120.901 0.381 . . . . 64.13 110.714 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.477 ' HB2' ' CG2' ' A' ' 105' ' ' VAL . 9.7 mp -113.76 137.42 51.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.293 -0.412 . . . . 75.22 110.231 175.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.831 ' HZ ' ' HB3' ' A' ' 20' ' ' TYR . 76.7 m-85 -105.05 106.9 17.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.986 -0.552 . . . . 70.12 110.1 177.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -117.15 145.36 35.63 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.137 -0.483 . . . . 73.41 111.041 -176.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.69 135.98 59.7 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.585 2.19 . . . . 74.43 111.749 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.466 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . . . -105.03 143.38 26.6 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.627 -0.261 . . . . 61.44 111.011 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 96' ' ' ALA . 26.7 Cg_exo -64.06 150.24 88.76 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 123.306 2.671 . . . . 75.22 112.477 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.84 10.74 86.02 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.081 -0.581 . . . . 70.53 112.117 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 57.4 35.27 25.77 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 122.889 0.475 . . . . 70.05 111.449 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 100' ' ' ARG . 2.2 mmp_? -58.66 -38.4 78.06 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.092 0.472 . . . . 64.51 110.736 176.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 149.38 -119.9 1.1 Allowed Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.812 -0.915 . . . . 51.41 110.812 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 92.4 m -129.0 127.93 42.64 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.989 0.423 . . . . 74.44 110.386 175.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -84.12 114.48 21.8 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.602 -0.726 . . . . 74.02 110.235 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.1 p -99.05 115.73 40.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.164 0.507 . . . . 70.32 110.661 177.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.824 HG12 ' HB2' ' A' ' 9' ' ' ALA . 21.7 m -86.81 110.68 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-O 121.444 0.64 . . . . 74.35 109.382 174.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 46.5 t -100.61 125.18 54.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.626 -0.715 . . . . 73.34 110.343 -176.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.598 ' HB2' ' HG2' ' A' ' 7' ' ' ARG . 26.9 ttt180 -137.03 113.08 9.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.235 -0.438 . . . . 74.11 111.201 174.007 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.0 mp -116.01 140.93 48.77 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.706 -0.679 . . . . 73.33 109.885 175.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.628 ' HA ' HG22 ' A' ' 5' ' ' VAL . 86.7 m -84.25 120.09 25.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.163 -0.471 . . . . 73.03 110.237 178.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.009 -0.541 . . . . 75.33 109.662 -178.099 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.45 0 N-CA-C 111.777 -0.529 . . . . 61.53 111.777 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.1 m -59.64 -40.06 86.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.846 0.355 . . . . 65.33 111.327 -176.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.522 ' O ' HG12 ' A' ' 121' ' ' ILE . . . -72.92 -24.82 60.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.316 -0.402 . . . . 74.21 111.506 -178.226 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.14 -28.72 73.82 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.921 -0.657 . . . . 71.15 112.637 -177.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.41 -43.27 81.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.357 . . . . 63.12 111.478 -178.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 117' ' ' ALA . 9.1 p -73.47 -20.49 18.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.834 0.35 . . . . 71.24 111.032 -176.178 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.522 HG12 ' O ' ' A' ' 117' ' ' ALA . 49.6 mm -63.39 -56.87 14.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.647 -0.251 . . . . 74.21 110.652 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.48 -31.07 72.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.153 0.502 . . . . 74.55 110.605 178.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -66.96 -31.04 71.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.415 -0.812 . . . . 73.23 110.689 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 17.9 tpt . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 115.816 -0.629 . . . . 75.55 110.921 -179.851 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 134' ' ' ARG . 8.6 mtp180 . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.728 0.299 . . . . 63.03 110.742 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.447 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 17.3 t70 -57.22 -38.8 74.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.92 -0.582 . . . . 74.41 110.082 177.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -62.48 -43.54 98.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.483 -0.781 . . . . 53.31 111.049 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.511 HD23 ' HB3' ' A' ' 8' ' ' ASP . 22.2 tp -75.3 -27.02 59.15 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.661 -0.496 . . . . 73.41 109.661 -178.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.538 ' HA ' ' CE ' ' A' ' 138' ' ' MET . 0.0 OUTLIER -64.41 -47.08 80.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.862 -0.608 . . . . 74.23 109.829 175.916 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 135' ' ' ASP . 81.6 mtp180 -61.91 -40.82 96.79 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.611 -0.722 . . . . 75.24 109.683 175.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.781 ' HZ ' HG11 ' A' ' 22' ' ' VAL . 89.8 t80 -56.55 -40.86 75.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.204 -0.907 . . . . 74.11 111.232 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.571 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 24.2 ttpp -65.23 -52.22 55.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.345 -0.389 . . . . 74.45 110.06 176.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -53.62 -44.94 69.91 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.458 -0.792 . . . . 75.21 111.321 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -62.81 -39.4 94.15 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.641 -0.254 . . . . 74.21 111.571 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.594 ' HB2' HG12 ' A' ' 12' ' ' ILE . 30.6 mt-30 -70.19 -47.27 62.25 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.958 -0.297 . . . . 74.41 111.504 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.571 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 11.0 pt-20 -76.45 -13.81 60.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.033 0.444 . . . . 61.44 111.231 -176.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -83.25 -43.51 15.99 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.791 -0.818 . . . . 43.15 108.791 172.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.488 0 CA-C-N 115.604 -0.726 . . . . 71.24 112.898 -179.065 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.5 mmm . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 120.677 0.275 . . . . 74.24 111.232 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -140.05 36.29 1.83 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.838 -0.696 . . . . 72.4 111.767 -176.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.439 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 7.4 mp0 -67.61 111.84 4.41 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.46 -0.57 . . . . 73.31 109.46 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.9 m -113.34 134.48 54.6 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.986 -0.552 . . . . 75.11 110.728 -173.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.708 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 4.4 p -93.48 98.82 8.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.929 0.871 . . . . 72.32 109.828 175.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.3 t -92.05 134.35 30.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.336 -0.847 . . . . 43.4 110.544 -176.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.645 ' HD2' ' O ' ' A' ' 7' ' ' ARG . 7.4 ppt_? -115.65 112.1 21.61 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.277 0.56 . . . . 73.31 110.261 175.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.435 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 31.3 t0 -157.48 172.52 18.42 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.002 -0.74 . . . . 65.25 109.002 177.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.649 ' HB2' HG12 ' A' ' 105' ' ' VAL . . . -138.39 132.27 31.18 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.733 0.301 . . . . 75.13 111.359 -176.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.467 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 23.8 m -110.76 145.95 16.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.194 -0.457 . . . . 70.14 110.581 178.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 97.4 m -109.71 118.78 37.45 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.053 -0.521 . . . . 52.11 111.031 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.762 HG21 ' HG3' ' A' ' 144' ' ' GLN . 5.0 mp -127.04 150.16 32.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.829 -0.623 . . . . 61.43 109.37 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.33 54.2 3.57 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.775 -0.726 . . . . 61.12 113.106 -178.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.587 ' HD3' ' HB2' ' A' ' 18' ' ' GLN . 50.9 mttp -131.67 144.4 53.15 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 108.849 -0.797 . . . . 71.11 108.849 174.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.59 -56.9 2.08 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.759 2.306 . . . . 62.52 113.803 -171.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.471 ' HA ' HD12 ' A' ' 19' ' ' LEU . . . 174.01 -47.48 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.649 0.738 . . . . 75.3 109.175 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -48.76 -47.15 41.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.081 -1.418 . . . . 72.14 111.952 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.587 ' HB2' ' HD3' ' A' ' 14' ' ' LYS . 67.5 mt-30 -83.39 -10.93 58.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.874 0.369 . . . . 65.03 111.119 -174.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' A' ' 16' ' ' ALA . 95.4 mt -77.57 -48.49 16.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.52 -0.309 . . . . 71.35 110.543 -178.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.675 ' HB3' ' HZ ' ' A' ' 93' ' ' PHE . 16.8 p90 -73.67 -23.85 59.89 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.107 -0.637 . . . . 71.45 109.483 175.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.522 ' HB3' ' HA ' ' A' ' 18' ' ' GLN . . . -73.18 -1.79 19.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.212 -0.904 . . . . 63.25 111.791 177.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.615 HG11 ' HZ ' ' A' ' 140' ' ' PHE . 12.1 p -54.06 -22.89 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 122.666 0.386 . . . . 73.02 111.681 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -75.17 -8.22 55.99 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.092 0.472 . . . . 73.15 110.955 178.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.516 ' HE ' ' HA ' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -115.83 -174.5 2.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.676 -0.693 . . . . 54.15 110.032 178.568 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.13 33.9 1.31 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.698 -0.683 . . . . 62.41 109.225 177.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.452 HD22 ' HB3' ' A' ' 18' ' ' GLN . 75.7 mt 55.26 85.25 0.19 Allowed Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 115.208 -0.905 . . . . 63.32 110.375 -173.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -82.52 167.51 15.11 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.11 2.54 . . . . 70.45 113.508 -173.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -143.71 69.96 0.41 Allowed Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.777 -0.647 . . . . 70.34 112.346 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.55 77.69 55.1 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 121.237 0.542 . . . . 63.23 111.391 177.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.415 ' HD2' HD12 ' A' ' 31' ' ' LEU . 5.7 Cg_exo -74.86 3.54 5.45 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.934 2.422 . . . . 51.51 111.919 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.426 ' H ' HD12 ' A' ' 31' ' ' LEU . 4.8 mp -80.06 -31.36 39.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.534 -0.757 . . . . 75.33 110.034 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.558 HD11 ' HB ' ' A' ' 39' ' ' VAL . 3.3 mm? -99.02 73.02 1.92 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.282 0.563 . . . . 64.44 110.302 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 26.8 ptm -146.18 160.07 42.46 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.459 -0.941 . . . . 65.43 108.459 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.84 HG22 ' H ' ' A' ' 35' ' ' HIS . 4.3 m 64.53 -163.45 0.26 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.384 -0.969 . . . . 72.13 108.384 -176.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.84 ' H ' HG22 ' A' ' 34' ' ' THR . 50.6 m170 -86.12 -179.11 6.68 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 121.932 -0.48 . . . . 75.11 110.217 175.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 36' ' ' LEU . 54.7 tp 74.35 28.24 1.37 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.686 0.755 . . . . 71.31 110.509 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.6 mtm-85 -95.91 120.31 35.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.008 -0.542 . . . . 72.43 109.841 176.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.548 ' O ' HG13 ' A' ' 51' ' ' VAL . 50.0 m -92.95 -39.62 11.03 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.48 -0.563 . . . . 54.11 109.48 173.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.558 ' HB ' HD11 ' A' ' 32' ' ' LEU . 23.4 t -83.42 84.56 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.894 -0.594 . . . . 75.2 111.299 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -82.12 48.27 1.23 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.247 0.546 . . . . 74.14 110.036 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 98.8 t -116.19 121.06 66.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.204 0.526 . . . . 73.33 110.586 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.74 HD12 ' HB3' ' A' ' 44' ' ' ASP . 0.9 OUTLIER -126.3 -38.37 2.14 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.463 -0.79 . . . . 72.45 110.821 -178.494 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.5 t70 75.19 -11.86 1.03 Allowed 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.606 -0.725 . . . . 74.22 111.255 174.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.74 ' HB3' HD12 ' A' ' 42' ' ' LEU . 6.1 t70 -44.24 -64.53 0.66 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.713 -1.13 . . . . 64.1 112.478 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.532 ' O ' ' HB2' ' A' ' 46' ' ' ARG . 1.1 tppm? -109.25 29.3 7.66 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.534 -0.543 . . . . 72.51 109.534 -177.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.532 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 0.7 OUTLIER 75.81 170.87 0.26 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 113.821 -1.536 . . . . 74.52 109.33 -162.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.3 m -165.12 -39.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.447 0.166 . . . . 72.23 111.447 -173.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.42 ' HG3' HG21 ' A' ' 60' ' ' VAL . 30.8 mmt180 64.26 99.83 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.823 -0.806 . . . . 64.32 108.823 -168.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 29.3 p90 -78.29 72.72 4.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.877 0.846 . . . . 70.13 111.737 -172.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.437 HG23 ' H ' ' A' ' 51' ' ' VAL . 1.7 t -92.06 -55.4 3.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.433 -0.803 . . . . 62.43 110.889 176.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 38' ' ' SER . 93.0 t 72.69 -42.71 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 123.152 0.581 . . . . 64.22 112.014 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -82.62 -35.05 27.35 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.275 0.472 . . . . 64.31 112.275 -173.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.88 143.78 86.97 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 111.986 0.365 . . . . 72.35 111.986 -173.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.22 129.72 16.48 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.682 2.255 . . . . 52.2 111.572 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 69.19 144.55 0.1 Allowed Pre-proline 0 N--CA 1.462 0.174 0 O-C-N 123.848 0.717 . . . . 75.01 110.729 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.527 ' HG2' HD12 ' A' ' 57' ' ' LEU . 36.0 Cg_endo -65.2 -18.54 61.39 Favored 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.232 1.955 . . . . 72.14 112.902 -177.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.694 HD12 HD22 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -132.51 4.34 3.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.197 0.522 . . . . 65.03 112.298 -175.409 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -87.37 43.81 3.23 Favored Glycine 0 C--N 1.316 -0.553 0 C-N-CA 120.487 -0.863 . . . . 62.12 113.193 -176.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -166.74 -52.91 0.03 OUTLIER 'General case' 0 C--O 1.233 0.209 0 N-CA-C 113.086 0.773 . . . . 73.12 113.086 -177.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.475 HG23 ' OE1' ' A' ' 63' ' ' GLU . 5.3 m -89.9 -0.51 8.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 113.519 0.933 . . . . 61.2 113.519 -167.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.1 m 75.21 -47.28 0.6 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.47 0.708 . . . . 72.15 112.706 172.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 26.1 m95 -129.65 121.69 27.51 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.09 -0.708 . . . . 64.35 109.09 173.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.604 ' HG3' ' HA ' ' A' ' 57' ' ' LEU . 0.8 OUTLIER -152.57 166.14 32.98 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.457 -0.792 . . . . 72.23 109.732 -175.185 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -130.67 139.2 50.32 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.883 -0.727 . . . . 73.24 112.493 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 19.6 tt0 -129.37 160.51 32.83 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.74 -1.118 . . . . 72.1 109.162 176.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.587 ' CD1' ' HA ' ' A' ' 77' ' ' TRP . 4.1 mm? -108.92 116.49 32.1 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.832 -0.803 . . . . 72.02 108.832 170.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.6 t -78.04 -16.65 57.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.06 -0.518 . . . . 75.21 112.174 -168.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.654 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -143.32 130.05 20.34 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 121.012 -0.275 . . . . 65.14 110.464 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.564 ' HA ' HG13 ' A' ' 75' ' ' ILE . 18.7 t70 -145.03 113.36 6.59 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.117 -0.492 . . . . 74.14 110.127 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.41 ' O ' HD11 ' A' ' 75' ' ' ILE . 78.8 mm-40 -130.33 144.92 55.22 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.625 -0.509 . . . . 71.22 109.625 176.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -52.67 -34.14 62.53 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.175 2.584 . . . . 73.32 113.009 -177.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -168.74 55.67 0.21 Allowed Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.868 -0.682 . . . . 45.14 111.994 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -127.87 -77.39 0.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.201 -0.296 . . . . 74.11 110.201 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 18.1 ptp180 -157.43 138.91 13.84 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.14 -0.482 . . . . 75.05 110.123 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.721 HD13 ' HE2' ' A' ' 93' ' ' PHE . 3.1 mp -129.57 122.06 54.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.196 -0.456 . . . . 73.42 109.966 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.654 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -111.34 130.41 55.69 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.939 -0.393 . . . . 65.3 109.939 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.587 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 4.6 p90 -85.31 153.65 22.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.568 0.699 . . . . 74.34 111.759 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.877 ' HG3' ' H ' ' A' ' 80' ' ' LEU . 4.1 tpp180 -144.32 172.82 12.4 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.707 -1.133 . . . . 63.24 108.686 -174.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.651 ' N ' ' HG3' ' A' ' 78' ' ' ARG . 59.0 m -145.64 24.84 1.36 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.755 -0.461 . . . . 51.41 109.755 174.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.877 ' H ' ' HG3' ' A' ' 78' ' ' ARG . 73.3 mt 63.96 149.64 0.11 Allowed Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 115.268 -0.878 . . . . 71.14 112.738 174.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -64.5 -8.22 16.54 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 122.345 2.03 . . . . 73.21 112.492 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -76.38 -57.22 4.0 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.854 -0.688 . . . . 73.12 111.865 175.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.75 -26.59 29.55 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.595 0.22 . . . . 71.13 111.595 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 63.31 103.92 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.361 0.664 . . . . 74.33 111.149 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.506 ' HB ' ' HB2' ' A' ' 79' ' ' SER . 17.1 tt -70.08 129.23 34.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.402 0.62 . . . . 52.5 111.184 -178.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -82.09 -29.17 31.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.476 -0.784 . . . . 73.23 110.015 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -88.73 168.27 12.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.593 -0.73 . . . . 74.15 110.562 -175.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.6 m -155.24 135.35 13.03 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.299 -0.26 . . . . 73.23 110.299 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.34 127.81 0.97 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.605 -0.807 . . . . 71.43 112.599 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 44.7 tt0 -115.37 118.52 33.46 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.612 -0.514 . . . . 71.34 109.612 176.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.623 HG12 HG12 ' A' ' 106' ' ' VAL . 3.8 m -87.15 130.38 37.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.873 0.368 . . . . 71.43 110.522 -177.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.657 ' HB2' HG23 ' A' ' 105' ' ' VAL . 9.5 mp -110.52 147.38 34.27 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.008 -0.367 . . . . 73.12 110.008 176.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.721 ' HE2' HD13 ' A' ' 75' ' ' ILE . 79.8 m-85 -117.61 132.01 56.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.831 0.348 . . . . 70.24 111.268 -177.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -141.86 145.15 35.38 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.94 -0.573 . . . . 74.53 109.902 173.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -58.01 127.62 25.73 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.474 2.116 . . . . 72.51 111.559 176.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.47 144.14 86.13 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.283 -0.417 . . . . 63.15 111.7 -174.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -58.45 138.39 85.54 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.911 2.408 . . . . 60.11 111.999 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.08 12.71 84.39 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.899 -0.667 . . . . 72.5 111.769 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 58.62 37.01 25.37 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 121.059 0.457 . . . . 63.35 111.051 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -78.95 1.14 24.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 55.14 111.411 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 129.7 -138.48 10.26 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.281 -0.728 . . . . 70.23 111.281 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 47.4 m -121.92 132.81 54.75 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.951 0.405 . . . . 74.4 110.23 176.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.52 ' HG2' ' HB1' ' A' ' 9' ' ' ALA . 42.5 tt0 -100.85 117.54 35.12 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.827 -0.624 . . . . 65.42 110.023 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.582 HG22 HG13 ' A' ' 106' ' ' VAL . 2.7 p -93.88 106.91 18.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.315 0.578 . . . . 73.15 110.757 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.657 HG23 ' HB2' ' A' ' 92' ' ' LEU . 10.8 m -88.23 114.24 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.759 -0.655 . . . . 72.3 110.343 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.623 HG12 HG12 ' A' ' 91' ' ' VAL . 27.2 m -124.15 134.97 65.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.404 0.621 . . . . 72.11 111.884 -175.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.523 ' HG3' ' HB3' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -118.32 97.89 6.0 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.821 -1.177 . . . . 72.45 107.821 170.089 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.526 ' H ' HD23 ' A' ' 108' ' ' LEU . 2.7 pt? -132.41 144.91 50.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.033 0.444 . . . . 64.25 110.792 -173.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.708 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 8.3 t -97.99 138.54 35.16 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.84 -0.618 . . . . 74.2 109.336 174.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -160.52 176.12 11.96 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.491 -0.322 . . . . 73.52 110.434 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.417 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 89.2 mtt180 -95.56 141.57 23.37 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 109.334 -0.617 . . . . 74.44 109.334 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.461 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 90.6 Cg_endo -88.41 153.94 6.58 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.492 2.128 . . . . 72.04 113.155 -174.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 15.6 Cg_exo -69.06 134.83 30.47 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.781 2.32 . . . . 75.32 111.447 175.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.25 -35.25 63.89 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.11 -0.567 . . . . 64.45 112.774 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -101.14 100.02 2.04 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.575 -0.821 . . . . 64.23 112.611 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.5 m -73.41 -22.31 60.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.923 0.392 . . . . 54.33 111.185 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.468 ' HA ' HG22 ' A' ' 120' ' ' VAL . . . -61.76 -22.79 65.71 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.219 -0.446 . . . . 74.53 111.571 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.87 -21.52 65.54 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.106 -0.569 . . . . 44.43 112.513 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -86.49 -44.68 11.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.928 0.394 . . . . 75.0 111.483 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 117' ' ' ALA . 27.6 m -67.7 -17.61 22.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.297 0.48 . . . . 74.15 112.297 -172.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.519 HD13 ' O ' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -61.9 -28.61 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 120.978 0.418 . . . . 74.32 110.35 178.257 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' A' ' 126' ' ' ASN . . . -69.74 -18.59 63.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.329 -0.396 . . . . 73.24 111.678 -177.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 57.7 ttp85 -65.88 -16.0 63.44 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.624 0.249 . . . . 73.34 111.311 -176.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.8 ttm -55.32 -43.19 74.69 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.961 0.41 . . . . 75.11 109.988 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -166.96 90.05 0.37 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.643 -0.873 . . . . 72.44 108.643 175.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.413 ' HB3' ' O ' ' A' ' 122' ' ' ALA . 28.9 p-10 -104.61 -30.79 9.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.997 -0.547 . . . . 64.05 111.138 -175.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 61.67 21.93 12.54 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.579 0.704 . . . . 65.45 110.226 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -124.1 86.88 53.82 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.66 -0.7 . . . . 74.41 110.727 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -76.62 74.98 4.59 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.284 1.99 . . . . 71.0 111.66 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.2 t -120.18 34.65 5.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.937 0.398 . . . . 65.33 110.853 -174.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 71.08 171.8 0.32 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.496 -0.775 . . . . 72.55 112.34 175.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -95.51 24.4 5.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.363 -0.835 . . . . 72.13 111.093 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.696 ' O ' ' HG2' ' A' ' 134' ' ' ARG . 3.1 mm? -116.09 177.21 4.77 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.966 -0.561 . . . . 74.44 109.664 178.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.696 ' HG2' ' O ' ' A' ' 133' ' ' LEU . 2.4 ptm180 48.58 32.6 3.54 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 124.074 0.859 . . . . 74.42 112.516 172.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -49.12 -52.08 28.22 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.258 0.623 . . . . 74.32 111.954 -173.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.475 ' O ' ' HG2' ' A' ' 139' ' ' ARG . 33.8 t70 -61.99 -39.01 90.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.569 -0.741 . . . . 74.25 112.192 -174.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.467 ' HG ' ' CG1' ' A' ' 10' ' ' VAL . 14.3 tp -80.34 -20.28 44.56 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.857 0.36 . . . . 70.53 110.899 -176.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.521 ' HA ' ' CE ' ' A' ' 138' ' ' MET . 22.4 mmt -65.78 -41.73 91.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.775 0.287 . . . . 61.12 111.775 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.475 ' HG2' ' O ' ' A' ' 136' ' ' ASP . 15.9 ptt180 -62.67 -31.21 72.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.832 0.349 . . . . 63.45 110.359 178.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.615 ' HZ ' HG11 ' A' ' 22' ' ' VAL . 92.2 t80 -64.58 -45.87 85.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.897 -0.592 . . . . 71.55 110.311 178.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.44 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 23.3 ttpp -57.1 -47.65 80.54 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.15 -0.477 . . . . 63.3 110.036 176.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 28.4 ttp180 -53.82 -45.77 70.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.052 -0.976 . . . . 71.22 111.816 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -77.79 -28.45 50.45 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.233 -0.439 . . . . 75.05 111.514 -175.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.762 ' HG3' HG21 ' A' ' 12' ' ' ILE . 4.9 tp-100 -71.31 -44.66 64.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.621 0.248 . . . . 73.32 110.502 175.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 11.1 pt-20 -71.64 -23.3 61.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.848 0.356 . . . . 72.41 110.764 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 1.0 OUTLIER -76.8 -47.79 20.52 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.557 -0.534 . . . . 73.51 109.557 178.189 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -66.18 123.5 23.65 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.776 -0.647 . . . . 52.13 112.606 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.405 HD23 ' N ' ' A' ' 149' ' ' GLU . 1.6 tt -152.67 132.73 13.42 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.325 -0.62 . . . . 73.34 109.325 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.469 ' CD ' ' H ' ' A' ' 150' ' ' HIS . 0.3 OUTLIER -138.99 171.76 13.85 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.814 -0.809 . . . . 72.12 108.814 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.469 ' H ' ' CD ' ' A' ' 149' ' ' GLU . 78.5 m80 -58.58 142.02 50.48 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.548 -0.538 . . . . 74.04 109.548 174.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -66.5 -23.01 66.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.789 0.328 . . . . 71.23 111.286 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -81.2 -18.16 47.12 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.447 -0.342 . . . . 63.45 110.171 175.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 65.6 t60 65.87 109.01 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.723 -0.671 . . . . 72.41 110.794 -175.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -116.72 116.37 27.4 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.171 -0.468 . . . . 73.42 109.997 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 51.9 t60 . . . . . 0 C--O 1.247 0.924 0 CA-C-O 118.429 -0.796 . . . . 71.23 110.036 -178.281 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.796 0.331 . . . . 73.43 110.949 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.52 -88.23 0.92 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.678 -0.772 . . . . 73.31 112.353 177.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 42.51 41.48 2.33 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.726 0.81 . . . . 75.45 111.574 -178.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.0 m -95.64 136.17 36.38 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.72 -0.673 . . . . 72.13 110.171 -177.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.617 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 11.1 p -126.19 137.21 58.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.307 -0.406 . . . . 72.34 110.378 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.0 t -95.75 116.44 37.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.294 -0.632 . . . . 75.14 109.294 174.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 59.9 ttt180 -125.77 108.38 11.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.08 0.467 . . . . 72.34 110.078 174.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.492 ' HA ' HD22 ' A' ' 133' ' ' LEU . 11.6 m-20 -143.73 159.14 43.03 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.13 -1.063 . . . . 74.3 108.13 176.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.849 ' H ' HD13 ' A' ' 133' ' ' LEU . . . -141.18 121.13 13.62 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.931 0.396 . . . . 73.54 110.642 -174.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.632 ' HB ' ' HB2' ' A' ' 141' ' ' LYS . 10.5 m -108.32 136.58 43.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.442 0.639 . . . . 54.04 111.714 -176.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.14 109.92 22.19 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.227 -0.897 . . . . 65.3 111.239 -177.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.875 HG23 ' HG3' ' A' ' 145' ' ' GLU . 4.8 mp -125.26 149.4 29.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.789 -0.819 . . . . 72.14 108.789 176.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.88 57.51 2.65 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 121.114 -0.565 . . . . 55.32 113.226 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.657 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 10.9 mmpt? -118.15 154.52 51.75 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 108.803 -0.814 . . . . 72.12 108.803 176.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -58.98 -57.66 0.9 Allowed 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.327 2.018 . . . . 72.44 113.026 -177.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.557 ' O ' ' HB2' ' A' ' 19' ' ' LEU . . . -178.26 -72.91 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.224 0.453 . . . . 61.44 112.224 178.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -66.36 -31.12 71.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.711 0.291 . . . . 74.23 111.174 -173.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -56.67 -32.28 65.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.424 -0.353 . . . . 74.02 110.552 175.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.557 ' HB2' ' O ' ' A' ' 16' ' ' ALA . 65.4 mt -62.89 -41.63 99.49 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.88 -0.6 . . . . 74.13 110.444 176.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.742 ' HB2' ' HZ ' ' A' ' 93' ' ' PHE . 77.9 t80 -73.07 -36.36 66.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.734 -0.666 . . . . 71.21 110.766 178.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.23 -3.61 30.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.683 -0.69 . . . . 75.21 112.188 -175.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.765 HG11 ' HZ ' ' A' ' 140' ' ' PHE . 9.0 p -53.69 -21.46 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 123.213 0.605 . . . . 72.32 112.242 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.8 t-105 -52.94 -37.25 60.74 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.445 0.64 . . . . 74.44 109.764 176.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.579 ' HD3' ' N ' ' A' ' 25' ' ' ASP . 4.0 tmt_? -109.59 159.76 16.83 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.866 -1.161 . . . . 72.24 107.866 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.579 ' N ' ' HD3' ' A' ' 24' ' ' ARG . 26.1 t70 -66.83 67.17 0.06 Allowed 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.497 0.554 . . . . 74.0 112.497 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.47 ' O ' ' HE1' ' A' ' 152' ' ' HIS . 3.6 mm? 41.86 79.3 0.33 Allowed Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 124.168 0.987 . . . . 65.13 112.78 169.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.522 ' HA ' ' NH1' ' A' ' 24' ' ' ARG . 31.6 Cg_exo -58.31 -57.8 0.97 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.445 2.097 . . . . 44.22 113.787 -172.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.16 -145.56 30.32 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.563 -0.827 . . . . 73.11 111.405 -172.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.511 ' N ' ' HD3' ' A' ' 30' ' ' PRO . 57.8 mt 44.32 53.7 11.18 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 113.424 0.898 . . . . 73.23 113.424 176.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.511 ' HD3' ' N ' ' A' ' 29' ' ' LEU . 2.9 Cg_endo -81.25 60.77 7.91 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 121.736 1.624 . . . . 64.43 111.125 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mp -150.72 -68.23 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.426 -0.806 . . . . 54.01 109.143 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 81.9 mt 64.51 -80.13 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 114.843 -1.072 . . . . 73.41 111.178 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.557 ' HG3' ' H ' ' A' ' 34' ' ' THR . 19.1 ptp -175.44 -60.84 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.044 -0.526 . . . . 74.42 110.217 -178.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.557 ' H ' ' HG3' ' A' ' 33' ' ' MET . 2.2 p -157.16 -68.94 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.501 0.667 . . . . 54.42 109.694 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -146.13 109.01 4.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.184 -0.917 . . . . 62.32 109.3 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 59.2 tp -154.8 105.41 2.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.437 -0.347 . . . . 72.53 110.705 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.625 ' HG3' HG22 ' A' ' 41' ' ' VAL . 23.8 ttp180 -116.69 87.78 2.76 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.029 0.442 . . . . 75.4 109.971 177.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.2 m -139.55 -2.77 1.55 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.13 -0.486 . . . . 65.13 111.442 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.547 HG13 ' H ' ' A' ' 40' ' ' GLU . 6.1 p -152.48 -61.49 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 121.029 -0.268 . . . . 74.22 111.375 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.547 ' H ' HG13 ' A' ' 39' ' ' VAL . 17.7 mm-40 -88.34 121.85 31.2 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.885 -0.413 . . . . 75.41 109.885 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.625 HG22 ' HG3' ' A' ' 37' ' ' ARG . 47.6 t -138.42 141.24 38.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 110.204 -0.295 . . . . 74.02 110.204 -178.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -75.07 -58.52 3.23 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.411 -0.588 . . . . 71.35 109.411 175.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.7 t70 73.7 -69.35 0.19 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.01 -0.995 . . . . 71.11 112.604 169.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -76.47 -33.43 58.69 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.247 0.546 . . . . 72.2 110.498 -176.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 14.5 mmmm -90.98 39.74 1.0 Allowed 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.913 -0.773 . . . . 63.24 108.913 172.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.468 HH11 ' HG3' ' A' ' 56' ' ' PRO . 2.8 ptp180 74.46 140.25 0.06 Allowed 'General case' 0 C--N 1.327 -0.375 0 O-C-N 125.352 1.657 . . . . 64.53 110.186 -172.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.8 m -64.91 -54.47 30.28 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.585 -0.734 . . . . 50.05 111.907 -172.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.496 ' HD3' ' OE2' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -149.33 144.73 26.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.773 0.32 . . . . 72.44 110.878 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.445 ' CG ' ' HD2' ' A' ' 46' ' ' ARG . 2.8 p-90 -152.71 143.98 23.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.159 -0.473 . . . . 71.43 111.084 -177.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 24.1 m 72.95 -63.04 0.45 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.579 -0.737 . . . . 73.12 112.776 173.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.0 m -66.28 89.85 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 121.298 0.571 . . . . 45.14 111.821 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 54.19 30.9 13.03 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.291 -0.868 . . . . 75.32 111.0 -174.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.473 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . . . -133.69 143.87 49.53 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.575 -0.739 . . . . 62.11 109.692 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 53' ' ' ALA . 6.9 Cg_exo -73.99 -164.64 0.22 Allowed 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 123.102 2.535 . . . . 24.31 112.435 -178.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.47 144.58 86.66 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.658 -0.701 . . . . 70.12 109.912 176.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.511 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 20.0 Cg_endo -59.7 -18.92 50.87 Favored 'Trans proline' 0 N--CA 1.474 0.37 0 C-N-CA 123.109 2.539 . . . . 75.24 113.265 -175.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.9 19.07 2.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.611 0.72 . . . . 74.54 110.565 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -136.15 115.09 1.26 Allowed Glycine 0 C--N 1.314 -0.64 0 CA-C-N 114.656 -1.157 . . . . 74.13 111.904 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 72.31 24.87 2.94 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.449 0.642 . . . . 63.43 110.302 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.9 p -136.81 162.5 34.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.305 -0.862 . . . . 71.43 109.18 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.7 m -67.96 -77.78 0.07 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.355 -0.239 . . . . 74.31 110.355 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 7.0 m-90 -146.34 143.19 28.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.813 0.34 . . . . 73.2 110.432 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.645 ' O ' ' HG ' ' A' ' 80' ' ' LEU . 6.5 mm-40 -132.85 166.0 23.31 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.782 -0.822 . . . . 75.34 108.782 168.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.44 114.07 24.69 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 120.002 -0.679 . . . . 53.41 109.381 172.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.465 ' HB2' HD23 ' A' ' 80' ' ' LEU . 1.2 mm-40 -107.92 134.23 51.13 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 109.587 -0.523 . . . . 65.02 109.587 176.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.746 HD12 ' HA ' ' A' ' 77' ' ' TRP . 3.6 mm? -88.21 137.91 31.91 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.581 -0.526 . . . . 24.11 109.581 -178.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.9 t -73.93 -9.18 58.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.497 0.665 . . . . 45.04 110.048 -177.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.91 123.35 10.36 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.973 -1.012 . . . . 74.21 108.725 166.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -139.09 83.64 1.96 Allowed 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.738 -0.838 . . . . 75.44 108.738 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 73' ' ' LYS . 48.5 mt-10 -115.86 143.86 31.58 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 114.879 -1.055 . . . . 71.24 109.581 -176.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.81 94.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.031 2.487 . . . . 50.32 113.029 -174.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 61.82 26.36 66.94 Favored Glycine 0 CA--C 1.518 0.277 0 CA-C-N 115.657 -0.701 . . . . 61.23 113.446 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.747 ' HE2' ' HA ' ' A' ' 73' ' ' LYS . 9.7 mmpt? -104.66 -72.56 0.7 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.18 0.514 . . . . 70.14 110.193 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.414 HH21 ' CD ' ' A' ' 90' ' ' GLU . 7.0 ptm180 -149.91 137.66 20.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.758 -0.655 . . . . 71.41 109.642 176.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 67.1 mt -122.18 110.3 26.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.768 -0.651 . . . . 74.35 109.394 177.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.667 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . . . -104.23 127.44 51.86 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.847 -0.615 . . . . 72.44 109.574 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.746 ' HA ' HD12 ' A' ' 66' ' ' LEU . 59.2 t90 -79.93 143.71 33.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.702 0.763 . . . . 73.32 111.509 -169.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.532 ' HG3' ' H ' ' A' ' 79' ' ' SER . 0.0 OUTLIER -166.61 175.35 8.03 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.834 -1.076 . . . . 65.4 108.99 -175.296 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.532 ' H ' ' HG3' ' A' ' 78' ' ' ARG . 46.9 m -141.57 165.63 26.95 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.348 -0.982 . . . . 64.03 108.348 174.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.645 ' HG ' ' O ' ' A' ' 63' ' ' GLU . 53.0 mt -60.57 150.76 73.53 Favored Pre-proline 0 C--N 1.326 -0.445 0 O-C-N 123.11 0.256 . . . . 63.43 110.729 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.31 -22.71 66.62 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 123.069 2.512 . . . . 71.14 112.82 -178.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.28 2.7 88.02 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.06 -0.591 . . . . 34.43 112.251 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -109.62 -168.89 1.38 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.715 0.293 . . . . 71.44 110.372 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -111.45 118.3 35.42 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.764 0.316 . . . . 65.11 110.553 -174.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.4 pt -110.19 129.73 64.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.032 0.444 . . . . 72.32 110.931 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -105.99 -85.48 0.49 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.138 -0.483 . . . . 64.02 111.906 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -96.03 166.48 11.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.935 0.397 . . . . 54.25 111.46 -171.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.7 t -103.81 139.02 39.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.031 -0.531 . . . . 73.14 109.875 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.612 ' HA3' ' HG ' ' A' ' 108' ' ' LEU . . . -158.69 129.12 2.19 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 121.038 -0.601 . . . . 32.41 112.113 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.667 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 45.5 tt0 -128.84 134.75 48.43 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.913 -0.403 . . . . 72.22 109.913 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 69.7 t -115.67 128.67 72.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.152 0.501 . . . . 62.32 111.144 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.612 ' HB2' ' HB ' ' A' ' 105' ' ' VAL . 6.8 mp -102.95 138.16 40.19 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.366 -0.834 . . . . 74.55 110.517 178.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.742 ' HZ ' ' HB2' ' A' ' 20' ' ' TYR . 89.2 m-85 -115.54 106.29 13.77 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.226 0.536 . . . . 72.21 109.695 175.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -124.26 144.5 45.8 Favored Pre-proline 0 C--N 1.317 -0.841 0 CA-C-N 116.138 -0.483 . . . . 52.31 110.61 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.26 125.98 19.58 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.639 2.226 . . . . 54.34 111.101 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.1 143.39 56.87 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.552 -0.295 . . . . 71.11 111.219 -175.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.527 ' O ' ' HG2' ' A' ' 100' ' ' ARG . 31.0 Cg_endo -65.37 156.5 63.0 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.775 2.316 . . . . 61.24 111.35 175.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 63.94 20.71 64.82 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.926 -0.654 . . . . 72.44 112.939 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 58.21 32.91 22.62 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.661 0.384 . . . . 63.21 112.006 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 97' ' ' PRO . 24.9 mmt180 -68.74 -18.98 64.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.862 0.363 . . . . 64.45 111.244 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 127.72 -133.12 7.72 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.305 -0.718 . . . . 73.31 111.305 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.2 m -118.65 132.85 56.18 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.518 -0.549 . . . . 60.43 109.518 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.487 ' HG2' ' HB1' ' A' ' 9' ' ' ALA . 40.1 tt0 -96.21 117.02 29.92 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.847 0.356 . . . . 54.3 110.535 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.48 HG23 ' CG1' ' A' ' 91' ' ' VAL . 1.7 p -88.33 103.97 14.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.818 0.818 . . . . 71.43 109.521 174.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.612 ' HB ' ' HB2' ' A' ' 92' ' ' LEU . 16.4 t -91.36 110.24 22.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.631 -1.168 . . . . 71.53 109.919 -175.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 47.7 t -100.74 117.77 46.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.232 -0.44 . . . . 40.15 111.217 -175.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -121.09 98.72 6.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.928 -0.578 . . . . 75.11 109.52 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.612 ' HG ' ' HA3' ' A' ' 89' ' ' GLY . 1.9 tt -138.83 137.3 36.48 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.84 -0.43 . . . . 73.21 109.84 -175.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 8.9 t -84.53 139.71 31.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.28 0.562 . . . . 65.13 111.254 -177.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -140.67 179.6 6.59 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.798 -0.637 . . . . 75.21 110.374 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -120.66 144.55 38.94 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.835 -0.62 . . . . 72.1 109.836 174.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -69.79 156.9 62.06 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 121.947 1.765 . . . . 72.34 110.946 171.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.02 -36.01 52.52 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.925 2.417 . . . . 71.52 112.566 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.86 97.7 0.38 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.754 -0.736 . . . . 42.15 112.271 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 142.02 -151.48 22.88 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.51 -0.853 . . . . 60.22 112.856 176.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.3 m -62.04 -23.86 66.72 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.066 0.546 . . . . 62.11 111.925 -174.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.91 -43.02 76.93 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.304 -0.407 . . . . 73.12 111.801 -176.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -78.59 -19.83 72.78 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.575 -0.822 . . . . 52.44 112.34 -178.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.49 -38.73 23.46 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.736 -0.273 . . . . 71.31 111.712 -175.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.5 m -64.5 -25.56 38.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.615 0.598 . . . . 52.22 112.615 -174.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 14.4 tt -75.13 -21.84 16.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.922 0.392 . . . . 70.54 111.085 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.97 -18.81 64.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.366 -0.379 . . . . 53.11 111.876 -175.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 123' ' ' ARG . 23.7 ttt85 -79.17 -14.5 59.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.059 0.457 . . . . 74.44 110.919 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 49.1 ttm -70.49 -25.86 63.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.238 -0.437 . . . . 72.24 110.322 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 68.09 177.62 0.25 Allowed 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.816 -0.629 . . . . 64.34 111.09 -176.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 65.6 -177.39 0.18 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.825 -0.625 . . . . 62.44 109.767 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -129.64 174.06 10.03 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 122.244 -0.285 . . . . 73.44 110.431 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -86.41 155.45 56.97 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 109.054 -0.721 . . . . 73.44 109.054 175.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.412 ' HB2' ' HB2' ' A' ' 132' ' ' GLN . 9.4 Cg_endo -52.0 -55.5 3.82 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.454 2.103 . . . . 72.14 112.197 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.2 m 69.8 -41.92 0.5 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.59 0.756 . . . . 33.31 111.961 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 23.6 tm0? -67.0 -46.24 75.15 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.473 -1.306 . . . . 73.34 107.473 169.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.427 ' HA ' ' OE1' ' A' ' 132' ' ' GLN . 15.6 mm-40 -85.82 137.62 32.65 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.76 -1.2 . . . . 64.54 107.76 164.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.849 HD13 ' H ' ' A' ' 9' ' ' ALA . 63.2 mt -71.3 168.44 17.34 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.007 0.432 . . . . 73.11 112.06 -170.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 23.5 mtp-105 -82.45 164.01 21.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.815 0.816 . . . . 73.13 113.049 -168.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -69.7 -33.18 72.16 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.494 -1.23 . . . . 73.34 112.639 -173.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -56.51 -55.65 31.1 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.048 0.388 . . . . 72.32 112.048 -175.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 15.5 tp -81.08 -20.7 40.96 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.851 -0.34 . . . . 62.43 110.975 -175.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.8 ttp -54.34 -38.65 66.27 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.49 -0.323 . . . . 74.12 110.896 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 139' ' ' ARG . 0.8 OUTLIER -70.86 -32.71 69.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.793 0.33 . . . . 74.14 110.738 179.438 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.765 ' HZ ' HG11 ' A' ' 22' ' ' VAL . 90.3 t80 -60.34 -35.17 75.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 64.4 110.439 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.632 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 38.8 tttp -55.02 -49.5 71.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.771 -0.649 . . . . 71.53 110.194 173.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.639 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 34.4 mmt180 -71.67 -25.69 62.22 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.805 -0.634 . . . . 73.14 111.772 -175.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -63.48 -44.32 94.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.861 0.362 . . . . 64.3 111.054 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.714 ' HG2' HG21 ' A' ' 12' ' ' ILE . 8.3 tt0 -82.36 -44.36 16.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.068 -0.514 . . . . 73.21 111.038 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.875 ' HG3' HG23 ' A' ' 12' ' ' ILE . 2.5 tt0 -66.52 -20.21 65.97 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 116.203 -0.453 . . . . 74.25 111.994 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.639 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 21.3 tp -64.71 -40.95 96.23 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.538 -0.542 . . . . 73.34 109.538 175.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 105.77 96.19 2.43 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.303 -0.862 . . . . 73.31 111.361 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.649 ' H ' HD23 ' A' ' 148' ' ' LEU . 2.5 pt? -122.62 127.37 49.29 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.11 0.481 . . . . 70.53 111.192 -176.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -154.94 95.42 1.75 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.31 -0.859 . . . . 72.22 109.213 171.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -127.54 137.41 52.61 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.6 -0.727 . . . . 60.41 110.478 -174.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 71.7 t60 73.9 8.91 4.8 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.889 0.743 . . . . 74.43 110.054 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.47 ' HE1' ' O ' ' A' ' 26' ' ' LEU . 1.9 t60 -68.56 128.96 38.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.104 -0.498 . . . . 75.31 110.026 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -130.33 136.3 48.97 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.782 -0.645 . . . . 75.51 109.704 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -111.75 151.17 29.27 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.423 -0.584 . . . . 74.04 109.423 175.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 66.8 t60 . . . . . 0 C--N 1.315 -0.918 0 N-CA-C 108.594 -0.891 . . . . 74.22 108.594 174.802 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.481 1.119 0 CA-C-O 120.887 0.375 . . . . 53.54 110.296 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -161.69 60.86 0.29 Allowed Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.326 -0.71 . . . . 52.13 111.326 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -90.5 107.03 18.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.023 0.44 . . . . 54.11 110.928 -177.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 50.5 m -124.54 120.73 32.82 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.144 -0.688 . . . . 63.22 109.144 176.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.782 HG13 ' HA ' ' A' ' 109' ' ' THR . 51.0 t -93.96 132.34 38.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.605 -0.725 . . . . 65.05 109.083 178.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.7 t -80.79 115.54 23.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.977 0.418 . . . . 71.4 111.397 -171.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.487 ' HG3' ' CB ' ' A' ' 107' ' ' ARG . 9.0 mpt_? -107.14 108.09 19.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.537 -0.912 . . . . 73.5 108.537 168.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.509 ' HB3' HD22 ' A' ' 137' ' ' LEU . 2.5 t70 -147.99 173.31 13.02 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.516 -0.55 . . . . 74.2 109.516 178.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.844 ' HB2' HG12 ' A' ' 105' ' ' VAL . . . -138.56 154.35 48.73 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.045 0.45 . . . . 52.4 111.488 -171.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.459 ' HB ' ' HB2' ' A' ' 141' ' ' LYS . 12.8 m -132.55 141.07 46.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.838 -0.619 . . . . 72.01 109.987 174.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.442 HG21 ' HG3' ' A' ' 100' ' ' ARG . 25.2 m -106.38 118.32 36.34 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.156 -0.475 . . . . 74.12 111.259 -174.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.953 HG23 ' HB3' ' A' ' 145' ' ' GLU . 3.9 mp -123.19 141.94 41.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.845 -0.616 . . . . 64.25 109.716 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.26 52.02 4.24 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.843 -0.694 . . . . 74.02 112.455 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.471 ' HB2' HD21 ' A' ' 19' ' ' LEU . 94.8 mttt -131.22 144.24 52.68 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.066 -0.716 . . . . 75.11 109.066 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.75 -58.87 1.01 Allowed 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 122.688 2.259 . . . . 73.11 113.783 -169.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.406 ' HA ' HD12 ' A' ' 19' ' ' LEU . . . 173.56 -52.87 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.311 0.577 . . . . 63.14 110.462 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -57.09 -46.0 82.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.266 -0.879 . . . . 52.12 111.66 -175.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -68.57 -8.85 45.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.401 -0.363 . . . . 72.42 111.945 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.471 HD21 ' HB2' ' A' ' 14' ' ' LYS . 96.5 mt -80.55 -20.56 43.16 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 122.378 -0.201 . . . . 73.22 110.928 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -70.94 -29.4 65.42 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.458 0.647 . . . . 72.14 109.704 174.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.726 ' HB1' ' HD2' ' A' ' 27' ' ' PRO . . . -71.51 -4.72 28.3 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.54 -0.754 . . . . 43.35 112.073 -174.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.2 p -60.4 -24.2 30.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 71.01 111.245 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -55.72 -43.46 76.57 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 112.375 0.509 . . . . 73.35 112.375 -177.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 24' ' ' ARG . 28.4 ttt180 -105.53 -76.09 0.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.235 -0.586 . . . . 73.35 112.057 -174.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -147.78 2.96 0.72 Allowed 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 120.474 -0.49 . . . . 74.2 112.207 -168.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.76 HD11 ' HA ' ' A' ' 144' ' ' GLN . 51.6 mt 58.67 63.97 3.69 Favored Pre-proline 0 N--CA 1.47 0.539 0 CA-C-N 116.196 -0.456 . . . . 75.33 111.75 -175.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.726 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 83.5 Cg_endo -96.19 158.84 1.34 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.774 2.316 . . . . 64.33 112.76 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.81 53.76 4.55 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.817 -0.706 . . . . 62.24 112.281 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.63 HD23 ' HB2' ' A' ' 27' ' ' PRO . 3.8 mm? -117.01 81.13 12.07 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-O 120.416 0.15 . . . . 70.23 111.326 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.763 ' HD2' HD12 ' A' ' 31' ' ' LEU . 3.4 Cg_exo -79.14 -13.91 13.69 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.332 2.021 . . . . 64.54 111.535 172.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.763 HD12 ' HD2' ' A' ' 30' ' ' PRO . 4.7 mp -96.1 11.28 34.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.725 -0.67 . . . . 71.1 111.681 -173.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.829 ' HA ' HD11 ' A' ' 36' ' ' LEU . 1.5 pp -73.46 -12.11 60.68 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.794 -0.362 . . . . 75.01 111.821 -177.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 53.4 ttp -106.61 -4.82 19.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.688 0.28 . . . . 73.32 111.5 -177.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.2 p -80.32 -71.53 0.45 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.625 -0.43 . . . . 72.12 110.38 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -170.49 96.18 0.24 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.955 0.407 . . . . 75.02 110.957 175.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.829 HD11 ' HA ' ' A' ' 32' ' ' LEU . 2.7 pp -168.02 -29.46 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.54 -0.754 . . . . 75.43 109.398 173.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.58 ' HD2' ' OE1' ' A' ' 52' ' ' GLU . 28.2 mtp180 68.45 9.01 7.02 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.226 -0.897 . . . . 72.23 113.088 168.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.5 ' H ' HD12 ' A' ' 36' ' ' LEU . 50.1 m -83.95 90.82 7.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.815 0.34 . . . . 72.24 110.142 174.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.1 p -159.97 149.56 6.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.912 -0.585 . . . . 35.13 109.879 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.589 ' HG2' ' H ' ' A' ' 41' ' ' VAL . 15.1 tt0 -98.68 -162.8 0.98 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.662 -0.496 . . . . 75.12 109.662 -177.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.589 ' H ' ' HG2' ' A' ' 40' ' ' GLU . 65.6 t -44.8 130.95 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 122.413 0.285 . . . . 75.01 110.85 177.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.471 ' CD1' ' H ' ' A' ' 45' ' ' LYS . 2.0 tm? -130.22 -61.52 0.97 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.106 -0.497 . . . . 62.5 110.924 -168.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 73.28 -41.51 0.5 Allowed 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 113.018 0.748 . . . . 72.31 113.018 175.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.462 ' OD2' ' HG2' ' A' ' 45' ' ' LYS . 8.8 t70 -47.9 -43.12 28.49 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.974 0.51 . . . . 71.33 111.921 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.532 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 27.3 mmtm -125.04 59.07 1.24 Allowed 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.007 0.432 . . . . 54.11 110.282 176.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.444 ' HD2' ' HG2' ' A' ' 65' ' ' GLU . 0.2 OUTLIER 74.01 157.73 0.19 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-N 114.775 -1.102 . . . . 74.24 112.108 177.893 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.472 ' H ' ' CD ' ' A' ' 63' ' ' GLU . 7.3 m -109.92 28.37 8.66 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.949 -1.023 . . . . 75.24 109.87 176.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.59 42.77 0.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 72.12 110.927 -174.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 20.6 t90 63.66 86.18 0.12 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.469 -0.787 . . . . 74.31 111.587 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.45 HG21 ' HB3' ' A' ' 37' ' ' ARG . 24.5 m 74.37 145.37 0.08 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.204 -0.907 . . . . 63.1 112.457 175.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.1 m -84.43 88.62 2.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.607 0.718 . . . . 72.53 111.582 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.58 ' OE1' ' HD2' ' A' ' 37' ' ' ARG . 41.8 tt0 -171.32 -34.07 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.303 -0.862 . . . . 73.24 109.213 177.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.75 149.43 84.98 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 114.82 -1.082 . . . . 64.43 111.757 -178.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -86.82 -177.86 2.4 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.004 2.469 . . . . 74.43 112.547 178.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 72.09 144.03 0.1 Allowed Pre-proline 0 N--CA 1.466 0.33 0 O-C-N 123.969 0.793 . . . . 72.14 111.311 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -66.95 -51.99 0.74 Allowed 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.239 1.959 . . . . 74.44 112.628 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.69 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 1.7 pt? -130.42 8.6 5.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.542 0.687 . . . . 75.11 110.74 -177.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.99 -75.79 1.68 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.086 -0.961 . . . . 64.31 112.505 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -116.24 -85.44 0.63 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.816 0.341 . . . . 14.11 110.69 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.7 p -154.05 15.68 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.939 0.876 . . . . 55.3 109.517 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.5 m -70.15 160.13 32.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.026 -0.988 . . . . 74.51 109.777 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 2.2 m95 -71.47 124.3 24.33 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.825 -0.806 . . . . 75.21 108.825 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.63 ' HB3' HD12 ' A' ' 80' ' ' LEU . 8.6 tp10 -140.46 153.21 46.17 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.145 -0.48 . . . . 65.41 110.846 -174.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -104.71 114.62 28.96 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.576 -0.738 . . . . 54.15 111.088 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -117.8 136.73 53.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.928 -0.578 . . . . 75.25 109.78 174.031 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.673 ' HG ' ' HA ' ' A' ' 77' ' ' TRP . 6.8 mp -91.37 128.38 37.17 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.73 0.3 . . . . 74.33 110.548 -178.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.782 ' HB ' ' HG3' ' A' ' 78' ' ' ARG . 12.9 t -70.55 -28.57 65.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 74.52 110.84 -173.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.11 131.46 17.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.895 -0.593 . . . . 50.21 109.793 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -141.5 91.88 2.42 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.037 0.446 . . . . 72.44 109.849 -178.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.608 ' HB2' ' H ' ' A' ' 74' ' ' ARG . 10.3 mm-40 -95.72 142.37 24.49 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 109.185 -0.672 . . . . 64.34 109.185 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.77 94.48 0.39 Allowed 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.417 2.078 . . . . 72.04 112.713 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.71 35.04 89.19 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.994 -0.622 . . . . 71.42 112.258 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.516 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 75.2 mmtt -127.05 -70.41 0.72 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.679 0.276 . . . . 70.11 110.332 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.608 ' H ' ' HB2' ' A' ' 70' ' ' GLU . 30.8 ptt-85 -150.58 132.35 15.0 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.737 -0.468 . . . . 75.24 109.737 176.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.579 ' HB ' HG13 ' A' ' 91' ' ' VAL . 3.9 mp -126.9 116.23 44.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.077 -0.511 . . . . 71.44 109.792 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -106.98 118.61 37.17 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.063 -0.517 . . . . 73.01 110.53 -178.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.673 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 36.2 m95 -87.07 145.58 26.41 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.841 -0.618 . . . . 62.3 111.238 -174.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.782 ' HG3' ' HB ' ' A' ' 67' ' ' THR . 19.0 mmm-85 -148.97 175.13 11.56 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.814 -0.63 . . . . 71.41 109.777 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.519 ' HB2' ' HB2' ' A' ' 86' ' ' GLU . 63.2 m -134.92 142.43 46.54 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.449 -0.945 . . . . 70.24 108.449 175.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.69 ' CD1' ' HB3' ' A' ' 57' ' ' LEU . 94.5 mt -67.0 153.12 95.15 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.579 -0.282 . . . . 55.53 110.931 -176.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -52.2 -16.78 5.13 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.953 3.102 . . . . 73.03 114.297 -173.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.85 -35.38 89.51 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.66 -0.781 . . . . 64.42 111.921 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.66 147.85 26.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.993 0.425 . . . . 72.14 111.093 -176.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.467 ' HD2' ' C ' ' A' ' 84' ' ' ARG . 6.0 ppt_? -115.44 -1.59 12.79 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.086 -0.507 . . . . 74.52 110.742 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.445 ' O ' HG13 ' A' ' 85' ' ' ILE . 10.1 tp -107.86 33.59 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.995 0.902 . . . . 60.33 110.247 -178.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 79' ' ' SER . 42.1 tt0 -64.24 122.01 15.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.664 -0.698 . . . . 73.5 110.555 177.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -103.59 140.56 37.37 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.355 -0.98 . . . . 71.43 108.355 174.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.1 m -94.77 126.19 39.93 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.19 0.519 . . . . 64.22 110.145 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 107' ' ' ARG . . . -159.0 146.39 12.95 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.304 -0.862 . . . . 62.34 111.443 -178.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -147.02 126.4 13.13 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 110.357 -0.238 . . . . 60.05 110.357 -176.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.656 HG23 HG23 ' A' ' 104' ' ' VAL . 2.5 p -108.6 121.68 62.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.055 0.455 . . . . 75.32 110.942 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.445 ' HB2' ' CG2' ' A' ' 105' ' ' VAL . 8.9 mp -108.96 139.82 43.3 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.736 -0.468 . . . . 73.24 109.736 174.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.513 ' HE2' HD13 ' A' ' 75' ' ' ILE . 93.9 m-85 -104.45 108.97 20.65 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.251 0.548 . . . . 72.54 110.073 178.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -126.73 144.88 51.46 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 115.461 -0.791 . . . . 72.54 110.046 -177.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.75 136.85 47.32 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.187 1.924 . . . . 42.21 111.551 176.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.524 ' CB ' ' HB3' ' A' ' 100' ' ' ARG . . . -77.63 146.99 74.13 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.185 -0.461 . . . . 75.12 110.011 178.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -37.78 108.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 124.111 3.208 . . . . 62.42 114.463 -172.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 90.04 -67.99 2.57 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 114.671 -1.149 . . . . 62.51 112.067 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -178.28 32.07 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.203 -0.498 . . . . 74.34 110.877 -174.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.524 ' HB3' ' CB ' ' A' ' 96' ' ' ALA . 21.8 tpp180 -74.2 -13.61 60.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.962 0.411 . . . . 74.22 110.802 -177.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 129.38 -157.53 21.76 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.962 -0.855 . . . . 32.32 110.962 -177.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 32.7 m -101.91 127.72 48.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.063 0.459 . . . . 73.01 109.815 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.422 ' CG ' ' HB1' ' A' ' 9' ' ' ALA . 44.2 tt0 -100.49 110.38 22.56 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.634 -0.712 . . . . 70.21 110.105 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.656 HG23 HG23 ' A' ' 91' ' ' VAL . 1.7 p -87.88 97.92 7.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.698 0.761 . . . . 71.14 109.364 175.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.844 HG12 ' HB2' ' A' ' 9' ' ' ALA . 22.7 m -84.43 110.79 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 115.059 -0.973 . . . . 71.11 109.802 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.7 p -112.67 123.89 68.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.797 -0.638 . . . . 64.14 110.878 -176.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.545 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 22.5 ptt180 -115.22 99.06 7.14 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.714 -0.676 . . . . 72.14 109.661 174.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 52.3 tp -120.46 141.98 49.67 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.021 -0.733 . . . . 71.33 109.021 -177.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.782 ' HA ' HG13 ' A' ' 5' ' ' VAL . 51.8 m -83.1 119.58 24.67 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.715 0.769 . . . . 53.25 111.922 -172.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -124.23 120.18 31.5 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.686 -1.143 . . . . 74.32 109.08 174.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -120.0 145.76 40.57 Favored Pre-proline 0 C--N 1.316 -0.849 0 N-CA-C 109.537 -0.542 . . . . 75.12 109.537 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.37 153.6 76.41 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.227 1.952 . . . . 73.03 111.343 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -80.18 5.12 6.24 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.565 2.176 . . . . 53.33 111.839 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 115.35 -147.86 18.92 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.005 -0.838 . . . . 50.05 111.005 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 61.38 45.46 96.37 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.924 -0.655 . . . . 65.22 112.824 176.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.9 m -62.41 -29.08 70.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.891 0.377 . . . . 75.34 110.912 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.83 -30.58 65.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.072 -0.513 . . . . 45.21 110.866 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -73.88 -20.23 79.74 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.81 -0.632 . . . . 51.41 112.916 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.51 -19.82 27.24 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 112.262 0.468 . . . . 32.51 112.262 -177.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.426 ' O ' ' HG3' ' A' ' 124' ' ' MET . 13.8 p -60.13 -29.79 44.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 62.2 111.832 -177.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.7 pp -65.46 -32.69 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 C-N-CA 120.85 -0.34 . . . . 75.31 111.022 -177.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.94 -39.36 56.3 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.689 -0.486 . . . . 63.21 109.689 176.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -59.01 -28.33 66.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.378 -0.828 . . . . 74.35 111.6 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.426 ' HG3' ' O ' ' A' ' 120' ' ' VAL . 66.1 mtt -60.07 -45.81 91.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.208 -0.451 . . . . 75.31 111.362 -178.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -106.86 -26.04 11.41 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.816 0.302 . . . . 72.14 111.816 -176.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -103.19 125.49 49.9 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.412 -0.588 . . . . 74.22 109.412 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -78.41 -0.87 30.88 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.271 -0.422 . . . . 72.1 111.509 -177.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 54.65 67.94 2.97 Favored Pre-proline 0 C--O 1.234 0.249 0 N-CA-C 109.289 -0.634 . . . . 74.33 109.289 -170.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -56.41 -41.41 76.51 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.08 2.52 . . . . 70.24 112.73 -172.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.6 t -147.26 168.22 22.28 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.64 -0.504 . . . . 74.25 109.64 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -92.87 -10.98 34.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.458 -0.337 . . . . 74.23 111.019 -175.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.02 116.71 12.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.573 0.701 . . . . 54.33 110.744 174.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 95.8 mt -127.95 135.02 49.37 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.695 -0.684 . . . . 63.34 110.121 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -88.96 40.44 0.98 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.874 0.369 . . . . 73.12 111.103 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.449 ' O ' ' HG3' ' A' ' 138' ' ' MET . 18.1 t70 -65.55 -43.92 88.42 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.002 0.43 . . . . 74.4 110.601 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -74.54 -36.46 63.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.239 0.542 . . . . 75.01 110.319 174.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.509 HD22 ' HB3' ' A' ' 8' ' ' ASP . 1.3 mp -70.63 -29.76 66.21 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.618 0.599 . . . . 75.12 112.618 -174.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.449 ' HG3' ' O ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -64.2 -26.2 68.41 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.412 -0.515 . . . . 63.41 110.076 175.442 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 55.8 mtt180 -69.61 -48.93 58.36 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.496 -0.557 . . . . 75.55 109.496 174.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -56.29 -48.95 75.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.841 -1.072 . . . . 62.31 110.985 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.592 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 0.6 OUTLIER -63.49 -44.13 95.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.016 -0.538 . . . . 73.21 110.141 179.748 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 48.0 ttt180 -57.46 -50.61 72.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.063 -0.517 . . . . 74.22 111.076 -175.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -66.17 -27.47 68.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.073 0.463 . . . . 65.34 110.594 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.76 ' HA ' HD11 ' A' ' 26' ' ' LEU . 54.5 tt0 -77.49 -29.21 52.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.795 -0.639 . . . . 72.44 112.035 -174.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.953 ' HB3' HG23 ' A' ' 12' ' ' ILE . 2.2 pp20? -108.49 -13.4 14.85 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.265 0.468 . . . . 73.21 112.265 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 57.5 tp -62.08 -40.33 95.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.265 0.555 . . . . 74.31 109.612 175.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -105.18 113.47 4.32 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.83 -0.7 . . . . 74.41 111.408 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 89.5 mt -80.78 -61.13 2.06 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.921 -0.4 . . . . 64.41 109.921 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -124.09 112.86 17.62 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.409 -0.96 . . . . 75.12 108.409 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -136.94 140.43 42.24 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.884 0.373 . . . . 73.42 110.864 -173.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -128.83 55.75 1.7 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.39 0.614 . . . . 62.43 109.987 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.444 ' HB3' ' H ' ' A' ' 153' ' ' HIS . 6.5 t60 51.37 -114.94 0.84 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.702 -1.135 . . . . 74.44 111.064 -176.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.444 ' H ' ' HB3' ' A' ' 152' ' ' HIS . 8.3 p-80 -173.04 157.69 3.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.721 0.296 . . . . 65.23 111.001 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -163.68 -107.87 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.283 -1.006 . . . . 73.43 108.283 171.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 . . . . . 0 C--O 1.246 0.892 0 CA-C-O 118.229 -0.891 . . . . 74.45 108.837 177.139 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtm . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 121.337 0.589 . . . . 72.41 110.135 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 123.06 -76.9 0.36 Allowed Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.508 -0.769 . . . . 32.33 111.222 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 47.29 55.32 8.34 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.361 0.6 . . . . 75.24 110.475 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.3 m -119.44 123.41 44.0 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.653 0.739 . . . . 60.44 111.617 -169.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.585 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 70.0 t -118.39 110.71 31.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 114.876 -1.056 . . . . 45.23 108.456 172.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.4 p -77.82 124.38 36.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.466 0.65 . . . . 73.03 110.44 -174.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.711 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -141.52 110.56 6.23 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.344 -0.844 . . . . 71.4 110.621 -179.889 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.506 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 14.3 t70 -146.21 171.38 15.03 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.036 -0.727 . . . . 64.11 109.036 175.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.68 ' HB2' HG12 ' A' ' 105' ' ' VAL . . . -139.72 120.69 14.57 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.939 0.4 . . . . 73.13 111.02 -174.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.1 m -115.09 143.44 24.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.985 -0.552 . . . . 74.44 110.163 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.544 HG21 ' HB2' ' A' ' 100' ' ' ARG . 42.6 m -103.79 111.87 24.57 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.967 -0.56 . . . . 71.4 110.322 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.642 HD13 ' HG2' ' A' ' 141' ' ' LYS . 9.4 mm -100.63 146.0 10.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.287 -0.415 . . . . 74.23 109.945 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.16 60.11 4.5 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.689 -0.767 . . . . 52.54 111.817 174.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.527 ' HB2' HD21 ' A' ' 19' ' ' LEU . 24.2 mmtm -141.19 145.25 37.85 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 109.764 -0.458 . . . . 62.1 109.764 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.41 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 72.9 Cg_exo -52.24 -57.68 1.98 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.157 2.572 . . . . 64.41 113.58 -175.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . 174.54 -46.66 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.932 0.396 . . . . 63.4 111.156 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -59.19 -45.43 91.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.075 -0.511 . . . . 74.54 110.866 -176.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.615 ' HA ' ' HB3' ' A' ' 21' ' ' ALA . 21.4 mp0 -66.64 -16.67 64.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.886 -0.597 . . . . 72.1 110.906 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.745 HD11 ' HB ' ' A' ' 102' ' ' THR . 74.5 mt -73.76 -45.5 51.45 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.36 -0.382 . . . . 74.14 110.256 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -74.28 -29.9 61.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.383 0.611 . . . . 73.34 109.896 174.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.615 ' HB3' ' HA ' ' A' ' 18' ' ' GLN . . . -70.34 -3.03 15.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.276 -0.874 . . . . 60.3 111.927 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.715 HG21 ' HD2' ' A' ' 140' ' ' PHE . 10.9 p -53.2 -21.21 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.096 0.558 . . . . 62.11 111.991 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 4.2 m95 -59.19 -26.15 64.57 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.796 0.332 . . . . 74.21 110.92 176.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -136.95 -164.67 1.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 74.21 110.168 -177.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.453 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 5.3 t70 -88.03 46.67 1.41 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.282 -0.417 . . . . 70.21 110.209 -176.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 25' ' ' ASP . 0.4 OUTLIER 43.14 84.87 0.18 Allowed Pre-proline 0 N--CA 1.476 0.86 0 C-N-CA 123.513 0.725 . . . . 71.11 111.965 -177.808 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.641 ' HB3' ' HB2' ' A' ' 38' ' ' SER . 32.1 Cg_exo -59.41 -55.61 1.73 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.983 2.455 . . . . 54.44 113.867 -173.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.71 71.34 1.03 Allowed Glycine 0 C--N 1.32 -0.309 0 C-N-CA 120.858 -0.687 . . . . 42.15 112.013 -176.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.587 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 0.8 OUTLIER -127.95 70.44 77.89 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.74 0.781 . . . . 54.21 112.007 -179.446 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -75.08 0.85 8.44 Favored 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.267 1.978 . . . . 64.43 112.027 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.4 ' N ' HD12 ' A' ' 31' ' ' LEU . 6.0 mp -82.36 -52.19 7.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.812 -0.631 . . . . 74.41 110.492 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.1 mt 59.74 31.09 20.64 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.717 -0.674 . . . . 74.54 111.519 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 50.0 ttm -132.61 135.02 45.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.614 -0.266 . . . . 63.13 110.761 -177.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.4 m 66.95 8.82 6.38 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 123.697 0.623 . . . . 70.22 111.925 175.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 57.61 143.68 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.995 1.318 . . . . 63.34 112.881 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.7 mp -112.95 -171.55 1.89 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.005 -0.739 . . . . 73.02 109.005 175.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -64.29 -23.28 67.24 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.391 0.615 . . . . 45.04 110.246 175.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.641 ' HB2' ' HB3' ' A' ' 27' ' ' PRO . 17.2 m -138.08 131.08 30.02 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.533 -0.758 . . . . 64.14 109.369 177.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.556 ' HA ' ' CD1' ' A' ' 29' ' ' LEU . 8.3 m -119.96 162.97 17.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.616 -0.265 . . . . 71.13 111.126 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.625 ' HG2' ' HD3' ' A' ' 45' ' ' LYS . 18.8 tt0 -88.64 13.61 11.86 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.914 0.864 . . . . 75.4 110.47 -176.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.524 HG11 ' HD1' ' A' ' 49' ' ' TRP . 14.6 p -141.85 128.55 19.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.326 -0.852 . . . . 65.11 109.708 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.1 tp -171.87 -53.74 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.694 0.283 . . . . 75.44 110.77 -172.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.552 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 32.0 t70 -161.09 -38.73 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.046 -0.524 . . . . 74.4 110.755 -177.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -68.69 -69.84 0.3 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.292 -0.867 . . . . 72.23 111.804 -175.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.644 ' HA ' ' CD2' ' A' ' 66' ' ' LEU . 39.2 mtpt -72.45 -43.86 63.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.16 0.505 . . . . 75.0 111.067 -178.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 46' ' ' ARG . 21.2 mtt180 -148.12 143.26 27.0 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.238 -0.892 . . . . 55.41 109.296 171.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.641 ' H ' ' HG3' ' A' ' 63' ' ' GLU . 15.2 m -79.77 115.25 19.26 Favored 'General case' 0 C--N 1.318 -0.765 0 O-C-N 123.583 0.552 . . . . 63.44 110.714 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.404 ' HG2' ' H ' ' A' ' 49' ' ' TRP . 31.5 ttp180 68.43 165.17 0.24 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.317 -0.856 . . . . 74.44 110.653 -176.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.524 ' HD1' HG11 ' A' ' 41' ' ' VAL . 39.4 t90 -76.48 80.77 3.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.202 0.525 . . . . 73.32 110.425 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.4 p -86.3 -80.76 0.23 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.989 -0.55 . . . . 72.42 110.377 177.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.461 HG12 ' HG3' ' A' ' 52' ' ' GLU . 47.7 t 67.56 -70.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 O-C-N 123.579 0.55 . . . . 64.2 111.533 178.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.461 ' HG3' HG12 ' A' ' 51' ' ' VAL . 48.3 mt-10 -120.27 94.26 4.32 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.031 0.443 . . . . 73.12 110.016 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.15 151.46 44.66 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.71 -0.677 . . . . 73.53 110.115 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.83 113.8 2.14 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.221 1.947 . . . . 72.34 110.913 174.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.49 ' HB3' ' HA3' ' A' ' 58' ' ' GLY . . . 66.38 143.3 0.08 OUTLIER Pre-proline 0 N--CA 1.466 0.344 0 O-C-N 123.971 0.794 . . . . 73.03 110.523 -171.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.49 ' HB2' HD11 ' A' ' 80' ' ' LEU . 11.0 Cg_endo -54.95 -54.6 4.2 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.515 2.143 . . . . 63.31 112.161 -177.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.665 ' H ' HD23 ' A' ' 57' ' ' LEU . 2.6 pt? -103.73 12.83 34.2 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.744 -0.662 . . . . 53.41 110.418 -176.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.49 ' HA3' ' HB3' ' A' ' 55' ' ' ALA . . . -78.01 5.67 52.8 Favored Glycine 0 C--N 1.318 -0.434 0 CA-C-N 115.263 -0.88 . . . . 64.33 113.526 -174.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -126.65 0.46 6.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.089 0.471 . . . . 44.22 111.172 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.9 m -128.01 179.6 3.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.245 -0.434 . . . . 74.42 110.972 -175.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.7 m -75.16 -42.69 55.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.554 0.692 . . . . 64.13 109.415 175.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -161.93 159.65 26.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.925 -1.034 . . . . 75.2 108.398 170.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.796 ' HB3' HD12 ' A' ' 80' ' ' LEU . 44.0 tt0 -136.72 137.93 40.47 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.955 -0.387 . . . . 75.14 109.955 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.9 114.67 26.31 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.312 -0.625 . . . . 61.31 109.312 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.422 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 7.6 tt0 -108.83 134.61 51.29 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.964 -0.294 . . . . 52.35 110.533 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.015 HD12 ' HA ' ' A' ' 77' ' ' TRP . 2.2 mm? -83.95 137.32 33.69 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.356 -0.609 . . . . 70.35 109.356 174.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.564 HG23 ' HB2' ' A' ' 78' ' ' ARG . 20.8 p -67.67 -34.37 76.79 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.502 0.668 . . . . 72.33 110.546 -176.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -135.72 124.85 24.43 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.979 -1.009 . . . . 72.1 110.725 177.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -117.36 90.77 3.41 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.432 -0.804 . . . . 71.4 109.581 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.99 ' HB3' ' HB2' ' A' ' 73' ' ' LYS . 48.9 mt-10 -120.02 86.52 37.09 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.483 -0.781 . . . . 73.12 110.452 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -60.6 107.03 0.39 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.599 2.199 . . . . 72.31 111.82 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.409 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 99.09 6.16 55.94 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.896 -0.669 . . . . 53.35 111.827 -177.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.99 ' HB2' ' HB3' ' A' ' 70' ' ' GLU . 2.8 mmmp? -128.62 -66.38 0.84 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.586 0.231 . . . . 70.24 110.488 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 22.4 ptt180 -168.3 150.09 5.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.323 -0.399 . . . . 75.31 110.643 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.6 mp -124.98 114.29 39.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 116.195 -0.457 . . . . 74.04 109.793 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.579 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . . . -101.68 121.02 41.25 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.076 -0.511 . . . . 74.21 110.448 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 1.015 ' HA ' HD12 ' A' ' 66' ' ' LEU . 26.3 m0 -80.49 155.43 27.03 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.989 0.737 . . . . 72.22 112.989 -172.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.573 ' HG3' ' H ' ' A' ' 79' ' ' SER . 24.7 tpp180 -176.62 174.63 1.83 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 114.394 -1.275 . . . . 54.45 108.238 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.573 ' H ' ' HG3' ' A' ' 78' ' ' ARG . 24.6 m -148.75 145.81 27.78 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.001 -1.111 . . . . 70.42 108.001 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.796 HD12 ' HB3' ' A' ' 63' ' ' GLU . 90.2 mt -71.7 152.08 93.48 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.911 -0.404 . . . . 75.44 109.911 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -52.35 -23.3 18.11 Favored 'Trans proline' 0 N--CA 1.476 0.445 0 C-N-CA 123.315 2.677 . . . . 72.44 113.93 -175.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -78.53 -4.14 87.16 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.821 -0.704 . . . . 62.33 112.997 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.33 -170.74 2.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.919 0.39 . . . . 60.23 110.935 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.466 ' HB2' HD12 ' A' ' 85' ' ' ILE . 86.8 mtt180 -118.06 -38.42 3.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.052 -0.522 . . . . 70.01 112.095 -172.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.466 HD12 ' HB2' ' A' ' 84' ' ' ARG . 4.8 mp -121.5 122.84 68.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.928 -0.309 . . . . 63.53 110.722 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.468 ' HB3' ' HB2' ' A' ' 79' ' ' SER . 11.3 pt-20 -125.79 123.19 38.22 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.53 -0.544 . . . . 74.23 109.53 172.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -111.64 138.67 47.88 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.032 -0.729 . . . . 74.14 109.032 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.2 m -96.04 128.15 42.69 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.685 -0.487 . . . . 34.5 109.685 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.24 123.73 0.69 Allowed Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.74 -0.743 . . . . 60.01 111.896 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 0.5 OUTLIER -108.95 126.19 52.83 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.904 0.383 . . . . 75.12 110.297 178.419 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 4.4 m -97.81 126.68 50.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.463 -0.569 . . . . 52.32 109.463 176.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.485 ' HB2' ' CG2' ' A' ' 105' ' ' VAL . 9.5 mp -105.32 139.06 40.53 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.422 -0.354 . . . . 65.24 110.886 -177.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -99.57 105.64 17.54 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.456 -0.942 . . . . 62.54 108.456 172.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.4 mtp85 -112.68 150.25 42.43 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 115.288 -0.869 . . . . 64.42 111.1 -171.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -49.71 127.3 18.41 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.427 2.084 . . . . 71.22 111.204 172.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.37 150.85 85.23 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.881 -0.599 . . . . 51.23 111.762 -172.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.78 109.43 0.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.824 2.349 . . . . 71.44 112.089 175.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.8 -73.9 1.34 Allowed Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.175 -0.92 . . . . 63.24 111.483 177.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 174.31 24.57 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.273 0.631 . . . . 72.22 111.264 -175.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.544 ' HB2' HG21 ' A' ' 11' ' ' THR . 19.6 mtp180 -82.62 7.04 15.8 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.544 0.572 . . . . 53.3 112.544 -171.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 126.68 -113.14 1.71 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.49 -0.862 . . . . 44.32 111.78 177.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.745 ' HB ' HD11 ' A' ' 19' ' ' LEU . 15.7 m -141.17 140.6 34.07 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.841 0.353 . . . . 72.1 110.265 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -96.59 119.02 34.3 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.176 -0.466 . . . . 63.12 110.755 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 p -100.67 107.49 21.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.495 0.664 . . . . 62.12 110.258 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.68 HG12 ' HB2' ' A' ' 9' ' ' ALA . 18.8 m -95.45 118.69 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 115.37 -0.832 . . . . 74.22 110.046 178.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.711 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 18.6 m -112.2 127.92 69.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.837 -0.62 . . . . 72.02 110.584 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.479 ' HG3' ' HB3' ' A' ' 7' ' ' ARG . 10.1 ttp180 -137.67 100.38 4.19 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.054 -0.521 . . . . 74.24 109.857 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 pp -145.46 155.23 42.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.974 -0.557 . . . . 74.24 109.508 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 11.4 t -80.82 137.69 36.21 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.154 -0.618 . . . . 64.04 109.876 -176.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -160.17 111.41 1.93 Allowed 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.069 -1.085 . . . . 73.4 108.069 -171.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.497 ' H ' ' HG3' ' A' ' 111' ' ' ARG . 1.2 ppt_? -95.36 144.53 27.96 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-O 121.041 0.448 . . . . 74.31 111.692 -170.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 111' ' ' ARG . 24.1 Cg_endo -91.21 160.59 3.79 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 123.154 2.569 . . . . 64.02 111.673 175.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -65.64 -22.92 57.3 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.473 2.115 . . . . 65.31 112.359 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -160.62 -133.13 1.43 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 121.001 -0.618 . . . . 23.12 111.998 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 121.48 -15.21 9.23 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.705 -0.759 . . . . 52.32 112.417 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.6 m -85.26 -48.8 8.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.078 0.466 . . . . 71.31 110.585 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.495 ' O ' HG22 ' A' ' 120' ' ' VAL . . . -72.69 -39.61 66.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.926 -0.579 . . . . 63.11 111.431 -177.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.5 ' O ' HG22 ' A' ' 121' ' ' ILE . . . -67.01 -20.02 70.43 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 121.037 -0.601 . . . . 62.54 113.273 -177.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.17 -21.31 60.72 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.228 0.455 . . . . 61.33 112.228 -175.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 117' ' ' ALA . 10.7 m -77.12 -18.84 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.509 0.559 . . . . 54.11 112.509 -173.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.5 HG22 ' O ' ' A' ' 118' ' ' GLY . 16.1 tt -68.86 -28.98 41.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.893 -0.323 . . . . 70.44 111.061 -176.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.516 ' HB2' ' HG2' ' A' ' 129' ' ' PRO . . . -61.33 -27.49 68.53 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.779 -0.646 . . . . 72.42 111.953 -175.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 16.7 mtm180 -66.79 -42.59 85.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.091 0.472 . . . . 71.13 110.009 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 40.5 ttp -71.18 -54.14 12.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.758 -0.656 . . . . 70.11 109.789 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.428 ' CD2' ' HG3' ' A' ' 127' ' ' GLN . 16.6 t80 -159.26 136.92 10.09 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.505 -0.924 . . . . 72.34 108.505 178.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -58.31 -74.0 0.07 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.046 0.387 . . . . 45.53 112.046 -170.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.428 ' HG3' ' CD2' ' A' ' 125' ' ' PHE . 92.5 mt-30 60.39 12.74 3.62 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.388 0.514 . . . . 64.42 112.388 178.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 56.42 82.08 0.25 Allowed Pre-proline 0 CA--C 1.534 0.35 0 O-C-N 123.541 0.525 . . . . 72.11 111.035 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.516 ' HG2' ' HB2' ' A' ' 122' ' ' ALA . 6.2 Cg_exo -79.03 -56.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.79 2.327 . . . . 42.13 112.818 -176.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 29.9 p -129.88 105.88 8.29 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.235 -0.439 . . . . 65.01 110.548 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -135.16 -66.29 0.58 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.114 -0.494 . . . . 75.41 110.553 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 67.56 -58.99 0.42 Allowed 'General case' 0 N--CA 1.466 0.342 0 O-C-N 124.013 0.821 . . . . 71.41 110.529 -172.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 42.4 tp 53.48 76.35 0.22 Allowed 'General case' 0 C--O 1.233 0.215 0 O-C-N 123.689 0.618 . . . . 74.42 111.58 174.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 33.9 mtt-85 57.08 42.9 25.14 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.532 -0.758 . . . . 74.44 110.369 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -56.96 -56.5 20.85 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.77 0.285 . . . . 72.15 111.77 -173.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -76.56 -39.52 52.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.886 0.374 . . . . 75.33 110.156 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.564 ' CD1' ' HE1' ' A' ' 140' ' ' PHE . 0.3 OUTLIER -53.75 -51.0 64.78 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.667 -0.697 . . . . 55.02 111.589 -178.938 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.53 ' HA ' ' CE ' ' A' ' 138' ' ' MET . 0.6 OUTLIER -65.17 -38.18 89.71 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.429 -0.35 . . . . 72.21 111.001 -175.927 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.422 ' O ' ' HB3' ' A' ' 142' ' ' ARG . 34.2 mtm105 -65.68 -51.66 57.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.509 -0.314 . . . . 72.14 111.676 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.715 ' HD2' HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -73.57 -30.21 62.89 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 120.06 -0.656 . . . . 63.5 109.779 -175.123 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.642 ' HG2' HD13 ' A' ' 12' ' ' ILE . 13.5 tmtt? -55.44 -50.44 69.83 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.235 -0.654 . . . . 62.53 109.235 173.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.602 ' HE ' ' HG3' ' A' ' 143' ' ' GLU . 43.7 ttp180 -52.53 -54.93 26.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.514 -1.221 . . . . 73.42 111.674 177.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.602 ' HG3' ' HE ' ' A' ' 142' ' ' ARG . 30.6 mt-10 -72.97 -34.02 66.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.958 -0.565 . . . . 73.1 111.812 -174.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.619 ' OE1' ' HA ' ' A' ' 19' ' ' LEU . 9.0 tt0 -61.65 -44.46 96.92 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.299 0.481 . . . . 75.43 112.299 -174.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -85.73 -8.74 57.98 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.272 -0.571 . . . . 75.42 111.12 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 57.5 tp -84.21 -53.18 5.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.082 0.468 . . . . 43.52 109.869 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 138.98 -176.48 20.89 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.933 -0.867 . . . . 43.4 110.933 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.533 ' HG ' ' H ' ' A' ' 149' ' ' GLU . 12.2 tp 71.67 175.91 0.28 Allowed 'General case' 0 CA--C 1.534 0.364 0 O-C-N 123.872 0.395 . . . . 72.14 110.418 177.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.533 ' H ' ' HG ' ' A' ' 148' ' ' LEU . 31.5 tt0 -77.45 -70.11 0.49 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.965 0.412 . . . . 60.22 110.597 177.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.597 ' HE1' ' HB2' ' A' ' 140' ' ' PHE . 0.1 OUTLIER -177.17 145.08 0.45 Allowed 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.531 -0.759 . . . . 72.15 109.329 -176.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -75.84 -29.0 58.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.719 0.295 . . . . 64.52 110.333 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 24.5 m170 63.08 -170.57 0.18 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.838 -0.619 . . . . 71.51 112.55 174.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.4 ' HB3' ' H ' ' A' ' 154' ' ' HIS . 0.9 OUTLIER 68.44 -89.32 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 114.752 -1.113 . . . . 64.15 111.14 174.557 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.4 ' H ' ' HB3' ' A' ' 153' ' ' HIS . 56.4 t-80 55.63 73.61 0.42 Allowed 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.494 0.496 . . . . 75.32 110.633 -176.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 24.2 t60 . . . . . 0 C--O 1.244 0.766 0 CA-C-O 118.361 -0.828 . . . . 52.51 109.314 179.313 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.467 ' O ' ' HG3' ' A' ' 3' ' ' GLU . 52.3 mtt . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 109.68 -0.489 . . . . 73.1 109.68 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.34 -97.27 0.76 Allowed Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 110.789 -0.924 . . . . 74.13 110.789 -172.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 1' ' ' MET . 35.9 mt-10 45.11 81.05 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.54 0.736 . . . . 64.2 112.551 169.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 110' ' ' TYR . 26.8 m -128.8 122.67 31.01 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.607 -0.516 . . . . 62.52 109.607 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 82.4 t -111.54 109.14 27.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.801 -0.444 . . . . 73.31 109.801 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.5 t -93.72 116.52 35.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.826 -0.625 . . . . 72.21 110.314 -176.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.44 109.79 13.15 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.965 -0.754 . . . . 73.01 108.965 172.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.577 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 7.0 t70 -157.72 172.03 19.24 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.039 -1.097 . . . . 62.13 108.039 175.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.473 ' CB ' HG22 ' A' ' 105' ' ' VAL . . . -136.84 121.05 17.91 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.949 0.404 . . . . 74.22 111.486 -173.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.9 m -109.27 141.67 23.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.256 -0.646 . . . . 63.22 109.256 175.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 t -116.47 124.68 50.55 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.937 0.875 . . . . 74.1 110.99 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.76 HG23 ' HB3' ' A' ' 145' ' ' GLU . 4.7 mp -121.85 150.18 25.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.692 -1.14 . . . . 51.31 109.685 -176.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.9 37.99 0.76 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.509 -0.377 . . . . 71.41 113.582 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.557 ' HG2' HG22 ' A' ' 12' ' ' ILE . 74.3 mmtt -105.66 152.0 39.98 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 108.264 -1.013 . . . . 52.11 108.264 175.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.73 -57.85 1.37 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.151 1.9 . . . . 51.25 112.593 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 173.33 -54.1 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.404 0.621 . . . . 53.34 110.164 178.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.756 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 7.8 mt-10 -55.56 -39.32 70.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.82 -1.082 . . . . 63.12 111.814 -175.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.612 ' NE2' ' HB2' ' A' ' 17' ' ' GLU . 2.5 mp0 -73.43 -14.11 61.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.864 -0.607 . . . . 74.34 111.135 -175.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.3 mt -76.04 -44.07 40.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.592 -0.276 . . . . 64.11 111.064 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.756 ' CE2' ' HA ' ' A' ' 17' ' ' GLU . 21.1 p90 -73.75 -23.47 59.74 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 119.999 -0.68 . . . . 74.11 110.22 175.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.631 ' HB1' ' HD2' ' A' ' 27' ' ' PRO . . . -75.58 -2.64 30.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.5 -0.773 . . . . 71.21 111.74 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.45 HG11 ' HZ ' ' A' ' 140' ' ' PHE . 15.0 p -52.14 -31.55 14.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 112.144 0.424 . . . . 74.45 112.144 -177.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -67.7 -13.0 61.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.706 0.289 . . . . 75.55 111.449 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.767 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . 39.3 mmt180 -117.14 15.28 14.99 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.193 -0.458 . . . . 72.3 110.715 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.436 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 11.6 t70 61.5 37.57 16.4 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.864 0.84 . . . . 71.34 109.117 -175.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER 43.84 85.33 0.17 Allowed Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 114.967 -1.015 . . . . 73.43 111.726 -177.492 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.767 ' HD3' ' HB2' ' A' ' 24' ' ' ARG . 63.3 Cg_endo -73.59 111.63 3.34 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.617 2.211 . . . . 74.41 112.579 -175.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.444 ' C ' ' HD3' ' A' ' 30' ' ' PRO . . . -79.14 97.61 1.55 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.584 -0.817 . . . . 60.0 111.482 176.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.44 74.06 11.22 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 121.057 0.456 . . . . 64.34 111.839 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.444 ' HD3' ' C ' ' A' ' 28' ' ' GLY . 8.0 Cg_exo -72.58 -4.1 14.68 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.888 2.392 . . . . 73.54 111.778 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.695 ' H ' HD12 ' A' ' 31' ' ' LEU . 4.4 mp -64.7 -35.11 79.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.803 -0.635 . . . . 72.14 110.07 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -76.97 -14.72 59.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.823 -0.626 . . . . 71.02 110.176 177.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 46.6 ttm 71.24 -57.09 0.61 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.248 -0.887 . . . . 73.43 111.604 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 45.3 p -69.53 141.13 53.92 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.209 -0.45 . . . . 72.41 110.965 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -72.72 -66.14 0.7 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.84 -0.43 . . . . 71.31 109.84 176.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 50.2 tp -139.86 87.74 2.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.24 -0.436 . . . . 61.23 110.018 175.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -173.32 128.87 0.45 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.799 -0.637 . . . . 71.51 109.605 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.416 ' HA ' ' CD2' ' A' ' 42' ' ' LEU . 43.0 m 67.14 9.0 6.6 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.406 0.521 . . . . 72.42 112.406 178.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.418 HG12 HG11 ' A' ' 51' ' ' VAL . 43.8 t -98.18 -53.92 7.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.811 -0.811 . . . . 72.02 108.811 174.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.472 ' HB3' ' H ' ' A' ' 41' ' ' VAL . 23.7 mm-40 -85.45 -160.16 0.5 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.064 -0.971 . . . . 62.04 110.665 173.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.77 ' HB ' ' HB3' ' A' ' 47' ' ' SER . 5.8 p -42.6 127.27 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 121.872 0.844 . . . . 72.1 112.279 -177.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.416 ' CD2' ' HA ' ' A' ' 38' ' ' SER . 73.0 mt -91.39 -30.74 16.35 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.964 -1.017 . . . . 71.1 110.298 -176.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -80.35 -3.99 51.71 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.337 -0.847 . . . . 53.24 111.583 -178.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.438 ' H ' HG22 ' A' ' 41' ' ' VAL . 16.3 t70 68.72 -39.67 0.42 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.943 0.897 . . . . 72.33 112.249 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 1.003 ' HG3' ' HG3' ' A' ' 46' ' ' ARG . 17.3 tppt? -88.77 -62.62 1.45 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.545 0.212 . . . . 73.03 111.468 178.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 1.003 ' HG3' ' HG3' ' A' ' 45' ' ' LYS . 70.4 mtp85 -117.98 129.93 55.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.792 0.33 . . . . 72.43 110.761 -175.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.77 ' HB3' ' HB ' ' A' ' 41' ' ' VAL . 46.7 p -96.62 150.1 21.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.232 -0.44 . . . . 61.24 110.9 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 48' ' ' ARG . 49.2 mtp180 -85.85 -37.64 18.97 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.306 -0.628 . . . . 73.44 109.306 175.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 33.3 t90 -161.21 133.95 6.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.375 -0.829 . . . . 73.03 109.838 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.408 HG22 ' H ' ' A' ' 53' ' ' ALA . 11.3 m -94.28 140.57 29.61 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.23 -0.441 . . . . 52.04 110.343 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.418 HG11 HG12 ' A' ' 39' ' ' VAL . 11.2 p -94.69 -26.13 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.678 0.275 . . . . 74.25 110.77 -175.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -56.91 -57.27 13.22 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.03 -0.729 . . . . 62.44 109.03 176.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.408 ' H ' HG22 ' A' ' 50' ' ' THR . . . -128.26 143.78 49.34 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.086 -0.961 . . . . 73.21 109.049 175.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.79 124.83 16.61 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.376 2.051 . . . . 61.41 112.257 -178.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 58' ' ' GLY . . . 70.36 142.41 0.09 OUTLIER Pre-proline 0 N--CA 1.467 0.402 0 O-C-N 123.957 0.786 . . . . 65.41 111.817 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.555 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 9.9 Cg_endo -53.86 -56.17 2.85 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 123.23 2.62 . . . . 73.11 113.052 -176.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.623 HD21 ' O ' ' A' ' 63' ' ' GLU . 0.1 OUTLIER -97.94 7.92 45.57 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.567 -0.453 . . . . 63.43 111.749 -177.457 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.563 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . 116.83 -82.8 0.33 Allowed Glycine 0 C--O 1.225 -0.465 0 C-N-CA 120.137 -1.03 . . . . 32.52 113.606 176.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -139.85 16.35 2.49 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 122.034 -0.686 . . . . 74.41 111.874 -176.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.475 HG22 ' HB2' ' A' ' 57' ' ' LEU . 34.5 m -101.22 11.19 7.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 120.978 -0.289 . . . . 74.42 111.216 -178.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.414 ' HB3' ' HE3' ' A' ' 62' ' ' TRP . 22.3 t 60.31 -152.68 0.39 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.094 -0.706 . . . . 71.2 109.094 -175.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.414 ' HE3' ' HB3' ' A' ' 61' ' ' SER . 1.2 m-90 74.98 -162.92 0.07 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.288 0.566 . . . . 72.33 112.51 173.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.623 ' O ' HD21 ' A' ' 57' ' ' LEU . 11.3 mt-10 -107.4 166.28 10.77 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.835 -1.075 . . . . 73.04 110.249 -175.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.555 ' HB2' ' CB ' ' A' ' 56' ' ' PRO . . . -105.09 146.87 28.54 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.5 -0.556 . . . . 61.12 109.5 169.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.827 ' HB2' HD23 ' A' ' 80' ' ' LEU . 5.5 tm-20 -108.05 135.21 49.8 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.356 -1.35 . . . . 51.21 107.356 177.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.719 HD21 ' HB2' ' A' ' 69' ' ' ASP . 29.3 tp -137.96 149.38 46.09 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.486 -0.486 . . . . 74.54 110.462 -171.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.9 t -119.11 -18.34 8.74 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.251 -0.58 . . . . 73.5 111.773 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -152.61 129.07 10.65 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 120.776 -0.37 . . . . 63.4 111.605 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.719 ' HB2' HD21 ' A' ' 66' ' ' LEU . 19.3 t70 -136.17 90.66 2.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.4 -0.818 . . . . 74.23 110.273 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 73' ' ' LYS . 31.4 mt-10 -139.38 142.82 33.6 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 110.067 -0.346 . . . . 65.21 110.067 177.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 16.5 Cg_exo -69.1 -55.06 0.21 Allowed 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.747 2.298 . . . . 63.12 113.061 -178.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.56 49.88 0.83 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.572 -0.823 . . . . 75.35 112.42 -176.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.568 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 7.7 mmmm -139.0 -74.48 0.38 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.026 0.441 . . . . 63.42 110.428 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.529 ' HB3' HD13 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -166.51 137.78 3.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.957 -0.565 . . . . 71.01 110.1 179.127 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.679 HD13 ' HE2' ' A' ' 93' ' ' PHE . 3.2 mp -109.44 110.11 30.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.901 -0.778 . . . . 72.21 108.901 173.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -119.2 115.19 23.69 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.438 -0.949 . . . . 23.34 108.438 176.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.695 ' HA ' HD12 ' A' ' 66' ' ' LEU . 63.0 p-90 -121.48 157.65 30.15 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.511 0.672 . . . . 65.35 111.544 -169.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.683 ' HD2' ' OE1' ' A' ' 65' ' ' GLU . 69.8 mtt180 -136.39 175.8 9.28 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 107.92 -1.141 . . . . 62.12 107.92 176.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.661 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 19.6 m -137.19 51.54 1.95 Allowed 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.678 -0.49 . . . . 61.31 109.678 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.827 HD23 ' HB2' ' A' ' 65' ' ' GLU . 13.0 mt 65.3 142.21 0.07 OUTLIER Pre-proline 0 N--CA 1.471 0.624 0 O-C-N 124.264 0.977 . . . . 64.11 111.014 -175.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 80' ' ' LEU . 22.4 Cg_exo -66.38 -35.33 31.57 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.461 2.107 . . . . 71.44 112.097 177.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.87 18.46 57.17 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.596 -0.811 . . . . 52.32 112.87 -177.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 79' ' ' SER . . . -118.14 -158.13 0.7 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 122.582 -0.363 . . . . 64.54 111.167 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -66.5 -66.07 0.6 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.642 0.608 . . . . 51.41 112.642 -168.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 50.2 mt 59.61 87.96 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.264 0.555 . . . . 74.24 110.547 -172.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -80.19 -46.25 16.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.98 -0.554 . . . . 63.05 110.952 -175.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.64 HD21 ' HB2' ' A' ' 108' ' ' LEU . 54.2 t30 -125.89 162.15 25.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.1 -0.5 . . . . 61.32 109.771 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.8 m -138.35 128.65 25.95 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.082 -0.34 . . . . 74.44 110.082 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.18 148.89 4.91 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.751 -0.737 . . . . 53.41 111.807 178.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.72 159.31 16.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.151 0.5 . . . . 72.22 111.369 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.9 p -110.89 128.05 67.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.667 -0.697 . . . . 64.33 110.492 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.529 HD13 ' HB3' ' A' ' 74' ' ' ARG . 3.9 mm? -100.25 126.88 46.6 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.499 -0.773 . . . . 74.51 110.357 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.679 ' HE2' HD13 ' A' ' 75' ' ' ILE . 85.7 m-85 -107.63 106.69 17.15 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.23 -0.656 . . . . 73.15 109.23 175.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.488 ' HD3' ' CG2' ' A' ' 105' ' ' VAL . 0.0 OUTLIER -129.93 144.9 54.92 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 116.152 -0.476 . . . . 74.15 110.763 -175.147 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -61.57 123.39 12.62 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.603 2.202 . . . . 62.41 111.377 175.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.7 144.03 93.23 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.287 -0.415 . . . . 71.15 110.247 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -43.25 115.31 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.584 2.856 . . . . 72.43 114.056 -176.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.15 -75.38 0.33 Allowed Glycine 0 N--CA 1.437 -1.268 0 CA-C-N 115.125 -0.943 . . . . 71.23 111.169 174.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 175.04 24.2 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.159 -0.521 . . . . 61.3 111.556 -175.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -67.87 -33.63 75.11 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.887 0.375 . . . . 64.14 111.505 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.02 -154.58 25.63 Favored Glycine 0 CA--C 1.506 -0.478 0 N-CA-C 111.33 -0.708 . . . . 62.55 111.33 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 91.6 m -106.79 117.83 35.08 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.252 0.549 . . . . 75.34 110.378 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.447 ' CG ' ' HB1' ' A' ' 9' ' ' ALA . 43.3 tt0 -78.86 115.85 18.81 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.125 -0.943 . . . . 72.21 110.408 178.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.4 p -94.01 103.95 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.708 0.766 . . . . 65.13 110.033 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.488 ' CG2' ' HD3' ' A' ' 94' ' ' ARG . 18.9 t -100.46 111.02 28.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 114.939 -1.028 . . . . 62.1 110.084 -177.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.472 HG12 HD22 ' A' ' 108' ' ' LEU . 10.9 t -120.14 132.33 70.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.031 0.443 . . . . 73.11 110.707 -178.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 107' ' ' ARG . 0.6 OUTLIER -118.13 103.31 9.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.833 -0.621 . . . . 75.55 109.843 175.214 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.64 ' HB2' HD21 ' A' ' 87' ' ' ASN . 2.3 pt? -150.68 155.25 38.96 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.449 -0.341 . . . . 53.33 111.058 -172.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 13.8 t -81.43 133.98 35.48 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.04 -1.096 . . . . 64.14 108.04 172.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.446 ' O ' ' HB ' ' A' ' 4' ' ' THR . 14.2 t80 -155.76 179.33 9.3 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.968 -0.753 . . . . 74.01 108.968 -167.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 4.8 ptt180 -143.83 144.4 26.73 Favored Pre-proline 0 C--N 1.313 -0.989 0 N-CA-C 109.669 -0.493 . . . . 62.41 109.669 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.456 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 72.3 Cg_endo -78.6 152.98 26.39 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.917 1.745 . . . . 62.42 112.247 178.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 11.3 Cg_exo -72.93 135.47 23.38 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.883 2.389 . . . . 72.33 111.571 176.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.28 150.39 47.06 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.839 -0.696 . . . . 70.44 111.762 178.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 88.74 52.25 2.85 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.323 -0.942 . . . . 53.21 111.841 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 16.5 m -61.91 -22.19 65.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.857 0.36 . . . . 50.35 110.744 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.23 -22.14 66.67 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.077 -0.511 . . . . 53.45 110.813 175.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -60.36 -20.54 55.35 Favored Glycine 0 CA--C 1.519 0.307 0 CA-C-N 116.108 -0.496 . . . . 74.5 112.424 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.93 -20.33 66.18 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 122.68 -0.306 . . . . 63.04 111.041 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.49 ' O ' ' HG2' ' A' ' 123' ' ' ARG . 66.5 t -69.23 -47.63 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.791 0.329 . . . . 73.35 110.41 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.427 ' O ' ' HB3' ' A' ' 124' ' ' MET . 14.2 tt -75.32 -27.05 19.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.043 0.449 . . . . 71.12 110.182 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.87 -42.93 84.79 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.373 -0.376 . . . . 72.21 111.052 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 120' ' ' VAL . 13.3 ptp180 -74.51 -14.8 60.86 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.142 0.496 . . . . 71.05 110.393 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.427 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 26.2 ttt -70.49 -33.04 70.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.609 -0.723 . . . . 60.43 110.002 176.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -83.95 -53.96 5.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.807 -0.633 . . . . 64.43 110.054 178.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -104.24 113.81 27.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.757 -0.656 . . . . 62.4 110.133 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -77.93 79.2 4.41 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.254 0.549 . . . . 73.31 111.045 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.509 ' HA ' ' HD3' ' A' ' 129' ' ' PRO . 41.0 mt-10 -103.1 140.72 21.31 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.282 -0.417 . . . . 74.15 109.944 176.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 128' ' ' GLU . 10.2 Cg_endo -91.72 -46.74 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.223 2.615 . . . . 44.03 113.92 -175.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 49.2 m -105.55 102.77 12.21 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.227 0.454 . . . . 74.22 112.227 -171.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.558 ' HA ' ' HG2' ' A' ' 138' ' ' MET . 27.4 mp0 -100.96 -40.19 7.38 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.41 -0.959 . . . . 72.54 108.41 168.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 59.26 -163.49 0.22 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.323 -0.853 . . . . 74.32 111.072 173.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.545 ' HG ' ' H ' ' A' ' 134' ' ' ARG . 22.9 tp -69.01 175.63 3.62 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.402 -1.333 . . . . 64.43 107.402 164.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.545 ' H ' ' HG ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER 49.35 33.4 5.35 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.873 0.844 . . . . 52.43 109.447 -169.429 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -48.06 -43.68 30.7 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 113.823 -1.535 . . . . 73.02 112.949 -173.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -73.34 -36.91 66.23 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.915 0.388 . . . . 71.34 111.048 -175.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.577 ' CD2' ' HB3' ' A' ' 8' ' ' ASP . 24.3 tp -77.05 -21.85 53.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.224 0.535 . . . . 72.41 109.729 -178.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.558 ' HG2' ' HA ' ' A' ' 131' ' ' GLN . 0.1 OUTLIER -63.89 -35.2 79.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.914 -0.584 . . . . 75.53 109.442 175.386 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.675 ' O ' ' HG3' ' A' ' 142' ' ' ARG . 52.6 mtt180 -73.14 -32.56 64.97 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.664 -0.698 . . . . 52.35 110.023 177.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.45 ' HZ ' HG11 ' A' ' 22' ' ' VAL . 83.4 t80 -62.05 -34.29 75.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.707 -0.679 . . . . 63.33 110.046 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.456 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 21.0 ttpp -60.81 -53.02 62.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.41 . . . . 73.02 110.957 176.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.675 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 3.5 ptm180 -64.68 -29.31 70.3 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.585 0.587 . . . . 61.31 112.585 -174.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -79.57 -33.62 41.62 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.143 -0.623 . . . . 73.34 110.42 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.516 ' HB2' HG12 ' A' ' 12' ' ' ILE . 13.4 mm-40 -59.31 -43.92 92.59 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.29 0.566 . . . . 71.13 111.263 176.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.76 ' HB3' HG23 ' A' ' 12' ' ' ILE . 9.0 pt-20 -81.97 -3.44 54.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.718 -0.674 . . . . 53.12 111.48 -177.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 54.2 tp -112.76 -61.56 1.71 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.063 0.459 . . . . 54.2 111.306 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 139.47 -92.85 0.19 Allowed Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 111.101 -0.8 . . . . 43.31 111.101 -173.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 60.7 tp -134.83 127.11 30.16 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.88 0.372 . . . . 65.22 110.764 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 150' ' ' HIS . 2.2 tm-20 -158.97 129.81 6.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.776 -1.194 . . . . 35.0 107.776 175.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.432 ' HB2' ' O ' ' A' ' 149' ' ' GLU . 10.1 m80 69.97 84.11 0.15 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.49 0.662 . . . . 75.01 111.04 -174.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -114.28 -20.17 10.98 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.481 -0.781 . . . . 64.32 109.829 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.5 t-80 -110.79 126.04 54.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.102 0.477 . . . . 65.52 110.64 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -98.53 149.77 22.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.914 -0.585 . . . . 63.24 109.997 175.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 26.2 m170 -79.41 91.39 5.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.89 0.376 . . . . 75.12 110.479 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 . . . . . 0 C--O 1.245 0.847 0 CA-C-O 118.43 -0.795 . . . . 75.42 109.259 179.815 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 109.954 -0.387 . . . . 64.43 109.954 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 146.43 146.49 4.4 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.858 -0.687 . . . . 72.51 112.212 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -79.72 176.79 9.4 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.031 0.443 . . . . 34.24 110.544 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.7 m -133.38 121.91 23.0 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.187 -0.461 . . . . 71.34 110.15 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.534 HG13 ' HA ' ' A' ' 109' ' ' THR . 74.6 t -108.44 136.39 44.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.126 -0.488 . . . . 72.41 110.034 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.6 t -78.77 117.28 24.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.095 0.474 . . . . 72.32 111.159 -173.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -140.06 109.81 6.36 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.541 -0.754 . . . . 75.22 109.971 173.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.544 ' HB3' HD23 ' A' ' 137' ' ' LEU . 4.1 t70 -151.46 172.57 15.77 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.759 -1.2 . . . . 64.14 107.759 174.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.436 ' HB1' ' CG ' ' A' ' 103' ' ' GLU . . . -139.8 120.81 14.61 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.05 0.453 . . . . 64.35 111.205 -172.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.589 HG23 HD11 ' A' ' 12' ' ' ILE . 19.4 m -111.24 148.9 14.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.73 -0.668 . . . . 65.34 110.313 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.6 t -114.44 103.75 11.36 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.796 0.808 . . . . 55.43 110.781 175.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.82 HG21 ' HB3' ' A' ' 144' ' ' GLN . 1.1 mp -96.16 151.81 3.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.238 -0.892 . . . . 73.44 108.711 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.39 51.12 1.39 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.322 -0.466 . . . . 74.1 113.483 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.696 ' HB3' ' HB2' ' A' ' 18' ' ' GLN . 79.7 mttt -128.13 144.82 53.07 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 108.049 -1.093 . . . . 64.13 108.049 172.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.418 ' HG3' ' OXT' ' A' ' 155' ' ' HIS . 48.8 Cg_exo -55.21 -57.74 1.51 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.32 2.013 . . . . 74.12 113.332 -174.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 173.32 -51.37 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.45 -0.945 . . . . 63.3 108.45 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.69 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 2.5 tt0 -48.76 -37.86 20.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 113.943 -1.48 . . . . 63.43 111.421 174.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.696 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 15.8 mm100 -85.84 -13.29 48.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.577 -0.738 . . . . 75.22 111.15 -176.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.698 HD22 HD13 ' A' ' 12' ' ' ILE . 91.7 mt -83.89 -53.21 5.75 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 112.079 0.4 . . . . 73.45 112.079 -177.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.69 ' CE2' ' HA ' ' A' ' 17' ' ' GLU . 32.7 p90 -66.96 -23.29 65.94 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.193 0.521 . . . . 44.14 111.06 -175.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.1 -3.01 30.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.771 -0.65 . . . . 71.34 111.661 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.573 ' HA ' ' HA ' ' A' ' 25' ' ' ASP . 13.5 p -52.64 -22.28 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 113.162 0.801 . . . . 71.41 113.162 -175.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -56.51 -32.32 64.93 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.138 0.494 . . . . 73.13 110.35 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -116.71 6.05 13.24 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.099 -0.704 . . . . 75.25 109.099 175.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.573 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 31.3 t70 48.63 95.69 0.01 OUTLIER 'General case' 0 C--O 1.235 0.305 0 CA-C-N 114.312 -1.313 . . . . 73.53 111.644 -168.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.526 HD22 ' NE2' ' A' ' 18' ' ' GLN . 16.5 mt 67.32 153.85 0.13 Allowed Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 114.686 -1.143 . . . . 63.34 111.232 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 26' ' ' LEU . 3.3 Cg_exo -76.63 108.88 2.75 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.684 2.256 . . . . 72.32 112.45 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.06 96.25 0.78 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 121.021 -0.609 . . . . 33.01 112.172 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 51.2 mt -75.58 150.37 84.39 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.502 0.191 . . . . 74.43 110.832 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.76 7.45 1.61 Allowed 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 123.294 2.663 . . . . 71.41 112.731 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.644 ' HG ' ' HB2' ' A' ' 36' ' ' LEU . 7.7 mp 65.81 8.19 5.11 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.111 -0.495 . . . . 73.31 110.804 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 59.46 20.15 8.53 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.623 -0.717 . . . . 64.12 110.584 -177.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 65.9 mtt 62.31 19.56 11.13 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.627 -0.715 . . . . 74.14 111.407 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.4 m -123.43 -63.38 1.24 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.302 -0.408 . . . . 72.41 109.965 177.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -179.86 142.82 0.17 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.411 -0.813 . . . . 71.44 109.347 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.644 ' HB2' ' HG ' ' A' ' 31' ' ' LEU . 1.0 OUTLIER -69.43 103.18 1.95 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.917 -0.772 . . . . 65.11 108.917 176.863 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -90.95 -35.76 14.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.332 -0.395 . . . . 64.42 110.579 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.8 p -175.73 156.11 1.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.955 -0.566 . . . . 73.13 110.307 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.4 t -105.41 97.75 5.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.14 -0.689 . . . . 72.51 109.14 173.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -128.08 140.13 52.12 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.973 -0.558 . . . . 72.22 110.841 -174.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.9 p -93.28 141.6 14.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.205 -0.452 . . . . 74.34 110.142 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 53' ' ' ALA . 94.6 mt -65.87 -45.44 82.09 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.323 0.49 . . . . 74.44 112.323 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -166.11 -85.43 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.962 0.411 . . . . 73.23 112.086 -173.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.2 t70 175.42 -47.87 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.072 -1.084 . . . . 71.54 108.072 -172.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.578 ' HB3' ' HB3' ' A' ' 56' ' ' PRO . 2.9 mptt -81.53 11.61 4.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.89 -1.05 . . . . 72.25 111.494 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -170.99 139.47 1.41 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.285 -0.635 . . . . 73.11 109.285 177.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.534 ' O ' ' HD2' ' A' ' 48' ' ' ARG . 12.1 p -139.11 105.44 5.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.933 0.397 . . . . 73.01 111.087 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.534 ' HD2' ' O ' ' A' ' 47' ' ' SER . 2.2 mpt_? -127.09 -85.66 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.804 0.335 . . . . 72.02 111.308 -176.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -135.46 -164.0 1.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.984 -0.553 . . . . 74.05 109.518 -175.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.5 p -90.13 19.08 5.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.442 0.639 . . . . 74.24 110.185 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.6 p -156.04 155.15 5.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.432 -0.804 . . . . 63.33 109.496 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.586 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 36.9 mt-10 64.78 98.91 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.794 0.684 . . . . 54.34 112.029 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.428 ' HA ' HD13 ' A' ' 42' ' ' LEU . . . -107.28 87.68 3.39 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.543 -0.753 . . . . 64.0 110.095 176.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.586 ' HD3' ' O ' ' A' ' 52' ' ' GLU . 4.9 Cg_exo -74.33 -171.57 0.95 Allowed 'Trans proline' 0 C--O 1.239 0.532 0 C-N-CA 123.235 2.623 . . . . 75.03 112.77 -173.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.61 146.45 98.56 Favored Pre-proline 0 N--CA 1.451 -0.412 0 CA-C-N 115.734 -0.667 . . . . 73.45 109.649 174.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.578 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 19.6 Cg_endo -57.44 -20.14 39.18 Favored 'Trans proline' 0 N--CA 1.476 0.463 0 C-N-CA 123.26 2.64 . . . . 61.14 113.445 -175.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.781 ' HA ' HD11 ' A' ' 80' ' ' LEU . 2.5 pt? -121.84 -6.91 9.04 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.523 -0.308 . . . . 71.44 111.36 -178.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.84 -111.71 2.66 Favored Glycine 0 N--CA 1.453 -0.209 0 CA-C-N 115.764 -0.653 . . . . 63.24 111.948 -175.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.35 -53.48 8.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.979 0.418 . . . . 61.15 110.218 175.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.0 p -177.84 -38.39 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.736 -0.665 . . . . 71.44 110.281 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.3 m -132.47 25.69 4.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.348 0.594 . . . . 31.12 109.696 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 42.4 t-105 -89.75 -33.51 16.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.587 -0.733 . . . . 62.25 111.009 -171.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.424 ' CD ' ' HE ' ' A' ' 48' ' ' ARG . 11.2 mm-40 -106.98 168.09 9.44 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.236 -0.893 . . . . 62.33 110.74 -175.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -116.98 124.75 50.14 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.562 -0.533 . . . . 72.42 109.562 175.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -106.1 134.97 48.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.823 0.344 . . . . 74.3 110.105 -178.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.841 HD12 ' HA ' ' A' ' 77' ' ' TRP . 3.1 mm? -97.7 151.98 19.57 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.837 -0.801 . . . . 55.13 108.837 176.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.1 p -75.32 -36.91 61.02 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.006 -0.739 . . . . 74.32 109.006 175.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -173.28 127.91 0.44 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.602 -1.181 . . . . 72.41 111.418 177.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -124.48 94.16 4.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.53 -0.759 . . . . 74.24 109.211 174.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 48.9 mt-10 -104.09 142.45 24.62 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 63.44 111.296 -174.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 31.5 Cg_exo -59.18 99.25 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.362 2.708 . . . . 74.33 113.694 -172.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.51 40.76 96.67 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.367 -0.833 . . . . 71.31 113.072 177.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -128.58 -79.67 0.57 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.021 0.438 . . . . 62.13 110.341 178.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -136.59 132.74 35.54 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.013 -0.54 . . . . 70.3 109.551 176.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 30.7 mm -120.36 110.34 28.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.809 -0.632 . . . . 75.15 109.354 -177.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -119.41 116.99 27.28 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.309 0.576 . . . . 71.41 110.47 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.841 ' HA ' HD12 ' A' ' 66' ' ' LEU . 44.9 m95 -89.9 159.56 16.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.374 -0.83 . . . . 72.21 111.072 -174.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -164.92 175.75 9.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.72 -0.673 . . . . 74.53 109.688 -178.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.575 ' HB3' ' O ' ' A' ' 84' ' ' ARG . 9.2 t -138.04 173.11 11.98 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.203 -1.406 . . . . 65.14 107.203 175.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.781 HD11 ' HA ' ' A' ' 57' ' ' LEU . 97.5 mt -79.01 144.28 63.15 Favored Pre-proline 0 C--N 1.314 -0.957 0 C-N-CA 121.054 -0.258 . . . . 73.54 110.689 -177.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.469 ' HA ' HG23 ' A' ' 85' ' ' ILE . 52.5 Cg_exo -56.14 -37.54 96.32 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.123 2.548 . . . . 74.52 112.676 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.69 -16.65 74.34 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.684 -0.769 . . . . 73.32 112.26 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.2 -62.58 1.26 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.705 0.288 . . . . 61.15 111.033 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.575 ' O ' ' HB3' ' A' ' 79' ' ' SER . 29.4 ttm180 -177.23 117.56 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.752 -0.658 . . . . 75.04 110.808 -173.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.469 HG23 ' HA ' ' A' ' 81' ' ' PRO . 2.1 pp -113.97 -166.58 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.543 -0.299 . . . . 65.14 110.732 175.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 49.4 mm-40 71.61 8.09 6.11 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.15 0.58 . . . . 73.11 111.707 -177.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -74.03 131.79 41.72 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.301 -0.629 . . . . 75.31 109.301 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.436 ' HB3' ' H ' ' A' ' 109' ' ' THR . 22.7 t -112.36 127.1 55.91 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.934 -0.395 . . . . 71.13 109.934 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -179.25 72.26 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.645 -0.788 . . . . 62.44 112.033 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -102.82 116.42 32.52 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.758 -0.46 . . . . 71.22 109.758 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.681 HG22 HG22 ' A' ' 106' ' ' VAL . 89.6 t -102.61 126.55 56.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.458 0.647 . . . . 73.35 111.267 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.538 ' HB2' ' HB ' ' A' ' 105' ' ' VAL . 3.2 mm? -110.4 120.81 43.62 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.965 -1.016 . . . . 71.11 109.833 176.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -97.62 118.04 33.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.929 0.395 . . . . 73.33 110.345 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.0 mtp180 -123.78 145.39 47.41 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.008 -0.542 . . . . 73.1 110.552 -176.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.34 119.01 6.0 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.591 2.194 . . . . 75.34 111.187 175.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . . . -82.95 143.99 47.01 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.045 0.45 . . . . 74.52 111.935 -173.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 96' ' ' ALA . 34.1 Cg_exo -60.54 131.01 35.87 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.312 2.675 . . . . 63.24 112.231 177.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.41 0.38 90.02 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 121.099 -0.572 . . . . 72.33 111.851 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 58.76 34.01 23.45 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 122.921 0.488 . . . . 75.12 111.306 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -60.37 -31.99 70.87 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.263 0.554 . . . . 72.33 110.504 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 170.49 -137.85 4.66 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.194 -1.162 . . . . 74.43 110.194 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 72.0 m -121.43 130.64 53.71 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 117.06 0.43 . . . . 62.4 110.19 175.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.436 ' CG ' ' HB1' ' A' ' 9' ' ' ALA . 42.5 tt0 -76.97 119.3 20.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.056 -0.52 . . . . 75.12 110.904 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.649 HG23 HG13 ' A' ' 91' ' ' VAL . 2.4 p -99.1 106.62 19.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.627 -0.715 . . . . 62.45 110.041 175.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.538 ' HB ' ' HB2' ' A' ' 92' ' ' LEU . 26.1 t -91.8 109.91 21.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.765 -0.652 . . . . 74.35 109.413 177.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.681 HG22 HG22 ' A' ' 91' ' ' VAL . 48.8 t -112.11 121.43 64.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.953 0.406 . . . . 64.44 110.71 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -113.97 104.82 12.54 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.72 -0.844 . . . . 72.14 108.72 172.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.662 ' H ' HD23 ' A' ' 108' ' ' LEU . 2.4 pt? -119.0 120.47 37.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.181 0.515 . . . . 71.11 109.824 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.534 ' HA ' HG13 ' A' ' 5' ' ' VAL . 86.6 m -103.45 125.26 49.93 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.2 -0.455 . . . . 62.14 110.787 -177.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -145.97 177.72 8.74 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.612 -0.884 . . . . 70.54 108.612 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 4.3 ptt180 -146.67 155.49 48.69 Favored Pre-proline 0 C--N 1.317 -0.807 0 CA-C-N 116.657 -0.247 . . . . 74.55 110.603 -175.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -63.23 155.91 58.77 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.398 2.065 . . . . 61.14 111.328 173.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -69.45 5.17 1.68 Allowed 'Trans proline' 0 N--CA 1.478 0.612 0 C-N-CA 123.294 2.663 . . . . 71.31 113.333 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -176.42 -47.46 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.969 -0.634 . . . . 65.11 111.581 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 160.37 -117.2 0.76 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.003 -0.617 . . . . 73.45 111.977 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.1 m -60.63 -27.99 68.2 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.648 0.24 . . . . 61.12 111.648 -176.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.88 -23.38 67.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.935 0.398 . . . . 74.12 111.194 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.73 -21.07 70.82 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.986 -0.626 . . . . 72.02 112.774 -177.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.99 -41.95 67.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.64 0.257 . . . . 72.34 111.451 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.4 m -76.67 -35.34 25.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.792 -0.363 . . . . 63.25 110.805 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.403 ' HA ' ' HB2' ' A' ' 124' ' ' MET . 79.2 mt -59.58 -30.9 45.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 116.358 -0.383 . . . . 72.53 110.709 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.952 ' HA ' ' HB3' ' A' ' 126' ' ' ASN . . . -52.64 -58.41 6.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.901 -0.591 . . . . 61.2 111.179 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -79.52 -17.02 54.96 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.15 -0.477 . . . . 72.34 111.26 -177.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.403 ' HB2' ' HA ' ' A' ' 121' ' ' ILE . 76.2 mtp -71.19 -53.66 13.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.483 -0.326 . . . . 73.32 111.343 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -156.05 -4.22 0.12 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.554 -0.458 . . . . 75.12 112.072 -176.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.952 ' HB3' ' HA ' ' A' ' 122' ' ' ALA . 63.4 t30 -82.47 -179.21 7.34 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.591 -0.522 . . . . 75.53 109.591 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -52.02 -57.86 8.26 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 111.816 0.302 . . . . 73.32 111.816 -177.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 122' ' ' ALA . 8.5 tp10 58.46 86.85 0.15 Allowed Pre-proline 0 N--CA 1.466 0.325 0 O-C-N 123.655 0.597 . . . . 72.34 111.15 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -71.4 67.74 2.76 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 123.124 2.549 . . . . 71.32 112.427 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.576 ' HB2' ' HG2' ' A' ' 132' ' ' GLN . 9.8 m 59.35 22.09 10.44 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.942 -0.572 . . . . 64.24 111.914 175.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 60.96 22.99 13.15 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.83 0.452 . . . . 65.53 111.316 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.75 ' HG3' ' HB2' ' A' ' 136' ' ' ASP . 2.7 pt20 -134.79 170.53 15.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.571 -0.286 . . . . 74.4 110.564 -177.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.409 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 95.1 mt -136.5 146.26 46.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.672 -0.24 . . . . 73.24 110.477 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 133' ' ' LEU . 52.2 mtt85 72.72 -57.13 0.64 Allowed 'General case' 0 N--CA 1.47 0.54 0 O-C-N 123.879 0.737 . . . . 54.21 112.587 177.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -69.92 -28.53 65.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.655 0.264 . . . . 74.53 110.346 -177.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.75 ' HB2' ' HG3' ' A' ' 132' ' ' GLN . 25.3 t70 -63.8 -30.48 71.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.927 0.394 . . . . 51.44 110.585 173.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.544 HD23 ' HB3' ' A' ' 8' ' ' ASP . 39.0 tp -67.9 -26.12 65.83 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.728 -0.471 . . . . 74.23 109.728 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.513 ' O ' ' HG2' ' A' ' 141' ' ' LYS . 2.8 mmt -66.74 -30.07 70.2 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.822 -0.626 . . . . 70.31 109.911 174.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 -78.52 -35.77 45.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.522 -0.763 . . . . 74.5 109.36 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -57.62 -49.15 77.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.204 -0.907 . . . . 72.25 111.729 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.739 ' HB2' HG13 ' A' ' 12' ' ' ILE . 13.4 ptmm? -60.21 -38.48 83.48 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.897 0.379 . . . . 72.24 110.238 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.671 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 35.6 ttp180 -64.02 -44.0 93.9 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.719 -0.673 . . . . 73.22 110.81 -176.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.491 ' HA ' HD12 ' A' ' 146' ' ' LEU . 41.7 mt-10 -65.42 -30.4 71.2 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.949 0.404 . . . . 71.4 110.66 177.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.82 ' HB3' HG21 ' A' ' 12' ' ' ILE . 0.9 OUTLIER -65.49 -47.0 77.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 73.23 111.054 178.436 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.404 ' HB3' HG22 ' A' ' 12' ' ' ILE . 6.2 pt-20 -80.41 -9.29 59.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.886 0.374 . . . . 73.02 111.066 -178.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.671 ' HG ' ' O ' ' A' ' 142' ' ' ARG . 55.4 mt -73.29 -41.13 63.96 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.721 -0.474 . . . . 70.1 109.721 170.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 91.41 149.62 23.95 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.048 -0.596 . . . . 64.22 112.703 177.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 5.9 tt -109.11 -69.06 0.88 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.5 -0.556 . . . . 55.22 109.5 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -104.25 -36.58 7.59 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.977 0.418 . . . . 72.55 110.686 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 21.9 m170 -114.2 102.62 10.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.437 -0.347 . . . . 65.12 110.371 -176.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -119.36 83.17 1.99 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.098 0.475 . . . . 73.43 110.289 177.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -168.25 134.5 1.94 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.504 -0.771 . . . . 71.12 109.874 176.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 30.5 t60 -77.91 102.54 7.35 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.49 -0.777 . . . . 74.3 111.057 -173.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -96.57 -7.3 34.8 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.947 -0.301 . . . . 73.42 111.39 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.418 ' OXT' ' HG3' ' A' ' 15' ' ' PRO . 16.6 t-160 . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.693 -0.67 . . . . 74.44 109.465 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 110.394 -0.224 . . . . 70.22 110.394 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 144.13 -149.11 21.14 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.211 -0.995 . . . . 52.42 112.517 178.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 53.11 72.95 0.39 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.389 0.614 . . . . 71.23 110.565 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.8 m -146.06 121.03 10.02 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.952 -0.567 . . . . 55.34 110.995 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.5 t -124.41 109.88 23.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.681 -0.691 . . . . 62.1 109.181 173.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.5 t -78.82 119.55 28.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 116.016 -0.538 . . . . 75.3 110.288 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.592 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 15.0 ptt180 -141.65 125.01 16.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.429 0.633 . . . . 74.51 111.225 176.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.431 ' HB3' HD23 ' A' ' 137' ' ' LEU . 3.8 t70 -157.42 174.1 15.91 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.946 -1.131 . . . . 62.43 107.946 174.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.623 ' HB1' ' HG2' ' A' ' 103' ' ' GLU . . . -134.45 122.37 22.39 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.798 0.332 . . . . 62.23 111.279 -170.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.549 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 17.1 m -108.04 130.14 61.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.271 0.557 . . . . 61.35 110.998 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.661 ' O ' ' HE2' ' A' ' 141' ' ' LYS . 21.2 m -86.83 100.16 12.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.715 -0.675 . . . . 73.25 110.497 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.701 HG21 ' HG3' ' A' ' 144' ' ' GLN . 66.9 mt -111.89 145.6 17.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.697 0.285 . . . . 71.52 111.105 -174.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.407 ' HA2' ' HA3' ' A' ' 101' ' ' GLY . . . -81.68 66.04 3.91 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 121.136 -0.554 . . . . 54.34 112.955 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.452 ' HD3' ' HB3' ' A' ' 18' ' ' GLN . 43.3 mttp -143.32 147.43 40.23 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.755 -0.461 . . . . 75.22 109.755 174.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.14 -55.65 2.99 Favored 'Trans proline' 0 N--CA 1.479 0.65 0 C-N-CA 123.406 2.737 . . . . 52.31 114.079 -172.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 174.65 -64.02 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.146 0.498 . . . . 70.32 110.015 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.43 ' OE1' ' HG2' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -56.54 -42.5 78.59 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.198 -0.91 . . . . 73.33 111.507 179.353 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.7 ' HG3' ' HB2' ' A' ' 150' ' ' HIS . 17.0 mm100 -62.0 -21.32 64.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 74.34 111.997 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.581 ' HA ' HE21 ' A' ' 144' ' ' GLN . 59.3 mt -73.96 -32.35 63.43 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.305 -0.247 . . . . 74.55 111.629 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -69.69 -24.22 63.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.182 0.515 . . . . 73.44 110.181 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.05 -23.85 67.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.752 -0.658 . . . . 75.14 111.616 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 19' ' ' LEU . 4.3 p -67.38 -21.97 28.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 121.174 0.512 . . . . 63.14 110.742 -178.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 54.8 t90 -64.49 -26.25 68.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.783 -0.644 . . . . 74.44 110.69 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.51 -82.65 0.64 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.767 -0.651 . . . . 75.24 109.647 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.546 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 28.5 t70 -165.92 149.66 7.85 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.466 -0.788 . . . . 74.41 109.031 178.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.4 ' H ' HD23 ' A' ' 26' ' ' LEU . 0.8 OUTLIER -112.37 86.14 7.81 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 121.086 0.47 . . . . 74.1 110.941 177.243 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.978 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 2.1 Cg_endo -87.2 146.27 7.49 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.433 2.755 . . . . 72.21 111.371 176.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.553 ' C ' ' HD3' ' A' ' 30' ' ' PRO . . . -79.47 56.76 4.45 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.861 -0.685 . . . . 62.3 112.733 -177.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.776 HD12 ' H ' ' A' ' 33' ' ' MET . 3.8 mm? -123.33 56.99 10.4 Favored Pre-proline 0 CA--C 1.534 0.33 0 O-C-N 122.741 -0.27 . . . . 75.44 111.707 176.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.553 ' HD3' ' C ' ' A' ' 28' ' ' GLY . 12.1 Cg_exo -70.49 -28.02 22.24 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.041 1.827 . . . . 63.31 111.331 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.629 ' H ' HD13 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -97.03 -6.46 35.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.364 -0.835 . . . . 74.14 110.787 177.52 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 71.2 mt 61.47 109.79 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.773 0.797 . . . . 64.43 113.123 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.776 ' H ' HD12 ' A' ' 29' ' ' LEU . 89.7 mtp -129.81 132.47 46.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.335 -0.848 . . . . 65.31 109.02 173.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.3 m -66.33 99.16 0.52 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.22 0.533 . . . . 72.34 111.446 -178.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.494 ' HB3' HD22 ' A' ' 36' ' ' LEU . 62.8 m170 -111.67 -75.98 0.6 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.727 -0.669 . . . . 71.42 109.32 174.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.494 HD22 ' HB3' ' A' ' 35' ' ' HIS . 2.9 mm? -124.8 17.35 8.67 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.74 -0.664 . . . . 40.42 109.532 177.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.429 ' HA ' ' OE2' ' A' ' 40' ' ' GLU . 77.5 mtm180 62.77 56.28 1.95 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.729 0.776 . . . . 75.44 109.537 -173.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.0 m -69.32 -77.99 0.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.747 -1.115 . . . . 70.33 112.433 -171.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.978 ' HB ' ' HG2' ' A' ' 27' ' ' PRO . 7.6 p -118.68 33.68 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.92 0.866 . . . . 60.12 110.69 -173.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.429 ' OE2' ' HA ' ' A' ' 37' ' ' ARG . 89.2 mt-10 -64.59 100.62 0.39 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.476 -0.784 . . . . 73.03 110.096 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.7 p -114.54 152.88 16.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.746 -0.661 . . . . 75.04 110.37 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.574 ' HG ' HG23 ' A' ' 51' ' ' VAL . 4.5 mp -77.22 -63.2 1.42 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.323 0.582 . . . . 73.43 110.303 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.859 ' HB3' ' HD3' ' A' ' 46' ' ' ARG . 15.2 t70 -150.07 168.96 22.38 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.269 -0.878 . . . . 72.42 109.213 -176.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -73.59 -22.35 60.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.352 . . . . 72.33 111.559 -173.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -79.18 6.67 9.14 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.179 0.437 . . . . 71.2 112.179 -177.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.859 ' HD3' ' HB3' ' A' ' 43' ' ' ASP . 0.0 OUTLIER -142.97 -167.07 2.44 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.084 -0.507 . . . . 62.23 109.75 179.343 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.7 m -112.27 173.47 6.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.771 0.796 . . . . 71.13 112.363 -174.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.614 ' HG3' ' HA ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -73.51 111.12 8.34 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.263 -0.88 . . . . 75.53 108.812 170.2 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 9.9 t-105 -136.74 -163.07 1.36 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.565 -0.531 . . . . 73.4 109.565 -175.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.501 ' O ' HG12 ' A' ' 51' ' ' VAL . 2.4 m -53.14 -27.67 22.19 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 122.766 0.426 . . . . 71.02 111.846 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.574 HG23 ' HG ' ' A' ' 42' ' ' LEU . 2.8 p 54.86 16.94 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.36 1.064 . . . . 62.12 112.392 176.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -93.69 -42.8 8.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.29 -0.414 . . . . 64.32 110.915 -176.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -99.94 143.94 27.43 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.512 -0.313 . . . . 43.52 110.775 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -89.18 159.86 5.71 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.939 2.426 . . . . 72.12 112.912 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.427 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . . . 64.1 78.5 0.27 Allowed Pre-proline 0 N--CA 1.464 0.237 0 CA-C-N 115.545 -0.752 . . . . 64.41 111.687 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.537 ' CB ' ' HB2' ' A' ' 63' ' ' GLU . 10.3 Cg_endo -54.43 -32.71 74.21 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 123.765 2.976 . . . . 65.11 113.051 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.815 ' HB3' HD21 ' A' ' 80' ' ' LEU . 0.7 OUTLIER -112.61 10.78 19.51 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.442 -0.799 . . . . 64.35 111.382 -173.784 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -80.19 -56.79 3.14 Favored Glycine 0 C--N 1.318 -0.453 0 CA-C-N 115.13 -0.941 . . . . 63.45 112.292 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.68 34.12 0.71 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.128 0.49 . . . . 75.2 111.144 -178.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.2 t 64.64 81.28 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.134 -0.939 . . . . 75.1 112.38 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.804 ' HA ' HD22 ' A' ' 80' ' ' LEU . 20.6 m 63.35 96.72 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.73 1.382 . . . . 52.44 114.73 167.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 20.2 m0 -114.42 -28.13 7.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.368 -0.833 . . . . 62.52 109.37 163.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.728 ' O ' HD13 ' A' ' 80' ' ' LEU . 7.2 mt-10 -117.44 174.59 6.06 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.402 -1.272 . . . . 74.34 112.954 -169.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.56 140.85 29.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.047 -0.979 . . . . 74.43 108.854 164.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.458 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 7.2 pt-20 -103.7 135.71 44.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.325 0.583 . . . . 75.53 111.748 -176.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.581 HD11 HG23 ' A' ' 75' ' ' ILE . 41.4 tp -105.12 126.38 52.01 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.817 -0.438 . . . . 71.1 109.817 177.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 64.2 p -84.11 -36.63 22.81 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.103 0.478 . . . . 63.3 111.224 -176.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.748 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -118.93 137.94 53.13 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.828 -0.624 . . . . 64.34 111.312 -170.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -139.61 33.3 2.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.781 -0.645 . . . . 72.42 109.856 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 1.01 ' HG3' ' HG2' ' A' ' 74' ' ' ARG . 5.4 mm-40 -57.33 142.83 75.29 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.427 -0.806 . . . . 72.45 110.307 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 9.2 Cg_exo -71.89 76.08 2.09 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.85 2.367 . . . . 74.13 112.173 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.47 43.82 43.69 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.947 -0.645 . . . . 70.21 112.076 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.611 ' HB2' ' HB3' ' A' ' 70' ' ' GLU . 70.9 mmtt -127.73 -69.3 0.74 Allowed 'General case' 0 C--N 1.328 -0.328 0 O-C-N 122.897 -0.178 . . . . 74.42 111.106 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 1.01 ' HG2' ' HG3' ' A' ' 70' ' ' GLU . 9.2 ptt180 -145.69 130.84 18.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.115 0.483 . . . . 72.33 110.397 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.683 HD13 ' HE2' ' A' ' 93' ' ' PHE . 2.3 mp -126.31 113.02 31.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.956 -0.565 . . . . 73.42 109.907 176.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.748 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -107.73 116.82 32.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.66 -0.7 . . . . 25.41 109.835 176.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.719 ' HZ3' HG13 ' A' ' 91' ' ' VAL . 31.5 p90 -98.72 143.54 28.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.471 0.653 . . . . 74.5 111.325 -174.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -141.21 179.18 6.91 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.959 -1.019 . . . . 74.33 109.44 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.5 m -132.84 147.79 52.3 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.203 -1.036 . . . . 53.02 108.203 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.815 HD21 ' HB3' ' A' ' 57' ' ' LEU . 5.4 mp -57.65 144.93 71.75 Favored Pre-proline 0 C--N 1.323 -0.549 0 O-C-N 123.497 0.498 . . . . 74.45 111.594 -176.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 80' ' ' LEU . 51.3 Cg_exo -56.35 -22.04 39.65 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.643 2.895 . . . . 71.34 113.766 -174.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -79.67 -14.83 80.59 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.015 -0.612 . . . . 44.44 112.311 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -111.17 172.32 6.95 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.683 0.277 . . . . 72.42 110.316 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -75.89 138.72 41.24 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.163 -0.68 . . . . 73.53 109.163 173.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.4 pt -75.92 88.87 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.32 0.581 . . . . 63.35 109.449 173.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -54.15 -34.67 60.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.192 -0.913 . . . . 75.1 112.047 -173.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.539 ' HB3' ' HE1' ' A' ' 77' ' ' TRP . 20.8 t-20 -166.73 132.82 2.31 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.897 -0.779 . . . . 65.45 108.897 178.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.0 m -115.6 128.57 56.04 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.053 -0.351 . . . . 63.51 110.053 177.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -174.77 -178.56 44.74 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.635 -0.793 . . . . 54.3 111.981 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -147.03 132.71 18.86 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.916 -0.401 . . . . 61.32 109.916 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.719 HG13 ' HZ3' ' A' ' 77' ' ' TRP . 25.2 m -107.68 138.01 36.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.016 0.436 . . . . 75.12 110.711 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.43 ' HB2' ' HB ' ' A' ' 105' ' ' VAL . 3.4 mm? -112.32 120.82 43.01 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.708 -0.678 . . . . 73.42 109.631 177.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.683 ' HE2' HD13 ' A' ' 75' ' ' ILE . 76.2 m-85 -98.11 112.42 24.39 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.924 0.393 . . . . 72.43 110.499 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.444 HH11 ' HD2' ' A' ' 94' ' ' ARG . 5.0 ptt180 -126.2 145.23 51.71 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.03 -0.532 . . . . 75.14 110.442 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -51.46 131.18 35.76 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.209 2.606 . . . . 74.44 112.296 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.641 ' HB1' HG23 ' A' ' 11' ' ' THR . . . -82.6 144.94 49.91 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.0 -0.545 . . . . 61.14 111.751 -175.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 96' ' ' ALA . 31.5 Cg_exo -58.79 133.19 52.32 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.913 2.409 . . . . 61.41 112.111 177.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.09 5.71 81.26 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 121.228 -0.511 . . . . 74.12 112.762 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 62.66 34.69 14.68 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.855 0.462 . . . . 72.12 111.34 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.16 -35.72 71.97 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 108.653 -0.869 . . . . 73.42 108.653 172.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.407 ' HA3' ' HA2' ' A' ' 13' ' ' GLY . . . 163.71 -107.16 0.29 Allowed Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 114.942 -1.026 . . . . 64.34 110.764 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.474 ' HB ' HD11 ' A' ' 19' ' ' LEU . 28.8 m -142.69 136.61 29.19 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 110.027 -0.36 . . . . 41.32 110.027 176.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.623 ' HG2' ' HB1' ' A' ' 9' ' ' ALA . 38.4 tt0 -96.57 108.38 20.96 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 109.326 -0.62 . . . . 74.33 109.326 177.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.4 p -87.79 108.66 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.679 0.752 . . . . 74.41 110.015 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.509 HG13 ' HB2' ' A' ' 9' ' ' ALA . 3.4 t -92.44 109.22 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 114.721 -1.127 . . . . 70.04 108.781 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.67 HG22 HD12 ' A' ' 108' ' ' LEU . 7.4 p -112.87 130.89 65.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 121.017 0.437 . . . . 75.31 111.303 -173.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.584 ' O ' ' HD3' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -123.6 125.83 45.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.778 -0.646 . . . . 75.11 110.097 174.361 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.67 HD12 HG22 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -150.52 152.54 34.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.936 -0.575 . . . . 74.1 110.141 -179.21 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.8 t -88.32 143.23 27.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.801 0.334 . . . . 64.32 111.022 -177.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.443 ' HD1' ' HA ' ' A' ' 110' ' ' TYR . 0.4 OUTLIER -152.47 126.22 8.95 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.103 -0.703 . . . . 73.04 109.103 177.858 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.5 ptt180 -121.75 144.41 40.67 Favored Pre-proline 0 C--N 1.315 -0.908 0 N-CA-C 109.328 -0.619 . . . . 71.51 109.328 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -61.63 152.18 75.49 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.259 1.973 . . . . 52.24 112.035 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -82.08 146.94 14.58 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.712 2.274 . . . . 72.21 112.653 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -100.61 128.69 9.65 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.833 -0.699 . . . . 65.41 111.748 177.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 137.24 -154.28 22.29 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.439 -0.886 . . . . 73.31 112.871 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.4 p -81.19 -25.06 37.06 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.224 0.453 . . . . 63.42 112.224 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.459 ' O ' HG22 ' A' ' 120' ' ' VAL . . . -64.83 -41.01 96.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.079 0.466 . . . . 64.54 110.717 178.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.55 -20.67 75.76 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.932 -0.652 . . . . 64.25 112.837 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.6 -40.72 95.81 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 111.728 0.27 . . . . 64.24 111.728 -176.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 117' ' ' ALA . 25.0 m -70.68 -27.84 32.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.767 0.318 . . . . 75.34 110.7 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 57.9 mt -75.04 -36.64 38.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.053 0.454 . . . . 71.13 110.231 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.27 -35.13 78.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.767 -0.651 . . . . 73.14 111.409 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 27.4 ptt85 -90.22 -14.37 33.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.975 0.417 . . . . 64.41 110.93 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 23.4 ttt -71.63 -52.1 19.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.029 -0.532 . . . . 74.14 110.641 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 60.2 -164.7 0.22 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.856 -0.611 . . . . 74.33 110.576 -176.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -81.44 89.64 6.15 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.677 -0.86 . . . . 64.33 108.677 175.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -63.78 -29.84 71.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.971 -0.558 . . . . 70.44 111.051 -174.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -123.05 86.37 51.05 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.343 -0.844 . . . . 72.04 109.855 -177.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -50.44 96.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.437 2.758 . . . . 75.45 112.939 -173.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.5 p -88.12 131.58 34.64 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.201 -0.909 . . . . 72.22 110.576 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -81.1 -10.91 59.6 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.379 0.609 . . . . 75.22 109.959 178.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -120.62 134.33 55.29 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.552 -0.907 . . . . 72.23 108.552 172.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.5 tt -70.66 -37.71 73.74 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.024 0.44 . . . . 75.02 110.199 -175.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.665 ' HB2' ' HB3' ' A' ' 137' ' ' LEU . 0.0 OUTLIER -82.33 28.16 0.47 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.191 -0.459 . . . . 74.1 112.07 -177.711 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -59.56 -35.84 75.03 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.025 0.441 . . . . 71.03 110.573 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -71.57 -37.68 71.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.279 0.561 . . . . 73.4 109.933 176.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.665 ' HB3' ' HB2' ' A' ' 134' ' ' ARG . 47.2 tp -66.27 -28.08 68.43 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.588 -0.733 . . . . 74.14 110.202 178.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.514 ' CE ' HG12 ' A' ' 10' ' ' VAL . 11.8 mmt -63.27 -39.76 95.5 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.101 0.477 . . . . 51.32 110.173 174.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -67.36 -39.7 85.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.61 -0.723 . . . . 75.42 109.796 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -59.47 -48.68 80.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.099 -0.955 . . . . 65.15 110.347 172.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.661 ' HE2' ' O ' ' A' ' 11' ' ' THR . 37.0 tttm -52.06 -49.93 62.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.432 -0.804 . . . . 60.55 111.657 177.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -56.08 -44.08 78.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.615 -0.721 . . . . 72.13 111.89 -174.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -68.51 -34.42 75.86 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 121.027 -0.269 . . . . 64.53 111.662 -176.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.701 ' HG3' HG21 ' A' ' 12' ' ' ILE . 5.4 tp60 -72.53 -34.9 67.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.807 0.336 . . . . 72.1 110.973 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.638 ' HB3' HG23 ' A' ' 12' ' ' ILE . 15.5 pt-20 -83.06 -38.79 22.05 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 121.022 -0.271 . . . . 74.31 110.606 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 22.4 tp -72.58 -23.62 60.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.941 0.401 . . . . 73.41 110.551 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -64.36 -22.5 67.51 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.749 -0.66 . . . . 74.51 112.976 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.917 ' HG ' ' H ' ' A' ' 149' ' ' GLU . 16.5 tp 60.59 -161.25 0.29 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.406 0.282 . . . . 61.21 110.509 177.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.917 ' H ' ' HG ' ' A' ' 148' ' ' LEU . 5.5 mm-40 70.26 123.63 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.761 0.824 . . . . 70.05 113.055 174.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.7 ' HB2' ' HG3' ' A' ' 18' ' ' GLN . 26.8 p80 173.4 7.48 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 114.849 -1.068 . . . . 64.14 110.721 175.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 68.74 123.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.411 0.684 . . . . 73.33 110.492 -172.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 24.3 t60 -82.0 82.01 7.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.013 0.435 . . . . 73.02 109.972 -176.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 64.8 t60 -64.15 116.0 5.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.594 -0.73 . . . . 65.13 110.664 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -82.18 123.6 29.14 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.178 -0.464 . . . . 65.42 109.756 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.754 -0.641 . . . . 74.23 109.748 176.879 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 120.769 0.319 . . . . 74.43 110.62 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.91 -97.38 2.31 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.577 -0.821 . . . . 43.4 111.813 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -83.5 120.05 25.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.013 0.435 . . . . 75.1 110.063 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.665 ' O ' ' HB3' ' A' ' 110' ' ' TYR . 87.4 m -145.61 121.33 10.52 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.865 -0.607 . . . . 71.53 109.729 177.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.7 p -89.71 98.84 8.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.697 0.76 . . . . 44.42 109.261 178.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.403 HG23 ' HB3' ' A' ' 108' ' ' LEU . 17.5 m -84.65 134.23 27.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.288 -0.869 . . . . 61.33 111.258 -173.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 7' ' ' ARG . 15.0 ptt180 -141.39 132.17 25.79 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.539 -0.755 . . . . 75.44 109.772 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -143.93 155.69 44.16 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.057 -0.72 . . . . 74.41 109.057 175.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -130.44 142.86 50.49 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.133 0.492 . . . . 61.22 111.231 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.57 ' HB ' ' HB2' ' A' ' 141' ' ' LYS . 12.4 m -123.42 137.28 57.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.469 -0.787 . . . . 63.11 110.206 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -95.58 118.47 32.33 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.243 -0.435 . . . . 72.05 110.969 -175.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.979 HG23 ' HG2' ' A' ' 145' ' ' GLU . 4.0 mp -122.46 139.24 49.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.017 -0.538 . . . . 72.2 109.565 176.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.07 53.19 3.76 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.804 -0.712 . . . . 71.33 112.847 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.56 ' HG2' ' HB3' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -123.37 144.81 44.87 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 108.78 -0.822 . . . . 71.14 108.78 176.207 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.58 -58.37 1.29 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.429 2.086 . . . . 71.12 113.0 -175.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.61 ' HA ' HD12 ' A' ' 19' ' ' LEU . . . 173.4 -52.98 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.62 0.575 . . . . 62.45 110.157 178.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -49.44 -49.34 45.57 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.779 -1.101 . . . . 74.44 112.377 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.56 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 7.0 tt0 -68.71 -20.66 64.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.008 -0.542 . . . . 64.42 112.113 -175.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.61 HD12 ' HA ' ' A' ' 16' ' ' ALA . 66.6 mt -67.6 -33.15 74.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.66 -0.245 . . . . 64.44 111.274 -176.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.404 ' O ' ' HD1' ' A' ' 23' ' ' TRP . 27.9 t80 -73.03 -23.95 60.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.991 0.424 . . . . 75.32 110.743 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.55 -3.53 34.69 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.924 0.392 . . . . 53.33 112.02 -177.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.6 p -56.16 -21.29 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 115.689 -0.687 . . . . 70.34 112.305 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.404 ' HD1' ' O ' ' A' ' 20' ' ' TYR . 51.1 m95 -48.21 -31.13 5.39 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.287 0.847 . . . . 71.33 113.287 -176.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -118.27 -85.37 0.65 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.502 -0.479 . . . . 71.11 111.318 176.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -150.74 35.92 0.62 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.118 0.485 . . . . 75.11 110.027 -175.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.459 HD13 ' HA2' ' A' ' 147' ' ' GLY . 9.6 mp 65.55 165.4 0.12 Allowed Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 115.465 -0.789 . . . . 73.41 110.914 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.5 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 31.6 Cg_exo -59.73 104.06 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.398 2.065 . . . . 64.11 111.824 176.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.4 ' H ' ' HB ' ' A' ' 39' ' ' VAL . . . 153.79 -50.44 0.49 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.84 -0.695 . . . . 41.44 111.714 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.505 ' C ' ' H ' ' A' ' 31' ' ' LEU . 3.8 mm? 61.54 168.06 0.09 OUTLIER Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 120.94 0.4 . . . . 74.52 111.94 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -58.54 9.3 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.62 2.88 . . . . 71.12 114.072 173.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.505 ' H ' ' C ' ' A' ' 29' ' ' LEU . 7.5 mp 68.54 33.83 3.82 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.312 0.645 . . . . 62.14 110.666 -177.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.484 ' H ' ' HG ' ' A' ' 32' ' ' LEU . 0.4 OUTLIER -70.49 87.23 0.64 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.445 -0.798 . . . . 75.32 111.285 -179.758 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 48.34 26.73 1.17 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.638 1.175 . . . . 65.3 113.309 174.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.9 t -117.74 122.42 43.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.489 0.661 . . . . 73.41 111.248 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 20.7 m80 -141.13 19.73 2.27 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.444 -0.798 . . . . 73.24 109.184 174.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.5 tp -87.83 7.56 30.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.948 -1.024 . . . . 74.31 110.412 -177.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 75.43 -18.06 0.47 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.404 -0.816 . . . . 74.54 111.715 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.9 m -71.18 95.89 1.31 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.642 -0.503 . . . . 61.03 109.642 173.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 27' ' ' PRO . 16.9 m -134.42 28.71 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.222 0.534 . . . . 73.14 110.81 -175.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.43 -164.75 1.39 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.654 -0.703 . . . . 72.44 110.598 -177.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.5 t -58.11 146.36 8.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.935 -0.575 . . . . 74.21 110.683 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.416 ' HB2' ' HA ' ' A' ' 49' ' ' TRP . 60.0 tp -54.29 -45.31 72.49 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.065 -0.516 . . . . 61.51 111.873 -175.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.61 ' HB3' ' CG ' ' A' ' 46' ' ' ARG . 15.1 t70 -151.89 163.03 40.09 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.695 -0.483 . . . . 75.43 109.695 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -92.2 -12.27 33.19 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 123.156 0.285 . . . . 65.43 111.684 -174.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 1.014 ' HE2' ' HA ' ' A' ' 45' ' ' LYS . 9.9 mmpt? -93.01 4.05 54.69 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.788 0.804 . . . . 72.15 110.552 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.61 ' CG ' ' HB3' ' A' ' 43' ' ' ASP . 0.5 OUTLIER -152.64 -177.03 5.99 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.137 -1.392 . . . . 72.44 111.041 -176.198 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.553 ' O ' ' HD3' ' A' ' 46' ' ' ARG . 21.1 m -113.34 -154.48 0.54 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.3 -1.0 . . . . 54.52 108.3 174.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 71.47 167.27 0.31 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.139 0.495 . . . . 65.33 111.067 170.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.416 ' HA ' ' HB2' ' A' ' 42' ' ' LEU . 76.4 t90 -150.92 110.25 3.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.405 -0.361 . . . . 64.43 110.181 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.449 HG22 ' H ' ' A' ' 52' ' ' GLU . 42.1 m -157.11 125.56 5.67 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.009 -0.737 . . . . 61.44 109.009 178.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.2 m -72.12 -13.32 16.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.351 0.5 . . . . 71.42 112.351 -173.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.449 ' H ' HG22 ' A' ' 50' ' ' THR . 3.1 mm-40 -134.28 100.3 4.65 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.991 0.424 . . . . 75.11 110.523 177.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -137.42 86.08 20.09 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.669 -0.696 . . . . 54.04 111.06 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -65.89 114.16 2.86 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.555 2.17 . . . . 73.4 110.943 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 67.39 144.1 0.09 OUTLIER Pre-proline 0 N--CA 1.466 0.367 0 O-C-N 123.967 0.792 . . . . 70.51 110.263 -170.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -65.64 -57.13 0.27 Allowed 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 120.888 1.059 . . . . 75.13 111.384 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.011 ' HB3' HD13 ' A' ' 80' ' ' LEU . 1.5 pt? -112.47 -0.64 15.21 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.659 -0.7 . . . . 42.14 111.178 -170.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.72 95.82 0.04 OUTLIER Glycine 0 C--O 1.23 -0.136 0 O-C-N 124.095 0.872 . . . . 74.25 113.735 -172.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 71.63 7.69 6.01 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.513 0.725 . . . . 55.41 111.637 173.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.549 HG23 ' H ' ' A' ' 62' ' ' TRP . 26.6 m -95.67 -31.47 4.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.409 -0.517 . . . . 73.3 110.671 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.7 t 58.06 18.02 4.88 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.832 -0.622 . . . . 60.34 112.33 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.549 ' H ' HG23 ' A' ' 60' ' ' VAL . 23.5 m95 -130.67 -0.32 4.35 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.088 0.773 . . . . 73.13 113.088 -175.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.533 ' HB3' HD12 ' A' ' 80' ' ' LEU . 9.7 tp10 -86.81 152.16 22.73 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.086 0.47 . . . . 62.32 110.589 -174.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -122.33 145.34 48.34 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.741 -0.663 . . . . 71.05 110.88 -178.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.475 ' HG2' ' H ' ' A' ' 66' ' ' LEU . 33.0 tt0 -105.53 172.28 6.88 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.863 -1.162 . . . . 71.11 107.863 172.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.497 ' CD1' ' HA ' ' A' ' 77' ' ' TRP . 11.6 tp -130.43 145.13 51.77 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 122.013 -0.429 . . . . 44.22 111.061 -174.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.707 HG23 ' HB2' ' A' ' 78' ' ' ARG . 61.5 p -96.68 -34.75 11.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.084 0.469 . . . . 62.22 110.983 178.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.574 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -140.44 136.02 32.61 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.731 -0.668 . . . . 43.42 110.857 -177.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.41 ' HB3' HD23 ' A' ' 66' ' ' LEU . 6.9 p-10 -137.38 75.05 1.51 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.576 0.703 . . . . 63.24 111.051 -177.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.496 ' HB2' ' H ' ' A' ' 74' ' ' ARG . 16.3 mm-40 -96.37 143.42 26.08 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.926 -0.579 . . . . 74.54 110.22 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -67.81 -38.11 14.3 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.832 2.355 . . . . 73.31 112.776 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -151.56 42.01 0.73 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.364 -0.922 . . . . 33.01 112.659 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.437 ' HD2' ' OE1' ' A' ' 70' ' ' GLU . 76.0 mttt -130.11 -74.34 0.55 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.169 -0.308 . . . . 71.2 110.169 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.496 ' H ' ' HB2' ' A' ' 70' ' ' GLU . 5.9 ptp180 -151.71 150.44 30.22 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.872 -0.418 . . . . 75.22 109.872 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.528 HD12 ' HE2' ' A' ' 93' ' ' PHE . 70.7 mt -134.97 109.49 11.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.365 -0.606 . . . . 70.24 109.365 171.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.574 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -96.65 116.04 28.44 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.213 -0.662 . . . . 63.12 109.213 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.497 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 12.8 t90 -81.81 154.07 26.11 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.38 -0.827 . . . . 74.51 110.394 -172.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.707 ' HB2' HG23 ' A' ' 67' ' ' THR . 64.5 ttt180 -140.42 173.3 11.64 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.89 -0.781 . . . . 62.1 108.89 -178.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.533 ' HB2' ' HA ' ' A' ' 85' ' ' ILE . 45.8 m -135.9 152.68 51.26 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.944 -0.391 . . . . 44.45 109.944 175.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.011 HD13 ' HB3' ' A' ' 57' ' ' LEU . 66.5 mt -78.32 145.78 69.1 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 116.205 -0.452 . . . . 71.02 110.973 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 80' ' ' LEU . 51.4 Cg_exo -57.47 -31.93 92.72 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.352 2.702 . . . . 72.44 112.343 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.449 ' H ' HD12 ' A' ' 57' ' ' LEU . . . -81.51 -5.41 89.96 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.107 -0.568 . . . . 62.54 112.255 178.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.57 -65.21 1.01 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.274 -0.269 . . . . 72.54 110.274 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.69 ' HG2' ' HB2' ' A' ' 86' ' ' GLU . 20.5 ttt180 -177.53 -53.57 0.01 OUTLIER 'General case' 0 C--N 1.335 -0.063 0 CA-C-N 116.074 -0.512 . . . . 63.12 111.005 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.533 ' HA ' ' HB2' ' A' ' 79' ' ' SER . 13.0 tt 44.85 40.88 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-O 122.213 1.006 . . . . 74.2 112.02 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.69 ' HB2' ' HG2' ' A' ' 84' ' ' ARG . 0.8 OUTLIER -97.55 -4.37 37.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.453 -0.794 . . . . 54.34 110.492 -179.716 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -135.03 172.51 12.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.574 -0.739 . . . . 71.33 110.311 -177.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.0 m -148.06 145.21 28.36 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.769 0.319 . . . . 74.04 110.625 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -142.68 122.83 2.02 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.319 -0.713 . . . . 75.33 111.319 177.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -117.56 120.79 39.14 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.171 -0.307 . . . . 74.22 110.171 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.539 HG22 HG22 ' A' ' 106' ' ' VAL . 78.3 t -112.83 119.75 61.21 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.625 0.726 . . . . 74.42 111.425 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.8 mp -104.51 125.05 50.32 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.151 -0.931 . . . . 74.23 110.15 176.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.528 ' HE2' HD12 ' A' ' 75' ' ' ILE . 73.6 m-85 -89.48 106.43 18.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.115 0.484 . . . . 74.4 109.818 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.425 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 33.3 ptt180 -127.18 143.98 48.99 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.859 -0.61 . . . . 71.43 110.816 -176.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 94' ' ' ARG . 30.3 Cg_exo -62.55 127.29 20.37 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.662 2.241 . . . . 74.44 111.5 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.52 146.83 96.5 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 116.081 -0.508 . . . . 71.23 110.23 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -48.19 127.53 15.41 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.64 2.893 . . . . 61.04 113.111 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.87 20.33 68.31 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.801 -0.636 . . . . 54.44 112.447 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 56.66 34.25 24.19 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.129 0.49 . . . . 65.13 111.347 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.436 HH11 ' HD3' ' A' ' 100' ' ' ARG . 4.4 mmp_? -82.11 0.47 40.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.053 -0.521 . . . . 74.04 111.439 -177.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 144.33 -157.53 27.2 Favored Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 111.063 -0.815 . . . . 64.34 111.063 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 71.7 m -121.52 128.04 51.63 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.609 -0.515 . . . . 72.2 109.609 176.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -103.91 130.78 51.55 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.26 0.552 . . . . 71.3 109.899 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.697 HG21 ' HE2' ' A' ' 140' ' ' PHE . 4.7 m -89.36 132.45 34.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 108.623 -0.88 . . . . 62.43 108.623 175.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 7.3 p -118.0 115.45 48.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 121.375 0.607 . . . . 74.41 109.896 -177.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.539 HG22 HG22 ' A' ' 91' ' ' VAL . 39.6 t -105.1 115.13 46.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.574 -0.739 . . . . 72.41 110.849 -174.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -90.52 106.42 18.49 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.422 -0.584 . . . . 61.14 109.422 173.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.425 ' HA ' HD22 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -99.3 135.67 40.38 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.794 -0.447 . . . . 64.03 109.794 -177.043 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.4 p -83.81 119.91 25.41 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.214 0.53 . . . . 73.34 111.236 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.665 ' HB3' ' O ' ' A' ' 4' ' ' THR . 81.2 t80 -132.73 112.24 11.82 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.594 -0.73 . . . . 62.42 109.257 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 25.6 ptt85 -138.04 154.73 74.47 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 115.705 -0.68 . . . . 74.42 110.119 -174.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 60.8 Cg_endo -72.82 156.87 52.52 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.409 2.073 . . . . 63.23 111.98 -177.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 36.5 Cg_exo -60.37 116.71 3.51 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.641 2.227 . . . . 75.23 111.829 177.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -77.95 66.3 3.13 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 116.084 -0.507 . . . . 41.44 112.069 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 169.92 143.94 4.1 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 121.183 -0.532 . . . . 44.32 111.952 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.0 t -61.05 -45.41 94.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.776 0.322 . . . . 54.22 110.554 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.24 -32.65 74.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.221 -0.445 . . . . 53.33 110.774 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -71.47 -37.0 62.62 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.772 -0.728 . . . . 41.42 111.993 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.79 -45.52 71.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.652 0.263 . . . . 71.41 111.544 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 28.1 m -66.09 -36.54 77.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.042 0.386 . . . . 64.21 112.042 -175.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 35.6 pt -75.66 -32.36 24.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 120.761 -0.376 . . . . 73.02 110.781 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . . . -69.57 -34.57 74.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.971 0.415 . . . . 64.33 110.171 176.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -59.23 -34.81 72.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.118 -0.492 . . . . 72.22 110.227 175.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 14.7 tpt -71.77 -51.87 20.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.862 -0.608 . . . . 74.12 110.646 176.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -126.6 88.24 2.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.078 0.466 . . . . 74.21 111.151 -178.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 122' ' ' ALA . 6.4 t30 -117.25 -49.61 2.58 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 107.78 -1.192 . . . . 71.43 107.78 173.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 58.22 51.35 8.61 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.742 -1.117 . . . . 63.51 112.01 171.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.471 ' HB3' ' HG2' ' A' ' 131' ' ' GLN . 51.5 mt-10 -127.82 82.66 67.95 Favored Pre-proline 0 C--N 1.327 -0.406 0 C-N-CA 120.82 -0.352 . . . . 71.41 111.045 176.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -72.24 -54.6 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.32 2.013 . . . . 71.31 110.539 172.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 56.5 p -115.66 3.93 14.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.421 -0.808 . . . . 74.5 109.865 173.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.471 ' HG2' ' HB3' ' A' ' 128' ' ' GLU . 75.8 mt-30 65.37 -169.19 0.2 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.424 -0.807 . . . . 71.54 110.325 -176.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -66.61 -25.99 66.87 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.269 -0.641 . . . . 61.33 109.269 171.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.849 ' HG ' ' H ' ' A' ' 134' ' ' ARG . 14.7 tp 54.13 -154.64 0.25 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 114.929 -1.032 . . . . 34.24 110.722 174.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.849 ' H ' ' HG ' ' A' ' 133' ' ' LEU . 54.4 ttt85 -79.83 -9.38 59.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.787 0.327 . . . . 74.34 110.123 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -54.09 -48.12 71.02 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.254 -0.43 . . . . 71.45 111.066 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -69.12 -35.8 76.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.146 -0.479 . . . . 63.22 111.07 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 16.3 tp -76.97 -21.84 54.13 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.33 -0.395 . . . . 55.34 110.442 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.642 ' HA ' ' CE ' ' A' ' 138' ' ' MET . 4.8 mmt -65.99 -37.7 86.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.404 -0.362 . . . . 73.02 110.572 175.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.36 -35.22 75.64 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.711 -0.478 . . . . 71.51 109.711 177.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.697 ' HE2' HG21 ' A' ' 104' ' ' VAL . 72.5 t80 -57.44 -46.36 83.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.791 -0.641 . . . . 73.24 109.862 175.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.57 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 40.5 tttp -63.61 -40.25 96.44 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.366 -0.379 . . . . 72.55 110.876 176.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.4 ' HD2' HD22 ' A' ' 146' ' ' LEU . 21.3 tpp180 -57.51 -58.34 8.74 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.194 -0.457 . . . . 70.12 110.421 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.432 ' HG2' HD12 ' A' ' 148' ' ' LEU . 1.7 mp0 -66.1 -28.21 68.65 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 121.114 -0.235 . . . . 71.11 111.352 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.734 ' HB3' HG12 ' A' ' 12' ' ' ILE . 25.4 mm-40 -56.91 -49.71 74.77 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.312 0.577 . . . . 75.21 111.263 176.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.979 ' HG2' HG23 ' A' ' 12' ' ' ILE . 26.8 mt-10 -87.35 -32.3 19.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.779 -0.646 . . . . 64.33 111.1 -175.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.4 HD22 ' HD2' ' A' ' 142' ' ' ARG . 24.2 tp -90.47 -58.09 2.61 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.479 0.657 . . . . 73.4 111.625 -174.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.459 ' HA2' HD13 ' A' ' 26' ' ' LEU . . . 128.01 172.16 13.16 Favored Glycine 0 N--CA 1.441 -0.967 0 N-CA-C 109.405 -1.478 . . . . 74.32 109.405 -167.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.432 HD12 ' HG2' ' A' ' 143' ' ' GLU . 27.7 tp -85.78 -0.57 55.62 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 117.812 0.806 . . . . 65.13 110.567 -175.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -94.22 120.66 34.78 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.898 -0.592 . . . . 55.43 111.382 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 9.7 t60 73.87 73.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.948 -1.024 . . . . 64.21 112.507 172.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -126.02 92.17 3.53 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.726 -0.842 . . . . 75.31 108.726 167.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.494 ' O ' ' HB2' ' A' ' 153' ' ' HIS . 83.0 t60 -74.69 127.07 32.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.962 -1.017 . . . . 70.13 112.008 -168.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.494 ' HB2' ' O ' ' A' ' 152' ' ' HIS . 7.4 t60 168.93 -62.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.618 -1.253 . . . . 61.23 107.618 176.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.444 ' HB2' ' O ' ' A' ' 153' ' ' HIS . 66.2 t60 168.34 -46.86 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 106.398 -1.704 . . . . 74.51 106.398 177.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 . . . . . 0 C--O 1.245 0.863 0 CA-C-N 114.054 -1.43 . . . . 44.42 107.704 168.402 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 110.378 -0.23 . . . . 71.44 110.378 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 117.97 -30.09 6.25 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.091 -0.803 . . . . 73.44 111.091 -178.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -86.39 170.59 11.86 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.109 -0.7 . . . . 71.55 109.109 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.633 ' HB ' ' O ' ' A' ' 110' ' ' TYR . 30.5 m -98.75 121.72 41.06 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 109.196 -0.668 . . . . 73.4 109.196 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.8 t -120.61 113.0 38.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.477 -0.564 . . . . 73.01 109.477 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 52.4 t -99.07 122.6 51.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.835 -0.62 . . . . 61.23 110.851 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.524 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 57.1 ttt-85 -126.12 109.59 12.55 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.363 -0.606 . . . . 73.11 109.363 171.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.597 ' HB3' HD22 ' A' ' 137' ' ' LEU . 18.1 t0 -130.83 151.14 51.58 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.954 -1.128 . . . . 72.12 107.954 177.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.658 ' HB2' HG12 ' A' ' 105' ' ' VAL . . . -135.99 129.48 32.14 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.948 0.404 . . . . 31.12 111.948 -170.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.846 ' HB ' ' HG3' ' A' ' 141' ' ' LYS . 16.1 m -120.56 143.25 33.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.896 -0.593 . . . . 73.1 110.188 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.426 HG21 ' HD3' ' A' ' 100' ' ' ARG . 26.6 m -107.25 114.1 27.93 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.582 -0.281 . . . . 63.41 110.669 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.972 HG23 ' HB3' ' A' ' 145' ' ' GLU . 4.9 mp -110.73 139.64 33.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.311 -0.404 . . . . 65.52 110.79 -176.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.46 60.31 4.55 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 121.249 -0.5 . . . . 73.34 113.039 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.676 ' HD3' ' HG2' ' A' ' 18' ' ' GLN . 43.0 mttp -140.69 150.38 59.94 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 110.2 -0.296 . . . . 71.31 110.2 176.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.441 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 51.4 Cg_exo -56.01 -59.28 0.75 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.817 2.345 . . . . 60.51 114.123 -173.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . 170.73 -48.04 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.453 0.644 . . . . 65.31 110.007 175.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -48.17 -56.36 8.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.257 -1.338 . . . . 71.22 112.954 -173.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.676 ' HG2' ' HD3' ' A' ' 14' ' ' LYS . 0.6 OUTLIER -80.9 -7.65 59.54 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.257 -0.429 . . . . 75.55 111.65 -173.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.55 ' CB ' ' HE2' ' A' ' 93' ' ' PHE . 64.0 mt -75.87 -26.8 57.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.796 -0.183 . . . . 64.31 111.163 177.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -65.18 -29.81 70.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.241 0.543 . . . . 71.43 110.447 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.45 -8.45 56.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.577 -0.738 . . . . 71.11 111.689 -175.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.474 HG11 ' HE2' ' A' ' 140' ' ' PHE . 6.2 p -60.16 -22.2 24.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.808 0.337 . . . . 74.14 111.735 -175.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -70.41 -23.48 62.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.919 0.39 . . . . 65.03 110.774 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.405 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 17.8 tpt180 -128.58 19.47 6.21 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.885 -0.413 . . . . 72.43 109.885 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.561 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 18.6 t70 64.84 162.43 0.13 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.62 -0.718 . . . . 61.42 110.968 -174.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.575 ' H ' HD23 ' A' ' 26' ' ' LEU . 1.3 pt? -113.95 85.7 10.25 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 121.364 0.602 . . . . 55.24 112.019 -175.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.561 ' HD3' ' O ' ' A' ' 25' ' ' ASP . 1.9 Cg_endo -84.75 -11.9 7.69 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.059 2.506 . . . . 72.31 111.623 173.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.38 57.94 6.36 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.819 -0.628 . . . . 74.45 112.698 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.514 ' N ' ' HD3' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -146.37 60.69 6.38 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 112.455 0.539 . . . . 74.21 112.455 178.403 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.514 ' HD3' ' N ' ' A' ' 29' ' ' LEU . 1.3 Cg_endo -84.49 -0.57 9.43 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.636 2.224 . . . . 63.15 111.67 175.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.465 HD12 ' HD2' ' A' ' 30' ' ' PRO . 6.6 mp -100.91 34.71 2.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.876 -0.602 . . . . 73.23 110.501 -177.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.662 ' H ' HD23 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -69.77 -15.22 63.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.235 -0.439 . . . . 51.14 111.981 -177.389 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.869 ' HG2' ' H ' ' A' ' 34' ' ' THR . 17.4 ttt 61.87 -164.73 0.24 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 110.175 -0.306 . . . . 65.54 110.175 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.869 ' H ' ' HG2' ' A' ' 33' ' ' MET . 0.9 OUTLIER -80.12 87.4 5.48 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.875 0.369 . . . . 74.32 111.062 176.895 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 65.18 74.4 0.39 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.369 -0.832 . . . . 73.0 112.656 177.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.529 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 61.1 tp -126.78 110.66 13.34 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.36 -0.978 . . . . 71.52 108.36 170.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.529 ' HB3' ' O ' ' A' ' 36' ' ' LEU . 26.5 ttt180 74.9 149.28 0.1 Allowed 'General case' 0 CA--C 1.535 0.375 0 O-C-N 124.065 0.853 . . . . 73.53 110.515 -174.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.8 m -71.98 102.11 2.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.361 -0.381 . . . . 52.5 110.494 178.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.424 HG13 HD13 ' A' ' 32' ' ' LEU . 13.0 p -156.49 158.85 3.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.391 -0.368 . . . . 74.35 110.147 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -61.91 156.49 20.76 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.625 -0.261 . . . . 75.01 110.589 177.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.727 HG22 HD22 ' A' ' 42' ' ' LEU . 8.3 p -74.56 -55.39 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 112.352 0.501 . . . . 75.53 112.352 -170.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.727 HD22 HG22 ' A' ' 41' ' ' VAL . 1.1 mm? -145.6 -68.46 0.29 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.949 0.404 . . . . 64.01 110.279 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 72.89 -13.59 0.66 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.135 -0.938 . . . . 73.13 112.563 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -93.41 -15.35 25.74 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.356 -0.609 . . . . 75.42 109.356 172.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -166.07 85.46 0.33 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.483 -0.932 . . . . 72.33 108.483 -175.747 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.415 ' HB3' ' O ' ' A' ' 45' ' ' LYS . 37.5 ttp180 75.55 132.59 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.102 -0.954 . . . . 72.33 112.347 176.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 25.8 m -152.4 115.87 4.75 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.041 -0.982 . . . . 64.35 111.064 177.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.491 ' HG3' ' OG1' ' A' ' 50' ' ' THR . 1.1 ptm180 -135.6 8.87 3.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.005 -0.543 . . . . 72.03 109.755 170.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 29.4 m-90 54.19 72.85 0.43 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.201 -0.908 . . . . 75.34 112.293 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.546 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -166.27 -73.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.463 -0.789 . . . . 71.34 110.185 174.163 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.546 HG12 ' O ' ' A' ' 50' ' ' THR . 1.4 p 57.12 15.55 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.623 1.169 . . . . 70.13 111.971 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 50' ' ' THR . 38.1 mt-10 -99.86 -18.32 17.2 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.939 -0.573 . . . . 73.21 110.548 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -103.24 150.55 38.04 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.861 -0.609 . . . . 64.05 110.567 -177.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.405 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 16.6 Cg_exo -69.0 173.96 9.54 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 123.186 2.591 . . . . 64.32 112.101 177.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 54' ' ' PRO . . . 72.51 153.78 0.15 Allowed Pre-proline 0 N--CA 1.466 0.37 0 C-N-CA 123.401 0.68 . . . . 75.42 111.394 -176.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.81 ' HB2' HD13 ' A' ' 57' ' ' LEU . 75.7 Cg_exo -49.29 -46.89 24.23 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.582 2.188 . . . . 63.43 111.762 176.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.81 HD13 ' HB2' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -137.51 -20.37 1.19 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.941 -0.572 . . . . 74.42 111.982 178.862 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.489 ' N ' HD22 ' A' ' 57' ' ' LEU . . . 74.06 -60.04 2.23 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.493 -0.861 . . . . 72.54 111.705 -174.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -134.75 151.01 50.64 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.797 -0.445 . . . . 74.24 109.797 177.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.701 HG12 HD13 ' A' ' 80' ' ' LEU . 30.7 m -105.85 134.48 47.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.655 0.264 . . . . 70.25 110.922 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.8 t -154.11 -56.75 0.11 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.509 -0.314 . . . . 74.14 110.807 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -139.1 -11.91 1.24 Allowed 'General case' 0 C--O 1.234 0.278 0 N-CA-C 112.487 0.551 . . . . 74.2 112.487 -174.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.588 ' HG2' ' CD1' ' A' ' 80' ' ' LEU . 1.8 pm0 -84.27 166.3 17.6 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.623 0.725 . . . . 74.34 112.58 -172.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -134.36 143.35 47.6 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.64 -1.164 . . . . 71.44 110.507 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.685 ' HB3' ' HD2' ' A' ' 78' ' ' ARG . 1.8 tm-20 -107.24 175.57 5.45 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.291 -1.003 . . . . 74.24 108.291 176.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.617 HD12 ' HA ' ' A' ' 77' ' ' TRP . 22.8 tp -124.08 119.64 30.05 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.132 -0.692 . . . . 75.41 109.132 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.3 t -81.53 -23.71 37.09 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.627 0.251 . . . . 64.12 111.389 -174.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.586 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . . . -144.12 127.31 16.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.932 0.396 . . . . 55.24 111.043 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.598 ' HB2' HD23 ' A' ' 66' ' ' LEU . 11.0 t70 -138.79 104.03 4.98 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.266 -0.879 . . . . 54.53 109.788 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.454 ' HB2' ' H ' ' A' ' 74' ' ' ARG . 8.0 mm-40 -106.71 144.2 28.58 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.718 -0.673 . . . . 73.22 109.855 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 35.3 Cg_exo -62.04 -24.61 76.82 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.92 2.414 . . . . 50.11 112.536 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.98 56.93 0.12 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.917 -0.659 . . . . 75.04 111.592 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -141.41 -68.76 0.38 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.345 -0.142 . . . . 74.45 111.019 -176.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.454 ' H ' ' HB2' ' A' ' 70' ' ' GLU . 18.5 ptt180 -153.32 155.38 36.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.857 0.36 . . . . 75.34 111.51 -176.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.896 ' HB ' HG12 ' A' ' 91' ' ' VAL . 49.0 mm -125.14 110.82 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.765 -0.652 . . . . 72.02 109.723 174.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.586 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . . . -108.81 120.41 42.4 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.981 -0.748 . . . . 71.25 108.981 174.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.617 ' HA ' HD12 ' A' ' 66' ' ' LEU . 13.7 p-90 -106.85 138.95 42.05 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.612 0.72 . . . . 64.41 112.195 -170.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.685 ' HD2' ' HB3' ' A' ' 65' ' ' GLU . 7.8 ptp85 -113.07 173.35 6.43 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 107.676 -1.231 . . . . 65.15 107.676 171.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.437 ' CB ' ' HD3' ' A' ' 84' ' ' ARG . 6.1 m -138.6 30.3 2.34 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.343 -0.543 . . . . 53.32 109.873 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.701 HD13 HG12 ' A' ' 60' ' ' VAL . 22.1 mt 66.52 147.02 0.11 Allowed Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 115.086 -0.961 . . . . 72.11 111.093 -175.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.64 -23.16 55.83 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 123.104 2.536 . . . . 64.51 113.529 -174.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.21 -3.32 88.92 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.717 -0.754 . . . . 64.01 113.263 -176.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -136.44 25.98 3.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.201 0.5 . . . . 75.31 111.851 -177.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.437 ' HD3' ' CB ' ' A' ' 79' ' ' SER . 9.4 mmm180 -126.83 107.79 10.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.827 0.346 . . . . 73.01 111.457 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.735 HG13 ' H ' ' A' ' 86' ' ' GLU . 13.8 pt -91.11 -63.3 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.053 -0.521 . . . . 63.31 110.298 173.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.735 ' H ' HG13 ' A' ' 85' ' ' ILE . 34.2 tt0 -163.74 109.42 1.07 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.885 0.374 . . . . 74.34 110.366 176.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -162.15 141.01 9.3 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.682 -0.859 . . . . 75.41 108.682 175.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.4 m -151.37 129.38 11.79 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.142 -0.318 . . . . 75.11 110.142 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.09 110.26 0.25 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.55 -0.833 . . . . 34.24 112.247 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.13 149.98 23.73 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.242 -0.281 . . . . 73.31 110.242 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.896 HG12 ' HB ' ' A' ' 75' ' ' ILE . 7.6 p -88.97 140.98 14.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.213 -0.662 . . . . 74.13 109.213 174.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.692 ' HB2' ' CG2' ' A' ' 105' ' ' VAL . 3.2 mm? -108.99 119.81 40.66 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.154 -0.684 . . . . 65.44 109.154 172.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.55 ' HE2' ' CB ' ' A' ' 19' ' ' LEU . 15.7 m-85 -96.91 106.03 18.28 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.824 -0.806 . . . . 61.55 108.824 174.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 32.7 mtp180 -125.95 142.9 43.69 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 116.112 -0.495 . . . . 72.13 110.046 -174.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -57.85 115.57 2.61 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.436 2.091 . . . . 74.25 110.634 175.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . . . -65.36 143.63 98.78 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.019 -0.537 . . . . 63.52 111.413 -173.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 96' ' ' ALA . 51.5 Cg_exo -55.79 137.39 78.39 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.885 2.39 . . . . 65.1 111.925 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.63 16.51 79.13 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.947 -0.644 . . . . 61.45 112.101 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 57.16 33.69 23.7 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.341 0.591 . . . . 64.22 110.794 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.426 ' HD3' HG21 ' A' ' 11' ' ' THR . 34.6 ttt180 -77.27 1.04 19.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.41 -0.814 . . . . 71.41 111.04 -175.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 123.23 -125.13 5.84 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 111.508 -0.637 . . . . 70.52 111.508 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 88.0 m -135.01 130.53 35.84 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.952 0.406 . . . . 73.15 110.564 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -100.9 113.91 27.3 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.902 -0.59 . . . . 74.15 109.534 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.2 m -88.74 127.29 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-O 121.703 0.763 . . . . 71.22 108.991 175.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.692 ' CG2' ' HB2' ' A' ' 92' ' ' LEU . 14.0 m -123.18 119.39 57.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.204 -0.907 . . . . 45.23 109.815 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.639 HG13 HG23 ' A' ' 91' ' ' VAL . 1.8 m -119.84 121.52 66.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.908 -0.587 . . . . 73.54 111.074 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.85 109.85 19.19 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.537 -0.912 . . . . 75.3 108.537 174.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.432 HD22 ' HE2' ' A' ' 110' ' ' TYR . 0.4 OUTLIER -141.12 151.39 43.9 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.058 0.456 . . . . 75.11 111.544 -174.435 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.9 t -98.77 133.09 43.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.378 0.609 . . . . 52.42 110.911 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.633 ' O ' ' HB ' ' A' ' 4' ' ' THR . 57.8 m-85 -151.68 -179.4 7.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.039 -0.982 . . . . 71.43 109.233 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -122.01 149.42 53.95 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 109.222 -0.659 . . . . 71.24 109.222 174.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.426 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 25.9 Cg_endo -61.42 152.43 72.96 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.448 2.099 . . . . 74.55 112.622 -177.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 25.6 Cg_exo -63.44 -52.4 1.98 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.953 2.436 . . . . 74.35 112.139 -178.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.29 -28.94 7.53 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.765 -0.731 . . . . 65.05 112.436 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -55.03 112.56 2.96 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.576 -0.345 . . . . 32.52 113.124 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.7 m -86.54 -30.61 21.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.93 0.395 . . . . 71.03 111.153 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.406 ' O ' HG22 ' A' ' 120' ' ' VAL . . . -64.93 -36.15 83.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.939 -0.573 . . . . 61.02 112.194 -173.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -60.14 -25.69 62.56 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 121.078 -0.582 . . . . 74.44 113.292 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.03 -46.76 86.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.727 0.299 . . . . 64.14 111.311 -177.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 117' ' ' ALA . 26.9 m -75.1 -23.73 17.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.495 -0.321 . . . . 53.4 111.177 -177.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 65.1 mt -72.7 -33.44 44.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.389 -0.369 . . . . 75.21 110.418 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.08 -22.64 65.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.169 -0.469 . . . . 72.51 111.279 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -63.87 -26.75 68.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.064 -0.517 . . . . 73.24 111.171 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 16.7 tpt -71.45 -26.86 62.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.949 0.404 . . . . 72.53 110.959 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -98.35 -174.22 2.77 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.254 -0.43 . . . . 70.44 111.256 -173.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -74.59 151.72 39.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.077 -0.511 . . . . 71.13 109.915 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -107.56 117.51 34.28 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.918 0.389 . . . . 65.12 111.488 -177.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -110.22 88.26 7.01 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.693 -0.685 . . . . 72.3 109.223 171.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -44.81 125.74 6.76 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.376 2.717 . . . . 61.13 113.134 -174.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.9 m -61.75 101.1 0.17 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.487 -0.778 . . . . 73.0 111.205 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -82.87 -10.53 58.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.291 0.567 . . . . 73.34 109.875 175.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -133.42 177.77 7.44 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.497 -0.927 . . . . 74.01 108.497 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.3 tt -71.3 -61.82 1.63 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.841 -0.344 . . . . 71.11 110.208 -177.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.571 ' HG2' ' H ' ' A' ' 137' ' ' LEU . 35.7 ttt85 -85.85 110.55 19.47 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.141 0.496 . . . . 74.2 110.369 178.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -61.51 -39.45 91.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.361 -0.836 . . . . 71.11 110.655 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -61.01 -34.99 75.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.836 -0.62 . . . . 74.31 111.206 177.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.597 HD22 ' HB3' ' A' ' 8' ' ' ASP . 11.5 tp -79.14 -35.8 41.51 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.503 0.668 . . . . 75.34 109.844 -175.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.3 ttp -66.28 -36.89 84.12 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.532 -0.758 . . . . 71.22 110.367 174.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -69.81 -51.05 37.06 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.128 -0.487 . . . . 75.54 112.182 -177.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.474 ' HE2' HG11 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -66.32 -29.54 69.76 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.261 -0.576 . . . . 71.2 109.685 -175.346 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.846 ' HG3' ' HB ' ' A' ' 10' ' ' VAL . 14.9 tmtt? -57.1 -42.37 80.66 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 115.788 -0.642 . . . . 62.12 110.46 173.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -55.11 -52.2 64.02 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.284 0.564 . . . . 73.42 110.269 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -66.58 -40.81 89.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.022 -0.99 . . . . 61.43 111.928 -172.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.518 ' CD ' HG12 ' A' ' 12' ' ' ILE . 4.6 pt20 -74.17 -17.3 60.93 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.571 0.582 . . . . 74.45 112.571 -173.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.972 ' HB3' HG23 ' A' ' 12' ' ' ILE . 19.7 pt-20 -110.73 -4.46 15.33 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.618 -0.433 . . . . 75.1 111.102 175.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 24.4 tp -61.8 -52.83 62.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.068 0.461 . . . . 72.41 110.453 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -109.32 119.23 5.45 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 121.022 -0.609 . . . . 73.11 111.77 175.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.507 HD23 ' HZ2' ' A' ' 14' ' ' LYS . 87.4 mt -85.7 -42.66 14.07 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.077 -0.342 . . . . 65.24 110.077 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 59.78 -86.94 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 O-C-N 124.106 0.879 . . . . 71.13 113.217 175.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -138.37 140.47 39.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.468 0.651 . . . . 60.04 112.148 -172.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -103.7 121.38 42.86 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.154 -0.93 . . . . 72.33 108.769 172.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -76.51 71.61 3.15 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.074 -0.713 . . . . 74.51 109.074 175.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 29.3 m170 57.01 -143.61 0.69 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.673 -0.694 . . . . 75.02 109.542 -174.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 76.3 m80 66.01 -86.33 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 122.569 0.348 . . . . 74.45 110.969 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 117.936 -1.031 . . . . 74.15 108.899 177.602 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.9 ttm . . . . . 0 N--CA 1.482 1.159 0 CA-C-O 121.101 0.477 . . . . 55.33 110.361 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -157.86 27.67 0.46 Allowed Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.589 -1.004 . . . . 62.3 110.589 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.517 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 2.5 pm0 -60.26 153.27 22.79 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.922 -0.639 . . . . 74.32 111.693 -176.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 47.5 m -132.42 126.95 34.3 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.598 -0.89 . . . . 75.54 108.598 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.817 HG22 HG23 ' A' ' 109' ' ' THR . 66.5 t -99.46 127.71 51.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 116.045 -0.525 . . . . 72.22 110.248 -173.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.6 m -83.77 126.28 40.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.387 0.613 . . . . 64.24 111.022 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.1 OUTLIER -142.28 118.03 10.46 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.569 -0.741 . . . . 61.03 110.553 -178.871 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.401 ' OD2' ' HD2' ' A' ' 134' ' ' ARG . 13.7 t70 -128.18 170.14 13.32 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.081 -0.711 . . . . 73.42 109.081 176.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.59 ' HB2' HG13 ' A' ' 105' ' ' VAL . . . -145.43 123.19 11.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.676 0.274 . . . . 71.11 111.325 -173.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.6 m -112.32 148.15 15.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.292 -0.413 . . . . 64.13 111.014 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.408 ' CG2' ' HB1' ' A' ' 96' ' ' ALA . 0.6 OUTLIER -105.21 110.43 22.8 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.952 -0.567 . . . . 70.33 112.0 -171.177 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.872 HG21 ' HB2' ' A' ' 144' ' ' GLN . 0.1 OUTLIER -124.4 151.23 29.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.109 0.48 . . . . 71.43 112.139 177.111 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.59 ' HA2' ' HA3' ' A' ' 101' ' ' GLY . . . -82.8 20.43 9.47 Favored Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.756 -0.656 . . . . 55.42 112.396 177.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.572 ' HB2' HD21 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -79.53 143.93 60.26 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.354 -0.61 . . . . 65.44 109.354 176.284 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.411 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 23.0 Cg_endo -62.28 -60.01 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.023 1.815 . . . . 74.12 113.359 -171.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.495 ' HA ' HD12 ' A' ' 19' ' ' LEU . . . 172.17 -50.76 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.492 0.717 . . . . 60.11 109.967 171.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.494 ' HA ' ' HD2' ' A' ' 20' ' ' TYR . 1.9 mp0 -56.29 -47.45 78.64 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.976 -0.556 . . . . 71.51 110.621 -177.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -66.71 -13.27 61.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.282 -0.872 . . . . 72.33 111.205 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.692 HD21 HG13 ' A' ' 12' ' ' ILE . 98.1 mt -83.88 -43.08 15.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.229 -0.441 . . . . 73.32 110.387 175.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.628 ' CE1' HD13 ' A' ' 75' ' ' ILE . 73.6 m-85 -62.68 -32.34 73.4 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.424 0.631 . . . . 64.13 109.8 176.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.52 -7.76 49.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.085 -0.961 . . . . 73.13 111.996 -176.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.557 HG21 ' CE2' ' A' ' 140' ' ' PHE . 7.8 p -53.74 -30.38 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 120.889 0.376 . . . . 72.24 111.65 -176.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 28.8 t90 -68.4 -23.73 64.68 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.044 0.449 . . . . 74.42 111.144 -177.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -124.21 13.54 8.97 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.583 -0.525 . . . . 71.42 109.583 -178.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.718 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 28.9 t70 62.38 168.73 0.12 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.427 -0.806 . . . . 55.23 110.532 -169.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.694 ' H ' HD23 ' A' ' 26' ' ' LEU . 1.3 pt? -104.83 87.2 1.73 Allowed Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 121.11 0.481 . . . . 74.4 110.767 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.718 ' HD3' ' O ' ' A' ' 25' ' ' ASP . 9.9 Cg_endo -89.39 -175.33 1.08 Allowed 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 123.208 2.605 . . . . 74.11 111.79 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.484 ' HA2' ' HB2' ' A' ' 38' ' ' SER . . . -144.37 -38.88 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.48 -0.867 . . . . 63.31 112.619 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.559 HD22 HD22 ' A' ' 32' ' ' LEU . 8.4 mp 65.22 160.87 0.12 Allowed Pre-proline 0 C--O 1.234 0.239 0 C-N-CA 122.967 0.507 . . . . 64.1 110.521 -174.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.09 61.6 3.23 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 121.6 1.534 . . . . 72.22 111.723 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.7 mp 44.53 72.54 0.19 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 114.753 -1.112 . . . . 74.43 112.587 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.559 HD22 HD22 ' A' ' 29' ' ' LEU . 1.8 pt? -81.86 -13.35 57.73 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.596 -0.52 . . . . 72.5 109.596 174.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 14.6 tpt 64.57 105.38 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.211 -0.904 . . . . 74.44 111.543 177.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.6 m -133.36 -51.37 0.87 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.053 -0.521 . . . . 75.0 111.464 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 24.6 t-80 -161.07 -179.48 7.54 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.17 -0.678 . . . . 74.11 109.17 -173.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.628 ' O ' ' HB2' ' A' ' 37' ' ' ARG . 3.2 mm? -57.97 137.69 56.56 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 108.067 -1.086 . . . . 72.2 108.067 167.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.628 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER 75.37 129.88 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 108.239 -1.023 . . . . 74.14 108.239 -164.05 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.484 ' HB2' ' HA2' ' A' ' 28' ' ' GLY . 17.5 m -44.86 -37.54 3.95 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.053 0.76 . . . . 65.42 113.053 -170.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 40' ' ' GLU . 6.4 p -144.01 -58.3 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 120.961 -0.296 . . . . 53.3 110.849 173.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.455 ' N ' HG13 ' A' ' 39' ' ' VAL . 1.9 tt0 50.27 -159.98 0.07 Allowed 'General case' 0 C--O 1.237 0.401 0 O-C-N 123.444 0.465 . . . . 62.24 110.066 -176.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.448 ' H ' ' HG2' ' A' ' 40' ' ' GLU . 38.3 t -59.85 132.84 25.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.732 -0.47 . . . . 71.23 109.732 173.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.664 HD12 ' HA ' ' A' ' 48' ' ' ARG . 84.5 mt -61.54 -71.1 0.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.234 0.827 . . . . 72.33 113.234 -167.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.787 ' HB2' HG23 ' A' ' 50' ' ' THR . 12.5 t70 -64.74 -53.42 47.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.557 0.694 . . . . 70.13 111.132 -174.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -169.44 -82.75 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.717 -1.129 . . . . 65.43 108.545 -176.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 50.8 mmtt -123.45 14.89 9.61 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.385 -0.968 . . . . 72.35 108.385 167.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.6 ' HG2' ' O ' ' A' ' 64' ' ' ALA . 31.5 mtm-85 -109.04 175.22 5.54 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 114.477 -1.238 . . . . 72.04 111.645 -171.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 50.8 m -75.05 -161.0 0.12 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.997 1.11 . . . . 51.44 113.997 -166.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.664 ' HA ' HD12 ' A' ' 42' ' ' LEU . 47.9 mtt85 -84.04 178.29 7.91 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 114.84 -1.073 . . . . 75.51 111.678 -176.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 94.7 m95 71.8 -35.31 0.32 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.737 0.815 . . . . 72.21 113.05 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.787 HG23 ' HB2' ' A' ' 43' ' ' ASP . 3.2 t -75.4 69.73 2.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 122.197 0.998 . . . . 72.33 111.247 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.1 m -128.31 -34.18 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.12 -0.945 . . . . 60.11 109.363 171.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -122.1 27.5 7.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.308 -0.86 . . . . 50.44 109.873 175.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.65 157.27 63.03 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.447 -0.797 . . . . 72.53 109.825 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.41 -178.05 1.06 Allowed 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.466 2.111 . . . . 70.41 112.068 177.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.75 143.51 39.33 Favored Pre-proline 0 C--O 1.236 0.354 0 CA-C-N 116.312 -0.403 . . . . 50.35 111.265 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.45 ' HB3' ' HG3' ' A' ' 63' ' ' GLU . 34.8 Cg_endo -60.38 -54.95 1.74 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.041 2.494 . . . . 71.43 111.449 -177.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.625 HD12 ' HG3' ' A' ' 65' ' ' GLU . 13.4 mt -78.79 8.62 5.15 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.642 -1.163 . . . . 62.53 110.493 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -94.93 -64.49 0.99 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.747 -0.661 . . . . 72.43 111.548 175.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -151.48 60.68 0.88 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.918 0.39 . . . . 63.34 111.726 -178.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 80.4 t -132.5 140.71 46.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.722 -0.473 . . . . 63.45 109.722 176.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.7 m -55.58 -70.37 0.11 Allowed 'General case' 0 N--CA 1.462 0.172 0 O-C-N 123.194 0.309 . . . . 55.35 111.316 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 70.4 p-90 -129.34 136.71 50.37 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.489 0.662 . . . . 74.54 111.155 176.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.585 ' OE2' ' HB3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -154.8 169.31 24.27 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.537 -1.21 . . . . 74.1 108.299 177.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.6 ' O ' ' HG2' ' A' ' 46' ' ' ARG . . . -118.83 113.9 21.81 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.492 -0.483 . . . . 62.42 110.17 175.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.625 ' HG3' HD12 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -106.77 135.74 47.79 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.745 -0.465 . . . . 74.23 109.745 178.328 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.521 HD12 ' HA ' ' A' ' 77' ' ' TRP . 3.0 mm? -86.57 147.05 26.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.139 -0.482 . . . . 75.31 111.305 -169.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.6 t -98.67 -16.5 19.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.082 0.467 . . . . 65.45 110.53 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.619 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -138.72 124.96 20.26 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.173 -0.677 . . . . 51.54 109.173 173.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -125.2 99.62 6.17 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.267 -0.424 . . . . 72.21 111.754 -171.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.45 ' O ' HD11 ' A' ' 75' ' ' ILE . 22.8 mt-10 -121.48 142.69 36.09 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.769 -0.826 . . . . 63.41 108.769 166.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 31.1 Cg_exo -61.16 -42.96 32.03 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.588 2.192 . . . . 73.14 112.328 -177.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -150.48 56.02 0.47 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.636 -0.792 . . . . 72.03 112.198 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -147.09 -82.43 0.13 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.816 -0.354 . . . . 53.31 110.914 174.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.596 ' HD2' ' OE2' ' A' ' 90' ' ' GLU . 16.7 ttp180 -124.38 123.14 39.53 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.444 -0.502 . . . . 74.24 111.168 -170.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.628 HD13 ' CE1' ' A' ' 20' ' ' TYR . 2.6 mp -125.82 110.87 25.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.748 -0.66 . . . . 63.33 110.506 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.619 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -96.6 116.11 28.56 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.259 -1.015 . . . . 42.5 108.259 170.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.611 ' CZ2' ' HB3' ' A' ' 87' ' ' ASN . 3.9 p-90 -85.69 151.72 23.64 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.409 0.623 . . . . 60.41 111.269 -171.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.557 ' HB3' ' O ' ' A' ' 65' ' ' GLU . 5.5 tpm_? -155.37 170.88 20.87 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.183 -1.414 . . . . 53.54 107.183 -175.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.547 ' HA ' ' HA ' ' A' ' 64' ' ' ALA . 20.0 p -145.24 170.38 16.38 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.075 0.464 . . . . 51.41 110.888 -177.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.506 HD11 ' HB2' ' A' ' 65' ' ' GLU . 5.7 mp -87.45 154.33 53.85 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.761 -0.654 . . . . 65.05 110.576 178.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.57 -1.4 3.93 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 123.089 2.526 . . . . 64.23 112.981 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.21 -8.18 66.84 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.994 -0.622 . . . . 61.53 112.136 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.17 -177.62 5.75 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.744 0.307 . . . . 75.2 110.56 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.48 ' HD2' ' HA ' ' A' ' 84' ' ' ARG . 14.3 tpt180 -122.12 -28.34 4.4 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.592 -0.443 . . . . 62.51 111.302 -178.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.85 132.56 70.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.117 0.484 . . . . 53.05 110.154 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -147.24 142.83 27.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.839 -0.618 . . . . 72.0 110.089 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.611 ' HB3' ' CZ2' ' A' ' 77' ' ' TRP . 28.1 t-20 -137.13 150.27 47.86 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.722 -0.844 . . . . 52.24 108.722 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 60.9 m -100.7 127.5 47.09 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.397 0.618 . . . . 70.33 110.216 -176.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.406 ' HA3' HD23 ' A' ' 108' ' ' LEU . . . -171.54 169.25 42.34 Favored Glycine 0 N--CA 1.438 -1.223 0 CA-C-N 115.227 -0.897 . . . . 33.02 111.559 -176.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.596 ' OE2' ' HD2' ' A' ' 74' ' ' ARG . 33.1 tt0 -144.64 129.42 18.26 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.993 -0.373 . . . . 74.34 109.993 -175.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.611 HG12 HG12 ' A' ' 106' ' ' VAL . 9.3 m -111.05 137.89 41.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 110.095 -0.335 . . . . 73.22 110.095 178.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.646 ' CD2' ' HB ' ' A' ' 105' ' ' VAL . 0.0 OUTLIER -128.19 119.7 25.76 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.75 0.786 . . . . 73.21 110.046 173.078 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.63 ' HE2' ' HB3' ' A' ' 19' ' ' LEU . 2.5 m-85 -97.73 106.43 18.74 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.485 -1.234 . . . . 72.41 109.215 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -119.66 144.93 38.02 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 115.418 -0.81 . . . . 71.03 110.35 -172.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -46.86 117.78 2.33 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.246 2.631 . . . . 75.12 112.102 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.408 ' HB1' ' CG2' ' A' ' 11' ' ' THR . . . -58.93 144.54 81.67 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.741 -0.663 . . . . 75.23 111.094 -176.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -46.31 115.98 1.36 Allowed 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 123.303 2.669 . . . . 75.54 113.022 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 96.15 3.57 60.25 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.665 -0.698 . . . . 50.41 112.162 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 64.79 32.49 10.98 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 123.08 0.552 . . . . 71.12 111.164 -178.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 37.7 ttt-85 -75.46 -19.43 59.44 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.957 -0.565 . . . . 72.03 110.992 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.59 ' HA3' ' HA2' ' A' ' 13' ' ' GLY . . . 165.82 -130.74 2.21 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.885 -0.886 . . . . 41.11 110.885 -175.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.2 m -138.73 133.95 32.9 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 110.152 -0.314 . . . . 62.11 110.152 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -96.55 133.06 41.49 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.928 -0.767 . . . . 62.23 108.928 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.635 HG12 HD11 ' A' ' 12' ' ' ILE . 1.5 p -95.15 100.32 10.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.794 0.807 . . . . 53.15 110.35 179.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.646 ' HB ' ' CD2' ' A' ' 92' ' ' LEU . 4.1 t -97.4 111.47 27.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.688 -1.142 . . . . 73.31 108.941 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.611 HG12 HG12 ' A' ' 91' ' ' VAL . 26.1 m -112.47 123.46 68.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.318 0.58 . . . . 75.35 111.517 -176.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 31.1 ttt85 -105.17 100.89 10.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.524 -0.762 . . . . 73.42 109.678 174.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.406 HD23 ' HA3' ' A' ' 89' ' ' GLY . 95.4 mt -116.94 126.8 53.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.257 -0.429 . . . . 45.31 110.146 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.817 HG23 HG22 ' A' ' 5' ' ' VAL . 25.9 m -90.22 116.26 28.08 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 120.214 -0.594 . . . . 73.55 110.726 -176.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -172.93 168.71 4.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.485 -0.78 . . . . 73.02 108.917 174.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -105.56 144.76 29.49 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 110.428 -0.212 . . . . 73.33 110.428 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.45 168.92 19.77 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 122.659 2.239 . . . . 55.34 111.586 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.665 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 7.3 Cg_endo -50.0 129.54 25.08 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.943 2.429 . . . . 71.51 112.029 177.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -49.22 -64.44 3.34 Favored Glycine 0 C--N 1.332 0.361 0 CA-C-N 115.36 -0.836 . . . . 72.32 114.554 -171.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -105.71 1.87 39.1 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.491 -0.862 . . . . 24.11 113.114 -175.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.665 ' HB2' ' HB2' ' A' ' 113' ' ' PRO . 13.0 m -86.08 -24.17 26.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.694 0.283 . . . . 73.15 111.152 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.63 -41.64 99.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.435 -0.348 . . . . 44.04 110.933 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.01 -31.25 77.97 Favored Glycine 0 N--CA 1.452 -0.256 0 CA-C-N 116.05 -0.523 . . . . 65.23 112.48 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.34 -29.3 64.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.163 0.506 . . . . 72.33 110.572 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 59.6 t -73.67 -51.36 25.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.881 -0.6 . . . . 71.05 110.51 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.9 pp -68.92 -22.64 26.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.24 -0.437 . . . . 73.41 111.981 -175.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -81.2 -30.96 34.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.742 0.306 . . . . 64.33 111.16 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -88.77 -39.16 14.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.4 -0.364 . . . . 71.52 111.219 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.562 ' SD ' ' HB3' ' A' ' 130' ' ' SER . 47.9 ttm -52.55 -51.58 58.98 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 123.33 0.394 . . . . 75.22 110.707 -177.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.429 ' HD1' ' HA ' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -167.29 111.57 0.71 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.067 -0.716 . . . . 54.42 109.067 176.09 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -57.23 -45.63 83.72 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.029 -0.532 . . . . 74.32 111.483 -174.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.411 ' O ' ' HB2' ' A' ' 128' ' ' GLU . 9.3 pt20 -118.44 169.75 9.51 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.16 -0.473 . . . . 71.1 109.924 178.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 127' ' ' GLN . 0.5 OUTLIER 69.82 153.27 0.14 Allowed Pre-proline 0 N--CA 1.471 0.577 0 O-C-N 123.801 0.688 . . . . 63.5 111.449 -175.252 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.85 128.73 26.45 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.624 2.216 . . . . 73.53 111.881 175.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.562 ' HB3' ' SD ' ' A' ' 124' ' ' MET . 14.4 m -68.2 136.65 53.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.985 -0.552 . . . . 62.43 110.447 -178.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -83.32 -172.68 4.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.007 0.432 . . . . 74.24 111.579 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -81.13 56.49 2.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.863 -0.608 . . . . 60.3 111.627 -172.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.406 HD23 ' HE2' ' A' ' 124' ' ' MET . 54.1 tp -77.91 100.42 6.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.426 0.631 . . . . 64.41 109.486 175.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.401 ' HD2' ' OD2' ' A' ' 8' ' ' ASP . 8.7 ptt180 -124.58 77.39 1.58 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.202 -0.908 . . . . 73.55 110.098 -174.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -58.53 -44.6 89.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.636 -0.711 . . . . 73.32 111.695 -175.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -60.54 -52.72 64.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.425 . . . . 72.34 111.087 -177.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -68.35 -36.13 78.77 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.545 -0.298 . . . . 72.12 111.27 -179.52 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 27.9 tpp -67.89 -41.64 82.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.884 0.373 . . . . 74.42 110.9 -177.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -63.63 -36.11 82.73 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.441 -0.577 . . . . 74.32 109.441 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.612 ' HE1' HG11 ' A' ' 104' ' ' VAL . 55.5 t80 -63.65 -49.85 71.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.427 -0.806 . . . . 72.31 110.25 174.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -55.81 -50.1 71.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.496 -0.775 . . . . 62.43 111.42 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -62.04 -45.34 94.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.335 -0.393 . . . . 71.14 110.924 -176.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -65.49 -28.85 69.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.313 -0.403 . . . . 74.21 111.716 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.872 ' HB2' HG21 ' A' ' 12' ' ' ILE . 9.9 mm-40 -68.62 -35.99 78.03 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.617 -0.433 . . . . 72.23 111.102 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.583 ' HG3' HG22 ' A' ' 12' ' ' ILE . 35.4 mt-10 -78.39 -37.15 44.73 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.713 -0.395 . . . . 75.23 110.143 178.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 67.2 mt -65.35 -40.55 93.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.972 -0.558 . . . . 72.14 110.678 176.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -80.02 55.23 4.54 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.095 -0.574 . . . . 75.4 112.054 176.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.516 HD22 ' HD3' ' A' ' 14' ' ' LYS . 57.1 tp 177.45 -48.17 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.945 -0.761 . . . . 73.34 108.945 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 71.11 -60.28 0.52 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.863 -1.062 . . . . 61.44 111.691 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 37.5 m170 -84.53 115.77 22.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.068 0.461 . . . . 73.24 110.728 -173.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -90.24 140.84 29.3 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.71 -0.677 . . . . 74.11 110.404 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -121.37 128.86 52.67 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.756 -0.461 . . . . 65.22 109.756 173.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 35.2 t60 -77.1 111.07 12.3 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.025 -0.534 . . . . 73.31 109.917 -177.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 59.11 -116.53 0.83 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.153 -0.684 . . . . 64.24 109.153 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.215 -0.898 . . . . 74.22 109.255 177.601 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 109.421 -0.585 . . . . 73.43 109.421 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.36 -51.48 1.61 Allowed Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 110.345 -1.102 . . . . 61.11 110.345 -171.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.479 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 1.4 pm0 -95.93 140.32 30.85 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.742 -0.836 . . . . 71.15 108.742 170.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.0 m -75.12 121.29 21.84 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.166 -0.309 . . . . 63.14 110.166 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.6 p -125.42 135.76 62.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.811 0.339 . . . . 70.44 110.45 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.3 t -119.93 126.38 75.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.692 -0.485 . . . . 72.33 109.692 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -127.78 132.84 49.46 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.054 0.454 . . . . 60.31 110.508 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.443 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 11.3 t70 -158.09 171.74 19.69 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.799 -1.186 . . . . 72.55 107.799 173.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.589 ' HB2' HG12 ' A' ' 105' ' ' VAL . . . -134.06 120.42 20.18 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.068 0.461 . . . . 73.41 112.12 -174.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.541 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 21.4 m -101.27 130.04 51.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.67 -0.696 . . . . 65.11 109.749 174.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.692 ' HA ' ' HA ' ' A' ' 103' ' ' GLU . 5.1 t -102.83 113.48 26.94 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.78 0.8 . . . . 71.32 110.436 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.631 HG23 ' HB3' ' A' ' 145' ' ' GLU . 4.5 mp -112.36 151.47 14.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.954 -1.021 . . . . 73.23 108.871 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.86 42.3 1.1 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.862 -0.685 . . . . 74.11 112.907 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.662 ' HB3' ' HB2' ' A' ' 18' ' ' GLN . 6.7 mmpt? -112.24 144.25 30.45 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 108.394 -0.965 . . . . 72.1 108.394 178.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -52.99 -57.96 1.75 Allowed 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.335 2.023 . . . . 54.1 113.738 -172.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 174.4 -53.46 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.251 0.548 . . . . 62.43 109.66 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.8 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 0.1 OUTLIER -54.43 -39.22 67.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.069 -0.969 . . . . 72.11 110.891 177.631 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.662 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 21.4 mm-40 -63.06 -27.79 69.64 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.061 -0.972 . . . . 71.54 111.37 -177.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.425 HD11 ' HB ' ' A' ' 102' ' ' THR . 95.5 mt -74.94 -48.35 24.93 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.9 -0.591 . . . . 31.14 111.162 -174.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.8 ' CE2' ' HA ' ' A' ' 17' ' ' GLU . 36.2 p90 -74.77 -23.42 58.52 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 119.704 -0.798 . . . . 61.1 110.643 177.259 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.56 -2.08 21.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.043 -0.526 . . . . 73.34 111.627 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.464 HG11 ' HZ ' ' A' ' 140' ' ' PHE . 12.0 p -53.38 -22.59 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 115.806 -0.633 . . . . 45.54 112.525 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -66.75 -27.31 67.5 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.275 0.559 . . . . 71.12 110.709 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.814 ' HG3' ' H ' ' A' ' 25' ' ' ASP . 15.0 tpp180 -105.54 -164.21 1.01 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.924 -1.139 . . . . 74.33 107.924 176.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.814 ' H ' ' HG3' ' A' ' 24' ' ' ARG . 28.6 t0 -83.93 36.47 0.56 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.45 0.643 . . . . 74.44 109.363 176.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.566 HD11 ' HA3' ' A' ' 147' ' ' GLY . 0.3 OUTLIER 41.89 63.1 6.9 Favored Pre-proline 0 N--CA 1.47 0.543 0 CA-C-N 114.897 -1.047 . . . . 72.12 112.279 -177.606 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.456 ' HD3' ' N ' ' A' ' 26' ' ' LEU . 89.9 Cg_endo -103.93 -4.86 0.21 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.225 2.617 . . . . 55.42 113.094 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.99 -113.66 4.44 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.484 -1.047 . . . . 75.13 110.484 -170.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.557 HD12 HD12 ' A' ' 31' ' ' LEU . 0.9 OUTLIER -159.08 151.7 17.95 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 109.344 -0.613 . . . . 74.21 109.344 174.393 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.452 ' HD2' HD21 ' A' ' 32' ' ' LEU . 31.5 Cg_exo -62.14 7.28 0.14 Allowed 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 123.524 2.816 . . . . 73.43 113.112 176.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.557 HD12 HD12 ' A' ' 29' ' ' LEU . 11.0 mp 67.79 63.15 0.4 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.567 0.699 . . . . 64.42 110.608 -177.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.474 ' HG ' ' HB ' ' A' ' 39' ' ' VAL . 2.7 mm? -73.95 81.91 1.69 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.152 -0.931 . . . . 64.04 110.265 177.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -134.76 7.99 3.53 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.626 -0.716 . . . . 72.32 110.159 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.6 p -88.1 172.87 9.2 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.875 -0.602 . . . . 51.34 110.115 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -104.51 18.82 21.46 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.595 -0.442 . . . . 73.55 111.449 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 tt -76.54 108.31 9.44 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 105.825 -1.917 . . . . 72.2 105.825 164.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -81.7 59.83 4.37 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.193 0.52 . . . . 64.54 112.285 -160.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.7 m -98.88 -59.99 1.62 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.459 -0.941 . . . . 62.21 108.459 170.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.474 ' HB ' ' HG ' ' A' ' 32' ' ' LEU . 21.8 t -124.48 84.95 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.272 -1.01 . . . . 64.34 108.272 170.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -103.96 135.3 45.74 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.678 -0.692 . . . . 72.14 110.765 -174.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 73.5 t -88.05 104.69 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-O 121.513 0.673 . . . . 52.15 109.993 174.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.5 tp -70.35 -52.33 23.41 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.802 -1.09 . . . . 73.05 109.477 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -164.19 156.06 16.49 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.905 -1.146 . . . . 74.55 107.905 175.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -85.67 66.22 9.54 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 122.313 1.054 . . . . 74.1 109.568 -177.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.908 ' HE2' ' HA ' ' A' ' 45' ' ' LYS . 2.1 mmpt? -139.06 -60.22 0.58 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 113.629 -1.623 . . . . 71.11 110.258 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.472 ' HD3' ' HG3' ' A' ' 63' ' ' GLU . 83.7 mtt180 -114.69 121.35 43.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.65 -0.705 . . . . 72.44 110.52 178.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.0 p -110.37 96.16 6.03 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.491 -0.559 . . . . 73.41 109.491 172.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.737 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 38.8 ptt180 -89.76 156.56 18.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.113 -0.494 . . . . 61.23 111.075 -176.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 71.94 -64.65 0.38 Allowed 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.96 0.788 . . . . 72.42 111.946 -177.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 53' ' ' ALA . 68.9 m 72.56 134.11 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.316 0.579 . . . . 71.32 111.823 178.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.4 t -100.13 -27.14 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.232 -0.44 . . . . 50.31 111.409 -177.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.674 ' HA ' ' NH2' ' A' ' 24' ' ' ARG . 15.8 mm-40 -70.86 -32.23 69.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.957 0.408 . . . . 52.03 111.433 -177.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.411 ' H ' HG22 ' A' ' 50' ' ' THR . . . -144.68 149.96 45.27 Favored Pre-proline 0 C--N 1.321 -0.674 0 N-CA-C 109.433 -0.581 . . . . 72.13 109.433 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -65.32 112.05 1.99 Allowed 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 121.831 1.687 . . . . 74.1 111.097 177.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.426 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . . . 65.64 142.25 0.07 OUTLIER Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 115.233 -0.894 . . . . 60.33 111.671 -174.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.73 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 38.4 Cg_exo -65.26 -56.72 0.33 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 123.059 2.506 . . . . 55.11 112.284 -178.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.675 HD21 ' HG ' ' A' ' 80' ' ' LEU . 0.4 OUTLIER -119.63 22.44 11.63 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.249 -0.887 . . . . 75.44 111.402 -178.001 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.49 19.3 35.58 Favored Glycine 0 C--N 1.31 -0.875 0 CA-C-N 114.964 -1.016 . . . . 42.41 112.735 178.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 71.28 28.36 3.01 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 122.998 0.519 . . . . 75.43 111.495 173.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.532 ' HB ' HD13 ' A' ' 57' ' ' LEU . 61.3 t -60.08 -50.2 81.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.905 -0.588 . . . . 73.4 109.485 174.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.412 ' HB2' ' H ' ' A' ' 62' ' ' TRP . 9.3 m -115.45 -88.37 0.58 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.285 -0.635 . . . . 73.13 109.285 170.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.412 ' H ' ' HB2' ' A' ' 61' ' ' SER . 78.6 m95 -158.18 -35.96 0.07 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.828 0.347 . . . . 63.21 110.875 174.072 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.737 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 1.4 pm0 -108.49 167.1 10.28 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.077 0.769 . . . . 74.42 113.077 -170.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.73 ' HB2' ' HB3' ' A' ' 56' ' ' PRO . . . -110.47 147.81 33.33 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.123 -1.066 . . . . 45.23 108.123 163.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.788 ' HB2' HD23 ' A' ' 80' ' ' LEU . 0.7 OUTLIER -112.57 134.15 54.24 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 107.708 -1.219 . . . . 74.42 107.708 -176.78 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -107.83 141.34 39.56 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 119.616 -0.834 . . . . 70.05 111.221 -171.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.9 t -108.1 -24.38 11.59 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.854 -0.338 . . . . 72.13 111.008 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.543 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . . . -135.98 153.78 51.29 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.542 -0.54 . . . . 60.21 109.542 175.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -150.61 16.68 0.8 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.876 0.325 . . . . 53.22 111.876 -172.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.601 ' HG2' ' HD3' ' A' ' 73' ' ' LYS . 1.6 mp0 -61.29 142.03 93.82 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 110.416 -0.216 . . . . 71.11 110.416 -176.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -79.51 -20.17 9.65 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.661 2.241 . . . . 74.23 113.017 -173.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -162.67 38.29 0.35 Allowed Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.303 -0.719 . . . . 72.33 111.303 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.601 ' HD3' ' HG2' ' A' ' 70' ' ' GLU . 54.3 tttp -129.74 -51.57 1.15 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.008 -0.367 . . . . 64.34 110.008 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.514 ' H ' ' HB2' ' A' ' 70' ' ' GLU . 29.3 ttp180 -166.09 129.47 2.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.25 -0.432 . . . . 73.34 110.902 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.646 ' HB ' HG22 ' A' ' 91' ' ' VAL . 6.3 mm -108.38 109.99 30.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.399 -0.963 . . . . 71.3 108.399 175.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.561 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . . . -129.94 116.3 18.42 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.05 0.452 . . . . 61.11 110.486 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.532 ' NE1' ' HA3' ' A' ' 89' ' ' GLY . 69.0 p-90 -113.18 155.54 24.82 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.629 -0.714 . . . . 70.24 109.928 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -142.87 176.45 9.06 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.935 -1.135 . . . . 75.53 107.935 175.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 51.3 p -96.05 177.68 5.66 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.924 -0.71 . . . . 74.05 110.153 174.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.788 HD23 ' HB2' ' A' ' 65' ' ' GLU . 7.3 mt -71.64 156.89 90.77 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 116.038 -0.528 . . . . 71.1 110.019 -177.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -52.93 -36.57 75.6 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.864 2.376 . . . . 74.14 112.755 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.92 21.44 44.93 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.764 -0.731 . . . . 73.42 112.696 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -120.5 176.64 5.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.608 0.242 . . . . 74.13 110.552 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.425 ' HD2' ' N ' ' A' ' 84' ' ' ARG . 8.5 mpt_? -115.05 144.85 42.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.534 -0.303 . . . . 73.32 110.351 -179.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.6 pp -88.91 166.74 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.984 0.421 . . . . 74.51 111.639 -178.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -126.07 -64.34 1.05 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.665 -0.698 . . . . 63.4 110.399 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -130.11 173.15 11.02 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.937 -1.135 . . . . 62.22 107.937 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.8 m -95.75 126.98 41.39 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.497 -0.557 . . . . 72.54 109.497 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.532 ' HA3' ' NE1' ' A' ' 77' ' ' TRP . . . -115.92 74.87 0.26 Allowed Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.663 -0.779 . . . . 73.11 111.85 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.561 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 35.2 tt0 -131.0 113.9 14.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.01 0.433 . . . . 71.15 110.241 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.646 HG22 ' HB ' ' A' ' 75' ' ' ILE . 18.6 m -120.47 131.91 71.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.533 -0.758 . . . . 71.24 109.401 177.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.79 ' HB2' HG23 ' A' ' 105' ' ' VAL . 4.5 mp -113.36 141.08 47.47 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.428 -0.509 . . . . 71.13 109.875 175.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.465 ' HZ ' ' HB3' ' A' ' 20' ' ' TYR . 58.2 m-85 -120.8 131.59 54.55 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.206 -0.452 . . . . 71.2 110.461 -177.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 34.2 ptt180 -141.18 142.8 28.44 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 109.53 -0.545 . . . . 74.42 109.53 173.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 94' ' ' ARG . 38.4 Cg_exo -62.67 112.89 1.75 Allowed 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 122.251 1.967 . . . . 72.45 110.757 174.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.45 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . . . -63.37 144.11 97.64 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.748 -0.66 . . . . 74.31 110.674 -174.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -23.5 109.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.691 1 C-N-CA 126.046 4.497 . . . . 65.44 115.356 -171.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.5 -67.79 3.65 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 114.77 -1.104 . . . . 41.32 111.849 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -177.81 38.41 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.731 -0.735 . . . . 72.23 110.453 -172.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.533 ' NE ' ' HA ' ' A' ' 100' ' ' ARG . 4.6 mmp_? -78.44 -6.98 56.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.259 0.552 . . . . 71.13 110.11 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 119.74 -143.66 17.06 Favored Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 110.145 -1.182 . . . . 63.32 110.145 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.425 ' HB ' HD11 ' A' ' 19' ' ' LEU . 30.6 m -127.22 116.5 20.68 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.791 -0.448 . . . . 74.35 109.791 174.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.692 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 11.0 pt-20 -88.38 138.42 31.45 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.253 -0.647 . . . . 71.44 109.253 177.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 1.5 p -108.49 108.83 26.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 115.336 -0.847 . . . . 65.42 111.135 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.79 HG23 ' HB2' ' A' ' 92' ' ' LEU . 2.6 m -87.27 110.35 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.446 -0.797 . . . . 63.14 109.319 174.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.83 138.48 50.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.678 -0.692 . . . . 71.21 110.676 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -122.84 102.35 7.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.658 -0.701 . . . . 65.14 110.702 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.481 HD21 ' CZ ' ' A' ' 110' ' ' TYR . 0.0 OUTLIER -123.19 152.82 40.85 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.133 -0.485 . . . . 72.1 109.772 178.782 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.7 t -100.58 149.34 23.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.381 0.61 . . . . 70.4 111.709 -172.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.481 ' CZ ' HD21 ' A' ' 108' ' ' LEU . 97.5 m-85 -123.85 159.15 30.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.166 -0.925 . . . . 75.32 109.019 174.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 42.9 mtt180 -89.93 143.84 30.61 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 108.984 -0.747 . . . . 72.32 108.984 172.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 111' ' ' ARG . 35.3 Cg_exo -61.81 151.26 82.01 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 122.092 1.861 . . . . 53.2 112.008 -177.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -97.45 5.27 1.47 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.264 2.643 . . . . 64.54 113.312 -178.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.84 89.48 0.66 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.855 -0.688 . . . . 72.43 112.413 -177.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -170.96 174.7 44.76 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 121.02 -0.61 . . . . 13.11 112.116 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.6 m -78.95 -12.47 60.03 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.654 0.242 . . . . 43.21 111.654 -177.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.43 -36.46 73.65 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.941 0.4 . . . . 74.3 111.395 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -73.28 -23.71 76.85 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.771 -0.728 . . . . 72.1 112.767 -177.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.09 -45.75 83.11 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.06 0.393 . . . . 63.32 112.06 -174.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 16.7 m -74.34 -41.77 50.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 111.977 0.362 . . . . 70.42 111.977 -176.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.8 pp -75.99 -22.73 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.729 0.299 . . . . 74.4 111.715 -176.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.846 ' HB1' ' HA ' ' A' ' 127' ' ' GLN . . . -68.4 -20.36 64.67 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.951 0.352 . . . . 41.34 111.951 -178.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -64.44 -14.55 57.47 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.924 -0.58 . . . . 73.4 111.796 -175.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -63.08 -41.93 99.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.581 -0.282 . . . . 54.45 111.213 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -153.59 -75.37 0.12 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.161 0.505 . . . . 73.02 110.63 -176.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -132.41 145.55 51.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.481 -0.781 . . . . 52.23 109.238 -176.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.846 ' HA ' ' HB1' ' A' ' 122' ' ' ALA . 10.0 pt20 -67.07 -26.62 66.82 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 123.354 0.409 . . . . 73.35 111.222 177.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -123.26 82.74 52.05 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.274 -0.421 . . . . 72.13 110.639 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -87.41 60.62 3.68 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.008 1.806 . . . . 71.41 111.656 178.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.3 t 55.81 112.02 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.236 -0.893 . . . . 24.53 112.165 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.527 ' CD ' ' H ' ' A' ' 131' ' ' GLN . 4.9 pm0 -75.55 67.15 2.02 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.275 0.56 . . . . 70.34 110.309 175.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 67.1 -67.31 0.17 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.08 -0.964 . . . . 72.32 111.086 -174.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.895 ' HG ' ' H ' ' A' ' 134' ' ' ARG . 16.6 tp 54.95 -153.9 0.3 Allowed 'General case' 0 CA--C 1.534 0.355 0 O-C-N 123.393 0.433 . . . . 64.0 110.372 178.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.895 ' H ' ' HG ' ' A' ' 133' ' ' LEU . 32.7 mtp-105 -84.3 -28.91 26.8 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 122.36 -0.213 . . . . 73.43 111.356 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.29 -39.33 94.28 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 111.935 0.346 . . . . 64.12 111.935 -171.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.491 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 32.5 t70 -70.33 -30.68 67.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.228 0.537 . . . . 73.33 110.155 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.541 ' HG ' ' CG1' ' A' ' 10' ' ' VAL . 22.2 tp -78.08 -27.96 48.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.069 -0.514 . . . . 70.12 109.817 178.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.559 ' HG2' ' O ' ' A' ' 134' ' ' ARG . 29.5 mmt -66.49 -42.15 87.88 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.16 -0.473 . . . . 74.44 110.409 176.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 136' ' ' ASP . 5.9 ppt_? -75.05 -27.61 60.08 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.009 -0.367 . . . . 75.13 110.009 178.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.464 ' HZ ' HG11 ' A' ' 22' ' ' VAL . 83.7 t80 -61.54 -39.83 92.48 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.094 0.473 . . . . 71.31 109.819 173.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 138' ' ' MET . 35.0 ttmt -56.44 -42.18 77.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.443 -0.799 . . . . 73.53 109.72 174.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.435 HH21 ' CD ' ' A' ' 145' ' ' GLU . 0.0 OUTLIER -58.43 -48.66 79.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.876 -1.056 . . . . 74.41 111.083 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.37 -31.43 72.09 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.436 -0.347 . . . . 61.44 111.635 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.551 ' HG3' HG21 ' A' ' 12' ' ' ILE . 24.3 tp60 -76.51 -43.38 39.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.726 0.298 . . . . 74.23 110.798 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.631 ' HB3' HG23 ' A' ' 12' ' ' ILE . 16.3 pt-20 -80.07 -4.32 52.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.867 0.365 . . . . 65.24 110.714 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 60.6 tp -65.84 -36.41 83.4 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.185 -0.672 . . . . 34.41 109.185 171.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.566 ' HA3' HD11 ' A' ' 26' ' ' LEU . . . -76.89 89.83 0.97 Allowed Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.398 -0.819 . . . . 73.43 112.3 176.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.408 ' HB3' ' O ' ' A' ' 147' ' ' GLY . 62.9 tp 73.96 114.29 0.06 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.57 0.748 . . . . 73.13 111.265 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -76.03 81.87 2.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.54 -0.754 . . . . 71.44 111.142 -178.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -108.13 13.27 26.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.902 0.858 . . . . 74.11 109.236 174.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -131.52 107.42 8.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.083 -0.962 . . . . 74.55 109.587 178.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -131.0 112.92 13.36 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.487 0.661 . . . . 73.41 111.057 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -155.2 80.77 1.06 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.282 -1.007 . . . . 73.31 108.282 177.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -77.38 100.85 6.1 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.704 -0.68 . . . . 74.51 111.471 -170.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 62.8 t60 . . . . . 0 C--O 1.244 0.786 0 CA-C-O 118.458 -0.782 . . . . 74.5 109.915 177.635 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.758 0.313 . . . . 70.54 110.555 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.16 -143.12 7.05 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.939 -0.648 . . . . 74.02 112.123 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -87.99 154.98 20.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.524 0.202 . . . . 62.11 110.58 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 97.7 m -135.44 122.24 21.06 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.213 0.53 . . . . 73.01 111.505 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.1 p -125.4 101.52 8.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.354 -0.839 . . . . 75.31 108.923 170.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.1 m -88.62 143.37 11.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.297 0.57 . . . . 75.03 111.22 -173.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.781 ' HD2' ' O ' ' A' ' 7' ' ' ARG . 0.5 OUTLIER -137.91 109.63 7.09 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.481 -0.782 . . . . 71.22 109.949 178.568 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.589 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 2.1 t70 -132.92 172.3 12.79 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.452 -0.573 . . . . 61.24 109.452 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.643 ' HB1' ' HG2' ' A' ' 103' ' ' GLU . . . -144.7 122.94 12.23 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.026 0.441 . . . . 55.55 111.007 -173.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.476 HG23 HD11 ' A' ' 12' ' ' ILE . 4.4 m -113.02 149.35 15.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.886 -0.597 . . . . 73.21 111.133 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.8 m -100.98 109.87 21.83 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.855 -0.611 . . . . 73.14 111.017 -175.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.801 HG13 ' HG2' ' A' ' 141' ' ' LYS . 4.5 mp -118.49 145.93 23.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 110.091 -0.337 . . . . 74.24 110.091 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.37 56.97 4.9 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 121.12 -0.562 . . . . 64.21 112.552 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.627 ' HG2' HG22 ' A' ' 12' ' ' ILE . 75.6 mmtt -121.77 156.56 58.85 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 108.584 -0.895 . . . . 73.44 108.584 175.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.422 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 47.1 Cg_exo -56.51 -59.1 0.73 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 121.762 1.641 . . . . 75.12 112.4 -178.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . 171.09 -58.72 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.768 0.667 . . . . 65.4 110.046 174.204 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -49.31 -55.01 14.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.525 -1.216 . . . . 54.45 112.215 -173.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.534 ' O ' HD12 ' A' ' 26' ' ' LEU . 16.9 mm-40 -69.39 -10.69 59.09 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.177 0.806 . . . . 64.14 113.177 -173.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.45 ' HA ' HD23 ' A' ' 19' ' ' LEU . 16.2 mt -63.47 -24.79 67.97 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.007 -0.433 . . . . 72.21 111.624 176.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -72.86 -25.0 60.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.943 0.402 . . . . 55.42 110.387 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.84 -9.0 58.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.222 -0.444 . . . . 74.1 111.726 -176.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.837 HG21 ' HG2' ' A' ' 144' ' ' GLN . 14.0 p -52.36 -21.92 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 112.247 0.462 . . . . 65.34 112.247 -175.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -51.76 -38.21 54.51 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.471 -0.331 . . . . 73.03 110.523 175.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -145.23 61.23 1.3 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.633 -0.258 . . . . 72.02 110.703 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.491 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 21.4 t70 63.07 171.35 0.15 Allowed 'General case' 0 CA--C 1.538 0.507 0 O-C-N 123.83 0.706 . . . . 74.53 111.525 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.534 HD12 ' O ' ' A' ' 18' ' ' GLN . 0.6 OUTLIER -104.05 85.83 1.14 Allowed Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 110.012 -0.366 . . . . 71.14 110.012 -178.119 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.549 ' HB2' HD12 ' A' ' 29' ' ' LEU . 61.4 Cg_endo -73.37 -29.79 10.89 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.282 1.988 . . . . 72.41 112.77 -175.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.88 28.77 64.16 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.909 -0.587 . . . . 71.33 113.032 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.549 HD12 ' HB2' ' A' ' 27' ' ' PRO . 1.6 mp -127.37 79.34 73.41 Favored Pre-proline 0 C--N 1.331 -0.206 0 O-C-N 122.358 -0.496 . . . . 43.45 111.785 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.404 ' HD2' HD12 ' A' ' 31' ' ' LEU . 91.2 Cg_endo -87.13 5.98 5.48 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.394 2.063 . . . . 64.5 111.541 171.094 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.404 HD12 ' HD2' ' A' ' 30' ' ' PRO . 7.5 mp -85.1 -0.17 53.64 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.609 -0.723 . . . . 64.44 111.85 -176.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.457 HD13 HD12 ' A' ' 36' ' ' LEU . 3.7 mm? -76.72 8.94 3.14 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.951 0.352 . . . . 52.21 111.951 -175.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 15.0 tmm? -61.52 -33.79 74.42 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.161 -0.472 . . . . 74.4 110.761 177.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.7 p -76.65 158.2 31.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.126 -0.488 . . . . 51.34 110.771 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -67.5 97.08 0.56 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.922 0.391 . . . . 72.4 111.228 -174.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.457 HD12 HD13 ' A' ' 32' ' ' LEU . 96.4 mt -131.41 -154.59 0.64 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.858 -0.61 . . . . 74.44 109.908 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -95.9 166.12 11.94 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.858 0.361 . . . . 73.34 110.22 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.7 m -74.85 95.47 2.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.929 -0.578 . . . . 61.55 111.773 -174.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 m -143.61 116.89 3.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.524 -0.307 . . . . 75.01 110.658 175.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 64.65 -163.91 0.25 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.991 -0.55 . . . . 61.12 111.848 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.9 t -62.6 137.95 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 115.936 -0.575 . . . . 54.13 110.715 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.0 tp -85.33 -81.11 0.2 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.842 -0.617 . . . . 61.11 112.248 -172.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.465 ' H ' ' HB2' ' A' ' 47' ' ' SER . 6.0 m-20 -66.75 -52.57 42.78 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.92 0.711 . . . . 64.44 112.92 -168.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -177.02 -77.3 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.807 0.337 . . . . 73.44 110.633 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.927 ' HB2' HD22 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -101.0 -28.31 12.81 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 120.91 0.386 . . . . 62.14 111.037 176.308 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.866 ' HG2' ' HB2' ' A' ' 66' ' ' LEU . 18.6 mmm180 -117.01 -169.95 1.74 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.873 -0.417 . . . . 72.4 109.873 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.465 ' HB2' ' H ' ' A' ' 43' ' ' ASP . 21.6 m 66.49 101.95 0.04 OUTLIER 'General case' 0 C--O 1.233 0.192 0 O-C-N 124.021 0.826 . . . . 75.44 110.696 -175.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.459 ' C ' ' H ' ' A' ' 50' ' ' THR . 46.5 mtm180 -71.23 -171.86 0.64 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.632 -0.713 . . . . 64.11 110.664 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 45.0 p90 -76.38 25.1 0.13 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.9 -0.591 . . . . 73.5 110.856 178.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.459 ' H ' ' C ' ' A' ' 48' ' ' ARG . 3.9 m -60.51 -72.32 0.11 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.745 -0.661 . . . . 61.34 110.598 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.7 t 52.84 26.76 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.935 0.874 . . . . 72.1 110.676 178.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.86 23.29 14.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.472 -0.786 . . . . 63.55 109.167 -177.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.563 ' HB1' ' HB3' ' A' ' 59' ' ' ALA . . . -167.78 144.3 3.46 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.114 -0.948 . . . . 74.22 109.486 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.515 ' O ' ' HA3' ' A' ' 58' ' ' GLY . 33.6 Cg_endo -68.83 114.33 3.51 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.03 1.82 . . . . 75.34 111.398 174.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 67.01 144.21 0.09 OUTLIER Pre-proline 0 N--CA 1.468 0.451 0 O-C-N 124.116 0.885 . . . . 72.55 111.392 -175.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.568 ' HG2' HD12 ' A' ' 57' ' ' LEU . 6.2 Cg_endo -52.91 -48.59 21.3 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.026 2.484 . . . . 75.14 112.536 179.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.767 HD12 ' H ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -90.14 0.84 56.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.075 0.464 . . . . 65.4 110.138 -176.355 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 54' ' ' PRO . . . -72.84 -18.75 79.07 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.853 -0.612 . . . . 53.01 113.688 -172.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.563 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . . . -154.89 -45.8 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.309 0.555 . . . . 42.14 112.105 -178.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.569 HG22 ' H ' ' A' ' 62' ' ' TRP . 5.7 p -93.68 117.53 37.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.388 0.613 . . . . 63.01 111.282 -176.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.1 m -79.1 -4.3 49.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.934 -0.576 . . . . 65.54 111.02 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.569 ' H ' HG22 ' A' ' 60' ' ' VAL . 19.0 m95 -90.93 -5.43 55.48 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.014 -0.539 . . . . 71.43 111.672 -177.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.749 ' O ' ' HG ' ' A' ' 80' ' ' LEU . 9.9 tp10 -85.27 167.0 16.03 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.879 -0.786 . . . . 73.24 108.879 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -120.62 139.48 52.93 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.823 -0.351 . . . . 61.14 111.203 -177.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.55 ' CG ' HD11 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -106.64 158.28 17.07 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.498 -0.556 . . . . 61.41 109.498 173.554 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.927 HD22 ' HB2' ' A' ' 45' ' ' LYS . 26.3 tp -109.64 141.45 42.17 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.359 -0.238 . . . . 62.03 110.359 -176.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.0 t -107.81 -6.98 16.45 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 120.861 -0.336 . . . . 64.44 111.708 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.673 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -153.98 124.82 7.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.654 0.264 . . . . 72.11 110.831 177.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.673 ' HB3' HD23 ' A' ' 66' ' ' LEU . 2.4 p30 -136.32 43.46 2.48 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.796 -0.638 . . . . 74.21 110.878 -176.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.476 ' HB2' ' H ' ' A' ' 74' ' ' ARG . 26.1 mm-40 -57.81 143.22 77.21 Favored Pre-proline 0 C--O 1.234 0.252 0 CA-C-N 116.173 -0.467 . . . . 74.1 110.412 -178.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.96 92.97 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.219 2.613 . . . . 75.32 113.208 -172.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 58.75 34.24 76.45 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.477 -0.783 . . . . 61.32 112.979 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 92' ' ' LEU . 92.0 mttt -129.1 -85.71 0.55 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.953 0.353 . . . . 74.02 111.953 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.79 ' HB2' ' HG ' ' A' ' 92' ' ' LEU . 31.8 ttt180 -118.23 113.78 22.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.412 0.625 . . . . 74.12 111.197 -173.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.48 HD13 ' HE2' ' A' ' 93' ' ' PHE . 3.8 mp -117.05 121.87 68.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.089 -0.959 . . . . 71.32 109.515 178.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.673 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -109.71 116.28 31.42 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.473 -0.566 . . . . 60.12 109.473 176.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.534 ' CZ2' ' HA3' ' A' ' 89' ' ' GLY . 31.4 p90 -87.85 141.33 28.67 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.626 0.727 . . . . 62.52 111.306 -173.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.49 ' HA ' ' NE ' ' A' ' 78' ' ' ARG . 0.5 OUTLIER -137.57 175.36 9.66 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.03 -0.986 . . . . 65.1 110.148 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.2 p -144.7 164.93 29.5 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.81 -0.811 . . . . 63.34 108.81 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.749 ' HG ' ' O ' ' A' ' 63' ' ' GLU . 14.3 mt -77.86 149.27 77.0 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.913 -0.403 . . . . 65.42 109.913 -177.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.12 -27.23 54.61 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.945 2.43 . . . . 74.34 112.791 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.75 0.72 82.91 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.902 -0.666 . . . . 65.22 113.189 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.63 159.4 20.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.047 0.423 . . . . 64.31 110.927 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -98.35 13.06 32.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.019 0.438 . . . . 65.13 110.769 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.432 HD12 ' N ' ' A' ' 85' ' ' ILE . 4.2 mp -99.44 80.14 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.573 -0.529 . . . . 64.24 109.573 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.675 ' HB3' ' HD2' ' A' ' 111' ' ' ARG . 35.8 tt0 -81.36 91.93 6.33 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.588 -0.523 . . . . 73.05 109.588 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -148.71 139.88 23.17 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.495 -0.775 . . . . 62.52 109.883 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.8 m -124.69 128.65 49.14 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.842 -0.799 . . . . 44.22 108.842 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.534 ' HA3' ' CZ2' ' A' ' 77' ' ' TRP . . . -155.69 174.0 33.73 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.014 -1.088 . . . . 71.43 112.89 -175.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -163.15 128.96 3.21 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.462 -0.57 . . . . 71.23 109.462 -175.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.788 ' HB ' HG12 ' A' ' 106' ' ' VAL . 2.5 p -122.58 120.9 62.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.159 0.504 . . . . 74.42 111.688 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.79 ' HG ' ' HB2' ' A' ' 74' ' ' ARG . 8.0 mp -110.97 122.63 48.36 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.83 -0.623 . . . . 75.2 110.087 173.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.48 ' HE2' HD13 ' A' ' 75' ' ' ILE . 79.1 m-85 -87.28 126.71 35.0 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.847 0.355 . . . . 74.33 110.556 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.69 144.06 49.79 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.351 -0.386 . . . . 75.22 110.375 177.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.46 131.12 30.56 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.56 2.173 . . . . 73.51 111.196 176.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.08 143.53 57.2 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.582 -0.281 . . . . 50.54 110.73 -177.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.88 141.97 96.18 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 123.131 2.554 . . . . 72.14 112.572 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.79 20.38 79.51 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.878 -0.601 . . . . 72.44 112.109 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 52.84 36.71 22.2 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 121.021 0.439 . . . . 72.35 110.893 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 -72.57 -18.88 61.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.789 -0.642 . . . . 73.11 110.94 -176.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 146.2 -143.05 11.1 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.978 -0.849 . . . . 61.42 110.978 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.6 m -123.83 131.35 53.57 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.123 0.487 . . . . 42.41 110.1 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.643 ' HG2' ' HB1' ' A' ' 9' ' ' ALA . 31.8 tt0 -99.64 121.41 41.18 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.832 -0.622 . . . . 44.2 110.105 -178.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.513 HG23 ' CG2' ' A' ' 91' ' ' VAL . 2.3 p -98.04 112.13 29.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.432 -0.804 . . . . 53.12 110.932 -178.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 92' ' ' LEU . 11.1 p -101.81 120.66 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-O 121.33 0.586 . . . . 73.41 109.786 177.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.788 HG12 ' HB ' ' A' ' 91' ' ' VAL . 30.3 m -123.77 147.1 28.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.945 -0.57 . . . . 70.41 111.596 -175.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -100.55 116.88 33.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.318 -0.855 . . . . 73.51 109.898 170.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.3 tt -113.06 120.59 41.86 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.018 -0.734 . . . . 74.43 109.018 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 25.1 m -109.71 133.12 53.49 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.252 -0.431 . . . . 63.3 111.099 -176.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -97.77 161.65 13.65 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.845 -0.798 . . . . 75.44 108.845 176.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.675 ' HD2' ' HB3' ' A' ' 86' ' ' GLU . 1.9 ptm180 -133.88 154.79 80.57 Favored Pre-proline 0 C--N 1.31 -1.115 0 CA-C-N 116.215 -0.448 . . . . 72.15 110.161 -174.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.52 152.9 80.46 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.344 2.029 . . . . 72.25 112.165 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 118' ' ' GLY . 41.8 Cg_endo -71.31 108.06 2.27 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.495 2.13 . . . . 72.0 112.134 177.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -127.51 104.89 0.71 Allowed Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 111.094 -0.802 . . . . 62.44 111.094 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.18 -168.5 28.54 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.246 -0.741 . . . . 62.2 111.246 -176.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.3 t -85.89 -40.44 15.93 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 117.233 0.516 . . . . 62.53 110.174 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.405 ' O ' HG12 ' A' ' 120' ' ' VAL . . . -73.0 -30.54 63.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.341 0.591 . . . . 74.51 110.126 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.496 ' O ' HG22 ' A' ' 121' ' ' ILE . . . -81.57 -19.92 65.09 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.337 -0.847 . . . . 64.31 113.043 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -79.44 -22.38 44.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 117.089 0.444 . . . . 75.51 112.094 -176.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 117' ' ' ALA . 7.0 p -64.96 -27.08 41.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.693 -0.23 . . . . 55.42 111.514 -174.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.496 HG22 ' O ' ' A' ' 118' ' ' GLY . 10.6 tp -65.45 -29.79 48.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.638 0.256 . . . . 74.33 110.727 -177.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.98 -23.15 59.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 65.05 110.922 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.4 -29.27 19.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.304 0.573 . . . . 73.53 109.608 176.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 28.0 ttt -71.37 -53.6 13.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.815 -0.63 . . . . 60.15 109.669 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -135.59 105.41 6.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.756 -0.656 . . . . 74.4 109.586 175.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -83.34 72.79 10.19 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.347 -0.612 . . . . 54.32 109.347 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 70.73 -50.51 0.67 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 114.888 -1.051 . . . . 71.22 110.561 -174.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 60.09 71.62 0.86 Allowed Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 123.977 0.911 . . . . 65.34 111.821 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -91.54 62.73 1.09 Allowed 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 122.708 2.272 . . . . 74.14 111.086 175.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 49.2 m -112.0 32.19 5.68 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.512 -0.767 . . . . 54.41 110.219 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 66.1 -165.06 0.23 Allowed 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.491 -0.777 . . . . 74.35 111.13 -177.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -61.3 134.39 56.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.679 -0.691 . . . . 75.53 110.718 178.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.6 mp -91.89 29.04 1.65 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.9 -0.591 . . . . 73.12 110.694 -175.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -54.89 -38.74 67.95 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.717 0.636 . . . . 73.15 112.717 -174.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -71.83 -37.64 70.28 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.48 -0.488 . . . . 72.44 111.037 -177.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -74.84 -38.29 62.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.243 0.544 . . . . 74.53 110.168 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.589 ' CD2' ' HB3' ' A' ' 8' ' ' ASP . 24.4 tp -66.59 -24.38 66.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.567 -0.742 . . . . 73.4 109.523 178.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.479 ' O ' ' HB3' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -62.64 -29.71 70.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.749 -0.66 . . . . 62.43 110.307 176.679 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -69.01 -43.42 74.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.889 -0.596 . . . . 75.44 110.149 176.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.525 ' O ' ' HG3' ' A' ' 144' ' ' GLN . 18.2 t80 -60.74 -37.96 83.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.876 -0.602 . . . . 65.35 109.9 174.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.801 ' HG2' HG13 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -53.64 -41.93 67.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.778 -0.647 . . . . 73.31 110.52 176.074 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -63.52 -31.36 72.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.879 -0.6 . . . . 64.43 110.436 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -79.17 -27.89 42.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.662 -0.699 . . . . 70.13 110.949 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.837 ' HG2' HG21 ' A' ' 22' ' ' VAL . 46.8 mt-30 -69.69 -40.61 76.24 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.069 0.461 . . . . 72.21 110.676 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.667 ' HB3' HG23 ' A' ' 12' ' ' ILE . 16.5 pt-20 -78.0 -13.63 59.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.926 -0.579 . . . . 63.31 110.4 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 58.4 tp -91.0 -61.58 1.64 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.818 -0.628 . . . . 75.52 110.88 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 74.4 110.72 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 110.97 -0.852 . . . . 71.23 110.97 -172.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.2 tt -145.43 134.32 22.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.114 0.483 . . . . 64.34 111.989 -171.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -122.52 177.06 5.58 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.368 -0.975 . . . . 74.41 108.368 168.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -114.2 -42.34 3.36 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 119.642 -0.823 . . . . 75.33 111.79 -174.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -169.59 150.08 4.03 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.961 -0.385 . . . . 75.0 109.961 176.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -153.98 135.17 14.02 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.166 -0.47 . . . . 63.34 110.382 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -87.77 166.26 14.75 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.187 -0.46 . . . . 75.44 110.513 -177.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -97.37 -175.25 3.16 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.261 -0.644 . . . . 74.34 109.261 175.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 59.8 m80 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.198 -0.906 . . . . 60.43 109.877 177.525 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 110.151 -0.314 . . . . 72.43 110.151 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -80.13 -59.2 2.62 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.698 -0.763 . . . . 73.24 111.555 177.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -84.66 -172.72 4.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.92 0.391 . . . . 51.15 110.044 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.491 HG23 ' HA ' ' A' ' 131' ' ' GLN . 11.3 m -118.36 121.45 40.4 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.69 -0.485 . . . . 52.14 109.69 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.678 HG13 ' CB ' ' A' ' 108' ' ' LEU . 77.4 t -107.87 110.39 31.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 116.345 -0.389 . . . . 74.35 110.05 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.8 m -146.68 151.3 14.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.926 -0.579 . . . . 73.41 110.15 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.46 109.79 22.28 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.204 -0.665 . . . . 64.25 109.204 173.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.443 ' HB3' HD23 ' A' ' 137' ' ' LEU . 2.6 t70 -157.36 174.27 15.68 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.105 -0.331 . . . . 74.33 110.105 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.481 ' HB2' HG22 ' A' ' 105' ' ' VAL . . . -131.43 131.5 43.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.242 -0.436 . . . . 73.54 110.848 -174.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.542 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 16.4 m -116.66 137.37 50.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.035 0.445 . . . . 62.4 110.663 177.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.1 m -83.65 105.14 14.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.935 -0.575 . . . . 54.24 110.222 -178.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.535 HD12 ' HB2' ' A' ' 144' ' ' GLN . 24.6 mm -114.3 149.93 16.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.727 0.299 . . . . 54.45 111.078 -177.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.76 25.68 8.26 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 121.159 -0.543 . . . . 75.34 112.67 177.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -98.4 145.65 30.23 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 108.764 -0.828 . . . . 70.23 108.764 176.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -59.0 -58.58 0.63 Allowed 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 121.946 1.764 . . . . 53.11 112.914 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 173.48 -43.55 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.097 0.559 . . . . 72.4 109.824 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.627 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 25.3 tt0 -48.3 -51.24 26.81 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 114.876 -1.057 . . . . 75.52 111.756 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -78.56 -11.09 59.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.611 -0.722 . . . . 63.21 111.504 -174.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.2 mt -83.66 -47.88 10.76 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.611 -0.268 . . . . 75.25 111.544 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.627 ' CE2' ' HA ' ' A' ' 17' ' ' GLU . 18.7 p90 -71.65 -24.37 61.84 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.383 -0.527 . . . . 74.01 110.811 -177.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.36 -13.36 61.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.974 -0.557 . . . . 51.45 111.495 -177.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.558 HG21 ' CZ ' ' A' ' 140' ' ' PHE . 6.1 p -57.01 -21.81 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 111.892 0.331 . . . . 72.52 111.892 -174.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -54.26 -31.81 54.57 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.139 -0.482 . . . . 71.22 110.696 177.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.64 ' NE ' ' HA ' ' A' ' 24' ' ' ARG . 4.7 tpm_? -135.42 32.33 3.09 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.425 -0.583 . . . . 64.21 109.425 176.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.691 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 29.2 t70 65.26 169.21 0.2 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.027 -0.988 . . . . 50.2 111.441 -177.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.57 86.84 2.39 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 121.034 0.445 . . . . 74.25 112.037 -176.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.691 ' HD3' ' O ' ' A' ' 25' ' ' ASP . 3.5 Cg_endo -86.32 -170.74 0.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.339 2.693 . . . . 74.11 112.233 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.55 92.8 0.61 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.983 -0.627 . . . . 74.43 112.573 -178.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.659 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -139.3 57.02 9.61 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 112.092 0.404 . . . . 62.12 112.092 175.978 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' A' ' 29' ' ' LEU . 2.9 Cg_exo -75.76 -10.98 20.16 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.416 2.077 . . . . 61.42 110.95 177.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 31' ' ' LEU . 4.0 mp -113.91 -65.69 1.16 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.291 -0.868 . . . . 75.21 108.825 176.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.659 ' HB2' ' HB2' ' A' ' 29' ' ' LEU . 30.6 tp 57.78 87.89 0.06 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.409 -0.814 . . . . 71.25 112.256 173.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 55.3 mtt -140.3 110.64 6.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.883 -0.599 . . . . 73.5 110.412 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.6 t -156.45 144.87 19.86 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.025 -0.361 . . . . 72.5 110.025 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 63.52 96.16 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.888 0.743 . . . . 63.51 110.426 -177.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.6 mp -65.06 102.05 0.58 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.886 -0.597 . . . . 74.44 112.449 -171.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 176.79 -41.54 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.676 -1.147 . . . . 75.35 108.229 175.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.5 m -172.03 -174.25 1.26 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 107.74 -1.207 . . . . 43.33 107.74 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 90.5 t -72.44 -16.15 18.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.878 -0.786 . . . . 63.24 108.878 167.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 75.44 13.22 3.08 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.295 -1.32 . . . . 75.12 109.881 -177.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.1 t -142.98 106.65 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 113.58 -1.645 . . . . 64.14 107.409 170.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.477 HD22 ' H ' ' A' ' 42' ' ' LEU . 2.9 mm? -63.16 -72.21 0.14 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.52 -0.764 . . . . 75.0 110.089 -175.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.537 ' HA ' ' HB2' ' A' ' 47' ' ' SER . 39.0 t70 60.65 129.02 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 122.7 1.238 . . . . 72.23 113.554 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.404 ' OD2' ' HG2' ' A' ' 45' ' ' LYS . 35.0 t70 173.38 -74.29 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 112.827 -1.988 . . . . 74.32 108.193 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.404 ' HG2' ' OD2' ' A' ' 44' ' ' ASP . 31.1 mmmt -103.4 -43.35 5.44 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.233 -0.894 . . . . 73.34 108.628 170.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.925 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 20.4 ptt180 -100.09 -172.78 2.28 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.303 -0.862 . . . . 72.15 110.728 177.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.537 ' HB2' ' HA ' ' A' ' 43' ' ' ASP . 17.9 m 69.35 -81.58 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.873 0.733 . . . . 72.25 110.593 -176.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.692 ' HD2' HD13 ' A' ' 66' ' ' LEU . 3.3 mmp_? 57.81 78.87 0.22 Allowed 'General case' 0 C--O 1.234 0.27 0 O-C-N 123.583 0.552 . . . . 61.14 112.095 177.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 6.3 m0 62.44 -165.24 0.24 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.168 -0.923 . . . . 73.02 111.761 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 21.9 m 60.61 89.95 0.07 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.62 -0.718 . . . . 54.53 111.45 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.5 t -81.22 -20.32 11.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.762 -0.654 . . . . 72.33 109.925 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -81.7 75.19 8.66 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.459 -0.791 . . . . 74.31 109.653 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 71.04 142.92 0.09 OUTLIER Pre-proline 0 N--CA 1.465 0.317 0 O-C-N 124.356 1.035 . . . . 54.51 110.391 -173.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.63 123.26 5.82 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.992 1.795 . . . . 61.33 112.75 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -120.79 84.0 37.19 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.968 -0.56 . . . . 62.43 110.922 176.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.546 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 6.5 Cg_exo -76.66 -50.08 0.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.843 2.362 . . . . 73.21 111.167 176.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 79' ' ' SER . 0.2 OUTLIER -122.58 41.15 3.5 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.496 -1.229 . . . . 72.43 110.153 177.925 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.58 -79.85 1.88 Allowed Glycine 0 C--N 1.31 -0.889 0 CA-C-N 114.446 -1.252 . . . . 71.02 111.786 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -163.96 99.29 0.86 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.809 0.338 . . . . 72.13 111.041 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.466 HG23 HD13 ' A' ' 57' ' ' LEU . 58.9 t -139.25 -87.89 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.266 -0.642 . . . . 52.14 109.266 173.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.7 m 174.5 21.37 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.202 1.001 . . . . 73.12 109.5 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.45 ' HB2' HD21 ' A' ' 57' ' ' LEU . 1.0 OUTLIER -122.95 -166.02 1.39 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.458 0.647 . . . . 71.21 112.523 -170.498 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.475 ' HG2' ' HD3' ' A' ' 46' ' ' ARG . 52.3 mt-10 -94.52 169.27 10.31 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.589 -1.187 . . . . 74.41 111.414 -175.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.925 ' HB3' ' HA ' ' A' ' 46' ' ' ARG . . . -103.97 155.28 18.78 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.819 -0.808 . . . . 64.11 108.819 169.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.485 ' HB2' HD23 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -121.31 134.83 55.16 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.197 -1.038 . . . . 74.21 108.197 179.076 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.692 HD13 ' HD2' ' A' ' 48' ' ' ARG . 30.9 tp -113.58 127.51 56.09 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.921 -0.312 . . . . 52.55 110.342 -170.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.0 p -92.4 -25.01 18.68 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.198 0.523 . . . . 61.45 111.119 -176.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.694 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -140.39 128.69 22.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.953 -0.567 . . . . 72.12 111.637 -177.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -130.19 26.47 5.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.352 -0.84 . . . . 74.0 110.189 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.818 ' HB3' ' HB3' ' A' ' 73' ' ' LYS . 6.0 mm-40 -62.63 141.79 96.87 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.805 -0.634 . . . . 64.44 110.673 -177.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 3.0 Cg_exo -76.45 95.89 1.06 Allowed 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 123.04 2.493 . . . . 55.35 112.026 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.74 21.04 62.58 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-N 116.064 -0.516 . . . . 41.4 112.742 178.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.818 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 1.3 tmtp? -109.76 -57.93 2.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.893 0.378 . . . . 75.12 109.985 -176.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.846 ' HG3' ' HG ' ' A' ' 92' ' ' LEU . 40.5 ttp180 -155.97 111.63 3.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.12 -0.491 . . . . 73.4 109.832 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.424 ' N ' HD12 ' A' ' 75' ' ' ILE . 3.8 mp -109.27 110.52 32.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.504 -0.554 . . . . 73.51 109.504 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.694 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -119.21 115.4 24.13 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.104 -0.498 . . . . 34.24 109.861 177.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.456 ' HZ3' HG12 ' A' ' 91' ' ' VAL . 39.9 p90 -105.3 135.98 45.67 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.697 -0.683 . . . . 64.35 109.914 -177.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.5 mmt85 -142.42 174.02 11.0 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.308 -0.86 . . . . 70.4 108.861 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.5 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 30.1 p -98.8 -163.44 1.04 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.82 -0.807 . . . . 74.43 108.82 171.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.485 HD23 ' HB2' ' A' ' 65' ' ' GLU . 14.6 mt -71.98 142.93 85.86 Favored Pre-proline 0 C--N 1.321 -0.662 0 C-N-CA 120.277 -0.569 . . . . 74.31 109.784 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -63.11 -20.31 70.86 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 123.158 2.572 . . . . 54.14 113.047 -174.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.56 16.35 34.41 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.895 -0.669 . . . . 74.13 112.55 178.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -123.25 176.79 5.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.914 0.387 . . . . 73.44 111.133 -177.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -63.15 137.32 58.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.718 -0.674 . . . . 64.45 109.912 175.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.406 ' HA ' ' OG ' ' A' ' 79' ' ' SER . 19.6 tt -115.82 -27.18 2.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.962 -0.295 . . . . 52.0 111.493 -176.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 66.41 -81.73 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 122.962 0.505 . . . . 74.33 111.81 178.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -133.24 132.42 41.43 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.747 -0.464 . . . . 72.14 109.747 -177.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.8 m -96.82 128.03 43.38 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.716 0.293 . . . . 73.12 110.45 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -125.63 144.48 15.15 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.997 -0.62 . . . . 71.12 111.712 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.411 ' HG2' ' HB3' ' A' ' 107' ' ' ARG . 9.2 pt-20 -156.64 133.17 10.06 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.133 -0.321 . . . . 74.53 110.133 177.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.474 ' CG2' HG23 ' A' ' 104' ' ' VAL . 2.4 p -124.41 118.47 53.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.329 0.585 . . . . 75.42 111.497 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.846 ' HG ' ' HG3' ' A' ' 74' ' ' ARG . 2.9 mp -108.14 126.91 53.32 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.973 -0.751 . . . . 72.13 108.973 174.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.514 ' HZ ' ' HB3' ' A' ' 20' ' ' TYR . 85.2 m-85 -91.46 120.95 32.74 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.046 0.45 . . . . 64.25 110.426 -178.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.409 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 2.0 mmp_? -110.5 143.94 29.16 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.821 -0.627 . . . . 72.21 109.912 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 94' ' ' ARG . 32.3 Cg_exo -59.64 116.69 3.46 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.298 1.998 . . . . 74.53 111.258 177.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . . . -63.44 144.21 97.68 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.409 . . . . 65.24 111.715 -174.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 96' ' ' ALA . 50.6 Cg_exo -54.65 130.68 41.59 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.978 2.452 . . . . 74.44 111.73 176.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.53 7.05 88.95 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.801 -0.714 . . . . 51.22 112.186 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 60.67 28.14 17.86 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.682 0.393 . . . . 72.15 111.591 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 66.2 mtt180 -89.29 14.53 10.84 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.173 0.435 . . . . 73.34 112.173 -176.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.97 -137.44 6.51 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.723 -0.751 . . . . 53.01 112.125 176.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 40.6 m -136.75 130.36 31.87 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.912 0.387 . . . . 74.31 110.098 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -91.32 115.68 28.22 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.315 0.579 . . . . 74.15 109.625 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.474 HG23 ' CG2' ' A' ' 91' ' ' VAL . 2.1 p -88.29 112.0 23.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.439 -0.8 . . . . 73.13 110.916 -176.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.481 HG22 ' HB2' ' A' ' 9' ' ' ALA . 23.9 t -100.27 110.44 27.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.277 -0.874 . . . . 53.15 109.748 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.406 HG23 HG22 ' A' ' 104' ' ' VAL . 12.2 t -118.62 127.85 75.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.067 0.46 . . . . 62.32 111.111 -177.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 107' ' ' ARG . 51.3 ttt-85 -106.73 122.39 46.27 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.012 -0.54 . . . . 74.42 110.178 176.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.678 ' CB ' HG13 ' A' ' 5' ' ' VAL . 4.6 mp -122.3 154.39 37.66 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.57 -0.53 . . . . 70.32 109.57 177.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.577 ' O ' HG11 ' A' ' 5' ' ' VAL . 6.2 m -84.75 119.33 25.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.789 0.328 . . . . 62.41 111.602 -177.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -125.82 120.99 32.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.453 0.644 . . . . 71.22 111.386 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -139.82 161.52 55.76 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.168 -0.924 . . . . 75.53 109.115 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -57.16 153.93 36.68 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.219 1.946 . . . . 55.43 111.184 171.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.607 ' O ' ' HB3' ' A' ' 117' ' ' ALA . 43.0 Cg_endo -69.41 85.93 0.55 Allowed 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.512 2.141 . . . . 62.24 113.844 -174.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 70.17 -5.54 6.53 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 114.875 0.71 . . . . 74.13 114.875 168.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.41 -76.01 1.73 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.968 -0.634 . . . . 75.11 112.282 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.3 m -72.23 -15.54 61.93 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.047 0.451 . . . . 65.32 111.42 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 113' ' ' PRO . . . -72.87 -19.9 61.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 61.2 110.973 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.557 ' HA2' HG22 ' A' ' 121' ' ' ILE . . . -55.92 -39.03 77.17 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 121.385 -0.436 . . . . 73.04 112.91 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.56 -29.34 70.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.127 0.489 . . . . 74.54 111.009 176.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 57.9 t -80.14 -46.81 21.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.829 -0.623 . . . . 53.35 110.614 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.557 HG22 ' HA2' ' A' ' 118' ' ' GLY . 15.5 tt -65.26 -21.69 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 116.271 -0.422 . . . . 72.22 110.925 -177.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.05 -25.25 63.57 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.503 -0.317 . . . . 61.53 111.131 176.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.442 ' C ' ' HD3' ' A' ' 123' ' ' ARG . 0.0 OUTLIER -74.95 -39.24 61.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.159 0.504 . . . . 71.13 110.094 175.967 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.416 ' O ' ' HB2' ' A' ' 125' ' ' PHE . 17.1 tpt -73.05 -31.18 64.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.054 -0.521 . . . . 74.52 111.063 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.416 ' HB2' ' O ' ' A' ' 124' ' ' MET . 90.7 m-85 71.79 -71.62 0.13 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.521 -0.763 . . . . 64.43 111.035 -177.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 62.2 t30 59.69 -164.99 0.21 Allowed 'General case' 0 CA--C 1.535 0.366 0 O-C-N 123.454 0.471 . . . . 72.0 109.972 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -98.78 -67.33 0.85 Allowed 'General case' 0 C--N 1.324 -0.533 0 O-C-N 122.005 -0.434 . . . . 73.41 110.864 175.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 51.71 64.41 7.85 Favored Pre-proline 0 CA--C 1.531 0.24 0 O-C-N 123.802 0.689 . . . . 70.13 109.858 -172.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -66.23 -37.35 24.98 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.697 2.265 . . . . 62.43 112.172 -174.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 48.0 t -178.62 -61.68 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.86 -0.792 . . . . 73.12 108.86 -178.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.491 ' HA ' HG23 ' A' ' 4' ' ' THR . 83.0 mt-30 60.1 17.21 6.59 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.301 -0.863 . . . . 74.31 111.555 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -130.39 58.51 1.67 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.339 -0.985 . . . . 63.22 108.339 172.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.549 ' HG ' ' H ' ' A' ' 135' ' ' ASP . 2.0 pt? -156.0 -176.42 5.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.338 -0.846 . . . . 63.41 109.938 -174.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -112.92 14.89 19.82 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.391 0.145 . . . . 64.01 111.391 -175.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.549 ' H ' ' HG ' ' A' ' 133' ' ' LEU . 34.9 t70 -57.41 -56.07 26.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.803 0.335 . . . . 63.2 111.82 -174.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -74.93 -32.53 61.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.399 -0.364 . . . . 64.41 110.994 -176.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.542 ' HG ' ' CG1' ' A' ' 10' ' ' VAL . 20.6 tp -70.58 -24.74 62.82 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.243 -0.435 . . . . 73.45 109.972 -177.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.43 ' HA ' ' CE ' ' A' ' 138' ' ' MET . 0.0 OUTLIER -68.76 -45.78 70.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.152 -0.476 . . . . 72.51 110.199 177.636 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 71.0 mtm-85 -67.13 -37.89 84.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 71.23 110.171 177.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.558 ' CZ ' HG21 ' A' ' 22' ' ' VAL . 84.0 t80 -57.03 -42.45 80.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.457 -0.792 . . . . 75.42 110.586 174.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.505 ' HG3' HD13 ' A' ' 12' ' ' ILE . 26.0 ttpp -57.19 -46.85 82.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 62.54 110.726 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -60.66 -41.7 95.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.53 -0.759 . . . . 65.25 112.341 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -79.31 -24.68 42.67 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.554 -0.459 . . . . 73.33 110.937 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.535 ' HB2' HD12 ' A' ' 12' ' ' ILE . 8.1 mm-40 -71.83 -49.74 35.72 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.794 0.331 . . . . 74.13 110.958 175.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 13.4 pt-20 -67.9 -30.77 70.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.217 -0.447 . . . . 73.24 110.331 -177.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 48.7 tp -71.17 -41.32 70.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.773 -0.649 . . . . 74.41 109.658 174.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 148' ' ' LEU . . . 67.99 46.32 67.05 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.567 -0.742 . . . . 71.45 111.344 -177.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.403 ' HB3' ' O ' ' A' ' 147' ' ' GLY . 46.1 tp 71.04 156.93 0.16 Allowed 'General case' 0 N--CA 1.463 0.202 0 O-C-N 124.206 0.592 . . . . 70.22 109.449 -171.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -74.78 75.52 2.1 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.363 0.602 . . . . 75.1 110.556 -177.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -121.64 1.18 10.0 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.642 -0.708 . . . . 73.21 109.954 178.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -154.48 137.84 15.81 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.699 -0.852 . . . . 54.33 108.699 -177.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 47.4 p-80 -104.6 139.9 38.8 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.581 -0.448 . . . . 74.03 110.638 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -71.06 -44.89 64.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.766 -0.652 . . . . 71.1 109.865 -177.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 179.12 -67.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.759 -1.11 . . . . 75.22 108.619 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.349 -0.834 . . . . 73.0 109.344 176.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.5 ttm . . . . . 0 N--CA 1.477 0.904 0 CA-C-O 120.795 0.331 . . . . 72.12 111.115 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.65 1.83 79.93 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.557 -0.83 . . . . 74.55 113.688 172.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.553 ' HA ' ' HG2' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -104.06 178.59 4.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 117.386 0.593 . . . . 71.44 110.309 179.459 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.4 m -146.05 120.48 9.67 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.119 -0.696 . . . . 53.45 109.119 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.846 HG22 HG22 ' A' ' 109' ' ' THR . 69.0 t -92.32 98.66 8.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.298 -0.63 . . . . 55.41 109.298 176.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.4 m -95.73 145.52 8.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.783 -0.644 . . . . 74.43 111.103 -174.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.489 ' HD2' ' O ' ' A' ' 7' ' ' ARG . 4.5 ppt_? -141.64 108.98 5.54 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.434 -0.803 . . . . 61.11 109.069 175.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -142.09 161.84 36.97 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.039 -0.726 . . . . 73.12 109.039 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.658 ' HB2' HG22 ' A' ' 105' ' ' VAL . . . -140.39 130.17 24.45 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.128 0.49 . . . . 71.51 111.969 -170.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.484 HG23 HD11 ' A' ' 12' ' ' ILE . 15.8 m -113.28 145.75 18.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.486 -0.779 . . . . 61.22 110.255 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 102' ' ' THR . 20.4 m -107.15 109.6 21.47 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.782 0.325 . . . . 64.32 111.067 -178.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.844 HG13 ' HG2' ' A' ' 141' ' ' LYS . 4.1 mp -98.82 147.97 6.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.26 -0.427 . . . . 73.41 109.883 -177.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.38 58.27 4.41 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.994 -0.622 . . . . 54.34 112.709 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.643 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 8.2 mmpt? -129.8 167.01 22.04 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 108.555 -0.905 . . . . 61.22 108.555 177.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 14' ' ' LYS . 27.5 Cg_endo -65.22 -58.35 0.21 Allowed 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 121.309 1.339 . . . . 75.25 112.306 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . 171.69 -55.73 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.622 0.725 . . . . 60.02 110.266 174.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -55.09 -51.82 65.17 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.46 -1.245 . . . . 74.4 112.848 -173.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -54.07 -27.11 30.51 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.154 0.427 . . . . 75.15 112.154 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.487 ' CD1' ' HB ' ' A' ' 102' ' ' THR . 56.2 mt -69.32 -20.41 63.87 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.167 0.432 . . . . 64.22 112.167 -175.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.454 ' CE1' HG21 ' A' ' 75' ' ' ILE . 46.3 t80 -72.0 -25.27 61.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.099 0.475 . . . . 73.43 110.65 175.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.6 -12.98 60.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.364 -0.38 . . . . 73.34 111.411 -176.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.4 p -53.95 -24.04 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 112.626 0.602 . . . . 64.33 112.626 -174.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.418 ' HD1' ' O ' ' A' ' 20' ' ' TYR . 98.1 m95 -57.69 -24.34 56.25 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.18 0.437 . . . . 74.35 112.18 -176.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.448 ' HA ' ' HD2' ' A' ' 24' ' ' ARG . 7.5 tpt180 -156.33 59.28 0.57 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.792 0.33 . . . . 71.33 110.582 175.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.709 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 18.3 t70 65.24 168.82 0.19 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.571 -0.74 . . . . 73.33 111.227 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.5 mt -102.29 87.8 1.2 Allowed Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.714 -0.476 . . . . 55.51 109.714 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.709 ' HD3' ' O ' ' A' ' 25' ' ' ASP . 2.3 Cg_endo -83.75 120.63 2.76 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.186 2.59 . . . . 72.0 112.697 -174.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.437 ' C ' ' HD3' ' A' ' 30' ' ' PRO . . . -78.88 79.33 1.59 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.811 -0.709 . . . . 41.21 111.752 177.146 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.753 HD13 HD12 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -134.5 52.12 7.25 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 112.189 0.44 . . . . 74.13 112.189 175.871 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.594 ' HD3' ' N ' ' A' ' 29' ' ' LEU . 4.5 Cg_endo -86.15 -3.9 8.71 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.311 2.007 . . . . 63.52 111.219 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.712 HD22 ' H ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -69.54 -30.8 68.7 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.653 -0.869 . . . . 72.22 108.653 178.886 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.8 mt 57.76 61.2 2.49 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 114.283 -1.326 . . . . 61.42 111.725 176.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.443 ' O ' ' HB ' ' A' ' 34' ' ' THR . 48.4 ttm -93.3 -65.09 1.02 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.23 -1.026 . . . . 64.14 108.23 172.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.483 HG23 ' N ' ' A' ' 35' ' ' HIS . 8.1 t 174.92 -60.07 0.01 OUTLIER 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.38 -0.827 . . . . 71.12 110.578 168.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.483 ' N ' HG23 ' A' ' 34' ' ' THR . 6.9 t-160 65.77 -60.1 0.29 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.556 0.742 . . . . 73.42 109.941 -172.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.5 tp 68.36 154.62 0.11 Allowed 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 124.093 0.957 . . . . 64.53 112.879 170.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.431 ' HB3' ' H ' ' A' ' 38' ' ' SER . 0.9 OUTLIER 173.75 -83.31 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 114.884 -1.053 . . . . 74.42 108.504 173.095 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.431 ' H ' ' HB3' ' A' ' 37' ' ' ARG . 9.5 t -160.34 27.44 0.16 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.78 -1.193 . . . . 75.32 107.78 173.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.523 HG12 ' H ' ' A' ' 41' ' ' VAL . 8.8 t -75.02 130.33 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 114.62 -1.173 . . . . 52.12 110.73 -174.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -93.88 18.22 10.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.086 -0.506 . . . . 64.52 111.516 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.523 ' H ' HG12 ' A' ' 39' ' ' VAL . 7.0 p -146.55 147.97 17.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.13 -0.486 . . . . 74.43 110.529 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.753 HD12 HD13 ' A' ' 29' ' ' LEU . 56.7 tp -177.74 -55.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.618 -0.882 . . . . 65.12 108.618 178.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.693 ' HB2' ' HA ' ' A' ' 49' ' ' TRP . 27.1 t70 -86.1 174.76 8.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.283 -0.872 . . . . 72.23 109.448 173.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.03 -24.6 63.3 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.385 -0.598 . . . . 75.51 109.385 -177.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.473 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 1.8 tppp? -100.2 23.59 9.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.647 -0.706 . . . . 75.03 110.491 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 67.7 mtt180 59.87 -164.82 0.21 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.879 -1.055 . . . . 72.1 111.882 175.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.579 ' OG ' ' HA ' ' A' ' 63' ' ' GLU . 74.8 m 43.55 69.7 0.38 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.588 0.958 . . . . 65.54 113.588 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 56.62 -162.3 0.18 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.559 -0.292 . . . . 73.2 110.498 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.693 ' HA ' ' HB2' ' A' ' 43' ' ' ASP . 12.4 p-90 -83.15 81.45 8.68 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.488 0.661 . . . . 70.33 110.428 177.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.2 t -86.33 77.78 9.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 122.039 0.923 . . . . 63.14 110.71 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.7 m -121.55 31.09 2.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.402 -0.817 . . . . 75.2 110.801 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -141.53 116.88 10.12 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.209 -0.451 . . . . 74.03 111.116 -177.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.443 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . . . 75.17 145.44 0.11 Allowed Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.656 1.222 . . . . 73.35 113.163 168.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 53' ' ' ALA . 3.2 Cg_exo -76.04 -172.9 1.48 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 123.408 2.739 . . . . 74.23 111.248 172.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 56.51 68.62 2.12 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.03 -0.532 . . . . 74.11 110.61 -176.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -68.9 -5.08 14.74 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.602 2.201 . . . . 71.31 113.885 -171.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.953 ' HB3' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -145.24 13.66 1.43 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.461 0.648 . . . . 72.3 111.384 178.098 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.04 -28.22 60.78 Favored Glycine 0 C--N 1.318 -0.426 0 CA-C-N 114.928 -1.033 . . . . 61.15 113.048 -178.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.72 23.27 1.94 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.863 0.363 . . . . 74.44 110.629 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.1 p -155.17 154.76 6.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.294 -0.412 . . . . 74.43 110.337 -174.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.569 ' O ' ' HB2' ' A' ' 62' ' ' TRP . 44.9 m -125.9 -163.71 1.24 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.979 -0.749 . . . . 73.23 108.979 175.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.569 ' HB2' ' O ' ' A' ' 61' ' ' SER . 10.4 m95 75.5 -12.02 1.03 Allowed 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.324 0.491 . . . . 74.21 112.324 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.646 ' HB2' HD11 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -85.77 151.17 24.04 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.979 0.418 . . . . 72.34 111.388 -171.112 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.93 115.85 25.76 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.651 -0.42 . . . . 63.1 111.076 176.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 1.052 ' HB2' HD23 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -105.61 133.66 49.99 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.859 -0.793 . . . . 73.02 108.859 175.842 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.488 HD12 ' HA ' ' A' ' 77' ' ' TRP . 1.6 mm? -88.91 145.5 25.5 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 121.085 -0.246 . . . . 74.33 110.791 -173.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.5 t -92.53 -21.48 20.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.957 0.408 . . . . 71.2 110.209 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.783 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -121.87 130.48 53.4 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.338 -0.616 . . . . 54.31 109.338 174.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -128.58 23.98 5.82 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.473 0.654 . . . . 71.41 110.249 -172.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.556 ' HB3' ' HD3' ' A' ' 73' ' ' LYS . 29.2 mt-10 -73.17 141.52 81.12 Favored Pre-proline 0 C--N 1.326 -0.429 0 C-N-CA 120.582 -0.447 . . . . 64.34 110.551 -174.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.62 88.33 1.04 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.8 2.333 . . . . 72.5 113.326 -173.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.78 12.07 78.19 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 121.045 -0.597 . . . . 63.45 112.281 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.556 ' HD3' ' HB3' ' A' ' 70' ' ' GLU . 42.9 mtpt -95.36 -69.19 0.76 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.909 0.385 . . . . 74.23 110.325 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.465 ' HD2' ' OE2' ' A' ' 90' ' ' GLU . 10.2 ttp180 -147.72 127.15 13.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.908 -0.587 . . . . 71.14 110.095 -175.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.625 HD13 ' HE2' ' A' ' 93' ' ' PHE . 4.6 mp -131.01 111.4 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.398 0.618 . . . . 72.33 111.216 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.783 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -104.87 125.93 51.42 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.211 -0.904 . . . . 73.24 108.707 170.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.488 ' HA ' HD12 ' A' ' 66' ' ' LEU . 64.8 p-90 -80.4 159.07 25.8 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.369 0.604 . . . . 75.4 111.349 -175.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.494 ' HB3' ' O ' ' A' ' 65' ' ' GLU . 44.7 ttp180 -158.64 164.38 36.04 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.05 -0.977 . . . . 74.4 108.64 -177.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.561 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 19.9 m -123.65 60.34 1.09 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.621 0.248 . . . . 61.02 110.343 -178.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.052 HD23 ' HB2' ' A' ' 65' ' ' GLU . 22.4 mt 68.09 153.95 0.14 Allowed Pre-proline 0 N--CA 1.471 0.621 0 CA-C-N 115.701 -0.682 . . . . 71.13 111.632 -178.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.26 -19.49 38.45 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.598 2.199 . . . . 74.03 111.784 173.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.76 -24.27 77.13 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.906 -0.664 . . . . 60.52 112.059 178.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 79' ' ' SER . . . -108.52 178.87 4.36 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.245 -0.65 . . . . 63.51 109.245 175.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.518 ' HD2' ' N ' ' A' ' 84' ' ' ARG . 5.1 mpt_? -118.28 164.86 14.58 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.89 0.376 . . . . 63.53 110.3 -177.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.586 HD11 ' HA ' ' A' ' 88' ' ' SER . 6.2 tt -131.62 108.52 14.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.657 -0.701 . . . . 74.55 109.484 176.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -77.15 -37.42 53.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.777 -0.647 . . . . 73.34 110.942 -175.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -126.28 132.17 51.73 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.69 -0.485 . . . . 74.55 109.69 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.586 ' HA ' HD11 ' A' ' 85' ' ' ILE . 25.8 m -95.87 128.17 42.52 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.963 0.411 . . . . 61.35 111.282 -173.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -109.63 90.35 0.59 Allowed Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.133 -0.787 . . . . 35.31 111.133 174.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.465 ' OE2' ' HD2' ' A' ' 74' ' ' ARG . 40.9 tt0 -102.63 118.63 37.27 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.922 0.392 . . . . 75.13 110.478 -177.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.7 m -112.43 142.82 23.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.407 -0.59 . . . . 62.23 109.407 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.657 HD23 ' HD3' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -134.56 137.74 44.03 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.367 0.603 . . . . 74.32 110.178 171.209 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.625 ' HE2' HD13 ' A' ' 75' ' ' ILE . 85.5 m-85 -97.22 119.0 34.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.315 -0.857 . . . . 74.21 110.15 -174.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.657 ' HD3' HD23 ' A' ' 92' ' ' LEU . 18.5 mmm180 -104.01 143.01 25.79 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.643 -0.503 . . . . 74.31 109.643 179.009 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.5 109.91 2.87 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.129 1.886 . . . . 72.14 111.439 176.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.633 ' HB1' ' HB3' ' A' ' 100' ' ' ARG . . . -73.68 144.03 82.65 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.362 -0.607 . . . . 70.24 109.362 177.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -48.6 113.33 0.82 Allowed 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 123.445 2.763 . . . . 62.14 114.479 -169.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.23 -66.54 3.78 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 114.875 -1.057 . . . . 32.22 112.501 170.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -170.13 24.04 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.085 -0.558 . . . . 63.32 110.821 -173.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.633 ' HB3' ' HB1' ' A' ' 96' ' ' ALA . 5.6 tpm_? -64.47 -22.86 67.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.057 -0.52 . . . . 74.35 110.499 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 127.92 -154.77 19.92 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.29 -0.724 . . . . 73.22 111.29 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 11' ' ' THR . 2.5 m -105.68 125.29 50.82 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.96 -0.385 . . . . 51.14 109.96 175.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -89.89 100.65 13.42 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.031 -0.729 . . . . 71.1 109.031 173.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.511 HG12 ' HD1' ' A' ' 93' ' ' PHE . 3.4 m -87.46 129.47 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 109.13 -0.693 . . . . 63.53 109.13 178.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.658 HG22 ' HB2' ' A' ' 9' ' ' ALA . 18.7 t -117.19 115.92 50.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 109.082 -0.71 . . . . 74.11 109.082 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.601 HG12 HD22 ' A' ' 108' ' ' LEU . 24.0 t -103.5 116.67 47.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.304 -0.407 . . . . 60.13 110.371 -177.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -107.54 107.72 18.69 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.566 -0.531 . . . . 72.15 109.566 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.601 HD22 HG12 ' A' ' 106' ' ' VAL . 2.6 pt? -145.7 152.04 38.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.133 -0.485 . . . . 65.33 110.232 -177.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.846 HG22 HG22 ' A' ' 5' ' ' VAL . 51.2 p -107.4 132.91 52.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.327 -0.397 . . . . 60.13 111.011 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -157.69 177.96 10.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.285 -0.416 . . . . 65.55 109.883 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.553 ' HG2' ' HA ' ' A' ' 3' ' ' GLU . 97.0 mtt180 -108.31 142.97 26.48 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-O 120.764 0.316 . . . . 75.31 110.409 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -86.7 162.16 9.24 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.94 2.426 . . . . 71.03 113.242 -173.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.8 162.66 40.56 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.548 2.165 . . . . 73.21 111.563 174.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -84.42 46.66 3.71 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.804 -0.713 . . . . 72.11 112.898 -176.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -110.77 33.41 5.93 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.78 -0.724 . . . . 71.3 112.151 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.5 m -64.78 -30.24 71.24 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 122.288 0.235 . . . . 45.54 111.501 -177.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.32 -28.34 69.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.516 -0.311 . . . . 52.44 111.364 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -60.82 -39.26 96.57 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.085 -0.578 . . . . 62.14 112.396 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.25 -34.43 78.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.144 0.497 . . . . 73.34 110.634 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.9 t -68.59 -43.32 83.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.792 -0.64 . . . . 71.44 110.17 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.7 mm -65.91 -36.62 77.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.969 -0.559 . . . . 71.21 110.487 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.39 -19.3 65.89 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.866 -0.607 . . . . 54.23 111.577 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -73.38 -32.31 64.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.777 0.322 . . . . 75.34 110.688 178.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 26.5 ttt -70.86 -26.0 63.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.11 0.481 . . . . 70.12 110.516 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -69.04 170.21 10.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.655 -0.702 . . . . 55.21 110.514 -177.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -56.18 153.63 9.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.912 -0.586 . . . . 71.15 111.468 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -47.93 -61.66 1.85 Allowed 'General case' 0 C--O 1.233 0.207 0 O-C-N 123.823 0.702 . . . . 73.22 111.278 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.404 ' HA ' ' HD2' ' A' ' 129' ' ' PRO . 11.4 mm-40 49.29 84.1 0.21 Allowed Pre-proline 0 N--CA 1.463 0.204 0 O-C-N 124.009 0.818 . . . . 73.51 112.016 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 128' ' ' GLU . 38.6 Cg_endo -65.26 101.94 0.44 Allowed 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.635 2.223 . . . . 75.34 111.951 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.7 t -160.74 -166.23 1.57 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.301 -0.629 . . . . 52.23 109.301 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -88.76 -47.64 8.08 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.692 -0.231 . . . . 75.42 110.395 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 43.23 48.07 5.58 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.993 0.902 . . . . 62.14 110.833 -176.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.444 ' O ' ' HB3' ' A' ' 134' ' ' ARG . 55.8 tp -161.23 161.87 30.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.343 -1.299 . . . . 70.43 108.523 -174.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.444 ' HB3' ' O ' ' A' ' 133' ' ' LEU . 42.0 ttm180 73.21 6.55 5.23 Favored 'General case' 0 C--O 1.219 -0.541 0 O-C-N 123.399 0.437 . . . . 74.0 111.601 173.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -54.61 -43.63 72.36 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.956 -0.465 . . . . 75.0 111.018 -175.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -68.64 -47.39 66.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 72.12 111.273 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 23.7 tp -69.49 -25.47 64.08 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.101 0.477 . . . . 72.02 110.219 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.465 ' HA ' ' CE ' ' A' ' 138' ' ' MET . 0.1 OUTLIER -69.9 -33.27 71.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.042 -0.526 . . . . 71.41 110.015 176.018 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -39.73 89.4 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.236 -0.438 . . . . 63.04 110.153 176.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -56.97 -52.21 66.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.987 -0.551 . . . . 53.31 109.916 174.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.844 ' HG2' HG13 ' A' ' 12' ' ' ILE . 14.5 tmtt? -59.06 -35.34 73.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.717 -0.674 . . . . 61.0 110.73 176.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.426 ' HD2' ' HA ' ' A' ' 142' ' ' ARG . 14.4 tpt180 -62.48 -58.78 6.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.02 -0.536 . . . . 71.53 109.997 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.658 ' HG2' ' H ' ' A' ' 149' ' ' GLU . 31.0 mt-10 -63.15 -32.98 74.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.025 -0.534 . . . . 64.54 110.906 -178.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -58.32 -37.04 74.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.675 -0.693 . . . . 75.34 112.369 -175.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.489 ' HB3' HG23 ' A' ' 12' ' ' ILE . 8.2 pt-20 -109.96 -18.09 13.46 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.827 -0.349 . . . . 70.32 111.894 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.414 ' O ' HD23 ' A' ' 146' ' ' LEU . 5.0 tt -87.23 -38.53 16.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.168 0.508 . . . . 63.2 110.283 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 125.84 -54.63 0.75 Allowed Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.343 -0.703 . . . . 72.21 111.343 -175.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.407 HD13 ' N ' ' A' ' 149' ' ' GLU . 1.7 tm? -174.81 130.39 0.32 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.953 -0.388 . . . . 53.33 109.953 178.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.658 ' H ' ' HG2' ' A' ' 143' ' ' GLU . 40.2 tt0 -129.89 105.34 7.93 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.636 -0.505 . . . . 74.03 109.636 175.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -133.14 19.86 4.06 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.015 0.436 . . . . 74.32 110.404 -177.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -74.9 145.74 42.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.204 -0.453 . . . . 44.33 109.872 172.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -71.77 80.29 0.86 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.934 -0.576 . . . . 64.14 110.369 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -76.29 122.38 24.33 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.652 -0.703 . . . . 72.54 111.466 -178.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -89.97 -34.72 15.9 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.027 -1.101 . . . . 73.11 108.027 170.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 . . . . . 0 C--O 1.247 0.97 0 CA-C-N 114.765 -1.107 . . . . 65.31 108.734 172.612 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.481 1.081 0 N-CA-C 110.426 -0.213 . . . . 74.43 110.426 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 162.38 -58.06 0.29 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.278 -0.963 . . . . 54.23 112.346 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 58.51 92.78 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.204 0.526 . . . . 63.34 110.668 -177.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.4 m -80.33 123.74 28.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.349 0.595 . . . . 62.52 111.227 -176.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 3.1 p -109.69 113.82 45.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.61 -0.723 . . . . 61.33 109.769 175.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.3 t -97.92 116.72 41.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 116.213 -0.449 . . . . 75.43 109.81 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -93.23 123.44 36.5 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.372 0.606 . . . . 61.32 110.84 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.78 ' HB3' HD22 ' A' ' 137' ' ' LEU . 20.4 t0 -142.08 156.1 45.39 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.84 -1.17 . . . . 71.43 107.84 176.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.42 128.47 25.55 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.756 -0.378 . . . . 72.35 110.826 -176.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.525 HG13 HD23 ' A' ' 137' ' ' LEU . 27.9 m -110.07 134.91 50.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.664 -0.495 . . . . 74.13 109.664 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.782 HG21 ' HG3' ' A' ' 100' ' ' ARG . 1.3 m -108.07 110.99 22.81 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.768 -0.456 . . . . 63.35 109.768 -178.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.618 ' HB ' HD21 ' A' ' 19' ' ' LEU . 12.9 mm -108.24 150.86 10.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.925 -0.58 . . . . 63.11 110.117 -174.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.83 44.54 2.32 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.14 -0.553 . . . . 72.1 112.523 176.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.419 ' HB2' HD21 ' A' ' 19' ' ' LEU . 67.0 mmtt -119.24 145.42 38.39 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 107.889 -1.152 . . . . 73.22 107.889 176.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.411 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 83.1 Cg_exo -48.49 -58.01 2.01 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.568 2.179 . . . . 73.3 113.57 -173.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . 173.34 -53.28 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.378 0.609 . . . . 72.43 110.389 177.049 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -52.93 -32.43 45.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.677 -1.147 . . . . 75.11 111.98 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -85.49 -8.52 58.31 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.943 -0.571 . . . . 74.25 111.37 -175.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.849 ' HB2' ' HE2' ' A' ' 93' ' ' PHE . 96.1 mt -79.31 -44.42 21.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.711 -0.222 . . . . 54.42 111.437 -176.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.549 ' HB2' ' HZ ' ' A' ' 93' ' ' PHE . 64.1 t80 -71.46 -30.31 65.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.511 0.672 . . . . 74.42 109.787 177.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.935 ' HB1' ' HA ' ' A' ' 26' ' ' LEU . . . -66.11 -3.96 6.52 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.245 -0.889 . . . . 73.34 112.357 -175.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.549 HG21 ' CD1' ' A' ' 140' ' ' PHE . 13.4 p -61.37 -22.18 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.348 -0.387 . . . . 75.42 111.333 176.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.417 ' HD1' ' O ' ' A' ' 20' ' ' TYR . 76.2 m95 -66.6 -10.83 49.7 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.82 0.343 . . . . 72.44 111.286 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.451 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 6.5 mmm180 -132.56 -84.47 0.48 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.643 -0.253 . . . . 75.13 111.298 173.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.593 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 3.9 t70 -166.8 33.51 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.885 -0.326 . . . . 72.23 110.73 -176.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.935 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 0.7 OUTLIER 44.19 71.87 1.36 Allowed Pre-proline 0 N--CA 1.472 0.666 0 O-C-N 123.758 0.661 . . . . 72.53 112.46 -177.692 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -86.9 -170.56 0.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.644 2.229 . . . . 71.1 112.359 -178.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -146.75 162.52 28.53 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 121.039 -0.601 . . . . 52.33 111.763 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.705 HD12 HD23 ' A' ' 32' ' ' LEU . 1.5 pt? -73.22 155.49 89.95 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 120.591 0.234 . . . . 70.44 111.141 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.473 ' HD2' HD22 ' A' ' 32' ' ' LEU . 19.1 Cg_exo -68.43 8.06 0.59 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.547 2.831 . . . . 41.03 113.354 177.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.542 ' H ' ' HG ' ' A' ' 29' ' ' LEU . 9.7 mp 66.78 49.11 1.27 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 122.806 0.442 . . . . 75.32 110.884 -177.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.79 ' H ' HD23 ' A' ' 32' ' ' LEU . 2.4 pt? -89.87 -0.68 57.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 73.54 110.717 177.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 70.8 mtm 65.06 2.18 1.73 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.586 0.958 . . . . 74.23 113.586 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.455 ' H ' ' HG ' ' A' ' 32' ' ' LEU . 17.6 m -79.24 -76.14 0.22 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.638 -0.504 . . . . 64.44 109.638 173.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.411 ' O ' HD13 ' A' ' 29' ' ' LEU . 5.3 t60 -161.3 -67.78 0.06 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.571 -0.9 . . . . 73.22 108.571 174.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.538 ' O ' HD12 ' A' ' 36' ' ' LEU . 3.7 pp -170.71 120.05 0.55 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.718 -0.674 . . . . 63.21 109.611 172.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.463 ' CG ' ' H ' ' A' ' 38' ' ' SER . 17.7 ttp180 -178.36 -178.09 0.6 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.986 -1.116 . . . . 75.1 107.986 -176.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.463 ' H ' ' CG ' ' A' ' 37' ' ' ARG . 23.7 m 75.23 7.03 4.15 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.434 0.635 . . . . 62.32 110.474 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.672 HG23 ' H ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -123.16 -70.56 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.38 -0.827 . . . . 52.3 109.664 173.245 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.672 ' H ' HG23 ' A' ' 39' ' ' VAL . 51.6 mt-10 50.29 55.7 9.07 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.472 0.482 . . . . 72.24 111.678 171.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.6 p -78.67 -26.75 13.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.03 -0.532 . . . . 75.1 112.221 -174.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.825 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 1.9 tm? 178.81 -57.17 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.245 0.545 . . . . 71.34 111.567 -174.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -124.93 -33.43 2.92 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.341 -0.845 . . . . 61.03 111.236 -165.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -44.25 -65.12 0.55 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.297 -0.865 . . . . 71.43 111.945 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.859 ' HE2' ' HA ' ' A' ' 45' ' ' LYS . 0.6 OUTLIER -113.95 -39.69 3.9 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.639 -0.875 . . . . 74.42 108.639 171.342 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.559 ' HG3' ' HB2' ' A' ' 48' ' ' ARG . 23.3 ptt180 174.92 -174.26 0.08 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.172 -1.377 . . . . 75.31 108.753 177.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.825 ' HB3' ' HA ' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -108.4 90.01 3.17 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.493 -0.558 . . . . 72.41 109.493 172.287 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.559 ' HB2' ' HG3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -145.86 -51.93 0.25 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.08 0.4 . . . . 64.45 112.08 -173.644 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.426 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 54.1 t-105 75.57 -33.2 0.22 Allowed 'General case' 0 N--CA 1.473 0.689 0 O-C-N 123.62 0.575 . . . . 73.51 111.158 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -92.04 130.33 37.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.827 0.346 . . . . 61.14 110.797 177.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.5 t -87.33 -47.38 15.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.046 -0.525 . . . . 72.21 111.221 -175.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -109.63 89.47 3.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.94 0.4 . . . . 74.4 111.035 -177.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.487 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . . . -133.28 144.03 50.75 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.891 -0.595 . . . . 72.24 110.29 176.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 53' ' ' ALA . 5.6 Cg_exo -78.56 142.77 18.61 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.815 2.343 . . . . 64.43 111.083 175.091 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 71.3 143.88 0.1 Allowed Pre-proline 0 N--CA 1.465 0.292 0 C-N-CA 123.473 0.709 . . . . 74.14 111.145 -175.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.518 ' HB2' HD22 ' A' ' 80' ' ' LEU . 20.5 Cg_endo -63.49 -47.66 7.15 Favored 'Trans proline' 0 CA--C 1.527 0.169 0 C-N-CA 122.501 2.134 . . . . 72.21 112.505 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.959 ' HB3' HD13 ' A' ' 80' ' ' LEU . 2.2 pt? -143.97 8.05 1.44 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.207 0.527 . . . . 73.44 110.898 -177.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.48 -70.19 2.2 Favored Glycine 0 C--N 1.319 -0.38 0 CA-C-N 115.627 -0.715 . . . . 64.25 111.695 -176.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.37 -73.67 0.19 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.842 -0.429 . . . . 44.02 109.842 176.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.9 p -143.27 113.96 2.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.442 0.639 . . . . 71.33 109.862 174.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.657 ' H ' HD12 ' A' ' 57' ' ' LEU . 26.5 m -132.07 -172.1 2.8 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.664 -0.698 . . . . 75.13 110.511 -174.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 44.6 m95 -97.25 4.04 51.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.384 0.612 . . . . 71.23 111.808 -176.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.526 ' HG3' ' CD1' ' A' ' 80' ' ' LEU . 2.1 pt-20 -86.15 164.99 16.92 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.381 -0.827 . . . . 64.34 111.086 -178.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -146.29 145.86 30.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.112 -0.494 . . . . 63.4 110.415 178.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.443 ' HG2' ' H ' ' A' ' 80' ' ' LEU . 15.3 pt-20 -108.27 154.99 20.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.211 -0.45 . . . . 72.23 111.113 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.1 tp -117.58 123.02 45.2 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.059 -0.719 . . . . 75.13 109.059 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.434 ' HB ' ' CG ' ' A' ' 78' ' ' ARG . 12.2 t -83.52 -22.53 32.42 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.621 -0.432 . . . . 70.3 112.073 -171.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.948 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -132.63 132.36 42.39 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.67 -0.412 . . . . 72.0 110.713 -178.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -139.42 40.87 2.06 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.793 -0.639 . . . . 62.32 110.797 -176.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.555 ' CB ' ' HB3' ' A' ' 73' ' ' LYS . 5.4 mm-40 -80.38 143.43 55.79 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 75.35 109.842 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 23.9 Cg_exo -64.82 -55.67 0.49 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.59 2.194 . . . . 45.32 112.528 -178.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -134.12 64.15 0.6 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.852 -0.689 . . . . 72.4 111.856 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.555 ' HB3' ' CB ' ' A' ' 70' ' ' GLU . 69.2 tttt -143.78 -78.83 0.21 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.898 -0.408 . . . . 65.41 109.898 -176.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -168.03 147.5 4.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.785 0.326 . . . . 73.22 110.682 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.714 HD13 ' HE1' ' A' ' 93' ' ' PHE . 2.4 mp -122.8 116.68 49.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.76 -0.655 . . . . 72.34 109.913 175.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.948 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -103.72 149.1 25.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.187 -0.46 . . . . 51.42 109.835 176.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 29.1 p-90 -94.0 152.6 18.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.098 0.475 . . . . 73.21 111.836 -172.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.434 ' CG ' ' HB ' ' A' ' 67' ' ' THR . 75.7 mmt-85 -144.27 173.53 11.68 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.071 -1.085 . . . . 74.11 108.071 169.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.622 ' OG ' HG13 ' A' ' 85' ' ' ILE . 11.5 m -150.13 22.75 0.85 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.799 -0.361 . . . . 74.11 110.598 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.959 HD13 ' HB3' ' A' ' 57' ' ' LEU . 91.2 mt 65.97 158.39 0.13 Allowed Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 115.834 -0.621 . . . . 62.45 110.233 -173.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.576 ' HD2' HD22 ' A' ' 57' ' ' LEU . 22.6 Cg_exo -67.7 5.39 1.03 Allowed 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.76 2.307 . . . . 72.34 113.264 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.558 ' HA3' HD11 ' A' ' 57' ' ' LEU . . . -103.11 -21.01 10.43 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.8 -0.714 . . . . 75.3 113.095 -177.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.502 ' O ' ' HB2' ' A' ' 79' ' ' SER . . . -150.45 167.98 25.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.154 0.477 . . . . 74.13 111.282 -175.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 84' ' ' ARG . 3.7 mpt_? -138.29 141.35 39.82 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.468 -0.567 . . . . 73.31 109.468 174.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.622 HG13 ' OG ' ' A' ' 79' ' ' SER . 71.1 mt -70.65 -16.45 19.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-O 120.917 0.389 . . . . 73.15 110.365 176.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 75.39 -38.37 0.36 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.685 0.794 . . . . 65.45 110.773 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -64.82 132.7 50.2 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.173 -0.677 . . . . 74.21 109.173 170.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.1 t -126.35 127.89 46.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.941 0.4 . . . . 71.41 110.899 -175.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.493 ' HA3' ' HB3' ' A' ' 107' ' ' ARG . . . 158.94 133.0 1.45 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 121.042 -0.599 . . . . 73.15 112.115 176.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -101.27 138.46 38.26 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.899 0.381 . . . . 51.15 109.977 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.507 HG22 HG12 ' A' ' 106' ' ' VAL . 63.1 t -89.04 125.02 42.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.79 -0.641 . . . . 62.43 111.484 -175.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.3 mp -107.37 132.04 53.59 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.053 -0.976 . . . . 73.43 110.241 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.849 ' HE2' ' HB2' ' A' ' 19' ' ' LEU . 91.9 m-85 -99.36 109.42 22.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.188 0.518 . . . . 64.2 109.872 177.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.477 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 21.0 mtp180 -109.67 144.65 30.33 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.554 -0.748 . . . . 74.33 110.176 -173.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 94' ' ' ARG . 11.9 Cg_exo -70.5 123.93 10.32 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.764 2.31 . . . . 71.4 112.636 -176.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.917 ' HB1' ' HB3' ' A' ' 100' ' ' ARG . . . -98.06 160.04 29.33 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 108.828 -0.804 . . . . 55.25 108.828 171.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.05 159.69 11.82 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 121.789 1.66 . . . . 75.22 110.604 169.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -52.38 -26.64 22.85 Favored Glycine 0 CA--C 1.519 0.3 0 N-CA-C 114.35 0.5 . . . . 71.13 114.35 -172.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -105.61 7.8 32.92 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 112.996 0.739 . . . . 44.43 112.996 -176.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.917 ' HB3' ' HB1' ' A' ' 96' ' ' ALA . 9.5 tpp180 -101.53 -35.99 8.95 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.343 -0.614 . . . . 71.3 109.343 175.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.615 ' O ' ' HB3' ' A' ' 96' ' ' ALA . . . 111.51 -130.05 9.5 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 121.15 -0.548 . . . . 72.3 112.012 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 54.7 m -129.89 132.91 46.57 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.73 -0.471 . . . . 65.23 109.73 173.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -88.24 107.02 18.59 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.126 0.489 . . . . 74.23 110.9 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 10' ' ' VAL . 6.4 p -88.33 101.59 11.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.466 -0.788 . . . . 73.32 109.812 174.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 59.5 t -86.25 108.5 17.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.901 -0.59 . . . . 73.13 110.187 -178.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.507 HG12 HG22 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -111.55 129.16 67.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.597 -0.728 . . . . 65.53 110.574 -178.275 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.493 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 39.9 ttm180 -107.79 110.68 22.55 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.61 -0.723 . . . . 72.5 109.452 177.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.503 ' H ' HD23 ' A' ' 108' ' ' LEU . 1.5 pt? -123.33 121.12 35.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.472 0.653 . . . . 60.2 111.7 -176.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 6.6 m -95.79 120.48 36.13 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.22 -0.9 . . . . 54.1 108.875 175.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -155.86 166.31 33.87 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.482 0.658 . . . . 63.43 111.458 -173.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.29 144.73 35.61 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 114.995 -1.002 . . . . 74.12 109.037 175.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.48 151.95 71.36 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.09 1.86 . . . . 74.42 112.389 -176.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -92.52 5.2 3.41 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.082 2.521 . . . . 71.35 112.532 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 116.7 -122.31 5.45 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.855 -0.688 . . . . 71.15 111.389 -178.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -139.43 -12.79 0.68 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.836 -0.697 . . . . 42.25 112.754 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.8 t -63.73 -49.0 74.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.758 0.313 . . . . 74.03 110.49 -178.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.53 -32.56 73.52 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.281 -0.418 . . . . 75.32 110.742 178.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.64 -29.1 71.51 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.754 -0.657 . . . . 64.33 112.204 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.01 -31.41 62.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.931 0.396 . . . . 65.25 110.677 178.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.24 -50.01 56.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.015 -0.539 . . . . 64.33 110.585 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.561 ' HA ' ' HB3' ' A' ' 124' ' ' MET . 29.0 pt -69.1 -21.56 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.489 . . . . 63.23 111.261 -178.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.25 -39.68 83.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.541 -0.3 . . . . 63.1 111.367 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -89.92 -23.03 21.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.239 0.542 . . . . 74.34 110.192 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.561 ' HB3' ' HA ' ' A' ' 121' ' ' ILE . 16.3 tpt -71.85 -32.34 67.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.735 -0.666 . . . . 72.3 110.993 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.455 ' HE1' ' HG2' ' A' ' 138' ' ' MET . 15.5 t80 -63.48 120.28 11.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.892 -0.594 . . . . 63.13 110.694 -177.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -61.47 -82.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.575 -0.739 . . . . 74.32 111.603 -175.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -134.99 -75.09 0.46 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.781 -0.452 . . . . 74.0 109.781 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -176.76 85.83 0.26 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.752 -0.658 . . . . 70.14 109.698 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.484 ' HG2' ' SD ' ' A' ' 138' ' ' MET . 7.8 Cg_exo -73.57 105.28 1.96 Allowed 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.694 2.263 . . . . 73.54 111.792 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 43.1 m 67.13 -167.85 0.2 Allowed 'General case' 0 C--O 1.235 0.303 0 O-C-N 123.731 0.644 . . . . 61.31 110.718 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -120.76 140.61 51.44 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.96 -0.296 . . . . 74.53 110.526 -177.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 66.95 94.24 0.07 Allowed 'General case' 0 N--CA 1.463 0.208 0 O-C-N 123.837 0.711 . . . . 74.25 111.025 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.458 ' N ' HD13 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -157.96 164.8 36.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.834 -0.621 . . . . 75.21 110.627 -178.525 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.639 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . 0.6 OUTLIER -105.22 134.07 48.94 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.308 -0.405 . . . . 70.04 110.695 174.491 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.517 ' HB2' HD12 ' A' ' 121' ' ' ILE . 9.1 m-20 -61.58 -30.68 70.83 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.238 -0.653 . . . . 53.23 109.238 178.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.13 -53.23 53.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.784 -1.098 . . . . 71.21 110.422 176.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.78 HD22 ' HB3' ' A' ' 8' ' ' ASP . 1.2 tp -79.74 -31.42 41.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.599 -0.728 . . . . 63.05 110.929 -178.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.698 ' SD ' ' HD3' ' A' ' 141' ' ' LYS . 28.3 tpp -63.67 -26.6 68.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.936 -0.574 . . . . 71.11 111.395 -177.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -62.91 -54.35 39.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.981 -0.554 . . . . 64.01 111.151 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.711 ' HE2' ' HG ' ' A' ' 137' ' ' LEU . 3.1 p90 -77.31 -29.71 53.75 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.93 -0.308 . . . . 72.22 110.493 -177.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.698 ' HD3' ' SD ' ' A' ' 138' ' ' MET . 51.3 tttm -49.41 -51.99 31.59 Favored 'General case' 0 C--O 1.232 0.153 0 O-C-N 123.28 0.363 . . . . 55.14 111.297 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.434 ' HA ' ' HG2' ' A' ' 145' ' ' GLU . 0.5 OUTLIER -67.44 -30.68 70.48 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.903 -0.589 . . . . 64.41 110.668 -174.775 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -71.67 -36.58 70.7 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.813 0.34 . . . . 74.11 110.15 177.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.459 ' HB3' HG21 ' A' ' 12' ' ' ILE . 14.1 mm100 -64.12 -38.33 90.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 74.04 111.438 177.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.469 ' HB3' HG23 ' A' ' 12' ' ' ILE . 11.6 pt-20 -87.91 -4.96 58.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.249 -0.432 . . . . 74.42 111.368 -176.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.6 tp -111.02 -38.3 5.12 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.767 0.318 . . . . 73.23 111.113 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -77.39 133.74 13.67 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.145 -0.55 . . . . 70.55 113.802 -173.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 81.3 mt -80.68 -168.94 1.94 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.572 -0.529 . . . . 73.15 109.572 172.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -70.47 -50.32 39.3 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.352 -0.24 . . . . 73.53 110.352 -178.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 32.6 m170 56.72 39.72 29.55 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.073 -0.512 . . . . 63.24 112.183 174.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.45 ' HE1' ' O ' ' A' ' 26' ' ' LEU . 56.3 m170 -102.37 136.72 41.69 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.203 0.525 . . . . 71.22 111.246 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -116.54 -30.97 5.69 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.461 -0.79 . . . . 75.15 110.268 177.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 58.64 87.76 0.07 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.841 -0.618 . . . . 73.14 110.954 177.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -124.66 157.9 34.45 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.052 -0.522 . . . . 72.5 110.457 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 . . . . . 0 C--O 1.245 0.817 0 CA-C-O 118.665 -0.683 . . . . 73.0 109.408 179.461 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 110.179 -0.304 . . . . 74.44 110.179 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -122.25 79.54 0.34 Allowed Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.735 -0.745 . . . . 72.35 112.217 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.04 99.74 0.38 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.062 0.458 . . . . 74.31 109.797 177.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.5 m -111.31 120.61 42.8 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.261 0.553 . . . . 73.11 110.879 -174.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.757 HG22 ' HB ' ' A' ' 109' ' ' THR . 99.0 t -126.04 105.96 15.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 108.711 -0.848 . . . . 74.12 108.711 175.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.9 p -78.94 139.37 18.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.998 -0.546 . . . . 71.1 110.753 -174.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.471 ' HB3' ' HG3' ' A' ' 107' ' ' ARG . 17.3 ptt180 -132.55 134.79 45.41 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.992 -0.549 . . . . 62.21 110.379 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.755 ' HB3' HD22 ' A' ' 137' ' ' LEU . 4.2 t70 -158.14 171.81 19.54 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.443 -0.947 . . . . 74.44 108.443 172.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.426 ' CB ' HG22 ' A' ' 105' ' ' VAL . . . -146.33 120.42 9.45 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.874 0.368 . . . . 65.5 111.286 -174.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.2 m -112.73 133.55 58.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.9 -0.591 . . . . 73.12 110.756 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.0 m -97.96 112.31 24.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.922 0.392 . . . . 75.11 111.069 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.904 HG21 ' HG3' ' A' ' 144' ' ' GLN . 4.4 mp -117.28 146.38 21.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.386 -0.598 . . . . 74.31 109.386 176.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.52 53.51 3.2 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.086 -0.578 . . . . 75.22 112.972 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.517 ' HG2' HG22 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -105.83 153.99 39.68 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 107.868 -1.16 . . . . 54.22 107.868 173.121 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.721 ' HG3' ' HA ' ' A' ' 153' ' ' HIS . 51.9 Cg_exo -55.43 -57.44 1.62 Allowed 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 121.795 1.664 . . . . 72.11 111.438 178.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 171.46 -49.63 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.27 0.981 . . . . 52.52 108.762 172.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -48.92 -44.22 40.2 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.17 -1.377 . . . . 61.42 112.124 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -64.61 -23.18 67.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.914 -0.584 . . . . 62.05 112.033 -176.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.469 ' O ' HG12 ' A' ' 22' ' ' VAL . 92.4 mt -76.98 -24.9 52.23 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.893 0.378 . . . . 71.2 110.577 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.569 ' HE1' HG12 ' A' ' 75' ' ' ILE . 55.9 t80 -72.12 -41.53 67.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.536 0.684 . . . . 74.2 109.795 175.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.836 ' HB1' ' HD2' ' A' ' 27' ' ' PRO . . . -76.43 -8.9 58.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.319 -0.855 . . . . 55.33 112.943 -175.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 19' ' ' LEU . 9.6 p -61.8 -22.3 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 111.765 0.283 . . . . 71.11 111.765 -174.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 33.6 t-105 -64.04 -14.79 56.94 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.401 -0.363 . . . . 73.3 111.147 -176.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -142.3 46.24 1.62 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.027 0.441 . . . . 63.31 110.784 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 36.3 t70 62.88 28.46 16.38 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.579 -0.737 . . . . 72.24 112.456 172.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.445 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 5.5 mp 53.46 80.27 0.3 Allowed Pre-proline 0 N--CA 1.47 0.557 0 CA-C-N 115.935 -0.575 . . . . 53.11 111.45 177.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.836 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 58.8 Cg_endo -72.79 169.4 22.12 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.693 2.262 . . . . 72.24 113.179 -177.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -113.92 -1.83 23.91 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.106 -0.798 . . . . 75.33 111.106 175.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 63.97 143.35 0.07 OUTLIER Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 124.09 0.956 . . . . 72.21 112.71 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -89.47 6.07 4.55 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 123.245 2.63 . . . . 72.55 112.464 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.1 mp 62.23 57.24 2.03 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.794 -0.639 . . . . 73.12 110.409 -176.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.797 ' HB2' ' HA ' ' A' ' 37' ' ' ARG . 1.2 pt? -74.23 78.22 1.8 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.583 -0.735 . . . . 55.1 111.014 -178.005 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 23.1 ptt? -146.77 -39.16 0.21 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.439 -0.801 . . . . 73.41 109.939 177.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.1 m -99.29 18.21 18.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.872 0.844 . . . . 40.13 109.786 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -153.48 -171.77 4.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.162 -0.927 . . . . 70.25 108.784 -175.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 99.4 mt -64.74 105.95 1.1 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.979 0.419 . . . . 54.05 110.249 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.797 ' HA ' ' HB2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -90.5 104.39 16.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.165 -0.47 . . . . 53.12 111.22 -177.198 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 43.4 m -151.76 -82.29 0.09 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.923 -0.581 . . . . 73.43 109.796 175.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.8 t 60.31 43.03 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 121.558 0.694 . . . . 72.24 110.102 178.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 60.16 -163.59 0.24 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.166 -0.924 . . . . 65.05 110.418 -177.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 99.0 t -66.09 119.21 10.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.264 -0.643 . . . . 75.33 109.264 172.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.518 HD22 ' H ' ' A' ' 42' ' ' LEU . 3.1 mm? -54.61 -63.75 1.05 Allowed 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.795 0.684 . . . . 61.04 110.793 -175.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -150.51 -166.87 2.66 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.661 -0.866 . . . . 72.21 108.661 176.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.25 6.95 3.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.487 0.66 . . . . 72.43 110.65 -175.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.838 ' HD2' HD22 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -62.7 -56.7 15.22 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.262 -0.881 . . . . 64.51 111.011 178.299 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.654 ' HG2' ' HB3' ' A' ' 45' ' ' LYS . 4.8 ptt180 -160.7 150.84 17.82 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.384 -0.826 . . . . 74.42 110.779 -168.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.7 t -75.44 -36.89 60.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.151 0.5 . . . . 61.01 109.994 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.3 mtt180 -134.17 165.23 25.57 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.691 -0.686 . . . . 65.45 110.072 175.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 31.1 t90 -120.39 -85.85 0.65 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.384 -0.371 . . . . 72.25 110.112 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 23.9 m -160.2 83.3 0.71 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.374 -0.602 . . . . 54.25 109.374 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.5 t -127.86 -82.33 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.199 -0.667 . . . . 74.3 109.199 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -116.84 67.86 0.73 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.624 -0.88 . . . . 53.43 108.624 172.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -170.04 164.82 6.01 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 114.93 -1.032 . . . . 55.24 109.433 -175.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.76 -172.4 0.47 Allowed 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.566 2.177 . . . . 74.43 111.975 175.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.95 144.61 98.87 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.216 -0.447 . . . . 74.12 110.212 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.415 ' HB2' HD12 ' A' ' 57' ' ' LEU . 8.8 Cg_endo -50.57 -36.33 49.4 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.166 2.578 . . . . 74.22 113.411 -175.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.789 HD11 ' HG2' ' A' ' 65' ' ' GLU . 3.0 mp -119.83 10.28 11.56 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.863 0.363 . . . . 72.32 110.324 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.414 ' C ' ' H ' ' A' ' 60' ' ' VAL . . . -122.16 125.88 6.23 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.935 -0.65 . . . . 12.1 111.971 -176.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 75.21 -23.01 0.24 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.744 0.818 . . . . 72.53 111.224 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.414 ' H ' ' C ' ' A' ' 58' ' ' GLY . 3.1 p -127.42 110.41 22.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.373 0.606 . . . . 73.43 110.042 173.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.52 ' HA ' HD23 ' A' ' 80' ' ' LEU . 3.8 t -99.78 6.99 45.38 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.44 0.638 . . . . 70.23 109.992 -178.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.46 1.25 57.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.47 -0.786 . . . . 73.15 110.795 -178.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -86.45 165.09 16.58 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.74 -0.664 . . . . 73.45 110.089 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -116.15 116.41 27.79 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.038 -0.356 . . . . 62.34 110.038 177.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.789 ' HG2' HD11 ' A' ' 57' ' ' LEU . 7.3 tp10 -123.99 154.92 39.13 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.387 -0.598 . . . . 74.13 109.387 177.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.949 ' HG ' ' HA ' ' A' ' 77' ' ' TRP . 3.3 mp -115.76 135.26 54.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.118 0.485 . . . . 74.02 111.6 -174.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.6 t -75.02 -32.41 61.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.313 -0.858 . . . . 74.44 111.474 -174.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.8 130.36 18.93 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.394 -0.522 . . . . 71.13 111.47 -176.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 8.0 p-10 -149.18 110.89 4.52 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.295 -0.866 . . . . 62.3 109.268 173.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.645 ' HB2' ' HB3' ' A' ' 73' ' ' LYS . 5.1 mm-40 -108.26 142.31 25.07 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 115.591 -0.731 . . . . 64.03 109.371 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 38.5 Cg_exo -61.98 -27.37 79.55 Favored 'Trans proline' 0 N--CA 1.466 -0.097 0 C-N-CA 122.806 2.337 . . . . 74.41 112.238 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -146.36 49.54 0.64 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.575 -0.822 . . . . 73.13 112.625 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.645 ' HB3' ' HB2' ' A' ' 70' ' ' GLU . 39.4 ttmt -148.37 -79.92 0.14 Allowed 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.77 -0.253 . . . . 70.11 110.587 177.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.638 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 10.3 ptp180 -154.47 150.91 28.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.996 0.426 . . . . 75.54 111.135 175.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.569 HG12 ' HE1' ' A' ' 20' ' ' TYR . 4.5 mp -123.33 110.47 26.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 108.771 -0.826 . . . . 62.33 108.771 173.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -126.14 141.82 51.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.301 0.572 . . . . 71.11 112.396 -172.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.949 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 0.5 OUTLIER -90.31 124.83 35.23 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.137 -0.938 . . . . 73.52 112.34 -173.374 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.669 ' HG3' ' O ' ' A' ' 77' ' ' TRP . 32.6 mtm180 175.54 118.73 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 O-C-N 124.382 1.052 . . . . 73.23 111.827 173.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.697 ' HB3' HD21 ' A' ' 57' ' ' LEU . 23.6 m -163.25 -54.32 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.657 0.265 . . . . 63.32 111.34 166.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.744 HD21 ' HA ' ' A' ' 57' ' ' LEU . 4.8 mp -102.72 146.41 32.34 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.697 0.284 . . . . 75.23 111.218 -176.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.46 -16.96 11.67 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 123.088 2.525 . . . . 61.44 112.508 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.67 13.05 54.65 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.904 -0.665 . . . . 74.21 112.293 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 84' ' ' ARG . . . -129.55 -165.72 1.56 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.157 -0.312 . . . . 75.44 110.157 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.542 ' O ' HG12 ' A' ' 85' ' ' ILE . 58.4 mtm180 73.47 -170.12 0.12 Allowed 'General case' 0 N--CA 1.465 0.325 0 O-C-N 123.864 0.727 . . . . 74.22 110.972 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 84' ' ' ARG . 14.2 pt 60.93 -46.26 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 125.896 1.678 . . . . 64.23 113.891 179.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -79.08 -31.33 44.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.151 0.501 . . . . 74.43 109.792 177.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -130.73 134.63 47.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.609 -0.723 . . . . 74.44 109.695 176.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.8 m -145.51 131.35 19.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.937 -0.574 . . . . 40.44 109.454 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 107' ' ' ARG . . . 173.0 127.15 0.95 Allowed Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 119.877 -1.154 . . . . 74.2 113.604 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 0.3 OUTLIER -118.87 142.03 48.11 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.269 -0.641 . . . . 72.51 109.269 171.432 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 95.6 t -100.84 136.86 30.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.58 -0.282 . . . . 65.13 110.478 177.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.798 ' HB2' ' HB ' ' A' ' 105' ' ' VAL . 3.4 mm? -113.66 120.41 40.79 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.924 -0.58 . . . . 65.41 109.85 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -98.82 105.85 18.05 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.982 -0.748 . . . . 55.41 108.982 172.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.462 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 0.7 OUTLIER -103.99 143.45 26.69 Favored Pre-proline 0 C--N 1.317 -0.841 0 CA-C-N 115.771 -0.649 . . . . 71.23 110.132 -175.519 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 94' ' ' ARG . 5.8 Cg_exo -74.32 103.16 1.64 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.24 1.96 . . . . 64.11 110.23 172.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.99 142.99 95.07 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.117 -0.492 . . . . 62.02 110.689 -174.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -40.04 120.21 0.77 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 124.311 3.341 . . . . 74.45 114.925 -171.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.25 -69.6 2.56 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.025 -0.989 . . . . 62.41 111.583 174.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 175.78 26.83 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.437 -0.882 . . . . 74.4 109.559 -176.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -66.19 -22.48 66.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.948 -0.569 . . . . 71.23 111.17 -174.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 138.64 -151.16 21.48 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.35 -0.7 . . . . 61.03 111.35 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.9 m -114.2 127.15 55.76 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.953 0.406 . . . . 61.22 110.268 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -95.73 111.21 23.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.773 -0.649 . . . . 60.23 110.121 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.6 p -88.29 99.31 8.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.839 0.828 . . . . 71.53 109.943 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.798 ' HB ' ' HB2' ' A' ' 92' ' ' LEU . 21.6 t -89.2 110.08 21.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 114.995 -1.002 . . . . 73.13 108.757 177.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.708 HG22 HD22 ' A' ' 108' ' ' LEU . 7.7 p -114.35 120.3 63.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 121.48 0.657 . . . . 73.14 110.869 -176.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.552 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 19.7 ttp180 -114.43 98.4 6.89 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.545 -0.752 . . . . 73.41 108.99 176.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.708 HD22 HG22 ' A' ' 106' ' ' VAL . 2.3 pt? -131.91 151.31 51.79 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.767 0.317 . . . . 71.13 111.027 -171.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.757 ' HB ' HG22 ' A' ' 5' ' ' VAL . 12.2 t -97.81 127.75 43.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.147 0.499 . . . . 74.21 110.756 179.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -168.77 166.84 11.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.303 -0.862 . . . . 75.04 109.38 -176.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -86.9 143.07 34.71 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.716 -0.476 . . . . 75.41 109.716 172.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.443 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 92.8 Cg_endo -83.93 153.29 12.97 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.329 2.019 . . . . 75.25 112.69 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 2.7 Cg_endo -85.4 77.26 2.81 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.08 2.52 . . . . 63.31 111.78 176.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -86.71 132.26 11.04 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.667 -0.777 . . . . 53.44 111.93 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 155.53 -123.57 1.36 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.745 -0.741 . . . . 62.41 113.033 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.7 m -61.59 -11.11 9.88 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.603 0.964 . . . . 62.52 113.603 -172.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.16 -35.11 61.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.738 0.304 . . . . 75.23 111.545 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.42 -28.74 42.73 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.593 -0.813 . . . . 70.21 112.704 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.09 -40.65 98.28 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.706 0.261 . . . . 54.41 111.706 -176.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.3 p -67.67 -30.4 48.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.967 0.413 . . . . 72.23 110.73 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 48.0 mm -73.44 -33.88 41.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.06 0.457 . . . . 73.33 110.411 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.861 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . . . -67.27 -19.88 65.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.959 -0.564 . . . . 65.53 111.373 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.58 ' NE ' ' HA ' ' A' ' 123' ' ' ARG . 5.6 mmp_? -77.7 -13.65 59.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.559 -0.291 . . . . 72.2 111.339 178.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.512 ' HG2' ' HD1' ' A' ' 125' ' ' PHE . 35.4 ttp -58.47 -39.43 79.91 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.955 -0.387 . . . . 72.14 109.955 176.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.512 ' HD1' ' HG2' ' A' ' 124' ' ' MET . 31.9 p90 -175.71 -42.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.571 -0.74 . . . . 63.13 109.441 172.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.415 ' O ' ' HB3' ' A' ' 127' ' ' GLN . 9.2 t30 178.43 172.19 0.72 Allowed 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.555 -1.276 . . . . 72.1 107.555 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.415 ' HB3' ' O ' ' A' ' 126' ' ' ASN . 62.9 tt0 75.25 110.41 0.07 Allowed 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.732 0.645 . . . . 72.33 111.133 177.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.861 ' HB3' ' HB2' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -113.86 87.86 13.23 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.509 -0.769 . . . . 75.03 110.814 -179.192 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.53 110.16 0.43 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.891 2.394 . . . . 40.33 112.5 -177.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.7 m -104.83 13.5 31.13 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.665 0.745 . . . . 70.4 109.851 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.404 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 34.6 tt0 -82.96 162.02 21.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.171 -0.922 . . . . 73.31 109.525 178.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -63.95 111.15 2.37 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.818 0.342 . . . . 74.33 110.865 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 131' ' ' GLN . 92.1 mt -114.2 174.74 5.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.079 0.466 . . . . 73.5 111.323 -177.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -106.96 48.63 0.83 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.857 -0.61 . . . . 73.02 110.24 -177.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -49.5 -56.5 9.6 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.652 -0.704 . . . . 75.14 112.854 -174.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -66.36 -33.78 76.49 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.835 -0.346 . . . . 64.43 111.216 -172.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.755 HD22 ' HB3' ' A' ' 8' ' ' ASP . 4.3 mp -71.01 -43.84 67.11 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.522 -0.308 . . . . 72.34 111.054 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.5 ttp -60.07 -37.92 81.32 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.141 0.496 . . . . 74.11 110.006 174.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -65.74 -54.78 22.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.441 -0.799 . . . . 71.23 111.269 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.563 ' CE2' ' HA ' ' A' ' 137' ' ' LEU . 4.2 p90 -73.52 -29.8 62.7 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 120.078 -0.649 . . . . 74.31 110.911 -176.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 145' ' ' GLU . 60.5 tttm -55.43 -47.11 76.5 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.677 -0.49 . . . . 71.24 109.677 174.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.466 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 11.4 mmm180 -51.18 -52.18 46.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.903 -1.044 . . . . 74.23 111.609 176.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -70.55 -45.12 66.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.102 -0.499 . . . . 62.43 111.241 -176.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.904 ' HG3' HG21 ' A' ' 12' ' ' ILE . 5.0 tp-100 -63.12 -43.9 97.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.82 -0.627 . . . . 62.1 111.301 -177.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.65 ' HG3' HG23 ' A' ' 12' ' ' ILE . 3.0 tt0 -77.03 -23.0 52.13 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 112.212 0.449 . . . . 74.01 112.212 -177.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 0.7 OUTLIER -63.07 -57.45 10.6 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.809 -0.441 . . . . 72.32 109.809 -179.258 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 159.77 134.58 1.7 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.449 -0.66 . . . . 53.14 111.449 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.407 HD22 ' HA ' ' A' ' 148' ' ' LEU . 1.4 tm? -138.63 113.26 8.99 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.152 0.501 . . . . 74.14 110.297 -178.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 63.59 -103.01 0.11 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.811 -1.086 . . . . 62.41 110.48 177.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -144.85 16.72 1.6 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.989 -0.375 . . . . 65.43 109.989 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -63.58 118.99 8.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 64.02 110.696 -175.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 -116.63 134.2 55.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.441 -0.799 . . . . 73.14 108.968 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.721 ' HA ' ' HG3' ' A' ' 15' ' ' PRO . 2.1 p80 -86.7 132.46 33.86 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.193 -0.603 . . . . 72.41 110.18 -175.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -124.76 103.5 8.12 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.111 -0.7 . . . . 64.55 109.111 176.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 6.6 t60 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.576 -0.726 . . . . 62.23 109.61 -175.155 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.1 ttm . . . . . 0 N--CA 1.479 0.995 0 CA-C-O 120.742 0.306 . . . . 75.53 110.402 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -117.9 -36.9 0.93 Allowed Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 110.994 -0.842 . . . . 63.34 110.994 174.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.431 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 1.1 mp0 -76.71 135.45 39.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.977 -0.611 . . . . 74.53 109.801 177.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.709 ' HB ' ' O ' ' A' ' 110' ' ' TYR . 28.2 m -101.83 121.59 42.38 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.591 -0.892 . . . . 71.33 108.591 175.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.891 HG22 HG22 ' A' ' 109' ' ' THR . 86.0 t -118.17 106.9 20.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.702 -0.681 . . . . 73.1 110.029 -174.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.2 m -114.23 142.56 26.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.198 0.523 . . . . 65.52 110.752 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -136.05 109.66 8.01 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.062 -0.718 . . . . 75.33 109.062 175.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.528 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 1.5 t70 -140.23 171.65 13.86 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.18 -0.674 . . . . 71.1 109.18 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.18 120.56 12.37 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.841 0.353 . . . . 65.34 110.575 -175.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.436 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 12.4 m -102.4 133.52 45.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.121 -0.49 . . . . 54.23 110.183 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.836 HG22 ' HB1' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -84.58 102.34 12.82 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.089 0.471 . . . . 72.34 110.275 -179.171 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.585 HG21 ' HG2' ' A' ' 144' ' ' GLN . 35.7 mm -107.47 138.91 31.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.752 -0.658 . . . . 72.23 111.272 -172.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.583 ' O ' ' HE3' ' A' ' 14' ' ' LYS . . . -85.58 39.9 3.02 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 121.358 -0.449 . . . . 74.34 113.541 -176.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.583 ' HE3' ' O ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -111.49 148.71 39.4 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.301 -0.629 . . . . 74.54 109.301 174.964 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.416 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 82.3 Cg_exo -50.52 -57.75 2.09 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.021 2.481 . . . . 72.45 114.0 -174.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' A' ' 19' ' ' LEU . . . 172.87 -63.48 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.582 0.551 . . . . 73.33 110.817 174.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.425 ' HG3' ' HB2' ' A' ' 71' ' ' PRO . 1.7 tm-20 -64.82 -34.73 79.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.962 -0.563 . . . . 73.24 110.648 -175.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.718 ' HB3' ' HG3' ' A' ' 27' ' ' PRO . 2.4 mp0 -63.41 -15.75 58.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.959 -0.564 . . . . 60.34 111.217 178.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' A' ' 16' ' ' ALA . 66.9 mt -75.1 -23.93 58.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.507 -0.315 . . . . 70.14 111.354 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.54 ' CE1' HG21 ' A' ' 75' ' ' ILE . 48.8 t80 -71.77 -27.25 62.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.183 0.516 . . . . 70.31 110.352 177.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.42 -7.11 34.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.847 -0.615 . . . . 53.3 111.52 -178.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.2 p -63.59 -22.3 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 116.412 -0.358 . . . . 64.54 110.365 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 47.3 t90 -60.27 -31.07 69.87 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.874 -0.603 . . . . 75.03 111.171 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 24' ' ' ARG . 22.2 mtm180 -94.91 -76.46 0.49 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.336 -0.393 . . . . 62.25 110.365 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.446 ' HB3' HD22 ' A' ' 29' ' ' LEU . 19.9 t70 -168.89 48.67 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.915 -0.772 . . . . 72.44 108.915 175.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.713 HD13 ' HA2' ' A' ' 147' ' ' GLY . 24.5 mt 67.56 161.1 0.14 Allowed Pre-proline 0 N--CA 1.468 0.458 0 CA-C-N 114.777 -1.101 . . . . 72.4 111.667 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.718 ' HG3' ' HB3' ' A' ' 18' ' ' GLN . 55.1 Cg_endo -70.62 122.34 8.79 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.483 2.122 . . . . 74.44 111.773 177.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.44 75.15 1.28 Allowed Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.851 -0.899 . . . . 50.23 110.851 -173.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' A' ' 31' ' ' LEU . 80.7 mt -68.87 153.48 95.96 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.364 -0.418 . . . . 72.41 111.591 -175.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -69.55 7.2 0.99 Allowed 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 123.322 2.681 . . . . 74.2 111.139 170.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.488 ' H ' ' C ' ' A' ' 29' ' ' LEU . 1.1 mm? 57.56 15.35 2.75 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.515 1.126 . . . . 63.3 112.218 -177.026 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 53.39 32.96 14.8 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.533 0.521 . . . . 64.01 111.366 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 25.0 ttt 70.83 146.45 0.07 Allowed 'General case' 0 CA--C 1.533 0.317 0 O-C-N 123.824 0.703 . . . . 73.35 111.548 178.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.8 p -73.78 56.94 0.57 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.624 -0.716 . . . . 73.02 111.496 177.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -165.59 -72.24 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.724 0.297 . . . . 65.33 111.74 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.4 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 3.1 pp -95.45 21.17 8.47 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.508 0.558 . . . . 50.11 112.508 -169.006 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -76.61 105.79 7.88 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.36 0.6 . . . . 74.54 111.585 -178.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.7 t -102.18 84.05 2.43 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.34 -0.615 . . . . 62.52 109.34 174.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.419 HG12 HG12 ' A' ' 41' ' ' VAL . 19.0 t -93.21 72.05 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.859 -0.61 . . . . 62.34 110.19 -177.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.634 ' HB3' ' HB2' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -84.83 81.54 8.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.981 -0.554 . . . . 61.41 109.934 179.155 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.419 HG12 HG12 ' A' ' 39' ' ' VAL . 12.5 p -129.11 135.58 61.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.313 -0.858 . . . . 55.24 109.18 175.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.9 tp -127.25 -49.94 1.43 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.982 0.42 . . . . 74.4 110.723 -174.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.544 ' OD2' ' HB2' ' A' ' 45' ' ' LYS . 20.9 t70 -128.33 156.42 43.1 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.972 -0.558 . . . . 72.32 110.024 -178.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -89.9 -19.2 24.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.97 0.414 . . . . 75.25 110.407 -177.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.544 ' HB2' ' OD2' ' A' ' 43' ' ' ASP . 31.7 mmtp -84.04 -60.2 2.17 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.42 -0.585 . . . . 73.53 109.42 174.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -91.0 109.4 20.64 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 115.979 -0.555 . . . . 65.01 109.926 177.305 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.8 t -78.99 133.55 36.84 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.283 -0.871 . . . . 51.31 109.809 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.431 ' NE ' ' HA ' ' A' ' 48' ' ' ARG . 2.4 mmp_? -86.62 -82.23 0.21 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.891 -0.595 . . . . 71.33 110.959 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.634 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 75.8 m95 -133.82 -66.08 0.65 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.493 -0.321 . . . . 72.54 110.823 177.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.604 ' O ' HG12 ' A' ' 51' ' ' VAL . 20.9 m 59.28 77.55 0.3 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.871 -0.788 . . . . 62.33 108.871 -168.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.604 HG12 ' O ' ' A' ' 50' ' ' THR . 1.0 OUTLIER 55.71 -174.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.054 0.941 . . . . 74.12 110.023 -170.732 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.559 ' H ' HG22 ' A' ' 51' ' ' VAL . 8.4 mp0 -82.27 66.06 7.68 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 121.276 -0.89 . . . . 74.25 110.813 178.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -159.66 69.17 3.13 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.83 -0.623 . . . . 60.13 110.616 175.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -86.25 116.06 1.43 Allowed 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.365 2.043 . . . . 55.22 112.573 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.413 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . . . -151.14 86.09 4.9 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 115.76 -0.654 . . . . 30.02 111.34 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 55' ' ' ALA . 19.2 Cg_endo -61.16 -54.85 1.53 Allowed 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.456 2.104 . . . . 62.01 111.294 175.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.685 HD11 ' HB1' ' A' ' 83' ' ' ALA . 3.2 pp -145.73 3.66 0.97 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.742 -0.663 . . . . 72.31 110.636 175.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.436 ' O ' HD12 ' A' ' 57' ' ' LEU . . . 92.74 170.28 40.27 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.301 -0.863 . . . . 71.24 112.128 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 73.23 -61.33 0.51 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.38 0.672 . . . . 62.22 111.181 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.573 HG23 ' HD1' ' A' ' 62' ' ' TRP . 3.2 p -127.4 103.33 10.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.694 0.759 . . . . 50.04 110.967 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.0 m -97.33 73.67 2.46 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.811 -0.631 . . . . 72.11 111.334 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.573 ' HD1' HG23 ' A' ' 60' ' ' VAL . 98.4 m95 -133.74 -36.37 0.95 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.168 0.508 . . . . 74.41 110.883 177.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.74 ' HB2' ' CD2' ' A' ' 80' ' ' LEU . 9.9 mm-40 -138.23 166.2 24.77 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.486 -0.779 . . . . 73.11 109.325 -175.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.952 ' HA ' HD11 ' A' ' 80' ' ' LEU . . . -157.99 158.73 35.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.344 0.592 . . . . 72.01 110.151 166.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 1.04 ' HB3' ' HB2' ' A' ' 79' ' ' SER . 0.2 OUTLIER -161.71 145.11 12.35 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 107.167 -1.419 . . . . 73.13 107.167 -177.253 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.532 HD12 ' HA ' ' A' ' 77' ' ' TRP . 1.4 mm? -114.39 131.88 56.42 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.428 0.529 . . . . 72.53 112.428 -168.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.4 t -92.61 -31.56 15.12 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.834 -0.621 . . . . 64.34 110.601 177.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.517 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -116.32 126.77 53.99 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.864 -0.421 . . . . 72.54 109.864 177.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.529 ' O ' ' HD3' ' A' ' 71' ' ' PRO . 10.0 p-10 -130.66 38.61 3.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.835 -0.62 . . . . 73.51 110.548 -174.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.597 ' HB3' ' HB3' ' A' ' 73' ' ' LYS . 4.5 mm-40 -97.78 88.25 0.6 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.038 -0.528 . . . . 53.22 110.6 -176.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.529 ' HD3' ' O ' ' A' ' 69' ' ' ASP . 33.9 Cg_endo -61.93 -28.61 81.14 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.828 2.352 . . . . 71.22 113.114 -170.089 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -114.63 27.44 8.81 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.658 -0.782 . . . . 54.13 112.293 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.597 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 49.6 tptt -142.55 -61.46 0.44 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.627 0.251 . . . . 74.15 110.943 -178.086 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.546 ' H ' ' HB2' ' A' ' 70' ' ' GLU . 23.0 ptt180 -165.13 140.04 5.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.109 0.481 . . . . 54.25 110.472 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.737 HD13 ' HE2' ' A' ' 93' ' ' PHE . 3.5 mp -121.72 125.5 73.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.147 -0.479 . . . . 64.41 109.9 175.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.517 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -139.11 117.46 11.98 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.79 -0.818 . . . . 51.02 108.79 176.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.532 ' HA ' HD12 ' A' ' 66' ' ' LEU . 10.2 p90 -96.41 120.47 36.79 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.443 -0.503 . . . . 72.41 111.263 -174.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.513 ' HG3' ' O ' ' A' ' 77' ' ' TRP . 17.2 mtt85 174.31 127.68 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 O-C-N 124.339 1.024 . . . . 72.43 112.833 173.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . 1.04 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 50.2 m -150.63 -32.35 0.18 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.757 -0.656 . . . . 72.24 109.954 167.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.952 HD11 ' HA ' ' A' ' 64' ' ' ALA . 3.9 mp -46.78 144.0 3.92 Favored Pre-proline 0 C--O 1.234 0.265 0 N-CA-C 113.125 0.787 . . . . 74.31 113.125 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -77.59 -17.48 14.29 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 123.438 2.759 . . . . 61.43 113.661 -175.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.41 -14.71 12.44 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.479 -0.867 . . . . 71.41 112.31 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.685 ' HB1' HD11 ' A' ' 57' ' ' LEU . . . -90.32 17.38 7.27 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.826 0.346 . . . . 65.23 111.826 -173.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -92.27 6.64 46.03 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.41 0.522 . . . . 74.55 112.41 -173.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.3 tt -67.59 116.39 7.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 107.806 -1.183 . . . . 75.33 107.806 168.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 13.0 pt-20 -77.69 81.01 4.14 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 114.779 1.4 . . . . 64.43 114.779 -160.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -84.77 129.23 34.85 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 104.601 -2.37 . . . . 71.43 104.601 151.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.0 t -94.66 135.56 35.98 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 118.913 -1.115 . . . . 74.21 112.145 -161.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -139.05 41.41 1.35 Allowed Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 114.895 -1.048 . . . . 53.14 111.074 177.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -102.43 113.67 27.2 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.525 -0.546 . . . . 75.35 109.525 177.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.4 m -115.33 132.42 64.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.993 -0.549 . . . . 74.14 110.77 -177.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.6 mp -108.5 130.49 55.26 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.049 -0.523 . . . . 52.43 110.605 178.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.737 ' HE2' HD13 ' A' ' 75' ' ' ILE . 63.3 m-85 -108.9 123.69 49.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.05 0.453 . . . . 73.14 110.332 178.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.568 ' NH1' HG21 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -141.27 152.07 63.25 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.94 -0.573 . . . . 74.03 110.176 177.866 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -52.38 126.86 21.9 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.852 2.368 . . . . 41.13 111.639 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.836 ' HB1' HG22 ' A' ' 11' ' ' THR . . . -92.44 143.17 26.88 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.101 -0.499 . . . . 72.4 111.444 -176.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -71.44 166.04 30.6 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.828 2.352 . . . . 61.04 112.39 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 68.31 17.87 70.79 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.085 -0.579 . . . . 64.03 112.344 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 55.56 27.89 11.05 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 122.733 0.413 . . . . 54.11 111.2 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 58.6 mtt-85 -78.86 -9.76 59.58 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.381 -0.372 . . . . 61.33 111.899 -175.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 119.32 -109.55 1.71 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.205 -0.998 . . . . 43.45 112.445 176.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.44 ' HB ' HD11 ' A' ' 19' ' ' LEU . 23.8 m -125.71 133.95 51.96 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.08 0.467 . . . . 75.11 111.18 -178.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.464 ' HB3' ' HG2' ' A' ' 94' ' ' ARG . 37.1 tt0 -87.28 105.05 16.97 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.62 -0.718 . . . . 75.34 109.347 175.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.0 p -89.2 103.3 13.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.864 0.84 . . . . 74.35 109.705 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.568 HG21 ' NH1' ' A' ' 94' ' ' ARG . 27.3 t -89.01 112.89 24.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.694 -1.139 . . . . 74.3 109.855 -177.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.407 ' CG1' HD23 ' A' ' 108' ' ' LEU . 46.8 t -116.12 116.52 52.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.626 -0.716 . . . . 73.24 111.345 -174.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -97.19 113.8 25.44 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.796 -1.187 . . . . 75.21 107.796 169.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.44 HD12 ' CD1' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -123.0 125.36 45.1 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.687 0.279 . . . . 74.31 110.364 -173.502 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.891 HG22 HG22 ' A' ' 5' ' ' VAL . 17.1 p -105.18 116.94 32.8 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.94 -0.393 . . . . 54.02 109.94 173.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.709 ' O ' ' HB ' ' A' ' 4' ' ' THR . 6.7 p90 -173.04 150.85 2.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.76 -0.655 . . . . 70.04 109.802 -176.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.402 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 61.8 mtt-85 -78.0 144.44 67.84 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 109.307 -0.627 . . . . 71.54 109.307 173.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.407 ' HD3' ' OG1' ' A' ' 4' ' ' THR . 35.5 Cg_exo -60.78 152.7 67.95 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.374 2.05 . . . . 71.11 112.154 -176.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.04 139.5 67.57 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.718 2.279 . . . . 70.34 112.048 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.27 117.37 1.04 Allowed Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.775 -0.726 . . . . 41.01 112.374 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 109.11 -94.32 0.83 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.646 -0.788 . . . . 44.33 113.049 177.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.6 t -62.96 -49.08 76.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.803 0.335 . . . . 73.32 111.176 -172.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.462 ' HA ' HG22 ' A' ' 120' ' ' VAL . . . -61.78 -30.72 70.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 43.35 111.042 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.72 -22.35 73.54 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.975 -0.631 . . . . 74.45 112.356 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.07 -40.28 17.0 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.766 0.317 . . . . 62.12 111.058 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 117' ' ' ALA . 33.3 m -74.71 -32.92 29.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 111.939 0.348 . . . . 74.1 111.939 -175.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.464 ' HA ' ' HG2' ' A' ' 124' ' ' MET . 37.3 pt -69.71 -23.97 26.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.895 0.378 . . . . 74.31 110.882 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.0 -21.04 60.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.957 -0.565 . . . . 30.21 110.912 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -86.27 -43.36 13.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.055 0.455 . . . . 75.41 110.555 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.464 ' HG2' ' HA ' ' A' ' 121' ' ' ILE . 23.6 ptp -72.4 -26.85 62.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 73.52 111.238 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 63.62 -85.74 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.235 0.614 . . . . 70.12 112.302 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 69.23 -55.05 0.57 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.426 0.69 . . . . 62.23 109.764 -168.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.64 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 0.0 OUTLIER -155.52 -164.21 1.69 Allowed 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 106.982 -1.488 . . . . 73.24 106.982 177.538 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -97.44 89.6 0.73 Allowed Pre-proline 0 C--N 1.318 -0.773 0 N-CA-C 109.654 -0.499 . . . . 64.31 109.654 169.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.64 ' HD3' ' O ' ' A' ' 127' ' ' GLN . 72.9 Cg_exo -46.14 129.75 13.05 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.58 2.853 . . . . 71.01 112.942 -170.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 43.9 t -90.41 148.18 22.97 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.553 -0.749 . . . . 73.2 110.465 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -70.12 -10.09 57.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.843 -0.617 . . . . 73.2 111.547 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -149.42 108.32 3.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.777 0.322 . . . . 52.33 110.14 175.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.711 ' HG ' ' H ' ' A' ' 134' ' ' ARG . 3.3 tp -175.61 -172.59 0.56 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.632 -0.877 . . . . 63.12 108.632 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.711 ' H ' ' HG ' ' A' ' 133' ' ' LEU . 8.4 mpt_? -85.46 30.16 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.656 -0.498 . . . . 75.24 109.656 171.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -48.82 -49.79 37.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.958 -1.019 . . . . 74.05 112.393 -172.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -67.77 -39.71 84.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.899 0.38 . . . . 72.42 111.548 -176.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.528 ' CD2' ' HB3' ' A' ' 8' ' ' ASP . 12.6 tp -79.67 -20.92 45.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.469 -0.332 . . . . 73.35 110.858 -175.092 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.553 ' HG2' ' O ' ' A' ' 134' ' ' ARG . 24.2 mmt -69.18 -44.01 73.07 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.652 0.263 . . . . 72.32 111.096 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.406 ' HD2' ' SD ' ' A' ' 124' ' ' MET . 89.8 mtm-85 -64.55 -42.64 95.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.956 0.408 . . . . 71.42 110.322 178.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -59.84 -45.47 92.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.278 -0.874 . . . . 71.42 110.152 176.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 39.5 tttp -58.05 -51.47 69.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.884 -0.598 . . . . 73.21 111.632 177.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 -56.61 -40.87 76.09 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.067 -0.515 . . . . 71.3 111.805 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -79.22 -36.06 40.69 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.668 -0.413 . . . . 74.13 110.764 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.653 ' HA ' HD21 ' A' ' 26' ' ' LEU . 61.4 tt0 -63.41 -43.57 97.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 74.31 111.42 -176.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.514 ' HB3' HG23 ' A' ' 12' ' ' ILE . 12.1 pt-20 -77.21 -24.06 51.34 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 120.83 -0.348 . . . . 74.22 111.023 -179.082 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 62.2 tp -66.27 -61.39 2.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.294 -0.412 . . . . 73.22 110.088 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.713 ' HA2' HD13 ' A' ' 26' ' ' LEU . . . 61.19 39.42 97.14 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.828 -0.701 . . . . 71.22 111.618 -177.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 60.2 tp 68.67 -73.5 0.09 Allowed 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.304 0.642 . . . . 70.44 111.07 -175.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.451 ' OE1' ' HB3' ' A' ' 152' ' ' HIS . 3.2 mm-40 63.79 164.43 0.13 Allowed 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.055 0.542 . . . . 64.24 111.693 -175.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -176.51 89.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.964 -0.562 . . . . 64.21 110.899 -175.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 21.9 t60 43.98 65.07 1.09 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.651 -0.704 . . . . 73.13 110.535 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.451 ' HB3' ' OE1' ' A' ' 149' ' ' GLU . 38.7 t-80 -155.36 -44.69 0.08 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.48 -0.782 . . . . 63.3 109.939 -172.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.432 ' O ' ' HB3' ' A' ' 154' ' ' HIS . 5.1 p80 43.06 51.18 5.48 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.8 1.24 . . . . 71.0 112.262 175.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.432 ' HB3' ' O ' ' A' ' 153' ' ' HIS . 78.0 t60 69.71 -74.01 0.09 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.772 -0.649 . . . . 72.43 109.616 -177.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 . . . . . 0 C--O 1.247 0.95 0 CA-C-O 118.218 -0.896 . . . . 74.51 109.515 169.11 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.982 0.42 . . . . 63.31 110.385 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 133.77 -57.39 0.71 Allowed Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.373 -1.091 . . . . 64.24 110.373 -177.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -112.96 151.11 30.95 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.29 -1.004 . . . . 74.2 108.29 171.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.707 ' HB ' ' O ' ' A' ' 110' ' ' TYR . 11.5 m -76.13 120.33 21.27 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.417 0.627 . . . . 74.21 110.686 -176.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.98 141.46 45.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.525 -0.761 . . . . 72.32 109.37 177.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.729 ' HB ' ' CE1' ' A' ' 110' ' ' TYR . 12.2 p -118.35 140.18 42.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.139 0.495 . . . . 61.22 110.515 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.567 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -136.32 109.73 7.91 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.542 -0.911 . . . . 64.32 108.542 172.152 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.544 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 4.2 t70 -132.17 171.38 13.73 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.653 -0.869 . . . . 72.04 108.653 -178.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.709 ' HB2' HG12 ' A' ' 105' ' ' VAL . . . -141.17 121.96 14.39 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.114 0.483 . . . . 73.15 111.366 -173.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.477 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 14.3 m -111.9 136.62 47.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.727 -0.67 . . . . 44.14 109.915 176.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.8 m -88.75 107.41 18.94 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.291 -0.413 . . . . 75.34 110.06 -178.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.563 HG23 ' HB3' ' A' ' 145' ' ' GLU . 14.2 mm -105.84 132.68 52.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.233 -0.44 . . . . 73.05 110.52 -176.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.94 58.03 4.94 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.912 -0.661 . . . . 73.44 112.584 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.638 ' HB2' HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -132.28 153.12 81.15 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 108.361 -0.977 . . . . 63.03 108.361 175.827 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.432 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 10.5 Cg_endo -54.6 -58.74 1.1 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.714 2.276 . . . . 73.52 113.692 -172.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . 172.16 -54.1 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.283 0.564 . . . . 65.45 110.808 175.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -55.5 -43.89 76.05 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.111 -0.95 . . . . 74.51 112.256 -174.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.591 ' HA ' ' HB3' ' A' ' 21' ' ' ALA . 2.7 mp0 -79.18 -8.32 58.91 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.043 -0.526 . . . . 72.21 111.172 -174.114 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.638 HD21 ' HB2' ' A' ' 14' ' ' LYS . 77.8 mt -73.95 -50.73 18.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.028 -0.533 . . . . 70.54 111.057 178.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.71 ' HB3' ' HZ ' ' A' ' 93' ' ' PHE . 17.1 p90 -74.37 -24.06 59.09 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.784 -0.766 . . . . 73.14 109.487 176.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.591 ' HB3' ' HA ' ' A' ' 18' ' ' GLN . . . -71.39 -2.98 18.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.278 -0.874 . . . . 74.03 111.107 176.037 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.679 HG11 ' HZ ' ' A' ' 140' ' ' PHE . 9.9 p -54.49 -21.57 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.049 -0.523 . . . . 74.02 111.029 176.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 15.5 t90 -60.14 -22.71 63.19 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.993 -0.549 . . . . 54.44 110.693 177.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -109.3 2.12 20.58 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.097 -0.501 . . . . 65.31 110.035 177.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.0 t70 55.54 80.35 0.14 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.899 -0.591 . . . . 73.55 110.87 -176.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.562 HD12 ' H ' ' A' ' 148' ' ' LEU . 68.5 mt 45.18 85.6 0.16 Allowed Pre-proline 0 N--CA 1.47 0.547 0 CA-C-N 115.544 -0.753 . . . . 74.13 111.998 -178.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 26' ' ' LEU . 10.9 Cg_endo -52.57 116.02 2.59 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.63 2.887 . . . . 64.32 113.336 -173.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -132.27 73.96 0.45 Allowed Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 110.618 -0.993 . . . . 45.32 110.618 176.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.643 HD22 HD23 ' A' ' 32' ' ' LEU . 0.4 OUTLIER -137.51 58.48 17.05 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 112.781 0.66 . . . . 54.33 112.781 -173.595 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.462 ' HD3' ' N ' ' A' ' 29' ' ' LEU . 13.9 Cg_exo -70.07 -13.57 34.04 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.206 1.937 . . . . 63.42 111.503 177.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.955 ' H ' HD13 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -89.8 -8.58 51.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.617 -0.719 . . . . 62.1 110.675 177.05 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.643 HD23 HD22 ' A' ' 29' ' ' LEU . 21.9 tp -98.52 29.53 3.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.659 0.742 . . . . 72.53 109.629 -178.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 89.2 mtp -93.67 168.45 11.01 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.311 -0.859 . . . . 63.33 109.269 174.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.805 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 5.7 t -70.97 102.32 2.39 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.489 0.661 . . . . 51.21 111.436 -176.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -164.07 -59.81 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.63 -0.713 . . . . 74.44 110.204 176.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.4 tp -71.54 -58.25 3.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.715 0.293 . . . . 55.2 110.99 -177.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -111.44 15.11 21.41 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.927 0.394 . . . . 55.21 110.109 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.6 m 55.45 35.53 25.25 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.535 -0.757 . . . . 61.15 111.22 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.4 p -74.18 103.54 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.471 0.653 . . . . 71.33 110.83 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.805 ' HB3' ' HB ' ' A' ' 34' ' ' THR . 13.9 pt-20 -146.52 140.24 26.03 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.612 -0.722 . . . . 74.41 109.505 176.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.0 t -84.28 137.36 21.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.048 0.452 . . . . 43.24 110.424 -178.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.401 ' N ' HD22 ' A' ' 42' ' ' LEU . 3.2 mm? -71.67 -63.94 1.03 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.466 -0.788 . . . . 50.14 110.507 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.534 ' HB3' ' HG2' ' A' ' 46' ' ' ARG . 29.0 t70 -81.54 -86.14 0.1 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.14 -0.482 . . . . 72.22 111.116 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -161.89 -63.66 0.05 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.862 0.363 . . . . 43.51 111.156 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.456 ' HD3' ' HA ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -126.43 32.86 5.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.417 0.627 . . . . 73.22 111.03 -172.66 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.534 ' HG2' ' HB3' ' A' ' 43' ' ' ASP . 8.5 ptp180 -130.28 -175.88 3.77 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.402 -0.817 . . . . 74.34 109.958 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.0 m -143.53 178.41 7.79 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.381 -0.372 . . . . 64.23 110.002 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.443 HH11 ' HD3' ' A' ' 48' ' ' ARG . 24.2 ttt180 -161.62 -56.99 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.07 -0.715 . . . . 65.23 109.07 174.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -89.61 -15.89 31.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.492 -0.776 . . . . 74.53 110.199 176.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 45.1 p 53.18 -171.5 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.501 -0.772 . . . . 74.41 111.786 -174.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.75 HG23 ' H ' ' A' ' 52' ' ' GLU . 1.9 m -126.75 -85.17 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.166 0.432 . . . . 64.21 112.166 -177.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.75 ' H ' HG23 ' A' ' 51' ' ' VAL . 29.7 mt-10 -102.99 -81.92 0.5 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.903 0.382 . . . . 71.22 110.387 -177.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.63 84.97 4.95 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.854 -0.612 . . . . 71.12 110.093 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -95.05 -168.51 0.15 Allowed 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 123.14 2.56 . . . . 63.54 111.886 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -161.66 85.73 1.65 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.325 -0.398 . . . . 62.12 110.497 174.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.841 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 14.4 Cg_exo -69.27 -54.24 0.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.591 2.194 . . . . 64.23 111.892 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.789 HD23 HG23 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -98.15 38.02 1.37 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.107 0.479 . . . . 55.0 110.312 -177.42 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.86 -58.89 4.59 Favored Glycine 0 C--N 1.318 -0.425 0 CA-C-N 116.033 -0.531 . . . . 64.13 112.626 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -121.75 -67.24 0.98 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.641 0.257 . . . . 52.14 110.826 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.789 HG23 HD23 ' A' ' 57' ' ' LEU . 15.6 m -55.99 140.01 14.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.254 -0.43 . . . . 60.12 110.584 178.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.533 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . 25.1 m -134.52 102.08 5.19 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.306 0.484 . . . . 71.54 112.306 -171.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 21.6 p-90 -157.48 -36.69 0.07 Allowed 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 120.991 -0.284 . . . . 63.23 111.507 173.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.631 ' HB3' HD11 ' A' ' 80' ' ' LEU . 34.7 tt0 -153.58 154.45 34.27 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.249 -0.432 . . . . 64.13 110.613 177.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.841 ' HB2' ' HB3' ' A' ' 56' ' ' PRO . . . -135.17 143.16 46.31 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.918 -0.771 . . . . 42.33 108.918 174.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.621 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -108.56 134.64 51.04 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.429 -0.952 . . . . 74.01 108.429 -175.959 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.448 ' HG ' ' HB3' ' A' ' 45' ' ' LYS . 1.2 mm? -113.83 116.63 29.63 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 121.846 -0.534 . . . . 74.33 110.294 -176.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.449 HG23 ' HB3' ' A' ' 76' ' ' ALA . 7.1 t -78.26 -26.03 47.04 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.627 -0.429 . . . . 71.14 111.568 -174.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . . . -147.42 129.61 15.59 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.767 0.318 . . . . 75.43 110.368 176.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -132.23 7.93 4.3 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.098 -0.501 . . . . 72.24 111.424 -175.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -59.18 93.41 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 123.94 0.896 . . . . 72.15 112.486 -173.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -59.74 114.16 1.94 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.314 2.676 . . . . 74.41 112.642 -169.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.53 6.37 70.66 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.84 -0.695 . . . . 72.43 112.519 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -123.91 -67.94 0.9 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.002 -0.37 . . . . 73.33 110.002 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.427 ' C ' HD12 ' A' ' 75' ' ' ILE . 15.4 ptt180 -150.6 134.9 17.05 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.983 -0.377 . . . . 74.43 109.983 175.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.621 HD13 ' HE2' ' A' ' 93' ' ' PHE . 3.5 mp -126.73 126.52 68.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 109.183 -0.673 . . . . 72.32 109.183 177.128 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.597 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . . . -139.59 120.57 14.57 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.969 -0.559 . . . . 71.21 110.559 -176.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 13.3 m-90 -98.04 152.17 19.57 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.78 -0.646 . . . . 73.33 110.483 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.621 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 1.0 OUTLIER -156.16 175.68 13.66 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.682 -0.858 . . . . 75.01 108.682 175.625 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . 1.053 ' HB2' ' HA ' ' A' ' 85' ' ' ILE . 20.3 m -105.91 -171.07 1.83 Allowed 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 109.672 -0.492 . . . . 71.21 109.672 176.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.631 HD11 ' HB3' ' A' ' 63' ' ' GLU . 12.6 mt -82.79 144.88 49.11 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.631 -0.259 . . . . 72.42 111.075 -175.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.94 -32.36 95.0 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.601 2.2 . . . . 64.23 111.436 173.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.97 35.83 3.86 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.482 -0.647 . . . . 43.24 111.482 175.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -155.01 -173.94 4.78 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.654 -0.498 . . . . 34.43 109.654 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -80.38 101.62 9.11 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.591 -0.522 . . . . 73.54 109.591 172.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 1.053 ' HA ' ' HB2' ' A' ' 79' ' ' SER . 0.0 OUTLIER -70.04 -51.37 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 116.175 -0.466 . . . . 75.3 109.777 -179.071 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 47.78 -83.25 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.371 1.068 . . . . 55.43 113.608 175.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -64.69 132.51 49.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.588 0.709 . . . . 54.53 111.52 -175.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.1 m -139.5 128.73 23.95 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.537 -0.756 . . . . 62.11 109.548 176.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.25 145.15 9.16 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.716 -0.754 . . . . 62.31 112.064 -178.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.597 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 43.4 tt0 -138.57 125.61 21.31 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.077 -0.342 . . . . 65.14 110.077 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.1 m -106.75 128.07 61.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.121 0.486 . . . . 64.21 110.223 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.671 ' HB2' HG23 ' A' ' 105' ' ' VAL . 9.1 mp -110.53 145.7 37.3 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.463 -0.569 . . . . 65.42 109.463 173.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.71 ' HZ ' ' HB3' ' A' ' 20' ' ' TYR . 73.9 m-85 -110.07 106.72 16.32 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.094 0.473 . . . . 65.14 111.104 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.411 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 99.8 mtt180 -112.3 142.87 27.74 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.304 -0.628 . . . . 74.5 109.304 175.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 94' ' ' ARG . 9.2 Cg_exo -72.16 125.19 10.63 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.421 2.08 . . . . 75.12 111.327 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.89 144.51 98.86 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.239 -0.652 . . . . 62.14 109.239 176.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -39.32 119.64 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.623 2.882 . . . . 75.45 113.622 -174.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 90.82 8.97 64.69 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.011 -0.614 . . . . 54.51 112.642 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 59.01 36.04 24.24 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.201 0.524 . . . . 74.33 110.427 -178.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -73.79 -65.42 0.83 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.672 -0.695 . . . . 61.34 110.458 -178.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -131.78 -167.85 11.97 Favored Glycine 0 N--CA 1.439 -1.127 0 N-CA-C 110.512 -1.035 . . . . 72.14 110.512 176.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.482 ' HB ' HD11 ' A' ' 19' ' ' LEU . 10.7 m -110.45 122.71 48.38 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.023 0.439 . . . . 73.1 110.182 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.511 ' HG2' ' HB1' ' A' ' 9' ' ' ALA . 41.3 tt0 -92.4 106.5 18.48 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.455 -0.943 . . . . 75.41 108.455 178.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 5.2 m -86.72 128.88 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 CA-C-O 121.393 0.615 . . . . 70.0 109.506 -177.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.709 HG12 ' HB2' ' A' ' 9' ' ' ALA . 3.5 m -108.95 114.98 48.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.521 -0.763 . . . . 65.21 109.797 178.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 40.1 t -110.02 119.12 58.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.828 -0.623 . . . . 64.31 111.377 -173.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -107.06 116.48 32.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.633 -0.712 . . . . 71.03 109.739 175.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.5 pp -147.0 151.69 37.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.934 0.397 . . . . 75.53 111.085 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.1 t -90.09 144.85 25.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.93 -0.577 . . . . 74.54 110.18 178.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.729 ' CE1' ' HB ' ' A' ' 6' ' ' VAL . 5.7 p90 -164.33 156.92 17.03 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.921 -0.4 . . . . 54.3 109.921 -178.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -134.71 144.68 51.7 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 116.619 -0.264 . . . . 73.34 110.383 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 39.7 Cg_endo -67.13 153.88 76.17 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.511 2.141 . . . . 74.52 111.691 -178.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 15.3 Cg_exo -68.64 108.69 1.91 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.738 2.292 . . . . 73.44 112.442 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -114.99 97.33 0.81 Allowed Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.638 -0.71 . . . . 54.43 111.352 175.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -165.95 144.13 8.95 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.637 -0.792 . . . . 55.32 112.342 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 38.0 t -86.29 -23.73 26.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.988 0.423 . . . . 55.11 110.572 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -68.41 -29.09 67.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.146 -0.479 . . . . 72.3 111.641 -174.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.456 ' O ' HG22 ' A' ' 121' ' ' ILE . . . -69.73 -19.68 75.18 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.098 -0.572 . . . . 44.34 113.041 -178.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.26 -20.34 65.99 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.307 0.484 . . . . 62.2 112.307 -174.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.57 -19.48 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.785 0.326 . . . . 73.22 111.723 -176.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.456 HG22 ' O ' ' A' ' 118' ' ' GLY . 13.8 tt -67.62 -22.64 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 121.032 0.444 . . . . 70.51 110.967 -177.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.54 -20.85 63.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.269 -0.423 . . . . 61.42 111.191 -178.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -71.03 -28.93 64.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.057 -0.52 . . . . 72.23 110.776 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.5 ttm -71.04 -53.62 14.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 74.44 111.153 -175.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -107.73 -79.63 0.58 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.121 0.486 . . . . 71.15 110.347 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -164.61 -55.89 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.258 -1.016 . . . . 64.12 108.258 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -177.65 147.75 0.52 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.884 -1.053 . . . . 75.34 109.9 171.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.46 ' HA ' ' HD2' ' A' ' 129' ' ' PRO . 28.5 tt0 -120.41 87.56 40.9 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 108.405 -0.961 . . . . 74.11 108.405 171.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 128' ' ' GLU . 1.7 Cg_endo -40.11 129.81 2.22 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 124.482 3.455 . . . . 71.35 113.635 -171.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.8 m -71.13 97.9 1.58 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.746 -0.661 . . . . 73.25 109.859 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -71.35 106.12 3.77 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.69 -0.686 . . . . 74.53 111.12 -176.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -111.6 72.2 0.77 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.323 -0.992 . . . . 64.1 108.323 174.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.33 -154.58 0.54 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.036 -0.984 . . . . 72.44 109.265 -178.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.549 ' O ' ' HG2' ' A' ' 138' ' ' MET . 51.0 mtp180 -93.16 14.2 18.76 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.061 -0.718 . . . . 74.21 109.061 173.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -57.22 -38.6 73.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.882 -1.054 . . . . 72.01 112.996 -171.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.48 -42.57 98.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.889 0.376 . . . . 60.23 110.889 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.544 ' CD2' ' HB3' ' A' ' 8' ' ' ASP . 13.9 tp -79.4 -20.95 46.37 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.254 -0.43 . . . . 71.43 110.112 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.549 ' HG2' ' O ' ' A' ' 134' ' ' ARG . 30.4 mmt -69.48 -47.51 63.68 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.307 -0.406 . . . . 60.42 110.268 175.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.07 -43.28 99.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.094 -0.503 . . . . 71.32 110.092 174.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.679 ' HZ ' HG11 ' A' ' 22' ' ' VAL . 67.8 t80 -57.22 -48.9 77.64 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.228 -0.897 . . . . 75.12 111.004 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.8 tttp -54.81 -56.23 21.63 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.185 -0.462 . . . . 75.11 111.727 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -55.49 -42.82 74.94 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.821 0.343 . . . . 62.35 111.737 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -75.49 -27.44 58.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.486 -0.325 . . . . 60.13 111.4 -178.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -80.94 -39.13 26.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.056 -0.52 . . . . 74.44 111.216 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.563 ' HB3' HG23 ' A' ' 12' ' ' ILE . 16.9 pt-20 -80.57 -36.85 32.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.55 -0.296 . . . . 73.35 111.495 -176.086 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.1 tt -71.79 -63.01 1.21 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.781 -0.452 . . . . 75.11 109.781 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.442 ' HA3' HD11 ' A' ' 26' ' ' LEU . . . 64.13 -172.73 16.01 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.652 -0.704 . . . . 72.33 113.486 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.562 ' H ' HD12 ' A' ' 26' ' ' LEU . 5.8 mp -116.63 164.53 14.48 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.681 -0.488 . . . . 63.24 109.681 178.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -59.86 118.19 5.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.117 0.484 . . . . 71.32 111.732 -175.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -148.23 168.74 21.7 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.75 -0.833 . . . . 75.31 108.75 177.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -80.53 148.2 30.49 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.228 -0.286 . . . . 75.41 110.228 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 40.5 m-70 -79.52 115.09 18.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.6 -0.273 . . . . 72.55 111.009 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -104.55 125.55 50.8 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.745 -0.465 . . . . 74.44 109.745 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -107.25 158.57 17.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.948 -0.569 . . . . 75.13 109.743 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 3.4 p80 . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.661 -0.685 . . . . 63.13 109.546 176.737 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 109.83 -0.433 . . . . 75.3 109.83 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -112.93 -114.8 3.29 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.538 -1.025 . . . . 55.12 110.538 175.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -71.75 120.84 17.92 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.691 -0.855 . . . . 64.43 108.691 173.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.6 m -83.6 133.83 34.83 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.014 0.435 . . . . 62.43 111.418 -173.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -120.21 119.15 59.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.145 -0.687 . . . . 64.51 109.145 173.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 71.4 t -101.16 116.76 45.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 121.303 0.573 . . . . 71.21 110.881 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -132.21 109.84 10.22 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.981 -1.008 . . . . 75.41 108.638 176.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.485 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 1.3 t70 -141.47 146.15 36.11 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.836 -1.172 . . . . 52.44 107.836 175.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -122.8 140.25 53.13 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.135 0.493 . . . . 62.34 110.982 -173.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.605 ' CG2' ' HG2' ' A' ' 141' ' ' LYS . 2.5 m -133.85 142.28 41.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.47 -0.786 . . . . 74.52 110.469 -176.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 29.7 m -94.0 133.7 37.17 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.975 -0.557 . . . . 72.13 111.125 -175.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.808 HD11 ' HG3' ' A' ' 141' ' ' LYS . 35.3 mt -121.38 140.15 46.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.654 -0.703 . . . . 72.12 109.917 172.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.538 ' H ' ' HB3' ' A' ' 145' ' ' GLU . . . -83.31 62.35 4.64 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.991 -0.624 . . . . 74.43 112.555 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.566 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 7.4 mmpt? -144.59 144.8 26.13 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 109.183 -0.673 . . . . 73.33 109.183 175.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.408 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 72.8 Cg_exo -51.81 -56.3 3.09 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.25 2.633 . . . . 72.52 113.945 -176.349 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . 174.51 -63.11 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.686 0.279 . . . . 74.31 110.836 177.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -50.23 -42.57 51.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.553 -0.749 . . . . 73.04 111.428 -176.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.598 ' HG3' ' HD2' ' A' ' 27' ' ' PRO . 2.6 mp0 -61.61 -23.55 66.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.727 -0.67 . . . . 62.41 111.863 -177.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.6 mt -77.8 -34.32 52.21 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.95 0.352 . . . . 61.41 111.95 -176.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -71.73 -28.07 63.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.644 0.735 . . . . 63.45 109.421 177.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.434 ' HB2' HG21 ' A' ' 39' ' ' VAL . . . -76.22 -2.69 32.52 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 114.901 -1.045 . . . . 73.43 112.385 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.829 HG21 ' HZ ' ' A' ' 140' ' ' PHE . 10.9 p -53.01 -22.56 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 113.042 0.756 . . . . 63.22 113.042 -174.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 23.2 m0 -63.18 -14.1 44.99 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.703 0.631 . . . . 74.34 112.703 -176.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.463 ' HA ' ' HD3' ' A' ' 24' ' ' ARG . 25.8 mmt180 -121.84 -80.15 0.62 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.407 -0.183 . . . . 75.22 110.624 175.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 26' ' ' LEU . 8.3 t70 -172.19 53.63 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.549 -0.537 . . . . 74.13 109.549 176.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 9.1 mp 66.37 165.89 0.12 Allowed Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 115.409 -0.814 . . . . 50.22 110.771 -178.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.598 ' HD2' ' HG3' ' A' ' 18' ' ' GLN . 35.4 Cg_exo -58.75 122.11 11.09 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.38 2.053 . . . . 73.33 111.781 177.085 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 160.17 103.26 0.19 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.685 -0.769 . . . . 72.42 112.093 -178.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 62.1 mt -128.21 62.72 59.76 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 120.624 0.25 . . . . 73.14 110.626 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -87.79 60.54 3.38 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.218 1.945 . . . . 65.44 112.572 -175.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.503 ' N ' HD13 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -145.63 7.73 1.12 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.409 -0.814 . . . . 74.34 109.079 173.359 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 32' ' ' LEU . 3.3 pp -154.41 144.98 22.28 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.523 -1.217 . . . . 70.31 107.725 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 56.6 mtt -78.31 -78.87 0.13 Allowed 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 121.0 -0.28 . . . . 61.44 110.31 176.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.847 HG22 ' H ' ' A' ' 35' ' ' HIS . 2.4 m 54.48 -163.54 0.12 Allowed 'General case' 0 CA--C 1.546 0.814 0 O-C-N 123.265 0.353 . . . . 70.42 111.06 176.121 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.847 ' H ' HG22 ' A' ' 34' ' ' THR . 2.3 t-80 -74.47 -161.56 0.13 Allowed 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 109.848 -0.427 . . . . 71.51 109.848 173.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.4 tp -55.35 -20.14 10.88 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.785 0.661 . . . . 72.02 112.785 -176.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.559 ' HG3' ' O ' ' A' ' 35' ' ' HIS . 52.5 mtt180 74.0 -71.32 0.13 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.487 0.715 . . . . 63.31 111.133 175.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.4 m 65.35 -84.88 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.085 -0.961 . . . . 53.52 110.315 -170.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.583 HG12 ' H ' ' A' ' 40' ' ' GLU . 2.1 t -144.33 172.8 5.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.427 -0.583 . . . . 72.31 109.427 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.583 ' H ' HG12 ' A' ' 39' ' ' VAL . 19.4 tt0 -77.08 77.54 3.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.145 0.498 . . . . 75.45 110.582 179.121 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.0 t -133.67 131.82 56.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.568 -0.901 . . . . 72.35 108.568 175.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.631 ' HB3' ' HB ' ' A' ' 50' ' ' THR . 3.3 pp -65.25 -37.2 86.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.934 0.397 . . . . 74.33 111.884 -171.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.628 ' N ' HD12 ' A' ' 42' ' ' LEU . 28.0 t70 -124.85 -161.76 1.04 Allowed 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.754 -0.832 . . . . 74.05 108.754 176.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.501 ' H ' ' CG ' ' A' ' 43' ' ' ASP . 10.7 m-20 -102.54 9.57 39.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.479 0.657 . . . . 63.51 109.6 178.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.704 ' HG3' ' HB3' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -103.84 -80.19 0.53 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.136 -0.938 . . . . 75.03 111.451 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.648 ' HG3' ' HB3' ' A' ' 64' ' ' ALA . 0.1 OUTLIER -145.03 -167.05 2.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.566 -0.288 . . . . 73.23 111.466 -172.482 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.0 m 64.98 -179.66 0.18 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.55 -0.75 . . . . 63.33 111.573 -177.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -143.69 -164.29 1.84 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 122.399 -0.188 . . . . 71.13 110.708 -173.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 77.5 t-105 75.41 -65.4 0.33 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.814 0.846 . . . . 74.45 113.146 170.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.631 ' HB ' ' HB3' ' A' ' 42' ' ' LEU . 2.4 m -81.64 169.83 16.54 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.637 -0.134 . . . . 63.42 110.637 -176.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.414 ' H ' HG22 ' A' ' 50' ' ' THR . 7.5 p -151.89 23.26 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 122.248 1.023 . . . . 71.14 109.555 176.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.504 ' H ' HG22 ' A' ' 50' ' ' THR . 9.0 tm-20 -103.08 3.89 36.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.121 -0.945 . . . . 74.31 110.388 -173.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 61.07 68.72 1.19 Allowed Pre-proline 0 N--CA 1.465 0.311 0 CA-C-N 115.701 -0.681 . . . . 71.13 111.773 -175.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.528 ' CD ' ' HB2' ' A' ' 42' ' ' LEU . 87.8 Cg_endo -96.05 -162.4 0.08 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 124.04 3.16 . . . . 64.34 111.434 174.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.04 142.77 45.3 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.281 -0.418 . . . . 42.1 110.613 176.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.87 -28.2 86.66 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.95 2.433 . . . . 72.13 113.009 -174.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.785 ' HB2' ' HG2' ' A' ' 63' ' ' GLU . 1.3 pt? -104.27 -10.19 18.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.256 -0.429 . . . . 72.03 111.736 -175.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 58.51 -109.43 1.97 Allowed Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.74 -0.743 . . . . 35.13 112.875 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -93.64 16.04 14.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.716 0.293 . . . . 70.22 111.59 -176.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.403 HG22 HD11 ' A' ' 57' ' ' LEU . 4.1 t 64.04 33.14 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 121.789 0.804 . . . . 74.53 110.68 176.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' A' ' 62' ' ' TRP . 30.8 m -141.87 131.67 24.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.792 -0.64 . . . . 64.25 110.035 175.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.449 ' HB2' ' O ' ' A' ' 61' ' ' SER . 2.5 m-90 71.53 6.13 5.62 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 123.636 0.585 . . . . 74.41 111.631 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.785 ' HG2' ' HB2' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -84.34 165.6 18.11 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.469 -0.787 . . . . 75.25 112.351 -176.828 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.648 ' HB3' ' HG3' ' A' ' 46' ' ' ARG . . . -162.14 160.61 27.42 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.429 -1.26 . . . . 63.52 108.582 176.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.574 ' HB2' ' HA ' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -108.05 133.97 51.6 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.986 -1.116 . . . . 65.14 107.986 177.01 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.704 ' HB3' ' HG3' ' A' ' 45' ' ' LYS . 40.1 tp -105.49 117.81 34.96 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.651 -0.82 . . . . 74.33 110.713 -169.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.8 t -93.32 -13.86 27.63 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.003 -0.544 . . . . 43.13 111.126 -175.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.464 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -147.25 125.16 11.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.952 0.406 . . . . 73.02 110.806 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.542 ' HB3' ' CD2' ' A' ' 66' ' ' LEU . 4.1 p-10 -140.19 40.5 1.94 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.498 -0.774 . . . . 72.44 109.835 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -60.03 144.96 85.9 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.078 -0.964 . . . . 75.55 109.919 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -47.25 -41.34 27.84 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.826 3.017 . . . . 73.11 113.451 -173.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -166.57 33.26 0.22 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.352 -0.928 . . . . 60.13 112.215 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -97.21 -63.46 1.13 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.164 0.507 . . . . 71.42 110.523 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 74' ' ' ARG . 3.5 ptp85 -161.51 140.84 10.1 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.758 -0.83 . . . . 71.44 108.758 177.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 68.5 mt -121.99 109.81 25.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 109.412 -0.588 . . . . 64.32 109.412 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.637 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . . . -111.34 115.32 29.1 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.975 -0.557 . . . . 75.51 110.499 -177.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 23.5 p-90 -96.1 124.09 39.97 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.921 0.867 . . . . 73.31 110.086 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.468 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 30.9 mmt180 -113.67 176.15 5.15 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.353 -1.351 . . . . 63.41 107.353 178.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.866 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 16.5 m -99.12 163.98 12.35 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 118.839 -1.144 . . . . 73.35 110.187 174.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.651 ' CD2' ' HB3' ' A' ' 57' ' ' LEU . 4.4 mp -69.55 161.5 73.62 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.885 -0.598 . . . . 64.2 110.784 -176.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.14 -40.82 75.81 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.769 2.313 . . . . 62.53 112.252 177.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.0 -20.86 58.56 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.786 -0.721 . . . . 73.5 112.327 178.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.428 ' HA ' ' NH1' ' A' ' 84' ' ' ARG . . . -82.38 167.31 18.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.749 0.309 . . . . 74.32 110.728 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.428 ' NH1' ' HA ' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -82.16 104.71 12.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.003 0.43 . . . . 62.31 110.507 -176.639 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.866 ' HB ' ' HB2' ' A' ' 79' ' ' SER . 6.8 tt -117.44 116.81 53.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.867 -0.606 . . . . 51.41 110.517 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -153.55 -42.15 0.09 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.052 -0.522 . . . . 52.34 109.961 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -77.18 154.17 33.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.123 -0.489 . . . . 73.23 110.166 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.4 m -96.13 127.64 42.32 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.363 -0.381 . . . . 63.12 110.65 -178.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -122.49 61.53 0.55 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.942 -0.647 . . . . 54.34 111.524 177.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.637 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 39.3 tt0 -102.69 121.97 43.51 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 122.627 -0.337 . . . . 71.23 110.661 -176.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.675 HG22 HG22 ' A' ' 106' ' ' VAL . 83.0 t -112.79 122.03 66.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.273 0.558 . . . . 74.42 110.684 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.906 ' HB2' ' HB ' ' A' ' 105' ' ' VAL . 10.1 mp -96.19 142.34 28.48 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.597 -0.729 . . . . 62.11 110.104 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -121.55 115.9 23.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.152 -0.476 . . . . 74.33 110.164 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.413 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 34.9 ptt180 -141.08 144.65 35.75 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.318 -0.401 . . . . 75.54 110.567 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 94' ' ' ARG . 45.0 Cg_exo -56.67 134.72 66.21 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.679 2.253 . . . . 70.55 111.932 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -94.61 145.04 28.93 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.996 -0.547 . . . . 75.15 111.706 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -54.12 151.33 28.46 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.088 2.525 . . . . 73.14 112.361 175.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.49 -0.89 79.42 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.72 -0.753 . . . . 51.32 111.251 -178.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 59.57 33.93 22.24 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 122.8 0.44 . . . . 53.01 111.031 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -64.09 -42.89 96.76 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.19 0.519 . . . . 71.51 110.419 176.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 162.24 -122.37 1.1 Allowed Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 115.46 -0.791 . . . . 73.33 111.421 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 39.3 m -128.72 135.09 48.76 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.564 0.697 . . . . 73.22 111.003 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -90.88 131.27 36.62 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.867 -1.061 . . . . 72.02 110.181 -178.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.454 HG22 HG23 ' A' ' 10' ' ' VAL . 17.9 m -87.41 131.58 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 108.164 -1.05 . . . . 62.13 108.164 173.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.906 ' HB ' ' HB2' ' A' ' 92' ' ' LEU . 44.3 t -123.1 111.49 29.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 116.022 -0.536 . . . . 74.01 110.391 -174.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.675 HG22 HG22 ' A' ' 91' ' ' VAL . 37.9 t -128.29 121.2 55.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.405 -0.361 . . . . 64.11 111.12 -177.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.578 ' O ' ' HD2' ' A' ' 107' ' ' ARG . 0.4 OUTLIER -107.05 108.83 20.51 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.278 0.561 . . . . 71.2 109.816 170.6 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 50.1 tp -114.19 142.82 45.76 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.032 -0.531 . . . . 55.32 110.847 -175.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.8 t -93.95 142.33 27.51 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.006 -0.543 . . . . 74.21 110.498 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -129.36 112.49 13.89 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.934 -0.575 . . . . 71.14 110.234 177.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 111' ' ' ARG . 14.3 mtm180 -107.85 158.19 34.1 Favored Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 109.227 -0.657 . . . . 74.14 109.227 178.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.464 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 37.1 Cg_exo -58.52 151.78 59.68 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.113 1.875 . . . . 65.15 111.935 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 16.0 Cg_exo -70.03 -54.15 0.22 Allowed 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.915 2.41 . . . . 72.34 111.972 -178.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -163.83 -79.49 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.906 -0.664 . . . . 62.1 111.842 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -124.73 -165.77 12.24 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.66 -0.781 . . . . 75.53 112.472 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.3 t -78.96 -26.97 43.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.51 0.195 . . . . 63.35 111.36 -175.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.65 -34.6 71.39 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.563 0.22 . . . . 61.31 111.448 -176.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.69 -31.82 76.89 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.922 -0.656 . . . . 73.23 112.397 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.96 -38.21 37.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.843 0.354 . . . . 63.33 110.588 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 93.4 t -61.32 -50.0 82.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.916 -0.584 . . . . 74.21 110.954 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.6 tp -65.8 -34.13 68.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 70.11 110.808 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.31 -37.11 84.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.443 -0.344 . . . . 50.42 111.192 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 70.2 ttp85 -68.33 -48.12 65.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.32 -0.4 . . . . 64.13 110.935 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 27.2 ptm -71.16 -28.49 64.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.437 -0.347 . . . . 71.05 111.154 -177.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -72.32 -41.65 66.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.385 -0.37 . . . . 72.31 110.456 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 49.3 t30 69.59 110.93 0.05 Allowed 'General case' 0 N--CA 1.469 0.488 0 O-C-N 124.129 0.893 . . . . 55.34 111.117 -177.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -104.14 139.5 39.11 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.748 -0.66 . . . . 73.25 110.678 -177.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -70.89 154.89 94.03 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.292 -0.413 . . . . 72.21 110.474 175.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.74 64.03 3.11 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.149 2.566 . . . . 72.22 112.7 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 131' ' ' GLN . 8.3 t -111.33 124.42 52.2 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.422 -0.955 . . . . 53.21 108.422 175.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 130' ' ' SER . 55.0 mt-30 70.31 153.55 0.12 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.839 0.712 . . . . 72.21 110.548 -171.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 64.06 -171.51 0.18 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.971 -0.559 . . . . 73.12 110.778 -177.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.4 mt 61.99 -168.92 0.18 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.115 -0.493 . . . . 52.53 110.692 -178.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -108.34 -13.84 14.8 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.771 -0.455 . . . . 73.24 109.771 176.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -60.7 -55.33 34.56 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.615 -0.72 . . . . 54.41 110.455 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -66.48 -30.84 71.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.16 0.505 . . . . 60.32 110.347 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.666 ' O ' ' HD3' ' A' ' 141' ' ' LYS . 43.5 tp -65.12 -48.24 74.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.616 -0.72 . . . . 72.45 110.167 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.415 ' HA ' ' CE ' ' A' ' 138' ' ' MET . 3.1 tpt -75.03 -35.12 61.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.494 -0.321 . . . . 74.54 110.692 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.9 ttm-85 -52.67 -54.8 28.39 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.969 -0.56 . . . . 73.51 111.124 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.829 ' HZ ' HG21 ' A' ' 22' ' ' VAL . 54.1 t80 -67.8 -46.05 73.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.799 -0.637 . . . . 65.31 111.625 -177.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.808 ' HG3' HD11 ' A' ' 12' ' ' ILE . 14.0 mptt -64.75 -35.04 79.8 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 111.94 0.348 . . . . 73.13 111.94 -173.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.432 ' HD3' ' HA ' ' A' ' 142' ' ' ARG . 16.7 mmt180 -66.32 -31.64 72.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.606 0.241 . . . . 64.45 111.308 177.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -79.67 -35.76 38.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.942 0.401 . . . . 75.15 110.443 176.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.406 ' HG2' HD13 ' A' ' 12' ' ' ILE . 6.0 tp60 -59.06 -44.06 91.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.851 -0.613 . . . . 72.13 111.529 178.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.538 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 7.9 pt-20 -72.82 -14.71 61.57 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.556 -0.458 . . . . 72.52 111.266 -178.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.88 -25.65 59.11 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.333 -0.618 . . . . 63.52 109.333 177.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.42 ' C ' HD12 ' A' ' 148' ' ' LEU . . . 137.03 -46.92 0.99 Allowed Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.668 -0.696 . . . . 41.11 112.439 176.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.42 HD12 ' C ' ' A' ' 147' ' ' GLY . 5.9 mp -132.94 152.56 51.9 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.12 -0.326 . . . . 73.23 110.12 -178.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.93 16.79 2.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.436 -0.347 . . . . 63.01 110.253 175.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 66.3 m80 68.75 97.92 0.06 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.328 -0.851 . . . . 73.4 110.454 -177.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -65.74 115.92 6.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.824 -0.625 . . . . 73.24 111.488 -174.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -125.7 -68.83 0.81 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.27 -1.011 . . . . 64.34 108.27 173.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -178.89 -37.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.325 -1.307 . . . . 75.21 108.38 178.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 69.15 123.04 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.099 0 CA-C-N 114.503 -1.226 . . . . 74.11 111.357 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 26.6 m170 . . . . . 0 C--O 1.245 0.859 0 N-CA-C 108.689 -0.856 . . . . 74.14 108.689 174.133 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.8 mtt . . . . . 0 N--CA 1.481 1.078 0 CA-C-O 121.17 0.509 . . . . 74.53 110.853 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 94.38 -0.63 66.06 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.438 -1.065 . . . . 53.4 110.438 -172.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.698 ' HG2' ' HD2' ' A' ' 112' ' ' PRO . 36.0 mt-10 -118.7 136.23 54.05 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.666 -0.865 . . . . 54.11 108.666 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.1 m -147.52 122.19 9.86 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.911 0.386 . . . . 71.05 110.783 -176.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.628 HG22 ' HA ' ' A' ' 109' ' ' THR . 41.0 t -101.88 97.25 5.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.556 -0.905 . . . . 53.44 108.556 174.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 107' ' ' ARG . 10.6 p -80.11 141.63 15.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.516 -0.766 . . . . 72.3 111.82 -168.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.598 ' HG2' ' HB2' ' A' ' 107' ' ' ARG . 2.8 tmm_? -134.74 116.61 15.07 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.368 -0.605 . . . . 74.14 109.368 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' HB3' HD23 ' A' ' 137' ' ' LEU . 4.8 t70 -144.71 173.05 12.17 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.709 -0.848 . . . . 72.35 108.709 173.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.824 ' HB2' HG12 ' A' ' 105' ' ' VAL . . . -134.47 126.59 29.75 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.133 0.492 . . . . 71.04 112.012 -171.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.486 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 36.0 m -121.66 134.23 65.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.793 -0.639 . . . . 64.44 109.956 176.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 t -110.08 123.38 49.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.688 0.756 . . . . 44.25 111.011 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.634 ' HB ' HD21 ' A' ' 19' ' ' LEU . 4.7 mp -118.71 151.04 20.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.768 -1.105 . . . . 70.23 109.712 -178.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.85 20.63 1.05 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 114.005 0.362 . . . . 42.05 114.005 -177.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.82 ' HE3' HD23 ' A' ' 19' ' ' LEU . 49.3 mtmt -89.95 144.07 30.93 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.197 -0.668 . . . . 62.3 109.197 173.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 95.0 Cg_exo -45.69 -57.96 1.89 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.977 2.451 . . . . 63.22 113.822 -174.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . 173.21 -58.24 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.578 0.704 . . . . 53.21 110.911 177.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -55.83 -36.75 67.82 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.456 -1.247 . . . . 63.22 112.247 -171.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.545 ' CG ' ' HD2' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -87.65 -5.33 58.76 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.132 -0.485 . . . . 60.55 111.853 -175.06 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.82 HD23 ' HE3' ' A' ' 14' ' ' LYS . 59.9 mt -68.56 -48.13 65.05 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.963 -0.295 . . . . 70.14 111.081 176.127 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.831 ' HB3' ' HZ ' ' A' ' 93' ' ' PHE . 1.1 p90 -73.15 -24.55 60.59 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.469 -0.493 . . . . 71.42 110.372 -177.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.56 -2.99 31.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.575 -0.738 . . . . 70.33 111.862 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.781 HG11 ' HZ ' ' A' ' 140' ' ' PHE . 14.8 p -54.2 -22.05 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 112.843 0.683 . . . . 54.1 112.843 -175.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 -68.48 -9.82 51.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.881 0.372 . . . . 75.21 111.11 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.844 ' HG2' ' H ' ' A' ' 25' ' ' ASP . 47.1 ttt180 -137.04 179.27 6.48 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.61 -0.515 . . . . 70.32 109.61 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.844 ' H ' ' HG2' ' A' ' 24' ' ' ARG . 0.8 OUTLIER -63.39 12.58 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.072 1.349 . . . . 74.2 112.873 177.511 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.475 ' H ' ' C ' ' A' ' 24' ' ' ARG . 41.2 mt 65.43 86.09 0.14 Allowed Pre-proline 0 N--CA 1.467 0.38 0 CA-C-O 121.184 0.516 . . . . 60.3 109.628 -176.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.842 ' HG3' ' HD3' ' A' ' 24' ' ' ARG . 33.2 Cg_exo -58.87 115.5 2.6 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 123.71 2.94 . . . . 74.14 114.031 -169.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.637 ' C ' ' HD3' ' A' ' 30' ' ' PRO . . . -92.05 71.0 1.73 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.061 -0.815 . . . . 75.51 111.061 172.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.498 ' N ' ' HD3' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -120.83 60.83 8.81 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 112.252 0.464 . . . . 63.52 112.252 179.089 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.637 ' HD3' ' C ' ' A' ' 28' ' ' GLY . 9.9 Cg_endo -90.04 -163.79 0.14 Allowed 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.849 2.366 . . . . 71.54 109.991 173.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.0 mp 65.22 -79.0 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.279 0.362 . . . . 63.54 110.087 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.736 HD13 HD13 ' A' ' 42' ' ' LEU . 83.6 mt 58.07 80.56 0.17 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.434 0.902 . . . . 73.22 113.434 175.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 21.6 ttt -113.82 112.06 22.76 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 107.758 -1.201 . . . . 73.24 107.758 167.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 t -46.13 -48.0 17.36 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.77 0.669 . . . . 64.2 111.689 -174.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 66.06 2.45 2.28 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.253 0.464 . . . . 62.43 112.253 166.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.2 mp 65.4 11.9 7.71 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.226 0.611 . . . . 72.22 111.312 -177.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -169.34 161.15 9.85 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.341 -0.391 . . . . 54.35 110.285 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.7 m 61.8 -154.55 0.35 Allowed 'General case' 0 CA--C 1.531 0.228 0 O-C-N 123.644 0.59 . . . . 61.22 110.507 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 40' ' ' GLU . 57.5 t 75.32 137.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 121.578 0.704 . . . . 75.33 111.972 175.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.644 ' HG2' ' H ' ' A' ' 41' ' ' VAL . 17.8 tt0 -97.8 -164.31 1.13 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.23 -0.895 . . . . 54.23 108.868 177.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.644 ' H ' ' HG2' ' A' ' 40' ' ' GLU . 27.0 t -64.7 148.94 11.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 110.245 -0.28 . . . . 75.44 110.245 178.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.736 HD13 HD13 ' A' ' 32' ' ' LEU . 4.3 mm? -56.25 -59.26 5.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.495 0.664 . . . . 74.44 111.682 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.522 ' OD1' ' HB2' ' A' ' 45' ' ' LYS . 2.1 p30 -160.71 177.51 10.39 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.84 -1.073 . . . . 74.42 110.346 -174.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -77.44 15.18 0.81 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.953 -0.567 . . . . 75.04 110.797 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.671 ' HG2' HD22 ' A' ' 66' ' ' LEU . 28.6 mttt -85.91 -45.27 11.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.002 -0.545 . . . . 75.31 111.15 -177.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.05 167.78 21.87 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.268 -0.878 . . . . 61.3 110.2 -175.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.9 m -92.54 156.19 17.3 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.176 -0.465 . . . . 71.11 110.969 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 70.41 151.72 0.1 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.985 -0.552 . . . . 75.21 111.769 176.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.589 ' HA ' HD23 ' A' ' 42' ' ' LEU . 41.3 p90 -88.36 103.93 16.29 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.456 0.646 . . . . 74.24 109.876 171.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 54' ' ' PRO . 2.8 p -108.15 -72.18 0.73 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.81 -0.632 . . . . 61.14 112.14 -176.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.5 m 47.77 -178.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.067 1.347 . . . . 71.04 113.804 -176.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 55.41 59.43 3.92 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.222 -0.899 . . . . 73.12 110.747 -177.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 49.66 74.72 0.76 Allowed Pre-proline 0 N--CA 1.467 0.38 0 CA-C-N 115.277 -0.874 . . . . 53.51 112.564 178.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.526 ' HB3' ' HB ' ' A' ' 50' ' ' THR . 86.0 Cg_endo -85.87 -178.29 2.85 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.5 2.133 . . . . 74.35 112.008 176.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.58 85.52 48.75 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.06 0.457 . . . . 70.15 110.978 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.562 ' HB3' ' HG2' ' A' ' 63' ' ' GLU . 4.3 Cg_exo -77.74 -45.64 0.14 Allowed 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.816 2.344 . . . . 41.21 112.245 178.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 58' ' ' GLY . 0.7 OUTLIER -112.48 -28.74 7.75 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.741 -0.663 . . . . 63.31 112.042 -173.614 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.494 ' N ' HD12 ' A' ' 57' ' ' LEU . . . -73.31 108.62 2.55 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.972 -0.632 . . . . 31.0 112.195 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 70.78 12.84 7.2 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 122.973 0.509 . . . . 64.3 110.778 177.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.7 t -131.62 -67.15 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.932 -0.576 . . . . 52.15 110.44 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.679 ' HA ' HD13 ' A' ' 80' ' ' LEU . 49.9 m 62.93 28.92 16.49 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.827 -0.624 . . . . 72.43 111.663 176.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -106.53 -15.66 14.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.393 0.616 . . . . 73.42 110.336 -177.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.562 ' HG2' ' HB3' ' A' ' 56' ' ' PRO . 10.4 tp10 -86.16 165.62 16.41 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.434 -0.803 . . . . 63.13 111.32 -172.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.05 129.73 38.89 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.181 -0.463 . . . . 73.1 109.881 173.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.22 135.73 51.32 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.736 0.303 . . . . 74.33 110.571 179.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.671 HD22 ' HG2' ' A' ' 45' ' ' LYS . 10.5 mp -104.63 127.28 52.33 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 120.253 -0.579 . . . . 72.03 109.597 174.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.3 t -95.46 -13.84 24.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.114 -0.494 . . . . 74.51 111.801 -172.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.616 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -123.32 128.04 49.36 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.944 -0.302 . . . . 75.32 110.782 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -137.91 84.83 2.06 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.895 -0.593 . . . . 73.54 110.443 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.532 ' HG3' ' HG2' ' A' ' 74' ' ' ARG . 6.6 mm-40 -107.18 141.68 23.44 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.361 -0.977 . . . . 75.01 108.361 173.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.46 93.82 0.59 Allowed 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.548 2.166 . . . . 72.12 112.376 -175.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 56.77 38.92 85.9 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.802 -0.635 . . . . 45.11 112.799 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -127.87 -46.37 1.41 Allowed 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.884 -0.326 . . . . 63.33 110.917 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.532 ' HG2' ' HG3' ' A' ' 70' ' ' GLU . 16.4 ptt-85 -159.91 147.64 16.8 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.48 -0.563 . . . . 75.43 109.48 173.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.643 HD11 ' HE2' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -147.34 120.54 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.411 0.624 . . . . 73.21 111.594 -179.498 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.689 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . . . -120.21 120.13 35.26 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.918 -1.037 . . . . 51.1 109.942 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.479 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 49.5 p90 -99.35 144.33 28.59 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.027 -0.533 . . . . 73.05 110.282 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -136.25 175.85 9.23 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.641 -0.874 . . . . 71.41 108.641 176.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.0 m -133.02 152.1 52.0 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.603 -0.517 . . . . 42.13 109.603 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.679 HD13 ' HA ' ' A' ' 61' ' ' SER . 62.9 mt -67.94 156.82 88.62 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.239 -0.437 . . . . 74.35 110.251 -178.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -56.82 -21.7 41.58 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.862 2.375 . . . . 61.23 113.337 -177.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.53 10.98 66.96 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.809 -0.71 . . . . 64.54 112.679 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.472 ' HB1' HG12 ' A' ' 85' ' ' ILE . . . -137.19 142.3 42.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.904 0.383 . . . . 33.52 111.105 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -118.96 41.81 2.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.584 0.707 . . . . 74.15 109.719 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.472 HG12 ' HB1' ' A' ' 83' ' ' ALA . 46.2 mm -77.75 118.26 24.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.131 -0.94 . . . . 74.53 111.525 -175.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 69.91 154.5 0.12 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.975 0.797 . . . . 75.41 112.34 171.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -72.35 135.91 46.01 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.88 -0.785 . . . . 70.31 108.88 174.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 26.2 m -94.95 145.02 25.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.291 0.567 . . . . 54.53 111.233 -174.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -174.62 -166.26 32.3 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.107 -0.952 . . . . 74.24 111.671 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.689 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 43.0 tt0 -145.44 136.81 25.04 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.292 -0.262 . . . . 73.31 110.292 -178.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.559 ' CG2' HG13 ' A' ' 75' ' ' ILE . 3.0 m -120.23 134.17 64.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 120.901 0.381 . . . . 64.13 110.714 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.477 ' HB2' ' CG2' ' A' ' 105' ' ' VAL . 9.7 mp -113.76 137.42 51.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.293 -0.412 . . . . 75.22 110.231 175.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.831 ' HZ ' ' HB3' ' A' ' 20' ' ' TYR . 76.7 m-85 -105.05 106.9 17.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.986 -0.552 . . . . 70.12 110.1 177.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -117.15 145.36 35.63 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.137 -0.483 . . . . 73.41 111.041 -176.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.69 135.98 59.7 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.585 2.19 . . . . 74.43 111.749 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.466 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . . . -105.03 143.38 26.6 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.627 -0.261 . . . . 61.44 111.011 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 96' ' ' ALA . 26.7 Cg_exo -64.06 150.24 88.76 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 123.306 2.671 . . . . 75.22 112.477 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.84 10.74 86.02 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.081 -0.581 . . . . 70.53 112.117 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 57.4 35.27 25.77 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 122.889 0.475 . . . . 70.05 111.449 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 100' ' ' ARG . 2.2 mmp_? -58.66 -38.4 78.06 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.092 0.472 . . . . 64.51 110.736 176.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 149.38 -119.9 1.1 Allowed Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.812 -0.915 . . . . 51.41 110.812 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 92.4 m -129.0 127.93 42.64 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.989 0.423 . . . . 74.44 110.386 175.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -84.12 114.48 21.8 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.602 -0.726 . . . . 74.02 110.235 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.1 p -99.05 115.73 40.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.164 0.507 . . . . 70.32 110.661 177.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.824 HG12 ' HB2' ' A' ' 9' ' ' ALA . 21.7 m -86.81 110.68 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-O 121.444 0.64 . . . . 74.35 109.382 174.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 46.5 t -100.61 125.18 54.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.626 -0.715 . . . . 73.34 110.343 -176.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.598 ' HB2' ' HG2' ' A' ' 7' ' ' ARG . 26.9 ttt180 -137.03 113.08 9.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.235 -0.438 . . . . 74.11 111.201 174.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.0 mp -116.01 140.93 48.77 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.706 -0.679 . . . . 73.33 109.885 175.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.628 ' HA ' HG22 ' A' ' 5' ' ' VAL . 86.7 m -84.25 120.09 25.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.163 -0.471 . . . . 73.03 110.237 178.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -120.77 133.67 55.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.009 -0.541 . . . . 75.33 109.662 -178.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.2 ptt180 -162.64 145.48 8.55 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 116.004 -0.543 . . . . 75.43 109.866 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.698 ' HD2' ' HG2' ' A' ' 3' ' ' GLU . 57.1 Cg_endo -72.42 154.42 55.71 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.465 2.11 . . . . 63.33 112.108 179.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -82.09 -166.15 0.38 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.776 2.317 . . . . 63.31 112.128 177.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.07 73.9 2.56 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.012 -0.613 . . . . 54.23 112.023 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -134.96 81.77 0.3 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.097 -0.573 . . . . 61.53 111.777 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.1 m -59.64 -40.06 86.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.846 0.355 . . . . 65.33 111.327 -176.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.522 ' O ' HG12 ' A' ' 121' ' ' ILE . . . -72.92 -24.82 60.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.316 -0.402 . . . . 74.21 111.506 -178.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.14 -28.72 73.82 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.921 -0.657 . . . . 71.15 112.637 -177.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.41 -43.27 81.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.357 . . . . 63.12 111.478 -178.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 117' ' ' ALA . 9.1 p -73.47 -20.49 18.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.834 0.35 . . . . 71.24 111.032 -176.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.522 HG12 ' O ' ' A' ' 117' ' ' ALA . 49.6 mm -63.39 -56.87 14.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.647 -0.251 . . . . 74.21 110.652 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.48 -31.07 72.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.153 0.502 . . . . 74.55 110.605 178.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -66.96 -31.04 71.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.415 -0.812 . . . . 73.23 110.689 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 17.9 tpt -66.36 -40.7 89.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.816 -0.629 . . . . 75.55 110.921 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -67.47 -60.97 2.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.411 -0.359 . . . . 73.53 110.635 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.0 t30 68.72 -2.01 1.82 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.927 -0.579 . . . . 70.03 111.968 175.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -56.49 -55.43 33.8 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.571 -0.529 . . . . 74.35 109.571 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -130.9 143.27 48.71 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.599 -0.728 . . . . 74.21 109.156 170.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.42 -4.56 13.73 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.88 2.387 . . . . 74.33 112.101 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.8 t 63.32 86.62 0.12 Allowed 'General case' 0 C--O 1.232 0.133 0 O-C-N 123.885 0.741 . . . . 65.35 109.497 -174.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -126.77 110.43 13.1 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.871 -0.604 . . . . 74.15 111.776 -172.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -97.15 138.5 34.56 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.766 -0.827 . . . . 70.4 108.766 169.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.1 mp -130.67 -173.04 2.96 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.376 0.608 . . . . 64.1 111.576 -172.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 134' ' ' ARG . 8.6 mtp180 -62.68 -22.53 66.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.314 -0.857 . . . . 63.03 110.742 175.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.447 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 17.3 t70 -57.22 -38.8 74.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.92 -0.582 . . . . 74.41 110.082 177.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -62.48 -43.54 98.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.483 -0.781 . . . . 53.31 111.049 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.511 HD23 ' HB3' ' A' ' 8' ' ' ASP . 22.2 tp -75.3 -27.02 59.15 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.661 -0.496 . . . . 73.41 109.661 -178.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.538 ' HA ' ' CE ' ' A' ' 138' ' ' MET . 0.0 OUTLIER -64.41 -47.08 80.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.862 -0.608 . . . . 74.23 109.829 175.916 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 135' ' ' ASP . 81.6 mtp180 -61.91 -40.82 96.79 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.611 -0.722 . . . . 75.24 109.683 175.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.781 ' HZ ' HG11 ' A' ' 22' ' ' VAL . 89.8 t80 -56.55 -40.86 75.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.204 -0.907 . . . . 74.11 111.232 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.571 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 24.2 ttpp -65.23 -52.22 55.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.345 -0.389 . . . . 74.45 110.06 176.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -53.62 -44.94 69.91 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.458 -0.792 . . . . 75.21 111.321 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -62.81 -39.4 94.15 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.641 -0.254 . . . . 74.21 111.571 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.594 ' HB2' HG12 ' A' ' 12' ' ' ILE . 30.6 mt-30 -70.19 -47.27 62.25 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.958 -0.297 . . . . 74.41 111.504 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.571 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 11.0 pt-20 -76.45 -13.81 60.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.033 0.444 . . . . 61.44 111.231 -176.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -83.25 -43.51 15.99 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.791 -0.818 . . . . 43.15 108.791 172.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -69.94 -42.43 69.13 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.604 -0.726 . . . . 71.24 112.898 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.819 HD22 ' HG2' ' A' ' 14' ' ' LYS . 4.8 tt -147.92 109.08 4.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.593 0.711 . . . . 71.15 110.46 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -120.86 10.59 10.92 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.77 -1.104 . . . . 73.25 109.275 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.604 ' H ' HD23 ' A' ' 148' ' ' LEU . 71.9 t60 70.73 -82.5 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 114.59 -1.186 . . . . 61.13 109.194 -172.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -145.4 164.24 32.12 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.898 -0.778 . . . . 73.13 108.898 172.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -64.02 123.84 20.04 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.443 0.64 . . . . 73.11 111.197 -173.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -88.33 -53.99 4.41 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.146 -0.934 . . . . 74.32 108.763 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 172.34 -19.68 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.377 -1.283 . . . . 73.31 108.446 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 . . . . . 0 C--O 1.246 0.875 0 CA-C-N 114.587 -1.188 . . . . 73.53 108.541 173.065 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.708 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 4.4 p . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 121.929 0.871 . . . . 72.319999999999993 109.828 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.3 t -92.05 134.35 30.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.336 -0.847 . . . . 43.399999999999999 110.544 -176.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.645 ' HD2' ' O ' ' A' ' 7' ' ' ARG . 7.4 ppt_? -115.65 112.1 21.61 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.277 0.56 . . . . 73.310000000000002 110.261 175.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.435 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 31.3 t0 -157.48 172.52 18.42 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.002 -0.74 . . . . 65.25 109.002 177.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.649 ' HB2' HG12 ' A' ' 105' ' ' VAL . . . -138.39 132.27 31.18 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.733 0.301 . . . . 75.129999999999995 111.359 -176.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.467 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 23.8 m -110.76 145.95 16.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.194 -0.457 . . . . 70.140000000000001 110.581 178.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 97.4 m -109.71 118.78 37.45 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.053 -0.521 . . . . 52.109999999999999 111.031 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.762 HG21 ' HG3' ' A' ' 144' ' ' GLN . 5.0 mp -127.04 150.16 32.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.829 -0.623 . . . . 61.43 109.37 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.33 54.2 3.57 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.775 -0.726 . . . . 61.119999999999997 113.106 -178.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.587 ' HD3' ' HB2' ' A' ' 18' ' ' GLN . 50.9 mttp -131.67 144.4 53.15 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 108.849 -0.797 . . . . 71.109999999999999 108.849 174.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.59 -56.9 2.08 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.759 2.306 . . . . 62.520000000000003 113.803 -171.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.471 ' HA ' HD12 ' A' ' 19' ' ' LEU . . . 174.01 -47.48 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.649 0.738 . . . . 75.299999999999997 109.175 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -48.76 -47.15 41.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.081 -1.418 . . . . 72.140000000000001 111.952 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.587 ' HB2' ' HD3' ' A' ' 14' ' ' LYS . 67.5 mt-30 -83.39 -10.93 58.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.874 0.369 . . . . 65.030000000000001 111.119 -174.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' A' ' 16' ' ' ALA . 95.4 mt -77.57 -48.49 16.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.52 -0.309 . . . . 71.349999999999994 110.543 -178.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.675 ' HB3' ' HZ ' ' A' ' 93' ' ' PHE . 16.8 p90 -73.67 -23.85 59.89 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.107 -0.637 . . . . 71.450000000000003 109.483 175.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.522 ' HB3' ' HA ' ' A' ' 18' ' ' GLN . . . -73.18 -1.79 19.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.212 -0.904 . . . . 63.25 111.791 177.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.615 HG11 ' HZ ' ' A' ' 140' ' ' PHE . 12.1 p -54.06 -22.89 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 122.666 0.386 . . . . 73.019999999999996 111.681 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -75.17 -8.22 55.99 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.092 0.472 . . . . 73.150000000000006 110.955 178.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.516 ' HA ' ' HE ' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -115.83 -174.5 2.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.676 -0.693 . . . . 54.149999999999999 110.032 178.568 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.13 33.9 1.31 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.698 -0.683 . . . . 62.409999999999997 109.225 177.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.452 HD22 ' HB3' ' A' ' 18' ' ' GLN . 75.7 mt 55.26 85.25 0.19 Allowed Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 115.208 -0.905 . . . . 63.32 110.375 -173.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo . . . . . 0 C--N 1.345 0.394 0 C-N-CA 123.11 2.54 . . . . 70.450000000000003 113.508 -173.898 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.346 0 CA-C-O 121.446 0.641 . . . . 73.239999999999995 112.493 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 19.6 tt0 -129.37 160.51 32.83 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.74 -1.118 . . . . 72.099999999999994 109.162 176.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.587 ' CD1' ' HA ' ' A' ' 77' ' ' TRP . 4.1 mm? -108.92 116.49 32.1 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.832 -0.803 . . . . 72.019999999999996 108.832 170.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.6 t -78.04 -16.65 57.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.06 -0.518 . . . . 75.209999999999994 112.174 -168.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.654 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -143.32 130.05 20.34 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 121.012 -0.275 . . . . 65.140000000000001 110.464 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.564 ' HA ' HG13 ' A' ' 75' ' ' ILE . 18.7 t70 -145.03 113.36 6.59 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.117 -0.492 . . . . 74.140000000000001 110.127 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.41 ' O ' HD11 ' A' ' 75' ' ' ILE . 78.8 mm-40 -130.33 144.92 55.22 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.625 -0.509 . . . . 71.219999999999999 109.625 176.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -52.67 -34.14 62.53 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.175 2.584 . . . . 73.319999999999993 113.009 -177.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -168.74 55.67 0.21 Allowed Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.868 -0.682 . . . . 45.140000000000001 111.994 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -127.87 -77.39 0.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.201 -0.296 . . . . 74.109999999999999 110.201 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 18.1 ptp180 -157.43 138.91 13.84 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.14 -0.482 . . . . 75.049999999999997 110.123 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.721 HD13 ' HE2' ' A' ' 93' ' ' PHE . 3.1 mp -129.57 122.06 54.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.196 -0.456 . . . . 73.420000000000002 109.966 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.654 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -111.34 130.41 55.69 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.939 -0.393 . . . . 65.299999999999997 109.939 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.587 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 4.6 p90 -85.31 153.65 22.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.568 0.699 . . . . 74.340000000000003 111.759 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.877 ' HG3' ' H ' ' A' ' 80' ' ' LEU . 4.1 tpp180 -144.32 172.82 12.4 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.707 -1.133 . . . . 63.240000000000002 108.686 -174.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.651 ' N ' ' HG3' ' A' ' 78' ' ' ARG . 59.0 m -145.64 24.84 1.36 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.755 -0.461 . . . . 51.409999999999997 109.755 174.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.877 ' H ' ' HG3' ' A' ' 78' ' ' ARG . 73.3 mt 63.96 149.64 0.11 Allowed Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 115.268 -0.878 . . . . 71.140000000000001 112.738 174.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -64.5 -8.22 16.54 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 122.345 2.03 . . . . 73.209999999999994 112.492 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -76.38 -57.22 4.0 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.854 -0.688 . . . . 73.120000000000005 111.865 175.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.75 -26.59 29.55 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.595 0.22 . . . . 71.129999999999995 111.595 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 63.31 103.92 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.361 0.664 . . . . 74.329999999999998 111.149 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.506 ' HB ' ' HB2' ' A' ' 79' ' ' SER . 17.1 tt -70.08 129.23 34.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.402 0.62 . . . . 52.5 111.184 -178.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -82.09 -29.17 31.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.476 -0.784 . . . . 73.230000000000004 110.015 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -88.73 168.27 12.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.593 -0.73 . . . . 74.150000000000006 110.562 -175.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.6 m -155.24 135.35 13.03 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.299 -0.26 . . . . 73.230000000000004 110.299 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.34 127.81 0.97 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.605 -0.807 . . . . 71.430000000000007 112.599 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 44.7 tt0 -115.37 118.52 33.46 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.612 -0.514 . . . . 71.340000000000003 109.612 176.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.623 HG12 HG12 ' A' ' 106' ' ' VAL . 3.8 m -87.15 130.38 37.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.873 0.368 . . . . 71.430000000000007 110.522 -177.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.657 ' HB2' HG23 ' A' ' 105' ' ' VAL . 9.5 mp -110.52 147.38 34.27 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.008 -0.367 . . . . 73.120000000000005 110.008 176.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.721 ' HE2' HD13 ' A' ' 75' ' ' ILE . 79.8 m-85 -117.61 132.01 56.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.831 0.348 . . . . 70.239999999999995 111.268 -177.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -141.86 145.15 35.38 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.94 -0.573 . . . . 74.530000000000001 109.902 173.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -58.01 127.62 25.73 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.474 2.116 . . . . 72.510000000000005 111.559 176.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.47 144.14 86.13 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.283 -0.417 . . . . 63.149999999999999 111.7 -174.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -58.45 138.39 85.54 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.911 2.408 . . . . 60.109999999999999 111.999 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.08 12.71 84.39 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.899 -0.667 . . . . 72.5 111.769 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 58.62 37.01 25.37 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 121.059 0.457 . . . . 63.350000000000001 111.051 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -78.95 1.14 24.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 55.140000000000001 111.411 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 129.7 -138.48 10.26 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.281 -0.728 . . . . 70.230000000000004 111.281 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 47.4 m -121.92 132.81 54.75 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.951 0.405 . . . . 74.400000000000006 110.23 176.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.52 ' HG2' ' HB1' ' A' ' 9' ' ' ALA . 42.5 tt0 -100.85 117.54 35.12 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.827 -0.624 . . . . 65.420000000000002 110.023 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.582 HG22 HG13 ' A' ' 106' ' ' VAL . 2.7 p -93.88 106.91 18.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.315 0.578 . . . . 73.150000000000006 110.757 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.657 HG23 ' HB2' ' A' ' 92' ' ' LEU . 10.8 m -88.23 114.24 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.759 -0.655 . . . . 72.299999999999997 110.343 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.623 HG12 HG12 ' A' ' 91' ' ' VAL . 27.2 m -124.15 134.97 65.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.404 0.621 . . . . 72.109999999999999 111.884 -175.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.523 ' HG3' ' HB3' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -118.32 97.89 6.0 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.821 -1.177 . . . . 72.450000000000003 107.821 170.089 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.526 HD23 ' H ' ' A' ' 108' ' ' LEU . 2.7 pt? -132.41 144.91 50.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.033 0.444 . . . . 64.25 110.792 -173.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.708 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 8.3 t -97.99 138.54 35.16 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.84 -0.618 . . . . 74.200000000000003 109.336 174.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 44.5 p90 . . . . . 0 C--N 1.318 -0.788 0 CA-C-N 116.491 -0.322 . . . . 73.519999999999996 110.434 -177.857 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.611 -0.196 . . . . 64.230000000000004 112.611 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.5 m -73.41 -22.31 60.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.923 0.392 . . . . 54.329999999999998 111.185 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.468 ' HA ' HG22 ' A' ' 120' ' ' VAL . . . -61.76 -22.79 65.71 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.219 -0.446 . . . . 74.530000000000001 111.571 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.87 -21.52 65.54 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.106 -0.569 . . . . 44.43 112.513 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -86.49 -44.68 11.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.928 0.394 . . . . 75.0 111.483 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 117' ' ' ALA . 27.6 m -67.7 -17.61 22.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.297 0.48 . . . . 74.150000000000006 112.297 -172.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.519 ' O ' HD13 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -61.9 -28.61 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 120.978 0.418 . . . . 74.319999999999993 110.35 178.257 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.74 -18.59 63.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.329 -0.396 . . . . 73.239999999999995 111.678 -177.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 57.7 ttp85 -65.88 -16.0 63.44 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.624 0.249 . . . . 73.340000000000003 111.311 -176.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.8 ttm . . . . . 0 C--O 1.234 0.279 0 CA-C-O 120.961 0.41 . . . . 75.109999999999999 109.988 176.714 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.406 ' O ' ' HG2' ' A' ' 138' ' ' MET . 2.4 ptm180 . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 112.516 0.562 . . . . 74.420000000000002 112.516 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -49.12 -52.08 28.22 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.258 0.623 . . . . 74.319999999999993 111.954 -173.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.475 ' O ' ' HG2' ' A' ' 139' ' ' ARG . 33.8 t70 -61.99 -39.01 90.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.569 -0.741 . . . . 74.25 112.192 -174.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.467 ' HG ' ' CG1' ' A' ' 10' ' ' VAL . 14.3 tp -80.34 -20.28 44.56 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.857 0.36 . . . . 70.530000000000001 110.899 -176.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.521 ' CE ' ' HA ' ' A' ' 138' ' ' MET . 22.4 mmt -65.78 -41.73 91.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.775 0.287 . . . . 61.119999999999997 111.775 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.475 ' HG2' ' O ' ' A' ' 136' ' ' ASP . 15.9 ptt180 -62.67 -31.21 72.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.832 0.349 . . . . 63.450000000000003 110.359 178.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.615 ' HZ ' HG11 ' A' ' 22' ' ' VAL . 92.2 t80 -64.58 -45.87 85.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.897 -0.592 . . . . 71.549999999999997 110.311 178.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.44 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 23.3 ttpp -57.1 -47.65 80.54 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.15 -0.477 . . . . 63.299999999999997 110.036 176.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 28.4 ttp180 -53.82 -45.77 70.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.052 -0.976 . . . . 71.219999999999999 111.816 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -77.79 -28.45 50.45 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.233 -0.439 . . . . 75.049999999999997 111.514 -175.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.762 ' HG3' HG21 ' A' ' 12' ' ' ILE . 4.9 tp-100 -71.31 -44.66 64.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.621 0.248 . . . . 73.319999999999993 110.502 175.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 11.1 pt-20 -71.64 -23.3 61.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.848 0.356 . . . . 72.409999999999997 110.764 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 1.0 OUTLIER -76.8 -47.79 20.52 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.557 -0.534 . . . . 73.510000000000005 109.557 178.189 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.484 0 CA-C-N 115.776 -0.647 . . . . 52.130000000000003 112.606 -179.673 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.617 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 11.1 p . . . . . 0 N--CA 1.449 -0.506 0 CA-C-O 120.906 0.384 . . . . 72.340000000000003 110.378 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.0 t -95.75 116.44 37.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.294 -0.632 . . . . 75.140000000000001 109.294 174.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 59.9 ttt180 -125.77 108.38 11.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.08 0.467 . . . . 72.340000000000003 110.078 174.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -143.73 159.14 43.03 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.13 -1.063 . . . . 74.299999999999997 108.13 176.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.487 ' HB1' ' HG2' ' A' ' 103' ' ' GLU . . . -141.18 121.13 13.62 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.931 0.396 . . . . 73.540000000000006 110.642 -174.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.632 ' HB ' ' HB2' ' A' ' 141' ' ' LYS . 10.5 m -108.32 136.58 43.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.442 0.639 . . . . 54.039999999999999 111.714 -176.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.14 109.92 22.19 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.227 -0.897 . . . . 65.299999999999997 111.239 -177.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.875 HG23 ' HG3' ' A' ' 145' ' ' GLU . 4.8 mp -125.26 149.4 29.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.789 -0.819 . . . . 72.140000000000001 108.789 176.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.88 57.51 2.65 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 121.114 -0.565 . . . . 55.32 113.226 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.657 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 10.9 mmpt? -118.15 154.52 51.75 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 108.803 -0.814 . . . . 72.120000000000005 108.803 176.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -58.98 -57.66 0.9 Allowed 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.327 2.018 . . . . 72.439999999999998 113.026 -177.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.557 ' O ' ' HB2' ' A' ' 19' ' ' LEU . . . -178.26 -72.91 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.224 0.453 . . . . 61.439999999999998 112.224 178.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -66.36 -31.12 71.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.711 0.291 . . . . 74.230000000000004 111.174 -173.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -56.67 -32.28 65.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.424 -0.353 . . . . 74.019999999999996 110.552 175.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.557 ' HB2' ' O ' ' A' ' 16' ' ' ALA . 65.4 mt -62.89 -41.63 99.49 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.88 -0.6 . . . . 74.129999999999995 110.444 176.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.742 ' HB2' ' HZ ' ' A' ' 93' ' ' PHE . 77.9 t80 -73.07 -36.36 66.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.734 -0.666 . . . . 71.209999999999994 110.766 178.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.23 -3.61 30.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.683 -0.69 . . . . 75.209999999999994 112.188 -175.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.765 HG11 ' HZ ' ' A' ' 140' ' ' PHE . 9.0 p -53.69 -21.46 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 123.213 0.605 . . . . 72.319999999999993 112.242 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.8 t-105 -52.94 -37.25 60.74 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.445 0.64 . . . . 74.439999999999998 109.764 176.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.579 ' HD3' ' N ' ' A' ' 25' ' ' ASP . 4.0 tmt_? -109.59 159.76 16.83 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.866 -1.161 . . . . 72.239999999999995 107.866 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.579 ' N ' ' HD3' ' A' ' 24' ' ' ARG . 26.1 t70 -66.83 67.17 0.06 Allowed 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.497 0.554 . . . . 74.0 112.497 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 41.86 79.3 0.33 Allowed Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 124.168 0.987 . . . . 65.129999999999995 112.78 169.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.522 ' HA ' ' NH1' ' A' ' 24' ' ' ARG . 31.6 Cg_exo . . . . . 0 C--N 1.344 0.336 0 C-N-CA 122.445 2.097 . . . . 44.219999999999999 113.787 -172.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.97 0 N-CA-C 109.381 -0.6 . . . . 53.409999999999997 109.381 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.465 ' HB2' HD23 ' A' ' 80' ' ' LEU . 1.2 mm-40 -107.92 134.23 51.13 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 109.587 -0.523 . . . . 65.019999999999996 109.587 176.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.746 HD12 ' HA ' ' A' ' 77' ' ' TRP . 3.6 mm? -88.21 137.91 31.91 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.581 -0.526 . . . . 24.109999999999999 109.581 -178.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.9 t -73.93 -9.18 58.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.497 0.665 . . . . 45.039999999999999 110.048 -177.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.91 123.35 10.36 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.973 -1.012 . . . . 74.209999999999994 108.725 166.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -139.09 83.64 1.96 Allowed 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.738 -0.838 . . . . 75.439999999999998 108.738 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 73' ' ' LYS . 48.5 mt-10 -115.86 143.86 31.58 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 114.879 -1.055 . . . . 71.239999999999995 109.581 -176.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.81 94.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.031 2.487 . . . . 50.32 113.029 -174.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 61.82 26.36 66.94 Favored Glycine 0 CA--C 1.518 0.277 0 CA-C-N 115.657 -0.701 . . . . 61.229999999999997 113.446 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.747 ' HE2' ' HA ' ' A' ' 73' ' ' LYS . 9.7 mmpt? -104.66 -72.56 0.7 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.18 0.514 . . . . 70.140000000000001 110.193 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.414 HH21 ' CD ' ' A' ' 90' ' ' GLU . 7.0 ptm180 -149.91 137.66 20.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.758 -0.655 . . . . 71.409999999999997 109.642 176.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 67.1 mt -122.18 110.3 26.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.768 -0.651 . . . . 74.349999999999994 109.394 177.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.667 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . . . -104.23 127.44 51.86 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.847 -0.615 . . . . 72.439999999999998 109.574 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.746 ' HA ' HD12 ' A' ' 66' ' ' LEU . 59.2 t90 -79.93 143.71 33.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.702 0.763 . . . . 73.319999999999993 111.509 -169.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.532 ' HG3' ' H ' ' A' ' 79' ' ' SER . 0.0 OUTLIER -166.61 175.35 8.03 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.834 -1.076 . . . . 65.400000000000006 108.99 -175.296 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.532 ' H ' ' HG3' ' A' ' 78' ' ' ARG . 46.9 m -141.57 165.63 26.95 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.348 -0.982 . . . . 64.030000000000001 108.348 174.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.465 HD23 ' HB2' ' A' ' 65' ' ' GLU . 53.0 mt -60.57 150.76 73.53 Favored Pre-proline 0 C--N 1.326 -0.445 0 O-C-N 123.11 0.256 . . . . 63.43 110.729 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.31 -22.71 66.62 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 123.069 2.512 . . . . 71.140000000000001 112.82 -178.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.28 2.7 88.02 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.06 -0.591 . . . . 34.43 112.251 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -109.62 -168.89 1.38 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.715 0.293 . . . . 71.439999999999998 110.372 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -111.45 118.3 35.42 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.764 0.316 . . . . 65.109999999999999 110.553 -174.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.4 pt -110.19 129.73 64.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.032 0.444 . . . . 72.319999999999993 110.931 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -105.99 -85.48 0.49 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.138 -0.483 . . . . 64.019999999999996 111.906 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -96.03 166.48 11.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.935 0.397 . . . . 54.25 111.46 -171.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.7 t -103.81 139.02 39.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.031 -0.531 . . . . 73.140000000000001 109.875 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.612 ' HA3' ' HG ' ' A' ' 108' ' ' LEU . . . -158.69 129.12 2.19 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 121.038 -0.601 . . . . 32.409999999999997 112.113 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.667 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 45.5 tt0 -128.84 134.75 48.43 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.913 -0.403 . . . . 72.219999999999999 109.913 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.48 ' CG1' HG23 ' A' ' 104' ' ' VAL . 69.7 t -115.67 128.67 72.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.152 0.501 . . . . 62.32 111.144 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.612 ' HB2' ' HB ' ' A' ' 105' ' ' VAL . 6.8 mp -102.95 138.16 40.19 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.366 -0.834 . . . . 74.549999999999997 110.517 178.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.742 ' HZ ' ' HB2' ' A' ' 20' ' ' TYR . 89.2 m-85 -115.54 106.29 13.77 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.226 0.536 . . . . 72.209999999999994 109.695 175.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -124.26 144.5 45.8 Favored Pre-proline 0 C--N 1.317 -0.841 0 CA-C-N 116.138 -0.483 . . . . 52.310000000000002 110.61 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.26 125.98 19.58 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.639 2.226 . . . . 54.340000000000003 111.101 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.1 143.39 56.87 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.552 -0.295 . . . . 71.109999999999999 111.219 -175.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.527 ' O ' ' HG2' ' A' ' 100' ' ' ARG . 31.0 Cg_endo -65.37 156.5 63.0 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.775 2.316 . . . . 61.240000000000002 111.35 175.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 63.94 20.71 64.82 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.926 -0.654 . . . . 72.439999999999998 112.939 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 58.21 32.91 22.62 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.661 0.384 . . . . 63.210000000000001 112.006 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 97' ' ' PRO . 24.9 mmt180 -68.74 -18.98 64.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.862 0.363 . . . . 64.450000000000003 111.244 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 127.72 -133.12 7.72 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.305 -0.718 . . . . 73.310000000000002 111.305 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.2 m -118.65 132.85 56.18 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.518 -0.549 . . . . 60.43 109.518 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.487 ' HG2' ' HB1' ' A' ' 9' ' ' ALA . 40.1 tt0 -96.21 117.02 29.92 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.847 0.356 . . . . 54.299999999999997 110.535 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.48 HG23 ' CG1' ' A' ' 91' ' ' VAL . 1.7 p -88.33 103.97 14.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.818 0.818 . . . . 71.430000000000007 109.521 174.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.612 ' HB ' ' HB2' ' A' ' 92' ' ' LEU . 16.4 t -91.36 110.24 22.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.631 -1.168 . . . . 71.530000000000001 109.919 -175.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 47.7 t -100.74 117.77 46.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.232 -0.44 . . . . 40.149999999999999 111.217 -175.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -121.09 98.72 6.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.928 -0.578 . . . . 75.109999999999999 109.52 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.612 ' HG ' ' HA3' ' A' ' 89' ' ' GLY . 1.9 tt -138.83 137.3 36.48 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.84 -0.43 . . . . 73.209999999999994 109.84 -175.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 8.9 t -84.53 139.71 31.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.28 0.562 . . . . 65.129999999999995 111.254 -177.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 . . . . . 0 C--N 1.324 -0.528 0 CA-C-N 115.798 -0.637 . . . . 75.209999999999994 110.374 -178.684 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.658 0 CA-C-O 120.818 0.121 . . . . 60.219999999999999 112.856 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.3 m -62.04 -23.86 66.72 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.066 0.546 . . . . 62.109999999999999 111.925 -174.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.91 -43.02 76.93 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.304 -0.407 . . . . 73.120000000000005 111.801 -176.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -78.59 -19.83 72.78 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.575 -0.822 . . . . 52.439999999999998 112.34 -178.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.49 -38.73 23.46 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.736 -0.273 . . . . 71.310000000000002 111.712 -175.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.5 m -64.5 -25.56 38.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.615 0.598 . . . . 52.219999999999999 112.615 -174.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 14.4 tt -75.13 -21.84 16.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.922 0.392 . . . . 70.540000000000006 111.085 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.97 -18.81 64.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.366 -0.379 . . . . 53.109999999999999 111.876 -175.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 123' ' ' ARG . 23.7 ttt85 -79.17 -14.5 59.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.059 0.457 . . . . 74.439999999999998 110.919 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 49.1 ttm . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 116.238 -0.437 . . . . 72.239999999999995 110.322 179.176 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 23.5 mtp-105 . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 121.815 0.816 . . . . 73.129999999999995 113.049 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -69.7 -33.18 72.16 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.494 -1.23 . . . . 73.340000000000003 112.639 -173.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -56.51 -55.65 31.1 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.048 0.388 . . . . 72.319999999999993 112.048 -175.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 15.5 tp -81.08 -20.7 40.96 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.851 -0.34 . . . . 62.43 110.975 -175.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.8 ttp -54.34 -38.65 66.27 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.49 -0.323 . . . . 74.120000000000005 110.896 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 139' ' ' ARG . 0.8 OUTLIER -70.86 -32.71 69.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.793 0.33 . . . . 74.140000000000001 110.738 179.438 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.765 ' HZ ' HG11 ' A' ' 22' ' ' VAL . 90.3 t80 -60.34 -35.17 75.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 64.400000000000006 110.439 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.632 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 38.8 tttp -55.02 -49.5 71.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.771 -0.649 . . . . 71.530000000000001 110.194 173.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.639 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 34.4 mmt180 -71.67 -25.69 62.22 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.805 -0.634 . . . . 73.140000000000001 111.772 -175.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -63.48 -44.32 94.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.861 0.362 . . . . 64.299999999999997 111.054 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.714 ' HG2' HG21 ' A' ' 12' ' ' ILE . 8.3 tt0 -82.36 -44.36 16.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.068 -0.514 . . . . 73.209999999999994 111.038 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.875 ' HG3' HG23 ' A' ' 12' ' ' ILE . 2.5 tt0 -66.52 -20.21 65.97 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 116.203 -0.453 . . . . 74.25 111.994 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.639 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 21.3 tp -64.71 -40.95 96.23 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.538 -0.542 . . . . 73.340000000000003 109.538 175.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.517 0 CA-C-N 115.303 -0.862 . . . . 73.310000000000002 111.361 178.941 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.782 HG13 ' HA ' ' A' ' 109' ' ' THR . 51.0 t . . . . . 0 N--CA 1.447 -0.612 0 N-CA-C 109.083 -0.71 . . . . 65.049999999999997 109.083 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.7 t -80.79 115.54 23.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.977 0.418 . . . . 71.400000000000006 111.397 -171.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.487 ' HG3' ' CB ' ' A' ' 107' ' ' ARG . 9.0 mpt_? -107.14 108.09 19.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.537 -0.912 . . . . 73.5 108.537 168.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.509 ' HB3' HD22 ' A' ' 137' ' ' LEU . 2.5 t70 -147.99 173.31 13.02 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.516 -0.55 . . . . 74.200000000000003 109.516 178.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.844 ' HB2' HG12 ' A' ' 105' ' ' VAL . . . -138.56 154.35 48.73 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.045 0.45 . . . . 52.399999999999999 111.488 -171.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.459 ' HB ' ' HB2' ' A' ' 141' ' ' LYS . 12.8 m -132.55 141.07 46.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.838 -0.619 . . . . 72.010000000000005 109.987 174.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.442 HG21 ' HG3' ' A' ' 100' ' ' ARG . 25.2 m -106.38 118.32 36.34 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.156 -0.475 . . . . 74.120000000000005 111.259 -174.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.953 HG23 ' HB3' ' A' ' 145' ' ' GLU . 3.9 mp -123.19 141.94 41.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.845 -0.616 . . . . 64.25 109.716 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.26 52.02 4.24 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.843 -0.694 . . . . 74.019999999999996 112.455 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.471 ' HB2' HD21 ' A' ' 19' ' ' LEU . 94.8 mttt -131.22 144.24 52.68 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.066 -0.716 . . . . 75.109999999999999 109.066 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.75 -58.87 1.01 Allowed 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 122.688 2.259 . . . . 73.109999999999999 113.783 -169.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.406 ' HA ' HD12 ' A' ' 19' ' ' LEU . . . 173.56 -52.87 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.311 0.577 . . . . 63.140000000000001 110.462 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -57.09 -46.0 82.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.266 -0.879 . . . . 52.119999999999997 111.66 -175.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -68.57 -8.85 45.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.401 -0.363 . . . . 72.420000000000002 111.945 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.471 HD21 ' HB2' ' A' ' 14' ' ' LYS . 96.5 mt -80.55 -20.56 43.16 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 122.378 -0.201 . . . . 73.219999999999999 110.928 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -70.94 -29.4 65.42 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.458 0.647 . . . . 72.140000000000001 109.704 174.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.726 ' HB1' ' HD2' ' A' ' 27' ' ' PRO . . . -71.51 -4.72 28.3 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.54 -0.754 . . . . 43.350000000000001 112.073 -174.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.2 p -60.4 -24.2 30.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 71.010000000000005 111.245 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -55.72 -43.46 76.57 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 112.375 0.509 . . . . 73.349999999999994 112.375 -177.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 24' ' ' ARG . 28.4 ttt180 -105.53 -76.09 0.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.235 -0.586 . . . . 73.349999999999994 112.057 -174.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -147.78 2.96 0.72 Allowed 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 120.474 -0.49 . . . . 74.200000000000003 112.207 -168.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.76 HD11 ' HA ' ' A' ' 144' ' ' GLN . 51.6 mt 58.67 63.97 3.69 Favored Pre-proline 0 N--CA 1.47 0.539 0 CA-C-N 116.196 -0.456 . . . . 75.329999999999998 111.75 -175.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.726 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 83.5 Cg_endo . . . . . 0 N--CA 1.454 -0.826 0 C-N-CA 122.774 2.316 . . . . 64.329999999999998 112.76 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.511 0 CA-C-O 121.057 0.456 . . . . 54.149999999999999 111.088 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -117.8 136.73 53.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.928 -0.578 . . . . 75.25 109.78 174.031 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.673 ' HG ' ' HA ' ' A' ' 77' ' ' TRP . 6.8 mp -91.37 128.38 37.17 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.73 0.3 . . . . 74.329999999999998 110.548 -178.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.782 ' HB ' ' HG3' ' A' ' 78' ' ' ARG . 12.9 t -70.55 -28.57 65.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 74.519999999999996 110.84 -173.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.11 131.46 17.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.895 -0.593 . . . . 50.210000000000001 109.793 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -141.5 91.88 2.42 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.037 0.446 . . . . 72.439999999999998 109.849 -178.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.608 ' HB2' ' H ' ' A' ' 74' ' ' ARG . 10.3 mm-40 -95.72 142.37 24.49 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 109.185 -0.672 . . . . 64.340000000000003 109.185 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.77 94.48 0.39 Allowed 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.417 2.078 . . . . 72.040000000000006 112.713 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.71 35.04 89.19 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.994 -0.622 . . . . 71.420000000000002 112.258 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.516 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 75.2 mmtt -127.05 -70.41 0.72 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.679 0.276 . . . . 70.109999999999999 110.332 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.608 ' H ' ' HB2' ' A' ' 70' ' ' GLU . 30.8 ptt-85 -150.58 132.35 15.0 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.737 -0.468 . . . . 75.239999999999995 109.737 176.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.579 ' HB ' HG13 ' A' ' 91' ' ' VAL . 3.9 mp -126.9 116.23 44.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.077 -0.511 . . . . 71.439999999999998 109.792 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -106.98 118.61 37.17 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.063 -0.517 . . . . 73.010000000000005 110.53 -178.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.673 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 36.2 m95 -87.07 145.58 26.41 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.841 -0.618 . . . . 62.299999999999997 111.238 -174.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.782 ' HG3' ' HB ' ' A' ' 67' ' ' THR . 19.0 mmm-85 -148.97 175.13 11.56 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.814 -0.63 . . . . 71.409999999999997 109.777 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.519 ' HB2' ' HB2' ' A' ' 86' ' ' GLU . 63.2 m -134.92 142.43 46.54 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.449 -0.945 . . . . 70.239999999999995 108.449 175.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 94.5 mt -67.0 153.12 95.15 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.579 -0.282 . . . . 55.530000000000001 110.931 -176.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -52.2 -16.78 5.13 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.953 3.102 . . . . 73.030000000000001 114.297 -173.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.85 -35.38 89.51 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.66 -0.781 . . . . 64.420000000000002 111.921 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.66 147.85 26.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.993 0.425 . . . . 72.140000000000001 111.093 -176.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.467 ' HD2' ' C ' ' A' ' 84' ' ' ARG . 6.0 ppt_? -115.44 -1.59 12.79 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.086 -0.507 . . . . 74.519999999999996 110.742 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.445 ' O ' HG13 ' A' ' 85' ' ' ILE . 10.1 tp -107.86 33.59 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.995 0.902 . . . . 60.329999999999998 110.247 -178.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 79' ' ' SER . 42.1 tt0 -64.24 122.01 15.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.664 -0.698 . . . . 73.5 110.555 177.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -103.59 140.56 37.37 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.355 -0.98 . . . . 71.430000000000007 108.355 174.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.1 m -94.77 126.19 39.93 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.19 0.519 . . . . 64.219999999999999 110.145 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 107' ' ' ARG . . . -159.0 146.39 12.95 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.304 -0.862 . . . . 62.340000000000003 111.443 -178.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -147.02 126.4 13.13 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 110.357 -0.238 . . . . 60.049999999999997 110.357 -176.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.656 HG23 HG23 ' A' ' 104' ' ' VAL . 2.5 p -108.6 121.68 62.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.055 0.455 . . . . 75.319999999999993 110.942 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.445 ' HB2' ' CG2' ' A' ' 105' ' ' VAL . 8.9 mp -108.96 139.82 43.3 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.736 -0.468 . . . . 73.239999999999995 109.736 174.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.513 ' HE2' HD13 ' A' ' 75' ' ' ILE . 93.9 m-85 -104.45 108.97 20.65 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.251 0.548 . . . . 72.540000000000006 110.073 178.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -126.73 144.88 51.46 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 115.461 -0.791 . . . . 72.540000000000006 110.046 -177.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.75 136.85 47.32 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.187 1.924 . . . . 42.210000000000001 111.551 176.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.524 ' CB ' ' HB3' ' A' ' 100' ' ' ARG . . . -77.63 146.99 74.13 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.185 -0.461 . . . . 75.120000000000005 110.011 178.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -37.78 108.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 124.111 3.208 . . . . 62.420000000000002 114.463 -172.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 90.04 -67.99 2.57 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 114.671 -1.149 . . . . 62.509999999999998 112.067 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -178.28 32.07 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.203 -0.498 . . . . 74.340000000000003 110.877 -174.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.524 ' HB3' ' CB ' ' A' ' 96' ' ' ALA . 21.8 tpp180 -74.2 -13.61 60.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.962 0.411 . . . . 74.219999999999999 110.802 -177.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 129.38 -157.53 21.76 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.962 -0.855 . . . . 32.32 110.962 -177.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 32.7 m -101.91 127.72 48.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.063 0.459 . . . . 73.010000000000005 109.815 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.422 ' CG ' ' HB1' ' A' ' 9' ' ' ALA . 44.2 tt0 -100.49 110.38 22.56 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.634 -0.712 . . . . 70.209999999999994 110.105 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.656 HG23 HG23 ' A' ' 91' ' ' VAL . 1.7 p -87.88 97.92 7.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.698 0.761 . . . . 71.140000000000001 109.364 175.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.844 HG12 ' HB2' ' A' ' 9' ' ' ALA . 22.7 m -84.43 110.79 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 115.059 -0.973 . . . . 71.109999999999999 109.802 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.7 p -112.67 123.89 68.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.797 -0.638 . . . . 64.140000000000001 110.878 -176.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.545 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 22.5 ptt180 -115.22 99.06 7.14 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.714 -0.676 . . . . 72.140000000000001 109.661 174.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 52.3 tp -120.46 141.98 49.67 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.021 -0.733 . . . . 71.329999999999998 109.021 -177.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.782 ' HA ' HG13 ' A' ' 5' ' ' VAL . 51.8 m -83.1 119.58 24.67 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.715 0.769 . . . . 53.25 111.922 -172.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 . . . . . 0 C--N 1.323 -0.554 0 CA-C-N 114.686 -1.143 . . . . 74.319999999999993 109.08 174.931 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.824 -0.111 . . . . 65.219999999999999 112.824 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.9 m -62.41 -29.08 70.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.891 0.377 . . . . 75.340000000000003 110.912 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.83 -30.58 65.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.072 -0.513 . . . . 45.210000000000001 110.866 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -73.88 -20.23 79.74 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.81 -0.632 . . . . 51.409999999999997 112.916 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.51 -19.82 27.24 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 112.262 0.468 . . . . 32.509999999999998 112.262 -177.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.426 ' O ' ' HG3' ' A' ' 124' ' ' MET . 13.8 p -60.13 -29.79 44.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 62.200000000000003 111.832 -177.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.7 pp -65.46 -32.69 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 C-N-CA 120.85 -0.34 . . . . 75.310000000000002 111.022 -177.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.94 -39.36 56.3 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.689 -0.486 . . . . 63.210000000000001 109.689 176.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -59.01 -28.33 66.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.378 -0.828 . . . . 74.349999999999994 111.6 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.426 ' HG3' ' O ' ' A' ' 120' ' ' VAL . 66.1 mtt . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 116.208 -0.451 . . . . 75.310000000000002 111.362 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 . . . . . 0 CA--C 1.532 0.26 0 CA-C-O 120.874 0.369 . . . . 73.120000000000005 111.103 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.449 ' O ' ' HG3' ' A' ' 138' ' ' MET . 18.1 t70 -65.55 -43.92 88.42 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.002 0.43 . . . . 74.400000000000006 110.601 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -74.54 -36.46 63.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.239 0.542 . . . . 75.010000000000005 110.319 174.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.509 HD22 ' HB3' ' A' ' 8' ' ' ASP . 1.3 mp -70.63 -29.76 66.21 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.618 0.599 . . . . 75.120000000000005 112.618 -174.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.449 ' HG3' ' O ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -64.2 -26.2 68.41 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.412 -0.515 . . . . 63.409999999999997 110.076 175.442 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 55.8 mtt180 -69.61 -48.93 58.36 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.496 -0.557 . . . . 75.549999999999997 109.496 174.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -56.29 -48.95 75.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.841 -1.072 . . . . 62.310000000000002 110.985 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.592 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 0.6 OUTLIER -63.49 -44.13 95.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.016 -0.538 . . . . 73.209999999999994 110.141 179.748 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 48.0 ttt180 -57.46 -50.61 72.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.063 -0.517 . . . . 74.219999999999999 111.076 -175.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -66.17 -27.47 68.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.073 0.463 . . . . 65.340000000000003 110.594 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.76 ' HA ' HD11 ' A' ' 26' ' ' LEU . 54.5 tt0 -77.49 -29.21 52.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.795 -0.639 . . . . 72.439999999999998 112.035 -174.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.953 ' HB3' HG23 ' A' ' 12' ' ' ILE . 2.2 pp20? -108.49 -13.4 14.85 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.265 0.468 . . . . 73.209999999999994 112.265 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 57.5 tp -62.08 -40.33 95.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.265 0.555 . . . . 74.310000000000002 109.612 175.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.71 0 C-N-CA 120.83 -0.7 . . . . 74.409999999999997 111.408 175.729 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.585 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 70.0 t . . . . . 0 N--CA 1.446 -0.675 0 N-CA-C 108.456 -0.942 . . . . 45.229999999999997 108.456 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.4 p -77.82 124.38 36.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.466 0.65 . . . . 73.030000000000001 110.44 -174.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.711 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -141.52 110.56 6.23 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.344 -0.844 . . . . 71.400000000000006 110.621 -179.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.506 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 14.3 t70 -146.21 171.38 15.03 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.036 -0.727 . . . . 64.109999999999999 109.036 175.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.68 ' HB2' HG12 ' A' ' 105' ' ' VAL . . . -139.72 120.69 14.57 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.939 0.4 . . . . 73.129999999999995 111.02 -174.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.1 m -115.09 143.44 24.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.985 -0.552 . . . . 74.439999999999998 110.163 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.544 HG21 ' HB2' ' A' ' 100' ' ' ARG . 42.6 m -103.79 111.87 24.57 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.967 -0.56 . . . . 71.400000000000006 110.322 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.642 HD13 ' HG2' ' A' ' 141' ' ' LYS . 9.4 mm -100.63 146.0 10.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.287 -0.415 . . . . 74.230000000000004 109.945 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.16 60.11 4.5 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.689 -0.767 . . . . 52.539999999999999 111.817 174.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.527 ' HB2' HD21 ' A' ' 19' ' ' LEU . 24.2 mmtm -141.19 145.25 37.85 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 109.764 -0.458 . . . . 62.100000000000001 109.764 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.41 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 72.9 Cg_exo -52.24 -57.68 1.98 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.157 2.572 . . . . 64.409999999999997 113.58 -175.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . 174.54 -46.66 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.932 0.396 . . . . 63.399999999999999 111.156 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -59.19 -45.43 91.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.075 -0.511 . . . . 74.540000000000006 110.866 -176.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.615 ' HA ' ' HB3' ' A' ' 21' ' ' ALA . 21.4 mp0 -66.64 -16.67 64.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.886 -0.597 . . . . 72.099999999999994 110.906 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.757 ' HA ' ' NE2' ' A' ' 144' ' ' GLN . 74.5 mt -73.76 -45.5 51.45 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.36 -0.382 . . . . 74.140000000000001 110.256 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -74.28 -29.9 61.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.383 0.611 . . . . 73.340000000000003 109.896 174.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.615 ' HB3' ' HA ' ' A' ' 18' ' ' GLN . . . -70.34 -3.03 15.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.276 -0.874 . . . . 60.299999999999997 111.927 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.715 HG21 ' HD2' ' A' ' 140' ' ' PHE . 10.9 p -53.2 -21.21 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.096 0.558 . . . . 62.109999999999999 111.991 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 4.2 m95 -59.19 -26.15 64.57 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.796 0.332 . . . . 74.209999999999994 110.92 176.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -136.95 -164.67 1.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 74.209999999999994 110.168 -177.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.453 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 5.3 t70 -88.03 46.67 1.41 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.282 -0.417 . . . . 70.209999999999994 110.209 -176.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 25' ' ' ASP . 0.4 OUTLIER 43.14 84.87 0.18 Allowed Pre-proline 0 N--CA 1.476 0.86 0 C-N-CA 123.513 0.725 . . . . 71.109999999999999 111.965 -177.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 C--N 1.344 0.298 0 C-N-CA 122.983 2.455 . . . . 54.439999999999998 113.867 -173.276 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.655 0 N-CA-C 109.312 -0.625 . . . . 61.310000000000002 109.312 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.422 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 7.6 tt0 -108.83 134.61 51.29 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.964 -0.294 . . . . 52.350000000000001 110.533 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.015 HD12 ' HA ' ' A' ' 77' ' ' TRP . 2.2 mm? -83.95 137.32 33.69 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.356 -0.609 . . . . 70.349999999999994 109.356 174.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.564 HG23 ' HB2' ' A' ' 78' ' ' ARG . 20.8 p -67.67 -34.37 76.79 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.502 0.668 . . . . 72.329999999999998 110.546 -176.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -135.72 124.85 24.43 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.979 -1.009 . . . . 72.099999999999994 110.725 177.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -117.36 90.77 3.41 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.432 -0.804 . . . . 71.400000000000006 109.581 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.99 ' HB3' ' HB2' ' A' ' 73' ' ' LYS . 48.9 mt-10 -120.02 86.52 37.09 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.483 -0.781 . . . . 73.120000000000005 110.452 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -60.6 107.03 0.39 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.599 2.199 . . . . 72.310000000000002 111.82 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.409 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 99.09 6.16 55.94 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.896 -0.669 . . . . 53.350000000000001 111.827 -177.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.99 ' HB2' ' HB3' ' A' ' 70' ' ' GLU . 2.8 mmmp? -128.62 -66.38 0.84 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.586 0.231 . . . . 70.239999999999995 110.488 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 22.4 ptt180 -168.3 150.09 5.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.323 -0.399 . . . . 75.310000000000002 110.643 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.6 mp -124.98 114.29 39.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 116.195 -0.457 . . . . 74.040000000000006 109.793 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.579 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . . . -101.68 121.02 41.25 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.076 -0.511 . . . . 74.209999999999994 110.448 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 1.015 ' HA ' HD12 ' A' ' 66' ' ' LEU . 26.3 m0 -80.49 155.43 27.03 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.989 0.737 . . . . 72.219999999999999 112.989 -172.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.573 ' HG3' ' H ' ' A' ' 79' ' ' SER . 24.7 tpp180 -176.62 174.63 1.83 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 114.394 -1.275 . . . . 54.450000000000003 108.238 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.573 ' H ' ' HG3' ' A' ' 78' ' ' ARG . 24.6 m -148.75 145.81 27.78 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.001 -1.111 . . . . 70.420000000000002 108.001 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.2 mt -71.7 152.08 93.48 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.911 -0.404 . . . . 75.439999999999998 109.911 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -52.35 -23.3 18.11 Favored 'Trans proline' 0 N--CA 1.476 0.445 0 C-N-CA 123.315 2.677 . . . . 72.439999999999998 113.93 -175.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -78.53 -4.14 87.16 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.821 -0.704 . . . . 62.329999999999998 112.997 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.33 -170.74 2.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.919 0.39 . . . . 60.229999999999997 110.935 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.466 ' HB2' HD12 ' A' ' 85' ' ' ILE . 86.8 mtt180 -118.06 -38.42 3.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.052 -0.522 . . . . 70.010000000000005 112.095 -172.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.466 HD12 ' HB2' ' A' ' 84' ' ' ARG . 4.8 mp -121.5 122.84 68.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.928 -0.309 . . . . 63.530000000000001 110.722 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.468 ' HB3' ' HB2' ' A' ' 79' ' ' SER . 11.3 pt-20 -125.79 123.19 38.22 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.53 -0.544 . . . . 74.230000000000004 109.53 172.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -111.64 138.67 47.88 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.032 -0.729 . . . . 74.140000000000001 109.032 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.2 m -96.04 128.15 42.69 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.685 -0.487 . . . . 34.5 109.685 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.24 123.73 0.69 Allowed Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.74 -0.743 . . . . 60.009999999999998 111.896 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 0.5 OUTLIER -108.95 126.19 52.83 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.904 0.383 . . . . 75.120000000000005 110.297 178.419 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 4.4 m -97.81 126.68 50.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.463 -0.569 . . . . 52.32 109.463 176.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.485 ' HB2' ' CG2' ' A' ' 105' ' ' VAL . 9.5 mp -105.32 139.06 40.53 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.422 -0.354 . . . . 65.239999999999995 110.886 -177.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -99.57 105.64 17.54 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.456 -0.942 . . . . 62.539999999999999 108.456 172.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.4 mtp85 -112.68 150.25 42.43 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 115.288 -0.869 . . . . 64.420000000000002 111.1 -171.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -49.71 127.3 18.41 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.427 2.084 . . . . 71.219999999999999 111.204 172.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.37 150.85 85.23 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.881 -0.599 . . . . 51.229999999999997 111.762 -172.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.78 109.43 0.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.824 2.349 . . . . 71.439999999999998 112.089 175.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.8 -73.9 1.34 Allowed Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.175 -0.92 . . . . 63.240000000000002 111.483 177.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 174.31 24.57 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.273 0.631 . . . . 72.219999999999999 111.264 -175.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.544 ' HB2' HG21 ' A' ' 11' ' ' THR . 19.6 mtp180 -82.62 7.04 15.8 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.544 0.572 . . . . 53.299999999999997 112.544 -171.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 126.68 -113.14 1.71 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.49 -0.862 . . . . 44.32 111.78 177.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.745 ' HB ' HD11 ' A' ' 19' ' ' LEU . 15.7 m -141.17 140.6 34.07 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.841 0.353 . . . . 72.099999999999994 110.265 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -96.59 119.02 34.3 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.176 -0.466 . . . . 63.119999999999997 110.755 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 p -100.67 107.49 21.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.495 0.664 . . . . 62.119999999999997 110.258 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.68 HG12 ' HB2' ' A' ' 9' ' ' ALA . 18.8 m -95.45 118.69 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 115.37 -0.832 . . . . 74.219999999999999 110.046 178.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.711 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 18.6 m -112.2 127.92 69.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.837 -0.62 . . . . 72.019999999999996 110.584 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.479 ' HG3' ' HB3' ' A' ' 7' ' ' ARG . 10.1 ttp180 -137.67 100.38 4.19 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.054 -0.521 . . . . 74.239999999999995 109.857 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 pp -145.46 155.23 42.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.974 -0.557 . . . . 74.239999999999995 109.508 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 11.4 t -80.82 137.69 36.21 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.154 -0.618 . . . . 64.040000000000006 109.876 -176.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 30.8 t80 . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 108.069 -1.085 . . . . 73.400000000000006 108.069 -171.946 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.418 0 N-CA-C 112.417 -0.273 . . . . 52.32 112.417 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.6 m -85.26 -48.8 8.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.078 0.466 . . . . 71.310000000000002 110.585 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.495 ' O ' HG22 ' A' ' 120' ' ' VAL . . . -72.69 -39.61 66.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.926 -0.579 . . . . 63.109999999999999 111.431 -177.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.5 ' O ' HG22 ' A' ' 121' ' ' ILE . . . -67.01 -20.02 70.43 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 121.037 -0.601 . . . . 62.539999999999999 113.273 -177.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.17 -21.31 60.72 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.228 0.455 . . . . 61.329999999999998 112.228 -175.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 117' ' ' ALA . 10.7 m -77.12 -18.84 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.509 0.559 . . . . 54.109999999999999 112.509 -173.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.5 HG22 ' O ' ' A' ' 118' ' ' GLY . 16.1 tt -68.86 -28.98 41.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.893 -0.323 . . . . 70.439999999999998 111.061 -176.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.33 -27.49 68.53 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.779 -0.646 . . . . 72.420000000000002 111.953 -175.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 16.7 mtm180 -66.79 -42.59 85.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.091 0.472 . . . . 71.129999999999995 110.009 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 40.5 ttp . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 115.758 -0.656 . . . . 70.109999999999999 109.789 177.616 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 33.9 mtt-85 . . . . . 0 N--CA 1.463 0.177 0 N-CA-C 110.369 -0.234 . . . . 74.439999999999998 110.369 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -56.96 -56.5 20.85 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.77 0.285 . . . . 72.150000000000006 111.77 -173.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -76.56 -39.52 52.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.886 0.374 . . . . 75.329999999999998 110.156 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.564 ' CD1' ' HE1' ' A' ' 140' ' ' PHE . 0.3 OUTLIER -53.75 -51.0 64.78 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.667 -0.697 . . . . 55.020000000000003 111.589 -178.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.53 ' CE ' ' HA ' ' A' ' 138' ' ' MET . 0.6 OUTLIER -65.17 -38.18 89.71 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.429 -0.35 . . . . 72.209999999999994 111.001 -175.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.422 ' O ' ' HB3' ' A' ' 142' ' ' ARG . 34.2 mtm105 -65.68 -51.66 57.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.509 -0.314 . . . . 72.140000000000001 111.676 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.715 ' HD2' HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -73.57 -30.21 62.89 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 120.06 -0.656 . . . . 63.5 109.779 -175.123 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.642 ' HG2' HD13 ' A' ' 12' ' ' ILE . 13.5 tmtt? -55.44 -50.44 69.83 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.235 -0.654 . . . . 62.530000000000001 109.235 173.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.602 ' HE ' ' HG3' ' A' ' 143' ' ' GLU . 43.7 ttp180 -52.53 -54.93 26.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.514 -1.221 . . . . 73.420000000000002 111.674 177.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.602 ' HG3' ' HE ' ' A' ' 142' ' ' ARG . 30.6 mt-10 -72.97 -34.02 66.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.958 -0.565 . . . . 73.099999999999994 111.812 -174.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.757 ' NE2' ' HA ' ' A' ' 19' ' ' LEU . 46.0 tt0 -61.65 -44.46 96.92 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.299 0.481 . . . . 75.430000000000007 112.299 -174.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -85.73 -8.74 57.98 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.272 -0.571 . . . . 75.420000000000002 111.12 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 57.5 tp -84.21 -53.18 5.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.082 0.468 . . . . 43.520000000000003 109.869 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.688 0 N-CA-C 110.933 -0.867 . . . . 43.399999999999999 110.933 -178.647 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 82.4 t . . . . . 0 N--CA 1.45 -0.467 0 N-CA-C 109.801 -0.444 . . . . 73.310000000000002 109.801 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.5 t -93.72 116.52 35.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.826 -0.625 . . . . 72.209999999999994 110.314 -176.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.44 109.79 13.15 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.965 -0.754 . . . . 73.010000000000005 108.965 172.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.577 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 7.0 t70 -157.72 172.03 19.24 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.039 -1.097 . . . . 62.130000000000003 108.039 175.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.473 ' CB ' HG22 ' A' ' 105' ' ' VAL . . . -136.84 121.05 17.91 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.949 0.404 . . . . 74.219999999999999 111.486 -173.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.9 m -109.27 141.67 23.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.256 -0.646 . . . . 63.219999999999999 109.256 175.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 t -116.47 124.68 50.55 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.937 0.875 . . . . 74.099999999999994 110.99 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.76 HG23 ' HB3' ' A' ' 145' ' ' GLU . 4.7 mp -121.85 150.18 25.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.692 -1.14 . . . . 51.310000000000002 109.685 -176.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.9 37.99 0.76 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.509 -0.377 . . . . 71.409999999999997 113.582 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.557 ' HG2' HG22 ' A' ' 12' ' ' ILE . 74.3 mmtt -105.66 152.0 39.98 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 108.264 -1.013 . . . . 52.109999999999999 108.264 175.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.73 -57.85 1.37 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.151 1.9 . . . . 51.25 112.593 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 173.33 -54.1 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.404 0.621 . . . . 53.340000000000003 110.164 178.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.756 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 7.8 mt-10 -55.56 -39.32 70.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.82 -1.082 . . . . 63.119999999999997 111.814 -175.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.612 ' NE2' ' HB2' ' A' ' 17' ' ' GLU . 2.5 mp0 -73.43 -14.11 61.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.864 -0.607 . . . . 74.340000000000003 111.135 -175.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.3 mt -76.04 -44.07 40.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.592 -0.276 . . . . 64.109999999999999 111.064 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.756 ' CE2' ' HA ' ' A' ' 17' ' ' GLU . 21.1 p90 -73.75 -23.47 59.74 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 119.999 -0.68 . . . . 74.109999999999999 110.22 175.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.631 ' HB1' ' HD2' ' A' ' 27' ' ' PRO . . . -75.58 -2.64 30.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.5 -0.773 . . . . 71.209999999999994 111.74 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.45 HG11 ' HZ ' ' A' ' 140' ' ' PHE . 15.0 p -52.14 -31.55 14.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 112.144 0.424 . . . . 74.450000000000003 112.144 -177.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -67.7 -13.0 61.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.706 0.289 . . . . 75.549999999999997 111.449 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.767 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . 39.3 mmt180 -117.14 15.28 14.99 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.193 -0.458 . . . . 72.299999999999997 110.715 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.436 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 11.6 t70 61.5 37.57 16.4 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.864 0.84 . . . . 71.340000000000003 109.117 -175.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER 43.84 85.33 0.17 Allowed Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 114.967 -1.015 . . . . 73.430000000000007 111.726 -177.492 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.767 ' HD3' ' HB2' ' A' ' 24' ' ' ARG . 63.3 Cg_endo . . . . . 0 N--CA 1.461 -0.402 0 C-N-CA 122.617 2.211 . . . . 74.409999999999997 112.579 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.589 0 N-CA-C 109.5 -0.556 . . . . 61.119999999999997 109.5 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.827 ' HB2' HD23 ' A' ' 80' ' ' LEU . 5.5 tm-20 -108.05 135.21 49.8 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.356 -1.35 . . . . 51.210000000000001 107.356 177.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.719 HD21 ' HB2' ' A' ' 69' ' ' ASP . 29.3 tp -137.96 149.38 46.09 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.486 -0.486 . . . . 74.540000000000006 110.462 -171.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.9 t -119.11 -18.34 8.74 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.251 -0.58 . . . . 73.5 111.773 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -152.61 129.07 10.65 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 120.776 -0.37 . . . . 63.399999999999999 111.605 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.719 ' HB2' HD21 ' A' ' 66' ' ' LEU . 19.3 t70 -136.17 90.66 2.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.4 -0.818 . . . . 74.230000000000004 110.273 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 73' ' ' LYS . 31.4 mt-10 -139.38 142.82 33.6 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 110.067 -0.346 . . . . 65.209999999999994 110.067 177.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 16.5 Cg_exo -69.1 -55.06 0.21 Allowed 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.747 2.298 . . . . 63.119999999999997 113.061 -178.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.56 49.88 0.83 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.572 -0.823 . . . . 75.349999999999994 112.42 -176.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.568 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 7.7 mmmm -139.0 -74.48 0.38 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.026 0.441 . . . . 63.420000000000002 110.428 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.529 ' HB3' HD13 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -166.51 137.78 3.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.957 -0.565 . . . . 71.010000000000005 110.1 179.127 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.679 HD13 ' HE2' ' A' ' 93' ' ' PHE . 3.2 mp -109.44 110.11 30.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.901 -0.778 . . . . 72.209999999999994 108.901 173.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -119.2 115.19 23.69 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.438 -0.949 . . . . 23.34 108.438 176.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.695 ' HA ' HD12 ' A' ' 66' ' ' LEU . 63.0 p-90 -121.48 157.65 30.15 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.511 0.672 . . . . 65.349999999999994 111.544 -169.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.683 ' HD2' ' OE1' ' A' ' 65' ' ' GLU . 69.8 mtt180 -136.39 175.8 9.28 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 107.92 -1.141 . . . . 62.119999999999997 107.92 176.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.661 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 19.6 m -137.19 51.54 1.95 Allowed 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.678 -0.49 . . . . 61.310000000000002 109.678 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.827 HD23 ' HB2' ' A' ' 65' ' ' GLU . 13.0 mt 65.3 142.21 0.07 OUTLIER Pre-proline 0 N--CA 1.471 0.624 0 O-C-N 124.264 0.977 . . . . 64.109999999999999 111.014 -175.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 80' ' ' LEU . 22.4 Cg_exo -66.38 -35.33 31.57 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.461 2.107 . . . . 71.439999999999998 112.097 177.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.87 18.46 57.17 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.596 -0.811 . . . . 52.32 112.87 -177.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 79' ' ' SER . . . -118.14 -158.13 0.7 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 122.582 -0.363 . . . . 64.540000000000006 111.167 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -66.5 -66.07 0.6 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.642 0.608 . . . . 51.409999999999997 112.642 -168.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 50.2 mt 59.61 87.96 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.264 0.555 . . . . 74.239999999999995 110.547 -172.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -80.19 -46.25 16.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.98 -0.554 . . . . 63.049999999999997 110.952 -175.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.64 HD21 ' HB2' ' A' ' 108' ' ' LEU . 54.2 t30 -125.89 162.15 25.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.1 -0.5 . . . . 61.32 109.771 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.8 m -138.35 128.65 25.95 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.082 -0.34 . . . . 74.439999999999998 110.082 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.18 148.89 4.91 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.751 -0.737 . . . . 53.409999999999997 111.807 178.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.72 159.31 16.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.151 0.5 . . . . 72.219999999999999 111.369 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.9 p -110.89 128.05 67.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.667 -0.697 . . . . 64.329999999999998 110.492 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.529 HD13 ' HB3' ' A' ' 74' ' ' ARG . 3.9 mm? -100.25 126.88 46.6 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.499 -0.773 . . . . 74.510000000000005 110.357 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.679 ' HE2' HD13 ' A' ' 75' ' ' ILE . 85.7 m-85 -107.63 106.69 17.15 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.23 -0.656 . . . . 73.150000000000006 109.23 175.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.488 ' HD3' ' CG2' ' A' ' 105' ' ' VAL . 0.0 OUTLIER -129.93 144.9 54.92 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 116.152 -0.476 . . . . 74.150000000000006 110.763 -175.147 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -61.57 123.39 12.62 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.603 2.202 . . . . 62.409999999999997 111.377 175.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.7 144.03 93.23 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.287 -0.415 . . . . 71.150000000000006 110.247 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -43.25 115.31 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.584 2.856 . . . . 72.430000000000007 114.056 -176.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.15 -75.38 0.33 Allowed Glycine 0 N--CA 1.437 -1.268 0 CA-C-N 115.125 -0.943 . . . . 71.230000000000004 111.169 174.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 175.04 24.2 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.159 -0.521 . . . . 61.299999999999997 111.556 -175.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -67.87 -33.63 75.11 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.887 0.375 . . . . 64.140000000000001 111.505 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.02 -154.58 25.63 Favored Glycine 0 CA--C 1.506 -0.478 0 N-CA-C 111.33 -0.708 . . . . 62.549999999999997 111.33 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 91.6 m -106.79 117.83 35.08 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.252 0.549 . . . . 75.340000000000003 110.378 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.447 ' CG ' ' HB1' ' A' ' 9' ' ' ALA . 43.3 tt0 -78.86 115.85 18.81 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.125 -0.943 . . . . 72.209999999999994 110.408 178.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.4 p -94.01 103.95 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.708 0.766 . . . . 65.129999999999995 110.033 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.488 ' CG2' ' HD3' ' A' ' 94' ' ' ARG . 18.9 t -100.46 111.02 28.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 114.939 -1.028 . . . . 62.100000000000001 110.084 -177.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.472 HG12 HD22 ' A' ' 108' ' ' LEU . 10.9 t -120.14 132.33 70.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.031 0.443 . . . . 73.109999999999999 110.707 -178.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 107' ' ' ARG . 0.6 OUTLIER -118.13 103.31 9.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.833 -0.621 . . . . 75.549999999999997 109.843 175.214 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.64 ' HB2' HD21 ' A' ' 87' ' ' ASN . 2.3 pt? -150.68 155.25 38.96 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.449 -0.341 . . . . 53.329999999999998 111.058 -172.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 13.8 t -81.43 133.98 35.48 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.04 -1.096 . . . . 64.140000000000001 108.04 172.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 14.2 t80 . . . . . 0 N--CA 1.442 -0.857 0 N-CA-C 108.968 -0.753 . . . . 74.010000000000005 108.968 -167.374 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.804 0 N-CA-C 111.841 -0.504 . . . . 53.210000000000001 111.841 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 16.5 m -61.91 -22.19 65.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.857 0.36 . . . . 50.350000000000001 110.744 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.23 -22.14 66.67 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.077 -0.511 . . . . 53.450000000000003 110.813 175.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -60.36 -20.54 55.35 Favored Glycine 0 CA--C 1.519 0.307 0 CA-C-N 116.108 -0.496 . . . . 74.5 112.424 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.93 -20.33 66.18 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 122.68 -0.306 . . . . 63.039999999999999 111.041 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.49 ' O ' ' HG2' ' A' ' 123' ' ' ARG . 66.5 t -69.23 -47.63 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.791 0.329 . . . . 73.349999999999994 110.41 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.427 ' O ' ' HB3' ' A' ' 124' ' ' MET . 14.2 tt -75.32 -27.05 19.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.043 0.449 . . . . 71.120000000000005 110.182 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.87 -42.93 84.79 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.373 -0.376 . . . . 72.209999999999994 111.052 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 120' ' ' VAL . 13.3 ptp180 -74.51 -14.8 60.86 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.142 0.496 . . . . 71.049999999999997 110.393 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.427 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 26.2 ttt . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 115.609 -0.723 . . . . 60.43 110.002 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.937 0 CA-C-O 121.873 0.844 . . . . 52.43 109.447 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -48.06 -43.68 30.7 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 113.823 -1.535 . . . . 73.019999999999996 112.949 -173.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -73.34 -36.91 66.23 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.915 0.388 . . . . 71.340000000000003 111.048 -175.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.577 ' CD2' ' HB3' ' A' ' 8' ' ' ASP . 24.3 tp -77.05 -21.85 53.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.224 0.535 . . . . 72.409999999999997 109.729 -178.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.529 ' CE ' ' HA ' ' A' ' 138' ' ' MET . 0.1 OUTLIER -63.89 -35.2 79.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.914 -0.584 . . . . 75.530000000000001 109.442 175.386 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.675 ' O ' ' HG3' ' A' ' 142' ' ' ARG . 52.6 mtt180 -73.14 -32.56 64.97 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.664 -0.698 . . . . 52.350000000000001 110.023 177.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.45 ' HZ ' HG11 ' A' ' 22' ' ' VAL . 83.4 t80 -62.05 -34.29 75.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.707 -0.679 . . . . 63.329999999999998 110.046 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.456 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 21.0 ttpp -60.81 -53.02 62.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.41 . . . . 73.019999999999996 110.957 176.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.675 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 3.5 ptm180 -64.68 -29.31 70.3 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.585 0.587 . . . . 61.310000000000002 112.585 -174.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -79.57 -33.62 41.62 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.143 -0.623 . . . . 73.340000000000003 110.42 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.516 ' HB2' HG12 ' A' ' 12' ' ' ILE . 13.4 mm-40 -59.31 -43.92 92.59 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.29 0.566 . . . . 71.129999999999995 111.263 176.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.76 ' HB3' HG23 ' A' ' 12' ' ' ILE . 9.0 pt-20 -81.97 -3.44 54.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.718 -0.674 . . . . 53.119999999999997 111.48 -177.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 54.2 tp -112.76 -61.56 1.71 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.063 0.459 . . . . 54.200000000000003 111.306 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.72 0 N-CA-C 111.101 -0.8 . . . . 43.310000000000002 111.101 -173.721 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.534 HG13 ' HA ' ' A' ' 109' ' ' THR . 74.6 t . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 110.034 -0.358 . . . . 72.409999999999997 110.034 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.6 t -78.77 117.28 24.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.095 0.474 . . . . 72.319999999999993 111.159 -173.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -140.06 109.81 6.36 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.541 -0.754 . . . . 75.219999999999999 109.971 173.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.544 ' HB3' HD23 ' A' ' 137' ' ' LEU . 4.1 t70 -151.46 172.57 15.77 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.759 -1.2 . . . . 64.140000000000001 107.759 174.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.436 ' HB1' ' CG ' ' A' ' 103' ' ' GLU . . . -139.8 120.81 14.61 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.05 0.453 . . . . 64.349999999999994 111.205 -172.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.589 HG23 HD11 ' A' ' 12' ' ' ILE . 19.4 m -111.24 148.9 14.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.73 -0.668 . . . . 65.340000000000003 110.313 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.6 t -114.44 103.75 11.36 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.796 0.808 . . . . 55.43 110.781 175.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.82 HG21 ' HB3' ' A' ' 144' ' ' GLN . 1.1 mp -96.16 151.81 3.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.238 -0.892 . . . . 73.439999999999998 108.711 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.39 51.12 1.39 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.322 -0.466 . . . . 74.099999999999994 113.483 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.696 ' HB3' ' HB2' ' A' ' 18' ' ' GLN . 79.7 mttt -128.13 144.82 53.07 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 108.049 -1.093 . . . . 64.129999999999995 108.049 172.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -55.21 -57.74 1.51 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.32 2.013 . . . . 74.120000000000005 113.332 -174.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 173.32 -51.37 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.45 -0.945 . . . . 63.299999999999997 108.45 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.69 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 2.5 tt0 -48.76 -37.86 20.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 113.943 -1.48 . . . . 63.43 111.421 174.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.696 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 31.0 mm-40 -85.84 -13.29 48.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.577 -0.738 . . . . 75.219999999999999 111.15 -176.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.698 HD22 HD13 ' A' ' 12' ' ' ILE . 91.7 mt -83.89 -53.21 5.75 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 112.079 0.4 . . . . 73.450000000000003 112.079 -177.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.69 ' CE2' ' HA ' ' A' ' 17' ' ' GLU . 32.7 p90 -66.96 -23.29 65.94 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.193 0.521 . . . . 44.140000000000001 111.06 -175.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.1 -3.01 30.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.771 -0.65 . . . . 71.340000000000003 111.661 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.573 ' HA ' ' HA ' ' A' ' 25' ' ' ASP . 13.5 p -52.64 -22.28 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 113.162 0.801 . . . . 71.409999999999997 113.162 -175.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -56.51 -32.32 64.93 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.138 0.494 . . . . 73.129999999999995 110.35 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -116.71 6.05 13.24 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.099 -0.704 . . . . 75.25 109.099 175.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.573 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 31.3 t70 48.63 95.69 0.01 OUTLIER 'General case' 0 C--O 1.235 0.305 0 CA-C-N 114.312 -1.313 . . . . 73.530000000000001 111.644 -168.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.446 ' CD2' ' HB3' ' A' ' 18' ' ' GLN . 16.5 mt 67.32 153.85 0.13 Allowed Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 114.686 -1.143 . . . . 63.340000000000003 111.232 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 26' ' ' LEU . 3.3 Cg_exo . . . . . 0 N--CA 1.46 -0.445 0 C-N-CA 122.684 2.256 . . . . 72.319999999999993 112.45 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.289 0 N-CA-C 109.562 -0.533 . . . . 72.420000000000002 109.562 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -106.1 134.97 48.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.823 0.344 . . . . 74.299999999999997 110.105 -178.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.841 HD12 ' HA ' ' A' ' 77' ' ' TRP . 3.1 mm? -97.7 151.98 19.57 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.837 -0.801 . . . . 55.130000000000003 108.837 176.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.1 p -75.32 -36.91 61.02 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.006 -0.739 . . . . 74.319999999999993 109.006 175.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -173.28 127.91 0.44 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.602 -1.181 . . . . 72.409999999999997 111.418 177.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -124.48 94.16 4.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.53 -0.759 . . . . 74.239999999999995 109.211 174.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 48.9 mt-10 -104.09 142.45 24.62 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 63.439999999999998 111.296 -174.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 31.5 Cg_exo -59.18 99.25 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.362 2.708 . . . . 74.329999999999998 113.694 -172.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.51 40.76 96.67 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.367 -0.833 . . . . 71.310000000000002 113.072 177.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -128.58 -79.67 0.57 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.021 0.438 . . . . 62.130000000000003 110.341 178.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -136.59 132.74 35.54 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.013 -0.54 . . . . 70.299999999999997 109.551 176.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 30.7 mm -120.36 110.34 28.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.809 -0.632 . . . . 75.150000000000006 109.354 -177.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -119.41 116.99 27.28 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.309 0.576 . . . . 71.409999999999997 110.47 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.841 ' HA ' HD12 ' A' ' 66' ' ' LEU . 44.9 m95 -89.9 159.56 16.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.374 -0.83 . . . . 72.209999999999994 111.072 -174.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -164.92 175.75 9.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.72 -0.673 . . . . 74.530000000000001 109.688 -178.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.575 ' HB3' ' O ' ' A' ' 84' ' ' ARG . 9.2 t -138.04 173.11 11.98 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.203 -1.406 . . . . 65.140000000000001 107.203 175.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 97.5 mt -79.01 144.28 63.15 Favored Pre-proline 0 C--N 1.314 -0.957 0 C-N-CA 121.054 -0.258 . . . . 73.540000000000006 110.689 -177.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.469 ' HA ' HG23 ' A' ' 85' ' ' ILE . 52.5 Cg_exo -56.14 -37.54 96.32 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.123 2.548 . . . . 74.519999999999996 112.676 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.69 -16.65 74.34 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.684 -0.769 . . . . 73.319999999999993 112.26 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.2 -62.58 1.26 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.705 0.288 . . . . 61.149999999999999 111.033 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.575 ' O ' ' HB3' ' A' ' 79' ' ' SER . 29.4 ttm180 -177.23 117.56 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.752 -0.658 . . . . 75.040000000000006 110.808 -173.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.469 HG23 ' HA ' ' A' ' 81' ' ' PRO . 2.1 pp -113.97 -166.58 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.543 -0.299 . . . . 65.140000000000001 110.732 175.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 49.4 mm-40 71.61 8.09 6.11 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.15 0.58 . . . . 73.109999999999999 111.707 -177.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -74.03 131.79 41.72 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.301 -0.629 . . . . 75.310000000000002 109.301 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.436 ' HB3' ' H ' ' A' ' 109' ' ' THR . 22.7 t -112.36 127.1 55.91 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.934 -0.395 . . . . 71.129999999999995 109.934 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -179.25 72.26 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.645 -0.788 . . . . 62.439999999999998 112.033 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -102.82 116.42 32.52 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.758 -0.46 . . . . 71.219999999999999 109.758 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.681 HG22 HG22 ' A' ' 106' ' ' VAL . 89.6 t -102.61 126.55 56.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.458 0.647 . . . . 73.349999999999994 111.267 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.538 ' HB2' ' HB ' ' A' ' 105' ' ' VAL . 3.2 mm? -110.4 120.81 43.62 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.965 -1.016 . . . . 71.109999999999999 109.833 176.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -97.62 118.04 33.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.929 0.395 . . . . 73.329999999999998 110.345 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.0 mtp180 -123.78 145.39 47.41 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.008 -0.542 . . . . 73.099999999999994 110.552 -176.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.34 119.01 6.0 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.591 2.194 . . . . 75.340000000000003 111.187 175.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . . . -82.95 143.99 47.01 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.045 0.45 . . . . 74.519999999999996 111.935 -173.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 96' ' ' ALA . 34.1 Cg_exo -60.54 131.01 35.87 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.312 2.675 . . . . 63.240000000000002 112.231 177.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.41 0.38 90.02 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 121.099 -0.572 . . . . 72.329999999999998 111.851 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 58.76 34.01 23.45 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 122.921 0.488 . . . . 75.120000000000005 111.306 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -60.37 -31.99 70.87 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.263 0.554 . . . . 72.329999999999998 110.504 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 170.49 -137.85 4.66 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.194 -1.162 . . . . 74.430000000000007 110.194 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 72.0 m -121.43 130.64 53.71 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 117.06 0.43 . . . . 62.399999999999999 110.19 175.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.436 ' CG ' ' HB1' ' A' ' 9' ' ' ALA . 42.5 tt0 -76.97 119.3 20.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.056 -0.52 . . . . 75.120000000000005 110.904 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.649 HG23 HG13 ' A' ' 91' ' ' VAL . 2.4 p -99.1 106.62 19.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.627 -0.715 . . . . 62.450000000000003 110.041 175.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.538 ' HB ' ' HB2' ' A' ' 92' ' ' LEU . 26.1 t -91.8 109.91 21.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.765 -0.652 . . . . 74.349999999999994 109.413 177.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.681 HG22 HG22 ' A' ' 91' ' ' VAL . 48.8 t -112.11 121.43 64.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.953 0.406 . . . . 64.439999999999998 110.71 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -113.97 104.82 12.54 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.72 -0.844 . . . . 72.140000000000001 108.72 172.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.662 HD23 ' H ' ' A' ' 108' ' ' LEU . 2.4 pt? -119.0 120.47 37.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.181 0.515 . . . . 71.109999999999999 109.824 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.534 ' HA ' HG13 ' A' ' 5' ' ' VAL . 86.6 m -103.45 125.26 49.93 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.2 -0.455 . . . . 62.140000000000001 110.787 -177.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 52.0 p90 . . . . . 0 N--CA 1.445 -0.707 0 N-CA-C 108.612 -0.884 . . . . 70.540000000000006 108.612 -179.359 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.462 0 N-CA-C 111.977 -0.449 . . . . 73.450000000000003 111.977 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.1 m -60.63 -27.99 68.2 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.648 0.24 . . . . 61.119999999999997 111.648 -176.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.88 -23.38 67.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.935 0.398 . . . . 74.120000000000005 111.194 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.73 -21.07 70.82 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.986 -0.626 . . . . 72.019999999999996 112.774 -177.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.99 -41.95 67.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.64 0.257 . . . . 72.340000000000003 111.451 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.4 m -76.67 -35.34 25.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.792 -0.363 . . . . 63.25 110.805 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.403 ' HA ' ' HB2' ' A' ' 124' ' ' MET . 79.2 mt -59.58 -30.9 45.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 116.358 -0.383 . . . . 72.530000000000001 110.709 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -52.64 -58.41 6.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.901 -0.591 . . . . 61.200000000000003 111.179 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -79.52 -17.02 54.96 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.15 -0.477 . . . . 72.340000000000003 111.26 -177.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.403 ' HB2' ' HA ' ' A' ' 121' ' ' ILE . 76.2 mtp . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.483 -0.326 . . . . 73.319999999999993 111.343 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 52.2 mtt85 . . . . . 0 N--CA 1.47 0.54 0 N-CA-C 112.587 0.588 . . . . 54.210000000000001 112.587 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -69.92 -28.53 65.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.655 0.264 . . . . 74.530000000000001 110.346 -177.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -63.8 -30.48 71.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.927 0.394 . . . . 51.439999999999998 110.585 173.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.544 HD23 ' HB3' ' A' ' 8' ' ' ASP . 39.0 tp -67.9 -26.12 65.83 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.728 -0.471 . . . . 74.230000000000004 109.728 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.513 ' O ' ' HG2' ' A' ' 141' ' ' LYS . 2.8 mmt -66.74 -30.07 70.2 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.822 -0.626 . . . . 70.310000000000002 109.911 174.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 -78.52 -35.77 45.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.522 -0.763 . . . . 74.5 109.36 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -57.62 -49.15 77.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.204 -0.907 . . . . 72.25 111.729 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.739 ' HB2' HG13 ' A' ' 12' ' ' ILE . 13.4 ptmm? -60.21 -38.48 83.48 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.897 0.379 . . . . 72.239999999999995 110.238 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.671 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 35.6 ttp180 -64.02 -44.0 93.9 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.719 -0.673 . . . . 73.219999999999999 110.81 -176.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.491 ' HA ' HD12 ' A' ' 146' ' ' LEU . 41.7 mt-10 -65.42 -30.4 71.2 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.949 0.404 . . . . 71.400000000000006 110.66 177.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.82 ' HB3' HG21 ' A' ' 12' ' ' ILE . 0.9 OUTLIER -65.49 -47.0 77.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 73.230000000000004 111.054 178.436 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.404 ' HB3' HG22 ' A' ' 12' ' ' ILE . 6.2 pt-20 -80.41 -9.29 59.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.886 0.374 . . . . 73.019999999999996 111.066 -178.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.671 ' HG ' ' O ' ' A' ' 142' ' ' ARG . 55.4 mt -73.29 -41.13 63.96 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.721 -0.474 . . . . 70.099999999999994 109.721 170.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.399 0 C-N-CA 121.048 -0.596 . . . . 64.219999999999999 112.703 177.082 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.5 t . . . . . 0 N--CA 1.45 -0.434 0 N-CA-C 109.181 -0.674 . . . . 62.100000000000001 109.181 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.5 t -78.82 119.55 28.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 116.016 -0.538 . . . . 75.299999999999997 110.288 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.592 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 15.0 ptt180 -141.65 125.01 16.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.429 0.633 . . . . 74.510000000000005 111.225 176.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.431 ' HB3' HD23 ' A' ' 137' ' ' LEU . 3.8 t70 -157.42 174.1 15.91 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.946 -1.131 . . . . 62.43 107.946 174.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.623 ' HB1' ' HG2' ' A' ' 103' ' ' GLU . . . -134.45 122.37 22.39 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.798 0.332 . . . . 62.229999999999997 111.279 -170.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.549 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 17.1 m -108.04 130.14 61.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.271 0.557 . . . . 61.350000000000001 110.998 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.661 ' O ' ' HE2' ' A' ' 141' ' ' LYS . 21.2 m -86.83 100.16 12.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.715 -0.675 . . . . 73.25 110.497 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.701 HG21 ' HG3' ' A' ' 144' ' ' GLN . 66.9 mt -111.89 145.6 17.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.697 0.285 . . . . 71.519999999999996 111.105 -174.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.407 ' HA2' ' HA3' ' A' ' 101' ' ' GLY . . . -81.68 66.04 3.91 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 121.136 -0.554 . . . . 54.340000000000003 112.955 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.452 ' HD3' ' HB3' ' A' ' 18' ' ' GLN . 43.3 mttp -143.32 147.43 40.23 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.755 -0.461 . . . . 75.219999999999999 109.755 174.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.14 -55.65 2.99 Favored 'Trans proline' 0 N--CA 1.479 0.65 0 C-N-CA 123.406 2.737 . . . . 52.310000000000002 114.079 -172.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 174.65 -64.02 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.146 0.498 . . . . 70.319999999999993 110.015 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.43 ' OE1' ' HG2' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -56.54 -42.5 78.59 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.198 -0.91 . . . . 73.329999999999998 111.507 179.353 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.452 ' HB3' ' HD3' ' A' ' 14' ' ' LYS . 31.4 mm-40 -62.0 -21.32 64.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 74.340000000000003 111.997 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.581 ' HA ' HE21 ' A' ' 144' ' ' GLN . 59.3 mt -73.96 -32.35 63.43 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.305 -0.247 . . . . 74.549999999999997 111.629 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -69.69 -24.22 63.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.182 0.515 . . . . 73.439999999999998 110.181 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.05 -23.85 67.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.752 -0.658 . . . . 75.140000000000001 111.616 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 19' ' ' LEU . 4.3 p -67.38 -21.97 28.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 121.174 0.512 . . . . 63.140000000000001 110.742 -178.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 54.8 t90 -64.49 -26.25 68.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.783 -0.644 . . . . 74.439999999999998 110.69 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.51 -82.65 0.64 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.767 -0.651 . . . . 75.239999999999995 109.647 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.546 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 28.5 t70 -165.92 149.66 7.85 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.466 -0.788 . . . . 74.409999999999997 109.031 178.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.4 ' H ' HD23 ' A' ' 26' ' ' LEU . 0.8 OUTLIER -112.37 86.14 7.81 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 121.086 0.47 . . . . 74.099999999999994 110.941 177.243 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.546 ' HD3' ' O ' ' A' ' 25' ' ' ASP . 2.1 Cg_endo . . . . . 0 N--CA 1.454 -0.84 0 C-N-CA 123.433 2.755 . . . . 72.209999999999994 111.371 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 108.854 -0.795 . . . . 74.430000000000007 108.854 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.458 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 7.2 pt-20 -103.7 135.71 44.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.325 0.583 . . . . 75.530000000000001 111.748 -176.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.581 HD11 HG23 ' A' ' 75' ' ' ILE . 41.4 tp -105.12 126.38 52.01 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.817 -0.438 . . . . 71.099999999999994 109.817 177.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 64.2 p -84.11 -36.63 22.81 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.103 0.478 . . . . 63.299999999999997 111.224 -176.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.748 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -118.93 137.94 53.13 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.828 -0.624 . . . . 64.340000000000003 111.312 -170.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -139.61 33.3 2.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.781 -0.645 . . . . 72.420000000000002 109.856 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 1.01 ' HG3' ' HG2' ' A' ' 74' ' ' ARG . 5.4 mm-40 -57.33 142.83 75.29 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.427 -0.806 . . . . 72.450000000000003 110.307 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 9.2 Cg_exo -71.89 76.08 2.09 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.85 2.367 . . . . 74.129999999999995 112.173 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.47 43.82 43.69 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.947 -0.645 . . . . 70.209999999999994 112.076 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.611 ' HB2' ' HB3' ' A' ' 70' ' ' GLU . 70.9 mmtt -127.73 -69.3 0.74 Allowed 'General case' 0 C--N 1.328 -0.328 0 O-C-N 122.897 -0.178 . . . . 74.420000000000002 111.106 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 1.01 ' HG2' ' HG3' ' A' ' 70' ' ' GLU . 9.2 ptt180 -145.69 130.84 18.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.115 0.483 . . . . 72.329999999999998 110.397 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.683 HD13 ' HE2' ' A' ' 93' ' ' PHE . 2.3 mp -126.31 113.02 31.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.956 -0.565 . . . . 73.420000000000002 109.907 176.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.748 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -107.73 116.82 32.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.66 -0.7 . . . . 25.41 109.835 176.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.719 ' HZ3' HG13 ' A' ' 91' ' ' VAL . 31.5 p90 -98.72 143.54 28.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.471 0.653 . . . . 74.5 111.325 -174.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -141.21 179.18 6.91 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.959 -1.019 . . . . 74.329999999999998 109.44 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.5 m -132.84 147.79 52.3 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.203 -1.036 . . . . 53.020000000000003 108.203 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.458 ' CD1' ' HB3' ' A' ' 65' ' ' GLU . 5.4 mp -57.65 144.93 71.75 Favored Pre-proline 0 C--N 1.323 -0.549 0 O-C-N 123.497 0.498 . . . . 74.450000000000003 111.594 -176.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 80' ' ' LEU . 51.3 Cg_exo -56.35 -22.04 39.65 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.643 2.895 . . . . 71.340000000000003 113.766 -174.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -79.67 -14.83 80.59 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.015 -0.612 . . . . 44.439999999999998 112.311 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -111.17 172.32 6.95 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.683 0.277 . . . . 72.420000000000002 110.316 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -75.89 138.72 41.24 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.163 -0.68 . . . . 73.530000000000001 109.163 173.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.4 pt -75.92 88.87 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.32 0.581 . . . . 63.350000000000001 109.449 173.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -54.15 -34.67 60.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.192 -0.913 . . . . 75.099999999999994 112.047 -173.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.594 HD22 ' N ' ' A' ' 88' ' ' SER . 0.2 OUTLIER -166.73 132.82 2.31 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.897 -0.779 . . . . 65.450000000000003 108.897 178.629 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.594 ' N ' HD22 ' A' ' 87' ' ' ASN . 30.0 m -115.6 128.57 56.04 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.053 -0.351 . . . . 63.509999999999998 110.053 177.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -174.77 -178.56 44.74 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.635 -0.793 . . . . 54.299999999999997 111.981 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -147.03 132.71 18.86 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.916 -0.401 . . . . 61.32 109.916 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.719 HG13 ' HZ3' ' A' ' 77' ' ' TRP . 25.2 m -107.68 138.01 36.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.016 0.436 . . . . 75.120000000000005 110.711 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.43 ' HB2' ' HB ' ' A' ' 105' ' ' VAL . 3.4 mm? -112.32 120.82 43.01 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.708 -0.678 . . . . 73.420000000000002 109.631 177.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.683 ' HE2' HD13 ' A' ' 75' ' ' ILE . 76.2 m-85 -98.11 112.42 24.39 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.924 0.393 . . . . 72.430000000000007 110.499 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.444 HH11 ' HD2' ' A' ' 94' ' ' ARG . 5.0 ptt180 -126.2 145.23 51.71 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.03 -0.532 . . . . 75.140000000000001 110.442 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -51.46 131.18 35.76 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.209 2.606 . . . . 74.439999999999998 112.296 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.641 ' HB1' HG23 ' A' ' 11' ' ' THR . . . -82.6 144.94 49.91 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.0 -0.545 . . . . 61.140000000000001 111.751 -175.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 96' ' ' ALA . 31.5 Cg_exo -58.79 133.19 52.32 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.913 2.409 . . . . 61.409999999999997 112.111 177.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.09 5.71 81.26 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 121.228 -0.511 . . . . 74.120000000000005 112.762 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 62.66 34.69 14.68 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.855 0.462 . . . . 72.120000000000005 111.34 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.16 -35.72 71.97 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 108.653 -0.869 . . . . 73.420000000000002 108.653 172.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.407 ' HA3' ' HA2' ' A' ' 13' ' ' GLY . . . 163.71 -107.16 0.29 Allowed Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 114.942 -1.026 . . . . 64.340000000000003 110.764 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.474 ' HB ' HD11 ' A' ' 19' ' ' LEU . 28.8 m -142.69 136.61 29.19 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 110.027 -0.36 . . . . 41.32 110.027 176.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.623 ' HG2' ' HB1' ' A' ' 9' ' ' ALA . 38.4 tt0 -96.57 108.38 20.96 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 109.326 -0.62 . . . . 74.329999999999998 109.326 177.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.4 p -87.79 108.66 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.679 0.752 . . . . 74.409999999999997 110.015 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.509 HG13 ' HB2' ' A' ' 9' ' ' ALA . 3.4 t -92.44 109.22 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 114.721 -1.127 . . . . 70.040000000000006 108.781 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.67 HG22 HD12 ' A' ' 108' ' ' LEU . 7.4 p -112.87 130.89 65.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 121.017 0.437 . . . . 75.310000000000002 111.303 -173.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.584 ' HD3' ' O ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -123.6 125.83 45.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.778 -0.646 . . . . 75.109999999999999 110.097 174.361 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.67 HD12 HG22 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -150.52 152.54 34.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.936 -0.575 . . . . 74.099999999999994 110.141 -179.21 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.8 t -88.32 143.23 27.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.801 0.334 . . . . 64.319999999999993 111.022 -177.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.443 ' HD1' ' HA ' ' A' ' 110' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--N 1.326 -0.415 0 N-CA-C 109.103 -0.703 . . . . 73.040000000000006 109.103 177.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.513 0 N-CA-C 112.871 -0.092 . . . . 73.310000000000002 112.871 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.4 p -81.19 -25.06 37.06 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.224 0.453 . . . . 63.420000000000002 112.224 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.459 ' O ' HG22 ' A' ' 120' ' ' VAL . . . -64.83 -41.01 96.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.079 0.466 . . . . 64.540000000000006 110.717 178.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.55 -20.67 75.76 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.932 -0.652 . . . . 64.25 112.837 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.6 -40.72 95.81 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 111.728 0.27 . . . . 64.239999999999995 111.728 -176.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 117' ' ' ALA . 25.0 m -70.68 -27.84 32.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.767 0.318 . . . . 75.340000000000003 110.7 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 57.9 mt -75.04 -36.64 38.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.053 0.454 . . . . 71.129999999999995 110.231 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.27 -35.13 78.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.767 -0.651 . . . . 73.140000000000001 111.409 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 27.4 ptt85 -90.22 -14.37 33.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.975 0.417 . . . . 64.409999999999997 110.93 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 23.4 ttt . . . . . 0 C--N 1.326 -0.449 0 CA-C-N 116.029 -0.532 . . . . 74.140000000000001 110.641 178.6 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.665 ' HB2' ' HB3' ' A' ' 137' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.223 0 N-CA-C 112.07 0.396 . . . . 74.099999999999994 112.07 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -59.56 -35.84 75.03 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.025 0.441 . . . . 71.030000000000001 110.573 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -71.57 -37.68 71.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.279 0.561 . . . . 73.400000000000006 109.933 176.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.665 ' HB3' ' HB2' ' A' ' 134' ' ' ARG . 47.2 tp -66.27 -28.08 68.43 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.588 -0.733 . . . . 74.140000000000001 110.202 178.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.514 ' CE ' HG12 ' A' ' 10' ' ' VAL . 11.8 mmt -63.27 -39.76 95.5 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.101 0.477 . . . . 51.32 110.173 174.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -67.36 -39.7 85.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.61 -0.723 . . . . 75.420000000000002 109.796 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -59.47 -48.68 80.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.099 -0.955 . . . . 65.150000000000006 110.347 172.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.661 ' HE2' ' O ' ' A' ' 11' ' ' THR . 37.0 tttm -52.06 -49.93 62.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.432 -0.804 . . . . 60.549999999999997 111.657 177.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -56.08 -44.08 78.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.615 -0.721 . . . . 72.129999999999995 111.89 -174.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -68.51 -34.42 75.86 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 121.027 -0.269 . . . . 64.530000000000001 111.662 -176.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.701 ' HG3' HG21 ' A' ' 12' ' ' ILE . 5.4 tp60 -72.53 -34.9 67.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.807 0.336 . . . . 72.099999999999994 110.973 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.638 ' HB3' HG23 ' A' ' 12' ' ' ILE . 15.5 pt-20 -83.06 -38.79 22.05 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 121.022 -0.271 . . . . 74.310000000000002 110.606 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 22.4 tp -72.58 -23.62 60.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.941 0.401 . . . . 73.409999999999997 110.551 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.392 0 CA-C-N 115.749 -0.66 . . . . 74.510000000000005 112.976 -179.723 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.447 -0.612 0 CA-C-O 121.697 0.76 . . . . 44.420000000000002 109.261 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.403 HG23 ' HB3' ' A' ' 108' ' ' LEU . 17.5 m -84.65 134.23 27.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.288 -0.869 . . . . 61.329999999999998 111.258 -173.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.413 ' HD2' HH11 ' A' ' 7' ' ' ARG . 15.0 ptt180 -141.39 132.17 25.79 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.539 -0.755 . . . . 75.439999999999998 109.772 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -143.93 155.69 44.16 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.057 -0.72 . . . . 74.409999999999997 109.057 175.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -130.44 142.86 50.49 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.133 0.492 . . . . 61.219999999999999 111.231 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.57 ' HB ' ' HB2' ' A' ' 141' ' ' LYS . 12.4 m -123.42 137.28 57.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.469 -0.787 . . . . 63.109999999999999 110.206 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -95.58 118.47 32.33 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.243 -0.435 . . . . 72.049999999999997 110.969 -175.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.979 HG23 ' HG2' ' A' ' 145' ' ' GLU . 4.0 mp -122.46 139.24 49.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.017 -0.538 . . . . 72.200000000000003 109.565 176.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.07 53.19 3.76 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.804 -0.712 . . . . 71.329999999999998 112.847 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.56 ' HG2' ' HB3' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -123.37 144.81 44.87 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 108.78 -0.822 . . . . 71.140000000000001 108.78 176.207 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.58 -58.37 1.29 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.429 2.086 . . . . 71.120000000000005 113.0 -175.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.61 ' HA ' HD12 ' A' ' 19' ' ' LEU . . . 173.4 -52.98 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.62 0.575 . . . . 62.450000000000003 110.157 178.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -49.44 -49.34 45.57 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.779 -1.101 . . . . 74.439999999999998 112.377 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.708 HE21 HD23 ' A' ' 26' ' ' LEU . 47.0 tt0 -68.71 -20.66 64.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.008 -0.542 . . . . 64.420000000000002 112.113 -175.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.61 HD12 ' HA ' ' A' ' 16' ' ' ALA . 66.6 mt -67.6 -33.15 74.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.66 -0.245 . . . . 64.439999999999998 111.274 -176.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.404 ' O ' ' HD1' ' A' ' 23' ' ' TRP . 27.9 t80 -73.03 -23.95 60.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.991 0.424 . . . . 75.319999999999993 110.743 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.55 -3.53 34.69 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.924 0.392 . . . . 53.329999999999998 112.02 -177.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.6 p -56.16 -21.29 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 115.689 -0.687 . . . . 70.340000000000003 112.305 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.404 ' HD1' ' O ' ' A' ' 20' ' ' TYR . 51.1 m95 -48.21 -31.13 5.39 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.287 0.847 . . . . 71.329999999999998 113.287 -176.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -118.27 -85.37 0.65 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.502 -0.479 . . . . 71.109999999999999 111.318 176.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -150.74 35.92 0.62 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.118 0.485 . . . . 75.109999999999999 110.027 -175.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.708 HD23 HE21 ' A' ' 18' ' ' GLN . 9.6 mp 65.55 165.4 0.12 Allowed Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 115.465 -0.789 . . . . 73.409999999999997 110.914 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.475 ' CD ' ' HG3' ' A' ' 18' ' ' GLN . 31.6 Cg_exo . . . . . 0 C--N 1.346 0.433 0 C-N-CA 122.398 2.065 . . . . 64.109999999999999 111.824 176.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.651 0 CA-C-O 120.892 0.377 . . . . 71.049999999999997 110.88 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.475 ' HG2' ' H ' ' A' ' 66' ' ' LEU . 33.0 tt0 -105.53 172.28 6.88 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.863 -1.162 . . . . 71.109999999999999 107.863 172.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.497 ' CD1' ' HA ' ' A' ' 77' ' ' TRP . 11.6 tp -130.43 145.13 51.77 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 122.013 -0.429 . . . . 44.219999999999999 111.061 -174.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.707 HG23 ' HB2' ' A' ' 78' ' ' ARG . 61.5 p -96.68 -34.75 11.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.084 0.469 . . . . 62.219999999999999 110.983 178.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.574 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -140.44 136.02 32.61 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.731 -0.668 . . . . 43.420000000000002 110.857 -177.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.41 ' HB3' HD23 ' A' ' 66' ' ' LEU . 6.9 p-10 -137.38 75.05 1.51 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.576 0.703 . . . . 63.240000000000002 111.051 -177.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.496 ' HB2' ' H ' ' A' ' 74' ' ' ARG . 16.3 mm-40 -96.37 143.42 26.08 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.926 -0.579 . . . . 74.540000000000006 110.22 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -67.81 -38.11 14.3 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.832 2.355 . . . . 73.310000000000002 112.776 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -151.56 42.01 0.73 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.364 -0.922 . . . . 33.009999999999998 112.659 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.437 ' HD2' ' OE1' ' A' ' 70' ' ' GLU . 76.0 mttt -130.11 -74.34 0.55 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.169 -0.308 . . . . 71.200000000000003 110.169 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.496 ' H ' ' HB2' ' A' ' 70' ' ' GLU . 5.9 ptp180 -151.71 150.44 30.22 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.872 -0.418 . . . . 75.219999999999999 109.872 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.528 HD12 ' HE2' ' A' ' 93' ' ' PHE . 70.7 mt -134.97 109.49 11.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.365 -0.606 . . . . 70.239999999999995 109.365 171.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.574 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -96.65 116.04 28.44 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.213 -0.662 . . . . 63.119999999999997 109.213 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.497 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 12.8 t90 -81.81 154.07 26.11 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.38 -0.827 . . . . 74.510000000000005 110.394 -172.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.707 ' HB2' HG23 ' A' ' 67' ' ' THR . 64.5 ttt180 -140.42 173.3 11.64 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.89 -0.781 . . . . 62.100000000000001 108.89 -178.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.533 ' HB2' ' HA ' ' A' ' 85' ' ' ILE . 45.8 m -135.9 152.68 51.26 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.944 -0.391 . . . . 44.450000000000003 109.944 175.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 66.5 mt -78.32 145.78 69.1 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 116.205 -0.452 . . . . 71.019999999999996 110.973 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 80' ' ' LEU . 51.4 Cg_exo -57.47 -31.93 92.72 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.352 2.702 . . . . 72.439999999999998 112.343 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.51 -5.41 89.96 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.107 -0.568 . . . . 62.539999999999999 112.255 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.57 -65.21 1.01 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.274 -0.269 . . . . 72.540000000000006 110.274 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.69 ' HG2' ' HB2' ' A' ' 86' ' ' GLU . 20.5 ttt180 -177.53 -53.57 0.01 OUTLIER 'General case' 0 C--N 1.335 -0.063 0 CA-C-N 116.074 -0.512 . . . . 63.119999999999997 111.005 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.533 ' HA ' ' HB2' ' A' ' 79' ' ' SER . 13.0 tt 44.85 40.88 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-O 122.213 1.006 . . . . 74.200000000000003 112.02 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.69 ' HB2' ' HG2' ' A' ' 84' ' ' ARG . 0.8 OUTLIER -97.55 -4.37 37.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.453 -0.794 . . . . 54.340000000000003 110.492 -179.716 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -135.03 172.51 12.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.574 -0.739 . . . . 71.329999999999998 110.311 -177.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.0 m -148.06 145.21 28.36 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.769 0.319 . . . . 74.040000000000006 110.625 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -142.68 122.83 2.02 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.319 -0.713 . . . . 75.329999999999998 111.319 177.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -117.56 120.79 39.14 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.171 -0.307 . . . . 74.219999999999999 110.171 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.539 HG22 HG22 ' A' ' 106' ' ' VAL . 78.3 t -112.83 119.75 61.21 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.625 0.726 . . . . 74.420000000000002 111.425 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.8 mp -104.51 125.05 50.32 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.151 -0.931 . . . . 74.230000000000004 110.15 176.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.528 ' HE2' HD12 ' A' ' 75' ' ' ILE . 73.6 m-85 -89.48 106.43 18.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.115 0.484 . . . . 74.400000000000006 109.818 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.425 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 33.3 ptt180 -127.18 143.98 48.99 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.859 -0.61 . . . . 71.430000000000007 110.816 -176.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 94' ' ' ARG . 30.3 Cg_exo -62.55 127.29 20.37 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.662 2.241 . . . . 74.439999999999998 111.5 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.52 146.83 96.5 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 116.081 -0.508 . . . . 71.230000000000004 110.23 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -48.19 127.53 15.41 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.64 2.893 . . . . 61.039999999999999 113.111 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.87 20.33 68.31 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.801 -0.636 . . . . 54.439999999999998 112.447 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 56.66 34.25 24.19 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.129 0.49 . . . . 65.129999999999995 111.347 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.436 HH11 ' HD3' ' A' ' 100' ' ' ARG . 4.4 mmp_? -82.11 0.47 40.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.053 -0.521 . . . . 74.040000000000006 111.439 -177.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 144.33 -157.53 27.2 Favored Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 111.063 -0.815 . . . . 64.340000000000003 111.063 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 71.7 m -121.52 128.04 51.63 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.609 -0.515 . . . . 72.200000000000003 109.609 176.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -103.91 130.78 51.55 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.26 0.552 . . . . 71.299999999999997 109.899 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.697 HG21 ' HE2' ' A' ' 140' ' ' PHE . 4.7 m -89.36 132.45 34.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 108.623 -0.88 . . . . 62.43 108.623 175.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 7.3 p -118.0 115.45 48.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 121.375 0.607 . . . . 74.409999999999997 109.896 -177.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.539 HG22 HG22 ' A' ' 91' ' ' VAL . 39.6 t -105.1 115.13 46.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.574 -0.739 . . . . 72.409999999999997 110.849 -174.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -90.52 106.42 18.49 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.422 -0.584 . . . . 61.140000000000001 109.422 173.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.425 ' HA ' HD22 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -99.3 135.67 40.38 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.794 -0.447 . . . . 64.030000000000001 109.794 -177.043 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.4 p -83.81 119.91 25.41 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.214 0.53 . . . . 73.340000000000003 111.236 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 81.2 t80 . . . . . 0 C--N 1.32 -0.708 0 CA-C-N 115.594 -0.73 . . . . 62.420000000000002 109.257 -179.884 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.907 0 N-CA-C 111.952 -0.459 . . . . 44.32 111.952 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.0 t -61.05 -45.41 94.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.776 0.322 . . . . 54.219999999999999 110.554 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.24 -32.65 74.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.221 -0.445 . . . . 53.329999999999998 110.774 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -71.47 -37.0 62.62 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.772 -0.728 . . . . 41.420000000000002 111.993 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.79 -45.52 71.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.652 0.263 . . . . 71.409999999999997 111.544 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 28.1 m -66.09 -36.54 77.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.042 0.386 . . . . 64.209999999999994 112.042 -175.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 35.6 pt -75.66 -32.36 24.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 120.761 -0.376 . . . . 73.019999999999996 110.781 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.57 -34.57 74.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.971 0.415 . . . . 64.329999999999998 110.171 176.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -59.23 -34.81 72.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.118 -0.492 . . . . 72.219999999999999 110.227 175.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 14.7 tpt . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 115.862 -0.608 . . . . 74.120000000000005 110.646 176.95 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.546 ' HG2' ' HG2' ' A' ' 138' ' ' MET . 54.4 ttt85 . . . . . 0 N--CA 1.453 -0.297 0 CA-C-O 120.787 0.327 . . . . 74.340000000000003 110.123 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -54.09 -48.12 71.02 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.254 -0.43 . . . . 71.450000000000003 111.066 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -69.12 -35.8 76.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.146 -0.479 . . . . 63.219999999999999 111.07 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 16.3 tp -76.97 -21.84 54.13 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.33 -0.395 . . . . 55.340000000000003 110.442 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.642 ' CE ' ' HA ' ' A' ' 138' ' ' MET . 4.8 mmt -65.99 -37.7 86.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.404 -0.362 . . . . 73.019999999999996 110.572 175.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.36 -35.22 75.64 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.711 -0.478 . . . . 71.510000000000005 109.711 177.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.697 ' HE2' HG21 ' A' ' 104' ' ' VAL . 72.5 t80 -57.44 -46.36 83.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.791 -0.641 . . . . 73.239999999999995 109.862 175.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.57 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 40.5 tttp -63.61 -40.25 96.44 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.366 -0.379 . . . . 72.549999999999997 110.876 176.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.4 ' HD2' HD22 ' A' ' 146' ' ' LEU . 21.3 tpp180 -57.51 -58.34 8.74 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.194 -0.457 . . . . 70.120000000000005 110.421 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -66.1 -28.21 68.65 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 121.114 -0.235 . . . . 71.109999999999999 111.352 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.734 ' HB3' HG12 ' A' ' 12' ' ' ILE . 25.4 mm-40 -56.91 -49.71 74.77 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.312 0.577 . . . . 75.209999999999994 111.263 176.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.979 ' HG2' HG23 ' A' ' 12' ' ' ILE . 26.8 mt-10 -87.35 -32.3 19.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.779 -0.646 . . . . 64.329999999999998 111.1 -175.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.4 HD22 ' HD2' ' A' ' 142' ' ' ARG . 24.2 tp -90.47 -58.09 2.61 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.479 0.657 . . . . 73.400000000000006 111.625 -174.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.459 ' HA2' HD13 ' A' ' 26' ' ' LEU . . . . . . . . 0 N--CA 1.441 -0.967 0 N-CA-C 109.405 -1.478 . . . . 74.319999999999993 109.405 -167.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.8 t . . . . . 0 N--CA 1.446 -0.674 0 N-CA-C 109.477 -0.564 . . . . 73.010000000000005 109.477 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 52.4 t -99.07 122.6 51.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.835 -0.62 . . . . 61.229999999999997 110.851 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.524 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 57.1 ttt-85 -126.12 109.59 12.55 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.363 -0.606 . . . . 73.109999999999999 109.363 171.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.597 ' HB3' HD22 ' A' ' 137' ' ' LEU . 18.1 t0 -130.83 151.14 51.58 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.954 -1.128 . . . . 72.120000000000005 107.954 177.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.658 ' HB2' HG12 ' A' ' 105' ' ' VAL . . . -135.99 129.48 32.14 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.948 0.404 . . . . 31.120000000000001 111.948 -170.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.846 ' HB ' ' HG3' ' A' ' 141' ' ' LYS . 16.1 m -120.56 143.25 33.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.896 -0.593 . . . . 73.099999999999994 110.188 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.426 HG21 ' HD3' ' A' ' 100' ' ' ARG . 26.6 m -107.25 114.1 27.93 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.582 -0.281 . . . . 63.409999999999997 110.669 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.972 HG23 ' HB3' ' A' ' 145' ' ' GLU . 4.9 mp -110.73 139.64 33.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.311 -0.404 . . . . 65.519999999999996 110.79 -176.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.46 60.31 4.55 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 121.249 -0.5 . . . . 73.340000000000003 113.039 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.676 ' HD3' ' HG2' ' A' ' 18' ' ' GLN . 43.0 mttp -140.69 150.38 59.94 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 110.2 -0.296 . . . . 71.310000000000002 110.2 176.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.441 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 51.4 Cg_exo -56.01 -59.28 0.75 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.817 2.345 . . . . 60.509999999999998 114.123 -173.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . 170.73 -48.04 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.453 0.644 . . . . 65.310000000000002 110.007 175.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -48.17 -56.36 8.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.257 -1.338 . . . . 71.219999999999999 112.954 -173.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.676 ' HG2' ' HD3' ' A' ' 14' ' ' LYS . 0.6 OUTLIER -80.9 -7.65 59.54 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.257 -0.429 . . . . 75.549999999999997 111.65 -173.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.55 ' CB ' ' HE2' ' A' ' 93' ' ' PHE . 64.0 mt -75.87 -26.8 57.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.796 -0.183 . . . . 64.310000000000002 111.163 177.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -65.18 -29.81 70.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.241 0.543 . . . . 71.430000000000007 110.447 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.45 -8.45 56.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.577 -0.738 . . . . 71.109999999999999 111.689 -175.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.474 HG11 ' HE2' ' A' ' 140' ' ' PHE . 6.2 p -60.16 -22.2 24.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.808 0.337 . . . . 74.140000000000001 111.735 -175.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -70.41 -23.48 62.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.919 0.39 . . . . 65.030000000000001 110.774 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.405 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 17.8 tpt180 -128.58 19.47 6.21 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.885 -0.413 . . . . 72.430000000000007 109.885 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.561 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 18.6 t70 64.84 162.43 0.13 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.62 -0.718 . . . . 61.420000000000002 110.968 -174.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.575 HD23 ' H ' ' A' ' 26' ' ' LEU . 1.3 pt? -113.95 85.7 10.25 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 121.364 0.602 . . . . 55.240000000000002 112.019 -175.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.561 ' HD3' ' O ' ' A' ' 25' ' ' ASP . 1.9 Cg_endo . . . . . 0 N--CA 1.459 -0.54 0 C-N-CA 123.059 2.506 . . . . 72.310000000000002 111.623 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.779 0 CA-C-O 121.221 0.534 . . . . 71.439999999999998 110.507 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.685 ' HB3' ' HD2' ' A' ' 78' ' ' ARG . 1.8 tm-20 -107.24 175.57 5.45 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.291 -1.003 . . . . 74.239999999999995 108.291 176.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.617 HD12 ' HA ' ' A' ' 77' ' ' TRP . 22.8 tp -124.08 119.64 30.05 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.132 -0.692 . . . . 75.409999999999997 109.132 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.3 t -81.53 -23.71 37.09 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.627 0.251 . . . . 64.120000000000005 111.389 -174.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.586 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . . . -144.12 127.31 16.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.932 0.396 . . . . 55.240000000000002 111.043 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.598 ' HB2' HD23 ' A' ' 66' ' ' LEU . 11.0 t70 -138.79 104.03 4.98 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.266 -0.879 . . . . 54.530000000000001 109.788 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.454 ' HB2' ' H ' ' A' ' 74' ' ' ARG . 8.0 mm-40 -106.71 144.2 28.58 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.718 -0.673 . . . . 73.219999999999999 109.855 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 35.3 Cg_exo -62.04 -24.61 76.82 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.92 2.414 . . . . 50.109999999999999 112.536 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.98 56.93 0.12 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.917 -0.659 . . . . 75.040000000000006 111.592 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -141.41 -68.76 0.38 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.345 -0.142 . . . . 74.450000000000003 111.019 -176.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.454 ' H ' ' HB2' ' A' ' 70' ' ' GLU . 18.5 ptt180 -153.32 155.38 36.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.857 0.36 . . . . 75.340000000000003 111.51 -176.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.896 ' HB ' HG12 ' A' ' 91' ' ' VAL . 49.0 mm -125.14 110.82 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.765 -0.652 . . . . 72.019999999999996 109.723 174.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.586 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . . . -108.81 120.41 42.4 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.981 -0.748 . . . . 71.25 108.981 174.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.617 ' HA ' HD12 ' A' ' 66' ' ' LEU . 13.7 p-90 -106.85 138.95 42.05 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.612 0.72 . . . . 64.409999999999997 112.195 -170.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.685 ' HD2' ' HB3' ' A' ' 65' ' ' GLU . 7.8 ptp85 -113.07 173.35 6.43 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 107.676 -1.231 . . . . 65.150000000000006 107.676 171.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.437 ' CB ' ' HD3' ' A' ' 84' ' ' ARG . 6.1 m -138.6 30.3 2.34 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.343 -0.543 . . . . 53.32 109.873 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.466 ' CD2' ' HB2' ' A' ' 65' ' ' GLU . 22.1 mt 66.52 147.02 0.11 Allowed Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 115.086 -0.961 . . . . 72.109999999999999 111.093 -175.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.64 -23.16 55.83 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 123.104 2.536 . . . . 64.510000000000005 113.529 -174.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.21 -3.32 88.92 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.717 -0.754 . . . . 64.010000000000005 113.263 -176.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -136.44 25.98 3.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.201 0.5 . . . . 75.310000000000002 111.851 -177.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.437 ' HD3' ' CB ' ' A' ' 79' ' ' SER . 9.4 mmm180 -126.83 107.79 10.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.827 0.346 . . . . 73.010000000000005 111.457 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.735 HG13 ' H ' ' A' ' 86' ' ' GLU . 13.8 pt -91.11 -63.3 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.053 -0.521 . . . . 63.310000000000002 110.298 173.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.735 ' H ' HG13 ' A' ' 85' ' ' ILE . 34.2 tt0 -163.74 109.42 1.07 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.885 0.374 . . . . 74.340000000000003 110.366 176.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -162.15 141.01 9.3 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.682 -0.859 . . . . 75.409999999999997 108.682 175.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.4 m -151.37 129.38 11.79 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.142 -0.318 . . . . 75.109999999999999 110.142 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.09 110.26 0.25 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.55 -0.833 . . . . 34.240000000000002 112.247 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.13 149.98 23.73 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.242 -0.281 . . . . 73.310000000000002 110.242 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.896 HG12 ' HB ' ' A' ' 75' ' ' ILE . 7.6 p -88.97 140.98 14.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.213 -0.662 . . . . 74.129999999999995 109.213 174.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.692 ' HB2' ' CG2' ' A' ' 105' ' ' VAL . 3.2 mm? -108.99 119.81 40.66 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.154 -0.684 . . . . 65.439999999999998 109.154 172.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.55 ' HE2' ' CB ' ' A' ' 19' ' ' LEU . 15.7 m-85 -96.91 106.03 18.28 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.824 -0.806 . . . . 61.549999999999997 108.824 174.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 32.7 mtp180 -125.95 142.9 43.69 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 116.112 -0.495 . . . . 72.129999999999995 110.046 -174.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -57.85 115.57 2.61 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.436 2.091 . . . . 74.25 110.634 175.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . . . -65.36 143.63 98.78 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.019 -0.537 . . . . 63.520000000000003 111.413 -173.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 96' ' ' ALA . 51.5 Cg_exo -55.79 137.39 78.39 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.885 2.39 . . . . 65.099999999999994 111.925 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.63 16.51 79.13 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.947 -0.644 . . . . 61.450000000000003 112.101 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 57.16 33.69 23.7 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.341 0.591 . . . . 64.219999999999999 110.794 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.426 ' HD3' HG21 ' A' ' 11' ' ' THR . 34.6 ttt180 -77.27 1.04 19.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.41 -0.814 . . . . 71.409999999999997 111.04 -175.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 123.23 -125.13 5.84 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 111.508 -0.637 . . . . 70.519999999999996 111.508 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 88.0 m -135.01 130.53 35.84 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.952 0.406 . . . . 73.150000000000006 110.564 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -100.9 113.91 27.3 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.902 -0.59 . . . . 74.150000000000006 109.534 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.2 m -88.74 127.29 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-O 121.703 0.763 . . . . 71.219999999999999 108.991 175.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.692 ' CG2' ' HB2' ' A' ' 92' ' ' LEU . 14.0 m -123.18 119.39 57.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.204 -0.907 . . . . 45.229999999999997 109.815 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.639 HG13 HG23 ' A' ' 91' ' ' VAL . 1.8 m -119.84 121.52 66.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.908 -0.587 . . . . 73.540000000000006 111.074 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.85 109.85 19.19 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.537 -0.912 . . . . 75.299999999999997 108.537 174.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.432 HD22 ' HE2' ' A' ' 110' ' ' TYR . 0.4 OUTLIER -141.12 151.39 43.9 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.058 0.456 . . . . 75.109999999999999 111.544 -174.435 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.9 t -98.77 133.09 43.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.378 0.609 . . . . 52.420000000000002 110.911 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.432 ' HE2' HD22 ' A' ' 108' ' ' LEU . 57.8 m-85 . . . . . 0 C--N 1.324 -0.524 0 CA-C-N 115.039 -0.982 . . . . 71.430000000000007 109.233 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.197 0 CA-C-O 120.989 0.216 . . . . 32.520000000000003 113.124 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.7 m -86.54 -30.61 21.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.93 0.395 . . . . 71.030000000000001 111.153 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.406 ' O ' HG22 ' A' ' 120' ' ' VAL . . . -64.93 -36.15 83.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.939 -0.573 . . . . 61.020000000000003 112.194 -173.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -60.14 -25.69 62.56 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 121.078 -0.582 . . . . 74.439999999999998 113.292 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.03 -46.76 86.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.727 0.299 . . . . 64.140000000000001 111.311 -177.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 117' ' ' ALA . 26.9 m -75.1 -23.73 17.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.495 -0.321 . . . . 53.399999999999999 111.177 -177.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 65.1 mt -72.7 -33.44 44.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.389 -0.369 . . . . 75.209999999999994 110.418 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.08 -22.64 65.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.169 -0.469 . . . . 72.510000000000005 111.279 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -63.87 -26.75 68.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.064 -0.517 . . . . 73.239999999999995 111.171 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 16.7 tpt . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 120.949 0.404 . . . . 72.530000000000001 110.959 -179.044 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.571 ' HG2' ' H ' ' A' ' 137' ' ' LEU . 35.7 ttt85 . . . . . 0 N--CA 1.449 -0.486 0 CA-C-O 121.141 0.496 . . . . 74.200000000000003 110.369 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -61.51 -39.45 91.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.361 -0.836 . . . . 71.109999999999999 110.655 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -61.01 -34.99 75.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.836 -0.62 . . . . 74.310000000000002 111.206 177.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.597 HD22 ' HB3' ' A' ' 8' ' ' ASP . 11.5 tp -79.14 -35.8 41.51 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.503 0.668 . . . . 75.340000000000003 109.844 -175.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.3 ttp -66.28 -36.89 84.12 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.532 -0.758 . . . . 71.219999999999999 110.367 174.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -69.81 -51.05 37.06 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.128 -0.487 . . . . 75.540000000000006 112.182 -177.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.474 ' HE2' HG11 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -66.32 -29.54 69.76 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.261 -0.576 . . . . 71.200000000000003 109.685 -175.346 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.846 ' HG3' ' HB ' ' A' ' 10' ' ' VAL . 14.9 tmtt? -57.1 -42.37 80.66 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 115.788 -0.642 . . . . 62.119999999999997 110.46 173.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -55.11 -52.2 64.02 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.284 0.564 . . . . 73.420000000000002 110.269 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -66.58 -40.81 89.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.022 -0.99 . . . . 61.43 111.928 -172.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.518 ' CD ' HG12 ' A' ' 12' ' ' ILE . 4.6 pt20 -74.17 -17.3 60.93 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.571 0.582 . . . . 74.450000000000003 112.571 -173.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.972 ' HB3' HG23 ' A' ' 12' ' ' ILE . 19.7 pt-20 -110.73 -4.46 15.33 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.618 -0.433 . . . . 75.099999999999994 111.102 175.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 24.4 tp -61.8 -52.83 62.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.068 0.461 . . . . 72.409999999999997 110.453 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.878 0 C-N-CA 121.022 -0.609 . . . . 73.109999999999999 111.77 175.631 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.817 HG22 HG23 ' A' ' 109' ' ' THR . 66.5 t . . . . . 0 N--CA 1.445 -0.678 0 CA-C-O 120.771 0.32 . . . . 72.219999999999999 110.248 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.6 m -83.77 126.28 40.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.387 0.613 . . . . 64.239999999999995 111.022 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.1 OUTLIER -142.28 118.03 10.46 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.569 -0.741 . . . . 61.030000000000001 110.553 -178.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.401 ' OD2' ' HD2' ' A' ' 134' ' ' ARG . 13.7 t70 -128.18 170.14 13.32 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.081 -0.711 . . . . 73.420000000000002 109.081 176.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.59 ' HB2' HG13 ' A' ' 105' ' ' VAL . . . -145.43 123.19 11.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.676 0.274 . . . . 71.109999999999999 111.325 -173.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.6 m -112.32 148.15 15.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.292 -0.413 . . . . 64.129999999999995 111.014 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.408 ' CG2' ' HB1' ' A' ' 96' ' ' ALA . 0.6 OUTLIER -105.21 110.43 22.8 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.952 -0.567 . . . . 70.329999999999998 112.0 -171.177 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.872 HG21 ' HB2' ' A' ' 144' ' ' GLN . 0.1 OUTLIER -124.4 151.23 29.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.109 0.48 . . . . 71.430000000000007 112.139 177.111 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.59 ' HA2' ' HA3' ' A' ' 101' ' ' GLY . . . -82.8 20.43 9.47 Favored Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.756 -0.656 . . . . 55.420000000000002 112.396 177.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.572 ' HB2' HD21 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -79.53 143.93 60.26 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.354 -0.61 . . . . 65.439999999999998 109.354 176.284 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.411 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 23.0 Cg_endo -62.28 -60.01 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.023 1.815 . . . . 74.120000000000005 113.359 -171.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.495 ' HA ' HD12 ' A' ' 19' ' ' LEU . . . 172.17 -50.76 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.492 0.717 . . . . 60.109999999999999 109.967 171.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.494 ' HA ' ' HD2' ' A' ' 20' ' ' TYR . 1.9 mp0 -56.29 -47.45 78.64 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.976 -0.556 . . . . 71.510000000000005 110.621 -177.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -66.71 -13.27 61.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.282 -0.872 . . . . 72.329999999999998 111.205 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.692 HD21 HG13 ' A' ' 12' ' ' ILE . 98.1 mt -83.88 -43.08 15.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.229 -0.441 . . . . 73.319999999999993 110.387 175.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.628 ' CE1' HD13 ' A' ' 75' ' ' ILE . 73.6 m-85 -62.68 -32.34 73.4 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.424 0.631 . . . . 64.129999999999995 109.8 176.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.52 -7.76 49.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.085 -0.961 . . . . 73.129999999999995 111.996 -176.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.557 HG21 ' CE2' ' A' ' 140' ' ' PHE . 7.8 p -53.74 -30.38 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 120.889 0.376 . . . . 72.239999999999995 111.65 -176.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 28.8 t90 -68.4 -23.73 64.68 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.044 0.449 . . . . 74.420000000000002 111.144 -177.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -124.21 13.54 8.97 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.583 -0.525 . . . . 71.420000000000002 109.583 -178.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.718 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 28.9 t70 62.38 168.73 0.12 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.427 -0.806 . . . . 55.229999999999997 110.532 -169.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.694 HD23 ' H ' ' A' ' 26' ' ' LEU . 1.3 pt? -104.83 87.2 1.73 Allowed Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 121.11 0.481 . . . . 74.400000000000006 110.767 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.718 ' HD3' ' O ' ' A' ' 25' ' ' ASP . 9.9 Cg_endo . . . . . 0 N--CA 1.45 -1.034 0 C-N-CA 123.208 2.605 . . . . 74.109999999999999 111.79 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 79' ' ' SER . . . . . . . . 0 N--CA 1.452 -0.373 0 N-CA-C 110.17 -0.307 . . . . 62.420000000000002 110.17 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.557 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -106.77 135.74 47.79 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.745 -0.465 . . . . 74.230000000000004 109.745 178.328 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.521 HD12 ' HA ' ' A' ' 77' ' ' TRP . 3.0 mm? -86.57 147.05 26.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.139 -0.482 . . . . 75.310000000000002 111.305 -169.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.6 t -98.67 -16.5 19.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.082 0.467 . . . . 65.450000000000003 110.53 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.619 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -138.72 124.96 20.26 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.173 -0.677 . . . . 51.539999999999999 109.173 173.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -125.2 99.62 6.17 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.267 -0.424 . . . . 72.209999999999994 111.754 -171.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.45 ' O ' HD11 ' A' ' 75' ' ' ILE . 22.8 mt-10 -121.48 142.69 36.09 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.769 -0.826 . . . . 63.409999999999997 108.769 166.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 31.1 Cg_exo -61.16 -42.96 32.03 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.588 2.192 . . . . 73.140000000000001 112.328 -177.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -150.48 56.02 0.47 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.636 -0.792 . . . . 72.030000000000001 112.198 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -147.09 -82.43 0.13 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.816 -0.354 . . . . 53.310000000000002 110.914 174.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.596 ' HD2' ' OE2' ' A' ' 90' ' ' GLU . 16.7 ttp180 -124.38 123.14 39.53 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.444 -0.502 . . . . 74.239999999999995 111.168 -170.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.628 HD13 ' CE1' ' A' ' 20' ' ' TYR . 2.6 mp -125.82 110.87 25.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.748 -0.66 . . . . 63.329999999999998 110.506 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.619 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -96.6 116.11 28.56 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.259 -1.015 . . . . 42.5 108.259 170.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.611 ' CZ2' ' HB3' ' A' ' 87' ' ' ASN . 3.9 p-90 -85.69 151.72 23.64 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.409 0.623 . . . . 60.409999999999997 111.269 -171.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.557 ' HB3' ' O ' ' A' ' 65' ' ' GLU . 5.5 tpm_? -155.37 170.88 20.87 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.183 -1.414 . . . . 53.539999999999999 107.183 -175.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.547 ' HA ' ' HA ' ' A' ' 64' ' ' ALA . 20.0 p -145.24 170.38 16.38 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.075 0.464 . . . . 51.409999999999997 110.888 -177.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.506 HD11 ' HB2' ' A' ' 65' ' ' GLU . 5.7 mp -87.45 154.33 53.85 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.761 -0.654 . . . . 65.049999999999997 110.576 178.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.57 -1.4 3.93 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 123.089 2.526 . . . . 64.230000000000004 112.981 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.21 -8.18 66.84 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.994 -0.622 . . . . 61.530000000000001 112.136 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.17 -177.62 5.75 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.744 0.307 . . . . 75.200000000000003 110.56 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.48 ' HD2' ' HA ' ' A' ' 84' ' ' ARG . 14.3 tpt180 -122.12 -28.34 4.4 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.592 -0.443 . . . . 62.509999999999998 111.302 -178.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.85 132.56 70.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.117 0.484 . . . . 53.049999999999997 110.154 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -147.24 142.83 27.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.839 -0.618 . . . . 72.0 110.089 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.611 ' HB3' ' CZ2' ' A' ' 77' ' ' TRP . 28.1 t-20 -137.13 150.27 47.86 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.722 -0.844 . . . . 52.240000000000002 108.722 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 60.9 m -100.7 127.5 47.09 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.397 0.618 . . . . 70.329999999999998 110.216 -176.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.406 ' HA3' HD23 ' A' ' 108' ' ' LEU . . . -171.54 169.25 42.34 Favored Glycine 0 N--CA 1.438 -1.223 0 CA-C-N 115.227 -0.897 . . . . 33.020000000000003 111.559 -176.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.596 ' OE2' ' HD2' ' A' ' 74' ' ' ARG . 33.1 tt0 -144.64 129.42 18.26 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.993 -0.373 . . . . 74.340000000000003 109.993 -175.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.611 HG12 HG12 ' A' ' 106' ' ' VAL . 9.3 m -111.05 137.89 41.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 110.095 -0.335 . . . . 73.219999999999999 110.095 178.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.646 ' CD2' ' HB ' ' A' ' 105' ' ' VAL . 0.0 OUTLIER -128.19 119.7 25.76 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.75 0.786 . . . . 73.209999999999994 110.046 173.078 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.63 ' HE2' ' HB3' ' A' ' 19' ' ' LEU . 2.5 m-85 -97.73 106.43 18.74 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.485 -1.234 . . . . 72.409999999999997 109.215 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -119.66 144.93 38.02 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 115.418 -0.81 . . . . 71.030000000000001 110.35 -172.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -46.86 117.78 2.33 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.246 2.631 . . . . 75.120000000000005 112.102 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.408 ' HB1' ' CG2' ' A' ' 11' ' ' THR . . . -58.93 144.54 81.67 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.741 -0.663 . . . . 75.230000000000004 111.094 -176.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -46.31 115.98 1.36 Allowed 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 123.303 2.669 . . . . 75.540000000000006 113.022 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 96.15 3.57 60.25 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.665 -0.698 . . . . 50.409999999999997 112.162 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 64.79 32.49 10.98 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 123.08 0.552 . . . . 71.120000000000005 111.164 -178.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 37.7 ttt-85 -75.46 -19.43 59.44 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.957 -0.565 . . . . 72.030000000000001 110.992 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.59 ' HA3' ' HA2' ' A' ' 13' ' ' GLY . . . 165.82 -130.74 2.21 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.885 -0.886 . . . . 41.109999999999999 110.885 -175.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.2 m -138.73 133.95 32.9 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 110.152 -0.314 . . . . 62.109999999999999 110.152 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -96.55 133.06 41.49 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.928 -0.767 . . . . 62.229999999999997 108.928 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.635 HG12 HD11 ' A' ' 12' ' ' ILE . 1.5 p -95.15 100.32 10.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.794 0.807 . . . . 53.149999999999999 110.35 179.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.646 ' HB ' ' CD2' ' A' ' 92' ' ' LEU . 4.1 t -97.4 111.47 27.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.688 -1.142 . . . . 73.310000000000002 108.941 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.611 HG12 HG12 ' A' ' 91' ' ' VAL . 26.1 m -112.47 123.46 68.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.318 0.58 . . . . 75.349999999999994 111.517 -176.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 31.1 ttt85 -105.17 100.89 10.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.524 -0.762 . . . . 73.420000000000002 109.678 174.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.406 HD23 ' HA3' ' A' ' 89' ' ' GLY . 95.4 mt -116.94 126.8 53.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.257 -0.429 . . . . 45.310000000000002 110.146 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.817 HG23 HG22 ' A' ' 5' ' ' VAL . 25.9 m -90.22 116.26 28.08 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 120.214 -0.594 . . . . 73.549999999999997 110.726 -176.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 51.2 p90 . . . . . 0 C--N 1.326 -0.455 0 CA-C-N 115.485 -0.78 . . . . 73.019999999999996 108.917 174.376 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 CA-C-O 120.558 -0.023 . . . . 24.109999999999999 113.114 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.0 m -86.08 -24.17 26.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.694 0.283 . . . . 73.150000000000006 111.152 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.63 -41.64 99.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.435 -0.348 . . . . 44.039999999999999 110.933 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.01 -31.25 77.97 Favored Glycine 0 N--CA 1.452 -0.256 0 CA-C-N 116.05 -0.523 . . . . 65.230000000000004 112.48 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.34 -29.3 64.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.163 0.506 . . . . 72.329999999999998 110.572 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 59.6 t -73.67 -51.36 25.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.881 -0.6 . . . . 71.049999999999997 110.51 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.9 pp -68.92 -22.64 26.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.24 -0.437 . . . . 73.409999999999997 111.981 -175.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -81.2 -30.96 34.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.742 0.306 . . . . 64.329999999999998 111.16 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -88.77 -39.16 14.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.4 -0.364 . . . . 71.519999999999996 111.219 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 47.9 ttm . . . . . 0 N--CA 1.464 0.253 0 O-C-N 123.33 0.394 . . . . 75.219999999999999 110.707 -177.201 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.401 ' HD2' ' OD2' ' A' ' 8' ' ' ASP . 8.7 ptt180 . . . . . 0 N--CA 1.451 -0.394 0 CA-C-O 121.056 0.455 . . . . 73.549999999999997 110.098 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -58.53 -44.6 89.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.636 -0.711 . . . . 73.319999999999993 111.695 -175.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -60.54 -52.72 64.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.425 . . . . 72.340000000000003 111.087 -177.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.463 ' HA ' HD13 ' A' ' 137' ' ' LEU . 0.1 OUTLIER -68.35 -36.13 78.77 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.545 -0.298 . . . . 72.120000000000005 111.27 -179.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 27.9 tpp -67.89 -41.64 82.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.884 0.373 . . . . 74.420000000000002 110.9 -177.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -63.63 -36.11 82.73 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.441 -0.577 . . . . 74.319999999999993 109.441 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.612 ' HE1' HG11 ' A' ' 104' ' ' VAL . 55.5 t80 -63.65 -49.85 71.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.427 -0.806 . . . . 72.310000000000002 110.25 174.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -55.81 -50.1 71.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.496 -0.775 . . . . 62.43 111.42 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -62.04 -45.34 94.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.335 -0.393 . . . . 71.140000000000001 110.924 -176.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -65.49 -28.85 69.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.313 -0.403 . . . . 74.209999999999994 111.716 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.872 ' HB2' HG21 ' A' ' 12' ' ' ILE . 9.9 mm-40 -68.62 -35.99 78.03 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.617 -0.433 . . . . 72.230000000000004 111.102 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.583 ' HG3' HG22 ' A' ' 12' ' ' ILE . 35.4 mt-10 -78.39 -37.15 44.73 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.713 -0.395 . . . . 75.230000000000004 110.143 178.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 67.2 mt -65.35 -40.55 93.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.972 -0.558 . . . . 72.140000000000001 110.678 176.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.405 0 C-N-CA 121.095 -0.574 . . . . 75.400000000000006 112.054 176.606 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 N--CA 1.452 -0.356 0 CA-C-O 120.811 0.339 . . . . 70.439999999999998 110.45 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.3 t -119.93 126.38 75.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.692 -0.485 . . . . 72.329999999999998 109.692 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -127.78 132.84 49.46 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.054 0.454 . . . . 60.310000000000002 110.508 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.443 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 11.3 t70 -158.09 171.74 19.69 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.799 -1.186 . . . . 72.549999999999997 107.799 173.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.589 ' HB2' HG12 ' A' ' 105' ' ' VAL . . . -134.06 120.42 20.18 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.068 0.461 . . . . 73.409999999999997 112.12 -174.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.541 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 21.4 m -101.27 130.04 51.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.67 -0.696 . . . . 65.109999999999999 109.749 174.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.692 ' HA ' ' HA ' ' A' ' 103' ' ' GLU . 5.1 t -102.83 113.48 26.94 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.78 0.8 . . . . 71.319999999999993 110.436 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.631 HG23 ' HB3' ' A' ' 145' ' ' GLU . 4.5 mp -112.36 151.47 14.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.954 -1.021 . . . . 73.230000000000004 108.871 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.86 42.3 1.1 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.862 -0.685 . . . . 74.109999999999999 112.907 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.662 ' HB3' ' HB2' ' A' ' 18' ' ' GLN . 6.7 mmpt? -112.24 144.25 30.45 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 108.394 -0.965 . . . . 72.099999999999994 108.394 178.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -52.99 -57.96 1.75 Allowed 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.335 2.023 . . . . 54.100000000000001 113.738 -172.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 174.4 -53.46 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.251 0.548 . . . . 62.43 109.66 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.8 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 0.1 OUTLIER -54.43 -39.22 67.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.069 -0.969 . . . . 72.109999999999999 110.891 177.631 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.662 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 21.4 mm-40 -63.06 -27.79 69.64 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.061 -0.972 . . . . 71.540000000000006 111.37 -177.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.526 ' HA ' ' NE2' ' A' ' 144' ' ' GLN . 95.5 mt -74.94 -48.35 24.93 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.9 -0.591 . . . . 31.140000000000001 111.162 -174.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.8 ' CE2' ' HA ' ' A' ' 17' ' ' GLU . 36.2 p90 -74.77 -23.42 58.52 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 119.704 -0.798 . . . . 61.100000000000001 110.643 177.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.56 -2.08 21.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.043 -0.526 . . . . 73.340000000000003 111.627 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.476 ' HB ' ' NE2' ' A' ' 144' ' ' GLN . 12.0 p -53.38 -22.59 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 115.806 -0.633 . . . . 45.539999999999999 112.525 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -66.75 -27.31 67.5 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.275 0.559 . . . . 71.120000000000005 110.709 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.814 ' HG3' ' H ' ' A' ' 25' ' ' ASP . 15.0 tpp180 -105.54 -164.21 1.01 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.924 -1.139 . . . . 74.329999999999998 107.924 176.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.814 ' H ' ' HG3' ' A' ' 24' ' ' ARG . 28.6 t0 -83.93 36.47 0.56 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.45 0.643 . . . . 74.439999999999998 109.363 176.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.566 HD11 ' HA3' ' A' ' 147' ' ' GLY . 0.3 OUTLIER 41.89 63.1 6.9 Favored Pre-proline 0 N--CA 1.47 0.543 0 CA-C-N 114.897 -1.047 . . . . 72.120000000000005 112.279 -177.606 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.456 ' HD3' ' N ' ' A' ' 26' ' ' LEU . 89.9 Cg_endo . . . . . 0 N--CA 1.452 -0.93 0 C-N-CA 123.225 2.617 . . . . 55.420000000000002 113.094 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.234 0 N-CA-C 108.123 -1.066 . . . . 45.229999999999997 108.123 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.788 ' HB2' HD23 ' A' ' 80' ' ' LEU . 0.7 OUTLIER -112.57 134.15 54.24 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 107.708 -1.219 . . . . 74.420000000000002 107.708 -176.78 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -107.83 141.34 39.56 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 119.616 -0.834 . . . . 70.049999999999997 111.221 -171.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.9 t -108.1 -24.38 11.59 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.854 -0.338 . . . . 72.129999999999995 111.008 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.543 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . . . -135.98 153.78 51.29 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.542 -0.54 . . . . 60.210000000000001 109.542 175.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -150.61 16.68 0.8 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.876 0.325 . . . . 53.219999999999999 111.876 -172.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.601 ' HG2' ' HD3' ' A' ' 73' ' ' LYS . 1.6 mp0 -61.29 142.03 93.82 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 110.416 -0.216 . . . . 71.109999999999999 110.416 -176.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -79.51 -20.17 9.65 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.661 2.241 . . . . 74.230000000000004 113.017 -173.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -162.67 38.29 0.35 Allowed Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.303 -0.719 . . . . 72.329999999999998 111.303 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.601 ' HD3' ' HG2' ' A' ' 70' ' ' GLU . 54.3 tttp -129.74 -51.57 1.15 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.008 -0.367 . . . . 64.340000000000003 110.008 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.514 ' H ' ' HB2' ' A' ' 70' ' ' GLU . 29.3 ttp180 -166.09 129.47 2.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.25 -0.432 . . . . 73.340000000000003 110.902 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.646 ' HB ' HG22 ' A' ' 91' ' ' VAL . 6.3 mm -108.38 109.99 30.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.399 -0.963 . . . . 71.299999999999997 108.399 175.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.561 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . . . -129.94 116.3 18.42 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.05 0.452 . . . . 61.109999999999999 110.486 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.532 ' NE1' ' HA3' ' A' ' 89' ' ' GLY . 69.0 p-90 -113.18 155.54 24.82 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.629 -0.714 . . . . 70.239999999999995 109.928 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -142.87 176.45 9.06 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.935 -1.135 . . . . 75.530000000000001 107.935 175.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 51.3 p -96.05 177.68 5.66 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.924 -0.71 . . . . 74.049999999999997 110.153 174.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.788 HD23 ' HB2' ' A' ' 65' ' ' GLU . 7.3 mt -71.64 156.89 90.77 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 116.038 -0.528 . . . . 71.099999999999994 110.019 -177.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -52.93 -36.57 75.6 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.864 2.376 . . . . 74.140000000000001 112.755 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.92 21.44 44.93 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.764 -0.731 . . . . 73.420000000000002 112.696 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -120.5 176.64 5.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.608 0.242 . . . . 74.129999999999995 110.552 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.425 ' HD2' ' N ' ' A' ' 84' ' ' ARG . 8.5 mpt_? -115.05 144.85 42.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.534 -0.303 . . . . 73.319999999999993 110.351 -179.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.6 pp -88.91 166.74 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.984 0.421 . . . . 74.510000000000005 111.639 -178.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -126.07 -64.34 1.05 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.665 -0.698 . . . . 63.399999999999999 110.399 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -130.11 173.15 11.02 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.937 -1.135 . . . . 62.219999999999999 107.937 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.8 m -95.75 126.98 41.39 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.497 -0.557 . . . . 72.540000000000006 109.497 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.532 ' HA3' ' NE1' ' A' ' 77' ' ' TRP . . . -115.92 74.87 0.26 Allowed Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.663 -0.779 . . . . 73.109999999999999 111.85 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.561 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 35.2 tt0 -131.0 113.9 14.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.01 0.433 . . . . 71.150000000000006 110.241 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.646 HG22 ' HB ' ' A' ' 75' ' ' ILE . 18.6 m -120.47 131.91 71.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.533 -0.758 . . . . 71.239999999999995 109.401 177.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.79 ' HB2' HG23 ' A' ' 105' ' ' VAL . 4.5 mp -113.36 141.08 47.47 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.428 -0.509 . . . . 71.129999999999995 109.875 175.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.465 ' HZ ' ' HB3' ' A' ' 20' ' ' TYR . 58.2 m-85 -120.8 131.59 54.55 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.206 -0.452 . . . . 71.200000000000003 110.461 -177.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 34.2 ptt180 -141.18 142.8 28.44 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 109.53 -0.545 . . . . 74.420000000000002 109.53 173.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 94' ' ' ARG . 38.4 Cg_exo -62.67 112.89 1.75 Allowed 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 122.251 1.967 . . . . 72.450000000000003 110.757 174.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.45 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . . . -63.37 144.11 97.64 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.748 -0.66 . . . . 74.310000000000002 110.674 -174.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -23.5 109.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.691 1 C-N-CA 126.046 4.497 . . . . 65.439999999999998 115.356 -171.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.5 -67.79 3.65 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 114.77 -1.104 . . . . 41.32 111.849 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -177.81 38.41 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.731 -0.735 . . . . 72.230000000000004 110.453 -172.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.533 ' HA ' ' NE ' ' A' ' 100' ' ' ARG . 4.6 mmp_? -78.44 -6.98 56.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.259 0.552 . . . . 71.129999999999995 110.11 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 119.74 -143.66 17.06 Favored Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 110.145 -1.182 . . . . 63.32 110.145 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.425 ' HB ' HD11 ' A' ' 19' ' ' LEU . 30.6 m -127.22 116.5 20.68 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.791 -0.448 . . . . 74.349999999999994 109.791 174.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.692 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 11.0 pt-20 -88.38 138.42 31.45 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.253 -0.647 . . . . 71.439999999999998 109.253 177.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 1.5 p -108.49 108.83 26.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 115.336 -0.847 . . . . 65.420000000000002 111.135 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.79 HG23 ' HB2' ' A' ' 92' ' ' LEU . 2.6 m -87.27 110.35 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.446 -0.797 . . . . 63.140000000000001 109.319 174.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.83 138.48 50.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.678 -0.692 . . . . 71.209999999999994 110.676 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -122.84 102.35 7.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.658 -0.701 . . . . 65.140000000000001 110.702 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.481 HD21 ' CZ ' ' A' ' 110' ' ' TYR . 0.0 OUTLIER -123.19 152.82 40.85 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.133 -0.485 . . . . 72.099999999999994 109.772 178.782 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.7 t -100.58 149.34 23.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.381 0.61 . . . . 70.400000000000006 111.709 -172.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.481 ' CZ ' HD21 ' A' ' 108' ' ' LEU . 97.5 m-85 . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 115.166 -0.925 . . . . 75.319999999999993 109.019 174.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.545 0 N-CA-C 112.116 -0.394 . . . . 13.109999999999999 112.116 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.6 m -78.95 -12.47 60.03 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.654 0.242 . . . . 43.210000000000001 111.654 -177.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.43 -36.46 73.65 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.941 0.4 . . . . 74.299999999999997 111.395 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -73.28 -23.71 76.85 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.771 -0.728 . . . . 72.099999999999994 112.767 -177.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.09 -45.75 83.11 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.06 0.393 . . . . 63.32 112.06 -174.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 16.7 m -74.34 -41.77 50.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 111.977 0.362 . . . . 70.420000000000002 111.977 -176.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.8 pp -75.99 -22.73 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.729 0.299 . . . . 74.400000000000006 111.715 -176.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.4 -20.36 64.67 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.951 0.352 . . . . 41.340000000000003 111.951 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -64.44 -14.55 57.47 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.924 -0.58 . . . . 73.400000000000006 111.796 -175.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.581 -0.282 . . . . 54.450000000000003 111.213 179.743 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.559 ' O ' ' HG2' ' A' ' 138' ' ' MET . 32.7 mtp-105 . . . . . 0 N--CA 1.451 -0.405 0 N-CA-C 111.356 0.132 . . . . 73.430000000000007 111.356 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.29 -39.33 94.28 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 111.935 0.346 . . . . 64.120000000000005 111.935 -171.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.491 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 32.5 t70 -70.33 -30.68 67.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.228 0.537 . . . . 73.329999999999998 110.155 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.541 ' HG ' ' CG1' ' A' ' 10' ' ' VAL . 22.2 tp -78.08 -27.96 48.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.069 -0.514 . . . . 70.120000000000005 109.817 178.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.559 ' HG2' ' O ' ' A' ' 134' ' ' ARG . 29.5 mmt -66.49 -42.15 87.88 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.16 -0.473 . . . . 74.439999999999998 110.409 176.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 136' ' ' ASP . 5.9 ppt_? -75.05 -27.61 60.08 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.009 -0.367 . . . . 75.129999999999995 110.009 178.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.464 ' HZ ' HG11 ' A' ' 22' ' ' VAL . 83.7 t80 -61.54 -39.83 92.48 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.094 0.473 . . . . 71.310000000000002 109.819 173.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 138' ' ' MET . 35.0 ttmt -56.44 -42.18 77.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.443 -0.799 . . . . 73.530000000000001 109.72 174.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.435 HH21 ' CD ' ' A' ' 145' ' ' GLU . 0.0 OUTLIER -58.43 -48.66 79.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.876 -1.056 . . . . 74.409999999999997 111.083 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.37 -31.43 72.09 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.436 -0.347 . . . . 61.439999999999998 111.635 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.551 ' HG3' HG21 ' A' ' 12' ' ' ILE . 6.6 tp-100 -76.51 -43.38 39.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.726 0.298 . . . . 74.230000000000004 110.798 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.631 ' HB3' HG23 ' A' ' 12' ' ' ILE . 16.3 pt-20 -80.07 -4.32 52.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.867 0.365 . . . . 65.239999999999995 110.714 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 60.6 tp -65.84 -36.41 83.4 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.185 -0.672 . . . . 34.409999999999997 109.185 171.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.566 ' HA3' HD11 ' A' ' 26' ' ' LEU . . . . . . . . 0 N--CA 1.449 -0.491 0 CA-C-N 115.398 -0.819 . . . . 73.430000000000007 112.3 176.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 108.923 -0.769 . . . . 75.310000000000002 108.923 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.1 m -88.62 143.37 11.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.297 0.57 . . . . 75.030000000000001 111.22 -173.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.781 ' HD2' ' O ' ' A' ' 7' ' ' ARG . 0.5 OUTLIER -137.91 109.63 7.09 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.481 -0.782 . . . . 71.219999999999999 109.949 178.568 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.589 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 2.1 t70 -132.92 172.3 12.79 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.452 -0.573 . . . . 61.240000000000002 109.452 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.643 ' HB1' ' HG2' ' A' ' 103' ' ' GLU . . . -144.7 122.94 12.23 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.026 0.441 . . . . 55.549999999999997 111.007 -173.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.476 HG23 HD11 ' A' ' 12' ' ' ILE . 4.4 m -113.02 149.35 15.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.886 -0.597 . . . . 73.209999999999994 111.133 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.8 m -100.98 109.87 21.83 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.855 -0.611 . . . . 73.140000000000001 111.017 -175.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.801 HG13 ' HG2' ' A' ' 141' ' ' LYS . 4.5 mp -118.49 145.93 23.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 110.091 -0.337 . . . . 74.239999999999995 110.091 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.37 56.97 4.9 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 121.12 -0.562 . . . . 64.209999999999994 112.552 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.627 ' HG2' HG22 ' A' ' 12' ' ' ILE . 75.6 mmtt -121.77 156.56 58.85 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 108.584 -0.895 . . . . 73.439999999999998 108.584 175.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.422 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 47.1 Cg_exo -56.51 -59.1 0.73 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 121.762 1.641 . . . . 75.120000000000005 112.4 -178.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . 171.09 -58.72 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.768 0.667 . . . . 65.400000000000006 110.046 174.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -49.31 -55.01 14.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.525 -1.216 . . . . 54.450000000000003 112.215 -173.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.534 ' O ' HD12 ' A' ' 26' ' ' LEU . 16.9 mm-40 -69.39 -10.69 59.09 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.177 0.806 . . . . 64.140000000000001 113.177 -173.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.45 ' HA ' HD23 ' A' ' 19' ' ' LEU . 16.2 mt -63.47 -24.79 67.97 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.007 -0.433 . . . . 72.209999999999994 111.624 176.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -72.86 -25.0 60.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.943 0.402 . . . . 55.420000000000002 110.387 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.84 -9.0 58.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.222 -0.444 . . . . 74.099999999999994 111.726 -176.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.837 HG21 ' HG2' ' A' ' 144' ' ' GLN . 14.0 p -52.36 -21.92 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 112.247 0.462 . . . . 65.340000000000003 112.247 -175.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -51.76 -38.21 54.51 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.471 -0.331 . . . . 73.030000000000001 110.523 175.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -145.23 61.23 1.3 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.633 -0.258 . . . . 72.019999999999996 110.703 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.491 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 21.4 t70 63.07 171.35 0.15 Allowed 'General case' 0 CA--C 1.538 0.507 0 O-C-N 123.83 0.706 . . . . 74.530000000000001 111.525 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.534 HD12 ' O ' ' A' ' 18' ' ' GLN . 0.6 OUTLIER -104.05 85.83 1.14 Allowed Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 110.012 -0.366 . . . . 71.140000000000001 110.012 -178.119 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 25' ' ' ASP . 61.4 Cg_endo . . . . . 0 C--N 1.344 0.292 0 C-N-CA 122.282 1.988 . . . . 72.409999999999997 112.77 -175.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.444 0 CA-C-O 120.676 0.274 . . . . 61.140000000000001 111.203 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.64 158.28 17.07 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.498 -0.556 . . . . 61.409999999999997 109.498 173.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.673 HD23 ' HB3' ' A' ' 69' ' ' ASP . 26.3 tp -109.64 141.45 42.17 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.359 -0.238 . . . . 62.030000000000001 110.359 -176.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.0 t -107.81 -6.98 16.45 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 120.861 -0.336 . . . . 64.439999999999998 111.708 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.673 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -153.98 124.82 7.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.654 0.264 . . . . 72.109999999999999 110.831 177.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.673 ' HB3' HD23 ' A' ' 66' ' ' LEU . 2.4 p30 -136.32 43.46 2.48 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.796 -0.638 . . . . 74.209999999999994 110.878 -176.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.476 ' HB2' ' H ' ' A' ' 74' ' ' ARG . 26.1 mm-40 -57.81 143.22 77.21 Favored Pre-proline 0 C--O 1.234 0.252 0 CA-C-N 116.173 -0.467 . . . . 74.099999999999994 110.412 -178.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.96 92.97 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.219 2.613 . . . . 75.319999999999993 113.208 -172.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 58.75 34.24 76.45 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.477 -0.783 . . . . 61.32 112.979 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 92' ' ' LEU . 92.0 mttt -129.1 -85.71 0.55 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.953 0.353 . . . . 74.019999999999996 111.953 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.79 ' HB2' ' HG ' ' A' ' 92' ' ' LEU . 31.8 ttt180 -118.23 113.78 22.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.412 0.625 . . . . 74.120000000000005 111.197 -173.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.48 HD13 ' HE2' ' A' ' 93' ' ' PHE . 3.8 mp -117.05 121.87 68.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.089 -0.959 . . . . 71.319999999999993 109.515 178.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.673 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -109.71 116.28 31.42 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.473 -0.566 . . . . 60.119999999999997 109.473 176.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.534 ' CZ2' ' HA3' ' A' ' 89' ' ' GLY . 31.4 p90 -87.85 141.33 28.67 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.626 0.727 . . . . 62.520000000000003 111.306 -173.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.49 ' NE ' ' HA ' ' A' ' 78' ' ' ARG . 0.5 OUTLIER -137.57 175.36 9.66 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.03 -0.986 . . . . 65.099999999999994 110.148 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.2 p -144.7 164.93 29.5 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.81 -0.811 . . . . 63.340000000000003 108.81 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.3 mt -77.86 149.27 77.0 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.913 -0.403 . . . . 65.420000000000002 109.913 -177.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.12 -27.23 54.61 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.945 2.43 . . . . 74.340000000000003 112.791 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.75 0.72 82.91 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.902 -0.666 . . . . 65.219999999999999 113.189 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.63 159.4 20.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.047 0.423 . . . . 64.310000000000002 110.927 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -98.35 13.06 32.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.019 0.438 . . . . 65.129999999999995 110.769 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.432 ' N ' HD12 ' A' ' 85' ' ' ILE . 4.2 mp -99.44 80.14 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.573 -0.529 . . . . 64.239999999999995 109.573 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -81.36 91.93 6.33 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.588 -0.523 . . . . 73.049999999999997 109.588 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -148.71 139.88 23.17 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.495 -0.775 . . . . 62.520000000000003 109.883 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.8 m -124.69 128.65 49.14 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.842 -0.799 . . . . 44.219999999999999 108.842 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.534 ' HA3' ' CZ2' ' A' ' 77' ' ' TRP . . . -155.69 174.0 33.73 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.014 -1.088 . . . . 71.430000000000007 112.89 -175.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -163.15 128.96 3.21 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.462 -0.57 . . . . 71.230000000000004 109.462 -175.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.788 ' HB ' HG12 ' A' ' 106' ' ' VAL . 2.5 p -122.58 120.9 62.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.159 0.504 . . . . 74.420000000000002 111.688 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.79 ' HG ' ' HB2' ' A' ' 74' ' ' ARG . 8.0 mp -110.97 122.63 48.36 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.83 -0.623 . . . . 75.200000000000003 110.087 173.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.48 ' HE2' HD13 ' A' ' 75' ' ' ILE . 79.1 m-85 -87.28 126.71 35.0 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.847 0.355 . . . . 74.329999999999998 110.556 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.69 144.06 49.79 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.351 -0.386 . . . . 75.219999999999999 110.375 177.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.46 131.12 30.56 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.56 2.173 . . . . 73.510000000000005 111.196 176.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.08 143.53 57.2 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.582 -0.281 . . . . 50.539999999999999 110.73 -177.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.88 141.97 96.18 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 123.131 2.554 . . . . 72.140000000000001 112.572 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.79 20.38 79.51 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.878 -0.601 . . . . 72.439999999999998 112.109 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 52.84 36.71 22.2 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 121.021 0.439 . . . . 72.349999999999994 110.893 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 -72.57 -18.88 61.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.789 -0.642 . . . . 73.109999999999999 110.94 -176.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 146.2 -143.05 11.1 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.978 -0.849 . . . . 61.420000000000002 110.978 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.6 m -123.83 131.35 53.57 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.123 0.487 . . . . 42.409999999999997 110.1 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.643 ' HG2' ' HB1' ' A' ' 9' ' ' ALA . 31.8 tt0 -99.64 121.41 41.18 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.832 -0.622 . . . . 44.200000000000003 110.105 -178.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.513 HG23 ' CG2' ' A' ' 91' ' ' VAL . 2.3 p -98.04 112.13 29.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.432 -0.804 . . . . 53.119999999999997 110.932 -178.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 92' ' ' LEU . 11.1 p -101.81 120.66 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-O 121.33 0.586 . . . . 73.409999999999997 109.786 177.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.788 HG12 ' HB ' ' A' ' 91' ' ' VAL . 30.3 m -123.77 147.1 28.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.945 -0.57 . . . . 70.409999999999997 111.596 -175.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -100.55 116.88 33.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.318 -0.855 . . . . 73.510000000000005 109.898 170.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.3 tt -113.06 120.59 41.86 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.018 -0.734 . . . . 74.430000000000007 109.018 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 25.1 m -109.71 133.12 53.49 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.252 -0.431 . . . . 63.299999999999997 111.099 -176.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 . . . . . 0 N--CA 1.443 -0.792 0 N-CA-C 108.845 -0.798 . . . . 75.439999999999998 108.845 176.189 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.581 0 N-CA-C 111.246 -0.741 . . . . 62.200000000000003 111.246 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.3 t -85.89 -40.44 15.93 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 117.233 0.516 . . . . 62.530000000000001 110.174 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.405 ' O ' HG12 ' A' ' 120' ' ' VAL . . . -73.0 -30.54 63.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.341 0.591 . . . . 74.510000000000005 110.126 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.496 ' O ' HG22 ' A' ' 121' ' ' ILE . . . -81.57 -19.92 65.09 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.337 -0.847 . . . . 64.310000000000002 113.043 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -79.44 -22.38 44.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 117.089 0.444 . . . . 75.510000000000005 112.094 -176.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 117' ' ' ALA . 7.0 p -64.96 -27.08 41.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.693 -0.23 . . . . 55.420000000000002 111.514 -174.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.496 HG22 ' O ' ' A' ' 118' ' ' GLY . 10.6 tp -65.45 -29.79 48.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.638 0.256 . . . . 74.329999999999998 110.727 -177.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.98 -23.15 59.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 65.049999999999997 110.922 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.4 -29.27 19.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.304 0.573 . . . . 73.530000000000001 109.608 176.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.815 -0.63 . . . . 60.149999999999999 109.669 177.281 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 . . . . . 0 N--CA 1.461 0.081 0 N-CA-C 112.717 0.636 . . . . 73.150000000000006 112.717 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -71.83 -37.64 70.28 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.48 -0.488 . . . . 72.439999999999998 111.037 -177.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -74.84 -38.29 62.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.243 0.544 . . . . 74.530000000000001 110.168 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.589 ' CD2' ' HB3' ' A' ' 8' ' ' ASP . 24.4 tp -66.59 -24.38 66.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.567 -0.742 . . . . 73.400000000000006 109.523 178.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.479 ' O ' ' HB3' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -62.64 -29.71 70.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.749 -0.66 . . . . 62.43 110.307 176.679 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -69.01 -43.42 74.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.889 -0.596 . . . . 75.439999999999998 110.149 176.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.525 ' O ' ' HG3' ' A' ' 144' ' ' GLN . 18.2 t80 -60.74 -37.96 83.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.876 -0.602 . . . . 65.349999999999994 109.9 174.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.801 ' HG2' HG13 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -53.64 -41.93 67.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.778 -0.647 . . . . 73.310000000000002 110.52 176.074 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -63.52 -31.36 72.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.879 -0.6 . . . . 64.430000000000007 110.436 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -79.17 -27.89 42.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.662 -0.699 . . . . 70.129999999999995 110.949 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.837 ' HG2' HG21 ' A' ' 22' ' ' VAL . 10.7 mt-30 -69.69 -40.61 76.24 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.069 0.461 . . . . 72.209999999999994 110.676 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.667 ' HB3' HG23 ' A' ' 12' ' ' ILE . 16.5 pt-20 -78.0 -13.63 59.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.926 -0.579 . . . . 63.310000000000002 110.4 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 58.4 tp -91.0 -61.58 1.64 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.818 -0.628 . . . . 75.519999999999996 110.88 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 110.97 -0.852 . . . . 71.230000000000004 110.97 -172.943 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.678 HG13 ' CB ' ' A' ' 108' ' ' LEU . 77.4 t . . . . . 0 N--CA 1.445 -0.679 0 CA-C-O 120.885 0.374 . . . . 74.349999999999994 110.05 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.8 m -146.68 151.3 14.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.926 -0.579 . . . . 73.409999999999997 110.15 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.46 109.79 22.28 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.204 -0.665 . . . . 64.25 109.204 173.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.443 ' HB3' HD23 ' A' ' 137' ' ' LEU . 2.6 t70 -157.36 174.27 15.68 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.105 -0.331 . . . . 74.329999999999998 110.105 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.481 ' HB2' HG22 ' A' ' 105' ' ' VAL . . . -131.43 131.5 43.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.242 -0.436 . . . . 73.540000000000006 110.848 -174.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.542 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 16.4 m -116.66 137.37 50.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.035 0.445 . . . . 62.399999999999999 110.663 177.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.1 m -83.65 105.14 14.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.935 -0.575 . . . . 54.240000000000002 110.222 -178.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.535 HD12 ' HB2' ' A' ' 144' ' ' GLN . 24.6 mm -114.3 149.93 16.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.727 0.299 . . . . 54.450000000000003 111.078 -177.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.76 25.68 8.26 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 121.159 -0.543 . . . . 75.340000000000003 112.67 177.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -98.4 145.65 30.23 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 108.764 -0.828 . . . . 70.230000000000004 108.764 176.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -59.0 -58.58 0.63 Allowed 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 121.946 1.764 . . . . 53.109999999999999 112.914 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 173.48 -43.55 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.097 0.559 . . . . 72.400000000000006 109.824 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.627 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 25.3 tt0 -48.3 -51.24 26.81 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 114.876 -1.057 . . . . 75.519999999999996 111.756 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -78.56 -11.09 59.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.611 -0.722 . . . . 63.210000000000001 111.504 -174.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.2 mt -83.66 -47.88 10.76 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.611 -0.268 . . . . 75.25 111.544 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.627 ' CE2' ' HA ' ' A' ' 17' ' ' GLU . 18.7 p90 -71.65 -24.37 61.84 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.383 -0.527 . . . . 74.010000000000005 110.811 -177.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.36 -13.36 61.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.974 -0.557 . . . . 51.450000000000003 111.495 -177.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.558 HG21 ' CZ ' ' A' ' 140' ' ' PHE . 6.1 p -57.01 -21.81 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 111.892 0.331 . . . . 72.519999999999996 111.892 -174.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -54.26 -31.81 54.57 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.139 -0.482 . . . . 71.219999999999999 110.696 177.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.64 ' HA ' ' NE ' ' A' ' 24' ' ' ARG . 4.7 tpm_? -135.42 32.33 3.09 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.425 -0.583 . . . . 64.209999999999994 109.425 176.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.691 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 29.2 t70 65.26 169.21 0.2 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.027 -0.988 . . . . 50.200000000000003 111.441 -177.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.57 86.84 2.39 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 121.034 0.445 . . . . 74.25 112.037 -176.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.691 ' HD3' ' O ' ' A' ' 25' ' ' ASP . 3.5 Cg_endo . . . . . 0 N--CA 1.457 -0.655 0 C-N-CA 123.339 2.693 . . . . 74.109999999999999 112.233 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.251 0 N-CA-C 108.819 -0.808 . . . . 64.109999999999999 108.819 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.485 ' HB2' HD23 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -121.31 134.83 55.16 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.197 -1.038 . . . . 74.209999999999994 108.197 179.076 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 30.9 tp -113.58 127.51 56.09 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.921 -0.312 . . . . 52.549999999999997 110.342 -170.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.0 p -92.4 -25.01 18.68 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.198 0.523 . . . . 61.450000000000003 111.119 -176.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.694 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -140.39 128.69 22.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.953 -0.567 . . . . 72.120000000000005 111.637 -177.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -130.19 26.47 5.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.352 -0.84 . . . . 74.0 110.189 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.818 ' HB3' ' HB3' ' A' ' 73' ' ' LYS . 6.0 mm-40 -62.63 141.79 96.87 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.805 -0.634 . . . . 64.439999999999998 110.673 -177.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 3.0 Cg_exo -76.45 95.89 1.06 Allowed 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 123.04 2.493 . . . . 55.350000000000001 112.026 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.74 21.04 62.58 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-N 116.064 -0.516 . . . . 41.399999999999999 112.742 178.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.818 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 1.3 tmtp? -109.76 -57.93 2.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.893 0.378 . . . . 75.120000000000005 109.985 -176.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.846 ' HG3' ' HG ' ' A' ' 92' ' ' LEU . 40.5 ttp180 -155.97 111.63 3.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.12 -0.491 . . . . 73.400000000000006 109.832 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.424 ' N ' HD12 ' A' ' 75' ' ' ILE . 3.8 mp -109.27 110.52 32.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.504 -0.554 . . . . 73.510000000000005 109.504 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.694 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -119.21 115.4 24.13 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.104 -0.498 . . . . 34.240000000000002 109.861 177.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.456 ' HZ3' HG12 ' A' ' 91' ' ' VAL . 39.9 p90 -105.3 135.98 45.67 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.697 -0.683 . . . . 64.349999999999994 109.914 -177.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.5 mmt85 -142.42 174.02 11.0 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.308 -0.86 . . . . 70.400000000000006 108.861 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.406 ' OG ' ' HA ' ' A' ' 85' ' ' ILE . 30.1 p -98.8 -163.44 1.04 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.82 -0.807 . . . . 74.430000000000007 108.82 171.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.485 HD23 ' HB2' ' A' ' 65' ' ' GLU . 14.6 mt -71.98 142.93 85.86 Favored Pre-proline 0 C--N 1.321 -0.662 0 C-N-CA 120.277 -0.569 . . . . 74.310000000000002 109.784 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -63.11 -20.31 70.86 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 123.158 2.572 . . . . 54.140000000000001 113.047 -174.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.56 16.35 34.41 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.895 -0.669 . . . . 74.129999999999995 112.55 178.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -123.25 176.79 5.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.914 0.387 . . . . 73.439999999999998 111.133 -177.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -63.15 137.32 58.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.718 -0.674 . . . . 64.450000000000003 109.912 175.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.406 ' HA ' ' OG ' ' A' ' 79' ' ' SER . 19.6 tt -115.82 -27.18 2.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.962 -0.295 . . . . 52.0 111.493 -176.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 66.41 -81.73 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 122.962 0.505 . . . . 74.329999999999998 111.81 178.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -133.24 132.42 41.43 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.747 -0.464 . . . . 72.140000000000001 109.747 -177.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.8 m -96.82 128.03 43.38 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.716 0.293 . . . . 73.120000000000005 110.45 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -125.63 144.48 15.15 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.997 -0.62 . . . . 71.120000000000005 111.712 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.411 ' HG2' ' HB3' ' A' ' 107' ' ' ARG . 9.2 pt-20 -156.64 133.17 10.06 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.133 -0.321 . . . . 74.530000000000001 110.133 177.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.474 ' CG2' HG23 ' A' ' 104' ' ' VAL . 2.4 p -124.41 118.47 53.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.329 0.585 . . . . 75.420000000000002 111.497 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.846 ' HG ' ' HG3' ' A' ' 74' ' ' ARG . 2.9 mp -108.14 126.91 53.32 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.973 -0.751 . . . . 72.129999999999995 108.973 174.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.514 ' HZ ' ' HB3' ' A' ' 20' ' ' TYR . 85.2 m-85 -91.46 120.95 32.74 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.046 0.45 . . . . 64.25 110.426 -178.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.409 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 2.0 mmp_? -110.5 143.94 29.16 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.821 -0.627 . . . . 72.209999999999994 109.912 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 94' ' ' ARG . 32.3 Cg_exo -59.64 116.69 3.46 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.298 1.998 . . . . 74.530000000000001 111.258 177.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . . . -63.44 144.21 97.68 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.409 . . . . 65.239999999999995 111.715 -174.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 96' ' ' ALA . 50.6 Cg_exo -54.65 130.68 41.59 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.978 2.452 . . . . 74.439999999999998 111.73 176.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.53 7.05 88.95 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.801 -0.714 . . . . 51.219999999999999 112.186 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 60.67 28.14 17.86 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.682 0.393 . . . . 72.150000000000006 111.591 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 66.2 mtt180 -89.29 14.53 10.84 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.173 0.435 . . . . 73.340000000000003 112.173 -176.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.97 -137.44 6.51 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.723 -0.751 . . . . 53.009999999999998 112.125 176.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 40.6 m -136.75 130.36 31.87 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.912 0.387 . . . . 74.310000000000002 110.098 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -91.32 115.68 28.22 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.315 0.579 . . . . 74.150000000000006 109.625 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.474 HG23 ' CG2' ' A' ' 91' ' ' VAL . 2.1 p -88.29 112.0 23.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.439 -0.8 . . . . 73.129999999999995 110.916 -176.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.481 HG22 ' HB2' ' A' ' 9' ' ' ALA . 23.9 t -100.27 110.44 27.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.277 -0.874 . . . . 53.149999999999999 109.748 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.406 HG23 HG22 ' A' ' 104' ' ' VAL . 12.2 t -118.62 127.85 75.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.067 0.46 . . . . 62.32 111.111 -177.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 107' ' ' ARG . 51.3 ttt-85 -106.73 122.39 46.27 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.012 -0.54 . . . . 74.420000000000002 110.178 176.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.678 ' CB ' HG13 ' A' ' 5' ' ' VAL . 4.6 mp -122.3 154.39 37.66 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.57 -0.53 . . . . 70.319999999999993 109.57 177.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.577 ' O ' HG11 ' A' ' 5' ' ' VAL . 6.2 m -84.75 119.33 25.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.789 0.328 . . . . 62.409999999999997 111.602 -177.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 14.2 p90 . . . . . 0 C--N 1.325 -0.484 0 CA-C-O 121.453 0.644 . . . . 71.219999999999999 111.386 -179.338 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.282 -0.327 . . . . 75.109999999999999 112.282 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.3 m -72.23 -15.54 61.93 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.047 0.451 . . . . 65.319999999999993 111.42 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -72.87 -19.9 61.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 61.200000000000003 110.973 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.557 ' HA2' HG22 ' A' ' 121' ' ' ILE . . . -55.92 -39.03 77.17 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 121.385 -0.436 . . . . 73.040000000000006 112.91 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.56 -29.34 70.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.127 0.489 . . . . 74.540000000000006 111.009 176.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 57.9 t -80.14 -46.81 21.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.829 -0.623 . . . . 53.350000000000001 110.614 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.557 HG22 ' HA2' ' A' ' 118' ' ' GLY . 15.5 tt -65.26 -21.69 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 116.271 -0.422 . . . . 72.219999999999999 110.925 -177.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.05 -25.25 63.57 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.503 -0.317 . . . . 61.530000000000001 111.131 176.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.442 ' HD3' ' C ' ' A' ' 123' ' ' ARG . 0.0 OUTLIER -74.95 -39.24 61.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.159 0.504 . . . . 71.129999999999995 110.094 175.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 17.1 tpt . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 116.054 -0.521 . . . . 74.519999999999996 111.063 179.293 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? . . . . . 0 N--CA 1.463 0.18 0 N-CA-C 111.391 0.145 . . . . 64.010000000000005 111.391 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -57.41 -56.07 26.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.803 0.335 . . . . 63.200000000000003 111.82 -174.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -74.93 -32.53 61.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.399 -0.364 . . . . 64.409999999999997 110.994 -176.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.542 ' HG ' ' CG1' ' A' ' 10' ' ' VAL . 20.6 tp -70.58 -24.74 62.82 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.243 -0.435 . . . . 73.450000000000003 109.972 -177.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.43 ' CE ' ' HA ' ' A' ' 138' ' ' MET . 0.0 OUTLIER -68.76 -45.78 70.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.152 -0.476 . . . . 72.510000000000005 110.199 177.636 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 71.0 mtm-85 -67.13 -37.89 84.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 71.230000000000004 110.171 177.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.558 ' CZ ' HG21 ' A' ' 22' ' ' VAL . 84.0 t80 -57.03 -42.45 80.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.457 -0.792 . . . . 75.420000000000002 110.586 174.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.505 ' HG3' HD13 ' A' ' 12' ' ' ILE . 26.0 ttpp -57.19 -46.85 82.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 62.539999999999999 110.726 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -60.66 -41.7 95.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.53 -0.759 . . . . 65.25 112.341 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -79.31 -24.68 42.67 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.554 -0.459 . . . . 73.329999999999998 110.937 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.535 ' HB2' HD12 ' A' ' 12' ' ' ILE . 8.1 mm-40 -71.83 -49.74 35.72 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.794 0.331 . . . . 74.129999999999995 110.958 175.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 13.4 pt-20 -67.9 -30.77 70.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.217 -0.447 . . . . 73.239999999999995 110.331 -177.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 48.7 tp -71.17 -41.32 70.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.773 -0.649 . . . . 74.409999999999997 109.658 174.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.551 0 CA-C-N 115.567 -0.742 . . . . 71.450000000000003 111.344 -177.927 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.846 HG22 HG22 ' A' ' 109' ' ' THR . 69.0 t . . . . . 0 N--CA 1.449 -0.507 0 N-CA-C 109.298 -0.63 . . . . 55.409999999999997 109.298 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.4 m -95.73 145.52 8.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.783 -0.644 . . . . 74.430000000000007 111.103 -174.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.489 ' HD2' ' O ' ' A' ' 7' ' ' ARG . 4.5 ppt_? -141.64 108.98 5.54 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.434 -0.803 . . . . 61.109999999999999 109.069 175.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -142.09 161.84 36.97 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.039 -0.726 . . . . 73.120000000000005 109.039 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.658 ' HB2' HG22 ' A' ' 105' ' ' VAL . . . -140.39 130.17 24.45 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.128 0.49 . . . . 71.510000000000005 111.969 -170.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.484 HG23 HD11 ' A' ' 12' ' ' ILE . 15.8 m -113.28 145.75 18.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.486 -0.779 . . . . 61.219999999999999 110.255 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 102' ' ' THR . 20.4 m -107.15 109.6 21.47 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.782 0.325 . . . . 64.319999999999993 111.067 -178.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.844 HG13 ' HG2' ' A' ' 141' ' ' LYS . 4.1 mp -98.82 147.97 6.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.26 -0.427 . . . . 73.409999999999997 109.883 -177.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.38 58.27 4.41 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.994 -0.622 . . . . 54.340000000000003 112.709 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.643 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 8.2 mmpt? -129.8 167.01 22.04 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 108.555 -0.905 . . . . 61.219999999999999 108.555 177.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 14' ' ' LYS . 27.5 Cg_endo -65.22 -58.35 0.21 Allowed 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 121.309 1.339 . . . . 75.25 112.306 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . 171.69 -55.73 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.622 0.725 . . . . 60.020000000000003 110.266 174.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -55.09 -51.82 65.17 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.46 -1.245 . . . . 74.400000000000006 112.848 -173.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -54.07 -27.11 30.51 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.154 0.427 . . . . 75.150000000000006 112.154 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.487 ' CD1' ' HB ' ' A' ' 102' ' ' THR . 56.2 mt -69.32 -20.41 63.87 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.167 0.432 . . . . 64.219999999999999 112.167 -175.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.454 ' CE1' HG21 ' A' ' 75' ' ' ILE . 46.3 t80 -72.0 -25.27 61.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.099 0.475 . . . . 73.430000000000007 110.65 175.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.6 -12.98 60.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.364 -0.38 . . . . 73.340000000000003 111.411 -176.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.4 p -53.95 -24.04 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 112.626 0.602 . . . . 64.329999999999998 112.626 -174.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.418 ' HD1' ' O ' ' A' ' 20' ' ' TYR . 98.1 m95 -57.69 -24.34 56.25 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.18 0.437 . . . . 74.349999999999994 112.18 -176.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.448 ' HA ' ' HD2' ' A' ' 24' ' ' ARG . 7.5 tpt180 -156.33 59.28 0.57 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.792 0.33 . . . . 71.329999999999998 110.582 175.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.709 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 18.3 t70 65.24 168.82 0.19 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.571 -0.74 . . . . 73.329999999999998 111.227 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.5 mt -102.29 87.8 1.2 Allowed Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.714 -0.476 . . . . 55.509999999999998 109.714 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.709 ' HD3' ' O ' ' A' ' 25' ' ' ASP . 2.3 Cg_endo . . . . . 0 N--CA 1.458 -0.597 0 C-N-CA 123.186 2.59 . . . . 72.0 112.697 -174.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.504 0 CA-C-O 120.719 0.295 . . . . 63.100000000000001 111.076 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 1.052 ' HB2' HD23 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -105.61 133.66 49.99 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.859 -0.793 . . . . 73.019999999999996 108.859 175.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.488 HD12 ' HA ' ' A' ' 77' ' ' TRP . 1.6 mm? -88.91 145.5 25.5 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 121.085 -0.246 . . . . 74.329999999999998 110.791 -173.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.5 t -92.53 -21.48 20.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.957 0.408 . . . . 71.200000000000003 110.209 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.783 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -121.87 130.48 53.4 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.338 -0.616 . . . . 54.310000000000002 109.338 174.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -128.58 23.98 5.82 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.473 0.654 . . . . 71.409999999999997 110.249 -172.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.556 ' HB3' ' HD3' ' A' ' 73' ' ' LYS . 29.2 mt-10 -73.17 141.52 81.12 Favored Pre-proline 0 C--N 1.326 -0.429 0 C-N-CA 120.582 -0.447 . . . . 64.340000000000003 110.551 -174.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.62 88.33 1.04 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.8 2.333 . . . . 72.5 113.326 -173.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.78 12.07 78.19 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 121.045 -0.597 . . . . 63.450000000000003 112.281 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.556 ' HD3' ' HB3' ' A' ' 70' ' ' GLU . 42.9 mtpt -95.36 -69.19 0.76 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.909 0.385 . . . . 74.230000000000004 110.325 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.465 ' HD2' ' OE2' ' A' ' 90' ' ' GLU . 10.2 ttp180 -147.72 127.15 13.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.908 -0.587 . . . . 71.140000000000001 110.095 -175.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.625 HD13 ' HE2' ' A' ' 93' ' ' PHE . 4.6 mp -131.01 111.4 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.398 0.618 . . . . 72.329999999999998 111.216 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.783 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -104.87 125.93 51.42 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.211 -0.904 . . . . 73.239999999999995 108.707 170.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.488 ' HA ' HD12 ' A' ' 66' ' ' LEU . 64.8 p-90 -80.4 159.07 25.8 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.369 0.604 . . . . 75.400000000000006 111.349 -175.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.494 ' HB3' ' O ' ' A' ' 65' ' ' GLU . 44.7 ttp180 -158.64 164.38 36.04 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.05 -0.977 . . . . 74.400000000000006 108.64 -177.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.561 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 19.9 m -123.65 60.34 1.09 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.621 0.248 . . . . 61.020000000000003 110.343 -178.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.052 HD23 ' HB2' ' A' ' 65' ' ' GLU . 22.4 mt 68.09 153.95 0.14 Allowed Pre-proline 0 N--CA 1.471 0.621 0 CA-C-N 115.701 -0.682 . . . . 71.129999999999995 111.632 -178.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.26 -19.49 38.45 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.598 2.199 . . . . 74.030000000000001 111.784 173.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.76 -24.27 77.13 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.906 -0.664 . . . . 60.520000000000003 112.059 178.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 79' ' ' SER . . . -108.52 178.87 4.36 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.245 -0.65 . . . . 63.509999999999998 109.245 175.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.518 ' HD2' ' N ' ' A' ' 84' ' ' ARG . 5.1 mpt_? -118.28 164.86 14.58 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.89 0.376 . . . . 63.530000000000001 110.3 -177.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.586 HD11 ' HA ' ' A' ' 88' ' ' SER . 6.2 tt -131.62 108.52 14.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.657 -0.701 . . . . 74.549999999999997 109.484 176.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -77.15 -37.42 53.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.777 -0.647 . . . . 73.340000000000003 110.942 -175.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -126.28 132.17 51.73 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.69 -0.485 . . . . 74.549999999999997 109.69 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.586 ' HA ' HD11 ' A' ' 85' ' ' ILE . 25.8 m -95.87 128.17 42.52 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.963 0.411 . . . . 61.350000000000001 111.282 -173.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -109.63 90.35 0.59 Allowed Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.133 -0.787 . . . . 35.310000000000002 111.133 174.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.465 ' OE2' ' HD2' ' A' ' 74' ' ' ARG . 40.9 tt0 -102.63 118.63 37.27 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.922 0.392 . . . . 75.129999999999995 110.478 -177.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.7 m -112.43 142.82 23.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.407 -0.59 . . . . 62.229999999999997 109.407 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.657 HD23 ' HD3' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -134.56 137.74 44.03 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.367 0.603 . . . . 74.319999999999993 110.178 171.209 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.625 ' HE2' HD13 ' A' ' 75' ' ' ILE . 85.5 m-85 -97.22 119.0 34.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.315 -0.857 . . . . 74.209999999999994 110.15 -174.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.657 ' HD3' HD23 ' A' ' 92' ' ' LEU . 18.5 mmm180 -104.01 143.01 25.79 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.643 -0.503 . . . . 74.310000000000002 109.643 179.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.5 109.91 2.87 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.129 1.886 . . . . 72.140000000000001 111.439 176.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.633 ' HB1' ' HB3' ' A' ' 100' ' ' ARG . . . -73.68 144.03 82.65 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.362 -0.607 . . . . 70.239999999999995 109.362 177.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -48.6 113.33 0.82 Allowed 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 123.445 2.763 . . . . 62.140000000000001 114.479 -169.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.23 -66.54 3.78 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 114.875 -1.057 . . . . 32.219999999999999 112.501 170.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -170.13 24.04 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.085 -0.558 . . . . 63.32 110.821 -173.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.633 ' HB3' ' HB1' ' A' ' 96' ' ' ALA . 5.6 tpm_? -64.47 -22.86 67.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.057 -0.52 . . . . 74.349999999999994 110.499 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 127.92 -154.77 19.92 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.29 -0.724 . . . . 73.219999999999999 111.29 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 11' ' ' THR . 2.5 m -105.68 125.29 50.82 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.96 -0.385 . . . . 51.140000000000001 109.96 175.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -89.89 100.65 13.42 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.031 -0.729 . . . . 71.099999999999994 109.031 173.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.511 HG12 ' HD1' ' A' ' 93' ' ' PHE . 3.4 m -87.46 129.47 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 109.13 -0.693 . . . . 63.530000000000001 109.13 178.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.658 HG22 ' HB2' ' A' ' 9' ' ' ALA . 18.7 t -117.19 115.92 50.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 109.082 -0.71 . . . . 74.109999999999999 109.082 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.601 HG12 HD22 ' A' ' 108' ' ' LEU . 24.0 t -103.5 116.67 47.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.304 -0.407 . . . . 60.130000000000003 110.371 -177.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -107.54 107.72 18.69 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.566 -0.531 . . . . 72.150000000000006 109.566 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.601 HD22 HG12 ' A' ' 106' ' ' VAL . 2.6 pt? -145.7 152.04 38.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.133 -0.485 . . . . 65.329999999999998 110.232 -177.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.846 HG22 HG22 ' A' ' 5' ' ' VAL . 51.2 p -107.4 132.91 52.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.327 -0.397 . . . . 60.130000000000003 111.011 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 49.2 p90 . . . . . 0 C--N 1.32 -0.685 0 CA-C-N 116.285 -0.416 . . . . 65.549999999999997 109.883 176.161 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.404 0 N-CA-C 112.151 -0.38 . . . . 71.299999999999997 112.151 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.5 m -64.78 -30.24 71.24 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 122.288 0.235 . . . . 45.539999999999999 111.501 -177.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.32 -28.34 69.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.516 -0.311 . . . . 52.439999999999998 111.364 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -60.82 -39.26 96.57 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.085 -0.578 . . . . 62.140000000000001 112.396 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.25 -34.43 78.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.144 0.497 . . . . 73.340000000000003 110.634 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.9 t -68.59 -43.32 83.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.792 -0.64 . . . . 71.439999999999998 110.17 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.7 mm -65.91 -36.62 77.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.969 -0.559 . . . . 71.209999999999994 110.487 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.39 -19.3 65.89 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.866 -0.607 . . . . 54.229999999999997 111.577 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -73.38 -32.31 64.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.777 0.322 . . . . 75.340000000000003 110.688 178.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 121.11 0.481 . . . . 70.120000000000005 110.516 179.517 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.444 ' O ' ' HG2' ' A' ' 134' ' ' ARG . 42.0 ttm180 . . . . . 0 C--O 1.219 -0.541 0 N-CA-C 111.601 0.223 . . . . 74.0 111.601 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -54.61 -43.63 72.36 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.956 -0.465 . . . . 75.0 111.018 -175.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -68.64 -47.39 66.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 72.120000000000005 111.273 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 23.7 tp -69.49 -25.47 64.08 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.101 0.477 . . . . 72.019999999999996 110.219 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.465 ' CE ' ' HA ' ' A' ' 138' ' ' MET . 0.1 OUTLIER -69.9 -33.27 71.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.042 -0.526 . . . . 71.409999999999997 110.015 176.018 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -39.73 89.4 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.236 -0.438 . . . . 63.039999999999999 110.153 176.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -56.97 -52.21 66.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.987 -0.551 . . . . 53.310000000000002 109.916 174.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.844 ' HG2' HG13 ' A' ' 12' ' ' ILE . 14.5 tmtt? -59.06 -35.34 73.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.717 -0.674 . . . . 61.0 110.73 176.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.426 ' HD2' ' HA ' ' A' ' 142' ' ' ARG . 14.4 tpt180 -62.48 -58.78 6.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.02 -0.536 . . . . 71.530000000000001 109.997 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -63.15 -32.98 74.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.025 -0.534 . . . . 64.540000000000006 110.906 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -58.32 -37.04 74.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.675 -0.693 . . . . 75.340000000000003 112.369 -175.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.489 ' HB3' HG23 ' A' ' 12' ' ' ILE . 8.2 pt-20 -109.96 -18.09 13.46 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.827 -0.349 . . . . 70.319999999999993 111.894 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 146' ' ' LEU . 5.0 tt -87.23 -38.53 16.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.168 0.508 . . . . 63.200000000000003 110.283 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.724 0 N-CA-C 111.343 -0.703 . . . . 72.209999999999994 111.343 -175.591 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 3.1 p . . . . . 0 N--CA 1.448 -0.55 0 CA-C-O 121.28 0.562 . . . . 61.329999999999998 109.769 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.3 t -97.92 116.72 41.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 116.213 -0.449 . . . . 75.430000000000007 109.81 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -93.23 123.44 36.5 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.372 0.606 . . . . 61.32 110.84 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.78 ' HB3' HD22 ' A' ' 137' ' ' LEU . 20.4 t0 -142.08 156.1 45.39 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.84 -1.17 . . . . 71.430000000000007 107.84 176.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.42 128.47 25.55 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.756 -0.378 . . . . 72.349999999999994 110.826 -176.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.525 HG13 HD23 ' A' ' 137' ' ' LEU . 27.9 m -110.07 134.91 50.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.664 -0.495 . . . . 74.129999999999995 109.664 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.782 HG21 ' HG3' ' A' ' 100' ' ' ARG . 1.3 m -108.07 110.99 22.81 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.768 -0.456 . . . . 63.350000000000001 109.768 -178.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.618 ' HB ' HD21 ' A' ' 19' ' ' LEU . 12.9 mm -108.24 150.86 10.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.925 -0.58 . . . . 63.109999999999999 110.117 -174.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.83 44.54 2.32 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.14 -0.553 . . . . 72.099999999999994 112.523 176.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.419 ' HB2' HD21 ' A' ' 19' ' ' LEU . 67.0 mmtt -119.24 145.42 38.39 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 107.889 -1.152 . . . . 73.219999999999999 107.889 176.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.411 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 83.1 Cg_exo -48.49 -58.01 2.01 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.568 2.179 . . . . 73.299999999999997 113.57 -173.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . 173.34 -53.28 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.378 0.609 . . . . 72.430000000000007 110.389 177.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -52.93 -32.43 45.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.677 -1.147 . . . . 75.109999999999999 111.98 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -85.49 -8.52 58.31 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.943 -0.571 . . . . 74.25 111.37 -175.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.849 ' HB2' ' HE2' ' A' ' 93' ' ' PHE . 96.1 mt -79.31 -44.42 21.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.711 -0.222 . . . . 54.420000000000002 111.437 -176.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.549 ' HB2' ' HZ ' ' A' ' 93' ' ' PHE . 64.1 t80 -71.46 -30.31 65.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.511 0.672 . . . . 74.420000000000002 109.787 177.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.935 ' HB1' ' HA ' ' A' ' 26' ' ' LEU . . . -66.11 -3.96 6.52 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.245 -0.889 . . . . 73.340000000000003 112.357 -175.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.549 HG21 ' CD1' ' A' ' 140' ' ' PHE . 13.4 p -61.37 -22.18 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.348 -0.387 . . . . 75.420000000000002 111.333 176.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.417 ' HD1' ' O ' ' A' ' 20' ' ' TYR . 76.2 m95 -66.6 -10.83 49.7 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.82 0.343 . . . . 72.439999999999998 111.286 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.451 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 6.5 mmm180 -132.56 -84.47 0.48 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.643 -0.253 . . . . 75.129999999999995 111.298 173.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.593 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 3.9 t70 -166.8 33.51 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.885 -0.326 . . . . 72.230000000000004 110.73 -176.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.935 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 0.7 OUTLIER 44.19 71.87 1.36 Allowed Pre-proline 0 N--CA 1.472 0.666 0 O-C-N 123.758 0.661 . . . . 72.530000000000001 112.46 -177.692 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo . . . . . 0 N--CA 1.457 -0.638 0 C-N-CA 122.644 2.229 . . . . 71.099999999999994 112.359 -178.431 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.302 0 CA-C-O 120.732 0.301 . . . . 63.399999999999999 110.415 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.443 ' HG2' ' H ' ' A' ' 80' ' ' LEU . 15.3 pt-20 -108.27 154.99 20.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.211 -0.45 . . . . 72.230000000000004 111.113 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.1 tp -117.58 123.02 45.2 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.059 -0.719 . . . . 75.129999999999995 109.059 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.434 ' HB ' ' CG ' ' A' ' 78' ' ' ARG . 12.2 t -83.52 -22.53 32.42 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.621 -0.432 . . . . 70.299999999999997 112.073 -171.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.948 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -132.63 132.36 42.39 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.67 -0.412 . . . . 72.0 110.713 -178.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -139.42 40.87 2.06 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.793 -0.639 . . . . 62.32 110.797 -176.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.555 ' CB ' ' HB3' ' A' ' 73' ' ' LYS . 5.4 mm-40 -80.38 143.43 55.79 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 75.349999999999994 109.842 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 23.9 Cg_exo -64.82 -55.67 0.49 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.59 2.194 . . . . 45.32 112.528 -178.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -134.12 64.15 0.6 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.852 -0.689 . . . . 72.400000000000006 111.856 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.555 ' HB3' ' CB ' ' A' ' 70' ' ' GLU . 69.2 tttt -143.78 -78.83 0.21 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.898 -0.408 . . . . 65.409999999999997 109.898 -176.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -168.03 147.5 4.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.785 0.326 . . . . 73.219999999999999 110.682 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.714 HD13 ' HE1' ' A' ' 93' ' ' PHE . 2.4 mp -122.8 116.68 49.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.76 -0.655 . . . . 72.340000000000003 109.913 175.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.948 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -103.72 149.1 25.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.187 -0.46 . . . . 51.420000000000002 109.835 176.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 29.1 p-90 -94.0 152.6 18.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.098 0.475 . . . . 73.209999999999994 111.836 -172.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.434 ' CG ' ' HB ' ' A' ' 67' ' ' THR . 75.7 mmt-85 -144.27 173.53 11.68 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.071 -1.085 . . . . 74.109999999999999 108.071 169.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.622 ' OG ' HG13 ' A' ' 85' ' ' ILE . 11.5 m -150.13 22.75 0.85 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.799 -0.361 . . . . 74.109999999999999 110.598 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.443 ' H ' ' HG2' ' A' ' 65' ' ' GLU . 91.2 mt 65.97 158.39 0.13 Allowed Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 115.834 -0.621 . . . . 62.450000000000003 110.233 -173.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -67.7 5.39 1.03 Allowed 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.76 2.307 . . . . 72.340000000000003 113.264 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.11 -21.01 10.43 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.8 -0.714 . . . . 75.299999999999997 113.095 -177.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.502 ' O ' ' HB2' ' A' ' 79' ' ' SER . . . -150.45 167.98 25.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.154 0.477 . . . . 74.129999999999995 111.282 -175.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 84' ' ' ARG . 3.7 mpt_? -138.29 141.35 39.82 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.468 -0.567 . . . . 73.310000000000002 109.468 174.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.622 HG13 ' OG ' ' A' ' 79' ' ' SER . 71.1 mt -70.65 -16.45 19.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-O 120.917 0.389 . . . . 73.150000000000006 110.365 176.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 75.39 -38.37 0.36 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.685 0.794 . . . . 65.450000000000003 110.773 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -64.82 132.7 50.2 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.173 -0.677 . . . . 74.209999999999994 109.173 170.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.1 t -126.35 127.89 46.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.941 0.4 . . . . 71.409999999999997 110.899 -175.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.493 ' HA3' ' HB3' ' A' ' 107' ' ' ARG . . . 158.94 133.0 1.45 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 121.042 -0.599 . . . . 73.150000000000006 112.115 176.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -101.27 138.46 38.26 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.899 0.381 . . . . 51.149999999999999 109.977 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.507 HG22 HG12 ' A' ' 106' ' ' VAL . 63.1 t -89.04 125.02 42.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.79 -0.641 . . . . 62.43 111.484 -175.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.3 mp -107.37 132.04 53.59 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.053 -0.976 . . . . 73.430000000000007 110.241 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.849 ' HE2' ' HB2' ' A' ' 19' ' ' LEU . 91.9 m-85 -99.36 109.42 22.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.188 0.518 . . . . 64.200000000000003 109.872 177.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.477 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 21.0 mtp180 -109.67 144.65 30.33 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.554 -0.748 . . . . 74.329999999999998 110.176 -173.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 94' ' ' ARG . 11.9 Cg_exo -70.5 123.93 10.32 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.764 2.31 . . . . 71.400000000000006 112.636 -176.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.917 ' HB1' ' HB3' ' A' ' 100' ' ' ARG . . . -98.06 160.04 29.33 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 108.828 -0.804 . . . . 55.25 108.828 171.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.05 159.69 11.82 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 121.789 1.66 . . . . 75.219999999999999 110.604 169.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -52.38 -26.64 22.85 Favored Glycine 0 CA--C 1.519 0.3 0 N-CA-C 114.35 0.5 . . . . 71.129999999999995 114.35 -172.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -105.61 7.8 32.92 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 112.996 0.739 . . . . 44.43 112.996 -176.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.917 ' HB3' ' HB1' ' A' ' 96' ' ' ALA . 9.5 tpp180 -101.53 -35.99 8.95 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.343 -0.614 . . . . 71.299999999999997 109.343 175.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.615 ' O ' ' HB3' ' A' ' 96' ' ' ALA . . . 111.51 -130.05 9.5 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 121.15 -0.548 . . . . 72.299999999999997 112.012 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 54.7 m -129.89 132.91 46.57 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.73 -0.471 . . . . 65.230000000000004 109.73 173.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -88.24 107.02 18.59 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.126 0.489 . . . . 74.230000000000004 110.9 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 10' ' ' VAL . 6.4 p -88.33 101.59 11.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.466 -0.788 . . . . 73.319999999999993 109.812 174.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 59.5 t -86.25 108.5 17.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.901 -0.59 . . . . 73.129999999999995 110.187 -178.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.507 HG12 HG22 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -111.55 129.16 67.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.597 -0.728 . . . . 65.530000000000001 110.574 -178.275 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.493 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 39.9 ttm180 -107.79 110.68 22.55 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.61 -0.723 . . . . 72.5 109.452 177.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.503 HD23 ' H ' ' A' ' 108' ' ' LEU . 1.5 pt? -123.33 121.12 35.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.472 0.653 . . . . 60.200000000000003 111.7 -176.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 6.6 m -95.79 120.48 36.13 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.22 -0.9 . . . . 54.100000000000001 108.875 175.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 31.1 p90 . . . . . 0 N--CA 1.447 -0.621 0 CA-C-O 121.482 0.658 . . . . 63.43 111.458 -173.805 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.395 0 N-CA-C 112.754 -0.138 . . . . 42.25 112.754 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.8 t -63.73 -49.0 74.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.758 0.313 . . . . 74.030000000000001 110.49 -178.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.53 -32.56 73.52 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.281 -0.418 . . . . 75.319999999999993 110.742 178.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.64 -29.1 71.51 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.754 -0.657 . . . . 64.329999999999998 112.204 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.01 -31.41 62.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.931 0.396 . . . . 65.25 110.677 178.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.24 -50.01 56.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.015 -0.539 . . . . 64.329999999999998 110.585 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.561 ' HA ' ' HB3' ' A' ' 124' ' ' MET . 29.0 pt -69.1 -21.56 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.489 . . . . 63.229999999999997 111.261 -178.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.25 -39.68 83.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.541 -0.3 . . . . 63.100000000000001 111.367 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -89.92 -23.03 21.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.239 0.542 . . . . 74.340000000000003 110.192 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.561 ' HB3' ' HA ' ' A' ' 121' ' ' ILE . 16.3 tpt . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.735 -0.666 . . . . 72.299999999999997 110.993 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.639 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.453 -0.275 0 CA-C-O 120.709 0.29 . . . . 70.040000000000006 110.695 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.517 ' HB2' HD12 ' A' ' 121' ' ' ILE . 9.1 m-20 -61.58 -30.68 70.83 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.238 -0.653 . . . . 53.229999999999997 109.238 178.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.13 -53.23 53.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.784 -1.098 . . . . 71.209999999999994 110.422 176.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.78 HD22 ' HB3' ' A' ' 8' ' ' ASP . 1.2 tp -79.74 -31.42 41.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.599 -0.728 . . . . 63.049999999999997 110.929 -178.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.698 ' SD ' ' HD3' ' A' ' 141' ' ' LYS . 28.3 tpp -63.67 -26.6 68.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.936 -0.574 . . . . 71.109999999999999 111.395 -177.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -62.91 -54.35 39.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.981 -0.554 . . . . 64.010000000000005 111.151 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.711 ' HE2' ' HG ' ' A' ' 137' ' ' LEU . 3.1 p90 -77.31 -29.71 53.75 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.93 -0.308 . . . . 72.219999999999999 110.493 -177.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.698 ' HD3' ' SD ' ' A' ' 138' ' ' MET . 51.3 tttm -49.41 -51.99 31.59 Favored 'General case' 0 C--O 1.232 0.153 0 O-C-N 123.28 0.363 . . . . 55.140000000000001 111.297 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.434 ' HA ' ' HG2' ' A' ' 145' ' ' GLU . 0.5 OUTLIER -67.44 -30.68 70.48 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.903 -0.589 . . . . 64.409999999999997 110.668 -174.775 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -71.67 -36.58 70.7 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.813 0.34 . . . . 74.109999999999999 110.15 177.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.459 ' HB3' HG21 ' A' ' 12' ' ' ILE . 14.1 mm100 -64.12 -38.33 90.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 74.040000000000006 111.438 177.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.469 ' HB3' HG23 ' A' ' 12' ' ' ILE . 11.6 pt-20 -87.91 -4.96 58.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.249 -0.432 . . . . 74.420000000000002 111.368 -176.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.6 tp -111.02 -38.3 5.12 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.767 0.318 . . . . 73.230000000000004 111.113 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.39 0 C-N-CA 121.145 -0.55 . . . . 70.549999999999997 113.802 -173.2 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.757 HG22 ' HB ' ' A' ' 109' ' ' THR . 99.0 t . . . . . 0 N--CA 1.447 -0.592 0 N-CA-C 108.711 -0.848 . . . . 74.120000000000005 108.711 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.9 p -78.94 139.37 18.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.998 -0.546 . . . . 71.099999999999994 110.753 -174.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.471 ' HB3' ' HG3' ' A' ' 107' ' ' ARG . 17.3 ptt180 -132.55 134.79 45.41 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.992 -0.549 . . . . 62.210000000000001 110.379 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.755 ' HB3' HD22 ' A' ' 137' ' ' LEU . 4.2 t70 -158.14 171.81 19.54 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.443 -0.947 . . . . 74.439999999999998 108.443 172.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.426 ' CB ' HG22 ' A' ' 105' ' ' VAL . . . -146.33 120.42 9.45 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.874 0.368 . . . . 65.5 111.286 -174.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.2 m -112.73 133.55 58.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.9 -0.591 . . . . 73.120000000000005 110.756 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.0 m -97.96 112.31 24.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.922 0.392 . . . . 75.109999999999999 111.069 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.904 HG21 ' HG3' ' A' ' 144' ' ' GLN . 4.4 mp -117.28 146.38 21.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.386 -0.598 . . . . 74.310000000000002 109.386 176.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.52 53.51 3.2 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.086 -0.578 . . . . 75.219999999999999 112.972 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.517 ' HG2' HG22 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -105.83 153.99 39.68 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 107.868 -1.16 . . . . 54.219999999999999 107.868 173.121 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.43 -57.44 1.62 Allowed 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 121.795 1.664 . . . . 72.109999999999999 111.438 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 171.46 -49.63 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.27 0.981 . . . . 52.520000000000003 108.762 172.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -48.92 -44.22 40.2 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.17 -1.377 . . . . 61.420000000000002 112.124 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -64.61 -23.18 67.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.914 -0.584 . . . . 62.049999999999997 112.033 -176.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.469 ' O ' HG12 ' A' ' 22' ' ' VAL . 92.4 mt -76.98 -24.9 52.23 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.893 0.378 . . . . 71.200000000000003 110.577 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.569 ' HE1' HG12 ' A' ' 75' ' ' ILE . 55.9 t80 -72.12 -41.53 67.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.536 0.684 . . . . 74.200000000000003 109.795 175.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.836 ' HB1' ' HD2' ' A' ' 27' ' ' PRO . . . -76.43 -8.9 58.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.319 -0.855 . . . . 55.329999999999998 112.943 -175.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 19' ' ' LEU . 9.6 p -61.8 -22.3 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 111.765 0.283 . . . . 71.109999999999999 111.765 -174.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 33.6 t-105 -64.04 -14.79 56.94 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.401 -0.363 . . . . 73.299999999999997 111.147 -176.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -142.3 46.24 1.62 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.027 0.441 . . . . 63.310000000000002 110.784 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 36.3 t70 62.88 28.46 16.38 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.579 -0.737 . . . . 72.239999999999995 112.456 172.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.445 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 5.5 mp 53.46 80.27 0.3 Allowed Pre-proline 0 N--CA 1.47 0.557 0 CA-C-N 115.935 -0.575 . . . . 53.109999999999999 111.45 177.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.836 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 58.8 Cg_endo . . . . . 0 C--O 1.233 0.245 0 C-N-CA 122.693 2.262 . . . . 72.239999999999995 113.179 -177.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 110.038 -0.356 . . . . 62.340000000000003 110.038 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.588 ' HB3' ' HB2' ' A' ' 79' ' ' SER . 7.3 tp10 -123.99 154.92 39.13 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.387 -0.598 . . . . 74.129999999999995 109.387 177.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.949 ' HG ' ' HA ' ' A' ' 77' ' ' TRP . 3.3 mp -115.76 135.26 54.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.118 0.485 . . . . 74.019999999999996 111.6 -174.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.6 t -75.02 -32.41 61.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.313 -0.858 . . . . 74.439999999999998 111.474 -174.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.8 130.36 18.93 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.394 -0.522 . . . . 71.129999999999995 111.47 -176.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 8.0 p-10 -149.18 110.89 4.52 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.295 -0.866 . . . . 62.299999999999997 109.268 173.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.645 ' HB2' ' HB3' ' A' ' 73' ' ' LYS . 5.1 mm-40 -108.26 142.31 25.07 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 115.591 -0.731 . . . . 64.030000000000001 109.371 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 38.5 Cg_exo -61.98 -27.37 79.55 Favored 'Trans proline' 0 N--CA 1.466 -0.097 0 C-N-CA 122.806 2.337 . . . . 74.409999999999997 112.238 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -146.36 49.54 0.64 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.575 -0.822 . . . . 73.129999999999995 112.625 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.645 ' HB3' ' HB2' ' A' ' 70' ' ' GLU . 39.4 ttmt -148.37 -79.92 0.14 Allowed 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.77 -0.253 . . . . 70.109999999999999 110.587 177.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.638 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 10.3 ptp180 -154.47 150.91 28.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.996 0.426 . . . . 75.540000000000006 111.135 175.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.569 HG12 ' HE1' ' A' ' 20' ' ' TYR . 4.5 mp -123.33 110.47 26.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 108.771 -0.826 . . . . 62.329999999999998 108.771 173.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -126.14 141.82 51.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.301 0.572 . . . . 71.109999999999999 112.396 -172.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.949 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 0.5 OUTLIER -90.31 124.83 35.23 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.137 -0.938 . . . . 73.519999999999996 112.34 -173.374 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.669 ' HG3' ' O ' ' A' ' 77' ' ' TRP . 32.6 mtm180 175.54 118.73 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 O-C-N 124.382 1.052 . . . . 73.230000000000004 111.827 173.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.588 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 23.6 m -163.25 -54.32 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.657 0.265 . . . . 63.32 111.34 166.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.8 mp -102.72 146.41 32.34 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.697 0.284 . . . . 75.230000000000004 111.218 -176.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.46 -16.96 11.67 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 123.088 2.525 . . . . 61.439999999999998 112.508 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.67 13.05 54.65 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.904 -0.665 . . . . 74.209999999999994 112.293 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 84' ' ' ARG . . . -129.55 -165.72 1.56 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.157 -0.312 . . . . 75.439999999999998 110.157 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.542 ' O ' HG12 ' A' ' 85' ' ' ILE . 58.4 mtm180 73.47 -170.12 0.12 Allowed 'General case' 0 N--CA 1.465 0.325 0 O-C-N 123.864 0.727 . . . . 74.219999999999999 110.972 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 84' ' ' ARG . 14.2 pt 60.93 -46.26 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 125.896 1.678 . . . . 64.230000000000004 113.891 179.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -79.08 -31.33 44.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.151 0.501 . . . . 74.430000000000007 109.792 177.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -130.73 134.63 47.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.609 -0.723 . . . . 74.439999999999998 109.695 176.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.8 m -145.51 131.35 19.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.937 -0.574 . . . . 40.439999999999998 109.454 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 107' ' ' ARG . . . 173.0 127.15 0.95 Allowed Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 119.877 -1.154 . . . . 74.200000000000003 113.604 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 0.3 OUTLIER -118.87 142.03 48.11 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.269 -0.641 . . . . 72.510000000000005 109.269 171.432 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 95.6 t -100.84 136.86 30.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.58 -0.282 . . . . 65.129999999999995 110.478 177.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.798 ' HB2' ' HB ' ' A' ' 105' ' ' VAL . 3.4 mm? -113.66 120.41 40.79 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.924 -0.58 . . . . 65.409999999999997 109.85 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -98.82 105.85 18.05 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.982 -0.748 . . . . 55.409999999999997 108.982 172.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.462 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 0.7 OUTLIER -103.99 143.45 26.69 Favored Pre-proline 0 C--N 1.317 -0.841 0 CA-C-N 115.771 -0.649 . . . . 71.230000000000004 110.132 -175.519 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 94' ' ' ARG . 5.8 Cg_exo -74.32 103.16 1.64 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.24 1.96 . . . . 64.109999999999999 110.23 172.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.99 142.99 95.07 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.117 -0.492 . . . . 62.020000000000003 110.689 -174.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -40.04 120.21 0.77 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 124.311 3.341 . . . . 74.450000000000003 114.925 -171.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.25 -69.6 2.56 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.025 -0.989 . . . . 62.409999999999997 111.583 174.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 175.78 26.83 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.437 -0.882 . . . . 74.400000000000006 109.559 -176.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -66.19 -22.48 66.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.948 -0.569 . . . . 71.230000000000004 111.17 -174.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 138.64 -151.16 21.48 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.35 -0.7 . . . . 61.030000000000001 111.35 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.9 m -114.2 127.15 55.76 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.953 0.406 . . . . 61.219999999999999 110.268 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -95.73 111.21 23.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.773 -0.649 . . . . 60.229999999999997 110.121 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.6 p -88.29 99.31 8.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.839 0.828 . . . . 71.530000000000001 109.943 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.798 ' HB ' ' HB2' ' A' ' 92' ' ' LEU . 21.6 t -89.2 110.08 21.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 114.995 -1.002 . . . . 73.129999999999995 108.757 177.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.708 HG22 HD22 ' A' ' 108' ' ' LEU . 7.7 p -114.35 120.3 63.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 121.48 0.657 . . . . 73.140000000000001 110.869 -176.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.552 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 19.7 ttp180 -114.43 98.4 6.89 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.545 -0.752 . . . . 73.409999999999997 108.99 176.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.708 HD22 HG22 ' A' ' 106' ' ' VAL . 2.3 pt? -131.91 151.31 51.79 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.767 0.317 . . . . 71.129999999999995 111.027 -171.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.757 ' HB ' HG22 ' A' ' 5' ' ' VAL . 12.2 t -97.81 127.75 43.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.147 0.499 . . . . 74.209999999999994 110.756 179.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 115.303 -0.862 . . . . 75.040000000000006 109.38 -176.41 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.706 0 CA-C-O 120.73 0.072 . . . . 62.409999999999997 113.033 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.7 m -61.59 -11.11 9.88 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.603 0.964 . . . . 62.520000000000003 113.603 -172.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.16 -35.11 61.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.738 0.304 . . . . 75.230000000000004 111.545 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.42 -28.74 42.73 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.593 -0.813 . . . . 70.209999999999994 112.704 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.09 -40.65 98.28 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.706 0.261 . . . . 54.409999999999997 111.706 -176.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.3 p -67.67 -30.4 48.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.967 0.413 . . . . 72.230000000000004 110.73 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 48.0 mm -73.44 -33.88 41.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.06 0.457 . . . . 73.329999999999998 110.411 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.27 -19.88 65.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.959 -0.564 . . . . 65.530000000000001 111.373 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.58 ' HA ' ' NE ' ' A' ' 123' ' ' ARG . 5.6 mmp_? -77.7 -13.65 59.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.559 -0.291 . . . . 72.200000000000003 111.339 178.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 35.4 ttp . . . . . 0 C--N 1.331 -0.205 0 N-CA-C 109.955 -0.387 . . . . 72.140000000000001 109.955 176.394 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 . . . . . 0 C--O 1.234 0.284 0 CA-C-O 120.82 0.343 . . . . 73.019999999999996 110.24 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -49.5 -56.5 9.6 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.652 -0.704 . . . . 75.140000000000001 112.854 -174.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -66.36 -33.78 76.49 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.835 -0.346 . . . . 64.430000000000007 111.216 -172.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.755 HD22 ' HB3' ' A' ' 8' ' ' ASP . 4.3 mp -71.01 -43.84 67.11 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.522 -0.308 . . . . 72.340000000000003 111.054 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.5 ttp -60.07 -37.92 81.32 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.141 0.496 . . . . 74.109999999999999 110.006 174.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -65.74 -54.78 22.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.441 -0.799 . . . . 71.230000000000004 111.269 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.563 ' CE2' ' HA ' ' A' ' 137' ' ' LEU . 4.2 p90 -73.52 -29.8 62.7 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 120.078 -0.649 . . . . 74.310000000000002 110.911 -176.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 145' ' ' GLU . 60.5 tttm -55.43 -47.11 76.5 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.677 -0.49 . . . . 71.239999999999995 109.677 174.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.466 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 11.4 mmm180 -51.18 -52.18 46.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.903 -1.044 . . . . 74.230000000000004 111.609 176.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -70.55 -45.12 66.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.102 -0.499 . . . . 62.43 111.241 -176.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.904 ' HG3' HG21 ' A' ' 12' ' ' ILE . 5.0 tp-100 -63.12 -43.9 97.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.82 -0.627 . . . . 62.100000000000001 111.301 -177.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.65 ' HG3' HG23 ' A' ' 12' ' ' ILE . 3.0 tt0 -77.03 -23.0 52.13 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 112.212 0.449 . . . . 74.010000000000005 112.212 -177.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 0.7 OUTLIER -63.07 -57.45 10.6 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.809 -0.441 . . . . 72.319999999999993 109.809 -179.258 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.637 0 N-CA-C 111.449 -0.66 . . . . 53.140000000000001 111.449 -179.961 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.891 HG22 HG22 ' A' ' 109' ' ' THR . 86.0 t . . . . . 0 N--CA 1.445 -0.677 0 N-CA-C 110.029 -0.36 . . . . 73.099999999999994 110.029 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.2 m -114.23 142.56 26.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.198 0.523 . . . . 65.519999999999996 110.752 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -136.05 109.66 8.01 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.062 -0.718 . . . . 75.329999999999998 109.062 175.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.528 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 1.5 t70 -140.23 171.65 13.86 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.18 -0.674 . . . . 71.099999999999994 109.18 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.18 120.56 12.37 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.841 0.353 . . . . 65.340000000000003 110.575 -175.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.436 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 12.4 m -102.4 133.52 45.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.121 -0.49 . . . . 54.229999999999997 110.183 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.836 HG22 ' HB1' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -84.58 102.34 12.82 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.089 0.471 . . . . 72.340000000000003 110.275 -179.171 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.585 HG21 ' HG2' ' A' ' 144' ' ' GLN . 35.7 mm -107.47 138.91 31.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.752 -0.658 . . . . 72.230000000000004 111.272 -172.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.583 ' O ' ' HE3' ' A' ' 14' ' ' LYS . . . -85.58 39.9 3.02 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 121.358 -0.449 . . . . 74.340000000000003 113.541 -176.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.583 ' HE3' ' O ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -111.49 148.71 39.4 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.301 -0.629 . . . . 74.540000000000006 109.301 174.964 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.416 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 82.3 Cg_exo -50.52 -57.75 2.09 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.021 2.481 . . . . 72.450000000000003 114.0 -174.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' A' ' 19' ' ' LEU . . . 172.87 -63.48 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.582 0.551 . . . . 73.329999999999998 110.817 174.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.425 ' HG3' ' HB2' ' A' ' 71' ' ' PRO . 1.7 tm-20 -64.82 -34.73 79.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.962 -0.563 . . . . 73.239999999999995 110.648 -175.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.718 ' HB3' ' HG3' ' A' ' 27' ' ' PRO . 2.4 mp0 -63.41 -15.75 58.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.959 -0.564 . . . . 60.340000000000003 111.217 178.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' A' ' 16' ' ' ALA . 66.9 mt -75.1 -23.93 58.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.507 -0.315 . . . . 70.140000000000001 111.354 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.54 ' CE1' HG21 ' A' ' 75' ' ' ILE . 48.8 t80 -71.77 -27.25 62.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.183 0.516 . . . . 70.310000000000002 110.352 177.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.42 -7.11 34.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.847 -0.615 . . . . 53.299999999999997 111.52 -178.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.2 p -63.59 -22.3 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 116.412 -0.358 . . . . 64.540000000000006 110.365 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 47.3 t90 -60.27 -31.07 69.87 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.874 -0.603 . . . . 75.030000000000001 111.171 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 24' ' ' ARG . 22.2 mtm180 -94.91 -76.46 0.49 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.336 -0.393 . . . . 62.25 110.365 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -168.89 48.67 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.915 -0.772 . . . . 72.439999999999998 108.915 175.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.713 HD13 ' HA2' ' A' ' 147' ' ' GLY . 24.5 mt 67.56 161.1 0.14 Allowed Pre-proline 0 N--CA 1.468 0.458 0 CA-C-N 114.777 -1.101 . . . . 72.400000000000006 111.667 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.718 ' HG3' ' HB3' ' A' ' 18' ' ' GLN . 55.1 Cg_endo . . . . . 0 C--N 1.344 0.341 0 C-N-CA 122.483 2.122 . . . . 74.439999999999998 111.773 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.952 ' HA ' HD11 ' A' ' 80' ' ' LEU . . . . . . . . 0 CA--C 1.512 -0.488 0 CA-C-O 121.344 0.592 . . . . 72.010000000000005 110.151 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 1.04 ' HB3' ' HB2' ' A' ' 79' ' ' SER . 0.2 OUTLIER -161.71 145.11 12.35 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 107.167 -1.419 . . . . 73.129999999999995 107.167 -177.253 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.532 HD12 ' HA ' ' A' ' 77' ' ' TRP . 1.4 mm? -114.39 131.88 56.42 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.428 0.529 . . . . 72.530000000000001 112.428 -168.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.4 t -92.61 -31.56 15.12 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.834 -0.621 . . . . 64.340000000000003 110.601 177.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.517 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -116.32 126.77 53.99 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.864 -0.421 . . . . 72.540000000000006 109.864 177.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.529 ' O ' ' HD3' ' A' ' 71' ' ' PRO . 10.0 p-10 -130.66 38.61 3.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.835 -0.62 . . . . 73.510000000000005 110.548 -174.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.597 ' HB3' ' HB3' ' A' ' 73' ' ' LYS . 4.5 mm-40 -97.78 88.25 0.6 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.038 -0.528 . . . . 53.219999999999999 110.6 -176.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.529 ' HD3' ' O ' ' A' ' 69' ' ' ASP . 33.9 Cg_endo -61.93 -28.61 81.14 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.828 2.352 . . . . 71.219999999999999 113.114 -170.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -114.63 27.44 8.81 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.658 -0.782 . . . . 54.130000000000003 112.293 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.597 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 49.6 tptt -142.55 -61.46 0.44 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.627 0.251 . . . . 74.150000000000006 110.943 -178.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.546 ' H ' ' HB2' ' A' ' 70' ' ' GLU . 23.0 ptt180 -165.13 140.04 5.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.109 0.481 . . . . 54.25 110.472 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.737 HD13 ' HE2' ' A' ' 93' ' ' PHE . 3.5 mp -121.72 125.5 73.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.147 -0.479 . . . . 64.409999999999997 109.9 175.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.517 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -139.11 117.46 11.98 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.79 -0.818 . . . . 51.020000000000003 108.79 176.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.532 ' HA ' HD12 ' A' ' 66' ' ' LEU . 10.2 p90 -96.41 120.47 36.79 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.443 -0.503 . . . . 72.409999999999997 111.263 -174.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.513 ' HG3' ' O ' ' A' ' 77' ' ' TRP . 17.2 mtt85 174.31 127.68 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 O-C-N 124.339 1.024 . . . . 72.430000000000007 112.833 173.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 1.04 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 50.2 m -150.63 -32.35 0.18 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.757 -0.656 . . . . 72.239999999999995 109.954 167.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.952 HD11 ' HA ' ' A' ' 64' ' ' ALA . 3.9 mp -46.78 144.0 3.92 Favored Pre-proline 0 C--O 1.234 0.265 0 N-CA-C 113.125 0.787 . . . . 74.310000000000002 113.125 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -77.59 -17.48 14.29 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 123.438 2.759 . . . . 61.43 113.661 -175.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.41 -14.71 12.44 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.479 -0.867 . . . . 71.409999999999997 112.31 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.682 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . . . -90.32 17.38 7.27 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.826 0.346 . . . . 65.230000000000004 111.826 -173.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -92.27 6.64 46.03 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.41 0.522 . . . . 74.549999999999997 112.41 -173.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.3 tt -67.59 116.39 7.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 107.806 -1.183 . . . . 75.329999999999998 107.806 168.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 13.0 pt-20 -77.69 81.01 4.14 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 114.779 1.4 . . . . 64.430000000000007 114.779 -160.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -84.77 129.23 34.85 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 104.601 -2.37 . . . . 71.430000000000007 104.601 151.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.0 t -94.66 135.56 35.98 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 118.913 -1.115 . . . . 74.209999999999994 112.145 -161.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -139.05 41.41 1.35 Allowed Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 114.895 -1.048 . . . . 53.140000000000001 111.074 177.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -102.43 113.67 27.2 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.525 -0.546 . . . . 75.349999999999994 109.525 177.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.4 m -115.33 132.42 64.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.993 -0.549 . . . . 74.140000000000001 110.77 -177.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.6 mp -108.5 130.49 55.26 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.049 -0.523 . . . . 52.43 110.605 178.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.737 ' HE2' HD13 ' A' ' 75' ' ' ILE . 63.3 m-85 -108.9 123.69 49.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.05 0.453 . . . . 73.140000000000001 110.332 178.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.568 ' NH1' HG21 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -141.27 152.07 63.25 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.94 -0.573 . . . . 74.030000000000001 110.176 177.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -52.38 126.86 21.9 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.852 2.368 . . . . 41.130000000000003 111.639 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.836 ' HB1' HG22 ' A' ' 11' ' ' THR . . . -92.44 143.17 26.88 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.101 -0.499 . . . . 72.400000000000006 111.444 -176.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -71.44 166.04 30.6 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.828 2.352 . . . . 61.039999999999999 112.39 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 68.31 17.87 70.79 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.085 -0.579 . . . . 64.030000000000001 112.344 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 55.56 27.89 11.05 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 122.733 0.413 . . . . 54.109999999999999 111.2 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 58.6 mtt-85 -78.86 -9.76 59.58 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.381 -0.372 . . . . 61.329999999999998 111.899 -175.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 119.32 -109.55 1.71 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.205 -0.998 . . . . 43.450000000000003 112.445 176.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.44 ' HB ' HD11 ' A' ' 19' ' ' LEU . 23.8 m -125.71 133.95 51.96 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.08 0.467 . . . . 75.109999999999999 111.18 -178.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.464 ' HB3' ' HG2' ' A' ' 94' ' ' ARG . 37.1 tt0 -87.28 105.05 16.97 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.62 -0.718 . . . . 75.340000000000003 109.347 175.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.0 p -89.2 103.3 13.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.864 0.84 . . . . 74.349999999999994 109.705 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.568 HG21 ' NH1' ' A' ' 94' ' ' ARG . 27.3 t -89.01 112.89 24.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.694 -1.139 . . . . 74.299999999999997 109.855 -177.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.407 ' CG1' HD23 ' A' ' 108' ' ' LEU . 46.8 t -116.12 116.52 52.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.626 -0.716 . . . . 73.239999999999995 111.345 -174.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -97.19 113.8 25.44 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.796 -1.187 . . . . 75.209999999999994 107.796 169.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.44 HD12 ' CD1' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -123.0 125.36 45.1 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.687 0.279 . . . . 74.310000000000002 110.364 -173.502 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.891 HG22 HG22 ' A' ' 5' ' ' VAL . 17.1 p -105.18 116.94 32.8 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.94 -0.393 . . . . 54.020000000000003 109.94 173.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.44 ' CD1' HD12 ' A' ' 108' ' ' LEU . 6.7 p90 . . . . . 0 C--N 1.322 -0.591 0 CA-C-N 115.76 -0.655 . . . . 70.040000000000006 109.802 -176.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.631 0 CA-C-O 120.454 -0.081 . . . . 44.329999999999998 113.049 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.6 t -62.96 -49.08 76.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.803 0.335 . . . . 73.319999999999993 111.176 -172.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.462 ' HA ' HG22 ' A' ' 120' ' ' VAL . . . -61.78 -30.72 70.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 43.350000000000001 111.042 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.72 -22.35 73.54 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.975 -0.631 . . . . 74.450000000000003 112.356 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.07 -40.28 17.0 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.766 0.317 . . . . 62.119999999999997 111.058 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 117' ' ' ALA . 33.3 m -74.71 -32.92 29.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 111.939 0.348 . . . . 74.099999999999994 111.939 -175.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.464 ' HA ' ' HG2' ' A' ' 124' ' ' MET . 37.3 pt -69.71 -23.97 26.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.895 0.378 . . . . 74.310000000000002 110.882 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.0 -21.04 60.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.957 -0.565 . . . . 30.210000000000001 110.912 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -86.27 -43.36 13.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.055 0.455 . . . . 75.409999999999997 110.555 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.464 ' HG2' ' HA ' ' A' ' 121' ' ' ILE . 23.6 ptp . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 73.519999999999996 111.238 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.553 ' O ' ' HG2' ' A' ' 138' ' ' MET . 8.4 mpt_? . . . . . 0 N--CA 1.463 0.178 0 N-CA-C 109.656 -0.498 . . . . 75.239999999999995 109.656 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -48.82 -49.79 37.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.958 -1.019 . . . . 74.049999999999997 112.393 -172.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -67.77 -39.71 84.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.899 0.38 . . . . 72.420000000000002 111.548 -176.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.528 ' CD2' ' HB3' ' A' ' 8' ' ' ASP . 12.6 tp -79.67 -20.92 45.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.469 -0.332 . . . . 73.349999999999994 110.858 -175.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.553 ' HG2' ' O ' ' A' ' 134' ' ' ARG . 24.2 mmt -69.18 -44.01 73.07 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.652 0.263 . . . . 72.319999999999993 111.096 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.406 ' HD2' ' SD ' ' A' ' 124' ' ' MET . 89.8 mtm-85 -64.55 -42.64 95.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.956 0.408 . . . . 71.420000000000002 110.322 178.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -59.84 -45.47 92.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.278 -0.874 . . . . 71.420000000000002 110.152 176.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 39.5 tttp -58.05 -51.47 69.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.884 -0.598 . . . . 73.209999999999994 111.632 177.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 -56.61 -40.87 76.09 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.067 -0.515 . . . . 71.299999999999997 111.805 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -79.22 -36.06 40.69 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.668 -0.413 . . . . 74.129999999999995 110.764 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.653 ' HA ' HD21 ' A' ' 26' ' ' LEU . 61.4 tt0 -63.41 -43.57 97.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 74.310000000000002 111.42 -176.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.514 ' HB3' HG23 ' A' ' 12' ' ' ILE . 12.1 pt-20 -77.21 -24.06 51.34 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 120.83 -0.348 . . . . 74.219999999999999 111.023 -179.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 62.2 tp -66.27 -61.39 2.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.294 -0.412 . . . . 73.219999999999999 110.088 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.713 ' HA2' HD13 ' A' ' 26' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.41 0 C-N-CA 120.828 -0.701 . . . . 71.219999999999999 111.618 -177.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.449 -0.507 0 N-CA-C 109.37 -0.604 . . . . 72.319999999999993 109.37 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.729 ' HB ' ' CE1' ' A' ' 110' ' ' TYR . 12.2 p -118.35 140.18 42.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.139 0.495 . . . . 61.219999999999999 110.515 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.567 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -136.32 109.73 7.91 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.542 -0.911 . . . . 64.319999999999993 108.542 172.152 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.544 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 4.2 t70 -132.17 171.38 13.73 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.653 -0.869 . . . . 72.040000000000006 108.653 -178.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.709 ' HB2' HG12 ' A' ' 105' ' ' VAL . . . -141.17 121.96 14.39 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.114 0.483 . . . . 73.150000000000006 111.366 -173.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.477 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 14.3 m -111.9 136.62 47.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.727 -0.67 . . . . 44.140000000000001 109.915 176.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.8 m -88.75 107.41 18.94 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.291 -0.413 . . . . 75.340000000000003 110.06 -178.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.563 HG23 ' HB3' ' A' ' 145' ' ' GLU . 14.2 mm -105.84 132.68 52.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.233 -0.44 . . . . 73.049999999999997 110.52 -176.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.94 58.03 4.94 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.912 -0.661 . . . . 73.439999999999998 112.584 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.638 ' HB2' HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -132.28 153.12 81.15 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 108.361 -0.977 . . . . 63.030000000000001 108.361 175.827 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.432 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 10.5 Cg_endo -54.6 -58.74 1.1 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.714 2.276 . . . . 73.519999999999996 113.692 -172.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . 172.16 -54.1 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.283 0.564 . . . . 65.450000000000003 110.808 175.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -55.5 -43.89 76.05 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.111 -0.95 . . . . 74.510000000000005 112.256 -174.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.591 ' HA ' ' HB3' ' A' ' 21' ' ' ALA . 2.7 mp0 -79.18 -8.32 58.91 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.043 -0.526 . . . . 72.209999999999994 111.172 -174.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.638 HD21 ' HB2' ' A' ' 14' ' ' LYS . 77.8 mt -73.95 -50.73 18.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.028 -0.533 . . . . 70.540000000000006 111.057 178.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.71 ' HB3' ' HZ ' ' A' ' 93' ' ' PHE . 17.1 p90 -74.37 -24.06 59.09 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.784 -0.766 . . . . 73.140000000000001 109.487 176.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.591 ' HB3' ' HA ' ' A' ' 18' ' ' GLN . . . -71.39 -2.98 18.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.278 -0.874 . . . . 74.030000000000001 111.107 176.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.679 HG11 ' HZ ' ' A' ' 140' ' ' PHE . 9.9 p -54.49 -21.57 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.049 -0.523 . . . . 74.019999999999996 111.029 176.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 15.5 t90 -60.14 -22.71 63.19 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.993 -0.549 . . . . 54.439999999999998 110.693 177.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -109.3 2.12 20.58 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.097 -0.501 . . . . 65.310000000000002 110.035 177.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.0 t70 55.54 80.35 0.14 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.899 -0.591 . . . . 73.549999999999997 110.87 -176.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.455 ' HA ' ' HD2' ' A' ' 27' ' ' PRO . 68.5 mt 45.18 85.6 0.16 Allowed Pre-proline 0 N--CA 1.47 0.547 0 CA-C-N 115.544 -0.753 . . . . 74.129999999999995 111.998 -178.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 26' ' ' LEU . 10.9 Cg_endo . . . . . 0 C--N 1.344 0.313 0 C-N-CA 123.63 2.887 . . . . 64.319999999999993 113.336 -173.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.397 0 N-CA-C 108.918 -0.771 . . . . 42.329999999999998 108.918 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.621 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -108.56 134.64 51.04 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.429 -0.952 . . . . 74.010000000000005 108.429 -175.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -113.83 116.63 29.63 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 121.846 -0.534 . . . . 74.329999999999998 110.294 -176.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.449 HG23 ' HB3' ' A' ' 76' ' ' ALA . 7.1 t -78.26 -26.03 47.04 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.627 -0.429 . . . . 71.140000000000001 111.568 -174.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . . . -147.42 129.61 15.59 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.767 0.318 . . . . 75.430000000000007 110.368 176.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -132.23 7.93 4.3 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.098 -0.501 . . . . 72.239999999999995 111.424 -175.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -59.18 93.41 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 123.94 0.896 . . . . 72.150000000000006 112.486 -173.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -59.74 114.16 1.94 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.314 2.676 . . . . 74.409999999999997 112.642 -169.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.53 6.37 70.66 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.84 -0.695 . . . . 72.430000000000007 112.519 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -123.91 -67.94 0.9 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.002 -0.37 . . . . 73.329999999999998 110.002 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.427 ' C ' HD12 ' A' ' 75' ' ' ILE . 15.4 ptt180 -150.6 134.9 17.05 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.983 -0.377 . . . . 74.430000000000007 109.983 175.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.621 HD13 ' HE2' ' A' ' 93' ' ' PHE . 3.5 mp -126.73 126.52 68.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 109.183 -0.673 . . . . 72.319999999999993 109.183 177.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.597 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . . . -139.59 120.57 14.57 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.969 -0.559 . . . . 71.209999999999994 110.559 -176.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 13.3 m-90 -98.04 152.17 19.57 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.78 -0.646 . . . . 73.329999999999998 110.483 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.621 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 1.0 OUTLIER -156.16 175.68 13.66 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.682 -0.858 . . . . 75.010000000000005 108.682 175.625 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 1.053 ' HB2' ' HA ' ' A' ' 85' ' ' ILE . 20.3 m -105.91 -171.07 1.83 Allowed 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 109.672 -0.492 . . . . 71.209999999999994 109.672 176.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.6 mt -82.79 144.88 49.11 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.631 -0.259 . . . . 72.420000000000002 111.075 -175.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.94 -32.36 95.0 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.601 2.2 . . . . 64.230000000000004 111.436 173.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.97 35.83 3.86 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.482 -0.647 . . . . 43.240000000000002 111.482 175.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -155.01 -173.94 4.78 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.654 -0.498 . . . . 34.43 109.654 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -80.38 101.62 9.11 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.591 -0.522 . . . . 73.540000000000006 109.591 172.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 1.053 ' HA ' ' HB2' ' A' ' 79' ' ' SER . 0.0 OUTLIER -70.04 -51.37 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 116.175 -0.466 . . . . 75.299999999999997 109.777 -179.071 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 47.78 -83.25 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.371 1.068 . . . . 55.43 113.608 175.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -64.69 132.51 49.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.588 0.709 . . . . 54.530000000000001 111.52 -175.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.1 m -139.5 128.73 23.95 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.537 -0.756 . . . . 62.109999999999999 109.548 176.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.25 145.15 9.16 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.716 -0.754 . . . . 62.310000000000002 112.064 -178.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.597 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 43.4 tt0 -138.57 125.61 21.31 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.077 -0.342 . . . . 65.140000000000001 110.077 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.1 m -106.75 128.07 61.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.121 0.486 . . . . 64.209999999999994 110.223 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.671 ' HB2' HG23 ' A' ' 105' ' ' VAL . 9.1 mp -110.53 145.7 37.3 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.463 -0.569 . . . . 65.420000000000002 109.463 173.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.71 ' HZ ' ' HB3' ' A' ' 20' ' ' TYR . 73.9 m-85 -110.07 106.72 16.32 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.094 0.473 . . . . 65.140000000000001 111.104 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.411 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 99.8 mtt180 -112.3 142.87 27.74 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.304 -0.628 . . . . 74.5 109.304 175.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 94' ' ' ARG . 9.2 Cg_exo -72.16 125.19 10.63 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.421 2.08 . . . . 75.120000000000005 111.327 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.89 144.51 98.86 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.239 -0.652 . . . . 62.140000000000001 109.239 176.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -39.32 119.64 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.623 2.882 . . . . 75.450000000000003 113.622 -174.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 90.82 8.97 64.69 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.011 -0.614 . . . . 54.509999999999998 112.642 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 59.01 36.04 24.24 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.201 0.524 . . . . 74.329999999999998 110.427 -178.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -73.79 -65.42 0.83 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.672 -0.695 . . . . 61.340000000000003 110.458 -178.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -131.78 -167.85 11.97 Favored Glycine 0 N--CA 1.439 -1.127 0 N-CA-C 110.512 -1.035 . . . . 72.140000000000001 110.512 176.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.482 ' HB ' HD11 ' A' ' 19' ' ' LEU . 10.7 m -110.45 122.71 48.38 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.023 0.439 . . . . 73.099999999999994 110.182 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.511 ' HG2' ' HB1' ' A' ' 9' ' ' ALA . 41.3 tt0 -92.4 106.5 18.48 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.455 -0.943 . . . . 75.409999999999997 108.455 178.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 5.2 m -86.72 128.88 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 CA-C-O 121.393 0.615 . . . . 70.0 109.506 -177.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.709 HG12 ' HB2' ' A' ' 9' ' ' ALA . 3.5 m -108.95 114.98 48.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.521 -0.763 . . . . 65.209999999999994 109.797 178.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 40.1 t -110.02 119.12 58.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.828 -0.623 . . . . 64.310000000000002 111.377 -173.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -107.06 116.48 32.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.633 -0.712 . . . . 71.030000000000001 109.739 175.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.5 pp -147.0 151.69 37.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.934 0.397 . . . . 75.530000000000001 111.085 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.1 t -90.09 144.85 25.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.93 -0.577 . . . . 74.540000000000006 110.18 178.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.729 ' CE1' ' HB ' ' A' ' 6' ' ' VAL . 5.7 p90 . . . . . 0 C--N 1.326 -0.449 0 N-CA-C 109.921 -0.4 . . . . 54.299999999999997 109.921 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.567 0 N-CA-C 112.342 -0.303 . . . . 55.32 112.342 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 38.0 t -86.29 -23.73 26.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.988 0.423 . . . . 55.109999999999999 110.572 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -68.41 -29.09 67.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.146 -0.479 . . . . 72.299999999999997 111.641 -174.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.456 ' O ' HG22 ' A' ' 121' ' ' ILE . . . -69.73 -19.68 75.18 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.098 -0.572 . . . . 44.340000000000003 113.041 -178.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.26 -20.34 65.99 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.307 0.484 . . . . 62.200000000000003 112.307 -174.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.57 -19.48 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.785 0.326 . . . . 73.219999999999999 111.723 -176.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.456 HG22 ' O ' ' A' ' 118' ' ' GLY . 13.8 tt -67.62 -22.64 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 121.032 0.444 . . . . 70.510000000000005 110.967 -177.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.54 -20.85 63.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.269 -0.423 . . . . 61.420000000000002 111.191 -178.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -71.03 -28.93 64.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.057 -0.52 . . . . 72.230000000000004 110.776 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.5 ttm . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 74.439999999999998 111.153 -175.358 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.549 ' O ' ' HG2' ' A' ' 138' ' ' MET . 51.0 mtp180 . . . . . 0 C--O 1.232 0.161 0 N-CA-C 109.061 -0.718 . . . . 74.209999999999994 109.061 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -57.22 -38.6 73.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.882 -1.054 . . . . 72.010000000000005 112.996 -171.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.48 -42.57 98.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.889 0.376 . . . . 60.229999999999997 110.889 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.544 ' CD2' ' HB3' ' A' ' 8' ' ' ASP . 13.9 tp -79.4 -20.95 46.37 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.254 -0.43 . . . . 71.430000000000007 110.112 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.549 ' HG2' ' O ' ' A' ' 134' ' ' ARG . 30.4 mmt -69.48 -47.51 63.68 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.307 -0.406 . . . . 60.420000000000002 110.268 175.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.07 -43.28 99.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.094 -0.503 . . . . 71.319999999999993 110.092 174.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.679 ' HZ ' HG11 ' A' ' 22' ' ' VAL . 67.8 t80 -57.22 -48.9 77.64 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.228 -0.897 . . . . 75.120000000000005 111.004 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.8 tttp -54.81 -56.23 21.63 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.185 -0.462 . . . . 75.109999999999999 111.727 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -55.49 -42.82 74.94 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.821 0.343 . . . . 62.350000000000001 111.737 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -75.49 -27.44 58.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.486 -0.325 . . . . 60.130000000000003 111.4 -178.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -80.94 -39.13 26.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.056 -0.52 . . . . 74.439999999999998 111.216 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.563 ' HB3' HG23 ' A' ' 12' ' ' ILE . 16.9 pt-20 -80.57 -36.85 32.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.55 -0.296 . . . . 73.349999999999994 111.495 -176.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.1 tt -71.79 -63.01 1.21 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.781 -0.452 . . . . 75.109999999999999 109.781 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.442 ' HA3' HD11 ' A' ' 26' ' ' LEU . . . . . . . . 0 N--CA 1.449 -0.466 0 CA-C-N 115.652 -0.704 . . . . 72.329999999999998 113.486 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.448 -0.558 0 N-CA-C 109.145 -0.687 . . . . 64.510000000000005 109.145 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 71.4 t -101.16 116.76 45.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 121.303 0.573 . . . . 71.209999999999994 110.881 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -132.21 109.84 10.22 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.981 -1.008 . . . . 75.409999999999997 108.638 176.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.485 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 1.3 t70 -141.47 146.15 36.11 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.836 -1.172 . . . . 52.439999999999998 107.836 175.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -122.8 140.25 53.13 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.135 0.493 . . . . 62.340000000000003 110.982 -173.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.605 ' CG2' ' HG2' ' A' ' 141' ' ' LYS . 2.5 m -133.85 142.28 41.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.47 -0.786 . . . . 74.519999999999996 110.469 -176.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 29.7 m -94.0 133.7 37.17 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.975 -0.557 . . . . 72.129999999999995 111.125 -175.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.808 HD11 ' HG3' ' A' ' 141' ' ' LYS . 35.3 mt -121.38 140.15 46.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.654 -0.703 . . . . 72.120000000000005 109.917 172.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.538 ' H ' ' HB3' ' A' ' 145' ' ' GLU . . . -83.31 62.35 4.64 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.991 -0.624 . . . . 74.430000000000007 112.555 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.566 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 7.4 mmpt? -144.59 144.8 26.13 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 109.183 -0.673 . . . . 73.329999999999998 109.183 175.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.408 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 72.8 Cg_exo -51.81 -56.3 3.09 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.25 2.633 . . . . 72.519999999999996 113.945 -176.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . 174.51 -63.11 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.686 0.279 . . . . 74.310000000000002 110.836 177.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -50.23 -42.57 51.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.553 -0.749 . . . . 73.040000000000006 111.428 -176.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.598 ' HG3' ' HD2' ' A' ' 27' ' ' PRO . 2.6 mp0 -61.61 -23.55 66.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.727 -0.67 . . . . 62.409999999999997 111.863 -177.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.6 mt -77.8 -34.32 52.21 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.95 0.352 . . . . 61.409999999999997 111.95 -176.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -71.73 -28.07 63.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.644 0.735 . . . . 63.450000000000003 109.421 177.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.22 -2.69 32.52 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 114.901 -1.045 . . . . 73.430000000000007 112.385 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.829 HG21 ' HZ ' ' A' ' 140' ' ' PHE . 10.9 p -53.01 -22.56 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 113.042 0.756 . . . . 63.219999999999999 113.042 -174.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 23.2 m0 -63.18 -14.1 44.99 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.703 0.631 . . . . 74.340000000000003 112.703 -176.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.463 ' HD3' ' HA ' ' A' ' 24' ' ' ARG . 25.8 mmt180 -121.84 -80.15 0.62 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.407 -0.183 . . . . 75.219999999999999 110.624 175.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 26' ' ' LEU . 8.3 t70 -172.19 53.63 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.549 -0.537 . . . . 74.129999999999995 109.549 176.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 9.1 mp 66.37 165.89 0.12 Allowed Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 115.409 -0.814 . . . . 50.219999999999999 110.771 -178.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.598 ' HD2' ' HG3' ' A' ' 18' ' ' GLN . 35.4 Cg_exo . . . . . 0 C--N 1.347 0.45 0 C-N-CA 122.38 2.053 . . . . 73.329999999999998 111.781 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.468 ' HB1' ' O ' ' A' ' 78' ' ' ARG . . . . . . . . 0 N--CA 1.446 -0.636 0 N-CA-C 108.582 -0.895 . . . . 63.520000000000003 108.582 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.574 ' HB2' ' HA ' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -108.05 133.97 51.6 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.986 -1.116 . . . . 65.140000000000001 107.986 177.01 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.542 ' CD2' ' HB3' ' A' ' 69' ' ' ASP . 40.1 tp -105.49 117.81 34.96 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.651 -0.82 . . . . 74.329999999999998 110.713 -169.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.8 t -93.32 -13.86 27.63 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.003 -0.544 . . . . 43.130000000000003 111.126 -175.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.464 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -147.25 125.16 11.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.952 0.406 . . . . 73.019999999999996 110.806 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.542 ' HB3' ' CD2' ' A' ' 66' ' ' LEU . 4.1 p-10 -140.19 40.5 1.94 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.498 -0.774 . . . . 72.439999999999998 109.835 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -60.03 144.96 85.9 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.078 -0.964 . . . . 75.549999999999997 109.919 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -47.25 -41.34 27.84 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.826 3.017 . . . . 73.109999999999999 113.451 -173.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -166.57 33.26 0.22 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.352 -0.928 . . . . 60.130000000000003 112.215 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -97.21 -63.46 1.13 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.164 0.507 . . . . 71.420000000000002 110.523 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 74' ' ' ARG . 3.5 ptp85 -161.51 140.84 10.1 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.758 -0.83 . . . . 71.439999999999998 108.758 177.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 68.5 mt -121.99 109.81 25.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 109.412 -0.588 . . . . 64.319999999999993 109.412 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.637 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . . . -111.34 115.32 29.1 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.975 -0.557 . . . . 75.510000000000005 110.499 -177.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 23.5 p-90 -96.1 124.09 39.97 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.921 0.867 . . . . 73.310000000000002 110.086 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.468 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 30.9 mmt180 -113.67 176.15 5.15 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.353 -1.351 . . . . 63.409999999999997 107.353 178.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.866 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 16.5 m -99.12 163.98 12.35 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 118.839 -1.144 . . . . 73.349999999999994 110.187 174.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.647 ' H ' HD12 ' A' ' 80' ' ' LEU . 4.4 mp -69.55 161.5 73.62 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.885 -0.598 . . . . 64.200000000000003 110.784 -176.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.14 -40.82 75.81 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.769 2.313 . . . . 62.530000000000001 112.252 177.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.0 -20.86 58.56 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.786 -0.721 . . . . 73.5 112.327 178.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.428 ' HA ' ' NH1' ' A' ' 84' ' ' ARG . . . -82.38 167.31 18.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.749 0.309 . . . . 74.319999999999993 110.728 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.428 ' NH1' ' HA ' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -82.16 104.71 12.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.003 0.43 . . . . 62.310000000000002 110.507 -176.639 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.866 ' HB ' ' HB2' ' A' ' 79' ' ' SER . 6.8 tt -117.44 116.81 53.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.867 -0.606 . . . . 51.409999999999997 110.517 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -153.55 -42.15 0.09 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.052 -0.522 . . . . 52.340000000000003 109.961 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -77.18 154.17 33.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.123 -0.489 . . . . 73.230000000000004 110.166 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.4 m -96.13 127.64 42.32 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.363 -0.381 . . . . 63.119999999999997 110.65 -178.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -122.49 61.53 0.55 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.942 -0.647 . . . . 54.340000000000003 111.524 177.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.637 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 39.3 tt0 -102.69 121.97 43.51 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 122.627 -0.337 . . . . 71.230000000000004 110.661 -176.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.675 HG22 HG22 ' A' ' 106' ' ' VAL . 83.0 t -112.79 122.03 66.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.273 0.558 . . . . 74.420000000000002 110.684 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.906 ' HB2' ' HB ' ' A' ' 105' ' ' VAL . 10.1 mp -96.19 142.34 28.48 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.597 -0.729 . . . . 62.109999999999999 110.104 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -121.55 115.9 23.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.152 -0.476 . . . . 74.329999999999998 110.164 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.413 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 34.9 ptt180 -141.08 144.65 35.75 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.318 -0.401 . . . . 75.540000000000006 110.567 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 94' ' ' ARG . 45.0 Cg_exo -56.67 134.72 66.21 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.679 2.253 . . . . 70.549999999999997 111.932 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -94.61 145.04 28.93 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.996 -0.547 . . . . 75.150000000000006 111.706 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -54.12 151.33 28.46 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.088 2.525 . . . . 73.140000000000001 112.361 175.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.49 -0.89 79.42 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.72 -0.753 . . . . 51.32 111.251 -178.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 59.57 33.93 22.24 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 122.8 0.44 . . . . 53.009999999999998 111.031 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -64.09 -42.89 96.76 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.19 0.519 . . . . 71.510000000000005 110.419 176.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 162.24 -122.37 1.1 Allowed Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 115.46 -0.791 . . . . 73.329999999999998 111.421 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 39.3 m -128.72 135.09 48.76 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.564 0.697 . . . . 73.219999999999999 111.003 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -90.88 131.27 36.62 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.867 -1.061 . . . . 72.019999999999996 110.181 -178.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.454 HG22 HG23 ' A' ' 10' ' ' VAL . 17.9 m -87.41 131.58 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 108.164 -1.05 . . . . 62.130000000000003 108.164 173.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.906 ' HB ' ' HB2' ' A' ' 92' ' ' LEU . 44.3 t -123.1 111.49 29.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 116.022 -0.536 . . . . 74.010000000000005 110.391 -174.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.675 HG22 HG22 ' A' ' 91' ' ' VAL . 37.9 t -128.29 121.2 55.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.405 -0.361 . . . . 64.109999999999999 111.12 -177.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.578 ' O ' ' HD2' ' A' ' 107' ' ' ARG . 0.4 OUTLIER -107.05 108.83 20.51 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.278 0.561 . . . . 71.200000000000003 109.816 170.6 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 50.1 tp -114.19 142.82 45.76 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.032 -0.531 . . . . 55.32 110.847 -175.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.8 t -93.95 142.33 27.51 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.006 -0.543 . . . . 74.209999999999994 110.498 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 . . . . . 0 C--N 1.322 -0.592 0 CA-C-N 115.934 -0.575 . . . . 71.140000000000001 110.234 177.874 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.846 0 N-CA-C 112.472 -0.251 . . . . 75.530000000000001 112.472 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.3 t -78.96 -26.97 43.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.51 0.195 . . . . 63.350000000000001 111.36 -175.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.65 -34.6 71.39 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.563 0.22 . . . . 61.310000000000002 111.448 -176.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.69 -31.82 76.89 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.922 -0.656 . . . . 73.230000000000004 112.397 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.96 -38.21 37.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.843 0.354 . . . . 63.329999999999998 110.588 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 93.4 t -61.32 -50.0 82.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.916 -0.584 . . . . 74.209999999999994 110.954 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.6 tp -65.8 -34.13 68.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 70.109999999999999 110.808 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.31 -37.11 84.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.443 -0.344 . . . . 50.420000000000002 111.192 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 70.2 ttp85 -68.33 -48.12 65.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.32 -0.4 . . . . 64.129999999999995 110.935 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 27.2 ptm . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.437 -0.347 . . . . 71.049999999999997 111.154 -177.282 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 109.771 -0.455 . . . . 73.239999999999995 109.771 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -60.7 -55.33 34.56 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.615 -0.72 . . . . 54.409999999999997 110.455 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -66.48 -30.84 71.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.16 0.505 . . . . 60.32 110.347 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.666 ' O ' ' HD3' ' A' ' 141' ' ' LYS . 43.5 tp -65.12 -48.24 74.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.616 -0.72 . . . . 72.450000000000003 110.167 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.415 ' CE ' ' HA ' ' A' ' 138' ' ' MET . 3.1 tpt -75.03 -35.12 61.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.494 -0.321 . . . . 74.540000000000006 110.692 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.9 ttm-85 -52.67 -54.8 28.39 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.969 -0.56 . . . . 73.510000000000005 111.124 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.829 ' HZ ' HG21 ' A' ' 22' ' ' VAL . 54.1 t80 -67.8 -46.05 73.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.799 -0.637 . . . . 65.310000000000002 111.625 -177.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.808 ' HG3' HD11 ' A' ' 12' ' ' ILE . 14.0 mptt -64.75 -35.04 79.8 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 111.94 0.348 . . . . 73.129999999999995 111.94 -173.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.432 ' HD3' ' HA ' ' A' ' 142' ' ' ARG . 16.7 mmt180 -66.32 -31.64 72.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.606 0.241 . . . . 64.450000000000003 111.308 177.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -79.67 -35.76 38.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.942 0.401 . . . . 75.150000000000006 110.443 176.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.406 ' HG2' HD13 ' A' ' 12' ' ' ILE . 6.0 tp60 -59.06 -44.06 91.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.851 -0.613 . . . . 72.129999999999995 111.529 178.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.538 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 7.9 pt-20 -72.82 -14.71 61.57 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.556 -0.458 . . . . 72.519999999999996 111.266 -178.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.88 -25.65 59.11 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.333 -0.618 . . . . 63.520000000000003 109.333 177.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.569 0 CA-C-N 115.668 -0.696 . . . . 41.109999999999999 112.439 176.704 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.628 HG22 ' HA ' ' A' ' 109' ' ' THR . 41.0 t . . . . . 0 N--CA 1.446 -0.674 0 N-CA-C 108.556 -0.905 . . . . 53.439999999999998 108.556 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 107' ' ' ARG . 10.6 p -80.11 141.63 15.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.516 -0.766 . . . . 72.299999999999997 111.82 -168.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.598 ' HG2' ' HB2' ' A' ' 107' ' ' ARG . 2.8 tmm_? -134.74 116.61 15.07 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.368 -0.605 . . . . 74.140000000000001 109.368 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' HB3' HD23 ' A' ' 137' ' ' LEU . 4.8 t70 -144.71 173.05 12.17 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.709 -0.848 . . . . 72.349999999999994 108.709 173.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.824 ' HB2' HG12 ' A' ' 105' ' ' VAL . . . -134.47 126.59 29.75 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.133 0.492 . . . . 71.040000000000006 112.012 -171.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.486 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 36.0 m -121.66 134.23 65.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.793 -0.639 . . . . 64.439999999999998 109.956 176.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 t -110.08 123.38 49.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.688 0.756 . . . . 44.25 111.011 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.634 ' HB ' HD21 ' A' ' 19' ' ' LEU . 4.7 mp -118.71 151.04 20.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.768 -1.105 . . . . 70.230000000000004 109.712 -178.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.85 20.63 1.05 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 114.005 0.362 . . . . 42.049999999999997 114.005 -177.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.82 ' HE3' HD23 ' A' ' 19' ' ' LEU . 49.3 mtmt -89.95 144.07 30.93 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.197 -0.668 . . . . 62.299999999999997 109.197 173.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 95.0 Cg_exo -45.69 -57.96 1.89 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.977 2.451 . . . . 63.219999999999999 113.822 -174.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . 173.21 -58.24 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.578 0.704 . . . . 53.210000000000001 110.911 177.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -55.83 -36.75 67.82 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.456 -1.247 . . . . 63.219999999999999 112.247 -171.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.545 ' CG ' ' HD2' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -87.65 -5.33 58.76 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.132 -0.485 . . . . 60.549999999999997 111.853 -175.06 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.82 HD23 ' HE3' ' A' ' 14' ' ' LYS . 59.9 mt -68.56 -48.13 65.05 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.963 -0.295 . . . . 70.140000000000001 111.081 176.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.831 ' HB3' ' HZ ' ' A' ' 93' ' ' PHE . 1.1 p90 -73.15 -24.55 60.59 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.469 -0.493 . . . . 71.420000000000002 110.372 -177.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.56 -2.99 31.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.575 -0.738 . . . . 70.329999999999998 111.862 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.781 HG11 ' HZ ' ' A' ' 140' ' ' PHE . 14.8 p -54.2 -22.05 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 112.843 0.683 . . . . 54.100000000000001 112.843 -175.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 -68.48 -9.82 51.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.881 0.372 . . . . 75.209999999999994 111.11 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.844 ' HG2' ' H ' ' A' ' 25' ' ' ASP . 47.1 ttt180 -137.04 179.27 6.48 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.61 -0.515 . . . . 70.319999999999993 109.61 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.844 ' H ' ' HG2' ' A' ' 24' ' ' ARG . 0.8 OUTLIER -63.39 12.58 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.072 1.349 . . . . 74.200000000000003 112.873 177.511 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.475 ' H ' ' C ' ' A' ' 24' ' ' ARG . 41.2 mt 65.43 86.09 0.14 Allowed Pre-proline 0 N--CA 1.467 0.38 0 CA-C-O 121.184 0.516 . . . . 60.299999999999997 109.628 -176.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.842 ' HG3' ' HD3' ' A' ' 24' ' ' ARG . 33.2 Cg_exo . . . . . 0 C--N 1.342 0.234 0 C-N-CA 123.71 2.94 . . . . 74.140000000000001 114.031 -169.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 109.881 -0.415 . . . . 73.099999999999994 109.881 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.22 135.73 51.32 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.736 0.303 . . . . 74.329999999999998 110.571 179.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.479 ' HG ' ' HA ' ' A' ' 77' ' ' TRP . 10.5 mp -104.63 127.28 52.33 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 120.253 -0.579 . . . . 72.030000000000001 109.597 174.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.3 t -95.46 -13.84 24.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.114 -0.494 . . . . 74.510000000000005 111.801 -172.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.616 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -123.32 128.04 49.36 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.944 -0.302 . . . . 75.319999999999993 110.782 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -137.91 84.83 2.06 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.895 -0.593 . . . . 73.540000000000006 110.443 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.532 ' HG3' ' HG2' ' A' ' 74' ' ' ARG . 6.6 mm-40 -107.18 141.68 23.44 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.361 -0.977 . . . . 75.010000000000005 108.361 173.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.46 93.82 0.59 Allowed 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.548 2.166 . . . . 72.120000000000005 112.376 -175.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 56.77 38.92 85.9 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.802 -0.635 . . . . 45.109999999999999 112.799 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -127.87 -46.37 1.41 Allowed 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.884 -0.326 . . . . 63.329999999999998 110.917 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.532 ' HG2' ' HG3' ' A' ' 70' ' ' GLU . 16.4 ptt-85 -159.91 147.64 16.8 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.48 -0.563 . . . . 75.430000000000007 109.48 173.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.643 HD11 ' HE2' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -147.34 120.54 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.411 0.624 . . . . 73.209999999999994 111.594 -179.498 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.689 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . . . -120.21 120.13 35.26 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.918 -1.037 . . . . 51.100000000000001 109.942 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.479 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 49.5 p90 -99.35 144.33 28.59 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.027 -0.533 . . . . 73.049999999999997 110.282 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -136.25 175.85 9.23 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.641 -0.874 . . . . 71.409999999999997 108.641 176.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.0 m -133.02 152.1 52.0 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.603 -0.517 . . . . 42.130000000000003 109.603 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.9 mt -67.94 156.82 88.62 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.239 -0.437 . . . . 74.349999999999994 110.251 -178.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -56.82 -21.7 41.58 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.862 2.375 . . . . 61.229999999999997 113.337 -177.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.53 10.98 66.96 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.809 -0.71 . . . . 64.540000000000006 112.679 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.472 ' HB1' HG12 ' A' ' 85' ' ' ILE . . . -137.19 142.3 42.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.904 0.383 . . . . 33.520000000000003 111.105 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -118.96 41.81 2.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.584 0.707 . . . . 74.150000000000006 109.719 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.472 HG12 ' HB1' ' A' ' 83' ' ' ALA . 46.2 mm -77.75 118.26 24.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.131 -0.94 . . . . 74.530000000000001 111.525 -175.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 69.91 154.5 0.12 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.975 0.797 . . . . 75.409999999999997 112.34 171.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -72.35 135.91 46.01 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.88 -0.785 . . . . 70.310000000000002 108.88 174.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 26.2 m -94.95 145.02 25.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.291 0.567 . . . . 54.530000000000001 111.233 -174.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -174.62 -166.26 32.3 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.107 -0.952 . . . . 74.239999999999995 111.671 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.689 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 43.0 tt0 -145.44 136.81 25.04 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.292 -0.262 . . . . 73.310000000000002 110.292 -178.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.559 ' CG2' HG13 ' A' ' 75' ' ' ILE . 3.0 m -120.23 134.17 64.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 120.901 0.381 . . . . 64.129999999999995 110.714 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.477 ' HB2' ' CG2' ' A' ' 105' ' ' VAL . 9.7 mp -113.76 137.42 51.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.293 -0.412 . . . . 75.219999999999999 110.231 175.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.831 ' HZ ' ' HB3' ' A' ' 20' ' ' TYR . 76.7 m-85 -105.05 106.9 17.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.986 -0.552 . . . . 70.120000000000005 110.1 177.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -117.15 145.36 35.63 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.137 -0.483 . . . . 73.409999999999997 111.041 -176.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.69 135.98 59.7 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.585 2.19 . . . . 74.430000000000007 111.749 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.466 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . . . -105.03 143.38 26.6 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.627 -0.261 . . . . 61.439999999999998 111.011 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 96' ' ' ALA . 26.7 Cg_exo -64.06 150.24 88.76 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 123.306 2.671 . . . . 75.219999999999999 112.477 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.84 10.74 86.02 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.081 -0.581 . . . . 70.530000000000001 112.117 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 57.4 35.27 25.77 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 122.889 0.475 . . . . 70.049999999999997 111.449 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 100' ' ' ARG . 2.2 mmp_? -58.66 -38.4 78.06 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.092 0.472 . . . . 64.510000000000005 110.736 176.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 149.38 -119.9 1.1 Allowed Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.812 -0.915 . . . . 51.409999999999997 110.812 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 92.4 m -129.0 127.93 42.64 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.989 0.423 . . . . 74.439999999999998 110.386 175.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -84.12 114.48 21.8 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.602 -0.726 . . . . 74.019999999999996 110.235 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.1 p -99.05 115.73 40.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.164 0.507 . . . . 70.319999999999993 110.661 177.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.824 HG12 ' HB2' ' A' ' 9' ' ' ALA . 21.7 m -86.81 110.68 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-O 121.444 0.64 . . . . 74.349999999999994 109.382 174.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 46.5 t -100.61 125.18 54.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.626 -0.715 . . . . 73.340000000000003 110.343 -176.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.598 ' HB2' ' HG2' ' A' ' 7' ' ' ARG . 26.9 ttt180 -137.03 113.08 9.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.235 -0.438 . . . . 74.109999999999999 111.201 174.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.0 mp -116.01 140.93 48.77 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.706 -0.679 . . . . 73.329999999999998 109.885 175.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.628 ' HA ' HG22 ' A' ' 5' ' ' VAL . 86.7 m -84.25 120.09 25.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.163 -0.471 . . . . 73.030000000000001 110.237 178.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.009 -0.541 . . . . 75.329999999999998 109.662 -178.099 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.45 0 N-CA-C 111.777 -0.529 . . . . 61.530000000000001 111.777 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.1 m -59.64 -40.06 86.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.846 0.355 . . . . 65.329999999999998 111.327 -176.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.522 ' O ' HG12 ' A' ' 121' ' ' ILE . . . -72.92 -24.82 60.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.316 -0.402 . . . . 74.209999999999994 111.506 -178.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.14 -28.72 73.82 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.921 -0.657 . . . . 71.150000000000006 112.637 -177.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.41 -43.27 81.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.357 . . . . 63.119999999999997 111.478 -178.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 117' ' ' ALA . 9.1 p -73.47 -20.49 18.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.834 0.35 . . . . 71.239999999999995 111.032 -176.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.522 HG12 ' O ' ' A' ' 117' ' ' ALA . 49.6 mm -63.39 -56.87 14.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.647 -0.251 . . . . 74.209999999999994 110.652 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.48 -31.07 72.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.153 0.502 . . . . 74.549999999999997 110.605 178.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -66.96 -31.04 71.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.415 -0.812 . . . . 73.230000000000004 110.689 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 17.9 tpt . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 115.816 -0.629 . . . . 75.549999999999997 110.921 -179.851 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 134' ' ' ARG . 8.6 mtp180 . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.728 0.299 . . . . 63.030000000000001 110.742 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.447 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 17.3 t70 -57.22 -38.8 74.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.92 -0.582 . . . . 74.409999999999997 110.082 177.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -62.48 -43.54 98.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.483 -0.781 . . . . 53.310000000000002 111.049 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.511 HD23 ' HB3' ' A' ' 8' ' ' ASP . 22.2 tp -75.3 -27.02 59.15 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.661 -0.496 . . . . 73.409999999999997 109.661 -178.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.538 ' CE ' ' HA ' ' A' ' 138' ' ' MET . 0.0 OUTLIER -64.41 -47.08 80.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.862 -0.608 . . . . 74.230000000000004 109.829 175.916 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 135' ' ' ASP . 81.6 mtp180 -61.91 -40.82 96.79 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.611 -0.722 . . . . 75.239999999999995 109.683 175.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.781 ' HZ ' HG11 ' A' ' 22' ' ' VAL . 89.8 t80 -56.55 -40.86 75.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.204 -0.907 . . . . 74.109999999999999 111.232 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.571 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 24.2 ttpp -65.23 -52.22 55.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.345 -0.389 . . . . 74.450000000000003 110.06 176.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -53.62 -44.94 69.91 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.458 -0.792 . . . . 75.209999999999994 111.321 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -62.81 -39.4 94.15 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.641 -0.254 . . . . 74.209999999999994 111.571 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.594 ' HB2' HG12 ' A' ' 12' ' ' ILE . 30.6 mt-30 -70.19 -47.27 62.25 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.958 -0.297 . . . . 74.409999999999997 111.504 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.571 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 11.0 pt-20 -76.45 -13.81 60.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.033 0.444 . . . . 61.439999999999998 111.231 -176.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -83.25 -43.51 15.99 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.791 -0.818 . . . . 43.149999999999999 108.791 172.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.488 0 CA-C-N 115.604 -0.726 . . . . 71.239999999999995 112.898 -179.065 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.5 mmm . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 120.677 0.275 . . . . 74.239999999999995 111.232 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -140.05 36.29 1.83 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.838 -0.696 . . . . 72.400000000000006 111.767 -176.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.439 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 7.4 mp0 -67.61 111.84 4.41 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.46 -0.57 . . . . 73.310000000000002 109.46 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.9 m -113.34 134.48 54.6 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.986 -0.552 . . . . 75.109999999999999 110.728 -173.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.708 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 4.4 p -93.48 98.82 8.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.929 0.871 . . . . 72.319999999999993 109.828 175.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.3 t -92.05 134.35 30.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.336 -0.847 . . . . 43.399999999999999 110.544 -176.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.645 ' HD2' ' O ' ' A' ' 7' ' ' ARG . 7.4 ppt_? -115.65 112.1 21.61 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.277 0.56 . . . . 73.310000000000002 110.261 175.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.435 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 31.3 t0 -157.48 172.52 18.42 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.002 -0.74 . . . . 65.25 109.002 177.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.649 ' HB2' HG12 ' A' ' 105' ' ' VAL . . . -138.39 132.27 31.18 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.733 0.301 . . . . 75.129999999999995 111.359 -176.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.467 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 23.8 m -110.76 145.95 16.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.194 -0.457 . . . . 70.140000000000001 110.581 178.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 97.4 m -109.71 118.78 37.45 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.053 -0.521 . . . . 52.109999999999999 111.031 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.762 HG21 ' HG3' ' A' ' 144' ' ' GLN . 5.0 mp -127.04 150.16 32.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.829 -0.623 . . . . 61.43 109.37 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.33 54.2 3.57 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.775 -0.726 . . . . 61.119999999999997 113.106 -178.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.587 ' HD3' ' HB2' ' A' ' 18' ' ' GLN . 50.9 mttp -131.67 144.4 53.15 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 108.849 -0.797 . . . . 71.109999999999999 108.849 174.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.59 -56.9 2.08 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.759 2.306 . . . . 62.520000000000003 113.803 -171.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.471 ' HA ' HD12 ' A' ' 19' ' ' LEU . . . 174.01 -47.48 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.649 0.738 . . . . 75.299999999999997 109.175 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -48.76 -47.15 41.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.081 -1.418 . . . . 72.140000000000001 111.952 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.587 ' HB2' ' HD3' ' A' ' 14' ' ' LYS . 67.5 mt-30 -83.39 -10.93 58.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.874 0.369 . . . . 65.030000000000001 111.119 -174.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' A' ' 16' ' ' ALA . 95.4 mt -77.57 -48.49 16.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.52 -0.309 . . . . 71.349999999999994 110.543 -178.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.675 ' HB3' ' HZ ' ' A' ' 93' ' ' PHE . 16.8 p90 -73.67 -23.85 59.89 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.107 -0.637 . . . . 71.450000000000003 109.483 175.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.522 ' HB3' ' HA ' ' A' ' 18' ' ' GLN . . . -73.18 -1.79 19.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.212 -0.904 . . . . 63.25 111.791 177.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.615 HG11 ' HZ ' ' A' ' 140' ' ' PHE . 12.1 p -54.06 -22.89 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 122.666 0.386 . . . . 73.019999999999996 111.681 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -75.17 -8.22 55.99 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.092 0.472 . . . . 73.150000000000006 110.955 178.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.516 ' HA ' ' HE ' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -115.83 -174.5 2.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.676 -0.693 . . . . 54.149999999999999 110.032 178.568 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.13 33.9 1.31 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.698 -0.683 . . . . 62.409999999999997 109.225 177.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.452 HD22 ' HB3' ' A' ' 18' ' ' GLN . 75.7 mt 55.26 85.25 0.19 Allowed Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 115.208 -0.905 . . . . 63.32 110.375 -173.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -82.52 167.51 15.11 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.11 2.54 . . . . 70.450000000000003 113.508 -173.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -143.71 69.96 0.41 Allowed Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.777 -0.647 . . . . 70.340000000000003 112.346 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.55 77.69 55.1 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 121.237 0.542 . . . . 63.229999999999997 111.391 177.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.415 ' HD2' HD12 ' A' ' 31' ' ' LEU . 5.7 Cg_exo -74.86 3.54 5.45 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.934 2.422 . . . . 51.509999999999998 111.919 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.426 ' H ' HD12 ' A' ' 31' ' ' LEU . 4.8 mp -80.06 -31.36 39.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.534 -0.757 . . . . 75.329999999999998 110.034 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.558 HD11 ' HB ' ' A' ' 39' ' ' VAL . 3.3 mm? -99.02 73.02 1.92 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.282 0.563 . . . . 64.439999999999998 110.302 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 26.8 ptm -146.18 160.07 42.46 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.459 -0.941 . . . . 65.430000000000007 108.459 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.84 HG22 ' H ' ' A' ' 35' ' ' HIS . 4.3 m 64.53 -163.45 0.26 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.384 -0.969 . . . . 72.129999999999995 108.384 -176.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.84 ' H ' HG22 ' A' ' 34' ' ' THR . 50.6 m170 -86.12 -179.11 6.68 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 121.932 -0.48 . . . . 75.109999999999999 110.217 175.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.537 ' O ' ' HG ' ' A' ' 36' ' ' LEU . 54.7 tp 74.35 28.24 1.37 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.686 0.755 . . . . 71.310000000000002 110.509 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.6 mtm-85 -95.91 120.31 35.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.008 -0.542 . . . . 72.430000000000007 109.841 176.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.548 ' O ' HG13 ' A' ' 51' ' ' VAL . 50.0 m -92.95 -39.62 11.03 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.48 -0.563 . . . . 54.109999999999999 109.48 173.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.558 ' HB ' HD11 ' A' ' 32' ' ' LEU . 23.4 t -83.42 84.56 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.894 -0.594 . . . . 75.200000000000003 111.299 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -82.12 48.27 1.23 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.247 0.546 . . . . 74.140000000000001 110.036 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 98.8 t -116.19 121.06 66.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.204 0.526 . . . . 73.329999999999998 110.586 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.74 HD12 ' HB3' ' A' ' 44' ' ' ASP . 0.9 OUTLIER -126.3 -38.37 2.14 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.463 -0.79 . . . . 72.450000000000003 110.821 -178.494 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.5 t70 75.19 -11.86 1.03 Allowed 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.606 -0.725 . . . . 74.219999999999999 111.255 174.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.74 ' HB3' HD12 ' A' ' 42' ' ' LEU . 6.1 t70 -44.24 -64.53 0.66 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.713 -1.13 . . . . 64.099999999999994 112.478 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.532 ' O ' ' HB2' ' A' ' 46' ' ' ARG . 1.1 tppm? -109.25 29.3 7.66 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.534 -0.543 . . . . 72.510000000000005 109.534 -177.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.532 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 0.7 OUTLIER 75.81 170.87 0.26 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 113.821 -1.536 . . . . 74.519999999999996 109.33 -162.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.3 m -165.12 -39.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.447 0.166 . . . . 72.230000000000004 111.447 -173.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.42 ' HG3' HG21 ' A' ' 60' ' ' VAL . 30.8 mmt180 64.26 99.83 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.823 -0.806 . . . . 64.319999999999993 108.823 -168.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 29.3 p90 -78.29 72.72 4.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.877 0.846 . . . . 70.129999999999995 111.737 -172.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.437 HG23 ' H ' ' A' ' 51' ' ' VAL . 1.7 t -92.06 -55.4 3.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.433 -0.803 . . . . 62.43 110.889 176.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 38' ' ' SER . 93.0 t 72.69 -42.71 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 123.152 0.581 . . . . 64.219999999999999 112.014 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -82.62 -35.05 27.35 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.275 0.472 . . . . 64.310000000000002 112.275 -173.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.88 143.78 86.97 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 111.986 0.365 . . . . 72.349999999999994 111.986 -173.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.22 129.72 16.48 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.682 2.255 . . . . 52.200000000000003 111.572 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 69.19 144.55 0.1 Allowed Pre-proline 0 N--CA 1.462 0.174 0 O-C-N 123.848 0.717 . . . . 75.010000000000005 110.729 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.527 ' HG2' HD12 ' A' ' 57' ' ' LEU . 36.0 Cg_endo -65.2 -18.54 61.39 Favored 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.232 1.955 . . . . 72.140000000000001 112.902 -177.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.694 HD12 HD22 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -132.51 4.34 3.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.197 0.522 . . . . 65.030000000000001 112.298 -175.409 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -87.37 43.81 3.23 Favored Glycine 0 C--N 1.316 -0.553 0 C-N-CA 120.487 -0.863 . . . . 62.119999999999997 113.193 -176.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -166.74 -52.91 0.03 OUTLIER 'General case' 0 C--O 1.233 0.209 0 N-CA-C 113.086 0.773 . . . . 73.120000000000005 113.086 -177.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.475 HG23 ' OE1' ' A' ' 63' ' ' GLU . 5.3 m -89.9 -0.51 8.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 113.519 0.933 . . . . 61.200000000000003 113.519 -167.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.1 m 75.21 -47.28 0.6 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.47 0.708 . . . . 72.150000000000006 112.706 172.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 26.1 m95 -129.65 121.69 27.51 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.09 -0.708 . . . . 64.349999999999994 109.09 173.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.604 ' HG3' ' HA ' ' A' ' 57' ' ' LEU . 0.8 OUTLIER -152.57 166.14 32.98 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.457 -0.792 . . . . 72.230000000000004 109.732 -175.185 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -130.67 139.2 50.32 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.883 -0.727 . . . . 73.239999999999995 112.493 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 19.6 tt0 -129.37 160.51 32.83 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.74 -1.118 . . . . 72.099999999999994 109.162 176.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.587 ' CD1' ' HA ' ' A' ' 77' ' ' TRP . 4.1 mm? -108.92 116.49 32.1 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.832 -0.803 . . . . 72.019999999999996 108.832 170.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.6 t -78.04 -16.65 57.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.06 -0.518 . . . . 75.209999999999994 112.174 -168.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.654 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -143.32 130.05 20.34 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 121.012 -0.275 . . . . 65.140000000000001 110.464 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.564 ' HA ' HG13 ' A' ' 75' ' ' ILE . 18.7 t70 -145.03 113.36 6.59 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.117 -0.492 . . . . 74.140000000000001 110.127 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.41 ' O ' HD11 ' A' ' 75' ' ' ILE . 78.8 mm-40 -130.33 144.92 55.22 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.625 -0.509 . . . . 71.219999999999999 109.625 176.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -52.67 -34.14 62.53 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.175 2.584 . . . . 73.319999999999993 113.009 -177.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -168.74 55.67 0.21 Allowed Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.868 -0.682 . . . . 45.140000000000001 111.994 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -127.87 -77.39 0.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.201 -0.296 . . . . 74.109999999999999 110.201 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 18.1 ptp180 -157.43 138.91 13.84 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.14 -0.482 . . . . 75.049999999999997 110.123 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.721 HD13 ' HE2' ' A' ' 93' ' ' PHE . 3.1 mp -129.57 122.06 54.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.196 -0.456 . . . . 73.420000000000002 109.966 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.654 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -111.34 130.41 55.69 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.939 -0.393 . . . . 65.299999999999997 109.939 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.587 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 4.6 p90 -85.31 153.65 22.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.568 0.699 . . . . 74.340000000000003 111.759 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.877 ' HG3' ' H ' ' A' ' 80' ' ' LEU . 4.1 tpp180 -144.32 172.82 12.4 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.707 -1.133 . . . . 63.240000000000002 108.686 -174.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.651 ' N ' ' HG3' ' A' ' 78' ' ' ARG . 59.0 m -145.64 24.84 1.36 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.755 -0.461 . . . . 51.409999999999997 109.755 174.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.877 ' H ' ' HG3' ' A' ' 78' ' ' ARG . 73.3 mt 63.96 149.64 0.11 Allowed Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 115.268 -0.878 . . . . 71.140000000000001 112.738 174.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -64.5 -8.22 16.54 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 122.345 2.03 . . . . 73.209999999999994 112.492 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -76.38 -57.22 4.0 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.854 -0.688 . . . . 73.120000000000005 111.865 175.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.75 -26.59 29.55 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.595 0.22 . . . . 71.129999999999995 111.595 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 63.31 103.92 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.361 0.664 . . . . 74.329999999999998 111.149 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.506 ' HB ' ' HB2' ' A' ' 79' ' ' SER . 17.1 tt -70.08 129.23 34.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.402 0.62 . . . . 52.5 111.184 -178.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -82.09 -29.17 31.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.476 -0.784 . . . . 73.230000000000004 110.015 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -88.73 168.27 12.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.593 -0.73 . . . . 74.150000000000006 110.562 -175.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.6 m -155.24 135.35 13.03 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.299 -0.26 . . . . 73.230000000000004 110.299 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.34 127.81 0.97 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.605 -0.807 . . . . 71.430000000000007 112.599 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 44.7 tt0 -115.37 118.52 33.46 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.612 -0.514 . . . . 71.340000000000003 109.612 176.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.623 HG12 HG12 ' A' ' 106' ' ' VAL . 3.8 m -87.15 130.38 37.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.873 0.368 . . . . 71.430000000000007 110.522 -177.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.657 ' HB2' HG23 ' A' ' 105' ' ' VAL . 9.5 mp -110.52 147.38 34.27 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.008 -0.367 . . . . 73.120000000000005 110.008 176.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.721 ' HE2' HD13 ' A' ' 75' ' ' ILE . 79.8 m-85 -117.61 132.01 56.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.831 0.348 . . . . 70.239999999999995 111.268 -177.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -141.86 145.15 35.38 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.94 -0.573 . . . . 74.530000000000001 109.902 173.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -58.01 127.62 25.73 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.474 2.116 . . . . 72.510000000000005 111.559 176.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.47 144.14 86.13 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.283 -0.417 . . . . 63.149999999999999 111.7 -174.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -58.45 138.39 85.54 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.911 2.408 . . . . 60.109999999999999 111.999 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.08 12.71 84.39 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.899 -0.667 . . . . 72.5 111.769 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 58.62 37.01 25.37 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 121.059 0.457 . . . . 63.350000000000001 111.051 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -78.95 1.14 24.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 55.140000000000001 111.411 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 129.7 -138.48 10.26 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.281 -0.728 . . . . 70.230000000000004 111.281 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 47.4 m -121.92 132.81 54.75 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.951 0.405 . . . . 74.400000000000006 110.23 176.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.52 ' HG2' ' HB1' ' A' ' 9' ' ' ALA . 42.5 tt0 -100.85 117.54 35.12 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.827 -0.624 . . . . 65.420000000000002 110.023 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.582 HG22 HG13 ' A' ' 106' ' ' VAL . 2.7 p -93.88 106.91 18.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.315 0.578 . . . . 73.150000000000006 110.757 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.657 HG23 ' HB2' ' A' ' 92' ' ' LEU . 10.8 m -88.23 114.24 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.759 -0.655 . . . . 72.299999999999997 110.343 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.623 HG12 HG12 ' A' ' 91' ' ' VAL . 27.2 m -124.15 134.97 65.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.404 0.621 . . . . 72.109999999999999 111.884 -175.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.523 ' HG3' ' HB3' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -118.32 97.89 6.0 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.821 -1.177 . . . . 72.450000000000003 107.821 170.089 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.526 HD23 ' H ' ' A' ' 108' ' ' LEU . 2.7 pt? -132.41 144.91 50.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.033 0.444 . . . . 64.25 110.792 -173.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.708 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 8.3 t -97.99 138.54 35.16 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.84 -0.618 . . . . 74.200000000000003 109.336 174.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -160.52 176.12 11.96 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.491 -0.322 . . . . 73.519999999999996 110.434 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.417 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 89.2 mtt180 -95.56 141.57 23.37 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 109.334 -0.617 . . . . 74.439999999999998 109.334 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.461 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 90.6 Cg_endo -88.41 153.94 6.58 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.492 2.128 . . . . 72.040000000000006 113.155 -174.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 15.6 Cg_exo -69.06 134.83 30.47 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.781 2.32 . . . . 75.319999999999993 111.447 175.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.25 -35.25 63.89 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.11 -0.567 . . . . 64.450000000000003 112.774 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -101.14 100.02 2.04 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.575 -0.821 . . . . 64.230000000000004 112.611 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.5 m -73.41 -22.31 60.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.923 0.392 . . . . 54.329999999999998 111.185 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.468 ' HA ' HG22 ' A' ' 120' ' ' VAL . . . -61.76 -22.79 65.71 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.219 -0.446 . . . . 74.530000000000001 111.571 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.87 -21.52 65.54 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.106 -0.569 . . . . 44.43 112.513 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -86.49 -44.68 11.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.928 0.394 . . . . 75.0 111.483 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 117' ' ' ALA . 27.6 m -67.7 -17.61 22.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.297 0.48 . . . . 74.150000000000006 112.297 -172.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.519 ' O ' HD13 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -61.9 -28.61 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 120.978 0.418 . . . . 74.319999999999993 110.35 178.257 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' A' ' 126' ' ' ASN . . . -69.74 -18.59 63.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.329 -0.396 . . . . 73.239999999999995 111.678 -177.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 57.7 ttp85 -65.88 -16.0 63.44 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.624 0.249 . . . . 73.340000000000003 111.311 -176.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.8 ttm -55.32 -43.19 74.69 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.961 0.41 . . . . 75.109999999999999 109.988 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -166.96 90.05 0.37 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.643 -0.873 . . . . 72.439999999999998 108.643 175.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.413 ' HB3' ' O ' ' A' ' 122' ' ' ALA . 28.9 p-10 -104.61 -30.79 9.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.997 -0.547 . . . . 64.049999999999997 111.138 -175.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 61.67 21.93 12.54 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.579 0.704 . . . . 65.450000000000003 110.226 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -124.1 86.88 53.82 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.66 -0.7 . . . . 74.409999999999997 110.727 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -76.62 74.98 4.59 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.284 1.99 . . . . 71.0 111.66 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.2 t -120.18 34.65 5.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.937 0.398 . . . . 65.329999999999998 110.853 -174.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 71.08 171.8 0.32 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.496 -0.775 . . . . 72.549999999999997 112.34 175.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -95.51 24.4 5.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.363 -0.835 . . . . 72.129999999999995 111.093 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.696 ' O ' ' HG2' ' A' ' 134' ' ' ARG . 3.1 mm? -116.09 177.21 4.77 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.966 -0.561 . . . . 74.439999999999998 109.664 178.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.696 ' HG2' ' O ' ' A' ' 133' ' ' LEU . 2.4 ptm180 48.58 32.6 3.54 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 124.074 0.859 . . . . 74.420000000000002 112.516 172.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -49.12 -52.08 28.22 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.258 0.623 . . . . 74.319999999999993 111.954 -173.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.475 ' O ' ' HG2' ' A' ' 139' ' ' ARG . 33.8 t70 -61.99 -39.01 90.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.569 -0.741 . . . . 74.25 112.192 -174.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.467 ' HG ' ' CG1' ' A' ' 10' ' ' VAL . 14.3 tp -80.34 -20.28 44.56 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.857 0.36 . . . . 70.530000000000001 110.899 -176.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.521 ' CE ' ' HA ' ' A' ' 138' ' ' MET . 22.4 mmt -65.78 -41.73 91.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.775 0.287 . . . . 61.119999999999997 111.775 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.475 ' HG2' ' O ' ' A' ' 136' ' ' ASP . 15.9 ptt180 -62.67 -31.21 72.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.832 0.349 . . . . 63.450000000000003 110.359 178.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.615 ' HZ ' HG11 ' A' ' 22' ' ' VAL . 92.2 t80 -64.58 -45.87 85.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.897 -0.592 . . . . 71.549999999999997 110.311 178.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.44 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 23.3 ttpp -57.1 -47.65 80.54 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.15 -0.477 . . . . 63.299999999999997 110.036 176.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 28.4 ttp180 -53.82 -45.77 70.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.052 -0.976 . . . . 71.219999999999999 111.816 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -77.79 -28.45 50.45 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.233 -0.439 . . . . 75.049999999999997 111.514 -175.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.762 ' HG3' HG21 ' A' ' 12' ' ' ILE . 4.9 tp-100 -71.31 -44.66 64.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.621 0.248 . . . . 73.319999999999993 110.502 175.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 11.1 pt-20 -71.64 -23.3 61.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.848 0.356 . . . . 72.409999999999997 110.764 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 1.0 OUTLIER -76.8 -47.79 20.52 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.557 -0.534 . . . . 73.510000000000005 109.557 178.189 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -66.18 123.5 23.65 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.776 -0.647 . . . . 52.130000000000003 112.606 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.405 HD23 ' N ' ' A' ' 149' ' ' GLU . 1.6 tt -152.67 132.73 13.42 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.325 -0.62 . . . . 73.340000000000003 109.325 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.469 ' CD ' ' H ' ' A' ' 150' ' ' HIS . 0.3 OUTLIER -138.99 171.76 13.85 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.814 -0.809 . . . . 72.120000000000005 108.814 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.469 ' H ' ' CD ' ' A' ' 149' ' ' GLU . 78.5 m80 -58.58 142.02 50.48 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.548 -0.538 . . . . 74.040000000000006 109.548 174.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -66.5 -23.01 66.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.789 0.328 . . . . 71.230000000000004 111.286 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -81.2 -18.16 47.12 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.447 -0.342 . . . . 63.450000000000003 110.171 175.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 65.6 t60 65.87 109.01 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.723 -0.671 . . . . 72.409999999999997 110.794 -175.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -116.72 116.37 27.4 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.171 -0.468 . . . . 73.420000000000002 109.997 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 51.9 t60 . . . . . 0 C--O 1.247 0.924 0 CA-C-O 118.429 -0.796 . . . . 71.230000000000004 110.036 -178.281 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.796 0.331 . . . . 73.430000000000007 110.949 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.52 -88.23 0.92 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.678 -0.772 . . . . 73.310000000000002 112.353 177.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 42.51 41.48 2.33 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.726 0.81 . . . . 75.450000000000003 111.574 -178.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.0 m -95.64 136.17 36.38 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.72 -0.673 . . . . 72.129999999999995 110.171 -177.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.617 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 11.1 p -126.19 137.21 58.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.307 -0.406 . . . . 72.340000000000003 110.378 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.0 t -95.75 116.44 37.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.294 -0.632 . . . . 75.140000000000001 109.294 174.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 59.9 ttt180 -125.77 108.38 11.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.08 0.467 . . . . 72.340000000000003 110.078 174.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.492 ' HA ' HD22 ' A' ' 133' ' ' LEU . 11.6 m-20 -143.73 159.14 43.03 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.13 -1.063 . . . . 74.299999999999997 108.13 176.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.849 ' H ' HD13 ' A' ' 133' ' ' LEU . . . -141.18 121.13 13.62 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.931 0.396 . . . . 73.540000000000006 110.642 -174.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.632 ' HB ' ' HB2' ' A' ' 141' ' ' LYS . 10.5 m -108.32 136.58 43.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.442 0.639 . . . . 54.039999999999999 111.714 -176.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.14 109.92 22.19 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.227 -0.897 . . . . 65.299999999999997 111.239 -177.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.875 HG23 ' HG3' ' A' ' 145' ' ' GLU . 4.8 mp -125.26 149.4 29.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.789 -0.819 . . . . 72.140000000000001 108.789 176.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.88 57.51 2.65 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 121.114 -0.565 . . . . 55.32 113.226 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.657 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 10.9 mmpt? -118.15 154.52 51.75 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 108.803 -0.814 . . . . 72.120000000000005 108.803 176.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -58.98 -57.66 0.9 Allowed 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.327 2.018 . . . . 72.439999999999998 113.026 -177.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.557 ' O ' ' HB2' ' A' ' 19' ' ' LEU . . . -178.26 -72.91 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.224 0.453 . . . . 61.439999999999998 112.224 178.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -66.36 -31.12 71.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.711 0.291 . . . . 74.230000000000004 111.174 -173.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -56.67 -32.28 65.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.424 -0.353 . . . . 74.019999999999996 110.552 175.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.557 ' HB2' ' O ' ' A' ' 16' ' ' ALA . 65.4 mt -62.89 -41.63 99.49 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.88 -0.6 . . . . 74.129999999999995 110.444 176.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.742 ' HB2' ' HZ ' ' A' ' 93' ' ' PHE . 77.9 t80 -73.07 -36.36 66.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.734 -0.666 . . . . 71.209999999999994 110.766 178.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.23 -3.61 30.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.683 -0.69 . . . . 75.209999999999994 112.188 -175.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.765 HG11 ' HZ ' ' A' ' 140' ' ' PHE . 9.0 p -53.69 -21.46 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 123.213 0.605 . . . . 72.319999999999993 112.242 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.8 t-105 -52.94 -37.25 60.74 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.445 0.64 . . . . 74.439999999999998 109.764 176.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.579 ' HD3' ' N ' ' A' ' 25' ' ' ASP . 4.0 tmt_? -109.59 159.76 16.83 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.866 -1.161 . . . . 72.239999999999995 107.866 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.579 ' N ' ' HD3' ' A' ' 24' ' ' ARG . 26.1 t70 -66.83 67.17 0.06 Allowed 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.497 0.554 . . . . 74.0 112.497 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.47 ' O ' ' HE1' ' A' ' 152' ' ' HIS . 3.6 mm? 41.86 79.3 0.33 Allowed Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 124.168 0.987 . . . . 65.129999999999995 112.78 169.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.522 ' HA ' ' NH1' ' A' ' 24' ' ' ARG . 31.6 Cg_exo -58.31 -57.8 0.97 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.445 2.097 . . . . 44.219999999999999 113.787 -172.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.16 -145.56 30.32 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.563 -0.827 . . . . 73.109999999999999 111.405 -172.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.511 ' N ' ' HD3' ' A' ' 30' ' ' PRO . 57.8 mt 44.32 53.7 11.18 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 113.424 0.898 . . . . 73.230000000000004 113.424 176.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.511 ' HD3' ' N ' ' A' ' 29' ' ' LEU . 2.9 Cg_endo -81.25 60.77 7.91 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 121.736 1.624 . . . . 64.430000000000007 111.125 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mp -150.72 -68.23 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.426 -0.806 . . . . 54.009999999999998 109.143 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 81.9 mt 64.51 -80.13 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 114.843 -1.072 . . . . 73.409999999999997 111.178 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.557 ' HG3' ' H ' ' A' ' 34' ' ' THR . 19.1 ptp -175.44 -60.84 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.044 -0.526 . . . . 74.420000000000002 110.217 -178.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.557 ' H ' ' HG3' ' A' ' 33' ' ' MET . 2.2 p -157.16 -68.94 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.501 0.667 . . . . 54.420000000000002 109.694 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -146.13 109.01 4.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.184 -0.917 . . . . 62.32 109.3 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 59.2 tp -154.8 105.41 2.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.437 -0.347 . . . . 72.530000000000001 110.705 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.625 ' HG3' HG22 ' A' ' 41' ' ' VAL . 23.8 ttp180 -116.69 87.78 2.76 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.029 0.442 . . . . 75.400000000000006 109.971 177.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.2 m -139.55 -2.77 1.55 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.13 -0.486 . . . . 65.129999999999995 111.442 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.547 HG13 ' H ' ' A' ' 40' ' ' GLU . 6.1 p -152.48 -61.49 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 121.029 -0.268 . . . . 74.219999999999999 111.375 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.547 ' H ' HG13 ' A' ' 39' ' ' VAL . 17.7 mm-40 -88.34 121.85 31.2 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.885 -0.413 . . . . 75.409999999999997 109.885 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.625 HG22 ' HG3' ' A' ' 37' ' ' ARG . 47.6 t -138.42 141.24 38.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 110.204 -0.295 . . . . 74.019999999999996 110.204 -178.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -75.07 -58.52 3.23 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.411 -0.588 . . . . 71.349999999999994 109.411 175.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.7 t70 73.7 -69.35 0.19 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.01 -0.995 . . . . 71.109999999999999 112.604 169.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -76.47 -33.43 58.69 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.247 0.546 . . . . 72.200000000000003 110.498 -176.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 14.5 mmmm -90.98 39.74 1.0 Allowed 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.913 -0.773 . . . . 63.240000000000002 108.913 172.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.468 HH11 ' HG3' ' A' ' 56' ' ' PRO . 2.8 ptp180 74.46 140.25 0.06 Allowed 'General case' 0 C--N 1.327 -0.375 0 O-C-N 125.352 1.657 . . . . 64.530000000000001 110.186 -172.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.8 m -64.91 -54.47 30.28 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.585 -0.734 . . . . 50.049999999999997 111.907 -172.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.496 ' HD3' ' OE2' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -149.33 144.73 26.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.773 0.32 . . . . 72.439999999999998 110.878 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.445 ' CG ' ' HD2' ' A' ' 46' ' ' ARG . 2.8 p-90 -152.71 143.98 23.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.159 -0.473 . . . . 71.430000000000007 111.084 -177.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 24.1 m 72.95 -63.04 0.45 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.579 -0.737 . . . . 73.120000000000005 112.776 173.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.0 m -66.28 89.85 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 121.298 0.571 . . . . 45.140000000000001 111.821 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 54.19 30.9 13.03 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.291 -0.868 . . . . 75.319999999999993 111.0 -174.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.473 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . . . -133.69 143.87 49.53 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.575 -0.739 . . . . 62.109999999999999 109.692 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 53' ' ' ALA . 6.9 Cg_exo -73.99 -164.64 0.22 Allowed 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 123.102 2.535 . . . . 24.309999999999999 112.435 -178.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.47 144.58 86.66 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.658 -0.701 . . . . 70.120000000000005 109.912 176.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.511 ' O ' ' HB2' ' A' ' 63' ' ' GLU . 20.0 Cg_endo -59.7 -18.92 50.87 Favored 'Trans proline' 0 N--CA 1.474 0.37 0 C-N-CA 123.109 2.539 . . . . 75.239999999999995 113.265 -175.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.9 19.07 2.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.611 0.72 . . . . 74.540000000000006 110.565 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -136.15 115.09 1.26 Allowed Glycine 0 C--N 1.314 -0.64 0 CA-C-N 114.656 -1.157 . . . . 74.129999999999995 111.904 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 72.31 24.87 2.94 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.449 0.642 . . . . 63.43 110.302 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.9 p -136.81 162.5 34.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.305 -0.862 . . . . 71.430000000000007 109.18 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.7 m -67.96 -77.78 0.07 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.355 -0.239 . . . . 74.310000000000002 110.355 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 7.0 m-90 -146.34 143.19 28.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.813 0.34 . . . . 73.200000000000003 110.432 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.645 ' O ' ' HG ' ' A' ' 80' ' ' LEU . 6.5 mm-40 -132.85 166.0 23.31 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.782 -0.822 . . . . 75.340000000000003 108.782 168.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.44 114.07 24.69 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 120.002 -0.679 . . . . 53.409999999999997 109.381 172.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.465 ' HB2' HD23 ' A' ' 80' ' ' LEU . 1.2 mm-40 -107.92 134.23 51.13 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 109.587 -0.523 . . . . 65.019999999999996 109.587 176.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.746 HD12 ' HA ' ' A' ' 77' ' ' TRP . 3.6 mm? -88.21 137.91 31.91 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.581 -0.526 . . . . 24.109999999999999 109.581 -178.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.9 t -73.93 -9.18 58.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.497 0.665 . . . . 45.039999999999999 110.048 -177.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.91 123.35 10.36 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.973 -1.012 . . . . 74.209999999999994 108.725 166.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -139.09 83.64 1.96 Allowed 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.738 -0.838 . . . . 75.439999999999998 108.738 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 73' ' ' LYS . 48.5 mt-10 -115.86 143.86 31.58 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 114.879 -1.055 . . . . 71.239999999999995 109.581 -176.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.81 94.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.031 2.487 . . . . 50.32 113.029 -174.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 61.82 26.36 66.94 Favored Glycine 0 CA--C 1.518 0.277 0 CA-C-N 115.657 -0.701 . . . . 61.229999999999997 113.446 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.747 ' HE2' ' HA ' ' A' ' 73' ' ' LYS . 9.7 mmpt? -104.66 -72.56 0.7 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.18 0.514 . . . . 70.140000000000001 110.193 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.414 HH21 ' CD ' ' A' ' 90' ' ' GLU . 7.0 ptm180 -149.91 137.66 20.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.758 -0.655 . . . . 71.409999999999997 109.642 176.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 67.1 mt -122.18 110.3 26.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.768 -0.651 . . . . 74.349999999999994 109.394 177.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.667 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . . . -104.23 127.44 51.86 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.847 -0.615 . . . . 72.439999999999998 109.574 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.746 ' HA ' HD12 ' A' ' 66' ' ' LEU . 59.2 t90 -79.93 143.71 33.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.702 0.763 . . . . 73.319999999999993 111.509 -169.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.532 ' HG3' ' H ' ' A' ' 79' ' ' SER . 0.0 OUTLIER -166.61 175.35 8.03 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.834 -1.076 . . . . 65.400000000000006 108.99 -175.296 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.532 ' H ' ' HG3' ' A' ' 78' ' ' ARG . 46.9 m -141.57 165.63 26.95 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.348 -0.982 . . . . 64.030000000000001 108.348 174.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.645 ' HG ' ' O ' ' A' ' 63' ' ' GLU . 53.0 mt -60.57 150.76 73.53 Favored Pre-proline 0 C--N 1.326 -0.445 0 O-C-N 123.11 0.256 . . . . 63.43 110.729 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.31 -22.71 66.62 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 123.069 2.512 . . . . 71.140000000000001 112.82 -178.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.28 2.7 88.02 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.06 -0.591 . . . . 34.43 112.251 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -109.62 -168.89 1.38 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.715 0.293 . . . . 71.439999999999998 110.372 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -111.45 118.3 35.42 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.764 0.316 . . . . 65.109999999999999 110.553 -174.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.4 pt -110.19 129.73 64.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.032 0.444 . . . . 72.319999999999993 110.931 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -105.99 -85.48 0.49 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.138 -0.483 . . . . 64.019999999999996 111.906 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -96.03 166.48 11.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.935 0.397 . . . . 54.25 111.46 -171.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.7 t -103.81 139.02 39.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.031 -0.531 . . . . 73.140000000000001 109.875 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.612 ' HA3' ' HG ' ' A' ' 108' ' ' LEU . . . -158.69 129.12 2.19 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 121.038 -0.601 . . . . 32.409999999999997 112.113 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.667 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 45.5 tt0 -128.84 134.75 48.43 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.913 -0.403 . . . . 72.219999999999999 109.913 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.48 ' CG1' HG23 ' A' ' 104' ' ' VAL . 69.7 t -115.67 128.67 72.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.152 0.501 . . . . 62.32 111.144 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.612 ' HB2' ' HB ' ' A' ' 105' ' ' VAL . 6.8 mp -102.95 138.16 40.19 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.366 -0.834 . . . . 74.549999999999997 110.517 178.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.742 ' HZ ' ' HB2' ' A' ' 20' ' ' TYR . 89.2 m-85 -115.54 106.29 13.77 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.226 0.536 . . . . 72.209999999999994 109.695 175.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -124.26 144.5 45.8 Favored Pre-proline 0 C--N 1.317 -0.841 0 CA-C-N 116.138 -0.483 . . . . 52.310000000000002 110.61 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.26 125.98 19.58 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.639 2.226 . . . . 54.340000000000003 111.101 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.1 143.39 56.87 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.552 -0.295 . . . . 71.109999999999999 111.219 -175.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.527 ' O ' ' HG2' ' A' ' 100' ' ' ARG . 31.0 Cg_endo -65.37 156.5 63.0 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.775 2.316 . . . . 61.240000000000002 111.35 175.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 63.94 20.71 64.82 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.926 -0.654 . . . . 72.439999999999998 112.939 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 58.21 32.91 22.62 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.661 0.384 . . . . 63.210000000000001 112.006 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 97' ' ' PRO . 24.9 mmt180 -68.74 -18.98 64.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.862 0.363 . . . . 64.450000000000003 111.244 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 127.72 -133.12 7.72 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.305 -0.718 . . . . 73.310000000000002 111.305 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.2 m -118.65 132.85 56.18 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.518 -0.549 . . . . 60.43 109.518 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.487 ' HG2' ' HB1' ' A' ' 9' ' ' ALA . 40.1 tt0 -96.21 117.02 29.92 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.847 0.356 . . . . 54.299999999999997 110.535 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.48 HG23 ' CG1' ' A' ' 91' ' ' VAL . 1.7 p -88.33 103.97 14.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.818 0.818 . . . . 71.430000000000007 109.521 174.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.612 ' HB ' ' HB2' ' A' ' 92' ' ' LEU . 16.4 t -91.36 110.24 22.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.631 -1.168 . . . . 71.530000000000001 109.919 -175.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 47.7 t -100.74 117.77 46.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.232 -0.44 . . . . 40.149999999999999 111.217 -175.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -121.09 98.72 6.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.928 -0.578 . . . . 75.109999999999999 109.52 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.612 ' HG ' ' HA3' ' A' ' 89' ' ' GLY . 1.9 tt -138.83 137.3 36.48 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.84 -0.43 . . . . 73.209999999999994 109.84 -175.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 8.9 t -84.53 139.71 31.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.28 0.562 . . . . 65.129999999999995 111.254 -177.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -140.67 179.6 6.59 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.798 -0.637 . . . . 75.209999999999994 110.374 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -120.66 144.55 38.94 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.835 -0.62 . . . . 72.099999999999994 109.836 174.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -69.79 156.9 62.06 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 121.947 1.765 . . . . 72.340000000000003 110.946 171.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.02 -36.01 52.52 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.925 2.417 . . . . 71.519999999999996 112.566 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.86 97.7 0.38 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.754 -0.736 . . . . 42.149999999999999 112.271 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 142.02 -151.48 22.88 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.51 -0.853 . . . . 60.219999999999999 112.856 176.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.3 m -62.04 -23.86 66.72 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.066 0.546 . . . . 62.109999999999999 111.925 -174.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.91 -43.02 76.93 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.304 -0.407 . . . . 73.120000000000005 111.801 -176.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -78.59 -19.83 72.78 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.575 -0.822 . . . . 52.439999999999998 112.34 -178.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.49 -38.73 23.46 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.736 -0.273 . . . . 71.310000000000002 111.712 -175.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.5 m -64.5 -25.56 38.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.615 0.598 . . . . 52.219999999999999 112.615 -174.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 14.4 tt -75.13 -21.84 16.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.922 0.392 . . . . 70.540000000000006 111.085 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.97 -18.81 64.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.366 -0.379 . . . . 53.109999999999999 111.876 -175.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 123' ' ' ARG . 23.7 ttt85 -79.17 -14.5 59.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.059 0.457 . . . . 74.439999999999998 110.919 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 49.1 ttm -70.49 -25.86 63.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.238 -0.437 . . . . 72.239999999999995 110.322 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 68.09 177.62 0.25 Allowed 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.816 -0.629 . . . . 64.340000000000003 111.09 -176.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.6 t30 65.6 -177.39 0.18 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.825 -0.625 . . . . 62.439999999999998 109.767 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -129.64 174.06 10.03 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 122.244 -0.285 . . . . 73.439999999999998 110.431 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -86.41 155.45 56.97 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 109.054 -0.721 . . . . 73.439999999999998 109.054 175.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.412 ' HB2' ' HB2' ' A' ' 132' ' ' GLN . 9.4 Cg_endo -52.0 -55.5 3.82 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.454 2.103 . . . . 72.140000000000001 112.197 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.2 m 69.8 -41.92 0.5 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.59 0.756 . . . . 33.310000000000002 111.961 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 23.6 tm0? -67.0 -46.24 75.15 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.473 -1.306 . . . . 73.340000000000003 107.473 169.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.427 ' OE1' ' HA ' ' A' ' 132' ' ' GLN . 15.6 mm-40 -85.82 137.62 32.65 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.76 -1.2 . . . . 64.540000000000006 107.76 164.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.849 HD13 ' H ' ' A' ' 9' ' ' ALA . 63.2 mt -71.3 168.44 17.34 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.007 0.432 . . . . 73.109999999999999 112.06 -170.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 23.5 mtp-105 -82.45 164.01 21.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.815 0.816 . . . . 73.129999999999995 113.049 -168.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -69.7 -33.18 72.16 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.494 -1.23 . . . . 73.340000000000003 112.639 -173.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -56.51 -55.65 31.1 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.048 0.388 . . . . 72.319999999999993 112.048 -175.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 15.5 tp -81.08 -20.7 40.96 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.851 -0.34 . . . . 62.43 110.975 -175.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.8 ttp -54.34 -38.65 66.27 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.49 -0.323 . . . . 74.120000000000005 110.896 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 139' ' ' ARG . 0.8 OUTLIER -70.86 -32.71 69.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.793 0.33 . . . . 74.140000000000001 110.738 179.438 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.765 ' HZ ' HG11 ' A' ' 22' ' ' VAL . 90.3 t80 -60.34 -35.17 75.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 64.400000000000006 110.439 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.632 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 38.8 tttp -55.02 -49.5 71.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.771 -0.649 . . . . 71.530000000000001 110.194 173.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.639 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 34.4 mmt180 -71.67 -25.69 62.22 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.805 -0.634 . . . . 73.140000000000001 111.772 -175.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -63.48 -44.32 94.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.861 0.362 . . . . 64.299999999999997 111.054 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.714 ' HG2' HG21 ' A' ' 12' ' ' ILE . 8.3 tt0 -82.36 -44.36 16.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.068 -0.514 . . . . 73.209999999999994 111.038 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.875 ' HG3' HG23 ' A' ' 12' ' ' ILE . 2.5 tt0 -66.52 -20.21 65.97 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 116.203 -0.453 . . . . 74.25 111.994 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.639 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 21.3 tp -64.71 -40.95 96.23 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.538 -0.542 . . . . 73.340000000000003 109.538 175.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 105.77 96.19 2.43 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.303 -0.862 . . . . 73.310000000000002 111.361 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.649 HD23 ' H ' ' A' ' 148' ' ' LEU . 2.5 pt? -122.62 127.37 49.29 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.11 0.481 . . . . 70.530000000000001 111.192 -176.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -154.94 95.42 1.75 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.31 -0.859 . . . . 72.219999999999999 109.213 171.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -127.54 137.41 52.61 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.6 -0.727 . . . . 60.409999999999997 110.478 -174.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 71.7 t60 73.9 8.91 4.8 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.889 0.743 . . . . 74.430000000000007 110.054 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.47 ' HE1' ' O ' ' A' ' 26' ' ' LEU . 1.9 t60 -68.56 128.96 38.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.104 -0.498 . . . . 75.310000000000002 110.026 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -130.33 136.3 48.97 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.782 -0.645 . . . . 75.510000000000005 109.704 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -111.75 151.17 29.27 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.423 -0.584 . . . . 74.040000000000006 109.423 175.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 66.8 t60 . . . . . 0 C--N 1.315 -0.918 0 N-CA-C 108.594 -0.891 . . . . 74.219999999999999 108.594 174.802 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.481 1.119 0 CA-C-O 120.887 0.375 . . . . 53.539999999999999 110.296 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -161.69 60.86 0.29 Allowed Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.326 -0.71 . . . . 52.130000000000003 111.326 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -90.5 107.03 18.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.023 0.44 . . . . 54.109999999999999 110.928 -177.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 50.5 m -124.54 120.73 32.82 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.144 -0.688 . . . . 63.219999999999999 109.144 176.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.782 HG13 ' HA ' ' A' ' 109' ' ' THR . 51.0 t -93.96 132.34 38.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.605 -0.725 . . . . 65.049999999999997 109.083 178.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.7 t -80.79 115.54 23.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.977 0.418 . . . . 71.400000000000006 111.397 -171.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.487 ' HG3' ' CB ' ' A' ' 107' ' ' ARG . 9.0 mpt_? -107.14 108.09 19.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.537 -0.912 . . . . 73.5 108.537 168.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.509 ' HB3' HD22 ' A' ' 137' ' ' LEU . 2.5 t70 -147.99 173.31 13.02 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.516 -0.55 . . . . 74.200000000000003 109.516 178.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.844 ' HB2' HG12 ' A' ' 105' ' ' VAL . . . -138.56 154.35 48.73 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.045 0.45 . . . . 52.399999999999999 111.488 -171.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.459 ' HB ' ' HB2' ' A' ' 141' ' ' LYS . 12.8 m -132.55 141.07 46.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.838 -0.619 . . . . 72.010000000000005 109.987 174.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.442 HG21 ' HG3' ' A' ' 100' ' ' ARG . 25.2 m -106.38 118.32 36.34 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.156 -0.475 . . . . 74.120000000000005 111.259 -174.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.953 HG23 ' HB3' ' A' ' 145' ' ' GLU . 3.9 mp -123.19 141.94 41.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.845 -0.616 . . . . 64.25 109.716 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.26 52.02 4.24 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.843 -0.694 . . . . 74.019999999999996 112.455 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.471 ' HB2' HD21 ' A' ' 19' ' ' LEU . 94.8 mttt -131.22 144.24 52.68 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.066 -0.716 . . . . 75.109999999999999 109.066 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.75 -58.87 1.01 Allowed 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 122.688 2.259 . . . . 73.109999999999999 113.783 -169.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.406 ' HA ' HD12 ' A' ' 19' ' ' LEU . . . 173.56 -52.87 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.311 0.577 . . . . 63.140000000000001 110.462 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -57.09 -46.0 82.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.266 -0.879 . . . . 52.119999999999997 111.66 -175.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -68.57 -8.85 45.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.401 -0.363 . . . . 72.420000000000002 111.945 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.471 HD21 ' HB2' ' A' ' 14' ' ' LYS . 96.5 mt -80.55 -20.56 43.16 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 122.378 -0.201 . . . . 73.219999999999999 110.928 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -70.94 -29.4 65.42 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.458 0.647 . . . . 72.140000000000001 109.704 174.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.726 ' HB1' ' HD2' ' A' ' 27' ' ' PRO . . . -71.51 -4.72 28.3 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.54 -0.754 . . . . 43.350000000000001 112.073 -174.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.2 p -60.4 -24.2 30.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 71.010000000000005 111.245 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -55.72 -43.46 76.57 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 112.375 0.509 . . . . 73.349999999999994 112.375 -177.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 24' ' ' ARG . 28.4 ttt180 -105.53 -76.09 0.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.235 -0.586 . . . . 73.349999999999994 112.057 -174.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -147.78 2.96 0.72 Allowed 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 120.474 -0.49 . . . . 74.200000000000003 112.207 -168.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.76 HD11 ' HA ' ' A' ' 144' ' ' GLN . 51.6 mt 58.67 63.97 3.69 Favored Pre-proline 0 N--CA 1.47 0.539 0 CA-C-N 116.196 -0.456 . . . . 75.329999999999998 111.75 -175.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.726 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 83.5 Cg_endo -96.19 158.84 1.34 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.774 2.316 . . . . 64.329999999999998 112.76 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.81 53.76 4.55 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.817 -0.706 . . . . 62.240000000000002 112.281 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.63 HD23 ' HB2' ' A' ' 27' ' ' PRO . 3.8 mm? -117.01 81.13 12.07 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-O 120.416 0.15 . . . . 70.230000000000004 111.326 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.763 ' HD2' HD12 ' A' ' 31' ' ' LEU . 3.4 Cg_exo -79.14 -13.91 13.69 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.332 2.021 . . . . 64.540000000000006 111.535 172.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.763 HD12 ' HD2' ' A' ' 30' ' ' PRO . 4.7 mp -96.1 11.28 34.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.725 -0.67 . . . . 71.099999999999994 111.681 -173.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.829 ' HA ' HD11 ' A' ' 36' ' ' LEU . 1.5 pp -73.46 -12.11 60.68 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.794 -0.362 . . . . 75.010000000000005 111.821 -177.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 53.4 ttp -106.61 -4.82 19.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.688 0.28 . . . . 73.319999999999993 111.5 -177.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.2 p -80.32 -71.53 0.45 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.625 -0.43 . . . . 72.120000000000005 110.38 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -170.49 96.18 0.24 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.955 0.407 . . . . 75.019999999999996 110.957 175.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.829 HD11 ' HA ' ' A' ' 32' ' ' LEU . 2.7 pp -168.02 -29.46 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.54 -0.754 . . . . 75.430000000000007 109.398 173.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.58 ' HD2' ' OE1' ' A' ' 52' ' ' GLU . 28.2 mtp180 68.45 9.01 7.02 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.226 -0.897 . . . . 72.230000000000004 113.088 168.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.5 ' H ' HD12 ' A' ' 36' ' ' LEU . 50.1 m -83.95 90.82 7.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.815 0.34 . . . . 72.239999999999995 110.142 174.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.1 p -159.97 149.56 6.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.912 -0.585 . . . . 35.130000000000003 109.879 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.589 ' HG2' ' H ' ' A' ' 41' ' ' VAL . 15.1 tt0 -98.68 -162.8 0.98 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.662 -0.496 . . . . 75.120000000000005 109.662 -177.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.589 ' H ' ' HG2' ' A' ' 40' ' ' GLU . 65.6 t -44.8 130.95 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 122.413 0.285 . . . . 75.010000000000005 110.85 177.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.471 ' CD1' ' H ' ' A' ' 45' ' ' LYS . 2.0 tm? -130.22 -61.52 0.97 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.106 -0.497 . . . . 62.5 110.924 -168.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 73.28 -41.51 0.5 Allowed 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 113.018 0.748 . . . . 72.310000000000002 113.018 175.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.462 ' OD2' ' HG2' ' A' ' 45' ' ' LYS . 8.8 t70 -47.9 -43.12 28.49 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.974 0.51 . . . . 71.329999999999998 111.921 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.532 ' HD3' ' HA ' ' A' ' 45' ' ' LYS . 27.3 mmtm -125.04 59.07 1.24 Allowed 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.007 0.432 . . . . 54.109999999999999 110.282 176.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.444 ' HD2' ' HG2' ' A' ' 65' ' ' GLU . 0.2 OUTLIER 74.01 157.73 0.19 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-N 114.775 -1.102 . . . . 74.239999999999995 112.108 177.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.472 ' H ' ' CD ' ' A' ' 63' ' ' GLU . 7.3 m -109.92 28.37 8.66 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.949 -1.023 . . . . 75.239999999999995 109.87 176.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.59 42.77 0.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 72.120000000000005 110.927 -174.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 20.6 t90 63.66 86.18 0.12 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.469 -0.787 . . . . 74.310000000000002 111.587 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.45 HG21 ' HB3' ' A' ' 37' ' ' ARG . 24.5 m 74.37 145.37 0.08 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.204 -0.907 . . . . 63.100000000000001 112.457 175.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.1 m -84.43 88.62 2.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.607 0.718 . . . . 72.530000000000001 111.582 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.58 ' OE1' ' HD2' ' A' ' 37' ' ' ARG . 41.8 tt0 -171.32 -34.07 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.303 -0.862 . . . . 73.239999999999995 109.213 177.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.75 149.43 84.98 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 114.82 -1.082 . . . . 64.430000000000007 111.757 -178.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -86.82 -177.86 2.4 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.004 2.469 . . . . 74.430000000000007 112.547 178.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 72.09 144.03 0.1 Allowed Pre-proline 0 N--CA 1.466 0.33 0 O-C-N 123.969 0.793 . . . . 72.140000000000001 111.311 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -66.95 -51.99 0.74 Allowed 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.239 1.959 . . . . 74.439999999999998 112.628 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.69 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 1.7 pt? -130.42 8.6 5.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.542 0.687 . . . . 75.109999999999999 110.74 -177.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.99 -75.79 1.68 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.086 -0.961 . . . . 64.310000000000002 112.505 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -116.24 -85.44 0.63 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.816 0.341 . . . . 14.109999999999999 110.69 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.7 p -154.05 15.68 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.939 0.876 . . . . 55.299999999999997 109.517 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.5 m -70.15 160.13 32.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.026 -0.988 . . . . 74.510000000000005 109.777 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 2.2 m95 -71.47 124.3 24.33 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.825 -0.806 . . . . 75.209999999999994 108.825 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.63 ' HB3' HD12 ' A' ' 80' ' ' LEU . 8.6 tp10 -140.46 153.21 46.17 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.145 -0.48 . . . . 65.409999999999997 110.846 -174.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -104.71 114.62 28.96 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.576 -0.738 . . . . 54.149999999999999 111.088 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -117.8 136.73 53.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.928 -0.578 . . . . 75.25 109.78 174.031 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.673 ' HG ' ' HA ' ' A' ' 77' ' ' TRP . 6.8 mp -91.37 128.38 37.17 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.73 0.3 . . . . 74.329999999999998 110.548 -178.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.782 ' HB ' ' HG3' ' A' ' 78' ' ' ARG . 12.9 t -70.55 -28.57 65.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 74.519999999999996 110.84 -173.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.11 131.46 17.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.895 -0.593 . . . . 50.210000000000001 109.793 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -141.5 91.88 2.42 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.037 0.446 . . . . 72.439999999999998 109.849 -178.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.608 ' HB2' ' H ' ' A' ' 74' ' ' ARG . 10.3 mm-40 -95.72 142.37 24.49 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 109.185 -0.672 . . . . 64.340000000000003 109.185 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.77 94.48 0.39 Allowed 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.417 2.078 . . . . 72.040000000000006 112.713 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.71 35.04 89.19 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.994 -0.622 . . . . 71.420000000000002 112.258 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.516 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 75.2 mmtt -127.05 -70.41 0.72 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.679 0.276 . . . . 70.109999999999999 110.332 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.608 ' H ' ' HB2' ' A' ' 70' ' ' GLU . 30.8 ptt-85 -150.58 132.35 15.0 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.737 -0.468 . . . . 75.239999999999995 109.737 176.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.579 ' HB ' HG13 ' A' ' 91' ' ' VAL . 3.9 mp -126.9 116.23 44.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.077 -0.511 . . . . 71.439999999999998 109.792 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -106.98 118.61 37.17 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.063 -0.517 . . . . 73.010000000000005 110.53 -178.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.673 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 36.2 m95 -87.07 145.58 26.41 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.841 -0.618 . . . . 62.299999999999997 111.238 -174.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.782 ' HG3' ' HB ' ' A' ' 67' ' ' THR . 19.0 mmm-85 -148.97 175.13 11.56 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.814 -0.63 . . . . 71.409999999999997 109.777 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.519 ' HB2' ' HB2' ' A' ' 86' ' ' GLU . 63.2 m -134.92 142.43 46.54 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.449 -0.945 . . . . 70.239999999999995 108.449 175.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.69 ' CD1' ' HB3' ' A' ' 57' ' ' LEU . 94.5 mt -67.0 153.12 95.15 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.579 -0.282 . . . . 55.530000000000001 110.931 -176.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -52.2 -16.78 5.13 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.953 3.102 . . . . 73.030000000000001 114.297 -173.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.85 -35.38 89.51 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.66 -0.781 . . . . 64.420000000000002 111.921 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.66 147.85 26.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.993 0.425 . . . . 72.140000000000001 111.093 -176.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.467 ' HD2' ' C ' ' A' ' 84' ' ' ARG . 6.0 ppt_? -115.44 -1.59 12.79 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.086 -0.507 . . . . 74.519999999999996 110.742 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.445 ' O ' HG13 ' A' ' 85' ' ' ILE . 10.1 tp -107.86 33.59 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.995 0.902 . . . . 60.329999999999998 110.247 -178.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 79' ' ' SER . 42.1 tt0 -64.24 122.01 15.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.664 -0.698 . . . . 73.5 110.555 177.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -103.59 140.56 37.37 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.355 -0.98 . . . . 71.430000000000007 108.355 174.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.1 m -94.77 126.19 39.93 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.19 0.519 . . . . 64.219999999999999 110.145 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 107' ' ' ARG . . . -159.0 146.39 12.95 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.304 -0.862 . . . . 62.340000000000003 111.443 -178.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -147.02 126.4 13.13 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 110.357 -0.238 . . . . 60.049999999999997 110.357 -176.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.656 HG23 HG23 ' A' ' 104' ' ' VAL . 2.5 p -108.6 121.68 62.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.055 0.455 . . . . 75.319999999999993 110.942 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.445 ' HB2' ' CG2' ' A' ' 105' ' ' VAL . 8.9 mp -108.96 139.82 43.3 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.736 -0.468 . . . . 73.239999999999995 109.736 174.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.513 ' HE2' HD13 ' A' ' 75' ' ' ILE . 93.9 m-85 -104.45 108.97 20.65 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.251 0.548 . . . . 72.540000000000006 110.073 178.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -126.73 144.88 51.46 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 115.461 -0.791 . . . . 72.540000000000006 110.046 -177.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.75 136.85 47.32 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.187 1.924 . . . . 42.210000000000001 111.551 176.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.524 ' CB ' ' HB3' ' A' ' 100' ' ' ARG . . . -77.63 146.99 74.13 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.185 -0.461 . . . . 75.120000000000005 110.011 178.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -37.78 108.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 124.111 3.208 . . . . 62.420000000000002 114.463 -172.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 90.04 -67.99 2.57 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 114.671 -1.149 . . . . 62.509999999999998 112.067 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -178.28 32.07 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.203 -0.498 . . . . 74.340000000000003 110.877 -174.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.524 ' HB3' ' CB ' ' A' ' 96' ' ' ALA . 21.8 tpp180 -74.2 -13.61 60.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.962 0.411 . . . . 74.219999999999999 110.802 -177.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 129.38 -157.53 21.76 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.962 -0.855 . . . . 32.32 110.962 -177.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 32.7 m -101.91 127.72 48.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.063 0.459 . . . . 73.010000000000005 109.815 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.422 ' CG ' ' HB1' ' A' ' 9' ' ' ALA . 44.2 tt0 -100.49 110.38 22.56 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.634 -0.712 . . . . 70.209999999999994 110.105 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.656 HG23 HG23 ' A' ' 91' ' ' VAL . 1.7 p -87.88 97.92 7.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.698 0.761 . . . . 71.140000000000001 109.364 175.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.844 HG12 ' HB2' ' A' ' 9' ' ' ALA . 22.7 m -84.43 110.79 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 115.059 -0.973 . . . . 71.109999999999999 109.802 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.7 p -112.67 123.89 68.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.797 -0.638 . . . . 64.140000000000001 110.878 -176.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.545 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 22.5 ptt180 -115.22 99.06 7.14 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.714 -0.676 . . . . 72.140000000000001 109.661 174.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 52.3 tp -120.46 141.98 49.67 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.021 -0.733 . . . . 71.329999999999998 109.021 -177.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.782 ' HA ' HG13 ' A' ' 5' ' ' VAL . 51.8 m -83.1 119.58 24.67 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.715 0.769 . . . . 53.25 111.922 -172.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -124.23 120.18 31.5 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.686 -1.143 . . . . 74.319999999999993 109.08 174.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -120.0 145.76 40.57 Favored Pre-proline 0 C--N 1.316 -0.849 0 N-CA-C 109.537 -0.542 . . . . 75.120000000000005 109.537 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.37 153.6 76.41 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.227 1.952 . . . . 73.030000000000001 111.343 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -80.18 5.12 6.24 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.565 2.176 . . . . 53.329999999999998 111.839 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 115.35 -147.86 18.92 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.005 -0.838 . . . . 50.049999999999997 111.005 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 61.38 45.46 96.37 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.924 -0.655 . . . . 65.219999999999999 112.824 176.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.9 m -62.41 -29.08 70.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.891 0.377 . . . . 75.340000000000003 110.912 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.83 -30.58 65.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.072 -0.513 . . . . 45.210000000000001 110.866 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -73.88 -20.23 79.74 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.81 -0.632 . . . . 51.409999999999997 112.916 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.51 -19.82 27.24 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 112.262 0.468 . . . . 32.509999999999998 112.262 -177.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.426 ' O ' ' HG3' ' A' ' 124' ' ' MET . 13.8 p -60.13 -29.79 44.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 62.200000000000003 111.832 -177.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.7 pp -65.46 -32.69 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 C-N-CA 120.85 -0.34 . . . . 75.310000000000002 111.022 -177.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.94 -39.36 56.3 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.689 -0.486 . . . . 63.210000000000001 109.689 176.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -59.01 -28.33 66.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.378 -0.828 . . . . 74.349999999999994 111.6 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.426 ' HG3' ' O ' ' A' ' 120' ' ' VAL . 66.1 mtt -60.07 -45.81 91.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.208 -0.451 . . . . 75.310000000000002 111.362 -178.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -106.86 -26.04 11.41 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.816 0.302 . . . . 72.140000000000001 111.816 -176.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -103.19 125.49 49.9 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.412 -0.588 . . . . 74.219999999999999 109.412 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -78.41 -0.87 30.88 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.271 -0.422 . . . . 72.099999999999994 111.509 -177.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 54.65 67.94 2.97 Favored Pre-proline 0 C--O 1.234 0.249 0 N-CA-C 109.289 -0.634 . . . . 74.329999999999998 109.289 -170.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -56.41 -41.41 76.51 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.08 2.52 . . . . 70.239999999999995 112.73 -172.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.6 t -147.26 168.22 22.28 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.64 -0.504 . . . . 74.25 109.64 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -92.87 -10.98 34.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.458 -0.337 . . . . 74.230000000000004 111.019 -175.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.02 116.71 12.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.573 0.701 . . . . 54.329999999999998 110.744 174.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 95.8 mt -127.95 135.02 49.37 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.695 -0.684 . . . . 63.340000000000003 110.121 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -88.96 40.44 0.98 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.874 0.369 . . . . 73.120000000000005 111.103 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.449 ' O ' ' HG3' ' A' ' 138' ' ' MET . 18.1 t70 -65.55 -43.92 88.42 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.002 0.43 . . . . 74.400000000000006 110.601 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -74.54 -36.46 63.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.239 0.542 . . . . 75.010000000000005 110.319 174.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.509 HD22 ' HB3' ' A' ' 8' ' ' ASP . 1.3 mp -70.63 -29.76 66.21 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.618 0.599 . . . . 75.120000000000005 112.618 -174.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.449 ' HG3' ' O ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -64.2 -26.2 68.41 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.412 -0.515 . . . . 63.409999999999997 110.076 175.442 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 55.8 mtt180 -69.61 -48.93 58.36 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.496 -0.557 . . . . 75.549999999999997 109.496 174.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -56.29 -48.95 75.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.841 -1.072 . . . . 62.310000000000002 110.985 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.592 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 0.6 OUTLIER -63.49 -44.13 95.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.016 -0.538 . . . . 73.209999999999994 110.141 179.748 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 48.0 ttt180 -57.46 -50.61 72.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.063 -0.517 . . . . 74.219999999999999 111.076 -175.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -66.17 -27.47 68.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.073 0.463 . . . . 65.340000000000003 110.594 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.76 ' HA ' HD11 ' A' ' 26' ' ' LEU . 54.5 tt0 -77.49 -29.21 52.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.795 -0.639 . . . . 72.439999999999998 112.035 -174.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.953 ' HB3' HG23 ' A' ' 12' ' ' ILE . 2.2 pp20? -108.49 -13.4 14.85 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.265 0.468 . . . . 73.209999999999994 112.265 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 57.5 tp -62.08 -40.33 95.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.265 0.555 . . . . 74.310000000000002 109.612 175.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -105.18 113.47 4.32 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.83 -0.7 . . . . 74.409999999999997 111.408 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 89.5 mt -80.78 -61.13 2.06 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.921 -0.4 . . . . 64.409999999999997 109.921 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -124.09 112.86 17.62 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.409 -0.96 . . . . 75.120000000000005 108.409 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -136.94 140.43 42.24 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.884 0.373 . . . . 73.420000000000002 110.864 -173.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -128.83 55.75 1.7 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.39 0.614 . . . . 62.43 109.987 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.444 ' HB3' ' H ' ' A' ' 153' ' ' HIS . 6.5 t60 51.37 -114.94 0.84 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.702 -1.135 . . . . 74.439999999999998 111.064 -176.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.444 ' H ' ' HB3' ' A' ' 152' ' ' HIS . 8.3 p-80 -173.04 157.69 3.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.721 0.296 . . . . 65.230000000000004 111.001 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -163.68 -107.87 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.283 -1.006 . . . . 73.430000000000007 108.283 171.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 . . . . . 0 C--O 1.246 0.892 0 CA-C-O 118.229 -0.891 . . . . 74.450000000000003 108.837 177.139 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtm . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 121.337 0.589 . . . . 72.409999999999997 110.135 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 123.06 -76.9 0.36 Allowed Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.508 -0.769 . . . . 32.329999999999998 111.222 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 47.29 55.32 8.34 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.361 0.6 . . . . 75.239999999999995 110.475 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.3 m -119.44 123.41 44.0 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.653 0.739 . . . . 60.439999999999998 111.617 -169.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.585 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 70.0 t -118.39 110.71 31.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 114.876 -1.056 . . . . 45.229999999999997 108.456 172.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.4 p -77.82 124.38 36.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.466 0.65 . . . . 73.030000000000001 110.44 -174.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.711 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -141.52 110.56 6.23 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.344 -0.844 . . . . 71.400000000000006 110.621 -179.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.506 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 14.3 t70 -146.21 171.38 15.03 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.036 -0.727 . . . . 64.109999999999999 109.036 175.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.68 ' HB2' HG12 ' A' ' 105' ' ' VAL . . . -139.72 120.69 14.57 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.939 0.4 . . . . 73.129999999999995 111.02 -174.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.1 m -115.09 143.44 24.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.985 -0.552 . . . . 74.439999999999998 110.163 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.544 HG21 ' HB2' ' A' ' 100' ' ' ARG . 42.6 m -103.79 111.87 24.57 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.967 -0.56 . . . . 71.400000000000006 110.322 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.642 HD13 ' HG2' ' A' ' 141' ' ' LYS . 9.4 mm -100.63 146.0 10.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.287 -0.415 . . . . 74.230000000000004 109.945 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.16 60.11 4.5 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.689 -0.767 . . . . 52.539999999999999 111.817 174.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.527 ' HB2' HD21 ' A' ' 19' ' ' LEU . 24.2 mmtm -141.19 145.25 37.85 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 109.764 -0.458 . . . . 62.100000000000001 109.764 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.41 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 72.9 Cg_exo -52.24 -57.68 1.98 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.157 2.572 . . . . 64.409999999999997 113.58 -175.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . 174.54 -46.66 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.932 0.396 . . . . 63.399999999999999 111.156 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -59.19 -45.43 91.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.075 -0.511 . . . . 74.540000000000006 110.866 -176.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.615 ' HA ' ' HB3' ' A' ' 21' ' ' ALA . 21.4 mp0 -66.64 -16.67 64.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.886 -0.597 . . . . 72.099999999999994 110.906 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.757 ' HA ' ' NE2' ' A' ' 144' ' ' GLN . 74.5 mt -73.76 -45.5 51.45 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.36 -0.382 . . . . 74.140000000000001 110.256 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -74.28 -29.9 61.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.383 0.611 . . . . 73.340000000000003 109.896 174.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.615 ' HB3' ' HA ' ' A' ' 18' ' ' GLN . . . -70.34 -3.03 15.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.276 -0.874 . . . . 60.299999999999997 111.927 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.715 HG21 ' HD2' ' A' ' 140' ' ' PHE . 10.9 p -53.2 -21.21 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.096 0.558 . . . . 62.109999999999999 111.991 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 4.2 m95 -59.19 -26.15 64.57 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.796 0.332 . . . . 74.209999999999994 110.92 176.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -136.95 -164.67 1.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 74.209999999999994 110.168 -177.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.453 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 5.3 t70 -88.03 46.67 1.41 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.282 -0.417 . . . . 70.209999999999994 110.209 -176.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 25' ' ' ASP . 0.4 OUTLIER 43.14 84.87 0.18 Allowed Pre-proline 0 N--CA 1.476 0.86 0 C-N-CA 123.513 0.725 . . . . 71.109999999999999 111.965 -177.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.641 ' HB3' ' HB2' ' A' ' 38' ' ' SER . 32.1 Cg_exo -59.41 -55.61 1.73 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.983 2.455 . . . . 54.439999999999998 113.867 -173.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.71 71.34 1.03 Allowed Glycine 0 C--N 1.32 -0.309 0 C-N-CA 120.858 -0.687 . . . . 42.149999999999999 112.013 -176.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.587 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 0.8 OUTLIER -127.95 70.44 77.89 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.74 0.781 . . . . 54.210000000000001 112.007 -179.446 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -75.08 0.85 8.44 Favored 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.267 1.978 . . . . 64.430000000000007 112.027 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.4 ' N ' HD12 ' A' ' 31' ' ' LEU . 6.0 mp -82.36 -52.19 7.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.812 -0.631 . . . . 74.409999999999997 110.492 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.1 mt 59.74 31.09 20.64 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.717 -0.674 . . . . 74.540000000000006 111.519 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 50.0 ttm -132.61 135.02 45.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.614 -0.266 . . . . 63.130000000000003 110.761 -177.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.4 m 66.95 8.82 6.38 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 123.697 0.623 . . . . 70.219999999999999 111.925 175.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 57.61 143.68 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.995 1.318 . . . . 63.340000000000003 112.881 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.7 mp -112.95 -171.55 1.89 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.005 -0.739 . . . . 73.019999999999996 109.005 175.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -64.29 -23.28 67.24 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.391 0.615 . . . . 45.039999999999999 110.246 175.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.641 ' HB2' ' HB3' ' A' ' 27' ' ' PRO . 17.2 m -138.08 131.08 30.02 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.533 -0.758 . . . . 64.140000000000001 109.369 177.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.556 ' HA ' ' CD1' ' A' ' 29' ' ' LEU . 8.3 m -119.96 162.97 17.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.616 -0.265 . . . . 71.129999999999995 111.126 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.625 ' HG2' ' HD3' ' A' ' 45' ' ' LYS . 18.8 tt0 -88.64 13.61 11.86 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.914 0.864 . . . . 75.400000000000006 110.47 -176.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.524 HG11 ' HD1' ' A' ' 49' ' ' TRP . 14.6 p -141.85 128.55 19.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.326 -0.852 . . . . 65.109999999999999 109.708 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.1 tp -171.87 -53.74 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.694 0.283 . . . . 75.439999999999998 110.77 -172.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.552 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 32.0 t70 -161.09 -38.73 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.046 -0.524 . . . . 74.400000000000006 110.755 -177.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -68.69 -69.84 0.3 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.292 -0.867 . . . . 72.230000000000004 111.804 -175.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.644 ' HA ' ' CD2' ' A' ' 66' ' ' LEU . 39.2 mtpt -72.45 -43.86 63.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.16 0.505 . . . . 75.0 111.067 -178.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 46' ' ' ARG . 21.2 mtt180 -148.12 143.26 27.0 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.238 -0.892 . . . . 55.409999999999997 109.296 171.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.641 ' H ' ' HG3' ' A' ' 63' ' ' GLU . 15.2 m -79.77 115.25 19.26 Favored 'General case' 0 C--N 1.318 -0.765 0 O-C-N 123.583 0.552 . . . . 63.439999999999998 110.714 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.404 ' HG2' ' H ' ' A' ' 49' ' ' TRP . 31.5 ttp180 68.43 165.17 0.24 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.317 -0.856 . . . . 74.439999999999998 110.653 -176.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.524 ' HD1' HG11 ' A' ' 41' ' ' VAL . 39.4 t90 -76.48 80.77 3.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.202 0.525 . . . . 73.319999999999993 110.425 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.4 p -86.3 -80.76 0.23 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.989 -0.55 . . . . 72.420000000000002 110.377 177.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.461 HG12 ' HG3' ' A' ' 52' ' ' GLU . 47.7 t 67.56 -70.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 O-C-N 123.579 0.55 . . . . 64.200000000000003 111.533 178.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.461 ' HG3' HG12 ' A' ' 51' ' ' VAL . 48.3 mt-10 -120.27 94.26 4.32 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.031 0.443 . . . . 73.120000000000005 110.016 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.15 151.46 44.66 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.71 -0.677 . . . . 73.530000000000001 110.115 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.83 113.8 2.14 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.221 1.947 . . . . 72.340000000000003 110.913 174.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.49 ' HB3' ' HA3' ' A' ' 58' ' ' GLY . . . 66.38 143.3 0.08 OUTLIER Pre-proline 0 N--CA 1.466 0.344 0 O-C-N 123.971 0.794 . . . . 73.030000000000001 110.523 -171.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.49 ' HB2' HD11 ' A' ' 80' ' ' LEU . 11.0 Cg_endo -54.95 -54.6 4.2 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.515 2.143 . . . . 63.310000000000002 112.161 -177.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.665 HD23 ' H ' ' A' ' 57' ' ' LEU . 2.6 pt? -103.73 12.83 34.2 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.744 -0.662 . . . . 53.409999999999997 110.418 -176.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.49 ' HA3' ' HB3' ' A' ' 55' ' ' ALA . . . -78.01 5.67 52.8 Favored Glycine 0 C--N 1.318 -0.434 0 CA-C-N 115.263 -0.88 . . . . 64.329999999999998 113.526 -174.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -126.65 0.46 6.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.089 0.471 . . . . 44.219999999999999 111.172 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.9 m -128.01 179.6 3.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.245 -0.434 . . . . 74.420000000000002 110.972 -175.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.7 m -75.16 -42.69 55.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.554 0.692 . . . . 64.129999999999995 109.415 175.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -161.93 159.65 26.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.925 -1.034 . . . . 75.200000000000003 108.398 170.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.796 ' HB3' HD12 ' A' ' 80' ' ' LEU . 44.0 tt0 -136.72 137.93 40.47 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.955 -0.387 . . . . 75.140000000000001 109.955 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.9 114.67 26.31 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.312 -0.625 . . . . 61.310000000000002 109.312 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.422 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 7.6 tt0 -108.83 134.61 51.29 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.964 -0.294 . . . . 52.350000000000001 110.533 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.015 HD12 ' HA ' ' A' ' 77' ' ' TRP . 2.2 mm? -83.95 137.32 33.69 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.356 -0.609 . . . . 70.349999999999994 109.356 174.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.564 HG23 ' HB2' ' A' ' 78' ' ' ARG . 20.8 p -67.67 -34.37 76.79 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.502 0.668 . . . . 72.329999999999998 110.546 -176.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -135.72 124.85 24.43 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.979 -1.009 . . . . 72.099999999999994 110.725 177.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -117.36 90.77 3.41 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.432 -0.804 . . . . 71.400000000000006 109.581 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.99 ' HB3' ' HB2' ' A' ' 73' ' ' LYS . 48.9 mt-10 -120.02 86.52 37.09 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.483 -0.781 . . . . 73.120000000000005 110.452 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -60.6 107.03 0.39 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.599 2.199 . . . . 72.310000000000002 111.82 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.409 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 99.09 6.16 55.94 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.896 -0.669 . . . . 53.350000000000001 111.827 -177.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.99 ' HB2' ' HB3' ' A' ' 70' ' ' GLU . 2.8 mmmp? -128.62 -66.38 0.84 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.586 0.231 . . . . 70.239999999999995 110.488 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 22.4 ptt180 -168.3 150.09 5.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.323 -0.399 . . . . 75.310000000000002 110.643 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.6 mp -124.98 114.29 39.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 116.195 -0.457 . . . . 74.040000000000006 109.793 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.579 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . . . -101.68 121.02 41.25 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.076 -0.511 . . . . 74.209999999999994 110.448 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 1.015 ' HA ' HD12 ' A' ' 66' ' ' LEU . 26.3 m0 -80.49 155.43 27.03 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.989 0.737 . . . . 72.219999999999999 112.989 -172.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.573 ' HG3' ' H ' ' A' ' 79' ' ' SER . 24.7 tpp180 -176.62 174.63 1.83 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 114.394 -1.275 . . . . 54.450000000000003 108.238 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.573 ' H ' ' HG3' ' A' ' 78' ' ' ARG . 24.6 m -148.75 145.81 27.78 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.001 -1.111 . . . . 70.420000000000002 108.001 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.796 HD12 ' HB3' ' A' ' 63' ' ' GLU . 90.2 mt -71.7 152.08 93.48 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.911 -0.404 . . . . 75.439999999999998 109.911 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -52.35 -23.3 18.11 Favored 'Trans proline' 0 N--CA 1.476 0.445 0 C-N-CA 123.315 2.677 . . . . 72.439999999999998 113.93 -175.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -78.53 -4.14 87.16 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.821 -0.704 . . . . 62.329999999999998 112.997 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.33 -170.74 2.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.919 0.39 . . . . 60.229999999999997 110.935 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.466 ' HB2' HD12 ' A' ' 85' ' ' ILE . 86.8 mtt180 -118.06 -38.42 3.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.052 -0.522 . . . . 70.010000000000005 112.095 -172.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.466 HD12 ' HB2' ' A' ' 84' ' ' ARG . 4.8 mp -121.5 122.84 68.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.928 -0.309 . . . . 63.530000000000001 110.722 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.468 ' HB3' ' HB2' ' A' ' 79' ' ' SER . 11.3 pt-20 -125.79 123.19 38.22 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.53 -0.544 . . . . 74.230000000000004 109.53 172.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -111.64 138.67 47.88 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.032 -0.729 . . . . 74.140000000000001 109.032 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.2 m -96.04 128.15 42.69 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.685 -0.487 . . . . 34.5 109.685 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.24 123.73 0.69 Allowed Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.74 -0.743 . . . . 60.009999999999998 111.896 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 0.5 OUTLIER -108.95 126.19 52.83 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.904 0.383 . . . . 75.120000000000005 110.297 178.419 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 4.4 m -97.81 126.68 50.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.463 -0.569 . . . . 52.32 109.463 176.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.485 ' HB2' ' CG2' ' A' ' 105' ' ' VAL . 9.5 mp -105.32 139.06 40.53 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.422 -0.354 . . . . 65.239999999999995 110.886 -177.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -99.57 105.64 17.54 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.456 -0.942 . . . . 62.539999999999999 108.456 172.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.4 mtp85 -112.68 150.25 42.43 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 115.288 -0.869 . . . . 64.420000000000002 111.1 -171.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -49.71 127.3 18.41 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.427 2.084 . . . . 71.219999999999999 111.204 172.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.37 150.85 85.23 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.881 -0.599 . . . . 51.229999999999997 111.762 -172.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.78 109.43 0.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.824 2.349 . . . . 71.439999999999998 112.089 175.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.8 -73.9 1.34 Allowed Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.175 -0.92 . . . . 63.240000000000002 111.483 177.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 174.31 24.57 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.273 0.631 . . . . 72.219999999999999 111.264 -175.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.544 ' HB2' HG21 ' A' ' 11' ' ' THR . 19.6 mtp180 -82.62 7.04 15.8 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.544 0.572 . . . . 53.299999999999997 112.544 -171.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 126.68 -113.14 1.71 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.49 -0.862 . . . . 44.32 111.78 177.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.745 ' HB ' HD11 ' A' ' 19' ' ' LEU . 15.7 m -141.17 140.6 34.07 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.841 0.353 . . . . 72.099999999999994 110.265 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -96.59 119.02 34.3 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.176 -0.466 . . . . 63.119999999999997 110.755 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 p -100.67 107.49 21.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.495 0.664 . . . . 62.119999999999997 110.258 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.68 HG12 ' HB2' ' A' ' 9' ' ' ALA . 18.8 m -95.45 118.69 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 115.37 -0.832 . . . . 74.219999999999999 110.046 178.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.711 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 18.6 m -112.2 127.92 69.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.837 -0.62 . . . . 72.019999999999996 110.584 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.479 ' HG3' ' HB3' ' A' ' 7' ' ' ARG . 10.1 ttp180 -137.67 100.38 4.19 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.054 -0.521 . . . . 74.239999999999995 109.857 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 pp -145.46 155.23 42.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.974 -0.557 . . . . 74.239999999999995 109.508 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 11.4 t -80.82 137.69 36.21 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.154 -0.618 . . . . 64.040000000000006 109.876 -176.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -160.17 111.41 1.93 Allowed 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.069 -1.085 . . . . 73.400000000000006 108.069 -171.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.497 ' H ' ' HG3' ' A' ' 111' ' ' ARG . 1.2 ppt_? -95.36 144.53 27.96 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-O 121.041 0.448 . . . . 74.310000000000002 111.692 -170.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 111' ' ' ARG . 24.1 Cg_endo -91.21 160.59 3.79 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 123.154 2.569 . . . . 64.019999999999996 111.673 175.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -65.64 -22.92 57.3 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.473 2.115 . . . . 65.310000000000002 112.359 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -160.62 -133.13 1.43 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 121.001 -0.618 . . . . 23.120000000000001 111.998 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 121.48 -15.21 9.23 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.705 -0.759 . . . . 52.32 112.417 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.6 m -85.26 -48.8 8.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.078 0.466 . . . . 71.310000000000002 110.585 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.495 ' O ' HG22 ' A' ' 120' ' ' VAL . . . -72.69 -39.61 66.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.926 -0.579 . . . . 63.109999999999999 111.431 -177.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.5 ' O ' HG22 ' A' ' 121' ' ' ILE . . . -67.01 -20.02 70.43 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 121.037 -0.601 . . . . 62.539999999999999 113.273 -177.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.17 -21.31 60.72 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.228 0.455 . . . . 61.329999999999998 112.228 -175.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 117' ' ' ALA . 10.7 m -77.12 -18.84 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.509 0.559 . . . . 54.109999999999999 112.509 -173.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.5 HG22 ' O ' ' A' ' 118' ' ' GLY . 16.1 tt -68.86 -28.98 41.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.893 -0.323 . . . . 70.439999999999998 111.061 -176.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.516 ' HB2' ' HG2' ' A' ' 129' ' ' PRO . . . -61.33 -27.49 68.53 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.779 -0.646 . . . . 72.420000000000002 111.953 -175.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 16.7 mtm180 -66.79 -42.59 85.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.091 0.472 . . . . 71.129999999999995 110.009 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 40.5 ttp -71.18 -54.14 12.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.758 -0.656 . . . . 70.109999999999999 109.789 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.428 ' CD2' ' HG3' ' A' ' 127' ' ' GLN . 16.6 t80 -159.26 136.92 10.09 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.505 -0.924 . . . . 72.340000000000003 108.505 178.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -58.31 -74.0 0.07 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.046 0.387 . . . . 45.530000000000001 112.046 -170.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.428 ' HG3' ' CD2' ' A' ' 125' ' ' PHE . 92.5 mt-30 60.39 12.74 3.62 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.388 0.514 . . . . 64.420000000000002 112.388 178.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 56.42 82.08 0.25 Allowed Pre-proline 0 CA--C 1.534 0.35 0 O-C-N 123.541 0.525 . . . . 72.109999999999999 111.035 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.516 ' HG2' ' HB2' ' A' ' 122' ' ' ALA . 6.2 Cg_exo -79.03 -56.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.79 2.327 . . . . 42.130000000000003 112.818 -176.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 29.9 p -129.88 105.88 8.29 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.235 -0.439 . . . . 65.010000000000005 110.548 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -135.16 -66.29 0.58 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.114 -0.494 . . . . 75.409999999999997 110.553 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 67.56 -58.99 0.42 Allowed 'General case' 0 N--CA 1.466 0.342 0 O-C-N 124.013 0.821 . . . . 71.409999999999997 110.529 -172.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 42.4 tp 53.48 76.35 0.22 Allowed 'General case' 0 C--O 1.233 0.215 0 O-C-N 123.689 0.618 . . . . 74.420000000000002 111.58 174.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 33.9 mtt-85 57.08 42.9 25.14 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.532 -0.758 . . . . 74.439999999999998 110.369 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -56.96 -56.5 20.85 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.77 0.285 . . . . 72.150000000000006 111.77 -173.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -76.56 -39.52 52.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.886 0.374 . . . . 75.329999999999998 110.156 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.564 ' CD1' ' HE1' ' A' ' 140' ' ' PHE . 0.3 OUTLIER -53.75 -51.0 64.78 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.667 -0.697 . . . . 55.020000000000003 111.589 -178.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.53 ' CE ' ' HA ' ' A' ' 138' ' ' MET . 0.6 OUTLIER -65.17 -38.18 89.71 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.429 -0.35 . . . . 72.209999999999994 111.001 -175.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.422 ' O ' ' HB3' ' A' ' 142' ' ' ARG . 34.2 mtm105 -65.68 -51.66 57.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.509 -0.314 . . . . 72.140000000000001 111.676 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.715 ' HD2' HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -73.57 -30.21 62.89 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 120.06 -0.656 . . . . 63.5 109.779 -175.123 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.642 ' HG2' HD13 ' A' ' 12' ' ' ILE . 13.5 tmtt? -55.44 -50.44 69.83 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.235 -0.654 . . . . 62.530000000000001 109.235 173.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.602 ' HE ' ' HG3' ' A' ' 143' ' ' GLU . 43.7 ttp180 -52.53 -54.93 26.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.514 -1.221 . . . . 73.420000000000002 111.674 177.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.602 ' HG3' ' HE ' ' A' ' 142' ' ' ARG . 30.6 mt-10 -72.97 -34.02 66.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.958 -0.565 . . . . 73.099999999999994 111.812 -174.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.757 ' NE2' ' HA ' ' A' ' 19' ' ' LEU . 46.0 tt0 -61.65 -44.46 96.92 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.299 0.481 . . . . 75.430000000000007 112.299 -174.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -85.73 -8.74 57.98 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.272 -0.571 . . . . 75.420000000000002 111.12 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 57.5 tp -84.21 -53.18 5.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.082 0.468 . . . . 43.520000000000003 109.869 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 138.98 -176.48 20.89 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.933 -0.867 . . . . 43.399999999999999 110.933 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.533 ' HG ' ' H ' ' A' ' 149' ' ' GLU . 12.2 tp 71.67 175.91 0.28 Allowed 'General case' 0 CA--C 1.534 0.364 0 O-C-N 123.872 0.395 . . . . 72.140000000000001 110.418 177.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.533 ' H ' ' HG ' ' A' ' 148' ' ' LEU . 31.5 tt0 -77.45 -70.11 0.49 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.965 0.412 . . . . 60.219999999999999 110.597 177.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.597 ' HE1' ' HB2' ' A' ' 140' ' ' PHE . 0.1 OUTLIER -177.17 145.08 0.45 Allowed 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.531 -0.759 . . . . 72.150000000000006 109.329 -176.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -75.84 -29.0 58.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.719 0.295 . . . . 64.519999999999996 110.333 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 24.5 m170 63.08 -170.57 0.18 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.838 -0.619 . . . . 71.510000000000005 112.55 174.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.4 ' HB3' ' H ' ' A' ' 154' ' ' HIS . 0.9 OUTLIER 68.44 -89.32 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 114.752 -1.113 . . . . 64.150000000000006 111.14 174.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.4 ' H ' ' HB3' ' A' ' 153' ' ' HIS . 56.4 t-80 55.63 73.61 0.42 Allowed 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.494 0.496 . . . . 75.319999999999993 110.633 -176.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 24.2 t60 . . . . . 0 C--O 1.244 0.766 0 CA-C-O 118.361 -0.828 . . . . 52.509999999999998 109.314 179.313 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.467 ' O ' ' HG3' ' A' ' 3' ' ' GLU . 52.3 mtt . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 109.68 -0.489 . . . . 73.099999999999994 109.68 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.34 -97.27 0.76 Allowed Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 110.789 -0.924 . . . . 74.129999999999995 110.789 -172.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 1' ' ' MET . 35.9 mt-10 45.11 81.05 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.54 0.736 . . . . 64.200000000000003 112.551 169.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 110' ' ' TYR . 26.8 m -128.8 122.67 31.01 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.607 -0.516 . . . . 62.520000000000003 109.607 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 82.4 t -111.54 109.14 27.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.801 -0.444 . . . . 73.310000000000002 109.801 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.5 t -93.72 116.52 35.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.826 -0.625 . . . . 72.209999999999994 110.314 -176.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.44 109.79 13.15 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.965 -0.754 . . . . 73.010000000000005 108.965 172.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.577 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 7.0 t70 -157.72 172.03 19.24 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.039 -1.097 . . . . 62.130000000000003 108.039 175.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.473 ' CB ' HG22 ' A' ' 105' ' ' VAL . . . -136.84 121.05 17.91 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.949 0.404 . . . . 74.219999999999999 111.486 -173.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.9 m -109.27 141.67 23.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.256 -0.646 . . . . 63.219999999999999 109.256 175.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 t -116.47 124.68 50.55 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.937 0.875 . . . . 74.099999999999994 110.99 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.76 HG23 ' HB3' ' A' ' 145' ' ' GLU . 4.7 mp -121.85 150.18 25.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.692 -1.14 . . . . 51.310000000000002 109.685 -176.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.9 37.99 0.76 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.509 -0.377 . . . . 71.409999999999997 113.582 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.557 ' HG2' HG22 ' A' ' 12' ' ' ILE . 74.3 mmtt -105.66 152.0 39.98 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 108.264 -1.013 . . . . 52.109999999999999 108.264 175.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.73 -57.85 1.37 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.151 1.9 . . . . 51.25 112.593 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 173.33 -54.1 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.404 0.621 . . . . 53.340000000000003 110.164 178.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.756 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 7.8 mt-10 -55.56 -39.32 70.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.82 -1.082 . . . . 63.119999999999997 111.814 -175.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.612 ' NE2' ' HB2' ' A' ' 17' ' ' GLU . 2.5 mp0 -73.43 -14.11 61.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.864 -0.607 . . . . 74.340000000000003 111.135 -175.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.3 mt -76.04 -44.07 40.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.592 -0.276 . . . . 64.109999999999999 111.064 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.756 ' CE2' ' HA ' ' A' ' 17' ' ' GLU . 21.1 p90 -73.75 -23.47 59.74 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 119.999 -0.68 . . . . 74.109999999999999 110.22 175.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.631 ' HB1' ' HD2' ' A' ' 27' ' ' PRO . . . -75.58 -2.64 30.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.5 -0.773 . . . . 71.209999999999994 111.74 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.45 HG11 ' HZ ' ' A' ' 140' ' ' PHE . 15.0 p -52.14 -31.55 14.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 112.144 0.424 . . . . 74.450000000000003 112.144 -177.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -67.7 -13.0 61.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.706 0.289 . . . . 75.549999999999997 111.449 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.767 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . 39.3 mmt180 -117.14 15.28 14.99 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.193 -0.458 . . . . 72.299999999999997 110.715 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.436 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 11.6 t70 61.5 37.57 16.4 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.864 0.84 . . . . 71.340000000000003 109.117 -175.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER 43.84 85.33 0.17 Allowed Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 114.967 -1.015 . . . . 73.430000000000007 111.726 -177.492 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.767 ' HD3' ' HB2' ' A' ' 24' ' ' ARG . 63.3 Cg_endo -73.59 111.63 3.34 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.617 2.211 . . . . 74.409999999999997 112.579 -175.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.444 ' C ' ' HD3' ' A' ' 30' ' ' PRO . . . -79.14 97.61 1.55 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.584 -0.817 . . . . 60.0 111.482 176.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.44 74.06 11.22 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 121.057 0.456 . . . . 64.340000000000003 111.839 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.444 ' HD3' ' C ' ' A' ' 28' ' ' GLY . 8.0 Cg_exo -72.58 -4.1 14.68 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.888 2.392 . . . . 73.540000000000006 111.778 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.695 ' H ' HD12 ' A' ' 31' ' ' LEU . 4.4 mp -64.7 -35.11 79.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.803 -0.635 . . . . 72.140000000000001 110.07 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -76.97 -14.72 59.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.823 -0.626 . . . . 71.019999999999996 110.176 177.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 46.6 ttm 71.24 -57.09 0.61 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.248 -0.887 . . . . 73.430000000000007 111.604 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 45.3 p -69.53 141.13 53.92 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.209 -0.45 . . . . 72.409999999999997 110.965 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -72.72 -66.14 0.7 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.84 -0.43 . . . . 71.310000000000002 109.84 176.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 50.2 tp -139.86 87.74 2.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.24 -0.436 . . . . 61.229999999999997 110.018 175.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -173.32 128.87 0.45 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.799 -0.637 . . . . 71.510000000000005 109.605 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.416 ' HA ' ' CD2' ' A' ' 42' ' ' LEU . 43.0 m 67.14 9.0 6.6 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.406 0.521 . . . . 72.420000000000002 112.406 178.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.418 HG12 HG11 ' A' ' 51' ' ' VAL . 43.8 t -98.18 -53.92 7.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.811 -0.811 . . . . 72.019999999999996 108.811 174.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.472 ' HB3' ' H ' ' A' ' 41' ' ' VAL . 23.7 mm-40 -85.45 -160.16 0.5 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.064 -0.971 . . . . 62.039999999999999 110.665 173.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.77 ' HB ' ' HB3' ' A' ' 47' ' ' SER . 5.8 p -42.6 127.27 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 121.872 0.844 . . . . 72.099999999999994 112.279 -177.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.416 ' CD2' ' HA ' ' A' ' 38' ' ' SER . 73.0 mt -91.39 -30.74 16.35 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.964 -1.017 . . . . 71.099999999999994 110.298 -176.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -80.35 -3.99 51.71 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.337 -0.847 . . . . 53.240000000000002 111.583 -178.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.438 ' H ' HG22 ' A' ' 41' ' ' VAL . 16.3 t70 68.72 -39.67 0.42 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.943 0.897 . . . . 72.329999999999998 112.249 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 1.003 ' HG3' ' HG3' ' A' ' 46' ' ' ARG . 17.3 tppt? -88.77 -62.62 1.45 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.545 0.212 . . . . 73.030000000000001 111.468 178.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 1.003 ' HG3' ' HG3' ' A' ' 45' ' ' LYS . 70.4 mtp85 -117.98 129.93 55.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.792 0.33 . . . . 72.430000000000007 110.761 -175.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.77 ' HB3' ' HB ' ' A' ' 41' ' ' VAL . 46.7 p -96.62 150.1 21.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.232 -0.44 . . . . 61.240000000000002 110.9 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 48' ' ' ARG . 49.2 mtp180 -85.85 -37.64 18.97 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.306 -0.628 . . . . 73.439999999999998 109.306 175.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 33.3 t90 -161.21 133.95 6.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.375 -0.829 . . . . 73.030000000000001 109.838 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.408 HG22 ' H ' ' A' ' 53' ' ' ALA . 11.3 m -94.28 140.57 29.61 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.23 -0.441 . . . . 52.039999999999999 110.343 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.418 HG11 HG12 ' A' ' 39' ' ' VAL . 11.2 p -94.69 -26.13 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.678 0.275 . . . . 74.25 110.77 -175.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -56.91 -57.27 13.22 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.03 -0.729 . . . . 62.439999999999998 109.03 176.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.408 ' H ' HG22 ' A' ' 50' ' ' THR . . . -128.26 143.78 49.34 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.086 -0.961 . . . . 73.209999999999994 109.049 175.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.79 124.83 16.61 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.376 2.051 . . . . 61.409999999999997 112.257 -178.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 58' ' ' GLY . . . 70.36 142.41 0.09 OUTLIER Pre-proline 0 N--CA 1.467 0.402 0 O-C-N 123.957 0.786 . . . . 65.409999999999997 111.817 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.555 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 9.9 Cg_endo -53.86 -56.17 2.85 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 123.23 2.62 . . . . 73.109999999999999 113.052 -176.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.623 HD21 ' O ' ' A' ' 63' ' ' GLU . 0.1 OUTLIER -97.94 7.92 45.57 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.567 -0.453 . . . . 63.43 111.749 -177.457 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.563 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . 116.83 -82.8 0.33 Allowed Glycine 0 C--O 1.225 -0.465 0 C-N-CA 120.137 -1.03 . . . . 32.520000000000003 113.606 176.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -139.85 16.35 2.49 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 122.034 -0.686 . . . . 74.409999999999997 111.874 -176.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.475 HG22 ' HB2' ' A' ' 57' ' ' LEU . 34.5 m -101.22 11.19 7.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 120.978 -0.289 . . . . 74.420000000000002 111.216 -178.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.414 ' HB3' ' HE3' ' A' ' 62' ' ' TRP . 22.3 t 60.31 -152.68 0.39 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.094 -0.706 . . . . 71.200000000000003 109.094 -175.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.414 ' HE3' ' HB3' ' A' ' 61' ' ' SER . 1.2 m-90 74.98 -162.92 0.07 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.288 0.566 . . . . 72.329999999999998 112.51 173.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.623 ' O ' HD21 ' A' ' 57' ' ' LEU . 11.3 mt-10 -107.4 166.28 10.77 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.835 -1.075 . . . . 73.040000000000006 110.249 -175.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.555 ' HB2' ' CB ' ' A' ' 56' ' ' PRO . . . -105.09 146.87 28.54 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.5 -0.556 . . . . 61.119999999999997 109.5 169.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.827 ' HB2' HD23 ' A' ' 80' ' ' LEU . 5.5 tm-20 -108.05 135.21 49.8 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.356 -1.35 . . . . 51.210000000000001 107.356 177.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.719 HD21 ' HB2' ' A' ' 69' ' ' ASP . 29.3 tp -137.96 149.38 46.09 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.486 -0.486 . . . . 74.540000000000006 110.462 -171.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.9 t -119.11 -18.34 8.74 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.251 -0.58 . . . . 73.5 111.773 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -152.61 129.07 10.65 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 120.776 -0.37 . . . . 63.399999999999999 111.605 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.719 ' HB2' HD21 ' A' ' 66' ' ' LEU . 19.3 t70 -136.17 90.66 2.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.4 -0.818 . . . . 74.230000000000004 110.273 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 73' ' ' LYS . 31.4 mt-10 -139.38 142.82 33.6 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 110.067 -0.346 . . . . 65.209999999999994 110.067 177.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 16.5 Cg_exo -69.1 -55.06 0.21 Allowed 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.747 2.298 . . . . 63.119999999999997 113.061 -178.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.56 49.88 0.83 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.572 -0.823 . . . . 75.349999999999994 112.42 -176.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.568 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 7.7 mmmm -139.0 -74.48 0.38 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.026 0.441 . . . . 63.420000000000002 110.428 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.529 ' HB3' HD13 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -166.51 137.78 3.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.957 -0.565 . . . . 71.010000000000005 110.1 179.127 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.679 HD13 ' HE2' ' A' ' 93' ' ' PHE . 3.2 mp -109.44 110.11 30.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.901 -0.778 . . . . 72.209999999999994 108.901 173.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -119.2 115.19 23.69 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.438 -0.949 . . . . 23.34 108.438 176.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.695 ' HA ' HD12 ' A' ' 66' ' ' LEU . 63.0 p-90 -121.48 157.65 30.15 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.511 0.672 . . . . 65.349999999999994 111.544 -169.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.683 ' HD2' ' OE1' ' A' ' 65' ' ' GLU . 69.8 mtt180 -136.39 175.8 9.28 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 107.92 -1.141 . . . . 62.119999999999997 107.92 176.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.661 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 19.6 m -137.19 51.54 1.95 Allowed 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.678 -0.49 . . . . 61.310000000000002 109.678 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.827 HD23 ' HB2' ' A' ' 65' ' ' GLU . 13.0 mt 65.3 142.21 0.07 OUTLIER Pre-proline 0 N--CA 1.471 0.624 0 O-C-N 124.264 0.977 . . . . 64.109999999999999 111.014 -175.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 80' ' ' LEU . 22.4 Cg_exo -66.38 -35.33 31.57 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.461 2.107 . . . . 71.439999999999998 112.097 177.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.87 18.46 57.17 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.596 -0.811 . . . . 52.32 112.87 -177.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 79' ' ' SER . . . -118.14 -158.13 0.7 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 122.582 -0.363 . . . . 64.540000000000006 111.167 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -66.5 -66.07 0.6 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.642 0.608 . . . . 51.409999999999997 112.642 -168.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 50.2 mt 59.61 87.96 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.264 0.555 . . . . 74.239999999999995 110.547 -172.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -80.19 -46.25 16.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.98 -0.554 . . . . 63.049999999999997 110.952 -175.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.64 HD21 ' HB2' ' A' ' 108' ' ' LEU . 54.2 t30 -125.89 162.15 25.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.1 -0.5 . . . . 61.32 109.771 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.8 m -138.35 128.65 25.95 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.082 -0.34 . . . . 74.439999999999998 110.082 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.18 148.89 4.91 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.751 -0.737 . . . . 53.409999999999997 111.807 178.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.72 159.31 16.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.151 0.5 . . . . 72.219999999999999 111.369 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.9 p -110.89 128.05 67.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.667 -0.697 . . . . 64.329999999999998 110.492 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.529 HD13 ' HB3' ' A' ' 74' ' ' ARG . 3.9 mm? -100.25 126.88 46.6 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.499 -0.773 . . . . 74.510000000000005 110.357 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.679 ' HE2' HD13 ' A' ' 75' ' ' ILE . 85.7 m-85 -107.63 106.69 17.15 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.23 -0.656 . . . . 73.150000000000006 109.23 175.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.488 ' HD3' ' CG2' ' A' ' 105' ' ' VAL . 0.0 OUTLIER -129.93 144.9 54.92 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 116.152 -0.476 . . . . 74.150000000000006 110.763 -175.147 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -61.57 123.39 12.62 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.603 2.202 . . . . 62.409999999999997 111.377 175.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.7 144.03 93.23 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.287 -0.415 . . . . 71.150000000000006 110.247 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -43.25 115.31 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.584 2.856 . . . . 72.430000000000007 114.056 -176.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.15 -75.38 0.33 Allowed Glycine 0 N--CA 1.437 -1.268 0 CA-C-N 115.125 -0.943 . . . . 71.230000000000004 111.169 174.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 175.04 24.2 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.159 -0.521 . . . . 61.299999999999997 111.556 -175.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -67.87 -33.63 75.11 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.887 0.375 . . . . 64.140000000000001 111.505 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.02 -154.58 25.63 Favored Glycine 0 CA--C 1.506 -0.478 0 N-CA-C 111.33 -0.708 . . . . 62.549999999999997 111.33 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 91.6 m -106.79 117.83 35.08 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.252 0.549 . . . . 75.340000000000003 110.378 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.447 ' CG ' ' HB1' ' A' ' 9' ' ' ALA . 43.3 tt0 -78.86 115.85 18.81 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.125 -0.943 . . . . 72.209999999999994 110.408 178.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.4 p -94.01 103.95 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.708 0.766 . . . . 65.129999999999995 110.033 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.488 ' CG2' ' HD3' ' A' ' 94' ' ' ARG . 18.9 t -100.46 111.02 28.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 114.939 -1.028 . . . . 62.100000000000001 110.084 -177.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.472 HG12 HD22 ' A' ' 108' ' ' LEU . 10.9 t -120.14 132.33 70.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.031 0.443 . . . . 73.109999999999999 110.707 -178.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 107' ' ' ARG . 0.6 OUTLIER -118.13 103.31 9.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.833 -0.621 . . . . 75.549999999999997 109.843 175.214 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.64 ' HB2' HD21 ' A' ' 87' ' ' ASN . 2.3 pt? -150.68 155.25 38.96 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.449 -0.341 . . . . 53.329999999999998 111.058 -172.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 13.8 t -81.43 133.98 35.48 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.04 -1.096 . . . . 64.140000000000001 108.04 172.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.446 ' O ' ' HB ' ' A' ' 4' ' ' THR . 14.2 t80 -155.76 179.33 9.3 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.968 -0.753 . . . . 74.010000000000005 108.968 -167.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 4.8 ptt180 -143.83 144.4 26.73 Favored Pre-proline 0 C--N 1.313 -0.989 0 N-CA-C 109.669 -0.493 . . . . 62.409999999999997 109.669 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.456 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 72.3 Cg_endo -78.6 152.98 26.39 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.917 1.745 . . . . 62.420000000000002 112.247 178.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 11.3 Cg_exo -72.93 135.47 23.38 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.883 2.389 . . . . 72.329999999999998 111.571 176.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.28 150.39 47.06 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.839 -0.696 . . . . 70.439999999999998 111.762 178.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 88.74 52.25 2.85 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.323 -0.942 . . . . 53.210000000000001 111.841 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 16.5 m -61.91 -22.19 65.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.857 0.36 . . . . 50.350000000000001 110.744 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.23 -22.14 66.67 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.077 -0.511 . . . . 53.450000000000003 110.813 175.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -60.36 -20.54 55.35 Favored Glycine 0 CA--C 1.519 0.307 0 CA-C-N 116.108 -0.496 . . . . 74.5 112.424 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.93 -20.33 66.18 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 122.68 -0.306 . . . . 63.039999999999999 111.041 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.49 ' O ' ' HG2' ' A' ' 123' ' ' ARG . 66.5 t -69.23 -47.63 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.791 0.329 . . . . 73.349999999999994 110.41 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.427 ' O ' ' HB3' ' A' ' 124' ' ' MET . 14.2 tt -75.32 -27.05 19.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.043 0.449 . . . . 71.120000000000005 110.182 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.87 -42.93 84.79 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.373 -0.376 . . . . 72.209999999999994 111.052 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 120' ' ' VAL . 13.3 ptp180 -74.51 -14.8 60.86 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.142 0.496 . . . . 71.049999999999997 110.393 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.427 ' HB3' ' O ' ' A' ' 121' ' ' ILE . 26.2 ttt -70.49 -33.04 70.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.609 -0.723 . . . . 60.43 110.002 176.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -83.95 -53.96 5.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.807 -0.633 . . . . 64.430000000000007 110.054 178.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -104.24 113.81 27.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.757 -0.656 . . . . 62.399999999999999 110.133 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.449 HE21 ' HB2' ' A' ' 127' ' ' GLN . 1.2 pt20 -77.93 79.2 4.41 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.254 0.549 . . . . 73.310000000000002 111.045 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.509 ' HA ' ' HD3' ' A' ' 129' ' ' PRO . 41.0 mt-10 -103.1 140.72 21.31 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.282 -0.417 . . . . 74.150000000000006 109.944 176.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 128' ' ' GLU . 10.2 Cg_endo -91.72 -46.74 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.223 2.615 . . . . 44.030000000000001 113.92 -175.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 49.2 m -105.55 102.77 12.21 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.227 0.454 . . . . 74.219999999999999 112.227 -171.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.558 ' HA ' ' HG2' ' A' ' 138' ' ' MET . 27.4 mp0 -100.96 -40.19 7.38 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.41 -0.959 . . . . 72.540000000000006 108.41 168.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 59.26 -163.49 0.22 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.323 -0.853 . . . . 74.319999999999993 111.072 173.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.545 ' HG ' ' H ' ' A' ' 134' ' ' ARG . 22.9 tp -69.01 175.63 3.62 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.402 -1.333 . . . . 64.430000000000007 107.402 164.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.545 ' H ' ' HG ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER 49.35 33.4 5.35 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.873 0.844 . . . . 52.43 109.447 -169.429 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -48.06 -43.68 30.7 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 113.823 -1.535 . . . . 73.019999999999996 112.949 -173.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -73.34 -36.91 66.23 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.915 0.388 . . . . 71.340000000000003 111.048 -175.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.577 ' CD2' ' HB3' ' A' ' 8' ' ' ASP . 24.3 tp -77.05 -21.85 53.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.224 0.535 . . . . 72.409999999999997 109.729 -178.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.558 ' HG2' ' HA ' ' A' ' 131' ' ' GLN . 0.1 OUTLIER -63.89 -35.2 79.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.914 -0.584 . . . . 75.530000000000001 109.442 175.386 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.675 ' O ' ' HG3' ' A' ' 142' ' ' ARG . 52.6 mtt180 -73.14 -32.56 64.97 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.664 -0.698 . . . . 52.350000000000001 110.023 177.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.45 ' HZ ' HG11 ' A' ' 22' ' ' VAL . 83.4 t80 -62.05 -34.29 75.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.707 -0.679 . . . . 63.329999999999998 110.046 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.456 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 21.0 ttpp -60.81 -53.02 62.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.41 . . . . 73.019999999999996 110.957 176.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.675 ' HG3' ' O ' ' A' ' 139' ' ' ARG . 3.5 ptm180 -64.68 -29.31 70.3 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.585 0.587 . . . . 61.310000000000002 112.585 -174.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -79.57 -33.62 41.62 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.143 -0.623 . . . . 73.340000000000003 110.42 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.516 ' HB2' HG12 ' A' ' 12' ' ' ILE . 13.4 mm-40 -59.31 -43.92 92.59 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.29 0.566 . . . . 71.129999999999995 111.263 176.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.76 ' HB3' HG23 ' A' ' 12' ' ' ILE . 9.0 pt-20 -81.97 -3.44 54.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.718 -0.674 . . . . 53.119999999999997 111.48 -177.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 54.2 tp -112.76 -61.56 1.71 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.063 0.459 . . . . 54.200000000000003 111.306 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 139.47 -92.85 0.19 Allowed Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 111.101 -0.8 . . . . 43.310000000000002 111.101 -173.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 60.7 tp -134.83 127.11 30.16 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.88 0.372 . . . . 65.219999999999999 110.764 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 150' ' ' HIS . 2.2 tm-20 -158.97 129.81 6.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.776 -1.194 . . . . 35.0 107.776 175.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.432 ' HB2' ' O ' ' A' ' 149' ' ' GLU . 10.1 m80 69.97 84.11 0.15 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.49 0.662 . . . . 75.010000000000005 111.04 -174.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -114.28 -20.17 10.98 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.481 -0.781 . . . . 64.319999999999993 109.829 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.5 t-80 -110.79 126.04 54.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.102 0.477 . . . . 65.519999999999996 110.64 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -98.53 149.77 22.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.914 -0.585 . . . . 63.240000000000002 109.997 175.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 26.2 m170 -79.41 91.39 5.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.89 0.376 . . . . 75.120000000000005 110.479 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 . . . . . 0 C--O 1.245 0.847 0 CA-C-O 118.43 -0.795 . . . . 75.420000000000002 109.259 179.815 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 109.954 -0.387 . . . . 64.430000000000007 109.954 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 146.43 146.49 4.4 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.858 -0.687 . . . . 72.510000000000005 112.212 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -79.72 176.79 9.4 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.031 0.443 . . . . 34.240000000000002 110.544 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.7 m -133.38 121.91 23.0 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.187 -0.461 . . . . 71.340000000000003 110.15 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.534 HG13 ' HA ' ' A' ' 109' ' ' THR . 74.6 t -108.44 136.39 44.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.126 -0.488 . . . . 72.409999999999997 110.034 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.6 t -78.77 117.28 24.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.095 0.474 . . . . 72.319999999999993 111.159 -173.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -140.06 109.81 6.36 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.541 -0.754 . . . . 75.219999999999999 109.971 173.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.544 ' HB3' HD23 ' A' ' 137' ' ' LEU . 4.1 t70 -151.46 172.57 15.77 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.759 -1.2 . . . . 64.140000000000001 107.759 174.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.436 ' HB1' ' CG ' ' A' ' 103' ' ' GLU . . . -139.8 120.81 14.61 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.05 0.453 . . . . 64.349999999999994 111.205 -172.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.589 HG23 HD11 ' A' ' 12' ' ' ILE . 19.4 m -111.24 148.9 14.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.73 -0.668 . . . . 65.340000000000003 110.313 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.6 t -114.44 103.75 11.36 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.796 0.808 . . . . 55.43 110.781 175.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.82 HG21 ' HB3' ' A' ' 144' ' ' GLN . 1.1 mp -96.16 151.81 3.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.238 -0.892 . . . . 73.439999999999998 108.711 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.39 51.12 1.39 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.322 -0.466 . . . . 74.099999999999994 113.483 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.696 ' HB3' ' HB2' ' A' ' 18' ' ' GLN . 79.7 mttt -128.13 144.82 53.07 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 108.049 -1.093 . . . . 64.129999999999995 108.049 172.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.418 ' HG3' ' OXT' ' A' ' 155' ' ' HIS . 48.8 Cg_exo -55.21 -57.74 1.51 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.32 2.013 . . . . 74.120000000000005 113.332 -174.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 173.32 -51.37 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.45 -0.945 . . . . 63.299999999999997 108.45 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.69 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 2.5 tt0 -48.76 -37.86 20.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 113.943 -1.48 . . . . 63.43 111.421 174.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.696 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 31.0 mm-40 -85.84 -13.29 48.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.577 -0.738 . . . . 75.219999999999999 111.15 -176.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.698 HD22 HD13 ' A' ' 12' ' ' ILE . 91.7 mt -83.89 -53.21 5.75 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 112.079 0.4 . . . . 73.450000000000003 112.079 -177.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.69 ' CE2' ' HA ' ' A' ' 17' ' ' GLU . 32.7 p90 -66.96 -23.29 65.94 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.193 0.521 . . . . 44.140000000000001 111.06 -175.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.1 -3.01 30.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.771 -0.65 . . . . 71.340000000000003 111.661 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.573 ' HA ' ' HA ' ' A' ' 25' ' ' ASP . 13.5 p -52.64 -22.28 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 113.162 0.801 . . . . 71.409999999999997 113.162 -175.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -56.51 -32.32 64.93 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.138 0.494 . . . . 73.129999999999995 110.35 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -116.71 6.05 13.24 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.099 -0.704 . . . . 75.25 109.099 175.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.573 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 31.3 t70 48.63 95.69 0.01 OUTLIER 'General case' 0 C--O 1.235 0.305 0 CA-C-N 114.312 -1.313 . . . . 73.530000000000001 111.644 -168.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.446 ' CD2' ' HB3' ' A' ' 18' ' ' GLN . 16.5 mt 67.32 153.85 0.13 Allowed Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 114.686 -1.143 . . . . 63.340000000000003 111.232 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 26' ' ' LEU . 3.3 Cg_exo -76.63 108.88 2.75 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.684 2.256 . . . . 72.319999999999993 112.45 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.06 96.25 0.78 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 121.021 -0.609 . . . . 33.009999999999998 112.172 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 51.2 mt -75.58 150.37 84.39 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.502 0.191 . . . . 74.430000000000007 110.832 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.76 7.45 1.61 Allowed 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 123.294 2.663 . . . . 71.409999999999997 112.731 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.644 ' HG ' ' HB2' ' A' ' 36' ' ' LEU . 7.7 mp 65.81 8.19 5.11 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.111 -0.495 . . . . 73.310000000000002 110.804 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 59.46 20.15 8.53 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.623 -0.717 . . . . 64.120000000000005 110.584 -177.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 65.9 mtt 62.31 19.56 11.13 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.627 -0.715 . . . . 74.140000000000001 111.407 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.4 m -123.43 -63.38 1.24 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.302 -0.408 . . . . 72.409999999999997 109.965 177.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -179.86 142.82 0.17 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.411 -0.813 . . . . 71.439999999999998 109.347 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.644 ' HB2' ' HG ' ' A' ' 31' ' ' LEU . 1.0 OUTLIER -69.43 103.18 1.95 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.917 -0.772 . . . . 65.109999999999999 108.917 176.863 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -90.95 -35.76 14.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.332 -0.395 . . . . 64.420000000000002 110.579 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.8 p -175.73 156.11 1.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.955 -0.566 . . . . 73.129999999999995 110.307 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.4 t -105.41 97.75 5.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.14 -0.689 . . . . 72.510000000000005 109.14 173.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -128.08 140.13 52.12 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.973 -0.558 . . . . 72.219999999999999 110.841 -174.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.9 p -93.28 141.6 14.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.205 -0.452 . . . . 74.340000000000003 110.142 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 53' ' ' ALA . 94.6 mt -65.87 -45.44 82.09 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.323 0.49 . . . . 74.439999999999998 112.323 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -166.11 -85.43 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.962 0.411 . . . . 73.230000000000004 112.086 -173.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.2 t70 175.42 -47.87 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.072 -1.084 . . . . 71.540000000000006 108.072 -172.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.578 ' HB3' ' HB3' ' A' ' 56' ' ' PRO . 2.9 mptt -81.53 11.61 4.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.89 -1.05 . . . . 72.25 111.494 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -170.99 139.47 1.41 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.285 -0.635 . . . . 73.109999999999999 109.285 177.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.534 ' O ' ' HD2' ' A' ' 48' ' ' ARG . 12.1 p -139.11 105.44 5.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.933 0.397 . . . . 73.010000000000005 111.087 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.534 ' HD2' ' O ' ' A' ' 47' ' ' SER . 2.2 mpt_? -127.09 -85.66 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.804 0.335 . . . . 72.019999999999996 111.308 -176.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -135.46 -164.0 1.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.984 -0.553 . . . . 74.049999999999997 109.518 -175.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.5 p -90.13 19.08 5.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.442 0.639 . . . . 74.239999999999995 110.185 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.6 p -156.04 155.15 5.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.432 -0.804 . . . . 63.329999999999998 109.496 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.586 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 36.9 mt-10 64.78 98.91 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.794 0.684 . . . . 54.340000000000003 112.029 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.428 ' HA ' HD13 ' A' ' 42' ' ' LEU . . . -107.28 87.68 3.39 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.543 -0.753 . . . . 64.0 110.095 176.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.586 ' HD3' ' O ' ' A' ' 52' ' ' GLU . 4.9 Cg_exo -74.33 -171.57 0.95 Allowed 'Trans proline' 0 C--O 1.239 0.532 0 C-N-CA 123.235 2.623 . . . . 75.030000000000001 112.77 -173.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.61 146.45 98.56 Favored Pre-proline 0 N--CA 1.451 -0.412 0 CA-C-N 115.734 -0.667 . . . . 73.450000000000003 109.649 174.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.578 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 19.6 Cg_endo -57.44 -20.14 39.18 Favored 'Trans proline' 0 N--CA 1.476 0.463 0 C-N-CA 123.26 2.64 . . . . 61.140000000000001 113.445 -175.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.781 ' HA ' HD11 ' A' ' 80' ' ' LEU . 2.5 pt? -121.84 -6.91 9.04 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.523 -0.308 . . . . 71.439999999999998 111.36 -178.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.84 -111.71 2.66 Favored Glycine 0 N--CA 1.453 -0.209 0 CA-C-N 115.764 -0.653 . . . . 63.240000000000002 111.948 -175.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.35 -53.48 8.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.979 0.418 . . . . 61.149999999999999 110.218 175.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.0 p -177.84 -38.39 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.736 -0.665 . . . . 71.439999999999998 110.281 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.3 m -132.47 25.69 4.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.348 0.594 . . . . 31.120000000000001 109.696 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 42.4 t-105 -89.75 -33.51 16.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.587 -0.733 . . . . 62.25 111.009 -171.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.424 ' CD ' ' HE ' ' A' ' 48' ' ' ARG . 11.2 mm-40 -106.98 168.09 9.44 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.236 -0.893 . . . . 62.329999999999998 110.74 -175.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -116.98 124.75 50.14 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.562 -0.533 . . . . 72.420000000000002 109.562 175.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -106.1 134.97 48.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.823 0.344 . . . . 74.299999999999997 110.105 -178.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.841 HD12 ' HA ' ' A' ' 77' ' ' TRP . 3.1 mm? -97.7 151.98 19.57 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.837 -0.801 . . . . 55.130000000000003 108.837 176.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.1 p -75.32 -36.91 61.02 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.006 -0.739 . . . . 74.319999999999993 109.006 175.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -173.28 127.91 0.44 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.602 -1.181 . . . . 72.409999999999997 111.418 177.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -124.48 94.16 4.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.53 -0.759 . . . . 74.239999999999995 109.211 174.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 48.9 mt-10 -104.09 142.45 24.62 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 63.439999999999998 111.296 -174.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 31.5 Cg_exo -59.18 99.25 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.362 2.708 . . . . 74.329999999999998 113.694 -172.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.51 40.76 96.67 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.367 -0.833 . . . . 71.310000000000002 113.072 177.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -128.58 -79.67 0.57 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.021 0.438 . . . . 62.130000000000003 110.341 178.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -136.59 132.74 35.54 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.013 -0.54 . . . . 70.299999999999997 109.551 176.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 30.7 mm -120.36 110.34 28.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.809 -0.632 . . . . 75.150000000000006 109.354 -177.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -119.41 116.99 27.28 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.309 0.576 . . . . 71.409999999999997 110.47 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.841 ' HA ' HD12 ' A' ' 66' ' ' LEU . 44.9 m95 -89.9 159.56 16.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.374 -0.83 . . . . 72.209999999999994 111.072 -174.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -164.92 175.75 9.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.72 -0.673 . . . . 74.530000000000001 109.688 -178.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.575 ' HB3' ' O ' ' A' ' 84' ' ' ARG . 9.2 t -138.04 173.11 11.98 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.203 -1.406 . . . . 65.140000000000001 107.203 175.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.781 HD11 ' HA ' ' A' ' 57' ' ' LEU . 97.5 mt -79.01 144.28 63.15 Favored Pre-proline 0 C--N 1.314 -0.957 0 C-N-CA 121.054 -0.258 . . . . 73.540000000000006 110.689 -177.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.469 ' HA ' HG23 ' A' ' 85' ' ' ILE . 52.5 Cg_exo -56.14 -37.54 96.32 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.123 2.548 . . . . 74.519999999999996 112.676 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.69 -16.65 74.34 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.684 -0.769 . . . . 73.319999999999993 112.26 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.2 -62.58 1.26 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.705 0.288 . . . . 61.149999999999999 111.033 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.575 ' O ' ' HB3' ' A' ' 79' ' ' SER . 29.4 ttm180 -177.23 117.56 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.752 -0.658 . . . . 75.040000000000006 110.808 -173.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.469 HG23 ' HA ' ' A' ' 81' ' ' PRO . 2.1 pp -113.97 -166.58 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.543 -0.299 . . . . 65.140000000000001 110.732 175.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 49.4 mm-40 71.61 8.09 6.11 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.15 0.58 . . . . 73.109999999999999 111.707 -177.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -74.03 131.79 41.72 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.301 -0.629 . . . . 75.310000000000002 109.301 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.436 ' HB3' ' H ' ' A' ' 109' ' ' THR . 22.7 t -112.36 127.1 55.91 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.934 -0.395 . . . . 71.129999999999995 109.934 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -179.25 72.26 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.645 -0.788 . . . . 62.439999999999998 112.033 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -102.82 116.42 32.52 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.758 -0.46 . . . . 71.219999999999999 109.758 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.681 HG22 HG22 ' A' ' 106' ' ' VAL . 89.6 t -102.61 126.55 56.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.458 0.647 . . . . 73.349999999999994 111.267 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.538 ' HB2' ' HB ' ' A' ' 105' ' ' VAL . 3.2 mm? -110.4 120.81 43.62 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.965 -1.016 . . . . 71.109999999999999 109.833 176.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -97.62 118.04 33.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.929 0.395 . . . . 73.329999999999998 110.345 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.0 mtp180 -123.78 145.39 47.41 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.008 -0.542 . . . . 73.099999999999994 110.552 -176.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.34 119.01 6.0 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.591 2.194 . . . . 75.340000000000003 111.187 175.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . . . -82.95 143.99 47.01 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.045 0.45 . . . . 74.519999999999996 111.935 -173.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 96' ' ' ALA . 34.1 Cg_exo -60.54 131.01 35.87 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.312 2.675 . . . . 63.240000000000002 112.231 177.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.41 0.38 90.02 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 121.099 -0.572 . . . . 72.329999999999998 111.851 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 58.76 34.01 23.45 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 122.921 0.488 . . . . 75.120000000000005 111.306 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -60.37 -31.99 70.87 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.263 0.554 . . . . 72.329999999999998 110.504 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 170.49 -137.85 4.66 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.194 -1.162 . . . . 74.430000000000007 110.194 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 72.0 m -121.43 130.64 53.71 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 117.06 0.43 . . . . 62.399999999999999 110.19 175.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.436 ' CG ' ' HB1' ' A' ' 9' ' ' ALA . 42.5 tt0 -76.97 119.3 20.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.056 -0.52 . . . . 75.120000000000005 110.904 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.649 HG23 HG13 ' A' ' 91' ' ' VAL . 2.4 p -99.1 106.62 19.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.627 -0.715 . . . . 62.450000000000003 110.041 175.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.538 ' HB ' ' HB2' ' A' ' 92' ' ' LEU . 26.1 t -91.8 109.91 21.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.765 -0.652 . . . . 74.349999999999994 109.413 177.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.681 HG22 HG22 ' A' ' 91' ' ' VAL . 48.8 t -112.11 121.43 64.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.953 0.406 . . . . 64.439999999999998 110.71 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -113.97 104.82 12.54 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.72 -0.844 . . . . 72.140000000000001 108.72 172.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.662 HD23 ' H ' ' A' ' 108' ' ' LEU . 2.4 pt? -119.0 120.47 37.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.181 0.515 . . . . 71.109999999999999 109.824 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.534 ' HA ' HG13 ' A' ' 5' ' ' VAL . 86.6 m -103.45 125.26 49.93 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.2 -0.455 . . . . 62.140000000000001 110.787 -177.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -145.97 177.72 8.74 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.612 -0.884 . . . . 70.540000000000006 108.612 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 4.3 ptt180 -146.67 155.49 48.69 Favored Pre-proline 0 C--N 1.317 -0.807 0 CA-C-N 116.657 -0.247 . . . . 74.549999999999997 110.603 -175.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -63.23 155.91 58.77 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.398 2.065 . . . . 61.140000000000001 111.328 173.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -69.45 5.17 1.68 Allowed 'Trans proline' 0 N--CA 1.478 0.612 0 C-N-CA 123.294 2.663 . . . . 71.310000000000002 113.333 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -176.42 -47.46 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.969 -0.634 . . . . 65.109999999999999 111.581 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 160.37 -117.2 0.76 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.003 -0.617 . . . . 73.450000000000003 111.977 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.1 m -60.63 -27.99 68.2 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.648 0.24 . . . . 61.119999999999997 111.648 -176.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.88 -23.38 67.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.935 0.398 . . . . 74.120000000000005 111.194 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.73 -21.07 70.82 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.986 -0.626 . . . . 72.019999999999996 112.774 -177.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.99 -41.95 67.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.64 0.257 . . . . 72.340000000000003 111.451 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.4 m -76.67 -35.34 25.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.792 -0.363 . . . . 63.25 110.805 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.403 ' HA ' ' HB2' ' A' ' 124' ' ' MET . 79.2 mt -59.58 -30.9 45.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 116.358 -0.383 . . . . 72.530000000000001 110.709 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.952 ' HA ' ' HB3' ' A' ' 126' ' ' ASN . . . -52.64 -58.41 6.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.901 -0.591 . . . . 61.200000000000003 111.179 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -79.52 -17.02 54.96 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.15 -0.477 . . . . 72.340000000000003 111.26 -177.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.403 ' HB2' ' HA ' ' A' ' 121' ' ' ILE . 76.2 mtp -71.19 -53.66 13.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.483 -0.326 . . . . 73.319999999999993 111.343 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -156.05 -4.22 0.12 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.554 -0.458 . . . . 75.120000000000005 112.072 -176.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.952 ' HB3' ' HA ' ' A' ' 122' ' ' ALA . 63.4 t30 -82.47 -179.21 7.34 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.591 -0.522 . . . . 75.530000000000001 109.591 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -52.02 -57.86 8.26 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 111.816 0.302 . . . . 73.319999999999993 111.816 -177.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 122' ' ' ALA . 8.5 tp10 58.46 86.85 0.15 Allowed Pre-proline 0 N--CA 1.466 0.325 0 O-C-N 123.655 0.597 . . . . 72.340000000000003 111.15 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -71.4 67.74 2.76 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 123.124 2.549 . . . . 71.319999999999993 112.427 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.576 ' HB2' ' HG2' ' A' ' 132' ' ' GLN . 9.8 m 59.35 22.09 10.44 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.942 -0.572 . . . . 64.239999999999995 111.914 175.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 60.96 22.99 13.15 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.83 0.452 . . . . 65.530000000000001 111.316 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.75 ' HG3' ' HB2' ' A' ' 136' ' ' ASP . 2.7 pt20 -134.79 170.53 15.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.571 -0.286 . . . . 74.400000000000006 110.564 -177.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.409 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 95.1 mt -136.5 146.26 46.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.672 -0.24 . . . . 73.239999999999995 110.477 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 133' ' ' LEU . 52.2 mtt85 72.72 -57.13 0.64 Allowed 'General case' 0 N--CA 1.47 0.54 0 O-C-N 123.879 0.737 . . . . 54.210000000000001 112.587 177.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -69.92 -28.53 65.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.655 0.264 . . . . 74.530000000000001 110.346 -177.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.75 ' HB2' ' HG3' ' A' ' 132' ' ' GLN . 25.3 t70 -63.8 -30.48 71.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.927 0.394 . . . . 51.439999999999998 110.585 173.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.544 HD23 ' HB3' ' A' ' 8' ' ' ASP . 39.0 tp -67.9 -26.12 65.83 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.728 -0.471 . . . . 74.230000000000004 109.728 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.513 ' O ' ' HG2' ' A' ' 141' ' ' LYS . 2.8 mmt -66.74 -30.07 70.2 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.822 -0.626 . . . . 70.310000000000002 109.911 174.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 -78.52 -35.77 45.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.522 -0.763 . . . . 74.5 109.36 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -57.62 -49.15 77.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.204 -0.907 . . . . 72.25 111.729 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.739 ' HB2' HG13 ' A' ' 12' ' ' ILE . 13.4 ptmm? -60.21 -38.48 83.48 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.897 0.379 . . . . 72.239999999999995 110.238 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.671 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 35.6 ttp180 -64.02 -44.0 93.9 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.719 -0.673 . . . . 73.219999999999999 110.81 -176.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.491 ' HA ' HD12 ' A' ' 146' ' ' LEU . 41.7 mt-10 -65.42 -30.4 71.2 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.949 0.404 . . . . 71.400000000000006 110.66 177.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.82 ' HB3' HG21 ' A' ' 12' ' ' ILE . 0.9 OUTLIER -65.49 -47.0 77.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 73.230000000000004 111.054 178.436 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.404 ' HB3' HG22 ' A' ' 12' ' ' ILE . 6.2 pt-20 -80.41 -9.29 59.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.886 0.374 . . . . 73.019999999999996 111.066 -178.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.671 ' HG ' ' O ' ' A' ' 142' ' ' ARG . 55.4 mt -73.29 -41.13 63.96 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.721 -0.474 . . . . 70.099999999999994 109.721 170.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 91.41 149.62 23.95 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.048 -0.596 . . . . 64.219999999999999 112.703 177.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 5.9 tt -109.11 -69.06 0.88 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.5 -0.556 . . . . 55.219999999999999 109.5 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -104.25 -36.58 7.59 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.977 0.418 . . . . 72.549999999999997 110.686 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 21.9 m170 -114.2 102.62 10.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.437 -0.347 . . . . 65.120000000000005 110.371 -176.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -119.36 83.17 1.99 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.098 0.475 . . . . 73.430000000000007 110.289 177.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -168.25 134.5 1.94 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.504 -0.771 . . . . 71.120000000000005 109.874 176.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 30.5 t60 -77.91 102.54 7.35 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.49 -0.777 . . . . 74.299999999999997 111.057 -173.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -96.57 -7.3 34.8 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.947 -0.301 . . . . 73.420000000000002 111.39 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.418 ' OXT' ' HG3' ' A' ' 15' ' ' PRO . 16.6 t-160 . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.693 -0.67 . . . . 74.439999999999998 109.465 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 110.394 -0.224 . . . . 70.219999999999999 110.394 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 144.13 -149.11 21.14 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.211 -0.995 . . . . 52.420000000000002 112.517 178.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 53.11 72.95 0.39 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.389 0.614 . . . . 71.230000000000004 110.565 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.8 m -146.06 121.03 10.02 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.952 -0.567 . . . . 55.340000000000003 110.995 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.5 t -124.41 109.88 23.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.681 -0.691 . . . . 62.100000000000001 109.181 173.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.5 t -78.82 119.55 28.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 116.016 -0.538 . . . . 75.299999999999997 110.288 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.592 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 15.0 ptt180 -141.65 125.01 16.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.429 0.633 . . . . 74.510000000000005 111.225 176.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.431 ' HB3' HD23 ' A' ' 137' ' ' LEU . 3.8 t70 -157.42 174.1 15.91 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.946 -1.131 . . . . 62.43 107.946 174.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.623 ' HB1' ' HG2' ' A' ' 103' ' ' GLU . . . -134.45 122.37 22.39 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.798 0.332 . . . . 62.229999999999997 111.279 -170.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.549 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 17.1 m -108.04 130.14 61.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.271 0.557 . . . . 61.350000000000001 110.998 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.661 ' O ' ' HE2' ' A' ' 141' ' ' LYS . 21.2 m -86.83 100.16 12.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.715 -0.675 . . . . 73.25 110.497 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.701 HG21 ' HG3' ' A' ' 144' ' ' GLN . 66.9 mt -111.89 145.6 17.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.697 0.285 . . . . 71.519999999999996 111.105 -174.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.407 ' HA2' ' HA3' ' A' ' 101' ' ' GLY . . . -81.68 66.04 3.91 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 121.136 -0.554 . . . . 54.340000000000003 112.955 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.452 ' HD3' ' HB3' ' A' ' 18' ' ' GLN . 43.3 mttp -143.32 147.43 40.23 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.755 -0.461 . . . . 75.219999999999999 109.755 174.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.14 -55.65 2.99 Favored 'Trans proline' 0 N--CA 1.479 0.65 0 C-N-CA 123.406 2.737 . . . . 52.310000000000002 114.079 -172.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 174.65 -64.02 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.146 0.498 . . . . 70.319999999999993 110.015 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.43 ' OE1' ' HG2' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -56.54 -42.5 78.59 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.198 -0.91 . . . . 73.329999999999998 111.507 179.353 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.7 ' HG3' ' HB2' ' A' ' 150' ' ' HIS . 31.4 mm-40 -62.0 -21.32 64.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 74.340000000000003 111.997 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.581 ' HA ' HE21 ' A' ' 144' ' ' GLN . 59.3 mt -73.96 -32.35 63.43 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.305 -0.247 . . . . 74.549999999999997 111.629 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -69.69 -24.22 63.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.182 0.515 . . . . 73.439999999999998 110.181 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.05 -23.85 67.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.752 -0.658 . . . . 75.140000000000001 111.616 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 19' ' ' LEU . 4.3 p -67.38 -21.97 28.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 121.174 0.512 . . . . 63.140000000000001 110.742 -178.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 54.8 t90 -64.49 -26.25 68.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.783 -0.644 . . . . 74.439999999999998 110.69 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.51 -82.65 0.64 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.767 -0.651 . . . . 75.239999999999995 109.647 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.546 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 28.5 t70 -165.92 149.66 7.85 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.466 -0.788 . . . . 74.409999999999997 109.031 178.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.4 ' H ' HD23 ' A' ' 26' ' ' LEU . 0.8 OUTLIER -112.37 86.14 7.81 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 121.086 0.47 . . . . 74.099999999999994 110.941 177.243 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.978 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 2.1 Cg_endo -87.2 146.27 7.49 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.433 2.755 . . . . 72.209999999999994 111.371 176.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.553 ' C ' ' HD3' ' A' ' 30' ' ' PRO . . . -79.47 56.76 4.45 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.861 -0.685 . . . . 62.299999999999997 112.733 -177.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.776 HD12 ' H ' ' A' ' 33' ' ' MET . 3.8 mm? -123.33 56.99 10.4 Favored Pre-proline 0 CA--C 1.534 0.33 0 O-C-N 122.741 -0.27 . . . . 75.439999999999998 111.707 176.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.553 ' HD3' ' C ' ' A' ' 28' ' ' GLY . 12.1 Cg_exo -70.49 -28.02 22.24 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.041 1.827 . . . . 63.310000000000002 111.331 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.629 HD13 ' H ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -97.03 -6.46 35.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.364 -0.835 . . . . 74.140000000000001 110.787 177.52 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 71.2 mt 61.47 109.79 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.773 0.797 . . . . 64.430000000000007 113.123 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.776 ' H ' HD12 ' A' ' 29' ' ' LEU . 89.7 mtp -129.81 132.47 46.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.335 -0.848 . . . . 65.310000000000002 109.02 173.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.3 m -66.33 99.16 0.52 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.22 0.533 . . . . 72.340000000000003 111.446 -178.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.494 ' HB3' HD22 ' A' ' 36' ' ' LEU . 62.8 m170 -111.67 -75.98 0.6 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.727 -0.669 . . . . 71.420000000000002 109.32 174.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.494 HD22 ' HB3' ' A' ' 35' ' ' HIS . 2.9 mm? -124.8 17.35 8.67 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.74 -0.664 . . . . 40.420000000000002 109.532 177.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.429 ' HA ' ' OE2' ' A' ' 40' ' ' GLU . 77.5 mtm180 62.77 56.28 1.95 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.729 0.776 . . . . 75.439999999999998 109.537 -173.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.0 m -69.32 -77.99 0.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.747 -1.115 . . . . 70.329999999999998 112.433 -171.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.978 ' HB ' ' HG2' ' A' ' 27' ' ' PRO . 7.6 p -118.68 33.68 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.92 0.866 . . . . 60.119999999999997 110.69 -173.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.429 ' OE2' ' HA ' ' A' ' 37' ' ' ARG . 89.2 mt-10 -64.59 100.62 0.39 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.476 -0.784 . . . . 73.030000000000001 110.096 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.7 p -114.54 152.88 16.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.746 -0.661 . . . . 75.040000000000006 110.37 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.574 ' HG ' HG23 ' A' ' 51' ' ' VAL . 4.5 mp -77.22 -63.2 1.42 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.323 0.582 . . . . 73.430000000000007 110.303 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.859 ' HB3' ' HD3' ' A' ' 46' ' ' ARG . 15.2 t70 -150.07 168.96 22.38 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.269 -0.878 . . . . 72.420000000000002 109.213 -176.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -73.59 -22.35 60.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.352 . . . . 72.329999999999998 111.559 -173.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -79.18 6.67 9.14 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.179 0.437 . . . . 71.200000000000003 112.179 -177.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.859 ' HD3' ' HB3' ' A' ' 43' ' ' ASP . 0.0 OUTLIER -142.97 -167.07 2.44 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.084 -0.507 . . . . 62.229999999999997 109.75 179.343 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.7 m -112.27 173.47 6.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.771 0.796 . . . . 71.129999999999995 112.363 -174.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.614 ' HG3' ' HA ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -73.51 111.12 8.34 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.263 -0.88 . . . . 75.530000000000001 108.812 170.2 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 9.9 t-105 -136.74 -163.07 1.36 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.565 -0.531 . . . . 73.400000000000006 109.565 -175.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.501 ' O ' HG12 ' A' ' 51' ' ' VAL . 2.4 m -53.14 -27.67 22.19 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 122.766 0.426 . . . . 71.019999999999996 111.846 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.574 HG23 ' HG ' ' A' ' 42' ' ' LEU . 2.8 p 54.86 16.94 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.36 1.064 . . . . 62.119999999999997 112.392 176.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -93.69 -42.8 8.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.29 -0.414 . . . . 64.319999999999993 110.915 -176.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -99.94 143.94 27.43 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.512 -0.313 . . . . 43.520000000000003 110.775 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -89.18 159.86 5.71 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.939 2.426 . . . . 72.120000000000005 112.912 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.427 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . . . 64.1 78.5 0.27 Allowed Pre-proline 0 N--CA 1.464 0.237 0 CA-C-N 115.545 -0.752 . . . . 64.409999999999997 111.687 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.537 ' CB ' ' HB2' ' A' ' 63' ' ' GLU . 10.3 Cg_endo -54.43 -32.71 74.21 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 123.765 2.976 . . . . 65.109999999999999 113.051 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.815 ' HB3' HD21 ' A' ' 80' ' ' LEU . 0.7 OUTLIER -112.61 10.78 19.51 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.442 -0.799 . . . . 64.349999999999994 111.382 -173.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -80.19 -56.79 3.14 Favored Glycine 0 C--N 1.318 -0.453 0 CA-C-N 115.13 -0.941 . . . . 63.450000000000003 112.292 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.68 34.12 0.71 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.128 0.49 . . . . 75.200000000000003 111.144 -178.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.2 t 64.64 81.28 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.134 -0.939 . . . . 75.099999999999994 112.38 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.804 ' HA ' HD22 ' A' ' 80' ' ' LEU . 20.6 m 63.35 96.72 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.73 1.382 . . . . 52.439999999999998 114.73 167.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 20.2 m0 -114.42 -28.13 7.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.368 -0.833 . . . . 62.520000000000003 109.37 163.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.728 ' O ' HD13 ' A' ' 80' ' ' LEU . 7.2 mt-10 -117.44 174.59 6.06 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.402 -1.272 . . . . 74.340000000000003 112.954 -169.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.56 140.85 29.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.047 -0.979 . . . . 74.430000000000007 108.854 164.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.458 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 7.2 pt-20 -103.7 135.71 44.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.325 0.583 . . . . 75.530000000000001 111.748 -176.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.581 HD11 HG23 ' A' ' 75' ' ' ILE . 41.4 tp -105.12 126.38 52.01 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.817 -0.438 . . . . 71.099999999999994 109.817 177.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 64.2 p -84.11 -36.63 22.81 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.103 0.478 . . . . 63.299999999999997 111.224 -176.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.748 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -118.93 137.94 53.13 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.828 -0.624 . . . . 64.340000000000003 111.312 -170.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -139.61 33.3 2.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.781 -0.645 . . . . 72.420000000000002 109.856 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 1.01 ' HG3' ' HG2' ' A' ' 74' ' ' ARG . 5.4 mm-40 -57.33 142.83 75.29 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.427 -0.806 . . . . 72.450000000000003 110.307 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 9.2 Cg_exo -71.89 76.08 2.09 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.85 2.367 . . . . 74.129999999999995 112.173 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.47 43.82 43.69 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.947 -0.645 . . . . 70.209999999999994 112.076 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.611 ' HB2' ' HB3' ' A' ' 70' ' ' GLU . 70.9 mmtt -127.73 -69.3 0.74 Allowed 'General case' 0 C--N 1.328 -0.328 0 O-C-N 122.897 -0.178 . . . . 74.420000000000002 111.106 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 1.01 ' HG2' ' HG3' ' A' ' 70' ' ' GLU . 9.2 ptt180 -145.69 130.84 18.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.115 0.483 . . . . 72.329999999999998 110.397 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.683 HD13 ' HE2' ' A' ' 93' ' ' PHE . 2.3 mp -126.31 113.02 31.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.956 -0.565 . . . . 73.420000000000002 109.907 176.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.748 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -107.73 116.82 32.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.66 -0.7 . . . . 25.41 109.835 176.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.719 ' HZ3' HG13 ' A' ' 91' ' ' VAL . 31.5 p90 -98.72 143.54 28.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.471 0.653 . . . . 74.5 111.325 -174.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -141.21 179.18 6.91 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.959 -1.019 . . . . 74.329999999999998 109.44 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.5 m -132.84 147.79 52.3 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.203 -1.036 . . . . 53.020000000000003 108.203 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.815 HD21 ' HB3' ' A' ' 57' ' ' LEU . 5.4 mp -57.65 144.93 71.75 Favored Pre-proline 0 C--N 1.323 -0.549 0 O-C-N 123.497 0.498 . . . . 74.450000000000003 111.594 -176.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 80' ' ' LEU . 51.3 Cg_exo -56.35 -22.04 39.65 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.643 2.895 . . . . 71.340000000000003 113.766 -174.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -79.67 -14.83 80.59 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.015 -0.612 . . . . 44.439999999999998 112.311 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -111.17 172.32 6.95 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.683 0.277 . . . . 72.420000000000002 110.316 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -75.89 138.72 41.24 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.163 -0.68 . . . . 73.530000000000001 109.163 173.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.4 pt -75.92 88.87 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.32 0.581 . . . . 63.350000000000001 109.449 173.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -54.15 -34.67 60.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.192 -0.913 . . . . 75.099999999999994 112.047 -173.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.594 HD22 ' N ' ' A' ' 88' ' ' SER . 0.2 OUTLIER -166.73 132.82 2.31 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.897 -0.779 . . . . 65.450000000000003 108.897 178.629 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.594 ' N ' HD22 ' A' ' 87' ' ' ASN . 30.0 m -115.6 128.57 56.04 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.053 -0.351 . . . . 63.509999999999998 110.053 177.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -174.77 -178.56 44.74 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.635 -0.793 . . . . 54.299999999999997 111.981 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -147.03 132.71 18.86 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.916 -0.401 . . . . 61.32 109.916 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.719 HG13 ' HZ3' ' A' ' 77' ' ' TRP . 25.2 m -107.68 138.01 36.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.016 0.436 . . . . 75.120000000000005 110.711 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.43 ' HB2' ' HB ' ' A' ' 105' ' ' VAL . 3.4 mm? -112.32 120.82 43.01 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.708 -0.678 . . . . 73.420000000000002 109.631 177.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.683 ' HE2' HD13 ' A' ' 75' ' ' ILE . 76.2 m-85 -98.11 112.42 24.39 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.924 0.393 . . . . 72.430000000000007 110.499 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.444 HH11 ' HD2' ' A' ' 94' ' ' ARG . 5.0 ptt180 -126.2 145.23 51.71 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.03 -0.532 . . . . 75.140000000000001 110.442 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -51.46 131.18 35.76 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.209 2.606 . . . . 74.439999999999998 112.296 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.641 ' HB1' HG23 ' A' ' 11' ' ' THR . . . -82.6 144.94 49.91 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.0 -0.545 . . . . 61.140000000000001 111.751 -175.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 96' ' ' ALA . 31.5 Cg_exo -58.79 133.19 52.32 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.913 2.409 . . . . 61.409999999999997 112.111 177.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.09 5.71 81.26 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 121.228 -0.511 . . . . 74.120000000000005 112.762 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 62.66 34.69 14.68 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.855 0.462 . . . . 72.120000000000005 111.34 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.16 -35.72 71.97 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 108.653 -0.869 . . . . 73.420000000000002 108.653 172.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.407 ' HA3' ' HA2' ' A' ' 13' ' ' GLY . . . 163.71 -107.16 0.29 Allowed Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 114.942 -1.026 . . . . 64.340000000000003 110.764 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.474 ' HB ' HD11 ' A' ' 19' ' ' LEU . 28.8 m -142.69 136.61 29.19 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 110.027 -0.36 . . . . 41.32 110.027 176.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.623 ' HG2' ' HB1' ' A' ' 9' ' ' ALA . 38.4 tt0 -96.57 108.38 20.96 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 109.326 -0.62 . . . . 74.329999999999998 109.326 177.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.4 p -87.79 108.66 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.679 0.752 . . . . 74.409999999999997 110.015 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.509 HG13 ' HB2' ' A' ' 9' ' ' ALA . 3.4 t -92.44 109.22 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 114.721 -1.127 . . . . 70.040000000000006 108.781 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.67 HG22 HD12 ' A' ' 108' ' ' LEU . 7.4 p -112.87 130.89 65.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 121.017 0.437 . . . . 75.310000000000002 111.303 -173.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.584 ' HD3' ' O ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -123.6 125.83 45.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.778 -0.646 . . . . 75.109999999999999 110.097 174.361 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.67 HD12 HG22 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -150.52 152.54 34.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.936 -0.575 . . . . 74.099999999999994 110.141 -179.21 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.8 t -88.32 143.23 27.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.801 0.334 . . . . 64.319999999999993 111.022 -177.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.443 ' HD1' ' HA ' ' A' ' 110' ' ' TYR . 0.4 OUTLIER -152.47 126.22 8.95 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.103 -0.703 . . . . 73.040000000000006 109.103 177.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.5 ptt180 -121.75 144.41 40.67 Favored Pre-proline 0 C--N 1.315 -0.908 0 N-CA-C 109.328 -0.619 . . . . 71.510000000000005 109.328 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -61.63 152.18 75.49 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.259 1.973 . . . . 52.240000000000002 112.035 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -82.08 146.94 14.58 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.712 2.274 . . . . 72.209999999999994 112.653 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -100.61 128.69 9.65 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.833 -0.699 . . . . 65.409999999999997 111.748 177.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 137.24 -154.28 22.29 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.439 -0.886 . . . . 73.310000000000002 112.871 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.4 p -81.19 -25.06 37.06 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.224 0.453 . . . . 63.420000000000002 112.224 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.459 ' O ' HG22 ' A' ' 120' ' ' VAL . . . -64.83 -41.01 96.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.079 0.466 . . . . 64.540000000000006 110.717 178.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.55 -20.67 75.76 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.932 -0.652 . . . . 64.25 112.837 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.6 -40.72 95.81 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 111.728 0.27 . . . . 64.239999999999995 111.728 -176.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 117' ' ' ALA . 25.0 m -70.68 -27.84 32.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.767 0.318 . . . . 75.340000000000003 110.7 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 57.9 mt -75.04 -36.64 38.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.053 0.454 . . . . 71.129999999999995 110.231 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.27 -35.13 78.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.767 -0.651 . . . . 73.140000000000001 111.409 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 27.4 ptt85 -90.22 -14.37 33.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.975 0.417 . . . . 64.409999999999997 110.93 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 23.4 ttt -71.63 -52.1 19.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.029 -0.532 . . . . 74.140000000000001 110.641 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 60.2 -164.7 0.22 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.856 -0.611 . . . . 74.329999999999998 110.576 -176.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -81.44 89.64 6.15 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.677 -0.86 . . . . 64.329999999999998 108.677 175.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -63.78 -29.84 71.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.971 -0.558 . . . . 70.439999999999998 111.051 -174.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -123.05 86.37 51.05 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.343 -0.844 . . . . 72.040000000000006 109.855 -177.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -50.44 96.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.437 2.758 . . . . 75.450000000000003 112.939 -173.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.5 p -88.12 131.58 34.64 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.201 -0.909 . . . . 72.219999999999999 110.576 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -81.1 -10.91 59.6 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.379 0.609 . . . . 75.219999999999999 109.959 178.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -120.62 134.33 55.29 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.552 -0.907 . . . . 72.230000000000004 108.552 172.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.5 tt -70.66 -37.71 73.74 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.024 0.44 . . . . 75.019999999999996 110.199 -175.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.665 ' HB2' ' HB3' ' A' ' 137' ' ' LEU . 0.0 OUTLIER -82.33 28.16 0.47 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.191 -0.459 . . . . 74.099999999999994 112.07 -177.711 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -59.56 -35.84 75.03 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.025 0.441 . . . . 71.030000000000001 110.573 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -71.57 -37.68 71.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.279 0.561 . . . . 73.400000000000006 109.933 176.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.665 ' HB3' ' HB2' ' A' ' 134' ' ' ARG . 47.2 tp -66.27 -28.08 68.43 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.588 -0.733 . . . . 74.140000000000001 110.202 178.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.514 ' CE ' HG12 ' A' ' 10' ' ' VAL . 11.8 mmt -63.27 -39.76 95.5 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.101 0.477 . . . . 51.32 110.173 174.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -67.36 -39.7 85.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.61 -0.723 . . . . 75.420000000000002 109.796 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -59.47 -48.68 80.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.099 -0.955 . . . . 65.150000000000006 110.347 172.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.661 ' HE2' ' O ' ' A' ' 11' ' ' THR . 37.0 tttm -52.06 -49.93 62.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.432 -0.804 . . . . 60.549999999999997 111.657 177.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -56.08 -44.08 78.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.615 -0.721 . . . . 72.129999999999995 111.89 -174.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -68.51 -34.42 75.86 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 121.027 -0.269 . . . . 64.530000000000001 111.662 -176.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.701 ' HG3' HG21 ' A' ' 12' ' ' ILE . 5.4 tp60 -72.53 -34.9 67.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.807 0.336 . . . . 72.099999999999994 110.973 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.638 ' HB3' HG23 ' A' ' 12' ' ' ILE . 15.5 pt-20 -83.06 -38.79 22.05 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 121.022 -0.271 . . . . 74.310000000000002 110.606 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 22.4 tp -72.58 -23.62 60.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.941 0.401 . . . . 73.409999999999997 110.551 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -64.36 -22.5 67.51 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.749 -0.66 . . . . 74.510000000000005 112.976 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.917 ' HG ' ' H ' ' A' ' 149' ' ' GLU . 16.5 tp 60.59 -161.25 0.29 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.406 0.282 . . . . 61.210000000000001 110.509 177.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.917 ' H ' ' HG ' ' A' ' 148' ' ' LEU . 5.5 mm-40 70.26 123.63 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.761 0.824 . . . . 70.049999999999997 113.055 174.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.7 ' HB2' ' HG3' ' A' ' 18' ' ' GLN . 26.8 p80 173.4 7.48 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 114.849 -1.068 . . . . 64.140000000000001 110.721 175.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.424 ' HE1' ' HG2' ' A' ' 30' ' ' PRO . 36.3 m80 68.74 123.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.411 0.684 . . . . 73.329999999999998 110.492 -172.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 24.3 t60 -82.0 82.01 7.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.013 0.435 . . . . 73.019999999999996 109.972 -176.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 64.8 t60 -64.15 116.0 5.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.594 -0.73 . . . . 65.129999999999995 110.664 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -82.18 123.6 29.14 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.178 -0.464 . . . . 65.420000000000002 109.756 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.754 -0.641 . . . . 74.230000000000004 109.748 176.879 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 120.769 0.319 . . . . 74.430000000000007 110.62 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.91 -97.38 2.31 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.577 -0.821 . . . . 43.399999999999999 111.813 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -83.5 120.05 25.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.013 0.435 . . . . 75.099999999999994 110.063 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.665 ' O ' ' HB3' ' A' ' 110' ' ' TYR . 87.4 m -145.61 121.33 10.52 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.865 -0.607 . . . . 71.530000000000001 109.729 177.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.7 p -89.71 98.84 8.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.697 0.76 . . . . 44.420000000000002 109.261 178.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.403 HG23 ' HB3' ' A' ' 108' ' ' LEU . 17.5 m -84.65 134.23 27.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.288 -0.869 . . . . 61.329999999999998 111.258 -173.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.413 ' HD2' HH11 ' A' ' 7' ' ' ARG . 15.0 ptt180 -141.39 132.17 25.79 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.539 -0.755 . . . . 75.439999999999998 109.772 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -143.93 155.69 44.16 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.057 -0.72 . . . . 74.409999999999997 109.057 175.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -130.44 142.86 50.49 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.133 0.492 . . . . 61.219999999999999 111.231 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.57 ' HB ' ' HB2' ' A' ' 141' ' ' LYS . 12.4 m -123.42 137.28 57.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.469 -0.787 . . . . 63.109999999999999 110.206 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -95.58 118.47 32.33 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.243 -0.435 . . . . 72.049999999999997 110.969 -175.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.979 HG23 ' HG2' ' A' ' 145' ' ' GLU . 4.0 mp -122.46 139.24 49.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.017 -0.538 . . . . 72.200000000000003 109.565 176.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.07 53.19 3.76 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.804 -0.712 . . . . 71.329999999999998 112.847 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.56 ' HG2' ' HB3' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -123.37 144.81 44.87 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 108.78 -0.822 . . . . 71.140000000000001 108.78 176.207 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.58 -58.37 1.29 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.429 2.086 . . . . 71.120000000000005 113.0 -175.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.61 ' HA ' HD12 ' A' ' 19' ' ' LEU . . . 173.4 -52.98 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.62 0.575 . . . . 62.450000000000003 110.157 178.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -49.44 -49.34 45.57 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.779 -1.101 . . . . 74.439999999999998 112.377 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.708 HE21 HD23 ' A' ' 26' ' ' LEU . 47.0 tt0 -68.71 -20.66 64.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.008 -0.542 . . . . 64.420000000000002 112.113 -175.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.61 HD12 ' HA ' ' A' ' 16' ' ' ALA . 66.6 mt -67.6 -33.15 74.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.66 -0.245 . . . . 64.439999999999998 111.274 -176.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.404 ' O ' ' HD1' ' A' ' 23' ' ' TRP . 27.9 t80 -73.03 -23.95 60.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.991 0.424 . . . . 75.319999999999993 110.743 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.55 -3.53 34.69 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.924 0.392 . . . . 53.329999999999998 112.02 -177.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.6 p -56.16 -21.29 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 115.689 -0.687 . . . . 70.340000000000003 112.305 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.404 ' HD1' ' O ' ' A' ' 20' ' ' TYR . 51.1 m95 -48.21 -31.13 5.39 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.287 0.847 . . . . 71.329999999999998 113.287 -176.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -118.27 -85.37 0.65 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.502 -0.479 . . . . 71.109999999999999 111.318 176.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -150.74 35.92 0.62 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.118 0.485 . . . . 75.109999999999999 110.027 -175.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.708 HD23 HE21 ' A' ' 18' ' ' GLN . 9.6 mp 65.55 165.4 0.12 Allowed Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 115.465 -0.789 . . . . 73.409999999999997 110.914 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.5 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 31.6 Cg_exo -59.73 104.06 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.398 2.065 . . . . 64.109999999999999 111.824 176.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.4 ' H ' ' HB ' ' A' ' 39' ' ' VAL . . . 153.79 -50.44 0.49 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.84 -0.695 . . . . 41.439999999999998 111.714 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.505 ' C ' ' H ' ' A' ' 31' ' ' LEU . 3.8 mm? 61.54 168.06 0.09 OUTLIER Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 120.94 0.4 . . . . 74.519999999999996 111.94 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -58.54 9.3 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.62 2.88 . . . . 71.120000000000005 114.072 173.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.505 ' H ' ' C ' ' A' ' 29' ' ' LEU . 7.5 mp 68.54 33.83 3.82 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.312 0.645 . . . . 62.140000000000001 110.666 -177.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.484 ' H ' ' HG ' ' A' ' 32' ' ' LEU . 0.4 OUTLIER -70.49 87.23 0.64 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.445 -0.798 . . . . 75.319999999999993 111.285 -179.758 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 48.34 26.73 1.17 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.638 1.175 . . . . 65.299999999999997 113.309 174.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.9 t -117.74 122.42 43.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.489 0.661 . . . . 73.409999999999997 111.248 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 20.7 m80 -141.13 19.73 2.27 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.444 -0.798 . . . . 73.239999999999995 109.184 174.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.5 tp -87.83 7.56 30.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.948 -1.024 . . . . 74.310000000000002 110.412 -177.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 75.43 -18.06 0.47 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.404 -0.816 . . . . 74.540000000000006 111.715 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.9 m -71.18 95.89 1.31 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.642 -0.503 . . . . 61.030000000000001 109.642 173.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 27' ' ' PRO . 16.9 m -134.42 28.71 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.222 0.534 . . . . 73.140000000000001 110.81 -175.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.43 -164.75 1.39 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.654 -0.703 . . . . 72.439999999999998 110.598 -177.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.5 t -58.11 146.36 8.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.935 -0.575 . . . . 74.209999999999994 110.683 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.416 ' HB2' ' HA ' ' A' ' 49' ' ' TRP . 60.0 tp -54.29 -45.31 72.49 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.065 -0.516 . . . . 61.509999999999998 111.873 -175.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.61 ' HB3' ' CG ' ' A' ' 46' ' ' ARG . 15.1 t70 -151.89 163.03 40.09 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.695 -0.483 . . . . 75.430000000000007 109.695 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -92.2 -12.27 33.19 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 123.156 0.285 . . . . 65.430000000000007 111.684 -174.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 1.014 ' HE2' ' HA ' ' A' ' 45' ' ' LYS . 9.9 mmpt? -93.01 4.05 54.69 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.788 0.804 . . . . 72.150000000000006 110.552 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.61 ' CG ' ' HB3' ' A' ' 43' ' ' ASP . 0.5 OUTLIER -152.64 -177.03 5.99 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.137 -1.392 . . . . 72.439999999999998 111.041 -176.198 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.553 ' O ' ' HD3' ' A' ' 46' ' ' ARG . 21.1 m -113.34 -154.48 0.54 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.3 -1.0 . . . . 54.520000000000003 108.3 174.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 71.47 167.27 0.31 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.139 0.495 . . . . 65.329999999999998 111.067 170.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.416 ' HA ' ' HB2' ' A' ' 42' ' ' LEU . 76.4 t90 -150.92 110.25 3.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.405 -0.361 . . . . 64.430000000000007 110.181 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.449 HG22 ' H ' ' A' ' 52' ' ' GLU . 42.1 m -157.11 125.56 5.67 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.009 -0.737 . . . . 61.439999999999998 109.009 178.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.2 m -72.12 -13.32 16.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.351 0.5 . . . . 71.420000000000002 112.351 -173.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.449 ' H ' HG22 ' A' ' 50' ' ' THR . 3.1 mm-40 -134.28 100.3 4.65 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.991 0.424 . . . . 75.109999999999999 110.523 177.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -137.42 86.08 20.09 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.669 -0.696 . . . . 54.039999999999999 111.06 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -65.89 114.16 2.86 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.555 2.17 . . . . 73.400000000000006 110.943 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 67.39 144.1 0.09 OUTLIER Pre-proline 0 N--CA 1.466 0.367 0 O-C-N 123.967 0.792 . . . . 70.510000000000005 110.263 -170.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -65.64 -57.13 0.27 Allowed 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 120.888 1.059 . . . . 75.129999999999995 111.384 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.011 ' HB3' HD13 ' A' ' 80' ' ' LEU . 1.5 pt? -112.47 -0.64 15.21 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.659 -0.7 . . . . 42.140000000000001 111.178 -170.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.72 95.82 0.04 OUTLIER Glycine 0 C--O 1.23 -0.136 0 O-C-N 124.095 0.872 . . . . 74.25 113.735 -172.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 71.63 7.69 6.01 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.513 0.725 . . . . 55.409999999999997 111.637 173.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.549 HG23 ' H ' ' A' ' 62' ' ' TRP . 26.6 m -95.67 -31.47 4.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.409 -0.517 . . . . 73.299999999999997 110.671 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.7 t 58.06 18.02 4.88 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.832 -0.622 . . . . 60.340000000000003 112.33 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.549 ' H ' HG23 ' A' ' 60' ' ' VAL . 23.5 m95 -130.67 -0.32 4.35 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.088 0.773 . . . . 73.129999999999995 113.088 -175.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.533 ' HB3' HD12 ' A' ' 80' ' ' LEU . 9.7 tp10 -86.81 152.16 22.73 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.086 0.47 . . . . 62.32 110.589 -174.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -122.33 145.34 48.34 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.741 -0.663 . . . . 71.049999999999997 110.88 -178.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.475 ' HG2' ' H ' ' A' ' 66' ' ' LEU . 33.0 tt0 -105.53 172.28 6.88 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.863 -1.162 . . . . 71.109999999999999 107.863 172.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.497 ' CD1' ' HA ' ' A' ' 77' ' ' TRP . 11.6 tp -130.43 145.13 51.77 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 122.013 -0.429 . . . . 44.219999999999999 111.061 -174.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.707 HG23 ' HB2' ' A' ' 78' ' ' ARG . 61.5 p -96.68 -34.75 11.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.084 0.469 . . . . 62.219999999999999 110.983 178.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.574 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -140.44 136.02 32.61 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.731 -0.668 . . . . 43.420000000000002 110.857 -177.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.41 ' HB3' HD23 ' A' ' 66' ' ' LEU . 6.9 p-10 -137.38 75.05 1.51 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.576 0.703 . . . . 63.240000000000002 111.051 -177.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.496 ' HB2' ' H ' ' A' ' 74' ' ' ARG . 16.3 mm-40 -96.37 143.42 26.08 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.926 -0.579 . . . . 74.540000000000006 110.22 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -67.81 -38.11 14.3 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.832 2.355 . . . . 73.310000000000002 112.776 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -151.56 42.01 0.73 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.364 -0.922 . . . . 33.009999999999998 112.659 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.437 ' HD2' ' OE1' ' A' ' 70' ' ' GLU . 76.0 mttt -130.11 -74.34 0.55 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.169 -0.308 . . . . 71.200000000000003 110.169 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.496 ' H ' ' HB2' ' A' ' 70' ' ' GLU . 5.9 ptp180 -151.71 150.44 30.22 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.872 -0.418 . . . . 75.219999999999999 109.872 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.528 HD12 ' HE2' ' A' ' 93' ' ' PHE . 70.7 mt -134.97 109.49 11.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.365 -0.606 . . . . 70.239999999999995 109.365 171.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.574 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -96.65 116.04 28.44 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.213 -0.662 . . . . 63.119999999999997 109.213 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.497 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 12.8 t90 -81.81 154.07 26.11 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.38 -0.827 . . . . 74.510000000000005 110.394 -172.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.707 ' HB2' HG23 ' A' ' 67' ' ' THR . 64.5 ttt180 -140.42 173.3 11.64 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.89 -0.781 . . . . 62.100000000000001 108.89 -178.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.533 ' HB2' ' HA ' ' A' ' 85' ' ' ILE . 45.8 m -135.9 152.68 51.26 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.944 -0.391 . . . . 44.450000000000003 109.944 175.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.011 HD13 ' HB3' ' A' ' 57' ' ' LEU . 66.5 mt -78.32 145.78 69.1 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 116.205 -0.452 . . . . 71.019999999999996 110.973 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 80' ' ' LEU . 51.4 Cg_exo -57.47 -31.93 92.72 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.352 2.702 . . . . 72.439999999999998 112.343 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.449 ' H ' HD12 ' A' ' 57' ' ' LEU . . . -81.51 -5.41 89.96 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.107 -0.568 . . . . 62.539999999999999 112.255 178.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.57 -65.21 1.01 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.274 -0.269 . . . . 72.540000000000006 110.274 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.69 ' HG2' ' HB2' ' A' ' 86' ' ' GLU . 20.5 ttt180 -177.53 -53.57 0.01 OUTLIER 'General case' 0 C--N 1.335 -0.063 0 CA-C-N 116.074 -0.512 . . . . 63.119999999999997 111.005 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.533 ' HA ' ' HB2' ' A' ' 79' ' ' SER . 13.0 tt 44.85 40.88 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-O 122.213 1.006 . . . . 74.200000000000003 112.02 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.69 ' HB2' ' HG2' ' A' ' 84' ' ' ARG . 0.8 OUTLIER -97.55 -4.37 37.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.453 -0.794 . . . . 54.340000000000003 110.492 -179.716 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -135.03 172.51 12.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.574 -0.739 . . . . 71.329999999999998 110.311 -177.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.0 m -148.06 145.21 28.36 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.769 0.319 . . . . 74.040000000000006 110.625 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -142.68 122.83 2.02 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.319 -0.713 . . . . 75.329999999999998 111.319 177.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -117.56 120.79 39.14 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.171 -0.307 . . . . 74.219999999999999 110.171 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.539 HG22 HG22 ' A' ' 106' ' ' VAL . 78.3 t -112.83 119.75 61.21 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.625 0.726 . . . . 74.420000000000002 111.425 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.8 mp -104.51 125.05 50.32 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.151 -0.931 . . . . 74.230000000000004 110.15 176.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.528 ' HE2' HD12 ' A' ' 75' ' ' ILE . 73.6 m-85 -89.48 106.43 18.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.115 0.484 . . . . 74.400000000000006 109.818 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.425 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 33.3 ptt180 -127.18 143.98 48.99 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.859 -0.61 . . . . 71.430000000000007 110.816 -176.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 94' ' ' ARG . 30.3 Cg_exo -62.55 127.29 20.37 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.662 2.241 . . . . 74.439999999999998 111.5 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.52 146.83 96.5 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 116.081 -0.508 . . . . 71.230000000000004 110.23 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -48.19 127.53 15.41 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.64 2.893 . . . . 61.039999999999999 113.111 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.87 20.33 68.31 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.801 -0.636 . . . . 54.439999999999998 112.447 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 56.66 34.25 24.19 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.129 0.49 . . . . 65.129999999999995 111.347 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.436 HH11 ' HD3' ' A' ' 100' ' ' ARG . 4.4 mmp_? -82.11 0.47 40.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.053 -0.521 . . . . 74.040000000000006 111.439 -177.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 144.33 -157.53 27.2 Favored Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 111.063 -0.815 . . . . 64.340000000000003 111.063 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 71.7 m -121.52 128.04 51.63 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.609 -0.515 . . . . 72.200000000000003 109.609 176.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -103.91 130.78 51.55 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.26 0.552 . . . . 71.299999999999997 109.899 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.697 HG21 ' HE2' ' A' ' 140' ' ' PHE . 4.7 m -89.36 132.45 34.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 108.623 -0.88 . . . . 62.43 108.623 175.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 7.3 p -118.0 115.45 48.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 121.375 0.607 . . . . 74.409999999999997 109.896 -177.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.539 HG22 HG22 ' A' ' 91' ' ' VAL . 39.6 t -105.1 115.13 46.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.574 -0.739 . . . . 72.409999999999997 110.849 -174.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -90.52 106.42 18.49 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.422 -0.584 . . . . 61.140000000000001 109.422 173.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.425 ' HA ' HD22 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -99.3 135.67 40.38 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.794 -0.447 . . . . 64.030000000000001 109.794 -177.043 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.4 p -83.81 119.91 25.41 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.214 0.53 . . . . 73.340000000000003 111.236 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.665 ' HB3' ' O ' ' A' ' 4' ' ' THR . 81.2 t80 -132.73 112.24 11.82 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.594 -0.73 . . . . 62.420000000000002 109.257 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 25.6 ptt85 -138.04 154.73 74.47 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 115.705 -0.68 . . . . 74.420000000000002 110.119 -174.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 60.8 Cg_endo -72.82 156.87 52.52 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.409 2.073 . . . . 63.229999999999997 111.98 -177.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 36.5 Cg_exo -60.37 116.71 3.51 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.641 2.227 . . . . 75.230000000000004 111.829 177.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -77.95 66.3 3.13 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 116.084 -0.507 . . . . 41.439999999999998 112.069 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 169.92 143.94 4.1 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 121.183 -0.532 . . . . 44.32 111.952 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.0 t -61.05 -45.41 94.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.776 0.322 . . . . 54.219999999999999 110.554 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.24 -32.65 74.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.221 -0.445 . . . . 53.329999999999998 110.774 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -71.47 -37.0 62.62 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.772 -0.728 . . . . 41.420000000000002 111.993 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.79 -45.52 71.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.652 0.263 . . . . 71.409999999999997 111.544 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 28.1 m -66.09 -36.54 77.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.042 0.386 . . . . 64.209999999999994 112.042 -175.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 35.6 pt -75.66 -32.36 24.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 120.761 -0.376 . . . . 73.019999999999996 110.781 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . . . -69.57 -34.57 74.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.971 0.415 . . . . 64.329999999999998 110.171 176.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -59.23 -34.81 72.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.118 -0.492 . . . . 72.219999999999999 110.227 175.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 14.7 tpt -71.77 -51.87 20.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.862 -0.608 . . . . 74.120000000000005 110.646 176.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -126.6 88.24 2.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.078 0.466 . . . . 74.209999999999994 111.151 -178.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 122' ' ' ALA . 6.4 t30 -117.25 -49.61 2.58 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 107.78 -1.192 . . . . 71.430000000000007 107.78 173.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 58.22 51.35 8.61 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.742 -1.117 . . . . 63.509999999999998 112.01 171.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.471 ' HB3' ' HG2' ' A' ' 131' ' ' GLN . 51.5 mt-10 -127.82 82.66 67.95 Favored Pre-proline 0 C--N 1.327 -0.406 0 C-N-CA 120.82 -0.352 . . . . 71.409999999999997 111.045 176.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -72.24 -54.6 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.32 2.013 . . . . 71.310000000000002 110.539 172.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 56.5 p -115.66 3.93 14.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.421 -0.808 . . . . 74.5 109.865 173.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.471 ' HG2' ' HB3' ' A' ' 128' ' ' GLU . 75.8 mt-30 65.37 -169.19 0.2 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.424 -0.807 . . . . 71.540000000000006 110.325 -176.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -66.61 -25.99 66.87 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.269 -0.641 . . . . 61.329999999999998 109.269 171.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.849 ' HG ' ' H ' ' A' ' 134' ' ' ARG . 14.7 tp 54.13 -154.64 0.25 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 114.929 -1.032 . . . . 34.240000000000002 110.722 174.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.849 ' H ' ' HG ' ' A' ' 133' ' ' LEU . 54.4 ttt85 -79.83 -9.38 59.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.787 0.327 . . . . 74.340000000000003 110.123 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -54.09 -48.12 71.02 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.254 -0.43 . . . . 71.450000000000003 111.066 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -69.12 -35.8 76.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.146 -0.479 . . . . 63.219999999999999 111.07 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 16.3 tp -76.97 -21.84 54.13 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.33 -0.395 . . . . 55.340000000000003 110.442 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.642 ' CE ' ' HA ' ' A' ' 138' ' ' MET . 4.8 mmt -65.99 -37.7 86.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.404 -0.362 . . . . 73.019999999999996 110.572 175.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.36 -35.22 75.64 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.711 -0.478 . . . . 71.510000000000005 109.711 177.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.697 ' HE2' HG21 ' A' ' 104' ' ' VAL . 72.5 t80 -57.44 -46.36 83.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.791 -0.641 . . . . 73.239999999999995 109.862 175.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.57 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 40.5 tttp -63.61 -40.25 96.44 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.366 -0.379 . . . . 72.549999999999997 110.876 176.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.4 ' HD2' HD22 ' A' ' 146' ' ' LEU . 21.3 tpp180 -57.51 -58.34 8.74 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.194 -0.457 . . . . 70.120000000000005 110.421 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.432 ' HG2' HD12 ' A' ' 148' ' ' LEU . 1.7 mp0 -66.1 -28.21 68.65 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 121.114 -0.235 . . . . 71.109999999999999 111.352 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.734 ' HB3' HG12 ' A' ' 12' ' ' ILE . 25.4 mm-40 -56.91 -49.71 74.77 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.312 0.577 . . . . 75.209999999999994 111.263 176.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.979 ' HG2' HG23 ' A' ' 12' ' ' ILE . 26.8 mt-10 -87.35 -32.3 19.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.779 -0.646 . . . . 64.329999999999998 111.1 -175.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.4 HD22 ' HD2' ' A' ' 142' ' ' ARG . 24.2 tp -90.47 -58.09 2.61 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.479 0.657 . . . . 73.400000000000006 111.625 -174.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.459 ' HA2' HD13 ' A' ' 26' ' ' LEU . . . 128.01 172.16 13.16 Favored Glycine 0 N--CA 1.441 -0.967 0 N-CA-C 109.405 -1.478 . . . . 74.319999999999993 109.405 -167.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.432 HD12 ' HG2' ' A' ' 143' ' ' GLU . 27.7 tp -85.78 -0.57 55.62 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 117.812 0.806 . . . . 65.129999999999995 110.567 -175.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -94.22 120.66 34.78 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.898 -0.592 . . . . 55.43 111.382 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 9.7 t60 73.87 73.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.948 -1.024 . . . . 64.209999999999994 112.507 172.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -126.02 92.17 3.53 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.726 -0.842 . . . . 75.310000000000002 108.726 167.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.494 ' O ' ' HB2' ' A' ' 153' ' ' HIS . 83.0 t60 -74.69 127.07 32.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.962 -1.017 . . . . 70.129999999999995 112.008 -168.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.494 ' HB2' ' O ' ' A' ' 152' ' ' HIS . 7.4 t60 168.93 -62.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.618 -1.253 . . . . 61.229999999999997 107.618 176.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.444 ' HB2' ' O ' ' A' ' 153' ' ' HIS . 66.2 t60 168.34 -46.86 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 106.398 -1.704 . . . . 74.510000000000005 106.398 177.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 . . . . . 0 C--O 1.245 0.863 0 CA-C-N 114.054 -1.43 . . . . 44.420000000000002 107.704 168.402 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 110.378 -0.23 . . . . 71.439999999999998 110.378 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 117.97 -30.09 6.25 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.091 -0.803 . . . . 73.439999999999998 111.091 -178.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -86.39 170.59 11.86 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.109 -0.7 . . . . 71.549999999999997 109.109 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.633 ' HB ' ' O ' ' A' ' 110' ' ' TYR . 30.5 m -98.75 121.72 41.06 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 109.196 -0.668 . . . . 73.400000000000006 109.196 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.8 t -120.61 113.0 38.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.477 -0.564 . . . . 73.010000000000005 109.477 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 52.4 t -99.07 122.6 51.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.835 -0.62 . . . . 61.229999999999997 110.851 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.524 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 57.1 ttt-85 -126.12 109.59 12.55 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.363 -0.606 . . . . 73.109999999999999 109.363 171.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.597 ' HB3' HD22 ' A' ' 137' ' ' LEU . 18.1 t0 -130.83 151.14 51.58 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.954 -1.128 . . . . 72.120000000000005 107.954 177.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.658 ' HB2' HG12 ' A' ' 105' ' ' VAL . . . -135.99 129.48 32.14 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.948 0.404 . . . . 31.120000000000001 111.948 -170.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.846 ' HB ' ' HG3' ' A' ' 141' ' ' LYS . 16.1 m -120.56 143.25 33.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.896 -0.593 . . . . 73.099999999999994 110.188 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.426 HG21 ' HD3' ' A' ' 100' ' ' ARG . 26.6 m -107.25 114.1 27.93 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.582 -0.281 . . . . 63.409999999999997 110.669 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.972 HG23 ' HB3' ' A' ' 145' ' ' GLU . 4.9 mp -110.73 139.64 33.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.311 -0.404 . . . . 65.519999999999996 110.79 -176.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.46 60.31 4.55 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 121.249 -0.5 . . . . 73.340000000000003 113.039 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.676 ' HD3' ' HG2' ' A' ' 18' ' ' GLN . 43.0 mttp -140.69 150.38 59.94 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 110.2 -0.296 . . . . 71.310000000000002 110.2 176.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.441 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 51.4 Cg_exo -56.01 -59.28 0.75 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.817 2.345 . . . . 60.509999999999998 114.123 -173.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . 170.73 -48.04 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.453 0.644 . . . . 65.310000000000002 110.007 175.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -48.17 -56.36 8.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.257 -1.338 . . . . 71.219999999999999 112.954 -173.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.676 ' HG2' ' HD3' ' A' ' 14' ' ' LYS . 0.6 OUTLIER -80.9 -7.65 59.54 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.257 -0.429 . . . . 75.549999999999997 111.65 -173.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.55 ' CB ' ' HE2' ' A' ' 93' ' ' PHE . 64.0 mt -75.87 -26.8 57.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.796 -0.183 . . . . 64.310000000000002 111.163 177.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -65.18 -29.81 70.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.241 0.543 . . . . 71.430000000000007 110.447 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.45 -8.45 56.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.577 -0.738 . . . . 71.109999999999999 111.689 -175.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.474 HG11 ' HE2' ' A' ' 140' ' ' PHE . 6.2 p -60.16 -22.2 24.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.808 0.337 . . . . 74.140000000000001 111.735 -175.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -70.41 -23.48 62.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.919 0.39 . . . . 65.030000000000001 110.774 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.405 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 17.8 tpt180 -128.58 19.47 6.21 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.885 -0.413 . . . . 72.430000000000007 109.885 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.561 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 18.6 t70 64.84 162.43 0.13 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.62 -0.718 . . . . 61.420000000000002 110.968 -174.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.575 HD23 ' H ' ' A' ' 26' ' ' LEU . 1.3 pt? -113.95 85.7 10.25 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 121.364 0.602 . . . . 55.240000000000002 112.019 -175.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.561 ' HD3' ' O ' ' A' ' 25' ' ' ASP . 1.9 Cg_endo -84.75 -11.9 7.69 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.059 2.506 . . . . 72.310000000000002 111.623 173.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.38 57.94 6.36 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.819 -0.628 . . . . 74.450000000000003 112.698 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.514 ' N ' ' HD3' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -146.37 60.69 6.38 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 112.455 0.539 . . . . 74.209999999999994 112.455 178.403 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.514 ' HD3' ' N ' ' A' ' 29' ' ' LEU . 1.3 Cg_endo -84.49 -0.57 9.43 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.636 2.224 . . . . 63.149999999999999 111.67 175.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.465 HD12 ' HD2' ' A' ' 30' ' ' PRO . 6.6 mp -100.91 34.71 2.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.876 -0.602 . . . . 73.230000000000004 110.501 -177.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.662 ' H ' HD23 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -69.77 -15.22 63.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.235 -0.439 . . . . 51.140000000000001 111.981 -177.389 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.869 ' HG2' ' H ' ' A' ' 34' ' ' THR . 17.4 ttt 61.87 -164.73 0.24 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 110.175 -0.306 . . . . 65.540000000000006 110.175 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.869 ' H ' ' HG2' ' A' ' 33' ' ' MET . 0.9 OUTLIER -80.12 87.4 5.48 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.875 0.369 . . . . 74.319999999999993 111.062 176.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 65.18 74.4 0.39 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.369 -0.832 . . . . 73.0 112.656 177.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.529 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 61.1 tp -126.78 110.66 13.34 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.36 -0.978 . . . . 71.519999999999996 108.36 170.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.529 ' HB3' ' O ' ' A' ' 36' ' ' LEU . 26.5 ttt180 74.9 149.28 0.1 Allowed 'General case' 0 CA--C 1.535 0.375 0 O-C-N 124.065 0.853 . . . . 73.530000000000001 110.515 -174.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.8 m -71.98 102.11 2.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.361 -0.381 . . . . 52.5 110.494 178.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.424 HG13 HD13 ' A' ' 32' ' ' LEU . 13.0 p -156.49 158.85 3.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.391 -0.368 . . . . 74.349999999999994 110.147 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -61.91 156.49 20.76 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.625 -0.261 . . . . 75.010000000000005 110.589 177.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.727 HG22 HD22 ' A' ' 42' ' ' LEU . 8.3 p -74.56 -55.39 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 112.352 0.501 . . . . 75.530000000000001 112.352 -170.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.727 HD22 HG22 ' A' ' 41' ' ' VAL . 1.1 mm? -145.6 -68.46 0.29 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.949 0.404 . . . . 64.010000000000005 110.279 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 72.89 -13.59 0.66 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.135 -0.938 . . . . 73.129999999999995 112.563 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -93.41 -15.35 25.74 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.356 -0.609 . . . . 75.420000000000002 109.356 172.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -166.07 85.46 0.33 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.483 -0.932 . . . . 72.329999999999998 108.483 -175.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.415 ' HB3' ' O ' ' A' ' 45' ' ' LYS . 37.5 ttp180 75.55 132.59 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.102 -0.954 . . . . 72.329999999999998 112.347 176.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 25.8 m -152.4 115.87 4.75 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.041 -0.982 . . . . 64.349999999999994 111.064 177.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.491 ' HG3' ' OG1' ' A' ' 50' ' ' THR . 1.1 ptm180 -135.6 8.87 3.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.005 -0.543 . . . . 72.030000000000001 109.755 170.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 29.4 m-90 54.19 72.85 0.43 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.201 -0.908 . . . . 75.340000000000003 112.293 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.546 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -166.27 -73.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.463 -0.789 . . . . 71.340000000000003 110.185 174.163 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.546 HG12 ' O ' ' A' ' 50' ' ' THR . 1.4 p 57.12 15.55 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.623 1.169 . . . . 70.129999999999995 111.971 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 50' ' ' THR . 38.1 mt-10 -99.86 -18.32 17.2 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.939 -0.573 . . . . 73.209999999999994 110.548 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -103.24 150.55 38.04 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.861 -0.609 . . . . 64.049999999999997 110.567 -177.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.405 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 16.6 Cg_exo -69.0 173.96 9.54 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 123.186 2.591 . . . . 64.319999999999993 112.101 177.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 54' ' ' PRO . . . 72.51 153.78 0.15 Allowed Pre-proline 0 N--CA 1.466 0.37 0 C-N-CA 123.401 0.68 . . . . 75.420000000000002 111.394 -176.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.81 ' HB2' HD13 ' A' ' 57' ' ' LEU . 75.7 Cg_exo -49.29 -46.89 24.23 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.582 2.188 . . . . 63.43 111.762 176.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.81 HD13 ' HB2' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -137.51 -20.37 1.19 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.941 -0.572 . . . . 74.420000000000002 111.982 178.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.489 ' N ' HD22 ' A' ' 57' ' ' LEU . . . 74.06 -60.04 2.23 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.493 -0.861 . . . . 72.540000000000006 111.705 -174.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -134.75 151.01 50.64 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.797 -0.445 . . . . 74.239999999999995 109.797 177.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.701 HG12 HD13 ' A' ' 80' ' ' LEU . 30.7 m -105.85 134.48 47.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.655 0.264 . . . . 70.25 110.922 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.8 t -154.11 -56.75 0.11 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.509 -0.314 . . . . 74.140000000000001 110.807 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -139.1 -11.91 1.24 Allowed 'General case' 0 C--O 1.234 0.278 0 N-CA-C 112.487 0.551 . . . . 74.200000000000003 112.487 -174.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.588 ' HG2' ' CD1' ' A' ' 80' ' ' LEU . 1.8 pm0 -84.27 166.3 17.6 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.623 0.725 . . . . 74.340000000000003 112.58 -172.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -134.36 143.35 47.6 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.64 -1.164 . . . . 71.439999999999998 110.507 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.685 ' HB3' ' HD2' ' A' ' 78' ' ' ARG . 1.8 tm-20 -107.24 175.57 5.45 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.291 -1.003 . . . . 74.239999999999995 108.291 176.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.617 HD12 ' HA ' ' A' ' 77' ' ' TRP . 22.8 tp -124.08 119.64 30.05 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.132 -0.692 . . . . 75.409999999999997 109.132 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.3 t -81.53 -23.71 37.09 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.627 0.251 . . . . 64.120000000000005 111.389 -174.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.586 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . . . -144.12 127.31 16.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.932 0.396 . . . . 55.240000000000002 111.043 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.598 ' HB2' HD23 ' A' ' 66' ' ' LEU . 11.0 t70 -138.79 104.03 4.98 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.266 -0.879 . . . . 54.530000000000001 109.788 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.454 ' HB2' ' H ' ' A' ' 74' ' ' ARG . 8.0 mm-40 -106.71 144.2 28.58 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.718 -0.673 . . . . 73.219999999999999 109.855 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 35.3 Cg_exo -62.04 -24.61 76.82 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.92 2.414 . . . . 50.109999999999999 112.536 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.98 56.93 0.12 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.917 -0.659 . . . . 75.040000000000006 111.592 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -141.41 -68.76 0.38 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.345 -0.142 . . . . 74.450000000000003 111.019 -176.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.454 ' H ' ' HB2' ' A' ' 70' ' ' GLU . 18.5 ptt180 -153.32 155.38 36.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.857 0.36 . . . . 75.340000000000003 111.51 -176.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.896 ' HB ' HG12 ' A' ' 91' ' ' VAL . 49.0 mm -125.14 110.82 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.765 -0.652 . . . . 72.019999999999996 109.723 174.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.586 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . . . -108.81 120.41 42.4 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.981 -0.748 . . . . 71.25 108.981 174.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.617 ' HA ' HD12 ' A' ' 66' ' ' LEU . 13.7 p-90 -106.85 138.95 42.05 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.612 0.72 . . . . 64.409999999999997 112.195 -170.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.685 ' HD2' ' HB3' ' A' ' 65' ' ' GLU . 7.8 ptp85 -113.07 173.35 6.43 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 107.676 -1.231 . . . . 65.150000000000006 107.676 171.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.437 ' CB ' ' HD3' ' A' ' 84' ' ' ARG . 6.1 m -138.6 30.3 2.34 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.343 -0.543 . . . . 53.32 109.873 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.701 HD13 HG12 ' A' ' 60' ' ' VAL . 22.1 mt 66.52 147.02 0.11 Allowed Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 115.086 -0.961 . . . . 72.109999999999999 111.093 -175.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.64 -23.16 55.83 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 123.104 2.536 . . . . 64.510000000000005 113.529 -174.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.21 -3.32 88.92 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.717 -0.754 . . . . 64.010000000000005 113.263 -176.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -136.44 25.98 3.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.201 0.5 . . . . 75.310000000000002 111.851 -177.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.437 ' HD3' ' CB ' ' A' ' 79' ' ' SER . 9.4 mmm180 -126.83 107.79 10.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.827 0.346 . . . . 73.010000000000005 111.457 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.735 HG13 ' H ' ' A' ' 86' ' ' GLU . 13.8 pt -91.11 -63.3 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.053 -0.521 . . . . 63.310000000000002 110.298 173.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.735 ' H ' HG13 ' A' ' 85' ' ' ILE . 34.2 tt0 -163.74 109.42 1.07 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.885 0.374 . . . . 74.340000000000003 110.366 176.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -162.15 141.01 9.3 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.682 -0.859 . . . . 75.409999999999997 108.682 175.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.4 m -151.37 129.38 11.79 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.142 -0.318 . . . . 75.109999999999999 110.142 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.09 110.26 0.25 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.55 -0.833 . . . . 34.240000000000002 112.247 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.13 149.98 23.73 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.242 -0.281 . . . . 73.310000000000002 110.242 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.896 HG12 ' HB ' ' A' ' 75' ' ' ILE . 7.6 p -88.97 140.98 14.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.213 -0.662 . . . . 74.129999999999995 109.213 174.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.692 ' HB2' ' CG2' ' A' ' 105' ' ' VAL . 3.2 mm? -108.99 119.81 40.66 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.154 -0.684 . . . . 65.439999999999998 109.154 172.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.55 ' HE2' ' CB ' ' A' ' 19' ' ' LEU . 15.7 m-85 -96.91 106.03 18.28 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.824 -0.806 . . . . 61.549999999999997 108.824 174.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 32.7 mtp180 -125.95 142.9 43.69 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 116.112 -0.495 . . . . 72.129999999999995 110.046 -174.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -57.85 115.57 2.61 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.436 2.091 . . . . 74.25 110.634 175.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . . . -65.36 143.63 98.78 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.019 -0.537 . . . . 63.520000000000003 111.413 -173.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 96' ' ' ALA . 51.5 Cg_exo -55.79 137.39 78.39 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.885 2.39 . . . . 65.099999999999994 111.925 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.63 16.51 79.13 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.947 -0.644 . . . . 61.450000000000003 112.101 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 57.16 33.69 23.7 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.341 0.591 . . . . 64.219999999999999 110.794 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.426 ' HD3' HG21 ' A' ' 11' ' ' THR . 34.6 ttt180 -77.27 1.04 19.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.41 -0.814 . . . . 71.409999999999997 111.04 -175.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 123.23 -125.13 5.84 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 111.508 -0.637 . . . . 70.519999999999996 111.508 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 88.0 m -135.01 130.53 35.84 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.952 0.406 . . . . 73.150000000000006 110.564 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -100.9 113.91 27.3 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.902 -0.59 . . . . 74.150000000000006 109.534 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.2 m -88.74 127.29 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-O 121.703 0.763 . . . . 71.219999999999999 108.991 175.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.692 ' CG2' ' HB2' ' A' ' 92' ' ' LEU . 14.0 m -123.18 119.39 57.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.204 -0.907 . . . . 45.229999999999997 109.815 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.639 HG13 HG23 ' A' ' 91' ' ' VAL . 1.8 m -119.84 121.52 66.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.908 -0.587 . . . . 73.540000000000006 111.074 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.85 109.85 19.19 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.537 -0.912 . . . . 75.299999999999997 108.537 174.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.432 HD22 ' HE2' ' A' ' 110' ' ' TYR . 0.4 OUTLIER -141.12 151.39 43.9 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.058 0.456 . . . . 75.109999999999999 111.544 -174.435 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.9 t -98.77 133.09 43.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.378 0.609 . . . . 52.420000000000002 110.911 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.633 ' O ' ' HB ' ' A' ' 4' ' ' THR . 57.8 m-85 -151.68 -179.4 7.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.039 -0.982 . . . . 71.430000000000007 109.233 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -122.01 149.42 53.95 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 109.222 -0.659 . . . . 71.239999999999995 109.222 174.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.426 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 25.9 Cg_endo -61.42 152.43 72.96 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.448 2.099 . . . . 74.549999999999997 112.622 -177.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 25.6 Cg_exo -63.44 -52.4 1.98 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.953 2.436 . . . . 74.349999999999994 112.139 -178.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.29 -28.94 7.53 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.765 -0.731 . . . . 65.049999999999997 112.436 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -55.03 112.56 2.96 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.576 -0.345 . . . . 32.520000000000003 113.124 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.7 m -86.54 -30.61 21.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.93 0.395 . . . . 71.030000000000001 111.153 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.406 ' O ' HG22 ' A' ' 120' ' ' VAL . . . -64.93 -36.15 83.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.939 -0.573 . . . . 61.020000000000003 112.194 -173.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -60.14 -25.69 62.56 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 121.078 -0.582 . . . . 74.439999999999998 113.292 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.03 -46.76 86.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.727 0.299 . . . . 64.140000000000001 111.311 -177.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 117' ' ' ALA . 26.9 m -75.1 -23.73 17.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.495 -0.321 . . . . 53.399999999999999 111.177 -177.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 65.1 mt -72.7 -33.44 44.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.389 -0.369 . . . . 75.209999999999994 110.418 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.08 -22.64 65.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.169 -0.469 . . . . 72.510000000000005 111.279 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -63.87 -26.75 68.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.064 -0.517 . . . . 73.239999999999995 111.171 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 16.7 tpt -71.45 -26.86 62.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.949 0.404 . . . . 72.530000000000001 110.959 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -98.35 -174.22 2.77 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.254 -0.43 . . . . 70.439999999999998 111.256 -173.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -74.59 151.72 39.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.077 -0.511 . . . . 71.129999999999995 109.915 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -107.56 117.51 34.28 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.918 0.389 . . . . 65.120000000000005 111.488 -177.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -110.22 88.26 7.01 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.693 -0.685 . . . . 72.299999999999997 109.223 171.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -44.81 125.74 6.76 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.376 2.717 . . . . 61.130000000000003 113.134 -174.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.9 m -61.75 101.1 0.17 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.487 -0.778 . . . . 73.0 111.205 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -82.87 -10.53 58.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.291 0.567 . . . . 73.340000000000003 109.875 175.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -133.42 177.77 7.44 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.497 -0.927 . . . . 74.010000000000005 108.497 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.3 tt -71.3 -61.82 1.63 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.841 -0.344 . . . . 71.109999999999999 110.208 -177.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.571 ' HG2' ' H ' ' A' ' 137' ' ' LEU . 35.7 ttt85 -85.85 110.55 19.47 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.141 0.496 . . . . 74.200000000000003 110.369 178.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -61.51 -39.45 91.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.361 -0.836 . . . . 71.109999999999999 110.655 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -61.01 -34.99 75.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.836 -0.62 . . . . 74.310000000000002 111.206 177.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.597 HD22 ' HB3' ' A' ' 8' ' ' ASP . 11.5 tp -79.14 -35.8 41.51 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.503 0.668 . . . . 75.340000000000003 109.844 -175.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.3 ttp -66.28 -36.89 84.12 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.532 -0.758 . . . . 71.219999999999999 110.367 174.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -69.81 -51.05 37.06 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.128 -0.487 . . . . 75.540000000000006 112.182 -177.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.474 ' HE2' HG11 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -66.32 -29.54 69.76 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.261 -0.576 . . . . 71.200000000000003 109.685 -175.346 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.846 ' HG3' ' HB ' ' A' ' 10' ' ' VAL . 14.9 tmtt? -57.1 -42.37 80.66 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 115.788 -0.642 . . . . 62.119999999999997 110.46 173.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -55.11 -52.2 64.02 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.284 0.564 . . . . 73.420000000000002 110.269 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -66.58 -40.81 89.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.022 -0.99 . . . . 61.43 111.928 -172.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.518 ' CD ' HG12 ' A' ' 12' ' ' ILE . 4.6 pt20 -74.17 -17.3 60.93 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.571 0.582 . . . . 74.450000000000003 112.571 -173.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.972 ' HB3' HG23 ' A' ' 12' ' ' ILE . 19.7 pt-20 -110.73 -4.46 15.33 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.618 -0.433 . . . . 75.099999999999994 111.102 175.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 24.4 tp -61.8 -52.83 62.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.068 0.461 . . . . 72.409999999999997 110.453 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -109.32 119.23 5.45 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 121.022 -0.609 . . . . 73.109999999999999 111.77 175.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.507 HD23 ' HZ2' ' A' ' 14' ' ' LYS . 87.4 mt -85.7 -42.66 14.07 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.077 -0.342 . . . . 65.239999999999995 110.077 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 59.78 -86.94 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 O-C-N 124.106 0.879 . . . . 71.129999999999995 113.217 175.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -138.37 140.47 39.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.468 0.651 . . . . 60.039999999999999 112.148 -172.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -103.7 121.38 42.86 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.154 -0.93 . . . . 72.329999999999998 108.769 172.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -76.51 71.61 3.15 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.074 -0.713 . . . . 74.510000000000005 109.074 175.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 29.3 m170 57.01 -143.61 0.69 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.673 -0.694 . . . . 75.019999999999996 109.542 -174.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 76.3 m80 66.01 -86.33 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 122.569 0.348 . . . . 74.450000000000003 110.969 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 117.936 -1.031 . . . . 74.150000000000006 108.899 177.602 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.9 ttm . . . . . 0 N--CA 1.482 1.159 0 CA-C-O 121.101 0.477 . . . . 55.329999999999998 110.361 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -157.86 27.67 0.46 Allowed Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.589 -1.004 . . . . 62.299999999999997 110.589 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.517 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 2.5 pm0 -60.26 153.27 22.79 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.922 -0.639 . . . . 74.319999999999993 111.693 -176.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 47.5 m -132.42 126.95 34.3 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.598 -0.89 . . . . 75.540000000000006 108.598 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.817 HG22 HG23 ' A' ' 109' ' ' THR . 66.5 t -99.46 127.71 51.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 116.045 -0.525 . . . . 72.219999999999999 110.248 -173.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.6 m -83.77 126.28 40.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.387 0.613 . . . . 64.239999999999995 111.022 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.1 OUTLIER -142.28 118.03 10.46 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.569 -0.741 . . . . 61.030000000000001 110.553 -178.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.401 ' OD2' ' HD2' ' A' ' 134' ' ' ARG . 13.7 t70 -128.18 170.14 13.32 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.081 -0.711 . . . . 73.420000000000002 109.081 176.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.59 ' HB2' HG13 ' A' ' 105' ' ' VAL . . . -145.43 123.19 11.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.676 0.274 . . . . 71.109999999999999 111.325 -173.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.6 m -112.32 148.15 15.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.292 -0.413 . . . . 64.129999999999995 111.014 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.408 ' CG2' ' HB1' ' A' ' 96' ' ' ALA . 0.6 OUTLIER -105.21 110.43 22.8 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.952 -0.567 . . . . 70.329999999999998 112.0 -171.177 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.872 HG21 ' HB2' ' A' ' 144' ' ' GLN . 0.1 OUTLIER -124.4 151.23 29.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.109 0.48 . . . . 71.430000000000007 112.139 177.111 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.59 ' HA2' ' HA3' ' A' ' 101' ' ' GLY . . . -82.8 20.43 9.47 Favored Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.756 -0.656 . . . . 55.420000000000002 112.396 177.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.572 ' HB2' HD21 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -79.53 143.93 60.26 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.354 -0.61 . . . . 65.439999999999998 109.354 176.284 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.411 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 23.0 Cg_endo -62.28 -60.01 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.023 1.815 . . . . 74.120000000000005 113.359 -171.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.495 ' HA ' HD12 ' A' ' 19' ' ' LEU . . . 172.17 -50.76 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.492 0.717 . . . . 60.109999999999999 109.967 171.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.494 ' HA ' ' HD2' ' A' ' 20' ' ' TYR . 1.9 mp0 -56.29 -47.45 78.64 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.976 -0.556 . . . . 71.510000000000005 110.621 -177.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -66.71 -13.27 61.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.282 -0.872 . . . . 72.329999999999998 111.205 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.692 HD21 HG13 ' A' ' 12' ' ' ILE . 98.1 mt -83.88 -43.08 15.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.229 -0.441 . . . . 73.319999999999993 110.387 175.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.628 ' CE1' HD13 ' A' ' 75' ' ' ILE . 73.6 m-85 -62.68 -32.34 73.4 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.424 0.631 . . . . 64.129999999999995 109.8 176.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.52 -7.76 49.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.085 -0.961 . . . . 73.129999999999995 111.996 -176.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.557 HG21 ' CE2' ' A' ' 140' ' ' PHE . 7.8 p -53.74 -30.38 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 120.889 0.376 . . . . 72.239999999999995 111.65 -176.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 28.8 t90 -68.4 -23.73 64.68 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.044 0.449 . . . . 74.420000000000002 111.144 -177.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -124.21 13.54 8.97 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.583 -0.525 . . . . 71.420000000000002 109.583 -178.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.718 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 28.9 t70 62.38 168.73 0.12 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.427 -0.806 . . . . 55.229999999999997 110.532 -169.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.694 HD23 ' H ' ' A' ' 26' ' ' LEU . 1.3 pt? -104.83 87.2 1.73 Allowed Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 121.11 0.481 . . . . 74.400000000000006 110.767 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.718 ' HD3' ' O ' ' A' ' 25' ' ' ASP . 9.9 Cg_endo -89.39 -175.33 1.08 Allowed 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 123.208 2.605 . . . . 74.109999999999999 111.79 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.484 ' HA2' ' HB2' ' A' ' 38' ' ' SER . . . -144.37 -38.88 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.48 -0.867 . . . . 63.310000000000002 112.619 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.559 HD22 HD22 ' A' ' 32' ' ' LEU . 8.4 mp 65.22 160.87 0.12 Allowed Pre-proline 0 C--O 1.234 0.239 0 C-N-CA 122.967 0.507 . . . . 64.099999999999994 110.521 -174.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.09 61.6 3.23 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 121.6 1.534 . . . . 72.219999999999999 111.723 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.7 mp 44.53 72.54 0.19 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 114.753 -1.112 . . . . 74.430000000000007 112.587 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.559 HD22 HD22 ' A' ' 29' ' ' LEU . 1.8 pt? -81.86 -13.35 57.73 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.596 -0.52 . . . . 72.5 109.596 174.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 14.6 tpt 64.57 105.38 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.211 -0.904 . . . . 74.439999999999998 111.543 177.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.6 m -133.36 -51.37 0.87 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.053 -0.521 . . . . 75.0 111.464 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 24.6 t-80 -161.07 -179.48 7.54 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.17 -0.678 . . . . 74.109999999999999 109.17 -173.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.628 ' O ' ' HB2' ' A' ' 37' ' ' ARG . 3.2 mm? -57.97 137.69 56.56 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 108.067 -1.086 . . . . 72.200000000000003 108.067 167.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.628 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER 75.37 129.88 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 108.239 -1.023 . . . . 74.140000000000001 108.239 -164.05 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.484 ' HB2' ' HA2' ' A' ' 28' ' ' GLY . 17.5 m -44.86 -37.54 3.95 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.053 0.76 . . . . 65.420000000000002 113.053 -170.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 40' ' ' GLU . 6.4 p -144.01 -58.3 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 120.961 -0.296 . . . . 53.299999999999997 110.849 173.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.455 ' N ' HG13 ' A' ' 39' ' ' VAL . 1.9 tt0 50.27 -159.98 0.07 Allowed 'General case' 0 C--O 1.237 0.401 0 O-C-N 123.444 0.465 . . . . 62.240000000000002 110.066 -176.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.448 ' H ' ' HG2' ' A' ' 40' ' ' GLU . 38.3 t -59.85 132.84 25.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.732 -0.47 . . . . 71.230000000000004 109.732 173.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.664 HD12 ' HA ' ' A' ' 48' ' ' ARG . 84.5 mt -61.54 -71.1 0.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.234 0.827 . . . . 72.329999999999998 113.234 -167.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.787 ' HB2' HG23 ' A' ' 50' ' ' THR . 12.5 t70 -64.74 -53.42 47.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.557 0.694 . . . . 70.129999999999995 111.132 -174.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -169.44 -82.75 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.717 -1.129 . . . . 65.430000000000007 108.545 -176.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 50.8 mmtt -123.45 14.89 9.61 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.385 -0.968 . . . . 72.349999999999994 108.385 167.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.6 ' HG2' ' O ' ' A' ' 64' ' ' ALA . 31.5 mtm-85 -109.04 175.22 5.54 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 114.477 -1.238 . . . . 72.040000000000006 111.645 -171.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 50.8 m -75.05 -161.0 0.12 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.997 1.11 . . . . 51.439999999999998 113.997 -166.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.664 ' HA ' HD12 ' A' ' 42' ' ' LEU . 47.9 mtt85 -84.04 178.29 7.91 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 114.84 -1.073 . . . . 75.510000000000005 111.678 -176.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 94.7 m95 71.8 -35.31 0.32 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.737 0.815 . . . . 72.209999999999994 113.05 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.787 HG23 ' HB2' ' A' ' 43' ' ' ASP . 3.2 t -75.4 69.73 2.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 122.197 0.998 . . . . 72.329999999999998 111.247 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.1 m -128.31 -34.18 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.12 -0.945 . . . . 60.109999999999999 109.363 171.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -122.1 27.5 7.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.308 -0.86 . . . . 50.439999999999998 109.873 175.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.65 157.27 63.03 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.447 -0.797 . . . . 72.530000000000001 109.825 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.41 -178.05 1.06 Allowed 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.466 2.111 . . . . 70.409999999999997 112.068 177.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.75 143.51 39.33 Favored Pre-proline 0 C--O 1.236 0.354 0 CA-C-N 116.312 -0.403 . . . . 50.350000000000001 111.265 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.45 ' HB3' ' HG3' ' A' ' 63' ' ' GLU . 34.8 Cg_endo -60.38 -54.95 1.74 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.041 2.494 . . . . 71.430000000000007 111.449 -177.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.625 HD12 ' HG3' ' A' ' 65' ' ' GLU . 13.4 mt -78.79 8.62 5.15 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.642 -1.163 . . . . 62.530000000000001 110.493 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -94.93 -64.49 0.99 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.747 -0.661 . . . . 72.430000000000007 111.548 175.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -151.48 60.68 0.88 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.918 0.39 . . . . 63.340000000000003 111.726 -178.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 80.4 t -132.5 140.71 46.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.722 -0.473 . . . . 63.450000000000003 109.722 176.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.7 m -55.58 -70.37 0.11 Allowed 'General case' 0 N--CA 1.462 0.172 0 O-C-N 123.194 0.309 . . . . 55.350000000000001 111.316 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 70.4 p-90 -129.34 136.71 50.37 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.489 0.662 . . . . 74.540000000000006 111.155 176.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.585 ' OE2' ' HB3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -154.8 169.31 24.27 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.537 -1.21 . . . . 74.099999999999994 108.299 177.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.6 ' O ' ' HG2' ' A' ' 46' ' ' ARG . . . -118.83 113.9 21.81 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.492 -0.483 . . . . 62.420000000000002 110.17 175.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.625 ' HG3' HD12 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -106.77 135.74 47.79 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.745 -0.465 . . . . 74.230000000000004 109.745 178.328 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.521 HD12 ' HA ' ' A' ' 77' ' ' TRP . 3.0 mm? -86.57 147.05 26.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.139 -0.482 . . . . 75.310000000000002 111.305 -169.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.6 t -98.67 -16.5 19.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.082 0.467 . . . . 65.450000000000003 110.53 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.619 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -138.72 124.96 20.26 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.173 -0.677 . . . . 51.539999999999999 109.173 173.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -125.2 99.62 6.17 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.267 -0.424 . . . . 72.209999999999994 111.754 -171.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.45 ' O ' HD11 ' A' ' 75' ' ' ILE . 22.8 mt-10 -121.48 142.69 36.09 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.769 -0.826 . . . . 63.409999999999997 108.769 166.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 31.1 Cg_exo -61.16 -42.96 32.03 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.588 2.192 . . . . 73.140000000000001 112.328 -177.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -150.48 56.02 0.47 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.636 -0.792 . . . . 72.030000000000001 112.198 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -147.09 -82.43 0.13 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.816 -0.354 . . . . 53.310000000000002 110.914 174.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.596 ' HD2' ' OE2' ' A' ' 90' ' ' GLU . 16.7 ttp180 -124.38 123.14 39.53 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.444 -0.502 . . . . 74.239999999999995 111.168 -170.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.628 HD13 ' CE1' ' A' ' 20' ' ' TYR . 2.6 mp -125.82 110.87 25.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.748 -0.66 . . . . 63.329999999999998 110.506 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.619 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -96.6 116.11 28.56 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.259 -1.015 . . . . 42.5 108.259 170.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.611 ' CZ2' ' HB3' ' A' ' 87' ' ' ASN . 3.9 p-90 -85.69 151.72 23.64 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.409 0.623 . . . . 60.409999999999997 111.269 -171.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.557 ' HB3' ' O ' ' A' ' 65' ' ' GLU . 5.5 tpm_? -155.37 170.88 20.87 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.183 -1.414 . . . . 53.539999999999999 107.183 -175.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.547 ' HA ' ' HA ' ' A' ' 64' ' ' ALA . 20.0 p -145.24 170.38 16.38 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.075 0.464 . . . . 51.409999999999997 110.888 -177.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.506 HD11 ' HB2' ' A' ' 65' ' ' GLU . 5.7 mp -87.45 154.33 53.85 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.761 -0.654 . . . . 65.049999999999997 110.576 178.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.57 -1.4 3.93 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 123.089 2.526 . . . . 64.230000000000004 112.981 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.21 -8.18 66.84 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.994 -0.622 . . . . 61.530000000000001 112.136 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.17 -177.62 5.75 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.744 0.307 . . . . 75.200000000000003 110.56 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.48 ' HD2' ' HA ' ' A' ' 84' ' ' ARG . 14.3 tpt180 -122.12 -28.34 4.4 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.592 -0.443 . . . . 62.509999999999998 111.302 -178.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.85 132.56 70.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.117 0.484 . . . . 53.049999999999997 110.154 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -147.24 142.83 27.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.839 -0.618 . . . . 72.0 110.089 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.611 ' HB3' ' CZ2' ' A' ' 77' ' ' TRP . 28.1 t-20 -137.13 150.27 47.86 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.722 -0.844 . . . . 52.240000000000002 108.722 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 60.9 m -100.7 127.5 47.09 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.397 0.618 . . . . 70.329999999999998 110.216 -176.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.406 ' HA3' HD23 ' A' ' 108' ' ' LEU . . . -171.54 169.25 42.34 Favored Glycine 0 N--CA 1.438 -1.223 0 CA-C-N 115.227 -0.897 . . . . 33.020000000000003 111.559 -176.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.596 ' OE2' ' HD2' ' A' ' 74' ' ' ARG . 33.1 tt0 -144.64 129.42 18.26 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.993 -0.373 . . . . 74.340000000000003 109.993 -175.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.611 HG12 HG12 ' A' ' 106' ' ' VAL . 9.3 m -111.05 137.89 41.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 110.095 -0.335 . . . . 73.219999999999999 110.095 178.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.646 ' CD2' ' HB ' ' A' ' 105' ' ' VAL . 0.0 OUTLIER -128.19 119.7 25.76 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.75 0.786 . . . . 73.209999999999994 110.046 173.078 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.63 ' HE2' ' HB3' ' A' ' 19' ' ' LEU . 2.5 m-85 -97.73 106.43 18.74 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.485 -1.234 . . . . 72.409999999999997 109.215 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -119.66 144.93 38.02 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 115.418 -0.81 . . . . 71.030000000000001 110.35 -172.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -46.86 117.78 2.33 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.246 2.631 . . . . 75.120000000000005 112.102 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.408 ' HB1' ' CG2' ' A' ' 11' ' ' THR . . . -58.93 144.54 81.67 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.741 -0.663 . . . . 75.230000000000004 111.094 -176.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -46.31 115.98 1.36 Allowed 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 123.303 2.669 . . . . 75.540000000000006 113.022 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 96.15 3.57 60.25 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.665 -0.698 . . . . 50.409999999999997 112.162 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 64.79 32.49 10.98 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 123.08 0.552 . . . . 71.120000000000005 111.164 -178.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 37.7 ttt-85 -75.46 -19.43 59.44 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.957 -0.565 . . . . 72.030000000000001 110.992 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.59 ' HA3' ' HA2' ' A' ' 13' ' ' GLY . . . 165.82 -130.74 2.21 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.885 -0.886 . . . . 41.109999999999999 110.885 -175.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.2 m -138.73 133.95 32.9 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 110.152 -0.314 . . . . 62.109999999999999 110.152 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -96.55 133.06 41.49 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.928 -0.767 . . . . 62.229999999999997 108.928 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.635 HG12 HD11 ' A' ' 12' ' ' ILE . 1.5 p -95.15 100.32 10.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.794 0.807 . . . . 53.149999999999999 110.35 179.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.646 ' HB ' ' CD2' ' A' ' 92' ' ' LEU . 4.1 t -97.4 111.47 27.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.688 -1.142 . . . . 73.310000000000002 108.941 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.611 HG12 HG12 ' A' ' 91' ' ' VAL . 26.1 m -112.47 123.46 68.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.318 0.58 . . . . 75.349999999999994 111.517 -176.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 31.1 ttt85 -105.17 100.89 10.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.524 -0.762 . . . . 73.420000000000002 109.678 174.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.406 HD23 ' HA3' ' A' ' 89' ' ' GLY . 95.4 mt -116.94 126.8 53.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.257 -0.429 . . . . 45.310000000000002 110.146 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.817 HG23 HG22 ' A' ' 5' ' ' VAL . 25.9 m -90.22 116.26 28.08 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 120.214 -0.594 . . . . 73.549999999999997 110.726 -176.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -172.93 168.71 4.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.485 -0.78 . . . . 73.019999999999996 108.917 174.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -105.56 144.76 29.49 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 110.428 -0.212 . . . . 73.329999999999998 110.428 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.45 168.92 19.77 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 122.659 2.239 . . . . 55.340000000000003 111.586 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.665 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 7.3 Cg_endo -50.0 129.54 25.08 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.943 2.429 . . . . 71.510000000000005 112.029 177.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -49.22 -64.44 3.34 Favored Glycine 0 C--N 1.332 0.361 0 CA-C-N 115.36 -0.836 . . . . 72.319999999999993 114.554 -171.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -105.71 1.87 39.1 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.491 -0.862 . . . . 24.109999999999999 113.114 -175.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.665 ' HB2' ' HB2' ' A' ' 113' ' ' PRO . 13.0 m -86.08 -24.17 26.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.694 0.283 . . . . 73.150000000000006 111.152 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.63 -41.64 99.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.435 -0.348 . . . . 44.039999999999999 110.933 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.01 -31.25 77.97 Favored Glycine 0 N--CA 1.452 -0.256 0 CA-C-N 116.05 -0.523 . . . . 65.230000000000004 112.48 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.34 -29.3 64.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.163 0.506 . . . . 72.329999999999998 110.572 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 59.6 t -73.67 -51.36 25.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.881 -0.6 . . . . 71.049999999999997 110.51 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.9 pp -68.92 -22.64 26.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.24 -0.437 . . . . 73.409999999999997 111.981 -175.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -81.2 -30.96 34.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.742 0.306 . . . . 64.329999999999998 111.16 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -88.77 -39.16 14.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.4 -0.364 . . . . 71.519999999999996 111.219 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.562 ' SD ' ' HB3' ' A' ' 130' ' ' SER . 47.9 ttm -52.55 -51.58 58.98 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 123.33 0.394 . . . . 75.219999999999999 110.707 -177.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.429 ' HD1' ' HA ' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -167.29 111.57 0.71 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.067 -0.716 . . . . 54.420000000000002 109.067 176.09 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -57.23 -45.63 83.72 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.029 -0.532 . . . . 74.319999999999993 111.483 -174.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.411 ' O ' ' HB2' ' A' ' 128' ' ' GLU . 9.3 pt20 -118.44 169.75 9.51 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.16 -0.473 . . . . 71.099999999999994 109.924 178.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 127' ' ' GLN . 0.5 OUTLIER 69.82 153.27 0.14 Allowed Pre-proline 0 N--CA 1.471 0.577 0 O-C-N 123.801 0.688 . . . . 63.5 111.449 -175.252 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.85 128.73 26.45 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.624 2.216 . . . . 73.530000000000001 111.881 175.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.562 ' HB3' ' SD ' ' A' ' 124' ' ' MET . 14.4 m -68.2 136.65 53.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.985 -0.552 . . . . 62.43 110.447 -178.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -83.32 -172.68 4.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.007 0.432 . . . . 74.239999999999995 111.579 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -81.13 56.49 2.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.863 -0.608 . . . . 60.299999999999997 111.627 -172.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.406 HD23 ' HE2' ' A' ' 124' ' ' MET . 54.1 tp -77.91 100.42 6.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.426 0.631 . . . . 64.409999999999997 109.486 175.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.401 ' HD2' ' OD2' ' A' ' 8' ' ' ASP . 8.7 ptt180 -124.58 77.39 1.58 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.202 -0.908 . . . . 73.549999999999997 110.098 -174.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -58.53 -44.6 89.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.636 -0.711 . . . . 73.319999999999993 111.695 -175.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -60.54 -52.72 64.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.425 . . . . 72.340000000000003 111.087 -177.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.463 ' HA ' HD13 ' A' ' 137' ' ' LEU . 0.1 OUTLIER -68.35 -36.13 78.77 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.545 -0.298 . . . . 72.120000000000005 111.27 -179.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 27.9 tpp -67.89 -41.64 82.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.884 0.373 . . . . 74.420000000000002 110.9 -177.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -63.63 -36.11 82.73 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.441 -0.577 . . . . 74.319999999999993 109.441 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.612 ' HE1' HG11 ' A' ' 104' ' ' VAL . 55.5 t80 -63.65 -49.85 71.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.427 -0.806 . . . . 72.310000000000002 110.25 174.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -55.81 -50.1 71.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.496 -0.775 . . . . 62.43 111.42 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -62.04 -45.34 94.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.335 -0.393 . . . . 71.140000000000001 110.924 -176.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -65.49 -28.85 69.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.313 -0.403 . . . . 74.209999999999994 111.716 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.872 ' HB2' HG21 ' A' ' 12' ' ' ILE . 9.9 mm-40 -68.62 -35.99 78.03 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.617 -0.433 . . . . 72.230000000000004 111.102 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.583 ' HG3' HG22 ' A' ' 12' ' ' ILE . 35.4 mt-10 -78.39 -37.15 44.73 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.713 -0.395 . . . . 75.230000000000004 110.143 178.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 67.2 mt -65.35 -40.55 93.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.972 -0.558 . . . . 72.140000000000001 110.678 176.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -80.02 55.23 4.54 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.095 -0.574 . . . . 75.400000000000006 112.054 176.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.516 HD22 ' HD3' ' A' ' 14' ' ' LYS . 57.1 tp 177.45 -48.17 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.945 -0.761 . . . . 73.340000000000003 108.945 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 71.11 -60.28 0.52 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.863 -1.062 . . . . 61.439999999999998 111.691 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 37.5 m170 -84.53 115.77 22.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.068 0.461 . . . . 73.239999999999995 110.728 -173.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -90.24 140.84 29.3 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.71 -0.677 . . . . 74.109999999999999 110.404 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -121.37 128.86 52.67 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.756 -0.461 . . . . 65.219999999999999 109.756 173.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 35.2 t60 -77.1 111.07 12.3 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.025 -0.534 . . . . 73.310000000000002 109.917 -177.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 59.11 -116.53 0.83 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.153 -0.684 . . . . 64.239999999999995 109.153 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.215 -0.898 . . . . 74.219999999999999 109.255 177.601 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 109.421 -0.585 . . . . 73.430000000000007 109.421 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.36 -51.48 1.61 Allowed Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 110.345 -1.102 . . . . 61.109999999999999 110.345 -171.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.479 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 1.4 pm0 -95.93 140.32 30.85 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.742 -0.836 . . . . 71.150000000000006 108.742 170.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.0 m -75.12 121.29 21.84 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.166 -0.309 . . . . 63.140000000000001 110.166 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.6 p -125.42 135.76 62.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.811 0.339 . . . . 70.439999999999998 110.45 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.3 t -119.93 126.38 75.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.692 -0.485 . . . . 72.329999999999998 109.692 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -127.78 132.84 49.46 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.054 0.454 . . . . 60.310000000000002 110.508 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.443 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 11.3 t70 -158.09 171.74 19.69 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.799 -1.186 . . . . 72.549999999999997 107.799 173.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.589 ' HB2' HG12 ' A' ' 105' ' ' VAL . . . -134.06 120.42 20.18 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.068 0.461 . . . . 73.409999999999997 112.12 -174.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.541 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 21.4 m -101.27 130.04 51.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.67 -0.696 . . . . 65.109999999999999 109.749 174.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.692 ' HA ' ' HA ' ' A' ' 103' ' ' GLU . 5.1 t -102.83 113.48 26.94 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.78 0.8 . . . . 71.319999999999993 110.436 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.631 HG23 ' HB3' ' A' ' 145' ' ' GLU . 4.5 mp -112.36 151.47 14.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.954 -1.021 . . . . 73.230000000000004 108.871 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.86 42.3 1.1 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.862 -0.685 . . . . 74.109999999999999 112.907 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.662 ' HB3' ' HB2' ' A' ' 18' ' ' GLN . 6.7 mmpt? -112.24 144.25 30.45 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 108.394 -0.965 . . . . 72.099999999999994 108.394 178.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -52.99 -57.96 1.75 Allowed 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.335 2.023 . . . . 54.100000000000001 113.738 -172.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 174.4 -53.46 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.251 0.548 . . . . 62.43 109.66 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.8 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 0.1 OUTLIER -54.43 -39.22 67.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.069 -0.969 . . . . 72.109999999999999 110.891 177.631 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.662 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 21.4 mm-40 -63.06 -27.79 69.64 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.061 -0.972 . . . . 71.540000000000006 111.37 -177.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.526 ' HA ' ' NE2' ' A' ' 144' ' ' GLN . 95.5 mt -74.94 -48.35 24.93 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.9 -0.591 . . . . 31.140000000000001 111.162 -174.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.8 ' CE2' ' HA ' ' A' ' 17' ' ' GLU . 36.2 p90 -74.77 -23.42 58.52 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 119.704 -0.798 . . . . 61.100000000000001 110.643 177.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.56 -2.08 21.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.043 -0.526 . . . . 73.340000000000003 111.627 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.476 ' HB ' ' NE2' ' A' ' 144' ' ' GLN . 12.0 p -53.38 -22.59 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 115.806 -0.633 . . . . 45.539999999999999 112.525 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -66.75 -27.31 67.5 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.275 0.559 . . . . 71.120000000000005 110.709 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.814 ' HG3' ' H ' ' A' ' 25' ' ' ASP . 15.0 tpp180 -105.54 -164.21 1.01 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.924 -1.139 . . . . 74.329999999999998 107.924 176.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.814 ' H ' ' HG3' ' A' ' 24' ' ' ARG . 28.6 t0 -83.93 36.47 0.56 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.45 0.643 . . . . 74.439999999999998 109.363 176.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.566 HD11 ' HA3' ' A' ' 147' ' ' GLY . 0.3 OUTLIER 41.89 63.1 6.9 Favored Pre-proline 0 N--CA 1.47 0.543 0 CA-C-N 114.897 -1.047 . . . . 72.120000000000005 112.279 -177.606 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.456 ' HD3' ' N ' ' A' ' 26' ' ' LEU . 89.9 Cg_endo -103.93 -4.86 0.21 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.225 2.617 . . . . 55.420000000000002 113.094 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.99 -113.66 4.44 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.484 -1.047 . . . . 75.129999999999995 110.484 -170.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.557 HD12 HD12 ' A' ' 31' ' ' LEU . 0.9 OUTLIER -159.08 151.7 17.95 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 109.344 -0.613 . . . . 74.209999999999994 109.344 174.393 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.452 ' HD2' HD21 ' A' ' 32' ' ' LEU . 31.5 Cg_exo -62.14 7.28 0.14 Allowed 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 123.524 2.816 . . . . 73.430000000000007 113.112 176.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.557 HD12 HD12 ' A' ' 29' ' ' LEU . 11.0 mp 67.79 63.15 0.4 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.567 0.699 . . . . 64.420000000000002 110.608 -177.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.474 ' HG ' ' HB ' ' A' ' 39' ' ' VAL . 2.7 mm? -73.95 81.91 1.69 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.152 -0.931 . . . . 64.040000000000006 110.265 177.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -134.76 7.99 3.53 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.626 -0.716 . . . . 72.319999999999993 110.159 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.6 p -88.1 172.87 9.2 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.875 -0.602 . . . . 51.340000000000003 110.115 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -104.51 18.82 21.46 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.595 -0.442 . . . . 73.549999999999997 111.449 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 tt -76.54 108.31 9.44 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 105.825 -1.917 . . . . 72.200000000000003 105.825 164.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -81.7 59.83 4.37 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.193 0.52 . . . . 64.540000000000006 112.285 -160.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.7 m -98.88 -59.99 1.62 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.459 -0.941 . . . . 62.210000000000001 108.459 170.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.474 ' HB ' ' HG ' ' A' ' 32' ' ' LEU . 21.8 t -124.48 84.95 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.272 -1.01 . . . . 64.340000000000003 108.272 170.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -103.96 135.3 45.74 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.678 -0.692 . . . . 72.140000000000001 110.765 -174.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 73.5 t -88.05 104.69 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-O 121.513 0.673 . . . . 52.149999999999999 109.993 174.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.5 tp -70.35 -52.33 23.41 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.802 -1.09 . . . . 73.049999999999997 109.477 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -164.19 156.06 16.49 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.905 -1.146 . . . . 74.549999999999997 107.905 175.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -85.67 66.22 9.54 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 122.313 1.054 . . . . 74.099999999999994 109.568 -177.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.908 ' HE2' ' HA ' ' A' ' 45' ' ' LYS . 2.1 mmpt? -139.06 -60.22 0.58 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 113.629 -1.623 . . . . 71.109999999999999 110.258 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.472 ' HD3' ' HG3' ' A' ' 63' ' ' GLU . 83.7 mtt180 -114.69 121.35 43.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.65 -0.705 . . . . 72.439999999999998 110.52 178.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.0 p -110.37 96.16 6.03 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.491 -0.559 . . . . 73.409999999999997 109.491 172.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.737 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 38.8 ptt180 -89.76 156.56 18.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.113 -0.494 . . . . 61.229999999999997 111.075 -176.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 71.94 -64.65 0.38 Allowed 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.96 0.788 . . . . 72.420000000000002 111.946 -177.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 53' ' ' ALA . 68.9 m 72.56 134.11 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.316 0.579 . . . . 71.319999999999993 111.823 178.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.4 t -100.13 -27.14 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.232 -0.44 . . . . 50.310000000000002 111.409 -177.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.674 ' HA ' ' NH2' ' A' ' 24' ' ' ARG . 15.8 mm-40 -70.86 -32.23 69.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.957 0.408 . . . . 52.030000000000001 111.433 -177.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.411 ' H ' HG22 ' A' ' 50' ' ' THR . . . -144.68 149.96 45.27 Favored Pre-proline 0 C--N 1.321 -0.674 0 N-CA-C 109.433 -0.581 . . . . 72.129999999999995 109.433 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -65.32 112.05 1.99 Allowed 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 121.831 1.687 . . . . 74.099999999999994 111.097 177.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.426 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . . . 65.64 142.25 0.07 OUTLIER Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 115.233 -0.894 . . . . 60.329999999999998 111.671 -174.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.73 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 38.4 Cg_exo -65.26 -56.72 0.33 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 123.059 2.506 . . . . 55.109999999999999 112.284 -178.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.675 HD21 ' HG ' ' A' ' 80' ' ' LEU . 0.4 OUTLIER -119.63 22.44 11.63 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.249 -0.887 . . . . 75.439999999999998 111.402 -178.001 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.49 19.3 35.58 Favored Glycine 0 C--N 1.31 -0.875 0 CA-C-N 114.964 -1.016 . . . . 42.409999999999997 112.735 178.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 71.28 28.36 3.01 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 122.998 0.519 . . . . 75.430000000000007 111.495 173.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.532 ' HB ' HD13 ' A' ' 57' ' ' LEU . 61.3 t -60.08 -50.2 81.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.905 -0.588 . . . . 73.400000000000006 109.485 174.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.412 ' HB2' ' H ' ' A' ' 62' ' ' TRP . 9.3 m -115.45 -88.37 0.58 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.285 -0.635 . . . . 73.129999999999995 109.285 170.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.412 ' H ' ' HB2' ' A' ' 61' ' ' SER . 78.6 m95 -158.18 -35.96 0.07 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.828 0.347 . . . . 63.210000000000001 110.875 174.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.737 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 1.4 pm0 -108.49 167.1 10.28 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.077 0.769 . . . . 74.420000000000002 113.077 -170.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.73 ' HB2' ' HB3' ' A' ' 56' ' ' PRO . . . -110.47 147.81 33.33 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.123 -1.066 . . . . 45.229999999999997 108.123 163.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.788 ' HB2' HD23 ' A' ' 80' ' ' LEU . 0.7 OUTLIER -112.57 134.15 54.24 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 107.708 -1.219 . . . . 74.420000000000002 107.708 -176.78 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -107.83 141.34 39.56 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 119.616 -0.834 . . . . 70.049999999999997 111.221 -171.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.9 t -108.1 -24.38 11.59 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.854 -0.338 . . . . 72.129999999999995 111.008 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.543 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . . . -135.98 153.78 51.29 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.542 -0.54 . . . . 60.210000000000001 109.542 175.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -150.61 16.68 0.8 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.876 0.325 . . . . 53.219999999999999 111.876 -172.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.601 ' HG2' ' HD3' ' A' ' 73' ' ' LYS . 1.6 mp0 -61.29 142.03 93.82 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 110.416 -0.216 . . . . 71.109999999999999 110.416 -176.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -79.51 -20.17 9.65 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.661 2.241 . . . . 74.230000000000004 113.017 -173.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -162.67 38.29 0.35 Allowed Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.303 -0.719 . . . . 72.329999999999998 111.303 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.601 ' HD3' ' HG2' ' A' ' 70' ' ' GLU . 54.3 tttp -129.74 -51.57 1.15 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.008 -0.367 . . . . 64.340000000000003 110.008 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.514 ' H ' ' HB2' ' A' ' 70' ' ' GLU . 29.3 ttp180 -166.09 129.47 2.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.25 -0.432 . . . . 73.340000000000003 110.902 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.646 ' HB ' HG22 ' A' ' 91' ' ' VAL . 6.3 mm -108.38 109.99 30.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.399 -0.963 . . . . 71.299999999999997 108.399 175.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.561 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . . . -129.94 116.3 18.42 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.05 0.452 . . . . 61.109999999999999 110.486 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.532 ' NE1' ' HA3' ' A' ' 89' ' ' GLY . 69.0 p-90 -113.18 155.54 24.82 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.629 -0.714 . . . . 70.239999999999995 109.928 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -142.87 176.45 9.06 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.935 -1.135 . . . . 75.530000000000001 107.935 175.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 51.3 p -96.05 177.68 5.66 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.924 -0.71 . . . . 74.049999999999997 110.153 174.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.788 HD23 ' HB2' ' A' ' 65' ' ' GLU . 7.3 mt -71.64 156.89 90.77 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 116.038 -0.528 . . . . 71.099999999999994 110.019 -177.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -52.93 -36.57 75.6 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.864 2.376 . . . . 74.140000000000001 112.755 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.92 21.44 44.93 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.764 -0.731 . . . . 73.420000000000002 112.696 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -120.5 176.64 5.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.608 0.242 . . . . 74.129999999999995 110.552 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.425 ' HD2' ' N ' ' A' ' 84' ' ' ARG . 8.5 mpt_? -115.05 144.85 42.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.534 -0.303 . . . . 73.319999999999993 110.351 -179.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.6 pp -88.91 166.74 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.984 0.421 . . . . 74.510000000000005 111.639 -178.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -126.07 -64.34 1.05 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.665 -0.698 . . . . 63.399999999999999 110.399 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -130.11 173.15 11.02 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.937 -1.135 . . . . 62.219999999999999 107.937 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.8 m -95.75 126.98 41.39 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.497 -0.557 . . . . 72.540000000000006 109.497 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.532 ' HA3' ' NE1' ' A' ' 77' ' ' TRP . . . -115.92 74.87 0.26 Allowed Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.663 -0.779 . . . . 73.109999999999999 111.85 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.561 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 35.2 tt0 -131.0 113.9 14.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.01 0.433 . . . . 71.150000000000006 110.241 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.646 HG22 ' HB ' ' A' ' 75' ' ' ILE . 18.6 m -120.47 131.91 71.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.533 -0.758 . . . . 71.239999999999995 109.401 177.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.79 ' HB2' HG23 ' A' ' 105' ' ' VAL . 4.5 mp -113.36 141.08 47.47 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.428 -0.509 . . . . 71.129999999999995 109.875 175.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.465 ' HZ ' ' HB3' ' A' ' 20' ' ' TYR . 58.2 m-85 -120.8 131.59 54.55 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.206 -0.452 . . . . 71.200000000000003 110.461 -177.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 34.2 ptt180 -141.18 142.8 28.44 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 109.53 -0.545 . . . . 74.420000000000002 109.53 173.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 94' ' ' ARG . 38.4 Cg_exo -62.67 112.89 1.75 Allowed 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 122.251 1.967 . . . . 72.450000000000003 110.757 174.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.45 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . . . -63.37 144.11 97.64 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.748 -0.66 . . . . 74.310000000000002 110.674 -174.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -23.5 109.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.691 1 C-N-CA 126.046 4.497 . . . . 65.439999999999998 115.356 -171.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.5 -67.79 3.65 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 114.77 -1.104 . . . . 41.32 111.849 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -177.81 38.41 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.731 -0.735 . . . . 72.230000000000004 110.453 -172.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.533 ' HA ' ' NE ' ' A' ' 100' ' ' ARG . 4.6 mmp_? -78.44 -6.98 56.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.259 0.552 . . . . 71.129999999999995 110.11 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 119.74 -143.66 17.06 Favored Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 110.145 -1.182 . . . . 63.32 110.145 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.425 ' HB ' HD11 ' A' ' 19' ' ' LEU . 30.6 m -127.22 116.5 20.68 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.791 -0.448 . . . . 74.349999999999994 109.791 174.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.692 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 11.0 pt-20 -88.38 138.42 31.45 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.253 -0.647 . . . . 71.439999999999998 109.253 177.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 1.5 p -108.49 108.83 26.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 115.336 -0.847 . . . . 65.420000000000002 111.135 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.79 HG23 ' HB2' ' A' ' 92' ' ' LEU . 2.6 m -87.27 110.35 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.446 -0.797 . . . . 63.140000000000001 109.319 174.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.83 138.48 50.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.678 -0.692 . . . . 71.209999999999994 110.676 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -122.84 102.35 7.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.658 -0.701 . . . . 65.140000000000001 110.702 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.481 HD21 ' CZ ' ' A' ' 110' ' ' TYR . 0.0 OUTLIER -123.19 152.82 40.85 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.133 -0.485 . . . . 72.099999999999994 109.772 178.782 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.7 t -100.58 149.34 23.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.381 0.61 . . . . 70.400000000000006 111.709 -172.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.481 ' CZ ' HD21 ' A' ' 108' ' ' LEU . 97.5 m-85 -123.85 159.15 30.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.166 -0.925 . . . . 75.319999999999993 109.019 174.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 42.9 mtt180 -89.93 143.84 30.61 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 108.984 -0.747 . . . . 72.319999999999993 108.984 172.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 111' ' ' ARG . 35.3 Cg_exo -61.81 151.26 82.01 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 122.092 1.861 . . . . 53.200000000000003 112.008 -177.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -97.45 5.27 1.47 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.264 2.643 . . . . 64.540000000000006 113.312 -178.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.84 89.48 0.66 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.855 -0.688 . . . . 72.430000000000007 112.413 -177.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -170.96 174.7 44.76 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 121.02 -0.61 . . . . 13.109999999999999 112.116 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.6 m -78.95 -12.47 60.03 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.654 0.242 . . . . 43.210000000000001 111.654 -177.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.43 -36.46 73.65 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.941 0.4 . . . . 74.299999999999997 111.395 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -73.28 -23.71 76.85 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.771 -0.728 . . . . 72.099999999999994 112.767 -177.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.09 -45.75 83.11 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.06 0.393 . . . . 63.32 112.06 -174.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 16.7 m -74.34 -41.77 50.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 111.977 0.362 . . . . 70.420000000000002 111.977 -176.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.8 pp -75.99 -22.73 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.729 0.299 . . . . 74.400000000000006 111.715 -176.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.846 ' HB1' ' HA ' ' A' ' 127' ' ' GLN . . . -68.4 -20.36 64.67 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.951 0.352 . . . . 41.340000000000003 111.951 -178.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -64.44 -14.55 57.47 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.924 -0.58 . . . . 73.400000000000006 111.796 -175.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -63.08 -41.93 99.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.581 -0.282 . . . . 54.450000000000003 111.213 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -153.59 -75.37 0.12 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.161 0.505 . . . . 73.019999999999996 110.63 -176.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -132.41 145.55 51.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.481 -0.781 . . . . 52.229999999999997 109.238 -176.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.846 ' HA ' ' HB1' ' A' ' 122' ' ' ALA . 10.0 pt20 -67.07 -26.62 66.82 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 123.354 0.409 . . . . 73.349999999999994 111.222 177.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -123.26 82.74 52.05 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.274 -0.421 . . . . 72.129999999999995 110.639 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -87.41 60.62 3.68 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.008 1.806 . . . . 71.409999999999997 111.656 178.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.3 t 55.81 112.02 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.236 -0.893 . . . . 24.530000000000001 112.165 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.527 ' H ' ' CD ' ' A' ' 131' ' ' GLN . 4.9 pm0 -75.55 67.15 2.02 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.275 0.56 . . . . 70.340000000000003 110.309 175.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 67.1 -67.31 0.17 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.08 -0.964 . . . . 72.319999999999993 111.086 -174.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.895 ' HG ' ' H ' ' A' ' 134' ' ' ARG . 16.6 tp 54.95 -153.9 0.3 Allowed 'General case' 0 CA--C 1.534 0.355 0 O-C-N 123.393 0.433 . . . . 64.0 110.372 178.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.895 ' H ' ' HG ' ' A' ' 133' ' ' LEU . 32.7 mtp-105 -84.3 -28.91 26.8 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 122.36 -0.213 . . . . 73.430000000000007 111.356 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.29 -39.33 94.28 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 111.935 0.346 . . . . 64.120000000000005 111.935 -171.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.491 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 32.5 t70 -70.33 -30.68 67.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.228 0.537 . . . . 73.329999999999998 110.155 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.541 ' HG ' ' CG1' ' A' ' 10' ' ' VAL . 22.2 tp -78.08 -27.96 48.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.069 -0.514 . . . . 70.120000000000005 109.817 178.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.559 ' HG2' ' O ' ' A' ' 134' ' ' ARG . 29.5 mmt -66.49 -42.15 87.88 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.16 -0.473 . . . . 74.439999999999998 110.409 176.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 136' ' ' ASP . 5.9 ppt_? -75.05 -27.61 60.08 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.009 -0.367 . . . . 75.129999999999995 110.009 178.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.464 ' HZ ' HG11 ' A' ' 22' ' ' VAL . 83.7 t80 -61.54 -39.83 92.48 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.094 0.473 . . . . 71.310000000000002 109.819 173.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 138' ' ' MET . 35.0 ttmt -56.44 -42.18 77.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.443 -0.799 . . . . 73.530000000000001 109.72 174.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.435 HH21 ' CD ' ' A' ' 145' ' ' GLU . 0.0 OUTLIER -58.43 -48.66 79.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.876 -1.056 . . . . 74.409999999999997 111.083 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.37 -31.43 72.09 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.436 -0.347 . . . . 61.439999999999998 111.635 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.551 ' HG3' HG21 ' A' ' 12' ' ' ILE . 6.6 tp-100 -76.51 -43.38 39.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.726 0.298 . . . . 74.230000000000004 110.798 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.631 ' HB3' HG23 ' A' ' 12' ' ' ILE . 16.3 pt-20 -80.07 -4.32 52.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.867 0.365 . . . . 65.239999999999995 110.714 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 60.6 tp -65.84 -36.41 83.4 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.185 -0.672 . . . . 34.409999999999997 109.185 171.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.566 ' HA3' HD11 ' A' ' 26' ' ' LEU . . . -76.89 89.83 0.97 Allowed Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.398 -0.819 . . . . 73.430000000000007 112.3 176.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.408 ' HB3' ' O ' ' A' ' 147' ' ' GLY . 62.9 tp 73.96 114.29 0.06 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.57 0.748 . . . . 73.129999999999995 111.265 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -76.03 81.87 2.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.54 -0.754 . . . . 71.439999999999998 111.142 -178.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -108.13 13.27 26.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.902 0.858 . . . . 74.109999999999999 109.236 174.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -131.52 107.42 8.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.083 -0.962 . . . . 74.549999999999997 109.587 178.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -131.0 112.92 13.36 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.487 0.661 . . . . 73.409999999999997 111.057 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -155.2 80.77 1.06 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.282 -1.007 . . . . 73.310000000000002 108.282 177.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -77.38 100.85 6.1 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.704 -0.68 . . . . 74.510000000000005 111.471 -170.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 62.8 t60 . . . . . 0 C--O 1.244 0.786 0 CA-C-O 118.458 -0.782 . . . . 74.5 109.915 177.635 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.758 0.313 . . . . 70.540000000000006 110.555 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.16 -143.12 7.05 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.939 -0.648 . . . . 74.019999999999996 112.123 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -87.99 154.98 20.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.524 0.202 . . . . 62.109999999999999 110.58 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 97.7 m -135.44 122.24 21.06 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.213 0.53 . . . . 73.010000000000005 111.505 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.1 p -125.4 101.52 8.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.354 -0.839 . . . . 75.310000000000002 108.923 170.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.1 m -88.62 143.37 11.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.297 0.57 . . . . 75.030000000000001 111.22 -173.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.781 ' HD2' ' O ' ' A' ' 7' ' ' ARG . 0.5 OUTLIER -137.91 109.63 7.09 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.481 -0.782 . . . . 71.219999999999999 109.949 178.568 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.589 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 2.1 t70 -132.92 172.3 12.79 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.452 -0.573 . . . . 61.240000000000002 109.452 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.643 ' HB1' ' HG2' ' A' ' 103' ' ' GLU . . . -144.7 122.94 12.23 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.026 0.441 . . . . 55.549999999999997 111.007 -173.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.476 HG23 HD11 ' A' ' 12' ' ' ILE . 4.4 m -113.02 149.35 15.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.886 -0.597 . . . . 73.209999999999994 111.133 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.8 m -100.98 109.87 21.83 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.855 -0.611 . . . . 73.140000000000001 111.017 -175.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.801 HG13 ' HG2' ' A' ' 141' ' ' LYS . 4.5 mp -118.49 145.93 23.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 110.091 -0.337 . . . . 74.239999999999995 110.091 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.37 56.97 4.9 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 121.12 -0.562 . . . . 64.209999999999994 112.552 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.627 ' HG2' HG22 ' A' ' 12' ' ' ILE . 75.6 mmtt -121.77 156.56 58.85 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 108.584 -0.895 . . . . 73.439999999999998 108.584 175.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.422 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 47.1 Cg_exo -56.51 -59.1 0.73 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 121.762 1.641 . . . . 75.120000000000005 112.4 -178.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . 171.09 -58.72 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.768 0.667 . . . . 65.400000000000006 110.046 174.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -49.31 -55.01 14.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.525 -1.216 . . . . 54.450000000000003 112.215 -173.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.534 ' O ' HD12 ' A' ' 26' ' ' LEU . 16.9 mm-40 -69.39 -10.69 59.09 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.177 0.806 . . . . 64.140000000000001 113.177 -173.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.45 ' HA ' HD23 ' A' ' 19' ' ' LEU . 16.2 mt -63.47 -24.79 67.97 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.007 -0.433 . . . . 72.209999999999994 111.624 176.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -72.86 -25.0 60.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.943 0.402 . . . . 55.420000000000002 110.387 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.84 -9.0 58.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.222 -0.444 . . . . 74.099999999999994 111.726 -176.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.837 HG21 ' HG2' ' A' ' 144' ' ' GLN . 14.0 p -52.36 -21.92 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 112.247 0.462 . . . . 65.340000000000003 112.247 -175.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -51.76 -38.21 54.51 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.471 -0.331 . . . . 73.030000000000001 110.523 175.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -145.23 61.23 1.3 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.633 -0.258 . . . . 72.019999999999996 110.703 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.491 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 21.4 t70 63.07 171.35 0.15 Allowed 'General case' 0 CA--C 1.538 0.507 0 O-C-N 123.83 0.706 . . . . 74.530000000000001 111.525 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.534 HD12 ' O ' ' A' ' 18' ' ' GLN . 0.6 OUTLIER -104.05 85.83 1.14 Allowed Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 110.012 -0.366 . . . . 71.140000000000001 110.012 -178.119 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.549 ' HB2' HD12 ' A' ' 29' ' ' LEU . 61.4 Cg_endo -73.37 -29.79 10.89 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.282 1.988 . . . . 72.409999999999997 112.77 -175.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.88 28.77 64.16 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.909 -0.587 . . . . 71.329999999999998 113.032 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.549 HD12 ' HB2' ' A' ' 27' ' ' PRO . 1.6 mp -127.37 79.34 73.41 Favored Pre-proline 0 C--N 1.331 -0.206 0 O-C-N 122.358 -0.496 . . . . 43.450000000000003 111.785 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.404 ' HD2' HD12 ' A' ' 31' ' ' LEU . 91.2 Cg_endo -87.13 5.98 5.48 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.394 2.063 . . . . 64.5 111.541 171.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.404 HD12 ' HD2' ' A' ' 30' ' ' PRO . 7.5 mp -85.1 -0.17 53.64 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.609 -0.723 . . . . 64.439999999999998 111.85 -176.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.457 HD13 HD12 ' A' ' 36' ' ' LEU . 3.7 mm? -76.72 8.94 3.14 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.951 0.352 . . . . 52.210000000000001 111.951 -175.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 15.0 tmm? -61.52 -33.79 74.42 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.161 -0.472 . . . . 74.400000000000006 110.761 177.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.7 p -76.65 158.2 31.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.126 -0.488 . . . . 51.340000000000003 110.771 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -67.5 97.08 0.56 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.922 0.391 . . . . 72.400000000000006 111.228 -174.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.457 HD12 HD13 ' A' ' 32' ' ' LEU . 96.4 mt -131.41 -154.59 0.64 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.858 -0.61 . . . . 74.439999999999998 109.908 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -95.9 166.12 11.94 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.858 0.361 . . . . 73.340000000000003 110.22 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.7 m -74.85 95.47 2.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.929 -0.578 . . . . 61.549999999999997 111.773 -174.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 m -143.61 116.89 3.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.524 -0.307 . . . . 75.010000000000005 110.658 175.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 64.65 -163.91 0.25 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.991 -0.55 . . . . 61.119999999999997 111.848 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.9 t -62.6 137.95 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 115.936 -0.575 . . . . 54.130000000000003 110.715 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.0 tp -85.33 -81.11 0.2 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.842 -0.617 . . . . 61.109999999999999 112.248 -172.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.465 ' H ' ' HB2' ' A' ' 47' ' ' SER . 6.0 m-20 -66.75 -52.57 42.78 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.92 0.711 . . . . 64.439999999999998 112.92 -168.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -177.02 -77.3 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.807 0.337 . . . . 73.439999999999998 110.633 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.927 ' HB2' HD22 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -101.0 -28.31 12.81 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 120.91 0.386 . . . . 62.140000000000001 111.037 176.308 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.866 ' HG2' ' HB2' ' A' ' 66' ' ' LEU . 18.6 mmm180 -117.01 -169.95 1.74 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.873 -0.417 . . . . 72.400000000000006 109.873 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.465 ' HB2' ' H ' ' A' ' 43' ' ' ASP . 21.6 m 66.49 101.95 0.04 OUTLIER 'General case' 0 C--O 1.233 0.192 0 O-C-N 124.021 0.826 . . . . 75.439999999999998 110.696 -175.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.459 ' C ' ' H ' ' A' ' 50' ' ' THR . 46.5 mtm180 -71.23 -171.86 0.64 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.632 -0.713 . . . . 64.109999999999999 110.664 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 45.0 p90 -76.38 25.1 0.13 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.9 -0.591 . . . . 73.5 110.856 178.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.459 ' H ' ' C ' ' A' ' 48' ' ' ARG . 3.9 m -60.51 -72.32 0.11 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.745 -0.661 . . . . 61.340000000000003 110.598 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.7 t 52.84 26.76 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.935 0.874 . . . . 72.099999999999994 110.676 178.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.86 23.29 14.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.472 -0.786 . . . . 63.549999999999997 109.167 -177.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.563 ' HB1' ' HB3' ' A' ' 59' ' ' ALA . . . -167.78 144.3 3.46 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.114 -0.948 . . . . 74.219999999999999 109.486 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.515 ' O ' ' HA3' ' A' ' 58' ' ' GLY . 33.6 Cg_endo -68.83 114.33 3.51 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.03 1.82 . . . . 75.340000000000003 111.398 174.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 67.01 144.21 0.09 OUTLIER Pre-proline 0 N--CA 1.468 0.451 0 O-C-N 124.116 0.885 . . . . 72.549999999999997 111.392 -175.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.568 ' HG2' HD12 ' A' ' 57' ' ' LEU . 6.2 Cg_endo -52.91 -48.59 21.3 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.026 2.484 . . . . 75.140000000000001 112.536 179.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.767 HD12 ' H ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -90.14 0.84 56.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.075 0.464 . . . . 65.400000000000006 110.138 -176.355 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 54' ' ' PRO . . . -72.84 -18.75 79.07 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.853 -0.612 . . . . 53.009999999999998 113.688 -172.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.563 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . . . -154.89 -45.8 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.309 0.555 . . . . 42.140000000000001 112.105 -178.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.569 HG22 ' H ' ' A' ' 62' ' ' TRP . 5.7 p -93.68 117.53 37.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.388 0.613 . . . . 63.009999999999998 111.282 -176.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.1 m -79.1 -4.3 49.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.934 -0.576 . . . . 65.540000000000006 111.02 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.569 ' H ' HG22 ' A' ' 60' ' ' VAL . 19.0 m95 -90.93 -5.43 55.48 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.014 -0.539 . . . . 71.430000000000007 111.672 -177.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.749 ' O ' ' HG ' ' A' ' 80' ' ' LEU . 9.9 tp10 -85.27 167.0 16.03 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.879 -0.786 . . . . 73.239999999999995 108.879 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -120.62 139.48 52.93 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.823 -0.351 . . . . 61.140000000000001 111.203 -177.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.55 ' CG ' HD11 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -106.64 158.28 17.07 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.498 -0.556 . . . . 61.409999999999997 109.498 173.554 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.927 HD22 ' HB2' ' A' ' 45' ' ' LYS . 26.3 tp -109.64 141.45 42.17 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.359 -0.238 . . . . 62.030000000000001 110.359 -176.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.0 t -107.81 -6.98 16.45 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 120.861 -0.336 . . . . 64.439999999999998 111.708 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.673 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -153.98 124.82 7.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.654 0.264 . . . . 72.109999999999999 110.831 177.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.673 ' HB3' HD23 ' A' ' 66' ' ' LEU . 2.4 p30 -136.32 43.46 2.48 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.796 -0.638 . . . . 74.209999999999994 110.878 -176.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.476 ' HB2' ' H ' ' A' ' 74' ' ' ARG . 26.1 mm-40 -57.81 143.22 77.21 Favored Pre-proline 0 C--O 1.234 0.252 0 CA-C-N 116.173 -0.467 . . . . 74.099999999999994 110.412 -178.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.96 92.97 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.219 2.613 . . . . 75.319999999999993 113.208 -172.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 58.75 34.24 76.45 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.477 -0.783 . . . . 61.32 112.979 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 92' ' ' LEU . 92.0 mttt -129.1 -85.71 0.55 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.953 0.353 . . . . 74.019999999999996 111.953 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.79 ' HB2' ' HG ' ' A' ' 92' ' ' LEU . 31.8 ttt180 -118.23 113.78 22.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.412 0.625 . . . . 74.120000000000005 111.197 -173.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.48 HD13 ' HE2' ' A' ' 93' ' ' PHE . 3.8 mp -117.05 121.87 68.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.089 -0.959 . . . . 71.319999999999993 109.515 178.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.673 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -109.71 116.28 31.42 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.473 -0.566 . . . . 60.119999999999997 109.473 176.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.534 ' CZ2' ' HA3' ' A' ' 89' ' ' GLY . 31.4 p90 -87.85 141.33 28.67 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.626 0.727 . . . . 62.520000000000003 111.306 -173.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.49 ' NE ' ' HA ' ' A' ' 78' ' ' ARG . 0.5 OUTLIER -137.57 175.36 9.66 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.03 -0.986 . . . . 65.099999999999994 110.148 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.2 p -144.7 164.93 29.5 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.81 -0.811 . . . . 63.340000000000003 108.81 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.749 ' HG ' ' O ' ' A' ' 63' ' ' GLU . 14.3 mt -77.86 149.27 77.0 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.913 -0.403 . . . . 65.420000000000002 109.913 -177.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.12 -27.23 54.61 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.945 2.43 . . . . 74.340000000000003 112.791 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.75 0.72 82.91 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.902 -0.666 . . . . 65.219999999999999 113.189 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.63 159.4 20.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.047 0.423 . . . . 64.310000000000002 110.927 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -98.35 13.06 32.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.019 0.438 . . . . 65.129999999999995 110.769 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.432 ' N ' HD12 ' A' ' 85' ' ' ILE . 4.2 mp -99.44 80.14 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.573 -0.529 . . . . 64.239999999999995 109.573 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.675 ' HB3' ' HD2' ' A' ' 111' ' ' ARG . 35.8 tt0 -81.36 91.93 6.33 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.588 -0.523 . . . . 73.049999999999997 109.588 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -148.71 139.88 23.17 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.495 -0.775 . . . . 62.520000000000003 109.883 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.8 m -124.69 128.65 49.14 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.842 -0.799 . . . . 44.219999999999999 108.842 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.534 ' HA3' ' CZ2' ' A' ' 77' ' ' TRP . . . -155.69 174.0 33.73 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.014 -1.088 . . . . 71.430000000000007 112.89 -175.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -163.15 128.96 3.21 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.462 -0.57 . . . . 71.230000000000004 109.462 -175.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.788 ' HB ' HG12 ' A' ' 106' ' ' VAL . 2.5 p -122.58 120.9 62.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.159 0.504 . . . . 74.420000000000002 111.688 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.79 ' HG ' ' HB2' ' A' ' 74' ' ' ARG . 8.0 mp -110.97 122.63 48.36 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.83 -0.623 . . . . 75.200000000000003 110.087 173.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.48 ' HE2' HD13 ' A' ' 75' ' ' ILE . 79.1 m-85 -87.28 126.71 35.0 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.847 0.355 . . . . 74.329999999999998 110.556 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.69 144.06 49.79 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.351 -0.386 . . . . 75.219999999999999 110.375 177.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.46 131.12 30.56 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.56 2.173 . . . . 73.510000000000005 111.196 176.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.08 143.53 57.2 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.582 -0.281 . . . . 50.539999999999999 110.73 -177.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.88 141.97 96.18 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 123.131 2.554 . . . . 72.140000000000001 112.572 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.79 20.38 79.51 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.878 -0.601 . . . . 72.439999999999998 112.109 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 52.84 36.71 22.2 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 121.021 0.439 . . . . 72.349999999999994 110.893 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 -72.57 -18.88 61.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.789 -0.642 . . . . 73.109999999999999 110.94 -176.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 146.2 -143.05 11.1 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.978 -0.849 . . . . 61.420000000000002 110.978 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.6 m -123.83 131.35 53.57 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.123 0.487 . . . . 42.409999999999997 110.1 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.643 ' HG2' ' HB1' ' A' ' 9' ' ' ALA . 31.8 tt0 -99.64 121.41 41.18 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.832 -0.622 . . . . 44.200000000000003 110.105 -178.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.513 HG23 ' CG2' ' A' ' 91' ' ' VAL . 2.3 p -98.04 112.13 29.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.432 -0.804 . . . . 53.119999999999997 110.932 -178.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 92' ' ' LEU . 11.1 p -101.81 120.66 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-O 121.33 0.586 . . . . 73.409999999999997 109.786 177.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.788 HG12 ' HB ' ' A' ' 91' ' ' VAL . 30.3 m -123.77 147.1 28.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.945 -0.57 . . . . 70.409999999999997 111.596 -175.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -100.55 116.88 33.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.318 -0.855 . . . . 73.510000000000005 109.898 170.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.3 tt -113.06 120.59 41.86 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.018 -0.734 . . . . 74.430000000000007 109.018 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 25.1 m -109.71 133.12 53.49 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.252 -0.431 . . . . 63.299999999999997 111.099 -176.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -97.77 161.65 13.65 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.845 -0.798 . . . . 75.439999999999998 108.845 176.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.675 ' HD2' ' HB3' ' A' ' 86' ' ' GLU . 1.9 ptm180 -133.88 154.79 80.57 Favored Pre-proline 0 C--N 1.31 -1.115 0 CA-C-N 116.215 -0.448 . . . . 72.150000000000006 110.161 -174.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.52 152.9 80.46 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.344 2.029 . . . . 72.25 112.165 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 118' ' ' GLY . 41.8 Cg_endo -71.31 108.06 2.27 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.495 2.13 . . . . 72.0 112.134 177.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -127.51 104.89 0.71 Allowed Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 111.094 -0.802 . . . . 62.439999999999998 111.094 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.18 -168.5 28.54 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.246 -0.741 . . . . 62.200000000000003 111.246 -176.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.3 t -85.89 -40.44 15.93 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 117.233 0.516 . . . . 62.530000000000001 110.174 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.405 ' O ' HG12 ' A' ' 120' ' ' VAL . . . -73.0 -30.54 63.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.341 0.591 . . . . 74.510000000000005 110.126 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.496 ' O ' HG22 ' A' ' 121' ' ' ILE . . . -81.57 -19.92 65.09 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.337 -0.847 . . . . 64.310000000000002 113.043 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -79.44 -22.38 44.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 117.089 0.444 . . . . 75.510000000000005 112.094 -176.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 117' ' ' ALA . 7.0 p -64.96 -27.08 41.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.693 -0.23 . . . . 55.420000000000002 111.514 -174.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.496 HG22 ' O ' ' A' ' 118' ' ' GLY . 10.6 tp -65.45 -29.79 48.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.638 0.256 . . . . 74.329999999999998 110.727 -177.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.98 -23.15 59.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 65.049999999999997 110.922 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.4 -29.27 19.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.304 0.573 . . . . 73.530000000000001 109.608 176.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 28.0 ttt -71.37 -53.6 13.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.815 -0.63 . . . . 60.149999999999999 109.669 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -135.59 105.41 6.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.756 -0.656 . . . . 74.400000000000006 109.586 175.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -83.34 72.79 10.19 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.347 -0.612 . . . . 54.32 109.347 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 70.73 -50.51 0.67 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 114.888 -1.051 . . . . 71.219999999999999 110.561 -174.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 60.09 71.62 0.86 Allowed Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 123.977 0.911 . . . . 65.340000000000003 111.821 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -91.54 62.73 1.09 Allowed 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 122.708 2.272 . . . . 74.140000000000001 111.086 175.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 49.2 m -112.0 32.19 5.68 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.512 -0.767 . . . . 54.409999999999997 110.219 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 66.1 -165.06 0.23 Allowed 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.491 -0.777 . . . . 74.349999999999994 111.13 -177.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -61.3 134.39 56.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.679 -0.691 . . . . 75.530000000000001 110.718 178.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.6 mp -91.89 29.04 1.65 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.9 -0.591 . . . . 73.120000000000005 110.694 -175.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -54.89 -38.74 67.95 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.717 0.636 . . . . 73.150000000000006 112.717 -174.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -71.83 -37.64 70.28 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.48 -0.488 . . . . 72.439999999999998 111.037 -177.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -74.84 -38.29 62.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.243 0.544 . . . . 74.530000000000001 110.168 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.589 ' CD2' ' HB3' ' A' ' 8' ' ' ASP . 24.4 tp -66.59 -24.38 66.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.567 -0.742 . . . . 73.400000000000006 109.523 178.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.479 ' O ' ' HB3' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -62.64 -29.71 70.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.749 -0.66 . . . . 62.43 110.307 176.679 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -69.01 -43.42 74.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.889 -0.596 . . . . 75.439999999999998 110.149 176.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.525 ' O ' ' HG3' ' A' ' 144' ' ' GLN . 18.2 t80 -60.74 -37.96 83.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.876 -0.602 . . . . 65.349999999999994 109.9 174.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.801 ' HG2' HG13 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -53.64 -41.93 67.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.778 -0.647 . . . . 73.310000000000002 110.52 176.074 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -63.52 -31.36 72.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.879 -0.6 . . . . 64.430000000000007 110.436 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -79.17 -27.89 42.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.662 -0.699 . . . . 70.129999999999995 110.949 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.837 ' HG2' HG21 ' A' ' 22' ' ' VAL . 10.7 mt-30 -69.69 -40.61 76.24 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.069 0.461 . . . . 72.209999999999994 110.676 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.667 ' HB3' HG23 ' A' ' 12' ' ' ILE . 16.5 pt-20 -78.0 -13.63 59.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.926 -0.579 . . . . 63.310000000000002 110.4 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 58.4 tp -91.0 -61.58 1.64 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.818 -0.628 . . . . 75.519999999999996 110.88 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 74.4 110.72 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 110.97 -0.852 . . . . 71.230000000000004 110.97 -172.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.2 tt -145.43 134.32 22.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.114 0.483 . . . . 64.340000000000003 111.989 -171.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -122.52 177.06 5.58 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.368 -0.975 . . . . 74.409999999999997 108.368 168.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -114.2 -42.34 3.36 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 119.642 -0.823 . . . . 75.329999999999998 111.79 -174.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -169.59 150.08 4.03 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.961 -0.385 . . . . 75.0 109.961 176.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -153.98 135.17 14.02 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.166 -0.47 . . . . 63.340000000000003 110.382 -177.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -87.77 166.26 14.75 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.187 -0.46 . . . . 75.439999999999998 110.513 -177.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -97.37 -175.25 3.16 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.261 -0.644 . . . . 74.340000000000003 109.261 175.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 59.8 m80 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.198 -0.906 . . . . 60.43 109.877 177.525 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 110.151 -0.314 . . . . 72.430000000000007 110.151 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -80.13 -59.2 2.62 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.698 -0.763 . . . . 73.239999999999995 111.555 177.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -84.66 -172.72 4.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.92 0.391 . . . . 51.149999999999999 110.044 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.491 HG23 ' HA ' ' A' ' 131' ' ' GLN . 11.3 m -118.36 121.45 40.4 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.69 -0.485 . . . . 52.140000000000001 109.69 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.678 HG13 ' CB ' ' A' ' 108' ' ' LEU . 77.4 t -107.87 110.39 31.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 116.345 -0.389 . . . . 74.349999999999994 110.05 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.8 m -146.68 151.3 14.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.926 -0.579 . . . . 73.409999999999997 110.15 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.46 109.79 22.28 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.204 -0.665 . . . . 64.25 109.204 173.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.443 ' HB3' HD23 ' A' ' 137' ' ' LEU . 2.6 t70 -157.36 174.27 15.68 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.105 -0.331 . . . . 74.329999999999998 110.105 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.481 ' HB2' HG22 ' A' ' 105' ' ' VAL . . . -131.43 131.5 43.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.242 -0.436 . . . . 73.540000000000006 110.848 -174.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.542 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 16.4 m -116.66 137.37 50.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.035 0.445 . . . . 62.399999999999999 110.663 177.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.1 m -83.65 105.14 14.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.935 -0.575 . . . . 54.240000000000002 110.222 -178.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.535 HD12 ' HB2' ' A' ' 144' ' ' GLN . 24.6 mm -114.3 149.93 16.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.727 0.299 . . . . 54.450000000000003 111.078 -177.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.76 25.68 8.26 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 121.159 -0.543 . . . . 75.340000000000003 112.67 177.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -98.4 145.65 30.23 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 108.764 -0.828 . . . . 70.230000000000004 108.764 176.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -59.0 -58.58 0.63 Allowed 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 121.946 1.764 . . . . 53.109999999999999 112.914 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 173.48 -43.55 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.097 0.559 . . . . 72.400000000000006 109.824 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.627 ' HA ' ' CE2' ' A' ' 20' ' ' TYR . 25.3 tt0 -48.3 -51.24 26.81 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 114.876 -1.057 . . . . 75.519999999999996 111.756 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -78.56 -11.09 59.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.611 -0.722 . . . . 63.210000000000001 111.504 -174.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.2 mt -83.66 -47.88 10.76 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.611 -0.268 . . . . 75.25 111.544 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.627 ' CE2' ' HA ' ' A' ' 17' ' ' GLU . 18.7 p90 -71.65 -24.37 61.84 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.383 -0.527 . . . . 74.010000000000005 110.811 -177.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.36 -13.36 61.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.974 -0.557 . . . . 51.450000000000003 111.495 -177.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.558 HG21 ' CZ ' ' A' ' 140' ' ' PHE . 6.1 p -57.01 -21.81 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 111.892 0.331 . . . . 72.519999999999996 111.892 -174.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -54.26 -31.81 54.57 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.139 -0.482 . . . . 71.219999999999999 110.696 177.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.64 ' HA ' ' NE ' ' A' ' 24' ' ' ARG . 4.7 tpm_? -135.42 32.33 3.09 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.425 -0.583 . . . . 64.209999999999994 109.425 176.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.691 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 29.2 t70 65.26 169.21 0.2 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.027 -0.988 . . . . 50.200000000000003 111.441 -177.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.57 86.84 2.39 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 121.034 0.445 . . . . 74.25 112.037 -176.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.691 ' HD3' ' O ' ' A' ' 25' ' ' ASP . 3.5 Cg_endo -86.32 -170.74 0.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.339 2.693 . . . . 74.109999999999999 112.233 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.55 92.8 0.61 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.983 -0.627 . . . . 74.430000000000007 112.573 -178.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.659 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -139.3 57.02 9.61 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 112.092 0.404 . . . . 62.119999999999997 112.092 175.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' A' ' 29' ' ' LEU . 2.9 Cg_exo -75.76 -10.98 20.16 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.416 2.077 . . . . 61.420000000000002 110.95 177.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.454 ' N ' HD12 ' A' ' 31' ' ' LEU . 4.0 mp -113.91 -65.69 1.16 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.291 -0.868 . . . . 75.209999999999994 108.825 176.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.659 ' HB2' ' HB2' ' A' ' 29' ' ' LEU . 30.6 tp 57.78 87.89 0.06 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.409 -0.814 . . . . 71.25 112.256 173.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 55.3 mtt -140.3 110.64 6.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.883 -0.599 . . . . 73.5 110.412 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.6 t -156.45 144.87 19.86 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.025 -0.361 . . . . 72.5 110.025 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 63.52 96.16 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.888 0.743 . . . . 63.509999999999998 110.426 -177.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.6 mp -65.06 102.05 0.58 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.886 -0.597 . . . . 74.439999999999998 112.449 -171.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 176.79 -41.54 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.676 -1.147 . . . . 75.349999999999994 108.229 175.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.5 m -172.03 -174.25 1.26 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 107.74 -1.207 . . . . 43.329999999999998 107.74 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 90.5 t -72.44 -16.15 18.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.878 -0.786 . . . . 63.240000000000002 108.878 167.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 75.44 13.22 3.08 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.295 -1.32 . . . . 75.120000000000005 109.881 -177.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.1 t -142.98 106.65 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 113.58 -1.645 . . . . 64.140000000000001 107.409 170.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.477 ' H ' HD22 ' A' ' 42' ' ' LEU . 2.9 mm? -63.16 -72.21 0.14 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.52 -0.764 . . . . 75.0 110.089 -175.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.537 ' HA ' ' HB2' ' A' ' 47' ' ' SER . 39.0 t70 60.65 129.02 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 122.7 1.238 . . . . 72.230000000000004 113.554 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.404 ' OD2' ' HG2' ' A' ' 45' ' ' LYS . 35.0 t70 173.38 -74.29 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 112.827 -1.988 . . . . 74.319999999999993 108.193 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.404 ' HG2' ' OD2' ' A' ' 44' ' ' ASP . 31.1 mmmt -103.4 -43.35 5.44 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.233 -0.894 . . . . 73.340000000000003 108.628 170.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.925 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 20.4 ptt180 -100.09 -172.78 2.28 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.303 -0.862 . . . . 72.150000000000006 110.728 177.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.537 ' HB2' ' HA ' ' A' ' 43' ' ' ASP . 17.9 m 69.35 -81.58 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.873 0.733 . . . . 72.25 110.593 -176.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.692 ' HD2' HD13 ' A' ' 66' ' ' LEU . 3.3 mmp_? 57.81 78.87 0.22 Allowed 'General case' 0 C--O 1.234 0.27 0 O-C-N 123.583 0.552 . . . . 61.140000000000001 112.095 177.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 6.3 m0 62.44 -165.24 0.24 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.168 -0.923 . . . . 73.019999999999996 111.761 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 21.9 m 60.61 89.95 0.07 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.62 -0.718 . . . . 54.530000000000001 111.45 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.5 t -81.22 -20.32 11.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.762 -0.654 . . . . 72.329999999999998 109.925 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -81.7 75.19 8.66 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.459 -0.791 . . . . 74.310000000000002 109.653 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 71.04 142.92 0.09 OUTLIER Pre-proline 0 N--CA 1.465 0.317 0 O-C-N 124.356 1.035 . . . . 54.509999999999998 110.391 -173.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.63 123.26 5.82 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.992 1.795 . . . . 61.329999999999998 112.75 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -120.79 84.0 37.19 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.968 -0.56 . . . . 62.43 110.922 176.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.546 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 6.5 Cg_exo -76.66 -50.08 0.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.843 2.362 . . . . 73.209999999999994 111.167 176.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 79' ' ' SER . 0.2 OUTLIER -122.58 41.15 3.5 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.496 -1.229 . . . . 72.430000000000007 110.153 177.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.58 -79.85 1.88 Allowed Glycine 0 C--N 1.31 -0.889 0 CA-C-N 114.446 -1.252 . . . . 71.019999999999996 111.786 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -163.96 99.29 0.86 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.809 0.338 . . . . 72.129999999999995 111.041 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.466 HG23 HD13 ' A' ' 57' ' ' LEU . 58.9 t -139.25 -87.89 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.266 -0.642 . . . . 52.140000000000001 109.266 173.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.7 m 174.5 21.37 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.202 1.001 . . . . 73.120000000000005 109.5 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.45 ' O ' ' HG2' ' A' ' 56' ' ' PRO . 1.0 OUTLIER -122.95 -166.02 1.39 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.458 0.647 . . . . 71.209999999999994 112.523 -170.498 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.475 ' HG2' ' HD3' ' A' ' 46' ' ' ARG . 52.3 mt-10 -94.52 169.27 10.31 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.589 -1.187 . . . . 74.409999999999997 111.414 -175.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.925 ' HB3' ' HA ' ' A' ' 46' ' ' ARG . . . -103.97 155.28 18.78 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.819 -0.808 . . . . 64.109999999999999 108.819 169.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.485 ' HB2' HD23 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -121.31 134.83 55.16 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.197 -1.038 . . . . 74.209999999999994 108.197 179.076 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.692 HD13 ' HD2' ' A' ' 48' ' ' ARG . 30.9 tp -113.58 127.51 56.09 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.921 -0.312 . . . . 52.549999999999997 110.342 -170.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.0 p -92.4 -25.01 18.68 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.198 0.523 . . . . 61.450000000000003 111.119 -176.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.694 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -140.39 128.69 22.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.953 -0.567 . . . . 72.120000000000005 111.637 -177.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -130.19 26.47 5.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.352 -0.84 . . . . 74.0 110.189 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.818 ' HB3' ' HB3' ' A' ' 73' ' ' LYS . 6.0 mm-40 -62.63 141.79 96.87 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.805 -0.634 . . . . 64.439999999999998 110.673 -177.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 3.0 Cg_exo -76.45 95.89 1.06 Allowed 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 123.04 2.493 . . . . 55.350000000000001 112.026 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.74 21.04 62.58 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-N 116.064 -0.516 . . . . 41.399999999999999 112.742 178.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.818 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 1.3 tmtp? -109.76 -57.93 2.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.893 0.378 . . . . 75.120000000000005 109.985 -176.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.846 ' HG3' ' HG ' ' A' ' 92' ' ' LEU . 40.5 ttp180 -155.97 111.63 3.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.12 -0.491 . . . . 73.400000000000006 109.832 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.424 ' N ' HD12 ' A' ' 75' ' ' ILE . 3.8 mp -109.27 110.52 32.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.504 -0.554 . . . . 73.510000000000005 109.504 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.694 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -119.21 115.4 24.13 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.104 -0.498 . . . . 34.240000000000002 109.861 177.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.456 ' HZ3' HG12 ' A' ' 91' ' ' VAL . 39.9 p90 -105.3 135.98 45.67 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.697 -0.683 . . . . 64.349999999999994 109.914 -177.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.5 mmt85 -142.42 174.02 11.0 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.308 -0.86 . . . . 70.400000000000006 108.861 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.5 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 30.1 p -98.8 -163.44 1.04 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.82 -0.807 . . . . 74.430000000000007 108.82 171.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.485 HD23 ' HB2' ' A' ' 65' ' ' GLU . 14.6 mt -71.98 142.93 85.86 Favored Pre-proline 0 C--N 1.321 -0.662 0 C-N-CA 120.277 -0.569 . . . . 74.310000000000002 109.784 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -63.11 -20.31 70.86 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 123.158 2.572 . . . . 54.140000000000001 113.047 -174.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.56 16.35 34.41 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.895 -0.669 . . . . 74.129999999999995 112.55 178.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -123.25 176.79 5.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.914 0.387 . . . . 73.439999999999998 111.133 -177.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -63.15 137.32 58.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.718 -0.674 . . . . 64.450000000000003 109.912 175.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.406 ' HA ' ' OG ' ' A' ' 79' ' ' SER . 19.6 tt -115.82 -27.18 2.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.962 -0.295 . . . . 52.0 111.493 -176.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 66.41 -81.73 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 122.962 0.505 . . . . 74.329999999999998 111.81 178.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -133.24 132.42 41.43 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.747 -0.464 . . . . 72.140000000000001 109.747 -177.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.8 m -96.82 128.03 43.38 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.716 0.293 . . . . 73.120000000000005 110.45 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -125.63 144.48 15.15 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.997 -0.62 . . . . 71.120000000000005 111.712 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.411 ' HG2' ' HB3' ' A' ' 107' ' ' ARG . 9.2 pt-20 -156.64 133.17 10.06 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.133 -0.321 . . . . 74.530000000000001 110.133 177.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.474 ' CG2' HG23 ' A' ' 104' ' ' VAL . 2.4 p -124.41 118.47 53.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.329 0.585 . . . . 75.420000000000002 111.497 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.846 ' HG ' ' HG3' ' A' ' 74' ' ' ARG . 2.9 mp -108.14 126.91 53.32 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.973 -0.751 . . . . 72.129999999999995 108.973 174.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.514 ' HZ ' ' HB3' ' A' ' 20' ' ' TYR . 85.2 m-85 -91.46 120.95 32.74 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.046 0.45 . . . . 64.25 110.426 -178.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.409 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 2.0 mmp_? -110.5 143.94 29.16 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.821 -0.627 . . . . 72.209999999999994 109.912 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 94' ' ' ARG . 32.3 Cg_exo -59.64 116.69 3.46 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.298 1.998 . . . . 74.530000000000001 111.258 177.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . . . -63.44 144.21 97.68 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.409 . . . . 65.239999999999995 111.715 -174.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 96' ' ' ALA . 50.6 Cg_exo -54.65 130.68 41.59 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.978 2.452 . . . . 74.439999999999998 111.73 176.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.53 7.05 88.95 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.801 -0.714 . . . . 51.219999999999999 112.186 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 60.67 28.14 17.86 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.682 0.393 . . . . 72.150000000000006 111.591 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 66.2 mtt180 -89.29 14.53 10.84 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.173 0.435 . . . . 73.340000000000003 112.173 -176.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.97 -137.44 6.51 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.723 -0.751 . . . . 53.009999999999998 112.125 176.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 40.6 m -136.75 130.36 31.87 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.912 0.387 . . . . 74.310000000000002 110.098 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -91.32 115.68 28.22 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.315 0.579 . . . . 74.150000000000006 109.625 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.474 HG23 ' CG2' ' A' ' 91' ' ' VAL . 2.1 p -88.29 112.0 23.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.439 -0.8 . . . . 73.129999999999995 110.916 -176.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.481 HG22 ' HB2' ' A' ' 9' ' ' ALA . 23.9 t -100.27 110.44 27.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.277 -0.874 . . . . 53.149999999999999 109.748 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.406 HG23 HG22 ' A' ' 104' ' ' VAL . 12.2 t -118.62 127.85 75.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.067 0.46 . . . . 62.32 111.111 -177.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 107' ' ' ARG . 51.3 ttt-85 -106.73 122.39 46.27 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.012 -0.54 . . . . 74.420000000000002 110.178 176.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.678 ' CB ' HG13 ' A' ' 5' ' ' VAL . 4.6 mp -122.3 154.39 37.66 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.57 -0.53 . . . . 70.319999999999993 109.57 177.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.577 ' O ' HG11 ' A' ' 5' ' ' VAL . 6.2 m -84.75 119.33 25.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.789 0.328 . . . . 62.409999999999997 111.602 -177.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -125.82 120.99 32.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.453 0.644 . . . . 71.219999999999999 111.386 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -139.82 161.52 55.76 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.168 -0.924 . . . . 75.530000000000001 109.115 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -57.16 153.93 36.68 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.219 1.946 . . . . 55.43 111.184 171.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.607 ' O ' ' HB3' ' A' ' 117' ' ' ALA . 43.0 Cg_endo -69.41 85.93 0.55 Allowed 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.512 2.141 . . . . 62.240000000000002 113.844 -174.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 70.17 -5.54 6.53 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 114.875 0.71 . . . . 74.129999999999995 114.875 168.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.41 -76.01 1.73 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.968 -0.634 . . . . 75.109999999999999 112.282 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.3 m -72.23 -15.54 61.93 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.047 0.451 . . . . 65.319999999999993 111.42 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 113' ' ' PRO . . . -72.87 -19.9 61.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 61.200000000000003 110.973 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.557 ' HA2' HG22 ' A' ' 121' ' ' ILE . . . -55.92 -39.03 77.17 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 121.385 -0.436 . . . . 73.040000000000006 112.91 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.56 -29.34 70.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.127 0.489 . . . . 74.540000000000006 111.009 176.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 57.9 t -80.14 -46.81 21.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.829 -0.623 . . . . 53.350000000000001 110.614 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.557 HG22 ' HA2' ' A' ' 118' ' ' GLY . 15.5 tt -65.26 -21.69 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 116.271 -0.422 . . . . 72.219999999999999 110.925 -177.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.05 -25.25 63.57 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.503 -0.317 . . . . 61.530000000000001 111.131 176.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.442 ' HD3' ' C ' ' A' ' 123' ' ' ARG . 0.0 OUTLIER -74.95 -39.24 61.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.159 0.504 . . . . 71.129999999999995 110.094 175.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.416 ' O ' ' HB2' ' A' ' 125' ' ' PHE . 17.1 tpt -73.05 -31.18 64.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.054 -0.521 . . . . 74.519999999999996 111.063 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.416 ' HB2' ' O ' ' A' ' 124' ' ' MET . 90.7 m-85 71.79 -71.62 0.13 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.521 -0.763 . . . . 64.430000000000007 111.035 -177.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 62.2 t30 59.69 -164.99 0.21 Allowed 'General case' 0 CA--C 1.535 0.366 0 O-C-N 123.454 0.471 . . . . 72.0 109.972 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -98.78 -67.33 0.85 Allowed 'General case' 0 C--N 1.324 -0.533 0 O-C-N 122.005 -0.434 . . . . 73.409999999999997 110.864 175.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 51.71 64.41 7.85 Favored Pre-proline 0 CA--C 1.531 0.24 0 O-C-N 123.802 0.689 . . . . 70.129999999999995 109.858 -172.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -66.23 -37.35 24.98 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.697 2.265 . . . . 62.43 112.172 -174.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 48.0 t -178.62 -61.68 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.86 -0.792 . . . . 73.120000000000005 108.86 -178.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.491 ' HA ' HG23 ' A' ' 4' ' ' THR . 83.0 mt-30 60.1 17.21 6.59 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.301 -0.863 . . . . 74.310000000000002 111.555 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -130.39 58.51 1.67 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.339 -0.985 . . . . 63.219999999999999 108.339 172.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.549 ' HG ' ' H ' ' A' ' 135' ' ' ASP . 2.0 pt? -156.0 -176.42 5.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.338 -0.846 . . . . 63.409999999999997 109.938 -174.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -112.92 14.89 19.82 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.391 0.145 . . . . 64.010000000000005 111.391 -175.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.549 ' H ' ' HG ' ' A' ' 133' ' ' LEU . 34.9 t70 -57.41 -56.07 26.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.803 0.335 . . . . 63.200000000000003 111.82 -174.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -74.93 -32.53 61.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.399 -0.364 . . . . 64.409999999999997 110.994 -176.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.542 ' HG ' ' CG1' ' A' ' 10' ' ' VAL . 20.6 tp -70.58 -24.74 62.82 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.243 -0.435 . . . . 73.450000000000003 109.972 -177.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.43 ' CE ' ' HA ' ' A' ' 138' ' ' MET . 0.0 OUTLIER -68.76 -45.78 70.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.152 -0.476 . . . . 72.510000000000005 110.199 177.636 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 71.0 mtm-85 -67.13 -37.89 84.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 71.230000000000004 110.171 177.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.558 ' CZ ' HG21 ' A' ' 22' ' ' VAL . 84.0 t80 -57.03 -42.45 80.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.457 -0.792 . . . . 75.420000000000002 110.586 174.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.505 ' HG3' HD13 ' A' ' 12' ' ' ILE . 26.0 ttpp -57.19 -46.85 82.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 62.539999999999999 110.726 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -60.66 -41.7 95.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.53 -0.759 . . . . 65.25 112.341 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -79.31 -24.68 42.67 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.554 -0.459 . . . . 73.329999999999998 110.937 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.535 ' HB2' HD12 ' A' ' 12' ' ' ILE . 8.1 mm-40 -71.83 -49.74 35.72 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.794 0.331 . . . . 74.129999999999995 110.958 175.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 13.4 pt-20 -67.9 -30.77 70.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.217 -0.447 . . . . 73.239999999999995 110.331 -177.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 48.7 tp -71.17 -41.32 70.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.773 -0.649 . . . . 74.409999999999997 109.658 174.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 148' ' ' LEU . . . 67.99 46.32 67.05 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.567 -0.742 . . . . 71.450000000000003 111.344 -177.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.403 ' HB3' ' O ' ' A' ' 147' ' ' GLY . 46.1 tp 71.04 156.93 0.16 Allowed 'General case' 0 N--CA 1.463 0.202 0 O-C-N 124.206 0.592 . . . . 70.219999999999999 109.449 -171.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -74.78 75.52 2.1 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.363 0.602 . . . . 75.099999999999994 110.556 -177.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -121.64 1.18 10.0 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.642 -0.708 . . . . 73.209999999999994 109.954 178.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -154.48 137.84 15.81 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.699 -0.852 . . . . 54.329999999999998 108.699 -177.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 47.4 p-80 -104.6 139.9 38.8 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.581 -0.448 . . . . 74.030000000000001 110.638 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -71.06 -44.89 64.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.766 -0.652 . . . . 71.099999999999994 109.865 -177.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 179.12 -67.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.759 -1.11 . . . . 75.219999999999999 108.619 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.349 -0.834 . . . . 73.0 109.344 176.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.5 ttm . . . . . 0 N--CA 1.477 0.904 0 CA-C-O 120.795 0.331 . . . . 72.120000000000005 111.115 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.65 1.83 79.93 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.557 -0.83 . . . . 74.549999999999997 113.688 172.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.553 ' HA ' ' HG2' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -104.06 178.59 4.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 117.386 0.593 . . . . 71.439999999999998 110.309 179.459 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.4 m -146.05 120.48 9.67 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.119 -0.696 . . . . 53.450000000000003 109.119 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.846 HG22 HG22 ' A' ' 109' ' ' THR . 69.0 t -92.32 98.66 8.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.298 -0.63 . . . . 55.409999999999997 109.298 176.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.4 m -95.73 145.52 8.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.783 -0.644 . . . . 74.430000000000007 111.103 -174.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.489 ' HD2' ' O ' ' A' ' 7' ' ' ARG . 4.5 ppt_? -141.64 108.98 5.54 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.434 -0.803 . . . . 61.109999999999999 109.069 175.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -142.09 161.84 36.97 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.039 -0.726 . . . . 73.120000000000005 109.039 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.658 ' HB2' HG22 ' A' ' 105' ' ' VAL . . . -140.39 130.17 24.45 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.128 0.49 . . . . 71.510000000000005 111.969 -170.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.484 HG23 HD11 ' A' ' 12' ' ' ILE . 15.8 m -113.28 145.75 18.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.486 -0.779 . . . . 61.219999999999999 110.255 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 102' ' ' THR . 20.4 m -107.15 109.6 21.47 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.782 0.325 . . . . 64.319999999999993 111.067 -178.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.844 HG13 ' HG2' ' A' ' 141' ' ' LYS . 4.1 mp -98.82 147.97 6.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.26 -0.427 . . . . 73.409999999999997 109.883 -177.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.38 58.27 4.41 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.994 -0.622 . . . . 54.340000000000003 112.709 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.643 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 8.2 mmpt? -129.8 167.01 22.04 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 108.555 -0.905 . . . . 61.219999999999999 108.555 177.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 14' ' ' LYS . 27.5 Cg_endo -65.22 -58.35 0.21 Allowed 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 121.309 1.339 . . . . 75.25 112.306 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . 171.69 -55.73 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.622 0.725 . . . . 60.020000000000003 110.266 174.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -55.09 -51.82 65.17 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.46 -1.245 . . . . 74.400000000000006 112.848 -173.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -54.07 -27.11 30.51 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.154 0.427 . . . . 75.150000000000006 112.154 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.487 ' CD1' ' HB ' ' A' ' 102' ' ' THR . 56.2 mt -69.32 -20.41 63.87 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.167 0.432 . . . . 64.219999999999999 112.167 -175.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.454 ' CE1' HG21 ' A' ' 75' ' ' ILE . 46.3 t80 -72.0 -25.27 61.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.099 0.475 . . . . 73.430000000000007 110.65 175.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.6 -12.98 60.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.364 -0.38 . . . . 73.340000000000003 111.411 -176.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.4 p -53.95 -24.04 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 112.626 0.602 . . . . 64.329999999999998 112.626 -174.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.418 ' HD1' ' O ' ' A' ' 20' ' ' TYR . 98.1 m95 -57.69 -24.34 56.25 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.18 0.437 . . . . 74.349999999999994 112.18 -176.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.448 ' HA ' ' HD2' ' A' ' 24' ' ' ARG . 7.5 tpt180 -156.33 59.28 0.57 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.792 0.33 . . . . 71.329999999999998 110.582 175.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.709 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 18.3 t70 65.24 168.82 0.19 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.571 -0.74 . . . . 73.329999999999998 111.227 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.5 mt -102.29 87.8 1.2 Allowed Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.714 -0.476 . . . . 55.509999999999998 109.714 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.709 ' HD3' ' O ' ' A' ' 25' ' ' ASP . 2.3 Cg_endo -83.75 120.63 2.76 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.186 2.59 . . . . 72.0 112.697 -174.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.437 ' C ' ' HD3' ' A' ' 30' ' ' PRO . . . -78.88 79.33 1.59 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.811 -0.709 . . . . 41.210000000000001 111.752 177.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.753 HD13 HD12 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -134.5 52.12 7.25 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 112.189 0.44 . . . . 74.129999999999995 112.189 175.871 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.594 ' HD3' ' N ' ' A' ' 29' ' ' LEU . 4.5 Cg_endo -86.15 -3.9 8.71 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.311 2.007 . . . . 63.520000000000003 111.219 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.712 HD22 ' H ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -69.54 -30.8 68.7 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.653 -0.869 . . . . 72.219999999999999 108.653 178.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.8 mt 57.76 61.2 2.49 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 114.283 -1.326 . . . . 61.420000000000002 111.725 176.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.443 ' O ' ' HB ' ' A' ' 34' ' ' THR . 48.4 ttm -93.3 -65.09 1.02 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.23 -1.026 . . . . 64.140000000000001 108.23 172.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.483 HG23 ' N ' ' A' ' 35' ' ' HIS . 8.1 t 174.92 -60.07 0.01 OUTLIER 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.38 -0.827 . . . . 71.120000000000005 110.578 168.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.483 ' N ' HG23 ' A' ' 34' ' ' THR . 6.9 t-160 65.77 -60.1 0.29 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.556 0.742 . . . . 73.420000000000002 109.941 -172.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.5 tp 68.36 154.62 0.11 Allowed 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 124.093 0.957 . . . . 64.530000000000001 112.879 170.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.431 ' HB3' ' H ' ' A' ' 38' ' ' SER . 0.9 OUTLIER 173.75 -83.31 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 114.884 -1.053 . . . . 74.420000000000002 108.504 173.095 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.431 ' H ' ' HB3' ' A' ' 37' ' ' ARG . 9.5 t -160.34 27.44 0.16 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.78 -1.193 . . . . 75.319999999999993 107.78 173.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.523 HG12 ' H ' ' A' ' 41' ' ' VAL . 8.8 t -75.02 130.33 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 114.62 -1.173 . . . . 52.119999999999997 110.73 -174.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -93.88 18.22 10.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.086 -0.506 . . . . 64.519999999999996 111.516 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.523 ' H ' HG12 ' A' ' 39' ' ' VAL . 7.0 p -146.55 147.97 17.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.13 -0.486 . . . . 74.430000000000007 110.529 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.753 HD12 HD13 ' A' ' 29' ' ' LEU . 56.7 tp -177.74 -55.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.618 -0.882 . . . . 65.120000000000005 108.618 178.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.693 ' HB2' ' HA ' ' A' ' 49' ' ' TRP . 27.1 t70 -86.1 174.76 8.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.283 -0.872 . . . . 72.230000000000004 109.448 173.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.03 -24.6 63.3 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.385 -0.598 . . . . 75.510000000000005 109.385 -177.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.473 ' HD3' ' HA ' ' A' ' 45' ' ' LYS . 1.8 tppp? -100.2 23.59 9.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.647 -0.706 . . . . 75.030000000000001 110.491 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 67.7 mtt180 59.87 -164.82 0.21 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.879 -1.055 . . . . 72.099999999999994 111.882 175.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.579 ' OG ' ' HA ' ' A' ' 63' ' ' GLU . 74.8 m 43.55 69.7 0.38 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.588 0.958 . . . . 65.540000000000006 113.588 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 56.62 -162.3 0.18 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.559 -0.292 . . . . 73.200000000000003 110.498 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.693 ' HA ' ' HB2' ' A' ' 43' ' ' ASP . 12.4 p-90 -83.15 81.45 8.68 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.488 0.661 . . . . 70.329999999999998 110.428 177.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.2 t -86.33 77.78 9.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 122.039 0.923 . . . . 63.140000000000001 110.71 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.7 m -121.55 31.09 2.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.402 -0.817 . . . . 75.200000000000003 110.801 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -141.53 116.88 10.12 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.209 -0.451 . . . . 74.030000000000001 111.116 -177.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.443 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . . . 75.17 145.44 0.11 Allowed Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.656 1.222 . . . . 73.349999999999994 113.163 168.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 53' ' ' ALA . 3.2 Cg_exo -76.04 -172.9 1.48 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 123.408 2.739 . . . . 74.230000000000004 111.248 172.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 56.51 68.62 2.12 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.03 -0.532 . . . . 74.109999999999999 110.61 -176.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -68.9 -5.08 14.74 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.602 2.201 . . . . 71.310000000000002 113.885 -171.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.953 ' HB3' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -145.24 13.66 1.43 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.461 0.648 . . . . 72.299999999999997 111.384 178.098 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.04 -28.22 60.78 Favored Glycine 0 C--N 1.318 -0.426 0 CA-C-N 114.928 -1.033 . . . . 61.149999999999999 113.048 -178.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.72 23.27 1.94 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.863 0.363 . . . . 74.439999999999998 110.629 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.1 p -155.17 154.76 6.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.294 -0.412 . . . . 74.430000000000007 110.337 -174.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.569 ' O ' ' HB2' ' A' ' 62' ' ' TRP . 44.9 m -125.9 -163.71 1.24 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.979 -0.749 . . . . 73.230000000000004 108.979 175.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.569 ' HB2' ' O ' ' A' ' 61' ' ' SER . 10.4 m95 75.5 -12.02 1.03 Allowed 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.324 0.491 . . . . 74.209999999999994 112.324 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.646 ' HB2' HD11 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -85.77 151.17 24.04 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.979 0.418 . . . . 72.340000000000003 111.388 -171.112 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.93 115.85 25.76 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.651 -0.42 . . . . 63.100000000000001 111.076 176.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 1.052 ' HB2' HD23 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -105.61 133.66 49.99 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.859 -0.793 . . . . 73.019999999999996 108.859 175.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.488 HD12 ' HA ' ' A' ' 77' ' ' TRP . 1.6 mm? -88.91 145.5 25.5 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 121.085 -0.246 . . . . 74.329999999999998 110.791 -173.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.5 t -92.53 -21.48 20.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.957 0.408 . . . . 71.200000000000003 110.209 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.783 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -121.87 130.48 53.4 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.338 -0.616 . . . . 54.310000000000002 109.338 174.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -128.58 23.98 5.82 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.473 0.654 . . . . 71.409999999999997 110.249 -172.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.556 ' HB3' ' HD3' ' A' ' 73' ' ' LYS . 29.2 mt-10 -73.17 141.52 81.12 Favored Pre-proline 0 C--N 1.326 -0.429 0 C-N-CA 120.582 -0.447 . . . . 64.340000000000003 110.551 -174.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.62 88.33 1.04 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.8 2.333 . . . . 72.5 113.326 -173.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.78 12.07 78.19 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 121.045 -0.597 . . . . 63.450000000000003 112.281 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.556 ' HD3' ' HB3' ' A' ' 70' ' ' GLU . 42.9 mtpt -95.36 -69.19 0.76 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.909 0.385 . . . . 74.230000000000004 110.325 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.465 ' HD2' ' OE2' ' A' ' 90' ' ' GLU . 10.2 ttp180 -147.72 127.15 13.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.908 -0.587 . . . . 71.140000000000001 110.095 -175.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.625 HD13 ' HE2' ' A' ' 93' ' ' PHE . 4.6 mp -131.01 111.4 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.398 0.618 . . . . 72.329999999999998 111.216 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.783 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -104.87 125.93 51.42 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.211 -0.904 . . . . 73.239999999999995 108.707 170.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.488 ' HA ' HD12 ' A' ' 66' ' ' LEU . 64.8 p-90 -80.4 159.07 25.8 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.369 0.604 . . . . 75.400000000000006 111.349 -175.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.494 ' HB3' ' O ' ' A' ' 65' ' ' GLU . 44.7 ttp180 -158.64 164.38 36.04 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.05 -0.977 . . . . 74.400000000000006 108.64 -177.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.561 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 19.9 m -123.65 60.34 1.09 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.621 0.248 . . . . 61.020000000000003 110.343 -178.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.052 HD23 ' HB2' ' A' ' 65' ' ' GLU . 22.4 mt 68.09 153.95 0.14 Allowed Pre-proline 0 N--CA 1.471 0.621 0 CA-C-N 115.701 -0.682 . . . . 71.129999999999995 111.632 -178.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.26 -19.49 38.45 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.598 2.199 . . . . 74.030000000000001 111.784 173.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.76 -24.27 77.13 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.906 -0.664 . . . . 60.520000000000003 112.059 178.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 79' ' ' SER . . . -108.52 178.87 4.36 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.245 -0.65 . . . . 63.509999999999998 109.245 175.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.518 ' HD2' ' N ' ' A' ' 84' ' ' ARG . 5.1 mpt_? -118.28 164.86 14.58 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.89 0.376 . . . . 63.530000000000001 110.3 -177.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.586 HD11 ' HA ' ' A' ' 88' ' ' SER . 6.2 tt -131.62 108.52 14.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.657 -0.701 . . . . 74.549999999999997 109.484 176.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -77.15 -37.42 53.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.777 -0.647 . . . . 73.340000000000003 110.942 -175.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -126.28 132.17 51.73 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.69 -0.485 . . . . 74.549999999999997 109.69 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.586 ' HA ' HD11 ' A' ' 85' ' ' ILE . 25.8 m -95.87 128.17 42.52 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.963 0.411 . . . . 61.350000000000001 111.282 -173.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -109.63 90.35 0.59 Allowed Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.133 -0.787 . . . . 35.310000000000002 111.133 174.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.465 ' OE2' ' HD2' ' A' ' 74' ' ' ARG . 40.9 tt0 -102.63 118.63 37.27 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.922 0.392 . . . . 75.129999999999995 110.478 -177.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.7 m -112.43 142.82 23.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.407 -0.59 . . . . 62.229999999999997 109.407 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.657 HD23 ' HD3' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -134.56 137.74 44.03 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.367 0.603 . . . . 74.319999999999993 110.178 171.209 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.625 ' HE2' HD13 ' A' ' 75' ' ' ILE . 85.5 m-85 -97.22 119.0 34.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.315 -0.857 . . . . 74.209999999999994 110.15 -174.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.657 ' HD3' HD23 ' A' ' 92' ' ' LEU . 18.5 mmm180 -104.01 143.01 25.79 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.643 -0.503 . . . . 74.310000000000002 109.643 179.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.5 109.91 2.87 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.129 1.886 . . . . 72.140000000000001 111.439 176.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.633 ' HB1' ' HB3' ' A' ' 100' ' ' ARG . . . -73.68 144.03 82.65 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.362 -0.607 . . . . 70.239999999999995 109.362 177.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -48.6 113.33 0.82 Allowed 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 123.445 2.763 . . . . 62.140000000000001 114.479 -169.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.23 -66.54 3.78 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 114.875 -1.057 . . . . 32.219999999999999 112.501 170.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -170.13 24.04 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.085 -0.558 . . . . 63.32 110.821 -173.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.633 ' HB3' ' HB1' ' A' ' 96' ' ' ALA . 5.6 tpm_? -64.47 -22.86 67.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.057 -0.52 . . . . 74.349999999999994 110.499 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 127.92 -154.77 19.92 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.29 -0.724 . . . . 73.219999999999999 111.29 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 11' ' ' THR . 2.5 m -105.68 125.29 50.82 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.96 -0.385 . . . . 51.140000000000001 109.96 175.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -89.89 100.65 13.42 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.031 -0.729 . . . . 71.099999999999994 109.031 173.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.511 HG12 ' HD1' ' A' ' 93' ' ' PHE . 3.4 m -87.46 129.47 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 109.13 -0.693 . . . . 63.530000000000001 109.13 178.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.658 HG22 ' HB2' ' A' ' 9' ' ' ALA . 18.7 t -117.19 115.92 50.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 109.082 -0.71 . . . . 74.109999999999999 109.082 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.601 HG12 HD22 ' A' ' 108' ' ' LEU . 24.0 t -103.5 116.67 47.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.304 -0.407 . . . . 60.130000000000003 110.371 -177.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -107.54 107.72 18.69 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.566 -0.531 . . . . 72.150000000000006 109.566 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.601 HD22 HG12 ' A' ' 106' ' ' VAL . 2.6 pt? -145.7 152.04 38.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.133 -0.485 . . . . 65.329999999999998 110.232 -177.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.846 HG22 HG22 ' A' ' 5' ' ' VAL . 51.2 p -107.4 132.91 52.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.327 -0.397 . . . . 60.130000000000003 111.011 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -157.69 177.96 10.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.285 -0.416 . . . . 65.549999999999997 109.883 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.553 ' HG2' ' HA ' ' A' ' 3' ' ' GLU . 97.0 mtt180 -108.31 142.97 26.48 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-O 120.764 0.316 . . . . 75.310000000000002 110.409 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -86.7 162.16 9.24 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.94 2.426 . . . . 71.030000000000001 113.242 -173.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.8 162.66 40.56 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.548 2.165 . . . . 73.209999999999994 111.563 174.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -84.42 46.66 3.71 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.804 -0.713 . . . . 72.109999999999999 112.898 -176.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -110.77 33.41 5.93 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.78 -0.724 . . . . 71.299999999999997 112.151 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.5 m -64.78 -30.24 71.24 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 122.288 0.235 . . . . 45.539999999999999 111.501 -177.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.32 -28.34 69.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.516 -0.311 . . . . 52.439999999999998 111.364 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -60.82 -39.26 96.57 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.085 -0.578 . . . . 62.140000000000001 112.396 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.25 -34.43 78.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.144 0.497 . . . . 73.340000000000003 110.634 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.9 t -68.59 -43.32 83.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.792 -0.64 . . . . 71.439999999999998 110.17 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.7 mm -65.91 -36.62 77.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.969 -0.559 . . . . 71.209999999999994 110.487 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.39 -19.3 65.89 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.866 -0.607 . . . . 54.229999999999997 111.577 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -73.38 -32.31 64.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.777 0.322 . . . . 75.340000000000003 110.688 178.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 26.5 ttt -70.86 -26.0 63.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.11 0.481 . . . . 70.120000000000005 110.516 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -69.04 170.21 10.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.655 -0.702 . . . . 55.210000000000001 110.514 -177.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -56.18 153.63 9.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.912 -0.586 . . . . 71.150000000000006 111.468 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -47.93 -61.66 1.85 Allowed 'General case' 0 C--O 1.233 0.207 0 O-C-N 123.823 0.702 . . . . 73.219999999999999 111.278 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.404 ' HA ' ' HD2' ' A' ' 129' ' ' PRO . 11.4 mm-40 49.29 84.1 0.21 Allowed Pre-proline 0 N--CA 1.463 0.204 0 O-C-N 124.009 0.818 . . . . 73.510000000000005 112.016 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 128' ' ' GLU . 38.6 Cg_endo -65.26 101.94 0.44 Allowed 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.635 2.223 . . . . 75.340000000000003 111.951 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.7 t -160.74 -166.23 1.57 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.301 -0.629 . . . . 52.229999999999997 109.301 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -88.76 -47.64 8.08 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.692 -0.231 . . . . 75.420000000000002 110.395 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 43.23 48.07 5.58 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.993 0.902 . . . . 62.140000000000001 110.833 -176.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.444 ' O ' ' HB3' ' A' ' 134' ' ' ARG . 55.8 tp -161.23 161.87 30.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.343 -1.299 . . . . 70.430000000000007 108.523 -174.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.444 ' HB3' ' O ' ' A' ' 133' ' ' LEU . 42.0 ttm180 73.21 6.55 5.23 Favored 'General case' 0 C--O 1.219 -0.541 0 O-C-N 123.399 0.437 . . . . 74.0 111.601 173.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -54.61 -43.63 72.36 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.956 -0.465 . . . . 75.0 111.018 -175.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -68.64 -47.39 66.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 72.120000000000005 111.273 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 23.7 tp -69.49 -25.47 64.08 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.101 0.477 . . . . 72.019999999999996 110.219 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.465 ' CE ' ' HA ' ' A' ' 138' ' ' MET . 0.1 OUTLIER -69.9 -33.27 71.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.042 -0.526 . . . . 71.409999999999997 110.015 176.018 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -39.73 89.4 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.236 -0.438 . . . . 63.039999999999999 110.153 176.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -56.97 -52.21 66.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.987 -0.551 . . . . 53.310000000000002 109.916 174.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.844 ' HG2' HG13 ' A' ' 12' ' ' ILE . 14.5 tmtt? -59.06 -35.34 73.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.717 -0.674 . . . . 61.0 110.73 176.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.426 ' HD2' ' HA ' ' A' ' 142' ' ' ARG . 14.4 tpt180 -62.48 -58.78 6.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.02 -0.536 . . . . 71.530000000000001 109.997 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.658 ' HG2' ' H ' ' A' ' 149' ' ' GLU . 31.0 mt-10 -63.15 -32.98 74.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.025 -0.534 . . . . 64.540000000000006 110.906 -178.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -58.32 -37.04 74.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.675 -0.693 . . . . 75.340000000000003 112.369 -175.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.489 ' HB3' HG23 ' A' ' 12' ' ' ILE . 8.2 pt-20 -109.96 -18.09 13.46 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.827 -0.349 . . . . 70.319999999999993 111.894 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 146' ' ' LEU . 5.0 tt -87.23 -38.53 16.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.168 0.508 . . . . 63.200000000000003 110.283 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 125.84 -54.63 0.75 Allowed Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.343 -0.703 . . . . 72.209999999999994 111.343 -175.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.407 HD13 ' N ' ' A' ' 149' ' ' GLU . 1.7 tm? -174.81 130.39 0.32 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.953 -0.388 . . . . 53.329999999999998 109.953 178.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.658 ' H ' ' HG2' ' A' ' 143' ' ' GLU . 40.2 tt0 -129.89 105.34 7.93 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.636 -0.505 . . . . 74.030000000000001 109.636 175.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -133.14 19.86 4.06 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.015 0.436 . . . . 74.319999999999993 110.404 -177.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -74.9 145.74 42.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.204 -0.453 . . . . 44.329999999999998 109.872 172.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -71.77 80.29 0.86 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.934 -0.576 . . . . 64.140000000000001 110.369 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -76.29 122.38 24.33 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.652 -0.703 . . . . 72.540000000000006 111.466 -178.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -89.97 -34.72 15.9 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.027 -1.101 . . . . 73.109999999999999 108.027 170.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 . . . . . 0 C--O 1.247 0.97 0 CA-C-N 114.765 -1.107 . . . . 65.310000000000002 108.734 172.612 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.481 1.081 0 N-CA-C 110.426 -0.213 . . . . 74.430000000000007 110.426 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 162.38 -58.06 0.29 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.278 -0.963 . . . . 54.229999999999997 112.346 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 58.51 92.78 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.204 0.526 . . . . 63.340000000000003 110.668 -177.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.4 m -80.33 123.74 28.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.349 0.595 . . . . 62.520000000000003 111.227 -176.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 3.1 p -109.69 113.82 45.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.61 -0.723 . . . . 61.329999999999998 109.769 175.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.3 t -97.92 116.72 41.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 116.213 -0.449 . . . . 75.430000000000007 109.81 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -93.23 123.44 36.5 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.372 0.606 . . . . 61.32 110.84 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.78 ' HB3' HD22 ' A' ' 137' ' ' LEU . 20.4 t0 -142.08 156.1 45.39 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.84 -1.17 . . . . 71.430000000000007 107.84 176.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.42 128.47 25.55 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.756 -0.378 . . . . 72.349999999999994 110.826 -176.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.525 HG13 HD23 ' A' ' 137' ' ' LEU . 27.9 m -110.07 134.91 50.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.664 -0.495 . . . . 74.129999999999995 109.664 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.782 HG21 ' HG3' ' A' ' 100' ' ' ARG . 1.3 m -108.07 110.99 22.81 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.768 -0.456 . . . . 63.350000000000001 109.768 -178.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.618 ' HB ' HD21 ' A' ' 19' ' ' LEU . 12.9 mm -108.24 150.86 10.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.925 -0.58 . . . . 63.109999999999999 110.117 -174.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.83 44.54 2.32 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.14 -0.553 . . . . 72.099999999999994 112.523 176.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.419 ' HB2' HD21 ' A' ' 19' ' ' LEU . 67.0 mmtt -119.24 145.42 38.39 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 107.889 -1.152 . . . . 73.219999999999999 107.889 176.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.411 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 83.1 Cg_exo -48.49 -58.01 2.01 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.568 2.179 . . . . 73.299999999999997 113.57 -173.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . 173.34 -53.28 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.378 0.609 . . . . 72.430000000000007 110.389 177.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -52.93 -32.43 45.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.677 -1.147 . . . . 75.109999999999999 111.98 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -85.49 -8.52 58.31 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.943 -0.571 . . . . 74.25 111.37 -175.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.849 ' HB2' ' HE2' ' A' ' 93' ' ' PHE . 96.1 mt -79.31 -44.42 21.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.711 -0.222 . . . . 54.420000000000002 111.437 -176.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.549 ' HB2' ' HZ ' ' A' ' 93' ' ' PHE . 64.1 t80 -71.46 -30.31 65.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.511 0.672 . . . . 74.420000000000002 109.787 177.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.935 ' HB1' ' HA ' ' A' ' 26' ' ' LEU . . . -66.11 -3.96 6.52 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.245 -0.889 . . . . 73.340000000000003 112.357 -175.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.549 HG21 ' CD1' ' A' ' 140' ' ' PHE . 13.4 p -61.37 -22.18 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.348 -0.387 . . . . 75.420000000000002 111.333 176.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.417 ' HD1' ' O ' ' A' ' 20' ' ' TYR . 76.2 m95 -66.6 -10.83 49.7 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.82 0.343 . . . . 72.439999999999998 111.286 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.451 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 6.5 mmm180 -132.56 -84.47 0.48 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.643 -0.253 . . . . 75.129999999999995 111.298 173.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.593 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 3.9 t70 -166.8 33.51 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.885 -0.326 . . . . 72.230000000000004 110.73 -176.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.935 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 0.7 OUTLIER 44.19 71.87 1.36 Allowed Pre-proline 0 N--CA 1.472 0.666 0 O-C-N 123.758 0.661 . . . . 72.530000000000001 112.46 -177.692 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -86.9 -170.56 0.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.644 2.229 . . . . 71.099999999999994 112.359 -178.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -146.75 162.52 28.53 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 121.039 -0.601 . . . . 52.329999999999998 111.763 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.705 HD12 HD23 ' A' ' 32' ' ' LEU . 1.5 pt? -73.22 155.49 89.95 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 120.591 0.234 . . . . 70.439999999999998 111.141 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.473 ' HD2' HD22 ' A' ' 32' ' ' LEU . 19.1 Cg_exo -68.43 8.06 0.59 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.547 2.831 . . . . 41.030000000000001 113.354 177.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.542 ' H ' ' HG ' ' A' ' 29' ' ' LEU . 9.7 mp 66.78 49.11 1.27 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 122.806 0.442 . . . . 75.319999999999993 110.884 -177.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.79 ' H ' HD23 ' A' ' 32' ' ' LEU . 2.4 pt? -89.87 -0.68 57.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 73.540000000000006 110.717 177.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 70.8 mtm 65.06 2.18 1.73 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.586 0.958 . . . . 74.230000000000004 113.586 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.455 ' H ' ' HG ' ' A' ' 32' ' ' LEU . 17.6 m -79.24 -76.14 0.22 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.638 -0.504 . . . . 64.439999999999998 109.638 173.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.411 ' O ' HD13 ' A' ' 29' ' ' LEU . 5.3 t60 -161.3 -67.78 0.06 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.571 -0.9 . . . . 73.219999999999999 108.571 174.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.538 ' O ' HD12 ' A' ' 36' ' ' LEU . 3.7 pp -170.71 120.05 0.55 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.718 -0.674 . . . . 63.210000000000001 109.611 172.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.463 ' CG ' ' H ' ' A' ' 38' ' ' SER . 17.7 ttp180 -178.36 -178.09 0.6 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.986 -1.116 . . . . 75.099999999999994 107.986 -176.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.463 ' H ' ' CG ' ' A' ' 37' ' ' ARG . 23.7 m 75.23 7.03 4.15 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.434 0.635 . . . . 62.32 110.474 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.672 HG23 ' H ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -123.16 -70.56 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.38 -0.827 . . . . 52.299999999999997 109.664 173.245 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.672 ' H ' HG23 ' A' ' 39' ' ' VAL . 51.6 mt-10 50.29 55.7 9.07 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.472 0.482 . . . . 72.239999999999995 111.678 171.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.6 p -78.67 -26.75 13.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.03 -0.532 . . . . 75.099999999999994 112.221 -174.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.825 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 1.9 tm? 178.81 -57.17 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.245 0.545 . . . . 71.340000000000003 111.567 -174.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -124.93 -33.43 2.92 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.341 -0.845 . . . . 61.030000000000001 111.236 -165.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -44.25 -65.12 0.55 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.297 -0.865 . . . . 71.430000000000007 111.945 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.859 ' HE2' ' HA ' ' A' ' 45' ' ' LYS . 0.6 OUTLIER -113.95 -39.69 3.9 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.639 -0.875 . . . . 74.420000000000002 108.639 171.342 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.559 ' HG3' ' HB2' ' A' ' 48' ' ' ARG . 23.3 ptt180 174.92 -174.26 0.08 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.172 -1.377 . . . . 75.310000000000002 108.753 177.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.825 ' HB3' ' HA ' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -108.4 90.01 3.17 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.493 -0.558 . . . . 72.409999999999997 109.493 172.287 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.559 ' HB2' ' HG3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -145.86 -51.93 0.25 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.08 0.4 . . . . 64.450000000000003 112.08 -173.644 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.426 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 54.1 t-105 75.57 -33.2 0.22 Allowed 'General case' 0 N--CA 1.473 0.689 0 O-C-N 123.62 0.575 . . . . 73.510000000000005 111.158 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -92.04 130.33 37.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.827 0.346 . . . . 61.140000000000001 110.797 177.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.5 t -87.33 -47.38 15.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.046 -0.525 . . . . 72.209999999999994 111.221 -175.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -109.63 89.47 3.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.94 0.4 . . . . 74.400000000000006 111.035 -177.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.487 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . . . -133.28 144.03 50.75 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.891 -0.595 . . . . 72.239999999999995 110.29 176.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 53' ' ' ALA . 5.6 Cg_exo -78.56 142.77 18.61 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.815 2.343 . . . . 64.430000000000007 111.083 175.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 71.3 143.88 0.1 Allowed Pre-proline 0 N--CA 1.465 0.292 0 C-N-CA 123.473 0.709 . . . . 74.140000000000001 111.145 -175.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.518 ' HB2' HD22 ' A' ' 80' ' ' LEU . 20.5 Cg_endo -63.49 -47.66 7.15 Favored 'Trans proline' 0 CA--C 1.527 0.169 0 C-N-CA 122.501 2.134 . . . . 72.209999999999994 112.505 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.959 ' HB3' HD13 ' A' ' 80' ' ' LEU . 2.2 pt? -143.97 8.05 1.44 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.207 0.527 . . . . 73.439999999999998 110.898 -177.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.48 -70.19 2.2 Favored Glycine 0 C--N 1.319 -0.38 0 CA-C-N 115.627 -0.715 . . . . 64.25 111.695 -176.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.37 -73.67 0.19 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.842 -0.429 . . . . 44.020000000000003 109.842 176.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.9 p -143.27 113.96 2.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.442 0.639 . . . . 71.329999999999998 109.862 174.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.657 ' H ' HD12 ' A' ' 57' ' ' LEU . 26.5 m -132.07 -172.1 2.8 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.664 -0.698 . . . . 75.129999999999995 110.511 -174.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 44.6 m95 -97.25 4.04 51.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.384 0.612 . . . . 71.230000000000004 111.808 -176.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.526 ' HG3' ' CD1' ' A' ' 80' ' ' LEU . 2.1 pt-20 -86.15 164.99 16.92 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.381 -0.827 . . . . 64.340000000000003 111.086 -178.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -146.29 145.86 30.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.112 -0.494 . . . . 63.399999999999999 110.415 178.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.443 ' HG2' ' H ' ' A' ' 80' ' ' LEU . 15.3 pt-20 -108.27 154.99 20.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.211 -0.45 . . . . 72.230000000000004 111.113 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.1 tp -117.58 123.02 45.2 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.059 -0.719 . . . . 75.129999999999995 109.059 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.434 ' HB ' ' CG ' ' A' ' 78' ' ' ARG . 12.2 t -83.52 -22.53 32.42 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.621 -0.432 . . . . 70.299999999999997 112.073 -171.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.948 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -132.63 132.36 42.39 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.67 -0.412 . . . . 72.0 110.713 -178.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -139.42 40.87 2.06 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.793 -0.639 . . . . 62.32 110.797 -176.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.555 ' CB ' ' HB3' ' A' ' 73' ' ' LYS . 5.4 mm-40 -80.38 143.43 55.79 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 75.349999999999994 109.842 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 23.9 Cg_exo -64.82 -55.67 0.49 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.59 2.194 . . . . 45.32 112.528 -178.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -134.12 64.15 0.6 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.852 -0.689 . . . . 72.400000000000006 111.856 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.555 ' HB3' ' CB ' ' A' ' 70' ' ' GLU . 69.2 tttt -143.78 -78.83 0.21 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.898 -0.408 . . . . 65.409999999999997 109.898 -176.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -168.03 147.5 4.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.785 0.326 . . . . 73.219999999999999 110.682 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.714 HD13 ' HE1' ' A' ' 93' ' ' PHE . 2.4 mp -122.8 116.68 49.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.76 -0.655 . . . . 72.340000000000003 109.913 175.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.948 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -103.72 149.1 25.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.187 -0.46 . . . . 51.420000000000002 109.835 176.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 29.1 p-90 -94.0 152.6 18.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.098 0.475 . . . . 73.209999999999994 111.836 -172.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.434 ' CG ' ' HB ' ' A' ' 67' ' ' THR . 75.7 mmt-85 -144.27 173.53 11.68 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.071 -1.085 . . . . 74.109999999999999 108.071 169.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.622 ' OG ' HG13 ' A' ' 85' ' ' ILE . 11.5 m -150.13 22.75 0.85 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.799 -0.361 . . . . 74.109999999999999 110.598 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.959 HD13 ' HB3' ' A' ' 57' ' ' LEU . 91.2 mt 65.97 158.39 0.13 Allowed Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 115.834 -0.621 . . . . 62.450000000000003 110.233 -173.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.576 ' HD2' HD22 ' A' ' 57' ' ' LEU . 22.6 Cg_exo -67.7 5.39 1.03 Allowed 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.76 2.307 . . . . 72.340000000000003 113.264 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.558 ' HA3' HD11 ' A' ' 57' ' ' LEU . . . -103.11 -21.01 10.43 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.8 -0.714 . . . . 75.299999999999997 113.095 -177.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.502 ' O ' ' HB2' ' A' ' 79' ' ' SER . . . -150.45 167.98 25.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.154 0.477 . . . . 74.129999999999995 111.282 -175.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 84' ' ' ARG . 3.7 mpt_? -138.29 141.35 39.82 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.468 -0.567 . . . . 73.310000000000002 109.468 174.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.622 HG13 ' OG ' ' A' ' 79' ' ' SER . 71.1 mt -70.65 -16.45 19.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-O 120.917 0.389 . . . . 73.150000000000006 110.365 176.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 75.39 -38.37 0.36 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.685 0.794 . . . . 65.450000000000003 110.773 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -64.82 132.7 50.2 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.173 -0.677 . . . . 74.209999999999994 109.173 170.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.1 t -126.35 127.89 46.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.941 0.4 . . . . 71.409999999999997 110.899 -175.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.493 ' HA3' ' HB3' ' A' ' 107' ' ' ARG . . . 158.94 133.0 1.45 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 121.042 -0.599 . . . . 73.150000000000006 112.115 176.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -101.27 138.46 38.26 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.899 0.381 . . . . 51.149999999999999 109.977 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.507 HG22 HG12 ' A' ' 106' ' ' VAL . 63.1 t -89.04 125.02 42.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.79 -0.641 . . . . 62.43 111.484 -175.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.3 mp -107.37 132.04 53.59 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.053 -0.976 . . . . 73.430000000000007 110.241 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.849 ' HE2' ' HB2' ' A' ' 19' ' ' LEU . 91.9 m-85 -99.36 109.42 22.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.188 0.518 . . . . 64.200000000000003 109.872 177.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.477 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 21.0 mtp180 -109.67 144.65 30.33 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.554 -0.748 . . . . 74.329999999999998 110.176 -173.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 94' ' ' ARG . 11.9 Cg_exo -70.5 123.93 10.32 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.764 2.31 . . . . 71.400000000000006 112.636 -176.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.917 ' HB1' ' HB3' ' A' ' 100' ' ' ARG . . . -98.06 160.04 29.33 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 108.828 -0.804 . . . . 55.25 108.828 171.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.05 159.69 11.82 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 121.789 1.66 . . . . 75.219999999999999 110.604 169.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -52.38 -26.64 22.85 Favored Glycine 0 CA--C 1.519 0.3 0 N-CA-C 114.35 0.5 . . . . 71.129999999999995 114.35 -172.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -105.61 7.8 32.92 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 112.996 0.739 . . . . 44.43 112.996 -176.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.917 ' HB3' ' HB1' ' A' ' 96' ' ' ALA . 9.5 tpp180 -101.53 -35.99 8.95 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.343 -0.614 . . . . 71.299999999999997 109.343 175.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.615 ' O ' ' HB3' ' A' ' 96' ' ' ALA . . . 111.51 -130.05 9.5 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 121.15 -0.548 . . . . 72.299999999999997 112.012 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 54.7 m -129.89 132.91 46.57 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.73 -0.471 . . . . 65.230000000000004 109.73 173.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -88.24 107.02 18.59 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.126 0.489 . . . . 74.230000000000004 110.9 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 10' ' ' VAL . 6.4 p -88.33 101.59 11.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.466 -0.788 . . . . 73.319999999999993 109.812 174.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 59.5 t -86.25 108.5 17.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.901 -0.59 . . . . 73.129999999999995 110.187 -178.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.507 HG12 HG22 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -111.55 129.16 67.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.597 -0.728 . . . . 65.530000000000001 110.574 -178.275 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.493 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 39.9 ttm180 -107.79 110.68 22.55 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.61 -0.723 . . . . 72.5 109.452 177.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.503 HD23 ' H ' ' A' ' 108' ' ' LEU . 1.5 pt? -123.33 121.12 35.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.472 0.653 . . . . 60.200000000000003 111.7 -176.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 6.6 m -95.79 120.48 36.13 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.22 -0.9 . . . . 54.100000000000001 108.875 175.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -155.86 166.31 33.87 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.482 0.658 . . . . 63.43 111.458 -173.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.29 144.73 35.61 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 114.995 -1.002 . . . . 74.120000000000005 109.037 175.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.48 151.95 71.36 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.09 1.86 . . . . 74.420000000000002 112.389 -176.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -92.52 5.2 3.41 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.082 2.521 . . . . 71.349999999999994 112.532 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 116.7 -122.31 5.45 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.855 -0.688 . . . . 71.150000000000006 111.389 -178.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -139.43 -12.79 0.68 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.836 -0.697 . . . . 42.25 112.754 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.8 t -63.73 -49.0 74.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.758 0.313 . . . . 74.030000000000001 110.49 -178.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.53 -32.56 73.52 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.281 -0.418 . . . . 75.319999999999993 110.742 178.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.64 -29.1 71.51 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.754 -0.657 . . . . 64.329999999999998 112.204 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.01 -31.41 62.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.931 0.396 . . . . 65.25 110.677 178.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.24 -50.01 56.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.015 -0.539 . . . . 64.329999999999998 110.585 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.561 ' HA ' ' HB3' ' A' ' 124' ' ' MET . 29.0 pt -69.1 -21.56 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.489 . . . . 63.229999999999997 111.261 -178.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.25 -39.68 83.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.541 -0.3 . . . . 63.100000000000001 111.367 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -89.92 -23.03 21.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.239 0.542 . . . . 74.340000000000003 110.192 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.561 ' HB3' ' HA ' ' A' ' 121' ' ' ILE . 16.3 tpt -71.85 -32.34 67.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.735 -0.666 . . . . 72.299999999999997 110.993 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.455 ' HE1' ' HG2' ' A' ' 138' ' ' MET . 15.5 t80 -63.48 120.28 11.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.892 -0.594 . . . . 63.130000000000003 110.694 -177.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -61.47 -82.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.575 -0.739 . . . . 74.319999999999993 111.603 -175.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -134.99 -75.09 0.46 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.781 -0.452 . . . . 74.0 109.781 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -176.76 85.83 0.26 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.752 -0.658 . . . . 70.140000000000001 109.698 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.484 ' HG2' ' SD ' ' A' ' 138' ' ' MET . 7.8 Cg_exo -73.57 105.28 1.96 Allowed 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.694 2.263 . . . . 73.540000000000006 111.792 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 43.1 m 67.13 -167.85 0.2 Allowed 'General case' 0 C--O 1.235 0.303 0 O-C-N 123.731 0.644 . . . . 61.310000000000002 110.718 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -120.76 140.61 51.44 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.96 -0.296 . . . . 74.530000000000001 110.526 -177.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 66.95 94.24 0.07 Allowed 'General case' 0 N--CA 1.463 0.208 0 O-C-N 123.837 0.711 . . . . 74.25 111.025 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.458 HD13 ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -157.96 164.8 36.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.834 -0.621 . . . . 75.209999999999994 110.627 -178.525 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.639 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . 0.6 OUTLIER -105.22 134.07 48.94 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.308 -0.405 . . . . 70.040000000000006 110.695 174.491 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.517 ' HB2' HD12 ' A' ' 121' ' ' ILE . 9.1 m-20 -61.58 -30.68 70.83 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.238 -0.653 . . . . 53.229999999999997 109.238 178.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.13 -53.23 53.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.784 -1.098 . . . . 71.209999999999994 110.422 176.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.78 HD22 ' HB3' ' A' ' 8' ' ' ASP . 1.2 tp -79.74 -31.42 41.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.599 -0.728 . . . . 63.049999999999997 110.929 -178.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.698 ' SD ' ' HD3' ' A' ' 141' ' ' LYS . 28.3 tpp -63.67 -26.6 68.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.936 -0.574 . . . . 71.109999999999999 111.395 -177.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -62.91 -54.35 39.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.981 -0.554 . . . . 64.010000000000005 111.151 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.711 ' HE2' ' HG ' ' A' ' 137' ' ' LEU . 3.1 p90 -77.31 -29.71 53.75 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.93 -0.308 . . . . 72.219999999999999 110.493 -177.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.698 ' HD3' ' SD ' ' A' ' 138' ' ' MET . 51.3 tttm -49.41 -51.99 31.59 Favored 'General case' 0 C--O 1.232 0.153 0 O-C-N 123.28 0.363 . . . . 55.140000000000001 111.297 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.434 ' HA ' ' HG2' ' A' ' 145' ' ' GLU . 0.5 OUTLIER -67.44 -30.68 70.48 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.903 -0.589 . . . . 64.409999999999997 110.668 -174.775 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -71.67 -36.58 70.7 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.813 0.34 . . . . 74.109999999999999 110.15 177.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.459 ' HB3' HG21 ' A' ' 12' ' ' ILE . 14.1 mm100 -64.12 -38.33 90.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 74.040000000000006 111.438 177.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.469 ' HB3' HG23 ' A' ' 12' ' ' ILE . 11.6 pt-20 -87.91 -4.96 58.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.249 -0.432 . . . . 74.420000000000002 111.368 -176.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.6 tp -111.02 -38.3 5.12 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.767 0.318 . . . . 73.230000000000004 111.113 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -77.39 133.74 13.67 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.145 -0.55 . . . . 70.549999999999997 113.802 -173.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 81.3 mt -80.68 -168.94 1.94 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.572 -0.529 . . . . 73.150000000000006 109.572 172.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -70.47 -50.32 39.3 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.352 -0.24 . . . . 73.530000000000001 110.352 -178.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 32.6 m170 56.72 39.72 29.55 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.073 -0.512 . . . . 63.240000000000002 112.183 174.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.45 ' HE1' ' O ' ' A' ' 26' ' ' LEU . 56.3 m170 -102.37 136.72 41.69 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.203 0.525 . . . . 71.219999999999999 111.246 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -116.54 -30.97 5.69 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.461 -0.79 . . . . 75.150000000000006 110.268 177.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 58.64 87.76 0.07 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.841 -0.618 . . . . 73.140000000000001 110.954 177.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -124.66 157.9 34.45 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.052 -0.522 . . . . 72.5 110.457 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 . . . . . 0 C--O 1.245 0.817 0 CA-C-O 118.665 -0.683 . . . . 73.0 109.408 179.461 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 110.179 -0.304 . . . . 74.439999999999998 110.179 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -122.25 79.54 0.34 Allowed Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.735 -0.745 . . . . 72.349999999999994 112.217 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.04 99.74 0.38 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.062 0.458 . . . . 74.310000000000002 109.797 177.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.5 m -111.31 120.61 42.8 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.261 0.553 . . . . 73.109999999999999 110.879 -174.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.757 HG22 ' HB ' ' A' ' 109' ' ' THR . 99.0 t -126.04 105.96 15.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 108.711 -0.848 . . . . 74.120000000000005 108.711 175.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.9 p -78.94 139.37 18.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.998 -0.546 . . . . 71.099999999999994 110.753 -174.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.471 ' HB3' ' HG3' ' A' ' 107' ' ' ARG . 17.3 ptt180 -132.55 134.79 45.41 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.992 -0.549 . . . . 62.210000000000001 110.379 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.755 ' HB3' HD22 ' A' ' 137' ' ' LEU . 4.2 t70 -158.14 171.81 19.54 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.443 -0.947 . . . . 74.439999999999998 108.443 172.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.426 ' CB ' HG22 ' A' ' 105' ' ' VAL . . . -146.33 120.42 9.45 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.874 0.368 . . . . 65.5 111.286 -174.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.2 m -112.73 133.55 58.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.9 -0.591 . . . . 73.120000000000005 110.756 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.0 m -97.96 112.31 24.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.922 0.392 . . . . 75.109999999999999 111.069 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.904 HG21 ' HG3' ' A' ' 144' ' ' GLN . 4.4 mp -117.28 146.38 21.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.386 -0.598 . . . . 74.310000000000002 109.386 176.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.52 53.51 3.2 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.086 -0.578 . . . . 75.219999999999999 112.972 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.517 ' HG2' HG22 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -105.83 153.99 39.68 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 107.868 -1.16 . . . . 54.219999999999999 107.868 173.121 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.721 ' HG3' ' HA ' ' A' ' 153' ' ' HIS . 51.9 Cg_exo -55.43 -57.44 1.62 Allowed 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 121.795 1.664 . . . . 72.109999999999999 111.438 178.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 171.46 -49.63 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.27 0.981 . . . . 52.520000000000003 108.762 172.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -48.92 -44.22 40.2 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.17 -1.377 . . . . 61.420000000000002 112.124 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -64.61 -23.18 67.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.914 -0.584 . . . . 62.049999999999997 112.033 -176.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.469 ' O ' HG12 ' A' ' 22' ' ' VAL . 92.4 mt -76.98 -24.9 52.23 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.893 0.378 . . . . 71.200000000000003 110.577 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.569 ' HE1' HG12 ' A' ' 75' ' ' ILE . 55.9 t80 -72.12 -41.53 67.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.536 0.684 . . . . 74.200000000000003 109.795 175.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.836 ' HB1' ' HD2' ' A' ' 27' ' ' PRO . . . -76.43 -8.9 58.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.319 -0.855 . . . . 55.329999999999998 112.943 -175.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 19' ' ' LEU . 9.6 p -61.8 -22.3 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 111.765 0.283 . . . . 71.109999999999999 111.765 -174.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 33.6 t-105 -64.04 -14.79 56.94 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.401 -0.363 . . . . 73.299999999999997 111.147 -176.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -142.3 46.24 1.62 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.027 0.441 . . . . 63.310000000000002 110.784 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 36.3 t70 62.88 28.46 16.38 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.579 -0.737 . . . . 72.239999999999995 112.456 172.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.445 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 5.5 mp 53.46 80.27 0.3 Allowed Pre-proline 0 N--CA 1.47 0.557 0 CA-C-N 115.935 -0.575 . . . . 53.109999999999999 111.45 177.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.836 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 58.8 Cg_endo -72.79 169.4 22.12 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.693 2.262 . . . . 72.239999999999995 113.179 -177.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -113.92 -1.83 23.91 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.106 -0.798 . . . . 75.329999999999998 111.106 175.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 63.97 143.35 0.07 OUTLIER Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 124.09 0.956 . . . . 72.209999999999994 112.71 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -89.47 6.07 4.55 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 123.245 2.63 . . . . 72.549999999999997 112.464 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.1 mp 62.23 57.24 2.03 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.794 -0.639 . . . . 73.120000000000005 110.409 -176.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.797 ' HB2' ' HA ' ' A' ' 37' ' ' ARG . 1.2 pt? -74.23 78.22 1.8 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.583 -0.735 . . . . 55.100000000000001 111.014 -178.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 23.1 ptt? -146.77 -39.16 0.21 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.439 -0.801 . . . . 73.409999999999997 109.939 177.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.1 m -99.29 18.21 18.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.872 0.844 . . . . 40.130000000000003 109.786 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -153.48 -171.77 4.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.162 -0.927 . . . . 70.25 108.784 -175.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 99.4 mt -64.74 105.95 1.1 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.979 0.419 . . . . 54.049999999999997 110.249 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.797 ' HA ' ' HB2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -90.5 104.39 16.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.165 -0.47 . . . . 53.119999999999997 111.22 -177.198 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 43.4 m -151.76 -82.29 0.09 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.923 -0.581 . . . . 73.430000000000007 109.796 175.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.8 t 60.31 43.03 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 121.558 0.694 . . . . 72.239999999999995 110.102 178.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 60.16 -163.59 0.24 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.166 -0.924 . . . . 65.049999999999997 110.418 -177.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 99.0 t -66.09 119.21 10.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.264 -0.643 . . . . 75.329999999999998 109.264 172.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.518 ' H ' HD22 ' A' ' 42' ' ' LEU . 3.1 mm? -54.61 -63.75 1.05 Allowed 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.795 0.684 . . . . 61.039999999999999 110.793 -175.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -150.51 -166.87 2.66 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.661 -0.866 . . . . 72.209999999999994 108.661 176.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.25 6.95 3.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.487 0.66 . . . . 72.430000000000007 110.65 -175.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.838 ' HD2' HD22 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -62.7 -56.7 15.22 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.262 -0.881 . . . . 64.510000000000005 111.011 178.299 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.654 ' HG2' ' HB3' ' A' ' 45' ' ' LYS . 4.8 ptt180 -160.7 150.84 17.82 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.384 -0.826 . . . . 74.420000000000002 110.779 -168.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.7 t -75.44 -36.89 60.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.151 0.5 . . . . 61.009999999999998 109.994 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.3 mtt180 -134.17 165.23 25.57 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.691 -0.686 . . . . 65.450000000000003 110.072 175.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 31.1 t90 -120.39 -85.85 0.65 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.384 -0.371 . . . . 72.25 110.112 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 23.9 m -160.2 83.3 0.71 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.374 -0.602 . . . . 54.25 109.374 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.5 t -127.86 -82.33 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.199 -0.667 . . . . 74.299999999999997 109.199 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -116.84 67.86 0.73 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.624 -0.88 . . . . 53.43 108.624 172.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -170.04 164.82 6.01 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 114.93 -1.032 . . . . 55.240000000000002 109.433 -175.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.76 -172.4 0.47 Allowed 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.566 2.177 . . . . 74.430000000000007 111.975 175.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.95 144.61 98.87 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.216 -0.447 . . . . 74.120000000000005 110.212 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.415 ' HB2' HD12 ' A' ' 57' ' ' LEU . 8.8 Cg_endo -50.57 -36.33 49.4 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.166 2.578 . . . . 74.219999999999999 113.411 -175.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.789 HD11 ' HG2' ' A' ' 65' ' ' GLU . 3.0 mp -119.83 10.28 11.56 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.863 0.363 . . . . 72.319999999999993 110.324 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.414 ' C ' ' H ' ' A' ' 60' ' ' VAL . . . -122.16 125.88 6.23 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.935 -0.65 . . . . 12.1 111.971 -176.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 75.21 -23.01 0.24 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.744 0.818 . . . . 72.530000000000001 111.224 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.414 ' H ' ' C ' ' A' ' 58' ' ' GLY . 3.1 p -127.42 110.41 22.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.373 0.606 . . . . 73.430000000000007 110.042 173.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.52 ' HA ' HD23 ' A' ' 80' ' ' LEU . 3.8 t -99.78 6.99 45.38 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.44 0.638 . . . . 70.230000000000004 109.992 -178.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.46 1.25 57.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.47 -0.786 . . . . 73.150000000000006 110.795 -178.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -86.45 165.09 16.58 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.74 -0.664 . . . . 73.450000000000003 110.089 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -116.15 116.41 27.79 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.038 -0.356 . . . . 62.340000000000003 110.038 177.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.789 ' HG2' HD11 ' A' ' 57' ' ' LEU . 7.3 tp10 -123.99 154.92 39.13 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.387 -0.598 . . . . 74.129999999999995 109.387 177.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.949 ' HG ' ' HA ' ' A' ' 77' ' ' TRP . 3.3 mp -115.76 135.26 54.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.118 0.485 . . . . 74.019999999999996 111.6 -174.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.6 t -75.02 -32.41 61.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.313 -0.858 . . . . 74.439999999999998 111.474 -174.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.8 130.36 18.93 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.394 -0.522 . . . . 71.129999999999995 111.47 -176.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 8.0 p-10 -149.18 110.89 4.52 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.295 -0.866 . . . . 62.299999999999997 109.268 173.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.645 ' HB2' ' HB3' ' A' ' 73' ' ' LYS . 5.1 mm-40 -108.26 142.31 25.07 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 115.591 -0.731 . . . . 64.030000000000001 109.371 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 38.5 Cg_exo -61.98 -27.37 79.55 Favored 'Trans proline' 0 N--CA 1.466 -0.097 0 C-N-CA 122.806 2.337 . . . . 74.409999999999997 112.238 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -146.36 49.54 0.64 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.575 -0.822 . . . . 73.129999999999995 112.625 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.645 ' HB3' ' HB2' ' A' ' 70' ' ' GLU . 39.4 ttmt -148.37 -79.92 0.14 Allowed 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.77 -0.253 . . . . 70.109999999999999 110.587 177.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.638 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 10.3 ptp180 -154.47 150.91 28.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.996 0.426 . . . . 75.540000000000006 111.135 175.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.569 HG12 ' HE1' ' A' ' 20' ' ' TYR . 4.5 mp -123.33 110.47 26.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 108.771 -0.826 . . . . 62.329999999999998 108.771 173.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -126.14 141.82 51.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.301 0.572 . . . . 71.109999999999999 112.396 -172.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.949 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 0.5 OUTLIER -90.31 124.83 35.23 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.137 -0.938 . . . . 73.519999999999996 112.34 -173.374 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.669 ' HG3' ' O ' ' A' ' 77' ' ' TRP . 32.6 mtm180 175.54 118.73 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 O-C-N 124.382 1.052 . . . . 73.230000000000004 111.827 173.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.697 ' HB3' HD21 ' A' ' 57' ' ' LEU . 23.6 m -163.25 -54.32 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.657 0.265 . . . . 63.32 111.34 166.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.744 HD21 ' HA ' ' A' ' 57' ' ' LEU . 4.8 mp -102.72 146.41 32.34 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.697 0.284 . . . . 75.230000000000004 111.218 -176.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.46 -16.96 11.67 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 123.088 2.525 . . . . 61.439999999999998 112.508 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.67 13.05 54.65 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.904 -0.665 . . . . 74.209999999999994 112.293 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 84' ' ' ARG . . . -129.55 -165.72 1.56 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.157 -0.312 . . . . 75.439999999999998 110.157 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.542 ' O ' HG12 ' A' ' 85' ' ' ILE . 58.4 mtm180 73.47 -170.12 0.12 Allowed 'General case' 0 N--CA 1.465 0.325 0 O-C-N 123.864 0.727 . . . . 74.219999999999999 110.972 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 84' ' ' ARG . 14.2 pt 60.93 -46.26 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 125.896 1.678 . . . . 64.230000000000004 113.891 179.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -79.08 -31.33 44.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.151 0.501 . . . . 74.430000000000007 109.792 177.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -130.73 134.63 47.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.609 -0.723 . . . . 74.439999999999998 109.695 176.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.8 m -145.51 131.35 19.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.937 -0.574 . . . . 40.439999999999998 109.454 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 107' ' ' ARG . . . 173.0 127.15 0.95 Allowed Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 119.877 -1.154 . . . . 74.200000000000003 113.604 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 0.3 OUTLIER -118.87 142.03 48.11 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.269 -0.641 . . . . 72.510000000000005 109.269 171.432 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 95.6 t -100.84 136.86 30.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.58 -0.282 . . . . 65.129999999999995 110.478 177.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.798 ' HB2' ' HB ' ' A' ' 105' ' ' VAL . 3.4 mm? -113.66 120.41 40.79 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.924 -0.58 . . . . 65.409999999999997 109.85 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -98.82 105.85 18.05 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.982 -0.748 . . . . 55.409999999999997 108.982 172.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.462 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 0.7 OUTLIER -103.99 143.45 26.69 Favored Pre-proline 0 C--N 1.317 -0.841 0 CA-C-N 115.771 -0.649 . . . . 71.230000000000004 110.132 -175.519 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 94' ' ' ARG . 5.8 Cg_exo -74.32 103.16 1.64 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.24 1.96 . . . . 64.109999999999999 110.23 172.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.99 142.99 95.07 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.117 -0.492 . . . . 62.020000000000003 110.689 -174.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -40.04 120.21 0.77 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 124.311 3.341 . . . . 74.450000000000003 114.925 -171.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.25 -69.6 2.56 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.025 -0.989 . . . . 62.409999999999997 111.583 174.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 175.78 26.83 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.437 -0.882 . . . . 74.400000000000006 109.559 -176.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -66.19 -22.48 66.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.948 -0.569 . . . . 71.230000000000004 111.17 -174.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 138.64 -151.16 21.48 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.35 -0.7 . . . . 61.030000000000001 111.35 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.9 m -114.2 127.15 55.76 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.953 0.406 . . . . 61.219999999999999 110.268 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -95.73 111.21 23.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.773 -0.649 . . . . 60.229999999999997 110.121 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.6 p -88.29 99.31 8.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.839 0.828 . . . . 71.530000000000001 109.943 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.798 ' HB ' ' HB2' ' A' ' 92' ' ' LEU . 21.6 t -89.2 110.08 21.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 114.995 -1.002 . . . . 73.129999999999995 108.757 177.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.708 HG22 HD22 ' A' ' 108' ' ' LEU . 7.7 p -114.35 120.3 63.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 121.48 0.657 . . . . 73.140000000000001 110.869 -176.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.552 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 19.7 ttp180 -114.43 98.4 6.89 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.545 -0.752 . . . . 73.409999999999997 108.99 176.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.708 HD22 HG22 ' A' ' 106' ' ' VAL . 2.3 pt? -131.91 151.31 51.79 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.767 0.317 . . . . 71.129999999999995 111.027 -171.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.757 ' HB ' HG22 ' A' ' 5' ' ' VAL . 12.2 t -97.81 127.75 43.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.147 0.499 . . . . 74.209999999999994 110.756 179.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -168.77 166.84 11.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.303 -0.862 . . . . 75.040000000000006 109.38 -176.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -86.9 143.07 34.71 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.716 -0.476 . . . . 75.409999999999997 109.716 172.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.443 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 92.8 Cg_endo -83.93 153.29 12.97 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.329 2.019 . . . . 75.25 112.69 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 2.7 Cg_endo -85.4 77.26 2.81 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.08 2.52 . . . . 63.310000000000002 111.78 176.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -86.71 132.26 11.04 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.667 -0.777 . . . . 53.439999999999998 111.93 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 155.53 -123.57 1.36 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.745 -0.741 . . . . 62.409999999999997 113.033 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.7 m -61.59 -11.11 9.88 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.603 0.964 . . . . 62.520000000000003 113.603 -172.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.16 -35.11 61.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.738 0.304 . . . . 75.230000000000004 111.545 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.42 -28.74 42.73 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.593 -0.813 . . . . 70.209999999999994 112.704 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.09 -40.65 98.28 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.706 0.261 . . . . 54.409999999999997 111.706 -176.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.3 p -67.67 -30.4 48.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.967 0.413 . . . . 72.230000000000004 110.73 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 48.0 mm -73.44 -33.88 41.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.06 0.457 . . . . 73.329999999999998 110.411 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.861 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . . . -67.27 -19.88 65.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.959 -0.564 . . . . 65.530000000000001 111.373 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.58 ' HA ' ' NE ' ' A' ' 123' ' ' ARG . 5.6 mmp_? -77.7 -13.65 59.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.559 -0.291 . . . . 72.200000000000003 111.339 178.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.512 ' HG2' ' HD1' ' A' ' 125' ' ' PHE . 35.4 ttp -58.47 -39.43 79.91 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.955 -0.387 . . . . 72.140000000000001 109.955 176.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.512 ' HD1' ' HG2' ' A' ' 124' ' ' MET . 31.9 p90 -175.71 -42.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.571 -0.74 . . . . 63.130000000000003 109.441 172.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.415 ' O ' ' HB3' ' A' ' 127' ' ' GLN . 9.2 t30 178.43 172.19 0.72 Allowed 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.555 -1.276 . . . . 72.099999999999994 107.555 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.415 ' HB3' ' O ' ' A' ' 126' ' ' ASN . 62.9 tt0 75.25 110.41 0.07 Allowed 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.732 0.645 . . . . 72.329999999999998 111.133 177.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.861 ' HB3' ' HB2' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -113.86 87.86 13.23 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.509 -0.769 . . . . 75.030000000000001 110.814 -179.192 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.53 110.16 0.43 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.891 2.394 . . . . 40.329999999999998 112.5 -177.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.7 m -104.83 13.5 31.13 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.665 0.745 . . . . 70.400000000000006 109.851 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.404 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 34.6 tt0 -82.96 162.02 21.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.171 -0.922 . . . . 73.310000000000002 109.525 178.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -63.95 111.15 2.37 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.818 0.342 . . . . 74.329999999999998 110.865 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 131' ' ' GLN . 92.1 mt -114.2 174.74 5.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.079 0.466 . . . . 73.5 111.323 -177.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -106.96 48.63 0.83 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.857 -0.61 . . . . 73.019999999999996 110.24 -177.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -49.5 -56.5 9.6 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.652 -0.704 . . . . 75.140000000000001 112.854 -174.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -66.36 -33.78 76.49 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.835 -0.346 . . . . 64.430000000000007 111.216 -172.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.755 HD22 ' HB3' ' A' ' 8' ' ' ASP . 4.3 mp -71.01 -43.84 67.11 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.522 -0.308 . . . . 72.340000000000003 111.054 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.5 ttp -60.07 -37.92 81.32 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.141 0.496 . . . . 74.109999999999999 110.006 174.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -65.74 -54.78 22.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.441 -0.799 . . . . 71.230000000000004 111.269 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.563 ' CE2' ' HA ' ' A' ' 137' ' ' LEU . 4.2 p90 -73.52 -29.8 62.7 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 120.078 -0.649 . . . . 74.310000000000002 110.911 -176.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 145' ' ' GLU . 60.5 tttm -55.43 -47.11 76.5 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.677 -0.49 . . . . 71.239999999999995 109.677 174.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.466 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 11.4 mmm180 -51.18 -52.18 46.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.903 -1.044 . . . . 74.230000000000004 111.609 176.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -70.55 -45.12 66.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.102 -0.499 . . . . 62.43 111.241 -176.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.904 ' HG3' HG21 ' A' ' 12' ' ' ILE . 5.0 tp-100 -63.12 -43.9 97.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.82 -0.627 . . . . 62.100000000000001 111.301 -177.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.65 ' HG3' HG23 ' A' ' 12' ' ' ILE . 3.0 tt0 -77.03 -23.0 52.13 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 112.212 0.449 . . . . 74.010000000000005 112.212 -177.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 0.7 OUTLIER -63.07 -57.45 10.6 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.809 -0.441 . . . . 72.319999999999993 109.809 -179.258 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 159.77 134.58 1.7 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.449 -0.66 . . . . 53.140000000000001 111.449 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.407 HD22 ' HA ' ' A' ' 148' ' ' LEU . 1.4 tm? -138.63 113.26 8.99 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.152 0.501 . . . . 74.140000000000001 110.297 -178.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 63.59 -103.01 0.11 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.811 -1.086 . . . . 62.409999999999997 110.48 177.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -144.85 16.72 1.6 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.989 -0.375 . . . . 65.430000000000007 109.989 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -63.58 118.99 8.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 64.019999999999996 110.696 -175.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 -116.63 134.2 55.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.441 -0.799 . . . . 73.140000000000001 108.968 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.721 ' HA ' ' HG3' ' A' ' 15' ' ' PRO . 2.1 p80 -86.7 132.46 33.86 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.193 -0.603 . . . . 72.409999999999997 110.18 -175.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -124.76 103.5 8.12 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.111 -0.7 . . . . 64.549999999999997 109.111 176.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 6.6 t60 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.576 -0.726 . . . . 62.229999999999997 109.61 -175.155 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.1 ttm . . . . . 0 N--CA 1.479 0.995 0 CA-C-O 120.742 0.306 . . . . 75.530000000000001 110.402 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -117.9 -36.9 0.93 Allowed Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 110.994 -0.842 . . . . 63.340000000000003 110.994 174.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.431 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 1.1 mp0 -76.71 135.45 39.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.977 -0.611 . . . . 74.530000000000001 109.801 177.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.709 ' HB ' ' O ' ' A' ' 110' ' ' TYR . 28.2 m -101.83 121.59 42.38 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.591 -0.892 . . . . 71.329999999999998 108.591 175.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.891 HG22 HG22 ' A' ' 109' ' ' THR . 86.0 t -118.17 106.9 20.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.702 -0.681 . . . . 73.099999999999994 110.029 -174.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.2 m -114.23 142.56 26.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.198 0.523 . . . . 65.519999999999996 110.752 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -136.05 109.66 8.01 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.062 -0.718 . . . . 75.329999999999998 109.062 175.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.528 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 1.5 t70 -140.23 171.65 13.86 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.18 -0.674 . . . . 71.099999999999994 109.18 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.18 120.56 12.37 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.841 0.353 . . . . 65.340000000000003 110.575 -175.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.436 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 12.4 m -102.4 133.52 45.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.121 -0.49 . . . . 54.229999999999997 110.183 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.836 HG22 ' HB1' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -84.58 102.34 12.82 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.089 0.471 . . . . 72.340000000000003 110.275 -179.171 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.585 HG21 ' HG2' ' A' ' 144' ' ' GLN . 35.7 mm -107.47 138.91 31.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.752 -0.658 . . . . 72.230000000000004 111.272 -172.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.583 ' O ' ' HE3' ' A' ' 14' ' ' LYS . . . -85.58 39.9 3.02 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 121.358 -0.449 . . . . 74.340000000000003 113.541 -176.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.583 ' HE3' ' O ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -111.49 148.71 39.4 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.301 -0.629 . . . . 74.540000000000006 109.301 174.964 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.416 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 82.3 Cg_exo -50.52 -57.75 2.09 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.021 2.481 . . . . 72.450000000000003 114.0 -174.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' A' ' 19' ' ' LEU . . . 172.87 -63.48 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.582 0.551 . . . . 73.329999999999998 110.817 174.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.425 ' HG3' ' HB2' ' A' ' 71' ' ' PRO . 1.7 tm-20 -64.82 -34.73 79.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.962 -0.563 . . . . 73.239999999999995 110.648 -175.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.718 ' HB3' ' HG3' ' A' ' 27' ' ' PRO . 2.4 mp0 -63.41 -15.75 58.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.959 -0.564 . . . . 60.340000000000003 111.217 178.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' A' ' 16' ' ' ALA . 66.9 mt -75.1 -23.93 58.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.507 -0.315 . . . . 70.140000000000001 111.354 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.54 ' CE1' HG21 ' A' ' 75' ' ' ILE . 48.8 t80 -71.77 -27.25 62.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.183 0.516 . . . . 70.310000000000002 110.352 177.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.42 -7.11 34.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.847 -0.615 . . . . 53.299999999999997 111.52 -178.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.2 p -63.59 -22.3 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 116.412 -0.358 . . . . 64.540000000000006 110.365 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 47.3 t90 -60.27 -31.07 69.87 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.874 -0.603 . . . . 75.030000000000001 111.171 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 24' ' ' ARG . 22.2 mtm180 -94.91 -76.46 0.49 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.336 -0.393 . . . . 62.25 110.365 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.446 ' HB3' HD22 ' A' ' 29' ' ' LEU . 19.9 t70 -168.89 48.67 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.915 -0.772 . . . . 72.439999999999998 108.915 175.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.713 HD13 ' HA2' ' A' ' 147' ' ' GLY . 24.5 mt 67.56 161.1 0.14 Allowed Pre-proline 0 N--CA 1.468 0.458 0 CA-C-N 114.777 -1.101 . . . . 72.400000000000006 111.667 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.718 ' HG3' ' HB3' ' A' ' 18' ' ' GLN . 55.1 Cg_endo -70.62 122.34 8.79 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.483 2.122 . . . . 74.439999999999998 111.773 177.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.44 75.15 1.28 Allowed Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.851 -0.899 . . . . 50.229999999999997 110.851 -173.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' A' ' 31' ' ' LEU . 80.7 mt -68.87 153.48 95.96 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.364 -0.418 . . . . 72.409999999999997 111.591 -175.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -69.55 7.2 0.99 Allowed 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 123.322 2.681 . . . . 74.200000000000003 111.139 170.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.488 ' H ' ' C ' ' A' ' 29' ' ' LEU . 1.1 mm? 57.56 15.35 2.75 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.515 1.126 . . . . 63.299999999999997 112.218 -177.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 53.39 32.96 14.8 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.533 0.521 . . . . 64.010000000000005 111.366 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 25.0 ttt 70.83 146.45 0.07 Allowed 'General case' 0 CA--C 1.533 0.317 0 O-C-N 123.824 0.703 . . . . 73.349999999999994 111.548 178.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.8 p -73.78 56.94 0.57 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.624 -0.716 . . . . 73.019999999999996 111.496 177.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -165.59 -72.24 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.724 0.297 . . . . 65.329999999999998 111.74 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.4 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 3.1 pp -95.45 21.17 8.47 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.508 0.558 . . . . 50.109999999999999 112.508 -169.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -76.61 105.79 7.88 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.36 0.6 . . . . 74.540000000000006 111.585 -178.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.7 t -102.18 84.05 2.43 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.34 -0.615 . . . . 62.520000000000003 109.34 174.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.419 HG12 HG12 ' A' ' 41' ' ' VAL . 19.0 t -93.21 72.05 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.859 -0.61 . . . . 62.340000000000003 110.19 -177.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.634 ' HB3' ' HB2' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -84.83 81.54 8.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.981 -0.554 . . . . 61.409999999999997 109.934 179.155 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.419 HG12 HG12 ' A' ' 39' ' ' VAL . 12.5 p -129.11 135.58 61.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.313 -0.858 . . . . 55.240000000000002 109.18 175.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.9 tp -127.25 -49.94 1.43 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.982 0.42 . . . . 74.400000000000006 110.723 -174.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.544 ' OD2' ' HB2' ' A' ' 45' ' ' LYS . 20.9 t70 -128.33 156.42 43.1 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.972 -0.558 . . . . 72.319999999999993 110.024 -178.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -89.9 -19.2 24.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.97 0.414 . . . . 75.25 110.407 -177.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.544 ' HB2' ' OD2' ' A' ' 43' ' ' ASP . 31.7 mmtp -84.04 -60.2 2.17 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.42 -0.585 . . . . 73.530000000000001 109.42 174.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -91.0 109.4 20.64 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 115.979 -0.555 . . . . 65.010000000000005 109.926 177.305 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.8 t -78.99 133.55 36.84 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.283 -0.871 . . . . 51.310000000000002 109.809 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.431 ' HA ' ' NE ' ' A' ' 48' ' ' ARG . 2.4 mmp_? -86.62 -82.23 0.21 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.891 -0.595 . . . . 71.329999999999998 110.959 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.634 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 75.8 m95 -133.82 -66.08 0.65 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.493 -0.321 . . . . 72.540000000000006 110.823 177.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.604 ' O ' HG12 ' A' ' 51' ' ' VAL . 20.9 m 59.28 77.55 0.3 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.871 -0.788 . . . . 62.329999999999998 108.871 -168.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.604 HG12 ' O ' ' A' ' 50' ' ' THR . 1.0 OUTLIER 55.71 -174.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.054 0.941 . . . . 74.120000000000005 110.023 -170.732 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.559 ' H ' HG22 ' A' ' 51' ' ' VAL . 8.4 mp0 -82.27 66.06 7.68 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 121.276 -0.89 . . . . 74.25 110.813 178.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -159.66 69.17 3.13 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.83 -0.623 . . . . 60.130000000000003 110.616 175.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -86.25 116.06 1.43 Allowed 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.365 2.043 . . . . 55.219999999999999 112.573 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.413 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . . . -151.14 86.09 4.9 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 115.76 -0.654 . . . . 30.02 111.34 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 55' ' ' ALA . 19.2 Cg_endo -61.16 -54.85 1.53 Allowed 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.456 2.104 . . . . 62.009999999999998 111.294 175.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.685 HD11 ' HB1' ' A' ' 83' ' ' ALA . 3.2 pp -145.73 3.66 0.97 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.742 -0.663 . . . . 72.310000000000002 110.636 175.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.436 ' O ' HD12 ' A' ' 57' ' ' LEU . . . 92.74 170.28 40.27 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.301 -0.863 . . . . 71.239999999999995 112.128 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 73.23 -61.33 0.51 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.38 0.672 . . . . 62.219999999999999 111.181 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.573 HG23 ' HD1' ' A' ' 62' ' ' TRP . 3.2 p -127.4 103.33 10.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.694 0.759 . . . . 50.039999999999999 110.967 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.0 m -97.33 73.67 2.46 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.811 -0.631 . . . . 72.109999999999999 111.334 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.573 ' HD1' HG23 ' A' ' 60' ' ' VAL . 98.4 m95 -133.74 -36.37 0.95 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.168 0.508 . . . . 74.409999999999997 110.883 177.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.74 ' HB2' ' CD2' ' A' ' 80' ' ' LEU . 9.9 mm-40 -138.23 166.2 24.77 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.486 -0.779 . . . . 73.109999999999999 109.325 -175.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.952 ' HA ' HD11 ' A' ' 80' ' ' LEU . . . -157.99 158.73 35.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.344 0.592 . . . . 72.010000000000005 110.151 166.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 1.04 ' HB3' ' HB2' ' A' ' 79' ' ' SER . 0.2 OUTLIER -161.71 145.11 12.35 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 107.167 -1.419 . . . . 73.129999999999995 107.167 -177.253 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.532 HD12 ' HA ' ' A' ' 77' ' ' TRP . 1.4 mm? -114.39 131.88 56.42 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.428 0.529 . . . . 72.530000000000001 112.428 -168.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.4 t -92.61 -31.56 15.12 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.834 -0.621 . . . . 64.340000000000003 110.601 177.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.517 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -116.32 126.77 53.99 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.864 -0.421 . . . . 72.540000000000006 109.864 177.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.529 ' O ' ' HD3' ' A' ' 71' ' ' PRO . 10.0 p-10 -130.66 38.61 3.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.835 -0.62 . . . . 73.510000000000005 110.548 -174.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.597 ' HB3' ' HB3' ' A' ' 73' ' ' LYS . 4.5 mm-40 -97.78 88.25 0.6 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.038 -0.528 . . . . 53.219999999999999 110.6 -176.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.529 ' HD3' ' O ' ' A' ' 69' ' ' ASP . 33.9 Cg_endo -61.93 -28.61 81.14 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.828 2.352 . . . . 71.219999999999999 113.114 -170.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -114.63 27.44 8.81 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.658 -0.782 . . . . 54.130000000000003 112.293 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.597 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 49.6 tptt -142.55 -61.46 0.44 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.627 0.251 . . . . 74.150000000000006 110.943 -178.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.546 ' H ' ' HB2' ' A' ' 70' ' ' GLU . 23.0 ptt180 -165.13 140.04 5.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.109 0.481 . . . . 54.25 110.472 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.737 HD13 ' HE2' ' A' ' 93' ' ' PHE . 3.5 mp -121.72 125.5 73.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.147 -0.479 . . . . 64.409999999999997 109.9 175.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.517 ' H ' ' HB3' ' A' ' 68' ' ' ALA . . . -139.11 117.46 11.98 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.79 -0.818 . . . . 51.020000000000003 108.79 176.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.532 ' HA ' HD12 ' A' ' 66' ' ' LEU . 10.2 p90 -96.41 120.47 36.79 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.443 -0.503 . . . . 72.409999999999997 111.263 -174.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.513 ' HG3' ' O ' ' A' ' 77' ' ' TRP . 17.2 mtt85 174.31 127.68 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 O-C-N 124.339 1.024 . . . . 72.430000000000007 112.833 173.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 1.04 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 50.2 m -150.63 -32.35 0.18 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.757 -0.656 . . . . 72.239999999999995 109.954 167.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.952 HD11 ' HA ' ' A' ' 64' ' ' ALA . 3.9 mp -46.78 144.0 3.92 Favored Pre-proline 0 C--O 1.234 0.265 0 N-CA-C 113.125 0.787 . . . . 74.310000000000002 113.125 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -77.59 -17.48 14.29 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 123.438 2.759 . . . . 61.43 113.661 -175.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.41 -14.71 12.44 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.479 -0.867 . . . . 71.409999999999997 112.31 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.685 ' HB1' HD11 ' A' ' 57' ' ' LEU . . . -90.32 17.38 7.27 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.826 0.346 . . . . 65.230000000000004 111.826 -173.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -92.27 6.64 46.03 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.41 0.522 . . . . 74.549999999999997 112.41 -173.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.3 tt -67.59 116.39 7.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 107.806 -1.183 . . . . 75.329999999999998 107.806 168.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 13.0 pt-20 -77.69 81.01 4.14 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 114.779 1.4 . . . . 64.430000000000007 114.779 -160.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -84.77 129.23 34.85 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 104.601 -2.37 . . . . 71.430000000000007 104.601 151.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.0 t -94.66 135.56 35.98 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 118.913 -1.115 . . . . 74.209999999999994 112.145 -161.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -139.05 41.41 1.35 Allowed Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 114.895 -1.048 . . . . 53.140000000000001 111.074 177.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -102.43 113.67 27.2 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.525 -0.546 . . . . 75.349999999999994 109.525 177.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.4 m -115.33 132.42 64.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.993 -0.549 . . . . 74.140000000000001 110.77 -177.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.6 mp -108.5 130.49 55.26 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.049 -0.523 . . . . 52.43 110.605 178.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.737 ' HE2' HD13 ' A' ' 75' ' ' ILE . 63.3 m-85 -108.9 123.69 49.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.05 0.453 . . . . 73.140000000000001 110.332 178.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.568 ' NH1' HG21 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -141.27 152.07 63.25 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.94 -0.573 . . . . 74.030000000000001 110.176 177.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -52.38 126.86 21.9 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.852 2.368 . . . . 41.130000000000003 111.639 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.836 ' HB1' HG22 ' A' ' 11' ' ' THR . . . -92.44 143.17 26.88 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.101 -0.499 . . . . 72.400000000000006 111.444 -176.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -71.44 166.04 30.6 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.828 2.352 . . . . 61.039999999999999 112.39 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 68.31 17.87 70.79 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.085 -0.579 . . . . 64.030000000000001 112.344 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 55.56 27.89 11.05 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 122.733 0.413 . . . . 54.109999999999999 111.2 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 58.6 mtt-85 -78.86 -9.76 59.58 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.381 -0.372 . . . . 61.329999999999998 111.899 -175.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 119.32 -109.55 1.71 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.205 -0.998 . . . . 43.450000000000003 112.445 176.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.44 ' HB ' HD11 ' A' ' 19' ' ' LEU . 23.8 m -125.71 133.95 51.96 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.08 0.467 . . . . 75.109999999999999 111.18 -178.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.464 ' HB3' ' HG2' ' A' ' 94' ' ' ARG . 37.1 tt0 -87.28 105.05 16.97 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.62 -0.718 . . . . 75.340000000000003 109.347 175.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.0 p -89.2 103.3 13.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.864 0.84 . . . . 74.349999999999994 109.705 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.568 HG21 ' NH1' ' A' ' 94' ' ' ARG . 27.3 t -89.01 112.89 24.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.694 -1.139 . . . . 74.299999999999997 109.855 -177.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.407 ' CG1' HD23 ' A' ' 108' ' ' LEU . 46.8 t -116.12 116.52 52.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.626 -0.716 . . . . 73.239999999999995 111.345 -174.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -97.19 113.8 25.44 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.796 -1.187 . . . . 75.209999999999994 107.796 169.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.44 HD12 ' CD1' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -123.0 125.36 45.1 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.687 0.279 . . . . 74.310000000000002 110.364 -173.502 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.891 HG22 HG22 ' A' ' 5' ' ' VAL . 17.1 p -105.18 116.94 32.8 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.94 -0.393 . . . . 54.020000000000003 109.94 173.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.709 ' O ' ' HB ' ' A' ' 4' ' ' THR . 6.7 p90 -173.04 150.85 2.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.76 -0.655 . . . . 70.040000000000006 109.802 -176.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.402 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 61.8 mtt-85 -78.0 144.44 67.84 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 109.307 -0.627 . . . . 71.540000000000006 109.307 173.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.407 ' HD3' ' OG1' ' A' ' 4' ' ' THR . 35.5 Cg_exo -60.78 152.7 67.95 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.374 2.05 . . . . 71.109999999999999 112.154 -176.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.04 139.5 67.57 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.718 2.279 . . . . 70.340000000000003 112.048 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.27 117.37 1.04 Allowed Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.775 -0.726 . . . . 41.009999999999998 112.374 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 109.11 -94.32 0.83 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.646 -0.788 . . . . 44.329999999999998 113.049 177.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.6 t -62.96 -49.08 76.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.803 0.335 . . . . 73.319999999999993 111.176 -172.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.462 ' HA ' HG22 ' A' ' 120' ' ' VAL . . . -61.78 -30.72 70.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 43.350000000000001 111.042 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.72 -22.35 73.54 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.975 -0.631 . . . . 74.450000000000003 112.356 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.07 -40.28 17.0 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.766 0.317 . . . . 62.119999999999997 111.058 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 117' ' ' ALA . 33.3 m -74.71 -32.92 29.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 111.939 0.348 . . . . 74.099999999999994 111.939 -175.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.464 ' HA ' ' HG2' ' A' ' 124' ' ' MET . 37.3 pt -69.71 -23.97 26.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.895 0.378 . . . . 74.310000000000002 110.882 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.0 -21.04 60.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.957 -0.565 . . . . 30.210000000000001 110.912 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -86.27 -43.36 13.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.055 0.455 . . . . 75.409999999999997 110.555 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.464 ' HG2' ' HA ' ' A' ' 121' ' ' ILE . 23.6 ptp -72.4 -26.85 62.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 73.519999999999996 111.238 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 63.62 -85.74 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.235 0.614 . . . . 70.120000000000005 112.302 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 69.23 -55.05 0.57 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.426 0.69 . . . . 62.229999999999997 109.764 -168.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.64 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 0.0 OUTLIER -155.52 -164.21 1.69 Allowed 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 106.982 -1.488 . . . . 73.239999999999995 106.982 177.538 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -97.44 89.6 0.73 Allowed Pre-proline 0 C--N 1.318 -0.773 0 N-CA-C 109.654 -0.499 . . . . 64.310000000000002 109.654 169.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.64 ' HD3' ' O ' ' A' ' 127' ' ' GLN . 72.9 Cg_exo -46.14 129.75 13.05 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.58 2.853 . . . . 71.010000000000005 112.942 -170.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 43.9 t -90.41 148.18 22.97 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.553 -0.749 . . . . 73.200000000000003 110.465 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -70.12 -10.09 57.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.843 -0.617 . . . . 73.200000000000003 111.547 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -149.42 108.32 3.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.777 0.322 . . . . 52.329999999999998 110.14 175.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.711 ' HG ' ' H ' ' A' ' 134' ' ' ARG . 3.3 tp -175.61 -172.59 0.56 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.632 -0.877 . . . . 63.119999999999997 108.632 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.711 ' H ' ' HG ' ' A' ' 133' ' ' LEU . 8.4 mpt_? -85.46 30.16 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.656 -0.498 . . . . 75.239999999999995 109.656 171.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -48.82 -49.79 37.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.958 -1.019 . . . . 74.049999999999997 112.393 -172.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -67.77 -39.71 84.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.899 0.38 . . . . 72.420000000000002 111.548 -176.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.528 ' CD2' ' HB3' ' A' ' 8' ' ' ASP . 12.6 tp -79.67 -20.92 45.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.469 -0.332 . . . . 73.349999999999994 110.858 -175.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.553 ' HG2' ' O ' ' A' ' 134' ' ' ARG . 24.2 mmt -69.18 -44.01 73.07 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.652 0.263 . . . . 72.319999999999993 111.096 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.406 ' HD2' ' SD ' ' A' ' 124' ' ' MET . 89.8 mtm-85 -64.55 -42.64 95.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.956 0.408 . . . . 71.420000000000002 110.322 178.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -59.84 -45.47 92.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.278 -0.874 . . . . 71.420000000000002 110.152 176.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 39.5 tttp -58.05 -51.47 69.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.884 -0.598 . . . . 73.209999999999994 111.632 177.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 -56.61 -40.87 76.09 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.067 -0.515 . . . . 71.299999999999997 111.805 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -79.22 -36.06 40.69 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.668 -0.413 . . . . 74.129999999999995 110.764 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.653 ' HA ' HD21 ' A' ' 26' ' ' LEU . 61.4 tt0 -63.41 -43.57 97.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 74.310000000000002 111.42 -176.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.514 ' HB3' HG23 ' A' ' 12' ' ' ILE . 12.1 pt-20 -77.21 -24.06 51.34 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 120.83 -0.348 . . . . 74.219999999999999 111.023 -179.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 62.2 tp -66.27 -61.39 2.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.294 -0.412 . . . . 73.219999999999999 110.088 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.713 ' HA2' HD13 ' A' ' 26' ' ' LEU . . . 61.19 39.42 97.14 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.828 -0.701 . . . . 71.219999999999999 111.618 -177.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 60.2 tp 68.67 -73.5 0.09 Allowed 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.304 0.642 . . . . 70.439999999999998 111.07 -175.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.451 ' OE1' ' HB3' ' A' ' 152' ' ' HIS . 3.2 mm-40 63.79 164.43 0.13 Allowed 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.055 0.542 . . . . 64.239999999999995 111.693 -175.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -176.51 89.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.964 -0.562 . . . . 64.209999999999994 110.899 -175.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 21.9 t60 43.98 65.07 1.09 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.651 -0.704 . . . . 73.129999999999995 110.535 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.451 ' HB3' ' OE1' ' A' ' 149' ' ' GLU . 38.7 t-80 -155.36 -44.69 0.08 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.48 -0.782 . . . . 63.299999999999997 109.939 -172.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.432 ' O ' ' HB3' ' A' ' 154' ' ' HIS . 5.1 p80 43.06 51.18 5.48 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.8 1.24 . . . . 71.0 112.262 175.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.432 ' HB3' ' O ' ' A' ' 153' ' ' HIS . 78.0 t60 69.71 -74.01 0.09 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.772 -0.649 . . . . 72.430000000000007 109.616 -177.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 . . . . . 0 C--O 1.247 0.95 0 CA-C-O 118.218 -0.896 . . . . 74.510000000000005 109.515 169.11 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.982 0.42 . . . . 63.310000000000002 110.385 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 133.77 -57.39 0.71 Allowed Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.373 -1.091 . . . . 64.239999999999995 110.373 -177.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -112.96 151.11 30.95 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.29 -1.004 . . . . 74.200000000000003 108.29 171.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.707 ' HB ' ' O ' ' A' ' 110' ' ' TYR . 11.5 m -76.13 120.33 21.27 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.417 0.627 . . . . 74.209999999999994 110.686 -176.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.98 141.46 45.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.525 -0.761 . . . . 72.319999999999993 109.37 177.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.729 ' HB ' ' CE1' ' A' ' 110' ' ' TYR . 12.2 p -118.35 140.18 42.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.139 0.495 . . . . 61.219999999999999 110.515 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.567 ' HA ' ' O ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -136.32 109.73 7.91 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.542 -0.911 . . . . 64.319999999999993 108.542 172.152 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.544 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 4.2 t70 -132.17 171.38 13.73 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.653 -0.869 . . . . 72.040000000000006 108.653 -178.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.709 ' HB2' HG12 ' A' ' 105' ' ' VAL . . . -141.17 121.96 14.39 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.114 0.483 . . . . 73.150000000000006 111.366 -173.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.477 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 14.3 m -111.9 136.62 47.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.727 -0.67 . . . . 44.140000000000001 109.915 176.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.8 m -88.75 107.41 18.94 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.291 -0.413 . . . . 75.340000000000003 110.06 -178.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.563 HG23 ' HB3' ' A' ' 145' ' ' GLU . 14.2 mm -105.84 132.68 52.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.233 -0.44 . . . . 73.049999999999997 110.52 -176.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.94 58.03 4.94 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.912 -0.661 . . . . 73.439999999999998 112.584 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.638 ' HB2' HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -132.28 153.12 81.15 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 108.361 -0.977 . . . . 63.030000000000001 108.361 175.827 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.432 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 10.5 Cg_endo -54.6 -58.74 1.1 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.714 2.276 . . . . 73.519999999999996 113.692 -172.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . 172.16 -54.1 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.283 0.564 . . . . 65.450000000000003 110.808 175.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -55.5 -43.89 76.05 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.111 -0.95 . . . . 74.510000000000005 112.256 -174.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.591 ' HA ' ' HB3' ' A' ' 21' ' ' ALA . 2.7 mp0 -79.18 -8.32 58.91 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.043 -0.526 . . . . 72.209999999999994 111.172 -174.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.638 HD21 ' HB2' ' A' ' 14' ' ' LYS . 77.8 mt -73.95 -50.73 18.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.028 -0.533 . . . . 70.540000000000006 111.057 178.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.71 ' HB3' ' HZ ' ' A' ' 93' ' ' PHE . 17.1 p90 -74.37 -24.06 59.09 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.784 -0.766 . . . . 73.140000000000001 109.487 176.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.591 ' HB3' ' HA ' ' A' ' 18' ' ' GLN . . . -71.39 -2.98 18.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.278 -0.874 . . . . 74.030000000000001 111.107 176.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.679 HG11 ' HZ ' ' A' ' 140' ' ' PHE . 9.9 p -54.49 -21.57 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.049 -0.523 . . . . 74.019999999999996 111.029 176.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 15.5 t90 -60.14 -22.71 63.19 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.993 -0.549 . . . . 54.439999999999998 110.693 177.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -109.3 2.12 20.58 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.097 -0.501 . . . . 65.310000000000002 110.035 177.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.0 t70 55.54 80.35 0.14 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.899 -0.591 . . . . 73.549999999999997 110.87 -176.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.562 HD12 ' H ' ' A' ' 148' ' ' LEU . 68.5 mt 45.18 85.6 0.16 Allowed Pre-proline 0 N--CA 1.47 0.547 0 CA-C-N 115.544 -0.753 . . . . 74.129999999999995 111.998 -178.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 26' ' ' LEU . 10.9 Cg_endo -52.57 116.02 2.59 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.63 2.887 . . . . 64.319999999999993 113.336 -173.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -132.27 73.96 0.45 Allowed Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 110.618 -0.993 . . . . 45.32 110.618 176.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.643 HD22 HD23 ' A' ' 32' ' ' LEU . 0.4 OUTLIER -137.51 58.48 17.05 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 112.781 0.66 . . . . 54.329999999999998 112.781 -173.595 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.462 ' HD3' ' N ' ' A' ' 29' ' ' LEU . 13.9 Cg_exo -70.07 -13.57 34.04 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.206 1.937 . . . . 63.420000000000002 111.503 177.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.955 HD13 ' H ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -89.8 -8.58 51.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.617 -0.719 . . . . 62.100000000000001 110.675 177.05 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.643 HD23 HD22 ' A' ' 29' ' ' LEU . 21.9 tp -98.52 29.53 3.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.659 0.742 . . . . 72.530000000000001 109.629 -178.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 89.2 mtp -93.67 168.45 11.01 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.311 -0.859 . . . . 63.329999999999998 109.269 174.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.805 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 5.7 t -70.97 102.32 2.39 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.489 0.661 . . . . 51.210000000000001 111.436 -176.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -164.07 -59.81 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.63 -0.713 . . . . 74.439999999999998 110.204 176.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.4 tp -71.54 -58.25 3.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.715 0.293 . . . . 55.200000000000003 110.99 -177.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -111.44 15.11 21.41 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.927 0.394 . . . . 55.210000000000001 110.109 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.6 m 55.45 35.53 25.25 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.535 -0.757 . . . . 61.149999999999999 111.22 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.4 p -74.18 103.54 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.471 0.653 . . . . 71.329999999999998 110.83 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.805 ' HB3' ' HB ' ' A' ' 34' ' ' THR . 13.9 pt-20 -146.52 140.24 26.03 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.612 -0.722 . . . . 74.409999999999997 109.505 176.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.0 t -84.28 137.36 21.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.048 0.452 . . . . 43.240000000000002 110.424 -178.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.401 ' N ' HD22 ' A' ' 42' ' ' LEU . 3.2 mm? -71.67 -63.94 1.03 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.466 -0.788 . . . . 50.140000000000001 110.507 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.534 ' HB3' ' HG2' ' A' ' 46' ' ' ARG . 29.0 t70 -81.54 -86.14 0.1 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.14 -0.482 . . . . 72.219999999999999 111.116 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -161.89 -63.66 0.05 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.862 0.363 . . . . 43.509999999999998 111.156 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.456 ' HD3' ' HA ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -126.43 32.86 5.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.417 0.627 . . . . 73.219999999999999 111.03 -172.66 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.534 ' HG2' ' HB3' ' A' ' 43' ' ' ASP . 8.5 ptp180 -130.28 -175.88 3.77 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.402 -0.817 . . . . 74.340000000000003 109.958 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.0 m -143.53 178.41 7.79 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.381 -0.372 . . . . 64.230000000000004 110.002 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.443 HH11 ' HD3' ' A' ' 48' ' ' ARG . 24.2 ttt180 -161.62 -56.99 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.07 -0.715 . . . . 65.230000000000004 109.07 174.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -89.61 -15.89 31.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.492 -0.776 . . . . 74.530000000000001 110.199 176.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 45.1 p 53.18 -171.5 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.501 -0.772 . . . . 74.409999999999997 111.786 -174.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.75 HG23 ' H ' ' A' ' 52' ' ' GLU . 1.9 m -126.75 -85.17 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.166 0.432 . . . . 64.209999999999994 112.166 -177.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.75 ' H ' HG23 ' A' ' 51' ' ' VAL . 29.7 mt-10 -102.99 -81.92 0.5 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.903 0.382 . . . . 71.219999999999999 110.387 -177.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.63 84.97 4.95 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.854 -0.612 . . . . 71.120000000000005 110.093 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -95.05 -168.51 0.15 Allowed 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 123.14 2.56 . . . . 63.539999999999999 111.886 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -161.66 85.73 1.65 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.325 -0.398 . . . . 62.119999999999997 110.497 174.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.841 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 14.4 Cg_exo -69.27 -54.24 0.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.591 2.194 . . . . 64.230000000000004 111.892 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.789 HD23 HG23 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -98.15 38.02 1.37 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.107 0.479 . . . . 55.0 110.312 -177.42 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.86 -58.89 4.59 Favored Glycine 0 C--N 1.318 -0.425 0 CA-C-N 116.033 -0.531 . . . . 64.129999999999995 112.626 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -121.75 -67.24 0.98 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.641 0.257 . . . . 52.140000000000001 110.826 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.789 HG23 HD23 ' A' ' 57' ' ' LEU . 15.6 m -55.99 140.01 14.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.254 -0.43 . . . . 60.119999999999997 110.584 178.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.533 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . 25.1 m -134.52 102.08 5.19 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.306 0.484 . . . . 71.540000000000006 112.306 -171.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 21.6 p-90 -157.48 -36.69 0.07 Allowed 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 120.991 -0.284 . . . . 63.229999999999997 111.507 173.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.631 ' HB3' HD11 ' A' ' 80' ' ' LEU . 34.7 tt0 -153.58 154.45 34.27 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.249 -0.432 . . . . 64.129999999999995 110.613 177.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.841 ' HB2' ' HB3' ' A' ' 56' ' ' PRO . . . -135.17 143.16 46.31 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.918 -0.771 . . . . 42.329999999999998 108.918 174.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.621 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -108.56 134.64 51.04 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.429 -0.952 . . . . 74.010000000000005 108.429 -175.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.448 ' HG ' ' HB3' ' A' ' 45' ' ' LYS . 1.2 mm? -113.83 116.63 29.63 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 121.846 -0.534 . . . . 74.329999999999998 110.294 -176.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.449 HG23 ' HB3' ' A' ' 76' ' ' ALA . 7.1 t -78.26 -26.03 47.04 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.627 -0.429 . . . . 71.140000000000001 111.568 -174.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . . . -147.42 129.61 15.59 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.767 0.318 . . . . 75.430000000000007 110.368 176.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -132.23 7.93 4.3 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.098 -0.501 . . . . 72.239999999999995 111.424 -175.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -59.18 93.41 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 123.94 0.896 . . . . 72.150000000000006 112.486 -173.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -59.74 114.16 1.94 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.314 2.676 . . . . 74.409999999999997 112.642 -169.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.53 6.37 70.66 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.84 -0.695 . . . . 72.430000000000007 112.519 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -123.91 -67.94 0.9 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.002 -0.37 . . . . 73.329999999999998 110.002 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.427 ' C ' HD12 ' A' ' 75' ' ' ILE . 15.4 ptt180 -150.6 134.9 17.05 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.983 -0.377 . . . . 74.430000000000007 109.983 175.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.621 HD13 ' HE2' ' A' ' 93' ' ' PHE . 3.5 mp -126.73 126.52 68.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 109.183 -0.673 . . . . 72.319999999999993 109.183 177.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.597 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . . . -139.59 120.57 14.57 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.969 -0.559 . . . . 71.209999999999994 110.559 -176.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 13.3 m-90 -98.04 152.17 19.57 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.78 -0.646 . . . . 73.329999999999998 110.483 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.621 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 1.0 OUTLIER -156.16 175.68 13.66 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.682 -0.858 . . . . 75.010000000000005 108.682 175.625 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 1.053 ' HB2' ' HA ' ' A' ' 85' ' ' ILE . 20.3 m -105.91 -171.07 1.83 Allowed 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 109.672 -0.492 . . . . 71.209999999999994 109.672 176.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.631 HD11 ' HB3' ' A' ' 63' ' ' GLU . 12.6 mt -82.79 144.88 49.11 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.631 -0.259 . . . . 72.420000000000002 111.075 -175.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.94 -32.36 95.0 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.601 2.2 . . . . 64.230000000000004 111.436 173.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.97 35.83 3.86 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.482 -0.647 . . . . 43.240000000000002 111.482 175.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -155.01 -173.94 4.78 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.654 -0.498 . . . . 34.43 109.654 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -80.38 101.62 9.11 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.591 -0.522 . . . . 73.540000000000006 109.591 172.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 1.053 ' HA ' ' HB2' ' A' ' 79' ' ' SER . 0.0 OUTLIER -70.04 -51.37 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 116.175 -0.466 . . . . 75.299999999999997 109.777 -179.071 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 47.78 -83.25 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.371 1.068 . . . . 55.43 113.608 175.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -64.69 132.51 49.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.588 0.709 . . . . 54.530000000000001 111.52 -175.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.1 m -139.5 128.73 23.95 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.537 -0.756 . . . . 62.109999999999999 109.548 176.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.25 145.15 9.16 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.716 -0.754 . . . . 62.310000000000002 112.064 -178.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.597 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 43.4 tt0 -138.57 125.61 21.31 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.077 -0.342 . . . . 65.140000000000001 110.077 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.1 m -106.75 128.07 61.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.121 0.486 . . . . 64.209999999999994 110.223 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.671 ' HB2' HG23 ' A' ' 105' ' ' VAL . 9.1 mp -110.53 145.7 37.3 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.463 -0.569 . . . . 65.420000000000002 109.463 173.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.71 ' HZ ' ' HB3' ' A' ' 20' ' ' TYR . 73.9 m-85 -110.07 106.72 16.32 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.094 0.473 . . . . 65.140000000000001 111.104 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.411 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 99.8 mtt180 -112.3 142.87 27.74 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.304 -0.628 . . . . 74.5 109.304 175.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 94' ' ' ARG . 9.2 Cg_exo -72.16 125.19 10.63 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.421 2.08 . . . . 75.120000000000005 111.327 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.89 144.51 98.86 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.239 -0.652 . . . . 62.140000000000001 109.239 176.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -39.32 119.64 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.623 2.882 . . . . 75.450000000000003 113.622 -174.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 90.82 8.97 64.69 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.011 -0.614 . . . . 54.509999999999998 112.642 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 59.01 36.04 24.24 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.201 0.524 . . . . 74.329999999999998 110.427 -178.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -73.79 -65.42 0.83 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.672 -0.695 . . . . 61.340000000000003 110.458 -178.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -131.78 -167.85 11.97 Favored Glycine 0 N--CA 1.439 -1.127 0 N-CA-C 110.512 -1.035 . . . . 72.140000000000001 110.512 176.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.482 ' HB ' HD11 ' A' ' 19' ' ' LEU . 10.7 m -110.45 122.71 48.38 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.023 0.439 . . . . 73.099999999999994 110.182 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.511 ' HG2' ' HB1' ' A' ' 9' ' ' ALA . 41.3 tt0 -92.4 106.5 18.48 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.455 -0.943 . . . . 75.409999999999997 108.455 178.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 5.2 m -86.72 128.88 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 CA-C-O 121.393 0.615 . . . . 70.0 109.506 -177.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.709 HG12 ' HB2' ' A' ' 9' ' ' ALA . 3.5 m -108.95 114.98 48.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.521 -0.763 . . . . 65.209999999999994 109.797 178.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 40.1 t -110.02 119.12 58.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.828 -0.623 . . . . 64.310000000000002 111.377 -173.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -107.06 116.48 32.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.633 -0.712 . . . . 71.030000000000001 109.739 175.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.5 pp -147.0 151.69 37.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.934 0.397 . . . . 75.530000000000001 111.085 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.1 t -90.09 144.85 25.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.93 -0.577 . . . . 74.540000000000006 110.18 178.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.729 ' CE1' ' HB ' ' A' ' 6' ' ' VAL . 5.7 p90 -164.33 156.92 17.03 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.921 -0.4 . . . . 54.299999999999997 109.921 -178.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -134.71 144.68 51.7 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 116.619 -0.264 . . . . 73.340000000000003 110.383 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 39.7 Cg_endo -67.13 153.88 76.17 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.511 2.141 . . . . 74.519999999999996 111.691 -178.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 15.3 Cg_exo -68.64 108.69 1.91 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.738 2.292 . . . . 73.439999999999998 112.442 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -114.99 97.33 0.81 Allowed Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.638 -0.71 . . . . 54.43 111.352 175.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -165.95 144.13 8.95 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.637 -0.792 . . . . 55.32 112.342 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 38.0 t -86.29 -23.73 26.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.988 0.423 . . . . 55.109999999999999 110.572 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -68.41 -29.09 67.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.146 -0.479 . . . . 72.299999999999997 111.641 -174.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.456 ' O ' HG22 ' A' ' 121' ' ' ILE . . . -69.73 -19.68 75.18 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.098 -0.572 . . . . 44.340000000000003 113.041 -178.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.26 -20.34 65.99 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.307 0.484 . . . . 62.200000000000003 112.307 -174.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.57 -19.48 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.785 0.326 . . . . 73.219999999999999 111.723 -176.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.456 HG22 ' O ' ' A' ' 118' ' ' GLY . 13.8 tt -67.62 -22.64 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 121.032 0.444 . . . . 70.510000000000005 110.967 -177.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.54 -20.85 63.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.269 -0.423 . . . . 61.420000000000002 111.191 -178.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -71.03 -28.93 64.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.057 -0.52 . . . . 72.230000000000004 110.776 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.5 ttm -71.04 -53.62 14.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 74.439999999999998 111.153 -175.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -107.73 -79.63 0.58 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.121 0.486 . . . . 71.150000000000006 110.347 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -164.61 -55.89 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.258 -1.016 . . . . 64.120000000000005 108.258 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -177.65 147.75 0.52 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.884 -1.053 . . . . 75.340000000000003 109.9 171.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.46 ' HA ' ' HD2' ' A' ' 129' ' ' PRO . 28.5 tt0 -120.41 87.56 40.9 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 108.405 -0.961 . . . . 74.109999999999999 108.405 171.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 128' ' ' GLU . 1.7 Cg_endo -40.11 129.81 2.22 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 124.482 3.455 . . . . 71.349999999999994 113.635 -171.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.8 m -71.13 97.9 1.58 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.746 -0.661 . . . . 73.25 109.859 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -71.35 106.12 3.77 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.69 -0.686 . . . . 74.530000000000001 111.12 -176.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -111.6 72.2 0.77 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.323 -0.992 . . . . 64.099999999999994 108.323 174.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.33 -154.58 0.54 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.036 -0.984 . . . . 72.439999999999998 109.265 -178.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.549 ' O ' ' HG2' ' A' ' 138' ' ' MET . 51.0 mtp180 -93.16 14.2 18.76 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.061 -0.718 . . . . 74.209999999999994 109.061 173.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -57.22 -38.6 73.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.882 -1.054 . . . . 72.010000000000005 112.996 -171.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.48 -42.57 98.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.889 0.376 . . . . 60.229999999999997 110.889 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.544 ' CD2' ' HB3' ' A' ' 8' ' ' ASP . 13.9 tp -79.4 -20.95 46.37 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.254 -0.43 . . . . 71.430000000000007 110.112 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.549 ' HG2' ' O ' ' A' ' 134' ' ' ARG . 30.4 mmt -69.48 -47.51 63.68 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.307 -0.406 . . . . 60.420000000000002 110.268 175.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.07 -43.28 99.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.094 -0.503 . . . . 71.319999999999993 110.092 174.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.679 ' HZ ' HG11 ' A' ' 22' ' ' VAL . 67.8 t80 -57.22 -48.9 77.64 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.228 -0.897 . . . . 75.120000000000005 111.004 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.8 tttp -54.81 -56.23 21.63 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.185 -0.462 . . . . 75.109999999999999 111.727 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -55.49 -42.82 74.94 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.821 0.343 . . . . 62.350000000000001 111.737 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -75.49 -27.44 58.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.486 -0.325 . . . . 60.130000000000003 111.4 -178.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -80.94 -39.13 26.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.056 -0.52 . . . . 74.439999999999998 111.216 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.563 ' HB3' HG23 ' A' ' 12' ' ' ILE . 16.9 pt-20 -80.57 -36.85 32.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.55 -0.296 . . . . 73.349999999999994 111.495 -176.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.1 tt -71.79 -63.01 1.21 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.781 -0.452 . . . . 75.109999999999999 109.781 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.442 ' HA3' HD11 ' A' ' 26' ' ' LEU . . . 64.13 -172.73 16.01 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.652 -0.704 . . . . 72.329999999999998 113.486 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.562 ' H ' HD12 ' A' ' 26' ' ' LEU . 5.8 mp -116.63 164.53 14.48 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.681 -0.488 . . . . 63.240000000000002 109.681 178.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -59.86 118.19 5.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.117 0.484 . . . . 71.319999999999993 111.732 -175.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -148.23 168.74 21.7 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.75 -0.833 . . . . 75.310000000000002 108.75 177.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -80.53 148.2 30.49 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.228 -0.286 . . . . 75.409999999999997 110.228 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 40.5 m-70 -79.52 115.09 18.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.6 -0.273 . . . . 72.549999999999997 111.009 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -104.55 125.55 50.8 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.745 -0.465 . . . . 74.439999999999998 109.745 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -107.25 158.57 17.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.948 -0.569 . . . . 75.129999999999995 109.743 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 3.4 p80 . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.661 -0.685 . . . . 63.130000000000003 109.546 176.737 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 109.83 -0.433 . . . . 75.299999999999997 109.83 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -112.93 -114.8 3.29 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.538 -1.025 . . . . 55.119999999999997 110.538 175.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -71.75 120.84 17.92 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.691 -0.855 . . . . 64.430000000000007 108.691 173.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.6 m -83.6 133.83 34.83 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.014 0.435 . . . . 62.43 111.418 -173.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -120.21 119.15 59.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.145 -0.687 . . . . 64.510000000000005 109.145 173.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 71.4 t -101.16 116.76 45.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 121.303 0.573 . . . . 71.209999999999994 110.881 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -132.21 109.84 10.22 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.981 -1.008 . . . . 75.409999999999997 108.638 176.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.485 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 1.3 t70 -141.47 146.15 36.11 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.836 -1.172 . . . . 52.439999999999998 107.836 175.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -122.8 140.25 53.13 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.135 0.493 . . . . 62.340000000000003 110.982 -173.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.605 ' CG2' ' HG2' ' A' ' 141' ' ' LYS . 2.5 m -133.85 142.28 41.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.47 -0.786 . . . . 74.519999999999996 110.469 -176.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 29.7 m -94.0 133.7 37.17 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.975 -0.557 . . . . 72.129999999999995 111.125 -175.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.808 HD11 ' HG3' ' A' ' 141' ' ' LYS . 35.3 mt -121.38 140.15 46.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.654 -0.703 . . . . 72.120000000000005 109.917 172.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.538 ' H ' ' HB3' ' A' ' 145' ' ' GLU . . . -83.31 62.35 4.64 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.991 -0.624 . . . . 74.430000000000007 112.555 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.566 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 7.4 mmpt? -144.59 144.8 26.13 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 109.183 -0.673 . . . . 73.329999999999998 109.183 175.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.408 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 72.8 Cg_exo -51.81 -56.3 3.09 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.25 2.633 . . . . 72.519999999999996 113.945 -176.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . 174.51 -63.11 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.686 0.279 . . . . 74.310000000000002 110.836 177.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -50.23 -42.57 51.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.553 -0.749 . . . . 73.040000000000006 111.428 -176.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.598 ' HG3' ' HD2' ' A' ' 27' ' ' PRO . 2.6 mp0 -61.61 -23.55 66.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.727 -0.67 . . . . 62.409999999999997 111.863 -177.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.6 mt -77.8 -34.32 52.21 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.95 0.352 . . . . 61.409999999999997 111.95 -176.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -71.73 -28.07 63.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.644 0.735 . . . . 63.450000000000003 109.421 177.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.434 ' HB2' HG21 ' A' ' 39' ' ' VAL . . . -76.22 -2.69 32.52 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 114.901 -1.045 . . . . 73.430000000000007 112.385 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.829 HG21 ' HZ ' ' A' ' 140' ' ' PHE . 10.9 p -53.01 -22.56 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 113.042 0.756 . . . . 63.219999999999999 113.042 -174.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 23.2 m0 -63.18 -14.1 44.99 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.703 0.631 . . . . 74.340000000000003 112.703 -176.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.463 ' HD3' ' HA ' ' A' ' 24' ' ' ARG . 25.8 mmt180 -121.84 -80.15 0.62 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.407 -0.183 . . . . 75.219999999999999 110.624 175.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 26' ' ' LEU . 8.3 t70 -172.19 53.63 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.549 -0.537 . . . . 74.129999999999995 109.549 176.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 9.1 mp 66.37 165.89 0.12 Allowed Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 115.409 -0.814 . . . . 50.219999999999999 110.771 -178.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.598 ' HD2' ' HG3' ' A' ' 18' ' ' GLN . 35.4 Cg_exo -58.75 122.11 11.09 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.38 2.053 . . . . 73.329999999999998 111.781 177.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 160.17 103.26 0.19 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.685 -0.769 . . . . 72.420000000000002 112.093 -178.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 62.1 mt -128.21 62.72 59.76 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 120.624 0.25 . . . . 73.140000000000001 110.626 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -87.79 60.54 3.38 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.218 1.945 . . . . 65.439999999999998 112.572 -175.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.503 ' N ' HD13 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -145.63 7.73 1.12 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.409 -0.814 . . . . 74.340000000000003 109.079 173.359 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.472 ' O ' HD12 ' A' ' 32' ' ' LEU . 3.3 pp -154.41 144.98 22.28 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.523 -1.217 . . . . 70.310000000000002 107.725 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 56.6 mtt -78.31 -78.87 0.13 Allowed 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 121.0 -0.28 . . . . 61.439999999999998 110.31 176.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.847 HG22 ' H ' ' A' ' 35' ' ' HIS . 2.4 m 54.48 -163.54 0.12 Allowed 'General case' 0 CA--C 1.546 0.814 0 O-C-N 123.265 0.353 . . . . 70.420000000000002 111.06 176.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.847 ' H ' HG22 ' A' ' 34' ' ' THR . 2.3 t-80 -74.47 -161.56 0.13 Allowed 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 109.848 -0.427 . . . . 71.510000000000005 109.848 173.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.4 tp -55.35 -20.14 10.88 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.785 0.661 . . . . 72.019999999999996 112.785 -176.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.559 ' HG3' ' O ' ' A' ' 35' ' ' HIS . 52.5 mtt180 74.0 -71.32 0.13 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.487 0.715 . . . . 63.310000000000002 111.133 175.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.4 m 65.35 -84.88 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.085 -0.961 . . . . 53.520000000000003 110.315 -170.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.583 HG12 ' H ' ' A' ' 40' ' ' GLU . 2.1 t -144.33 172.8 5.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.427 -0.583 . . . . 72.310000000000002 109.427 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.583 ' H ' HG12 ' A' ' 39' ' ' VAL . 19.4 tt0 -77.08 77.54 3.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.145 0.498 . . . . 75.450000000000003 110.582 179.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.0 t -133.67 131.82 56.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.568 -0.901 . . . . 72.349999999999994 108.568 175.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.631 ' HB3' ' HB ' ' A' ' 50' ' ' THR . 3.3 pp -65.25 -37.2 86.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.934 0.397 . . . . 74.329999999999998 111.884 -171.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.628 ' N ' HD12 ' A' ' 42' ' ' LEU . 28.0 t70 -124.85 -161.76 1.04 Allowed 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.754 -0.832 . . . . 74.049999999999997 108.754 176.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.501 ' H ' ' CG ' ' A' ' 43' ' ' ASP . 10.7 m-20 -102.54 9.57 39.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.479 0.657 . . . . 63.509999999999998 109.6 178.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.704 ' HG3' ' HB3' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -103.84 -80.19 0.53 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.136 -0.938 . . . . 75.030000000000001 111.451 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.648 ' HG3' ' HB3' ' A' ' 64' ' ' ALA . 0.1 OUTLIER -145.03 -167.05 2.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.566 -0.288 . . . . 73.230000000000004 111.466 -172.482 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.0 m 64.98 -179.66 0.18 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.55 -0.75 . . . . 63.329999999999998 111.573 -177.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -143.69 -164.29 1.84 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 122.399 -0.188 . . . . 71.129999999999995 110.708 -173.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 77.5 t-105 75.41 -65.4 0.33 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.814 0.846 . . . . 74.450000000000003 113.146 170.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.631 ' HB ' ' HB3' ' A' ' 42' ' ' LEU . 2.4 m -81.64 169.83 16.54 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.637 -0.134 . . . . 63.420000000000002 110.637 -176.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.414 ' H ' HG22 ' A' ' 50' ' ' THR . 7.5 p -151.89 23.26 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 122.248 1.023 . . . . 71.140000000000001 109.555 176.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.504 ' H ' HG22 ' A' ' 50' ' ' THR . 9.0 tm-20 -103.08 3.89 36.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.121 -0.945 . . . . 74.310000000000002 110.388 -173.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 61.07 68.72 1.19 Allowed Pre-proline 0 N--CA 1.465 0.311 0 CA-C-N 115.701 -0.681 . . . . 71.129999999999995 111.773 -175.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.528 ' CD ' ' HB2' ' A' ' 42' ' ' LEU . 87.8 Cg_endo -96.05 -162.4 0.08 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 124.04 3.16 . . . . 64.340000000000003 111.434 174.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.04 142.77 45.3 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.281 -0.418 . . . . 42.100000000000001 110.613 176.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.87 -28.2 86.66 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.95 2.433 . . . . 72.129999999999995 113.009 -174.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.785 ' HB2' ' HG2' ' A' ' 63' ' ' GLU . 1.3 pt? -104.27 -10.19 18.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.256 -0.429 . . . . 72.030000000000001 111.736 -175.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 58.51 -109.43 1.97 Allowed Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.74 -0.743 . . . . 35.130000000000003 112.875 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -93.64 16.04 14.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.716 0.293 . . . . 70.219999999999999 111.59 -176.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.403 HG22 HD11 ' A' ' 57' ' ' LEU . 4.1 t 64.04 33.14 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 121.789 0.804 . . . . 74.530000000000001 110.68 176.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' A' ' 62' ' ' TRP . 30.8 m -141.87 131.67 24.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.792 -0.64 . . . . 64.25 110.035 175.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.449 ' HB2' ' O ' ' A' ' 61' ' ' SER . 2.5 m-90 71.53 6.13 5.62 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 123.636 0.585 . . . . 74.409999999999997 111.631 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.785 ' HG2' ' HB2' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -84.34 165.6 18.11 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.469 -0.787 . . . . 75.25 112.351 -176.828 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.648 ' HB3' ' HG3' ' A' ' 46' ' ' ARG . . . -162.14 160.61 27.42 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.429 -1.26 . . . . 63.520000000000003 108.582 176.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.574 ' HB2' ' HA ' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -108.05 133.97 51.6 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.986 -1.116 . . . . 65.140000000000001 107.986 177.01 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.704 ' HB3' ' HG3' ' A' ' 45' ' ' LYS . 40.1 tp -105.49 117.81 34.96 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.651 -0.82 . . . . 74.329999999999998 110.713 -169.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.8 t -93.32 -13.86 27.63 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.003 -0.544 . . . . 43.130000000000003 111.126 -175.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.464 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -147.25 125.16 11.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.952 0.406 . . . . 73.019999999999996 110.806 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.542 ' HB3' ' CD2' ' A' ' 66' ' ' LEU . 4.1 p-10 -140.19 40.5 1.94 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.498 -0.774 . . . . 72.439999999999998 109.835 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -60.03 144.96 85.9 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.078 -0.964 . . . . 75.549999999999997 109.919 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -47.25 -41.34 27.84 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.826 3.017 . . . . 73.109999999999999 113.451 -173.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -166.57 33.26 0.22 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.352 -0.928 . . . . 60.130000000000003 112.215 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -97.21 -63.46 1.13 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.164 0.507 . . . . 71.420000000000002 110.523 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 74' ' ' ARG . 3.5 ptp85 -161.51 140.84 10.1 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.758 -0.83 . . . . 71.439999999999998 108.758 177.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 68.5 mt -121.99 109.81 25.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 109.412 -0.588 . . . . 64.319999999999993 109.412 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.637 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . . . -111.34 115.32 29.1 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.975 -0.557 . . . . 75.510000000000005 110.499 -177.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 23.5 p-90 -96.1 124.09 39.97 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.921 0.867 . . . . 73.310000000000002 110.086 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.468 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 30.9 mmt180 -113.67 176.15 5.15 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.353 -1.351 . . . . 63.409999999999997 107.353 178.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.866 ' HB2' ' HB ' ' A' ' 85' ' ' ILE . 16.5 m -99.12 163.98 12.35 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 118.839 -1.144 . . . . 73.349999999999994 110.187 174.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.651 ' CD2' ' HB3' ' A' ' 57' ' ' LEU . 4.4 mp -69.55 161.5 73.62 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.885 -0.598 . . . . 64.200000000000003 110.784 -176.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.14 -40.82 75.81 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.769 2.313 . . . . 62.530000000000001 112.252 177.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.0 -20.86 58.56 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.786 -0.721 . . . . 73.5 112.327 178.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.428 ' HA ' ' NH1' ' A' ' 84' ' ' ARG . . . -82.38 167.31 18.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.749 0.309 . . . . 74.319999999999993 110.728 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.428 ' NH1' ' HA ' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -82.16 104.71 12.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.003 0.43 . . . . 62.310000000000002 110.507 -176.639 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.866 ' HB ' ' HB2' ' A' ' 79' ' ' SER . 6.8 tt -117.44 116.81 53.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.867 -0.606 . . . . 51.409999999999997 110.517 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -153.55 -42.15 0.09 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.052 -0.522 . . . . 52.340000000000003 109.961 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -77.18 154.17 33.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.123 -0.489 . . . . 73.230000000000004 110.166 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.4 m -96.13 127.64 42.32 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.363 -0.381 . . . . 63.119999999999997 110.65 -178.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -122.49 61.53 0.55 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.942 -0.647 . . . . 54.340000000000003 111.524 177.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.637 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 39.3 tt0 -102.69 121.97 43.51 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 122.627 -0.337 . . . . 71.230000000000004 110.661 -176.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.675 HG22 HG22 ' A' ' 106' ' ' VAL . 83.0 t -112.79 122.03 66.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.273 0.558 . . . . 74.420000000000002 110.684 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.906 ' HB2' ' HB ' ' A' ' 105' ' ' VAL . 10.1 mp -96.19 142.34 28.48 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.597 -0.729 . . . . 62.109999999999999 110.104 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -121.55 115.9 23.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.152 -0.476 . . . . 74.329999999999998 110.164 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.413 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 34.9 ptt180 -141.08 144.65 35.75 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.318 -0.401 . . . . 75.540000000000006 110.567 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 94' ' ' ARG . 45.0 Cg_exo -56.67 134.72 66.21 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.679 2.253 . . . . 70.549999999999997 111.932 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -94.61 145.04 28.93 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.996 -0.547 . . . . 75.150000000000006 111.706 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -54.12 151.33 28.46 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.088 2.525 . . . . 73.140000000000001 112.361 175.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.49 -0.89 79.42 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.72 -0.753 . . . . 51.32 111.251 -178.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 59.57 33.93 22.24 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 122.8 0.44 . . . . 53.009999999999998 111.031 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -64.09 -42.89 96.76 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.19 0.519 . . . . 71.510000000000005 110.419 176.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 162.24 -122.37 1.1 Allowed Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 115.46 -0.791 . . . . 73.329999999999998 111.421 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 39.3 m -128.72 135.09 48.76 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.564 0.697 . . . . 73.219999999999999 111.003 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -90.88 131.27 36.62 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.867 -1.061 . . . . 72.019999999999996 110.181 -178.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.454 HG22 HG23 ' A' ' 10' ' ' VAL . 17.9 m -87.41 131.58 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 108.164 -1.05 . . . . 62.130000000000003 108.164 173.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.906 ' HB ' ' HB2' ' A' ' 92' ' ' LEU . 44.3 t -123.1 111.49 29.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 116.022 -0.536 . . . . 74.010000000000005 110.391 -174.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.675 HG22 HG22 ' A' ' 91' ' ' VAL . 37.9 t -128.29 121.2 55.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.405 -0.361 . . . . 64.109999999999999 111.12 -177.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.578 ' O ' ' HD2' ' A' ' 107' ' ' ARG . 0.4 OUTLIER -107.05 108.83 20.51 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.278 0.561 . . . . 71.200000000000003 109.816 170.6 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 50.1 tp -114.19 142.82 45.76 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.032 -0.531 . . . . 55.32 110.847 -175.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.8 t -93.95 142.33 27.51 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.006 -0.543 . . . . 74.209999999999994 110.498 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -129.36 112.49 13.89 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.934 -0.575 . . . . 71.140000000000001 110.234 177.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 111' ' ' ARG . 14.3 mtm180 -107.85 158.19 34.1 Favored Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 109.227 -0.657 . . . . 74.140000000000001 109.227 178.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.464 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 37.1 Cg_exo -58.52 151.78 59.68 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.113 1.875 . . . . 65.150000000000006 111.935 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 16.0 Cg_exo -70.03 -54.15 0.22 Allowed 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.915 2.41 . . . . 72.340000000000003 111.972 -178.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -163.83 -79.49 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.906 -0.664 . . . . 62.100000000000001 111.842 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -124.73 -165.77 12.24 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.66 -0.781 . . . . 75.530000000000001 112.472 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.3 t -78.96 -26.97 43.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.51 0.195 . . . . 63.350000000000001 111.36 -175.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.65 -34.6 71.39 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.563 0.22 . . . . 61.310000000000002 111.448 -176.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.69 -31.82 76.89 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.922 -0.656 . . . . 73.230000000000004 112.397 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.96 -38.21 37.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.843 0.354 . . . . 63.329999999999998 110.588 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 93.4 t -61.32 -50.0 82.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.916 -0.584 . . . . 74.209999999999994 110.954 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.6 tp -65.8 -34.13 68.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 70.109999999999999 110.808 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.31 -37.11 84.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.443 -0.344 . . . . 50.420000000000002 111.192 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 70.2 ttp85 -68.33 -48.12 65.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.32 -0.4 . . . . 64.129999999999995 110.935 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 27.2 ptm -71.16 -28.49 64.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.437 -0.347 . . . . 71.049999999999997 111.154 -177.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -72.32 -41.65 66.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.385 -0.37 . . . . 72.310000000000002 110.456 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 49.3 t30 69.59 110.93 0.05 Allowed 'General case' 0 N--CA 1.469 0.488 0 O-C-N 124.129 0.893 . . . . 55.340000000000003 111.117 -177.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -104.14 139.5 39.11 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.748 -0.66 . . . . 73.25 110.678 -177.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -70.89 154.89 94.03 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.292 -0.413 . . . . 72.209999999999994 110.474 175.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.74 64.03 3.11 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.149 2.566 . . . . 72.219999999999999 112.7 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 131' ' ' GLN . 8.3 t -111.33 124.42 52.2 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.422 -0.955 . . . . 53.210000000000001 108.422 175.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 130' ' ' SER . 55.0 mt-30 70.31 153.55 0.12 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.839 0.712 . . . . 72.209999999999994 110.548 -171.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 64.06 -171.51 0.18 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.971 -0.559 . . . . 73.120000000000005 110.778 -177.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.4 mt 61.99 -168.92 0.18 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.115 -0.493 . . . . 52.530000000000001 110.692 -178.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -108.34 -13.84 14.8 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.771 -0.455 . . . . 73.239999999999995 109.771 176.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -60.7 -55.33 34.56 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.615 -0.72 . . . . 54.409999999999997 110.455 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -66.48 -30.84 71.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.16 0.505 . . . . 60.32 110.347 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.666 ' O ' ' HD3' ' A' ' 141' ' ' LYS . 43.5 tp -65.12 -48.24 74.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.616 -0.72 . . . . 72.450000000000003 110.167 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.415 ' CE ' ' HA ' ' A' ' 138' ' ' MET . 3.1 tpt -75.03 -35.12 61.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.494 -0.321 . . . . 74.540000000000006 110.692 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.9 ttm-85 -52.67 -54.8 28.39 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.969 -0.56 . . . . 73.510000000000005 111.124 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.829 ' HZ ' HG21 ' A' ' 22' ' ' VAL . 54.1 t80 -67.8 -46.05 73.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.799 -0.637 . . . . 65.310000000000002 111.625 -177.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.808 ' HG3' HD11 ' A' ' 12' ' ' ILE . 14.0 mptt -64.75 -35.04 79.8 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 111.94 0.348 . . . . 73.129999999999995 111.94 -173.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.432 ' HD3' ' HA ' ' A' ' 142' ' ' ARG . 16.7 mmt180 -66.32 -31.64 72.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.606 0.241 . . . . 64.450000000000003 111.308 177.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -79.67 -35.76 38.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.942 0.401 . . . . 75.150000000000006 110.443 176.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.406 ' HG2' HD13 ' A' ' 12' ' ' ILE . 6.0 tp60 -59.06 -44.06 91.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.851 -0.613 . . . . 72.129999999999995 111.529 178.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.538 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 7.9 pt-20 -72.82 -14.71 61.57 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.556 -0.458 . . . . 72.519999999999996 111.266 -178.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.88 -25.65 59.11 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.333 -0.618 . . . . 63.520000000000003 109.333 177.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.42 ' C ' HD12 ' A' ' 148' ' ' LEU . . . 137.03 -46.92 0.99 Allowed Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.668 -0.696 . . . . 41.109999999999999 112.439 176.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.42 HD12 ' C ' ' A' ' 147' ' ' GLY . 5.9 mp -132.94 152.56 51.9 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.12 -0.326 . . . . 73.230000000000004 110.12 -178.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.93 16.79 2.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.436 -0.347 . . . . 63.009999999999998 110.253 175.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 66.3 m80 68.75 97.92 0.06 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.328 -0.851 . . . . 73.400000000000006 110.454 -177.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -65.74 115.92 6.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.824 -0.625 . . . . 73.239999999999995 111.488 -174.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -125.7 -68.83 0.81 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.27 -1.011 . . . . 64.340000000000003 108.27 173.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -178.89 -37.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.325 -1.307 . . . . 75.209999999999994 108.38 178.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 69.15 123.04 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.099 0 CA-C-N 114.503 -1.226 . . . . 74.109999999999999 111.357 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 26.6 m170 . . . . . 0 C--O 1.245 0.859 0 N-CA-C 108.689 -0.856 . . . . 74.140000000000001 108.689 174.133 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.8 mtt . . . . . 0 N--CA 1.481 1.078 0 CA-C-O 121.17 0.509 . . . . 74.530000000000001 110.853 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 94.38 -0.63 66.06 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.438 -1.065 . . . . 53.399999999999999 110.438 -172.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.698 ' HG2' ' HD2' ' A' ' 112' ' ' PRO . 36.0 mt-10 -118.7 136.23 54.05 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.666 -0.865 . . . . 54.109999999999999 108.666 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.1 m -147.52 122.19 9.86 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.911 0.386 . . . . 71.049999999999997 110.783 -176.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.628 HG22 ' HA ' ' A' ' 109' ' ' THR . 41.0 t -101.88 97.25 5.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.556 -0.905 . . . . 53.439999999999998 108.556 174.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 107' ' ' ARG . 10.6 p -80.11 141.63 15.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.516 -0.766 . . . . 72.299999999999997 111.82 -168.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.598 ' HG2' ' HB2' ' A' ' 107' ' ' ARG . 2.8 tmm_? -134.74 116.61 15.07 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.368 -0.605 . . . . 74.140000000000001 109.368 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' HB3' HD23 ' A' ' 137' ' ' LEU . 4.8 t70 -144.71 173.05 12.17 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.709 -0.848 . . . . 72.349999999999994 108.709 173.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.824 ' HB2' HG12 ' A' ' 105' ' ' VAL . . . -134.47 126.59 29.75 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.133 0.492 . . . . 71.040000000000006 112.012 -171.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.486 ' CG1' ' HG ' ' A' ' 137' ' ' LEU . 36.0 m -121.66 134.23 65.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.793 -0.639 . . . . 64.439999999999998 109.956 176.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 t -110.08 123.38 49.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.688 0.756 . . . . 44.25 111.011 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.634 ' HB ' HD21 ' A' ' 19' ' ' LEU . 4.7 mp -118.71 151.04 20.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.768 -1.105 . . . . 70.230000000000004 109.712 -178.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.85 20.63 1.05 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 114.005 0.362 . . . . 42.049999999999997 114.005 -177.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.82 ' HE3' HD23 ' A' ' 19' ' ' LEU . 49.3 mtmt -89.95 144.07 30.93 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.197 -0.668 . . . . 62.299999999999997 109.197 173.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 95.0 Cg_exo -45.69 -57.96 1.89 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.977 2.451 . . . . 63.219999999999999 113.822 -174.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 15' ' ' PRO . . . 173.21 -58.24 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.578 0.704 . . . . 53.210000000000001 110.911 177.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -55.83 -36.75 67.82 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.456 -1.247 . . . . 63.219999999999999 112.247 -171.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.545 ' CG ' ' HD2' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -87.65 -5.33 58.76 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.132 -0.485 . . . . 60.549999999999997 111.853 -175.06 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.82 HD23 ' HE3' ' A' ' 14' ' ' LYS . 59.9 mt -68.56 -48.13 65.05 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.963 -0.295 . . . . 70.140000000000001 111.081 176.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.831 ' HB3' ' HZ ' ' A' ' 93' ' ' PHE . 1.1 p90 -73.15 -24.55 60.59 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.469 -0.493 . . . . 71.420000000000002 110.372 -177.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.56 -2.99 31.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.575 -0.738 . . . . 70.329999999999998 111.862 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.781 HG11 ' HZ ' ' A' ' 140' ' ' PHE . 14.8 p -54.2 -22.05 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 112.843 0.683 . . . . 54.100000000000001 112.843 -175.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 -68.48 -9.82 51.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.881 0.372 . . . . 75.209999999999994 111.11 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.844 ' HG2' ' H ' ' A' ' 25' ' ' ASP . 47.1 ttt180 -137.04 179.27 6.48 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.61 -0.515 . . . . 70.319999999999993 109.61 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.844 ' H ' ' HG2' ' A' ' 24' ' ' ARG . 0.8 OUTLIER -63.39 12.58 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.072 1.349 . . . . 74.200000000000003 112.873 177.511 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.475 ' H ' ' C ' ' A' ' 24' ' ' ARG . 41.2 mt 65.43 86.09 0.14 Allowed Pre-proline 0 N--CA 1.467 0.38 0 CA-C-O 121.184 0.516 . . . . 60.299999999999997 109.628 -176.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.842 ' HG3' ' HD3' ' A' ' 24' ' ' ARG . 33.2 Cg_exo -58.87 115.5 2.6 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 123.71 2.94 . . . . 74.140000000000001 114.031 -169.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.637 ' C ' ' HD3' ' A' ' 30' ' ' PRO . . . -92.05 71.0 1.73 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.061 -0.815 . . . . 75.510000000000005 111.061 172.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.498 ' N ' ' HD3' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -120.83 60.83 8.81 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 112.252 0.464 . . . . 63.520000000000003 112.252 179.089 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.637 ' HD3' ' C ' ' A' ' 28' ' ' GLY . 9.9 Cg_endo -90.04 -163.79 0.14 Allowed 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.849 2.366 . . . . 71.540000000000006 109.991 173.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.0 mp 65.22 -79.0 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.279 0.362 . . . . 63.539999999999999 110.087 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.736 HD13 HD13 ' A' ' 42' ' ' LEU . 83.6 mt 58.07 80.56 0.17 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.434 0.902 . . . . 73.219999999999999 113.434 175.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 21.6 ttt -113.82 112.06 22.76 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 107.758 -1.201 . . . . 73.239999999999995 107.758 167.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 t -46.13 -48.0 17.36 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.77 0.669 . . . . 64.200000000000003 111.689 -174.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 66.06 2.45 2.28 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.253 0.464 . . . . 62.43 112.253 166.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.2 mp 65.4 11.9 7.71 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.226 0.611 . . . . 72.219999999999999 111.312 -177.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -169.34 161.15 9.85 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.341 -0.391 . . . . 54.350000000000001 110.285 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.7 m 61.8 -154.55 0.35 Allowed 'General case' 0 CA--C 1.531 0.228 0 O-C-N 123.644 0.59 . . . . 61.219999999999999 110.507 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 40' ' ' GLU . 57.5 t 75.32 137.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 121.578 0.704 . . . . 75.329999999999998 111.972 175.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.644 ' HG2' ' H ' ' A' ' 41' ' ' VAL . 17.8 tt0 -97.8 -164.31 1.13 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.23 -0.895 . . . . 54.229999999999997 108.868 177.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.644 ' H ' ' HG2' ' A' ' 40' ' ' GLU . 27.0 t -64.7 148.94 11.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 110.245 -0.28 . . . . 75.439999999999998 110.245 178.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.736 HD13 HD13 ' A' ' 32' ' ' LEU . 4.3 mm? -56.25 -59.26 5.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.495 0.664 . . . . 74.439999999999998 111.682 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.522 ' OD1' ' HB2' ' A' ' 45' ' ' LYS . 2.1 p30 -160.71 177.51 10.39 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.84 -1.073 . . . . 74.420000000000002 110.346 -174.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -77.44 15.18 0.81 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.953 -0.567 . . . . 75.040000000000006 110.797 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.671 ' HG2' HD22 ' A' ' 66' ' ' LEU . 28.6 mttt -85.91 -45.27 11.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.002 -0.545 . . . . 75.310000000000002 111.15 -177.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.05 167.78 21.87 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.268 -0.878 . . . . 61.299999999999997 110.2 -175.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.9 m -92.54 156.19 17.3 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.176 -0.465 . . . . 71.109999999999999 110.969 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 70.41 151.72 0.1 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.985 -0.552 . . . . 75.209999999999994 111.769 176.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.589 ' HA ' HD23 ' A' ' 42' ' ' LEU . 41.3 p90 -88.36 103.93 16.29 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.456 0.646 . . . . 74.239999999999995 109.876 171.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 54' ' ' PRO . 2.8 p -108.15 -72.18 0.73 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.81 -0.632 . . . . 61.140000000000001 112.14 -176.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.5 m 47.77 -178.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.067 1.347 . . . . 71.040000000000006 113.804 -176.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 55.41 59.43 3.92 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.222 -0.899 . . . . 73.120000000000005 110.747 -177.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 49.66 74.72 0.76 Allowed Pre-proline 0 N--CA 1.467 0.38 0 CA-C-N 115.277 -0.874 . . . . 53.509999999999998 112.564 178.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.526 ' HB3' ' HB ' ' A' ' 50' ' ' THR . 86.0 Cg_endo -85.87 -178.29 2.85 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.5 2.133 . . . . 74.349999999999994 112.008 176.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.58 85.52 48.75 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.06 0.457 . . . . 70.150000000000006 110.978 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.562 ' HB3' ' HG2' ' A' ' 63' ' ' GLU . 4.3 Cg_exo -77.74 -45.64 0.14 Allowed 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.816 2.344 . . . . 41.210000000000001 112.245 178.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 58' ' ' GLY . 0.7 OUTLIER -112.48 -28.74 7.75 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.741 -0.663 . . . . 63.310000000000002 112.042 -173.614 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.494 ' N ' HD12 ' A' ' 57' ' ' LEU . . . -73.31 108.62 2.55 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.972 -0.632 . . . . 31.0 112.195 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 70.78 12.84 7.2 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 122.973 0.509 . . . . 64.299999999999997 110.778 177.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.7 t -131.62 -67.15 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.932 -0.576 . . . . 52.149999999999999 110.44 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.679 ' HA ' HD13 ' A' ' 80' ' ' LEU . 49.9 m 62.93 28.92 16.49 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.827 -0.624 . . . . 72.430000000000007 111.663 176.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -106.53 -15.66 14.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.393 0.616 . . . . 73.420000000000002 110.336 -177.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.562 ' HG2' ' HB3' ' A' ' 56' ' ' PRO . 10.4 tp10 -86.16 165.62 16.41 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.434 -0.803 . . . . 63.130000000000003 111.32 -172.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.05 129.73 38.89 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.181 -0.463 . . . . 73.099999999999994 109.881 173.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.22 135.73 51.32 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.736 0.303 . . . . 74.329999999999998 110.571 179.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.671 HD22 ' HG2' ' A' ' 45' ' ' LYS . 10.5 mp -104.63 127.28 52.33 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 120.253 -0.579 . . . . 72.030000000000001 109.597 174.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.3 t -95.46 -13.84 24.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.114 -0.494 . . . . 74.510000000000005 111.801 -172.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.616 ' HB3' ' H ' ' A' ' 76' ' ' ALA . . . -123.32 128.04 49.36 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.944 -0.302 . . . . 75.319999999999993 110.782 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -137.91 84.83 2.06 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.895 -0.593 . . . . 73.540000000000006 110.443 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.532 ' HG3' ' HG2' ' A' ' 74' ' ' ARG . 6.6 mm-40 -107.18 141.68 23.44 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.361 -0.977 . . . . 75.010000000000005 108.361 173.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.46 93.82 0.59 Allowed 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.548 2.166 . . . . 72.120000000000005 112.376 -175.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 56.77 38.92 85.9 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.802 -0.635 . . . . 45.109999999999999 112.799 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -127.87 -46.37 1.41 Allowed 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.884 -0.326 . . . . 63.329999999999998 110.917 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.532 ' HG2' ' HG3' ' A' ' 70' ' ' GLU . 16.4 ptt-85 -159.91 147.64 16.8 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.48 -0.563 . . . . 75.430000000000007 109.48 173.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.643 HD11 ' HE2' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -147.34 120.54 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.411 0.624 . . . . 73.209999999999994 111.594 -179.498 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.689 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . . . -120.21 120.13 35.26 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.918 -1.037 . . . . 51.100000000000001 109.942 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.479 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 49.5 p90 -99.35 144.33 28.59 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.027 -0.533 . . . . 73.049999999999997 110.282 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -136.25 175.85 9.23 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.641 -0.874 . . . . 71.409999999999997 108.641 176.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.0 m -133.02 152.1 52.0 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.603 -0.517 . . . . 42.130000000000003 109.603 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.679 HD13 ' HA ' ' A' ' 61' ' ' SER . 62.9 mt -67.94 156.82 88.62 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.239 -0.437 . . . . 74.349999999999994 110.251 -178.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -56.82 -21.7 41.58 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.862 2.375 . . . . 61.229999999999997 113.337 -177.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.53 10.98 66.96 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.809 -0.71 . . . . 64.540000000000006 112.679 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.472 ' HB1' HG12 ' A' ' 85' ' ' ILE . . . -137.19 142.3 42.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.904 0.383 . . . . 33.520000000000003 111.105 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -118.96 41.81 2.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.584 0.707 . . . . 74.150000000000006 109.719 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.472 HG12 ' HB1' ' A' ' 83' ' ' ALA . 46.2 mm -77.75 118.26 24.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.131 -0.94 . . . . 74.530000000000001 111.525 -175.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 69.91 154.5 0.12 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.975 0.797 . . . . 75.409999999999997 112.34 171.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -72.35 135.91 46.01 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.88 -0.785 . . . . 70.310000000000002 108.88 174.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 26.2 m -94.95 145.02 25.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.291 0.567 . . . . 54.530000000000001 111.233 -174.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -174.62 -166.26 32.3 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.107 -0.952 . . . . 74.239999999999995 111.671 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.689 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 43.0 tt0 -145.44 136.81 25.04 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.292 -0.262 . . . . 73.310000000000002 110.292 -178.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.559 ' CG2' HG13 ' A' ' 75' ' ' ILE . 3.0 m -120.23 134.17 64.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 120.901 0.381 . . . . 64.129999999999995 110.714 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.477 ' HB2' ' CG2' ' A' ' 105' ' ' VAL . 9.7 mp -113.76 137.42 51.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.293 -0.412 . . . . 75.219999999999999 110.231 175.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.831 ' HZ ' ' HB3' ' A' ' 20' ' ' TYR . 76.7 m-85 -105.05 106.9 17.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.986 -0.552 . . . . 70.120000000000005 110.1 177.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -117.15 145.36 35.63 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.137 -0.483 . . . . 73.409999999999997 111.041 -176.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.69 135.98 59.7 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.585 2.19 . . . . 74.430000000000007 111.749 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.466 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . . . -105.03 143.38 26.6 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.627 -0.261 . . . . 61.439999999999998 111.011 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 96' ' ' ALA . 26.7 Cg_exo -64.06 150.24 88.76 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 123.306 2.671 . . . . 75.219999999999999 112.477 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.84 10.74 86.02 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.081 -0.581 . . . . 70.530000000000001 112.117 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 57.4 35.27 25.77 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 122.889 0.475 . . . . 70.049999999999997 111.449 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 100' ' ' ARG . 2.2 mmp_? -58.66 -38.4 78.06 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.092 0.472 . . . . 64.510000000000005 110.736 176.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 149.38 -119.9 1.1 Allowed Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.812 -0.915 . . . . 51.409999999999997 110.812 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 92.4 m -129.0 127.93 42.64 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.989 0.423 . . . . 74.439999999999998 110.386 175.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -84.12 114.48 21.8 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.602 -0.726 . . . . 74.019999999999996 110.235 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.1 p -99.05 115.73 40.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.164 0.507 . . . . 70.319999999999993 110.661 177.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.824 HG12 ' HB2' ' A' ' 9' ' ' ALA . 21.7 m -86.81 110.68 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-O 121.444 0.64 . . . . 74.349999999999994 109.382 174.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 46.5 t -100.61 125.18 54.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.626 -0.715 . . . . 73.340000000000003 110.343 -176.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.598 ' HB2' ' HG2' ' A' ' 7' ' ' ARG . 26.9 ttt180 -137.03 113.08 9.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.235 -0.438 . . . . 74.109999999999999 111.201 174.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.0 mp -116.01 140.93 48.77 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.706 -0.679 . . . . 73.329999999999998 109.885 175.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.628 ' HA ' HG22 ' A' ' 5' ' ' VAL . 86.7 m -84.25 120.09 25.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.163 -0.471 . . . . 73.030000000000001 110.237 178.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -120.77 133.67 55.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.009 -0.541 . . . . 75.329999999999998 109.662 -178.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.2 ptt180 -162.64 145.48 8.55 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 116.004 -0.543 . . . . 75.430000000000007 109.866 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.698 ' HD2' ' HG2' ' A' ' 3' ' ' GLU . 57.1 Cg_endo -72.42 154.42 55.71 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.465 2.11 . . . . 63.329999999999998 112.108 179.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -82.09 -166.15 0.38 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.776 2.317 . . . . 63.310000000000002 112.128 177.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.07 73.9 2.56 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.012 -0.613 . . . . 54.229999999999997 112.023 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -134.96 81.77 0.3 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.097 -0.573 . . . . 61.530000000000001 111.777 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.1 m -59.64 -40.06 86.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.846 0.355 . . . . 65.329999999999998 111.327 -176.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.522 ' O ' HG12 ' A' ' 121' ' ' ILE . . . -72.92 -24.82 60.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.316 -0.402 . . . . 74.209999999999994 111.506 -178.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.14 -28.72 73.82 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.921 -0.657 . . . . 71.150000000000006 112.637 -177.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.41 -43.27 81.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.357 . . . . 63.119999999999997 111.478 -178.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 117' ' ' ALA . 9.1 p -73.47 -20.49 18.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.834 0.35 . . . . 71.239999999999995 111.032 -176.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.522 HG12 ' O ' ' A' ' 117' ' ' ALA . 49.6 mm -63.39 -56.87 14.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.647 -0.251 . . . . 74.209999999999994 110.652 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.48 -31.07 72.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.153 0.502 . . . . 74.549999999999997 110.605 178.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -66.96 -31.04 71.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.415 -0.812 . . . . 73.230000000000004 110.689 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 17.9 tpt -66.36 -40.7 89.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.816 -0.629 . . . . 75.549999999999997 110.921 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -67.47 -60.97 2.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.411 -0.359 . . . . 73.530000000000001 110.635 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.0 t30 68.72 -2.01 1.82 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.927 -0.579 . . . . 70.030000000000001 111.968 175.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -56.49 -55.43 33.8 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.571 -0.529 . . . . 74.349999999999994 109.571 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -130.9 143.27 48.71 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.599 -0.728 . . . . 74.209999999999994 109.156 170.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.42 -4.56 13.73 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.88 2.387 . . . . 74.329999999999998 112.101 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.8 t 63.32 86.62 0.12 Allowed 'General case' 0 C--O 1.232 0.133 0 O-C-N 123.885 0.741 . . . . 65.349999999999994 109.497 -174.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -126.77 110.43 13.1 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.871 -0.604 . . . . 74.150000000000006 111.776 -172.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -97.15 138.5 34.56 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.766 -0.827 . . . . 70.400000000000006 108.766 169.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.1 mp -130.67 -173.04 2.96 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.376 0.608 . . . . 64.099999999999994 111.576 -172.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 134' ' ' ARG . 8.6 mtp180 -62.68 -22.53 66.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.314 -0.857 . . . . 63.030000000000001 110.742 175.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.447 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 17.3 t70 -57.22 -38.8 74.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.92 -0.582 . . . . 74.409999999999997 110.082 177.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -62.48 -43.54 98.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.483 -0.781 . . . . 53.310000000000002 111.049 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.511 HD23 ' HB3' ' A' ' 8' ' ' ASP . 22.2 tp -75.3 -27.02 59.15 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.661 -0.496 . . . . 73.409999999999997 109.661 -178.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.538 ' CE ' ' HA ' ' A' ' 138' ' ' MET . 0.0 OUTLIER -64.41 -47.08 80.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.862 -0.608 . . . . 74.230000000000004 109.829 175.916 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 135' ' ' ASP . 81.6 mtp180 -61.91 -40.82 96.79 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.611 -0.722 . . . . 75.239999999999995 109.683 175.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.781 ' HZ ' HG11 ' A' ' 22' ' ' VAL . 89.8 t80 -56.55 -40.86 75.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.204 -0.907 . . . . 74.109999999999999 111.232 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.571 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 24.2 ttpp -65.23 -52.22 55.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.345 -0.389 . . . . 74.450000000000003 110.06 176.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -53.62 -44.94 69.91 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.458 -0.792 . . . . 75.209999999999994 111.321 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -62.81 -39.4 94.15 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.641 -0.254 . . . . 74.209999999999994 111.571 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.594 ' HB2' HG12 ' A' ' 12' ' ' ILE . 30.6 mt-30 -70.19 -47.27 62.25 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.958 -0.297 . . . . 74.409999999999997 111.504 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.571 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 11.0 pt-20 -76.45 -13.81 60.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.033 0.444 . . . . 61.439999999999998 111.231 -176.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -83.25 -43.51 15.99 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.791 -0.818 . . . . 43.149999999999999 108.791 172.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -69.94 -42.43 69.13 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.604 -0.726 . . . . 71.239999999999995 112.898 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.819 HD22 ' HG2' ' A' ' 14' ' ' LYS . 4.8 tt -147.92 109.08 4.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.593 0.711 . . . . 71.150000000000006 110.46 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -120.86 10.59 10.92 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.77 -1.104 . . . . 73.25 109.275 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.604 ' H ' HD23 ' A' ' 148' ' ' LEU . 71.9 t60 70.73 -82.5 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 114.59 -1.186 . . . . 61.130000000000003 109.194 -172.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -145.4 164.24 32.12 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.898 -0.778 . . . . 73.129999999999995 108.898 172.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -64.02 123.84 20.04 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.443 0.64 . . . . 73.109999999999999 111.197 -173.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -88.33 -53.99 4.41 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.146 -0.934 . . . . 74.319999999999993 108.763 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 172.34 -19.68 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.377 -1.283 . . . . 73.310000000000002 108.446 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 . . . . . 0 C--O 1.246 0.875 0 CA-C-N 114.587 -1.188 . . . . 73.530000000000001 108.541 173.065 . . . . . . . . 0 0 . 1 stop_ save_